ASSAY_ID ASSAY PROJECT PLATE WELL WELL_TYPE RAW_VALUE_A BSUB_VALUE_A Z_SCORE_A COMPOSITE_Z REPRODUCIBILITY CHEMBANK_ID VIRTUAL_ID SMILES 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A01 compound treatment 0.0755 0.00256 0.3 0.3036 1.0 PhilEx1_000001 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A02 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000002 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A03 compound treatment 0.074 0.00106 0.13 0.1259 1.0 PhilEx1_000003 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A04 compound treatment 0.0735 5.62E-4 0.07 0.0667 1.0 PhilEx1_000004 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A05 compound treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx1_000005 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A06 compound treatment 0.07 -0.00294 -0.35 -0.3481 -1.0 PhilEx1_000006 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A07 compound treatment 0.082 0.00906 1.07 1.0738 1.0 PhilEx1_000007 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A08 compound treatment 0.073 6.25E-5 0.01 0.0074 1.0 PhilEx1_000008 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A09 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000009 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A10 compound treatment 0.073 6.25E-5 0.01 0.0074 1.0 PhilEx1_000010 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A11 compound treatment 0.0765 0.00356 0.42 0.4221 1.0 PhilEx1_000011 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A12 compound treatment 0.08 0.00706 0.84 0.8368 1.0 PhilEx1_000012 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A13 compound treatment 0.0765 0.00356 0.42 0.4221 1.0 PhilEx1_000013 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A14 compound treatment 0.0735 5.62E-4 0.07 0.0667 1.0 PhilEx1_000014 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A15 mock treatment 0.077 0.00406 0.48 0.4814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A16 mock treatment 0.079 0.00606 0.72 0.7183 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A17 mock treatment 0.0785 0.00556 0.66 0.6591 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A18 mock treatment 0.077 0.00406 0.48 0.4814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A19 mock treatment 0.083 0.0101 1.19 1.1923 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A20 mock treatment 0.0825 0.00956 1.13 1.1331 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A21 mock treatment 0.082 0.00906 1.07 1.0738 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A22 mock treatment 0.085 0.0121 1.43 1.4293 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A23 mock treatment 0.088 0.0151 1.78 1.7848 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 A24 mock treatment 0.0815 0.00856 1.01 1.0146 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B01 compound treatment 0.067 -0.00594 -0.7 -0.7035 -1.0 PhilEx1_000015 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B02 compound treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 PhilEx1_000016 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B03 compound treatment 0.078 0.00506 0.6 0.5999 1.0 PhilEx1_000017 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B04 compound treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 PhilEx1_000018 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B05 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000019 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B06 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000020 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B07 compound treatment 0.075 0.00206 0.24 0.2444 1.0 PhilEx1_000021 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B08 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000022 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B09 compound treatment 0.0745 0.00156 0.19 0.1851 1.0 PhilEx1_000023 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B10 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000024 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B11 compound treatment 0.077 0.00406 0.48 0.4814 1.0 PhilEx1_000025 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B12 compound treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx1_000026 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B13 compound treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 PhilEx1_000027 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B14 compound treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 PhilEx1_000028 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B15 mock treatment 0.091 0.0181 2.14 2.1402 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B16 mock treatment 0.0755 0.00256 0.3 0.3036 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B17 mock treatment 0.092 0.0191 2.26 2.2587 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B18 mock treatment 0.075 0.00206 0.24 0.2444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B19 mock treatment 0.1055 0.0326 3.86 3.8583 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B20 mock treatment 0.081 0.00806 0.96 0.9553 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B21 mock treatment 0.081 0.00806 0.96 0.9553 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B22 mock treatment 0.0815 0.00856 1.01 1.0146 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B23 mock treatment 0.0795 0.00656 0.78 0.7776 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 B24 mock treatment 0.079 0.00606 0.72 0.7183 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C01 compound treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx1_000029 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C02 compound treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx1_000030 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C03 compound treatment 0.0765 0.00356 0.42 0.4221 1.0 PhilEx1_000031 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C04 compound treatment 0.0745 0.00156 0.19 0.1851 1.0 PhilEx1_000032 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C05 compound treatment 0.073 6.25E-5 0.01 0.0074 1.0 PhilEx1_000033 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C06 compound treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx1_000034 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C07 compound treatment 0.081 0.00806 0.96 0.9553 1.0 PhilEx1_000035 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C08 compound treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx1_000036 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C09 compound treatment 0.077 0.00406 0.48 0.4814 1.0 PhilEx1_000037 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C10 compound treatment 0.073 6.25E-5 0.01 0.0074 1.0 PhilEx1_000038 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C11 compound treatment 0.082 0.00906 1.07 1.0738 1.0 PhilEx1_000039 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C12 compound treatment 0.0745 0.00156 0.19 0.1851 1.0 PhilEx1_000040 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C13 compound treatment 0.0735 5.62E-4 0.07 0.0667 1.0 PhilEx1_000041 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C14 compound treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx1_000042 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C15 mock treatment 0.076 0.00306 0.36 0.3629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C16 mock treatment 0.0745 0.00156 0.19 0.1851 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C17 mock treatment 0.0775 0.00456 0.54 0.5406 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C18 mock treatment 0.074 0.00106 0.13 0.1259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C19 mock treatment 0.084 0.0111 1.31 1.3108 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C20 mock treatment 0.076 0.00306 0.36 0.3629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C21 mock treatment 0.076 0.00306 0.36 0.3629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C22 mock treatment 0.077 0.00406 0.48 0.4814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C23 mock treatment 0.0745 0.00156 0.19 0.1851 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 C24 mock treatment 0.0755 0.00256 0.3 0.3036 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D01 compound treatment 0.0805 0.00756 0.9 0.8961 1.0 PhilEx1_000043 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D02 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000044 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D03 compound treatment 0.0895 0.0166 1.96 1.9625 1.0 PhilEx1_000045 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D04 compound treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 PhilEx1_000046 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D05 compound treatment 0.1025 0.0296 3.5 3.5029 1.0 PhilEx1_000047 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D06 compound treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx1_000048 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D07 compound treatment 0.091 0.0181 2.14 2.1402 1.0 PhilEx1_000049 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D08 compound treatment 0.078 0.00506 0.6 0.5999 1.0 PhilEx1_000050 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D09 compound treatment 0.099 0.0261 3.09 3.0881 1.0 PhilEx1_000051 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D10 compound treatment 0.0775 0.00456 0.54 0.5406 1.0 PhilEx1_000052 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D11 compound treatment 0.081 0.00806 0.96 0.9553 1.0 PhilEx1_000053 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D12 compound treatment 0.08 0.00706 0.84 0.8368 1.0 PhilEx1_000054 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D13 compound treatment 0.08 0.00706 0.84 0.8368 1.0 PhilEx1_000055 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D14 compound treatment 0.077 0.00406 0.48 0.4814 1.0 PhilEx1_000056 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D15 mock treatment 0.083 0.0101 1.19 1.1923 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D16 mock treatment 0.0785 0.00556 0.66 0.6591 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D17 mock treatment 0.0815 0.00856 1.01 1.0146 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D18 mock treatment 0.0765 0.00356 0.42 0.4221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D19 mock treatment 0.079 0.00606 0.72 0.7183 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D20 mock treatment 0.077 0.00406 0.48 0.4814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D21 mock treatment 0.0795 0.00656 0.78 0.7776 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D22 mock treatment 0.075 0.00206 0.24 0.2444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D23 mock treatment 0.0745 0.00156 0.19 0.1851 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 D24 mock treatment 0.0745 0.00156 0.19 0.1851 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E01 compound treatment 0.075 0.00206 0.24 0.2444 1.0 PhilEx1_000057 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E02 compound treatment 0.0735 5.62E-4 0.07 0.0667 1.0 PhilEx1_000058 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E03 compound treatment 0.0765 0.00356 0.42 0.4221 1.0 PhilEx1_000059 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E04 compound treatment 0.075 0.00206 0.24 0.2444 1.0 PhilEx1_000060 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E05 compound treatment 0.078 0.00506 0.6 0.5999 1.0 PhilEx1_000061 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E06 compound treatment 0.075 0.00206 0.24 0.2444 1.0 PhilEx1_000062 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E07 compound treatment 0.095 0.0221 2.61 2.6142 1.0 PhilEx1_000063 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E08 compound treatment 0.0775 0.00456 0.54 0.5406 1.0 PhilEx1_000064 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E09 compound treatment 0.079 0.00606 0.72 0.7183 1.0 PhilEx1_000065 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E10 compound treatment 0.0795 0.00656 0.78 0.7776 1.0 PhilEx1_000066 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E11 compound treatment 0.097 0.0241 2.85 2.8512 1.0 PhilEx1_000067 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E12 compound treatment 0.078 0.00506 0.6 0.5999 1.0 PhilEx1_000068 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E13 mock treatment 0.078 0.00506 0.6 0.5999 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E14 mock treatment 0.0795 0.00656 0.78 0.7776 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E15 mock treatment 0.081 0.00806 0.96 0.9553 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E16 mock treatment 0.08 0.00706 0.84 0.8368 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E17 mock treatment 0.086 0.0131 1.55 1.5478 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E18 mock treatment 0.0795 0.00656 0.78 0.7776 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E19 mock treatment 0.0835 0.0106 1.25 1.2516 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E20 mock treatment 0.0745 0.00156 0.19 0.1851 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E21 mock treatment 0.075 0.00206 0.24 0.2444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E22 mock treatment 0.074 0.00106 0.13 0.1259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E23 mock treatment 0.0735 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 E24 mock treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F01 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000069 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F02 compound treatment 0.07 -0.00294 -0.35 -0.3481 -1.0 PhilEx1_000070 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F03 compound treatment 0.073 6.25E-5 0.01 0.0074 1.0 PhilEx1_000071 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F04 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000072 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F05 compound treatment 0.0735 5.62E-4 0.07 0.0667 1.0 PhilEx1_000073 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F06 compound treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 PhilEx1_000074 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F07 compound treatment 0.103 0.0301 3.56 3.5621 1.0 PhilEx1_000075 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F08 compound treatment 0.073 6.25E-5 0.01 0.0074 1.0 PhilEx1_000076 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F09 compound treatment 0.081 0.00806 0.96 0.9553 1.0 PhilEx1_000077 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F10 compound treatment 0.075 0.00206 0.24 0.2444 1.0 PhilEx1_000078 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F11 compound treatment 0.084 0.0111 1.31 1.3108 1.0 PhilEx1_000079 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F12 compound treatment 0.076 0.00306 0.36 0.3629 1.0 PhilEx1_000080 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F13 mock treatment 0.077 0.00406 0.48 0.4814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F14 mock treatment 0.0735 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F15 mock treatment 0.0765 0.00356 0.42 0.4221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F16 mock treatment 0.0745 0.00156 0.19 0.1851 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F17 mock treatment 0.0765 0.00356 0.42 0.4221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F18 mock treatment 0.074 0.00106 0.13 0.1259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F19 mock treatment 0.0735 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F20 mock treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F21 mock treatment 0.0805 0.00756 0.9 0.8961 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F22 mock treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F23 mock treatment 0.07 -0.00294 -0.35 -0.3481 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 F24 mock treatment 0.07 -0.00294 -0.35 -0.3481 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G01 compound treatment 0.0665 -0.00644 -0.76 -0.7628 -1.0 PhilEx1_000081 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G02 compound treatment 0.0645 -0.00844 -1.0 -0.9998 -1.0 PhilEx1_000082 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G03 compound treatment 0.0795 0.00656 0.78 0.7776 1.0 PhilEx1_000083 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G04 compound treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 PhilEx1_000084 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G05 compound treatment 0.067 -0.00594 -0.7 -0.7035 -1.0 PhilEx1_000085 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G06 compound treatment 0.067 -0.00594 -0.7 -0.7035 -1.0 PhilEx1_000086 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G07 compound treatment 0.078 0.00506 0.6 0.5999 1.0 PhilEx1_000087 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G08 compound treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx1_000088 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G09 compound treatment 0.073 6.25E-5 0.01 0.0074 1.0 PhilEx1_000089 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G10 compound treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 PhilEx1_000090 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G11 compound treatment 0.074 0.00106 0.13 0.1259 1.0 PhilEx1_000091 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G12 compound treatment 0.0745 0.00156 0.19 0.1851 1.0 PhilEx1_000092 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G13 mock treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G14 mock treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G15 mock treatment 0.07 -0.00294 -0.35 -0.3481 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G16 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G17 mock treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G18 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G19 mock treatment 0.0735 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G20 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G21 mock treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G22 mock treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G23 mock treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 G24 mock treatment 0.067 -0.00594 -0.7 -0.7035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H01 compound treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 PhilEx1_000093 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H02 compound treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 PhilEx1_000094 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H03 compound treatment 0.073 6.25E-5 0.01 0.0074 1.0 PhilEx1_000095 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H04 compound treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 PhilEx1_000096 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H05 compound treatment 0.0745 0.00156 0.19 0.1851 1.0 PhilEx1_000097 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H06 compound treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 PhilEx1_000098 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H07 compound treatment 0.084 0.0111 1.31 1.3108 1.0 PhilEx1_000099 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H08 compound treatment 0.0765 0.00356 0.42 0.4221 1.0 PhilEx1_000100 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H09 compound treatment 0.101 0.0281 3.33 3.3251 1.0 PhilEx1_000101 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H10 compound treatment 0.0775 0.00456 0.54 0.5406 1.0 PhilEx1_000102 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H11 compound treatment 0.1195 0.0466 5.52 5.5172 1.0 PhilEx1_000103 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H12 compound treatment 0.082 0.00906 1.07 1.0738 1.0 PhilEx1_000104 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H13 mock treatment 0.0735 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H14 mock treatment 0.073 6.25E-5 0.01 0.0074 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H15 mock treatment 0.076 0.00306 0.36 0.3629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H16 mock treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H17 mock treatment 0.0735 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H18 mock treatment 0.073 6.25E-5 0.01 0.0074 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H19 mock treatment 0.0785 0.00556 0.66 0.6591 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H20 mock treatment 0.0765 0.00356 0.42 0.4221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H21 mock treatment 0.078 0.00506 0.6 0.5999 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H22 mock treatment 0.076 0.00306 0.36 0.3629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H23 mock treatment 0.0735 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 H24 mock treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I01 compound treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 PhilEx1_000105 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I02 compound treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 PhilEx1_000106 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I03 compound treatment 0.0735 5.62E-4 0.07 0.0667 1.0 PhilEx1_000107 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I04 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000108 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I05 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000109 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I06 compound treatment 0.068 -0.00494 -0.59 -0.585 -1.0 PhilEx1_000110 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I07 compound treatment 0.0755 0.00256 0.3 0.3036 1.0 PhilEx1_000111 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I08 compound treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 PhilEx1_000112 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I09 compound treatment 0.0745 0.00156 0.19 0.1851 1.0 PhilEx1_000113 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I10 compound treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx1_000114 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I11 compound treatment 0.0745 0.00156 0.19 0.1851 1.0 PhilEx1_000115 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I12 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000116 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I13 mock treatment 0.063 -0.00994 -1.18 -1.1775 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I14 mock treatment 0.101 0.0281 3.33 3.3251 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I15 mock treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I16 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I17 mock treatment 0.07 -0.00294 -0.35 -0.3481 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I18 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I19 mock treatment 0.0895 0.0166 1.96 1.9625 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I20 mock treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I21 mock treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I22 mock treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I23 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 I24 mock treatment 0.0655 -0.00744 -0.88 -0.8813 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J01 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000117 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J02 compound treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 PhilEx1_000118 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J03 compound treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx1_000119 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J04 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000120 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J05 compound treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 PhilEx1_000121 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J06 compound treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 PhilEx1_000122 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J07 compound treatment 0.084 0.0111 1.31 1.3108 1.0 PhilEx1_000123 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J08 compound treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx1_000124 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J09 compound treatment 0.0805 0.00756 0.9 0.8961 1.0 PhilEx1_000125 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J10 compound treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx1_000126 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J11 compound treatment 0.0835 0.0106 1.25 1.2516 1.0 PhilEx1_000127 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J12 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000128 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J13 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J14 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J15 mock treatment 0.076 0.00306 0.36 0.3629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J16 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J17 mock treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J18 mock treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J19 mock treatment 0.0755 0.00256 0.3 0.3036 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J20 mock treatment 0.073 6.25E-5 0.01 0.0074 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J21 mock treatment 0.075 0.00206 0.24 0.2444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J22 mock treatment 0.073 6.25E-5 0.01 0.0074 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J23 mock treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 J24 mock treatment 0.066 -0.00694 -0.82 -0.822 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K01 compound treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 PhilEx1_000129 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K02 compound treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 PhilEx1_000130 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K03 compound treatment 0.076 0.00306 0.36 0.3629 1.0 PhilEx1_000131 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K04 compound treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 PhilEx1_000132 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K05 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000133 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K06 compound treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 PhilEx1_000134 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K07 compound treatment 0.074 0.00106 0.13 0.1259 1.0 PhilEx1_000135 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K08 compound treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 PhilEx1_000136 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K09 compound treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx1_000137 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K10 compound treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 PhilEx1_000138 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K11 compound treatment 0.0735 5.62E-4 0.07 0.0667 1.0 PhilEx1_000139 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K12 compound treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 PhilEx1_000140 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K13 mock treatment 0.068 -0.00494 -0.59 -0.585 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K14 mock treatment 0.066 -0.00694 -0.82 -0.822 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K15 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K16 mock treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K17 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K18 mock treatment 0.067 -0.00594 -0.7 -0.7035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K19 mock treatment 0.0735 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K20 mock treatment 0.07 -0.00294 -0.35 -0.3481 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K21 mock treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K22 mock treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K23 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 K24 mock treatment 0.066 -0.00694 -0.82 -0.822 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L01 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000141 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L02 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000142 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L03 compound treatment 0.101 0.0281 3.33 3.3251 1.0 PhilEx1_000143 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L04 compound treatment 0.068 -0.00494 -0.59 -0.585 -1.0 PhilEx1_000144 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L05 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000145 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L06 compound treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 PhilEx1_000146 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L07 compound treatment 0.0755 0.00256 0.3 0.3036 1.0 PhilEx1_000147 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L08 compound treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx1_000148 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L09 compound treatment 0.0745 0.00156 0.19 0.1851 1.0 PhilEx1_000149 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L10 compound treatment 0.073 6.25E-5 0.01 0.0074 1.0 PhilEx1_000150 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L11 compound treatment 0.0775 0.00456 0.54 0.5406 1.0 PhilEx1_000151 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L12 compound treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx1_000152 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L13 mock treatment 0.073 6.25E-5 0.01 0.0074 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L14 mock treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L15 mock treatment 0.095 0.0221 2.61 2.6142 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L16 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L17 mock treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L18 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L19 mock treatment 0.0735 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L20 mock treatment 0.0735 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L21 mock treatment 0.0935 0.0206 2.44 2.4365 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L22 mock treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L23 mock treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 L24 mock treatment 0.066 -0.00694 -0.82 -0.822 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M01 compound treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 PhilEx1_000153 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M02 compound treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 PhilEx1_000154 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M03 compound treatment 0.067 -0.00594 -0.7 -0.7035 -1.0 PhilEx1_000155 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M04 compound treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 PhilEx1_000156 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M05 compound treatment 0.068 -0.00494 -0.59 -0.585 -1.0 PhilEx1_000157 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M06 compound treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 PhilEx1_000158 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M07 compound treatment 0.0745 0.00156 0.19 0.1851 1.0 PhilEx1_000159 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M08 compound treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 PhilEx1_000160 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M09 compound treatment 0.0735 5.62E-4 0.07 0.0667 1.0 PhilEx1_000161 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M10 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000162 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M11 compound treatment 0.0845 0.0116 1.37 1.37 1.0 PhilEx1_000163 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M12 compound treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx1_000164 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M13 mock treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M14 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M15 mock treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M16 mock treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M17 mock treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M18 mock treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M19 mock treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M20 mock treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M21 mock treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M22 mock treatment 0.07 -0.00294 -0.35 -0.3481 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M23 mock treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 M24 mock treatment 0.067 -0.00594 -0.7 -0.7035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N01 compound treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 PhilEx1_000165 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N02 compound treatment 0.07 -0.00294 -0.35 -0.3481 -1.0 PhilEx1_000166 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N03 compound treatment 0.0745 0.00156 0.19 0.1851 1.0 PhilEx1_000167 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N04 compound treatment 0.07 -0.00294 -0.35 -0.3481 -1.0 PhilEx1_000168 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N05 compound treatment 0.075 0.00206 0.24 0.2444 1.0 PhilEx1_000169 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N06 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000170 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N07 compound treatment 0.0855 0.0126 1.49 1.4885 1.0 PhilEx1_000171 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N08 compound treatment 0.074 0.00106 0.13 0.1259 1.0 PhilEx1_000172 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N09 compound treatment 0.0765 0.00356 0.42 0.4221 1.0 PhilEx1_000173 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N10 compound treatment 0.077 0.00406 0.48 0.4814 1.0 PhilEx1_000174 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N11 compound treatment 0.0775 0.00456 0.54 0.5406 1.0 PhilEx1_000175 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N12 compound treatment 0.0765 0.00356 0.42 0.4221 1.0 PhilEx1_000176 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N13 mock treatment 0.074 0.00106 0.13 0.1259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N14 mock treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N15 mock treatment 0.073 6.25E-5 0.01 0.0074 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N16 mock treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N17 mock treatment 0.0755 0.00256 0.3 0.3036 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N18 mock treatment 0.073 6.25E-5 0.01 0.0074 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N19 mock treatment 0.08 0.00706 0.84 0.8368 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N20 mock treatment 0.074 0.00106 0.13 0.1259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N21 mock treatment 0.0755 0.00256 0.3 0.3036 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N22 mock treatment 0.073 6.25E-5 0.01 0.0074 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N23 mock treatment 0.073 6.25E-5 0.01 0.0074 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 N24 mock treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O01 compound treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 PhilEx1_000177 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O02 compound treatment 0.0665 -0.00644 -0.76 -0.7628 -1.0 PhilEx1_000178 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O03 compound treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 PhilEx1_000179 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O04 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000180 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O05 compound treatment 0.072 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx1_000181 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O06 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000182 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O07 compound treatment 0.0775 0.00456 0.54 0.5406 1.0 PhilEx1_000183 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O08 compound treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 PhilEx1_000184 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O09 compound treatment 0.076 0.00306 0.36 0.3629 1.0 PhilEx1_000185 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O10 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000186 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O11 compound treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 PhilEx1_000187 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O12 compound treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 PhilEx1_000188 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O13 mock treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O14 mock treatment 0.067 -0.00594 -0.7 -0.7035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O15 mock treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O16 mock treatment 0.068 -0.00494 -0.59 -0.585 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O17 mock treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O18 mock treatment 0.0655 -0.00744 -0.88 -0.8813 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O19 mock treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O20 mock treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O21 mock treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O22 mock treatment 0.0695 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O23 mock treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 O24 mock treatment 0.0715 -0.00144 -0.17 -0.1703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P01 compound treatment 0.0635 -0.00944 -1.12 -1.1183 -1.0 PhilEx1_000189 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P02 compound treatment 0.063 -0.00994 -1.18 -1.1775 -1.0 PhilEx1_000190 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P03 compound treatment 0.0665 -0.00644 -0.76 -0.7628 -1.0 PhilEx1_000191 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P04 compound treatment 0.061 -0.0119 -1.41 -1.4145 -1.0 PhilEx1_000192 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P05 compound treatment 0.066 -0.00694 -0.82 -0.822 -1.0 PhilEx1_000193 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P06 compound treatment 0.064 -0.00894 -1.06 -1.059 -1.0 PhilEx1_000194 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P07 compound treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx1_000195 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P08 compound treatment 0.066 -0.00694 -0.82 -0.822 -1.0 PhilEx1_000196 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P09 compound treatment 0.069 -0.00394 -0.47 -0.4666 -1.0 PhilEx1_000197 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P10 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000198 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P11 compound treatment 0.077 0.00406 0.48 0.4814 1.0 PhilEx1_000199 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P12 compound treatment 0.0705 -0.00244 -0.29 -0.2888 -1.0 PhilEx1_000200 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P13 mock treatment 0.0675 -0.00544 -0.64 -0.6443 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P14 mock treatment 0.067 -0.00594 -0.7 -0.7035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P15 mock treatment 0.082 0.00906 1.07 1.0738 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P16 mock treatment 0.068 -0.00494 -0.59 -0.585 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P17 mock treatment 0.065 -0.00794 -0.94 -0.9405 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P18 mock treatment 0.0645 -0.00844 -1.0 -0.9998 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P19 mock treatment 0.0725 -4.38E-4 -0.05 -0.0518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P20 mock treatment 0.0685 -0.00444 -0.53 -0.5258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P21 mock treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P22 mock treatment 0.071 -0.00194 -0.23 -0.2296 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P23 mock treatment 0.066 -0.00694 -0.82 -0.822 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1080 P24 mock treatment 0.0635 -0.00944 -1.12 -1.1183 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A01 mock treatment 0.08 0.0103 1.22 1.2247 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A02 mock treatment 0.073 0.00334 0.4 0.3953 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A03 compound treatment 0.076 0.00634 0.75 0.7508 1.0 2060025 SpecPlus_000001 CC(=O)O[C@H]1C[C@@]2(C)[C@@H](OC(=O)[C@H]3O[C@]32[C@]4(C)[C@@H](CC5C(C)(C)[C@@H](C[C@H](OC(=O)C)[C@]5(C)C14)OC(=O)C)OC(=O)C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A04 compound treatment 0.075 0.00534 0.63 0.6323 1.0 2060026 SpecPlus_000002 COC(=O)C[C@H]1C(C)(C)[C@@H](OC(=O)C)[C@@H]2CC3C(CC[C@@]4(C)[C@@H](OC(=O)CC34)c5ccoc5)[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A05 compound treatment 0.078 0.00834 0.99 0.9877 1.0 3054122 SpecPlus_000003 CC(=O)O[C@@H]1C[C@@]2(C)[C@@H](C[C@H]3O[C@]32[C@@]4(C)C1[C@@]5(C)C=CC(=O)C(C)(C)C5=C(O)C4=O)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A06 compound treatment 0.072 0.00234 0.28 0.2768 1.0 2060027 SpecPlus_000004 CC(=O)O[C@@H]1CC2C(C)(C)[C@@H](O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]54[C@]13C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A07 compound treatment 0.081 0.0113 1.34 1.3432 1.0 2060028 SpecPlus_000005 COC(=O)C[C@H]1C2(C)CC3(OC4(C)O[C@@]56[C@H](OC(=O)C)[C@@]3(O)C2OC(=O)C(C)C)[C@]1(C)[C@@]6(O4)[C@H](OC(=O)C)C(OC(=O)C)[C@@]7(C)[C@@H](OC(=O)/C(=C(\O)/C(C)C)/C57)c8ccoc8 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A08 compound treatment 0.083 0.0133 1.58 1.5802 1.0 2060029 SpecPlus_000006 CC(=O)O[C@H]1CC[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A09 compound treatment 0.074 0.00434 0.51 0.5138 1.0 2060030 SpecPlus_000007 COC(=O)C[C@H]1C(C)(C)C(=O)[C@@H]2CC3C(CC[C@@]4(C)[C@@H](OC(=O)C=C34)c5ccoc5)[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A10 compound treatment 0.076 0.00634 0.75 0.7508 1.0 3173352 SpecPlus_000008 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A11 compound treatment 0.0795 0.00984 1.17 1.1655 1.0 2060031 SpecPlus_000009 C[C@]12CCC3[C@@]4(C)C=CC(=O)C(C)(C)C4=C(O)C(=O)[C@@]3(C)[C@]25O[C@@H]5C[C@H]1c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A12 compound treatment 0.0805 0.0108 1.28 1.284 1.0 2060032 SpecPlus_000010 C[C@]12CCC3[C@@](C)([C@H](O)CC4[C@]3(C)[C@@H](O)CC(=O)OC4(C)C)C25OC5C(=O)OC1c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A13 compound treatment 0.083 0.0133 1.58 1.5802 1.0 2060033 SpecPlus_000011 CO[C@@H]1C(OC(=O)C(C)C)[C@@]2(C)[C@@H](OC(=O)/C(=C(\O)/C(C)C)/C2[C@@]34OC5(C)O[C@]14[C@]6(C)[C@@H](CC(=O)OC)C7(C)CC6(O5)[C@](OC)(C7OC(=O)C)[C@H]3OC)c8ccoc8 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A14 compound treatment 0.0765 0.00684 0.81 0.81 1.0 2060034 SpecPlus_000012 CC(C)c1c(O)ccc2c1CCC3[C@](C)(CCC[C@@]32C)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A15 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 2060035 SpecPlus_000013 CC1(C)C2C[C@@H](O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)[C@@]2(C)C=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A16 compound treatment 0.0805 0.0108 1.28 1.284 1.0 2060036 SpecPlus_000014 CC1=CCc2c(O)c3c(=O)cc(C)oc3cc2OC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A17 compound treatment 0.0775 0.00784 0.93 0.9285 1.0 2060037 SpecPlus_000015 CC(=O)O[C@@H]1CC[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A18 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 3054128 SpecPlus_000016 COC1C[C@H]2N3CC(O)C2(C=C1)c4cc5OCOc5cc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A19 compound treatment 0.082 0.0123 1.46 1.4617 1.0 2060038 SpecPlus_000017 COC(=O)C[C@H]1C(C)(C)C(=O)C=C[C@]1(C)C2CC[C@@]3(C)[C@@H](OC(=O)C=C3C2=C)c4ccoc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A20 compound treatment 0.0775 0.00784 0.93 0.9285 1.0 2060039 SpecPlus_000018 CC(=CCc1c(O)cc2oc(C)cc(=O)c2c1O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A21 compound treatment 0.0765 0.00684 0.81 0.81 1.0 3173357 SpecPlus_000019 CC(=C)[C@@H]1CC[C@@]2(CCC3[C@H](CCC4[C@@]3(C)CCC5C(C)(C)[C@H](O)CC[C@@]54C)C12)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A22 compound treatment 0.0815 0.0118 1.4 1.4025 1.0 3054129 SpecPlus_000020 CO[C@@H]1CC2N3CC(O)C2(C=C1)c4cc5OCOc5c(OC)c4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A23 mock treatment 0.088 0.0183 2.17 2.1726 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 A24 mock treatment 0.0835 0.0138 1.64 1.6394 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B01 mock treatment 0.0645 -0.00516 -0.61 -0.6119 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B02 mock treatment 0.0705 8.36E-4 0.1 0.0991 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B03 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060040 SpecPlus_000021 CCOC(=O)C1(O)Oc2cc(OC)cc(OC)c2C(=O)C1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B04 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 3054130 SpecPlus_000022 CC(CCC=C(C)C)[C@@H]1CC[C@]2(C)C3=C(CC[C@@]12C)C4(C)CC[C@H](OC(=O)C)C(C)(C)C4CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B05 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060041 SpecPlus_000023 COc1cc2CCN(C)C(Cc3ccc(O)cc3)c2cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B06 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060042 SpecPlus_000024 CCC(C)c1cnc(CC(C)C)c(=O)n1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B07 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060043 SpecPlus_000025 COc1cc(OC)c(Cl)c2OC3(C(C)CC(=O)C=C3O)C(=O)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B08 compound treatment 0.071 0.00134 0.16 0.1583 1.0 2060044 SpecPlus_000026 CC(=O)Oc1cc(cc(OC(=O)C)c1OC(=O)C)c2coc3cc(OC(=O)C)c(OC(=O)C)c(OC(=O)C)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B09 compound treatment 0.066 -0.00366 -0.43 -0.4341 -1.0 2060045 SpecPlus_000027 CC(=C)/C=C\1/C=CC(=O)C(=C1)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B10 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060046 SpecPlus_000028 C[C@H]1[C@@H]2CC[C@@]3(C)C=CC(=O)[C@@]4(C)O[C@]43[C@H]2OC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B11 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060047 SpecPlus_000029 OC(C(=O)O)C(O)(Cc1ccc(O)cc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B12 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 2060048 SpecPlus_000030 CC(=O)c1c(O)c(C)c(O)c2c1oc3c(C(=O)C)c(O)c(C)c(O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B13 compound treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 2060049 SpecPlus_000031 Cc1cc(=O)c2c(O)c(C)c(O)cc2o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B14 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060050 SpecPlus_000032 COc1ccc(cc1)c2cc(=O)c3c(OC)cccc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B15 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060051 SpecPlus_000033 Cc1cc(=O)c2c(O)cc(O)c(C)c2o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B16 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 2069262 SpecPlus_000034 COc1cc(/C=C/C=O)cc(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B17 compound treatment 0.0745 0.00484 0.57 0.573 1.0 2060052 SpecPlus_000035 Oc1ccc2C3=C4C=CC(=O)C=C4C[C@@]3(O)COc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B18 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 2060053 SpecPlus_000036 COc1c(CC=C(C)C)c2OC(C)(C)C=Cc2c3oc(=O)c(c(OC(=O)C)c13)c4ccc(OC(=O)C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B19 compound treatment 0.078 0.00834 0.99 0.9877 1.0 2060054 SpecPlus_000037 CC(=O)OC(OC(=O)C)c1c(OC(=O)C)cc(C)c2C(=O)Oc3c(C)c(OC(=O)C)c4C(=O)OC(OC(=O)C)c4c3Oc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B20 compound treatment 0.0795 0.00984 1.17 1.1655 1.0 3173360 SpecPlus_000038 CC(CCC(=O)O)[C@H]1CCC2C3CC[C@@H]4CCCC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B21 compound treatment 0.078 0.00834 0.99 0.9877 1.0 2120750 SpecPlus_000039 CC(C)C(C)/C=C/C(C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B22 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 3173475 SpecPlus_000040 CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](OC3O[C@H](C)C[C@@H]([C@H]3OC(=O)C)N(C)C)[C@@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@@H](OC(=O)C)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B23 mock treatment 0.0805 0.0108 1.28 1.284 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 B24 mock treatment 0.0725 0.00284 0.34 0.336 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C01 mock treatment 0.0715 0.00184 0.22 0.2176 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C02 mock treatment 0.0715 0.00184 0.22 0.2176 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C03 compound treatment 0.074 0.00434 0.51 0.5138 1.0 2060055 SpecPlus_000041 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C5OC54[C@]13C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C04 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060056 SpecPlus_000042 COc1cc(O)c2c(=O)cc(C)oc2c1CC=C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C05 compound treatment 0.071 0.00134 0.16 0.1583 1.0 2060057 SpecPlus_000043 COC(=O)C[C@H]1C(C)(C)[C@@H](OC(=O)C)[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C06 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 1352641 SpecPlus_000044 COc1c2ccoc2nc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C07 compound treatment 0.0775 0.00784 0.93 0.9285 1.0 1094519 SpecPlus_000045 CC(=O)N1CCCC1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C08 compound treatment 0.0745 0.00484 0.57 0.573 1.0 2060058 SpecPlus_000046 CC1(C)CC[C@@]2(CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@@H](O)C(C)(C)C5CC[C@]43C)C2C1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C09 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060059 SpecPlus_000047 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](C[C@H]5O[C@]543)c6ccoc6)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C10 compound treatment 0.074 0.00434 0.51 0.5138 1.0 3173478 SpecPlus_000048 C[C@H]1C(=O)CCC2[C@]1(C)CCC3[C@@]2(C)CC[C@@]4(C)C5CC(C)(C)CC[C@]5(C)CC[C@]34C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C11 compound treatment 0.075 0.00534 0.63 0.6323 1.0 2060060 SpecPlus_000049 CC1(C)C2CC(=O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)[C@@]2(C)C=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C12 compound treatment 0.075 0.00534 0.63 0.6323 1.0 2060061 SpecPlus_000050 Cc1cc(=O)c2c(O)c3CCC(C)(C)Oc3cc2o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C13 compound treatment 0.073 0.00334 0.4 0.3953 1.0 2060062 SpecPlus_000051 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C14 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 3054135 SpecPlus_000052 CC(=O)O[C@H]1CC[C@@]2(C)C(CC[C@]3(C)C2CC=C4C5CC(C)(C)CC[C@]5(C)CC[C@]43C)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C15 compound treatment 0.073 0.00334 0.4 0.3953 1.0 2060063 SpecPlus_000053 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](C(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C16 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 3054136 SpecPlus_000054 CC1(C)CC[C@]2(C)CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)C2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C17 compound treatment 0.075 0.00534 0.63 0.6323 1.0 2060064 SpecPlus_000055 CCC(C)C(=O)OC1[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@](C)([C@@H](CC(=O)OC)C1(C)C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C18 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060065 SpecPlus_000056 COC[C@@]12CN(C=O)C3[C@@H]4[C@H](OC)C2[C@]3(C5CC6(O)C(OC(=O)c7ccccc7)C5C4(OC(=O)C)C(O)C6OC)[C@H](C[C@H]1O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C19 compound treatment 0.076 0.00634 0.75 0.7508 1.0 2060066 SpecPlus_000057 COC(=O)CC1C(C)(C)C(=O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C20 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 2060067 SpecPlus_000058 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](O)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C5OC54[C@]13C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C21 compound treatment 0.076 0.00634 0.75 0.7508 1.0 3173485 SpecPlus_000059 OC[C@H]1O[C@H](Oc2cccc3[C@H]([C@@H]4c5cccc(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5C(=O)c7c(O)cc(cc47)C(=O)O)c8cc(cc(O)c8C(=O)c23)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C22 compound treatment 0.076 0.00634 0.75 0.7508 1.0 2060068 SpecPlus_000060 COC1C(O)C(O[C@H]2CC[C@]3(C=O)C4[C@@H](C[C@]5(C)[C@H](CC[C@]5(O)C4CC[C@]3(O)C2)C6=CC(=O)OC6)OC(=O)C)OC(C)C1OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C23 mock treatment 0.0745 0.00484 0.57 0.573 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 C24 mock treatment 0.077 0.00734 0.87 0.8693 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D01 mock treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D02 mock treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D03 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060069 SpecPlus_000061 COc1cc(cc(O)c1OC)c2coc3cc(OCc4ccccc4)c(OC)c(O)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D04 compound treatment 0.072 0.00234 0.28 0.2768 1.0 3173486 SpecPlus_000062 CC(=O)O[C@H]1CC[C@@]2(C)[C@H](CCC3C2CC[C@]4(C)C(CC[C@]34O)C5=CC(=O)OC5)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D05 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060070 SpecPlus_000063 COc1c(O)cc(O)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D06 compound treatment 0.0745 0.00484 0.57 0.573 1.0 2060071 SpecPlus_000064 CCOC(=O)c1c(C)cc(O)c(C=O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D07 compound treatment 0.0855 0.0158 1.88 1.8764 1.0 2060072 SpecPlus_000065 Oc1ccc(cc1)C(C=C)C2=CC(=O)C=CC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D08 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 2060073 SpecPlus_000066 CC(=O)OCC(OC(=O)C)C(OC(=O)C)C(OC(=O)C)C(OC(=O)C)C(COC(=O)C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D09 compound treatment 0.076 0.00634 0.75 0.7508 1.0 2060074 SpecPlus_000067 COc1cc2OCC3Oc4c5CC(Oc5cc(OC(=O)C)c4C(=O)C3c2cc1OC)C(=C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D10 compound treatment 0.077 0.00734 0.87 0.8693 1.0 2060075 SpecPlus_000068 CC(C)CCCC(C)C1CC[C@@]2(C)C3=C(CC[C@]12C)[C@@]4(C)CC[C@H](O)C(C)(C)C4CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D11 compound treatment 0.0815 0.0118 1.4 1.4025 1.0 2060076 SpecPlus_000069 COc1cc(OC)c2c(=O)cc(oc2c1)c3ccc(OC)c(I)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D12 compound treatment 0.0785 0.00884 1.05 1.047 1.0 2060077 SpecPlus_000070 CC(=CCCC1(C)Oc2c(CC=C(C)C)c3OC4(C5CCC=C4C(=O)c3c(O)c2C=C1)C(C/C=C(\C)/C(=O)O)(OC5(C)C)C(=O)O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D13 compound treatment 0.078 0.00834 0.99 0.9877 1.0 1095778 SpecPlus_000071 COc1cc(C)c2c(=O)c3c(O)cc(OC)cc3oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D14 compound treatment 0.0765 0.00684 0.81 0.81 1.0 3054028 SpecPlus_000072 CC(CCC=C(C)C)[C@@H]1CC[C@]2(C)C3=C(CC[C@@]12C)C4(C)CC[C@H](O)C(C)(C)C4CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D15 compound treatment 0.079 0.00934 1.11 1.1062 1.0 2060078 SpecPlus_000073 COc1cc2OC[C@H]3Oc4c(CC=C(C)C)c(O)ccc4C(=O)[C@H]3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D16 compound treatment 0.0765 0.00684 0.81 0.81 1.0 2060079 SpecPlus_000074 CC(=CCCC1(C)Oc2c(CC=C(C)C)c3OC4(C5CC6C=C4C(=O)c3c(O)c2C=C1)C(C/C=C(/C)\C(=O)O)(OC5(C)C)C6O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D17 compound treatment 0.08 0.0103 1.22 1.2247 1.0 3054030 SpecPlus_000075 Oc1cc(O)cc(/C=C/c2ccccc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D18 compound treatment 0.074 0.00434 0.51 0.5138 1.0 2060080 SpecPlus_000076 CC(=CCCC1(C)Oc2c(CC=C(C)C)c3OC4(C5CC6CC4C(=O)c3c(O)c2C=C1)C(C/C=C(/C)\C(=O)O)(OC5(C)C)C6O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D19 compound treatment 0.0775 0.00784 0.93 0.9285 1.0 3054032 SpecPlus_000077 COc1cc(C/C=C/c2ccccc2)c(OC)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D20 compound treatment 0.0765 0.00684 0.81 0.81 1.0 2060081 SpecPlus_000078 CC(=CCc1c(O)cc(C)oc1=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D21 compound treatment 0.079 0.00934 1.11 1.1062 1.0 1092958 SpecPlus_000079 COC1=CC(=O)C(=CC1=O)C(C=C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D22 compound treatment 0.0745 0.00484 0.57 0.573 1.0 2060082 SpecPlus_000080 COC(=O)c1cc(OC)c(=O)c2c(OC)c(OC)ccc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D23 mock treatment 0.0745 0.00484 0.57 0.573 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 D24 mock treatment 0.0765 0.00684 0.81 0.81 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E01 mock treatment 0.0755 0.00584 0.69 0.6915 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E02 mock treatment 0.0725 0.00284 0.34 0.336 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E03 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060083 SpecPlus_000081 COC(=O)C(O)[C@H]1C(C)(C)C(=O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E04 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060084 SpecPlus_000082 C[C@@]12CCC3C(CC[C@H]4CC=CC[C@@]43C)C2CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E05 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060085 SpecPlus_000083 C[C@]12CCC3[C@@](C)([C@H](O)CC4[C@]3(C)C=CC(=O)OC4(C)C)C25OC5C(=O)O[C@H]1c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E06 compound treatment 0.073 0.00334 0.4 0.3953 1.0 2060086 SpecPlus_000084 CCC(C)C(=O)O[C@@H]1C[C@@]2(C)[C@@H](OC(=O)CC32OC4(C)OC53[C@H](OC(=O)C(C)C)[C@@]6(O)[C@@H](OC(=O)C7(C)OC7C)[C@@]8(C)C[C@]6(O)[C@@](C)([C@H]8CC(=O)OC)C15O4)c9ccoc9 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E07 compound treatment 0.0835 0.0138 1.64 1.6394 1.0 2060087 SpecPlus_000085 COC(=O)C(O)[C@H]1C(C)(C)C(OC(=O)/C(=C/C)/C)[C@@H]2C=C3C(CC[C@@]4(C)[C@@H](OC(=O)CC34)c5ccoc5)[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E08 compound treatment 0.075 0.00534 0.63 0.6323 1.0 2060088 SpecPlus_000086 COc1cc2ccc(=O)oc2c(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E09 compound treatment 0.077 0.00734 0.87 0.8693 1.0 2060089 SpecPlus_000087 CCC(C)C(=O)O[C@@H]1C[C@@]2(C)[C@@H](OC(=O)CC32OC4(C)O[C@]53[C@H](OC(=O)C)[C@@]6(O)C(OC(=O)C7(C)OC7C)C8(C)CC6(O)[C@@](C)([C@H]8CC(=O)OC)[C@@]15O4)c9ccoc9 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E10 compound treatment 0.0785 0.00884 1.05 1.047 1.0 1000946 SpecPlus_000088 COc1ccc(CC2N(C)CCc3cc(OC)c(OC)cc23)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E11 compound treatment 0.0805 0.0108 1.28 1.284 1.0 2060090 SpecPlus_000089 COC(=O)C[C@H]1C(C)(C)C(OC(=O)C)[C@]2(O)C=C3C(CC[C@@]4(C)[C@@H](OC(=O)CC34)c5ccoc5)[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E12 compound treatment 0.078 0.00834 0.99 0.9877 1.0 1029487 SpecPlus_000090 OCC(O)Cc1ccc2OCOc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E13 compound treatment 0.0765 0.00684 0.81 0.81 1.0 2060091 SpecPlus_000091 CC(CC(O)C1OC1(C)C)[C@@H]2CCC3(C)C4=CCC5C(C)(C)C(=O)CCC5(C)C4CC[C@@]23C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E14 compound treatment 0.079 0.00934 1.11 1.1062 1.0 2060092 SpecPlus_000092 CC(=O)O[C@H]1CC[C@@]2(C)[C@@H](CCC3C4CC=C(C(=O)C)[C@@]4(C)C(=O)CC32)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E15 compound treatment 0.0805 0.0108 1.28 1.284 1.0 2060093 SpecPlus_000093 CC([C@@H]1CC[C@]2(C)C3=CCC4C(C)(C)C(=O)CC[C@]4(C)C3CC[C@@]12C)C5OC(C)(C)C(O)C5O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E16 compound treatment 0.0785 0.00884 1.05 1.047 1.0 3472730 SpecPlus_000094 CC12CCC3C(CC=C4CC(O)CCC34C)C2CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E17 compound treatment 0.0825 0.0128 1.52 1.5209 1.0 2060094 SpecPlus_000095 COC(=O)C(O)[C@H]1C(C)(C)[C@@H](OC(=O)C)[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E18 compound treatment 0.074 0.00434 0.51 0.5138 1.0 3173612 SpecPlus_000096 CC(=O)OC1CC2(O)C3CCC4CC(CC[C@]4(C)C3CC[C@]2(C)C1C5=CC(=O)OC5)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E19 compound treatment 0.0785 0.00884 1.05 1.047 1.0 2060095 SpecPlus_000097 COC(=O)C[C@H]1C(C)(C)[C@@H](O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E20 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060096 SpecPlus_000098 CC(=O)O[C@@H]1CC(=O)[C@@]2(C)C(CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E21 compound treatment 0.076 0.00634 0.75 0.7508 1.0 2060097 SpecPlus_000099 C[C@]12CCC3C([C@H](O)CC4C(C)(C)C(=O)C=C[C@]34C)[C@]25O[C@@H]5C[C@H]1c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E22 compound treatment 0.073 0.00334 0.4 0.3953 1.0 2060098 SpecPlus_000100 C[C@@]12CCC3C(CC[C@H]4C[C@@H](Cl)CC[C@@]43C)C2CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E23 mock treatment 0.074 0.00434 0.51 0.5138 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 E24 mock treatment 0.074 0.00434 0.51 0.5138 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F01 mock treatment 0.07 3.36E-4 0.04 0.0398 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F02 mock treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F03 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 3173615 SpecPlus_000101 CCC(CCC(C)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F04 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060099 SpecPlus_000102 Oc1cc(O)c2c(=O)c(coc2c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F05 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 2060100 SpecPlus_000103 OC(=O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F06 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060101 SpecPlus_000104 COc1ccc(cc1OC)[C@H]2Oc3c(I)c(OC)cc(OC)c3C[C@@H]2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F07 compound treatment 0.0785 0.00884 1.05 1.047 1.0 2060102 SpecPlus_000105 COc1ccc2C(=O)c3cc(OC)c(OC)cc3CC(=O)COc2c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F08 compound treatment 0.072 0.00234 0.28 0.2768 1.0 2060103 SpecPlus_000106 COc1ccc2C(=O)[C@@H]3[C@@H](COc4cc(OC)c(OC)cc34)Oc2c1CC=C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F09 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 1082584 SpecPlus_000107 COc1cc2OCc3oc4c5CC(Oc5ccc4c(=O)c3-c2cc1OC)C(=C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F10 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060104 SpecPlus_000108 COc1cc(C)c2c(=O)c3c(O)cc(O)cc3oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F11 compound treatment 0.0785 0.00884 1.05 1.047 1.0 1105460 SpecPlus_000109 COc1ccc2C3COc4cc(O)ccc4C3Oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F12 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 2060105 SpecPlus_000110 CC1(C)Oc2cc3occ(c4ccc5OCOc5c4)c(=O)c3c(O)c2C=C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F13 compound treatment 0.0775 0.00784 0.93 0.9285 1.0 2060106 SpecPlus_000111 COc1cc(cc(OC)c1OC)c2coc3cc(OC)c(OC)c(OC)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F14 compound treatment 0.072 0.00234 0.28 0.2768 1.0 2060107 SpecPlus_000112 COC1=C(OC)C(=O)C(=CC1=O)[C@H](C=C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F15 compound treatment 0.076 0.00634 0.75 0.7508 1.0 1372522 SpecPlus_000113 COc1ccc(cc1)c2coc3cc(OC)ccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F16 compound treatment 0.074 0.00434 0.51 0.5138 1.0 2060108 SpecPlus_000114 CC1=C(Cl)C(=O)C=C(O)C21Oc3cc(O)c(Cl)c(C)c3C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F17 compound treatment 0.0745 0.00484 0.57 0.573 1.0 1539748 SpecPlus_000115 COc1ccccc1c2coc3cc(O)ccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F18 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060109 SpecPlus_000116 CC(=O)Oc1ccc2C3c4cc(OC(=O)C)c(OC(=O)C)c(OC(=O)C)c4CC3(O)COc2c1OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F19 compound treatment 0.074 0.00434 0.51 0.5138 1.0 2060110 SpecPlus_000117 COc1ccc(c(OC)c1)c2coc3cc(O)ccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F20 compound treatment 0.0745 0.00484 0.57 0.573 1.0 2060111 SpecPlus_000118 COc1cc(O)c(cc1O)C(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F21 compound treatment 0.0745 0.00484 0.57 0.573 1.0 2060112 SpecPlus_000119 COc1ccc(/C=C/c2cc(O)cc(O)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F22 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060113 SpecPlus_000120 Cc1cc(O)cc(O)c1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F23 mock treatment 0.072 0.00234 0.28 0.2768 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 F24 mock treatment 0.0715 0.00184 0.22 0.2176 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G01 mock treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G02 mock treatment 0.0625 -0.00716 -0.85 -0.8489 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G03 compound treatment 0.065 -0.00466 -0.55 -0.5526 -1.0 3173736 SpecPlus_000121 C[C@]12CCC3[C@@]4(C)[C@@H](O)C[C@@H](O)C(C)(C)C4C[C@@H](O)[C@@]3(C)C25OC5C[C@H]1c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G04 compound treatment 0.0655 -0.00416 -0.49 -0.4934 -1.0 2060114 SpecPlus_000122 COc1c2OCOc2cc3cc[n+](C)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G05 compound treatment 0.0655 -0.00416 -0.49 -0.4934 -1.0 2060115 SpecPlus_000123 CC(=CCOc1cc2oc(=O)ccc2cc1O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G06 compound treatment 0.065 -0.00466 -0.55 -0.5526 -1.0 1019607 SpecPlus_000124 CN(C)Cc1c(C)[nH]c2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G07 compound treatment 0.0775 0.00784 0.93 0.9285 1.0 2060116 SpecPlus_000125 CCC(=O)OC1[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@](C)([C@@H](CC(=O)OC)C1(C)C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G08 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060117 SpecPlus_000126 Cc1ccc2c(CC[C@H]3CC(=O)CC[C@@]32C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G09 compound treatment 0.072 0.00234 0.28 0.2768 1.0 2060118 SpecPlus_000127 COC(=O)CC1C(C)(C)C(O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G10 compound treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 2060119 SpecPlus_000128 CC(C)c1c(O)c(cc2c1CCC3C(C)(C)CCC[C@@]32C)c4cc5c(CCC6C(C)(C)CCC[C@@]65C)c(C(C)C)c4O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G11 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060120 SpecPlus_000129 OC[C@H]1O[C@H](Oc2cccc3[C@H]([C@H]4c5cccc(O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O)[C@H]6O)c5C(=O)c7c(O)cc(cc47)C(=O)O)c8cc(cc(O)c8C(=O)c23)C(=O)O)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G12 compound treatment 0.0725 0.00284 0.34 0.336 1.0 3054523 SpecPlus_000130 C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)C2[C@H]1C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G13 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 2060121 SpecPlus_000131 COC(=O)C[C@H]1C(C)(C)C2(Cl)O[C@]34CC2C(=O)[C@]1(C)C4CC[C@@]5(C)[C@@H](OC(=O)C=C35)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G14 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 2060122 SpecPlus_000132 CC1(C)Oc2cc3oc(=O)ccc3cc2C=C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G15 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060123 SpecPlus_000133 COC(=O)C[C@H]1C(C)(C)[C@@H](O)[C@@H]2CC3C(CC[C@@]4(C)[C@@H](OC(=O)C=C34)c5ccoc5)[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G16 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 2060124 SpecPlus_000134 COC(=O)[C@@]1(C)CCC[C@@]2(C)C1CCc3c(C(C)C)c(O)ccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G17 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060125 SpecPlus_000135 COC(=O)C[C@H]1C(C)(C)C(=O)[C@@H]2C[C@]3(O)C(CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G18 compound treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 2060126 SpecPlus_000136 CC(C)c1c(O)ccc2c1CCC3[C@@](C)(CO)CCC[C@@]32C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G19 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060127 SpecPlus_000137 COC1CC2=C3C[C@H]4C(=O)C(C)(C)[C@H](CC(=O)OC)[C@@](C)(C3CC[C@@]2(C)[C@@H](O1)c5ccoc5)C4=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G20 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060128 SpecPlus_000138 CO[C@@H]1C(OC(=O)C(C)C)[C@@]2(C)[C@@H](OC(=O)/C(=C(\OC)/C(C)C)/C2[C@@]34OC5(C)O[C@]14[C@]6(C)[C@@H](CC(=O)OC)C7(C)CC6(O5)[C@](OC)(C7OC(=O)C)[C@H]3OC)c8ccoc8 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G21 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 2060129 SpecPlus_000139 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G22 compound treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 2060130 SpecPlus_000140 COc1ccc(cc1)[C@@H](C)C(=O)c2ccc(O)cc2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G23 mock treatment 0.07 3.36E-4 0.04 0.0398 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 G24 mock treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H01 mock treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H02 mock treatment 0.0655 -0.00416 -0.49 -0.4934 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H03 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 2060131 SpecPlus_000141 CCOC(=O)c1oc2c(OC)c(O)cc(O)c2c(=O)c1c3cc(OC)c(OC)c(OC)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H04 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060132 SpecPlus_000142 CC1=CC(=O)C2C(C)(C)CCC[C@]2(C)[C@@]1(O)CCc3ccoc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H05 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060133 SpecPlus_000143 COc1cc(cc(O)c1OC)c2coc3cc(O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c(O)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H06 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060134 SpecPlus_000144 COc1cc2ccc(=O)oc2c3ccoc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H07 compound treatment 0.0815 0.0118 1.4 1.4025 1.0 2060135 SpecPlus_000145 COc1c(O)cc2occ(c3ccc(O)cc3)c(=O)c2c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H08 compound treatment 0.0745 0.00484 0.57 0.573 1.0 2060136 SpecPlus_000146 CC(=C)c1cc2cc(C(=O)C)c(O)cc2o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H09 compound treatment 0.079 0.00934 1.11 1.1062 1.0 2060137 SpecPlus_000147 COc1ccc(cc1)c2coc3c(OC)c(OC)cc(OC)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H10 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060138 SpecPlus_000148 C[C@]1([C@H]2[C@H](C(=O)O)[C@]3(CC(=C)[C@@]4(O)C3)[C@@H](CC4)[C@]52OC1=O)[C@@H](O)C=C5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H11 compound treatment 0.0765 0.00684 0.81 0.81 1.0 3054572 SpecPlus_000149 CC(=O)O[C@@H]1CC[C@@]2(C)C(CC[C@]3(C)C2CC=C4C5CC(C)(C)CC[C@@]5(CC[C@]43C)C(=O)O)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H12 compound treatment 0.081 0.0113 1.34 1.3432 1.0 1090422 SpecPlus_000150 Cc1cc(O)cc(O)c1C(=O)Oc2cc(C)c(C(=O)O)c(O)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H13 compound treatment 0.0745 0.00484 0.57 0.573 1.0 2060139 SpecPlus_000151 COc1ccc([C@@H]2COc3c(OC)c(OC)ccc3C2)c(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H14 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 2060140 SpecPlus_000152 COc1cc2occc2c3oc(=O)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H15 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060141 SpecPlus_000153 COC1=CC(=O)C(=CC1=O)C(C=C)c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H16 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 1086162 SpecPlus_000154 COc1c2ccoc2c(OC)c3oc(=O)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H17 compound treatment 0.0725 0.00284 0.34 0.336 1.0 3173749 SpecPlus_000155 COc1cc2OC[C@H]3Oc4c5CC(Oc5ccc4C(=O)[C@H]3c2cc1OC)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H18 compound treatment 0.072 0.00234 0.28 0.2768 1.0 2060142 SpecPlus_000156 CC(=O)OC1C/C(=C/CC/C(=C/CC[C@](C)(O)C2CC1C(=C)C(=O)O2)/C)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H19 compound treatment 0.076 0.00634 0.75 0.7508 1.0 2060143 SpecPlus_000157 COC1=CC(=O)C(=CC1=O)C(C=C)c2ccc(O)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H20 compound treatment 0.075 0.00534 0.63 0.6323 1.0 3054620 SpecPlus_000158 COc1c2C=CC(C)(C)Oc2c(CC=C(C)C)c3OCC(=C(O)c13)c4ccc(OC(=O)C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H21 compound treatment 0.076 0.00634 0.75 0.7508 1.0 1008719 SpecPlus_000159 COC(=O)C(O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H22 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060144 SpecPlus_000160 COc1cccc(c1)c2cc(=O)c3cc(OC)ccc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H23 mock treatment 0.072 0.00234 0.28 0.2768 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 H24 mock treatment 0.07 3.36E-4 0.04 0.0398 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I01 mock treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I02 mock treatment 0.065 -0.00466 -0.55 -0.5526 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I03 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060145 SpecPlus_000161 CC1(C)C2CC(=O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)[C@@]2(C)C=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I04 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060146 SpecPlus_000162 C[C@@]12CCC(=O)C=C2CCc3ccc(O)cc31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I05 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060147 SpecPlus_000163 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I06 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 2060148 SpecPlus_000164 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](O)C[C@H](O)[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C5OC54[C@]13C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I07 compound treatment 0.076 0.00634 0.75 0.7508 1.0 3173867 SpecPlus_000165 COC(=O)C[C@H]1C(C)(C)C(=O)[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I08 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060149 SpecPlus_000166 Cc1cc(O)c2C(=O)c3c(O)cccc3Cc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I09 compound treatment 0.072 0.00234 0.28 0.2768 1.0 2060150 SpecPlus_000167 CC1(C)[C@H](O)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]3(C)OC(=O)CC12)c5ccoc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I10 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060151 SpecPlus_000168 COC(=O)[C@@H]1OC(=O)C2OC23[C@@]1(C)CCC4[C@@]5(C)[C@H](C[C@@H](OC(=O)C)C(C)(C)C5C[C@H](O)[C@]43C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I11 compound treatment 0.073 0.00334 0.4 0.3953 1.0 2060152 SpecPlus_000169 CC(=O)O[C@@H]1CC2C(C)(C)C=CC(=O)[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C5OC54[C@]13C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I12 compound treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 2060153 SpecPlus_000170 COc1cccc2c1CCC3=CC(=O)CC[C@@]32C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I13 compound treatment 0.056 -0.0137 -1.62 -1.619 -1.0 2060154 SpecPlus_000171 CC(=O)O[C@H]1CC[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I14 compound treatment 0.064 -0.00566 -0.67 -0.6711 -1.0 2060155 SpecPlus_000172 COC(=O)[C@@H]1OC(=O)C2OC23[C@@]1(C)CCC4[C@@]5(C)[C@H](C[C@@H](OC(=O)C)C(C)(C)C5C[C@@H](O)[C@]43C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I15 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060156 SpecPlus_000173 CCC(C)C(O)C(=O)O[C@H]1[C@H](OC=O)C(C(=C)C2(O)C(=O)C[C@@H](c3ccoc3)[C@]12C)[C@]4(C)C(CC(=O)OC)[C@@](C)(COC(=O)C)OC(=O)C[C@@H]4OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I16 compound treatment 0.0665 -0.00316 -0.37 -0.3749 -1.0 2060157 SpecPlus_000174 CC(=O)C1CCC2C3CCC4C[C@H](O)CCC4(C)C3C[C@H](O)C12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I17 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060158 SpecPlus_000175 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](OC(=O)C)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I18 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060159 SpecPlus_000176 COC(=O)[C@@H]1OC(=O)C2OC23[C@@]1(C)CCC4[C@@]5(C)CCC(=O)C(C)(C)C5C[C@@H](OC(=O)C)[C@]43C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I19 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060160 SpecPlus_000177 CC(=O)O[C@@H]1CC2C(C)(C)CCC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I20 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060161 SpecPlus_000178 CC(=C)[C@H]1COc2cc3oc(=O)ccc3cc2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I21 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060162 SpecPlus_000179 COC(=O)C[C@H]1C(C)(C)[C@@H](O)[C@@H]2CC3=C4C=C(OC)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I22 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 3054675 SpecPlus_000180 CC(C)CCCC(C)C1CCC2/C(=C/C=C\3/C[C@@H](O)CCC3=C)/CCCC12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I23 mock treatment 0.066 -0.00366 -0.43 -0.4341 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 I24 mock treatment 0.065 -0.00466 -0.55 -0.5526 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J01 mock treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J02 mock treatment 0.0665 -0.00316 -0.37 -0.3749 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J03 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 2060163 SpecPlus_000181 COc1ccc2C(=O)[C@@H]3[C@@H](COc4cc(OC)c(OC)cc34)Oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J04 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 2060164 SpecPlus_000182 CC12CCC3C(CC3(C)C)C(=O)CCC2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J05 compound treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 2060165 SpecPlus_000183 COc1cc2OCc3oc4c5CC(Oc5ccc4c(=O)c3-c2cc1OC)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J06 compound treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 2060166 SpecPlus_000184 CC1(C)CC2C1CCC(=C)/C(=N\O)/CCC2=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J07 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 2060167 SpecPlus_000185 COC(=O)c1cc(O)c(=O)c2c(O)c(O)ccc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J08 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 2060168 SpecPlus_000186 C/C(=C/CC1[C@](C)(O)CC[C@H]2C(C)(C)CCC[C@]12C)/C=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J09 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060169 SpecPlus_000187 Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c4cc(O)c(O)c(O)c4c5c(O)c(O)c(O)cc5[C@H]6Oc7cc(O)cc(O)c7C[C@H]6OC(=O)c8cc(O)c(O)c(O)c8 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J10 compound treatment 0.071 0.00134 0.16 0.1583 1.0 2060170 SpecPlus_000188 CC(=O)OC1CCC2(O)CC1(C)CCC3C2CC3(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J11 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060171 SpecPlus_000189 COC(=O)/C(=C\CC1(OC(C)(C)C2CC3C=C4C(=O)c5c(O)c6C7CC(C)(CCC7=C(C)C)Oc6c(CCC(C)(C)Cl)c5OC241)C3=O)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J12 compound treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 2060172 SpecPlus_000190 CC1(C)CC2C1CCC3(CBr)CCC4C(CC(=O)O)C(=O)OC24C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J13 compound treatment 0.065 -0.00466 -0.55 -0.5526 -1.0 449 SpecPlus_000191 CC1=CC(=O)c2ccccc2C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J14 compound treatment 0.0655 -0.00416 -0.49 -0.4934 -1.0 2060173 SpecPlus_000192 CC(C)C1CCC(C)(O)C2CCC(=CC12)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J15 compound treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 2060174 SpecPlus_000193 CC(=CCc1c2OC(C)(C)C=Cc2c(O)c3c(=O)c(O)c(oc13)c4ccccc4)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J16 compound treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 2060175 SpecPlus_000194 C[C@](O)(CCC1C(=C)CCC2[C@@](C)(CO)CCC[C@]12C)C=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J17 compound treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 3173879 SpecPlus_000195 CC(=CCc1c2OC(C)(C)C=Cc2c(OC(=O)C)c3c(=O)c(OC(=O)C)c(oc13)c4ccccc4)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J18 compound treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 2060176 SpecPlus_000196 CC(=O)/C=C\[C@H]1[C@](C)(O)CCC2C(C)(C)CCC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J19 compound treatment 0.072 0.00234 0.28 0.2768 1.0 1017609 SpecPlus_000197 CC(=CCc1c(O)c2c(=O)c(coc2c3C=CC(C)(C)Oc13)c4ccc(O)cc4)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J20 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 1107153 SpecPlus_000198 CC(=O)c1cc2C=CC(C)(C)Oc2cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J21 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 1112405 SpecPlus_000199 COc1cc2OCOc2cc1c3cc4cc5ccoc5cc4oc3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J22 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 1019872 SpecPlus_000200 COc1cc2COC(=O)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J23 mock treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 J24 mock treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K01 mock treatment 0.0665 -0.00316 -0.37 -0.3749 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K02 mock treatment 0.0645 -0.00516 -0.61 -0.6119 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K03 compound treatment 0.063 -0.00666 -0.79 -0.7896 -1.0 2060177 SpecPlus_000201 CC1(C)C2C[C@@H](O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6)[C@@]2(C)[C@H]7O[C@H]7C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K04 compound treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 2060178 SpecPlus_000202 CC12C[C@@H](O)C3C(CCC4CC(O)CCC43C)C2(O)CCC1C5=CC(=O)OC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K05 compound treatment 0.0665 -0.00316 -0.37 -0.3749 -1.0 2060179 SpecPlus_000203 COc1cccc2c1CCC3CC(=O)CC[C@@]32C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K06 compound treatment 0.0645 -0.00516 -0.61 -0.6119 -1.0 2060180 SpecPlus_000204 CC1=CCC2[C@@]3(C)[C@@H](O)[C@@H](O)CC(C)(C)C3CC4OC(=O)C=C1[C@]42C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K07 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 2060181 SpecPlus_000205 COc1ccc2c(CC=C3C(C)(C)C(O)CC[C@@]32C)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K08 compound treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 3173991 SpecPlus_000206 C[C@@]12CCC3C(CC[C@@H]4C[C@@H](O)CC[C@@]43C)[C@@]2(O)C[C@H](O)[C@@H]1C5=CC(=O)OC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K09 compound treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 2060182 SpecPlus_000207 COc1ccc2c(CCC3C(C)(C)CCC[C@@]32C)c1C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K10 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 2060183 SpecPlus_000208 CC12C(CCC2(O)C3CCC4CC(O)CCC4(C)C3CC1O)C5=CC(=O)OC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K11 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 3173992 SpecPlus_000209 CC(C)c1c(O)ccc2c1CCC3C(C)(C)CCC[C@@]32C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K12 compound treatment 0.0655 -0.00416 -0.49 -0.4934 -1.0 2060184 SpecPlus_000210 CC1CCc2c(O)c3c(=O)cc(C)oc3cc2OC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K13 compound treatment 0.066 -0.00366 -0.43 -0.4341 -1.0 3173993 SpecPlus_000211 O[C@H]1CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]2[C@H]1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K14 compound treatment 0.066 -0.00366 -0.43 -0.4341 -1.0 2060185 SpecPlus_000212 COc1ccc2[C@@H]3COc4cc(OC)ccc4[C@@H]3Oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K15 compound treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 1051795 SpecPlus_000213 CC(=O)OC1CCC2(C=O)C3CCC4(C)C(CCC4(O)C3CCC2(O)C1)C5=CC(=O)OC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K16 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060186 SpecPlus_000214 CC(=O)OC1CCC2(C3CCC4(C)C(CCC54OC2=O)C6=CC(=O)OC6)C(O)(CCC35)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K17 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 3053987 SpecPlus_000215 CC(=O)C1CC[C@H]2C3CC[C@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K18 compound treatment 0.0665 -0.00316 -0.37 -0.3749 -1.0 2060187 SpecPlus_000216 COc1cccc(/C=C/C(=O)O)c1C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K19 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 2060188 SpecPlus_000217 C[C@H]1C2C(CC3C4CCC5C[C@@H](O)CCC5(C)C4=CCC23C)OC61CCC(C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K20 compound treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 3173995 SpecPlus_000218 C[C@H]1C2C(O[C@@]31CC[C@@H](C)CO3)C(O)C4C5CC[C@H]6C[C@H](O[C@@H]7O[C@H](CO)[C@H](O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O[C@@H]9OC[C@@H](O)[C@H](O)[C@H]9O)[C@H]8O[C@@H]%10O[C@H](CO)[C@H](O)[C@H](O[C@@H]%11O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%11O)[C@H]%10O)[C@H](O)[C@H]7O)[C@H](O)C[C@]6(C)C5CC[C@]24C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K21 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060189 SpecPlus_000219 C[C@H]1C2C(CC3C4CC[C@H]5C[C@@H](O)CCC5(C)C4C[C@@H](O)C23C)OC61CCC(C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K22 compound treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 2060190 SpecPlus_000220 C[C@H]1[C@H]2[C@H](CC3C4CC[C@H]5C[C@H](CC[C@]5(C)C4C(=O)[C@@H](OC(=O)C)[C@]23C)OC(=O)C)O[C@@]61CCC(C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K23 mock treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 K24 mock treatment 0.066 -0.00366 -0.43 -0.4341 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L01 mock treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L02 mock treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L03 compound treatment 0.0655 -0.00416 -0.49 -0.4934 -1.0 3173997 SpecPlus_000221 COC(=O)CC1C(C)(C)C(=O)C=CC1(C)C2CC[C@@]3(C)[C@@H](OC(=O)C4OC43C2=C)c5ccoc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L04 compound treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 2060191 SpecPlus_000222 CC1(C)CC2C1CCC(=O)C(CCC2=C)C3CC(=O)OC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L05 compound treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 2070 SpecPlus_000223 COc1ccc(cc1)c2coc3cc(O)ccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L06 compound treatment 0.0665 -0.00316 -0.37 -0.3749 -1.0 2060192 SpecPlus_000224 CC1(C)CC2C1CCC3(C)CCCC2(O)C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L07 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 3173998 SpecPlus_000225 CC(=O)O[C@@H]1C2CC[C@@H]3C1(C[C@@]2(C)O)C[C@@H](O)[C@@]4(O)[C@@H](C[C@H](O)C4(C)C)[C@]3(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L08 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060193 SpecPlus_000226 CC1(C)C2CC1C(=C)C(N)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L09 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 2060194 SpecPlus_000227 COc1cc(O)c(C(=O)O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L10 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060195 SpecPlus_000228 CC1(C)CC23C1CCC3(C)C(O)CCC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L11 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060196 SpecPlus_000229 COc1cc2OCC3Oc4cc5OC(C)(C)C=Cc5c(O)c4C(=O)C3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L12 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 2060197 SpecPlus_000230 COC1(C)CCC2OC2(C)CCC3C1CC3(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L13 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 2060198 SpecPlus_000231 COc1ccc2C=C3c4cc(OC)c(OC)cc4OCC3(O)Oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L14 compound treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 2060199 SpecPlus_000232 CC1(C)CC2C1CCC3(C)OC2(C)CCC3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L15 compound treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 3054042 SpecPlus_000233 COc1ccc(/C=C/C(=O)O)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L16 compound treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 2060200 SpecPlus_000234 CC12CCC3C(CC3(C)C)C(C)(O)CCC2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L17 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060201 SpecPlus_000235 CC(=O)OCC(O)CC(O)CCCCCCCCCCCC#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L18 compound treatment 0.0665 -0.00316 -0.37 -0.3749 -1.0 2060202 SpecPlus_000236 CC1(C)CC2C1CCC3(C)OC2(C)CCC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L19 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060203 SpecPlus_000237 CCOC(=O)c1c(C)cc(O)c(C)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L20 compound treatment 0.071 0.00134 0.16 0.1583 1.0 2060204 SpecPlus_000238 CC(=O)OC1CC(C)(C)C2CCC3(C)CC12CCC3OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L21 compound treatment 0.071 0.00134 0.16 0.1583 1.0 1049467 SpecPlus_000239 COC(=O)c1c(C)cc(OC(=O)c2c(C)cc(O)c(C=O)c2O)c(C)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L22 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 3054095 SpecPlus_000240 CCC(/C=C/[C@@H](C)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L23 mock treatment 0.0715 0.00184 0.22 0.2176 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 L24 mock treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M01 mock treatment 0.0655 -0.00416 -0.49 -0.4934 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M02 mock treatment 0.064 -0.00566 -0.67 -0.6711 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M03 compound treatment 0.065 -0.00466 -0.55 -0.5526 -1.0 3173999 SpecPlus_000241 C[C@H]1C2C(CC3C4CC[C@H]5CC(CCC5(C)C4CC(=O)C23C)OC(=O)C)OC61CCC(C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M04 compound treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 3174000 SpecPlus_000242 C[C@H]1[C@H]2[C@H](CC3C4CC[C@@H]5C[C@@H](O)CC[C@]5(C)C4CC[C@]23C)O[C@@]61CCC(C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M05 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 3054097 SpecPlus_000243 C[C@H]1[C@H]2[C@H](CC3C4CC[C@H]5C[C@@H](O)CC[C@]5(C)C4CC[C@]23C)O[C@@]61CC[C@@H](C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M06 compound treatment 0.066 -0.00366 -0.43 -0.4341 -1.0 2060205 SpecPlus_000244 C[C@H]1[C@H]2[C@H](CC3C4CC[C@@H]5CC(=O)CC[C@]5(C)C4CC[C@]23C)O[C@@]61CCC(C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M07 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 1002679 SpecPlus_000245 OCC(O)C(O)C(O)C(O)C(O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M08 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060206 SpecPlus_000246 CCC(CCC(C)C1CCC2C3CC=C4C[C@H](CC[C@]4(C)C3CC[C@]12C)OC(=O)C)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M09 compound treatment 0.071 0.00134 0.16 0.1583 1.0 2060207 SpecPlus_000247 CC1(C)[C@H](O)C[C@H](O)[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M10 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 1071570 SpecPlus_000248 CCOC(=O)c1c(C)cc(O)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M11 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060208 SpecPlus_000249 COC(=O)C[C@H]1C(C)(C)[C@@H](O)[C@@H]2CC3=C4CC(O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M12 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060209 SpecPlus_000250 COc1cc2OCC3Oc4c(C(=O)O)c(O)ccc4C(=O)C3(O)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M13 compound treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 2060210 SpecPlus_000251 CC(=O)O[C@@H]1CC2C(C)(C)C3(CC[C@]2(C)C4CC[C@@]5(C)[C@@H](OC(=O)C6OC65[C@]14C)c7ccoc7)SCCS3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M14 compound treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 2060211 SpecPlus_000252 CC[C@@]1(O)C[C@H](OC2C[C@H](C(O)C(C)O2)N(C)C)c3c(O)c4C(=O)c5c(O)ccc(O)c5C(=O)c4cc3[C@H]1C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M15 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 2060212 SpecPlus_000253 CC1(C)[C@H](O)CC(=O)[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M16 compound treatment 0.0685 -0.00116 -0.14 -0.1379 -1.0 1010377 SpecPlus_000254 Oc1ccc2C3c4cc(O)c(O)cc4CC3(O)COc2c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M17 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060213 SpecPlus_000255 CC1(C)C2CC(=O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)[C@@]2(C)[C@H]6O[C@H]6C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M18 compound treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 2060214 SpecPlus_000256 COc1c(ccc2OC(C)(C)C=Cc12)c3coc4cc5OC(C)(C)C(O)Cc5cc4c3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M19 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2069251 SpecPlus_000257 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](O)C[C@H](O)[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]54[C@]13C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M20 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 1010376 SpecPlus_000258 Oc1ccc2C3c4cc(O)c(O)cc4CC3(O)COc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M21 compound treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 2060215 SpecPlus_000259 CC1(C)C2C=C[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6)[C@@]2(C)C=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M22 compound treatment 0.072 0.00234 0.28 0.2768 1.0 2060216 SpecPlus_000260 COc1cc2OC[C@H]3Oc4c(ccc5oc(cc45)C(C)C)C(=O)[C@H]3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M23 mock treatment 0.0715 0.00184 0.22 0.2176 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 M24 mock treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N01 mock treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N02 mock treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N03 compound treatment 0.0695 -1.64E-4 -0.02 -0.0194 -1.0 2060217 SpecPlus_000261 COc1c(ccc2OC(C)(C)CCc12)C3COc4cc5OC(C)(C)C(O)Cc5cc4C3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N04 compound treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 1072288 SpecPlus_000262 CC(=C)C1CNC(C1CC(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N05 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060218 SpecPlus_000263 COc1c(CC(=O)c2cc3CC(O)C(C)(C)Oc3cc2O)ccc4OC(C)(C)C=Cc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N06 compound treatment 0.076 0.00634 0.75 0.7508 1.0 3053934 SpecPlus_000264 CC(CCC=C(C)C)C1CC[C@@]2(C)C3=C(CCC12C)C4(C)CCC(OC(=O)C)C(C)(C)C4CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N07 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 3174115 SpecPlus_000265 CC[C@H](CCC(C)[C@H]1CCC2C3CCC4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N08 compound treatment 0.074 0.00434 0.51 0.5138 1.0 2060219 SpecPlus_000266 CC(=O)OC/1CCC(=C)[C@H]2CC(C)(C)[C@@H]2C\C=C1/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N09 compound treatment 0.075 0.00534 0.63 0.6323 1.0 1001923 SpecPlus_000267 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3ccc(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N10 compound treatment 0.076 0.00634 0.75 0.7508 1.0 1114909 SpecPlus_000268 COc1cc(CC=C)ccc1OC(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N11 compound treatment 0.076 0.00634 0.75 0.7508 1.0 907310 SpecPlus_000269 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N12 compound treatment 0.074 0.00434 0.51 0.5138 1.0 2060220 SpecPlus_000270 CC/1[C@H]2C[C@@H](C\C1=N/O)C2(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N13 compound treatment 0.072 0.00234 0.28 0.2768 1.0 2060221 SpecPlus_000271 COc1ccc(cc1)[C@H]2Oc3cc(OC)cc(OC)c3C[C@H]2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N14 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060222 SpecPlus_000272 C/C/1=C\CCC(=O)C2CC(C)(C)C2CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N15 compound treatment 0.0785 0.00884 1.05 1.047 1.0 2060223 SpecPlus_000273 COc1cc(OC)c2C[C@H](O)[C@H](Oc2c1)c3ccc(OC)c(OC)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N16 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 1099943 SpecPlus_000274 COc1c2C=CC(C)(C)Oc2c(CC=C(C)C)c3oc(=O)c(c(O)c13)c4ccc(O)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N17 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 2060224 SpecPlus_000275 Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c4ccc(O)c(O)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N18 compound treatment 0.0725 0.00284 0.34 0.336 1.0 3174120 SpecPlus_000276 CCCCCCCCCCCC[C@@H]([C@@H](C)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N19 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 1859 SpecPlus_000277 Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c4cc(O)c(O)c(O)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N20 compound treatment 0.074 0.00434 0.51 0.5138 1.0 2060225 SpecPlus_000278 COC(=O)c1c(C)c2Oc3c(Cl)c(OC(=O)C)c(Cl)c(C)c3C(=O)Oc2c(C)c1OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N21 compound treatment 0.074 0.00434 0.51 0.5138 1.0 2060226 SpecPlus_000279 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c4c(=O)c(O)cc(cc34)[C@H]5Oc6cc(O)cc(O)c6C[C@H]5OC(=O)c7cc(O)c(O)c(O)c7 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N22 compound treatment 0.073 0.00334 0.4 0.3953 1.0 2060227 SpecPlus_000280 COC(=O)C[C@H](OC(=O)C)[C@@]1(C)[C@@H](C[C@@H](OC(=O)C)[C@]2(C)C1CC[C@@]3(C)[C@@H](CC=C32)C4COC(=O)C4)C(=C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N23 mock treatment 0.075 0.00534 0.63 0.6323 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 N24 mock treatment 0.0775 0.00784 0.93 0.9285 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O01 mock treatment 0.0635 -0.00616 -0.73 -0.7304 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O02 mock treatment 0.062 -0.00766 -0.91 -0.9081 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O03 compound treatment 0.0675 -0.00216 -0.26 -0.2564 -1.0 2060228 SpecPlus_000281 COC(=O)CC1[C@@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]53O[C@]2(O)[C@@H]([C@H]5OC(=O)C)C(OC(=O)C)C1(C)C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O04 compound treatment 0.068 -0.00166 -0.2 -0.1972 -1.0 2060229 SpecPlus_000282 Oc1cc(OC(=O)c2cc(O)c(O)c(O)c2)c3C[C@@H](OC(=O)c4cc(O)c(O)c(O)c4)[C@H](Oc3c1)c5cc(O)c(O)c(O)c5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O05 compound treatment 0.071 0.00134 0.16 0.1583 1.0 2060230 SpecPlus_000283 CC(=O)O[C@H]1C[C@@H](O)C(C)(C)C2C[C@@H](OC(=O)C)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6)[C@@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O06 compound treatment 0.072 0.00234 0.28 0.2768 1.0 2060231 SpecPlus_000284 COc1cc(OC)c(cc1OC)c2coc3cc(O)c(OC)c(O)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O07 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 2060232 SpecPlus_000285 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O08 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 1051460 SpecPlus_000286 COc1cc(C(=O)O)c2Oc3c(C=O)c(O)cc(C)c3C(=O)Oc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O09 compound treatment 0.073 0.00334 0.4 0.3953 1.0 2060233 SpecPlus_000287 COC(=O)C[C@H]1C(C)(C)[C@H](O)[C@@H]2CC3=C4CC(O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O10 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060234 SpecPlus_000288 COC(=O)c1c(C)c2Oc3c(Cl)c(O)c(Cl)c(C)c3C(=O)Oc2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O11 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060235 SpecPlus_000289 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)[C@@H]3O[C@@H]3[C@]2(C)C4CC[C@@]5(C)[C@@H](OC(=O)C=C5[C@]14C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O12 compound treatment 0.0745 0.00484 0.57 0.573 1.0 2060236 SpecPlus_000290 COc1cc(OC)c2C[C@H](OS(=O)(=O)c3ccc(C)cc3)[C@H](Oc2c1)c4ccc(OC)c(OC)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O13 compound treatment 0.072 0.00234 0.28 0.2768 1.0 2060237 SpecPlus_000291 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)C(=O)O)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O14 compound treatment 0.0725 0.00284 0.34 0.336 1.0 2060238 SpecPlus_000292 Cc1cc(O)cc(O)c1C(=O)Oc2cc(C)c(C(=O)Oc3cc(C)c(C(=O)O)c(O)c3)c(O)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O15 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 2060239 SpecPlus_000293 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](CC=C4[C@]13C)C5CO[C@H]([C@H](O)C5)C(C)(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O16 compound treatment 0.0745 0.00484 0.57 0.573 1.0 1057125 SpecPlus_000294 CC(C)(C=C)c1c2OC(C)(C)C=Cc2c(O)c3c(=O)c4ccc(O)c(O)c4oc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O17 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060240 SpecPlus_000295 CC1=C2C(O)C(=O)OC3CC4C(C)(C)C(=O)C=C[C@]4(C)C(CC1)[C@@]32C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O18 compound treatment 0.0725 0.00284 0.34 0.336 1.0 3174236 SpecPlus_000296 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c4c(=O)c(O)cc(cc34)[C@H]5Oc6cc(O)cc(O)c6C[C@H]5O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O19 compound treatment 0.0775 0.00784 0.93 0.9285 1.0 2060241 SpecPlus_000297 CC1(C)C2C[C@@H](O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)[C@@]2(C)CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O20 compound treatment 0.075 0.00534 0.63 0.6323 1.0 2060242 SpecPlus_000298 COc1ccc(cc1)c2cc(=O)c3c(O)c(OC)c(O[C@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O21 compound treatment 0.0755 0.00584 0.69 0.6915 1.0 2060243 SpecPlus_000299 CC1(C)[C@@H]2O[C@@H]2C(=O)[C@@]3(C)C1CC(=O)[C@]4(C)C3CC[C@@]5(C)[C@@H](OC(=O)C6OC654)c7ccoc7 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O22 compound treatment 0.078 0.00834 0.99 0.9877 1.0 2060244 SpecPlus_000300 COC1=CC(=O)OC(CCc2ccc(OC)c(OC)c2)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O23 mock treatment 0.0795 0.00984 1.17 1.1655 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 O24 mock treatment 0.0765 0.00684 0.81 0.81 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P01 mock treatment 0.0625 -0.00716 -0.85 -0.8489 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P02 mock treatment 0.065 -0.00466 -0.55 -0.5526 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P03 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 2069225 SpecPlus_000301 Oc1cc(O)c2C[C@@H](OC(=O)c3cc(O)c(O)c(O)c3)[C@H](Oc2c1)c4cc(O)c(O)c5c(=O)c(O)cc(cc45)[C@H]6Oc7cc(O)cc(O)c7C[C@H]6OC(=O)c8cc(O)c(O)c(O)c8 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P04 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 2060245 SpecPlus_000302 OC[C@H]1O[C@@](CO)(O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P05 compound treatment 0.07 3.36E-4 0.04 0.0398 1.0 3054057 SpecPlus_000303 CC(=CCC/C(=C/CCC(C)(O)C=C)/C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P06 compound treatment 0.069 -6.64E-4 -0.08 -0.0787 -1.0 2060246 SpecPlus_000304 C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H](C/C=C/3\[C@H](O)COC3=O)C(=C)CCC12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P07 compound treatment 0.078 0.00834 0.99 0.9877 1.0 425 SpecPlus_000305 Oc1ccc(cc1)c2coc3cc(O)cc(O)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P08 compound treatment 0.0815 0.0118 1.4 1.4025 1.0 1984013 SpecPlus_000306 C/C=C/c1ccc2OCOc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P09 compound treatment 0.0735 0.00384 0.45 0.4545 1.0 1016781 SpecPlus_000307 OC(=O)c1cc(O)c(O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P10 compound treatment 0.072 0.00234 0.28 0.2768 1.0 1001982 SpecPlus_000308 Nc1nc2[nH]c(=O)cnc2c(=O)[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P11 compound treatment 0.0705 8.36E-4 0.1 0.0991 1.0 2060247 SpecPlus_000309 COc1cc(OC)c2C[C@@H](O)[C@H](Oc2c1)c3ccc(OC)c(OC)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P12 compound treatment 0.073 0.00334 0.4 0.3953 1.0 3054108 SpecPlus_000310 Nc1nc2ncc(=O)[nH]c2c(=O)[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P13 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 653 SpecPlus_000311 Oc1cc2cccc(O)c(=O)c2c(O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P14 compound treatment 0.0725 0.00284 0.34 0.336 1.0 1053058 SpecPlus_000312 COc1cc(OC)c2c(=O)c(O)c(oc2c1)c3ccc(OC)c(OC)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P15 compound treatment 0.078 0.00834 0.99 0.9877 1.0 1210108 SpecPlus_000313 Oc1ccc2cccc(O)c(=O)c2c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P16 compound treatment 0.074 0.00434 0.51 0.5138 1.0 3174242 SpecPlus_000314 OC[C@H]1O[C@@H](Oc2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P17 compound treatment 0.073 0.00334 0.4 0.3953 1.0 2060248 SpecPlus_000315 OC1=Cc2c(O)cc(O)cc2OC1(O)c3ccc(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P18 compound treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 1952709 SpecPlus_000316 COc1ccc2c(C)cc(=O)oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P19 compound treatment 0.0785 0.00884 1.05 1.047 1.0 2060249 SpecPlus_000317 COc1ccc(cc1)c2coc3c(OC)c(O)ccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P20 compound treatment 0.0725 0.00284 0.34 0.336 1.0 3047 SpecPlus_000318 C[C@H]1[C@@H]2CC[C@@]3(C)C=CC(=O)C(=C3[C@H]2OC1=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P21 compound treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 2060250 SpecPlus_000319 COc1cc(C(=O)O)c(O)c2OCOc21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P22 compound treatment 0.0715 0.00184 0.22 0.2176 1.0 1009294 SpecPlus_000320 Oc1ccc2C(=O)c3ccccc3C(=O)c2c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P23 mock treatment 0.067 -0.00266 -0.32 -0.3156 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1081 P24 mock treatment 0.055 -0.0147 -1.74 -1.7375 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A01 mock treatment 0.079 0.00972 1.15 1.1515 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A02 mock treatment 0.076 0.00672 0.8 0.796 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A03 compound treatment 0.078 0.00872 1.03 1.033 1.0 1025940 SpecPlus_000321 Cc1cc(O)c2C(=O)c3c(O)cccc3C(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A04 compound treatment 0.081 0.0117 1.39 1.3884 1.0 1112402 SpecPlus_000322 COc1ccc2ccc(=O)oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A05 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 3054266 SpecPlus_000323 CC(CCC=C(C)C)C1CC[C@@]2(C)C3=C(CC[C@]12C)C4(C)CCC(O)C(C)(C)C4CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A06 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 3174244 SpecPlus_000324 N=c1[nH]c(=O)c2[nH]c(=O)c(=O)[nH]c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A07 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 3174245 SpecPlus_000325 OC[C@H]1O[C@@H](Oc2cc(O)cc(O)c2C(=O)CCc3ccc(O)cc3)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A08 compound treatment 0.076 0.00672 0.8 0.796 1.0 3054270 SpecPlus_000326 COC(=O)[C@@H]1C(O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A09 compound treatment 0.075 0.00572 0.68 0.6775 1.0 2359 SpecPlus_000327 CCOC(=O)C1=C[C@]2(CC)CCCN3CCc4c([C@@H]32)n1c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A10 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 2060251 SpecPlus_000328 NCC(N)C(=O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A11 compound treatment 0.076 0.00672 0.8 0.796 1.0 2060252 SpecPlus_000329 CC(=CCCC1(C)Oc2c(CC=C(C)C)c3O[C@]4(C5C[C@H]6C=C4C(=O)c3c(OC(=O)C)c2C=C1)C(C/C=C(\C)/C(=O)O)(OC5(C)C)C6=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A12 compound treatment 0.0785 0.00922 1.09 1.0922 1.0 2060253 SpecPlus_000330 NC(CC(=O)c1ccccc1N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A13 compound treatment 0.0795 0.0102 1.21 1.2107 1.0 2060254 SpecPlus_000331 CC(=O)CC1CCCCN1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A14 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 599 SpecPlus_000332 Cc1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A15 compound treatment 0.072 0.00272 0.32 0.322 1.0 647 SpecPlus_000333 Oc1ccc(CCC(=O)c2c(O)cc(O)cc2O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A16 compound treatment 0.0795 0.0102 1.21 1.2107 1.0 1020463 SpecPlus_000334 Oc1cc2ccc(=O)oc2cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A17 compound treatment 0.0755 0.00622 0.74 0.7367 1.0 2060255 SpecPlus_000335 CC(=O)Oc1ccc(/C=C/c2cc(OC(=O)C)cc(OC(=O)C)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A18 compound treatment 0.0695 2.18E-4 0.03 0.0258 1.0 812 SpecPlus_000336 COC1=CC(=O)C[C@@H](C)[C@@]21Oc3c(C2=O)c(OC)cc(OC)c3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A19 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 2060256 SpecPlus_000337 CC(=CC1C(CO)C1(C)C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A20 compound treatment 0.0755 0.00622 0.74 0.7367 1.0 3174249 SpecPlus_000338 CC(CCC(=O)O)[C@H]1CCC2C3CC[C@@H]4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A21 compound treatment 0.073 0.00372 0.44 0.4405 1.0 2060257 SpecPlus_000339 CC1(C)[C@H](O)C[C@H](O)[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A22 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 3054588 SpecPlus_000340 COC(=O)c1c(C)c2Oc3c(Cl)c(O)c(Cl)c(C)c3C(=O)Oc2c(C)c1OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A23 mock treatment 0.089 0.0197 2.34 2.3364 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 A24 mock treatment 0.0805 0.0112 1.33 1.3292 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B01 mock treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B02 mock treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B03 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2060258 SpecPlus_000341 CC(=O)O[C@H]1Cc2c(OC(=O)C)cc(OC(=O)C)cc2O[C@@H]1c3ccc(OC(=O)C)c(OC(=O)C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B04 compound treatment 0.0695 2.18E-4 0.03 0.0258 1.0 2060259 SpecPlus_000342 COc1ccc2c(=O)c(CC(=O)O)coc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B05 compound treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 2060260 SpecPlus_000343 COc1ccc(cc1)C2CC(=O)c3ccc(OC)cc3O2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B06 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2476 SpecPlus_000344 CCOP(=S)(OCC)Oc1cc(C)nc(n1)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B07 compound treatment 0.0755 0.00622 0.74 0.7367 1.0 3054634 SpecPlus_000345 COc1c(CC=C(C)C)c2OC(C)(C)C=Cc2c3oc(=O)c(c(O)c13)c4ccc(O)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B08 compound treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 2477 SpecPlus_000346 CCOP(=S)(OCC)SCSP(=S)(OCC)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B09 compound treatment 0.0655 -0.00378 -0.45 -0.4482 -1.0 1059133 SpecPlus_000347 COc1ccc(C(=O)c2ccccc2)c(O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B10 compound treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 2478 SpecPlus_000348 COP(=S)(OC)Oc1ccc(cc1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B11 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2060261 SpecPlus_000349 CC(C)(O)[C@H]1CC[C@@]2(C)[C@H]1CC[C@@]3(C)[C@@H]2CCC4[C@@]5(C)CCCC(C)(C)C5[C@@H](O)C[C@]43C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B12 compound treatment 0.072 0.00272 0.32 0.322 1.0 2479 SpecPlus_000350 CCOP(=S)(OCC)Oc1ccc2c(C)c(Cl)c(=O)oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B13 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2060262 SpecPlus_000351 CC1(C)CC[C@@]2([C@@H](O)C[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)C2C1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B14 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2480 SpecPlus_000352 COP(=S)(OC)SCn1nnc2ccccc2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B15 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 2060263 SpecPlus_000353 COc1ccc(C(=O)c2ccc(O)cc2)c(O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B16 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2481 SpecPlus_000354 CCOP(=S)(OCC)SCCSCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B17 compound treatment 0.09 0.0207 2.45 2.4548 1.0 1034509 SpecPlus_000355 Cc1cc(=O)c2COc3cc(O)c(O)c(C(=O)O)c3-c2o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B18 compound treatment 0.072 0.00272 0.32 0.322 1.0 2482 SpecPlus_000356 CCOC(=O)/C=C(\C)/OP(=O)(OC)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B19 compound treatment 0.0765 0.00722 0.86 0.8552 1.0 3174361 SpecPlus_000357 CCC/C=C/C=C/[C@@H]1C[C@@H](O)[C@@H](O)C(=O)[C@H]1C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B20 compound treatment 0.077 0.00772 0.91 0.9145 1.0 2483 SpecPlus_000358 COP(=O)(OC)OC(Br)C(Cl)(Cl)Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B21 compound treatment 0.077 0.00772 0.91 0.9145 1.0 1039256 SpecPlus_000359 COc1cc(cc(OC)c1OC)C(=O)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B22 compound treatment 0.0735 0.00422 0.5 0.4998 1.0 2484 SpecPlus_000360 COP(=O)(OC)OC=C(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B23 mock treatment 0.0755 0.00622 0.74 0.7367 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 B24 mock treatment 0.0745 0.00522 0.62 0.6183 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C01 mock treatment 0.083 0.0137 1.63 1.6254 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C02 mock treatment 0.074 0.00472 0.56 0.559 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C03 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 2060264 SpecPlus_000361 C[C@@H]1CC[C@]2(CCC3(C)[C@]4(OC2=O)C=CC5[C@@]6(C)CC[C@H](O)C(C)(C)C6CC[C@]53C)C4[C@H]1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C04 compound treatment 0.075 0.00572 0.68 0.6775 1.0 2060265 SpecPlus_000362 COC(=O)CCC(C)[C@H]1CCC2C3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C05 compound treatment 0.072 0.00272 0.32 0.322 1.0 2060266 SpecPlus_000363 C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CC(=O)C4[C@@]5(C)CC[C@H](OC(=O)C)C(C)(C)C5CC[C@]43C)C2[C@H]1C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C06 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2060267 SpecPlus_000364 CC(CCC(=O)O)[C@H]1CCC2C3CC[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C07 compound treatment 0.079 0.00972 1.15 1.1515 1.0 2060268 SpecPlus_000365 C[C@@H]1CC[C@]2(CCC3(C)[C@]4(OC2=O)C=CC5[C@@]6(C)CCC(=O)C(C)(C)C6CC[C@]53C)C4[C@H]1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C08 compound treatment 0.0755 0.00622 0.74 0.7367 1.0 2060269 SpecPlus_000366 C[C@H]1CN(C[C@@H](C)N1)c2c(F)c(F)c3c(=O)c(cn(C4CC4)c3c2F)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C09 compound treatment 0.08 0.0107 1.27 1.2699 1.0 2060270 SpecPlus_000367 CC(C)c1ccc2c(CCC3C(C)(CCCC32C)C(=O)N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C10 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2060271 SpecPlus_000368 CCC(C)C(=O)c1c(O)c(C)c2oc3c(C)c(O)c(C(=O)C(C)CC)c(O)c3c2c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C11 compound treatment 0.074 0.00472 0.56 0.559 1.0 2060272 SpecPlus_000369 CC1CCC2C(CC2(C)C)C(=C)CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C12 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2060273 SpecPlus_000370 COc1cc2OCc3oc4cc(O)cc(O)c4c(=O)c3-c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C13 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2060274 SpecPlus_000371 CC(C)C1CC=C(C)C2CC(=O)C(=CC12)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C14 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 3174366 SpecPlus_000372 C[C@H]1C2C(CC3C4CC[C@@H]5C[C@H](CC[C@]5(C)C4CC[C@]23C)OC(=O)C)O[C@]61CCC(C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C15 compound treatment 0.0735 0.00422 0.5 0.4998 1.0 2060275 SpecPlus_000373 CC(=CC[C@H](O)C1CCC(=CC1)C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C16 compound treatment 0.073 0.00372 0.44 0.4405 1.0 3174367 SpecPlus_000374 NCCC(=O)N[C@@H](Cc1c[nH]cn1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C17 compound treatment 0.074 0.00472 0.56 0.559 1.0 3053888 SpecPlus_000375 CC(=CCC[C@](C)(OC(=O)C)C1CCC(=CC1)C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C18 compound treatment 0.0765 0.00722 0.86 0.8552 1.0 2060276 SpecPlus_000376 C[C@@H]1C(=O)OC2[C@H](O)C34[C@@H]5OC(=O)[C@@]4(O[C@@H]6OC(=O)[C@H](O)[C@@]63[C@@H]([C@H]5O)C(C)(C)C)[C@@]12O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C19 compound treatment 0.073 0.00372 0.44 0.4405 1.0 3053889 SpecPlus_000377 C[C@@H]1CC[C@H]2C(C)(C)C3CC12CC[C@@]3(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C20 compound treatment 0.073 0.00372 0.44 0.4405 1.0 3174369 SpecPlus_000378 C[C@H]1OC(C[C@H](O)C1O)O[C@@H]2[C@@H](C)OC(C[C@@H]2O)O[C@@H]3[C@@H](C)O[C@H](C[C@@H]3O)O[C@H]4CC[C@@]5(C)[C@H](CC[C@@H]6C5CC[C@]7(C)[C@H]([C@@H](O)C[C@]67O)C8=CC(=O)OC8)C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C21 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 3053891 SpecPlus_000379 OC(=O)C/C(=C\C(=O)O)/C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C22 compound treatment 0.0735 0.00422 0.5 0.4998 1.0 2880 SpecPlus_000380 N[C@@H](CCC(=O)N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C23 mock treatment 0.073 0.00372 0.44 0.4405 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 C24 mock treatment 0.077 0.00772 0.91 0.9145 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D01 mock treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D02 mock treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D03 compound treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 976 SpecPlus_000381 CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D04 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 2485 SpecPlus_000382 CCS(=O)CCSP(=O)(OC)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D05 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 2060277 SpecPlus_000383 COc1cccc2c(=O)c(OC)c(oc12)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D06 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2486 SpecPlus_000384 CNC(=O)CSP(=S)(OC)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D07 compound treatment 0.087 0.0177 2.1 2.0994 1.0 1727302 SpecPlus_000385 COc1ccc(cc1)c2coc3cc(OC)cc(O)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D08 compound treatment 0.076 0.00672 0.8 0.796 1.0 2487 SpecPlus_000386 CCOC(=O)CC(SP(=S)(OC)OC)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D09 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 2060278 SpecPlus_000387 COC(=O)/C=C/C(=C/C=C/C(=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C(=O)O)/C)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D10 compound treatment 0.075 0.00572 0.68 0.6775 1.0 2488 SpecPlus_000388 CCOP(=S)(OCC)SCn1c(=O)oc2cc(Cl)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D11 compound treatment 0.0795 0.0102 1.21 1.2107 1.0 2060279 SpecPlus_000389 CC(=O)OC1CC[C@@]2(C)C(CC[C@]3(C)C2CCC4C5CC(C)(C)CCC5(CC[C@]43C)C(=O)O)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D12 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 2489 SpecPlus_000390 COP(=O)(N)SC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D13 compound treatment 0.0785 0.00922 1.09 1.0922 1.0 2269 SpecPlus_000391 Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D14 compound treatment 0.076 0.00672 0.8 0.796 1.0 2490 SpecPlus_000392 CCOP(=S)(OCC)SCSCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D15 compound treatment 0.078 0.00872 1.03 1.033 1.0 2060280 SpecPlus_000393 C[C@H]1C2C(CC3C4CC[C@H]5C[C@H](CC[C@]5(C)C4CC[C@]23C)OC(=O)C)O[C@]61CCC(C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D16 compound treatment 0.075 0.00572 0.68 0.6775 1.0 2491 SpecPlus_000394 COC(=O)c1c(Cl)c(Cl)c(C(=O)OC)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D17 compound treatment 0.0785 0.00922 1.09 1.0922 1.0 2060281 SpecPlus_000395 C[C@@]12CC[C@H](O)C[C@H]2CCc3ccccc31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D18 compound treatment 0.0735 0.00422 0.5 0.4998 1.0 2492 SpecPlus_000396 CC(C)Nc1nc(Cl)nc(NC(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D19 compound treatment 0.075 0.00572 0.68 0.6775 1.0 2060282 SpecPlus_000397 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D20 compound treatment 0.075 0.00572 0.68 0.6775 1.0 2493 SpecPlus_000398 CCC(=O)Nc1ccc(Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D21 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 2060283 SpecPlus_000399 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)C(=O)OC(=O)C=C43)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D22 compound treatment 0.0735 0.00422 0.5 0.4998 1.0 2494 SpecPlus_000400 CCNc1nc(Cl)nc(NCC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D23 mock treatment 0.0735 0.00422 0.5 0.4998 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 D24 mock treatment 0.0745 0.00522 0.62 0.6183 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E01 mock treatment 0.074 0.00472 0.56 0.559 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E02 mock treatment 0.074 0.00472 0.56 0.559 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E03 compound treatment 0.0755 0.00622 0.74 0.7367 1.0 1014978 SpecPlus_000401 OCC(O)C(O)C(O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E04 compound treatment 0.075 0.00572 0.68 0.6775 1.0 2060284 SpecPlus_000402 COc1cc(OC)c(c(OC)c1)c2c(OC)cc(OC)cc2OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E05 compound treatment 0.078 0.00872 1.03 1.033 1.0 2060285 SpecPlus_000403 O=C1CCCCC/C=C/CCCCCCCCO1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E06 compound treatment 0.0765 0.00722 0.86 0.8552 1.0 2060286 SpecPlus_000404 CC(C)CC(=O)c1c(O)c(CC=C(C)C)c(O)c2c(cc(=O)oc12)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E07 compound treatment 0.0835 0.0142 1.68 1.6847 1.0 2060287 SpecPlus_000405 Cc1c(O)c(O)cc2c1CC=C3[C@@]2(C)CC[C@@]4(C)C5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E08 compound treatment 0.077 0.00772 0.91 0.9145 1.0 1010251 SpecPlus_000406 O=C(Nc1ccccc1)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E09 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 1045072 SpecPlus_000407 NC(CSCSCC(N)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E10 compound treatment 0.079 0.00972 1.15 1.1515 1.0 2060288 SpecPlus_000408 Oc1ccc(cc1)C(=O)c2cccc(O)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E11 compound treatment 0.08 0.0107 1.27 1.2699 1.0 3174484 SpecPlus_000409 C[C@@]12CCC3C(CC[C@H]4C[C@@H](O)CC[C@@]43C)C2CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E12 compound treatment 0.077 0.00772 0.91 0.9145 1.0 2060289 SpecPlus_000410 COc1cc2OCC3Oc4c5C=CC(C)(C)Oc5ccc4C(=O)C3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E13 compound treatment 0.078 0.00872 1.03 1.033 1.0 2060290 SpecPlus_000411 C[C@@H]1OC(O[C@H]2CC[C@@]3(C)C(CC[C@]4(C)C3CC=C5C6CC(C)(C)CC[C@@]6(C(O)C[C@]54C)C(=O)O[C@@H]7OC[C@H](O)[C@@H](O)[C@H]7OC8O[C@@H](C)[C@H](O[C@@H]9O[C@H](CO)[C@@H](O)[C@H](O)[C@H]9O)[C@@H](O)[C@H]8O)C2(C)C)[C@H](O)[C@H](O)[C@H]1O[C@@H]%10OC[C@@H](O)[C@H](O)[C@H]%10O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E14 compound treatment 0.08 0.0107 1.27 1.2699 1.0 1009973 SpecPlus_000412 OC(C(O)C(O)C(=O)O)C(O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E15 compound treatment 0.0855 0.0162 1.92 1.9216 1.0 2060291 SpecPlus_000413 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](O)CC[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C5OC54[C@]13C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E16 compound treatment 0.0795 0.0102 1.21 1.2107 1.0 2060292 SpecPlus_000414 CC1(C)[C@H](O)C[C@H](O)[C@@]2(C)C1C[C@@H](O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E17 compound treatment 0.0785 0.00922 1.09 1.0922 1.0 2060293 SpecPlus_000415 C[C@@H]1CC[C@H]2C(C)(C)C3C[C@@]12CC[C@@]3(C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E18 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2060294 SpecPlus_000416 COc1ccc2C(=O)C(Cc3ccc(OC)c(O)c3)COc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E19 compound treatment 0.0765 0.00722 0.86 0.8552 1.0 3054072 SpecPlus_000417 OC(=O)CCCCCCCCCCCCC1CCC=C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E20 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 1009993 SpecPlus_000418 NCCCN 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E21 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 3054971 SpecPlus_000419 O[C@@H]1C[C@](O)(C[C@@H](O)[C@@H]1O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E22 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 3054972 SpecPlus_000420 CC(C)C1=CC2=CCC3[C@](C)(CCC[C@]3(C)C2CC1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E23 mock treatment 0.072 0.00272 0.32 0.322 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 E24 mock treatment 0.0725 0.00322 0.38 0.3813 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F01 mock treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F02 mock treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F03 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2060295 SpecPlus_000421 CC(C)C1COc2cc3oc(=O)ccc3cc2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F04 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 2495 SpecPlus_000422 CCNc1nc(Cl)nc(NC(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F05 compound treatment 0.072 0.00272 0.32 0.322 1.0 2060296 SpecPlus_000423 COc1ccc2CCC3CC(O)CC[C@]3(C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F06 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2496 SpecPlus_000424 CN(C)C(=O)Nc1ccc(Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F07 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 3054974 SpecPlus_000425 COC(=O)C1=CO[C@@H](C)[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@@H]21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F08 compound treatment 0.0735 0.00422 0.5 0.4998 1.0 2497 SpecPlus_000426 CNC(=O)N(C)c1nnc(s1)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F09 compound treatment 0.075 0.00572 0.68 0.6775 1.0 2060297 SpecPlus_000427 COc1cccc2c(C)cc(O)nc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F10 compound treatment 0.073 0.00372 0.44 0.4405 1.0 2498 SpecPlus_000428 COc1c(Cl)ccc(Cl)c1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F11 compound treatment 0.0765 0.00722 0.86 0.8552 1.0 2060298 SpecPlus_000429 CCCCCC1C(CC(=O)O)CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F12 compound treatment 0.0755 0.00622 0.74 0.7367 1.0 2499 SpecPlus_000430 CCCCN(CC)c1c(cc(cc1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F13 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2060299 SpecPlus_000431 CC1(C)CC2/C(=C/C=C/C(C)(O)CCC21O)/CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F14 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2500 SpecPlus_000432 COc1nc(NC(C)C)nc(NC(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F15 compound treatment 0.074 0.00472 0.56 0.559 1.0 2060300 SpecPlus_000433 COc1ccc(cc1)c2cc(=O)c3c(O)cc(O)c(c4cc(ccc4OC)c5cc(=O)c6c(O)cc(O)cc6o5)c3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F16 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2501 SpecPlus_000434 CCc1cccc(C)c1N(C(C)COC)C(=O)CCl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F17 compound treatment 0.072 0.00272 0.32 0.322 1.0 2060301 SpecPlus_000435 COc1ccc(cc1O)c2cc(=O)c3c(O)cc(O)cc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F18 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2502 SpecPlus_000436 Clc1cccc(Cl)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F19 compound treatment 0.071 0.00172 0.2 0.2035 1.0 3054976 SpecPlus_000437 CC(C)[C@@H]1CC[C@@H](C)CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F20 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2503 SpecPlus_000438 CSc1nc(NC(C)C)nc(NC(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F21 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2060302 SpecPlus_000439 CC(C)CCC[C@@H](C)CCC[C@@H](C)CC/C(=C/CO)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F22 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 2504 SpecPlus_000440 CCCN(CCC)c1c(cc(cc1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F23 mock treatment 0.07 7.18E-4 0.09 0.085 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 F24 mock treatment 0.0715 0.00222 0.26 0.2628 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G01 mock treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G02 mock treatment 0.064 -0.00528 -0.63 -0.6259 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G03 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 2475 SpecPlus_000441 CC(=CC1C(C(=O)O)C1(C)C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G04 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 2060303 SpecPlus_000442 Cc1occc(=O)c1/C=C/O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G05 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 1003823 SpecPlus_000443 Cc1occc(=O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G06 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 2060304 SpecPlus_000444 OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)[C@@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G07 compound treatment 0.076 0.00672 0.8 0.796 1.0 3174490 SpecPlus_000445 COc1cc2OC[C@H]3Oc4c5C[C@@H](Oc5cc(O)c4C(=O)[C@H]3c2cc1OC)C(=C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G08 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2060305 SpecPlus_000446 CCCCC[C@H](CC(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G09 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2060306 SpecPlus_000447 C[C@@H](CCOC(=O)C)CCC=C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G10 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 401 SpecPlus_000448 COc1cccc2c1cc([N+](=O)[O-])c3c(cc4OCOc4c23)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G11 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2060307 SpecPlus_000449 COc1ccc2[C@@H](O)[C@H](Cc3ccc(OC)c(OC)c3)COc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G12 compound treatment 0.073 0.00372 0.44 0.4405 1.0 2060308 SpecPlus_000450 C/C(=C/C(=O)O)/C=C/C1(O)C(=CC(=O)CC1(C)C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G13 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 3174492 SpecPlus_000451 CN1[C@H]2CC3CC1C(O)C2O3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G14 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 1043296 SpecPlus_000452 Cc1nccc2c3ccc(O)cc3[nH]c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G15 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 1052459 SpecPlus_000453 COc1c2ccoc2cc3oc(C)cc(=O)c13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G16 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 3054980 SpecPlus_000454 Nc1ncnc2n(cnc12)C3C[C@H](O)[C@@H](CO)O3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G17 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 3174493 SpecPlus_000455 N[C@H]([C@@H](O)[C@H](O)[C@H](O)CO)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G18 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 2060309 SpecPlus_000456 CC12CCC3C(CCC4(O)CC(O)CCC34/C=N/NC(=O)N)C2(O)CCC1C5=CC(=O)OC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G19 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 1003215 SpecPlus_000457 CC(C)C1=CC(=O)C(=CC1=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G20 compound treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 3054981 SpecPlus_000458 COc1ccc(cc1)c2cc(=O)c3c(OC(=O)C)cc(OC(=O)C)cc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G21 compound treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 2060310 SpecPlus_000459 CC(C)C1=CC2=CC[C@H]3[C@](C)(CO)CCC[C@]3(C)C2CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G22 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 1113841 SpecPlus_000460 Oc1ccc2c(=O)c(O)c(oc2c1)c3ccc(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G23 mock treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 G24 mock treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H01 mock treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H02 mock treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H03 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 3174602 SpecPlus_000461 O=c1[nH]cnc2nc[nH]c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H04 compound treatment 0.075 0.00572 0.68 0.6775 1.0 2505 SpecPlus_000462 CC(C)N1C(=O)c2ccccc2NS1(=O)=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H05 compound treatment 0.073 0.00372 0.44 0.4405 1.0 1016582 SpecPlus_000463 COc1cc(O)c2c(=O)c(O)c(oc2c1)c3ccc(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H06 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2506 SpecPlus_000464 OC(=O)COc1ccc(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H07 compound treatment 0.08 0.0107 1.27 1.2699 1.0 2060311 SpecPlus_000465 CC(CCC(=O)O)[C@H]1CCC2C3CC[C@@H]4CC(=O)CC[C@]4(C)C3C=C[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H08 compound treatment 0.0755 0.00622 0.74 0.7367 1.0 2507 SpecPlus_000466 OC(=O)CCCOc1ccc(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H09 compound treatment 0.078 0.00872 1.03 1.033 1.0 2060312 SpecPlus_000467 NC(Cc1ccc(O)cc1)C(=O)N[C@@H](CCCNC(=N)N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H10 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 2508 SpecPlus_000468 OC(=O)COc1cc(Cl)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H11 compound treatment 0.0765 0.00722 0.86 0.8552 1.0 2060313 SpecPlus_000469 C/C/1=C/CC(C)(C)\C=C\C\C(=C\CC1)\C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H12 compound treatment 0.08 0.0107 1.27 1.2699 1.0 2509 SpecPlus_000470 CCc1cccc(CC)c1N(COC)C(=O)CCl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H13 compound treatment 0.072 0.00272 0.32 0.322 1.0 1090658 SpecPlus_000471 COc1cc(O)c2C(=O)c3c(O)cc(C)cc3C(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H14 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2510 SpecPlus_000472 COC(=O)COc1ccc(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H15 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 3419385 SpecPlus_000473 CC12CC=C3C(CCC4=CC(=O)C=CC43C)C2CCC1C(=O)CN5CCN(CC5)c6cc(nc(n6)N7CCCC7)N8CCCC8 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H16 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2511 SpecPlus_000474 COC(=O)CCCOc1ccc(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H17 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2572 SpecPlus_000475 COc1cc2CC[N+](C)(C)[C@@H]3Cc4ccc(O)c(Oc5cc6[C@H](Cc7ccc(Oc(c1O)c32)cc7)N(C)CCc6cc5OC)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H18 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2512 SpecPlus_000476 COC(=O)COc1cc(Cl)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H19 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 1119359 SpecPlus_000477 COc1cc2ccc(=O)oc2c(O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H20 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2513 SpecPlus_000478 OC(=O)CNCP(=O)(O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H21 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 2060314 SpecPlus_000479 COC(=O)c1c(C)c2Oc3c(Cl)c(OC)c(Cl)c(C)c3C(=O)Oc2c(C)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H22 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2514 SpecPlus_000480 CCCCCCC(C)OC(=O)COc1ccc(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H23 mock treatment 0.0695 2.18E-4 0.03 0.0258 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 H24 mock treatment 0.07 7.18E-4 0.09 0.085 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I01 mock treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I02 mock treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I03 compound treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 3174607 SpecPlus_000481 CC[C@@H]1[C@@H](OC(=O)C)N2[C@H]3C[C@@]45C(OC(=O)C)C3[C@@H]1CC2[C@@H]5N(C)c6ccccc64 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I04 compound treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 1010348 SpecPlus_000482 OC1=CC(=O)c2ccccc2C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I05 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2060046 SpecPlus_000483 C[C@H]1[C@@H]2CC[C@@]3(C)C=CC(=O)[C@@]4(C)O[C@]43[C@H]2OC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I06 compound treatment 0.0695 2.18E-4 0.03 0.0258 1.0 1009367 SpecPlus_000484 OC1=CC2=C3c4ccc(O)c(O)c4OCC3(O)CC2=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I07 compound treatment 0.073 0.00372 0.44 0.4405 1.0 1003115 SpecPlus_000485 COc1cc(cc(OC)c1O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I08 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2060315 SpecPlus_000486 C[N+]1(C)C[C@H](O)[C@@H](C1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I09 compound treatment 0.073 0.00372 0.44 0.4405 1.0 2060316 SpecPlus_000487 COc1c2C=CC(C)(C)Oc2cc3occ(c4ccc5OCOc5c4)c(=O)c13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I10 compound treatment 0.071 0.00172 0.2 0.2035 1.0 1002002 SpecPlus_000488 O[C@@H]1CC(=C[C@@H](O)[C@H]1O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I11 compound treatment 0.0765 0.00722 0.86 0.8552 1.0 2060317 SpecPlus_000489 COc1cc(OC)c2c(OC)c(c3ccc4OCOc4c3)c(=O)oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I12 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 1024984 SpecPlus_000490 COc1cc2cccc(OC)c(=O)c2c(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I13 compound treatment 0.0595 -0.00978 -1.16 -1.1591 -1.0 1065857 SpecPlus_000491 NC(CNC(=O)N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I14 compound treatment 0.064 -0.00528 -0.63 -0.6259 -1.0 3174608 SpecPlus_000492 COC1C(O)C(O)C(O)[C@@H](O)C1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I15 compound treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 1651081 SpecPlus_000493 COc1cc(O)c2c(=O)c(coc2c1)c3ccc(O)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I16 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 3174609 SpecPlus_000494 CC(C)c1c(C(=O)c2ccccc2)c(c(c3ccc(F)cc3)n1CC[C@@H](O)C[C@@H](O)CC(=O)O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I17 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 1011559 SpecPlus_000495 Cc1cc(=O)oc2cc(O)c(O)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I18 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 3174610 SpecPlus_000496 COc1cc(cc(OC)c1OC)C(=O)O[C@H]2CC[C@@]3(C)[C@@H]4CC[C@@H]5[C@@]3(C[C@@]6(O)[C@@H]7CN8C[C@@H](C)CC[C@H]8[C@@](C)(O)[C@@]7(O)[C@@H](O)C[C@@]56O)O[C@@]42O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I19 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 1030891 SpecPlus_000497 Cc1cc(=O)oc2c(O)c(O)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I20 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 2060318 SpecPlus_000498 C/C(=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@]12O[C@]2(C)C[C@@H](O)CC1(C)C)/C=C/C=C(\C)/C=C/C3=C(C)C[C@@H](O)CC3(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I21 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2060319 SpecPlus_000499 COc1ccc(cc1)c2oc3ccccc3c(=O)c2OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I22 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 839435 SpecPlus_000500 NCCCCNC(=N)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I23 mock treatment 0.0655 -0.00378 -0.45 -0.4482 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 I24 mock treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J01 mock treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J02 mock treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J03 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 854065 SpecPlus_000501 CCCCCCCCCCCC1=C(O)C(=O)C=C(O)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J04 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2515 SpecPlus_000502 CCCCCCC(C)OC(=O)COc1cc(Cl)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J05 compound treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 2060320 SpecPlus_000503 COc1ccc2CC[C@@H]3CC(=O)CC[C@]3(C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J06 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 2516 SpecPlus_000504 CC(C)OC(=O)Nc1cccc(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J07 compound treatment 0.073 0.00372 0.44 0.4405 1.0 2060321 SpecPlus_000505 C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc3cc(O)c4c(=O)cc(oc4c3)c5ccc(O)cc5)[C@H](O)[C@H](O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J08 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2517 SpecPlus_000506 CC(C)N(C(=O)CCl)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J09 compound treatment 0.073 0.00372 0.44 0.4405 1.0 2060322 SpecPlus_000507 COc1ccc2c(=O)c(OC)c(oc2c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J10 compound treatment 0.077 0.00772 0.91 0.9145 1.0 2518 SpecPlus_000508 CCCCSP(=O)(SCCCC)SCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J11 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2060323 SpecPlus_000509 COc1ccccc1c2cc(=O)c3c(OC)cccc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J12 compound treatment 0.074 0.00472 0.56 0.559 1.0 2519 SpecPlus_000510 CC(C)N(C(C)C)C(=O)SCC(=C(Cl)Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J13 compound treatment 0.064 -0.00528 -0.63 -0.6259 -1.0 2060324 SpecPlus_000511 CC12CC[C@@H]3[C@H](CC3(C)C)C(=C)CC2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J14 compound treatment 0.065 -0.00428 -0.51 -0.5074 -1.0 2520 SpecPlus_000512 Clc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J15 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 3174614 SpecPlus_000513 CC(C)CCCC(C)C1CCC2C3CC=C4C[C@@H](O)CCC4(C)C3CCC12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J16 compound treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 2521 SpecPlus_000514 Oc1c(Cl)c(Cl)c(Cl)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J17 compound treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 3174615 SpecPlus_000515 CC(C)CCCC(C)[C@H]1CCC2C3CC=C4CC(=O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J18 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 2522 SpecPlus_000516 CNC(=O)Oc1cccc2CC(C)(C)Oc21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J19 compound treatment 0.0695 2.18E-4 0.03 0.0258 1.0 2060325 SpecPlus_000517 COc1ccc2C[C@@H]3N(C)CCc4cc(OC)c(OC)c(c34)-c2c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J20 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 2523 SpecPlus_000518 CCOP(=S)(OCC)Oc1nc(Cl)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J21 compound treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 1737132 SpecPlus_000519 COc1cc-2c(CC3N(C)CCc4cc(O)c(OC)c2c34)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J22 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 2524 SpecPlus_000520 COP(=O)(NC(=O)C)SC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J23 mock treatment 0.0655 -0.00378 -0.45 -0.4482 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 J24 mock treatment 0.0655 -0.00378 -0.45 -0.4482 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K01 mock treatment 0.065 -0.00428 -0.51 -0.5074 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K02 mock treatment 0.0655 -0.00378 -0.45 -0.4482 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K03 compound treatment 0.065 -0.00428 -0.51 -0.5074 -1.0 1499608 SpecPlus_000521 COc1ccc2c(=O)cc(oc2c1)c3ccccc3OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K04 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 2060326 SpecPlus_000522 CC(=C)C1CC[C@@](C)(O)C2CC3OC3(C)C2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K05 compound treatment 0.077 0.00772 0.91 0.9145 1.0 1031375 SpecPlus_000523 NC(CCCNC(=O)N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K06 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 2060327 SpecPlus_000524 COc1cc2CCN(C)[C@H]3Oc4ccc(O)c(Oc5cc6[C@H](Cc7ccc(Oc(c1O)c32)cc7)N(C)CCc6cc5OC)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K07 compound treatment 0.072 0.00272 0.32 0.322 1.0 2060328 SpecPlus_000525 CC(C)CC(=O)c1c(O)c(C)c(O)c2c1oc3c(C(=O)CC(C)C)c(O)c(C)c(O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K08 compound treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 3172723 SpecPlus_000526 CC(=O)OC[C@@]1(O)C[C@@]2(C[C@H]1CCC23)CCC4c5ccoc5CC[C@@]43C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K09 compound treatment 0.071 0.00172 0.2 0.2035 1.0 1001933 SpecPlus_000527 CNC(=O)Oc1ccc2N(C)C3N(C)CCC3(C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K10 compound treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 1978 SpecPlus_000528 OC(=O)/C=C/c1ccc(O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K11 compound treatment 0.0695 2.18E-4 0.03 0.0258 1.0 2060329 SpecPlus_000529 CCOc1ccc(cc1)c2cc(=O)c3c(OCC)cc(OCC)c(c4cc(ccc4OC)c5cc(=O)c6c(OCC)cc(OC)cc6o5)c3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K12 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 2060330 SpecPlus_000530 OC[C@H](O)[C@@H](O)[C@H](O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)[C@H](O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K13 compound treatment 0.0655 -0.00378 -0.45 -0.4482 -1.0 2181 SpecPlus_000531 Oc1cc(O)c2c(=O)c(O)c(oc2c1)c3cc(O)c(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K14 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 2554 SpecPlus_000532 C[C@H]1[C@H]2CCC3C4CC=C5C[C@H](CC[C@]5(C)C4CC[C@]23CN1C)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K15 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 2060331 SpecPlus_000533 CC1=CCC(=C)[C@H]2CC(C)(C)[C@@H]2CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K16 compound treatment 0.065 -0.00428 -0.51 -0.5074 -1.0 2060332 SpecPlus_000534 OC/C=C/c1ccc(O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K17 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 1013195 SpecPlus_000535 Nc1ncnc2[nH]cnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K18 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 3055245 SpecPlus_000536 CCC[C@@H]1CCCCN1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K19 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 3172726 SpecPlus_000537 C[C@]12C3CCC(O3)[C@]2(C)C(=O)OC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K20 compound treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 3055248 SpecPlus_000538 C=CC(C1=CC(=O)C=CC1=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K21 compound treatment 0.0655 -0.00378 -0.45 -0.4482 -1.0 3172727 SpecPlus_000539 CC(=C)[C@@H]1CC[C@]2(CO)CC[C@]3(C)[C@H](CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)C12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K22 compound treatment 0.065 -0.00428 -0.51 -0.5074 -1.0 2060333 SpecPlus_000540 COc1ccc(/C=C/c2cc(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K23 mock treatment 0.064 -0.00528 -0.63 -0.6259 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 K24 mock treatment 0.0655 -0.00378 -0.45 -0.4482 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L01 mock treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L02 mock treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L03 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 4895 SpecPlus_000541 C[n+]1cccc(c1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L04 compound treatment 0.0695 2.18E-4 0.03 0.0258 1.0 3172728 SpecPlus_000542 CNC(=O)O/N=C(/C)\SC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L05 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 2060334 SpecPlus_000543 C[C@H]1[C@@H](O)C[C@H]2[C@@H]1[C@H](O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)OC=C2C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L06 compound treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 3055253 SpecPlus_000544 CNC(=O)O/N=C/C(C)(C)SC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L07 compound treatment 0.072 0.00272 0.32 0.322 1.0 1275107 SpecPlus_000545 C1Cc2c(CN1)[nH]c3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L08 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2527 SpecPlus_000546 COP(=S)(OC)Oc1ccc(Sc2ccc(OP(=S)(OC)OC)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L09 compound treatment 0.071 0.00172 0.2 0.2035 1.0 802058 SpecPlus_000547 COc1cc(/C=C/C(=O)O)ccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L10 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2528 SpecPlus_000548 CNC(=O)Oc1cccc2OC(C)(C)Oc21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L11 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2081691 SpecPlus_000549 CC(=CCC/C(=C/CC/C(=C/CO)/C)/C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L12 compound treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 2529 SpecPlus_000550 COP(=S)(OC)Oc1ccc(SC)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L13 compound treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 3172730 SpecPlus_000551 OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NCc4ccco4)ncnc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L14 compound treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 2530 SpecPlus_000552 CCCSP(=O)(OCC)SCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L15 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 907179 SpecPlus_000553 C/C(=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)C(O)CC1(C)C)/C=C/C=C(\C)/C=C/C2=C(C)C(=O)C(O)CC2(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L16 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 2531 SpecPlus_000554 CNC(=O)Oc1ccccc1OC(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L17 compound treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 1713087 SpecPlus_000555 COc1ccc(cc1OC)c2cc(=O)c3ccccc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L18 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 2532 SpecPlus_000556 CC(C)(C)c1ccc(OC2CCCCC2OS(=O)OCC#C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L19 compound treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 2060335 SpecPlus_000557 Oc1ccc2C3Oc4cc5OCOc5cc4C3COc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L20 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 2533 SpecPlus_000558 Clc1ccc(cc1)C(c2ccc(Cl)cc2)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L21 compound treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 3172732 SpecPlus_000559 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@](C)(C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L22 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 3055306 SpecPlus_000560 C[C@@H]1CC[C@]2(CO)CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)C(C)(C)C5CC[C@]43C)[C@@H]2[C@H]1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L23 mock treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 L24 mock treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M01 mock treatment 0.065 -0.00428 -0.51 -0.5074 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M02 mock treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M03 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 3172733 SpecPlus_000561 Cc1c(C(=O)O)c(O)cc2C(=O)c3c(O)c(O)c(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(O)c3C(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M04 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 2060336 SpecPlus_000562 CCOc1cccc(c1)C(=O)c2ccc(O)c(O)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M05 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 3055308 SpecPlus_000563 COC(=O)C1=CO[C@@H](O[C@@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@@H]3[C@@H](C)[C@@H](O)C[C@@H]31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M06 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 2060337 SpecPlus_000564 COc1ccc(cc1O)c2oc3cc(O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)c(OC)c(O)c3c(=O)c2OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M07 compound treatment 0.072 0.00272 0.32 0.322 1.0 3055310 SpecPlus_000565 COc1c(O)cc2C(=O)O[C@H]3[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]3c2c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M08 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2060338 SpecPlus_000566 CC(C)c1ccc2c(CC[C@H]3C4=C(CC[C@@]32C)C(=O)OC4)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M09 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2060339 SpecPlus_000567 COc1cc2N3C4[C@H]5[C@H]6C[C@@H]7N(CC[C@@]74c2cc1OC)CC6=CCOC5CC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M10 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 3055313 SpecPlus_000568 CC(C)[C@@]12O[C@H]2[C@@H]3O[C@]34[C@]5(O[C@H]5C[C@H]6C7=C(CC[C@@]64C)C(=O)OC7)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M11 compound treatment 0.072 0.00272 0.32 0.322 1.0 1113269 SpecPlus_000569 CN1Cc2c3OCOc3ccc2C4C(O)Cc5cc6OCOc6cc5C41 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M12 compound treatment 0.069 -2.82E-4 -0.03 -0.0334 -1.0 2060340 SpecPlus_000570 CC(=O)/C(=C\c1ccccc1)/CC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M13 compound treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 1064620 SpecPlus_000571 COC1=CC23CCCN3CCc4cc5OCOc5cc4C2C1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M14 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 2060341 SpecPlus_000572 COc1ccc2C(=O)C3(CC3Oc2c1)c4ccccc4OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M15 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 2060342 SpecPlus_000573 O[C@@H]1[C@H](Oc2cc(O)ccc2C1=O)c3cc(O)c(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M16 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 1020994 SpecPlus_000574 COc1c(O)cc2oc3cc(O)c(CC=C(C)C)c(O)c3c(=O)c2c1CC=C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M17 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2060343 SpecPlus_000575 CCCc1occc(=O)c1/C=C/O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M18 compound treatment 0.0855 0.0162 1.92 1.9216 1.0 3172852 SpecPlus_000576 CC1(C)CC[C@@]2(CC[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O)[C@@](C)(CO)C5CC[C@]43C)C2C1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M19 compound treatment 0.068 -0.00128 -0.15 -0.1519 -1.0 3055321 SpecPlus_000577 CC(CCC(=O)O)[C@H]1CCC2C3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)C3C[C@H](O)[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M20 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 3172853 SpecPlus_000578 C[C@@H]1OC(O[C@@H]2[C@@H](O)[C@@H](O)COC2O[C@H]3CC[C@@]4(C)C(CC[C@]5(C)C4CC=C6C7CC(C)(C)CC[C@@]7(CC[C@]65C)C(=O)O)[C@]3(C)CO)[C@H](O)[C@H](O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M21 compound treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 2060344 SpecPlus_000579 CC(CCC(=O)O)[C@H]1CCC2C3CC[C@@H]4C[C@H](O)CC[C@]4(C)C3C=C[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M22 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 2060345 SpecPlus_000580 C[C@@H]1OC(O[C@H]2[C@H](O)[C@@H](O)[C@H](OC[C@H]3O[C@@H](OC(=O)[C@@]45CCC(C)(C)CC5C6=CCC7[C@@]8(C)CC[C@H](OC9OC[C@H](O)[C@H](O)[C@H]9OC%10O[C@@H](C)[C@H](O)[C@@H](O)[C@H]%10O)[C@@](C)(CO)C8CC[C@@]7(C)[C@]6(C)CC4)[C@H](O)[C@@H](O)[C@@H]3O)O[C@@H]2CO)[C@H](O)[C@H](O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M23 mock treatment 0.0685 -7.82E-4 -0.09 -0.0927 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 M24 mock treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N01 mock treatment 0.064 -0.00528 -0.63 -0.6259 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N02 mock treatment 0.0695 2.18E-4 0.03 0.0258 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N03 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2060346 SpecPlus_000581 CC(=O)Oc1cc2c(CC=C3[C@@]2(C)CC[C@@]4(C)C5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(=O)O)c(C)c1OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N04 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2534 SpecPlus_000582 ClC(=C(c1ccc(Cl)cc1)c2ccc(Cl)cc2)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N05 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2060347 SpecPlus_000583 COc1cc(ccc1O)c2oc3c(OC)c(O)cc(O)c3c(=O)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N06 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2535 SpecPlus_000584 CC1(C)C(C(Cl)Cl)C2(Cl)C(Cl)C(Cl)C1(Cl)C2(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N07 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2060348 SpecPlus_000585 CCC/C=C/1\OC(=O)C2=C1CCC=C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N08 compound treatment 0.076 0.00672 0.8 0.796 1.0 2536 SpecPlus_000586 ClC1CC2C(C1Cl)C3(Cl)C(Cl)C(Cl)C2(Cl)C3(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N09 compound treatment 0.0735 0.00422 0.5 0.4998 1.0 3055363 SpecPlus_000587 COc1cc(/C=C/C(=C/C(=O)\C=C\c2ccc(O)c(OC)c2)/O)ccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N10 compound treatment 0.073 0.00372 0.44 0.4405 1.0 2537 SpecPlus_000588 COc1ccc(cc1)C(c2ccc(OC)cc2)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N11 compound treatment 0.073 0.00372 0.44 0.4405 1.0 2060349 SpecPlus_000589 CCC[C@H]1CC2=C(C[C@@H](CC)CC3=C1C(=O)OC3=O)C(=O)OC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N12 compound treatment 0.079 0.00972 1.15 1.1515 1.0 2538 SpecPlus_000590 ClC1C=CC2C1C3(Cl)C(=C(Cl)C2(Cl)C3(Cl)Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N13 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 2060350 SpecPlus_000591 CC(=O)O[C@@H]1CC2C(C)(C)[C@H](O)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]13C)c5ccoc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N14 compound treatment 0.081 0.0117 1.39 1.3884 1.0 2539 SpecPlus_000592 CC1(C)C2(Cl)C(Cl)C1(Cl)C(Cl)(C(Cl)Cl)C(Cl)C2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N15 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 3172856 SpecPlus_000593 O[C@H]1C=C2CCN3Cc4cc5OCOc5cc4C(C32)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N16 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2540 SpecPlus_000594 ClC1=C(Cl)C2(Cl)C3C4CC(C=C4)C3C1(Cl)C2(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N17 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2060351 SpecPlus_000595 C[C@H]1[C@H]2[C@H](CC3C4CC[C@H]5C[C@H](CC[C@]5(C)C4=CC(=O)[C@]23C)OC(=O)C)OC61OCC(C)CC6Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N18 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2060352 SpecPlus_000596 O=C(O[C@H]1Cc2c(OC(=O)c3ccccc3)cc(OC(=O)c4ccccc4)cc2O[C@@H]1c5ccc(OC(=O)c6ccccc6)c(OC(=O)c7ccccc7)c5)c8ccccc8 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N19 compound treatment 0.072 0.00272 0.32 0.322 1.0 3055370 SpecPlus_000597 COC(=O)c1c(C)c2Oc3c(Cl)c(OC(=O)C)c(Cl)c(C)c3C(=O)Oc2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N20 compound treatment 0.071 0.00172 0.2 0.2035 1.0 2060353 SpecPlus_000598 Cc1c(O)cc(O)c2c(=O)c(coc12)c3ccc(O)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N21 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2060354 SpecPlus_000599 COc1ccc(cc1)c2coc3cc(OC(=O)C)cc(OC(=O)C)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N22 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2541 SpecPlus_000600 ClC1=C(Cl)C2(Cl)C3COS(=O)OCC3C1(Cl)C2(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N23 mock treatment 0.0725 0.00322 0.38 0.3813 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 N24 mock treatment 0.0745 0.00522 0.62 0.6183 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O01 mock treatment 0.072 0.00272 0.32 0.322 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O02 mock treatment 0.066 -0.00328 -0.39 -0.3889 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O03 compound treatment 0.0665 -0.00278 -0.33 -0.3297 -1.0 2060355 SpecPlus_000601 CC1=C(C=C)/C(=C/c2[nH]c(Cc3[nH]c(\C=C\4/NC(=O)C(=C4C)C=C)c(C)c3CCC(=O)O)c(CCC(=O)O)c2C)/NC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O04 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 829 SpecPlus_000602 CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)c3c(C)cc4c(C(C)C)c(O)c(O)c(C=O)c4c3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O05 compound treatment 0.072 0.00272 0.32 0.322 1.0 1055132 SpecPlus_000603 COc1cc2cc[n+]3c(C)c4cc(OC)c(OC)cc4cc3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O06 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 1054504 SpecPlus_000604 COc1c(OCC(O)C(C)(C)O)ccc2c(OC)c3ccoc3nc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O07 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 2060356 SpecPlus_000605 CC(C)CCCC1(C)Oc2c(CCC(C)C)c3OC4(C5CC6CC4C(=O)c3c(O)c2C=C1)C(CCC(C)C(=O)O)(OC5(C)C)C6O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O08 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 3055414 SpecPlus_000606 OC[C@@H]1CCCN2CCCC[C@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O09 compound treatment 0.074 0.00472 0.56 0.559 1.0 2060357 SpecPlus_000607 CC(=O)O[C@@H]1CC2C(C)(C)CCC(=O)[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C5OC54[C@]13C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O10 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 1024517 SpecPlus_000608 COc1cc2CCNC(C)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O11 compound treatment 0.071 0.00172 0.2 0.2035 1.0 1035065 SpecPlus_000609 Cc1nccc2c3ccccc3[nH]c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O12 compound treatment 0.072 0.00272 0.32 0.322 1.0 1592184 SpecPlus_000610 O=C1CCCC2C3CC(CN21)[C@@H]4CCCCN4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O13 compound treatment 0.0765 0.00722 0.86 0.8552 1.0 297849 SpecPlus_000611 COc1ccc2c(c1)[nH]c3c(C)nccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O14 compound treatment 0.072 0.00272 0.32 0.322 1.0 2060358 SpecPlus_000612 C[C@@H]1CCC2[C@](C)(CO)[C@@H](O)CC[C@]2(C)[C@]31CC[C@@](CO)(CCO)O3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O15 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 2060359 SpecPlus_000613 COc1ccc(cc1)c2c(O)c3c(OC)c4C=CC(C)(C)Oc4cc3oc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O16 compound treatment 0.075 0.00572 0.68 0.6775 1.0 1052338 SpecPlus_000614 COc1cc2C(C)NCCc2cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O17 compound treatment 0.073 0.00372 0.44 0.4405 1.0 2060360 SpecPlus_000615 C1CN=C(C1)c2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O18 compound treatment 0.077 0.00772 0.91 0.9145 1.0 852250 SpecPlus_000616 C1CCC(NC1)c2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O19 compound treatment 0.081 0.0117 1.39 1.3884 1.0 1040989 SpecPlus_000617 c1ccc2c(c1)[nH]c3ncccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O20 compound treatment 0.076 0.00672 0.8 0.796 1.0 3172862 SpecPlus_000618 O=c1cccc2C3CNC[C@@H](C3)Cn21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O21 compound treatment 0.073 0.00372 0.44 0.4405 1.0 1084508 SpecPlus_000619 COc1ccc2cc3-c4cc(OC)c(OC)cc4CC[n+]3cc2c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O22 compound treatment 0.0765 0.00722 0.86 0.8552 1.0 2060361 SpecPlus_000620 C/C=C(/C)\C(=O)O[C@@H]1[C@H](OC(=O)C)[C@]2(CO)[C@H](O)C[C@]3(C)C(=CCC4[C@@]5(C)CC[C@H](O[C@@H]6O[C@@H]([C@@H](O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O[C@@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)C(=O)O)[C@](C)(CO)C5CC[C@]43C)C2CC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O23 mock treatment 0.079 0.00972 1.15 1.1515 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 O24 mock treatment 0.0775 0.00822 0.97 0.9737 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P01 mock treatment 0.061 -0.00828 -0.98 -0.9814 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P02 mock treatment 0.0615 -0.00778 -0.92 -0.9221 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P03 compound treatment 0.0745 0.00522 0.62 0.6183 1.0 2060362 SpecPlus_000621 COc1ccc(cc1)c2c(OC)c3c(OC)c4C=CC(C)(C)Oc4cc3oc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P04 compound treatment 0.0595 -0.00978 -1.16 -1.1591 -1.0 2542 SpecPlus_000622 CCCCOC(=O)c1ccccc1C(=O)OCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P05 compound treatment 0.0735 0.00422 0.5 0.4998 1.0 2060363 SpecPlus_000623 COc1cc(O)cc(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P06 compound treatment 0.08 0.0107 1.27 1.2699 1.0 2543 SpecPlus_000624 CCCCCCCCCc1ccc(O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P07 compound treatment 0.072 0.00272 0.32 0.322 1.0 2060364 SpecPlus_000625 CC(=O)O[C@@H]1C[C@H](OC(=O)C)[C@@]2(C)C(C[C@@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C=C43)c5ccoc5)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P08 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 2544 SpecPlus_000626 CCOCN(C(=O)CCl)c1c(C)cccc1CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P09 compound treatment 0.0785 0.00922 1.09 1.0922 1.0 3172979 SpecPlus_000627 C[C@H]1C2C(CC3C4CC=C5C[C@@H](O)CC[C@]5(C)C4CC[C@]23C)O[C@@]61CC[C@@H](C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P10 compound treatment 0.0775 0.00822 0.97 0.9737 1.0 2545 SpecPlus_000628 CCCCOC(=O)c1ccccc1C(=O)OCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P11 compound treatment 0.0765 0.00722 0.86 0.8552 1.0 2060365 SpecPlus_000629 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)C3OC3[C@]2(C)C4CC[C@@]5(C)[C@@H](OC(=O)C6OC65[C@]14C)c7ccoc7 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P12 compound treatment 0.0735 0.00422 0.5 0.4998 1.0 1304 SpecPlus_000630 ClC1=C(Cl)C2(Cl)C3C4CC(C5OC54)C3C1(Cl)C2(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P13 compound treatment 0.0705 0.00122 0.14 0.1443 1.0 2060366 SpecPlus_000631 CC1(C)C=CC(=O)[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P14 compound treatment 0.073 0.00372 0.44 0.4405 1.0 2060367 SpecPlus_000632 CS(=O)(=O)CCCCN=C=S 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P15 compound treatment 0.075 0.00572 0.68 0.6775 1.0 2060368 SpecPlus_000633 CNC(Cc1c[nH]c2ccccc12)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P16 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 2060369 SpecPlus_000634 C[C@@]12CCC(=O)C[C@H]2CC[C@]3(CC4CC[C@H]31)C[C@]4(O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P17 compound treatment 0.0725 0.00322 0.38 0.3813 1.0 2060370 SpecPlus_000635 COc1cc2OCOc2cc1c3coc4c5C=CC(C)(C)Oc5c(OC)cc4c3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P18 compound treatment 0.063 -0.00628 -0.74 -0.7444 -1.0 2060371 SpecPlus_000636 COC(=O)C[C@H]1C(C)(C)C2(O)OC34CC2C(=O)[C@]1(C)C4CC[C@@]5(C)[C@@H](OC(=O)C=C35)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P19 compound treatment 0.0715 0.00222 0.26 0.2628 1.0 2060372 SpecPlus_000637 COC(=O)C[C@H]1C(C)(C)C(=O)[C@@H]2CC3=C(CC[C@@]4(C)[C@@H](OC(=O)C=C34)c5ccoc5)[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P20 compound treatment 0.067 -0.00228 -0.27 -0.2704 -1.0 2060373 SpecPlus_000638 COc1c(O)cc2c(cc(=O)oc2c1OC)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P21 compound treatment 0.063 -0.00628 -0.74 -0.7444 -1.0 2060374 SpecPlus_000639 CCC(C)C(OC(=O)C)C(=O)O[C@H]1[C@H](O)C2[C@@]3(C)C=CC(=O)C(C)(C)C3C[C@@H](OC(=O)C(O)C(C)C)[C@@]2(C)[C@]45O[C@@H]5C[C@@H](c6ccoc6)[C@]14C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P22 compound treatment 0.07 7.18E-4 0.09 0.085 1.0 3055472 SpecPlus_000640 CC(C)CCCC(C)[C@H]1CCC2C3CC[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P23 mock treatment 0.0635 -0.00578 -0.69 -0.6851 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1082 P24 mock treatment 0.0675 -0.00178 -0.21 -0.2112 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A01 mock treatment 0.092 0.0165 1.95 1.9522 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A02 mock treatment 0.0825 0.00698 0.83 0.8265 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A03 compound treatment 0.0815 0.00598 0.71 0.708 1.0 1492782 SpecPlus_000641 OCNC(=O)c1cccnc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A04 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 2060375 SpecPlus_000642 CC(=O)O[C@H]1C[C@@H](O)C(C)(C)C2CC(=O)[C@]3(C)C(CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6)[C@@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A05 compound treatment 0.089 0.0135 1.6 1.5967 1.0 2060376 SpecPlus_000643 CC(=O)Oc1cccc2C(=O)c3cc(cc(OC(=O)C)c3C(=O)c12)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A06 compound treatment 0.066 -0.00952 -1.13 -1.1286 -1.0 3055475 SpecPlus_000644 COc1ccc(/C=C/C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A07 compound treatment 0.0865 0.011 1.3 1.3005 1.0 1009851 SpecPlus_000645 O=C1c2ccccc2C(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A08 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 1047043 SpecPlus_000646 COc1cc(C)c(C(=O)Oc2cc(C)c(C(=O)O)c(O)c2)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A09 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 1693 SpecPlus_000647 NCCCNCCSP(=O)(O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A10 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2060377 SpecPlus_000648 COc1c(ccc2OC(C)(C)CCc12)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A11 compound treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 3172984 SpecPlus_000649 COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CC=C5C(=C(O)C(=O)C=C5[C@]4(C)CC[C@@]3(C)[C@@H]2C1)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A12 compound treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 2060378 SpecPlus_000650 Oc1nc2cc(Cl)c(Cl)cc2nc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A13 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2060379 SpecPlus_000651 COc1ccc(cc1)c2coc3c(OC)c(OC)ccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A14 compound treatment 0.0665 -0.00902 -1.07 -1.0693 -1.0 2060380 SpecPlus_000652 CCC(=O)OCC(=O)[C@@]1(OC(=O)CC)[C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)C3(F)[C@@H](O)C[C@@]21C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A15 compound treatment 0.0645 -0.011 -1.31 -1.3063 -1.0 1111718 SpecPlus_000653 NC1(CCC1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A16 compound treatment 0.063 -0.0125 -1.48 -1.484 -1.0 1001282 SpecPlus_000654 NCCS 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A17 compound treatment 0.0685 -0.00702 -0.83 -0.8323 -1.0 2060381 SpecPlus_000655 COc1c(Cl)c(C)c2Oc3c(Cl)c(OC)c(Cl)c(C)c3C(=O)Oc2c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A18 compound treatment 0.077 0.00148 0.17 0.1748 1.0 1001451 SpecPlus_000656 Cc1cc(C)cc(OCC2CNC(=O)O2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A19 compound treatment 0.083 0.00748 0.89 0.8858 1.0 2060382 SpecPlus_000657 C/C/1=C\CC(C)(C)\C=C\CC2(C)OC2CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A20 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 2060383 SpecPlus_000658 COc1cc(cc(OC)c1OC)c2oc3cc(O)ccc3c(=O)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A21 compound treatment 0.079 0.00348 0.41 0.4118 1.0 2060384 SpecPlus_000659 CO[C@@H]1C[C@H](O[C@H]2CC[C@]3(C=O)C4CC[C@]5(C)[C@H](CC[C@]5(O)C4CC[C@]3(O)C2)C6=CC(=O)OC6)O[C@H](C)[C@H]1O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A22 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 2060385 SpecPlus_000660 COC(=O)C[C@H]1C(C)(C)[C@@H](OC(=O)C(C)C)[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A23 mock treatment 0.084 0.00848 1.0 1.0043 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 A24 mock treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B01 mock treatment 0.086 0.0105 1.24 1.2412 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B02 mock treatment 0.0815 0.00598 0.71 0.708 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B03 compound treatment 0.0825 0.00698 0.83 0.8265 1.0 193 SpecPlus_000661 COc1cc2CCN(C)[C@H]3Cc4ccc(OC)c(Oc5ccc(C[C@@H]6N(C)CCc7cc(OC)c(Oc(c1OC)c32)cc67)cc5)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B04 compound treatment 0.0835 0.00798 0.95 0.945 1.0 2308 SpecPlus_000662 Cc1ccc(cc1NC(=O)c2cccc(NC(=O)Nc3cccc(c3)C(=O)Nc4cc(ccc4C)C(=O)Nc5ccc(c6cc(cc(c56)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O)c2)C(=O)Nc7ccc(c8cc(cc(c78)S(=O)(=O)O)S(=O)(=O)O)S(=O)(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B05 compound treatment 0.085 0.00948 1.12 1.1227 1.0 907463 SpecPlus_000663 Cc1nc2ccccn2c(=O)c1CCN3CCC(CC3)C(=O)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B06 compound treatment 0.079 0.00348 0.41 0.4118 1.0 1002022 SpecPlus_000664 NC(CCC(=O)O)C=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B07 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 2060386 SpecPlus_000665 CCN1C[C@]2(C)CC[C@H](OC)[C@@]34C2[C@H](O)[C@]5(OCO[C@]65C[C@H](OC)[C@H]7C[C@]4(O)C6[C@H]7O)C13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B08 compound treatment 0.077 0.00148 0.17 0.1748 1.0 790507 SpecPlus_000666 OC(=O)CN1C(=O)c2cccc3cccc(C1=O)c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B09 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 4480 SpecPlus_000667 CC(C)NC(=N)NC(=N)Nc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B10 compound treatment 0.068 -0.00752 -0.89 -0.8916 -1.0 2060387 SpecPlus_000668 OC(=O)CCCCCCCn1ccnc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B11 compound treatment 0.066 -0.00952 -1.13 -1.1286 -1.0 1837 SpecPlus_000669 CS(=O)(=O)c1ccc(cc1)C2=C(C(=O)OC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B12 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 1044852 SpecPlus_000670 OC(=O)c1cc2cc(Cl)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B13 compound treatment 0.0705 -0.00502 -0.6 -0.5954 -1.0 2060388 SpecPlus_000671 CC(=O)OC[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CCc5c(C)c(OC(=O)C)c(OC(=O)C)cc5[C@]4(C)CC[C@@]3(C)C2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B14 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 2060389 SpecPlus_000672 OC(=O)Cc1c[nH]cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B15 compound treatment 0.065 -0.0105 -1.25 -1.2471 -1.0 2060390 SpecPlus_000673 CC(=O)O[C@H]1CC[C@@]2(C)C(C[C@H](OC(=O)C)[C@]3(C)C2CC[C@@]4(C)C(OC(=O)C=C43)c5ccoc5)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B16 compound treatment 0.068 -0.00752 -0.89 -0.8916 -1.0 2060391 SpecPlus_000674 OC1/C(=C/C(=O)O)/CCCc2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B17 compound treatment 0.069 -0.00652 -0.77 -0.7731 -1.0 3173106 SpecPlus_000675 COC(=O)c1c(C)c2Oc3c(Cl)c(O)c(Cl)c(C)c3C(=O)Oc2c(C)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B18 compound treatment 0.0705 -0.00502 -0.6 -0.5954 -1.0 1014792 SpecPlus_000676 OC(=O)c1cc2ccccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B19 compound treatment 0.0815 0.00598 0.71 0.708 1.0 2060392 SpecPlus_000677 CCOc1ccc(cc1)C(=O)c2ccc(O)c(O)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B20 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 348755 SpecPlus_000678 OC(=O)c1cc2cc(F)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B21 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 2060393 SpecPlus_000679 C/C(=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)C(=O)CCC1(C)C)/C=C/C=C(\C)/C=C/C2=C(C)C(=O)CCC2(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B22 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 3173108 SpecPlus_000680 CC[C@H]([C@@H]1O[C@@H]([C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2O[C@@]3(O[C@@]4(CC[C@](C)(O4)C5CC[C@](O)(CC)[C@H](C)O5)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)[C@@H](C)C[C@H]1C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B23 mock treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 B24 mock treatment 0.0695 -0.00602 -0.71 -0.7139 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C01 mock treatment 0.081 0.00548 0.65 0.6488 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C02 mock treatment 0.0815 0.00598 0.71 0.708 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C03 compound treatment 0.084 0.00848 1.0 1.0043 1.0 3055569 SpecPlus_000681 OCc1cccnc1.OC(C(O)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C04 compound treatment 0.0865 0.011 1.3 1.3005 1.0 2060394 SpecPlus_000682 CC12C[C@@H](O)C3C(CCC4CC(O)CCC43C)C2=CCC1C5=CC(=O)OC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C05 compound treatment 0.09 0.0145 1.72 1.7152 1.0 3202 SpecPlus_000683 COc1ccccc1N2CCN(CCCNc3cc(=O)n(C)c(=O)n3C)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C06 compound treatment 0.083 0.00748 0.89 0.8858 1.0 2576 SpecPlus_000684 S=C=NCc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C07 compound treatment 0.078 0.00248 0.29 0.2933 1.0 3055573 SpecPlus_000685 OC[C@H]1OC([C@H](O)[C@@H]1O)n2cnc3c(=O)[nH]cnc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C08 compound treatment 0.076 4.75E-4 0.06 0.0563 1.0 1000656 SpecPlus_000686 OC1=C([C@H]2CC[C@@H](CC2)c3ccc(Cl)cc3)C(=O)c4ccccc4C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C09 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 2060395 SpecPlus_000687 CC(C)C(NC(=O)C(CC(=O)O)NC(=O)C(CCCCN)NC(=O)C(N)CCCNC(=N)N)C(=O)NC(Cc1ccc(O)cc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C10 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 2060396 SpecPlus_000688 OC[C@H]1O[C@@H](Oc2ccc(C(=O)/C=C/c3ccccc3)c(O)c2)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C11 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 2060397 SpecPlus_000689 COc1ccc2C(=O)/C(=C/c3ccc(OC)c(O)c3)/COc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C12 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2060398 SpecPlus_000690 COC1=C(Cl)C(=O)C2(Oc3cc(O)c(Cl)c(C)c3C2=O)C(=C1Cl)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C13 compound treatment 0.072 -0.00352 -0.42 -0.4176 -1.0 2060399 SpecPlus_000691 CC(C)CCCC(C)[C@H]1CCC2C3C[C@@H](O)[C@@]4(O)C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C14 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 1898 SpecPlus_000692 OC(=O)CC[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C15 compound treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 2060400 SpecPlus_000693 CC(C)c1ccc2c(CCC3[C@](C)(CN)CCC[C@@]32C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C16 compound treatment 0.076 4.75E-4 0.06 0.0563 1.0 1087705 SpecPlus_000694 CCOC(=O)C1=C(O)C(=O)N(Cc2ccccc2)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C17 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 2060401 SpecPlus_000695 CO[C@@H]1C[C@H]2N3C[C@@H](O)C2(C=C1)c4cc5OCOc5cc4[C@@H]3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C18 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 1000009 SpecPlus_000696 C/C(=C\C=C\C(=C/C(=O)O)\C)/C=C/C1=C(C)CCCC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C19 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 2060402 SpecPlus_000697 COc1ccc2CC[C@H]3CC(=O)CC[C@]3(C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C20 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 1552436 SpecPlus_000698 COc1ccc(cc1)c2cc(=O)c3cc(OC)ccc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C21 compound treatment 0.077 0.00148 0.17 0.1748 1.0 2060403 SpecPlus_000699 COc1ccc(C2COc3cc(O)ccc3C2)c(OC)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C22 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 2060404 SpecPlus_000700 CC1=C(Cl)C(=O)C(=C(O)C21Oc3cc(O)c(Cl)c(C)c3C2=O)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C23 mock treatment 0.0775 0.00198 0.23 0.2341 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 C24 mock treatment 0.079 0.00348 0.41 0.4118 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D01 mock treatment 0.0775 0.00198 0.23 0.2341 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D02 mock treatment 0.089 0.0135 1.6 1.5967 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D03 compound treatment 0.083 0.00748 0.89 0.8858 1.0 2060405 SpecPlus_000701 CC1(C)[C@H](CC(=O)O)[C@@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4[C@]3(O)C[C@@H](C1=O)C2=O)c5ccoc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D04 compound treatment 0.0835 0.00798 0.95 0.945 1.0 2272 SpecPlus_000702 OC(=O)C(Cc1ccc(O)c(O)c1)OC(=O)/C=C/c2ccc(O)c(O)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D05 compound treatment 0.0865 0.011 1.3 1.3005 1.0 2060406 SpecPlus_000703 COc1ccccc1/C=C\C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D06 compound treatment 0.09 0.0145 1.72 1.7152 1.0 832189 SpecPlus_000704 CC(=O)CC(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D07 compound treatment 0.08 0.00448 0.53 0.5303 1.0 2060407 SpecPlus_000705 COc1ccc(/C=C/C(=O)O)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D08 compound treatment 0.0825 0.00698 0.83 0.8265 1.0 2553 SpecPlus_000706 CNNC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D09 compound treatment 0.08 0.00448 0.53 0.5303 1.0 1014978 SpecPlus_000707 OCC(O)C(O)C(O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D10 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 2575 SpecPlus_000708 CCS(=O)(=O)CCn1c(C)ncc1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D11 compound treatment 0.08 0.00448 0.53 0.5303 1.0 3173115 SpecPlus_000709 C[C@H]1[C@H]2[C@H](CC3C4CC[C@H]5C[C@@H](O)CC[C@]5(C)C4CC[C@]23C)O[C@]61CCC(C)CN6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D12 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 1923 SpecPlus_000710 NC1(CC1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D13 compound treatment 0.0815 0.00598 0.71 0.708 1.0 2060408 SpecPlus_000711 COC(=O)C[C@H]1C(C)(C)[C@H](C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D14 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 383 SpecPlus_000712 CC[C@@]1(O)C(=O)OCc2c1cc3-c4nc5ccccc5cc4Cn3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D15 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 1015281 SpecPlus_000713 COc1cc(O)c(C(=O)C)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D16 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 2060409 SpecPlus_000714 N[C@@H](CCCNC(=N)NC(CCC(=O)O)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D17 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 2060410 SpecPlus_000715 CC1(C)[C@H](O)CC(=O)[C@@]2(C)C1C[C@@H](O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)C5OC543)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D18 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 115 SpecPlus_000716 COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D19 compound treatment 0.0815 0.00598 0.71 0.708 1.0 2060411 SpecPlus_000717 O[C@H]1Cc2ccc(O)cc2O[C@@H]1c3ccc(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D20 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 397 SpecPlus_000718 CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c2cccc(Oc3ccccc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D21 compound treatment 0.08 0.00448 0.53 0.5303 1.0 2060412 SpecPlus_000719 C[C@]12[C@H](CC[C@]2(O)[C@@]34OC4C[C@@H]5C[C@@H](O)CC[C@]5(C)C3[C@H](O)C1=O)C6=CC(=O)OC6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D22 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 873168 SpecPlus_000720 OC(=O)c1cc(O)c2ccc(Cl)cc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D23 mock treatment 0.078 0.00248 0.29 0.2933 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 D24 mock treatment 0.0825 0.00698 0.83 0.8265 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E01 mock treatment 0.0785 0.00298 0.35 0.3526 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E02 mock treatment 0.079 0.00348 0.41 0.4118 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E03 compound treatment 0.0835 0.00798 0.95 0.945 1.0 2060413 SpecPlus_000721 CC(C)CCCC(C)[C@H]1CCC2C3CC[C@H]4CC(=O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E04 compound treatment 0.085 0.00948 1.12 1.1227 1.0 1091368 SpecPlus_000722 CNc1ccccc1C(=O)N2CCc3c([nH]c4ccccc34)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E05 compound treatment 0.0895 0.014 1.66 1.6559 1.0 1095093 SpecPlus_000723 CNCCC(Oc1ccc(cc1)C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E06 compound treatment 0.081 0.00548 0.65 0.6488 1.0 1032994 SpecPlus_000724 O=C1CC(Oc2ccccc12)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E07 compound treatment 0.08 0.00448 0.53 0.5303 1.0 2060414 SpecPlus_000725 OC(=O)c1nc2cc(Cl)c(Cl)cc2nc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E08 compound treatment 0.079 0.00348 0.41 0.4118 1.0 2060415 SpecPlus_000726 COC(=O)C[C@H]1C(C)(C)C(=O)[C@@H]2CC3=C4C=CO[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E09 compound treatment 0.081 0.00548 0.65 0.6488 1.0 225 SpecPlus_000727 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E10 compound treatment 0.078 0.00248 0.29 0.2933 1.0 2060416 SpecPlus_000728 Sc1nc2ccccc2s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E11 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 3054809 SpecPlus_000729 COc1ccc2C(=O)C(Cc3ccc(OC)c(OC(=O)C)c3)COc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E12 compound treatment 0.08 0.00448 0.53 0.5303 1.0 2060417 SpecPlus_000730 CC(=C)C1Cc2c(O1)ccc(C(=O)O)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E13 compound treatment 0.077 0.00148 0.17 0.1748 1.0 2060418 SpecPlus_000731 COc1ccccc1c2cc(=O)c3cccc(OC)c3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E14 compound treatment 0.076 4.75E-4 0.06 0.0563 1.0 2060419 SpecPlus_000732 COc1cc(OC)c2C[C@@H](OC(=O)c3cc(OC)c(OC)c(OC)c3)[C@H](Oc2c1)c4cc(OC)c(OC)c(OC)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E15 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 3173232 SpecPlus_000733 CO/N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(=O)OC(C)OC(=O)C)COC(=O)N)\c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E16 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 2060420 SpecPlus_000734 CC(=O)O[C@@H]1CC2C(C)(C)[C@@H](O)CCC2(C)C3CC[C@@]4(C)[C@@H](OC(=O)C=C4C13C)c5ccoc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E17 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 2060421 SpecPlus_000735 C[C@](O)(CCC1C(=C)C[C@H](O)C2C(C)(C)CCCC12C)C=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E18 compound treatment 0.076 4.75E-4 0.06 0.0563 1.0 3856 SpecPlus_000736 CNC1(C)C2CCC(C2)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E19 compound treatment 0.077 0.00148 0.17 0.1748 1.0 3173234 SpecPlus_000737 Cn1c(=O)[nH]c(=O)c2nc[nH]c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E20 compound treatment 0.077 0.00148 0.17 0.1748 1.0 1084508 SpecPlus_000738 COc1ccc2cc3-c4cc(OC)c(OC)cc4CC[n+]3cc2c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E21 compound treatment 0.078 0.00248 0.29 0.2933 1.0 2060422 SpecPlus_000739 CCOc1ccc(cc1)C(=O)c2cc(O)c(OC)c(OC)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E22 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 2060423 SpecPlus_000740 COC1=C(Cl)C(=O)C2(Oc3cc(OC)c(Cl)c(C)c3C2=O)C(=C1Cl)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E23 mock treatment 0.078 0.00248 0.29 0.2933 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 E24 mock treatment 0.078 0.00248 0.29 0.2933 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F01 mock treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F02 mock treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F03 compound treatment 0.0795 0.00398 0.47 0.471 1.0 2060424 SpecPlus_000741 C[C@@]12CC[C@@H](O)C[C@H]2CCc3ccccc31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F04 compound treatment 0.081 0.00548 0.65 0.6488 1.0 117 SpecPlus_000742 CCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F05 compound treatment 0.095 0.0195 2.31 2.3076 1.0 2060425 SpecPlus_000743 COC(=O)[C@@H]1OC(=O)[C@H]2O[C@@]23[C@@]1(C)CCC4[C@@]5(C)CCC(=O)C(C)(C)C5C[C@@H](OC(=O)C)[C@]43C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F06 compound treatment 0.08 0.00448 0.53 0.5303 1.0 1211 SpecPlus_000744 CON 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F07 compound treatment 0.0855 0.00998 1.18 1.182 1.0 1045087 SpecPlus_000745 Cc1coc2ccccc2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F08 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 765 SpecPlus_000746 Oc1ccnc(S)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F09 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 2060426 SpecPlus_000747 COc1c(O)cccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F10 compound treatment 0.077 0.00148 0.17 0.1748 1.0 2546 SpecPlus_000748 COC(=O)NC(=S)Nc1ccccc1NC(=S)NC(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F11 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 2060427 SpecPlus_000749 CO[C@@H]1C[C@H](O[C@H]2CC[C@]3(C)C4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CC[C@]3(O)C2)C6=CC(=O)OC6)O[C@H](C)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F12 compound treatment 0.078 0.00248 0.29 0.2933 1.0 1537011 SpecPlus_000750 CN(C)CCC(c1ccc(Br)cc1)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F13 compound treatment 0.081 0.00548 0.65 0.6488 1.0 2060428 SpecPlus_000751 CCOC(=O)C(=O)C1(Oc2cc(OC)cc(OC)c2C(=O)C1c3ccccc3)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F14 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 2777 SpecPlus_000752 COc1cc(N)c(Cl)cc1C(=O)NC2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F15 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 2060429 SpecPlus_000753 COC1CC(O[C@H]2CC[C@]3(C=O)C4CC[C@]5(C)C(CC[C@]5(O)C4CC[C@]3(O)C2)C6=CC(=O)OC6)OC(C)C1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F16 compound treatment 0.078 0.00248 0.29 0.2933 1.0 3173238 SpecPlus_000754 C[C@@H]1O[C@@H](O[C@H]2CC[C@@]3(C=O)C(CCC4C3CC[C@]5(C)[C@H](CC[C@]45O)C6=CC(=O)OC6)C2)[C@H](O)[C@H](O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F17 compound treatment 0.077 0.00148 0.17 0.1748 1.0 1111461 SpecPlus_000755 CC(=CCOc1c2occc2cc3ccc(=O)oc13)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F18 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 907149 SpecPlus_000756 CN(C)c1nc(N)c(nc1Cl)C(=O)NC(=N)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F19 compound treatment 0.0805 0.00498 0.59 0.5895 1.0 2060430 SpecPlus_000757 O[C@@H]1O[C@H](COC(=O)CC[N+](=O)[O-])[C@H](OC(=O)CC[N+](=O)[O-])[C@H](OC(=O)CC[N+](=O)[O-])[C@@H]1OC(=O)CC[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F20 compound treatment 0.0825 0.00698 0.83 0.8265 1.0 1950 SpecPlus_000758 Oc1cc2oc(cc(=O)c2c(O)c1O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F21 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 3173239 SpecPlus_000759 CC(N/C(=N/C#N)/Nc1ccncc1)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F22 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 89599 SpecPlus_000760 OC(=O)c1cc(O)c2c(Cl)cc(Cl)cc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F23 mock treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 F24 mock treatment 0.0785 0.00298 0.35 0.3526 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G01 mock treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G02 mock treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G03 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 2060431 SpecPlus_000761 COc1cc2OCOc2cc1c3coc4c5CCC(C)(C)Oc5ccc4c3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G04 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 831758 SpecPlus_000762 Oc1ccc(/C=C/C(=O)c2ccc(O)cc2O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G05 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 2060432 SpecPlus_000763 CC[C@@]1(O)C(=O)OCc2c1cc3-c4nc5ccc(O)cc5cc4Cn3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G06 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 1001204 SpecPlus_000764 COc1ccc(cc1)C(=O)CC(=O)c2ccc(cc2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G07 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 3173241 SpecPlus_000765 C[C@@]12CCC3C(CC[C@H]4C[C@@H](CC[C@@]43C)OS(=O)(=O)O)C2CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G08 compound treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 2060433 SpecPlus_000766 COc1ccc(cc1)c2cc(=O)c3c(O)cc(O[C@H]4O[C@H](CO[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G09 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 3173242 SpecPlus_000767 Nc1nc2cc(Cl)ccc2o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G10 compound treatment 0.07 -0.00552 -0.65 -0.6546 -1.0 1008566 SpecPlus_000768 Cc1cc(c(O)c(c1)C(C)(C)C)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G11 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 2101 SpecPlus_000769 Oc1ccc(O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G12 compound treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 3173243 SpecPlus_000770 C/C=C\1/C[C@@H](C)[C@](O)(CCO)C(=O)OCC2=CCN3CC[C@@H](OC1=O)C32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G13 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2060434 SpecPlus_000771 COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CCc5c(C)c(OC(=O)C)c(OC(=O)C)cc5[C@]4(C)CC[C@@]3(C)C2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G14 compound treatment 0.069 -0.00652 -0.77 -0.7731 -1.0 2060435 SpecPlus_000772 COC(=O)C(OC(=O)C)[C@H]1C(C)(C)C(=O)C[C@@H]2O[C@@]34CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC(C3=C)[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G15 compound treatment 0.069 -0.00652 -0.77 -0.7731 -1.0 2060436 SpecPlus_000773 O=C(CCCCCCCCCCCCC1CCCC1)Nc2ccc(cc2)S(=O)(=O)c3ccc(NC(=O)CCCCCCCCCCCCC4CCCC4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G16 compound treatment 0.0695 -0.00602 -0.71 -0.7139 -1.0 2060437 SpecPlus_000774 COC(=O)C(O)[C@H]1C(C)(C)[C@H](O)[C@@H]2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G17 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 1004889 SpecPlus_000775 CC(=O)Nc1cccc(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G18 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 2060438 SpecPlus_000776 CC(C)(C)NCC(O)COc1cccc2[nH]c(O)nc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G19 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2555 SpecPlus_000777 CCOC(=O)NC1=C(C2CC2)C(=O)C(=C(C3CC3)C1=O)NC(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G20 compound treatment 0.07 -0.00552 -0.65 -0.6546 -1.0 1386109 SpecPlus_000778 Oc1ccc2c(=O)c(O)c(oc2c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G21 compound treatment 0.0695 -0.00602 -0.71 -0.7139 -1.0 907181 SpecPlus_000779 NC(=N)NC(=O)c1nc(Cl)c(nc1N)N2CCCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G22 compound treatment 0.07 -0.00552 -0.65 -0.6546 -1.0 3173362 SpecPlus_000780 C[C@H]1CC[C@@H]2N(C1)C[C@H]3[C@@H]4CC5(O[C@@]6(O)[C@H]7C[C@@H](O)[C@H]5[C@]4(O)[C@@H](O)[C@H](O)[C@@H]3[C@]2(C)O)[C@@]7(C)CC[C@@H]6O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G23 mock treatment 0.0695 -0.00602 -0.71 -0.7139 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 G24 mock treatment 0.069 -0.00652 -0.77 -0.7731 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H01 mock treatment 0.0775 0.00198 0.23 0.2341 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H02 mock treatment 0.077 0.00148 0.17 0.1748 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H03 compound treatment 0.0825 0.00698 0.83 0.8265 1.0 1402956 SpecPlus_000781 CC(N)C(O)c1ccc(O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H04 compound treatment 0.082 0.00648 0.77 0.7673 1.0 2060439 SpecPlus_000782 COC1=C(OC)C(=O)C(=C(C)C1=O)C/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC\C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H05 compound treatment 0.083 0.00748 0.89 0.8858 1.0 2060440 SpecPlus_000783 COC(=O)C[C@H]1C(C)(C)C(=C2CC3=C4CC(=O)O[C@@H](c5ccoc5)[C@]4(C)CCC3[C@@]1(C)C2=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H06 compound treatment 0.0965 0.021 2.49 2.4854 1.0 2060441 SpecPlus_000784 OC(=O)c1cc(O)c2C(=O)c3c(O)cc(O)cc3C(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H07 compound treatment 0.079 0.00348 0.41 0.4118 1.0 1897 SpecPlus_000785 NNCc1cccc(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H08 compound treatment 0.0795 0.00398 0.47 0.471 1.0 3173364 SpecPlus_000786 C[C@H]1[C@@]2(C)CCC3C(CCC4C[C@H](CC[C@@]43C)O[C@H]5O[C@H](CO)[C@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](O[C@H]7OC[C@@H](O)[C@H](O)[C@H]7O[C@H]8O[C@H](CO)[C@@H](O)[C@H](O)[C@H]8O)[C@H]6O)[C@H](O)[C@H]5O)C2O[C@]91CC[C@H](C)CN9 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H09 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 1008060 SpecPlus_000787 C1CCc2nnnn2CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H10 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 3197 SpecPlus_000788 Fc1ccc(cc1)[C@@H]2CCNC[C@H]2COc3ccc4OCOc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H11 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 352677 SpecPlus_000789 COc1ccccc1N2CCNCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H12 compound treatment 0.0845 0.00898 1.06 1.0635 1.0 2060442 SpecPlus_000790 CCC(N)C(O)c1ccc(O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H13 compound treatment 0.086 0.0105 1.24 1.2412 1.0 907089 SpecPlus_000791 Cn1c(=O)n(C)c2ncn(CCCl)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H14 compound treatment 0.083 0.00748 0.89 0.8858 1.0 1000697 SpecPlus_000792 COc1cc(cc(OC)c1O)[C@H]2[C@@H]3C(COC3=O)C(O[C@@H]4O[C@@H]5CO[C@H](OC5[C@H](O)[C@H]4O)c6cccs6)c7cc8OCOc8cc27 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H15 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 1464728 SpecPlus_000793 Cn1c(=O)[nH]c2nc[nH]c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H16 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 2060443 SpecPlus_000794 CC(CN1c2ccccc2Sc3cccnc13)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H17 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 1055442 SpecPlus_000795 Nc1nc(O)c2nc(cnc2n1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H18 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 2547 SpecPlus_000796 CC(=CC1C(C(=O)OCc2cccc(Oc3ccccc3)c2)C1(C)C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H19 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 907114 SpecPlus_000797 CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H20 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 1835 SpecPlus_000798 CCCc1nn(C)c2c(=O)[nH]c(nc12)c3cc(ccc3OCC)S(=O)(=O)N4CCN(C)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H21 compound treatment 0.077 0.00148 0.17 0.1748 1.0 2566 SpecPlus_000799 CCCCCCCCC(=O)NCc1ccc(O)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H22 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 1505499 SpecPlus_000800 OC(=O)c1cc2c(Cl)cc(Cl)cc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H23 mock treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 H24 mock treatment 0.076 4.75E-4 0.06 0.0563 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I01 mock treatment 0.0785 0.00298 0.35 0.3526 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I02 mock treatment 0.076 4.75E-4 0.06 0.0563 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I03 compound treatment 0.079 0.00348 0.41 0.4118 1.0 290 SpecPlus_000801 CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@]2(O)[C@@H]3C=C(C)C(=O)[C@@]3(O)CC(=C[C@H]2[C@@H]4C(C)(C)[C@@]41OC(=O)C)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I04 compound treatment 0.08 0.00448 0.53 0.5303 1.0 2060444 SpecPlus_000802 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c4c(=O)c(O)cccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I05 compound treatment 0.0805 0.00498 0.59 0.5895 1.0 2060445 SpecPlus_000803 CC(C)CCCC(C)[C@H]1CCC2C3C=CC4=CC(=O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I06 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2060446 SpecPlus_000804 CC1(C)[C@@H](O)C=C[C@@]2(C)C1CC(=O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I07 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 2294 SpecPlus_000805 CC(=O)NC(C(=O)O)C(C)(C)SN=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I08 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 3173368 SpecPlus_000806 O=C1CC[C@]2(/C=C/C(=O)NCCCCNCCCNC(=O)\C=C\c3ccc4O[C@@H]2C1)c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I09 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 1865 SpecPlus_000807 Clc1cccc(Nc2nnc(c3ccccc3)c4ccccc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I10 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 3684 SpecPlus_000808 OC(=O)C1=CCCNC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I11 compound treatment 0.0705 -0.00502 -0.6 -0.5954 -1.0 1006104 SpecPlus_000809 Cc1cc(=O)oc2cc(O)cc(O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I12 compound treatment 0.0675 -0.00802 -0.95 -0.9508 -1.0 3173369 SpecPlus_000810 CC(C)c1c(OC(=O)C)ccc2c1CCC3C(C)(C)CCC[C@@]32C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I13 compound treatment 0.059 -0.0165 -1.96 -1.958 -1.0 2060447 SpecPlus_000811 CCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCC(O)COP(=O)(O)OCC(COC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC)OC(=O)CCCCCCCCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I14 compound treatment 0.0655 -0.01 -1.19 -1.1878 -1.0 2060448 SpecPlus_000812 COc1ccc2[C@H](O)[C@H](Cc3ccc(OC)c(OC)c3)COc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I15 compound treatment 0.07 -0.00552 -0.65 -0.6546 -1.0 2060449 SpecPlus_000813 CCCCCCCCCCCCCC1CC(CO)OC(C)(C)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I16 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 470 SpecPlus_000814 OC(=O)CCCc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I17 compound treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 2060450 SpecPlus_000815 COc1ccc(cc1)c2coc3cc(OC)c(OC)cc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I18 compound treatment 0.07 -0.00552 -0.65 -0.6546 -1.0 1024489 SpecPlus_000816 Cc1cc(O)cc(=O)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I19 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 1001621 SpecPlus_000817 Oc1cc(cc(O)c1O)C(=O)Oc2cc(cc(O)c2O)C(=O)OC[C@H]3O[C@H](OC(=O)c4cc(O)c(O)c(OC(=O)c5cc(O)c(O)c(O)c5)c4)[C@H](OC(=O)c6cc(O)c(O)c(OC(=O)c7cc(O)c(O)c(O)c7)c6)[C@@H](OC(=O)c8cc(O)c(O)c(OC(=O)c9cc(O)c(O)c(O)c9)c8)[C@@H]3OC(=O)c%10cc(O)c(O)c(OC(=O)c%11cc(O)c(O)c(O)c%11)c%10 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I20 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 2060451 SpecPlus_000818 CC(C)(O)CC[C@@H](O)[C@](C)(O)C1CC[C@@]2(O)C3=CC(=O)C4C[C@@H](O)[C@@H](O)C[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I21 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 3173490 SpecPlus_000819 C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O[C@@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)cc(O)c4c3=O)c6ccc(O)cc6)[C@H](O)[C@@H](O)[C@H]2O)[C@H](O)[C@H](O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I22 compound treatment 0.072 -0.00352 -0.42 -0.4176 -1.0 1754 SpecPlus_000820 CCCN[C@H]1CCc2nc(N)sc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I23 mock treatment 0.0695 -0.00602 -0.71 -0.7139 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 I24 mock treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J01 mock treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J02 mock treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J03 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 2060452 SpecPlus_000821 CC1(C)O[C@@H]2C[C@](O)(C[C@@H](O)[C@@H]2O1)C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J04 compound treatment 0.093 0.0175 2.07 2.0707 1.0 2548 SpecPlus_000822 CCCCC[C@](C)(C/C=C/C=C/C(=O)OC(C)C)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J05 compound treatment 0.081 0.00548 0.65 0.6488 1.0 4362 SpecPlus_000823 CN1CCN(CC1)C2=Nc3ccccc3Oc4ccc(Cl)cc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J06 compound treatment 0.0795 0.00398 0.47 0.471 1.0 2060453 SpecPlus_000824 Clc1c(Cl)c(C#N)c(Cl)c(C#N)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J07 compound treatment 0.077 0.00148 0.17 0.1748 1.0 2830 SpecPlus_000825 Clc1ccc2n(C3CCN(CCCn4c(=O)[nH]c5ccccc45)CC3)c(=O)[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J08 compound treatment 0.0805 0.00498 0.59 0.5895 1.0 2060454 SpecPlus_000826 Oc1cc(O)c2c(=O)cc(oc2c1)c3cc(O)c(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J09 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 3173492 SpecPlus_000827 COc1cc2CC[C@H](NC(=O)C)c3cc(=O)c(O)ccc3-c2c(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J10 compound treatment 0.085 0.00948 1.12 1.1227 1.0 3173493 SpecPlus_000828 CC1=C2CCC3C4CCC(=O)[C@@]4(C)CCC3[C@@]2(C)CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J11 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 1429 SpecPlus_000829 CCCCOC(=O)c1ccc(N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J12 compound treatment 0.072 -0.00352 -0.42 -0.4176 -1.0 2060455 SpecPlus_000830 NC(=N)Nc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J13 compound treatment 0.069 -0.00652 -0.77 -0.7731 -1.0 1036721 SpecPlus_000831 Oc1c(oc2ccccc2c1=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J14 compound treatment 0.078 0.00248 0.29 0.2933 1.0 1008178 SpecPlus_000832 COc1cc(C)c(C(=O)Oc2cc(C)c(C(=O)O)c(O)c2C)c(OC)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J15 compound treatment 0.072 -0.00352 -0.42 -0.4176 -1.0 1606 SpecPlus_000833 NS(=O)(=O)c1cc2c(NC(CSCC=C)NS2(=O)=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J16 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 2060456 SpecPlus_000834 C[C@@H]1CC(Cl)CC[C@H]1C(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J17 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2060457 SpecPlus_000835 COc1cc(O)c2c(=O)cc(oc2c1)c3ccc(O)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J18 compound treatment 0.07 -0.00552 -0.65 -0.6546 -1.0 907120 SpecPlus_000836 CC(N)C(=O)OC(C)(C)Cc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J19 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 2060458 SpecPlus_000837 CC(=O)Oc1cccc(C(=O)O)c1OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J20 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 2060459 SpecPlus_000838 OC[C@H]1OC2[C@@H](Oc3nc(=N)ccn23)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J21 compound treatment 0.072 -0.00352 -0.42 -0.4176 -1.0 2060460 SpecPlus_000839 NC1=NCC(O1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J22 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 3173494 SpecPlus_000840 COC1CC(CC(C)C2CC(=O)C(C)/C=C(\C)/C(O)C(OC)C(=O)C(C)CC(C)/C=C/C=C/C=C(\C)/C(CC3CCC(C)C(O)(O3)C(=O)C(=O)N4CCCCC4C(=O)O2)OC)CCC1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J23 mock treatment 0.07 -0.00552 -0.65 -0.6546 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 J24 mock treatment 0.072 -0.00352 -0.42 -0.4176 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K01 mock treatment 0.0775 0.00198 0.23 0.2341 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K02 mock treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K03 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 2060461 SpecPlus_000841 COc1ccc(C2COc3c(OC)c(O)ccc3C2)c(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K04 compound treatment 0.077 0.00148 0.17 0.1748 1.0 3474304 SpecPlus_000842 COc1ccc(cc1)C(CN(C)C)C2(O)CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K05 compound treatment 0.078 0.00248 0.29 0.2933 1.0 366 SpecPlus_000843 OC(=O)Cc1nn(Cc2ccc(Br)cc2F)c(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K06 compound treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 2060462 SpecPlus_000844 C[C@H]1[C@@H]2[C@@H](O)C[C@@]3(C)C=CC(=O)C(=C3[C@@]2(C)OC1=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K07 compound treatment 0.082 0.00648 0.77 0.7673 1.0 3173495 SpecPlus_000845 COC(=O)C[C@H]1[C@@]2(C)C(OC3CC(C(=C32)C)c4ccoc4)[C@@H]5OC(=O)[C@]6(C)C=CC(=O)[C@@]1(C)C56 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K08 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2060463 SpecPlus_000846 COc1ccc(cc1)c2coc3c(OC)c(OC)cc(O)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K09 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 2060464 SpecPlus_000847 CC(C)CCCC(C)[C@H]1CCC2C3C(CC[C@]12C)[C@@]4(C)CC[C@H](O)C[C@@H]4CC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K10 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 2060465 SpecPlus_000848 CC(=O)O[C@H]1CC[C@@]2(C)C(CC[C@]3(C)C2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@]43C)C(=O)O)C1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K11 compound treatment 0.072 -0.00352 -0.42 -0.4176 -1.0 3055171 SpecPlus_000849 COC(=O)[C@]1(C)CC[C@]2(C)CC[C@]3(C)C4=CCc5c(C)c(O)c(O)cc5[C@]4(C)CC[C@@]3(C)C2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K12 compound treatment 0.0695 -0.00602 -0.71 -0.7139 -1.0 1010201 SpecPlus_000850 ClC1=C(Cl)C(=O)C(=C(Cl)C1=O)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K13 compound treatment 0.0695 -0.00602 -0.71 -0.7139 -1.0 2060466 SpecPlus_000851 OC(=O)Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K14 compound treatment 0.07 -0.00552 -0.65 -0.6546 -1.0 2060467 SpecPlus_000852 COc1ccc2C(=O)/C(=C\c3ccc(OC)c(OC)c3)/COc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K15 compound treatment 0.077 0.00148 0.17 0.1748 1.0 2060468 SpecPlus_000853 CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K16 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 840551 SpecPlus_000854 NCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K17 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 3055207 SpecPlus_000855 COc1cc(O)cc(/C=C/c2ccccc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K18 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 2060469 SpecPlus_000856 C[C@H]1CC2C3CC[C@](O)(C(=O)COC(=O)C)C3(C)C[C@H](O)C2C4(C)C=CC(=O)C=C14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K19 compound treatment 0.07 -0.00552 -0.65 -0.6546 -1.0 3055209 SpecPlus_000857 COc1cc(C(=O)O)c2Oc3c(C(O)O)c(O)cc(C)c3C(=O)Oc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K20 compound treatment 0.0685 -0.00702 -0.83 -0.8323 -1.0 1015899 SpecPlus_000858 NCC(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K21 compound treatment 0.0675 -0.00802 -0.95 -0.9508 -1.0 2060470 SpecPlus_000859 CC1CCC=C2C(CC(CC12C)C(=C)C)OC(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K22 compound treatment 0.0705 -0.00502 -0.6 -0.5954 -1.0 1044412 SpecPlus_000860 Oc1cc2ccccc2oc1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K23 mock treatment 0.069 -0.00652 -0.77 -0.7731 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 K24 mock treatment 0.07 -0.00552 -0.65 -0.6546 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L01 mock treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L02 mock treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L03 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 1009556 SpecPlus_000861 Nc1c2ccccc2nc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L04 compound treatment 0.0795 0.00398 0.47 0.471 1.0 2060471 SpecPlus_000862 C[C@H]1[C@H]2[C@H](OC1=O)[C@@H]3C(=CC(=O)C3=C(C)C[C@@H]2O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L05 compound treatment 0.0795 0.00398 0.47 0.471 1.0 2060472 SpecPlus_000863 C[C@@]12CCC3C(C=CC4=CC(=O)CC[C@]34C)C2CC[C@@]1(O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L06 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 593 SpecPlus_000864 Oc1ccc2ccc(=O)oc2c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L07 compound treatment 0.0795 0.00398 0.47 0.471 1.0 1009258 SpecPlus_000865 O=C1NC(=O)C(=O)C(=O)N1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L08 compound treatment 0.076 4.75E-4 0.06 0.0563 1.0 2060473 SpecPlus_000866 C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@](C)(O)CC[C@@H]1[C@@]23O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L09 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 3055218 SpecPlus_000867 OCC(O)[C@H]1OC(=O)C(=C1O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L10 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 1001314 SpecPlus_000868 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)[C@@H]4N[C@@H](COCCOC)O[C@H]([C@H]4C)[C@]1(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L11 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 1473 SpecPlus_000869 CC1(C)[C@@H](O)CC[C@@]2(C)C1CC[C@]3(C)C2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@]43C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L12 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 3474312 SpecPlus_000870 Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CC3CCCC3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L13 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 1000219 SpecPlus_000871 N[C@@H](Cc1cc(I)c(Oc2cc(I)c(O)c(I)c2)c(I)c1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L14 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2060474 SpecPlus_000872 O[C@@H]1Cc2c(O)cc(O)c([C@@H]3[C@@H](O)[C@H](Oc4c([C@@H]5[C@@H](O)[C@H](Oc6cc(O)cc(O)c56)c7cc(O)c(O)c(O)c7)c(O)cc(O)c34)c8cc(O)c(O)c(O)c8)c2O[C@@H]1c9cc(O)c(O)c(O)c9 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L15 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2060475 SpecPlus_000873 COc1cc(OC)c2C(=O)CC(Oc2c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L16 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 3474314 SpecPlus_000874 CN1CCCCC1C(=O)Nc2c(C)cccc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L17 compound treatment 0.076 4.75E-4 0.06 0.0563 1.0 2552 SpecPlus_000875 OC[C@H]1O[C@H](C(O)[C@H]1O)n2c(F)cc(=O)[nH]c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L18 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 2060476 SpecPlus_000876 C[C@H]1[C@@H]2CCC(=C3[C@@H]([C@H]2OC1=O)C(=CC3=O)C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L19 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 2060477 SpecPlus_000877 CC(C)CCCC(C)C1CCC2C3=CC[C@H]4C[C@@H](O)CCC4(C)C3CCC12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L20 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 1089854 SpecPlus_000878 Cc1ncc(CNC(=O)N(CCCl)N=O)c(N)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L21 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 2060478 SpecPlus_000879 CNc1ccc(cc1)C(=O)CC(O)CCC(C)C2OC(=O)CC(O)CC(=O)CC(O)CC(O)CC(O)CC(O)CC3(O)CC(O)C(C(CC(O[C@@H]4O[C@H](C)[C@@H](O)[C@H](N)[C@@H]4O)/C=C/C=C/C=C/C=C/C=C/C=C/C=C/C2C)O3)C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L22 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 2060479 SpecPlus_000880 COC(=O)c1c(C)cc(OC(=O)c2c(C)cc(O)c(CO)c2O)c(C)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L23 mock treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 L24 mock treatment 0.08 0.00448 0.53 0.5303 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M01 mock treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M02 mock treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M03 compound treatment 0.076 4.75E-4 0.06 0.0563 1.0 2060480 SpecPlus_000881 Oc1ccc(cc1)C2CC(=O)c3ccccc3O2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M04 compound treatment 0.0795 0.00398 0.47 0.471 1.0 3173624 SpecPlus_000882 CC1CCC2=C1C[C@@H](CC[C@@H]2C)C(C)(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M05 compound treatment 0.079 0.00348 0.41 0.4118 1.0 3173625 SpecPlus_000883 Nc1nc2n(cnc2c(=O)[nH]1)C3C[C@H](O)[C@@H](CO)O3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M06 compound treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 1002856 SpecPlus_000884 CCC(C(=O)N)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M07 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 3173626 SpecPlus_000885 CC(C)C(C)/C=C/C(C)C1CCC2C3=CC=C4C(C)(C)C(CCC4(C)C3CCC12C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M08 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 3055280 SpecPlus_000886 CCCCCCc1ccc(O)cc1O.Nc1c2ccccc2nc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M09 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 3173627 SpecPlus_000887 CCCCCC(O)C1C(O)CC(O)CC(O)CC(O)CC(O)CC(O)CC(O)/C(=C/C=C/C=C/C=C/C=C/C(O)C(C)OC1=O)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M10 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 2060481 SpecPlus_000888 COc1ccc([C@@H]2COc3c(OC)c(O)ccc3C2)c(OC)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M11 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 2060482 SpecPlus_000889 CC(C)c1cc2CCC3C(C)(C)CCC[C@]3(C(=O)O)c2c(O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M12 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 2060483 SpecPlus_000890 CC(=O)N[C@@H](CC(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M13 compound treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 3173628 SpecPlus_000891 CN1C(C)(C)CCCC1(C)C.OC(C(O)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M14 compound treatment 0.0705 -0.00502 -0.6 -0.5954 -1.0 1001523 SpecPlus_000892 Nc1ccc(C(=O)Oc2ccccc2)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M15 compound treatment 0.0725 -0.00302 -0.36 -0.3584 -1.0 2060485 SpecPlus_000893 COc1cc2OCC3Oc4c5CCC(C)(C)Oc5cc(OC)c4C(=O)C3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M16 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 2060486 SpecPlus_000894 CC(=O)Oc1ccccc1C(=O)Oc2ccccc2C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M17 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 1000094 SpecPlus_000895 CCC(C)(C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M18 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 1734308 SpecPlus_000896 Oc1cc(O)c2C(=O)C[C@H](Oc2c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M19 compound treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 1002855 SpecPlus_000897 CCC(C(=O)O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M20 compound treatment 0.072 -0.00352 -0.42 -0.4176 -1.0 3173630 SpecPlus_000898 C[C@@H]1CC[C@@]2(CC[C@]3(C)C(=CCC4[C@@]5(C)CCC(OC(=O)C)C(C)(C)C5CC[C@]43C)C2C1C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M21 compound treatment 0.0695 -0.00602 -0.71 -0.7139 -1.0 1091345 SpecPlus_000899 Nc1nc(N)c2nc(CNc3ccc(cc3)C(=O)NC(CCC(=O)O)C(=O)O)cnc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M22 compound treatment 0.0695 -0.00602 -0.71 -0.7139 -1.0 907273 SpecPlus_000900 Fc1ccc(cc1)C(OCCN2CCN(CCCc3ccccc3)CC2)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M23 mock treatment 0.0715 -0.00402 -0.48 -0.4769 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 M24 mock treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N01 mock treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N02 mock treatment 0.076 4.75E-4 0.06 0.0563 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N03 compound treatment 0.079 0.00348 0.41 0.4118 1.0 3055336 SpecPlus_000901 Oc1ccc2sc(=O)oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N04 compound treatment 0.0825 0.00698 0.83 0.8265 1.0 1765 SpecPlus_000902 CC1(C)NC(=O)N(C1=O)c2ccc([N+](=O)[O-])c(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N05 compound treatment 0.08 0.00448 0.53 0.5303 1.0 3173631 SpecPlus_000903 Oc1c(oc2ccc3occc3c2c1=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N06 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 1013144 SpecPlus_000904 O=C1OC(=O)C2C3CCC(O3)C21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N07 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 1002775 SpecPlus_000905 Cc1cccc(C(=O)O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N08 compound treatment 0.0835 0.00798 0.95 0.945 1.0 2060487 SpecPlus_000906 OC(=O)C1CC(CN2CCCCC12)[C@H]3CCCCN3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N09 compound treatment 0.077 0.00148 0.17 0.1748 1.0 3173633 SpecPlus_000907 CC1=C(N2[C@H](SC1)[C@H](NC(=O)C(N)c3ccccc3)C2=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N10 compound treatment 0.0835 0.00798 0.95 0.945 1.0 1307902 SpecPlus_000908 CN1CCCCC1c2ccc(nc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N11 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 2060488 SpecPlus_000909 CC(=CCC[C@@](C)(O)C=C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N12 compound treatment 0.092 0.0165 1.95 1.9522 1.0 1216977 SpecPlus_000910 CC1(C)Oc2ccc3ccc(=O)oc3c2CC1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N13 compound treatment 0.076 4.75E-4 0.06 0.0563 1.0 1661997 SpecPlus_000911 CC12CCC3C(CCc4cc(OC(=O)c5ccccc5)ccc34)C2CCC1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N14 compound treatment 0.08 0.00448 0.53 0.5303 1.0 2060489 SpecPlus_000912 C/C=C(/C)\C(=O)O[C@@H]1Cc2c(OC1(C)C)ccc3ccc(=O)oc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N15 compound treatment 0.078 0.00248 0.29 0.2933 1.0 1554635 SpecPlus_000913 COc1cc(OC)c2c(=O)cc(oc2c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N16 compound treatment 0.0815 0.00598 0.71 0.708 1.0 2060490 SpecPlus_000914 C/C=C(\C)/C(=O)O[C@H]1[C@@H](OC(=O)C)C(C)(C)Oc2ccc3ccc(=O)oc3c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N17 compound treatment 0.096 0.0205 2.43 2.4261 1.0 2562 SpecPlus_000915 OC(=O)CF 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N18 compound treatment 0.078 0.00248 0.29 0.2933 1.0 2060491 SpecPlus_000916 CC(C)CC(=O)O[C@@H]1[C@H](OC(=O)C)c2c(OC1(C)C)ccc3ccc(=O)oc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N19 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 1000807 SpecPlus_000917 CN1CCN(CC1)C(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N20 compound treatment 0.076 4.75E-4 0.06 0.0563 1.0 3055383 SpecPlus_000918 CC(C)(O)[C@@H]1Cc2cc3ccc(=O)oc3cc2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N21 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 1003514 SpecPlus_000919 COc1cc(cc(OC)c1OC)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N22 compound treatment 0.086 0.0105 1.24 1.2412 1.0 3161 SpecPlus_000920 CN(Cc1ccc(cc1)C(C)(C)C)Cc2cccc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N23 mock treatment 0.077 0.00148 0.17 0.1748 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 N24 mock treatment 0.0785 0.00298 0.35 0.3526 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O01 mock treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O02 mock treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O03 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 1040795 SpecPlus_000921 COc1cccc(O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O04 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 2060492 SpecPlus_000922 C[C@H]1C[C@@H](O)[C@]2(O)[C@@]31CC(=O)[C@@](C)(O)[C@]2(C)COC(=O)C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O05 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 1054271 SpecPlus_000923 COc1ccc(cc1O)c2cc(=O)c3c(O)c(OC)c(OC)cc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O06 compound treatment 0.076 4.75E-4 0.06 0.0563 1.0 2060493 SpecPlus_000924 COc1ccc2c(=O)c(coc2c1)c3ccc4OCOc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O07 compound treatment 0.08 0.00448 0.53 0.5303 1.0 1109169 SpecPlus_000925 COc1ccc2c(=O)c(coc2c1)c3cc4OCOc4cc3OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O08 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 3173754 SpecPlus_000926 CO[C@H]1[C@H](C)O[C@H](C[C@@H]1O)O[C@H]2CC[C@@]3(C)[C@H](CCC4C3C[C@@H](O)[C@]5(C)[C@H]([C@H](C[C@]45O)OC(=O)C)C6=CC(=O)OC6)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O09 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 3055391 SpecPlus_000927 OC[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(oc3c2)c4ccc(O)cc4)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O10 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 1913604 SpecPlus_000928 OC(=O)CCCN1C(=O)c2cccc3cccc(C1=O)c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O11 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 3100 SpecPlus_000929 COc1c2OCOc2cc3CCN(C)Cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O12 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 2060494 SpecPlus_000930 COc1ccc2C(=O)C(Cc3ccc(OC)c(OC)c3)COc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O13 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 3173755 SpecPlus_000931 C[C@@]12CC(=O)C3C(CCC4=CC(=O)CC[C@]34C)C2CC[C@]1(O)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O14 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 2060495 SpecPlus_000932 O[C@@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3cc(O)c(O)c(O)c3c4c(O)c(O)c(O)cc4[C@H]5Oc6cc(O)cc(O)c6C[C@H]5OC(=O)c7cc(O)c(O)c(O)c7 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O15 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 2060496 SpecPlus_000933 CC1(C)C=C[C@H](O)[C@@]2(C)C1C[C@@H](O)[C@]3(C)C2CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]543)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O16 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 1001994 SpecPlus_000934 C[C@@H](N)[C@@H](O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O17 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 1013678 SpecPlus_000935 Oc1ccccc1C(=O)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O18 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 2060497 SpecPlus_000936 CC(C)(O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O19 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 2060498 SpecPlus_000937 C[C@H]1CC2C3CC[C@](O)(C(=O)COC(=O)CCC(=O)O)C3(C)C[C@H](O)C2C4(C)C=CC(=O)C=C14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O20 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 2561 SpecPlus_000938 Oc1ccc(cc1[N+](=O)[O-])[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O21 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 2060499 SpecPlus_000939 OC[C@H]1O[C@@H](Oc2cc(O)c3c(=O)cc(oc3c2)c4ccc(O)cc4)[C@H](O[C@@H]5OC[C@](O)(CO)[C@H]5O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O22 compound treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 2060500 SpecPlus_000940 NCCc1cccc(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O23 mock treatment 0.078 0.00248 0.29 0.2933 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 O24 mock treatment 0.0785 0.00298 0.35 0.3526 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P01 mock treatment 0.0705 -0.00502 -0.6 -0.5954 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P02 mock treatment 0.059 -0.0165 -1.96 -1.958 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P03 compound treatment 0.067 -0.00852 -1.01 -1.0101 -1.0 3173759 SpecPlus_000941 COc1cc(cc(OC)c1O)[C@H]2[C@@H]3C(COC3=O)C(OC4O[C@@H]5COC(C)O[C@H]5[C@H](O)[C@H]4O)c6cc7OCOc7cc26 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P04 compound treatment 0.0695 -0.00602 -0.71 -0.7139 -1.0 3055445 SpecPlus_000942 CC(=O)OC(C)(C)[C@@H]1Cc2cc3ccc(=O)oc3cc2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P05 compound treatment 0.071 -0.00452 -0.54 -0.5361 -1.0 3173760 SpecPlus_000943 COc1cc2CCN(C)[C@@H]3Cc4cccc(Oc5ccc(C[C@@H]6N(C)CCc7cc(OC)c(Oc(c1OC)c32)cc67)c(O)c5)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P06 compound treatment 0.0655 -0.01 -1.19 -1.1878 -1.0 2060501 SpecPlus_000944 CC(C)(OC(=O)c1ccccc1)[C@@H]2Cc3cc4ccc(=O)oc4cc3O2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P07 compound treatment 0.0845 0.00898 1.06 1.0635 1.0 1004713 SpecPlus_000945 CNc1ccccc1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P08 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 1023016 SpecPlus_000946 COc1ccc2ccc(=O)oc2c1CC=C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P09 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 3173761 SpecPlus_000947 N[C@@H](C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P10 compound treatment 0.0735 -0.00202 -0.24 -0.2399 -1.0 1463965 SpecPlus_000948 CC1(C)CCc2c3OC(C)(C)C=Cc3c4occ(c5ccc(O)cc5)c(=O)c4c2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P11 compound treatment 0.075 -5.25E-4 -0.06 -0.0622 -1.0 3173762 SpecPlus_000949 CC1OC(O[C@@H]/2CC3O[C@@](O)(C[C@H](O)C3C(=O)O)CC(O)CC(O)C(O)CCC(O)CC(O)CC(=O)O[C@@H](C)[C@H](C)[C@H](O)[C@@H](C)\C=C\C=C\C=C\C=C\C=C\C=C\C=C2)C(O)[C@H](N)C1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P12 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 1296906 SpecPlus_000950 COc1ccc(C(=O)CC(=O)O)c2OC(C)(C)C=Cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P13 compound treatment 0.0785 0.00298 0.35 0.3526 1.0 1001284 SpecPlus_000951 CC(C)C1NC(=O)C(NC(=O)c2ccc(C)c3oc4c(C)c(=O)c(N)c(C(=O)NC5C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C6CCCC6C(=O)C(NC5=O)C(C)C)c4nc23)C(C)OC(=O)C(C(C)C)N(C)C(=O)CN(C)C(=O)C7CCCC7C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P14 compound treatment 0.0745 -0.00102 -0.12 -0.1214 -1.0 1204574 SpecPlus_000952 COc1c(oc2cc3oc(=O)ccc3cc12)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P15 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 2558 SpecPlus_000953 c1ccc2c(c1)cc3ccc4cccc5ccc2c3c45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P16 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 1101055 SpecPlus_000954 CC(NC(C)(C)C)C(=O)c1cccc(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P17 compound treatment 0.0765 9.75E-4 0.12 0.1156 1.0 2060502 SpecPlus_000955 COc1cc(cc(OC)c1O)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P18 compound treatment 0.0775 0.00198 0.23 0.2341 1.0 2321 SpecPlus_000956 COc1ccc2CC3N(CCc4cc(OC)c(OC)cc34)Cc2c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P19 compound treatment 0.0795 0.00398 0.47 0.471 1.0 3173763 SpecPlus_000957 O[C@@H]1C[C@](O)(C[C@@H](OC(=O)/C=C/c2ccc(O)c(O)c2)[C@@H]1O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P20 compound treatment 0.0755 -2.46E-5 0.0 -0.0029 -1.0 2060503 SpecPlus_000958 C1Oc2ccc(cc2O1)[C@H]3OC[C@@H]4[C@@H](OC[C@H]34)c5ccc6OCOc6c5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P21 compound treatment 0.0795 0.00398 0.47 0.471 1.0 2060504 SpecPlus_000959 Cc1cc(O)c(C)c(O)c1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P22 compound treatment 0.074 -0.00152 -0.18 -0.1806 -1.0 1001642 SpecPlus_000960 OC[C@H]1OC(C[C@@H]1O)n2cc(c(=O)[nH]c2=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P23 mock treatment 0.073 -0.00252 -0.3 -0.2991 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1083 P24 mock treatment 0.0635 -0.012 -1.42 -1.4248 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A01 mock treatment 0.093 0.0158 1.88 1.8777 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A02 mock treatment 0.0805 0.00335 0.4 0.3966 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A03 compound treatment 0.082 0.00485 0.57 0.5743 1.0 1907838 Bionet1_000081 CN(C)/C=N\C(=O)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A04 compound treatment 0.0855 0.00835 0.99 0.989 1.0 1156141 Bionet1_000082 COc1ccc(cc1)n2nc(C(=O)Nc3ccccc3)c4ccccc4c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A05 compound treatment 0.088 0.0108 1.29 1.2852 1.0 1907839 Bionet1_000083 O/N=C/NC(=O)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A06 compound treatment 0.069 -0.00815 -0.97 -0.9661 -1.0 1210239 Bionet1_000084 COc1ccc(cc1)n2nc(C(=O)Oc3ccccc3)c4ccccc4c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A07 compound treatment 0.073 -0.00415 -0.49 -0.4921 -1.0 1907840 Bionet1_000085 CO/N=C/NC(=O)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A08 compound treatment 0.0825 0.00535 0.63 0.6335 1.0 1907841 Bionet1_000086 FC(F)(F)c1nc2oc3ccccc3c(=O)c2cc1C(=O)NCc4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A09 compound treatment 0.07 -0.00715 -0.85 -0.8476 -1.0 1907842 Bionet1_000087 Clc1ccc(NC(=O)n2ccc(n2)c3ccc(cc3)n4ccnc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A10 compound treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 1907843 Bionet1_000088 FC(F)(F)c1nc2oc3ccccc3c(=O)c2cc1C(=O)NCc4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A11 compound treatment 0.0735 -0.00365 -0.43 -0.4329 -1.0 1907844 Bionet1_000089 C/C(=N\OC(=O)Nc1ccc(Cl)cc1)/c2ccc(cc2)n3ccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A12 compound treatment 0.0715 -0.00565 -0.67 -0.6699 -1.0 1907845 Bionet1_000090 CC(C)NC(=O)c1cc2c(=O)c3ccccc3oc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A13 compound treatment 0.0695 -0.00765 -0.91 -0.9068 -1.0 1907846 Bionet1_000091 Oc1ccc(Cl)cc1N/C=C\2/Sc3cc(Cl)ccc3NC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A14 compound treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 1907847 Bionet1_000092 CN(C)C(=O)Nc1cc2c(=O)c3ccccc3oc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A15 compound treatment 0.0695 -0.00765 -0.91 -0.9068 -1.0 1907848 Bionet1_000093 CN(C)/C=N/S(=O)(=O)c1ccc(Oc2c(Cl)c(Cl)nn2C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A16 compound treatment 0.0835 0.00635 0.75 0.752 1.0 1907849 Bionet1_000094 CON(C)C(=O)Nc1cc2c(=O)c3ccccc3oc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A17 compound treatment 0.064 -0.0132 -1.56 -1.5585 -1.0 1409233 Bionet1_000095 Clc1ccc(cc1)C2CC(=O)C3=C(C2)OC(=O)CC3c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A18 compound treatment 0.0725 -0.00465 -0.55 -0.5514 -1.0 1907850 Bionet1_000096 CCSC(=O)Nc1cc2c(=O)c3ccccc3oc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A19 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1907851 Bionet1_000097 FC(F)(F)c1ccccc1N/C=C\2/Sc3cc(Cl)ccc3NC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A20 compound treatment 0.0735 -0.00365 -0.43 -0.4329 -1.0 1516152 Bionet1_000098 O=c1n(Cc2cccnc2)ccc3nc4oc5ccccc5c(=O)c4cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A21 compound treatment 0.073 -0.00415 -0.49 -0.4921 -1.0 1907852 Bionet1_000099 FC(F)(F)c1cccc(N/C=C\2/Sc3cc(Cl)ccc3NC2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A22 compound treatment 0.0715 -0.00565 -0.67 -0.6699 -1.0 1736385 Bionet1_000100 O=c1n(Cc2ccncc2)ccc3nc4oc5ccccc5c(=O)c4cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A23 mock treatment 0.085 0.00785 0.93 0.9298 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 A24 mock treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B01 mock treatment 0.0835 0.00635 0.75 0.752 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B02 mock treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B03 compound treatment 0.082 0.00485 0.57 0.5743 1.0 1907853 Bionet1_000101 Clc1ccc(cc1)c2nc(nc(N3CCOCC3)c2C#N)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B04 compound treatment 0.0815 0.00435 0.52 0.515 1.0 1907854 Bionet1_000102 FC(F)(F)c1cccc(Cn2cc(ccc2=O)C(=O)Nc3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B05 compound treatment 0.0865 0.00935 1.11 1.1075 1.0 1907855 Bionet1_000103 CC(C)Nc1nc(nc(c1C#N)c2ccc(Cl)cc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B06 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1568869 Bionet1_000104 Clc1cccc(Cl)c1Cn2cc(NC(=O)Nc3ccccc3)ccc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B07 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1231829 Bionet1_000105 CC(C)Nc1nc(nc(c1C#N)c2ccc(Cl)cc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B08 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1489554 Bionet1_000106 Clc1cccc(Cl)c1Cn2cc(NC(=O)OCC#C)ccc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B09 compound treatment 0.0725 -0.00465 -0.55 -0.5514 -1.0 1907856 Bionet1_000107 CCN(CC)c1nc(nc(c1C#N)c2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B10 compound treatment 0.0655 -0.0117 -1.38 -1.3808 -1.0 1439159 Bionet1_000108 CC(C)(C)NC(=O)Nc1ccc(=O)n(Cc2c(Cl)cccc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B11 compound treatment 0.0695 -0.00765 -0.91 -0.9068 -1.0 1369131 Bionet1_000109 CN1CCN(CC1)c2nc(nc(c2C#N)c3ccc(Cl)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B12 compound treatment 0.07 -0.00715 -0.85 -0.8476 -1.0 1247971 Bionet1_000110 Clc1cccc(Cl)c1Cn2cc(ccc2=O)C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B13 compound treatment 0.0685 -0.00865 -1.03 -1.0253 -1.0 1907857 Bionet1_000111 CCN(CC)c1nc(nc(c1C#N)c2ccc(Cl)cc2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B14 compound treatment 0.086 0.00885 1.05 1.0483 1.0 1555183 Bionet1_000112 Clc1cccc(Cl)c1Cn2cc(ccc2=O)C(=O)NCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B15 compound treatment 0.065 -0.0122 -1.44 -1.44 -1.0 1419239 Bionet1_000113 CN1CCN(CC1)c2nc(nc(c2C#N)c3ccccc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B16 compound treatment 0.069 -0.00815 -0.97 -0.9661 -1.0 1907858 Bionet1_000114 CN(C)CCCNC(=O)c1ccc(=O)n(Cc2c(Cl)cccc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B17 compound treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 1277711 Bionet1_000115 CN1CCN(CC1)c2nc(nc(c2C#N)c3ccc(Cl)cc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B18 compound treatment 0.0665 -0.0107 -1.26 -1.2623 -1.0 1125710 Bionet1_000116 CCN(CC)C(=O)c1ccc(=O)n(Cc2c(Cl)cccc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B19 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1561998 Bionet1_000117 CCN(CC)c1nc(nc(c1C#N)c2ccc(Cl)cc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B20 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1221478 Bionet1_000118 Clc1cccc(Cl)c1Cn2cc(ccc2=O)C(=O)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B21 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1636764 Bionet1_000119 CN1CCN(CC1)c2nc(nc(c2C#N)c3ccc(Cl)cc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B22 compound treatment 0.073 -0.00415 -0.49 -0.4921 -1.0 1907859 Bionet1_000120 FC(F)(F)Oc1ccc(NC(=O)c2ccc(=O)n(Cc3ccccc3)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B23 mock treatment 0.071 -0.00615 -0.73 -0.7291 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 B24 mock treatment 0.069 -0.00815 -0.97 -0.9661 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C01 mock treatment 0.08 0.00285 0.34 0.3373 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C02 mock treatment 0.0825 0.00535 0.63 0.6335 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C03 compound treatment 0.085 0.00785 0.93 0.9298 1.0 1907860 Bionet1_000121 COc1cc(Br)cc(/C=N\c2cccc(c2)C(F)(F)F)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C04 compound treatment 0.087 0.00985 1.17 1.1667 1.0 1907861 Bionet1_000122 FC(F)(F)c1nc2oc3ccccc3c(=O)c2cc1C(=O)NCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C05 compound treatment 0.0895 0.0123 1.46 1.463 1.0 1907862 Bionet1_000123 CCOC(=O)COc1c(OC)cc(Br)cc1/C=N\c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C06 compound treatment 0.084 0.00685 0.81 0.8113 1.0 1907863 Bionet1_000124 [O-][N+](=O)c1cc(/C=N/OC(=O)c2ccccc2)ccc1Oc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C07 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1664470 Bionet1_000125 NC(=O)Cn1nnc(n1)N(Cc2ccc(Cl)cc2)Cc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C08 compound treatment 0.083 0.00585 0.69 0.6928 1.0 1907864 Bionet1_000126 [O-][N+](=O)c1cc(/C=N/OC(=O)c2ccccc2)ccc1Oc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C09 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1907865 Bionet1_000127 CO/N=C\C(/C=C/c1ccccc1)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C10 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1672129 Bionet1_000128 CN1CCN(CC1)c2ccc(cc2)c3ccnn3C(=O)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C11 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1907866 Bionet1_000129 CN(NC(=O)Nc1cccc(c1)C(F)(F)F)c2c(Cl)c(Cl)nn2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C12 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1907867 Bionet1_000130 Clc1ccc(N/C=C/2\C(=O)N(CS2(=O)=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C13 compound treatment 0.085 0.00785 0.93 0.9298 1.0 1907868 Bionet1_000131 COC(=O)c1sccc1NC(=O)c2cn(nc2C)C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C14 compound treatment 0.073 -0.00415 -0.49 -0.4921 -1.0 1907869 Bionet1_000132 Clc1ccc(N/C=C/2\C(=O)N(CS2=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C15 compound treatment 0.0735 -0.00365 -0.43 -0.4329 -1.0 1907870 Bionet1_000133 O=C/1NN=C(\C1=C\Nc2ccc(Oc3ccccc3)cc2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C16 compound treatment 0.072 -0.00515 -0.61 -0.6106 -1.0 1907871 Bionet1_000134 COc1ccc(N/C=C/2\C(=O)N(CS2(=O)=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C17 compound treatment 0.072 -0.00515 -0.61 -0.6106 -1.0 1907872 Bionet1_000135 FC(F)(F)C/1=NN(C(=O)\C1=C/Nc2ccccc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C18 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1907873 Bionet1_000136 FC(F)(F)c1cccc(NC(=O)N2CCSc3cc(Cl)ccc23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C19 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1907874 Bionet1_000137 FC(F)(F)C/1=NN(C(=O)\C1=C/Nc2cccc(Cl)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C20 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1335060 Bionet1_000138 Clc1ccc(cc1)S(=O)(=O)N2CCSc3cc(Cl)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C21 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1907875 Bionet1_000139 FC(F)(F)C/1=NN(C(=O)\C1=C/Nc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C22 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1682580 Bionet1_000140 COc1ccc(cc1)S(=O)(=O)N2CCSc3cc(Cl)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C23 mock treatment 0.079 0.00185 0.22 0.2188 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 C24 mock treatment 0.08 0.00285 0.34 0.3373 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D01 mock treatment 0.0775 3.47E-4 0.04 0.0411 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D02 mock treatment 0.078 8.47E-4 0.1 0.1003 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D03 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1312830 Bionet1_000141 CN1CCN(CC1)c2nc(nc(c2C#N)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D04 compound treatment 0.0835 0.00635 0.75 0.752 1.0 1907876 Bionet1_000142 FC(F)(F)c1cccc(c1)C2OCC3(CO2)CSc4ccccc4C3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D05 compound treatment 0.0905 0.0133 1.58 1.5815 1.0 1907877 Bionet1_000143 FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NOCC#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D06 compound treatment 0.0815 0.00435 0.52 0.515 1.0 1907878 Bionet1_000144 FC(F)(F)c1cccc(Oc2nnc(Cc3ccccc3)c4ccccc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D07 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1907879 Bionet1_000145 FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NOCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D08 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1514069 Bionet1_000146 Clc1ccc(CSc2nnc(Cc3ccccc3)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D09 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1907880 Bionet1_000147 Clc1ccc(cc1)c2ncc(s2)C(=O)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D10 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1430963 Bionet1_000148 Clc1ccc(Cn2cccc(C(=O)Nc3ccccc3)c2=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D11 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1596601 Bionet1_000149 Brc1ccc(cc1)C(=O)c2cnc(Nc3ccccc3)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D12 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1423401 Bionet1_000150 Clc1ccc(Cn2cccc(C(=O)NCc3ccccc3)c2=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D13 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1907881 Bionet1_000151 Clc1ccc(cc1)c2ncc(s2)C(=O)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D14 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1477014 Bionet1_000152 Clc1ccc(Cn2cccc(C(=O)N3CCOCC3)c2=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D15 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1907882 Bionet1_000153 Clc1ccc(cc1)c2ncc(s2)C(=O)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D16 compound treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 1128049 Bionet1_000154 Clc1cccc(Cl)c1Cn2cccc(C(=O)Nc3ccccc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D17 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1531507 Bionet1_000155 Clc1ccc(cc1)c2ncc(s2)C(=O)c3ccc(cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D18 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1584601 Bionet1_000156 Clc1cccc(Cl)c1Cn2cccc(C(=O)NCc3ccccc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D19 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1740551 Bionet1_000157 O=C(c1cnc(Nc2ccccc2)s1)c3ccc(cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D20 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1907883 Bionet1_000158 FC(F)(F)c1cccc(Cn2cccc(C(=O)Nc3ccccc3)c2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D21 compound treatment 0.082 0.00485 0.57 0.5743 1.0 1907884 Bionet1_000159 Clc1ccc(C(=O)c2cnc(Nc3ccccc3Cl)s2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D22 compound treatment 0.0835 0.00635 0.75 0.752 1.0 1907885 Bionet1_000160 Clc1ccc(NC(=O)c2cccn(Cc3cccc(Cl)c3)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D23 mock treatment 0.08 0.00285 0.34 0.3373 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 D24 mock treatment 0.084 0.00685 0.81 0.8113 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E01 mock treatment 0.079 0.00185 0.22 0.2188 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E02 mock treatment 0.081 0.00385 0.46 0.4558 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E03 compound treatment 0.0855 0.00835 0.99 0.989 1.0 1907886 Bionet1_000161 FC(F)(F)C/1=NN(C(=O)\C1=C/Nc2cccc(c2)C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E04 compound treatment 0.087 0.00985 1.17 1.1667 1.0 1907887 Bionet1_000162 Clc1cccc(Cl)c1CSc2nc3nccc(c4ccccc4)n3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E05 compound treatment 0.088 0.0108 1.29 1.2852 1.0 1907888 Bionet1_000163 FC(F)(F)C/1=NN(C(=O)\C1=C/Nc2ccc(cc2)C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E06 compound treatment 0.0825 0.00535 0.63 0.6335 1.0 1907889 Bionet1_000164 Clc1cccc(Cl)c1CSc2nc3nccc(c4ccccn4)n3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E07 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1177978 Bionet1_000165 O=S(=O)(c1ccccc1)n2cc(c(n2)N3CCOCC3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E08 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1907890 Bionet1_000166 Clc1ccc(/C=C/c2nc3ccccc3c(=O)n2c4ccccc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E09 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1907891 Bionet1_000167 CN(C)c1nn(cc1c2ccccc2)C(=O)Nc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E10 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1907892 Bionet1_000168 COc1ccc(/C=C/c2nc3ccccc3c(=O)n2c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E11 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1907893 Bionet1_000169 CN(C)c1nn(cc1c2ccccc2)C(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E12 compound treatment 0.0825 0.00535 0.63 0.6335 1.0 1907894 Bionet1_000170 COc1cccc(/C=C/c2nc3ccccc3c(=O)n2c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E13 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1907895 Bionet1_000171 CN(C)c1nn(cc1c2ccccc2)C(=S)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E14 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1907896 Bionet1_000172 CNc1nn(cc1[N+](=O)[O-])S(=O)(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E15 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1907897 Bionet1_000173 CN(C)c1nn(cc1c2ccccc2)C(=S)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E16 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1198543 Bionet1_000174 Cc1nc2oc3ccccc3c(=O)c2cc1C(=O)NCc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E17 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1907898 Bionet1_000175 COC(Cc1nnc(SCc2ccccc2)n1c3ccccc3)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E18 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1907899 Bionet1_000176 FC(F)(F)c1cccc(NC(=O)Cc2nc(=O)c3ccccc3s2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E19 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1907900 Bionet1_000177 COC(Cc1nnc(SCc2ccccc2)n1c3ccc(Cl)cc3)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E20 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1655354 Bionet1_000178 CSc1nc2nccc(C(C)Oc3ccc(Cl)cc3Cl)n2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E21 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1907901 Bionet1_000179 COC(Cc1nnc(SCC#C)n1c2cccc(c2)C(F)(F)F)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E22 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1907902 Bionet1_000180 CN(C)/C=C(/C(=O)c1ccc(Cl)cc1)\S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E23 mock treatment 0.0805 0.00335 0.4 0.3966 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 E24 mock treatment 0.0805 0.00335 0.4 0.3966 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F01 mock treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F02 mock treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F03 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1443658 Bionet1_000181 Clc1ccccc1Nc2ncc(s2)C(=O)c3ccc(cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F04 compound treatment 0.082 0.00485 0.57 0.5743 1.0 1907903 Bionet1_000182 Fc1ccc(NC(=O)c2cccn(Cc3cccc(Cl)c3)c2=O)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F05 compound treatment 0.0865 0.00935 1.11 1.1075 1.0 1907904 Bionet1_000183 Clc1ccccc1Nc2ncc(s2)C(=O)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F06 compound treatment 0.082 0.00485 0.57 0.5743 1.0 1907905 Bionet1_000184 CN(C)CCNC(=O)c1cccn(Cc2cccc(c2)C(F)(F)F)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F07 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1265704 Bionet1_000185 Clc1ccc(cc1Cl)C(=O)c2cnc(Nc3ccccc3Cl)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F08 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1226268 Bionet1_000186 CN(C)CCNC(=O)c1cccn(Cc2c(Cl)cccc2Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F09 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1313674 Bionet1_000187 Fc1ccc(cc1)C(=O)c2cnc(Nc3ccc(Cl)c(Cl)c3)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F10 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1321594 Bionet1_000188 CN1CCN(CC1)C(=O)c2cccn(Cc3c(Cl)cccc3Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F11 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1683152 Bionet1_000189 Clc1ccc(cc1)C(=O)c2cnc(Nc3ccc(Cl)c(Cl)c3)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F12 compound treatment 0.0835 0.00635 0.75 0.752 1.0 1907906 Bionet1_000190 FC(F)(F)c1cccc(NC(=O)c2cccn(Cc3ccccc3)c2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F13 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1907907 Bionet1_000191 N#Cc1c(Sc2ccccc2)nc(nc1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F14 compound treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 1907908 Bionet1_000192 FC(F)(F)Oc1ccc(NC(=O)c2cccn(Cc3ccccc3)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F15 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1907909 Bionet1_000193 NCCNC(=O)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F16 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1254840 Bionet1_000194 Fc1ccc(NC(=O)Nc2cccn(Cc3ccc(Cl)cc3)c2=O)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F17 compound treatment 0.084 0.00685 0.81 0.8113 1.0 1907910 Bionet1_000195 [O-][N+](=O)c1ccc(CO/N=C/c2c(nc3sccn23)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F18 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1457322 Bionet1_000196 Cc1cccc(C)c1NC(=O)Nc2cccn(Cc3ccc(Cl)cc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F19 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1907911 Bionet1_000197 COc1ccc(cc1)C(=O)O/N=C/c2c(nc3sccn23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F20 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1216393 Bionet1_000198 Cc1ccc(NC(=O)Nc2cccn(Cc3ccc(Cl)cc3)c2=O)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F21 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1907912 Bionet1_000199 Clc1ccc(NC(=O)C(=O)NN/C=C/2\OC(=O)c3ccccc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F22 compound treatment 0.0885 0.0113 1.34 1.3445 1.0 1191923 Bionet1_000200 CN1CCN(CC1)C(=O)Nc2cccn(Cc3ccc(Cl)c(Cl)c3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F23 mock treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 F24 mock treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G01 mock treatment 0.08 0.00285 0.34 0.3373 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G02 mock treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G03 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1907913 Bionet1_000201 FC(F)(F)c1cccc(N/C=C/c2onc(c2C#N)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G04 compound treatment 0.083 0.00585 0.69 0.6928 1.0 1907914 Bionet1_000202 Nc1ncc(c(n1)c2ccc(Cl)cc2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G05 compound treatment 0.084 0.00685 0.81 0.8113 1.0 1907915 Bionet1_000203 Cc1ccc(N/C=C/c2onc(c2C#N)c3ccccc3Cl)cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G06 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1907916 Bionet1_000204 CN(C)/C=C(/C(=O)c1ccc(Cl)cc1)\S(=O)(=O)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G07 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1907917 Bionet1_000205 Clc1ccc(N/C=C/c2onc(c2C#N)c3ccccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G08 compound treatment 0.0815 0.00435 0.52 0.515 1.0 1907918 Bionet1_000206 Cc1ccc(cc1)S(=O)(=O)c2cnc(N)nc2c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G09 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1907919 Bionet1_000207 COc1ccc(N/C=C/c2onc(c2C#N)c3ccccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G10 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1351582 Bionet1_000208 Cc1ccc2oc3nc(C)c(cc3c(=O)c2c1)C(=O)NCc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G11 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1907920 Bionet1_000209 COc1ccc(N/C=C/c2onc(c2C#N)c3ccccc3Cl)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G12 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1161021 Bionet1_000210 Brc1ccc(cc1)c2ccnc3nc(nn23)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G13 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1907921 Bionet1_000211 Clc1cc(Cl)cc(N/C=C/c2onc(c2C#N)c3ccccc3Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G14 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1597676 Bionet1_000212 C1CN(CCO1)c2nc3nccc(c4ccc(cc4)c5ccccc5)n3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G15 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1907922 Bionet1_000213 Clc1cccc(N/C=C/c2onc(c2C#N)c3ccccc3Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G16 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1377034 Bionet1_000214 Clc1ccc(c(Cl)c1)c2ccnc3nc(nn23)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G17 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1907923 Bionet1_000215 Clc1cccc(Cl)c1c2noc(/C=C/Nc3ccccc3)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G18 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1589535 Bionet1_000216 C1CN(CCO1)c2nc3nccc(c4ccc(Oc5ccccc5)cc4)n3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G19 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1907924 Bionet1_000217 Clc1ccc(N/C=C/c2onc(c2C#N)c3c(Cl)cccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G20 compound treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 1505175 Bionet1_000218 Clc1ccc(NC(=O)N2CCN(CC2)c3cccc(Cl)n3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G21 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1907925 Bionet1_000219 Fc1ccc(N/C=C/c2onc(c2C#N)c3c(Cl)cccc3Cl)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G22 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1263635 Bionet1_000220 Clc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3cccc(Cl)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G23 mock treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 G24 mock treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H01 mock treatment 0.0775 3.47E-4 0.04 0.0411 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H02 mock treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H03 compound treatment 0.0865 0.00935 1.11 1.1075 1.0 1907926 Bionet1_000221 Clc1ccc(cc1)C(=O)C/C=N/OCc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H04 compound treatment 0.0865 0.00935 1.11 1.1075 1.0 1563074 Bionet1_000222 Clc1ccc(Cn2cccc(NC(=O)OCC#C)c2=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H05 compound treatment 0.085 0.00785 0.93 0.9298 1.0 1907927 Bionet1_000223 Clc1ccc(CO/N=C/NC(=O)/C(=C/c2cccs2)/C#N)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H06 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1907928 Bionet1_000224 FC(F)(F)c1cccc(CNC(=O)c2cccn(Cc3ccccc3)c2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H07 compound treatment 0.0875 0.0103 1.23 1.226 1.0 1907929 Bionet1_000225 COc1ccc(cc1)C(=O)C/C=N/OCc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H08 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1724228 Bionet1_000226 Clc1ccc(Cn2cc(ccc2=O)C(=O)NCCN3CCOCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H09 compound treatment 0.0925 0.0153 1.82 1.8184 1.0 1907930 Bionet1_000227 Clc1ccc(CO/N=C/NC(=O)/C(=C\c2ccccc2)/C#N)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H10 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1907931 Bionet1_000228 FC(F)(F)COC(=O)Nc1cccn(Cc2ccc(Cl)c(Cl)c2)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H11 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1907932 Bionet1_000229 Clc1cccc(Cl)c1CO/N=C/NC(=O)/C(=C\c2ccccc2)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H12 compound treatment 0.0835 0.00635 0.75 0.752 1.0 1342989 Bionet1_000230 Clc1ccc(Cn2cccc(NC(=O)Oc3cccnc3)c2=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H13 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1907933 Bionet1_000231 Clc1ccc(CO/N=C/NC(=O)/C(=C\c2ccccc2)/C#N)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H14 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1907934 Bionet1_000232 [O-][N+](=O)c1cc(cn(Cc2ccc(Cl)c(Cl)c2)c1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H15 compound treatment 0.082 0.00485 0.57 0.5743 1.0 1907935 Bionet1_000233 Clc1ccc(cc1)C(=O)C/C=N/OCc2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H16 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1469293 Bionet1_000234 Oc1ccc2cc(NC(=O)c3ccc(Cl)cc3Cl)c(=O)oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H17 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1907936 Bionet1_000235 O/N=C/c1c(SCc2cccc(c2)C(F)(F)F)nc3sccn13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H18 compound treatment 0.0895 0.0123 1.46 1.463 1.0 1641579 Bionet1_000236 COc1ccc2cc(NC(=O)c3ccc(Cl)cc3Cl)c(=O)oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H19 compound treatment 0.0825 0.00535 0.63 0.6335 1.0 1907937 Bionet1_000237 Clc1ccc(Sc2nc(nc(c2C#N)c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H20 compound treatment 0.087 0.00985 1.17 1.1667 1.0 1713813 Bionet1_000238 Clc1ccc(Cn2cccc(C(=O)Nc3nccs3)c2=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H21 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1907938 Bionet1_000239 Clc1ccc(cc1)c2nc(nc(Sc3ccccc3)c2C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H22 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1679759 Bionet1_000240 Clc1ccc(Cn2cccc(C(=O)Nc3cccnc3)c2=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H23 mock treatment 0.0775 3.47E-4 0.04 0.0411 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 H24 mock treatment 0.078 8.47E-4 0.1 0.1003 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I01 mock treatment 0.08 0.00285 0.34 0.3373 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I02 mock treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I03 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1907939 Bionet1_000241 COc1ccccc1N/C=C/c2onc(c2C#N)c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I04 compound treatment 0.0835 0.00635 0.75 0.752 1.0 1180025 Bionet1_000242 C1CN(CCN1C(c2ccccc2)c3ccccc3)c4cnc5ccccc5n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I05 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1907940 Bionet1_000243 COc1ccc(N/C=C/c2onc(c2C#N)c3c(Cl)cccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I06 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1708400 Bionet1_000244 Nc1c(cnc2nc(nn12)N3CCN(CC3)c4ccccc4)c5ccc(F)cc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I07 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1907941 Bionet1_000245 Cc1ccc(N/C=C/c2onc(c2C#N)c3c(Cl)cccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I08 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1472356 Bionet1_000246 Cc1nc2oc3ccc(F)cc3c(=O)c2cc1C(=O)Nc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I09 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1907942 Bionet1_000247 Fc1cccc(Cl)c1c2noc(/C=C/Nc3ccc(Cl)cc3)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I10 compound treatment 0.0865 0.00935 1.11 1.1075 1.0 1558634 Bionet1_000248 Cc1nc2oc3ccc(F)cc3c(=O)c2cc1C(=O)NCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I11 compound treatment 0.073 -0.00415 -0.49 -0.4921 -1.0 1907943 Bionet1_000249 COc1cccc(N/C=C/c2onc(c2C#N)c3c(F)cccc3Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I12 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1233178 Bionet1_000250 Cc1nc2oc3ccc(F)cc3c(=O)c2cc1C(=O)NCc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I13 compound treatment 0.0665 -0.0107 -1.26 -1.2623 -1.0 1907944 Bionet1_000251 COC(=O)c1c(/C=C/Nc2ccccc2)onc1c3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I14 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1907945 Bionet1_000252 FC(F)(F)c1cccc(CS(=O)(=O)c2cnc3ccccc3n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I15 compound treatment 0.094 0.0168 2.0 1.9962 1.0 1907946 Bionet1_000253 CNC1=C(CC(=C(N1C)N2CCN(CC2)S(=O)(=O)C)[N+](=O)[O-])[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I16 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1119661 Bionet1_000254 CC(Oc1ccc(Cl)cc1)c2ccnn2S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I17 compound treatment 0.0735 -0.00365 -0.43 -0.4329 -1.0 1907947 Bionet1_000255 CN(C)S(=O)(=O)c1ccc(N/C=C/2\C(=O)NN=C2C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I18 compound treatment 0.0725 -0.00465 -0.55 -0.5514 -1.0 1651727 Bionet1_000256 Cc1nc2oc3ccc(Cl)cc3c(=O)c2cc1C(=O)Nc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I19 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1907948 Bionet1_000257 CN(C)S(=O)(=O)c1ccc(N/C=C/2\C(=O)N(C)N=C2C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I20 compound treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 1218761 Bionet1_000258 Cc1nc2oc3ccc(Cl)cc3c(=O)c2cc1C(=O)NCc4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I21 compound treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 1907949 Bionet1_000259 CN(C)S(=O)(=O)c1ccc(N/C=C/2\C(=O)NN=C2c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I22 compound treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 1347908 Bionet1_000260 Cc1nc2oc3ccc(Cl)cc3c(=O)c2cc1C(=O)Nc4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I23 mock treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 I24 mock treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J01 mock treatment 0.0775 3.47E-4 0.04 0.0411 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J02 mock treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J03 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1907950 Bionet1_000261 COc1ccc(cc1)c2nc(nc(N3CCOCC3)c2C#N)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J04 compound treatment 0.0845 0.00735 0.87 0.8705 1.0 1371363 Bionet1_000262 Clc1ccc(Cn2cccc(C(=O)Nc3nncs3)c2=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J05 compound treatment 0.083 0.00585 0.69 0.6928 1.0 1405736 Bionet1_000263 COc1ccc(cc1)c2nc(nc(N3CCN(C)CC3)c2C#N)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J06 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1641405 Bionet1_000264 Clc1ccc(Cn2cccc(C(=O)Nc3ccccn3)c2=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J07 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1176722 Bionet1_000265 COc1ccc(cc1)c2nc(nc(N3CCOCC3)c2C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J08 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1738446 Bionet1_000266 CN(C)CCNC(=O)c1cccn(Cc2ccc(Cl)c(Cl)c2)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J09 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1276454 Bionet1_000267 COc1ccc(cc1)c2nc(nc(N3CCN(C)CC3)c2C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J10 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1907951 Bionet1_000268 COc1ccc2cc(NC(=O)c3cccc(c3)C(F)(F)F)c(=O)oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J11 compound treatment 0.0735 -0.00365 -0.43 -0.4329 -1.0 1608299 Bionet1_000269 CCN(CC)c1nc(nc(c1C#N)c2ccc(OC)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J12 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1599052 Bionet1_000270 CN(C)CCNC(=O)c1ccc(=O)n(Cc2c(Cl)cccc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J13 compound treatment 0.0715 -0.00565 -0.67 -0.6699 -1.0 1907952 Bionet1_000271 COc1ccc(cc1)c2nc(nc(Sc3ccccc3)c2C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J14 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1286465 Bionet1_000272 Clc1cccc(Cn2cccc(C(=O)NCc3ccccc3)c2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J15 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1907953 Bionet1_000273 Clc1ccc(cc1)C(=O)O/N=C/c2c(nc3sccn23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J16 compound treatment 0.084 0.00685 0.81 0.8113 1.0 1432531 Bionet1_000274 CCN(CC)C(=O)c1cc(Cl)c(=O)n(Cc2ccc(Cl)c(Cl)c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J17 compound treatment 0.084 0.00685 0.81 0.8113 1.0 1529897 Bionet1_000275 CCOC(=O)c1cc(NC(=O)c2ccc(Cl)cc2)c(=O)oc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J18 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1628795 Bionet1_000276 Clc1ccc(Cn2cc(cc(Cl)c2=O)C(=O)NCC=C)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J19 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1907954 Bionet1_000277 CN(C)/C=C/c1oc(=O)c(NC(=O)c2ccc(Cl)cc2)cc1C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J20 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1907955 Bionet1_000278 [O-][N+](=O)c1cc(cn(Cc2c(Cl)cccc2Cl)c1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J21 compound treatment 0.0895 0.0123 1.46 1.463 1.0 1473981 Bionet1_000279 CCOC(=O)c1cc(NC(=O)c2ccc(OC)cc2)c(=O)oc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J22 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1664412 Bionet1_000280 Clc1cccc(Cl)c1Cn2cc(cc(Cl)c2=O)C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J23 mock treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 J24 mock treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K01 mock treatment 0.0775 3.47E-4 0.04 0.0411 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K02 mock treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K03 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1907956 Bionet1_000281 CCOC/1=NN(C(=O)\C1=C/Nc2ccc(cc2)C(=O)OC)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K04 compound treatment 0.082 0.00485 0.57 0.5743 1.0 1624222 Bionet1_000282 Cc1nc2oc3ccc(Cl)cc3c(=O)c2cc1C(=O)OCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K05 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1907957 Bionet1_000283 CCOC/1=NN(C(=O)\C1=C/Nc2cc(Cl)cc(Cl)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K06 compound treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 1907958 Bionet1_000284 CO/N=C/c1c(Sc2cccc(c2)C(F)(F)F)nc3sccn13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K07 compound treatment 0.0845 0.00735 0.87 0.8705 1.0 1907959 Bionet1_000285 CCOC/1=NN(C(=O)\C1=C/NCc2ccc(Cl)cc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K08 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1907960 Bionet1_000286 Clc1nc2sccn2c1/C=N/OCc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K09 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1907961 Bionet1_000287 CCOC/1=NN(C(=O)\C1=C/Nc2ccc(C)c(C)c2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K10 compound treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 1907962 Bionet1_000288 COc1ccc(N/N=C(/C#N)\S(=O)(=O)c2nsc(C)c2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K11 compound treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 1907963 Bionet1_000289 CCOC/1=NN(C(=O)\C1=C/Nc2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K12 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1907964 Bionet1_000290 Cc1snc(c1C#N)S(=O)(=O)/C(=N/Nc2cccc(c2)C(F)(F)F)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K13 compound treatment 0.073 -0.00415 -0.49 -0.4921 -1.0 1907965 Bionet1_000291 CCOC/1=NN(C(=O)\C1=C/Nc2ccc(C)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K14 compound treatment 0.0735 -0.00365 -0.43 -0.4329 -1.0 1907966 Bionet1_000292 Cc1snc(c1C#N)S(=O)(=O)/C(=N/Nc2ccc(cc2)C(F)(F)F)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K15 compound treatment 0.0855 0.00835 0.99 0.989 1.0 1907967 Bionet1_000293 CCOC/1=NN(C(=O)\C1=C/Nc2ccc(OC)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K16 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1907968 Bionet1_000294 CN(C)C(=C(C#N)C#N)N1CCN(CC1)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K17 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1907969 Bionet1_000295 CCOC/1=NN(C(=O)\C1=C/NN2CCOCC2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K18 compound treatment 0.0855 0.00835 0.99 0.989 1.0 1907970 Bionet1_000296 Clc1nc2sccn2c1/C=N/OCc3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K19 compound treatment 0.0725 -0.00465 -0.55 -0.5514 -1.0 1907971 Bionet1_000297 CCOC/1=NN(C(=O)\C1=C/Nc2ccc(F)cc2F)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K20 compound treatment 0.086 0.00885 1.05 1.0483 1.0 1907972 Bionet1_000298 Clc1nc2sccn2c1/C=N/OCc3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K21 compound treatment 0.0725 -0.00465 -0.55 -0.5514 -1.0 1907973 Bionet1_000299 CCOC/1=NN(C(=O)\C1=C/NCc2cccnc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K22 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1907974 Bionet1_000300 Cc1snc(c1C#N)S(=O)(=O)/C(=N\Nc2ccc(Cl)cc2)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K23 mock treatment 0.073 -0.00415 -0.49 -0.4921 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 K24 mock treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L01 mock treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L02 mock treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L03 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1684368 Bionet1_000301 COc1ccc(cc1)C(=O)Nc2cc(C(=O)c3ccccc3)c(C)oc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L04 compound treatment 0.0835 0.00635 0.75 0.752 1.0 1631680 Bionet1_000302 CCN(CC)C(=O)c1cc(Cl)c(=O)n(Cc2c(Cl)cccc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L05 compound treatment 0.085 0.00785 0.93 0.9298 1.0 1187135 Bionet1_000303 Cc1oc(=O)c(NC(=O)c2ccc(Cl)cc2)cc1C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L06 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1907975 Bionet1_000304 FC(F)(F)c1cccc(Cn2cc(cc(Cl)c2=O)C(=O)NCC=C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L07 compound treatment 0.0815 0.00435 0.52 0.515 1.0 1907976 Bionet1_000305 COc1ccc(cc1)C(=O)Nc2cc(C(=O)C)c(/C=C/N(C)C)oc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L08 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1907977 Bionet1_000306 COC(=O)c1ccc(Cn2cc(cc([N+](=O)[O-])c2=O)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L09 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1907978 Bionet1_000307 FC(F)(F)c1cccc(c1)C(=O)Nc2cc3C(=O)CCCc3oc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L10 compound treatment 0.0865 0.00935 1.11 1.1075 1.0 1907979 Bionet1_000308 FC(F)(F)c1ccc(=O)n(Cc2ccc(cc2)C(=O)NCc3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L11 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1907980 Bionet1_000309 COc1ccc(Sc2cc(nc(n2)c3ccccn3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L12 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1907981 Bionet1_000310 CC(C)(C)NC(=O)c1ccc(Cn2cc(ccc2=O)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L13 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1907982 Bionet1_000311 FC(F)(F)c1cc(Sc2ccc(Cl)cc2)nc(n1)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L14 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1907983 Bionet1_000312 FC(F)(F)c1ccc(=O)n(Cc2ccc(cc2)C(=O)NCc3ccncc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L15 compound treatment 0.088 0.0108 1.29 1.2852 1.0 1907984 Bionet1_000313 FC(F)(F)c1cccc(Oc2cc(nc(n2)c3ccccn3)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L16 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1907985 Bionet1_000314 FC(F)(F)c1ccc(=O)n(Cc2ccc(cc2)C(=O)NCC3CC3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L17 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1907986 Bionet1_000315 FC(F)(F)c1cc(Oc2ccc(Cl)cc2)nc(n1)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L18 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1907987 Bionet1_000316 FC(F)(F)c1ccc(=O)n(Cc2ccc(cc2)C(=O)NCc3cccnc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L19 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1907988 Bionet1_000317 COC(=O)c1cc(NC(=O)c2cccc(c2)C(F)(F)F)c(=O)oc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L20 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1907989 Bionet1_000318 FC(F)(F)c1ccc(=O)n(Cc2ccc(cc2)C(=O)NCc3ccccn3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L21 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1907990 Bionet1_000319 CN(C)/C=C/c1oc(=O)c(NC(=O)c2cccc(c2)C(F)(F)F)cc1C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L22 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1907991 Bionet1_000320 Cc1cccc(NC(=O)c2ccc(Cn3cc(ccc3=O)C(F)(F)F)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L23 mock treatment 0.0775 3.47E-4 0.04 0.0411 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 L24 mock treatment 0.0805 0.00335 0.4 0.3966 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M01 mock treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M02 mock treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M03 compound treatment 0.087 0.00985 1.17 1.1667 1.0 1907992 Bionet1_000321 CCOC/1=NN(C(=O)\C1=C/NCc2cccs2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M04 compound treatment 0.0905 0.0133 1.58 1.5815 1.0 1907993 Bionet1_000322 CO/N=C/c1ccc(Sc2cccc(c2)C(F)(F)F)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M05 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1907994 Bionet1_000323 CCOC/1=NN(C(=O)\C1=C/NCc2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M06 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1907995 Bionet1_000324 CO/N=C/c1ccc(SCc2cccc(c2)C(F)(F)F)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M07 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1907996 Bionet1_000325 CCOC/1=NN(C(=O)\C1=C/Nc2ccc(O)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M08 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1907997 Bionet1_000326 O/N=C/c1ccc(SCc2cccc(c2)C(F)(F)F)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M09 compound treatment 0.0735 -0.00365 -0.43 -0.4329 -1.0 1907998 Bionet1_000327 CCSC(SCC)C(=O)NNC(=S)Nc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M10 compound treatment 0.092 0.0148 1.76 1.7592 1.0 1907999 Bionet1_000328 CC(C)Sc1ccc(/C=N/OCc2c(Cl)cccc2Cl)cc1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M11 compound treatment 0.082 0.00485 0.57 0.5743 1.0 1908000 Bionet1_000329 CCSC(SCC)C(=O)NNC(=S)Nc1cccc(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M12 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1908001 Bionet1_000330 Clc1nc2sccn2c1/C=N/c3ccc(Oc4ccccc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M13 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1908002 Bionet1_000331 CN(C)c1nn(cc1c2ccc(Oc3ccccc3)cc2)C(=O)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M14 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1908003 Bionet1_000332 CS/C(=N/C=[N+](C)C)/Nc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M15 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1281020 Bionet1_000333 CN(C)c1nn(cc1c2ccc(Oc3ccccc3)cc2)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M16 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1908004 Bionet1_000334 CS/C(=N/C=[N+](C)C)/Nc1ccccc1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M17 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1908005 Bionet1_000335 COC(=O)c1ccc(N/C=C\2/CCN(C2=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M18 compound treatment 0.087 0.00985 1.17 1.1667 1.0 1651846 Bionet1_000336 CN(C)S(=O)(=O)c1ccc(NCc2n[nH]c(=O)c3ccccc23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M19 compound treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 1908006 Bionet1_000337 CN(C)/C=C/c1snc(SCc2c(Cl)cccc2Cl)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M20 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1908007 Bionet1_000338 Clc1ccc(cc1)N2CCN(Cc3n[nH]c(=O)c4ccccc34)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M21 compound treatment 0.0835 0.00635 0.75 0.752 1.0 1908008 Bionet1_000339 CN(C)/C=C/c1snc(SCc2ccc(Cl)cc2Cl)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M22 compound treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 1908009 Bionet1_000340 Clc1ccc(CONCc2n[nH]c(=O)c3ccccc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M23 mock treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 M24 mock treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N01 mock treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N02 mock treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N03 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1908010 Bionet1_000341 CCOC(=O)C(C)Sc1cc(nc(n1)c2ccccn2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N04 compound treatment 0.083 0.00585 0.69 0.6928 1.0 1908011 Bionet1_000342 FC(F)(F)c1ccc(=O)n(Cc2ccc(cc2)C(=O)NCc3cccs3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N05 compound treatment 0.0815 0.00435 0.52 0.515 1.0 1908012 Bionet1_000343 COC(=O)c1ccccc1Oc2cc(nc(n2)c3ccccn3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N06 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1908013 Bionet1_000344 FC(F)(F)c1cc(c2ccc(nc2n1)N3CCOCC3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N07 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1908014 Bionet1_000345 FC(F)(F)c1cc(Oc2ccccc2Cl)nc(n1)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N08 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1908015 Bionet1_000346 Cc1cc(C)n(n1)c2ccc3c(cc(nc3n2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N09 compound treatment 0.0815 0.00435 0.52 0.515 1.0 1908016 Bionet1_000347 FC(F)(F)c1cc(NCc2ccccc2C(F)(F)F)nc(n1)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N10 compound treatment 0.081 0.00385 0.46 0.4558 1.0 1908017 Bionet1_000348 FC(F)(F)c1cc(c2ccc(Nc3ccccc3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N11 compound treatment 0.091 0.0138 1.64 1.6407 1.0 1908018 Bionet1_000349 FC(F)(F)c1cc(NCc2ccccc2Cl)nc(n1)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N12 compound treatment 0.082 0.00485 0.57 0.5743 1.0 1908019 Bionet1_000350 COc1ccc(Nc2ccc3c(cc(nc3n2)C(F)(F)F)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N13 compound treatment 0.086 0.00885 1.05 1.0483 1.0 1908020 Bionet1_000351 Cn1nc(c(/C=N/OCc2c(Cl)cccc2Cl)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N14 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1908021 Bionet1_000352 FC(F)(F)c1cc(c2ccc(Nc3ccc(Cl)cc3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N15 compound treatment 0.0815 0.00435 0.52 0.515 1.0 1908022 Bionet1_000353 Cn1nc(c(/C=N/OCc2ccc(Cl)c(Cl)c2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N16 compound treatment 0.0845 0.00735 0.87 0.8705 1.0 1908023 Bionet1_000354 FC(F)(F)c1cc(c2ccc(Oc3ccc(Cl)cc3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N17 compound treatment 0.0905 0.0133 1.58 1.5815 1.0 1908024 Bionet1_000355 Cn1nc(c(/C=N/OCc2ccc(cc2)[N+](=O)[O-])c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N18 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1908025 Bionet1_000356 FC(F)(F)c1cc(c2ccc(Nc3ccc(C#N)cc3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N19 compound treatment 0.0815 0.00435 0.52 0.515 1.0 1908026 Bionet1_000357 Cn1nc(c(/C=N/OC(=O)c2ccc(Cl)cc2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N20 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1908027 Bionet1_000358 CC(=O)c1ccccc1Nc2ccc3c(cc(nc3n2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N21 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1908028 Bionet1_000359 Cn1nc(c(/C=N/OC(=O)c2cccc(c2)C(F)(F)F)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N22 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1908029 Bionet1_000360 FC(F)(F)c1cc(c2ccc(Sc3ccccc3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N23 mock treatment 0.08 0.00285 0.34 0.3373 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 N24 mock treatment 0.0795 0.00235 0.28 0.2781 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O01 mock treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O02 mock treatment 0.0705 -0.00665 -0.79 -0.7883 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O03 compound treatment 0.072 -0.00515 -0.61 -0.6106 -1.0 1908030 Bionet1_000361 CN(C)/C=C/c1snc(SCc2c(F)cccc2Cl)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O04 compound treatment 0.0985 0.0213 2.53 2.5294 1.0 1908031 Bionet1_000362 COC(=O)c1sccc1c2ccc(/C=N/OC(=O)c3ccccc3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O05 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1908032 Bionet1_000363 Cc1nc(CSc2nsc(/C=C/Nc3ccccc3)c2C#N)cs1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O06 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1908033 Bionet1_000364 CCOC(=O)C(=Cc1ccc(o1)c2ccsc2C(=O)OC)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O07 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1908034 Bionet1_000365 Cc1cc(C)c(C(=O)N)c(NC(=O)Nc2cccc(c2)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O08 compound treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 1709704 Bionet1_000366 COC(=O)c1sccc1c2ccc(o2)C(=O)Nc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O09 compound treatment 0.0745 -0.00265 -0.31 -0.3144 -1.0 1908035 Bionet1_000367 Cc1cc(C)c(C(=O)N)c(NC(=O)Nc2ccc(OC(F)(F)F)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O10 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1908036 Bionet1_000368 COC(=O)c1sccc1c2ccc(COC(=O)NC3CCCCC3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O11 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1742999 Bionet1_000369 Clc1ccc(cc1)n2nc(C(=O)NCc3ccccc3)c4ccccc4c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O12 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1908037 Bionet1_000370 COC(=O)c1sccc1c2ccc(COC(=O)c3ccc(Cl)cc3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O13 compound treatment 0.0725 -0.00465 -0.55 -0.5514 -1.0 1162954 Bionet1_000371 Clc1ccc(cc1)n2nc(C(=O)N3CCCC3)c4ccccc4c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O14 compound treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 1908038 Bionet1_000372 COC(=O)c1sccc1c2ccc(COC(=O)Nc3ccccc3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O15 compound treatment 0.0815 0.00435 0.52 0.515 1.0 1908039 Bionet1_000373 Cn1nc(Cl)c(Cl)c1Oc2ccc(cc2)S(=O)(=O)Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O16 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1908040 Bionet1_000374 COC(=O)c1sccc1c2ccc(COC(=O)c3ccc(OC)cc3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O17 compound treatment 0.0815 0.00435 0.52 0.515 1.0 1427131 Bionet1_000375 Fc1ccc(cc1)n2nc(C(=O)Nc3ccccc3)c4ccccc4c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O18 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1570750 Bionet1_000376 COC(=O)c1sc(nc1N)N2CCN(CC2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O19 compound treatment 0.0765 -6.53E-4 -0.08 -0.0774 -1.0 1293220 Bionet1_000377 Fc1ccc(cc1)n2nc(C(=O)Oc3ccccc3)c4ccccc4c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O20 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1201188 Bionet1_000378 O=C(c1cc(c(s1)N2CCOCC2)c3ccccn3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O21 compound treatment 0.072 -0.00515 -0.61 -0.6106 -1.0 1356705 Bionet1_000379 Clc1ccc(NC(=O)c2nn(c3ccccc3)c(=O)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O22 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1171077 Bionet1_000380 CN(C)c1sc(cc1c2ccc(Oc3ccccc3)cc2)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O23 mock treatment 0.0785 0.00135 0.16 0.1596 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 O24 mock treatment 0.079 0.00185 0.22 0.2188 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P01 mock treatment 0.074 -0.00315 -0.37 -0.3736 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P02 mock treatment 0.0725 -0.00465 -0.55 -0.5514 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P03 compound treatment 0.066 -0.0112 -1.32 -1.3215 -1.0 1125455 Bionet1_000381 Cc1oc(=O)c(NC(=O)c2cccc(Cl)c2)cc1C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P04 compound treatment 0.0665 -0.0107 -1.26 -1.2623 -1.0 1908041 Bionet1_000382 FC(F)(F)c1cc(c2ccc(Oc3ccccc3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P05 compound treatment 0.0685 -0.00865 -1.03 -1.0253 -1.0 1420981 Bionet1_000383 CCOC(=O)c1cc(NC(=O)c2cccc(Cl)c2)c(=O)oc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P06 compound treatment 0.0685 -0.00865 -1.03 -1.0253 -1.0 1908042 Bionet1_000384 COCCCNc1ccc2c(cc(nc2n1)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P07 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1230065 Bionet1_000385 CCOC(=O)c1cc(NC(=O)c2ccc(C)cc2)c(=O)oc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P08 compound treatment 0.09 0.0128 1.52 1.5222 1.0 1908043 Bionet1_000386 FC(F)(F)c1cc(c2ccc(SCc3ccccc3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P09 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1183648 Bionet1_000387 CN1CCN(CC1)C(=O)c2ccc(=O)n(Cc3ccc(Cl)c(Cl)c3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P10 compound treatment 0.0805 0.00335 0.4 0.3966 1.0 1908044 Bionet1_000388 COc1ccc(Oc2ccc3c(cc(nc3n2)C(F)(F)F)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P11 compound treatment 0.076 -0.00115 -0.14 -0.1366 -1.0 1644688 Bionet1_000389 Clc1ccc(Cn2cc(ccc2=O)C(=O)Nc3ccccc3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P12 compound treatment 0.079 0.00185 0.22 0.2188 1.0 1908045 Bionet1_000390 Fc1ccc(Oc2ccc3c(cc(nc3n2)C(F)(F)F)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P13 compound treatment 0.08 0.00285 0.34 0.3373 1.0 1460766 Bionet1_000391 Clc1ccc(Cn2cc(ccc2=O)C(=O)NCc3ccccc3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P14 compound treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 1908046 Bionet1_000392 Oc1ccc(Oc2ccc3c(cc(nc3n2)C(F)(F)F)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P15 compound treatment 0.082 0.00485 0.57 0.5743 1.0 1291088 Bionet1_000393 Fc1ccc(NC(=O)c2ccc(=O)n(Cc3ccc(Cl)c(Cl)c3)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P16 compound treatment 0.078 8.47E-4 0.1 0.1003 1.0 1908047 Bionet1_000394 FC(F)(F)c1cc(c2ccc(nc2n1)N3CCNCC3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P17 compound treatment 0.0775 3.47E-4 0.04 0.0411 1.0 1124809 Bionet1_000395 Clc1ccc(Cn2cc(ccc2=O)C(=O)Nc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P18 compound treatment 0.0795 0.00235 0.28 0.2781 1.0 1908048 Bionet1_000396 NC(=O)C1CCN(CC1)c2ccc3c(cc(nc3n2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P19 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1147341 Bionet1_000397 Fc1ccc(NC(=O)c2ccc(=O)n(Cc3ccc(Cl)cc3)c2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P20 compound treatment 0.0785 0.00135 0.16 0.1596 1.0 1908049 Bionet1_000398 FC(F)(F)c1cnc(Oc2ccc(cc2)n3cc4ccsc4c3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P21 compound treatment 0.077 -1.53E-4 -0.02 -0.0182 -1.0 1728690 Bionet1_000399 CN(C(=O)c1ccc(=O)n(Cc2ccc(Cl)cc2)c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P22 compound treatment 0.075 -0.00215 -0.26 -0.2551 -1.0 1908050 Bionet1_000400 O=C(Nc1ccccc1)Nn2c(nnc2c3ccccn3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P23 mock treatment 0.0755 -0.00165 -0.2 -0.1959 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1234 P24 mock treatment 0.0615 -0.0157 -1.85 -1.8548 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A01 mock treatment 0.0755 0.00407 0.48 0.4824 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A02 mock treatment 0.072 5.71E-4 0.07 0.0677 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A03 compound treatment 0.0795 0.00807 0.96 0.9564 1.0 1910474 Bionet1_003921 Cn1nc(c2cc(sc12)C(=O)Nc3cccc(c3)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A04 compound treatment 0.079 0.00757 0.9 0.8971 1.0 1910475 Bionet1_003922 COc1ccc(/N=C/2\C(=O)N(Cc3ccccc3Cl)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A05 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910476 Bionet1_003923 Cn1nc(c2cc(sc12)C(=O)Nc3ccc(Cl)cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A06 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1237657 Bionet1_003924 COCc1cc(nc(n1)S(=O)Cc2ccc(Cl)cc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A07 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1910477 Bionet1_003925 Cc1cc(C)cc(/N=C\2/C(=O)N(Cc3ccccc3Cl)c4ccccc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A08 compound treatment 0.08 0.00857 1.02 1.0156 1.0 1910478 Bionet1_003926 CC(C)(C)C1COc2ccccc2N1C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A09 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1910479 Bionet1_003927 Fc1ccc(/N=C\2/C(=O)N(Cc3ccccc3Cl)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A10 compound treatment 0.0795 0.00807 0.96 0.9564 1.0 1279535 Bionet1_003928 OCc1cnc(S(=O)Cc2ccc(Cl)cc2)n1Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A11 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1910480 Bionet1_003929 Cn1nc(c2cc(CSc3c(Cl)cccc3Cl)sc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A12 compound treatment 0.078 0.00657 0.78 0.7786 1.0 1910481 Bionet1_003930 FC(F)(F)c1cccc(CSCC(=O)c2cc(no2)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A13 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1910482 Bionet1_003931 Cn1nc(c2cc(COc3ccc(Cl)cc3Cl)sc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A14 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910483 Bionet1_003932 Nc1nc(SCc2ccc(Cl)cc2)c(C#N)c(n1)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A15 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910484 Bionet1_003933 Clc1ccc(CN2C(=O)/C(=N/c3ccc(Cl)cc3)/c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A16 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1910485 Bionet1_003934 COc1ccc(CSc2nc(N)nc(c3cccs3)c2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A17 compound treatment 0.081 0.00957 1.13 1.1341 1.0 1910486 Bionet1_003935 COc1ccc(/N=C\2/C(=O)N(Cc3ccc(Cl)cc3)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A18 compound treatment 0.083 0.0116 1.37 1.3711 1.0 1910487 Bionet1_003936 FC(F)(F)c1cccc(Cn2ccc(c(C#N)c2=O)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A19 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1910488 Bionet1_003937 Fc1ccc(/N=C\2/C(=O)N(Cc3c(Cl)cccc3Cl)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A20 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1613404 Bionet1_003938 Cc1ccc(cc1)S(=O)(=O)c2c(C)cc(C)nc2Oc3cccc(C)c3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A21 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1910489 Bionet1_003939 Cc1cccc(C)c1NC(=O)O/N=C(/COc2ccccc2[N+](=O)[O-])\C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A22 compound treatment 0.0815 0.0101 1.19 1.1934 1.0 1296756 Bionet1_003940 OC1(CN2CCOCC2)CCN(CC1)C(=O)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A23 mock treatment 0.0895 0.0181 2.14 2.1413 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 A24 mock treatment 0.082 0.0106 1.25 1.2526 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B01 mock treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B02 mock treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B03 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1204177 Bionet1_003941 Cc1c(C)n(Cc2ccccc2)c(c1CNC(=O)c3cccs3)n4cccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B04 compound treatment 0.075 0.00357 0.42 0.4232 1.0 1910490 Bionet1_003942 FCCCOc1ccc(cc1)/C(=C/Nc2cccc(c2)C(F)(F)F)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B05 compound treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 1910491 Bionet1_003943 Fc1ccc(CSc2nnc(o2)c3sccc3n4cccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B06 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1910492 Bionet1_003944 Fc1ccc(N/C=C/C(=O)c2cccc(OCc3c(F)cccc3Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B07 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910493 Bionet1_003945 Clc1cccc(CSc2nnc(o2)c3sccc3n4cccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B08 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1910494 Bionet1_003946 Cc1ccc(cc1)S(=O)(=O)n2ccc(n2)c3ccc(OCCCF)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B09 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1150751 Bionet1_003947 Fc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ccc(nn3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B10 compound treatment 0.0715 7.14E-5 0.01 0.0085 1.0 1910495 Bionet1_003948 Cc1cccc(Oc2nc3cc(Cl)c(Cl)cc3nc2C(F)(F)F)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B11 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1577897 Bionet1_003949 Cc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3cc(C)c4cccc(C)c4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B12 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1910496 Bionet1_003950 FC(F)(F)c1cccc(/C=N/NC(=O)CN2CCS(=O)(=O)CC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B13 compound treatment 0.069 -0.00243 -0.29 -0.2878 -1.0 1468747 Bionet1_003951 Cc1cc(C)c(C#N)c(n1)N2CCN(CC2)S(=O)(=O)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B14 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1910497 Bionet1_003952 CC(C)(C)c1ccc(/C=N/NC(=O)CN2CCS(=O)(=O)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B15 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1426726 Bionet1_003953 Cc1cc(C)c(C#N)c(n1)N2CCN(CC2)S(=O)(=O)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B16 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910498 Bionet1_003954 CN(C)/C=C/c1c(nnn1c2cc(cc(c2)C(F)(F)F)C(F)(F)F)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B17 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1640915 Bionet1_003955 Cc1ccc(NC(=O)N2CCC(CC2)c3nc4ccccc4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B18 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910499 Bionet1_003956 [O-][N+](=O)c1cc(N/C=C/C(=O)c2ccc(OCCCF)cc2)ccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B19 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1711809 Bionet1_003957 Fc1ccc(NC(=O)N2CCC(CC2)c3nc4ccccc4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B20 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1910500 Bionet1_003958 FCCCOc1ccc(cc1)C(=O)/C=C/Nc2ccc(Oc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B21 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1166474 Bionet1_003959 Cc1cccc(NC(=O)N2CCC(CC2)c3nc4ccccc4s3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B22 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910501 Bionet1_003960 Clc1cccc(c1)C(=O)NNc2nc3ccccc3nc2Cc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B23 mock treatment 0.0775 0.00607 0.72 0.7194 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 B24 mock treatment 0.077 0.00557 0.66 0.6602 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C01 mock treatment 0.072 5.71E-4 0.07 0.0677 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C02 mock treatment 0.0735 0.00207 0.25 0.2454 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C03 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1201562 Bionet1_003961 Cc1ccc(cc1)S(=O)(=O)N2C(COc3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C04 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910502 Bionet1_003962 CCOC(=O)c1ccc(/N=C/c2ccccc2Oc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C05 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1424451 Bionet1_003963 Cc1ccc2OCC(N(c2c1)S(=O)(=O)c3ccc(Cl)cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C06 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1910503 Bionet1_003964 COC(OC)c1ccnc(n1)c2ccc(OC(=O)c3cccs3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C07 compound treatment 0.0785 0.00707 0.84 0.8379 1.0 1169169 Bionet1_003965 COc1ccc(cc1)S(=O)(=O)N2C(COc3ccc(C)cc23)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C08 compound treatment 0.074 0.00257 0.3 0.3047 1.0 1910504 Bionet1_003966 COC(OC)c1ccnc(n1)c2ccc(OC(=O)c3ccc(F)cc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C09 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910505 Bionet1_003967 Cc1ccc2OCC(N(C(=O)c3cccc(c3)C(F)(F)F)c2c1)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C10 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910506 Bionet1_003968 FCCCOc1ccc(/C=N/OCc2c(Cl)cccc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C11 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910507 Bionet1_003969 Clc1cccc(c1)C(=O)NCCOC(=O)Nc2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C12 compound treatment 0.0745 0.00307 0.36 0.3639 1.0 1910508 Bionet1_003970 COC(OC)c1ccnc(n1)c2ccc(OC(=O)c3ccc(cc3)[N+](=O)[O-])cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C13 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910509 Bionet1_003971 Brc1cccc(c1)C(=O)NCCOC(=O)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C14 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1598935 Bionet1_003972 Clc1cccc(C(=O)c2c[nH]c(c2)C(=O)NCc3cccs3)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C15 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1910510 Bionet1_003973 Cn1nc(c(/C=C/C(=O)c2ccc(Cl)c(Cl)c2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C16 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910511 Bionet1_003974 CN(C)CCCNC(=O)c1cc(c[nH]1)C(=O)c2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C17 compound treatment 0.0745 0.00307 0.36 0.3639 1.0 1910512 Bionet1_003975 CCOC(=O)c1cnc(nc1Sc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C18 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1217050 Bionet1_003976 Clc1cccc(Cl)c1C(=O)c2c[nH]c(c2)C(=O)NCc3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C19 compound treatment 0.0745 0.00307 0.36 0.3639 1.0 1910513 Bionet1_003977 CCOC(=O)c1cnc(nc1Sc2ccc(C)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C20 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1430862 Bionet1_003978 Clc1cccc(Cl)c1C(=O)c2c[nH]c(c2)C(=O)NC3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C21 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910514 Bionet1_003979 CCOC(=O)c1cnc(nc1Sc2cccc(Cl)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C22 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1242005 Bionet1_003980 Fc1ccc(CNC(=O)c2cc(c[nH]2)C(=O)c3cccc(Cl)c3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C23 mock treatment 0.075 0.00357 0.42 0.4232 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 C24 mock treatment 0.078 0.00657 0.78 0.7786 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D01 mock treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D02 mock treatment 0.072 5.71E-4 0.07 0.0677 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D03 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1126842 Bionet1_003981 Clc1cccc(NC(=O)N2CCC(CC2)c3nc4ccccc4s3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D04 compound treatment 0.074 0.00257 0.3 0.3047 1.0 1910515 Bionet1_003982 FCCCOc1ccc(/C=C/C(=O)NCc2ccc3OCOc3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D05 compound treatment 0.0715 7.14E-5 0.01 0.0085 1.0 1315490 Bionet1_003983 Clc1ccc(NC(=O)N2CCC(CC2)c3nc4ccccc4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D06 compound treatment 0.0715 7.14E-5 0.01 0.0085 1.0 1910516 Bionet1_003984 [O-][N+](=O)c1cc(NS(=O)(=O)c2cc(Cl)ccc2Cl)ccc1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D07 compound treatment 0.0865 0.0151 1.79 1.7858 1.0 1351800 Bionet1_003985 Cc1cc(C)c(C#N)c(n1)N2CCCN(CC2)S(=O)(=O)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D08 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1910517 Bionet1_003986 COc1ccc(CNC(=O)/C=C/c2ccc(OCCCF)cc2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D09 compound treatment 0.0785 0.00707 0.84 0.8379 1.0 1910518 Bionet1_003987 Cc1cccc(CO/N=C/c2c(nc3ccc(Cl)cn23)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D10 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910519 Bionet1_003988 Cc1ccc(N/C=C/C(=O)c2cccc(OCc3c(F)cccc3Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D11 compound treatment 0.082 0.0106 1.25 1.2526 1.0 1910520 Bionet1_003989 Fc1ccc(CO/N=C/c2c(nc3ccc(Cl)cn23)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D12 compound treatment 0.08 0.00857 1.02 1.0156 1.0 1389989 Bionet1_003990 Cc1cc(I)cn2cc(nc12)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D13 compound treatment 0.0785 0.00707 0.84 0.8379 1.0 1910521 Bionet1_003991 Cc1ccn2c(/C=N/OCc3ccc(F)cc3)c(nc2c1)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D14 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1141909 Bionet1_003992 CC(C)CC(N1Cc2ccccc2C1=O)C(=O)Nc3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D15 compound treatment 0.085 0.0136 1.61 1.6081 1.0 1910522 Bionet1_003993 Cc1ccn2c(/C=N/OCc3cccc(F)c3)c(nc2c1)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D16 compound treatment 0.0825 0.0111 1.31 1.3119 1.0 1512809 Bionet1_003994 OCC(Cc1ccccc1)NC(=O)c2ccc(I)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D17 compound treatment 0.0795 0.00807 0.96 0.9564 1.0 1910523 Bionet1_003995 Sc1nnc(c2cccs2)n1/N=C/c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D18 compound treatment 0.0745 0.00307 0.36 0.3639 1.0 1215520 Bionet1_003996 OCC(NC(=O)c1ccc(I)cc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D19 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1910524 Bionet1_003997 Nn1c(SCc2c(Cl)cccc2Cl)nnc1c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D20 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1910525 Bionet1_003998 FC(F)(F)c1cccc(c1)c2cn3cc(I)ccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D21 compound treatment 0.0795 0.00807 0.96 0.9564 1.0 1910526 Bionet1_003999 COC(=O)c1sccc1n2cccc2C(=O)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D22 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910527 Bionet1_004000 COc1ccc(N/C=C/C(=O)c2sc(nc2C)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D23 mock treatment 0.0755 0.00407 0.48 0.4824 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 D24 mock treatment 0.0765 0.00507 0.6 0.6009 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E01 mock treatment 0.074 0.00257 0.3 0.3047 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E02 mock treatment 0.075 0.00357 0.42 0.4232 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E03 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1910528 Bionet1_004001 CCOC(=O)c1cnc(nc1Sc2cccc(C)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E04 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1910529 Bionet1_004002 COC(OC)c1ccnc(n1)c2ccc(OC(=O)c3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E05 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910530 Bionet1_004003 CCOC(=O)c1cnc(nc1Sc2ccc(OC)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E06 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1910531 Bionet1_004004 CCOC(=O)C/C(=N/NC(=O)/C(=N/Nc1ccccc1[N+](=O)[O-])/C#N)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E07 compound treatment 0.084 0.0126 1.49 1.4896 1.0 1910532 Bionet1_004005 CCOC(=O)c1cnc(nc1Sc2cc(C)ccc2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E08 compound treatment 0.0785 0.00707 0.84 0.8379 1.0 1910533 Bionet1_004006 CCCc1c(C)nn(C(=O)/C(=N/Nc2ccccc2[N+](=O)[O-])/C#N)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E09 compound treatment 0.079 0.00757 0.9 0.8971 1.0 1180452 Bionet1_004007 CCOC(=O)c1cnc(nc1Oc2ccc(Cl)c(Cl)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E10 compound treatment 0.081 0.00957 1.13 1.1341 1.0 1910534 Bionet1_004008 CC/C(=N\NC(=O)\C(=N\Nc1ccccc1[N+](=O)[O-])\C#N)/CC(=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E11 compound treatment 0.081 0.00957 1.13 1.1341 1.0 1247003 Bionet1_004009 CCOC(=O)c1cnc(nc1Oc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E12 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1910535 Bionet1_004010 Fc1cc(ccc1I)c2nccc(n2)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E13 compound treatment 0.078 0.00657 0.78 0.7786 1.0 1910536 Bionet1_004011 CCOC(=O)c1cnc(nc1Oc2cccc(Cl)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E14 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1910537 Bionet1_004012 C/C(=N\NC(=O)\C(=N\Nc1ccccc1[N+](=O)[O-])\C#N)/CC(=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E15 compound treatment 0.0785 0.00707 0.84 0.8379 1.0 1498796 Bionet1_004013 Clc1ccc(Sc2nc(ncc2C(=O)NCC=C)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E16 compound treatment 0.078 0.00657 0.78 0.7786 1.0 1910538 Bionet1_004014 [O-][N+](=O)c1ccc(Oc2ccc(c(F)c2)c3ccccc3)c(Br)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E17 compound treatment 0.085 0.0136 1.61 1.6081 1.0 1910539 Bionet1_004015 CO/N=C(/CCS(=O)(=O)c1ccc(C)cc1)\c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E18 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1910540 Bionet1_004016 Fc1ccc(N/C=C/C(=O)c2ccc(OCc3c(F)cccc3Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E19 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1236485 Bionet1_004017 Cc1ccc(Sc2cc3ccccc3nc2c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E20 compound treatment 0.074 0.00257 0.3 0.3047 1.0 1910541 Bionet1_004018 Cc1ccc(N/C=C/C(=O)c2ccc(OCc3c(F)cccc3Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E21 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1910542 Bionet1_004019 Clc1ccc(Sc2cc3ccccc3nc2c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E22 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910543 Bionet1_004020 Clc1ccc(COc2ccc(/C=C/C(=O)N3CCOCC3)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E23 mock treatment 0.075 0.00357 0.42 0.4232 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 E24 mock treatment 0.0745 0.00307 0.36 0.3639 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F01 mock treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F02 mock treatment 0.072 5.71E-4 0.07 0.0677 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F03 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910544 Bionet1_004021 COc1cnc(nc1Sc2ccc(Br)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F04 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910545 Bionet1_004022 Cc1nc(sc1C(=O)/C=C/Nc2ccc(C)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F05 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1665399 Bionet1_004023 O=c1cc(N2CCN(CC2)S(=O)(=O)c3ccccc3)c(n[nH]1)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F06 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910546 Bionet1_004024 Cc1nc(sc1C(=O)C2C(c3ccccc3)C2(C#N)C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F07 compound treatment 0.08 0.00857 1.02 1.0156 1.0 1512031 Bionet1_004025 O=C(N1CCOCC1)c2cc3cccnc3n2S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F08 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1910547 Bionet1_004026 Clc1ccc(CNC(=O)/C=C/c2cnc3ccccc3c2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F09 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910548 Bionet1_004027 Clc1ccc(Sc2cc(Cl)c(nn2)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F10 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910549 Bionet1_004028 Brc1ccc(cc1)C(=O)CSc2nccn2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F11 compound treatment 0.079 0.00757 0.9 0.8971 1.0 1910550 Bionet1_004029 Clc1cc(Sc2ccc(Br)cc2)nnc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F12 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910551 Bionet1_004030 Clc1cc(OCc2ccccc2)ccc1C(=O)NNC(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F13 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910552 Bionet1_004031 Clc1ccc(Oc2cc(Cl)c(nn2)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F14 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1910553 Bionet1_004032 CCNC(=S)NNC(=O)c1ccc(OCc2ccccc2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F15 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910554 Bionet1_004033 COc1cnc(nc1Sc2cccc(Cl)c2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F16 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1910555 Bionet1_004034 Clc1cc(OCc2ccccc2)ccc1C(=O)NNC(=S)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F17 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910556 Bionet1_004035 COc1cnc(nc1Sc2ccc(Cl)cc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F18 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1642801 Bionet1_004036 Clc1ccccc1CNC(=O)c2ccc(OCc3ccccc3)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F19 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1910557 Bionet1_004037 CCN(CC)C(=O)C(=O)c1cccn1c2c(sc3ccccc23)C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F20 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910558 Bionet1_004038 O=C1N(CCCSc2nccn2c3ccccc3)C(=O)c4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F21 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910559 Bionet1_004039 CCCNC(=O)C(=O)c1cccn1c2c(sc3ccccc23)C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F22 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1359490 Bionet1_004040 CCOC(=O)c1nc2ccc(I)cn2c1Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F23 mock treatment 0.0725 0.00107 0.13 0.127 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 F24 mock treatment 0.0735 0.00207 0.25 0.2454 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G01 mock treatment 0.0665 -0.00493 -0.58 -0.584 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G02 mock treatment 0.0655 -0.00593 -0.7 -0.7025 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G03 compound treatment 0.0675 -0.00393 -0.47 -0.4655 -1.0 1462038 Bionet1_004041 Clc1ccc(cc1)C23N(CCN3C(=O)c4ccccc42)C(=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G04 compound treatment 0.069 -0.00243 -0.29 -0.2878 -1.0 1910560 Bionet1_004042 CC(Oc1ccc(c(F)c1)c2ccccc2)C(=O)/C=C/Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G05 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1327272 Bionet1_004043 COc1ccc(Sc2cc3ccccc3nc2c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G06 compound treatment 0.066 -0.00543 -0.64 -0.6432 -1.0 1910561 Bionet1_004044 CCC(C)NC(=O)/C=C/c1ccc(OCc2ccc(Cl)cc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G07 compound treatment 0.078 0.00657 0.78 0.7786 1.0 1340843 Bionet1_004045 Brc1ccc(Sc2cc3ccccc3nc2c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G08 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910562 Bionet1_004046 [O-][N+](=O)c1ccc(Oc2ccc(Br)cc2)c(Br)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G09 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910563 Bionet1_004047 ClCC(=O)N1CCN2C(=O)c3ccccc3C12c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G10 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1910564 Bionet1_004048 [O-][N+](=O)c1ccc(cc1)N2CCN(Cc3ccc(OCCCF)cc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G11 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910565 Bionet1_004049 Brc1ccc(cc1)c2ccc(NC(=O)c3ccccc3)c(=O)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G12 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910566 Bionet1_004050 FCCCOc1ccc(/C=C/C(=O)N2CCN(Cc3ccccc3)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G13 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910567 Bionet1_004051 Brc1ccc(cc1)c2ccc(NC(=O)c3cccs3)c(=O)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G14 compound treatment 0.067 -0.00443 -0.52 -0.5247 -1.0 1910568 Bionet1_004052 Cc1ccc(N2CCN(CC2)C(=O)/C=C/c3ccc(OCCCF)cc3)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G15 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1694638 Bionet1_004053 Fc1ccc(cc1)n2ncc(NCc3ccccc3)c(Br)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G16 compound treatment 0.0675 -0.00393 -0.47 -0.4655 -1.0 1910569 Bionet1_004054 FCCCOc1ccc(/C=C/C(=O)NCc2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G17 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1331363 Bionet1_004055 Fc1ccc(cc1)n2ncc(Cl)c(Oc3ccc(Cl)cc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G18 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1910570 Bionet1_004056 COc1ccccc1/N=C/c2cc(Br)cc(Br)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G19 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1305425 Bionet1_004057 Cn1nc(c(CN2CCN(CC2)c3ccccc3)c1Cl)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G20 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910571 Bionet1_004058 FC(F)(Cl)c1nnc2ccc(Sc3nc4ccccc4s3)nn12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G21 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1327484 Bionet1_004059 COc1ccc(Oc2c(Br)cnn(c3ccc(C)cc3)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G22 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1910572 Bionet1_004060 COC(=O)c1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G23 mock treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 G24 mock treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H01 mock treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H02 mock treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H03 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910573 Bionet1_004061 COC(=O)c1sc2ccccc2c1n3cccc3C(=O)C(=O)NC(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H04 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910574 Bionet1_004062 COc1ccc(N/C=C/C(=O)c2sc(nc2C)c3cccnc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H05 compound treatment 0.074 0.00257 0.3 0.3047 1.0 1910575 Bionet1_004063 FC(F)(F)c1cccc(Oc2ncc(cn2)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H06 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910576 Bionet1_004064 Cc1nc(sc1C(=O)/C=C/Nc2ccc(Cl)cc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H07 compound treatment 0.084 0.0126 1.49 1.4896 1.0 1910577 Bionet1_004065 Clc1ccc(cc1)c2cnc(Oc3cc(Cl)ccc3Cl)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H08 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1302957 Bionet1_004066 CC1(C)CC(=O)C2(C(c3ccc(Cl)cc3Cl)C2(C#N)C#N)C(=O)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H09 compound treatment 0.0795 0.00807 0.96 0.9564 1.0 1910578 Bionet1_004067 COc1cnc(nc1Sc2ccccc2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H10 compound treatment 0.075 0.00357 0.42 0.4232 1.0 1910579 Bionet1_004068 CN(C)/C=C/C(=C/C(=O)C(F)(F)F)/Nc1ccccc1c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H11 compound treatment 0.0785 0.00707 0.84 0.8379 1.0 1910580 Bionet1_004069 Cc1cccc(CO/N=C/c2c(nc3cc(C)ccn23)c4ccc(Cl)cc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H12 compound treatment 0.0815 0.0101 1.19 1.1934 1.0 1910581 Bionet1_004070 COC(=O)c1cc(Cl)ccc1N/C(=C/C(=O)C(F)(F)F)/C=C/N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H13 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910582 Bionet1_004071 Cc1cccc(CO/N=C/c2c(nc3c(C)cccn23)c4ccc(Cl)cc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H14 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1910583 Bionet1_004072 FC(F)(F)c1cccc(Oc2ccc(cc2)C3=C(CCC(=O)N3)C#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H15 compound treatment 0.083 0.0116 1.37 1.3711 1.0 1910584 Bionet1_004073 Cc1cccn2c(/C=N/OCc3cccc(F)c3)c(nc12)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H16 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1910585 Bionet1_004074 Oc1nc2cc(Cl)c(Cl)cc2nc1c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H17 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1910586 Bionet1_004075 Cc1cccn2c(/C=N/OCc3ccc(F)cc3)c(nc12)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H18 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910587 Bionet1_004076 CN(C)/C=C/C(=O)C(Cc1ccc(Cl)cc1)Cc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H19 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910588 Bionet1_004077 COC(=O)c1nn(c(Cl)c1/C=N/OCc2cccc(F)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H20 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910589 Bionet1_004078 OC(CN(Cc1ccc(Cl)cc1)C(=O)Nc2ccccc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H21 compound treatment 0.0785 0.00707 0.84 0.8379 1.0 1910590 Bionet1_004079 COC(=O)c1nn(c(Cl)c1/C=N/OCc2ccc(C)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H22 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910591 Bionet1_004080 COc1ccc(cc1)C(=O)c2nnn(c2C)c3ccc(OC(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H23 mock treatment 0.0745 0.00307 0.36 0.3639 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 H24 mock treatment 0.0715 7.14E-5 0.01 0.0085 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I01 mock treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I02 mock treatment 0.0675 -0.00393 -0.47 -0.4655 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I03 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1193122 Bionet1_004081 Cc1ccc(Sc2c(NCC=C)cnn(c3ccc(C)cc3)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I04 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1666051 Bionet1_004082 COC(=O)c1ccc(NC(=O)c2ccc(Cl)c(Cl)c2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I05 compound treatment 0.069 -0.00243 -0.29 -0.2878 -1.0 1910592 Bionet1_004083 COc1ccc(NC(=O)c2cc3c(nn(C)c3s2)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I06 compound treatment 0.0665 -0.00493 -0.58 -0.584 -1.0 1910593 Bionet1_004084 FC(F)(F)c1ccc(Sc2ccc3nnc(n3n2)C(F)(F)Cl)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I07 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1207473 Bionet1_004085 Cc1ccc(Sc2c(cnn(c3ccc(C)cc3)c2=O)N4CCOCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I08 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1910594 Bionet1_004086 Oc1c(Br)cc(Br)cc1/C=N/c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I09 compound treatment 0.0715 7.14E-5 0.01 0.0085 1.0 1571009 Bionet1_004087 Cc1cc(oc(=O)c1NC(=O)c2ccccc2)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I10 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910595 Bionet1_004088 Oc1c(Br)cc(Br)cc1/C=N/c2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I11 compound treatment 0.0715 7.14E-5 0.01 0.0085 1.0 1665602 Bionet1_004089 Cc1ccc(cc1)C(=O)Nc2c(C)cc(oc2=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I12 compound treatment 0.067 -0.00443 -0.52 -0.5247 -1.0 1129145 Bionet1_004090 Oc1c(Br)cc(Br)cc1CNc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I13 compound treatment 0.056 -0.0154 -1.83 -1.8281 -1.0 1910596 Bionet1_004091 Cn1nc(c2ccccc2)c3cc(sc13)c4nnc(SCC=C)n4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I14 compound treatment 0.0645 -0.00693 -0.82 -0.821 -1.0 1466882 Bionet1_004092 Oc1c(Br)cc(Br)cc1CNc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I15 compound treatment 0.0665 -0.00493 -0.58 -0.584 -1.0 1910597 Bionet1_004093 FC(F)(F)c1cccc(Cn2ccc(c(C#N)c2=O)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I16 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1532611 Bionet1_004094 O=C(COc1ccc(cc1)c2nccc(n2)c3cccs3)NC4CCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I17 compound treatment 0.069 -0.00243 -0.29 -0.2878 -1.0 1700098 Bionet1_004095 O=C(NCc1ccc(cc1)C(=O)NC2CCCCC2)OCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I18 compound treatment 0.067 -0.00443 -0.52 -0.5247 -1.0 1910598 Bionet1_004096 FCCCOc1ccc(cc1)/C(=C/Nc2ccc(OC(F)(F)F)cc2)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I19 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1536021 Bionet1_004097 Clc1ccc(NC(=O)c2ccc(CNC(=O)OCc3ccccc3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I20 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1910599 Bionet1_004098 Cc1ccc(/C=N/Nc2nc3ccccc3nc2Cc4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I21 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1675083 Bionet1_004099 OC(c1cccs1)c2cc3cccnc3n2S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I22 compound treatment 0.068 -0.00343 -0.41 -0.4063 -1.0 1910600 Bionet1_004100 COc1ccc(O)c(/C=N/Nc2nc3ccccc3nc2Cc4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I23 mock treatment 0.068 -0.00343 -0.41 -0.4063 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 I24 mock treatment 0.066 -0.00543 -0.64 -0.6432 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J01 mock treatment 0.068 -0.00343 -0.41 -0.4063 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J02 mock treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J03 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910601 Bionet1_004101 C/C(=N\OC(=O)Nc1ccccc1)/c2sc(nc2C)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J04 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910602 Bionet1_004102 CC(C(=O)c1cn(nn1)c2ccc(OC(F)(F)F)cc2)n3cncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J05 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1910603 Bionet1_004103 CC(C)NC(=O)O/N=C(\C)/c1sc(nc1C)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J06 compound treatment 0.068 -0.00343 -0.41 -0.4063 -1.0 1262418 Bionet1_004104 CCCc1ccc(c(F)c1)c2ccc(cc2)c3[nH]ncc3c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J07 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1389812 Bionet1_004105 Clc1cccc(Cn2nc(c3ccccc3)c(cc2=O)N4CCCCC4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J08 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1584495 Bionet1_004106 C=CCNC(=O)CN1C(=O)C2C(C3c4ccccc4C2c5ccccc35)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J09 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910604 Bionet1_004107 O=C(NNC(=O)c1ccccc1)C(=O)c2c([nH]c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J10 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1658850 Bionet1_004108 Cc1nc2ccccn2c1C(=O)CSc3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J11 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1447737 Bionet1_004109 CCOC(=O)CON1C(=O)C2C(C3c4ccccc4C2c5ccccc35)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J12 compound treatment 0.068 -0.00343 -0.41 -0.4063 -1.0 1910605 Bionet1_004110 Cc1nc2ccccn2c1C(=O)CSc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J13 compound treatment 0.0625 -0.00893 -1.06 -1.0579 -1.0 1910606 Bionet1_004111 Cc1ccc(CSc2nc(Cl)c3sc4ccccc4c3n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J14 compound treatment 0.068 -0.00343 -0.41 -0.4063 -1.0 1910607 Bionet1_004112 Cc1ccc(/C=N/NC(=O)C2CCN(CC2)S(=O)(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J15 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910608 Bionet1_004113 CSc1nc(Sc2ccc(Cl)cc2)c3sc4ccccc4c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J16 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910609 Bionet1_004114 CC/C=N/NC(=O)C1CCN(CC1)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J17 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910610 Bionet1_004115 C=CCSc1nc(Sc2ccccc2)c3sc4ccccc4c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J18 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910611 Bionet1_004116 Clc1ccc(cc1)S(=O)(=O)N2CCC(CC2)C(=O)N/N=C/c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J19 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1910612 Bionet1_004117 C=CCSc1nc(Oc2ccccc2)c3sc4ccccc4c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J20 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1301549 Bionet1_004118 COCc1cc(nc(SCc2ccc(Cl)cc2)n1)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J21 compound treatment 0.0835 0.0121 1.43 1.4303 1.0 1910613 Bionet1_004119 Cc1ccccc1Oc2nc(SCC=C)nc3c4ccccc4sc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J22 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910614 Bionet1_004120 FC(F)(F)c1ccc(C(=O)N2CCCC2)c(=O)n1Cc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J23 mock treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 J24 mock treatment 0.069 -0.00243 -0.29 -0.2878 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K01 mock treatment 0.0675 -0.00393 -0.47 -0.4655 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K02 mock treatment 0.0655 -0.00593 -0.7 -0.7025 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K03 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910615 Bionet1_004121 Cc1ccc(cc1)C(=O)NNC(=O)c2cc3cc(ccc3s2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K04 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1910616 Bionet1_004122 FCCCOc1ccc(/C=N/NC(=O)c2ccc(cc2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K05 compound treatment 0.0675 -0.00393 -0.47 -0.4655 -1.0 1910617 Bionet1_004123 COC(=O)c1sccc1n2cccc2C(=O)C(=O)N3CC(C)OC(C)C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K06 compound treatment 0.068 -0.00343 -0.41 -0.4063 -1.0 1509151 Bionet1_004124 CN1C(=O)C(CC(=O)c2ccc(Br)cc2)C(=O)N(C)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K07 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910618 Bionet1_004125 COC(=O)c1sccc1n2cccc2C(=O)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K08 compound treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 1910619 Bionet1_004126 Cc1ccc(Oc2nc3cc(Cl)c(Cl)cc3nc2C(F)(F)F)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K09 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910620 Bionet1_004127 Brc1ccc(NC(=O)c2snnc2c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K10 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910621 Bionet1_004128 Oc1c(Br)cc(Br)cc1/C=N/Cc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K11 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910622 Bionet1_004129 Clc1cc(Cl)cc(NC(=O)c2snnc2c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K12 compound treatment 0.0675 -0.00393 -0.47 -0.4655 -1.0 1910623 Bionet1_004130 COc1cc(NC(=O)Cc2ncc(cc2Cl)C(F)(F)F)cc(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K13 compound treatment 0.0665 -0.00493 -0.58 -0.584 -1.0 1910624 Bionet1_004131 COc1ccc(/C=C/C(=O)c2sc(nc2C)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K14 compound treatment 0.066 -0.00543 -0.64 -0.6432 -1.0 1910625 Bionet1_004132 CCCCCC1CCC(CC1)c2ccc(/N=C/c3ccc4OCOc4c3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K15 compound treatment 0.067 -0.00443 -0.52 -0.5247 -1.0 1910626 Bionet1_004133 CSc1cc(c(s1)C(=O)Nc2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K16 compound treatment 0.0675 -0.00393 -0.47 -0.4655 -1.0 1167061 Bionet1_004134 CC(C)N(C(C)C)C(=O)CC1ON(C)C(=O)N1c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K17 compound treatment 0.068 -0.00343 -0.41 -0.4063 -1.0 1910627 Bionet1_004135 CSc1cc(c(s1)C(=O)Nc2ccc(F)cc2F)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K18 compound treatment 0.0665 -0.00493 -0.58 -0.584 -1.0 1910628 Bionet1_004136 FC(F)(F)c1cc(nc(c1C#N)c2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K19 compound treatment 0.069 -0.00243 -0.29 -0.2878 -1.0 1910629 Bionet1_004137 COc1ccc(NC(=O)c2sc(SC)cc2c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K20 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910630 Bionet1_004138 Cc1cccc(n1)n2cnc(c2)C(=O)NNC(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K21 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910631 Bionet1_004139 C/C(=N\OC(=O)c1ccc(Cl)cc1)/c2sc(nc2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K22 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1558123 Bionet1_004140 Clc1ccc(SCC2CNc3nc4ccccc4c(=O)n23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K23 mock treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 K24 mock treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L01 mock treatment 0.067 -0.00443 -0.52 -0.5247 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L02 mock treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L03 compound treatment 0.0675 -0.00393 -0.47 -0.4655 -1.0 1910632 Bionet1_004141 FC(F)(F)c1cc(=O)n(nc1C(=O)c2ccccc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L04 compound treatment 0.0675 -0.00393 -0.47 -0.4655 -1.0 1910633 Bionet1_004142 COc1cccc(OC)c1C(=O)NNC(=O)c2ccccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L05 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1910634 Bionet1_004143 FC(F)(F)c1cc(=O)n(nc1C(=O)c2cccc(Cl)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L06 compound treatment 0.069 -0.00243 -0.29 -0.2878 -1.0 1910635 Bionet1_004144 FC(F)(F)c1cccc(c1)C(=O)NNC(=O)c2ccccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L07 compound treatment 0.075 0.00357 0.42 0.4232 1.0 1910636 Bionet1_004145 Fc1ccc(cc1)C(=O)NCc2nnc(SCC=C)n2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L08 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1323434 Bionet1_004146 Cc1c(C)n(Cc2ccccc2)c(c1CNC(=O)c3ccc(C)cc3)n4cccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L09 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1281362 Bionet1_004147 COc1ccc(Oc2c(cnn(c3ccc(C)cc3)c2=O)N(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L10 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1220573 Bionet1_004148 CCNC(=O)NCc1c(C)c(C)n(Cc2ccccc2)c1n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L11 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1614859 Bionet1_004149 COC(=O)c1ccccc1Sc2nccc(c2C#N)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L12 compound treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 1910637 Bionet1_004150 COc1ccc(CSc2nnc(o2)c3sccc3n4cccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L13 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910638 Bionet1_004151 FC(F)(F)c1cccc(c1)c2ccnc(Sc3cccc(Cl)c3)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L14 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910639 Bionet1_004152 Clc1ccc(CSc2nnc(o2)c3sccc3n4cccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L15 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1910640 Bionet1_004153 CN(C)CCCNC(=O)/C=C/c1ccc(OCc2c(F)cccc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L16 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1649372 Bionet1_004154 Cc1c(C)n(Cc2ccccc2)c(c1CNC(=O)c3cccc(C)c3)n4cccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L17 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910641 Bionet1_004155 COC(OC)c1ccnc(n1)c2ccc(I)c(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L18 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1321471 Bionet1_004156 CCn1c(SCC=C)nnc1c2nn(ccc2=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L19 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910642 Bionet1_004157 COC(=O)/C(=C/c1ccnc(n1)c2ccc(OC(=O)c3cccs3)cc2)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L20 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1447893 Bionet1_004158 CCn1c(SC=C=C)nnc1c2nn(ccc2=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L21 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1910643 Bionet1_004159 Cc1ccc(CNC(=O)/C=C/c2ccc(OCc3cccc(Cl)c3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L22 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1702159 Bionet1_004160 Cc1cccc2c(C)cc(nc12)N3CCN(CC3)S(=O)(=O)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L23 mock treatment 0.074 0.00257 0.3 0.3047 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 L24 mock treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M01 mock treatment 0.069 -0.00243 -0.29 -0.2878 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M02 mock treatment 0.0665 -0.00493 -0.58 -0.584 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M03 compound treatment 0.067 -0.00443 -0.52 -0.5247 -1.0 1910644 Bionet1_004161 C/C(=N\OC(=O)Nc1ccccc1)/c2sc(nc2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M04 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1175101 Bionet1_004162 Brc1ccc(SCC2CNc3nc4ccccc4c(=O)n23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M05 compound treatment 0.069 -0.00243 -0.29 -0.2878 -1.0 1910645 Bionet1_004163 COC(=O)c1sc2ccccc2c1n3cccc3C(=O)C(=O)N4CCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M06 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910646 Bionet1_004164 Cc1ccc(cc1)S(=O)(=O)NNC(=O)c2sccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M07 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1280576 Bionet1_004165 Fc1ccc(cc1)C(=O)N2CCN(CC2)c3cc(=O)[nH]nc3c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M08 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1910647 Bionet1_004166 Clc1ccc(cc1)S(=O)(=O)NNC(=O)c2sccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M09 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1740589 Bionet1_004167 O=C(N1CCN(CC1)c2cc(=O)[nH]nc2c3ccccc3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M10 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910648 Bionet1_004168 Fc1ccc(cc1)S(=O)(=O)NNC(=O)c2sccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M11 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1168227 Bionet1_004169 Cc1ccc(cc1)C(=O)N2CCN(CC2)c3cc(=O)[nH]nc3c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M12 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910649 Bionet1_004170 COc1ccc(cc1)S(=O)(=O)NNC(=O)c2sccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M13 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1292933 Bionet1_004171 Fc1ccccc1N2CCN(CC2)C(=O)c3snnc3c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M14 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1910650 Bionet1_004172 Fc1ccccc1S(=O)(=O)NNC(=O)c2sccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M15 compound treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 1910651 Bionet1_004173 CC(C)NC(=O)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M16 compound treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 1910652 Bionet1_004174 Clc1ccc(NC(=O)NNC(=O)c2sccc2n3cccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M17 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910653 Bionet1_004175 FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NC2CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M18 compound treatment 0.067 -0.00443 -0.52 -0.5247 -1.0 1910654 Bionet1_004176 Clc1cccc(NC(=O)NNC(=O)c2sccc2n3cccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M19 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910655 Bionet1_004177 FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M20 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910656 Bionet1_004178 Cc1cccc(C)c1NC(=O)NNC(=O)c2sccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M21 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910657 Bionet1_004179 CCCNC(=O)c1cc(OCC(F)(F)F)ccc1OCC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M22 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1910658 Bionet1_004180 FC(F)(F)c1cccc(NC(=O)NNC(=O)c2sccc2n3cccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M23 mock treatment 0.0725 0.00107 0.13 0.127 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 M24 mock treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N01 mock treatment 0.0675 -0.00393 -0.47 -0.4655 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N02 mock treatment 0.073 0.00157 0.19 0.1862 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N03 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1910659 Bionet1_004181 Clc1cccc(COc2ccc(/C=C/C(=O)NCc3cccs3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N04 compound treatment 0.0785 0.00707 0.84 0.8379 1.0 1230704 Bionet1_004182 Cc1cccc2c(C)cc(nc12)N3CCN(CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N05 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910660 Bionet1_004183 COc1ccc(NC(=O)/C=C/c2ccc(OCc3cccc(Cl)c3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N06 compound treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 1357420 Bionet1_004184 Cc1cccc2c(C)cc(nc12)N3CCN(CC3)S(=O)(=O)Cc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N07 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1910661 Bionet1_004185 Clc1cccc(COc2ccc(/C=C/C(=O)NC3CCCC3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N08 compound treatment 0.0745 0.00307 0.36 0.3639 1.0 1628224 Bionet1_004186 Cc1ccc(cc1)S(=O)(=O)N2CCCN(CC2)c3nc(C)cc(C)c3C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N09 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910662 Bionet1_004187 Clc1cccc(COc2ccc(/C=C/C(=O)N3CCOCC3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N10 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1910663 Bionet1_004188 COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC)CCl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N11 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1910664 Bionet1_004189 OC/1/C(=C/c2ccccc2)/CN(Cc3ccccc3)C\C1=C/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N12 compound treatment 0.074 0.00257 0.3 0.3047 1.0 1716810 Bionet1_004190 Clc1ccc(CNC(=O)c2ccc(cc2)N3CCCC3=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N13 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1910665 Bionet1_004191 Clc1ccc(CNC(=O)/C=C/c2ccc(OCc3ccccc3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N14 compound treatment 0.0755 0.00407 0.48 0.4824 1.0 1607137 Bionet1_004192 Clc1ccc(cc1)N2CCN(CC2)C(=O)c3ccc(cc3)N4CCCC4=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N15 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910666 Bionet1_004193 COc1ccc(NC(=O)/C=C/c2ccc(OCc3ccccc3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N16 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910667 Bionet1_004194 FC(F)(F)c1nc2cc(Cl)c(Cl)cc2nc1Oc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N17 compound treatment 0.076 0.00457 0.54 0.5417 1.0 1910668 Bionet1_004195 CC(Oc1ccc(c(F)c1)c2ccccc2)C(=O)/C=C/Nc3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N18 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1910669 Bionet1_004196 Clc1ccc(CC(=O)c2c[nH]c(c2)C(=O)NCCCN3CCOCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N19 compound treatment 0.0795 0.00807 0.96 0.9564 1.0 1910670 Bionet1_004197 [O-][N+](=O)c1ccc(Sc2c(Cl)cccc2Cl)c(Br)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N20 compound treatment 0.075 0.00357 0.42 0.4232 1.0 1910671 Bionet1_004198 Cc1cccc(C)c1Oc2nc3cc(Cl)c(Cl)cc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N21 compound treatment 0.075 0.00357 0.42 0.4232 1.0 1910672 Bionet1_004199 CCC(C)NC(=O)/C=C/c1ccc(OCc2ccc(Br)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N22 compound treatment 0.0745 0.00307 0.36 0.3639 1.0 1548784 Bionet1_004200 Oc1c(Br)cc(Br)cc1CNCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N23 mock treatment 0.077 0.00557 0.66 0.6602 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 N24 mock treatment 0.077 0.00557 0.66 0.6602 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O01 mock treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O02 mock treatment 0.065 -0.00643 -0.76 -0.7617 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O03 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1910673 Bionet1_004201 FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NNC(=O)C2CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O04 compound treatment 0.0715 7.14E-5 0.01 0.0085 1.0 1910674 Bionet1_004202 Cc1ccc(cc1)S(=O)(=O)NNC(=O)c2ccccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O05 compound treatment 0.0695 -0.00193 -0.23 -0.2285 -1.0 1124798 Bionet1_004203 OC1(CSc2ccccc2)CCN(CC1)C(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O06 compound treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 1910675 Bionet1_004204 Clc1ccc(C(=O)NNC(=O)c2ccccc2n3cccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O07 compound treatment 0.0775 0.00607 0.72 0.7194 1.0 1183970 Bionet1_004205 OC1(CSc2ccc(Cl)cc2)CCN(CC1)C(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O08 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910676 Bionet1_004206 Clc1ccc(cc1Cl)C(=O)NNC(=O)c2ccccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O09 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1591346 Bionet1_004207 Cc1cc(C)cc(Oc2nc(cc(C)c2S(=O)(=O)C)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O10 compound treatment 0.0715 7.14E-5 0.01 0.0085 1.0 1910677 Bionet1_004208 COc1ccc(cc1)S(=O)(=O)NNC(=O)c2ccccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O11 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1376188 Bionet1_004209 Cc1cccc(Oc2nc(cc(C)c2S(=O)(=O)C)c3ccccc3)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O12 compound treatment 0.074 0.00257 0.3 0.3047 1.0 1910678 Bionet1_004210 Fc1ccccc1S(=O)(=O)NNC(=O)c2ccccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O13 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1542456 Bionet1_004211 CCN(CC)CC1(O)CCN(CC1)C(=O)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O14 compound treatment 0.074 0.00257 0.3 0.3047 1.0 1910679 Bionet1_004212 COC(=O)c1ccccc1S(=O)(=O)NNC(=O)c2ccccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O15 compound treatment 0.0745 0.00307 0.36 0.3639 1.0 1910680 Bionet1_004213 Cn1cc(C(=O)N2CCN(CC2)c3ccccc3F)c(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O16 compound treatment 0.0735 0.00207 0.25 0.2454 1.0 1910681 Bionet1_004214 Clc1ccc(/C=N\NC(=O)c2sccc2n3cccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O17 compound treatment 0.075 0.00357 0.42 0.4232 1.0 1910682 Bionet1_004215 Cn1cc(NC(=O)OCc2ccc(Cl)cc2Cl)c(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O18 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1910683 Bionet1_004216 Clc1ccc(/C=N\NC(=O)c2ccccc2n3cccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O19 compound treatment 0.079 0.00757 0.9 0.8971 1.0 1910684 Bionet1_004217 CC(OC(=O)Nc1ccc(Cl)c(Cl)c1)c2sc3ncnn3c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O20 compound treatment 0.077 0.00557 0.66 0.6602 1.0 1910685 Bionet1_004218 Brc1cccc(/C=N\NC(=O)c2ccccc2n3cccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O21 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1234447 Bionet1_004219 CCS(=O)(=O)c1ccc(C(=O)Nc2ccccc2)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O22 compound treatment 0.079 0.00757 0.9 0.8971 1.0 1910686 Bionet1_004220 C/C(=N\NC(=O)c1sccc1n2cccc2)/c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O23 mock treatment 0.0825 0.0111 1.31 1.3119 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 O24 mock treatment 0.0785 0.00707 0.84 0.8379 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P01 mock treatment 0.071 -4.29E-4 -0.05 -0.0508 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P02 mock treatment 0.069 -0.00243 -0.29 -0.2878 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P03 compound treatment 0.075 0.00357 0.42 0.4232 1.0 1910687 Bionet1_004221 CCOC(=O)Cc1cccc[n+]1Cc2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P04 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910688 Bionet1_004222 CCCCCC1CCC(CC1)c2ccc(NC(=O)c3cccs3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P05 compound treatment 0.068 -0.00343 -0.41 -0.4063 -1.0 1910689 Bionet1_004223 Cc1cc(N/C=C/C(=O)c2ccc(OCCCF)cc2)ccc1Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P06 compound treatment 0.066 -0.00543 -0.64 -0.6432 -1.0 1910690 Bionet1_004224 CCCCCC1CCC(CC1)c2ccc(NS(=O)(=O)c3ccc(C)cc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P07 compound treatment 0.08 0.00857 1.02 1.0156 1.0 1910691 Bionet1_004225 CCOC(=O)Cc1cccc[n+]1Cc2cccc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P08 compound treatment 0.075 0.00357 0.42 0.4232 1.0 1910692 Bionet1_004226 CCCCCC1CCC(CC1)c2ccc(NC(=O)Cc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P09 compound treatment 0.078 0.00657 0.78 0.7786 1.0 1910693 Bionet1_004227 Cc1cccc(c1)C(=O)NNc2nc3ccccc3nc2Cc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P10 compound treatment 0.0785 0.00707 0.84 0.8379 1.0 1910694 Bionet1_004228 CCCCCC1CCC(CC1)c2ccc3ncc(C(=O)OCC)c(O)c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P11 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1555455 Bionet1_004229 Cc1ccccc1C(=O)Nc2ncc(I)cc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P12 compound treatment 0.0765 0.00507 0.6 0.6009 1.0 1910695 Bionet1_004230 [O-][N+](=O)c1ccc(C/2CCCC\C2=N/OC(=O)Nc3ccccc3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P13 compound treatment 0.0685 -0.00293 -0.35 -0.347 -1.0 1690338 Bionet1_004231 Cc1cc(I)cnc1NC(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P14 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1292765 Bionet1_004232 Clc1ccc(CNC(=O)c2ccc(OCc3ccccc3)cc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P15 compound treatment 0.075 0.00357 0.42 0.4232 1.0 1349102 Bionet1_004233 COC(=O)c1cc(Br)c(NC(=O)c2ccco2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P16 compound treatment 0.0745 0.00307 0.36 0.3639 1.0 1910696 Bionet1_004234 CCNC(=O)O/N=C/1\CCCCC1c2ccc(cc2[N+](=O)[O-])[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P17 compound treatment 0.072 5.71E-4 0.07 0.0677 1.0 1910697 Bionet1_004235 FCCCOc1ccc(cc1)/C(=C/Nc2ccc(Oc3ccccc3)cc2)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P18 compound treatment 0.0625 -0.00893 -1.06 -1.0579 -1.0 1910698 Bionet1_004236 COc1cc(Br)cc(/C=N/Cc2cccc(c2)C(F)(F)F)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P19 compound treatment 0.0785 0.00707 0.84 0.8379 1.0 1910699 Bionet1_004237 FCCCOc1ccc(cc1)/C(=C/Nc2cc(Cl)cc(Cl)c2)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P20 compound treatment 0.073 0.00157 0.19 0.1862 1.0 1910700 Bionet1_004238 Cc1ccc(cc1)S(=O)(=O)N2C=CC3C2CCC(Br)C3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P21 compound treatment 0.0725 0.00107 0.13 0.127 1.0 1910701 Bionet1_004239 COc1cc(N/C=C(\C#N)/c2ccc(OCCCF)cc2)cc(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P22 compound treatment 0.07 -0.00143 -0.17 -0.1693 -1.0 1910702 Bionet1_004240 Clc1ccc(C2=Nn3c(nnc3SC2)c4ccccc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P23 mock treatment 0.0705 -9.29E-4 -0.11 -0.11 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1235 P24 mock treatment 0.0635 -0.00793 -0.94 -0.9395 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A01 compound treatment 0.087 0.0125 1.49 1.4867 1.0 3173 Maybridge2_000001 CCOC(=O)c1c(N)sc2CN(Cc3ccccc3)CCc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A02 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 2074535 Maybridge2_000002 CCN(CC)C(=O)Oc1ccc(Br)cc1C(=O)Nc2cc(Cl)cc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A03 compound treatment 0.078 0.00355 0.42 0.4203 1.0 2074536 Maybridge2_000003 CN1CCc2ccccc2C1Cc3ccccc3NS(=O)(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A04 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074537 Maybridge2_000004 Fc1cccc(Cl)c1CN(Cc2c(F)cccc2Cl)OC(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A05 compound treatment 0.0835 0.00905 1.07 1.072 1.0 2074538 Maybridge2_000005 CCN(CC)/C=C/c1nnnn1c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A06 compound treatment 0.0635 -0.011 -1.3 -1.2978 -1.0 2074539 Maybridge2_000006 Brc1cc(Br)cc(CN2CCOCC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A07 compound treatment 0.082 0.00755 0.89 0.8942 1.0 2074540 Maybridge2_000007 CN1C2CCC1CC(C2)NC(=O)Nc3ccc(OC(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A08 compound treatment 0.0855 0.011 1.31 1.3089 1.0 2074541 Maybridge2_000008 Clc1ccc(cc1)S(=O)(=O)Oc2cccc(c2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A09 compound treatment 0.079 0.00455 0.54 0.5388 1.0 1619298 Maybridge2_000009 CN1C2CCC1CC(C2)NC(=O)CSCc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A10 compound treatment 0.076 0.00155 0.18 0.1833 1.0 2074542 Maybridge2_000010 COc1ccc(cc1)S(=O)(=O)N2CCCC2c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A11 compound treatment 0.0775 0.00305 0.36 0.361 1.0 1346942 Maybridge2_000011 CN1C2CCC1CC(C2)NC(=O)CSc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A12 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 1121004 Maybridge2_000012 Clc1ccc(cc1)c2csc(n2)c3ccc(cc3)S(=O)(=O)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A13 compound treatment 0.076 0.00155 0.18 0.1833 1.0 2074543 Maybridge2_000013 CCN(C(Cc1ccccc1)c2ccc(OC)cc2)C(=O)c3c(C)onc3c4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A14 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 2074544 Maybridge2_000014 CCn1cc(C(=O)Nc2ccccc2)c(=O)c3cc(Cl)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A15 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074545 Maybridge2_000015 Oc1c(Cl)cc(Cl)cc1C2N3CCCCC3Cn4cccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A16 compound treatment 0.0685 -0.00595 -0.71 -0.7054 -1.0 2074546 Maybridge2_000016 COc1ccc(cc1Br)C2NN=C3C2N4CCC3CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A17 compound treatment 0.068 -0.00645 -0.76 -0.7646 -1.0 2074547 Maybridge2_000017 Cc1cc(C)c(NC(=O)N2CCCC2)c3CC(C)(C)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A18 compound treatment 0.0805 0.00605 0.72 0.7165 1.0 2074548 Maybridge2_000018 Cn1ncc(Br)c1NC(=O)CN2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A19 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 2074549 Maybridge2_000019 OC(=O)c1cc(NC(=O)/C=C/c2cccs2)ccc1N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A20 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 1231779 Maybridge2_000020 Clc1cc(Cl)cc(NC(=O)N2CCN(Cc3ccccc3)CC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A21 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 2074550 Maybridge2_000021 CS/C(=N/c1cc(cc(c1)C(F)(F)F)C(F)(F)F)/N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A22 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074551 Maybridge2_000022 C(NC1Cc2ccccc2C1)c3nc(no3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A23 mock treatment 0.087 0.0125 1.49 1.4867 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 A24 mock treatment 0.076 0.00155 0.18 0.1833 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B01 compound treatment 0.0925 0.018 2.14 2.1384 1.0 2074552 Maybridge2_000023 Fc1ccc(cc1)C(=O)C2CCN(Cc3c[nH]nc3c4ccccc4)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B02 compound treatment 0.082 0.00755 0.89 0.8942 1.0 2074553 Maybridge2_000024 O=S(=O)(Nc1ccc(cc1)N2CCCCC2)c3ccc(s3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B03 compound treatment 0.0835 0.00905 1.07 1.072 1.0 1413006 Maybridge2_000025 Cc1cc(C)cc(NC(=O)N2CCN(Cc3ccncc3)CC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B04 compound treatment 0.083 0.00855 1.01 1.0127 1.0 2074554 Maybridge2_000026 COc1cccc(NC(=O)Nc2cc(ccc2N3CCCC3)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B05 compound treatment 0.083 0.00855 1.01 1.0127 1.0 1077004 Maybridge2_000027 Cc1ccc(cc1)C(=O)CN(Cc2ccccc2)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B06 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074555 Maybridge2_000028 OC(=O)CSCC(=O)Nc1cc(ccc1N2CCCC2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B07 compound treatment 0.08 0.00555 0.66 0.6572 1.0 2074556 Maybridge2_000029 CN(C1CCCCC1)C(=O)c2ccc3OCOc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B08 compound treatment 0.0775 0.00305 0.36 0.361 1.0 2074557 Maybridge2_000030 OC(=O)CCC(=O)N1CCN(CC1)C2c3ccccc3-c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B09 compound treatment 0.0695 -0.00495 -0.59 -0.5869 -1.0 1442259 Maybridge2_000031 CN1CCc2c(C(=O)c3ccc(Cl)cc3)c(N)sc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B10 compound treatment 0.0685 -0.00595 -0.71 -0.7054 -1.0 2074558 Maybridge2_000032 FC(F)(F)Oc1ccc(cc1)C2N(CCc3sccc23)S(=O)(=O)c4ccc(C#N)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B11 compound treatment 0.066 -0.00845 -1.0 -1.0016 -1.0 2074559 Maybridge2_000033 Fc1ccc(C(=O)Nc2ccc(cc2)N3CCCCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B12 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074560 Maybridge2_000034 CCOC(=O)N1CCC(CC1)NC(=O)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B13 compound treatment 0.0675 -0.00695 -0.82 -0.8239 -1.0 1269114 Maybridge2_000035 Cc1ccc(cc1Cl)S(=O)(=O)Nc2ccc(cc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B14 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 1590511 Maybridge2_000036 O=C(N1CCCCCC1)c2ccc(cc2)C(=O)N3CCCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B15 compound treatment 0.069 -0.00545 -0.65 -0.6461 -1.0 2074561 Maybridge2_000037 Clc1cc(Cl)cc(Oc2ccc(o2)C(=O)N3CCCCC3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B16 compound treatment 0.063 -0.0115 -1.36 -1.3571 -1.0 2074562 Maybridge2_000038 CC(C)(C)c1ccc(NC(=O)N2CCCN(CC2)c3ccc(cn3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B17 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074563 Maybridge2_000039 FC(F)(F)Oc1ccc(cc1)C2N(Cc3ccc4OCCc4c3)CCc5sccc25 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B18 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074564 Maybridge2_000040 Fc1ccc(CN2CC(CC2=O)C(=O)Nc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B19 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074565 Maybridge2_000041 CN(C1CCCCC1)C(=O)Nc2c(C)onc2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B20 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074566 Maybridge2_000042 O=C(NCc1ccc(C#N)cc1)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B21 compound treatment 0.069 -0.00545 -0.65 -0.6461 -1.0 2074567 Maybridge2_000043 Clc1cc(Cl)cc(NC(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B22 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074568 Maybridge2_000044 CN(C)c1ccc(NC(=O)Nc2cccs2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B23 mock treatment 0.075 5.47E-4 0.06 0.0648 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 B24 mock treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C01 compound treatment 0.0845 0.01 1.19 1.1905 1.0 1180495 Maybridge2_000045 CN(C)CCNS(=O)(=O)c1ccc(s1)c2csc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C02 compound treatment 0.0815 0.00705 0.83 0.835 1.0 2074569 Maybridge2_000046 CCN(CC)C(=O)Oc1ccc(Br)cc1C(=O)Nc2ccc(F)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C03 compound treatment 0.0825 0.00805 0.95 0.9535 1.0 1724527 Maybridge2_000047 Clc1ccc(cc1)C2N(Cc3ccccc3)CCC4CCCCN24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C04 compound treatment 0.085 0.0105 1.25 1.2497 1.0 2074570 Maybridge2_000048 Fc1cccc(Cl)c1CN(Cc2c(F)cccc2Cl)OC(=O)C3CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C05 compound treatment 0.088 0.0135 1.61 1.6052 1.0 1401898 Maybridge2_000049 CN(C)CC(O)Cn1c2ccc(Cl)cc2c3cc(Cl)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C06 compound treatment 0.08 0.00555 0.66 0.6572 1.0 2074571 Maybridge2_000050 Brc1cc(Br)cc(CN2CCSCC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C07 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 1413543 Maybridge2_000051 CN1C2CCC1CC(C2)NC(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C08 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074572 Maybridge2_000052 CSCc1c(C)nn(C(=O)N(C)C)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C09 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 1241925 Maybridge2_000053 CN1C2CCC1CC(C2)NC(=O)CSCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C10 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074573 Maybridge2_000054 Clc1ccc(c(Cl)c1)S(=O)(=O)N2CCCC2c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C11 compound treatment 0.089 0.0145 1.72 1.7237 1.0 2074574 Maybridge2_000055 COc1cccc(c1)c2c(OC)cccc2C3CCCCN(C)C3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C12 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 1129748 Maybridge2_000056 CC(C)(C)c1csc(n1)c2ccc(cc2)S(=O)(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C13 compound treatment 0.08 0.00555 0.66 0.6572 1.0 2074575 Maybridge2_000057 CCN(C(Cc1ccccc1)c2ccc(OC)cc2)C(=O)c3c(C)onc3c4c(Cl)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C14 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 2074576 Maybridge2_000058 CCn1cc(C(=O)Nc2ccc(cc2)C(F)(F)F)c(=O)c3cc(Cl)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C15 compound treatment 0.079 0.00455 0.54 0.5388 1.0 2074577 Maybridge2_000059 Fc1cccc(F)c1C(=O)N2CCCCC2Cn3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C16 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 1396629 Maybridge2_000060 CN1N=C2C(C1c3ccc(Cl)c(Cl)c3)N4CCC2CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C17 compound treatment 0.0935 0.019 2.26 2.2569 1.0 2074578 Maybridge2_000061 Cc1cc(C)c(NC(=O)N(CC=C)CC=C)c2CC(C)(C)C(=O)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C18 compound treatment 0.076 0.00155 0.18 0.1833 1.0 2074579 Maybridge2_000062 COC(=O)c1cn(Cc2ccc(cc2)C(F)(F)F)cc(F)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C19 compound treatment 0.077 0.00255 0.3 0.3018 1.0 2074580 Maybridge2_000063 CN(C)c1ccc(CO)c(F)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C20 compound treatment 0.077 0.00255 0.3 0.3018 1.0 1253399 Maybridge2_000064 Fc1ccc(C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C21 compound treatment 0.0835 0.00905 1.07 1.072 1.0 2074581 Maybridge2_000065 CS/C(=N\c1cc(cc(c1)C(F)(F)F)C(F)(F)F)/N2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C22 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 1713118 Maybridge2_000066 Fc1cccc(Cl)c1CN2CCN(CC2)C(=O)Nc3cc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C23 mock treatment 0.077 0.00255 0.3 0.3018 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 C24 mock treatment 0.0785 0.00405 0.48 0.4795 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D01 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 2074582 Maybridge2_000067 O=S(=O)(Oc1ccccc1N2CCCCC2)c3ccc(s3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D02 compound treatment 0.079 0.00455 0.54 0.5388 1.0 2074583 Maybridge2_000068 CCCc1c(cnn1c2ccccc2)C(=O)Nc3ccc(cc3)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D03 compound treatment 0.0815 0.00705 0.83 0.835 1.0 1547353 Maybridge2_000069 Cc1[nH]c2ccccc2c1CN3CCN(CC3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D04 compound treatment 0.089 0.0145 1.72 1.7237 1.0 2074584 Maybridge2_000070 CC(C)(C)c1ccc(NC(=O)Nc2cc(ccc2N3CCCC3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D05 compound treatment 0.0855 0.011 1.31 1.3089 1.0 2074585 Maybridge2_000071 FC(F)(F)Oc1ccc(cc1)C2N(Cc3ccccc3)CCc4sccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D06 compound treatment 0.0795 0.00505 0.6 0.598 1.0 2074586 Maybridge2_000072 Fc1ccc(CNC(=O)C2CN(Cc3ccco3)C(=O)C2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D07 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 2074587 Maybridge2_000073 CCOC(=O)C1CCN(CC(=O)c2ccc(C)cc2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D08 compound treatment 0.076 0.00155 0.18 0.1833 1.0 2074588 Maybridge2_000074 OC(=O)CSCC(=O)N1CCN(CC1)C2c3ccccc3-c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D09 compound treatment 0.077 0.00255 0.3 0.3018 1.0 2074589 Maybridge2_000075 O=C(CC1NCCNC1=O)NC2Cc3ccccc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D10 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074590 Maybridge2_000076 Fc1cccc(c1)S(=O)(=O)N2CCc3sccc3C2c4ccc(OC(F)(F)F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D11 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 2074591 Maybridge2_000077 Clc1cccc(NC(=O)Nc2ccc(cc2)N3CCCCC3)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D12 compound treatment 0.076 0.00155 0.18 0.1833 1.0 2074592 Maybridge2_000078 CCOC(=O)N1CCC(CC1)NC(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D13 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 1119500 Maybridge2_000079 Cc1c(sc2ccc(Cl)cc12)S(=O)(=O)Nc3ccc(cc3)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D14 compound treatment 0.0755 0.00105 0.12 0.124 1.0 1006240 Maybridge2_000080 OC(CN1CCCC1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D15 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074593 Maybridge2_000081 O=C(NC1CCN(Cc2ccccc2)CC1)c3ccc(s3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D16 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074594 Maybridge2_000082 Cc1ccc(cc1C)C(=O)N2CCCN(CC2)c3ccc(cn3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D17 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074595 Maybridge2_000083 FC(F)(F)Oc1ccc(cc1)C2N(Cc3nc4ccccc4s3)CCc5sccc25 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D18 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 2074596 Maybridge2_000084 COc1ccc(NC(=O)C2CN(Cc3ccc(F)cc3)C(=O)C2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D19 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 2074597 Maybridge2_000085 CN(Cc1ccccc1)S(=O)(=O)c2cn(C)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D20 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 2074598 Maybridge2_000086 CN(C)c1ccc(NC(=O)Nc2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D21 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 2074599 Maybridge2_000087 COc1cccc(NC(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D22 compound treatment 0.078 0.00355 0.42 0.4203 1.0 2074600 Maybridge2_000088 COc1ccc(Cl)cc1NC(=O)Nc2ccc(cc2)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D23 mock treatment 0.0785 0.00405 0.48 0.4795 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 D24 mock treatment 0.082 0.00755 0.89 0.8942 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E01 compound treatment 0.089 0.0145 1.72 1.7237 1.0 1137390 Maybridge2_000089 Fc1cccc(Cl)c1CN2CCN(CC2)C(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E02 compound treatment 0.0775 0.00305 0.36 0.361 1.0 2074601 Maybridge2_000090 Fc1ccc(NC(=O)CCN2CCCCC2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E03 compound treatment 0.0815 0.00705 0.83 0.835 1.0 1518121 Maybridge2_000091 O=C(CCN1CCCC1)c2ccc(cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E04 compound treatment 0.083 0.00855 1.01 1.0127 1.0 2074602 Maybridge2_000092 FC(F)(F)c1cc(Br)ccc1/C=C/c2noc(CN3CCSCC3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E05 compound treatment 0.0865 0.012 1.43 1.4274 1.0 1636659 Maybridge2_000093 CN1CCN(CC1)c2cc(nc3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E06 compound treatment 0.0815 0.00705 0.83 0.835 1.0 2074603 Maybridge2_000094 CN(C)/C=C(\C#N)/C(=O)Nc1cc(ccc1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E07 compound treatment 0.0815 0.00705 0.83 0.835 1.0 1223321 Maybridge2_000095 CN1C2CCC1CC(C2)NC(=O)Nc3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E08 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 2074604 Maybridge2_000096 O=C(/C=C\1/NC(=O)CS1)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E09 compound treatment 0.086 0.0115 1.37 1.3682 1.0 1322935 Maybridge2_000097 CN1C2CCC1CC(C2)NC(=O)CS(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E10 compound treatment 0.0775 0.00305 0.36 0.361 1.0 2074605 Maybridge2_000098 CN(C)/C=C/C(=O)c1nnn(c1C)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E11 compound treatment 0.0805 0.00605 0.72 0.7165 1.0 2074606 Maybridge2_000099 C(Oc1cnc(nc1)N2CCNCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E12 compound treatment 0.079 0.00455 0.54 0.5388 1.0 2074607 Maybridge2_000100 CN(C)/C=C/C(=O)c1ccc(o1)c2cc(Cl)cc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E13 compound treatment 0.0775 0.00305 0.36 0.361 1.0 1608666 Maybridge2_000101 CCN(C(Cc1ccccc1)c2ccc(OC)cc2)C(=O)c3sc4ccccc4c3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E14 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 2074608 Maybridge2_000102 CN1C/C(=C\c2cccc3ccccc23)/C(=O)\C(=C\c4cccc5ccccc45)\C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E15 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074609 Maybridge2_000103 CN1CCN(Cc2nc(/C=C/c3cc(cc(c3)C(F)(F)F)C(F)(F)F)no2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E16 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 2074610 Maybridge2_000104 CSc1nsc(SC)c1NC(=O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E17 compound treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 1127399 Maybridge2_000105 CC1CN(Cc2c(F)cccc2Cl)CC(C)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E18 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 2074611 Maybridge2_000106 Clc1ccc(Cl)c(NC(=O)CC2NCCCNC2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E19 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 2074612 Maybridge2_000107 CN(C)CCCN/C(=N\O)/c1c(Cl)cccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E20 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 1451184 Maybridge2_000108 Fc1cccc(Cl)c1C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E21 compound treatment 0.078 0.00355 0.42 0.4203 1.0 1083885 Maybridge2_000109 CN(Cc1ccccc1)C(=O)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E22 compound treatment 0.0775 0.00305 0.36 0.361 1.0 1267524 Maybridge2_000110 CCN(CC)c1ccc(NC(=O)c2ccccc2C(=O)O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E23 mock treatment 0.0775 0.00305 0.36 0.361 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 E24 mock treatment 0.078 0.00355 0.42 0.4203 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F01 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074613 Maybridge2_000111 OC(=O)c1ccccc1C(=O)N2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F02 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074614 Maybridge2_000112 Cc1onc(c1C(=O)Nc2ccc(cc2)N3CCCCC3)c4c(Cl)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F03 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 1181710 Maybridge2_000113 Cc1[nH]c2ccccc2c1CN3CCN(CC3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F04 compound treatment 0.079 0.00455 0.54 0.5388 1.0 2074615 Maybridge2_000114 C(N1CCC2(CC1)Nc3ccccc3S2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F05 compound treatment 0.0835 0.00905 1.07 1.072 1.0 2074616 Maybridge2_000115 FC(F)(F)Oc1ccc(cc1)C2N(Cc3ccccn3)CCc4sccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F06 compound treatment 0.079 0.00455 0.54 0.5388 1.0 2074617 Maybridge2_000116 CC(C)(CC(=O)NC1CCN(Cc2ccccc2)CC1)Sc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F07 compound treatment 0.077 0.00255 0.3 0.3018 1.0 2074618 Maybridge2_000117 CCOC(=O)C1CCN(CC(=O)c2ccc(OC)cc2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F08 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 1943800 Maybridge2_000118 CN1CCN(CC(=O)N2c3ccccc3Sc4ccccc24)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F09 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 1147671 Maybridge2_000119 Cc1nnsc1C(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F10 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074619 Maybridge2_000120 O=C(CN1CCN(CC1)c2ccccc2)N3c4ccccc4Sc5ccccc35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F11 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 1636373 Maybridge2_000121 Cc1cc(C)cc(NC(=O)Nc2ccc(cc2)N3CCCCC3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F12 compound treatment 0.076 0.00155 0.18 0.1833 1.0 2074620 Maybridge2_000122 CCOC(=O)N1CCC(CC1)NC(=O)C2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F13 compound treatment 0.0775 0.00305 0.36 0.361 1.0 1861722 Maybridge2_000123 O=C(Nc1ccccc1N2CCCCC2)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F14 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074621 Maybridge2_000124 CN(CCc1ccccn1)S(=O)(=O)c2ccc3OCCc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F15 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074622 Maybridge2_000125 Fc1ccc(cc1)C(=O)C2CCN(CC2)C(=O)c3ccc(s3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F16 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074623 Maybridge2_000126 Fc1ccc(c(F)c1)S(=O)(=O)N2CCCN(CC2)c3ccc(cn3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F17 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074624 Maybridge2_000127 CS(=O)(=O)N1CCN(CC1)C2c3ccccc3-c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F18 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 2074625 Maybridge2_000128 Cc1ccc(NC(=O)C2CN(Cc3ccc(F)cc3)C(=O)C2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F19 compound treatment 0.0755 0.00105 0.12 0.124 1.0 1430320 Maybridge2_000129 COc1ccc-2c(NC(c3cccn32)c4ccc(cc4)N(C)C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F20 compound treatment 0.08 0.00555 0.66 0.6572 1.0 2074626 Maybridge2_000130 CN(C)c1ccc(NC(=O)Nc2ccc(F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F21 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074627 Maybridge2_000131 CC(C)(C)c1ccc(NC(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F22 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074628 Maybridge2_000132 CN(C)c1ccc(NC(=O)Nc2ccc(OCc3ccccc3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F23 mock treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 F24 mock treatment 0.0765 0.00205 0.24 0.2425 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G01 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 1693364 Maybridge2_000133 CC(C)N1CCN(CC1)c2ncnc3scc(c4ccccc4)c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G02 compound treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 2074629 Maybridge2_000134 Fc1ccc(NC(=O)CN2CCCCC2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G03 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 1601195 Maybridge2_000135 CC1CC(C)CN(Cc2cc(Cl)c(O)c(Cl)c2)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G04 compound treatment 0.076 0.00155 0.18 0.1833 1.0 2074630 Maybridge2_000136 Cc1cc(cc(C)c1F)S(=O)(=O)N2CCSCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G05 compound treatment 0.0855 0.011 1.31 1.3089 1.0 1636659 Maybridge2_000137 CN1CCN(CC1)c2cc(nc3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G06 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074631 Maybridge2_000138 O=C(N1CCSCC1)C2(CC3CC4CC(C3)C2)C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G07 compound treatment 0.077 0.00255 0.3 0.3018 1.0 1354633 Maybridge2_000139 CN1C2CCC1CC(C2)NC(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G08 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074632 Maybridge2_000140 CN(C)/C=C/C(=O)c1nnn(c1C)c2cccc(Cl)c2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G09 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 1360057 Maybridge2_000141 CN1C2CCC1CC(C2)NC(=O)CS(=O)(=O)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G10 compound treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 2074633 Maybridge2_000142 CN(C)/C=C/C(=O)c1nnn(c1C)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G11 compound treatment 0.079 0.00455 0.54 0.5388 1.0 2074634 Maybridge2_000143 N#CCCCN(Cc1ccccc1)Cc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G12 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074635 Maybridge2_000144 CN(C)/C=C/C(=O)c1ccc(C)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G13 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074636 Maybridge2_000145 CN(C)c1ccc(C2=NCCCN2)c(SCc3cccc(c3)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G14 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 2074637 Maybridge2_000146 CN1C/C(=C\c2cccs2)/C(=O)\C(=C\c3cccs3)\C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G15 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074638 Maybridge2_000147 FC(F)(F)c1cc(/C=C/c2noc(CN3CCCCCC3)n2)cc(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G16 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074639 Maybridge2_000148 COc1ccc(cc1)C2N(C)C(=O)c3ccccc3S2(=O)=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G17 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074640 Maybridge2_000149 CN(C)c1ccc(/C=C/C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G18 compound treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 1007333 Maybridge2_000150 CN1CCN(CC(O)c2ccccc2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G19 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074641 Maybridge2_000151 CN(C)CCCNS(=O)(=O)c1c(C)c(C)c(C)c(C)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G20 compound treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 1686641 Maybridge2_000152 Clc1ccsc1C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G21 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074642 Maybridge2_000153 CC1CN(CCCNC(=O)Nc2ccc(Cl)cc2)CC(C)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G22 compound treatment 0.0695 -0.00495 -0.59 -0.5869 -1.0 2074643 Maybridge2_000154 NC(=O)C1CCN(CC1)c2c(Cl)cncc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G23 mock treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 G24 mock treatment 0.068 -0.00645 -0.76 -0.7646 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H01 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074644 Maybridge2_000155 Fc1ccc(cc1)N2C(=O)CCN(Cc3ccccc3)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H02 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 2074645 Maybridge2_000156 Clc1ccc2[nH]c(cc2c1)C(=O)Nc3ccc(cc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H03 compound treatment 0.0775 0.00305 0.36 0.361 1.0 1426576 Maybridge2_000157 CN1CCN(CC1)c2ccc(NC(=O)c3cccs3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H04 compound treatment 0.0835 0.00905 1.07 1.072 1.0 2074646 Maybridge2_000158 Cc1cc(C(=O)Nc2cc(ccc2N3CCCC3)C(F)(F)F)n(C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H05 compound treatment 0.0905 0.016 1.9 1.9014 1.0 2074647 Maybridge2_000159 CC(C)N(Cc1ccccc1)S(=O)(=O)c2ccc(CNC(=O)c3ccc(Cl)cc3)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H06 compound treatment 0.077 0.00255 0.3 0.3018 1.0 2074648 Maybridge2_000160 CC(C)(CC(=O)N1CCN(CC1)c2ncccc2C(F)(F)F)Sc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H07 compound treatment 0.08 0.00555 0.66 0.6572 1.0 1269767 Maybridge2_000161 Cc1cc(C(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35)c(C)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H08 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 2074649 Maybridge2_000162 CCN(CC)CC(=O)N1c2ccccc2Sc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H09 compound treatment 0.076 0.00155 0.18 0.1833 1.0 1192023 Maybridge2_000163 O=C(N1CCN(CC1)C2c3ccccc3-c4ccccc24)c5ccno5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H10 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074650 Maybridge2_000164 O=C(CN1CCOCC1)N2c3ccccc3Sc4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H11 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 1322755 Maybridge2_000165 Cc1cccc(Cl)c1NC(=O)Nc2ccc(cc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H12 compound treatment 0.083 0.00855 1.01 1.0127 1.0 2074651 Maybridge2_000166 CCOC(=O)N1CCC(CC1)NC(=O)c2cc(Cl)sc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H13 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074652 Maybridge2_000167 Clc1cc(C(=O)Nc2ccccc2N3CCCCC3)c(Cl)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H14 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 2074653 Maybridge2_000168 CC(C)(C)OC(=O)N1CCCN(CC1)C(=O)c2sc3ccccc3c2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H15 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074654 Maybridge2_000169 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)c3ccc(s3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H16 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074655 Maybridge2_000170 Fc1cccc(c1)S(=O)(=O)N2CCCN(CC2)c3ccc(cn3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H17 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 2074656 Maybridge2_000171 CN(CCc1ccccn1)C(=O)Nc2ccc(cc2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H18 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074657 Maybridge2_000172 Cc1ccc2cc(NC(=O)C3CN(Cc4ccc(F)cc4)C(=O)C3)ccc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H19 compound treatment 0.079 0.00455 0.54 0.5388 1.0 2074658 Maybridge2_000173 O=C(N1CCCCC1c2ccccn2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H20 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 2074659 Maybridge2_000174 CN(C)c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H21 compound treatment 0.081 0.00655 0.78 0.7757 1.0 2074660 Maybridge2_000175 Fc1ccc(NC(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H22 compound treatment 0.078 0.00355 0.42 0.4203 1.0 2074661 Maybridge2_000176 CN(C)c1ccc(NC(=O)c2cccs2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H23 mock treatment 0.0755 0.00105 0.12 0.124 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 H24 mock treatment 0.075 5.47E-4 0.06 0.0648 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I01 compound treatment 0.0775 0.00305 0.36 0.361 1.0 1192854 Maybridge2_000177 CCOC(=O)c1ccc(cc1)N2CC3CCCCN3C2c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I02 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 2074662 Maybridge2_000178 CN(C)/C=N/C(=O)c1c(C)onc1c2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I03 compound treatment 0.0805 0.00605 0.72 0.7165 1.0 1358017 Maybridge2_000179 CC1CCN(Cc2cc(Cl)c(O)c(Cl)c2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I04 compound treatment 0.079 0.00455 0.54 0.5388 1.0 2074663 Maybridge2_000180 Fc1ccc(cc1)C2CCCN2S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I05 compound treatment 0.0805 0.00605 0.72 0.7165 1.0 1597589 Maybridge2_000181 CN1C2CCC1CC(C2)NS(=O)(=O)c3cc(Cl)c(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I06 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074664 Maybridge2_000182 CN(C)c1ccc(/C=N/O)c(N(C)C)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I07 compound treatment 0.079 0.00455 0.54 0.5388 1.0 1410644 Maybridge2_000183 CN1C2CCC1CC(C2)NC(=O)CSc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I08 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074665 Maybridge2_000184 CN(C)/C=C/C(=O)c1nnn(c1C)c2ccc(F)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I09 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 1455937 Maybridge2_000185 CN1C2CCC1CC(C2)NC(=O)CS(=O)(=O)c3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I10 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074666 Maybridge2_000186 CN(C)/C=C/C(=O)c1nnn(c1C)c2cc(Cl)ccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I11 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 2074667 Maybridge2_000187 CCCCNC1N=C(c2ccccc2)c3ccccc3N(C)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I12 compound treatment 0.068 -0.00645 -0.76 -0.7646 -1.0 2074668 Maybridge2_000188 CN(C)c1cc(oc(=O)c1Cl)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I13 compound treatment 0.0635 -0.011 -1.3 -1.2978 -1.0 2074669 Maybridge2_000189 Cc1ccc(cc1)S(=O)(=O)N2CCCC(C2)n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I14 compound treatment 0.066 -0.00845 -1.0 -1.0016 -1.0 2074670 Maybridge2_000190 CC1CNC(N1)SCc2ccc(C)c(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I15 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 1725187 Maybridge2_000191 COC(=O)c1ccc(CN2CCOCC2)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I16 compound treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 2074671 Maybridge2_000192 COc1cc2CCN(Cc3ccc(F)cc3)C(=O)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I17 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 2074672 Maybridge2_000193 CN(C)CCCNS(=O)(=O)c1cc(Cl)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I18 compound treatment 0.069 -0.00545 -0.65 -0.6461 -1.0 2074673 Maybridge2_000194 CC(C)(C)OC(=O)N1CCC(CNC(=O)c2ccccc2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I19 compound treatment 0.0835 0.00905 1.07 1.072 1.0 2074674 Maybridge2_000195 CCN(CC)CCNS(=O)(=O)c1c(C)c(C)c(C)c(C)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I20 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 1562614 Maybridge2_000196 Brc1ccsc1C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I21 compound treatment 0.0815 0.00705 0.83 0.835 1.0 2074675 Maybridge2_000197 CN(C)CCCNC(=O)c1cc(Br)ccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I22 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 1311571 Maybridge2_000198 CC1(C)CCc2cc(CN3CCN(CC3)c4ccccn4)ccc2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I23 mock treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 I24 mock treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J01 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074676 Maybridge2_000199 Cc1cc(C)cc(c1)N2C(=O)CCN(Cc3ccccc3)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J02 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074677 Maybridge2_000200 Clc1ccc2[nH]c(cc2c1)C(=O)NC3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J03 compound treatment 0.078 0.00355 0.42 0.4203 1.0 2074678 Maybridge2_000201 O=C(CN1CCOCC1)Nc2ccccc2Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J04 compound treatment 0.0835 0.00905 1.07 1.072 1.0 2074679 Maybridge2_000202 Cc1c(csc1C(=O)Nc2cc(ccc2N3CCCC3)C(F)(F)F)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J05 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 2074680 Maybridge2_000203 CC(C)N(Cc1ccccc1)C(=O)c2ccc(OC(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J06 compound treatment 0.083 0.00855 1.01 1.0127 1.0 2074681 Maybridge2_000204 CC(C)(CC(=O)N1CCN(CC1)c2ccccc2)Sc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J07 compound treatment 0.0775 0.00305 0.36 0.361 1.0 2074682 Maybridge2_000205 CC1=NCCN1CCNC(=O)Nc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J08 compound treatment 0.0835 0.00905 1.07 1.072 1.0 2074683 Maybridge2_000206 CN(C)c1ccc(Nc2nc(c(s2)C(=O)c3ccc(F)cc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J09 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 1280598 Maybridge2_000207 Cc1cc(no1)C(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J10 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 2074684 Maybridge2_000208 O=C(CN1CCCCC1)N2c3ccccc3Sc4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J11 compound treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 2074685 Maybridge2_000209 FC(F)(F)Oc1ccccc1NC(=O)Nc2ccc(cc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J12 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074686 Maybridge2_000210 CCOC(=O)N1CCC(CC1)NC(=O)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J13 compound treatment 0.0695 -0.00495 -0.59 -0.5869 -1.0 2074687 Maybridge2_000211 CCCc1c(cnn1c2ccccc2)C(=O)Nc3ccccc3N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J14 compound treatment 0.0685 -0.00595 -0.71 -0.7054 -1.0 2074688 Maybridge2_000212 O=C(NC1CCN(Cc2ccccc2)CC1)c3ccsc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J15 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074689 Maybridge2_000213 CN1CCN(CC1)C(=O)c2ccc(s2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J16 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074690 Maybridge2_000214 FC(F)(F)c1ccc(nc1)N2CCCN(CC2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J17 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 1181324 Maybridge2_000215 O=C(Nc1ccccc1)N2CCN(CC2)C3c4ccccc4-c5ccccc35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J18 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074691 Maybridge2_000216 Clc1ccc(CCN2CC(CC2=O)C(=O)Nc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J19 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074692 Maybridge2_000217 OC(=O)c1ccccc1C(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J20 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074693 Maybridge2_000218 CN(C)c1ccc(NC(=O)Nc2ccc(cc2)C(C)(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J21 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074694 Maybridge2_000219 Cc1ccc(F)cc1NC(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J22 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 1248737 Maybridge2_000220 CN(C)c1ccc(NC(=O)c2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J23 mock treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 J24 mock treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K01 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 1325314 Maybridge2_000221 CN1CCc2ccccc2C1Cc3ccccc3NC(=O)c4c(C)onc4c5ccccc5Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K02 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074695 Maybridge2_000222 COc1ccc(cc1)C(=O)/C(=C/N(C)C)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K03 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074696 Maybridge2_000223 CN(C)/C=C/1\N=C(OC1=O)c2cccnc2Sc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K04 compound treatment 0.077 0.00255 0.3 0.3018 1.0 2074697 Maybridge2_000224 Cc1cc(cc(C)c1F)S(=O)(=O)N2CCCC2c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K05 compound treatment 0.077 0.00255 0.3 0.3018 1.0 1422067 Maybridge2_000225 CN1C2CCC1CC(C2)NS(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K06 compound treatment 0.082 0.00755 0.89 0.8942 1.0 2074698 Maybridge2_000226 CN(C)/C=N/C(=C(/C#N)\C(=O)C)/SCc1c(Cl)cccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K07 compound treatment 0.081 0.00655 0.78 0.7757 1.0 1644872 Maybridge2_000227 CN1C2CCC1CC(C2)NC(=O)CSc3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K08 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074699 Maybridge2_000228 CN(C)C(=O)N1CCC(CC1)C(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K09 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074700 Maybridge2_000229 CN1C2CCC1CC(C2)/N=C\c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K10 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074701 Maybridge2_000230 Cc1c(C)c(C)c(C(=O)C2CCN(CC2)C(=O)Nc3ccc(Cl)cc3Cl)c(C)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K11 compound treatment 0.0805 0.00605 0.72 0.7165 1.0 2074702 Maybridge2_000231 C[C@@H](N1[C@H]2CCC(=O)C[C@@H]2CCC1=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K12 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074703 Maybridge2_000232 CN(C)/C=C/C(=N)SCc1c(Cl)cccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K13 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 2074704 Maybridge2_000233 COc1cccc(OC)c1C(=O)Nc2c3c(cc(N4CCCC4)c2C)C(C)(C)CC3(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K14 compound treatment 0.08 0.00555 0.66 0.6572 1.0 2074705 Maybridge2_000234 CN1CNC(=NC1)SCc2cccc(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K15 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 2074706 Maybridge2_000235 Fc1cccc(Cl)c1NC(=O)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K16 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074707 Maybridge2_000236 COc1cc2CCN(Cc3c(Cl)cccc3Cl)C(=O)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K17 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074708 Maybridge2_000237 Clc1c(C#N)ccc(N2CCCC2)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K18 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 2074709 Maybridge2_000238 Cc1cn(CCC(=O)Nc2ccc(cc2)N3CCOCC3)c4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K19 compound treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 2074710 Maybridge2_000239 FC(F)(F)c1cc(/C=C\c2noc(n2)c3ccc(CN4CCCC4)cc3)cc(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K20 compound treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 1138919 Maybridge2_000240 COc1ccc2[nH]c(cc2c1)C(=O)N(C)C3CCN(C)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K21 compound treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 1707521 Maybridge2_000241 CCN1CCCC1CNC(=O)c2c(C)onc2c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K22 compound treatment 0.069 -0.00545 -0.65 -0.6461 -1.0 1663898 Maybridge2_000242 CC1(C)CCc2cc(CN3CCN(CC3)c4ccc(F)cc4)ccc2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K23 mock treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 K24 mock treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L01 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074711 Maybridge2_000243 O=C(Nc1ccc2OCCc2c1)N(CCC#N)Cc3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L02 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074712 Maybridge2_000244 Fc1ccc(cc1)N2CCN(CC2)C(=O)c3cc4cc(Cl)ccc4[nH]3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L03 compound treatment 0.0755 0.00105 0.12 0.124 1.0 1539911 Maybridge2_000245 CN(C1CCN(C)CC1)C(=O)c2cnn(c2C)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L04 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 2074713 Maybridge2_000246 FC(F)(F)c1ccc(N2CCCC2)c(NC(=O)Nc3cccc4ccccc34)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L05 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 2074714 Maybridge2_000247 CC(C)N(Cc1ccccc1)C(=O)c2ccccc2C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L06 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074715 Maybridge2_000248 O=C(NC1CCN(Cc2ccccc2)CC1)c3ccc4OCCCOc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L07 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 1303662 Maybridge2_000249 COc1ccc(cc1)C(=O)c2c(N)sc3CN(Cc4ccccc4)CCc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L08 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074716 Maybridge2_000250 OC(CNCC1COc2ccccc2O1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L09 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 1610217 Maybridge2_000251 Clc1ccc(C(=O)Nc2ccc(cc2)N3CCCCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L10 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074717 Maybridge2_000252 FC(F)(F)c1ccc(cc1)C(=O)NCCCN2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L11 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 2074718 Maybridge2_000253 CCc1cccc(C)c1NC(=O)Nc2ccc(cc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L12 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 2074719 Maybridge2_000254 CCOC(=O)N1CCC(CC1)NC(=O)c2sc3ccccc3c2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L13 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074720 Maybridge2_000255 O=C(Nc1ccccc1N2CCCCC2)C3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L14 compound treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 2074721 Maybridge2_000256 CCOC(=O)N1CCC(CC1)NC(=O)c2cc(C)cc(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L15 compound treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 2074722 Maybridge2_000257 FC(F)(F)Oc1ccc(cc1)C2N(Cc3ccc[nH]3)CCc4sccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L16 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074723 Maybridge2_000258 FC(F)(F)c1ccc(cc1)S(=O)(=O)N2CCCN(CC2)c3ccc(cn3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L17 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074724 Maybridge2_000259 CC(C)N(Cc1ccccc1)C(=O)c2c(C)onc2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L18 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074725 Maybridge2_000260 COc1ccc(NC(=O)C2CN(CCc3ccc(Cl)cc3)C(=O)C2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L19 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074726 Maybridge2_000261 Clc1cccc(NC(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L20 compound treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 1880074 Maybridge2_000262 CN(C)c1ccc(NC(=O)Nc2cccc(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L21 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 1658667 Maybridge2_000263 O=C(N1CCN(CC1)C(=O)c2ccccc2)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L22 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074727 Maybridge2_000264 CN(C)c1ccc(NC(=O)c2snnc2C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L23 mock treatment 0.0745 4.69E-5 0.01 0.0056 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 L24 mock treatment 0.0775 0.00305 0.36 0.361 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M01 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074728 Maybridge2_000265 C/C=C(\C)/C(=O)Nc1ccccc1CC2N(C)CCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M02 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074729 Maybridge2_000266 Fc1cccc(Cl)c1CN(Cc2c(F)cccc2Cl)OC(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M03 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 2074730 Maybridge2_000267 CN(C)/C=C/1\N=C(OC1=O)c2cccnc2Sc3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M04 compound treatment 0.077 0.00255 0.3 0.3018 1.0 2074731 Maybridge2_000268 Fc1ccc(cc1)C2CCCN2C(=O)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M05 compound treatment 0.0775 0.00305 0.36 0.361 1.0 1449556 Maybridge2_000269 CN1C2CCC1CC(C2)NS(=O)(=O)c3ccc(C#N)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M06 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 2074732 Maybridge2_000270 CN(C)C(=O)n1cc(C#N)c(n1)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M07 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 1452846 Maybridge2_000271 CN1C2CCC1CC(C2)NC(=O)CSc3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M08 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074733 Maybridge2_000272 CN(C)C(=O)ONC(=O)Cc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M09 compound treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 1139053 Maybridge2_000273 CN1C2CCC1CC(C2)NCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M10 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074734 Maybridge2_000274 CNC(=O)N1CCC(CC1)C(=O)c2c(C)c(C)c(C)c(C)c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M11 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 1631500 Maybridge2_000275 CC1C(OCCN1Cc2c(C)c(C)c(C)c(C)c2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M12 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074735 Maybridge2_000276 CN(C)/C=C/C(=N)SCc1c(F)cccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M13 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074736 Maybridge2_000277 FC(F)(F)c1cc(C#CCN2CCCC2)cc(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M14 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 1466440 Maybridge2_000278 Clc1cccc(c1)C(=O)Nc2ccc(N3CCOCC3)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M15 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 2074737 Maybridge2_000279 Fc1cccc(Cl)c1NC(=O)N2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M16 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074738 Maybridge2_000280 COc1cc2CCN(Cc3cccc(Cl)c3)C(=O)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M17 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074739 Maybridge2_000281 FC(F)(F)c1cccc(CN(Cc2cccc(c2)C(F)(F)F)OC(=O)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M18 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 1568873 Maybridge2_000282 Fc1ccc(NC(=O)N2CCN(Cc3ccccc3)CC2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M19 compound treatment 0.0815 0.00705 0.83 0.835 1.0 2074740 Maybridge2_000283 FC(F)(F)c1cc(/C=C\c2noc(n2)c3ccccc3CN4CCCC4)cc(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M20 compound treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 1236024 Maybridge2_000284 CN(C1CCN(C)CC1)C(=O)c2cnn(c2C)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M21 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074741 Maybridge2_000285 CN(C)C(=O)Oc1ccc(Br)cc1C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M22 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074742 Maybridge2_000286 O=C(Nc1ccc(OCc2ccccc2)cc1)Oc3ccccc3N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M23 mock treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 M24 mock treatment 0.075 5.47E-4 0.06 0.0648 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N01 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074743 Maybridge2_000287 CC(C)(C)c1ccc(NC(=O)N(CCC#N)CCc2ccccn2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N02 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074744 Maybridge2_000288 FC(F)(F)c1ccc(N2CCCC2)c(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N03 compound treatment 0.078 0.00355 0.42 0.4203 1.0 2074745 Maybridge2_000289 CC(C)N(Cc1ccccc1)C(=O)c2ccc3OCOc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N04 compound treatment 0.0805 0.00605 0.72 0.7165 1.0 2074746 Maybridge2_000290 OC(=O)CCC(=O)Nc1cc(ccc1N2CCCC2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N05 compound treatment 0.0775 0.00305 0.36 0.361 1.0 2074747 Maybridge2_000291 CC(C)N(Cc1ccccc1)S(=O)(=O)c2ccc(s2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N06 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074748 Maybridge2_000292 O=S(=O)(NCc1ccc(cc1)N2CCOCC2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N07 compound treatment 0.0775 0.00305 0.36 0.361 1.0 1121411 Maybridge2_000293 COc1ccc(cc1)C(=O)c2c(N)sc3CN(C)CCc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N08 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 2074749 Maybridge2_000294 O=S1(=O)CCN(CC2COc3ccccc3O2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N09 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 1198415 Maybridge2_000295 Clc1ccc(cc1)C(=O)Nc2ccc(cc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N10 compound treatment 0.076 0.00155 0.18 0.1833 1.0 2074750 Maybridge2_000296 FC(F)(F)c1cccnc1N2CCN(Cc3ccc[nH]3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N11 compound treatment 0.0755 0.00105 0.12 0.124 1.0 1511787 Maybridge2_000297 O=S(=O)(Nc1ccc(cc1)N2CCCCC2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N12 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 2074751 Maybridge2_000298 Cc1ccc(C)n1CC2CCNCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N13 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 1861731 Maybridge2_000299 Cc1ccc(cc1)C(=O)Nc2ccccc2N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N14 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074752 Maybridge2_000300 Fc1ccc(NC(=O)N2CCCN(CC2)c3ccc(cn3)C(F)(F)F)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N15 compound treatment 0.0755 0.00105 0.12 0.124 1.0 2074753 Maybridge2_000301 FC(F)(F)Oc1ccc(cc1)C2N(Cc3c[nH]c4ccccc34)CCc5sccc25 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N16 compound treatment 0.078 0.00355 0.42 0.4203 1.0 2074754 Maybridge2_000302 Clc1c(sc2ccccc12)C(=O)N3CCN(CC3)C(=O)C4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N17 compound treatment 0.0765 0.00205 0.24 0.2425 1.0 2074755 Maybridge2_000303 CC(C)N(Cc1ccccc1)C(=O)c2ccc3nsnc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N18 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 2074756 Maybridge2_000304 Cc1ccc(NC(=O)C2CN(CCc3ccc(Cl)cc3)C(=O)C2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N19 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074757 Maybridge2_000305 FC(F)(F)c1cccc(NC(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N20 compound treatment 0.076 0.00155 0.18 0.1833 1.0 2074758 Maybridge2_000306 CN(C)c1ccc(NC(=O)Nc2ccccc2F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N21 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074759 Maybridge2_000307 C1Cc2c([nH]c3ccccc23)C4(CCNCC4)N1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N22 compound treatment 0.0875 0.013 1.55 1.5459 1.0 2074760 Maybridge2_000308 CN(C)c1ccc(NC(=O)c2sc3ccccc3c2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N23 mock treatment 0.0755 0.00105 0.12 0.124 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 N24 mock treatment 0.076 0.00155 0.18 0.1833 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O01 compound treatment 0.0675 -0.00695 -0.82 -0.8239 -1.0 1510389 Maybridge2_000309 CN1CCc2ccccc2C1Cc3ccccc3NS(=O)(=O)c4cc(Cl)c(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O02 compound treatment 0.0665 -0.00795 -0.94 -0.9424 -1.0 2074761 Maybridge2_000310 Clc1ccc(C(=O)NC(=N)N2CCCC2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O03 compound treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 2074762 Maybridge2_000311 CN1C2CCC1CC(C2)NC(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O04 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074763 Maybridge2_000312 Clc1ccc(Oc2ccccc2S(=O)(=O)N3CCSCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O05 compound treatment 0.075 5.47E-4 0.06 0.0648 1.0 2074764 Maybridge2_000313 CN1C2CCC1CC(C2)NS(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O06 compound treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 2074765 Maybridge2_000314 Clc1cc(c(Cl)s1)S(=O)(=O)N2CCSCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O07 compound treatment 0.0745 4.69E-5 0.01 0.0056 1.0 1582773 Maybridge2_000315 CN1C2CCC1CC(C2)NC(=O)CSc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O08 compound treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 2074766 Maybridge2_000316 Clc1cc(NC(=O)N2CCOCC2)c(Cl)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O09 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074767 Maybridge2_000317 CN1C2CCC1CC(C2)/N=C\c3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O10 compound treatment 0.07 -0.00445 -0.53 -0.5277 -1.0 2074768 Maybridge2_000318 NC(=S)c1ccc(cc1)S(=O)(=O)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O11 compound treatment 0.0695 -0.00495 -0.59 -0.5869 -1.0 1446135 Maybridge2_000319 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)Nc2ccc(F)c(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O12 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074769 Maybridge2_000320 CN(C)/C=C/C(=O)c1ccc(cc1)S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O13 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 1328314 Maybridge2_000321 Cc1ccc2oc(=O)cc(CN3CCOCC3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O14 compound treatment 0.071 -0.00345 -0.41 -0.4092 -1.0 2074770 Maybridge2_000322 C1CN2CCC1C3=NNC(C23)c4ccc(cc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O15 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 2074771 Maybridge2_000323 Cc1onc(c1C(=O)N2CCC=CC2)c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O16 compound treatment 0.0785 0.00405 0.48 0.4795 1.0 2074772 Maybridge2_000324 COc1cc2CCN(Cc3ccc(C)cc3)C(=O)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O17 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074773 Maybridge2_000325 CN(C)c1ccc(NC(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O18 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 1284206 Maybridge2_000326 Fc1ccc(NC(=O)N2CCN(Cc3ccccc3)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O19 compound treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 2074774 Maybridge2_000327 CS/C(=N/c1cc(cc(c1)C(F)(F)F)C(F)(F)F)/N2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O20 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 2074775 Maybridge2_000328 Brc1ccsc1C(=O)Oc2ccccc2N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O21 compound treatment 0.0695 -0.00495 -0.59 -0.5869 -1.0 2074776 Maybridge2_000329 CCN(CC)C(=O)Oc1ccc(Br)cc1C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O22 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 2074777 Maybridge2_000330 CC(C)(C)c1ccc(NC(=O)Oc2ccccc2N3CCOCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O23 mock treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 O24 mock treatment 0.0765 0.00205 0.24 0.2425 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P01 compound treatment 0.066 -0.00845 -1.0 -1.0016 -1.0 1443960 Maybridge2_000331 Fc1ccc(cc1)N2CCN(Cc3c[nH]c4ccccc34)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P02 compound treatment 0.063 -0.0115 -1.36 -1.3571 -1.0 2074778 Maybridge2_000332 FC(F)(F)c1ccc(N2CCCC2)c(NC(=O)Nc3cccs3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P03 compound treatment 0.0645 -0.00995 -1.18 -1.1793 -1.0 2074779 Maybridge2_000333 O=C(NC1CCN(Cc2ccccc2)CC1)Nc3csc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P04 compound treatment 0.0715 -0.00295 -0.35 -0.3499 -1.0 2074780 Maybridge2_000334 OC(=O)c1ccccc1C(=O)Nc2cc(ccc2N3CCCC3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P05 compound treatment 0.068 -0.00645 -0.76 -0.7646 -1.0 2074781 Maybridge2_000335 CC(C)N(Cc1ccccc1)S(=O)(=O)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P06 compound treatment 0.0665 -0.00795 -0.94 -0.9424 -1.0 2074782 Maybridge2_000336 OC(=O)CCCC(=O)N1CCN(CC1)C2c3ccccc3-c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P07 compound treatment 0.0755 0.00105 0.12 0.124 1.0 1511990 Maybridge2_000337 Nc1sc2CN(Cc3ccccc3)CCc2c1C(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P08 compound treatment 0.0795 0.00505 0.6 0.598 1.0 2074783 Maybridge2_000338 Cc1ccc(cc1)C2Nc3ccccc3C(=O)N2CCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P09 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 2074784 Maybridge2_000339 FC(F)(F)c1cc(cc(c1)C(F)(F)F)C(=O)Nc2ccc(cc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P10 compound treatment 0.078 0.00355 0.42 0.4203 1.0 1361938 Maybridge2_000340 CCN(CC)c1ccc(CN2CCN(Cc3ccccc3)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P11 compound treatment 0.0725 -0.00195 -0.23 -0.2314 -1.0 1735126 Maybridge2_000341 Fc1ccccc1S(=O)(=O)Nc2ccc(cc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P12 compound treatment 0.0775 0.00305 0.36 0.361 1.0 1553691 Maybridge2_000342 O=C(N1CCCC1)c2ccc(cc2)C(=O)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P13 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 1861719 Maybridge2_000343 Clc1c(sc2ccccc12)C(=O)Nc3ccccc3N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P14 compound treatment 0.073 -0.00145 -0.17 -0.1722 -1.0 2074785 Maybridge2_000344 Fc1ccc(NC(=O)N2CCCN(CC2)c3ccc(cn3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P15 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074786 Maybridge2_000345 OC(=O)c1cc(ccc1N2CCOCC2)n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P16 compound treatment 0.074 -4.53E-4 -0.05 -0.0537 -1.0 2074787 Maybridge2_000346 OC(=O)C1CN(C2Cc3ccccc3C2)C(=O)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P17 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074788 Maybridge2_000347 CN(C1CCCCC1)C(=O)c2cc(C)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P18 compound treatment 0.09 0.0155 1.84 1.8422 1.0 2074789 Maybridge2_000348 Cc1ccc2cc(NC(=O)C3CN(CCc4ccc(Cl)cc4)C(=O)C3)ccc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P19 compound treatment 0.0695 -0.00495 -0.59 -0.5869 -1.0 2074790 Maybridge2_000349 Cc1ccc(NC(=O)N2CCN(CC2)C3c4ccccc4-c5ccccc35)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P20 compound treatment 0.0735 -9.53E-4 -0.11 -0.1129 -1.0 2074791 Maybridge2_000350 CN(C)c1ccc(NC(=O)Nc2cc(C)cc(C)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P21 compound treatment 0.0685 -0.00595 -0.71 -0.7054 -1.0 2074792 Maybridge2_000351 Clc1cccc(c1)S(=O)(=O)Nc2ccc(cc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P22 compound treatment 0.072 -0.00245 -0.29 -0.2907 -1.0 1219896 Maybridge2_000352 Cc1ccc(CN2CCS(=O)(=O)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P23 mock treatment 0.0705 -0.00395 -0.47 -0.4684 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1303 P24 mock treatment 0.062 -0.0125 -1.48 -1.4756 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A01 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2074793 Maybridge2_000353 Cc1ccc(NC(=O)C2CN(Cc3ccco3)C(=O)C2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A02 compound treatment 0.057 -0.0158 -1.87 -1.871 -1.0 1173073 Maybridge2_000354 CN(C)CCNc1cc(nc2ccccc12)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A03 compound treatment 0.082 0.00921 1.09 1.0913 1.0 1014318 Maybridge2_000355 OC(=O)CN(Cc1ccccc1)Cc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A04 compound treatment 0.081 0.00821 0.97 0.9728 1.0 2074794 Maybridge2_000356 CS/C(=C(/C#N)\S(=O)(=O)c1ccc(Cl)cc1)/N2CCSCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A05 compound treatment 0.088 0.0152 1.8 1.8022 1.0 2074795 Maybridge2_000357 Fc1cn(C2CCCO2)c(=O)n(Cc3cccc4ccccc34)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A06 compound treatment 0.0655 -0.00729 -0.86 -0.8638 -1.0 1411803 Maybridge2_000358 S=C1SC(CC(=C1)N2CCCCC2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A07 compound treatment 0.084 0.0112 1.33 1.3282 1.0 2074796 Maybridge2_000359 Cc1cc(C)c(C#N)c(n1)N2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A08 compound treatment 0.0795 0.00671 0.8 0.795 1.0 1585551 Maybridge2_000360 Cc1ccc(SC2CN(C2)C(c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A09 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 1016614 Maybridge2_000361 CN(C)c1ccc(cc1)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A10 compound treatment 0.076 0.00321 0.38 0.3803 1.0 2074797 Maybridge2_000362 Cc1nc2c(N3CCOCC3)c(Cl)c(Cl)c(Cl)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A11 compound treatment 0.0785 0.00571 0.68 0.6765 1.0 2074798 Maybridge2_000363 Clc1ccc(cc1)C2C3CCc4ccccc4C3=NN2C(=O)CN5CCOCC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A12 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 1360824 Maybridge2_000364 COC(=O)C1CSC(=CC1N(C)C)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A13 compound treatment 0.078 0.00521 0.62 0.6173 1.0 2074799 Maybridge2_000365 C1CCN(C1)c2nnc(c3ccccc3)c(n2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A14 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 2074800 Maybridge2_000366 O=C/1Nc2ccccc2\C1=N\C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A15 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074801 Maybridge2_000367 Cc1sc(NC(=O)CN2CCN(CC2)c3ccccc3)c(C#N)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A16 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074802 Maybridge2_000368 COc1c(Cl)cc(Cl)c(OC)c1C(=O)N2CC(C)OC(C)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A17 compound treatment 0.0675 -0.00529 -0.63 -0.6269 -1.0 2074803 Maybridge2_000369 O=C(Cn1cnc2sc(cc2c1=O)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A18 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074804 Maybridge2_000370 CC(=O)Cn1cc(Cl)c(=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A19 compound treatment 0.078 0.00521 0.62 0.6173 1.0 2074805 Maybridge2_000371 CC(=O)c1sc2nsc(SCCN3CCCC3)c2c1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A20 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074806 Maybridge2_000372 COc1cc(c(cn1)C(=O)N(C)Cc2ccccc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A21 compound treatment 0.0775 0.00471 0.56 0.5581 1.0 2074807 Maybridge2_000373 CCOC(=O)c1cc(sc1NC(=O)CN2CCCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A22 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074808 Maybridge2_000374 CCSc1cc(c(cn1)C(=O)N(C)Cc2c(OC)cccc2OC)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A23 mock treatment 0.0865 0.0137 1.62 1.6245 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 A24 mock treatment 0.0765 0.00371 0.44 0.4396 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B01 compound treatment 0.0805 0.00771 0.91 0.9135 1.0 2074809 Maybridge2_000375 CC(C)N(C(C)C)C1N=C(c2ccccc2)c3cc(Cl)ccc3N(C)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B02 compound treatment 0.081 0.00821 0.97 0.9728 1.0 2074810 Maybridge2_000376 Clc1cccc(NC(=O)OC2CN3CCC2CC3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B03 compound treatment 0.085 0.0122 1.45 1.4467 1.0 1238984 Maybridge2_000377 Clc1ccc(C(=O)N2CCN(Cc3ccccc3)CC2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B04 compound treatment 0.0855 0.0127 1.51 1.506 1.0 2074811 Maybridge2_000378 OC(=O)CC1(CC(=O)Nc2ccc(cc2)N3CCCCC3)CCCCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B05 compound treatment 0.0865 0.0137 1.62 1.6245 1.0 2074812 Maybridge2_000379 CCCc1c(C)nc(SCc2c(F)cccc2Cl)nc1OC(=O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B06 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074813 Maybridge2_000380 Fc1ccc(cc1)S(=O)(=O)N2CCC(=CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B07 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074814 Maybridge2_000381 Clc1ccc(Cn2nnc(n2)N3CCCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B08 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074815 Maybridge2_000382 O=C(N1CCC(=CC1)c2ccccc2)c3csc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B09 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074816 Maybridge2_000383 CN(C)C(=O)Oc1nc(nc(C)c1C)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B10 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2074817 Maybridge2_000384 O=S(=O)(N1CCC(=CC1)c2ccccc2)c3ccsc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B11 compound treatment 0.063 -0.00979 -1.16 -1.1601 -1.0 2074818 Maybridge2_000385 CC(=O)N1C(CSC1c2cccs2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B12 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 2074819 Maybridge2_000386 Cc1ccc(C)n1CCN2CCN(CC2)S(=O)(=O)Cc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B13 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2071084 Maybridge2_000387 CN1C/C(=C\c2ccccc2)/C(=O)\C(=C\c3ccccc3)\C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B14 compound treatment 0.069 -0.00379 -0.45 -0.4491 -1.0 2074820 Maybridge2_000388 CN1CCN(CC1)c2ccc(NC(=O)c3cccc4CC(C)(C)Oc43)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B15 compound treatment 0.0665 -0.00629 -0.75 -0.7453 -1.0 2074821 Maybridge2_000389 CC1C(N2CCCCC2)C(=O)N(C1=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B16 compound treatment 0.066 -0.00679 -0.8 -0.8046 -1.0 2074822 Maybridge2_000390 Fc1cc(CN2CCS(=O)(=O)CC2)c3OCOCc3c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B17 compound treatment 0.067 -0.00579 -0.69 -0.6861 -1.0 2074823 Maybridge2_000391 CN(C)c1ccncc1C(O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B18 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074824 Maybridge2_000392 O=S1(=O)CCN(Cc2ccc(cc2)N3CCOCC3)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B19 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074825 Maybridge2_000393 Fc1ccc(cc1)C2CCCN2S(=O)(=O)c3cccc4cccnc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B20 compound treatment 0.07 -0.00279 -0.33 -0.3306 -1.0 2074826 Maybridge2_000394 FC(F)(F)c1ccc(cc1)S(=O)(=O)NCCN2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B21 compound treatment 0.0685 -0.00429 -0.51 -0.5084 -1.0 2074827 Maybridge2_000395 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCCC2c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B22 compound treatment 0.067 -0.00579 -0.69 -0.6861 -1.0 2074828 Maybridge2_000396 OC(CN1CCC(=CC1)c2ccccc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B23 mock treatment 0.073 2.1E-4 0.02 0.0248 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 B24 mock treatment 0.0655 -0.00729 -0.86 -0.8638 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C01 compound treatment 0.076 0.00321 0.38 0.3803 1.0 2074829 Maybridge2_000397 Fc1ccc(NC(=O)C2CN(Cc3ccco3)C(=O)C2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C02 compound treatment 0.078 0.00521 0.62 0.6173 1.0 1122383 Maybridge2_000398 CN1CCN(CC1)c2cc(nc3ccccc23)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C03 compound treatment 0.0825 0.00971 1.15 1.1505 1.0 2074830 Maybridge2_000399 Cc1ccccc1Cn2cc(C)c(=O)[nH]c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C04 compound treatment 0.0845 0.0117 1.39 1.3875 1.0 2074831 Maybridge2_000400 Clc1ccc(CS(=O)(=O)/C(=C/N2CCOCC2)/C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C05 compound treatment 0.087 0.0142 1.68 1.6837 1.0 1009314 Maybridge2_000401 CCN(CC)c1ncnc2[nH]cnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C06 compound treatment 0.08 0.00721 0.85 0.8543 1.0 2074832 Maybridge2_000402 COc1ccc(cc1)C(=O)/C(=C/N2CCc3ccccc3C2)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C07 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074833 Maybridge2_000403 Cc1cc(C)c2c(n1)sc3c(=O)n(CC=C)cnc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C08 compound treatment 0.076 0.00321 0.38 0.3803 1.0 1199989 Maybridge2_000404 C1C(CN1C(c2ccccc2)c3ccccc3)Sc4nc5ccccc5s4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C09 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074834 Maybridge2_000405 O=C(Nc1csc2ccccc12)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C10 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074835 Maybridge2_000406 CCN(CC)CC(=O)c1sc2ccc(Cl)cc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C11 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074836 Maybridge2_000407 O=C(CN1CCc2ccccc12)N3CCc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C12 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074837 Maybridge2_000408 Brc1ccc(cc1)n2nnnc2/C=C/N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C13 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2074838 Maybridge2_000409 O=C(CN1CCCc2ccccc12)N3CCCc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C14 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 1480993 Maybridge2_000410 O=C(N1CCN(Cc2ccccc2)CC1)c3cc4CCc5ccccc5-c4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C15 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074839 Maybridge2_000411 Cc1sc(NC(=O)CN2CCc3ccccc23)c(C#N)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C16 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 2074840 Maybridge2_000412 Oc1cc(CN2CCCC2)nc(n1)c3cc(cc(c3)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C17 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2074841 Maybridge2_000413 CC(=O)Cn1cnc2sc(cc2c1=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C18 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074842 Maybridge2_000414 Clc1ccc(cc1)C(=O)N(Cc2cccnc2)Cc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C19 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074843 Maybridge2_000415 CC(=O)c1sc2nsc(SCCN3CCOCC3)c2c1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C20 compound treatment 0.0775 0.00471 0.56 0.5581 1.0 2074844 Maybridge2_000416 COc1cc(c(cn1)C(=O)N(C)Cc2cccc(Cl)c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C21 compound treatment 0.076 0.00321 0.38 0.3803 1.0 2074845 Maybridge2_000417 Fc1ccc(cc1)N2CCN(CC2)C3=Cc4ccccc4CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C22 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074846 Maybridge2_000418 COc1cccc(OC)c1CN(C)C(=O)c2cnccc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C23 mock treatment 0.0765 0.00371 0.44 0.4396 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 C24 mock treatment 0.079 0.00621 0.74 0.7358 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D01 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 1687697 Maybridge2_000419 Clc1ccccc1CN2CCN(CC2)c3cccc4[nH]ccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D02 compound treatment 0.078 0.00521 0.62 0.6173 1.0 2074847 Maybridge2_000420 Clc1ccc(NC(=O)OC2CN3CCC2CC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D03 compound treatment 0.08 0.00721 0.85 0.8543 1.0 1224648 Maybridge2_000421 O=C(N1CCN(Cc2ccccc2)CC1)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D04 compound treatment 0.082 0.00921 1.09 1.0913 1.0 2074848 Maybridge2_000422 Cc1noc(c1NC(=O)N2CCSCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D05 compound treatment 0.086 0.0132 1.57 1.5652 1.0 2074849 Maybridge2_000423 Cc1nc(nc(O)c1Cc2c(F)cccc2Cl)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D06 compound treatment 0.0805 0.00771 0.91 0.9135 1.0 2074850 Maybridge2_000424 Cc1ccc(cc1F)S(=O)(=O)N2CCC(=CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D07 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074851 Maybridge2_000425 CN(C)C(=O)Oc1cc(C)nc(n1)c2ccc(F)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D08 compound treatment 0.076 0.00321 0.38 0.3803 1.0 2074852 Maybridge2_000426 O=C(N1CCC(=CC1)c2ccccc2)c3csc(n3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D09 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074853 Maybridge2_000427 CCc1cc(OC(=O)N(C)C)nc(n1)c2ccc(F)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D10 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074854 Maybridge2_000428 O=S(=O)(N1CCC(=CC1)c2ccccc2)c3ccc4OCCCOc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D11 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074855 Maybridge2_000429 CCN(CC)C(=O)Sc1c(Br)cc(Br)cc1Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D12 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074856 Maybridge2_000430 NC(=O)C1CCN(CC1)S(=O)(=O)Cc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D13 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074637 Maybridge2_000431 CN1C/C(=C\c2cccs2)/C(=O)\C(=C\c3cccs3)\C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D14 compound treatment 0.08 0.00721 0.85 0.8543 1.0 2074857 Maybridge2_000432 CC1(C)Cc2cccc(C(=O)N3CCC(CC3)C(=O)c4ccc(Cl)cc4)c2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D15 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 2074858 Maybridge2_000433 CN1N=C/2C(CN(C)C\C2=C/c3ccc(cc3)C(F)(F)F)C1c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D16 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 2074859 Maybridge2_000434 O=S1(=O)CCN(Cc2ccc(cc2)n3cccn3)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D17 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074860 Maybridge2_000435 CC(=O)N1CCC(CC1)C(=O)Nc2nc3ccc(Cl)cc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D18 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074861 Maybridge2_000436 O=S(=O)(N(Cc1ccccn1)Cc2ccccn2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D19 compound treatment 0.0815 0.00871 1.03 1.032 1.0 2074862 Maybridge2_000437 CN1CCOc2cc(ccc12)S(=O)(=O)N3CCCC3c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D20 compound treatment 0.077 0.00421 0.5 0.4988 1.0 2074863 Maybridge2_000438 Cc1cc(nn1C)C(=O)N2CCN(CC2)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D21 compound treatment 0.0785 0.00571 0.68 0.6765 1.0 2074864 Maybridge2_000439 Cc1ccc(cc1)S(=O)(=O)N2CCCC2c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D22 compound treatment 0.076 0.00321 0.38 0.3803 1.0 2074865 Maybridge2_000440 OC(CNCc1cc2ccccc2s1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D23 mock treatment 0.0775 0.00471 0.56 0.5581 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 D24 mock treatment 0.082 0.00921 1.09 1.0913 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E01 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074866 Maybridge2_000441 FC(F)(F)c1ccc(nc1)N2CCCN(CC2)C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E02 compound treatment 0.078 0.00521 0.62 0.6173 1.0 2074867 Maybridge2_000442 CN(C)C(=O)Oc1ccnc(SCc2c(Cl)cccc2Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E03 compound treatment 0.0805 0.00771 0.91 0.9135 1.0 1286698 Maybridge2_000443 CN(C)c1ccc(NC(=O)c2ccc(Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E04 compound treatment 0.0835 0.0107 1.27 1.269 1.0 2074868 Maybridge2_000444 Cc1nc(ncc1S(=O)(=O)c2ccc(Cl)cc2)N3CCSCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E05 compound treatment 0.085 0.0122 1.45 1.4467 1.0 1538786 Maybridge2_000445 Clc1ccc(CNCc2cccnc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E06 compound treatment 0.079 0.00621 0.74 0.7358 1.0 2074869 Maybridge2_000446 CN(C)CC#Cc1ccc(s1)c2ccn(n2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E07 compound treatment 0.086 0.0132 1.57 1.5652 1.0 2074870 Maybridge2_000447 Cc1cc(C)c2c(n1)sc3c(ncnc32)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E08 compound treatment 0.0805 0.00771 0.91 0.9135 1.0 2074871 Maybridge2_000448 OC(=O)CCCN1CCC(=CC1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E09 compound treatment 0.0785 0.00571 0.68 0.6765 1.0 2074872 Maybridge2_000449 NC(=O)C1CCN(CC1)C(=O)Nc2csc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E10 compound treatment 0.0775 0.00471 0.56 0.5581 1.0 2074873 Maybridge2_000450 CN(C)/C=C(\C#N)/C(=O)c1sc2ccc(Cl)cc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E11 compound treatment 0.0775 0.00471 0.56 0.5581 1.0 2074874 Maybridge2_000451 O=C(CN1CCCc2ccccc12)N3CCc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E12 compound treatment 0.079 0.00621 0.74 0.7358 1.0 2074875 Maybridge2_000452 Brc1ccc(cc1)n2nnnc2/C=C/N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E13 compound treatment 0.077 0.00421 0.5 0.4988 1.0 2074876 Maybridge2_000453 O=C(CN1CCc2ccccc12)N3CCCc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E14 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074877 Maybridge2_000454 CN(CCC#N)c1ccc(/C=C\2/N=C(OC2=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E15 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074878 Maybridge2_000455 Cc1sc(NC(=O)CN2CCCC2)c(C#N)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E16 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074879 Maybridge2_000456 CC1CN(CC(C)O1)c2nc(cc(c2C#N)C(F)(F)F)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E17 compound treatment 0.077 0.00421 0.5 0.4988 1.0 1247492 Maybridge2_000457 Clc1ccccc1Cn2cnc3sc(cc3c2=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E18 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074880 Maybridge2_000458 CC(C)(C)C(=O)N(Cc1ccc(Cl)cc1)Cc2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E19 compound treatment 0.08 0.00721 0.85 0.8543 1.0 2074881 Maybridge2_000459 Nc1c(sc2nsc(SCCN3CCCCC3)c12)C(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E20 compound treatment 0.077 0.00421 0.5 0.4988 1.0 2074882 Maybridge2_000460 CCN(Cc1cccc(Cl)c1)C(=O)c2cnc(OC)cc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E21 compound treatment 0.077 0.00421 0.5 0.4988 1.0 2074883 Maybridge2_000461 C(C1CCN(CC1)C2=Cc3ccccc3CC2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E22 compound treatment 0.074 0.00121 0.14 0.1433 1.0 1203973 Maybridge2_000462 CN(C)c1ccncc1C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E23 mock treatment 0.0765 0.00371 0.44 0.4396 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 E24 mock treatment 0.077 0.00421 0.5 0.4988 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F01 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 1379513 Maybridge2_000463 Clc1ccc(CN2CCN(CC2)c3cccc4[nH]ccc34)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F02 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2074884 Maybridge2_000464 Cc1ccccc1NC(=O)OC2CN3CCC2CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F03 compound treatment 0.076 0.00321 0.38 0.3803 1.0 1240135 Maybridge2_000465 CN1CCN(CC1)c2c3C4CCC(C)(c3nc5ccccc25)C4(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F04 compound treatment 0.0785 0.00571 0.68 0.6765 1.0 2074885 Maybridge2_000466 FC(F)(F)c1cccc(CS(=O)(=O)N2CCOCC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F05 compound treatment 0.088 0.0152 1.8 1.8022 1.0 2074886 Maybridge2_000467 CN(C)C(=O)Oc1cc(C)nc(SCc2c(Cl)cccc2Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F06 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074887 Maybridge2_000468 Fc1cccc(c1)C(=O)N2CCC(=CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F07 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074888 Maybridge2_000469 CCN(CC)C(=O)Oc1cc(C)nc(n1)c2ccc(F)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F08 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2074889 Maybridge2_000470 Cc1c(Cl)cc(F)cc1S(=O)(=O)N2CCC(=CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F09 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074890 Maybridge2_000471 CCCc1cc(=O)oc2cc(OC(=O)N(C)C)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F10 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 1620449 Maybridge2_000472 Fc1ccccc1S(=O)(=O)N2CCC(=CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F11 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2074891 Maybridge2_000473 CCCN(CCC)S(=O)(=O)c1ccc(cc1)c2nc3ccc(C)cc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F12 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074892 Maybridge2_000474 O=S(=O)(N1CCCCC1c2cccnc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F13 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2074893 Maybridge2_000475 O=S(=O)(N1CCOCC1)c2csc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F14 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 2074894 Maybridge2_000476 CN1CCN(CC1)C(=O)c2cccc3CC(C)(C)Oc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F15 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2074895 Maybridge2_000477 Cc1csc2c(=O)n(CCN3CCSCC3)c(=O)[nH]c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F16 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 2074896 Maybridge2_000478 Cn1cccc1CN2CCS(=O)(=O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F17 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074897 Maybridge2_000479 CC(=O)N1CCC(CC1)C(=O)Nc2ccc3nc(C)ccc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F18 compound treatment 0.079 0.00621 0.74 0.7358 1.0 1398018 Maybridge2_000480 Clc1ccc(cc1)S(=O)(=O)N(Cc2ccccn2)Cc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F19 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074898 Maybridge2_000481 Fc1ccc(cc1)C2CCCN2S(=O)(=O)c3ccc(cc3)c4cnco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F20 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2074899 Maybridge2_000482 Cc1cc(nn1C)C(=O)N2CCN=C(C=C2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F21 compound treatment 0.082 0.00921 1.09 1.0913 1.0 2074900 Maybridge2_000483 Fc1ccccc1NC(=O)N2CCCC2c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F22 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074901 Maybridge2_000484 OC(CNCc1ccc(cc1)c2cccs2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F23 mock treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 F24 mock treatment 0.0745 0.00171 0.2 0.2026 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G01 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2074902 Maybridge2_000485 CC(C)(C)NC(=O)N1CCCN(CC1)c2ccc(cn2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G02 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074903 Maybridge2_000486 CN(C)C(=O)Oc1ccnc(SCc2ccc(Cl)cc2Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G03 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2074904 Maybridge2_000487 COC(=O)C1Cc2c([nH]c3ccccc23)C(N1)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G04 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074905 Maybridge2_000488 O=C1CS(=O)(=O)C(N1CC2CC2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G05 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 1288613 Maybridge2_000489 C(NCc1cccnc1)c2ccco2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G06 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074906 Maybridge2_000490 ON=C1CC2CCCC(C1)N2Cc3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G07 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074907 Maybridge2_000491 CN1CCN(CC1)c2ncnc3c2sc4nc(C)cc(C)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G08 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 1401140 Maybridge2_000492 Brc1ccc(s1)S(=O)(=O)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G09 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 2074908 Maybridge2_000493 CC1CCN(CC1)C(=O)Nc2csc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G10 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 2074909 Maybridge2_000494 Ic1ccc(NC(=O)CN2CCCC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G11 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 2074910 Maybridge2_000495 O=C(CN1CCCC1)N2CCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G12 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 1615107 Maybridge2_000496 CN(C)CCC(O)c1ccc2OCCCCOc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G13 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 2074911 Maybridge2_000497 O=C(CN1CCN(CC1)c2ccccc2)N3CCCc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G14 compound treatment 0.069 -0.00379 -0.45 -0.4491 -1.0 1590454 Maybridge2_000498 CN(C)CCC(=O)Nc1nc(cs1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G15 compound treatment 0.0685 -0.00429 -0.51 -0.5084 -1.0 1327521 Maybridge2_000499 CCN(CC)c1ncnc2sc(cc12)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G16 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 2074912 Maybridge2_000500 CN(C)C(=O)Oc1cc(CSC(C)(C)C)nc(n1)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G17 compound treatment 0.076 0.00321 0.38 0.3803 1.0 1511025 Maybridge2_000501 CCOC(=O)Cn1cnc2sc(cc2c1=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G18 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2074913 Maybridge2_000502 Clc1ccc(CN(Cc2cccnc2)S(=O)(=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G19 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074914 Maybridge2_000503 Nc1c(sc2nsc(SCCN3CCOCC3)c12)C(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G20 compound treatment 0.068 -0.00479 -0.57 -0.5676 -1.0 2074915 Maybridge2_000504 CCN(Cc1cccc(Cl)c1Cl)C(=O)c2cnc(OC)cc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G21 compound treatment 0.0675 -0.00529 -0.63 -0.6269 -1.0 2074916 Maybridge2_000505 CC1CCc2c(C#N)c(NC(=O)CN(Cc3ccccc3)Cc4ccccc4)sc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G22 compound treatment 0.0685 -0.00429 -0.51 -0.5084 -1.0 2074917 Maybridge2_000506 CN(C)/C=C/C(=O)c1cc(cc(c1O)C(C)(C)C)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G23 mock treatment 0.068 -0.00479 -0.57 -0.5676 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 G24 mock treatment 0.067 -0.00579 -0.69 -0.6861 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H01 compound treatment 0.0875 0.0147 1.74 1.743 1.0 1462187 Maybridge2_000507 Fc1ccccc1CN2CCN(CC2)c3cccc4[nH]ccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H02 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074918 Maybridge2_000508 Cc1cccc(NC(=O)OC2CN3CCC2CC3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H03 compound treatment 0.077 0.00421 0.5 0.4988 1.0 1623409 Maybridge2_000509 CN1CCN(CC1)c2cc(nc3ccccc23)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H04 compound treatment 0.0815 0.00871 1.03 1.032 1.0 2074919 Maybridge2_000510 FC(F)(F)c1cccc(CS(=O)(=O)N2CCCCC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H05 compound treatment 0.085 0.0122 1.45 1.4467 1.0 2074920 Maybridge2_000511 CN(C)C(=O)Oc1cc(C)nc(n1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H06 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074921 Maybridge2_000512 O=C(N1CCC(=CC1)c2ccccc2)c3ccsc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H07 compound treatment 0.081 0.00821 0.97 0.9728 1.0 2074922 Maybridge2_000513 CC(C)CCc1c(C)nc(nc1O)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H08 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074923 Maybridge2_000514 Clc1cc(Cl)cc(c1)S(=O)(=O)N2CCC(=CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H09 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074924 Maybridge2_000515 CCCc1cc(OC(=O)N(C)C)nc(n1)c2cccc(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H10 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 2074925 Maybridge2_000516 COc1ccc(c(OC)c1)S(=O)(=O)N2CCC(=CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H11 compound treatment 0.0845 0.0117 1.39 1.3875 1.0 2074926 Maybridge2_000517 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H12 compound treatment 0.076 0.00321 0.38 0.3803 1.0 2074927 Maybridge2_000518 Fc1ccc(CN2CCCN(Cc3ccc(F)cc3)C2c4ccco4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H13 compound treatment 0.07 -0.00279 -0.33 -0.3306 -1.0 1939214 Maybridge2_000519 COc1ccc(cc1)N2C(=O)CC(N3CCSCC3)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H14 compound treatment 0.07 -0.00279 -0.33 -0.3306 -1.0 2074928 Maybridge2_000520 CC1(C)Cc2cccc(C(=O)N3CCC(O)(CC3)c4ccc(Cl)cc4)c2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H15 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2074929 Maybridge2_000521 O=C1CC2(CCCc3ccccc32)C(=O)N1CN4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H16 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074930 Maybridge2_000522 Cc1cc(CN2CCS(=O)(=O)CC2)no1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H17 compound treatment 0.0775 0.00471 0.56 0.5581 1.0 2074931 Maybridge2_000523 CC(=O)N1CCC(CC1)C(=O)NCc2ccc(cc2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H18 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2074932 Maybridge2_000524 OC1(CCN(CC1)C(=O)c2cnc3ccccc3n2)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H19 compound treatment 0.076 0.00321 0.38 0.3803 1.0 2074933 Maybridge2_000525 Fc1ccc(cc1)C2CCCN2S(=O)(=O)c3ccc(Oc4ccccc4)nc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H20 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2074934 Maybridge2_000526 Cc1cc(nn1C)C(=O)Nc2ccccc2N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H21 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074935 Maybridge2_000527 Cc1cccc(NC(=O)N2CCCC2c3cccnc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H22 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2074936 Maybridge2_000528 O=C(NCc1ccsc1)C2CCCCN2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H23 mock treatment 0.0735 7.1E-4 0.08 0.0841 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 H24 mock treatment 0.0745 0.00171 0.2 0.2026 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I01 compound treatment 0.078 0.00521 0.62 0.6173 1.0 2074937 Maybridge2_000529 Cc1ccc(F)cc1NC(=O)N2CCCN(CC2)c3ccc(cn3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I02 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074938 Maybridge2_000530 COc1cc(/N=C(/SCc2c(C)c(C)c(C)c(C)c2C)\N3CCOCC3)c(OC)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I03 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074939 Maybridge2_000531 Clc1cccnc1N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I04 compound treatment 0.079 0.00621 0.74 0.7358 1.0 2074940 Maybridge2_000532 CN(C)C(=O)CS(=O)(=O)c1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I05 compound treatment 0.0785 0.00571 0.68 0.6765 1.0 2074941 Maybridge2_000533 O=C(NC1CCCCC1)C2N(Cc3ccco3)C(=O)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I06 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 1575317 Maybridge2_000534 O=C(Nc1ccccc1)OC2CN(C2)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I07 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 1985907 Maybridge2_000535 CCN(CC)c1ncnc2c1sc3nc(C)cc(C)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I08 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 1203540 Maybridge2_000536 O=S(=O)(N1CCN(Cc2ccccc2)CC1)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I09 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 2074942 Maybridge2_000537 CN1CCC(CNC(=O)Nc2csc3ccccc23)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I10 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 1098492 Maybridge2_000538 Ic1ccc(NC(=O)CN2CCCCC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I11 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074943 Maybridge2_000539 O=C(CN1CCN(CC1)c2ccccc2)N3CCc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I12 compound treatment 0.0835 0.0107 1.27 1.269 1.0 2074944 Maybridge2_000540 O=c1[nH]c2ccccc2c(=O)n1CCN3CCSCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I13 compound treatment 0.0635 -0.00929 -1.1 -1.1008 -1.0 2074945 Maybridge2_000541 CCN(CC)c1ncc(C#N)c(N)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I14 compound treatment 0.082 0.00921 1.09 1.0913 1.0 1477602 Maybridge2_000542 Clc1ccc(cc1)c2csc(NC(=O)CCN3CCCC3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I15 compound treatment 0.0795 0.00671 0.8 0.795 1.0 1285881 Maybridge2_000543 C1CCN(C1)c2ncnc3sc(cc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I16 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2074946 Maybridge2_000544 CN1CSc2nc(C)cc(C)c2C1=N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I17 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074947 Maybridge2_000545 CCOC(=O)c1cc(sc1NC(=O)CN2CCc3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I18 compound treatment 0.081 0.00821 0.97 0.9728 1.0 2074948 Maybridge2_000546 CN(C)C(=O)Nc1cnccc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I19 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074949 Maybridge2_000547 Nc1c(sc2nsc(SCCN3CCOCC3)c12)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I20 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074950 Maybridge2_000548 COc1cc(c(cn1)C(=O)N(C)Cc2ccc(Cl)c(Cl)c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I21 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 1531885 Maybridge2_000549 C1C(CN1C(c2ccccc2)c3ccccc3)Oc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I22 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2074951 Maybridge2_000550 COc1ccc2nccc([C@@H](O)C3CC4CCN3CC4C=C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I23 mock treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 I24 mock treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J01 compound treatment 0.076 0.00321 0.38 0.3803 1.0 1277060 Maybridge2_000551 Clc1ccc(CN2CCN(CC2)c3cccc4[nH]ccc34)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J02 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2074952 Maybridge2_000552 FC(F)(F)c1cccc(NC(=O)OC2CN3CCC2CC3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J03 compound treatment 0.077 0.00421 0.5 0.4988 1.0 1317869 Maybridge2_000553 CN1CCN(CC1)c2c3CCc4ccccc4-c3nc5ccccc25 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J04 compound treatment 0.0875 0.0147 1.74 1.743 1.0 2074953 Maybridge2_000554 CN1CCN(CC1)S(=O)(=O)Cc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J05 compound treatment 0.0785 0.00571 0.68 0.6765 1.0 2074954 Maybridge2_000555 CC1CN(CC(C)O1)c2nc(O)cc(n2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J06 compound treatment 0.082 0.00921 1.09 1.0913 1.0 2074955 Maybridge2_000556 O=C(N1CCC(=CC1)c2ccccc2)c3ccc4OCCc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J07 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074956 Maybridge2_000557 CC(C)CCc1c(C)nc(nc1O)N2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J08 compound treatment 0.079 0.00621 0.74 0.7358 1.0 2074957 Maybridge2_000558 O=S(=O)(N1CCC(=CC1)c2ccccc2)c3ccc4OCCc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J09 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2074958 Maybridge2_000559 Oc1ccccc1/C=N/c2ccc(cc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J10 compound treatment 0.079 0.00621 0.74 0.7358 1.0 2074959 Maybridge2_000560 Clc1ccc(CS(=O)(=O)N2CCCCCC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J11 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 2074960 Maybridge2_000561 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)Nc2cc(ccc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J12 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074961 Maybridge2_000562 Fc1ccc(CN2CCCN(Cc3ccc(F)cc3)C2c4cccnc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J13 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 2074962 Maybridge2_000563 Cc1ccc(N2C(=O)CC(N3CCSCC3)C2=O)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J14 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074963 Maybridge2_000564 Fc1ccc(cc1)N2CCN(CC2)C(=O)c3cc(F)cc4COCOc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J15 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074964 Maybridge2_000565 Oc1cc2OCOc2cc1C(N3CCCC3)c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J16 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074965 Maybridge2_000566 O=S1(=O)CCN(Cc2csc(n2)c3cccs3)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J17 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074966 Maybridge2_000567 CC(=O)N1CCC(CC1)C(=O)NCc2cc3ccccc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J18 compound treatment 0.085 0.0122 1.45 1.4467 1.0 2074967 Maybridge2_000568 O=C(N(Cc1ccccn1)Cc2ccccn2)c3csc(n3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J19 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 2074968 Maybridge2_000569 Cc1c(cnn1c2ccccc2)S(=O)(=O)N3CCCC3c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J20 compound treatment 0.0785 0.00571 0.68 0.6765 1.0 2074969 Maybridge2_000570 OC(CN1CCCN(CC1)c2nc(ns2)c3ccccc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J21 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2074970 Maybridge2_000571 FC(F)(F)c1ccccc1NC(=O)N2CCCC2c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J22 compound treatment 0.087 0.0142 1.68 1.6837 1.0 2074971 Maybridge2_000572 Clc1cccc(c1)N2CCN(CC2)C(=O)c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J23 mock treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 J24 mock treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K01 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074972 Maybridge2_000573 CN(C)c1ccc(cc1)C(=O)Nc2ccc(Oc3c(Cl)cccc3Cl)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K02 compound treatment 0.079 0.00621 0.74 0.7358 1.0 2074973 Maybridge2_000574 CC(C)c1ccc(/N=C(/SCc2c(C)c(C)c(C)c(C)c2C)\N3CCOCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K03 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2074974 Maybridge2_000575 Cc1nnsc1C(=O)N2CCC(O)(CC2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K04 compound treatment 0.0775 0.00471 0.56 0.5581 1.0 2074975 Maybridge2_000576 Clc1ccc(cc1)S(=O)(=O)/C(=C/NN2CCCCC2)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K05 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2074976 Maybridge2_000577 Cn1cnc2n(ncc2c1=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K06 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 1199768 Maybridge2_000578 Clc1ccc(NC(=O)OC2CN(C2)C(c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K07 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074977 Maybridge2_000579 Cc1cc(C)c2c(n1)sc3c(ncnc32)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K08 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 1679524 Maybridge2_000580 Clc1ccc(s1)S(=O)(=O)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K09 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074978 Maybridge2_000581 O=C(Nc1csc2ccccc12)N3CCSCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K10 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 1024901 Maybridge2_000582 Oc1ccc2ccccc2c1C(N3CCCCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K11 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074979 Maybridge2_000583 CN1CCN(CC(=O)N2CCc3ccccc23)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K12 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 1117813 Maybridge2_000584 Clc1ccc(cc1)c2nc3cc(CN4CCCCC4)ccc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K13 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074980 Maybridge2_000585 Nc1nc(ncc1C#N)N(Cc2ccccc2)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K14 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 2074981 Maybridge2_000586 Cc1cc(Br)ccc1NC(=O)CN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K15 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 1696248 Maybridge2_000587 C1CN(CCO1)c2ncnc3sc(cc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K16 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074982 Maybridge2_000588 Cc1nc(C)nc(n1)N(Cc2ccccc2)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K17 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074983 Maybridge2_000589 CCOC(=O)c1cc(sc1NC(=O)CN2CCCCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K18 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2074984 Maybridge2_000590 CN(Cc1ccccc1Cl)C(=O)c2cnccc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K19 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 2074985 Maybridge2_000591 Nc1c(sc2nsc(SCCN3CCCC3)c12)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K20 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 2074986 Maybridge2_000592 CN(Cc1c(C)cc(Cl)cc1Cl)C(=O)c2cnc(Oc3ccccc3)cc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K21 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 1684983 Maybridge2_000593 Fc1ccc2[nH]c3CCN(Cc4ccc(Cl)cc4Cl)Cc3c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K22 compound treatment 0.069 -0.00379 -0.45 -0.4491 -1.0 1305796 Maybridge2_000594 Cc1cc(C)c(OC2CN(C2)C(c3ccccc3)c4ccccc4)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K23 mock treatment 0.069 -0.00379 -0.45 -0.4491 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 K24 mock treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L01 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 1614244 Maybridge2_000595 C(N1CCN(CC1)c2cccc3[nH]ccc23)c4ccc5ccccc5c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L02 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074987 Maybridge2_000596 FC(F)(F)c1ccc(NC(=O)OC2CN3CCC2CC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L03 compound treatment 0.076 0.00321 0.38 0.3803 1.0 1550156 Maybridge2_000597 CC1C(N(C)C(CC1(O)c2ccc(F)cc2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L04 compound treatment 0.085 0.0122 1.45 1.4467 1.0 2074988 Maybridge2_000598 O=S(=O)(N1CCC(=CC1)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L05 compound treatment 0.0885 0.0157 1.86 1.8614 1.0 2074989 Maybridge2_000599 Oc1cc(nc(n1)N2CCCC2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L06 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2074990 Maybridge2_000600 O=C(N1CCC(=CC1)c2ccccc2)c3ccc(s3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L07 compound treatment 0.0925 0.0197 2.34 2.3354 1.0 2074991 Maybridge2_000601 CC(=C)Cc1c(C)nc(nc1O)N2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L08 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2074992 Maybridge2_000602 Cc1cc(c(o1)C(F)(F)F)S(=O)(=O)N2CCC(=CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L09 compound treatment 0.0755 0.00271 0.32 0.3211 1.0 2074993 Maybridge2_000603 C1CN=C(Nc2ccc(cc2)N3CCOCC3)S1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L10 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2074994 Maybridge2_000604 CN1CCN(CC1)S(=O)(=O)Cc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L11 compound treatment 0.081 0.00821 0.97 0.9728 1.0 1233213 Maybridge2_000605 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L12 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2074995 Maybridge2_000606 Fc1ccc(CN2CCCN(Cc3ccc(F)cc3)C2c4cccs4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L13 compound treatment 0.0815 0.00871 1.03 1.032 1.0 2074996 Maybridge2_000607 Cc1cccc(C)c1N2C(=O)CC(N3CCSCC3)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L14 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2074997 Maybridge2_000608 O=C(N1CCSCC1)c2cccc3OCCCOc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L15 compound treatment 0.084 0.0112 1.33 1.3282 1.0 2074998 Maybridge2_000609 CN(C)/C=C/1\C(=O)N(C(=O)\C1=N\c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L16 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2074999 Maybridge2_000610 O=S1(=O)CCN(Cc2cc3ccccc3s2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L17 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2075000 Maybridge2_000611 CC(=O)N1CCC(CC1)C(=O)Nc2cc(C)cc(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L18 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2075001 Maybridge2_000612 O=S(=O)(NCCN1CCCC1)c2cc3ccccc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L19 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2075002 Maybridge2_000613 O=S(=O)(N1CCCC1c2cccnc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L20 compound treatment 0.078 0.00521 0.62 0.6173 1.0 2075003 Maybridge2_000614 OC(CN1CCC(O)(CC1)c2ccc(Cl)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L21 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 2075004 Maybridge2_000615 Fc1ccccc1NC(=O)OC2CN3CCC2CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L22 compound treatment 0.0785 0.00571 0.68 0.6765 1.0 2075005 Maybridge2_000616 Clc1ccc(cc1)C(=O)C2CCN(CC2)C(=O)c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L23 mock treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 L24 mock treatment 0.075 0.00221 0.26 0.2618 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M01 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2075006 Maybridge2_000617 O=C(OCC1CCCN2CCCCC12)/C=C/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M02 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 1386650 Maybridge2_000618 Cc1c(CN2CCSCC2)c(=O)n(c3ccccc3)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M03 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2075007 Maybridge2_000619 OC1(CCN(CC1)C(=O)c2cc(F)cc3COCOc23)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M04 compound treatment 0.0775 0.00471 0.56 0.5581 1.0 2075008 Maybridge2_000620 CCOC(=O)c1sc(SC)c2C(=O)/C(=C/N(C)C)/CCc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M05 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 1333727 Maybridge2_000621 CCN(CC)c1ncnc2n(ncc12)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M06 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 1395190 Maybridge2_000622 Clc1cc(Cl)cc(NC(=O)OC2CN(C2)C(c3ccccc3)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M07 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2075009 Maybridge2_000623 O=c1[nH]cc(N2CCCCCC2)c(=O)[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M08 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 2075010 Maybridge2_000624 CN1CCN(CC1)c2cc(nc3ccc(F)cc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M09 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 2075011 Maybridge2_000625 Cc1cc(NC(=O)CN2CCCCC2)n(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M10 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 1150533 Maybridge2_000626 Oc1ccc2ccccc2c1C(N3CCCCC3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M11 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 2075012 Maybridge2_000627 O=C(CN1CCOCC1)N2CCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M12 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2075013 Maybridge2_000628 FC(F)(F)c1ccc(cc1)C2C3N4CCC(CC4)C3=NN2c5cc(Cl)ccc5Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M13 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 2075014 Maybridge2_000629 CCOC(=O)N1CCc2c(C#N)c(N)sc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M14 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 2075015 Maybridge2_000630 Cc1cc(Br)ccc1NC(=O)CN2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M15 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 1194772 Maybridge2_000631 Fc1ccc(Cn2cnc3sc(cc3c2=O)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M16 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2075016 Maybridge2_000632 Cc1nc(C)nc(n1)N(Cc2ccccc2Cl)Cc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M17 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2075017 Maybridge2_000633 CC(=O)c1sc2nsc(SCCN3CCCCC3)c2c1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M18 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2075018 Maybridge2_000634 COc1cc(c(cn1)C(=O)N(C)Cc2ccc(Cl)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M19 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 1488100 Maybridge2_000635 CN1CCN(CC1)c2ncnc3sc(cc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M20 compound treatment 0.0835 0.0107 1.27 1.269 1.0 2075019 Maybridge2_000636 CN(Cc1c(C)cc(Cl)cc1Cl)C(=O)c2cnc(Oc3ccc(Cl)cc3)cc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M21 compound treatment 0.069 -0.00379 -0.45 -0.4491 -1.0 1372843 Maybridge2_000637 CN(C)CCN1C(=O)c2ccccc2Sc3ccccc3S1(=O)=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M22 compound treatment 0.069 -0.00379 -0.45 -0.4491 -1.0 2075020 Maybridge2_000638 CN(C)/C=C/C(=O)c1sc(nc1C)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M23 mock treatment 0.07 -0.00279 -0.33 -0.3306 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 M24 mock treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N01 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 1578630 Maybridge2_000639 Clc1cccc(Cl)c1C(=O)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N02 compound treatment 0.0805 0.00771 0.91 0.9135 1.0 2075021 Maybridge2_000640 O=C(NCc1cc2ccccc2s1)c3ccccc3N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N03 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 1607897 Maybridge2_000641 CC1C(O)CC(N(C)C1c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N04 compound treatment 0.089 0.0162 1.92 1.9207 1.0 2075022 Maybridge2_000642 O=S(=O)(N1CCC(=CC1)c2ccccc2)c3ccc4ccccc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N05 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2075023 Maybridge2_000643 Oc1cc(nc(n1)N2CCSCC2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N06 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2075024 Maybridge2_000644 O=C(N1CCC(=CC1)c2ccccc2)c3cc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N07 compound treatment 0.0765 0.00371 0.44 0.4396 1.0 2075025 Maybridge2_000645 CN(C)C(=O)Oc1cc(C)nc(n1)c2ccc(C)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N08 compound treatment 0.086 0.0132 1.57 1.5652 1.0 2075026 Maybridge2_000646 O=S(=O)(N1CCC(=CC1)c2ccccc2)c3ccc4OCCOc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N09 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2075027 Maybridge2_000647 CC(C)(C)NC(=O)N1CCOCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N10 compound treatment 0.08 0.00721 0.85 0.8543 1.0 2075028 Maybridge2_000648 Clc1ccc(CS(=O)(=O)N2CCc3ccccc3C2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N11 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2075029 Maybridge2_000649 CN(C)c1ccc(/C=C\2/N=C(OC2=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N12 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2075030 Maybridge2_000650 Fc1ccc(CN2CCCN(Cc3ccc(F)cc3)C2c4csnn4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N13 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2075031 Maybridge2_000651 Cc1ccc(cc1)N2C(=O)C(C(C2=O)c3ccccc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N14 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2075032 Maybridge2_000652 Cc1onc(c1CN2CCS(=O)(=O)CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N15 compound treatment 0.075 0.00221 0.26 0.2618 1.0 1611256 Maybridge2_000653 O=C(N1CCOCC1)c2ccc3ncsc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N16 compound treatment 0.0825 0.00971 1.15 1.1505 1.0 2075033 Maybridge2_000654 O=S1(=O)CCN(Cc2ccc3OCCCOc3c2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N17 compound treatment 0.077 0.00421 0.5 0.4988 1.0 2075034 Maybridge2_000655 CCOc1ccc(NC(=O)C2CCN(CC2)C(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N18 compound treatment 0.084 0.0112 1.33 1.3282 1.0 2075035 Maybridge2_000656 CC1(C)CCc2cc(ccc2O1)S(=O)(=O)NCCN3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N19 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 2075036 Maybridge2_000657 Fc1ccc(cc1)S(=O)(=O)N2CCCC2c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N20 compound treatment 0.081 0.00821 0.97 0.9728 1.0 2075037 Maybridge2_000658 OC(CN1CCC(CC1)c2c[nH]c3ccccc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N21 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 2075038 Maybridge2_000659 Fc1ccc(NC(=O)OC2CN3CCC2CC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N22 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 1730920 Maybridge2_000660 COc1ccc(CN2CCCN(Cc3ccc(OC)cc3)C2c4ccc(F)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N23 mock treatment 0.0735 7.1E-4 0.08 0.0841 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 N24 mock treatment 0.0745 0.00171 0.2 0.2026 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O01 compound treatment 0.0685 -0.00429 -0.51 -0.5084 -1.0 2075039 Maybridge2_000661 O=C(OCC1CCCN2CCCCC12)c3cc4ccccc4oc3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O02 compound treatment 0.067 -0.00579 -0.69 -0.6861 -1.0 2075040 Maybridge2_000662 CCN/C=C(\C#N)/S(=O)(=O)c1ccc(Br)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O03 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 2075041 Maybridge2_000663 Cc1onc(c1C(=O)N2CCNCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O04 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2075042 Maybridge2_000664 CN(C)/C=C/C(=O)c1ccc(s1)c2cc(n(C)n2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O05 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 2075043 Maybridge2_000665 CCN(CC)CC(=O)Nc1cc(C)nn1c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O06 compound treatment 0.0675 -0.00529 -0.63 -0.6269 -1.0 1620788 Maybridge2_000666 Clc1ccc(SC2CN(C2)C(c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O07 compound treatment 0.074 0.00121 0.14 0.1433 1.0 1257903 Maybridge2_000667 Cc1ccc(cc1)S(=O)(=O)N2CCCCC2c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O08 compound treatment 0.079 0.00621 0.74 0.7358 1.0 2075044 Maybridge2_000668 CCN(CC)C(=O)c1ccc(s1)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O09 compound treatment 0.0685 -0.00429 -0.51 -0.5084 -1.0 2075045 Maybridge2_000669 Fc1ccc(cc1)C2C3CCc4ccccc4C3=NN2C(=O)CN5CCCCC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O10 compound treatment 0.0685 -0.00429 -0.51 -0.5084 -1.0 2075046 Maybridge2_000670 COc1cc2CCN3CC(=O)Nc4ccccc4C3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O11 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 2075047 Maybridge2_000671 CN1CCN(CC1)c2nnc(c3ccccc3)c(n2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O12 compound treatment 0.0685 -0.00429 -0.51 -0.5084 -1.0 1311955 Maybridge2_000672 O=C1N(C2CCN(Cc3ccccc3)CC2)C(=O)c4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O13 compound treatment 0.0685 -0.00429 -0.51 -0.5084 -1.0 2075048 Maybridge2_000673 Cc1sc(NC(=O)CN2CCOCC2)c(C#N)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O14 compound treatment 0.069 -0.00379 -0.45 -0.4491 -1.0 2075049 Maybridge2_000674 FC(F)(F)c1cc(NC(=O)CN2CCCC2)cc(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O15 compound treatment 0.0795 0.00671 0.8 0.795 1.0 2075050 Maybridge2_000675 O=C(Cn1cnc2sc(cc2c1=O)c3ccccc3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O16 compound treatment 0.0705 -0.00229 -0.27 -0.2714 -1.0 2075051 Maybridge2_000676 CN(C)C(=O)Oc1nc(cs1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O17 compound treatment 0.0715 -0.00129 -0.15 -0.1529 -1.0 2075052 Maybridge2_000677 Nc1c(sc2nsc(SCCN3CCCCC3)c12)C(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O18 compound treatment 0.07 -0.00279 -0.33 -0.3306 -1.0 2075053 Maybridge2_000678 CCOc1cc(c(cn1)C(=O)N(C)Cc2ccc(Cl)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O19 compound treatment 0.073 2.1E-4 0.02 0.0248 1.0 1249246 Maybridge2_000679 C=CCn1cnc2sc(cc2c1=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O20 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 2075054 Maybridge2_000680 COc1cccc(OC)c1CN(C)C(=O)c2cnc(SC)cc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O21 compound treatment 0.0695 -0.00329 -0.39 -0.3899 -1.0 1166834 Maybridge2_000681 C=CCN1Cc2ccc3ccccc3c2-c4c(C1)ccc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O22 compound treatment 0.07 -0.00279 -0.33 -0.3306 -1.0 1560070 Maybridge2_000682 C(N1CCN(CC1)c2cccc3[nH]ccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O23 mock treatment 0.073 2.1E-4 0.02 0.0248 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 O24 mock treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P01 compound treatment 0.067 -0.00579 -0.69 -0.6861 -1.0 1561821 Maybridge2_000683 Cc1cc(c(C)cc1Cl)S(=O)(=O)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P02 compound treatment 0.061 -0.0118 -1.4 -1.397 -1.0 2075055 Maybridge2_000684 O=C(NCc1cccs1)c2ccccc2N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P03 compound treatment 0.065 -0.00779 -0.92 -0.9231 -1.0 2075056 Maybridge2_000685 Fc1cccc(NC(=O)CN2CCCCC2)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P04 compound treatment 0.0615 -0.0113 -1.34 -1.3378 -1.0 2075057 Maybridge2_000686 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCC(=CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P05 compound treatment 0.069 -0.00379 -0.45 -0.4491 -1.0 2075058 Maybridge2_000687 CCN(CC)C(=O)Oc1cc(nc(n1)c2ccc(Cl)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P06 compound treatment 0.065 -0.00779 -0.92 -0.9231 -1.0 2075059 Maybridge2_000688 O=C(N1CCC(=CC1)c2ccccc2)c3ccc4occc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P07 compound treatment 0.071 -0.00179 -0.21 -0.2121 -1.0 2075060 Maybridge2_000689 CN(C)C(=O)Oc1nc(nc(C)c1CC(=C)C)c2ccc(C)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P08 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2075061 Maybridge2_000690 O=S(=O)(N1CCC(=CC1)c2ccccc2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P09 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 2075062 Maybridge2_000691 CC(=O)N1C(CSC1c2ccc(C)cc2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P10 compound treatment 0.0805 0.00771 0.91 0.9135 1.0 2075063 Maybridge2_000692 FC(F)(F)C1=NCCN(C=C1)S(=O)(=O)Cc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P11 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2071191 Maybridge2_000693 CN1C/C(=C\c2ccccc2Cl)/C(=O)\C(=C\c3ccccc3Cl)\C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P12 compound treatment 0.0825 0.00971 1.15 1.1505 1.0 2075064 Maybridge2_000694 CC1(C)Cc2cccc(C(=O)NC3CCN(Cc4ccccc4)CC3)c2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P13 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2075065 Maybridge2_000695 Cc1ccc(cc1)N2C(=O)C(C(C2=O)c3ccccc3)N4CCSCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P14 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2075066 Maybridge2_000696 Cc1cc(CN2CCS(=O)(=O)CC2)c(o1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P15 compound treatment 0.076 0.00321 0.38 0.3803 1.0 2075067 Maybridge2_000697 Fc1ccc(cc1)C(=O)N2CCN=C(C=C2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P16 compound treatment 0.0745 0.00171 0.2 0.2026 1.0 2075068 Maybridge2_000698 CN1CCN(CC1)c2ccc(CN3CCS(=O)(=O)CC3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P17 compound treatment 0.075 0.00221 0.26 0.2618 1.0 2075069 Maybridge2_000699 Fc1ccc(cc1)C2CCCN2S(=O)(=O)c3ccc(s3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P18 compound treatment 0.0735 7.1E-4 0.08 0.0841 1.0 2075070 Maybridge2_000700 Clc1ccc(cc1)S(=O)(=O)NCCN2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P19 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 2075071 Maybridge2_000701 Clc1ccc(cc1)S(=O)(=O)N2CCCC2c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P20 compound treatment 0.074 0.00121 0.14 0.1433 1.0 2075072 Maybridge2_000702 Cc1cc(N2CCN(CC(O)C(F)(F)F)CC2)c3ccccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P21 compound treatment 0.072 -7.9E-4 -0.09 -0.0936 -1.0 2075073 Maybridge2_000703 Clc1ccccc1NC(=O)OC2CN3CCC2CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P22 compound treatment 0.0725 -2.9E-4 -0.03 -0.0344 -1.0 1672764 Maybridge2_000704 COc1ccc(CN2CCCN(Cc3ccc(OC)cc3)C2c4cccc(C)n4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P23 mock treatment 0.0755 0.00271 0.32 0.3211 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1304 P24 mock treatment 0.0605 -0.0123 -1.46 -1.4563 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A01 compound treatment 0.0885 0.0136 1.61 1.6089 1.0 2125345 Peakdale2_000001 Cc1ccc(cc1)c2cnc(NCCC#N)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A02 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125346 Peakdale2_000002 Cn1cc(cn1)c2ccccc2NC(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A03 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125347 Peakdale2_000003 COCCNc1ncc(cn1)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A04 compound treatment 0.079 0.00408 0.48 0.4832 1.0 2125348 Peakdale2_000004 Fc1ccc(cc1)c2cnc(NCCC#N)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A05 compound treatment 0.0875 0.0126 1.49 1.4904 1.0 2125349 Peakdale2_000005 COc1ccc(cc1)c2cnc(NCc3ccncc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A06 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125350 Peakdale2_000006 Fc1ccc(cc1)c2cnc(nc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A07 compound treatment 0.0805 0.00558 0.66 0.661 1.0 2125351 Peakdale2_000007 COc1ccc(cc1)c2cnc(nc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A08 compound treatment 0.079 0.00408 0.48 0.4832 1.0 2125352 Peakdale2_000008 Fc1ccc(cc1)c2cnc(NCc3ccco3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A09 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125353 Peakdale2_000009 Cc1ccc(cc1)c2cnc(NCC=C)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A10 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125354 Peakdale2_000010 Clc1ccc(CNc2ncc(cn2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A11 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125355 Peakdale2_000011 OC1CCN(CC1)c2ncc(cn2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A12 compound treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 2125356 Peakdale2_000012 CCN(CC)c1cc(nc(C)n1)c2cncc(c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A13 compound treatment 0.07 -0.00492 -0.58 -0.5832 -1.0 2125357 Peakdale2_000013 Cc1ccc(cc1)c2cnc(nc2)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A14 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125358 Peakdale2_000014 Cc1nc(cc(n1)c2cncc(c2)c3ccccc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A15 compound treatment 0.0705 -0.00442 -0.52 -0.5239 -1.0 2125359 Peakdale2_000015 CC(Nc1ncc(cn1)c2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A16 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125360 Peakdale2_000016 CN(Cc1ccccc1)c2cc(nc(C)n2)c3cncc(c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A17 compound treatment 0.071 -0.00392 -0.46 -0.4647 -1.0 2125361 Peakdale2_000017 C1CCC(CC1)Nc2ncc(cn2)c3cc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A18 compound treatment 0.0815 0.00658 0.78 0.7794 1.0 2125362 Peakdale2_000018 CN1CCN(CC1)c2cc(nc(C)n2)c3cncc(c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A19 compound treatment 0.079 0.00408 0.48 0.4832 1.0 2125363 Peakdale2_000019 Cc1ccccc1C(=O)Nc2ccccc2c3cnn(C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A20 compound treatment 0.079 0.00408 0.48 0.4832 1.0 2125364 Peakdale2_000020 Cc1nc(NCc2ccccc2)cc(n1)c3cncc(c3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A21 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125365 Peakdale2_000021 Cn1cc(cn1)c2ccccc2NC(=O)Cc3cc(F)cc(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A22 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125366 Peakdale2_000022 CC(Nc1cc(nc(C)n1)c2cncc(c2)c3ccc(F)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A23 mock treatment 0.085 0.0101 1.19 1.1942 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 A24 mock treatment 0.078 0.00308 0.36 0.3647 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B01 compound treatment 0.0805 0.00558 0.66 0.661 1.0 2125367 Peakdale2_000023 Cc1nc(NC2CC2)cc(n1)c3cncc(c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B02 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125368 Peakdale2_000024 C1CN(CCO1)c2cc(nc(n2)c3ccccc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B03 compound treatment 0.0825 0.00758 0.9 0.8979 1.0 2125369 Peakdale2_000025 Cc1ccc(cc1)c2cnn(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B04 compound treatment 0.0825 0.00758 0.9 0.8979 1.0 2125370 Peakdale2_000026 CC(Nc1cc(nc(n1)c2ccccc2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B05 compound treatment 0.1035 0.0286 3.39 3.3862 1.0 2125371 Peakdale2_000027 C(c1ccccc1)n2cc(cn2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B06 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125372 Peakdale2_000028 Clc1ccc(CNc2cc(nc(n2)c3cccnc3)c4cccnc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B07 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125373 Peakdale2_000029 O=C(N1CCCC1)c2ccc(nc2)c3cnn(c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B08 compound treatment 0.085 0.0101 1.19 1.1942 1.0 2125374 Peakdale2_000030 Clc1ccc(CNc2cc(nc(n2)c3ccncc3)c4cccnc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B09 compound treatment 0.071 -0.00392 -0.46 -0.4647 -1.0 2123860 Peakdale2_000031 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B10 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125375 Peakdale2_000032 Cc1nc(NCC=C)cc(n1)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B11 compound treatment 0.069 -0.00592 -0.7 -0.7017 -1.0 2125376 Peakdale2_000033 Cc1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B12 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125377 Peakdale2_000034 Cc1nc(NC2CCCCC2)cc(n1)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B13 compound treatment 0.0705 -0.00442 -0.52 -0.5239 -1.0 2125378 Peakdale2_000035 Brc1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)N4CCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B14 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125379 Peakdale2_000036 CN1CCN(CC1)c2cc(nc(n2)c3ccccc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B15 compound treatment 0.069 -0.00592 -0.7 -0.7017 -1.0 2125380 Peakdale2_000037 OC1CCN(CC1)c2cc(nc(n2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B16 compound treatment 0.063 -0.0119 -1.41 -1.4126 -1.0 2125381 Peakdale2_000038 C=CCNc1cc(nc(n1)c2cccnc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B17 compound treatment 0.0685 -0.00642 -0.76 -0.7609 -1.0 2125382 Peakdale2_000039 CN1CCN(CC1)c2cc(nc(n2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B18 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2124445 Peakdale2_000040 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCN(Cc3cccc(Cl)n3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B19 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2124194 Peakdale2_000041 Cc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B20 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125383 Peakdale2_000042 Cc1nc(cc(n1)c2ccc(F)cc2)N3CCC4(CC3)OCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B21 compound treatment 0.0645 -0.0104 -1.23 -1.2349 -1.0 2125384 Peakdale2_000043 Cc1nc(NCc2ccccc2)cc(n1)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B22 compound treatment 0.0685 -0.00642 -0.76 -0.7609 -1.0 2125385 Peakdale2_000044 CN1CCN(CC1)c2cc(nc(C)n2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B23 mock treatment 0.0695 -0.00542 -0.64 -0.6424 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 B24 mock treatment 0.071 -0.00392 -0.46 -0.4647 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C01 compound treatment 0.0795 0.00458 0.54 0.5425 1.0 2125386 Peakdale2_000045 Clc1ccc(cc1)c2cnc(NCCC#N)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C02 compound treatment 0.082 0.00708 0.84 0.8387 1.0 2125387 Peakdale2_000046 CCNC(=O)Nc1ccccc1c2cnn(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C03 compound treatment 0.0855 0.0106 1.25 1.2534 1.0 2125388 Peakdale2_000047 COCCNc1ncc(cn1)c2cc3ccccc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C04 compound treatment 0.0895 0.0146 1.73 1.7274 1.0 2125389 Peakdale2_000048 Cc1cnc(CNc2ncc(cn2)c3ccc(F)cc3)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C05 compound treatment 0.091 0.0161 1.91 1.9051 1.0 2125390 Peakdale2_000049 C(Nc1ncc(cn1)c2cccs2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C06 compound treatment 0.085 0.0101 1.19 1.1942 1.0 2125391 Peakdale2_000050 Fc1ccc(cc1)c2cnc(nc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C07 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125392 Peakdale2_000051 Clc1ccc(cc1)c2cnc(nc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C08 compound treatment 0.08 0.00508 0.6 0.6017 1.0 2125393 Peakdale2_000052 C(Nc1ncc(cn1)c2ccccc2)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C09 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125394 Peakdale2_000053 COc1ccc(cc1)c2cnc(NCC=C)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C10 compound treatment 0.081 0.00608 0.72 0.7202 1.0 2125395 Peakdale2_000054 Fc1ccc(cc1)c2cnc(NC3CCCCC3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C11 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125396 Peakdale2_000055 Cc1ccc(cc1)c2cnc(NCc3ccccc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C12 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125397 Peakdale2_000056 CCN(CC)c1cc(nc(C)n1)c2cncc(c2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C13 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125398 Peakdale2_000057 COc1ccc(cc1)c2cnc(nc2)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C14 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125399 Peakdale2_000058 Cc1nc(cc(n1)c2cncc(c2)c3ccc(F)cc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C15 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125400 Peakdale2_000059 CC(Nc1ncc(cn1)c2cccs2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C16 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125401 Peakdale2_000060 CN(Cc1ccccc1)c2cc(nc(C)n2)c3cncc(c3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C17 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125402 Peakdale2_000061 Cc1ccc(cc1)c2cnc(NC3CC3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C18 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125403 Peakdale2_000062 CN1CCN(CC1)c2cc(nc(C)n2)c3cncc(c3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C19 compound treatment 0.081 0.00608 0.72 0.7202 1.0 2125404 Peakdale2_000063 Cn1cc(cn1)c2ccccc2NC(=O)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C20 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125405 Peakdale2_000064 Cc1ccc(cc1)c2cncc(c2)c3cc(NCc4ccco4)nc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C21 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125406 Peakdale2_000065 CC(C)CC(=O)Nc1ccccc1c2cnn(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C22 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125407 Peakdale2_000066 Cc1ccc(cc1)c2cncc(c2)c3cc(NCc4ccc(Cl)cc4)nc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C23 mock treatment 0.077 0.00208 0.25 0.2462 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 C24 mock treatment 0.08 0.00508 0.6 0.6017 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D01 compound treatment 0.0785 0.00358 0.42 0.424 1.0 2125408 Peakdale2_000067 Cc1nc(NC2CC2)cc(n1)c3cncc(c3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D02 compound treatment 0.0805 0.00558 0.66 0.661 1.0 2125409 Peakdale2_000068 C1CCN(CC1)c2cc(nc(n2)c3ccccc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D03 compound treatment 0.0935 0.0186 2.2 2.2013 1.0 2125410 Peakdale2_000069 Cc1ccc(cc1)c2cnn(CCO)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D04 compound treatment 0.0855 0.0106 1.25 1.2534 1.0 2125411 Peakdale2_000070 Clc1ccc(CNc2cc(nc(n2)c3ccccc3)c4cccnc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D05 compound treatment 0.0855 0.0106 1.25 1.2534 1.0 2123519 Peakdale2_000071 COc1cccc(OC)c1CN2CCC(CC2)N(C)C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D06 compound treatment 0.0825 0.00758 0.9 0.8979 1.0 2125412 Peakdale2_000072 C1CC1Nc2cc(nc(n2)c3cccnc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D07 compound treatment 0.08 0.00508 0.6 0.6017 1.0 2125413 Peakdale2_000073 O=C(NCc1ccccc1)c2ccc(nc2)c3cnn(c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D08 compound treatment 0.0785 0.00358 0.42 0.424 1.0 2125414 Peakdale2_000074 C1CC1Nc2cc(nc(n2)c3ccncc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D09 compound treatment 0.0785 0.00358 0.42 0.424 1.0 2125415 Peakdale2_000075 Clc1ccc(CNC(=O)c2ccc(nc2)c3cnn(c3)c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D10 compound treatment 0.0795 0.00458 0.54 0.5425 1.0 2125416 Peakdale2_000076 CN1CCN(CC1)c2cc(nc(C)n2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D11 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125417 Peakdale2_000077 Cc1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)N4CCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D12 compound treatment 0.0805 0.00558 0.66 0.661 1.0 2125418 Peakdale2_000078 Cc1nc(NC2CC2)cc(n1)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D13 compound treatment 0.0785 0.00358 0.42 0.424 1.0 2125419 Peakdale2_000079 CC(C)c1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)N4CCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D14 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125420 Peakdale2_000080 C(Nc1cc(nc(n1)c2ccccc2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D15 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125421 Peakdale2_000081 C(Nc1cc(nc(n1)c2cccnc2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D16 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125422 Peakdale2_000082 C(Nc1cc(nc(n1)c2cccnc2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D17 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125423 Peakdale2_000083 OC1CCN(CC1)c2cc(nc(n2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D18 compound treatment 0.0795 0.00458 0.54 0.5425 1.0 2125424 Peakdale2_000084 CC(Nc1cc(nc(n1)c2ccncc2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D19 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125425 Peakdale2_000085 Cc1nc(cc(n1)c2cccnc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D20 compound treatment 0.086 0.0111 1.31 1.3126 1.0 2125426 Peakdale2_000086 CCN(CC)c1cc(nc(C)n1)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D21 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125427 Peakdale2_000087 Cc1nc(NCc2ccco2)cc(n1)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D22 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125428 Peakdale2_000088 Cc1nc(cc(n1)c2ccc(F)cc2)N3CCC(O)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D23 mock treatment 0.079 0.00408 0.48 0.4832 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 D24 mock treatment 0.083 0.00808 0.96 0.9572 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E01 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125429 Peakdale2_000089 Cc1ccc(cc1)c2cnc(NCc3cnc(C)cn3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E02 compound treatment 0.082 0.00708 0.84 0.8387 1.0 2125430 Peakdale2_000090 Cc1nc(cc(n1)c2cncc(Br)c2)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E03 compound treatment 0.0835 0.00858 1.02 1.0164 1.0 2125431 Peakdale2_000091 Cc1ccc(cc1)c2cnc(nc2)N3CCC4(CC3)OCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E04 compound treatment 0.0895 0.0146 1.73 1.7274 1.0 2125432 Peakdale2_000092 Cc1cnc(CNc2ncc(cn2)c3ccccc3)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E05 compound treatment 0.0875 0.0126 1.49 1.4904 1.0 2125433 Peakdale2_000093 Cc1ccc(cc1)c2cnc(nc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E06 compound treatment 0.102 0.0271 3.21 3.2085 1.0 2125434 Peakdale2_000094 CN(Cc1ccccc1)c2ncc(cn2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E07 compound treatment 0.081 0.00608 0.72 0.7202 1.0 2125435 Peakdale2_000095 C1CCN(CC1)c2ncc(cn2)c3cc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E08 compound treatment 0.085 0.0101 1.19 1.1942 1.0 2125436 Peakdale2_000096 Fc1ccc(cc1)c2cnc(nc2)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E09 compound treatment 0.081 0.00608 0.72 0.7202 1.0 2125437 Peakdale2_000097 Clc1ccc(cc1)c2cnc(NCC=C)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E10 compound treatment 0.084 0.00908 1.08 1.0757 1.0 2125438 Peakdale2_000098 C1CCC(CC1)Nc2ncc(cn2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E11 compound treatment 0.0805 0.00558 0.66 0.661 1.0 2125439 Peakdale2_000099 COc1ccc(cc1)c2cnc(NCc3ccccc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E12 compound treatment 0.082 0.00708 0.84 0.8387 1.0 2125440 Peakdale2_000100 Cc1ccc(cc1)c2cncc(c2)c3cc(NCc4ccncc4)nc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E13 compound treatment 0.0795 0.00458 0.54 0.5425 1.0 2122582 Peakdale2_000101 COc1cccc(CCN2CCCC2)c1NC(=O)c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E14 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125441 Peakdale2_000102 Cc1ccc(cc1)c2cncc(c2)c3cc(nc(C)n3)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E15 compound treatment 0.0835 0.00858 1.02 1.0164 1.0 2125442 Peakdale2_000103 COc1ccc(cc1)c2cnc(NCc3ccc(Cl)cc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E16 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125443 Peakdale2_000104 Cc1ccc(cc1)c2cncc(c2)c3cc(NCC=C)nc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E17 compound treatment 0.091 0.0161 1.91 1.9051 1.0 2125444 Peakdale2_000105 COc1ccc(cc1)c2cnc(NC3CC3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E18 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125445 Peakdale2_000106 Cc1nc(cc(n1)c2cncc(c2)c3cccs3)N4CCC(O)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E19 compound treatment 0.08 0.00508 0.6 0.6017 1.0 2125446 Peakdale2_000107 Cn1cc(cn1)c2ccccc2NC(=O)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E20 compound treatment 0.0775 0.00258 0.31 0.3055 1.0 2125447 Peakdale2_000108 Cc1nc(NCc2ccco2)cc(n1)c3cncc(c3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E21 compound treatment 0.0785 0.00358 0.42 0.424 1.0 2125448 Peakdale2_000109 Cn1cc(cn1)c2ccccc2NC(=O)Cc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E22 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125449 Peakdale2_000110 Cc1nc(NCc2ccc(Cl)cc2)cc(n1)c3cncc(c3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E23 mock treatment 0.0775 0.00258 0.31 0.3055 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 E24 mock treatment 0.077 0.00208 0.25 0.2462 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F01 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125450 Peakdale2_000111 Cc1cc(C)cc(NC(=O)N2CCNC(=O)CC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F02 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125451 Peakdale2_000112 CN(Cc1ccccc1)c2cc(nc(n2)c3ccccc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F03 compound treatment 0.0785 0.00358 0.42 0.424 1.0 2125452 Peakdale2_000113 C(c1ccccc1)n2cc(cn2)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F04 compound treatment 0.0815 0.00658 0.78 0.7794 1.0 2125453 Peakdale2_000114 C1CC1Nc2cc(nc(n2)c3ccccc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F05 compound treatment 0.086 0.0111 1.31 1.3126 1.0 2125454 Peakdale2_000115 CN(Cc1ccccc1)C(=O)c2ccc(nc2)c3cnn(C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F06 compound treatment 0.082 0.00708 0.84 0.8387 1.0 2125455 Peakdale2_000116 CCN(CC)c1cc(nc(n1)c2ccncc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F07 compound treatment 0.0785 0.00358 0.42 0.424 1.0 2125456 Peakdale2_000117 Clc1ccc(CNC(=O)c2ccc(nc2)c3cnn(c3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F08 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125457 Peakdale2_000118 Cc1nc(NCCC#N)cc(n1)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F09 compound treatment 0.089 0.0141 1.67 1.6681 1.0 2125458 Peakdale2_000119 Clc1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)NC4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F10 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125459 Peakdale2_000120 Cc1nc(NCc2ccccc2)cc(n1)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F11 compound treatment 0.093 0.0181 2.14 2.1421 1.0 2125460 Peakdale2_000121 Cc1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F12 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125461 Peakdale2_000122 Cc1nc(NCCc2c[nH]c3ccccc23)cc(n1)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F13 compound treatment 0.0835 0.00858 1.02 1.0164 1.0 2125462 Peakdale2_000123 CCN(CC)c1cc(nc(n1)c2cccnc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F14 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125463 Peakdale2_000124 CC(Nc1cc(nc(n1)c2ccccc2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F15 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125464 Peakdale2_000125 C1CC1Nc2cc(nc(n2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F16 compound treatment 0.079 0.00408 0.48 0.4832 1.0 2125465 Peakdale2_000126 CC(Nc1cc(nc(n1)c2cccnc2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F17 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125466 Peakdale2_000127 C(Nc1cc(nc(n1)c2ccncc2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F18 compound treatment 0.0785 0.00358 0.42 0.424 1.0 2125467 Peakdale2_000128 Clc1ccc(CNc2cc(nc(n2)c3ccncc3)c4ccncc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F19 compound treatment 0.086 0.0111 1.31 1.3126 1.0 2125468 Peakdale2_000129 Cc1nc(cc(n1)c2cccnc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F20 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125469 Peakdale2_000130 Cc1nc(NCc2ccncc2)cc(n1)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F21 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125470 Peakdale2_000131 Cc1nc(cc(n1)c2cccnc2)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F22 compound treatment 0.084 0.00908 1.08 1.0757 1.0 2125471 Peakdale2_000132 Cc1nc(NCc2ccccc2)cc(n1)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F23 mock treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 F24 mock treatment 0.076 0.00108 0.13 0.1277 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G01 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125472 Peakdale2_000133 Cc1cnc(CNc2ncc(cn2)c3ccc(Cl)cc3)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G02 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125473 Peakdale2_000134 CC(Nc1cc(nc(C)n1)c2cncc(Br)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G03 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125474 Peakdale2_000135 Clc1ccc(cc1)c2cnc(nc2)N3CCC4(CC3)OCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G04 compound treatment 0.0775 0.00258 0.31 0.3055 1.0 2125475 Peakdale2_000136 COCCNc1ncc(cn1)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G05 compound treatment 0.08 0.00508 0.6 0.6017 1.0 2125476 Peakdale2_000137 COc1ccc(cc1)c2cnc(nc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G06 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125477 Peakdale2_000138 OCCCNc1ncc(cn1)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G07 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125478 Peakdale2_000139 CN(Cc1ccccc1)c2ncc(cn2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G08 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125479 Peakdale2_000140 Fc1ccc(cc1)c2cnc(NCCc3ccccc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G09 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125480 Peakdale2_000141 C=CCNc1ncc(cn1)c2cc3ccccc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G10 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125481 Peakdale2_000142 Fc1ccc(cc1)c2cnc(NC3CC3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G11 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125482 Peakdale2_000143 Clc1ccc(cc1)c2cnc(NCc3ccccc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G12 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125483 Peakdale2_000144 Cc1nc(NCc2ccncc2)cc(n1)c3cncc(c3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G13 compound treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 2125484 Peakdale2_000145 Cc1ccc(cc1)c2cnc(NCCc3ccccc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G14 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2123560 Peakdale2_000146 CC(=O)N1CCc2ccc(cc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G15 compound treatment 0.07 -0.00492 -0.58 -0.5832 -1.0 2125485 Peakdale2_000147 Clc1ccc(CNc2ncc(cn2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G16 compound treatment 0.071 -0.00392 -0.46 -0.4647 -1.0 2125486 Peakdale2_000148 Cc1nc(NCC=C)cc(n1)c2cncc(c2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G17 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125487 Peakdale2_000149 FC(F)(F)Oc1ccc(cc1)c2cnc(NC3CC3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G18 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125488 Peakdale2_000150 Cc1nc(cc(n1)c2cncc(c2)c3ccccc3)N4CCC(O)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G19 compound treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 2125489 Peakdale2_000151 Cn1cc(cn1)c2ccccc2NC(=O)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G20 compound treatment 0.0705 -0.00442 -0.52 -0.5239 -1.0 2125490 Peakdale2_000152 Cc1nc(NCc2ccco2)cc(n1)c3cncc(c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G21 compound treatment 0.0715 -0.00342 -0.41 -0.4055 -1.0 2125491 Peakdale2_000153 Cn1cc(cn1)c2ccccc2NC(=O)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G22 compound treatment 0.0705 -0.00442 -0.52 -0.5239 -1.0 2125492 Peakdale2_000154 Cc1nc(NCc2ccc(Cl)cc2)cc(n1)c3cncc(c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G23 mock treatment 0.0695 -0.00542 -0.64 -0.6424 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 G24 mock treatment 0.068 -0.00692 -0.82 -0.8202 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H01 compound treatment 0.0835 0.00858 1.02 1.0164 1.0 2125493 Peakdale2_000155 Cn1cc(cn1)c2cnc3ccccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H02 compound treatment 0.0775 0.00258 0.31 0.3055 1.0 2125494 Peakdale2_000156 C=CCNc1cc(nc(n1)c2ccccc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H03 compound treatment 0.08 0.00508 0.6 0.6017 1.0 2125495 Peakdale2_000157 Cn1cc(cn1)c2ccncn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H04 compound treatment 0.0825 0.00758 0.9 0.8979 1.0 2125496 Peakdale2_000158 CCN(CC)c1cc(nc(n1)c2cccnc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H05 compound treatment 0.085 0.0101 1.19 1.1942 1.0 2125497 Peakdale2_000159 Cn1cc(cn1)c2ccc(cn2)C(=O)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H06 compound treatment 0.084 0.00908 1.08 1.0757 1.0 2125498 Peakdale2_000160 C1CCN(CC1)c2cc(nc(n2)c3ccncc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H07 compound treatment 0.08 0.00508 0.6 0.6017 1.0 2125499 Peakdale2_000161 O=C(NC1CC1)c2ccc(nc2)c3cnn(c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H08 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125500 Peakdale2_000162 COCCNc1cc(nc(C)n1)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H09 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125501 Peakdale2_000163 CN(Cc1ccccc1)C(=O)c2ccc(nc2)c3cnn(c3)c4ccc(F)cc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H10 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125502 Peakdale2_000164 Cc1nc(NCc2ccco2)cc(n1)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H11 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125503 Peakdale2_000165 Cc1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)NCc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H12 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125504 Peakdale2_000166 CCN(CC)c1cc(nc(n1)c2ccccc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H13 compound treatment 0.0805 0.00558 0.66 0.661 1.0 2125505 Peakdale2_000167 C1CN(CCO1)c2cc(nc(n2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H14 compound treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 2125506 Peakdale2_000168 Clc1ccc(CNc2cc(nc(n2)c3ccccc3)c4ccncc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H15 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125507 Peakdale2_000169 CCN(CC)c1cc(nc(n1)c2ccncc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H16 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125508 Peakdale2_000170 C1CC1Nc2cc(nc(n2)c3cccnc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H17 compound treatment 0.081 0.00608 0.72 0.7202 1.0 2125509 Peakdale2_000171 CC(Nc1cc(nc(n1)c2ccncc2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H18 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125510 Peakdale2_000172 C1CC1Nc2cc(nc(n2)c3ccncc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H19 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125511 Peakdale2_000173 CN(Cc1ccccc1)c2cc(nc(C)n2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H20 compound treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 2125512 Peakdale2_000174 Cc1nc(cc(n1)c2ccc(F)cc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H21 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125513 Peakdale2_000175 Cc1nc(NCCc2ccccc2)cc(n1)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H22 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125514 Peakdale2_000176 Cc1nc(NCc2ccco2)cc(n1)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H23 mock treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 H24 mock treatment 0.076 0.00108 0.13 0.1277 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I01 compound treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 2125515 Peakdale2_000177 Cc1cnc(CNc2ncc(cn2)c3cccs3)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I02 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125516 Peakdale2_000178 Cc1nc(NCc2ccc(Cl)cc2)cc(n1)c3cncc(Br)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I03 compound treatment 0.0805 0.00558 0.66 0.661 1.0 2125517 Peakdale2_000179 C1COC2(CCN(CC2)c3ncc(cn3)c4cccs4)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I04 compound treatment 0.0845 0.00958 1.13 1.1349 1.0 2125518 Peakdale2_000180 Fc1ccc(cc1)c2cnc(nc2)N3CCC4(CC3)OCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I05 compound treatment 0.089 0.0141 1.67 1.6681 1.0 2125519 Peakdale2_000181 Clc1ccc(cc1)c2cnc(nc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I06 compound treatment 0.082 0.00708 0.84 0.8387 1.0 2125520 Peakdale2_000182 Fc1ccc(cc1)c2cnc(NCC=C)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I07 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125521 Peakdale2_000183 CN(Cc1ccccc1)c2ncc(cn2)c3cc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I08 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125522 Peakdale2_000184 C(Cc1ccccc1)Nc2ncc(cn2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I09 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125523 Peakdale2_000185 CN1CCN(CC1)c2ncc(cn2)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I10 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125524 Peakdale2_000186 C1CC1Nc2ncc(cn2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I11 compound treatment 0.0715 -0.00342 -0.41 -0.4055 -1.0 2125525 Peakdale2_000187 Cc1ccc(cc1)c2cnc(NCc3ccco3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I12 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125526 Peakdale2_000188 Cc1nc(NCc2ccncc2)cc(n1)c3cncc(c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I13 compound treatment 0.062 -0.0129 -1.53 -1.5311 -1.0 2125527 Peakdale2_000189 C(Cc1ccccc1)Nc2ncc(cn2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I14 compound treatment 0.0845 0.00958 1.13 1.1349 1.0 2125528 Peakdale2_000190 Cc1nc(cc(n1)c2cncc(c2)c3ccccc3)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I15 compound treatment 0.0715 -0.00342 -0.41 -0.4055 -1.0 2125529 Peakdale2_000191 Clc1ccc(CNc2ncc(cn2)c3cccs3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I16 compound treatment 0.071 -0.00392 -0.46 -0.4647 -1.0 2125530 Peakdale2_000192 Cc1nc(NCC=C)cc(n1)c2cncc(c2)c3cc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I17 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125531 Peakdale2_000193 Clc1ccc(cc1)c2cnc(NC3CC3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I18 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125532 Peakdale2_000194 Cc1nc(cc(n1)c2cncc(c2)c3ccc(F)cc3)N4CCC(O)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I19 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125533 Peakdale2_000195 Cn1cc(cn1)c2ccccc2NC(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I20 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125534 Peakdale2_000196 Cc1nc(NCc2ccco2)cc(n1)c3cncc(c3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I21 compound treatment 0.0715 -0.00342 -0.41 -0.4055 -1.0 2125535 Peakdale2_000197 Cn1cc(cn1)c2ccccc2NC(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I22 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125536 Peakdale2_000198 Cc1nc(NCc2ccc(Cl)cc2)cc(n1)c3cncc(c3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I23 mock treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 I24 mock treatment 0.075 7.81E-5 0.01 0.0093 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J01 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125537 Peakdale2_000199 Cn1cc(cn1)c2ccnc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J02 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125538 Peakdale2_000200 CN1CCN(CC1)c2cc(nc(n2)c3ccccc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J03 compound treatment 0.0805 0.00558 0.66 0.661 1.0 2125539 Peakdale2_000201 OCCn1cc(cn1)c2ccncn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J04 compound treatment 0.0845 0.00958 1.13 1.1349 1.0 2125540 Peakdale2_000202 C1CCN(CC1)c2cc(nc(n2)c3cccnc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J05 compound treatment 0.085 0.0101 1.19 1.1942 1.0 2123428 Peakdale2_000203 O=C(NCCc1ccccc1)c2ccc(CCN3CCCC3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J06 compound treatment 0.0835 0.00858 1.02 1.0164 1.0 2125541 Peakdale2_000204 CN(Cc1ccccc1)c2cc(nc(n2)c3ccncc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J07 compound treatment 0.0775 0.00258 0.31 0.3055 1.0 2123503 Peakdale2_000205 CCCN1CCC(CC1)N(C(=O)CC)c2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J08 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125542 Peakdale2_000206 CCN(CC)c1cc(nc(C)n1)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J09 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125543 Peakdale2_000207 Fc1ccc(c(F)c1)n2cc(cn2)c3ccc(cn3)C(=O)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J10 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125544 Peakdale2_000208 Cc1nc(cc(n1)c2ccncc2)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J11 compound treatment 0.0715 -0.00342 -0.41 -0.4055 -1.0 2125545 Peakdale2_000209 Cc1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)NC4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J12 compound treatment 0.0705 -0.00442 -0.52 -0.5239 -1.0 2125546 Peakdale2_000210 C1CN(CCO1)c2cc(nc(n2)c3ccccc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J13 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125547 Peakdale2_000211 C1CCN(CC1)c2cc(nc(n2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J14 compound treatment 0.07 -0.00492 -0.58 -0.5832 -1.0 2125548 Peakdale2_000212 C1CC1Nc2cc(nc(n2)c3ccccc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J15 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125549 Peakdale2_000213 C1CN(CCO1)c2cc(nc(n2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J16 compound treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 2125550 Peakdale2_000214 CCN(CC)c1cc(nc(n1)c2ccncc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J17 compound treatment 0.0835 0.00858 1.02 1.0164 1.0 2125551 Peakdale2_000215 C1CC1Nc2cc(nc(n2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J18 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125552 Peakdale2_000216 CN(C)CCNc1cc(nc(C)n1)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J19 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125553 Peakdale2_000217 Cc1nc(NCCCO)cc(n1)c2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J20 compound treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 2125554 Peakdale2_000218 Cc1nc(cc(n1)c2ccc(F)cc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J21 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125555 Peakdale2_000219 CC(Nc1cc(nc(C)n1)c2cccnc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J22 compound treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 2125556 Peakdale2_000220 Cc1nc(cc(n1)c2ccc(F)cc2)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J23 mock treatment 0.0695 -0.00542 -0.64 -0.6424 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 J24 mock treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K01 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125557 Peakdale2_000221 Cc1cnc(CNc2ncc(cn2)c3cc4ccccc4s3)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K02 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125558 Peakdale2_000222 Cc1nc(NC2CCCCC2)cc(n1)c3cncc(Br)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K03 compound treatment 0.0775 0.00258 0.31 0.3055 1.0 2125559 Peakdale2_000223 CCN(CC)c1ncc(cn1)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K04 compound treatment 0.0795 0.00458 0.54 0.5425 1.0 2125560 Peakdale2_000224 CCN(CC)c1ncc(cn1)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K05 compound treatment 0.0845 0.00958 1.13 1.1349 1.0 2125561 Peakdale2_000225 C1CN(CCO1)c2ncc(cn2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K06 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125562 Peakdale2_000226 CN1CCN(CC1)c2ncc(cn2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K07 compound treatment 0.086 0.0111 1.31 1.3126 1.0 2125563 Peakdale2_000227 OCCCNc1ncc(cn1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K08 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125564 Peakdale2_000228 Fc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K09 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125565 Peakdale2_000229 Cc1ccc(cc1)c2cnc(nc2)N3CCC(O)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K10 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125566 Peakdale2_000230 Fc1ccc(cc1)c2cnc(NCCc3c[nH]c4ccccc34)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K11 compound treatment 0.0785 0.00358 0.42 0.424 1.0 2125567 Peakdale2_000231 COc1ccc(cc1)c2cnc(NCc3ccco3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K12 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125568 Peakdale2_000232 Cc1nc(NCc2ccncc2)cc(n1)c3cncc(c3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K13 compound treatment 0.0715 -0.00342 -0.41 -0.4055 -1.0 2125569 Peakdale2_000233 C(Cc1ccccc1)Nc2ncc(cn2)c3cc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K14 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125570 Peakdale2_000234 Cc1nc(cc(n1)c2cncc(c2)c3ccc(F)cc3)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K15 compound treatment 0.08 0.00508 0.6 0.6017 1.0 2125571 Peakdale2_000235 Cc1ccc(cc1)c2cnc(NC3CCCCC3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K16 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125572 Peakdale2_000236 Cc1nc(NCC=C)cc(n1)c2cncc(c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K17 compound treatment 0.083 0.00808 0.96 0.9572 1.0 2122941 Peakdale2_000237 O=C(NCCN1CCOCC1)c2ccc3cc[nH]c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K18 compound treatment 0.0795 0.00458 0.54 0.5425 1.0 2125573 Peakdale2_000238 Cc1ccc(cc1)c2cncc(c2)c3cc(NCc4ccccc4)nc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K19 compound treatment 0.07 -0.00492 -0.58 -0.5832 -1.0 2125574 Peakdale2_000239 CC(=O)Nc1ccccc1c2cnn(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K20 compound treatment 0.068 -0.00692 -0.82 -0.8202 -1.0 2125575 Peakdale2_000240 CC(Nc1cc(nc(C)n1)c2cncc(c2)c3ccc(C)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K21 compound treatment 0.069 -0.00592 -0.7 -0.7017 -1.0 2125576 Peakdale2_000241 Cn1cc(cn1)c2ccccc2NC(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K22 compound treatment 0.07 -0.00492 -0.58 -0.5832 -1.0 2125577 Peakdale2_000242 Cc1ccc(cc1)c2cncc(c2)c3cc(NC4CC4)nc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K23 mock treatment 0.0705 -0.00442 -0.52 -0.5239 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 K24 mock treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L01 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125578 Peakdale2_000243 OCCn1cc(cn1)c2ccnc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L02 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125579 Peakdale2_000244 OC1CCN(CC1)c2cc(nc(n2)c3ccccc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L03 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125580 Peakdale2_000245 Clc1ccc(cc1)c2cnn(Cc3ccccc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L04 compound treatment 0.086 0.0111 1.31 1.3126 1.0 2125581 Peakdale2_000246 CN(Cc1ccccc1)c2cc(nc(n2)c3cccnc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L05 compound treatment 0.094 0.0191 2.26 2.2606 1.0 2125582 Peakdale2_000247 Cn1cc(cn1)c2ccc(cn2)C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L06 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125583 Peakdale2_000248 C=CCNc1cc(nc(n1)c2ccncc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L07 compound treatment 0.0825 0.00758 0.9 0.8979 1.0 2125584 Peakdale2_000249 CN(Cc1ccccc1)C(=O)c2ccc(nc2)c3cnn(c3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L08 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125585 Peakdale2_000250 Cc1nc(cc(n1)c2ccncc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L09 compound treatment 0.087 0.0121 1.43 1.4311 1.0 2125586 Peakdale2_000251 Fc1ccc(c(F)c1)n2cc(cn2)c3ccc(cn3)C(=O)N4CCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L10 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125587 Peakdale2_000252 Cc1nc(NCCc2ccccc2)cc(n1)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L11 compound treatment 0.0845 0.00958 1.13 1.1349 1.0 2125588 Peakdale2_000253 CN(Cc1ccccc1)C(=O)c2ccc(nc2)c3cnn(c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L12 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125589 Peakdale2_000254 C1CCN(CC1)c2cc(nc(n2)c3ccccc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L13 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125590 Peakdale2_000255 CN(Cc1ccccc1)c2cc(nc(n2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L14 compound treatment 0.0715 -0.00342 -0.41 -0.4055 -1.0 2125591 Peakdale2_000256 CCN(CC)c1cc(nc(n1)c2cccnc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L15 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125592 Peakdale2_000257 C1CCN(CC1)c2cc(nc(n2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L16 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125593 Peakdale2_000258 C1CCN(CC1)c2cc(nc(n2)c3ccncc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L17 compound treatment 0.084 0.00908 1.08 1.0757 1.0 2125594 Peakdale2_000259 CN(C)CCNc1cc(nc(C)n1)c2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L18 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125595 Peakdale2_000260 Cc1nc(NCCC#N)cc(n1)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L19 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125596 Peakdale2_000261 Cc1nc(NCC=C)cc(n1)c2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L20 compound treatment 0.0705 -0.00442 -0.52 -0.5239 -1.0 2125597 Peakdale2_000262 CN(Cc1ccccc1)c2cc(nc(C)n2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L21 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125598 Peakdale2_000263 Cc1nc(NC2CCCCC2)cc(n1)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L22 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125599 Peakdale2_000264 Cc1nc(NCCc2ccccc2)cc(n1)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L23 mock treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 L24 mock treatment 0.079 0.00408 0.48 0.4832 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M01 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125600 Peakdale2_000265 COCCNc1ncc(cn1)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M02 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125601 Peakdale2_000266 Cc1nc(NCCc2c[nH]c3ccccc23)cc(n1)c4cncc(Br)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M03 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125602 Peakdale2_000267 CCN(CC)c1ncc(cn1)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M04 compound treatment 0.0805 0.00558 0.66 0.661 1.0 2125603 Peakdale2_000268 Fc1ccc(cc1)c2cnc(NCc3ccncc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M05 compound treatment 0.0795 0.00458 0.54 0.5425 1.0 2125604 Peakdale2_000269 C1CN(CCO1)c2ncc(cn2)c3cc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M06 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125605 Peakdale2_000270 Fc1ccc(cc1)c2cnc(NCc3ccccc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M07 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125606 Peakdale2_000271 OCCCNc1ncc(cn1)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M08 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125607 Peakdale2_000272 C1CN(CCN1c2ccccn2)c3ncc(cn3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M09 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125608 Peakdale2_000273 COc1ccc(cc1)c2cnc(nc2)N3CCC(O)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M10 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125609 Peakdale2_000274 CCN(CC)c1cc(nc(C)n1)c2cncc(c2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M11 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125610 Peakdale2_000275 Clc1ccc(cc1)c2cnc(NCc3ccco3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M12 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125611 Peakdale2_000276 Cc1ccc(cc1)c2cncc(c2)c3cc(nc(C)n3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M13 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125612 Peakdale2_000277 Cc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M14 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125613 Peakdale2_000278 CN(Cc1ccccc1)c2cc(nc(C)n2)c3cncc(c3)c4ccc(C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M15 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125614 Peakdale2_000279 Clc1ccc(cc1)c2cnc(NC3CCCCC3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M16 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125615 Peakdale2_000280 CN1CCN(CC1)c2cc(nc(C)n2)c3cncc(c3)c4ccc(C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M17 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125616 Peakdale2_000281 Clc1ccc(cc1)c2cnc(NCCc3c[nH]c4ccccc34)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M18 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125617 Peakdale2_000282 Cc1nc(NCc2ccccc2)cc(n1)c3cncc(c3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M19 compound treatment 0.07 -0.00492 -0.58 -0.5832 -1.0 2125618 Peakdale2_000283 Cn1cc(cn1)c2ccccc2NC(=O)/C=C/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M20 compound treatment 0.071 -0.00392 -0.46 -0.4647 -1.0 2125619 Peakdale2_000284 CC(Nc1cc(nc(C)n1)c2cncc(c2)c3cccs3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M21 compound treatment 0.069 -0.00592 -0.7 -0.7017 -1.0 2125620 Peakdale2_000285 Cn1cc(cn1)c2ccccc2NC(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M22 compound treatment 0.073 -0.00192 -0.23 -0.2277 -1.0 2125621 Peakdale2_000286 COc1ccc(cc1)c2cncc(c2)c3cc(NC4CC4)nc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M23 mock treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 M24 mock treatment 0.075 7.81E-5 0.01 0.0093 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N01 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125622 Peakdale2_000287 Cn1cc(cn1)c2cnccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N02 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125623 Peakdale2_000288 C(Nc1cc(nc(n1)c2ccccc2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N03 compound treatment 0.079 0.00408 0.48 0.4832 1.0 2125624 Peakdale2_000289 Cn1cc(cn1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N04 compound treatment 0.08 0.00508 0.6 0.6017 1.0 2125625 Peakdale2_000290 C=CCNc1cc(nc(n1)c2cccnc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N05 compound treatment 0.079 0.00408 0.48 0.4832 1.0 2125626 Peakdale2_000291 Cn1cc(cn1)c2ccc(cn2)C(=O)NCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N06 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125627 Peakdale2_000292 C(Nc1cc(nc(n1)c2ccncc2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N07 compound treatment 0.0785 0.00358 0.42 0.424 1.0 2125628 Peakdale2_000293 Clc1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N08 compound treatment 0.076 0.00108 0.13 0.1277 1.0 2125629 Peakdale2_000294 Cc1nc(cc(n1)c2ccncc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N09 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125630 Peakdale2_000295 Fc1ccc(c(F)c1)n2cc(cn2)c3ccc(cn3)C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N10 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125631 Peakdale2_000296 CC(Nc1cc(nc(C)n1)c2ccncc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N11 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2124205 Peakdale2_000297 CCN1Cc2ccccc2-n3cccc3C1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N12 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125632 Peakdale2_000298 CN(Cc1ccccc1)c2cc(nc(n2)c3ccccc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N13 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125633 Peakdale2_000299 C=CCNc1cc(nc(n1)c2cccnc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N14 compound treatment 0.083 0.00808 0.96 0.9572 1.0 2125634 Peakdale2_000300 C1CCN(CC1)c2cc(nc(n2)c3cccnc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N15 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125635 Peakdale2_000301 CN(Cc1ccccc1)c2cc(nc(n2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N16 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125636 Peakdale2_000302 CN(Cc1ccccc1)c2cc(nc(n2)c3ccncc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N17 compound treatment 0.0775 0.00258 0.31 0.3055 1.0 2125637 Peakdale2_000303 COCCNc1cc(nc(C)n1)c2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N18 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125638 Peakdale2_000304 Cc1cnc(CNc2cc(nc(C)n2)c3ccc(F)cc3)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N19 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125639 Peakdale2_000305 CN1CCN(CC1)c2cc(nc(C)n2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N20 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125640 Peakdale2_000306 Cc1nc(NCCCO)cc(n1)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N21 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125641 Peakdale2_000307 Cc1nc(NC2CC2)cc(n1)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N22 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125642 Peakdale2_000308 Cc1nc(cc(n1)c2ccc(F)cc2)N3CCN(CC3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N23 mock treatment 0.076 0.00108 0.13 0.1277 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 N24 mock treatment 0.078 0.00308 0.36 0.3647 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O01 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125643 Peakdale2_000309 COCCNc1ncc(cn1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O02 compound treatment 0.0705 -0.00442 -0.52 -0.5239 -1.0 2123203 Peakdale2_000310 CN1CCN(CC1)C2c3cccn3-c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O03 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125644 Peakdale2_000311 Cc1ccc(cc1)c2cnc(NCc3ccncc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O04 compound treatment 0.0965 0.0216 2.56 2.5568 1.0 2125645 Peakdale2_000312 C(Nc1ncc(cn1)c2ccccc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O05 compound treatment 0.08 0.00508 0.6 0.6017 1.0 2125646 Peakdale2_000313 Cc1ccc(cc1)c2cnc(nc2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O06 compound treatment 0.08 0.00508 0.6 0.6017 1.0 2125647 Peakdale2_000314 C(Nc1ncc(cn1)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O07 compound treatment 0.0775 0.00258 0.31 0.3055 1.0 2125648 Peakdale2_000315 OCCCNc1ncc(cn1)c2cc3ccccc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O08 compound treatment 0.085 0.0101 1.19 1.1942 1.0 2125649 Peakdale2_000316 Fc1ccc(cc1)c2cnc(NCc3ccc(Cl)cc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O09 compound treatment 0.0825 0.00758 0.9 0.8979 1.0 2125650 Peakdale2_000317 OC1CCN(CC1)c2ncc(cn2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O10 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125651 Peakdale2_000318 CCN(CC)c1cc(nc(C)n1)c2cncc(c2)c3cc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O11 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125652 Peakdale2_000319 C(Nc1ncc(cn1)c2cccs2)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O12 compound treatment 0.0755 5.78E-4 0.07 0.0685 1.0 2125653 Peakdale2_000320 Cc1nc(cc(n1)c2cncc(c2)c3cccs3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O13 compound treatment 0.0815 0.00658 0.78 0.7794 1.0 2125654 Peakdale2_000321 CC(Nc1ncc(cn1)c2ccc(C)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O14 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125655 Peakdale2_000322 CN(Cc1ccccc1)c2cc(nc(C)n2)c3cncc(c3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O15 compound treatment 0.0765 0.00158 0.19 0.187 1.0 2125656 Peakdale2_000323 C1CCC(CC1)Nc2ncc(cn2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O16 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125657 Peakdale2_000324 CN1CCN(CC1)c2cc(nc(C)n2)c3cncc(c3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O17 compound treatment 0.077 0.00208 0.25 0.2462 1.0 2125658 Peakdale2_000325 CCNC(=O)Nc1ccccc1c2cnn(c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O18 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125659 Peakdale2_000326 Cc1nc(NCc2ccccc2)cc(n1)c3cncc(c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O19 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125660 Peakdale2_000327 Cn1cc(cn1)c2ccccc2NC(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O20 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125661 Peakdale2_000328 CC(Nc1cc(nc(C)n1)c2cncc(c2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O21 compound treatment 0.071 -0.00392 -0.46 -0.4647 -1.0 2125662 Peakdale2_000329 Cc1cc(C)cc(NC(=O)Nc2ccccc2c3cnn(C)c3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O22 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125663 Peakdale2_000330 Cc1nc(NC2CC2)cc(n1)c3cncc(c3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O23 mock treatment 0.0775 0.00258 0.31 0.3055 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 O24 mock treatment 0.079 0.00408 0.48 0.4832 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P01 compound treatment 0.0695 -0.00542 -0.64 -0.6424 -1.0 2125664 Peakdale2_000331 COc1ccc(cc1)c2cnn(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P02 compound treatment 0.0575 -0.0174 -2.06 -2.0643 -1.0 2125665 Peakdale2_000332 C(Nc1cc(nc(n1)c2ccccc2)c3cccnc3)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P03 compound treatment 0.0665 -0.00842 -1.0 -0.9979 -1.0 2125666 Peakdale2_000333 OCCn1cc(cn1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P04 compound treatment 0.068 -0.00692 -0.82 -0.8202 -1.0 2125667 Peakdale2_000334 C(Nc1cc(nc(n1)c2cccnc2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P05 compound treatment 0.0675 -0.00742 -0.88 -0.8794 -1.0 2125668 Peakdale2_000335 Cn1cc(cn1)c2ccc(cn2)C(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P06 compound treatment 0.068 -0.00692 -0.82 -0.8202 -1.0 2125669 Peakdale2_000336 CC(Nc1cc(nc(n1)c2ccncc2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P07 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125670 Peakdale2_000337 Clc1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)NCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P08 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125671 Peakdale2_000338 Cc1nc(NCCCO)cc(n1)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P09 compound treatment 0.072 -0.00292 -0.35 -0.3462 -1.0 2125672 Peakdale2_000339 CN(Cc1ccccc1)C(=O)c2ccc(nc2)c3cnn(c3)c4ccc(C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P10 compound treatment 0.0675 -0.00742 -0.88 -0.8794 -1.0 2125673 Peakdale2_000340 Cc1nc(NCc2ccc(Cl)cc2)cc(n1)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P11 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125674 Peakdale2_000341 Brc1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P12 compound treatment 0.0705 -0.00442 -0.52 -0.5239 -1.0 2125675 Peakdale2_000342 C=CCNc1cc(nc(n1)c2ccccc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P13 compound treatment 0.078 0.00308 0.36 0.3647 1.0 2125676 Peakdale2_000343 CN1CCN(CC1)c2cc(nc(n2)c3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P14 compound treatment 0.075 7.81E-5 0.01 0.0093 1.0 2125677 Peakdale2_000344 CN(Cc1ccccc1)c2cc(nc(n2)c3cccnc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P15 compound treatment 0.079 0.00408 0.48 0.4832 1.0 2125678 Peakdale2_000345 C=CCNc1cc(nc(n1)c2ccncc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P16 compound treatment 0.074 -9.22E-4 -0.11 -0.1092 -1.0 2125679 Peakdale2_000346 C=CCNc1cc(nc(n1)c2ccncc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P17 compound treatment 0.0875 0.0126 1.49 1.4904 1.0 2125680 Peakdale2_000347 CCN(CC)c1cc(nc(C)n1)c2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P18 compound treatment 0.0745 -4.22E-4 -0.05 -0.05 -1.0 2125681 Peakdale2_000348 COCCNc1cc(nc(C)n1)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P19 compound treatment 0.0845 0.00958 1.13 1.1349 1.0 2125682 Peakdale2_000349 Cc1nc(cc(n1)c2cccnc2)N3CCC(O)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P20 compound treatment 0.0735 -0.00142 -0.17 -0.1685 -1.0 2125683 Peakdale2_000350 Cc1nc(NCC=C)cc(n1)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P21 compound treatment 0.07 -0.00492 -0.58 -0.5832 -1.0 2125684 Peakdale2_000351 CCN(CC)c1cc(nc(n1)c2ccccc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P22 compound treatment 0.0725 -0.00242 -0.29 -0.287 -1.0 2125685 Peakdale2_000352 CC(Nc1cc(nc(C)n1)c2ccc(F)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P23 mock treatment 0.0705 -0.00442 -0.52 -0.5239 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1305 P24 mock treatment 0.07 -0.00492 -0.58 -0.5832 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A01 compound treatment 0.084 0.00641 0.76 0.7593 1.0 2075074 MixCom4_000001 COc1ccc(CN2CCCN(Cc3ccc(OC)cc3)C2c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A02 compound treatment 0.0845 0.00691 0.82 0.8185 1.0 2079852 MixCom4_000002 Cc1nc(NC2CCCCC2)cc(n1)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A03 compound treatment 0.083 0.00541 0.64 0.6408 1.0 2075075 MixCom4_000003 CN1CCN(CC1)c2ccc(CNC(=O)C3=Cc4ccccc4OC3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A04 compound treatment 0.0745 -0.00309 -0.37 -0.3664 -1.0 2079853 MixCom4_000004 Fc1ccc(cc1)c2cc(NCc3ccccc3)nc(n2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A05 compound treatment 0.0865 0.00891 1.06 1.0555 1.0 2075076 MixCom4_000005 OC(CN1CCN(CC1)c2c(Cl)cncc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A06 compound treatment 0.0705 -0.00709 -0.84 -0.8403 -1.0 2079854 MixCom4_000006 Fc1ccc(cc1)c2cc(NCc3ccccc3)nc(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A07 compound treatment 0.0565 -0.0211 -2.5 -2.4992 -1.0 2075077 MixCom4_000007 CCc1ccc(cc1)S(=O)(=O)NCc2ccc(cc2)N3CCN(C)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A08 compound treatment 0.058 -0.0196 -2.32 -2.3214 -1.0 2079855 MixCom4_000008 Fc1ccc(cc1)c2cc(NCC=C)nc(n2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A09 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2075078 MixCom4_000009 CC(C)S(=O)(=O)NCc1ccc(cc1)N2CCN(C)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A10 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2079856 MixCom4_000010 Cc1cnc(CNc2cc(nc(C)n2)c3ccccc3F)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A11 compound treatment 0.064 -0.0136 -1.61 -1.6105 -1.0 2075079 MixCom4_000011 OC(CNCc1csc(n1)c2cccs2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A12 compound treatment 0.0555 -0.0221 -2.62 -2.6177 -1.0 2079857 MixCom4_000012 Cc1nc(NCCCO)cc(n1)c2ccccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A13 compound treatment 0.0605 -0.0171 -2.03 -2.0252 -1.0 2075080 MixCom4_000013 O=C(CN1C(=O)c2ccccc2C1=O)N3CCC(=CC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A14 compound treatment 0.061 -0.0166 -1.97 -1.966 -1.0 2079858 MixCom4_000014 Cc1nc(cc(n1)c2ccccc2F)N3CCN(CC3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A15 compound treatment 0.0595 -0.0181 -2.14 -2.1437 -1.0 2075081 MixCom4_000015 COc1cc2CCN(Cc2cc1OC)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A16 compound treatment 0.0625 -0.0151 -1.79 -1.7882 -1.0 2079859 MixCom4_000016 Fc1ccccc1c2cc(nc(n2)c3ccccc3)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A17 compound treatment 0.0605 -0.0171 -2.03 -2.0252 -1.0 2075082 MixCom4_000017 Cc1cc(c(C)s1)S(=O)(=O)Nc2ccc3N4CCCC4COc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A18 compound treatment 0.061 -0.0166 -1.97 -1.966 -1.0 2079860 MixCom4_000018 Fc1ccccc1c2cc(nc(n2)c3cccnc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A19 compound treatment 0.082 0.00441 0.52 0.5223 1.0 2075083 MixCom4_000019 CN(C)/C=C/C(=O)c1sc(nc1C)c2c(Cl)cc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A20 compound treatment 0.0835 0.00591 0.7 0.7001 1.0 2079861 MixCom4_000020 Fc1ccccc1c2cc(NC3CC3)nc(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A21 compound treatment 0.081 0.00341 0.4 0.4038 1.0 2075084 MixCom4_000021 CN(C)/C(=N\O)/c1c(Cl)cccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A22 compound treatment 0.086 0.00841 1.0 0.9963 1.0 2079862 MixCom4_000022 OC1CCN(CC1)c2cc(nc(n2)c3ccncc3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A23 mock treatment 0.0835 0.00591 0.7 0.7001 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 A24 mock treatment 0.077 -5.92E-4 -0.07 -0.0701 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B01 compound treatment 0.0825 0.00491 0.58 0.5816 1.0 2079863 MixCom4_000023 Cc1nc(NCc2ccncc2)cc(n1)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B02 compound treatment 0.08 0.00241 0.29 0.2853 1.0 2075085 MixCom4_000024 CN(C)/C=C/C(=O)c1c(C)onc1c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B03 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 2079864 MixCom4_000025 Cc1nc(NCc2ccco2)cc(n1)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B04 compound treatment 0.0825 0.00491 0.58 0.5816 1.0 2075086 MixCom4_000026 NC(=O)C1=CN(Cc2c(Cl)cccc2Cl)CCC1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B05 compound treatment 0.079 0.00141 0.17 0.1669 1.0 2079865 MixCom4_000027 FC(F)(F)Oc1ccc(cc1)c2cnc(nc2)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B06 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 1233106 MixCom4_000028 CN1CCN(CC1)c2ccc(NS(=O)(=O)c3ccc(Br)cc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B07 compound treatment 0.0615 -0.0161 -1.91 -1.9067 -1.0 2079866 MixCom4_000029 CN(C)CCNc1ccc(cc1F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B08 mock treatment 0.0615 -0.0161 -1.91 -1.9067 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B09 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2079867 MixCom4_000030 CS(=O)(=O)c1ccc(NCc2ccccc2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B10 mock treatment 0.0585 -0.0191 -2.26 -2.2622 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B11 compound treatment 0.0585 -0.0191 -2.26 -2.2622 -1.0 2079868 MixCom4_000031 CS(=O)(=O)c1ccc(cc1)N2CCC3(CC2)OCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B12 compound treatment 0.066 -0.0116 -1.37 -1.3735 -1.0 2079908 MixCom4_000032 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)c4ccc(cc4)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B13 compound treatment 0.066 -0.0116 -1.37 -1.3735 -1.0 2079869 MixCom4_000033 CS(=O)(=O)c1ccc(NCCc2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B14 compound treatment 0.0655 -0.0121 -1.43 -1.4328 -1.0 2079910 MixCom4_000034 Cc1cccc2nc3CCN(Cc3c(=O)n12)C(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B15 compound treatment 0.0655 -0.0121 -1.43 -1.4328 -1.0 2079870 MixCom4_000035 CS(=O)(=O)c1ccc(N2CCN(CC2)C(=O)c3ccccc3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B16 compound treatment 0.0645 -0.0131 -1.55 -1.5513 -1.0 2079915 MixCom4_000036 Cc1cccc2nc3CCN(Cc3c(=O)n12)C(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B17 compound treatment 0.0645 -0.0131 -1.55 -1.5513 -1.0 2079871 MixCom4_000037 CC(=O)N1CCCN(CC1)c2ccc(cc2F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B18 compound treatment 0.0635 -0.0141 -1.67 -1.6697 -1.0 2079917 MixCom4_000038 CCCN1CCC(CC1)N(C(=O)c2cccs2)c3ccc4N(CCc4c3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B19 compound treatment 0.0865 0.00891 1.06 1.0555 1.0 2079872 MixCom4_000039 O=C(C1CCCCC1)N2CCc3nc4ccccn4c(=O)c3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B20 compound treatment 0.083 0.00541 0.64 0.6408 1.0 2079919 MixCom4_000040 COc1cccc(OC)c1CN2CCC(CC2)N(C(=O)c3cccc(c3)C(F)(F)F)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B21 compound treatment 0.0845 0.00691 0.82 0.8185 1.0 2079873 MixCom4_000041 CCC(=O)N1CCc2nc3ccccn3c(=O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B22 compound treatment 0.0835 0.00591 0.7 0.7001 1.0 2079921 MixCom4_000042 OC(=O)C1N(Cc2ccccc2-n3cccc13)C4CCNCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B23 mock treatment 0.0845 0.00691 0.82 0.8185 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 B24 mock treatment 0.08 0.00241 0.29 0.2853 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C01 compound treatment 0.0695 -0.00809 -0.96 -0.9588 -1.0 2075090 MixCom4_000043 COc1ccc(CN2CCCN(Cc3ccc(OC)cc3)C2c4cccc(Cl)c4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C02 compound treatment 0.081 0.00341 0.4 0.4038 1.0 2079874 MixCom4_000044 Cc1nc(NC2CC2)cc(n1)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C03 compound treatment 0.083 0.00541 0.64 0.6408 1.0 2075091 MixCom4_000045 CN1CCN(CC1)c2ccc(CNC(=O)C3CCC3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C04 compound treatment 0.085 0.00741 0.88 0.8778 1.0 2079875 MixCom4_000046 CCN(CC)c1cc(nc(n1)c2cccnc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C05 compound treatment 0.081 0.00341 0.4 0.4038 1.0 2075092 MixCom4_000047 CN1CCN(CC1)c2ccc(CNCC(O)C(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C06 compound treatment 0.081 0.00341 0.4 0.4038 1.0 2079876 MixCom4_000048 Fc1ccc(cc1)c2cc(NCc3ccco3)nc(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C07 compound treatment 0.0645 -0.0131 -1.55 -1.5513 -1.0 2075093 MixCom4_000049 CN1CCN(CC1)c2ccc(CNS(=O)(=O)c3ccc(Cl)cc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C08 compound treatment 0.074 -0.00359 -0.43 -0.4256 -1.0 2079877 MixCom4_000050 CN1CCN(CC1)c2cc(nc(n2)c3ccncc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C09 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2075094 MixCom4_000051 CN1CCN(CC1)c2ccc(CNS(=O)(=O)C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C10 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2079878 MixCom4_000052 COCCNc1cc(nc(C)n1)c2ccccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C11 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2075095 MixCom4_000053 Cc1cc(CNCC(O)C(F)(F)F)no1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C12 compound treatment 0.0725 -0.00509 -0.6 -0.6033 -1.0 2079879 MixCom4_000054 Cc1nc(NCC=C)cc(n1)c2ccccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C13 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2075096 MixCom4_000055 O=C(C1CCCCN1)N2CCN(Cc3cccnc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C14 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2079880 MixCom4_000056 CC(Nc1cc(nc(C)n1)c2ccccc2F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C15 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2075097 MixCom4_000057 COc1cc2CCN(Cc2cc1OC)S(=O)(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C16 compound treatment 0.0935 0.0159 1.88 1.885 1.0 2079881 MixCom4_000058 CN(Cc1ccccc1)c2cc(nc(n2)c3ccccc3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C17 compound treatment 0.064 -0.0136 -1.61 -1.6105 -1.0 1575275 MixCom4_000059 Fc1ccc(cc1)C2NCCc3c2[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C18 compound treatment 0.075 -0.00259 -0.31 -0.3071 -1.0 2079882 MixCom4_000060 Clc1ccc(cc1)c2cnc(nc2)N3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C19 compound treatment 0.082 0.00441 0.52 0.5223 1.0 2075098 MixCom4_000061 CN(C)/C=C/C(=O)c1ccc(o1)c2cc(ccc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C20 compound treatment 0.0825 0.00491 0.58 0.5816 1.0 2079883 MixCom4_000062 CCN(CC)c1cc(nc(n1)c2ccncc2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C21 compound treatment 0.0845 0.00691 0.82 0.8185 1.0 2075099 MixCom4_000063 CSc1nc(nn1C(=O)N(C)C)c2ccc(cc2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C22 compound treatment 0.087 0.00941 1.11 1.1148 1.0 2079884 MixCom4_000064 Fc1ccccc1c2cc(NCc3ccccc3)nc(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C23 mock treatment 0.086 0.00841 1.0 0.9963 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 C24 mock treatment 0.089 0.0114 1.35 1.3518 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D01 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2079885 MixCom4_000065 Cc1nc(cc(n1)c2cccc(c2)C(F)(F)F)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D02 compound treatment 0.075 -0.00259 -0.31 -0.3071 -1.0 2075087 MixCom4_000066 CN(C)/C=C/C(=O)c1cc(no1)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D03 compound treatment 0.08 0.00241 0.29 0.2853 1.0 2079886 MixCom4_000067 CC(Nc1cc(nc(C)n1)c2cccc(c2)C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D04 compound treatment 0.0785 9.08E-4 0.11 0.1076 1.0 1384637 MixCom4_000068 Clc1ccc(cc1)C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D05 compound treatment 0.0785 9.08E-4 0.11 0.1076 1.0 2079887 MixCom4_000069 C1CCN(C1)c2ncc(cn2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D06 compound treatment 0.0745 -0.00309 -0.37 -0.3664 -1.0 1669460 MixCom4_000070 CN1CCN(CC1)c2ccc(NS(=O)(=O)c3ccc(F)cc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D07 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2079888 MixCom4_000071 Cc1cnc(CNc2ccc(cc2F)S(=O)(=O)C)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D08 mock treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D09 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2079889 MixCom4_000072 CS(=O)(=O)c1ccc(NCc2ccco2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D10 mock treatment 0.067 -0.0106 -1.26 -1.255 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D11 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2079890 MixCom4_000073 CS(=O)(=O)c1ccc(NCc2cccnc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D12 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2079923 MixCom4_000074 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D13 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2079891 MixCom4_000075 CS(=O)(=O)c1ccc(cc1)N2CCN(CC2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D14 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2079925 MixCom4_000076 CC(=O)N1CCc2nc3cccc(C)n3c(=O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D15 compound treatment 0.0755 -0.00209 -0.25 -0.2479 -1.0 2079892 MixCom4_000077 CS(=O)(=O)c1ccc(N2CCN(CC2)C(=O)c3ccc(Cl)cc3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D16 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2079938 MixCom4_000078 CCCN(C1CCN(C)CC1)C(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D17 compound treatment 0.066 -0.0116 -1.37 -1.3735 -1.0 2079893 MixCom4_000079 CS(=O)(=O)c1ccc(cc1)N2CCCNCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D18 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2079940 MixCom4_000080 CC(=O)N1CCc2cc(NC3CCN(Cc4ccccc4)CC3)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D19 compound treatment 0.084 0.00641 0.76 0.7593 1.0 2079894 MixCom4_000081 Fc1cc(F)cc(CC(=O)N2CCc3nc4ccccn4c(=O)c3C2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D20 compound treatment 0.0825 0.00491 0.58 0.5816 1.0 2079944 MixCom4_000082 FC(F)(F)c1cccc(CNC(=O)c2ccc(CCN3CCCC3)nc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D21 compound treatment 0.083 0.00541 0.64 0.6408 1.0 2079895 MixCom4_000083 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D22 compound treatment 0.081 0.00341 0.4 0.4038 1.0 2079946 MixCom4_000084 OC(=O)C1N(Cc2ccccc2)Cc3ccccc3-n4cccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D23 mock treatment 0.087 0.00941 1.11 1.1148 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 D24 mock treatment 0.0935 0.0159 1.88 1.885 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E01 compound treatment 0.0725 -0.00509 -0.6 -0.6033 -1.0 2075103 MixCom4_000085 COc1ccc(CN2CCCN(Cc3ccc(OC)cc3)C2c4ccsc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E02 compound treatment 0.0865 0.00891 1.06 1.0555 1.0 2079896 MixCom4_000086 Cc1nc(NCCc2c[nH]c3ccccc23)cc(n1)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E03 compound treatment 0.082 0.00441 0.52 0.5223 1.0 2075104 MixCom4_000087 CN1CCN(CC1)c2ccc(CNC(=O)C3CCCCC3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E04 compound treatment 0.087 0.00941 1.11 1.1148 1.0 2079897 MixCom4_000088 Fc1ccc(cc1)c2cc(nc(n2)c3cccnc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E05 compound treatment 0.08 0.00241 0.29 0.2853 1.0 2075105 MixCom4_000089 OC(CN1CCCN(CC1)c2nccc(n2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E06 compound treatment 0.0845 0.00691 0.82 0.8185 1.0 2079898 MixCom4_000090 Fc1ccc(cc1)c2cc(NCc3ccc(Cl)cc3)nc(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E07 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2075106 MixCom4_000091 CN1CCN(CC1)c2ccc(CNS(=O)(=O)c3cc(F)ccc3C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E08 compound treatment 0.0705 -0.00709 -0.84 -0.8403 -1.0 2079899 MixCom4_000092 Fc1ccc(cc1)c2cc(NCc3ccccc3)nc(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E09 compound treatment 0.072 -0.00559 -0.66 -0.6626 -1.0 2075107 MixCom4_000093 CN1CCN(CC1)c2ccc(CNS(=O)(=O)c3ccsc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E10 compound treatment 0.0785 9.08E-4 0.11 0.1076 1.0 2079900 MixCom4_000094 Cc1nc(cc(n1)c2ccccc2F)N3CCC4(CC3)OCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E11 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2075108 MixCom4_000095 OC(CN1CCCN(Cc2ccc(F)cc2)CC1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E12 compound treatment 0.0705 -0.00709 -0.84 -0.8403 -1.0 2079901 MixCom4_000096 CN1CCN(CC1)c2cc(nc(C)n2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E13 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2075109 MixCom4_000097 Clc1c(sc2ccccc12)C(=O)N3CCN(Cc4cccnc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E14 compound treatment 0.077 -5.92E-4 -0.07 -0.0701 -1.0 2079902 MixCom4_000098 Cc1nc(NC2CCCCC2)cc(n1)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E15 compound treatment 0.0695 -0.00809 -0.96 -0.9588 -1.0 2075110 MixCom4_000099 COc1cc2CCN(Cc2cc1OC)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E16 compound treatment 0.082 0.00441 0.52 0.5223 1.0 2079903 MixCom4_000100 CN1CCN(CC1)c2cc(nc(n2)c3ccccc3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E17 compound treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 2075111 MixCom4_000101 ClC1=C(CN2CCSCC2)CSc3ccc(Cl)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E18 compound treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 2079904 MixCom4_000102 CN(Cc1ccccc1)c2cc(nc(n2)c3cccnc3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E19 compound treatment 0.0775 -9.18E-5 -0.01 -0.0109 -1.0 2075112 MixCom4_000103 CN1CCN(CC1)c2ccccc2/C=C\3/C(=O)Nc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E20 compound treatment 0.081 0.00341 0.4 0.4038 1.0 2079905 MixCom4_000104 Fc1ccccc1c2cc(NCc3ccncc3)nc(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E21 compound treatment 0.081 0.00341 0.4 0.4038 1.0 2075113 MixCom4_000105 CN(C)/C=C/C(=O)c1nn(ccc1=O)c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E22 compound treatment 0.0875 0.00991 1.17 1.174 1.0 2079906 MixCom4_000106 Fc1ccccc1c2cc(NCc3ccco3)nc(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E23 mock treatment 0.0865 0.00891 1.06 1.0555 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 E24 mock treatment 0.0855 0.00791 0.94 0.937 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F01 compound treatment 0.0785 9.08E-4 0.11 0.1076 1.0 2079907 MixCom4_000107 Cc1nc(cc(n1)c2cccc(c2)C(F)(F)F)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F02 compound treatment 0.073 -0.00459 -0.54 -0.5441 -1.0 2075088 MixCom4_000108 Fc1ccc(cc1Cl)S(=O)(=O)NN2C3CSC2CS3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F03 compound treatment 0.084 0.00641 0.76 0.7593 1.0 2079909 MixCom4_000109 Cc1nc(NCc2ccc(Cl)cc2)cc(n1)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F04 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 1214022 MixCom4_000110 Cc1ccc(cc1)C(=O)N2CCN(Cc3ccc4OCOc4c3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F05 compound treatment 0.08 0.00241 0.29 0.2853 1.0 2079911 MixCom4_000111 Fc1ccc(cc1)c2cnc(nc2)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F06 mock treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F07 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2079912 MixCom4_000112 CC(C)N(C(C)C)c1ccc(cc1F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F08 mock treatment 0.065 -0.0126 -1.49 -1.492 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F09 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2079913 MixCom4_000113 CS(=O)(=O)c1ccc(N2CCc3ccccc3C2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F10 mock treatment 0.0745 -0.00309 -0.37 -0.3664 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F11 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2079914 MixCom4_000114 CS(=O)(=O)c1ccc(cc1)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F12 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2079948 MixCom4_000115 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F13 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2079916 MixCom4_000116 CC(Nc1ccc(cc1)S(=O)(=O)C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F14 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2079950 MixCom4_000117 Cc1cccc2nc3CCN(Cc3c(=O)n12)C(=O)c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F15 compound treatment 0.066 -0.0116 -1.37 -1.3735 -1.0 2079918 MixCom4_000118 CS(=O)(=O)c1ccc(N2CCN(CC2)C(=O)c3c(F)cccc3F)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F16 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2079952 MixCom4_000119 Fc1c(F)c(F)c2c(CC(=O)NCCN3CCOCC3)c[nH]c2c1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F17 compound treatment 0.066 -0.0116 -1.37 -1.3735 -1.0 2079920 MixCom4_000120 CS(=O)(=O)c1ccc(cc1)N2CCCC(O)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F18 compound treatment 0.0635 -0.0141 -1.67 -1.6697 -1.0 2079726 MixCom4_000121 OC(=O)C1CCN(Cc2ccccn2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F19 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 2079922 MixCom4_000122 CC(C)CC(=O)N1CCc2nc3ccccn3c(=O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F20 compound treatment 0.0795 0.00191 0.23 0.2261 1.0 2079966 MixCom4_000123 Clc1ccc(cc1)c2csc(c2)C(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F21 compound treatment 0.0765 -0.00109 -0.13 -0.1294 -1.0 2079924 MixCom4_000124 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F22 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 2079734 MixCom4_000125 OC(=O)C1CCN(Cc2ccncc2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F23 mock treatment 0.0805 0.00291 0.34 0.3446 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 F24 mock treatment 0.0845 0.00691 0.82 0.8185 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G01 compound treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 2075114 MixCom4_000126 COc1ccc(CN2CCCN(Cc3ccc(OC)cc3)C2c4cccnc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G02 compound treatment 0.0745 -0.00309 -0.37 -0.3664 -1.0 2079926 MixCom4_000127 Fc1ccc(cc1)c2cc(nc(n2)c3ccccc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G03 compound treatment 0.0845 0.00691 0.82 0.8185 1.0 2075115 MixCom4_000128 CN1CCN(CC1)c2ccc(CNC(=O)c3ccco3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G04 compound treatment 0.0795 0.00191 0.23 0.2261 1.0 2079927 MixCom4_000129 Fc1ccc(cc1)c2cc(nc(n2)c3cccnc3)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G05 compound treatment 0.09 0.0124 1.47 1.4702 1.0 2075116 MixCom4_000130 OC(CN1CCCc2cc(ccc12)C(=O)O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G06 compound treatment 0.082 0.00441 0.52 0.5223 1.0 2079928 MixCom4_000131 Fc1ccc(cc1)c2cc(NC3CC3)nc(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G07 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2075117 MixCom4_000132 CN1CCN(CC1)c2ccc(CNS(=O)(=O)c3ccc(F)cc3Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G08 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2079929 MixCom4_000133 Fc1ccc(cc1)c2cc(NCc3ccco3)nc(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G09 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2075118 MixCom4_000134 CN1CCN(CC1)c2ccc(CNS(=O)(=O)c3cc(C)sc3C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G10 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2079930 MixCom4_000135 CCN(CC)c1cc(nc(C)n1)c2ccccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G11 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2075119 MixCom4_000136 OC(CN1CCN(Cc2c(F)cccc2Cl)CC1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G12 compound treatment 0.0715 -0.00609 -0.72 -0.7218 -1.0 2079931 MixCom4_000137 Cc1nc(cc(n1)c2ccccc2F)N3CCC(O)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G13 compound treatment 0.071 -0.00659 -0.78 -0.7811 -1.0 2075120 MixCom4_000138 O=C(N1CCSCC1)c2nc3ccccc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G14 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2079932 MixCom4_000139 Cc1nc(NC2CC2)cc(n1)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G15 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 1461440 MixCom4_000140 COc1cc2CCN(Cc2cc1OC)S(=O)(=O)c3ccc(F)c(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G16 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2079933 MixCom4_000141 OC1CCN(CC1)c2cc(nc(n2)c3ccccc3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G17 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2075121 MixCom4_000142 ClC1=C(CN2CCCCC2)CSc3ccc(Cl)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G18 compound treatment 0.0795 0.00191 0.23 0.2261 1.0 2079934 MixCom4_000143 Fc1ccccc1c2cc(NCC=C)nc(n2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G19 compound treatment 0.0785 9.08E-4 0.11 0.1076 1.0 2075122 MixCom4_000144 CN1CCN(CC1)c2ccccc2/C=N/c3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G20 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 2079935 MixCom4_000145 Fc1ccccc1c2cc(nc(n2)c3ccncc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G21 compound treatment 0.085 0.00741 0.88 0.8778 1.0 2075123 MixCom4_000146 COCc1cc(nc(n1)c2csc(C)n2)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G22 compound treatment 0.0795 0.00191 0.23 0.2261 1.0 2079936 MixCom4_000147 CC(Nc1cc(nc(n1)c2ccncc2)c3ccccc3F)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G23 mock treatment 0.0815 0.00391 0.46 0.4631 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 G24 mock treatment 0.0785 9.08E-4 0.11 0.1076 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H01 compound treatment 0.0725 -0.00509 -0.6 -0.6033 -1.0 2079937 MixCom4_000148 CN(Cc1ccccc1)c2cc(nc(C)n2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H02 compound treatment 0.0755 -0.00209 -0.25 -0.2479 -1.0 2075089 MixCom4_000149 FC(F)(F)C1CCN(CC1)c2ccc(cc2NC(=O)c3cccs3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H03 compound treatment 0.0785 9.08E-4 0.11 0.1076 1.0 2079939 MixCom4_000150 Cc1nc(NC2CC2)cc(n1)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H04 compound treatment 0.0815 0.00391 0.46 0.4631 1.0 1510899 MixCom4_000151 O=C(N1CCN(Cc2ccc3OCOc3c2)CC1)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H05 compound treatment 0.0805 0.00291 0.34 0.3446 1.0 1653366 MixCom4_000152 OC(=O)CC1(CC(=O)NC2CC2)CCCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H06 mock treatment 0.077 -5.92E-4 -0.07 -0.0701 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H07 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2079941 MixCom4_000153 CS(=O)(=O)c1ccc(N2CCC3(CC2)OCCO3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H08 mock treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H09 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2079942 MixCom4_000154 CS(=O)(=O)c1ccc(NCCc2ccccc2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H10 mock treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H11 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2079943 MixCom4_000155 CS(=O)(=O)c1ccc(cc1)N2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H12 compound treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 2079972 MixCom4_000156 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)c4c(F)cccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H13 compound treatment 0.0645 -0.0131 -1.55 -1.5513 -1.0 2079945 MixCom4_000157 CC1CN(CC(C)O1)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H14 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2079974 MixCom4_000158 Cc1cccc2nc3CCN(Cc3c(=O)n12)C(=O)Cc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H15 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2079947 MixCom4_000159 CS(=O)(=O)c1ccc(cc1)N2CCC(O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H16 compound treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 2079653 MixCom4_000160 O=C1Cc2ccccc2N1C3CCN(CCC#N)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H17 compound treatment 0.0715 -0.00609 -0.72 -0.7218 -1.0 2079949 MixCom4_000161 CS(=O)(=O)c1ccc(N2CCCC(O)C2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H18 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2079977 MixCom4_000162 C1CN(CCO1)C2c3cccn3-c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H19 compound treatment 0.077 -5.92E-4 -0.07 -0.0701 -1.0 2079951 MixCom4_000163 CC(C)(C)c1ccc(cc1)C(=O)N2CCc3nc4ccccn4c(=O)c3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H20 compound treatment 0.0785 9.08E-4 0.11 0.1076 1.0 2079979 MixCom4_000164 CN1CCN(CC1)C(=O)c2cc(cs2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H21 compound treatment 0.08 0.00241 0.29 0.2853 1.0 2079953 MixCom4_000165 CC(=O)N1CCc2nc3c(C)cccn3c(=O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H22 compound treatment 0.085 0.00741 0.88 0.8778 1.0 2079981 MixCom4_000166 CN1CCC(CC1)N(C(=O)c2ccc(cc2)C(F)(F)F)c3ccc4CCN(C(=O)C)c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H23 mock treatment 0.0815 0.00391 0.46 0.4631 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 H24 mock treatment 0.0825 0.00491 0.58 0.5816 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I01 compound treatment 0.0725 -0.00509 -0.6 -0.6033 -1.0 2075124 MixCom4_000167 COc1ccc(CC(=O)Nc2ccccc2N3CCCCC3)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I02 compound treatment 0.074 -0.00359 -0.43 -0.4256 -1.0 2079954 MixCom4_000168 Fc1ccc(cc1)c2cc(nc(n2)c3ccccc3)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I03 compound treatment 0.0765 -0.00109 -0.13 -0.1294 -1.0 2075125 MixCom4_000169 CN1CCN(CC1)c2ccc(CNC(=O)c3cc4ccccc4o3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I04 compound treatment 0.079 0.00141 0.17 0.1669 1.0 2079955 MixCom4_000170 CN(Cc1ccccc1)c2cc(nc(n2)c3cccnc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I05 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 2075126 MixCom4_000171 OC(CN1CCN(Cc2ccc3OCOc3c2)CC1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I06 compound treatment 0.076 -0.00159 -0.19 -0.1886 -1.0 2079956 MixCom4_000172 CCN(CC)c1cc(nc(n1)c2ccncc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I07 compound treatment 0.064 -0.0136 -1.61 -1.6105 -1.0 2075127 MixCom4_000173 CN1CCN(CC1)c2ccc(CNS(=O)(=O)c3cccc(F)c3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I08 compound treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 2079957 MixCom4_000174 Fc1ccc(cc1)c2cc(NCc3ccc(Cl)cc3)nc(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I09 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2075128 MixCom4_000175 OC(CNC1CCN(Cc2ccccc2)CC1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I10 compound treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 2079958 MixCom4_000176 CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c3ccc4[nH]c(C)cc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I11 compound treatment 0.0645 -0.0131 -1.55 -1.5513 -1.0 2075129 MixCom4_000177 OC(CN1CCN(CC1)c2ccc(F)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I12 compound treatment 0.066 -0.0116 -1.37 -1.3735 -1.0 2079959 MixCom4_000178 Cc1nc(NCc2ccccc2)cc(n1)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I13 compound treatment 0.0595 -0.0181 -2.14 -2.1437 -1.0 2075130 MixCom4_000179 O=C(Nc1ccccc1N2CCOCC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I14 compound treatment 0.0625 -0.0151 -1.79 -1.7882 -1.0 2079960 MixCom4_000180 Cc1nc(NCCc2c[nH]c3ccccc23)cc(n1)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I15 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2075131 MixCom4_000181 O=C1C2CCN(CC2)C31CC3c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I16 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2079961 MixCom4_000182 CCCN1CCC(CC1)N(C2CC2)C(=O)c3cccc(NC(=O)c4ccc(cc4)C(C)(C)C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I17 compound treatment 0.0775 -9.18E-5 -0.01 -0.0109 -1.0 2075132 MixCom4_000183 CCN(CC)C(=O)c1cc2sccc2s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I18 compound treatment 0.0655 -0.0121 -1.43 -1.4328 -1.0 2079962 MixCom4_000184 CN1CCN(CC1)c2cc(nc(n2)c3cccnc3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I19 compound treatment 0.0775 -9.18E-5 -0.01 -0.0109 -1.0 2075133 MixCom4_000185 Cc1c(C)c(C)c(CS/C(=N/c2cc(Cl)ccc2Cl)/N3CCOCC3)c(C)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I20 compound treatment 0.0785 9.08E-4 0.11 0.1076 1.0 2079963 MixCom4_000186 Fc1ccccc1c2cc(nc(n2)c3ccncc3)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I21 compound treatment 0.081 0.00341 0.4 0.4038 1.0 2075134 MixCom4_000187 COC(=O)c1c(/C=C/N(C)C)onc1c2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I22 compound treatment 0.0805 0.00291 0.34 0.3446 1.0 2079964 MixCom4_000188 Fc1ccccc1c2cc(NC3CC3)nc(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I23 mock treatment 0.08 0.00241 0.29 0.2853 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 I24 mock treatment 0.0815 0.00391 0.46 0.4631 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J01 compound treatment 0.071 -0.00659 -0.78 -0.7811 -1.0 2079965 MixCom4_000189 Cc1nc(NCC=C)cc(n1)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J02 compound treatment 0.074 -0.00359 -0.43 -0.4256 -1.0 2075100 MixCom4_000190 COc1ccc(NC(=O)Nc2cc(ccc2N3CCC(CC3)C(F)(F)F)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J03 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 2079967 MixCom4_000191 FC(F)(F)c1cccc(c1)c2cc(NC3CC3)nc(n2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J04 compound treatment 0.0965 0.0189 2.24 2.2404 1.0 1151412 MixCom4_000192 CC(C)(C)C(=O)N1CCN(Cc2ccc3OCOc3c2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J05 compound treatment 0.076 -0.00159 -0.19 -0.1886 -1.0 2079968 MixCom4_000193 CNC(=O)CC1(CC(=O)O)CCCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J06 mock treatment 0.0765 -0.00109 -0.13 -0.1294 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J07 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2079969 MixCom4_000194 CS(=O)(=O)c1ccc(NCc2cccnc2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J08 mock treatment 0.0715 -0.00609 -0.72 -0.7218 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J09 compound treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 2079970 MixCom4_000195 CS(=O)(=O)c1ccc(N2CCN(CC2)c3ccccn3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J10 mock treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J11 compound treatment 0.0695 -0.00809 -0.96 -0.9588 -1.0 2079971 MixCom4_000196 CN1CCN(CC1)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J12 compound treatment 0.0695 -0.00809 -0.96 -0.9588 -1.0 2079994 MixCom4_000197 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J13 compound treatment 0.0615 -0.0161 -1.91 -1.9067 -1.0 2079973 MixCom4_000198 CS(=O)(=O)c1ccc(cc1)N2CCN(CC2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J14 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2079996 MixCom4_000199 Cc1cccc2nc3CCN(Cc3c(=O)n12)C(=O)C4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J15 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2079975 MixCom4_000200 CS(=O)(=O)c1ccc(N2CCC(O)CC2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J16 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2080001 MixCom4_000201 CN(C)CCC(=O)c1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J17 compound treatment 0.0655 -0.0121 -1.43 -1.4328 -1.0 2079976 MixCom4_000202 FC(F)(F)c1cccc(c1)C(=O)N2CCc3nc4ccccn4c(=O)c3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J18 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2079730 MixCom4_000203 O=C(C1CCN(Cc2ccccn2)CC1)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J19 compound treatment 0.0745 -0.00309 -0.37 -0.3664 -1.0 2079978 MixCom4_000204 O=C(N1CCc2nc3ccccn3c(=O)c2C1)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J20 compound treatment 0.074 -0.00359 -0.43 -0.4256 -1.0 2080004 MixCom4_000205 CCCN1CCC(CC1)N(C(=O)C2CC2)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J21 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 2079980 MixCom4_000206 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J22 compound treatment 0.0775 -9.18E-5 -0.01 -0.0109 -1.0 2079773 MixCom4_000207 Cc1ccccc1C(=O)N2CCC(CC2)N3CCN(CC3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J23 mock treatment 0.077 -5.92E-4 -0.07 -0.0701 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 J24 mock treatment 0.0775 -9.18E-5 -0.01 -0.0109 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K01 compound treatment 0.077 -5.92E-4 -0.07 -0.0701 -1.0 2075135 MixCom4_000208 COc1ccc(CC(=O)N2CCN(CC2)C(c3ccccc3)c4ccccc4)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K02 compound treatment 0.0785 9.08E-4 0.11 0.1076 1.0 2079982 MixCom4_000209 CN(Cc1ccccc1)c2cc(nc(n2)c3ccccc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K03 compound treatment 0.08 0.00241 0.29 0.2853 1.0 2075136 MixCom4_000210 CN1CCN(CC1)c2ccc(CNC(=O)c3ccsc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K04 compound treatment 0.0765 -0.00109 -0.13 -0.1294 -1.0 2079983 MixCom4_000211 Fc1ccc(cc1)c2cc(NCC=C)nc(n2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K05 compound treatment 0.0755 -0.00209 -0.25 -0.2479 -1.0 2075137 MixCom4_000212 Fc1ccc(cc1)C2CCCN2C(=O)C3CCCCN3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K06 compound treatment 0.072 -0.00559 -0.66 -0.6626 -1.0 2079984 MixCom4_000213 Fc1ccc(cc1)c2cc(nc(n2)c3ccncc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K07 compound treatment 0.066 -0.0116 -1.37 -1.3735 -1.0 2075138 MixCom4_000214 CN1CCN(CC1)c2ccc(CNS(=O)(=O)Cc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K08 compound treatment 0.074 -0.00359 -0.43 -0.4256 -1.0 2079985 MixCom4_000215 Fc1ccc(cc1)c2cc(NC3CC3)nc(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K09 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2075139 MixCom4_000216 OC(CNCC1COc2ccccc2O1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K10 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2079986 MixCom4_000217 Cc1nc(cc(n1)c2ccccc2F)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K11 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2075140 MixCom4_000218 OC(CN1CCN=C(C=C1)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K12 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2079987 MixCom4_000219 Cc1nc(NCc2ccco2)cc(n1)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K13 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2075141 MixCom4_000220 COc1cc2CCN(Cc2cc1OC)C(=O)COc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K14 compound treatment 0.065 -0.0126 -1.49 -1.492 -1.0 2079988 MixCom4_000221 Cc1cnc(CNc2cc(nc(n2)c3ccccc3)c4ccccc4F)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K15 compound treatment 0.0655 -0.0121 -1.43 -1.4328 -1.0 2075142 MixCom4_000222 CN1C/2CCC1/C(=C\c3ccc(F)cc3)/C(=O)\C2=C\c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K16 compound treatment 0.0695 -0.00809 -0.96 -0.9588 -1.0 2079989 MixCom4_000223 CC(Nc1cc(nc(n1)c2ccccc2)c3ccccc3F)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K17 compound treatment 0.0655 -0.0121 -1.43 -1.4328 -1.0 2075143 MixCom4_000224 OC(CNCc1ccc(cc1)C(F)(F)F)CO/N=C/C2=C(Cl)c3cc(Cl)ccc3OC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K18 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2079990 MixCom4_000225 OC1CCN(CC1)c2cc(nc(n2)c3cccnc3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K19 compound treatment 0.071 -0.00659 -0.78 -0.7811 -1.0 2075144 MixCom4_000226 CN(C)c1ccc(CC(C)(C)NC(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K20 compound treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 2079991 MixCom4_000227 CN(Cc1ccccc1)c2cc(nc(n2)c3ccncc3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K21 compound treatment 0.0725 -0.00509 -0.6 -0.6033 -1.0 2075145 MixCom4_000228 CCOC(=O)c1nc(C)sc1C(=O)/C=C/N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K22 compound treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 2079992 MixCom4_000229 Cc1cnc(CNc2cc(nc(C)n2)c3cccc(c3)C(F)(F)F)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K23 mock treatment 0.077 -5.92E-4 -0.07 -0.0701 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 K24 mock treatment 0.078 4.08E-4 0.05 0.0484 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L01 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2079993 MixCom4_000230 CN1CCN(CC1)c2cc(nc(C)n2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L02 compound treatment 0.074 -0.00359 -0.43 -0.4256 -1.0 1676216 MixCom4_000231 O=C(N1CCN(CC1)C2c3ccccc3-c4ccccc24)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L03 compound treatment 0.074 -0.00359 -0.43 -0.4256 -1.0 2079995 MixCom4_000232 FC(F)(F)c1cccc(c1)c2cc(NC3CC3)nc(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L04 compound treatment 0.0805 0.00291 0.34 0.3446 1.0 2075101 MixCom4_000233 CC(C)(C)OC(=O)NC1CCNCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L05 compound treatment 0.0975 0.0199 2.36 2.3589 1.0 2079997 MixCom4_000234 OC(=O)CC1(CC(=O)N2CCCC2)CCCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L06 mock treatment 0.0795 0.00191 0.23 0.2261 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L07 compound treatment 0.071 -0.00659 -0.78 -0.7811 -1.0 2079998 MixCom4_000235 CS(=O)(=O)c1ccc(N2CCOCC2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L08 mock treatment 0.067 -0.0106 -1.26 -1.255 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L09 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2079999 MixCom4_000236 CS(=O)(=O)c1ccc(NC2CCCCC2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L10 mock treatment 0.0745 -0.00309 -0.37 -0.3664 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L11 compound treatment 0.0695 -0.00809 -0.96 -0.9588 -1.0 2080000 MixCom4_000237 CS(=O)(=O)c1ccc(NCc2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L12 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2080007 MixCom4_000238 Cc1ccccc1C(=O)N2CCc3nc4c(C)cccn4c(=O)c3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L13 compound treatment 0.072 -0.00559 -0.66 -0.6626 -1.0 2080002 MixCom4_000239 CS(=O)(=O)c1ccc(cc1)N2CCN(CC2)C(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L14 compound treatment 0.0815 0.00391 0.46 0.4631 1.0 2080009 MixCom4_000240 Cc1cccc2nc3CCN(Cc3c(=O)n12)C(=O)Cc4cc(F)cc(F)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L15 compound treatment 0.0705 -0.00709 -0.84 -0.8403 -1.0 2080003 MixCom4_000241 CS(=O)(=O)c1ccc(cc1)N2CCNCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L16 compound treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 2080022 MixCom4_000242 CN1CCC(CC1)Nc2ccc3N(CCc3c2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L17 compound treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 2080005 MixCom4_000243 CC(C)(C)C(=O)N1CCc2nc3ccccn3c(=O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L18 compound treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 2080024 MixCom4_000244 COc1ccc(cc1)S(=O)(=O)N2CCCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L19 compound treatment 0.072 -0.00559 -0.66 -0.6626 -1.0 2080006 MixCom4_000245 Fc1cccc(F)c1C(=O)N2CCc3nc4ccccn4c(=O)c3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L20 compound treatment 0.0745 -0.00309 -0.37 -0.3664 -1.0 2080029 MixCom4_000246 CCCN1CCC(CC1)N(C(=O)c2cccc(c2)C(F)(F)F)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L21 compound treatment 0.0765 -0.00109 -0.13 -0.1294 -1.0 2080008 MixCom4_000247 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)Cc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L22 compound treatment 0.076 -0.00159 -0.19 -0.1886 -1.0 2079746 MixCom4_000248 Clc1cccc(CNC(=O)C2CCN(Cc3cccnc3)CC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L23 mock treatment 0.0815 0.00391 0.46 0.4631 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 L24 mock treatment 0.0855 0.00791 0.94 0.937 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M01 compound treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 2075146 MixCom4_000249 COc1ccc(cc1)C(=O)NCc2ccc(cc2)N3CCN(C)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M02 compound treatment 0.071 -0.00659 -0.78 -0.7811 -1.0 2080010 MixCom4_000250 CN1CCN(CC1)c2cc(nc(n2)c3ccccc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M03 compound treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 2075147 MixCom4_000251 CN1CCN(CC1)c2ccc(CNC(=O)c3ccc(C)c(C)c3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M04 compound treatment 0.0745 -0.00309 -0.37 -0.3664 -1.0 2080011 MixCom4_000252 CN1CCN(CC1)c2cc(nc(n2)c3cccnc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M05 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 2075148 MixCom4_000253 CN1CCN(CC1)c2ccc(CNS(=O)(=O)c3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M06 compound treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 2080012 MixCom4_000254 Fc1ccc(cc1)c2cc(nc(n2)c3ccncc3)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M07 compound treatment 0.0695 -0.00809 -0.96 -0.9588 -1.0 2075149 MixCom4_000255 CN1CCN(CC1)c2ccc(CNS(=O)(=O)Cc3ccc(Cl)cc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M08 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2080013 MixCom4_000256 CN(C)CCNc1cc(nc(C)n1)c2ccccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M09 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2075150 MixCom4_000257 OC(CNCc1ccco1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M10 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2080014 MixCom4_000258 Cc1nc(cc(n1)c2ccccc2F)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M11 compound treatment 0.066 -0.0116 -1.37 -1.3735 -1.0 1478188 MixCom4_000259 O=C(CN1C(=O)c2ccccc2C1=O)N3CCCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M12 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2080015 MixCom4_000260 Cc1nc(cc(n1)c2ccccc2F)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M13 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2075151 MixCom4_000261 COc1cc2CCN(Cc2cc1OC)C(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M14 compound treatment 0.072 -0.00559 -0.66 -0.6626 -1.0 2080016 MixCom4_000262 CCN(CC)c1cc(nc(n1)c2ccccc2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M15 compound treatment 0.067 -0.0106 -1.26 -1.255 -1.0 2075152 MixCom4_000263 O=C(COc1ccccc1)Nc2ccc3N4CCCC4COc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M16 compound treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 2080017 MixCom4_000264 CCN(CC)c1cc(nc(n1)c2cccnc2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M17 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2075153 MixCom4_000265 OC(CO/N=C/C1=C(Cl)c2cc(Cl)ccc2OC1)CN3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M18 compound treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 2080018 MixCom4_000266 Fc1ccccc1c2cc(NCc3ccccc3)nc(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M19 compound treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 1173337 MixCom4_000267 Clc1cccc(Cl)c1c2noc(CN3CCOCC3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M20 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 2080019 MixCom4_000268 Fc1ccccc1c2cc(NCC=C)nc(n2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M21 compound treatment 0.086 0.00841 1.0 0.9963 1.0 2075154 MixCom4_000269 CN(C)/C=C/C(=O)c1csc(n1)c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M22 compound treatment 0.075 -0.00259 -0.31 -0.3071 -1.0 2080020 MixCom4_000270 Cc1nc(cc(n1)c2cccc(c2)C(F)(F)F)N3CCC4(CC3)OCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M23 mock treatment 0.078 4.08E-4 0.05 0.0484 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 M24 mock treatment 0.081 0.00341 0.4 0.4038 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N01 compound treatment 0.072 -0.00559 -0.66 -0.6626 -1.0 2080021 MixCom4_000271 Cc1nc(cc(n1)c2cccc(c2)C(F)(F)F)N3CCC(O)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N02 compound treatment 0.072 -0.00559 -0.66 -0.6626 -1.0 1188987 MixCom4_000272 CC(C)(C)C(=O)N1CCN(CC1)C2c3ccccc3-c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N03 compound treatment 0.081 0.00341 0.4 0.4038 1.0 2080023 MixCom4_000273 FC(F)(F)c1cccc(c1)c2cc(NC3CC3)nc(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N04 compound treatment 0.0765 -0.00109 -0.13 -0.1294 -1.0 1627910 MixCom4_000274 CN1CCN(CC1)c2ccc(NC(=O)c3ccccc3Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N05 compound treatment 0.077 -5.92E-4 -0.07 -0.0701 -1.0 2080025 MixCom4_000275 OC(=O)CC1(CC(=O)N2CCc3ccccc3C2)CCCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N06 mock treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N07 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2080026 MixCom4_000276 CS(=O)(=O)c1ccc(N2CCCCC2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N08 mock treatment 0.072 -0.00559 -0.66 -0.6626 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N09 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2080027 MixCom4_000277 CC1CN(CC(C)O1)c2ccc(cc2F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N10 mock treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N11 compound treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 2080028 MixCom4_000278 CS(=O)(=O)c1ccc(NCc2ccco2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N12 compound treatment 0.0745 -0.00309 -0.37 -0.3664 -1.0 2080032 MixCom4_000279 CCC(=O)N1CCc2nc3c(C)cccn3c(=O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N13 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2080030 MixCom4_000280 CS(=O)(=O)c1ccc(cc1)N2CCN(CC2)C(=O)c3c(F)cccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N14 compound treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 2080034 MixCom4_000281 CC(C)CC(=O)N1CCc2nc3cccc(C)n3c(=O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N15 compound treatment 0.0765 -0.00109 -0.13 -0.1294 -1.0 2080031 MixCom4_000282 CS(=O)(=O)c1ccc(N2CCNCC2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N16 compound treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 2080036 MixCom4_000283 CN1CCC(CC1)N(C(=O)C2CC2)c3ccc4N(CCc4c3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N17 compound treatment 0.078 4.08E-4 0.05 0.0484 1.0 2080033 MixCom4_000284 Clc1ccc(C(=O)N2CCc3nc4ccccn4c(=O)c3C2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N18 compound treatment 0.0705 -0.00709 -0.84 -0.8403 -1.0 2080038 MixCom4_000285 COc1cccc(OC)c1C(=O)N2CCCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N19 compound treatment 0.075 -0.00259 -0.31 -0.3071 -1.0 2080035 MixCom4_000286 Clc1ccc(cc1)C(=O)N2CCc3nc4ccccn4c(=O)c3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N20 compound treatment 0.081 0.00341 0.4 0.4038 1.0 2080051 MixCom4_000287 CCCN1CCC(CC1)N(C2CC2)C(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N21 compound treatment 0.0835 0.00591 0.7 0.7001 1.0 2080037 MixCom4_000288 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)C4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N22 compound treatment 0.08 0.00241 0.29 0.2853 1.0 2080053 MixCom4_000289 COc1ccc(cc1)c2cnc(NCCN(C)C)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N23 mock treatment 0.0825 0.00491 0.58 0.5816 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 N24 mock treatment 0.0835 0.00591 0.7 0.7001 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O01 compound treatment 0.072 -0.00559 -0.66 -0.6626 -1.0 2075155 MixCom4_000290 CN1CCN(CC1)c2ccc(CNC(=O)c3csc4ccccc34)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O02 compound treatment 0.071 -0.00659 -0.78 -0.7811 -1.0 2080039 MixCom4_000291 OC1CCN(CC1)c2cc(nc(n2)c3ccccc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O03 compound treatment 0.0795 0.00191 0.23 0.2261 1.0 2075156 MixCom4_000292 OC(CN1CCC(CC1)C(=O)c2ccc(F)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O04 compound treatment 0.076 -0.00159 -0.19 -0.1886 -1.0 2080040 MixCom4_000293 OC1CCN(CC1)c2cc(nc(n2)c3cccnc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O05 compound treatment 0.0835 0.00591 0.7 0.7001 1.0 2075157 MixCom4_000294 CN1CCN(CC1)c2ccc(CNS(=O)(=O)c3ccccc3C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O06 compound treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 2080041 MixCom4_000295 CN(Cc1ccccc1)c2cc(nc(n2)c3ccncc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O07 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2075158 MixCom4_000296 CN1CCN(CC1)c2ccc(CNS(=O)(=O)Cc3cccc(c3)C(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O08 compound treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 2080042 MixCom4_000297 Cc1nc(NCCC#N)cc(n1)c2ccccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O09 compound treatment 0.0695 -0.00809 -0.96 -0.9588 -1.0 2075159 MixCom4_000298 Cn1cccc1CNCC(O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O10 compound treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 2080043 MixCom4_000299 CN(Cc1ccccc1)c2cc(nc(C)n2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O11 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 1677557 MixCom4_000300 CC1CCN(CC1)C(=O)CN2C(=O)c3ccccc3C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O12 compound treatment 0.0715 -0.00609 -0.72 -0.7218 -1.0 2080044 MixCom4_000301 Cc1nc(NCCc2ccccc2)cc(n1)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O13 compound treatment 0.0705 -0.00709 -0.84 -0.8403 -1.0 2075160 MixCom4_000302 COc1cc2CCN(Cc2cc1OC)C(=O)C3CCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O14 compound treatment 0.0705 -0.00709 -0.84 -0.8403 -1.0 2080045 MixCom4_000303 Fc1ccccc1c2cc(nc(n2)c3ccccc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O15 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2075161 MixCom4_000304 Cc1ccc(F)cc1S(=O)(=O)Nc2ccc3N4CCCC4COc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O16 compound treatment 0.085 0.00741 0.88 0.8778 1.0 2080046 MixCom4_000305 Fc1ccccc1c2cc(NCc3ccncc3)nc(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O17 compound treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 2075162 MixCom4_000306 OC(CNCc1ccc(F)cc1)CO/N=C/C2=C(Cl)c3cc(Cl)ccc3OC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O18 compound treatment 0.08 0.00241 0.29 0.2853 1.0 2080047 MixCom4_000307 Fc1ccccc1c2cc(NCc3ccco3)nc(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O19 compound treatment 0.0765 -0.00109 -0.13 -0.1294 -1.0 1606129 MixCom4_000308 Clc1cccc(Cl)c1c2noc(CN3CCCCC3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O20 compound treatment 0.0815 0.00391 0.46 0.4631 1.0 2080048 MixCom4_000309 CN1CCN(CC1)c2cc(nc(n2)c3ccncc3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O21 compound treatment 0.077 -5.92E-4 -0.07 -0.0701 -1.0 2075163 MixCom4_000310 CN(C)/C=C/C(=O)c1cc(no1)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O22 compound treatment 0.0735 -0.00409 -0.48 -0.4848 -1.0 2080049 MixCom4_000311 CCN(CC)c1cc(nc(C)n1)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O23 mock treatment 0.0815 0.00391 0.46 0.4631 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 O24 mock treatment 0.0825 0.00491 0.58 0.5816 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P01 compound treatment 0.0705 -0.00709 -0.84 -0.8403 -1.0 2080050 MixCom4_000312 Cc1nc(NCc2ccccc2)cc(n1)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P02 compound treatment 0.071 -0.00659 -0.78 -0.7811 -1.0 2075102 MixCom4_000313 NC(=O)C1=CN(Cc2ccc(Cl)cc2)CCC1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P03 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2080052 MixCom4_000314 COc1ccc(cc1)c2cnc(nc2)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P04 compound treatment 0.07 -0.00759 -0.9 -0.8996 -1.0 1443609 MixCom4_000315 CN1CCN(CC1)c2ccc(NS(=O)(=O)c3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P05 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2080054 MixCom4_000316 Fc1ccc(CC(=O)N2CCNC(=O)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P06 mock treatment 0.0755 -0.00209 -0.25 -0.2479 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P07 compound treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 2080055 MixCom4_000317 CN1CCN(CC1)c2ccc(cc2F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P08 mock treatment 0.076 -0.00159 -0.19 -0.1886 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P09 compound treatment 0.0665 -0.0111 -1.31 -1.3143 -1.0 2080056 MixCom4_000318 CN(C)CCNc1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P10 compound treatment 0.069 -0.00859 -1.02 -1.018 -1.0 2080057 MixCom4_000319 CC(C)CC(=O)N1CCc2nc3c(C)cccn3c(=O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P11 compound treatment 0.0685 -0.00909 -1.08 -1.0773 -1.0 2080058 MixCom4_000320 CS(=O)(=O)c1ccc(cc1)N2CCc3ccccc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P12 compound treatment 0.0675 -0.0101 -1.2 -1.1958 -1.0 2080059 MixCom4_000321 Cc1cccc2nc3CCN(Cc3c(=O)n12)C(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P13 compound treatment 0.0655 -0.0121 -1.43 -1.4328 -1.0 2080060 MixCom4_000322 CS(=O)(=O)c1ccc(cc1)N2CCN(CC2)C(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P14 compound treatment 0.0745 -0.00309 -0.37 -0.3664 -1.0 2080061 MixCom4_000323 Cc1cccc2nc3CCN(Cc3c(=O)n12)C(=O)c4ccc(cc4)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P15 compound treatment 0.074 -0.00359 -0.43 -0.4256 -1.0 2080062 MixCom4_000324 CC(=O)N1CCCN(CC1)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P16 compound treatment 0.077 -5.92E-4 -0.07 -0.0701 -1.0 2080063 MixCom4_000325 CN1CCC(CC1)N(C(=O)c2ccc(cc2)C(F)(F)F)c3ccc4N(CCc4c3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P17 compound treatment 0.068 -0.00959 -1.14 -1.1365 -1.0 2080064 MixCom4_000326 O=C(Cc1ccccc1)N2CCc3nc4ccccn4c(=O)c3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P18 compound treatment 0.079 0.00141 0.17 0.1669 1.0 2080065 MixCom4_000327 COc1cccc(OC)c1CN2CCC(CC2)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P19 compound treatment 0.076 -0.00159 -0.19 -0.1886 -1.0 2080066 MixCom4_000328 Cc1ccccc1C(=O)N2CCc3nc4ccccn4c(=O)c3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P20 compound treatment 0.0855 0.00791 0.94 0.937 1.0 2080067 MixCom4_000329 O=C(NCCN1CCOCC1)c2cccc3cc[nH]c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P21 compound treatment 0.0715 -0.00609 -0.72 -0.7218 -1.0 2080068 MixCom4_000330 Cc1cccn2c(=O)c3CN(CCc3nc12)C(=O)Cc4cc(F)cc(F)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P22 compound treatment 0.0765 -0.00109 -0.13 -0.1294 -1.0 2080069 MixCom4_000331 CN1CCN(CC1)c2nc3ccccc3n4ccnc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P23 mock treatment 0.0655 -0.0121 -1.43 -1.4328 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1306 P24 mock treatment 0.063 -0.0146 -1.73 -1.729 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A01 compound treatment 0.0865 0.0114 1.35 1.3497 1.0 Starr1_000001 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A02 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000002 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A03 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000003 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A04 compound treatment 0.082 0.00689 0.82 0.8165 1.0 Starr1_000004 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A05 compound treatment 0.081 0.00589 0.7 0.698 1.0 Starr1_000005 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A06 compound treatment 0.0585 -0.0166 -1.97 -1.968 -1.0 Starr1_000006 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A07 compound treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 Starr1_000007 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A08 compound treatment 0.0705 -0.00461 -0.55 -0.5462 -1.0 Starr1_000008 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A09 compound treatment 0.0675 -0.00761 -0.9 -0.9016 -1.0 Starr1_000009 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A10 compound treatment 0.0645 -0.0106 -1.26 -1.2571 -1.0 Starr1_000010 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A11 compound treatment 0.068 -0.00711 -0.84 -0.8424 -1.0 Starr1_000011 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A12 compound treatment 0.059 -0.0161 -1.91 -1.9088 -1.0 Starr1_000012 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A13 compound treatment 0.067 -0.00811 -0.96 -0.9609 -1.0 Starr1_000013 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A14 compound treatment 0.065 -0.0101 -1.2 -1.1979 -1.0 Starr1_000014 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A15 compound treatment 0.0645 -0.0106 -1.26 -1.2571 -1.0 Starr1_000015 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A16 compound treatment 0.065 -0.0101 -1.2 -1.1979 -1.0 Starr1_000016 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A17 compound treatment 0.065 -0.0101 -1.2 -1.1979 -1.0 Starr1_000017 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A18 compound treatment 0.0705 -0.00461 -0.55 -0.5462 -1.0 Starr1_000018 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A19 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000019 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A20 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000020 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A21 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000021 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A22 compound treatment 0.0705 -0.00461 -0.55 -0.5462 -1.0 Starr1_000022 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A23 mock treatment 0.079 0.00389 0.46 0.461 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 A24 mock treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B01 compound treatment 0.083 0.00789 0.93 0.935 1.0 Starr1_000023 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B02 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000024 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B03 compound treatment 0.0815 0.00639 0.76 0.7572 1.0 Starr1_000025 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B04 compound treatment 0.0845 0.00939 1.11 1.1127 1.0 Starr1_000026 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B05 compound treatment 0.0825 0.00739 0.88 0.8757 1.0 Starr1_000027 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B06 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000028 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B07 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000029 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B08 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000030 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B09 compound treatment 0.071 -0.00411 -0.49 -0.4869 -1.0 Starr1_000031 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B10 compound treatment 0.067 -0.00811 -0.96 -0.9609 -1.0 Starr1_000032 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B11 compound treatment 0.067 -0.00811 -0.96 -0.9609 -1.0 Starr1_000033 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B12 compound treatment 0.065 -0.0101 -1.2 -1.1979 -1.0 Starr1_000034 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B13 compound treatment 0.067 -0.00811 -0.96 -0.9609 -1.0 Starr1_000035 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B14 compound treatment 0.066 -0.00911 -1.08 -1.0794 -1.0 Starr1_000036 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B15 compound treatment 0.063 -0.0121 -1.43 -1.4348 -1.0 Starr1_000037 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B16 compound treatment 0.0675 -0.00761 -0.9 -0.9016 -1.0 Starr1_000038 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B17 compound treatment 0.068 -0.00711 -0.84 -0.8424 -1.0 Starr1_000039 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B18 compound treatment 0.068 -0.00711 -0.84 -0.8424 -1.0 Starr1_000040 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B19 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000041 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B20 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000042 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B21 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000043 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B22 compound treatment 0.066 -0.00911 -1.08 -1.0794 -1.0 Starr1_000044 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B23 mock treatment 0.0695 -0.00561 -0.66 -0.6647 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 B24 mock treatment 0.0635 -0.0116 -1.38 -1.3756 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C01 compound treatment 0.0845 0.00939 1.11 1.1127 1.0 Starr1_000045 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C02 compound treatment 0.085 0.00989 1.17 1.1719 1.0 Starr1_000046 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C03 compound treatment 0.085 0.00989 1.17 1.1719 1.0 Starr1_000047 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C04 compound treatment 0.085 0.00989 1.17 1.1719 1.0 Starr1_000048 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C05 compound treatment 0.088 0.0129 1.53 1.5274 1.0 Starr1_000049 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C06 compound treatment 0.085 0.00989 1.17 1.1719 1.0 Starr1_000050 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C07 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000051 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C08 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000052 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C09 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000053 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C10 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000054 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C11 compound treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 Starr1_000055 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C12 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000056 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C13 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000057 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C14 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000058 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C15 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000059 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C16 compound treatment 0.088 0.0129 1.53 1.5274 1.0 Starr1_000060 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C17 compound treatment 0.072 -0.00311 -0.37 -0.3684 -1.0 Starr1_000061 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C18 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000062 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C19 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000063 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C20 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000064 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C21 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000065 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C22 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000066 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C23 mock treatment 0.077 0.00189 0.22 0.224 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 C24 mock treatment 0.0795 0.00439 0.52 0.5202 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D01 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000067 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D02 compound treatment 0.081 0.00589 0.7 0.698 1.0 Starr1_000068 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D03 compound treatment 0.0805 0.00539 0.64 0.6387 1.0 Starr1_000069 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D04 compound treatment 0.082 0.00689 0.82 0.8165 1.0 Starr1_000070 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D05 compound treatment 0.084 0.00889 1.05 1.0535 1.0 Starr1_000071 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D06 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000072 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D07 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000073 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D08 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000074 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D09 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000075 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D10 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000076 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D11 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000077 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D12 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000078 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D13 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000079 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D14 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000080 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D15 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000081 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D16 compound treatment 0.072 -0.00311 -0.37 -0.3684 -1.0 Starr1_000082 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D17 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000083 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D18 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000084 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D19 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000085 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D20 compound treatment 0.0775 0.00239 0.28 0.2833 1.0 Starr1_000086 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D21 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000087 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D22 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000088 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D23 mock treatment 0.0785 0.00339 0.4 0.4018 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 D24 mock treatment 0.0825 0.00739 0.88 0.8757 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E01 compound treatment 0.08 0.00489 0.58 0.5795 1.0 Starr1_000089 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E02 compound treatment 0.081 0.00589 0.7 0.698 1.0 Starr1_000090 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E03 compound treatment 0.083 0.00789 0.93 0.935 1.0 Starr1_000091 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E04 compound treatment 0.0855 0.0104 1.23 1.2312 1.0 Starr1_000092 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E05 compound treatment 0.086 0.0109 1.29 1.2904 1.0 Starr1_000093 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E06 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000094 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E07 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000095 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E08 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000096 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E09 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000097 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E10 compound treatment 0.0805 0.00539 0.64 0.6387 1.0 Starr1_000098 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E11 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000099 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E12 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000100 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E13 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000101 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E14 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000102 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E15 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000103 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E16 compound treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 Starr1_000104 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E17 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000105 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E18 compound treatment 0.072 -0.00311 -0.37 -0.3684 -1.0 Starr1_000106 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E19 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000107 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E20 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000108 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E21 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000109 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E22 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000110 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E23 mock treatment 0.077 0.00189 0.22 0.224 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 E24 mock treatment 0.078 0.00289 0.34 0.3425 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F01 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000111 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F02 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000112 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F03 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000113 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F04 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000114 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F05 compound treatment 0.083 0.00789 0.93 0.935 1.0 Starr1_000115 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F06 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000116 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F07 compound treatment 0.0775 0.00239 0.28 0.2833 1.0 Starr1_000117 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F08 compound treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 Starr1_000118 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F09 compound treatment 0.082 0.00689 0.82 0.8165 1.0 Starr1_000119 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F10 compound treatment 0.087 0.0119 1.41 1.4089 1.0 Starr1_000120 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F11 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000121 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F12 compound treatment 0.0775 0.00239 0.28 0.2833 1.0 Starr1_000122 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F13 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000123 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F14 compound treatment 0.0705 -0.00461 -0.55 -0.5462 -1.0 Starr1_000124 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F15 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000125 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F16 compound treatment 0.072 -0.00311 -0.37 -0.3684 -1.0 Starr1_000126 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F17 compound treatment 0.0855 0.0104 1.23 1.2312 1.0 Starr1_000127 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F18 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000128 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F19 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000129 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F20 compound treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 Starr1_000130 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F21 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000131 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F22 compound treatment 0.0725 -0.00261 -0.31 -0.3092 -1.0 Starr1_000132 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F23 mock treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 F24 mock treatment 0.076 8.91E-4 0.11 0.1055 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G01 compound treatment 0.08 0.00489 0.58 0.5795 1.0 Starr1_000133 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G02 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000134 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G03 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000135 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G04 compound treatment 0.0805 0.00539 0.64 0.6387 1.0 Starr1_000136 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G05 compound treatment 0.0825 0.00739 0.88 0.8757 1.0 Starr1_000137 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G06 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000138 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G07 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000139 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G08 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000140 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G09 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000141 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G10 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000142 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G11 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000143 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G12 compound treatment 0.0805 0.00539 0.64 0.6387 1.0 Starr1_000144 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G13 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000145 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G14 compound treatment 0.0815 0.00639 0.76 0.7572 1.0 Starr1_000146 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G15 compound treatment 0.072 -0.00311 -0.37 -0.3684 -1.0 Starr1_000147 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G16 compound treatment 0.0805 0.00539 0.64 0.6387 1.0 Starr1_000148 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G17 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000149 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G18 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000150 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G19 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000151 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G20 compound treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 Starr1_000152 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G21 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000153 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G22 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000154 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G23 mock treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 G24 mock treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H01 compound treatment 0.082 0.00689 0.82 0.8165 1.0 Starr1_000155 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H02 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000156 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H03 compound treatment 0.0835 0.00839 0.99 0.9942 1.0 Starr1_000157 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H04 compound treatment 0.085 0.00989 1.17 1.1719 1.0 Starr1_000158 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H05 compound treatment 0.086 0.0109 1.29 1.2904 1.0 Starr1_000159 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H06 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000160 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H07 compound treatment 0.086 0.0109 1.29 1.2904 1.0 Starr1_000161 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H08 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000162 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H09 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000163 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H10 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000164 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H11 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000165 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H12 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000166 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H13 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000167 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H14 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000168 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H15 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000169 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H16 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000170 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H17 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000171 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H18 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000172 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H19 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000173 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H20 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000174 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H21 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000175 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H22 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000176 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H23 mock treatment 0.0765 0.00139 0.16 0.1648 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 H24 mock treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I01 compound treatment 0.0815 0.00639 0.76 0.7572 1.0 Starr1_000177 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I02 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000178 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I03 compound treatment 0.08 0.00489 0.58 0.5795 1.0 Starr1_000179 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I04 compound treatment 0.081 0.00589 0.7 0.698 1.0 Starr1_000180 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I05 compound treatment 0.081 0.00589 0.7 0.698 1.0 Starr1_000181 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I06 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000182 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I07 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000183 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I08 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000184 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I09 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000185 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I10 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000186 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I11 compound treatment 0.071 -0.00411 -0.49 -0.4869 -1.0 Starr1_000187 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I12 compound treatment 0.069 -0.00611 -0.72 -0.7239 -1.0 Starr1_000188 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I13 compound treatment 0.06 -0.0151 -1.79 -1.7903 -1.0 Starr1_000189 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I14 compound treatment 0.067 -0.00811 -0.96 -0.9609 -1.0 Starr1_000190 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I15 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000191 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I16 compound treatment 0.0695 -0.00561 -0.66 -0.6647 -1.0 Starr1_000192 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I17 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000193 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I18 compound treatment 0.0705 -0.00461 -0.55 -0.5462 -1.0 Starr1_000194 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I19 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000195 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I20 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000196 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I21 compound treatment 0.0725 -0.00261 -0.31 -0.3092 -1.0 Starr1_000197 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I22 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000198 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I23 mock treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 I24 mock treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J01 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000199 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J02 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000200 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J03 compound treatment 0.0805 0.00539 0.64 0.6387 1.0 Starr1_000201 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J04 compound treatment 0.0815 0.00639 0.76 0.7572 1.0 Starr1_000202 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J05 compound treatment 0.087 0.0119 1.41 1.4089 1.0 Starr1_000203 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J06 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000204 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J07 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000205 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J08 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000206 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J09 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000207 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J10 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000208 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J11 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000209 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J12 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000210 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J13 compound treatment 0.0695 -0.00561 -0.66 -0.6647 -1.0 Starr1_000211 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J14 compound treatment 0.0695 -0.00561 -0.66 -0.6647 -1.0 Starr1_000212 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J15 compound treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 Starr1_000213 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J16 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000214 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J17 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000215 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J18 compound treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 Starr1_000216 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J19 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000217 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J20 compound treatment 0.072 -0.00311 -0.37 -0.3684 -1.0 Starr1_000218 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J21 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000219 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J22 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000220 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J23 mock treatment 0.0725 -0.00261 -0.31 -0.3092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 J24 mock treatment 0.072 -0.00311 -0.37 -0.3684 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K01 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000221 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K02 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000222 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K03 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000223 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K04 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000224 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K05 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000225 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K06 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000226 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K07 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000227 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K08 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000228 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K09 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000229 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K10 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000230 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K11 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000231 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K12 compound treatment 0.0705 -0.00461 -0.55 -0.5462 -1.0 Starr1_000232 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K13 compound treatment 0.07 -0.00511 -0.61 -0.6054 -1.0 Starr1_000233 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K14 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000234 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K15 compound treatment 0.071 -0.00411 -0.49 -0.4869 -1.0 Starr1_000235 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K16 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000236 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K17 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000237 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K18 compound treatment 0.083 0.00789 0.93 0.935 1.0 Starr1_000238 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K19 compound treatment 0.07 -0.00511 -0.61 -0.6054 -1.0 Starr1_000239 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K20 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000240 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K21 compound treatment 0.0685 -0.00661 -0.78 -0.7831 -1.0 Starr1_000241 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K22 compound treatment 0.0705 -0.00461 -0.55 -0.5462 -1.0 Starr1_000242 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K23 mock treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 K24 mock treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L01 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000243 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L02 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000244 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L03 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000245 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L04 compound treatment 0.081 0.00589 0.7 0.698 1.0 Starr1_000246 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L05 compound treatment 0.08 0.00489 0.58 0.5795 1.0 Starr1_000247 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L06 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000248 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L07 compound treatment 0.0815 0.00639 0.76 0.7572 1.0 Starr1_000249 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L08 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000250 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L09 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000251 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L10 compound treatment 0.087 0.0119 1.41 1.4089 1.0 Starr1_000252 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L11 compound treatment 0.0815 0.00639 0.76 0.7572 1.0 Starr1_000253 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L12 compound treatment 0.0815 0.00639 0.76 0.7572 1.0 Starr1_000254 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L13 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000255 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L14 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000256 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L15 compound treatment 0.08 0.00489 0.58 0.5795 1.0 Starr1_000257 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L16 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000258 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L17 compound treatment 0.086 0.0109 1.29 1.2904 1.0 Starr1_000259 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L18 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000260 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L19 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000261 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L20 compound treatment 0.0775 0.00239 0.28 0.2833 1.0 Starr1_000262 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L21 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000263 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L22 compound treatment 0.0725 -0.00261 -0.31 -0.3092 -1.0 Starr1_000264 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L23 mock treatment 0.0765 0.00139 0.16 0.1648 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 L24 mock treatment 0.078 0.00289 0.34 0.3425 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M01 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000265 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M02 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000266 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M03 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000267 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M04 compound treatment 0.08 0.00489 0.58 0.5795 1.0 Starr1_000268 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M05 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000269 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M06 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000270 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M07 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000271 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M08 compound treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 Starr1_000272 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M09 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000273 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M10 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000274 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M11 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000275 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M12 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000276 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M13 compound treatment 0.0725 -0.00261 -0.31 -0.3092 -1.0 Starr1_000277 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M14 compound treatment 0.0725 -0.00261 -0.31 -0.3092 -1.0 Starr1_000278 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M15 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000279 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M16 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000280 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M17 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000281 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M18 compound treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 Starr1_000282 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M19 compound treatment 0.072 -0.00311 -0.37 -0.3684 -1.0 Starr1_000283 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M20 compound treatment 0.071 -0.00411 -0.49 -0.4869 -1.0 Starr1_000284 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M21 compound treatment 0.071 -0.00411 -0.49 -0.4869 -1.0 Starr1_000285 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M22 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000286 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M23 mock treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 M24 mock treatment 0.074 -0.00111 -0.13 -0.1314 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N01 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000287 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N02 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000288 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N03 compound treatment 0.0815 0.00639 0.76 0.7572 1.0 Starr1_000289 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N04 compound treatment 0.084 0.00889 1.05 1.0535 1.0 Starr1_000290 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N05 compound treatment 0.081 0.00589 0.7 0.698 1.0 Starr1_000291 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N06 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000292 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N07 compound treatment 0.0865 0.0114 1.35 1.3497 1.0 Starr1_000293 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N08 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000294 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N09 compound treatment 0.0815 0.00639 0.76 0.7572 1.0 Starr1_000295 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N10 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000296 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N11 compound treatment 0.0825 0.00739 0.88 0.8757 1.0 Starr1_000297 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N12 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000298 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N13 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000299 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N14 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000300 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N15 compound treatment 0.082 0.00689 0.82 0.8165 1.0 Starr1_000301 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N16 compound treatment 0.078 0.00289 0.34 0.3425 1.0 Starr1_000302 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N17 compound treatment 0.081 0.00589 0.7 0.698 1.0 Starr1_000303 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N18 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000304 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N19 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000305 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N20 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000306 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N21 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000307 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N22 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000308 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N23 mock treatment 0.078 0.00289 0.34 0.3425 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 N24 mock treatment 0.077 0.00189 0.22 0.224 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O01 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000309 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O02 compound treatment 0.073 -0.00211 -0.25 -0.2499 -1.0 Starr1_000310 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O03 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000311 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O04 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000312 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O05 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000313 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O06 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000314 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O07 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000315 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O08 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000316 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O09 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000317 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O10 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000318 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O11 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000319 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O12 compound treatment 0.0775 0.00239 0.28 0.2833 1.0 Starr1_000320 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O13 compound treatment 0.08 0.00489 0.58 0.5795 1.0 Starr1_000321 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O14 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000322 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O15 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000323 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O16 compound treatment 0.084 0.00889 1.05 1.0535 1.0 Starr1_000324 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O17 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000325 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O18 compound treatment 0.0755 3.91E-4 0.05 0.0463 1.0 Starr1_000326 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O19 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000327 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O20 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000328 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O21 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000329 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O22 compound treatment 0.0765 0.00139 0.16 0.1648 1.0 Starr1_000330 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O23 mock treatment 0.0785 0.00339 0.4 0.4018 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 O24 mock treatment 0.0795 0.00439 0.52 0.5202 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P01 compound treatment 0.0735 -0.00161 -0.19 -0.1907 -1.0 Starr1_000331 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P02 compound treatment 0.07 -0.00511 -0.61 -0.6054 -1.0 Starr1_000332 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P03 compound treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 Starr1_000333 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P04 compound treatment 0.0705 -0.00461 -0.55 -0.5462 -1.0 Starr1_000334 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P05 compound treatment 0.0695 -0.00561 -0.66 -0.6647 -1.0 Starr1_000335 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P06 compound treatment 0.07 -0.00511 -0.61 -0.6054 -1.0 Starr1_000336 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P07 compound treatment 0.075 -1.09E-4 -0.01 -0.013 -1.0 Starr1_000337 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P08 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000338 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P09 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000339 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P10 compound treatment 0.0815 0.00639 0.76 0.7572 1.0 Starr1_000340 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P11 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000341 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P12 compound treatment 0.0795 0.00439 0.52 0.5202 1.0 Starr1_000342 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P13 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000343 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P14 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000344 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P15 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000345 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P16 compound treatment 0.0785 0.00339 0.4 0.4018 1.0 Starr1_000346 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P17 compound treatment 0.079 0.00389 0.46 0.461 1.0 Starr1_000347 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P18 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000348 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P19 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000349 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P20 compound treatment 0.077 0.00189 0.22 0.224 1.0 Starr1_000350 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P21 compound treatment 0.076 8.91E-4 0.11 0.1055 1.0 Starr1_000351 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P22 compound treatment 0.0745 -6.09E-4 -0.07 -0.0722 -1.0 Starr1_000352 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P23 mock treatment 0.0775 0.00239 0.28 0.2833 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1338 P24 mock treatment 0.0715 -0.00361 -0.43 -0.4277 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A01 compound treatment 0.087 0.0103 1.22 1.2193 1.0 Starr1_000353 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A02 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000354 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A03 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000355 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A04 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000356 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A05 compound treatment 0.088 0.0113 1.34 1.3378 1.0 Starr1_000357 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A06 compound treatment 0.0575 -0.0192 -2.28 -2.2762 -1.0 Starr1_000358 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A07 compound treatment 0.078 0.00129 0.15 0.1529 1.0 Starr1_000359 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A08 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000360 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A09 compound treatment 0.07 -0.00671 -0.8 -0.795 -1.0 Starr1_000361 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A10 compound treatment 0.063 -0.0137 -1.62 -1.6245 -1.0 Starr1_000362 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A11 compound treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 Starr1_000363 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A12 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000364 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A13 compound treatment 0.0695 -0.00721 -0.85 -0.8543 -1.0 Starr1_000365 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A14 compound treatment 0.071 -0.00571 -0.68 -0.6765 -1.0 Starr1_000366 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A15 compound treatment 0.067 -0.00971 -1.15 -1.1505 -1.0 Starr1_000367 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A16 compound treatment 0.066 -0.0107 -1.27 -1.269 -1.0 Starr1_000368 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A17 compound treatment 0.0655 -0.0112 -1.33 -1.3282 -1.0 Starr1_000369 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A18 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000370 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A19 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000371 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A20 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000372 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A21 compound treatment 0.07 -0.00671 -0.8 -0.795 -1.0 Starr1_000373 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A22 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000374 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A23 mock treatment 0.084 0.00729 0.86 0.8638 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 A24 mock treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B01 compound treatment 0.086 0.00929 1.1 1.1008 1.0 Starr1_000375 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B02 compound treatment 0.082 0.00529 0.63 0.6269 1.0 Starr1_000376 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B03 compound treatment 0.083 0.00629 0.75 0.7453 1.0 Starr1_000377 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B04 compound treatment 0.0845 0.00779 0.92 0.9231 1.0 Starr1_000378 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B05 compound treatment 0.0865 0.00979 1.16 1.1601 1.0 Starr1_000379 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B06 compound treatment 0.078 0.00129 0.15 0.1529 1.0 Starr1_000380 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B07 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000381 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B08 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000382 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B09 compound treatment 0.0705 -0.00621 -0.74 -0.7358 -1.0 Starr1_000383 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B10 compound treatment 0.07 -0.00671 -0.8 -0.795 -1.0 Starr1_000384 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B11 compound treatment 0.0665 -0.0102 -1.21 -1.2097 -1.0 Starr1_000385 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B12 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000386 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B13 compound treatment 0.0715 -0.00521 -0.62 -0.6173 -1.0 Starr1_000387 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B14 compound treatment 0.0705 -0.00621 -0.74 -0.7358 -1.0 Starr1_000388 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B15 compound treatment 0.0685 -0.00821 -0.97 -0.9728 -1.0 Starr1_000389 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B16 compound treatment 0.0665 -0.0102 -1.21 -1.2097 -1.0 Starr1_000390 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B17 compound treatment 0.07 -0.00671 -0.8 -0.795 -1.0 Starr1_000391 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B18 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000392 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B19 compound treatment 0.079 0.00229 0.27 0.2714 1.0 Starr1_000393 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B20 compound treatment 0.071 -0.00571 -0.68 -0.6765 -1.0 Starr1_000394 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B21 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000395 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B22 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000396 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B23 mock treatment 0.0775 7.9E-4 0.09 0.0936 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 B24 mock treatment 0.0685 -0.00821 -0.97 -0.9728 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C01 compound treatment 0.083 0.00629 0.75 0.7453 1.0 Starr1_000397 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C02 compound treatment 0.0815 0.00479 0.57 0.5676 1.0 Starr1_000398 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C03 compound treatment 0.084 0.00729 0.86 0.8638 1.0 Starr1_000399 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C04 compound treatment 0.0875 0.0108 1.28 1.2785 1.0 Starr1_000400 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C05 compound treatment 0.091 0.0143 1.69 1.6933 1.0 Starr1_000401 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C06 compound treatment 0.0895 0.0128 1.52 1.5155 1.0 Starr1_000402 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C07 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000403 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C08 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000404 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C09 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000405 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C10 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000406 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C11 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000407 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C12 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000408 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C13 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000409 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C14 compound treatment 0.0705 -0.00621 -0.74 -0.7358 -1.0 Starr1_000410 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C15 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000411 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C16 compound treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 Starr1_000412 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C17 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000413 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C18 compound treatment 0.0895 0.0128 1.52 1.5155 1.0 Starr1_000414 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C19 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000415 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C20 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000416 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C21 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000417 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C22 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000418 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C23 mock treatment 0.0795 0.00279 0.33 0.3306 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 C24 mock treatment 0.08 0.00329 0.39 0.3899 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D01 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000419 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D02 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000420 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D03 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000421 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D04 compound treatment 0.083 0.00629 0.75 0.7453 1.0 Starr1_000422 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D05 compound treatment 0.087 0.0103 1.22 1.2193 1.0 Starr1_000423 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D06 compound treatment 0.082 0.00529 0.63 0.6269 1.0 Starr1_000424 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D07 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000425 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D08 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000426 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D09 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000427 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D10 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000428 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D11 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000429 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D12 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000430 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D13 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000431 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D14 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000432 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D15 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000433 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D16 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000434 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D17 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000435 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D18 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000436 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D19 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000437 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D20 compound treatment 0.0795 0.00279 0.33 0.3306 1.0 Starr1_000438 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D21 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000439 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D22 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000440 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D23 mock treatment 0.0805 0.00379 0.45 0.4491 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 D24 mock treatment 0.0845 0.00779 0.92 0.9231 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E01 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000441 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E02 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000442 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E03 compound treatment 0.0835 0.00679 0.8 0.8046 1.0 Starr1_000443 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E04 compound treatment 0.085 0.00829 0.98 0.9823 1.0 Starr1_000444 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E05 compound treatment 0.0885 0.0118 1.4 1.397 1.0 Starr1_000445 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E06 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000446 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E07 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000447 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E08 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000448 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E09 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000449 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E10 compound treatment 0.079 0.00229 0.27 0.2714 1.0 Starr1_000450 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E11 compound treatment 0.0795 0.00279 0.33 0.3306 1.0 Starr1_000451 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E12 compound treatment 0.079 0.00229 0.27 0.2714 1.0 Starr1_000452 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E13 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000453 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E14 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000454 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E15 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000455 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E16 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000456 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E17 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000457 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E18 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000458 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E19 compound treatment 0.0795 0.00279 0.33 0.3306 1.0 Starr1_000459 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E20 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000460 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E21 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000461 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E22 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000462 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E23 mock treatment 0.08 0.00329 0.39 0.3899 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 E24 mock treatment 0.0805 0.00379 0.45 0.4491 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F01 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000463 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F02 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000464 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F03 compound treatment 0.078 0.00129 0.15 0.1529 1.0 Starr1_000465 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F04 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000466 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F05 compound treatment 0.085 0.00829 0.98 0.9823 1.0 Starr1_000467 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F06 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000468 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F07 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000469 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F08 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000470 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F09 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000471 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F10 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000472 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F11 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000473 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F12 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000474 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F13 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000475 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F14 compound treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 Starr1_000476 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F15 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000477 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F16 compound treatment 0.078 0.00129 0.15 0.1529 1.0 Starr1_000478 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F17 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000479 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F18 compound treatment 0.079 0.00229 0.27 0.2714 1.0 Starr1_000480 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F19 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000481 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F20 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000482 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F21 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000483 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F22 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000484 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F23 mock treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 F24 mock treatment 0.079 0.00229 0.27 0.2714 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G01 compound treatment 0.078 0.00129 0.15 0.1529 1.0 Starr1_000485 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G02 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000486 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G03 compound treatment 0.079 0.00229 0.27 0.2714 1.0 Starr1_000487 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G04 compound treatment 0.0815 0.00479 0.57 0.5676 1.0 Starr1_000488 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G05 compound treatment 0.0845 0.00779 0.92 0.9231 1.0 Starr1_000489 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G06 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000490 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G07 compound treatment 0.0835 0.00679 0.8 0.8046 1.0 Starr1_000491 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G08 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000492 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G09 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000493 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G10 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000494 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G11 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000495 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G12 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000496 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G13 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000497 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G14 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000498 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G15 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000499 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G16 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000500 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G17 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000501 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G18 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000502 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G19 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000503 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G20 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000504 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G21 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000505 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G22 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000506 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G23 mock treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 G24 mock treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H01 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000507 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H02 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000508 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H03 compound treatment 0.0815 0.00479 0.57 0.5676 1.0 Starr1_000509 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H04 compound treatment 0.0815 0.00479 0.57 0.5676 1.0 Starr1_000510 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H05 compound treatment 0.0835 0.00679 0.8 0.8046 1.0 Starr1_000511 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H06 compound treatment 0.085 0.00829 0.98 0.9823 1.0 Starr1_000512 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H07 compound treatment 0.083 0.00629 0.75 0.7453 1.0 Starr1_000513 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H08 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000514 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H09 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000515 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H10 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000516 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H11 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000517 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H12 compound treatment 0.084 0.00729 0.86 0.8638 1.0 Starr1_000518 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H13 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000519 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H14 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000520 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H15 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000521 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H16 compound treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 Starr1_000522 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H17 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000523 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H18 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000524 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H19 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000525 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H20 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000526 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H21 compound treatment 0.079 0.00229 0.27 0.2714 1.0 Starr1_000527 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H22 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000528 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H23 mock treatment 0.0775 7.9E-4 0.09 0.0936 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 H24 mock treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I01 compound treatment 0.078 0.00129 0.15 0.1529 1.0 Starr1_000529 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I02 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000530 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I03 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000531 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I04 compound treatment 0.079 0.00229 0.27 0.2714 1.0 Starr1_000532 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I05 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000533 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I06 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000534 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I07 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000535 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I08 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000536 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I09 compound treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 Starr1_000537 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I10 compound treatment 0.0715 -0.00521 -0.62 -0.6173 -1.0 Starr1_000538 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I11 compound treatment 0.07 -0.00671 -0.8 -0.795 -1.0 Starr1_000539 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I12 compound treatment 0.0675 -0.00921 -1.09 -1.0913 -1.0 Starr1_000540 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I13 compound treatment 0.0605 -0.0162 -1.92 -1.9207 -1.0 Starr1_000541 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I14 compound treatment 0.0675 -0.00921 -1.09 -1.0913 -1.0 Starr1_000542 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I15 compound treatment 0.071 -0.00571 -0.68 -0.6765 -1.0 Starr1_000543 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I16 compound treatment 0.0695 -0.00721 -0.85 -0.8543 -1.0 Starr1_000544 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I17 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000545 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I18 compound treatment 0.071 -0.00571 -0.68 -0.6765 -1.0 Starr1_000546 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I19 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000547 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I20 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000548 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I21 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000549 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I22 compound treatment 0.078 0.00129 0.15 0.1529 1.0 Starr1_000550 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I23 mock treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 I24 mock treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J01 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000551 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J02 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000552 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J03 compound treatment 0.0795 0.00279 0.33 0.3306 1.0 Starr1_000553 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J04 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000554 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J05 compound treatment 0.081 0.00429 0.51 0.5084 1.0 Starr1_000555 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J06 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000556 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J07 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000557 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J08 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000558 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J09 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000559 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J10 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000560 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J11 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000561 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J12 compound treatment 0.071 -0.00571 -0.68 -0.6765 -1.0 Starr1_000562 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J13 compound treatment 0.07 -0.00671 -0.8 -0.795 -1.0 Starr1_000563 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J14 compound treatment 0.07 -0.00671 -0.8 -0.795 -1.0 Starr1_000564 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J15 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000565 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J16 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000566 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J17 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000567 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J18 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000568 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J19 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000569 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J20 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000570 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J21 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000571 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J22 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000572 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J23 mock treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 J24 mock treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K01 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000573 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K02 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000574 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K03 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000575 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K04 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000576 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K05 compound treatment 0.0795 0.00279 0.33 0.3306 1.0 Starr1_000577 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K06 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000578 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K07 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000579 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K08 compound treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 Starr1_000580 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K09 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000581 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K10 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000582 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K11 compound treatment 0.0715 -0.00521 -0.62 -0.6173 -1.0 Starr1_000583 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K12 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000584 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K13 compound treatment 0.0715 -0.00521 -0.62 -0.6173 -1.0 Starr1_000585 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K14 compound treatment 0.0715 -0.00521 -0.62 -0.6173 -1.0 Starr1_000586 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K15 compound treatment 0.0715 -0.00521 -0.62 -0.6173 -1.0 Starr1_000587 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K16 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000588 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K17 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000589 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K18 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000590 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K19 compound treatment 0.071 -0.00571 -0.68 -0.6765 -1.0 Starr1_000591 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K20 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000592 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K21 compound treatment 0.07 -0.00671 -0.8 -0.795 -1.0 Starr1_000593 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K22 compound treatment 0.0705 -0.00621 -0.74 -0.7358 -1.0 Starr1_000594 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K23 mock treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 K24 mock treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L01 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000595 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L02 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000596 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L03 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000597 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L04 compound treatment 0.081 0.00429 0.51 0.5084 1.0 Starr1_000598 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L05 compound treatment 0.082 0.00529 0.63 0.6269 1.0 Starr1_000599 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L06 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000600 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L07 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000601 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L08 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000602 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L09 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000603 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L10 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000604 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L11 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000605 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L12 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000606 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L13 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000607 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L14 compound treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 Starr1_000608 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L15 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000609 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L16 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000610 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L17 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000611 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L18 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000612 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L19 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000613 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L20 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000614 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L21 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000615 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L22 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000616 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L23 mock treatment 0.077 2.9E-4 0.03 0.0344 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 L24 mock treatment 0.0805 0.00379 0.45 0.4491 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M01 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000617 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M02 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000618 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M03 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000619 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M04 compound treatment 0.081 0.00429 0.51 0.5084 1.0 Starr1_000620 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M05 compound treatment 0.0795 0.00279 0.33 0.3306 1.0 Starr1_000621 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M06 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000622 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M07 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000623 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M08 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000624 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M09 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000625 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M10 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000626 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M11 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000627 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M12 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000628 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M13 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000629 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M14 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000630 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M15 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000631 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M16 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000632 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M17 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000633 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M18 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000634 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M19 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000635 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M20 compound treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 Starr1_000636 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M21 compound treatment 0.071 -0.00571 -0.68 -0.6765 -1.0 Starr1_000637 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M22 compound treatment 0.0715 -0.00521 -0.62 -0.6173 -1.0 Starr1_000638 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M23 mock treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 M24 mock treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N01 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000639 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N02 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000640 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N03 compound treatment 0.0795 0.00279 0.33 0.3306 1.0 Starr1_000641 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N04 compound treatment 0.0825 0.00579 0.69 0.6861 1.0 Starr1_000642 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N05 compound treatment 0.0805 0.00379 0.45 0.4491 1.0 Starr1_000643 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N06 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000644 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N07 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000645 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N08 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000646 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N09 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000647 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N10 compound treatment 0.0825 0.00579 0.69 0.6861 1.0 Starr1_000648 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N11 compound treatment 0.078 0.00129 0.15 0.1529 1.0 Starr1_000649 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N12 compound treatment 0.0895 0.0128 1.52 1.5155 1.0 Starr1_000650 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N13 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000651 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N14 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000652 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N15 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000653 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N16 compound treatment 0.0785 0.00179 0.21 0.2121 1.0 Starr1_000654 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N17 compound treatment 0.08 0.00329 0.39 0.3899 1.0 Starr1_000655 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N18 compound treatment 0.079 0.00229 0.27 0.2714 1.0 Starr1_000656 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N19 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000657 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N20 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000658 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N21 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000659 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N22 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000660 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N23 mock treatment 0.078 0.00129 0.15 0.1529 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 N24 mock treatment 0.0775 7.9E-4 0.09 0.0936 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O01 compound treatment 0.07 -0.00671 -0.8 -0.795 -1.0 Starr1_000661 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O02 compound treatment 0.071 -0.00571 -0.68 -0.6765 -1.0 Starr1_000662 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O03 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000663 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O04 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000664 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O05 compound treatment 0.0795 0.00279 0.33 0.3306 1.0 Starr1_000665 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O06 compound treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 Starr1_000666 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O07 compound treatment 0.077 2.9E-4 0.03 0.0344 1.0 Starr1_000667 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O08 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000668 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O09 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000669 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O10 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000670 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O11 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000671 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O12 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000672 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O13 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000673 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O14 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000674 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O15 compound treatment 0.075 -0.00171 -0.2 -0.2026 -1.0 Starr1_000675 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O16 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000676 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O17 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000677 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O18 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000678 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O19 compound treatment 0.076 -7.1E-4 -0.08 -0.0841 -1.0 Starr1_000679 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O20 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000680 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O21 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000681 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O22 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000682 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O23 mock treatment 0.079 0.00229 0.27 0.2714 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 O24 mock treatment 0.0775 7.9E-4 0.09 0.0936 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P01 compound treatment 0.068 -0.00871 -1.03 -1.032 -1.0 Starr1_000683 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P02 compound treatment 0.0585 -0.0182 -2.16 -2.1577 -1.0 Starr1_000684 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P03 compound treatment 0.0675 -0.00921 -1.09 -1.0913 -1.0 Starr1_000685 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P04 compound treatment 0.066 -0.0107 -1.27 -1.269 -1.0 Starr1_000686 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P05 compound treatment 0.07 -0.00671 -0.8 -0.795 -1.0 Starr1_000687 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P06 compound treatment 0.066 -0.0107 -1.27 -1.269 -1.0 Starr1_000688 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P07 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000689 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P08 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000690 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P09 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000691 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P10 compound treatment 0.0735 -0.00321 -0.38 -0.3803 -1.0 Starr1_000692 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P11 compound treatment 0.0745 -0.00221 -0.26 -0.2618 -1.0 Starr1_000693 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P12 compound treatment 0.0755 -0.00121 -0.14 -0.1433 -1.0 Starr1_000694 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P13 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000695 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P14 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000696 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P15 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000697 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P16 compound treatment 0.074 -0.00271 -0.32 -0.3211 -1.0 Starr1_000698 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P17 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000699 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P18 compound treatment 0.0775 7.9E-4 0.09 0.0936 1.0 Starr1_000700 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P19 compound treatment 0.073 -0.00371 -0.44 -0.4396 -1.0 Starr1_000701 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P20 compound treatment 0.0765 -2.1E-4 -0.02 -0.0248 -1.0 Starr1_000702 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P21 compound treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 Starr1_000703 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P22 compound treatment 0.072 -0.00471 -0.56 -0.5581 -1.0 Starr1_000704 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P23 mock treatment 0.0725 -0.00421 -0.5 -0.4988 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1339 P24 mock treatment 0.063 -0.0137 -1.62 -1.6245 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A01 compound treatment 0.084 0.00857 1.02 1.0158 1.0 Starr1_000705 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A02 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000706 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A03 compound treatment 0.078 0.00257 0.3 0.3048 1.0 Starr1_000707 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A04 compound treatment 0.0795 0.00407 0.48 0.4826 1.0 Starr1_000708 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A05 compound treatment 0.085 0.00957 1.13 1.1343 1.0 Starr1_000709 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A06 compound treatment 0.0655 -0.00993 -1.18 -1.1763 -1.0 Starr1_000710 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A07 compound treatment 0.072 -0.00343 -0.41 -0.4061 -1.0 Starr1_000711 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A08 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000712 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A09 compound treatment 0.0785 0.00307 0.36 0.3641 1.0 Starr1_000713 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A10 compound treatment 0.0675 -0.00793 -0.94 -0.9393 -1.0 Starr1_000714 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A11 compound treatment 0.07 -0.00543 -0.64 -0.6431 -1.0 Starr1_000715 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A12 compound treatment 0.0675 -0.00793 -0.94 -0.9393 -1.0 Starr1_000716 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A13 compound treatment 0.067 -0.00843 -1.0 -0.9986 -1.0 Starr1_000717 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A14 compound treatment 0.0675 -0.00793 -0.94 -0.9393 -1.0 Starr1_000718 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A15 compound treatment 0.067 -0.00843 -1.0 -0.9986 -1.0 Starr1_000719 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A16 compound treatment 0.0665 -0.00893 -1.06 -1.0578 -1.0 Starr1_000720 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A17 compound treatment 0.059 -0.0164 -1.95 -1.9465 -1.0 Starr1_000721 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A18 compound treatment 0.0655 -0.00993 -1.18 -1.1763 -1.0 Starr1_000722 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A19 compound treatment 0.078 0.00257 0.3 0.3048 1.0 Starr1_000723 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A20 compound treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 Starr1_000724 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A21 compound treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 Starr1_000725 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A22 mock treatment 0.0675 -0.00793 -0.94 -0.9393 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A23 mock treatment 0.0805 0.00507 0.6 0.6011 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 A24 mock treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B01 compound treatment 0.085 0.00957 1.13 1.1343 1.0 Starr1_000726 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B02 compound treatment 0.079 0.00357 0.42 0.4233 1.0 Starr1_000727 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B03 compound treatment 0.0825 0.00707 0.84 0.838 1.0 Starr1_000728 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B04 compound treatment 0.085 0.00957 1.13 1.1343 1.0 Starr1_000729 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B05 compound treatment 0.0855 0.0101 1.19 1.1935 1.0 Starr1_000730 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B06 compound treatment 0.081 0.00557 0.66 0.6603 1.0 Starr1_000731 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B07 compound treatment 0.08 0.00457 0.54 0.5418 1.0 Starr1_000732 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B08 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000733 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B09 compound treatment 0.072 -0.00343 -0.41 -0.4061 -1.0 Starr1_000734 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B10 compound treatment 0.0715 -0.00393 -0.47 -0.4654 -1.0 Starr1_000735 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B11 compound treatment 0.069 -0.00643 -0.76 -0.7616 -1.0 Starr1_000736 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B12 compound treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 Starr1_000737 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B13 compound treatment 0.069 -0.00643 -0.76 -0.7616 -1.0 Starr1_000738 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B14 compound treatment 0.0695 -0.00593 -0.7 -0.7023 -1.0 Starr1_000739 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B15 compound treatment 0.069 -0.00643 -0.76 -0.7616 -1.0 Starr1_000740 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B16 compound treatment 0.0675 -0.00793 -0.94 -0.9393 -1.0 Starr1_000741 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B17 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000742 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B18 compound treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 Starr1_000743 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B19 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000744 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B20 compound treatment 0.067 -0.00843 -1.0 -0.9986 -1.0 Starr1_000745 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B21 compound treatment 0.068 -0.00743 -0.88 -0.8801 -1.0 Starr1_000746 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B22 mock treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B23 mock treatment 0.0795 0.00407 0.48 0.4826 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 B24 mock treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C01 compound treatment 0.0815 0.00607 0.72 0.7195 1.0 Starr1_000747 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C02 compound treatment 0.0815 0.00607 0.72 0.7195 1.0 Starr1_000748 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C03 compound treatment 0.084 0.00857 1.02 1.0158 1.0 Starr1_000749 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C04 compound treatment 0.094 0.0186 2.2 2.2007 1.0 Starr1_000750 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C05 compound treatment 0.0885 0.0131 1.55 1.549 1.0 Starr1_000751 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C06 compound treatment 0.0815 0.00607 0.72 0.7195 1.0 Starr1_000752 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C07 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000753 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C08 compound treatment 0.099 0.0236 2.79 2.7931 1.0 Starr1_000754 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C09 compound treatment 0.081 0.00557 0.66 0.6603 1.0 Starr1_000755 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C10 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000756 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C11 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000757 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C12 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000758 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C13 compound treatment 0.071 -0.00443 -0.52 -0.5246 -1.0 Starr1_000759 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C14 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000760 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C15 compound treatment 0.0875 0.0121 1.43 1.4305 1.0 Starr1_000761 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C16 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000762 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C17 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000763 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C18 compound treatment 0.079 0.00357 0.42 0.4233 1.0 Starr1_000764 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C19 compound treatment 0.0795 0.00407 0.48 0.4826 1.0 Starr1_000765 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C20 compound treatment 0.0845 0.00907 1.08 1.075 1.0 Starr1_000766 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C21 compound treatment 0.08 0.00457 0.54 0.5418 1.0 Starr1_000767 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C22 mock treatment 0.076 5.73E-4 0.07 0.0678 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C23 mock treatment 0.078 0.00257 0.3 0.3048 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 C24 mock treatment 0.0805 0.00507 0.6 0.6011 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D01 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000768 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D02 compound treatment 0.0775 0.00207 0.25 0.2456 1.0 Starr1_000769 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D03 compound treatment 0.0805 0.00507 0.6 0.6011 1.0 Starr1_000770 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D04 compound treatment 0.08 0.00457 0.54 0.5418 1.0 Starr1_000771 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D05 compound treatment 0.084 0.00857 1.02 1.0158 1.0 Starr1_000772 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D06 compound treatment 0.0815 0.00607 0.72 0.7195 1.0 Starr1_000773 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D07 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000774 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D08 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000775 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D09 mock treatment 0.0775 0.00207 0.25 0.2456 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D10 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000776 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D11 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000777 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D12 compound treatment 0.0775 0.00207 0.25 0.2456 1.0 Starr1_000778 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D13 compound treatment 0.087 0.0116 1.37 1.3712 1.0 Starr1_000779 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D14 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000780 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D15 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000781 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D16 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000782 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D17 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000783 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D18 compound treatment 0.076 5.73E-4 0.07 0.0678 1.0 Starr1_000784 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D19 compound treatment 0.0795 0.00407 0.48 0.4826 1.0 Starr1_000785 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D20 compound treatment 0.078 0.00257 0.3 0.3048 1.0 Starr1_000786 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D21 compound treatment 0.0785 0.00307 0.36 0.3641 1.0 Starr1_000787 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D22 mock treatment 0.077 0.00157 0.19 0.1863 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D23 mock treatment 0.0795 0.00407 0.48 0.4826 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 D24 mock treatment 0.0825 0.00707 0.84 0.838 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E01 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000788 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E02 compound treatment 0.079 0.00357 0.42 0.4233 1.0 Starr1_000789 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E03 compound treatment 0.08 0.00457 0.54 0.5418 1.0 Starr1_000790 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E04 compound treatment 0.083 0.00757 0.9 0.8973 1.0 Starr1_000791 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E05 compound treatment 0.085 0.00957 1.13 1.1343 1.0 Starr1_000792 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E06 compound treatment 0.0935 0.0181 2.14 2.1414 1.0 Starr1_000793 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E07 compound treatment 0.0805 0.00507 0.6 0.6011 1.0 Starr1_000794 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E08 compound treatment 0.078 0.00257 0.3 0.3048 1.0 Starr1_000795 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E09 mock treatment 0.0805 0.00507 0.6 0.6011 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E10 compound treatment 0.076 5.73E-4 0.07 0.0678 1.0 Starr1_000796 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E11 compound treatment 0.078 0.00257 0.3 0.3048 1.0 Starr1_000797 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E12 compound treatment 0.099 0.0236 2.79 2.7931 1.0 Starr1_000798 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E13 compound treatment 0.0845 0.00907 1.08 1.075 1.0 Starr1_000799 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E14 compound treatment 0.0845 0.00907 1.08 1.075 1.0 Starr1_000800 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E15 compound treatment 0.111 0.0356 4.21 4.215 1.0 Starr1_000801 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E16 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000802 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E17 compound treatment 0.104 0.0286 3.39 3.3856 1.0 Starr1_000803 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E18 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000804 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E19 compound treatment 0.0895 0.0141 1.67 1.6675 1.0 Starr1_000805 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E20 compound treatment 0.0775 0.00207 0.25 0.2456 1.0 Starr1_000806 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E21 compound treatment 0.079 0.00357 0.42 0.4233 1.0 Starr1_000807 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E22 mock treatment 0.077 0.00157 0.19 0.1863 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E23 mock treatment 0.0795 0.00407 0.48 0.4826 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 E24 mock treatment 0.08 0.00457 0.54 0.5418 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F01 compound treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 Starr1_000808 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F02 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000809 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F03 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000810 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F04 compound treatment 0.079 0.00357 0.42 0.4233 1.0 Starr1_000811 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F05 compound treatment 0.0825 0.00707 0.84 0.838 1.0 Starr1_000812 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F06 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000813 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F07 compound treatment 0.08 0.00457 0.54 0.5418 1.0 Starr1_000814 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F08 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000815 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F09 mock treatment 0.078 0.00257 0.3 0.3048 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F10 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000816 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F11 compound treatment 0.0885 0.0131 1.55 1.549 1.0 Starr1_000817 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F12 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000818 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F13 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000819 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F14 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000820 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F15 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000821 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F16 compound treatment 0.0835 0.00807 0.96 0.9565 1.0 Starr1_000822 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F17 compound treatment 0.076 5.73E-4 0.07 0.0678 1.0 Starr1_000823 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F18 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000824 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F19 compound treatment 0.0775 0.00207 0.25 0.2456 1.0 Starr1_000825 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F20 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000826 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F21 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000827 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F22 mock treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F23 mock treatment 0.0755 7.26E-5 0.01 0.0086 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 F24 mock treatment 0.078 0.00257 0.3 0.3048 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G01 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000828 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G02 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000829 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G03 compound treatment 0.0795 0.00407 0.48 0.4826 1.0 Starr1_000830 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G04 compound treatment 0.0825 0.00707 0.84 0.838 1.0 Starr1_000831 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G05 compound treatment 0.0815 0.00607 0.72 0.7195 1.0 Starr1_000832 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G06 compound treatment 0.0815 0.00607 0.72 0.7195 1.0 Starr1_000833 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G07 compound treatment 0.0805 0.00507 0.6 0.6011 1.0 Starr1_000834 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G08 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000835 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G09 mock treatment 0.0935 0.0181 2.14 2.1414 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G10 compound treatment 0.078 0.00257 0.3 0.3048 1.0 Starr1_000836 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G11 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000837 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G12 compound treatment 0.083 0.00757 0.9 0.8973 1.0 Starr1_000838 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G13 compound treatment 0.086 0.0106 1.25 1.2527 1.0 Starr1_000839 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G14 compound treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 Starr1_000840 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G15 compound treatment 0.085 0.00957 1.13 1.1343 1.0 Starr1_000841 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G16 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000842 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G17 compound treatment 0.0785 0.00307 0.36 0.3641 1.0 Starr1_000843 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G18 compound treatment 0.076 5.73E-4 0.07 0.0678 1.0 Starr1_000844 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G19 compound treatment 0.078 0.00257 0.3 0.3048 1.0 Starr1_000845 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G20 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000846 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G21 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000847 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G22 mock treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G23 mock treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 G24 mock treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H01 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000848 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H02 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000849 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H03 compound treatment 0.079 0.00357 0.42 0.4233 1.0 Starr1_000850 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H04 compound treatment 0.0805 0.00507 0.6 0.6011 1.0 Starr1_000851 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H05 compound treatment 0.0825 0.00707 0.84 0.838 1.0 Starr1_000852 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H06 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000853 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H07 compound treatment 0.083 0.00757 0.9 0.8973 1.0 Starr1_000854 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H08 compound treatment 0.076 5.73E-4 0.07 0.0678 1.0 Starr1_000855 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H09 mock treatment 0.077 0.00157 0.19 0.1863 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H10 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000856 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H11 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000857 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H12 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000858 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H13 compound treatment 0.07 -0.00543 -0.64 -0.6431 -1.0 Starr1_000859 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H14 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000860 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H15 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000861 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H16 compound treatment 0.072 -0.00343 -0.41 -0.4061 -1.0 Starr1_000862 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H17 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000863 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H18 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000864 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H19 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000865 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H20 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000866 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H21 compound treatment 0.0775 0.00207 0.25 0.2456 1.0 Starr1_000867 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H22 mock treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H23 mock treatment 0.077 0.00157 0.19 0.1863 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 H24 mock treatment 0.077 0.00157 0.19 0.1863 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I01 compound treatment 0.0775 0.00207 0.25 0.2456 1.0 Starr1_000868 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I02 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000869 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I03 compound treatment 0.0785 0.00307 0.36 0.3641 1.0 Starr1_000870 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I04 compound treatment 0.087 0.0116 1.37 1.3712 1.0 Starr1_000871 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I05 compound treatment 0.0795 0.00407 0.48 0.4826 1.0 Starr1_000872 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I06 compound treatment 0.084 0.00857 1.02 1.0158 1.0 Starr1_000873 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I07 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000874 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I08 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000875 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I09 mock treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I10 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000876 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I11 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000877 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I12 compound treatment 0.068 -0.00743 -0.88 -0.8801 -1.0 Starr1_000878 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I13 compound treatment 0.0615 -0.0139 -1.65 -1.6503 -1.0 Starr1_000879 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I14 compound treatment 0.0685 -0.00693 -0.82 -0.8208 -1.0 Starr1_000880 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I15 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000881 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I16 compound treatment 0.084 0.00857 1.02 1.0158 1.0 Starr1_000882 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I17 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000883 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I18 compound treatment 0.081 0.00557 0.66 0.6603 1.0 Starr1_000884 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I19 compound treatment 0.0835 0.00807 0.96 0.9565 1.0 Starr1_000885 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I20 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000886 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I21 compound treatment 0.076 5.73E-4 0.07 0.0678 1.0 Starr1_000887 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I22 mock treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I23 mock treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 I24 mock treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J01 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000888 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J02 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000889 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J03 compound treatment 0.08 0.00457 0.54 0.5418 1.0 Starr1_000890 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J04 compound treatment 0.08 0.00457 0.54 0.5418 1.0 Starr1_000891 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J05 compound treatment 0.0805 0.00507 0.6 0.6011 1.0 Starr1_000892 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J06 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000893 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J07 compound treatment 0.079 0.00357 0.42 0.4233 1.0 Starr1_000894 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J08 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000895 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J09 mock treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J10 compound treatment 0.0805 0.00507 0.6 0.6011 1.0 Starr1_000896 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J11 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000897 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J12 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000898 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J13 compound treatment 0.072 -0.00343 -0.41 -0.4061 -1.0 Starr1_000899 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J14 compound treatment 0.071 -0.00443 -0.52 -0.5246 -1.0 Starr1_000900 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J15 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000901 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J16 compound treatment 0.093 0.0176 2.08 2.0822 1.0 Starr1_000902 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J17 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000903 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J18 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000904 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J19 compound treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 Starr1_000905 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J20 compound treatment 0.0715 -0.00393 -0.47 -0.4654 -1.0 Starr1_000906 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J21 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000907 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J22 mock treatment 0.0755 7.26E-5 0.01 0.0086 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J23 mock treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 J24 mock treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K01 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000908 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K02 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000909 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K03 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000910 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K04 compound treatment 0.0815 0.00607 0.72 0.7195 1.0 Starr1_000911 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K05 compound treatment 0.081 0.00557 0.66 0.6603 1.0 Starr1_000912 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K06 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000913 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K07 compound treatment 0.089 0.0136 1.61 1.6082 1.0 Starr1_000914 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K08 compound treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 Starr1_000915 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K09 mock treatment 0.0755 7.26E-5 0.01 0.0086 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K10 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000916 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K11 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000917 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K12 compound treatment 0.078 0.00257 0.3 0.3048 1.0 Starr1_000918 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K13 compound treatment 0.0705 -0.00493 -0.58 -0.5839 -1.0 Starr1_000919 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K14 compound treatment 0.072 -0.00343 -0.41 -0.4061 -1.0 Starr1_000920 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K15 compound treatment 0.078 0.00257 0.3 0.3048 1.0 Starr1_000921 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K16 compound treatment 0.0835 0.00807 0.96 0.9565 1.0 Starr1_000922 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K17 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000923 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K18 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000924 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K19 compound treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 Starr1_000925 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K20 compound treatment 0.071 -0.00443 -0.52 -0.5246 -1.0 Starr1_000926 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K21 compound treatment 0.072 -0.00343 -0.41 -0.4061 -1.0 Starr1_000927 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K22 mock treatment 0.07 -0.00543 -0.64 -0.6431 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K23 mock treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 K24 mock treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L01 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000928 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L02 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000929 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L03 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000930 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L04 compound treatment 0.08 0.00457 0.54 0.5418 1.0 Starr1_000931 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L05 compound treatment 0.0785 0.00307 0.36 0.3641 1.0 Starr1_000932 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L06 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000933 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L07 compound treatment 0.081 0.00557 0.66 0.6603 1.0 Starr1_000934 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L08 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000935 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L09 mock treatment 0.0765 0.00107 0.13 0.1271 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L10 compound treatment 0.091 0.0156 1.85 1.8452 1.0 Starr1_000936 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L11 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000937 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L12 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000938 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L13 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000939 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L14 compound treatment 0.079 0.00357 0.42 0.4233 1.0 Starr1_000940 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L15 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000941 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L16 compound treatment 0.0835 0.00807 0.96 0.9565 1.0 Starr1_000942 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L17 compound treatment 0.0795 0.00407 0.48 0.4826 1.0 Starr1_000943 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L18 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000944 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L19 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000945 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L20 compound treatment 0.072 -0.00343 -0.41 -0.4061 -1.0 Starr1_000946 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L21 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000947 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L22 mock treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L23 mock treatment 0.0755 7.26E-5 0.01 0.0086 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 L24 mock treatment 0.079 0.00357 0.42 0.4233 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M01 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000948 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M02 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000949 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M03 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000950 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M04 compound treatment 0.083 0.00757 0.9 0.8973 1.0 Starr1_000951 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M05 compound treatment 0.1075 0.0321 3.8 3.8003 1.0 Starr1_000952 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M06 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000953 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M07 compound treatment 0.114 0.0386 4.57 4.5705 1.0 Starr1_000954 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M08 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000955 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M09 mock treatment 0.072 -0.00343 -0.41 -0.4061 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M10 compound treatment 0.085 0.00957 1.13 1.1343 1.0 Starr1_000956 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M11 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000957 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M12 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000958 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M13 compound treatment 0.0775 0.00207 0.25 0.2456 1.0 Starr1_000959 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M14 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000960 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M15 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000961 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M16 compound treatment 0.083 0.00757 0.9 0.8973 1.0 Starr1_000962 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M17 compound treatment 0.076 5.73E-4 0.07 0.0678 1.0 Starr1_000963 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M18 compound treatment 0.0895 0.0141 1.67 1.6675 1.0 Starr1_000964 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M19 compound treatment 0.078 0.00257 0.3 0.3048 1.0 Starr1_000965 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M20 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000966 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M21 compound treatment 0.0785 0.00307 0.36 0.3641 1.0 Starr1_000967 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M22 mock treatment 0.076 5.73E-4 0.07 0.0678 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M23 mock treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 M24 mock treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N01 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000968 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N02 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000969 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N03 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000970 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N04 compound treatment 0.079 0.00357 0.42 0.4233 1.0 Starr1_000971 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N05 compound treatment 0.0775 0.00207 0.25 0.2456 1.0 Starr1_000972 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N06 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_000973 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N07 compound treatment 0.0785 0.00307 0.36 0.3641 1.0 Starr1_000974 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N08 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000975 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N09 mock treatment 0.0755 7.26E-5 0.01 0.0086 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N10 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000976 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N11 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000977 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N12 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_000978 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N13 compound treatment 0.0815 0.00607 0.72 0.7195 1.0 Starr1_000979 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N14 compound treatment 0.08 0.00457 0.54 0.5418 1.0 Starr1_000980 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N15 compound treatment 0.076 5.73E-4 0.07 0.0678 1.0 Starr1_000981 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N16 compound treatment 0.08 0.00457 0.54 0.5418 1.0 Starr1_000982 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N17 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000983 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N18 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_000984 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N19 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000985 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N20 compound treatment 0.076 5.73E-4 0.07 0.0678 1.0 Starr1_000986 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N21 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_000987 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N22 mock treatment 0.0755 7.26E-5 0.01 0.0086 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N23 mock treatment 0.076 5.73E-4 0.07 0.0678 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 N24 mock treatment 0.0775 0.00207 0.25 0.2456 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O01 compound treatment 0.0715 -0.00393 -0.47 -0.4654 -1.0 Starr1_000988 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O02 compound treatment 0.07 -0.00543 -0.64 -0.6431 -1.0 Starr1_000989 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O03 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000990 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O04 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_000991 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O05 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_000992 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O06 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000993 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O07 compound treatment 0.0775 0.00207 0.25 0.2456 1.0 Starr1_000994 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O08 compound treatment 0.0715 -0.00393 -0.47 -0.4654 -1.0 Starr1_000995 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O09 mock treatment 0.0795 0.00407 0.48 0.4826 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O10 compound treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 Starr1_000996 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O11 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000997 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O12 compound treatment 0.0955 0.0201 2.38 2.3784 1.0 Starr1_000998 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O13 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_000999 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O14 compound treatment 0.075 -4.27E-4 -0.05 -0.0506 -1.0 Starr1_001000 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O15 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_001001 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O16 compound treatment 0.0815 0.00607 0.72 0.7195 1.0 Starr1_001002 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O17 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_001003 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O18 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_001004 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O19 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_001005 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O20 compound treatment 0.0775 0.00207 0.25 0.2456 1.0 Starr1_001006 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O21 mock treatment 0.073 -0.00243 -0.29 -0.2876 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O22 mock treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O23 mock treatment 0.0775 0.00207 0.25 0.2456 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 O24 mock treatment 0.076 5.73E-4 0.07 0.0678 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P01 compound treatment 0.067 -0.00843 -1.0 -0.9986 -1.0 Starr1_001007 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P02 compound treatment 0.0665 -0.00893 -1.06 -1.0578 -1.0 Starr1_001008 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P03 compound treatment 0.0665 -0.00893 -1.06 -1.0578 -1.0 Starr1_001009 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P04 compound treatment 0.066 -0.00943 -1.12 -1.1171 -1.0 Starr1_001010 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P05 compound treatment 0.069 -0.00643 -0.76 -0.7616 -1.0 Starr1_001011 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P06 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_001012 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P07 compound treatment 0.0755 7.26E-5 0.01 0.0086 1.0 Starr1_001013 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P08 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_001014 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P09 mock treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P10 compound treatment 0.071 -0.00443 -0.52 -0.5246 -1.0 Starr1_001015 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P11 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_001016 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P12 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_001017 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P13 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_001018 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P14 compound treatment 0.0725 -0.00293 -0.35 -0.3469 -1.0 Starr1_001019 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P15 compound treatment 0.0745 -9.27E-4 -0.11 -0.1099 -1.0 Starr1_001020 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P16 compound treatment 0.0765 0.00107 0.13 0.1271 1.0 Starr1_001021 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P17 compound treatment 0.077 0.00157 0.19 0.1863 1.0 Starr1_001022 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P18 compound treatment 0.074 -0.00143 -0.17 -0.1691 -1.0 Starr1_001023 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P19 compound treatment 0.072 -0.00343 -0.41 -0.4061 -1.0 Starr1_001024 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P20 compound treatment 0.0735 -0.00193 -0.23 -0.2284 -1.0 Starr1_001025 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P21 mock treatment 0.072 -0.00343 -0.41 -0.4061 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P22 mock treatment 0.0765 0.00107 0.13 0.1271 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P23 mock treatment 0.071 -0.00443 -0.52 -0.5246 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1340 P24 mock treatment 0.068 -0.00743 -0.88 -0.8801 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A01 compound treatment 0.098 0.0266 3.15 3.1474 1.0 PhilEx2_000001 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A02 compound treatment 0.078 0.00656 0.78 0.7776 1.0 PhilEx2_000002 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A03 compound treatment 0.0845 0.0131 1.55 1.5478 1.0 PhilEx2_000003 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A04 compound treatment 0.092 0.0206 2.44 2.4365 1.0 PhilEx2_000004 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A05 compound treatment 0.097 0.0256 3.03 3.0289 1.0 PhilEx2_000005 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A06 compound treatment 0.066 -0.00544 -0.64 -0.6443 -1.0 PhilEx2_000006 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A07 compound treatment 0.099 0.0276 3.27 3.2659 1.0 PhilEx2_000007 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A08 compound treatment 0.094 0.0226 2.67 2.6734 1.0 PhilEx2_000008 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A09 compound treatment 0.0895 0.0181 2.14 2.1402 1.0 PhilEx2_000009 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A10 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000010 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A11 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000011 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A12 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000012 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A13 compound treatment 0.0885 0.0171 2.02 2.0217 1.0 PhilEx2_000013 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A14 compound treatment 0.081 0.00956 1.13 1.1331 1.0 PhilEx2_000014 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A15 compound treatment 0.081 0.00956 1.13 1.1331 1.0 PhilEx2_000015 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A16 compound treatment 0.08 0.00856 1.01 1.0146 1.0 PhilEx2_000016 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A17 compound treatment 0.0765 0.00506 0.6 0.5999 1.0 PhilEx2_000017 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A18 compound treatment 0.0915 0.0201 2.38 2.3772 1.0 PhilEx2_000018 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A19 compound treatment 0.071 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx2_000019 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A20 compound treatment 0.0735 0.00206 0.24 0.2444 1.0 PhilEx2_000020 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A21 compound treatment 0.0675 -0.00394 -0.47 -0.4666 -1.0 PhilEx2_000021 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A22 compound treatment 0.0625 -0.00894 -1.06 -1.059 -1.0 PhilEx2_000022 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A23 mock treatment 0.076 0.00456 0.54 0.5406 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 A24 mock treatment 0.063 -0.00844 -1.0 -0.9998 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B01 compound treatment 0.09 0.0186 2.2 2.1995 1.0 PhilEx2_000023 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B02 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000024 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B03 compound treatment 0.0805 0.00906 1.07 1.0738 1.0 PhilEx2_000025 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B04 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000026 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B05 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000027 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B06 compound treatment 0.071 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx2_000028 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B07 compound treatment 0.091 0.0196 2.32 2.318 1.0 PhilEx2_000029 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B08 compound treatment 0.0875 0.0161 1.9 1.9032 1.0 PhilEx2_000030 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B09 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000031 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B10 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000032 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B11 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000033 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B12 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000034 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B13 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000035 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B14 compound treatment 0.08 0.00856 1.01 1.0146 1.0 PhilEx2_000036 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B15 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000037 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B16 compound treatment 0.0785 0.00706 0.84 0.8368 1.0 PhilEx2_000038 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B17 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000039 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B18 compound treatment 0.09 0.0186 2.2 2.1995 1.0 PhilEx2_000040 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B19 compound treatment 0.0765 0.00506 0.6 0.5999 1.0 PhilEx2_000041 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B20 compound treatment 0.0665 -0.00494 -0.59 -0.585 -1.0 PhilEx2_000042 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B21 compound treatment 0.0665 -0.00494 -0.59 -0.585 -1.0 PhilEx2_000043 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B22 compound treatment 0.0605 -0.0109 -1.3 -1.296 -1.0 PhilEx2_000044 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B23 mock treatment 0.0635 -0.00794 -0.94 -0.9405 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 B24 mock treatment 0.067 -0.00444 -0.53 -0.5258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C01 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000045 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C02 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000046 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C03 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000047 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C04 compound treatment 0.092 0.0206 2.44 2.4365 1.0 PhilEx2_000048 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C05 compound treatment 0.095 0.0236 2.79 2.7919 1.0 PhilEx2_000049 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C06 compound treatment 0.0895 0.0181 2.14 2.1402 1.0 PhilEx2_000050 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C07 compound treatment 0.094 0.0226 2.67 2.6734 1.0 PhilEx2_000051 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C08 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000052 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C09 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000053 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C10 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000054 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C11 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000055 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C12 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000056 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C13 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000057 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C14 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000058 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C15 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000059 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C16 compound treatment 0.0885 0.0171 2.02 2.0217 1.0 PhilEx2_000060 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C17 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000061 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C18 compound treatment 0.087 0.0156 1.84 1.844 1.0 PhilEx2_000062 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C19 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000063 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C20 compound treatment 0.073 0.00156 0.19 0.1851 1.0 PhilEx2_000064 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C21 compound treatment 0.072 5.62E-4 0.07 0.0667 1.0 PhilEx2_000065 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C22 compound treatment 0.073 0.00156 0.19 0.1851 1.0 PhilEx2_000066 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C23 mock treatment 0.074 0.00256 0.3 0.3036 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 C24 mock treatment 0.075 0.00356 0.42 0.4221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D01 compound treatment 0.08 0.00856 1.01 1.0146 1.0 PhilEx2_000067 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D02 compound treatment 0.0805 0.00906 1.07 1.0738 1.0 PhilEx2_000068 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D03 compound treatment 0.081 0.00956 1.13 1.1331 1.0 PhilEx2_000069 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D04 compound treatment 0.0875 0.0161 1.9 1.9032 1.0 PhilEx2_000070 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D05 compound treatment 0.0895 0.0181 2.14 2.1402 1.0 PhilEx2_000071 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D06 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000072 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D07 compound treatment 0.089 0.0176 2.08 2.081 1.0 PhilEx2_000073 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D08 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000074 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D09 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000075 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D10 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000076 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D11 compound treatment 0.087 0.0156 1.84 1.844 1.0 PhilEx2_000077 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D12 compound treatment 0.1115 0.0401 4.75 4.747 1.0 PhilEx2_000078 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D13 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000079 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D14 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000080 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D15 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000081 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D16 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000082 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D17 compound treatment 0.0845 0.0131 1.55 1.5478 1.0 PhilEx2_000083 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D18 compound treatment 0.087 0.0156 1.84 1.844 1.0 PhilEx2_000084 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D19 compound treatment 0.078 0.00656 0.78 0.7776 1.0 PhilEx2_000085 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D20 compound treatment 0.0755 0.00406 0.48 0.4814 1.0 PhilEx2_000086 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D21 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000087 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D22 compound treatment 0.0715 6.25E-5 0.01 0.0074 1.0 PhilEx2_000088 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D23 mock treatment 0.072 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 D24 mock treatment 0.076 0.00456 0.54 0.5406 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E01 compound treatment 0.082 0.0106 1.25 1.2516 1.0 PhilEx2_000089 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E02 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000090 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E03 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000091 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E04 compound treatment 0.0895 0.0181 2.14 2.1402 1.0 PhilEx2_000092 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E05 compound treatment 0.0915 0.0201 2.38 2.3772 1.0 PhilEx2_000093 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E06 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000094 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E07 compound treatment 0.092 0.0206 2.44 2.4365 1.0 PhilEx2_000095 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E08 compound treatment 0.0905 0.0191 2.26 2.2587 1.0 PhilEx2_000096 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E09 compound treatment 0.0885 0.0171 2.02 2.0217 1.0 PhilEx2_000097 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E10 compound treatment 0.0875 0.0161 1.9 1.9032 1.0 PhilEx2_000098 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E11 compound treatment 0.0895 0.0181 2.14 2.1402 1.0 PhilEx2_000099 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E12 compound treatment 0.094 0.0226 2.67 2.6734 1.0 PhilEx2_000100 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E13 compound treatment 0.09 0.0186 2.2 2.1995 1.0 PhilEx2_000101 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E14 compound treatment 0.0845 0.0131 1.55 1.5478 1.0 PhilEx2_000102 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E15 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000103 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E16 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000104 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E17 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000105 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E18 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000106 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E19 compound treatment 0.076 0.00456 0.54 0.5406 1.0 PhilEx2_000107 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E20 compound treatment 0.074 0.00256 0.3 0.3036 1.0 PhilEx2_000108 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E21 compound treatment 0.074 0.00256 0.3 0.3036 1.0 PhilEx2_000109 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E22 compound treatment 0.072 5.62E-4 0.07 0.0667 1.0 PhilEx2_000110 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E23 mock treatment 0.073 0.00156 0.19 0.1851 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 E24 mock treatment 0.075 0.00356 0.42 0.4221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F01 compound treatment 0.076 0.00456 0.54 0.5406 1.0 PhilEx2_000111 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F02 compound treatment 0.0755 0.00406 0.48 0.4814 1.0 PhilEx2_000112 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F03 compound treatment 0.0785 0.00706 0.84 0.8368 1.0 PhilEx2_000113 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F04 compound treatment 0.091 0.0196 2.32 2.318 1.0 PhilEx2_000114 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F05 compound treatment 0.097 0.0256 3.03 3.0289 1.0 PhilEx2_000115 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F06 compound treatment 0.0845 0.0131 1.55 1.5478 1.0 PhilEx2_000116 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F07 compound treatment 0.0925 0.0211 2.5 2.4957 1.0 PhilEx2_000117 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F08 compound treatment 0.0845 0.0131 1.55 1.5478 1.0 PhilEx2_000118 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F09 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000119 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F10 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000120 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F11 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000121 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F12 compound treatment 0.0965 0.0251 2.97 2.9697 1.0 PhilEx2_000122 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F13 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000123 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F14 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000124 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F15 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000125 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F16 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000126 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F17 compound treatment 0.0885 0.0171 2.02 2.0217 1.0 PhilEx2_000127 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F18 compound treatment 0.0925 0.0211 2.5 2.4957 1.0 PhilEx2_000128 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F19 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000129 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F20 compound treatment 0.074 0.00256 0.3 0.3036 1.0 PhilEx2_000130 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F21 compound treatment 0.0745 0.00306 0.36 0.3629 1.0 PhilEx2_000131 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F22 compound treatment 0.0715 6.25E-5 0.01 0.0074 1.0 PhilEx2_000132 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F23 mock treatment 0.0705 -9.38E-4 -0.11 -0.1111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 F24 mock treatment 0.072 5.62E-4 0.07 0.0667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G01 compound treatment 0.0815 0.0101 1.19 1.1923 1.0 PhilEx2_000133 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G02 compound treatment 0.0775 0.00606 0.72 0.7183 1.0 PhilEx2_000134 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G03 compound treatment 0.0815 0.0101 1.19 1.1923 1.0 PhilEx2_000135 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G04 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000136 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G05 compound treatment 0.097 0.0256 3.03 3.0289 1.0 PhilEx2_000137 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G06 compound treatment 0.078 0.00656 0.78 0.7776 1.0 PhilEx2_000138 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G07 compound treatment 0.11 0.0386 4.57 4.5693 1.0 PhilEx2_000139 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G08 compound treatment 0.0895 0.0181 2.14 2.1402 1.0 PhilEx2_000140 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G09 compound treatment 0.1045 0.0331 3.92 3.9176 1.0 PhilEx2_000141 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G10 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000142 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G11 compound treatment 0.095 0.0236 2.79 2.7919 1.0 PhilEx2_000143 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G12 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000144 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G13 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000145 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G14 compound treatment 0.0875 0.0161 1.9 1.9032 1.0 PhilEx2_000146 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G15 compound treatment 0.1015 0.0301 3.56 3.5621 1.0 PhilEx2_000147 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G16 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000148 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G17 compound treatment 0.089 0.0176 2.08 2.081 1.0 PhilEx2_000149 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G18 compound treatment 0.09 0.0186 2.2 2.1995 1.0 PhilEx2_000150 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G19 compound treatment 0.0755 0.00406 0.48 0.4814 1.0 PhilEx2_000151 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G20 compound treatment 0.072 5.62E-4 0.07 0.0667 1.0 PhilEx2_000152 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G21 compound treatment 0.072 5.62E-4 0.07 0.0667 1.0 PhilEx2_000153 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G22 compound treatment 0.071 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx2_000154 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G23 mock treatment 0.0695 -0.00194 -0.23 -0.2296 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 G24 mock treatment 0.0705 -9.38E-4 -0.11 -0.1111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H01 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000155 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H02 compound treatment 0.078 0.00656 0.78 0.7776 1.0 PhilEx2_000156 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H03 compound treatment 0.0805 0.00906 1.07 1.0738 1.0 PhilEx2_000157 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H04 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000158 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H05 compound treatment 0.0955 0.0241 2.85 2.8512 1.0 PhilEx2_000159 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H06 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000160 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H07 compound treatment 0.096 0.0246 2.91 2.9104 1.0 PhilEx2_000161 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H08 compound treatment 0.0845 0.0131 1.55 1.5478 1.0 PhilEx2_000162 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H09 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000163 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H10 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000164 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H11 compound treatment 0.088 0.0166 1.96 1.9625 1.0 PhilEx2_000165 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H12 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000166 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H13 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000167 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H14 compound treatment 0.08 0.00856 1.01 1.0146 1.0 PhilEx2_000168 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H15 compound treatment 0.089 0.0176 2.08 2.081 1.0 PhilEx2_000169 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H16 compound treatment 0.0805 0.00906 1.07 1.0738 1.0 PhilEx2_000170 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H17 compound treatment 0.088 0.0166 1.96 1.9625 1.0 PhilEx2_000171 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H18 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000172 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H19 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000173 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H20 compound treatment 0.075 0.00356 0.42 0.4221 1.0 PhilEx2_000174 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H21 compound treatment 0.076 0.00456 0.54 0.5406 1.0 PhilEx2_000175 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H22 compound treatment 0.0715 6.25E-5 0.01 0.0074 1.0 PhilEx2_000176 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H23 mock treatment 0.0705 -9.38E-4 -0.11 -0.1111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 H24 mock treatment 0.073 0.00156 0.19 0.1851 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I01 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000177 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I02 compound treatment 0.0785 0.00706 0.84 0.8368 1.0 PhilEx2_000178 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I03 compound treatment 0.0875 0.0161 1.9 1.9032 1.0 PhilEx2_000179 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I04 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000180 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I05 compound treatment 0.0945 0.0231 2.73 2.7327 1.0 PhilEx2_000181 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I06 compound treatment 0.0755 0.00406 0.48 0.4814 1.0 PhilEx2_000182 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I07 compound treatment 0.091 0.0196 2.32 2.318 1.0 PhilEx2_000183 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I08 compound treatment 0.082 0.0106 1.25 1.2516 1.0 PhilEx2_000184 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I09 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000185 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I10 compound treatment 0.078 0.00656 0.78 0.7776 1.0 PhilEx2_000186 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I11 compound treatment 0.0925 0.0211 2.5 2.4957 1.0 PhilEx2_000187 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I12 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000188 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I13 compound treatment 0.08 0.00856 1.01 1.0146 1.0 PhilEx2_000189 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I14 compound treatment 0.08 0.00856 1.01 1.0146 1.0 PhilEx2_000190 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I15 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000191 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I16 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000192 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I17 compound treatment 0.0805 0.00906 1.07 1.0738 1.0 PhilEx2_000193 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I18 compound treatment 0.0815 0.0101 1.19 1.1923 1.0 PhilEx2_000194 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I19 compound treatment 0.072 5.62E-4 0.07 0.0667 1.0 PhilEx2_000195 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I20 compound treatment 0.071 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx2_000196 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I21 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000197 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I22 compound treatment 0.0715 6.25E-5 0.01 0.0074 1.0 PhilEx2_000198 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I23 mock treatment 0.07 -0.00144 -0.17 -0.1703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 I24 mock treatment 0.0725 0.00106 0.13 0.1259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J01 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000199 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J02 compound treatment 0.0775 0.00606 0.72 0.7183 1.0 PhilEx2_000200 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J03 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000201 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J04 compound treatment 0.087 0.0156 1.84 1.844 1.0 PhilEx2_000202 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J05 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000203 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J06 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000204 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J07 compound treatment 0.0895 0.0181 2.14 2.1402 1.0 PhilEx2_000205 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J08 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000206 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J09 compound treatment 0.081 0.00956 1.13 1.1331 1.0 PhilEx2_000207 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J10 compound treatment 0.08 0.00856 1.01 1.0146 1.0 PhilEx2_000208 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J11 compound treatment 0.078 0.00656 0.78 0.7776 1.0 PhilEx2_000209 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J12 compound treatment 0.0775 0.00606 0.72 0.7183 1.0 PhilEx2_000210 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J13 compound treatment 0.0775 0.00606 0.72 0.7183 1.0 PhilEx2_000211 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J14 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000212 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J15 compound treatment 0.0815 0.0101 1.19 1.1923 1.0 PhilEx2_000213 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J16 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000214 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J17 compound treatment 0.0805 0.00906 1.07 1.0738 1.0 PhilEx2_000215 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J18 compound treatment 0.0795 0.00806 0.96 0.9553 1.0 PhilEx2_000216 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J19 compound treatment 0.072 5.62E-4 0.07 0.0667 1.0 PhilEx2_000217 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J20 compound treatment 0.0705 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx2_000218 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J21 compound treatment 0.072 5.62E-4 0.07 0.0667 1.0 PhilEx2_000219 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J22 compound treatment 0.0695 -0.00194 -0.23 -0.2296 -1.0 PhilEx2_000220 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J23 mock treatment 0.069 -0.00244 -0.29 -0.2888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 J24 mock treatment 0.0715 6.25E-5 0.01 0.0074 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K01 compound treatment 0.08 0.00856 1.01 1.0146 1.0 PhilEx2_000221 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K02 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000222 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K03 compound treatment 0.0775 0.00606 0.72 0.7183 1.0 PhilEx2_000223 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K04 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000224 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K05 compound treatment 0.082 0.0106 1.25 1.2516 1.0 PhilEx2_000225 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K06 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000226 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K07 compound treatment 0.101 0.0296 3.5 3.5029 1.0 PhilEx2_000227 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K08 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000228 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K09 compound treatment 0.0805 0.00906 1.07 1.0738 1.0 PhilEx2_000229 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K10 compound treatment 0.0795 0.00806 0.96 0.9553 1.0 PhilEx2_000230 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K11 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000231 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K12 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000232 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K13 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000233 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K14 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000234 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K15 compound treatment 0.082 0.0106 1.25 1.2516 1.0 PhilEx2_000235 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K16 compound treatment 0.082 0.0106 1.25 1.2516 1.0 PhilEx2_000236 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K17 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000237 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K18 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000238 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K19 compound treatment 0.0695 -0.00194 -0.23 -0.2296 -1.0 PhilEx2_000239 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K20 compound treatment 0.068 -0.00344 -0.41 -0.4073 -1.0 PhilEx2_000240 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K21 compound treatment 0.0695 -0.00194 -0.23 -0.2296 -1.0 PhilEx2_000241 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K22 compound treatment 0.068 -0.00344 -0.41 -0.4073 -1.0 PhilEx2_000242 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K23 mock treatment 0.0675 -0.00394 -0.47 -0.4666 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 K24 mock treatment 0.0705 -9.38E-4 -0.11 -0.1111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L01 compound treatment 0.0785 0.00706 0.84 0.8368 1.0 PhilEx2_000243 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L02 compound treatment 0.078 0.00656 0.78 0.7776 1.0 PhilEx2_000244 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L03 compound treatment 0.079 0.00756 0.9 0.8961 1.0 PhilEx2_000245 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L04 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000246 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L05 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000247 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L06 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000248 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L07 compound treatment 0.098 0.0266 3.15 3.1474 1.0 PhilEx2_000249 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L08 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000250 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L09 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000251 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L10 compound treatment 0.0805 0.00906 1.07 1.0738 1.0 PhilEx2_000252 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L11 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000253 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L12 compound treatment 0.082 0.0106 1.25 1.2516 1.0 PhilEx2_000254 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L13 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000255 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L14 compound treatment 0.08 0.00856 1.01 1.0146 1.0 PhilEx2_000256 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L15 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000257 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L16 compound treatment 0.08 0.00856 1.01 1.0146 1.0 PhilEx2_000258 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L17 compound treatment 0.088 0.0166 1.96 1.9625 1.0 PhilEx2_000259 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L18 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000260 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L19 compound treatment 0.0735 0.00206 0.24 0.2444 1.0 PhilEx2_000261 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L20 compound treatment 0.069 -0.00244 -0.29 -0.2888 -1.0 PhilEx2_000262 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L21 compound treatment 0.071 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx2_000263 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L22 compound treatment 0.0705 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx2_000264 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L23 mock treatment 0.07 -0.00144 -0.17 -0.1703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 L24 mock treatment 0.074 0.00256 0.3 0.3036 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M01 compound treatment 0.0795 0.00806 0.96 0.9553 1.0 PhilEx2_000265 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M02 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000266 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M03 compound treatment 0.089 0.0176 2.08 2.081 1.0 PhilEx2_000267 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M04 compound treatment 0.087 0.0156 1.84 1.844 1.0 PhilEx2_000268 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M05 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000269 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M06 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000270 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M07 compound treatment 0.0895 0.0181 2.14 2.1402 1.0 PhilEx2_000271 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M08 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000272 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M09 compound treatment 0.083 0.0116 1.37 1.37 1.0 PhilEx2_000273 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M10 compound treatment 0.088 0.0166 1.96 1.9625 1.0 PhilEx2_000274 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M11 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000275 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M12 compound treatment 0.118 0.0466 5.52 5.5172 1.0 PhilEx2_000276 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M13 compound treatment 0.088 0.0166 1.96 1.9625 1.0 PhilEx2_000277 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M14 compound treatment 0.078 0.00656 0.78 0.7776 1.0 PhilEx2_000278 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M15 compound treatment 0.082 0.0106 1.25 1.2516 1.0 PhilEx2_000279 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M16 compound treatment 0.082 0.0106 1.25 1.2516 1.0 PhilEx2_000280 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M17 compound treatment 0.0845 0.0131 1.55 1.5478 1.0 PhilEx2_000281 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M18 compound treatment 0.0875 0.0161 1.9 1.9032 1.0 PhilEx2_000282 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M19 compound treatment 0.0725 0.00106 0.13 0.1259 1.0 PhilEx2_000283 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M20 compound treatment 0.074 0.00256 0.3 0.3036 1.0 PhilEx2_000284 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M21 compound treatment 0.0705 -9.38E-4 -0.11 -0.1111 -1.0 PhilEx2_000285 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M22 compound treatment 0.0685 -0.00294 -0.35 -0.3481 -1.0 PhilEx2_000286 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M23 mock treatment 0.0685 -0.00294 -0.35 -0.3481 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 M24 mock treatment 0.071 -4.38E-4 -0.05 -0.0518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N01 compound treatment 0.0805 0.00906 1.07 1.0738 1.0 PhilEx2_000287 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N02 compound treatment 0.081 0.00956 1.13 1.1331 1.0 PhilEx2_000288 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N03 compound treatment 0.081 0.00956 1.13 1.1331 1.0 PhilEx2_000289 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N04 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000290 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N05 compound treatment 0.0855 0.0141 1.67 1.6663 1.0 PhilEx2_000291 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N06 compound treatment 0.0795 0.00806 0.96 0.9553 1.0 PhilEx2_000292 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N07 compound treatment 0.0925 0.0211 2.5 2.4957 1.0 PhilEx2_000293 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N08 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000294 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N09 compound treatment 0.092 0.0206 2.44 2.4365 1.0 PhilEx2_000295 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N10 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000296 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N11 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000297 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N12 compound treatment 0.094 0.0226 2.67 2.6734 1.0 PhilEx2_000298 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N13 compound treatment 0.0895 0.0181 2.14 2.1402 1.0 PhilEx2_000299 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N14 compound treatment 0.0905 0.0191 2.26 2.2587 1.0 PhilEx2_000300 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N15 compound treatment 0.0915 0.0201 2.38 2.3772 1.0 PhilEx2_000301 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N16 compound treatment 0.0875 0.0161 1.9 1.9032 1.0 PhilEx2_000302 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N17 compound treatment 0.094 0.0226 2.67 2.6734 1.0 PhilEx2_000303 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N18 compound treatment 0.0905 0.0191 2.26 2.2587 1.0 PhilEx2_000304 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N19 compound treatment 0.0765 0.00506 0.6 0.5999 1.0 PhilEx2_000305 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N20 compound treatment 0.0735 0.00206 0.24 0.2444 1.0 PhilEx2_000306 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N21 compound treatment 0.0725 0.00106 0.13 0.1259 1.0 PhilEx2_000307 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N22 compound treatment 0.073 0.00156 0.19 0.1851 1.0 PhilEx2_000308 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N23 mock treatment 0.074 0.00256 0.3 0.3036 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 N24 mock treatment 0.0735 0.00206 0.24 0.2444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O01 compound treatment 0.078 0.00656 0.78 0.7776 1.0 PhilEx2_000309 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O02 compound treatment 0.076 0.00456 0.54 0.5406 1.0 PhilEx2_000310 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O03 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000311 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O04 compound treatment 0.0805 0.00906 1.07 1.0738 1.0 PhilEx2_000312 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O05 compound treatment 0.0845 0.0131 1.55 1.5478 1.0 PhilEx2_000313 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O06 compound treatment 0.077 0.00556 0.66 0.6591 1.0 PhilEx2_000314 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O07 compound treatment 0.089 0.0176 2.08 2.081 1.0 PhilEx2_000315 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O08 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000316 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O09 compound treatment 0.082 0.0106 1.25 1.2516 1.0 PhilEx2_000317 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O10 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000318 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O11 compound treatment 0.087 0.0156 1.84 1.844 1.0 PhilEx2_000319 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O12 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000320 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O13 compound treatment 0.081 0.00956 1.13 1.1331 1.0 PhilEx2_000321 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O14 compound treatment 0.081 0.00956 1.13 1.1331 1.0 PhilEx2_000322 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O15 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000323 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O16 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000324 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O17 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000325 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O18 compound treatment 0.0845 0.0131 1.55 1.5478 1.0 PhilEx2_000326 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O19 compound treatment 0.076 0.00456 0.54 0.5406 1.0 PhilEx2_000327 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O20 compound treatment 0.074 0.00256 0.3 0.3036 1.0 PhilEx2_000328 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O21 compound treatment 0.073 0.00156 0.19 0.1851 1.0 PhilEx2_000329 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O22 compound treatment 0.0725 0.00106 0.13 0.1259 1.0 PhilEx2_000330 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O23 mock treatment 0.076 0.00456 0.54 0.5406 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 O24 mock treatment 0.0695 -0.00194 -0.23 -0.2296 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P01 compound treatment 0.0775 0.00606 0.72 0.7183 1.0 PhilEx2_000331 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P02 compound treatment 0.0695 -0.00194 -0.23 -0.2296 -1.0 PhilEx2_000332 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P03 compound treatment 0.075 0.00356 0.42 0.4221 1.0 PhilEx2_000333 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P04 compound treatment 0.071 -4.38E-4 -0.05 -0.0518 -1.0 PhilEx2_000334 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P05 compound treatment 0.078 0.00656 0.78 0.7776 1.0 PhilEx2_000335 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P06 compound treatment 0.0715 6.25E-5 0.01 0.0074 1.0 PhilEx2_000336 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P07 compound treatment 0.0865 0.0151 1.78 1.7848 1.0 PhilEx2_000337 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P08 compound treatment 0.089 0.0176 2.08 2.081 1.0 PhilEx2_000338 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P09 compound treatment 0.0835 0.0121 1.43 1.4293 1.0 PhilEx2_000339 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P10 compound treatment 0.085 0.0136 1.61 1.607 1.0 PhilEx2_000340 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P11 compound treatment 0.088 0.0166 1.96 1.9625 1.0 PhilEx2_000341 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P12 compound treatment 0.0875 0.0161 1.9 1.9032 1.0 PhilEx2_000342 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P13 compound treatment 0.09 0.0186 2.2 2.1995 1.0 PhilEx2_000343 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P14 compound treatment 0.0825 0.0111 1.31 1.3108 1.0 PhilEx2_000344 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P15 compound treatment 0.086 0.0146 1.73 1.7255 1.0 PhilEx2_000345 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P16 compound treatment 0.084 0.0126 1.49 1.4885 1.0 PhilEx2_000346 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P17 compound treatment 0.088 0.0166 1.96 1.9625 1.0 PhilEx2_000347 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P18 compound treatment 0.0845 0.0131 1.55 1.5478 1.0 PhilEx2_000348 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P19 compound treatment 0.0755 0.00406 0.48 0.4814 1.0 PhilEx2_000349 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P20 compound treatment 0.076 0.00456 0.54 0.5406 1.0 PhilEx2_000350 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P21 compound treatment 0.075 0.00356 0.42 0.4221 1.0 PhilEx2_000351 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P22 compound treatment 0.0765 0.00506 0.6 0.5999 1.0 PhilEx2_000352 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P23 mock treatment 0.08 0.00856 1.01 1.0146 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1341 P24 mock treatment 0.068 -0.00344 -0.41 -0.4073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A01 compound treatment 0.0775 0.00164 0.19 0.1941 1.0 PhilEx2_000353 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A02 compound treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 PhilEx2_000354 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A03 compound treatment 0.08 0.00414 0.49 0.4903 1.0 PhilEx2_000355 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A04 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000356 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A05 compound treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 PhilEx2_000357 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A06 compound treatment 0.069 -0.00686 -0.81 -0.8131 -1.0 PhilEx2_000358 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A07 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000359 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A08 compound treatment 0.0805 0.00464 0.55 0.5495 1.0 PhilEx2_000360 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A09 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000361 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A10 compound treatment 0.077 0.00114 0.13 0.1348 1.0 PhilEx2_000362 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A11 compound treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 PhilEx2_000363 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A12 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000364 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A13 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000365 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A14 compound treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 PhilEx2_000366 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A15 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000367 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A16 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000368 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A17 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000369 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A18 compound treatment 0.0675 -0.00836 -0.99 -0.9908 -1.0 PhilEx2_000370 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A19 compound treatment 0.076 1.38E-4 0.02 0.0163 1.0 PhilEx2_000371 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A20 mock treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A21 mock treatment 0.0845 0.00864 1.02 1.0235 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A22 mock treatment 0.08 0.00414 0.49 0.4903 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A23 mock treatment 0.0875 0.0116 1.38 1.379 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 A24 mock treatment 0.0815 0.00564 0.67 0.668 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B01 compound treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 PhilEx2_000372 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B02 compound treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 PhilEx2_000373 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B03 compound treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 PhilEx2_000374 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B04 compound treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 PhilEx2_000375 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B05 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000376 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B06 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000377 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B07 compound treatment 0.0855 0.00964 1.14 1.142 1.0 PhilEx2_000378 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B08 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000379 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B09 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000380 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B10 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000381 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B11 compound treatment 0.077 0.00114 0.13 0.1348 1.0 PhilEx2_000382 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B12 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000383 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B13 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000384 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B14 compound treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 PhilEx2_000385 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B15 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000386 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B16 compound treatment 0.076 1.38E-4 0.02 0.0163 1.0 PhilEx2_000387 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B17 compound treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 PhilEx2_000388 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B18 compound treatment 0.069 -0.00686 -0.81 -0.8131 -1.0 PhilEx2_000389 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B19 compound treatment 0.08 0.00414 0.49 0.4903 1.0 PhilEx2_000390 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B20 mock treatment 0.08 0.00414 0.49 0.4903 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B21 mock treatment 0.079 0.00314 0.37 0.3718 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B22 mock treatment 0.0765 6.38E-4 0.08 0.0756 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B23 mock treatment 0.0795 0.00364 0.43 0.4311 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 B24 mock treatment 0.0785 0.00264 0.31 0.3126 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C01 compound treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 PhilEx2_000391 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C02 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000392 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C03 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000393 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C04 compound treatment 0.096 0.0201 2.39 2.3861 1.0 PhilEx2_000394 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C05 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000395 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C06 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000396 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C07 compound treatment 0.0845 0.00864 1.02 1.0235 1.0 PhilEx2_000397 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C08 compound treatment 0.0785 0.00264 0.31 0.3126 1.0 PhilEx2_000398 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C09 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000399 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C10 compound treatment 0.0785 0.00264 0.31 0.3126 1.0 PhilEx2_000400 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C11 compound treatment 0.084 0.00814 0.96 0.9643 1.0 PhilEx2_000401 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C12 compound treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 PhilEx2_000402 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C13 compound treatment 0.0795 0.00364 0.43 0.4311 1.0 PhilEx2_000403 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C14 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000404 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C15 compound treatment 0.082 0.00614 0.73 0.7273 1.0 PhilEx2_000405 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C16 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000406 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C17 compound treatment 0.0795 0.00364 0.43 0.4311 1.0 PhilEx2_000407 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C18 compound treatment 0.0785 0.00264 0.31 0.3126 1.0 PhilEx2_000408 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C19 compound treatment 0.077 0.00114 0.13 0.1348 1.0 PhilEx2_000409 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C20 mock treatment 0.079 0.00314 0.37 0.3718 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C21 mock treatment 0.0815 0.00564 0.67 0.668 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C22 mock treatment 0.0795 0.00364 0.43 0.4311 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C23 mock treatment 0.0765 6.38E-4 0.08 0.0756 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 C24 mock treatment 0.079 0.00314 0.37 0.3718 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D01 compound treatment 0.068 -0.00786 -0.93 -0.9316 -1.0 PhilEx2_000410 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D02 compound treatment 0.0685 -0.00736 -0.87 -0.8723 -1.0 PhilEx2_000411 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D03 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000412 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D04 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000413 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D05 compound treatment 0.0905 0.0146 1.73 1.7344 1.0 PhilEx2_000414 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D06 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000415 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D07 compound treatment 0.093 0.0171 2.03 2.0307 1.0 PhilEx2_000416 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D08 compound treatment 0.084 0.00814 0.96 0.9643 1.0 PhilEx2_000417 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D09 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000418 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D10 compound treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 PhilEx2_000419 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D11 compound treatment 0.082 0.00614 0.73 0.7273 1.0 PhilEx2_000420 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D12 compound treatment 0.098 0.0221 2.62 2.6231 1.0 PhilEx2_000421 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D13 compound treatment 0.081 0.00514 0.61 0.6088 1.0 PhilEx2_000422 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D14 compound treatment 0.0845 0.00864 1.02 1.0235 1.0 PhilEx2_000423 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D15 compound treatment 0.079 0.00314 0.37 0.3718 1.0 PhilEx2_000424 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D16 compound treatment 0.076 1.38E-4 0.02 0.0163 1.0 PhilEx2_000425 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D17 compound treatment 0.079 0.00314 0.37 0.3718 1.0 PhilEx2_000426 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D18 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000427 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D19 compound treatment 0.077 0.00114 0.13 0.1348 1.0 PhilEx2_000428 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D20 mock treatment 0.0795 0.00364 0.43 0.4311 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D21 mock treatment 0.0815 0.00564 0.67 0.668 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D22 mock treatment 0.076 1.38E-4 0.02 0.0163 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D23 mock treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 D24 mock treatment 0.078 0.00214 0.25 0.2533 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E01 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000429 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E02 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000430 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E03 compound treatment 0.082 0.00614 0.73 0.7273 1.0 PhilEx2_000431 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E04 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000432 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E05 compound treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 PhilEx2_000433 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E06 compound treatment 0.0835 0.00764 0.91 0.905 1.0 PhilEx2_000434 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E07 compound treatment 0.0845 0.00864 1.02 1.0235 1.0 PhilEx2_000435 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E08 compound treatment 0.077 0.00114 0.13 0.1348 1.0 PhilEx2_000436 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E09 compound treatment 0.087 0.0111 1.32 1.3197 1.0 PhilEx2_000437 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E10 compound treatment 0.0805 0.00464 0.55 0.5495 1.0 PhilEx2_000438 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E11 compound treatment 0.0855 0.00964 1.14 1.142 1.0 PhilEx2_000439 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E12 compound treatment 0.0945 0.0186 2.21 2.2084 1.0 PhilEx2_000440 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E13 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000441 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E14 compound treatment 0.093 0.0171 2.03 2.0307 1.0 PhilEx2_000442 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E15 compound treatment 0.08 0.00414 0.49 0.4903 1.0 PhilEx2_000443 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E16 compound treatment 0.096 0.0201 2.39 2.3861 1.0 PhilEx2_000444 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E17 compound treatment 0.079 0.00314 0.37 0.3718 1.0 PhilEx2_000445 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E18 compound treatment 0.0885 0.0126 1.5 1.4975 1.0 PhilEx2_000446 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E19 compound treatment 0.0785 0.00264 0.31 0.3126 1.0 PhilEx2_000447 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E20 mock treatment 0.077 0.00114 0.13 0.1348 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E21 mock treatment 0.0765 6.38E-4 0.08 0.0756 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E22 mock treatment 0.0765 6.38E-4 0.08 0.0756 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E23 mock treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 E24 mock treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F01 compound treatment 0.069 -0.00686 -0.81 -0.8131 -1.0 PhilEx2_000448 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F02 compound treatment 0.069 -0.00686 -0.81 -0.8131 -1.0 PhilEx2_000449 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F03 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000450 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F04 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000451 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F05 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000452 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F06 compound treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 PhilEx2_000453 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F07 compound treatment 0.079 0.00314 0.37 0.3718 1.0 PhilEx2_000454 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F08 compound treatment 0.079 0.00314 0.37 0.3718 1.0 PhilEx2_000455 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F09 compound treatment 0.076 1.38E-4 0.02 0.0163 1.0 PhilEx2_000456 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F10 compound treatment 0.093 0.0171 2.03 2.0307 1.0 PhilEx2_000457 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F11 compound treatment 0.0845 0.00864 1.02 1.0235 1.0 PhilEx2_000458 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F12 compound treatment 0.079 0.00314 0.37 0.3718 1.0 PhilEx2_000459 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F13 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000460 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F14 compound treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 PhilEx2_000461 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F15 compound treatment 0.083 0.00714 0.85 0.8458 1.0 PhilEx2_000462 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F16 compound treatment 0.084 0.00814 0.96 0.9643 1.0 PhilEx2_000463 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F17 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000464 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F18 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000465 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F19 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000466 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F20 mock treatment 0.087 0.0111 1.32 1.3197 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F21 mock treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F22 mock treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F23 mock treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 F24 mock treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G01 compound treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 PhilEx2_000467 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G02 compound treatment 0.068 -0.00786 -0.93 -0.9316 -1.0 PhilEx2_000468 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G03 compound treatment 0.071 -0.00486 -0.58 -0.5761 -1.0 PhilEx2_000469 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G04 compound treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 PhilEx2_000470 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G05 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000471 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G06 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000472 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G07 compound treatment 0.081 0.00514 0.61 0.6088 1.0 PhilEx2_000473 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G08 compound treatment 0.076 1.38E-4 0.02 0.0163 1.0 PhilEx2_000474 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G09 compound treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 PhilEx2_000475 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G10 compound treatment 0.0795 0.00364 0.43 0.4311 1.0 PhilEx2_000476 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G11 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000477 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G12 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000478 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G13 compound treatment 0.076 1.38E-4 0.02 0.0163 1.0 PhilEx2_000479 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G14 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000480 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G15 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000481 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G16 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000482 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G17 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000483 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G18 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000484 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G19 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000485 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G20 mock treatment 0.0805 0.00464 0.55 0.5495 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G21 mock treatment 0.0765 6.38E-4 0.08 0.0756 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G22 mock treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G23 mock treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 G24 mock treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H01 compound treatment 0.068 -0.00786 -0.93 -0.9316 -1.0 PhilEx2_000486 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H02 compound treatment 0.067 -0.00886 -1.05 -1.0501 -1.0 PhilEx2_000487 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H03 compound treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 PhilEx2_000488 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H04 compound treatment 0.077 0.00114 0.13 0.1348 1.0 PhilEx2_000489 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H05 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000490 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H06 compound treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 PhilEx2_000491 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H07 compound treatment 0.0825 0.00664 0.79 0.7865 1.0 PhilEx2_000492 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H08 compound treatment 0.077 0.00114 0.13 0.1348 1.0 PhilEx2_000493 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H09 compound treatment 0.08 0.00414 0.49 0.4903 1.0 PhilEx2_000494 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H10 compound treatment 0.0885 0.0126 1.5 1.4975 1.0 PhilEx2_000495 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H11 compound treatment 0.0805 0.00464 0.55 0.5495 1.0 PhilEx2_000496 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H12 compound treatment 0.087 0.0111 1.32 1.3197 1.0 PhilEx2_000497 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H13 compound treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 PhilEx2_000498 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H14 compound treatment 0.0835 0.00764 0.91 0.905 1.0 PhilEx2_000499 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H15 compound treatment 0.0775 0.00164 0.19 0.1941 1.0 PhilEx2_000500 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H16 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000501 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H17 compound treatment 0.0965 0.0206 2.45 2.4454 1.0 PhilEx2_000502 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H18 compound treatment 0.077 0.00114 0.13 0.1348 1.0 PhilEx2_000503 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H19 compound treatment 0.1005 0.0246 2.92 2.9194 1.0 PhilEx2_000504 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H20 mock treatment 0.082 0.00614 0.73 0.7273 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H21 mock treatment 0.0835 0.00764 0.91 0.905 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H22 mock treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H23 mock treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 H24 mock treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I01 compound treatment 0.0675 -0.00836 -0.99 -0.9908 -1.0 PhilEx2_000505 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I02 compound treatment 0.0665 -0.00936 -1.11 -1.1093 -1.0 PhilEx2_000506 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I03 compound treatment 0.08 0.00414 0.49 0.4903 1.0 PhilEx2_000507 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I04 compound treatment 0.0675 -0.00836 -0.99 -0.9908 -1.0 PhilEx2_000508 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I05 compound treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 PhilEx2_000509 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I06 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000510 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I07 compound treatment 0.0775 0.00164 0.19 0.1941 1.0 PhilEx2_000511 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I08 compound treatment 0.071 -0.00486 -0.58 -0.5761 -1.0 PhilEx2_000512 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I09 compound treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 PhilEx2_000513 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I10 compound treatment 0.0705 -0.00536 -0.64 -0.6354 -1.0 PhilEx2_000514 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I11 compound treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 PhilEx2_000515 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I12 compound treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 PhilEx2_000516 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I13 compound treatment 0.056 -0.0199 -2.35 -2.3535 -1.0 PhilEx2_000517 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I14 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000518 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I15 compound treatment 0.067 -0.00886 -1.05 -1.0501 -1.0 PhilEx2_000519 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I16 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000520 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I17 compound treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 PhilEx2_000521 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I18 compound treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 PhilEx2_000522 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I19 mock treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I20 mock treatment 0.071 -0.00486 -0.58 -0.5761 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I21 mock treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I22 mock treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I23 mock treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 I24 mock treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J01 compound treatment 0.0655 -0.0104 -1.23 -1.2278 -1.0 PhilEx2_000523 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J02 compound treatment 0.067 -0.00886 -1.05 -1.0501 -1.0 PhilEx2_000524 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J03 compound treatment 0.079 0.00314 0.37 0.3718 1.0 PhilEx2_000525 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J04 compound treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 PhilEx2_000526 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J05 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000527 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J06 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000528 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J07 compound treatment 0.0785 0.00264 0.31 0.3126 1.0 PhilEx2_000529 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J08 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000530 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J09 compound treatment 0.076 1.38E-4 0.02 0.0163 1.0 PhilEx2_000531 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J10 compound treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 PhilEx2_000532 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J11 compound treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 PhilEx2_000533 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J12 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000534 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J13 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000535 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J14 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000536 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J15 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000537 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J16 compound treatment 0.0705 -0.00536 -0.64 -0.6354 -1.0 PhilEx2_000538 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J17 compound treatment 0.071 -0.00486 -0.58 -0.5761 -1.0 PhilEx2_000539 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J18 compound treatment 0.0685 -0.00736 -0.87 -0.8723 -1.0 PhilEx2_000540 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J19 mock treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J20 mock treatment 0.0775 0.00164 0.19 0.1941 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J21 mock treatment 0.0765 6.38E-4 0.08 0.0756 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J22 mock treatment 0.071 -0.00486 -0.58 -0.5761 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J23 mock treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 J24 mock treatment 0.0685 -0.00736 -0.87 -0.8723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K01 compound treatment 0.066 -0.00986 -1.17 -1.1686 -1.0 PhilEx2_000541 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K02 compound treatment 0.0645 -0.0114 -1.35 -1.3463 -1.0 PhilEx2_000542 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K03 compound treatment 0.0655 -0.0104 -1.23 -1.2278 -1.0 PhilEx2_000543 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K04 compound treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 PhilEx2_000544 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K05 compound treatment 0.0785 0.00264 0.31 0.3126 1.0 PhilEx2_000545 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K06 compound treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 PhilEx2_000546 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K07 compound treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 PhilEx2_000547 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K08 compound treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 PhilEx2_000548 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K09 compound treatment 0.089 0.0131 1.56 1.5567 1.0 PhilEx2_000549 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K10 compound treatment 0.0785 0.00264 0.31 0.3126 1.0 PhilEx2_000550 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K11 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000551 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K12 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000552 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K13 compound treatment 0.0665 -0.00936 -1.11 -1.1093 -1.0 PhilEx2_000553 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K14 compound treatment 0.0665 -0.00936 -1.11 -1.1093 -1.0 PhilEx2_000554 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K15 compound treatment 0.0675 -0.00836 -0.99 -0.9908 -1.0 PhilEx2_000555 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K16 compound treatment 0.0705 -0.00536 -0.64 -0.6354 -1.0 PhilEx2_000556 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K17 compound treatment 0.0665 -0.00936 -1.11 -1.1093 -1.0 PhilEx2_000557 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K18 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000558 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K19 mock treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K20 mock treatment 0.0765 6.38E-4 0.08 0.0756 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K21 mock treatment 0.071 -0.00486 -0.58 -0.5761 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K22 mock treatment 0.069 -0.00686 -0.81 -0.8131 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K23 mock treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 K24 mock treatment 0.0685 -0.00736 -0.87 -0.8723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L01 compound treatment 0.067 -0.00886 -1.05 -1.0501 -1.0 PhilEx2_000559 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L02 compound treatment 0.0685 -0.00736 -0.87 -0.8723 -1.0 PhilEx2_000560 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L03 compound treatment 0.069 -0.00686 -0.81 -0.8131 -1.0 PhilEx2_000561 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L04 compound treatment 0.0675 -0.00836 -0.99 -0.9908 -1.0 PhilEx2_000562 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L05 compound treatment 0.0685 -0.00736 -0.87 -0.8723 -1.0 PhilEx2_000563 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L06 compound treatment 0.071 -0.00486 -0.58 -0.5761 -1.0 PhilEx2_000564 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L07 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000565 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L08 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000566 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L09 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000567 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L10 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000568 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L11 compound treatment 0.0855 0.00964 1.14 1.142 1.0 PhilEx2_000569 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L12 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000570 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L13 compound treatment 0.08 0.00414 0.49 0.4903 1.0 PhilEx2_000571 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L14 compound treatment 0.0835 0.00764 0.91 0.905 1.0 PhilEx2_000572 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L15 compound treatment 0.0875 0.0116 1.38 1.379 1.0 PhilEx2_000573 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L16 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000574 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L17 compound treatment 0.0885 0.0126 1.5 1.4975 1.0 PhilEx2_000575 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L18 compound treatment 0.0795 0.00364 0.43 0.4311 1.0 PhilEx2_000576 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L19 mock treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L20 mock treatment 0.077 0.00114 0.13 0.1348 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L21 mock treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L22 mock treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L23 mock treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 L24 mock treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M01 compound treatment 0.0645 -0.0114 -1.35 -1.3463 -1.0 PhilEx2_000577 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M02 compound treatment 0.0655 -0.0104 -1.23 -1.2278 -1.0 PhilEx2_000578 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M03 compound treatment 0.066 -0.00986 -1.17 -1.1686 -1.0 PhilEx2_000579 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M04 compound treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 PhilEx2_000580 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M05 compound treatment 0.068 -0.00786 -0.93 -0.9316 -1.0 PhilEx2_000581 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M06 compound treatment 0.0665 -0.00936 -1.11 -1.1093 -1.0 PhilEx2_000582 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M07 compound treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 PhilEx2_000583 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M08 compound treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 PhilEx2_000584 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M09 compound treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 PhilEx2_000585 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M10 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000586 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M11 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000587 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M12 compound treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 PhilEx2_000588 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M13 compound treatment 0.068 -0.00786 -0.93 -0.9316 -1.0 PhilEx2_000589 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M14 compound treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 PhilEx2_000590 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M15 compound treatment 0.083 0.00714 0.85 0.8458 1.0 PhilEx2_000591 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M16 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000592 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M17 compound treatment 0.081 0.00514 0.61 0.6088 1.0 PhilEx2_000593 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M18 compound treatment 0.0675 -0.00836 -0.99 -0.9908 -1.0 PhilEx2_000594 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M19 mock treatment 0.076 1.38E-4 0.02 0.0163 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M20 mock treatment 0.069 -0.00686 -0.81 -0.8131 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M21 mock treatment 0.0815 0.00564 0.67 0.668 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M22 mock treatment 0.069 -0.00686 -0.81 -0.8131 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M23 mock treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 M24 mock treatment 0.0685 -0.00736 -0.87 -0.8723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N01 compound treatment 0.064 -0.0119 -1.41 -1.4055 -1.0 PhilEx2_000595 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N02 compound treatment 0.0675 -0.00836 -0.99 -0.9908 -1.0 PhilEx2_000596 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N03 compound treatment 0.073 -0.00286 -0.34 -0.3391 -1.0 PhilEx2_000597 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N04 compound treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 PhilEx2_000598 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N05 compound treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 PhilEx2_000599 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N06 compound treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 PhilEx2_000600 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N07 compound treatment 0.0785 0.00264 0.31 0.3126 1.0 PhilEx2_000601 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N08 compound treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 PhilEx2_000602 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N09 compound treatment 0.0815 0.00564 0.67 0.668 1.0 PhilEx2_000603 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N10 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000604 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N11 compound treatment 0.0915 0.0156 1.85 1.8529 1.0 PhilEx2_000605 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N12 compound treatment 0.0775 0.00164 0.19 0.1941 1.0 PhilEx2_000606 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N13 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000607 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N14 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000608 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N15 compound treatment 0.0775 0.00164 0.19 0.1941 1.0 PhilEx2_000609 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N16 compound treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 PhilEx2_000610 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N17 compound treatment 0.076 1.38E-4 0.02 0.0163 1.0 PhilEx2_000611 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N18 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000612 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N19 mock treatment 0.076 1.38E-4 0.02 0.0163 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N20 mock treatment 0.0835 0.00764 0.91 0.905 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N21 mock treatment 0.0735 -0.00236 -0.28 -0.2799 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N22 mock treatment 0.076 1.38E-4 0.02 0.0163 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N23 mock treatment 0.0765 6.38E-4 0.08 0.0756 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 N24 mock treatment 0.076 1.38E-4 0.02 0.0163 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O01 compound treatment 0.069 -0.00686 -0.81 -0.8131 -1.0 PhilEx2_000613 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O02 compound treatment 0.0615 -0.0144 -1.7 -1.7018 -1.0 PhilEx2_000614 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O03 compound treatment 0.068 -0.00786 -0.93 -0.9316 -1.0 PhilEx2_000615 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O04 compound treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 PhilEx2_000616 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O05 compound treatment 0.0685 -0.00736 -0.87 -0.8723 -1.0 PhilEx2_000617 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O06 compound treatment 0.0775 0.00164 0.19 0.1941 1.0 PhilEx2_000618 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O07 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000619 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O08 compound treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 PhilEx2_000620 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O09 compound treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 PhilEx2_000621 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O10 compound treatment 0.0825 0.00664 0.79 0.7865 1.0 PhilEx2_000622 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O11 compound treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 PhilEx2_000623 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O12 compound treatment 0.0795 0.00364 0.43 0.4311 1.0 PhilEx2_000624 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O13 compound treatment 0.078 0.00214 0.25 0.2533 1.0 PhilEx2_000625 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O14 compound treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 PhilEx2_000626 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O15 compound treatment 0.0695 -0.00636 -0.75 -0.7538 -1.0 PhilEx2_000627 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O16 compound treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 PhilEx2_000628 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O17 compound treatment 0.0775 0.00164 0.19 0.1941 1.0 PhilEx2_000629 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O18 compound treatment 0.0725 -0.00336 -0.4 -0.3984 -1.0 PhilEx2_000630 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O19 mock treatment 0.0835 0.00764 0.91 0.905 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O20 mock treatment 0.0755 -3.62E-4 -0.04 -0.0429 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O21 mock treatment 0.076 1.38E-4 0.02 0.0163 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O22 mock treatment 0.076 1.38E-4 0.02 0.0163 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O23 mock treatment 0.079 0.00314 0.37 0.3718 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 O24 mock treatment 0.077 0.00114 0.13 0.1348 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P01 compound treatment 0.054 -0.0219 -2.59 -2.5904 -1.0 PhilEx2_000631 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P02 compound treatment 0.059 -0.0169 -2.0 -1.998 -1.0 PhilEx2_000632 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P03 compound treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 PhilEx2_000633 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P04 compound treatment 0.0685 -0.00736 -0.87 -0.8723 -1.0 PhilEx2_000634 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P05 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000635 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P06 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000636 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P07 compound treatment 0.086 0.0101 1.2 1.2012 1.0 PhilEx2_000637 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P08 compound treatment 0.0745 -0.00136 -0.16 -0.1614 -1.0 PhilEx2_000638 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P09 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000639 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P10 compound treatment 0.082 0.00614 0.73 0.7273 1.0 PhilEx2_000640 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P11 compound treatment 0.0775 0.00164 0.19 0.1941 1.0 PhilEx2_000641 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P12 compound treatment 0.0765 6.38E-4 0.08 0.0756 1.0 PhilEx2_000642 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P13 compound treatment 0.074 -0.00186 -0.22 -0.2206 -1.0 PhilEx2_000643 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P14 compound treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 PhilEx2_000644 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P15 compound treatment 0.0785 0.00264 0.31 0.3126 1.0 PhilEx2_000645 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P16 compound treatment 0.0845 0.00864 1.02 1.0235 1.0 PhilEx2_000646 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P17 compound treatment 0.075 -8.62E-4 -0.1 -0.1021 -1.0 PhilEx2_000647 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P18 compound treatment 0.07 -0.00586 -0.69 -0.6946 -1.0 PhilEx2_000648 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P19 mock treatment 0.081 0.00514 0.61 0.6088 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P20 mock treatment 0.078 0.00214 0.25 0.2533 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P21 mock treatment 0.072 -0.00386 -0.46 -0.4576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P22 mock treatment 0.08 0.00414 0.49 0.4903 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P23 mock treatment 0.0715 -0.00436 -0.52 -0.5169 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1342 P24 mock treatment 0.057 -0.0189 -2.23 -2.235 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A01 mock treatment 0.077 0.00351 0.42 0.4164 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A02 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A03 compound treatment 0.0755 0.00201 0.24 0.2387 1.0 3001896 Bio2_000321 C[C@H]1[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@@]24[C@@H](/C=C/C[C@H](C)C(=O)[C@@](C)(O)/C=C/[C@H]4OC(=O)C)[C@H](O)C1=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A04 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A05 compound treatment 0.075 0.00151 0.18 0.1794 1.0 236 Bio2_000322 SC(=S)OC1CC2CC1C3CCCC23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A06 mock treatment 0.0675 -0.00599 -0.71 -0.7092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A07 compound treatment 0.076 0.00251 0.3 0.2979 1.0 159 Bio2_000323 COc1c(C=O)c(O)cc2C(=O)c3ccccc3C(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A08 mock treatment 0.0845 0.011 1.31 1.3051 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A09 compound treatment 0.0675 -0.00599 -0.71 -0.7092 -1.0 2370 Bio2_000324 OCc1ccc(o1)c2nn(Cc3ccccc3)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A10 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A11 compound treatment 0.069 -0.00449 -0.53 -0.5315 -1.0 251 Bio2_000325 Nc1ncnc2n(cnc12)C3(CO)OC(=C)C(O)C3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A12 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A13 compound treatment 0.0755 0.00201 0.24 0.2387 1.0 3001897 Bio2_000326 OC[C@H]1*C[C@@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A14 mock treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A15 compound treatment 0.069 -0.00449 -0.53 -0.5315 -1.0 1907766 Bio2_000327 OC[C@H]1*C[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A16 mock treatment 0.0765 0.00301 0.36 0.3572 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A17 compound treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 3103895 Bio2_000328 C[C@@H]1CC2C3CCC4=CC(=O)C=CC4(C)[C@@]3(F)[C@@H](O)CC2(C)[C@@]1(O)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A18 mock treatment 0.0625 -0.011 -1.3 -1.3017 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A19 compound treatment 0.076 0.00251 0.3 0.2979 1.0 3103896 Bio2_000329 CCCC(=O)Nc1ncnc2n(cnc12)C3O[C@H]4COP(=O)(O)O[C@@H]4[C@@H]3OC(=O)CCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A20 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A21 compound treatment 0.0745 0.00101 0.12 0.1202 1.0 3001899 Bio2_000330 CCCC(=O)Nc1nc2n(cnc2c(=O)[nH]1)C3O[C@H]4COP(=O)(O)O[C@@H]4[C@@H]3OC(=O)CCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A22 mock treatment 0.077 0.00351 0.42 0.4164 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A23 mock treatment 0.087 0.0135 1.6 1.6013 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 A24 mock treatment 0.082 0.00851 1.01 1.0089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B01 mock treatment 0.069 -0.00449 -0.53 -0.5315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B02 mock treatment 0.0695 -0.00399 -0.47 -0.4723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B03 compound treatment 0.0735 1.43E-5 0.0 0.0017 1.0 440 Bio2_000331 COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B04 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B05 compound treatment 0.07 -0.00349 -0.41 -0.413 -1.0 442 Bio2_000332 CCCCCCCCCCCCCCCCCCc1ccc(cc1)C(=O)/C=C/C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B06 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B07 compound treatment 0.085 0.0115 1.36 1.3643 1.0 3103897 Bio2_000333 C[C@@H](CC(O)[C@H]1OC2CC[C@@]3(CC[C@H](O3)/C=C/[C@@H](C)[C@@H]4CC(=C[C@@]5(O[C@H](C[C@@](C)(O)C(=O)O)CCC5O)O4)C)OC2[C@H](O)C1=C)C6O[C@@]7(CCCCO7)CC[C@H]6C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B08 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B09 compound treatment 0.086 0.0125 1.48 1.4828 1.0 3104621 Bio2_000334 CC[C@H]/1CC[C@H]2O[C@@]3(CC[C@@H](C)[C@@H](C[C@H](C)O)O3)[C@H](C)[C@@H](OC(=O)/C=C/[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)C\C=C\C=C1)[C@H]2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B10 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B11 compound treatment 0.0815 0.00801 0.95 0.9496 1.0 324 Bio2_000335 Cn1cnc2c(NCc3ccccc3)nc(NCCO)nc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B12 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B13 compound treatment 0.078 0.00451 0.53 0.5349 1.0 3103898 Bio2_000336 CC1OC(OC2CC(O)C3(CO)C4[C@H](O)CC5(C)C(CCC5(O)C4CCC3(O)C2)C6=CC(=O)OC6)C(O)C(O)C1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B14 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B15 compound treatment 0.0955 0.022 2.61 2.6085 1.0 444 Bio2_000337 COC(=O)C1=C(C)NC(=C(C1C)C(=O)OCCSc2ccccc2)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B16 mock treatment 0.0735 1.43E-5 0.0 0.0017 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B17 compound treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 453 Bio2_000338 COc1cccc(c1N)c2cc(=O)c3ccccc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B18 mock treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B19 compound treatment 0.0775 0.00401 0.48 0.4757 1.0 1907767 Bio2_000339 CN(C)c1ccc(/C=C/2\C(=O)Nc3ccccc23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B20 mock treatment 0.0735 1.43E-5 0.0 0.0017 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B21 compound treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 387 Bio2_000340 CC(C)C[C@H](NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CC(C)C)C(C)C)C(C)C)[C@@H](O)CC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B22 mock treatment 0.075 0.00151 0.18 0.1794 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B23 mock treatment 0.0775 0.00401 0.48 0.4757 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 B24 mock treatment 0.076 0.00251 0.3 0.2979 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C01 mock treatment 0.072 -0.00149 -0.18 -0.176 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C02 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C03 compound treatment 0.077 0.00351 0.42 0.4164 1.0 1907768 Bio2_000341 [O-][N+](=O)c1ccc(Cl)c(c1)C(=O)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C04 mock treatment 0.075 0.00151 0.18 0.1794 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C05 compound treatment 0.074 5.14E-4 0.06 0.0609 1.0 1907769 Bio2_000342 *C1CCc2cc(O)c(O)cc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C06 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C07 compound treatment 0.0835 0.01 1.19 1.1866 1.0 2098 Bio2_000343 CC(C)c1cccc(=O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C08 mock treatment 0.0745 0.00101 0.12 0.1202 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C09 compound treatment 0.1055 0.032 3.79 3.7934 1.0 411 Bio2_000344 [I+]1c2ccccc2-c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C10 mock treatment 0.076 0.00251 0.3 0.2979 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C11 compound treatment 0.095 0.0215 2.55 2.5492 1.0 1961 Bio2_000345 CC(C)(C)c1cc(O)c(cc1O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C12 mock treatment 0.0875 0.014 1.66 1.6606 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C13 compound treatment 0.074 5.14E-4 0.06 0.0609 1.0 3103899 Bio2_000346 COc1cccc2C(=O)C3C(C(=C4[C@H](C[C@@](O)(CC4=C3O)C(=O)CO)OC5CC(N)C(O)C(C)O5)O)C(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C14 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C15 compound treatment 0.074 5.14E-4 0.06 0.0609 1.0 3000146 Bio2_000347 OC[C@H]1O[C@H](C(O)[C@H]1O)n2cnc3cc(Cl)c(Cl)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C16 mock treatment 0.08 0.00651 0.77 0.7719 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C17 compound treatment 0.076 0.00251 0.3 0.2979 1.0 3103900 Bio2_000348 OC(=O)c1ccc(cc1)C2=C3C=CC4=[N+]3[Mn+3]5([N+]6=C7C=CC6=C(c8ccc2n85)c9ccc(cc9)C(=O)O)n%10c(=C4c%11ccc(cc%11)C(=O)O)ccc%10=C7c%12ccc(cc%12)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C18 mock treatment 0.082 0.00851 1.01 1.0089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C19 compound treatment 0.0765 0.00301 0.36 0.3572 1.0 3002358 Bio2_000349 COc1cc2CCN(C)[C@@H]3Cc4ccc(OC(=O)c5ccc(cc5)[N+](=O)[O-])c(Oc6ccc(C[C@@H]7N(C)CCc8ccc(Oc(c1OC)c32)cc78)cc6)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C20 mock treatment 0.076 0.00251 0.3 0.2979 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C21 compound treatment 0.0755 0.00201 0.24 0.2387 1.0 3002360 Bio2_000350 *[C@H]1O[C@@H]1C(=O)N[C@@H](CC(C)C)C(=O)NCCC(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C22 mock treatment 0.077 0.00351 0.42 0.4164 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C23 mock treatment 0.0745 0.00101 0.12 0.1202 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 C24 mock treatment 0.0765 0.00301 0.36 0.3572 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D01 mock treatment 0.0695 -0.00399 -0.47 -0.4723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D02 mock treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D03 compound treatment 0.0835 0.01 1.19 1.1866 1.0 384 Bio2_000351 O=c1[nH]c2ccccc2c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D04 mock treatment 0.0735 1.43E-5 0.0 0.0017 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D05 compound treatment 0.077 0.00351 0.42 0.4164 1.0 290 Bio2_000352 CCCCCCCCCCCCCC(=O)O[C@@H]1[C@@H](C)[C@]2(O)[C@@H]3C=C(C)C(=O)[C@@]3(O)CC(=C[C@H]2[C@@H]4C(C)(C)[C@@]41OC(=O)C)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D06 mock treatment 0.075 0.00151 0.18 0.1794 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D07 compound treatment 0.089 0.0155 1.84 1.8383 1.0 455 Bio2_000353 Cc1ccc(cc1)C(=O)Cn2c3CCCCc3sc2=N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D08 mock treatment 0.09 0.0165 1.96 1.9568 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D09 compound treatment 0.081 0.00751 0.89 0.8904 1.0 1907770 Bio2_000354 Clc1ccc(cc1)c2nc3sccn3c2/C=N/OCc4ccc(Cl)c(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D10 mock treatment 0.077 0.00351 0.42 0.4164 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D11 compound treatment 0.0935 0.02 2.37 2.3715 1.0 347 Bio2_000355 CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D12 mock treatment 0.081 0.00751 0.89 0.8904 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D13 compound treatment 0.084 0.0105 1.25 1.2458 1.0 1907771 Bio2_000356 CC1[C@@H]2NC[C@@H](C)C[C@H]2O[C@@]31CC[C@H]4[C@@H]5CC=C6C[C@@H](O)CC[C@]6(C)[C@H]5CC4=C3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D14 mock treatment 0.081 0.00751 0.89 0.8904 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D15 compound treatment 0.08 0.00651 0.77 0.7719 1.0 275745 Bio2_000357 Cc1ccc(cc1)c2nn(c3ncnc(N)c23)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D16 mock treatment 0.077 0.00351 0.42 0.4164 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D17 compound treatment 0.093 0.0195 2.31 2.3122 1.0 349 Bio2_000358 COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D18 mock treatment 0.0755 0.00201 0.24 0.2387 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D19 compound treatment 0.0785 0.00501 0.59 0.5941 1.0 244 Bio2_000359 CC[N+](C)(CC)CCC[n+]1c(c2ccccc2)c3cc(N)ccc3c4ccc(N)cc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D20 mock treatment 0.078 0.00451 0.53 0.5349 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D21 compound treatment 0.082 0.00851 1.01 1.0089 1.0 3002368 Bio2_000360 CC(C)NC[C@H](O)COc1cccc2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D22 mock treatment 0.0765 0.00301 0.36 0.3572 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D23 mock treatment 0.0765 0.00301 0.36 0.3572 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 D24 mock treatment 0.0785 0.00501 0.59 0.5941 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E01 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E02 mock treatment 0.0755 0.00201 0.24 0.2387 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E03 compound treatment 0.077 0.00351 0.42 0.4164 1.0 413 Bio2_000361 CCCCCC[C@@H]([C@@H](C)O)n1cnc2c(N)ncnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E04 mock treatment 0.0795 0.00601 0.71 0.7126 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E05 compound treatment 0.0775 0.00401 0.48 0.4757 1.0 1907772 Bio2_000362 CC(=O)[C@H]1[C@@H](CC2C3CC=C4C[C@@H](O)CCC4(C)C3CCC12C)C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E06 mock treatment 0.0965 0.023 2.73 2.727 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E07 compound treatment 0.0865 0.013 1.54 1.5421 1.0 386 Bio2_000363 C[C@@]12CC[C@H]3[C@@H](CCc4cc(O)ccc34)[C@@H]2CC[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E08 mock treatment 0.0785 0.00501 0.59 0.5941 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E09 compound treatment 0.0805 0.00701 0.83 0.8311 1.0 2080384 Bio2_000364 COc1cc(cc(OC)c1O)[C@H]2[C@@H]3[C@H](COC3=O)[C@H](OC4OC5COC(C)OC5C(O)C4O)c6cc7OCOc7cc26 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E10 mock treatment 0.081 0.00751 0.89 0.8904 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E11 compound treatment 0.0915 0.018 2.13 2.1345 1.0 415 Bio2_000365 FC(F)(F)Oc1ccc(NN=C(C#N)C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E12 mock treatment 0.0785 0.00501 0.59 0.5941 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E13 compound treatment 0.0775 0.00401 0.48 0.4757 1.0 3002452 Bio2_000366 CC(=O)O[C@H]1[C@@H](O)[C@H]2C(C)(C)CC[C@@H](O)[C@]2(C)[C@@]3(O)C(=O)C[C@@](C)(O[C@]13C)C=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E14 mock treatment 0.0945 0.021 2.49 2.49 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E15 compound treatment 0.0805 0.00701 0.83 0.8311 1.0 3104393 Bio2_000367 CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)/C(=C/C=C\[C@H](OC)[C@@H](OC(=O)N)/C(=C/[C@H](C)[C@H]1O)/C)/C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E16 mock treatment 0.0825 0.00901 1.07 1.0681 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E17 compound treatment 0.0785 0.00501 0.59 0.5941 1.0 3103903 Bio2_000368 Cc1ccc(cc1)C2=CCc3cc(C)cc(C)c3C2=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E18 mock treatment 0.083 0.00951 1.13 1.1273 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E19 compound treatment 0.074 5.14E-4 0.06 0.0609 1.0 576 Bio2_000369 Cn1cc(C2=C(C(=O)NC2=O)c3cn(CCCSC(=N)N)c4ccccc34)c5ccccc15 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E20 mock treatment 0.0925 0.019 2.25 2.253 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E21 compound treatment 0.0755 0.00201 0.24 0.2387 1.0 162 Bio2_000370 CNC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)[C@H](CC(C)C)CC(=O)NO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E22 mock treatment 0.078 0.00451 0.53 0.5349 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E23 mock treatment 0.075 0.00151 0.18 0.1794 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 E24 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F01 mock treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F02 mock treatment 0.0705 -0.00299 -0.35 -0.3538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F03 compound treatment 0.081 0.00751 0.89 0.8904 1.0 3002455 Bio2_000371 *[C@H]1O[C@H]([C@H](O)[C@@H]1NC(=O)C(N)Cc2ccccc2)n3cnc4c(ncnc34)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F04 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F05 compound treatment 0.0825 0.00901 1.07 1.0681 1.0 1907773 Bio2_000372 NC(=O)c1ccc(cc1)c2nc(c([nH]2)c3ccc4OCOc4c3)c5ccccn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F06 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F07 compound treatment 0.0855 0.012 1.42 1.4236 1.0 1000035 Bio2_000373 O=C1c2ccccc2-c3n[nH]c4cccc1c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F08 mock treatment 0.076 0.00251 0.3 0.2979 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F09 compound treatment 0.083 0.00951 1.13 1.1273 1.0 353 Bio2_000374 Oc1cc(O)c2c(=O)c(O)c(oc2c1)c3ccc(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F10 mock treatment 0.0755 0.00201 0.24 0.2387 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F11 compound treatment 0.0845 0.011 1.31 1.3051 1.0 3104890 Bio2_000375 CO[C@@H]1CC(CC(C)[C@@H]2CC(=O)[C@H](C)/C=C(\C)/[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C(\C)/[C@H](C[C@@H]3CC[C@@H](C)[C@@](O)(O3)C(=O)C(=O)N4CCCC[C@H]4C(=O)O2)OC)CC[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F12 mock treatment 0.082 0.00851 1.01 1.0089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F13 compound treatment 0.081 0.00751 0.89 0.8904 1.0 1907774 Bio2_000376 CC(C)[C@@H]1NC(=O)[C@H](Cc2ccccc2)NC(=O)[C@@H](CC(=O)O)NC(=O)CNC(=O)[C@H](CCCNC(=N)N)NC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F14 mock treatment 0.077 0.00351 0.42 0.4164 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F15 compound treatment 0.0755 0.00201 0.24 0.2387 1.0 285 Bio2_000377 O=C(NCCCCCCNC(=O)ON=C1CCCCC1)ON=C2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F16 mock treatment 0.088 0.0145 1.72 1.7198 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F17 compound treatment 0.075 0.00151 0.18 0.1794 1.0 151 Bio2_000378 CCCCCCCCCCCCCCCC(=O)C1=C(O)C(CO)OC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F18 mock treatment 0.078 0.00451 0.53 0.5349 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F19 compound treatment 0.0875 0.014 1.66 1.6606 1.0 291 Bio2_000379 CC[C@H](CO)Nc1nc(NCc2ccccc2)c3ncn(C(C)C)c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F20 mock treatment 0.0775 0.00401 0.48 0.4757 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F21 compound treatment 0.079 0.00551 0.65 0.6534 1.0 320 Bio2_000380 CC(=O)c1c(O)c(C)c(O)c(Cc2c(O)c(C(=O)/C=C/c3ccccc3)c4OC(C)(C)C=Cc4c2O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F22 mock treatment 0.075 0.00151 0.18 0.1794 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F23 mock treatment 0.0735 1.43E-5 0.0 0.0017 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 F24 mock treatment 0.0735 1.43E-5 0.0 0.0017 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G01 mock treatment 0.068 -0.00549 -0.65 -0.65 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G02 mock treatment 0.0655 -0.00799 -0.95 -0.9462 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G03 compound treatment 0.0705 -0.00299 -0.35 -0.3538 -1.0 152 Bio2_000381 Cn1c2ccccc2c3c4C(=O)NCc4c5c6ccccc6n(CCC#N)c5c13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G04 mock treatment 0.0735 1.43E-5 0.0 0.0017 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G05 compound treatment 0.0755 0.00201 0.24 0.2387 1.0 1298 Bio2_000382 CS(=O)(=O)Nc1ccc(cc1Oc2ccccc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G06 mock treatment 0.0885 0.015 1.78 1.779 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G07 compound treatment 0.0845 0.011 1.31 1.3051 1.0 414 Bio2_000383 CC1CNCCN1S(=O)(=O)c2cccc3cnccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G08 mock treatment 0.084 0.0105 1.25 1.2458 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G09 compound treatment 0.077 0.00351 0.42 0.4164 1.0 607 Bio2_000384 Brc1ccc(/C=C/CNCCNS(=O)(=O)c2cccc3cnccc23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G10 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G11 compound treatment 0.0825 0.00901 1.07 1.0681 1.0 3002468 Bio2_000385 NCCNOc1cccc2cnccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G12 mock treatment 0.079 0.00551 0.65 0.6534 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G13 compound treatment 0.0745 0.00101 0.12 0.1202 1.0 610 Bio2_000386 O=S(=O)(N1CCCNCC1)c2cccc3cnccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G14 mock treatment 0.0825 0.00901 1.07 1.0681 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G15 compound treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 609 Bio2_000387 NC(=N)NCCNS(=O)(=O)c1cccc2cnccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G16 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G17 compound treatment 0.0735 1.43E-5 0.0 0.0017 1.0 611 Bio2_000388 COCc1cc(O)c(O)c(O)c1c2c(O)c(O)c(O)cc2COC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G18 mock treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G19 compound treatment 0.091 0.0175 2.08 2.0753 1.0 465 Bio2_000389 NCCc1c[nH]cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G20 mock treatment 0.0745 0.00101 0.12 0.1202 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G21 compound treatment 0.0805 0.00701 0.83 0.8311 1.0 239 Bio2_000390 CC(=O)OCOC(c1ccc2ccccc2c1)P(=O)(OCOC(=O)C)OCOC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G22 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G23 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 G24 mock treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H01 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H02 mock treatment 0.0695 -0.00399 -0.47 -0.4723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H03 compound treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 3104891 Bio2_000391 CC(=O)OCOC(P(=O)OCOC(=O)C)c1cc(ccc1Oc2ccc(Br)cc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H04 mock treatment 0.0705 -0.00299 -0.35 -0.3538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H05 compound treatment 0.0925 0.019 2.25 2.253 1.0 1907775 Bio2_000392 CS(=O)(=O)c1ccc(cc1)c2nc(c([nH]2)c3ccncc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H06 mock treatment 0.0735 1.43E-5 0.0 0.0017 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H07 compound treatment 0.0835 0.01 1.19 1.1866 1.0 457 Bio2_000393 Oc1ccc(cc1)c2nc(c([nH]2)c3ccncc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H08 mock treatment 0.0765 0.00301 0.36 0.3572 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H09 compound treatment 0.0815 0.00801 0.95 0.9496 1.0 1000586 Bio2_000394 O/N=C\1/C(=C\2/C(=O)Nc3ccccc23)/Nc4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H10 mock treatment 0.0745 0.00101 0.12 0.1202 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H11 compound treatment 0.092 0.0185 2.19 2.1938 1.0 3104892 Bio2_000395 O=C/1Nc2ccccc2\C1=C/3\Nc4ccccc4C3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H12 mock treatment 0.0815 0.00801 0.95 0.9496 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H13 compound treatment 0.074 5.14E-4 0.06 0.0609 1.0 429 Bio2_000396 NCCc1c[nH]c2ccc(O)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H14 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H15 compound treatment 0.0735 1.43E-5 0.0 0.0017 1.0 2269 Bio2_000397 Oc1ccc(/C=C/c2cc(O)cc(O)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H16 mock treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H17 compound treatment 0.0905 0.017 2.02 2.016 1.0 2301 Bio2_000398 O=C1CCc2c(O1)ccc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H18 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H19 compound treatment 0.0895 0.016 1.9 1.8975 1.0 650 Bio2_000399 CC(C)(C)n1nc(c2ccc(Cl)cc2)c3c(N)ncnc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H20 mock treatment 0.079 0.00551 0.65 0.6534 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H21 compound treatment 0.08 0.00651 0.77 0.7719 1.0 648 Bio2_000400 Oc1cc(O)cc(/C=C/c2ccc(O)c(O)c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H22 mock treatment 0.076 0.00251 0.3 0.2979 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H23 mock treatment 0.075 0.00151 0.18 0.1794 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 H24 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I01 mock treatment 0.068 -0.00549 -0.65 -0.65 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I02 mock treatment 0.0675 -0.00599 -0.71 -0.7092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I03 compound treatment 0.067 -0.00649 -0.77 -0.7685 -1.0 369 Bio2_000401 CCOc1ccc(cc1)c2nc3cc(ccc3[nH]2)c4nc5cc(ccc5[nH]4)N6CCN(C)CC6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I04 mock treatment 0.0695 -0.00399 -0.47 -0.4723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I05 compound treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 1001953 Bio2_000402 C/C=C/1\C2Cc3[nH]c(=O)ccc3C1(N)CC(=C2)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I06 mock treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I07 compound treatment 0.076 0.00251 0.3 0.2979 1.0 1907776 Bio2_000403 CC(C)[C@H](O)CCC(C)C1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I08 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I09 compound treatment 0.0855 0.012 1.42 1.4236 1.0 3002553 Bio2_000404 C[C@@H]([C@@H](C)N1CC(=O)NC(=O)C1)N2CC(=O)NC(=O)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I10 mock treatment 0.072 -0.00149 -0.18 -0.176 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I11 compound treatment 0.0845 0.011 1.31 1.3051 1.0 2797 Bio2_000405 COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I12 mock treatment 0.068 -0.00549 -0.65 -0.65 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I13 compound treatment 0.0565 -0.017 -2.01 -2.0126 -1.0 3002555 Bio2_000406 *CC[C@@H](C)C[C@H](C)C[C@H](C)C(=O)/C=C(\O)/[C@H](C)C[C@H](C)C/C=C/[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](O)C[C@@H]1CC[C@](C)(O1)[C@H]2CC[C@](C)(O2)[C@@H](C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I14 mock treatment 0.0645 -0.00899 -1.06 -1.0647 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I15 compound treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 1505 Bio2_000407 CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I16 mock treatment 0.067 -0.00649 -0.77 -0.7685 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I17 compound treatment 0.0845 0.011 1.31 1.3051 1.0 1054783 Bio2_000408 OCCSC1=C(SCCO)C(=O)c2ccccc2C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I18 mock treatment 0.069 -0.00449 -0.53 -0.5315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I19 compound treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 422 Bio2_000409 Oc1cccc2C(=O)C=CC(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I20 mock treatment 0.0815 0.00801 0.95 0.9496 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I21 compound treatment 0.0735 1.43E-5 0.0 0.0017 1.0 1907777 Bio2_000410 COC(=O)[C@@]1(O)C[C@@H]2O[C@@]1(C)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I22 mock treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I23 mock treatment 0.069 -0.00449 -0.53 -0.5315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 I24 mock treatment 0.067 -0.00649 -0.77 -0.7685 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J01 mock treatment 0.067 -0.00649 -0.77 -0.7685 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J02 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J03 compound treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 837968 Bio2_000411 Nc1ncnc2n(cnc12)C3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J04 mock treatment 0.0705 -0.00299 -0.35 -0.3538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J05 compound treatment 0.0745 0.00101 0.12 0.1202 1.0 790507 Bio2_000412 OC(=O)CN1C(=O)c2cccc3cccc(C1=O)c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J06 mock treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J07 compound treatment 0.0795 0.00601 0.71 0.7126 1.0 3104896 Bio2_000413 CN[C@@H]1C[C@@]2(C)O[C@@H]([C@@H]1OC)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J08 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J09 compound treatment 0.0815 0.00801 0.95 0.9496 1.0 197 Bio2_000414 O[C@@H]1CN2CCC[C@@H](O)[C@@H]2[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J10 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J11 compound treatment 0.0805 0.00701 0.83 0.8311 1.0 368 Bio2_000415 CC/C(=C(\c1ccccc1)/c2ccc(OCCN(C)C)cc2)/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J12 mock treatment 0.0805 0.00701 0.83 0.8311 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J13 compound treatment 0.0735 1.43E-5 0.0 0.0017 1.0 1000045 Bio2_000416 CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)C4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(=O)C)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J14 mock treatment 0.084 0.0105 1.25 1.2458 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J15 compound treatment 0.0745 0.00101 0.12 0.1202 1.0 658 Bio2_000417 Clc1cc(Cl)cc(/C=C(\C#N)/c2cccnc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J16 mock treatment 0.0705 -0.00299 -0.35 -0.3538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J17 compound treatment 0.0755 0.00201 0.24 0.2387 1.0 370 Bio2_000418 O=C1N(C2CCC(=O)NC2=O)C(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J18 mock treatment 0.069 -0.00449 -0.53 -0.5315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J19 compound treatment 0.0745 0.00101 0.12 0.1202 1.0 358 Bio2_000419 N[C@@H](CCCNC(=S)N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J20 mock treatment 0.078 0.00451 0.53 0.5349 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J21 compound treatment 0.0735 1.43E-5 0.0 0.0017 1.0 572 Bio2_000420 CN(C)CCCn1cc(C2=C(C(=O)NC2=O)c3c[nH]c4ccccc34)c5ccccc15 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J22 mock treatment 0.072 -0.00149 -0.18 -0.176 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J23 mock treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 J24 mock treatment 0.0695 -0.00399 -0.47 -0.4723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K01 mock treatment 0.065 -0.00849 -1.01 -1.0055 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K02 mock treatment 0.0665 -0.00699 -0.83 -0.8277 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K03 compound treatment 0.067 -0.00649 -0.77 -0.7685 -1.0 3419827 Bio2_000421 CN(C(Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N4CCN(CC4)c5ccccc5)S(=O)(=O)c6cccc7cnccc67 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K04 mock treatment 0.0765 0.00301 0.36 0.3572 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K05 compound treatment 0.075 0.00151 0.18 0.1794 1.0 1907778 Bio2_000422 *[C@@]1(O)C[C@@H]2O[C@@]1(C)n3c4ccccc4c5c6CNC(=O)c6c7c8ccccc8n2c7c35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K06 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K07 compound treatment 0.0745 0.00101 0.12 0.1202 1.0 3104897 Bio2_000423 CCC(C)[C@@H](CO[C@@H](Cc1ccccc1)C(=O)N[C@@H](CCS(=O)(=O)C)C(=O)OC(C)C)NC[C@@H](N)CS 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K08 mock treatment 0.0745 0.00101 0.12 0.1202 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K09 compound treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 1908 Bio2_000424 [O-][n+]1onc(c1C#N)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K10 mock treatment 0.088 0.0145 1.72 1.7198 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K11 compound treatment 0.078 0.00451 0.53 0.5349 1.0 3001166 Bio2_000425 C[C@H]/1CC[C@@H]2C[C@H](C[C@@](O)(O2)[C@@H]3CSC(=O)N3)OC(=O)\C=C(\C)/CC/C=C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K12 mock treatment 0.07 -0.00349 -0.41 -0.413 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K13 compound treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 284 Bio2_000426 OC(=O)c1cc(ccc1O)N(Cc2ccccc2O)Cc3cc(O)ccc3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K14 mock treatment 0.0675 -0.00599 -0.71 -0.7092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K15 compound treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 1907779 Bio2_000427 CC(C)n1cnc2c(NCc3ccccc3)nc(NCCO)nc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K16 mock treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K17 compound treatment 0.078 0.00451 0.53 0.5349 1.0 3104898 Bio2_000428 CC(C)C[C@H](NC(=O)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K18 mock treatment 0.078 0.00451 0.53 0.5349 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K19 compound treatment 0.07 -0.00349 -0.41 -0.413 -1.0 1954 Bio2_000429 Cc1ccc(cc1)S(=O)(=O)/C=C/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K20 mock treatment 0.0795 0.00601 0.71 0.7126 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K21 compound treatment 0.0855 0.012 1.42 1.4236 1.0 1002387 Bio2_000430 Oc1ccc(C=C(C#N)C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K22 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K23 mock treatment 0.0695 -0.00399 -0.47 -0.4723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 K24 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L01 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L02 mock treatment 0.07 -0.00349 -0.41 -0.413 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L03 compound treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 566 Bio2_000431 COc1cc(/C=C(\C#N)/C(=O)N)cc(CSc2nc3ccccc3s2)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L04 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L05 compound treatment 0.076 0.00251 0.3 0.2979 1.0 1907780 Bio2_000432 COC1=CC(=O)OC(C1)/C=C/c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L06 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L07 compound treatment 0.078 0.00451 0.53 0.5349 1.0 431 Bio2_000433 C(CN(Cc1ccccn1)Cc2ccccn2)N(Cc3ccccn3)Cc4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L08 mock treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L09 compound treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 199 Bio2_000434 C[C@H](/C=C(\C)/C=C/C(=O)NO)C(=O)c1ccc(cc1)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L10 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L11 compound treatment 0.081 0.00751 0.89 0.8904 1.0 437 Bio2_000435 CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L12 mock treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L13 compound treatment 0.076 0.00251 0.3 0.2979 1.0 3001422 Bio2_000436 *C1OC(OC2OC(CC(O)C3OC(C(O)C3O)n4ccc(=O)[nH]c4=O)C(O)C(O)C2NC(=O)/C=C\*C(C)C)C(NC(=O)C)C(O)C1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L14 mock treatment 0.0695 -0.00399 -0.47 -0.4723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L15 compound treatment 0.084 0.0105 1.25 1.2458 1.0 203 Bio2_000437 NC(=C(C#N)C#N)/C(=C/c1ccc2[nH]ccc2c1)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L16 mock treatment 0.0705 -0.00299 -0.35 -0.3538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L17 compound treatment 0.082 0.00851 1.01 1.0089 1.0 553 Bio2_000438 Oc1cc(C=C(C#N)C#N)ccc1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L18 mock treatment 0.069 -0.00449 -0.53 -0.5315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L19 compound treatment 0.076 0.00251 0.3 0.2979 1.0 568 Bio2_000439 COc1ccc(C=C(C#N)C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L20 mock treatment 0.0735 1.43E-5 0.0 0.0017 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L21 compound treatment 0.0745 0.00101 0.12 0.1202 1.0 5 Bio2_000440 CC(C)(C)c1cc(C=C(C#N)C#N)cc(c1O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L22 mock treatment 0.0735 1.43E-5 0.0 0.0017 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L23 mock treatment 0.0745 0.00101 0.12 0.1202 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 L24 mock treatment 0.07 -0.00349 -0.41 -0.413 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M01 mock treatment 0.065 -0.00849 -1.01 -1.0055 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M02 mock treatment 0.0675 -0.00599 -0.71 -0.7092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M03 compound treatment 0.086 0.0125 1.48 1.4828 1.0 423 Bio2_000441 COC(=O)[C@@H](N)CCCNC(=N)N[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M04 mock treatment 0.075 0.00151 0.18 0.1794 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M05 compound treatment 0.077 0.00351 0.42 0.4164 1.0 321 Bio2_000442 O=c1cc(oc2c(cccc12)c3ccccc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M06 mock treatment 0.078 0.00451 0.53 0.5349 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M07 compound treatment 0.072 -0.00149 -0.18 -0.176 -1.0 243 Bio2_000443 O=C1C=C(Nc2ccccc2)C(=O)c3cccnc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M08 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M09 compound treatment 0.082 0.00851 1.01 1.0089 1.0 1059329 Bio2_000444 Nc1ncnc2n(cc(I)c12)C3OC(CO)C(O)C3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M10 mock treatment 0.075 0.00151 0.18 0.1794 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M11 compound treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 3104900 Bio2_000445 C/C(=C\CCC1C=CC(OC1O)C2=CC(=O)OC2O)/CCC3=C(C)CCCC3(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M12 mock treatment 0.0745 0.00101 0.12 0.1202 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M13 compound treatment 0.07 -0.00349 -0.41 -0.413 -1.0 192 Bio2_000446 CCCCC(C)/C=C(\C)/C=C(\C)/C(=O)NC1=CC(O)(\C=C\C=C\C=C\C(=O)NC2=C(O)CCC2=O)C3OC3C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M14 mock treatment 0.0695 -0.00399 -0.47 -0.4723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M15 compound treatment 0.0765 0.00301 0.36 0.3572 1.0 907409 Bio2_000447 CC[C@H](C)[C@H](N)C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M16 mock treatment 0.07 -0.00349 -0.41 -0.413 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M17 compound treatment 0.07 -0.00349 -0.41 -0.413 -1.0 419 Bio2_000448 CC1=NN(C(=O)C1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M18 mock treatment 0.069 -0.00449 -0.53 -0.5315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M19 compound treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 3002144 Bio2_000449 CN1C(=O)[C@@]23CC4=CC=C[C@H](O)[C@H]4N3C(=O)[C@@]1(CO)[S+](C)S2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M20 mock treatment 0.0705 -0.00299 -0.35 -0.3538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M21 compound treatment 0.0705 -0.00299 -0.35 -0.3538 -1.0 638 Bio2_000450 C/C(=C(\C#N)/C(=O)Nc1cc(Br)ccc1Br)/O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M22 mock treatment 0.0705 -0.00299 -0.35 -0.3538 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M23 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 M24 mock treatment 0.0695 -0.00399 -0.47 -0.4723 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N01 mock treatment 0.066 -0.00749 -0.89 -0.887 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N02 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N03 compound treatment 0.07 -0.00349 -0.41 -0.413 -1.0 3104901 Bio2_000451 CCCc1cc(OC)ccc1C.CC12CCCCC2CCC1NCCCCCCN3C(=O)C=CC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N04 mock treatment 0.069 -0.00449 -0.53 -0.5315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N05 compound treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 325 Bio2_000452 N/C(=C(/C#N)\C(=C(/N)\Sc1ccccc1N)\C#N)/Sc2ccccc2N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N06 mock treatment 0.085 0.0115 1.36 1.3643 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N07 compound treatment 0.0755 0.00201 0.24 0.2387 1.0 2430 Bio2_000453 CC(C)C1NC(=O)C(C)OC(=O)C(NC(=O)C(OC(=O)C(NC(=O)C(C)OC(=O)C(NC(=O)C(OC(=O)C(NC(=O)C(C)OC(=O)C(NC(=O)C(OC1=O)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N08 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N09 compound treatment 0.0775 0.00401 0.48 0.4757 1.0 3002149 Bio2_000454 *[C@@H]1[C@H]([C@@H]2CN(C[C@](O)(CC)C2)CCc3c1[nH]c4ccccc34)c5cc6c(cc5OC)N(C)[C@@H]7[C@@]86CCN9CC=C[C@](CC)([C@H]98)[C@@H](O)[C@]7(O)C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N10 mock treatment 0.082 0.00851 1.01 1.0089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N11 compound treatment 0.074 5.14E-4 0.06 0.0609 1.0 3002210 Bio2_000455 *CCCCCCNOc1cccc2c(Cl)cccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N12 mock treatment 0.1005 0.027 3.2 3.2009 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N13 compound treatment 0.083 0.00951 1.13 1.1273 1.0 293 Bio2_000456 COC[C@H]1OC(=O)c2coc3C(=O)C4=C([C@@H](C[C@@]5(C)C4CCC5=O)OC(=O)C)[C@]1(C)c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N14 mock treatment 0.0895 0.016 1.9 1.8975 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N15 compound treatment 0.0835 0.01 1.19 1.1866 1.0 677 Bio2_000457 C[C@@H](N)[C@H]1CC[C@@H](CC1)C(=O)Nc2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N16 mock treatment 0.087 0.0135 1.6 1.6013 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N17 compound treatment 0.0845 0.011 1.31 1.3051 1.0 3000363 Bio2_000458 COC(=O)[C@H]1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N18 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N19 compound treatment 0.0895 0.016 1.9 1.8975 1.0 207 Bio2_000459 CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)/C=C/S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N20 mock treatment 0.078 0.00451 0.53 0.5349 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N21 compound treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 352 Bio2_000460 CN(C)c1cccc(c1)C(=O)Nc2ccc(C)c(NC(=O)c3ccc(O)cc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N22 mock treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N23 mock treatment 0.0745 0.00101 0.12 0.1202 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 N24 mock treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O01 mock treatment 0.066 -0.00749 -0.89 -0.887 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O02 mock treatment 0.0635 -0.00999 -1.18 -1.1832 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O03 compound treatment 0.068 -0.00549 -0.65 -0.65 -1.0 3002219 Bio2_000461 *CCC(NC(=O)c1ccc(cc1)N(C)Cc2cnc3nc(N)nc(N)c3n2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O04 mock treatment 0.0675 -0.00599 -0.71 -0.7092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O05 compound treatment 0.0805 0.00701 0.83 0.8311 1.0 1001921 Bio2_000462 Clc1ccc(cn1)C2CC3CCC2N3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O06 mock treatment 0.0815 0.00801 0.95 0.9496 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O07 compound treatment 0.0765 0.00301 0.36 0.3572 1.0 381 Bio2_000463 CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3CCCC(=O)O3)[C@@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O08 mock treatment 0.072 -0.00149 -0.18 -0.176 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O09 compound treatment 0.074 5.14E-4 0.06 0.0609 1.0 1000019 Bio2_000464 CO[C@@]12[C@H]3N[C@H]3CN2C4=C([C@H]1COC(=O)N)C(=O)C(=C(C)C4=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O10 mock treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O11 compound treatment 0.0785 0.00501 0.59 0.5941 1.0 281 Bio2_000465 Ic1cccc2c(cccc12)S(=O)(=O)N3CCCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O12 mock treatment 0.087 0.0135 1.6 1.6013 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O13 compound treatment 0.078 0.00451 0.53 0.5349 1.0 3002225 Bio2_000466 Clc1cccc2c(cccc12)S(=O)(=O)N3CC*CCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O14 mock treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O15 compound treatment 0.08 0.00651 0.77 0.7719 1.0 438 Bio2_000467 CCOC(=O)C1=C(C)NC(=S)NC1c2cccc(O)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O16 mock treatment 0.0835 0.01 1.19 1.1866 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O17 compound treatment 0.0765 0.00301 0.36 0.3572 1.0 656 Bio2_000468 Oc1c(Br)cc(/C=C/2\C(=O)Nc3ccc(I)cc23)cc1Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O18 mock treatment 0.072 -0.00149 -0.18 -0.176 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O19 compound treatment 0.0755 0.00201 0.24 0.2387 1.0 3104902 Bio2_000469 CC[C@]1(CC[C@@H](O1)[C@]2(C)CC[C@]3(C[C@H](O)[C@@H](C)[C@H](O3)[C@@H](C)C/C=C(\C)/OO)O2)[C@@H]4O[C@H](C[C@@H]4C)[C@H]5O[C@@](O)(CO)[C@H](C)C[C@@H]5C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O20 mock treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O21 compound treatment 0.074 5.14E-4 0.06 0.0609 1.0 1907781 Bio2_000470 CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(\C)/[C@H]2OC(=O)C3CCCCN3C(=O)C(=O)[C@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)\C)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O22 mock treatment 0.0775 0.00401 0.48 0.4757 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O23 mock treatment 0.0775 0.00401 0.48 0.4757 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 O24 mock treatment 0.078 0.00451 0.53 0.5349 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P01 mock treatment 0.0755 0.00201 0.24 0.2387 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P02 mock treatment 0.0675 -0.00599 -0.71 -0.7092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P03 compound treatment 0.067 -0.00649 -0.77 -0.7685 -1.0 201 Bio2_000471 COC(=O)C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)OCc1ccccc1)C(C)C)C(=O)CF 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P04 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P05 compound treatment 0.0745 0.00101 0.12 0.1202 1.0 2217 Bio2_000472 CS(=O)(=O)Nc1ccc(cc1OC2CCCCC2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P06 mock treatment 0.0685 -0.00499 -0.59 -0.5908 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P07 compound treatment 0.0775 0.00401 0.48 0.4757 1.0 1917 Bio2_000473 CC1=C(C)C(=O)C(=C(C)C1=O)CCCCC#CCCCC#CCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P08 mock treatment 0.08 0.00651 0.77 0.7719 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P09 compound treatment 0.0755 0.00201 0.24 0.2387 1.0 3002232 Bio2_000474 *CC/C(=C/Cc1c(O)c2C(=O)OCc2c(C)c1OC)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P10 mock treatment 0.0775 0.00401 0.48 0.4757 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P11 compound treatment 0.074 5.14E-4 0.06 0.0609 1.0 2288 Bio2_000475 CC(=CCC(O)C1=CC(=O)c2c(O)ccc(O)c2C1=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P12 mock treatment 0.076 0.00251 0.3 0.2979 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P13 compound treatment 0.071 -0.00249 -0.29 -0.2945 -1.0 3104904 Bio2_000476 C1C[C@H]2CCCCCC[C@H]3CCN4CCC[C@H](CCCCCC[C@H]5CCN(C1)[C@@H]2O5)[C@H]4O3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P14 mock treatment 0.076 0.00251 0.3 0.2979 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P15 compound treatment 0.076 0.00251 0.3 0.2979 1.0 1907782 Bio2_000477 Oc1ccc(/C=C(/C#N)\C(=O)OC\C=C\c2ccccc2)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P16 mock treatment 0.075 0.00151 0.18 0.1794 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P17 compound treatment 0.073 -4.86E-4 -0.06 -0.0576 -1.0 3104917 Bio2_000478 C/C=C/C\C=C\CCC(=O)[C@H]1O[C@H]1C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P18 mock treatment 0.0715 -0.00199 -0.24 -0.2353 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P19 compound treatment 0.079 0.00551 0.65 0.6534 1.0 1395 Bio2_000479 CC(COc1ccccc1)N(CCCl)Cc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P20 mock treatment 0.077 0.00351 0.42 0.4164 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P21 compound treatment 0.0725 -9.86E-4 -0.12 -0.1168 -1.0 1303231 Bio2_000480 CN(C)CC(O)Cn1c2ccc(Br)cc2c3cc(Br)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P22 mock treatment 0.074 5.14E-4 0.06 0.0609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P23 mock treatment 0.072 -0.00149 -0.18 -0.176 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.1362 P24 mock treatment 0.0595 -0.014 -1.66 -1.6572 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A01 mock treatment 0.0795 0.00841 1.0 0.9968 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A02 mock treatment 0.07 -0.00109 -0.13 -0.1288 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A03 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 315 Bio2_000481 CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)/C=C/CCCCCCCCCCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A04 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 85 Bio2_000482 CCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)NC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A05 compound treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 29 Bio2_000483 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NCCCCCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A06 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 302 Bio2_000484 CCCCC[C@H](O)C/C=C/1\[C@@H](C/C=C\CCCC(=O)O)C=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A07 compound treatment 0.075 0.00391 0.46 0.4636 1.0 10 Bio2_000485 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N[C@H](C)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A08 compound treatment 0.068 -0.00309 -0.37 -0.3658 -1.0 262 Bio2_000486 CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A09 compound treatment 0.066 -0.00509 -0.6 -0.6028 -1.0 100 Bio2_000487 C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C\3/C[C@@H](O)C[C@H](O)C3=C)/CCC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A10 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 1000034 Bio2_000488 CCCCCCCCCCCCCCC[C@@H](O)[C@@H](N)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A11 compound treatment 0.0715 4.13E-4 0.05 0.0489 1.0 148 Bio2_000489 CCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A12 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 122 Bio2_000490 C(c1c[nH]c2ccccc12)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A13 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 150 Bio2_000491 CCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A14 compound treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 31 Bio2_000492 CCCCCCCCCCCCCCC[C@H](O)[C@@H](N)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A15 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 171 Bio2_000493 CCCCCCCC/C=C\CCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCC/C=C\CCCCCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A16 compound treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 33 Bio2_000494 CCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A17 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 141 Bio2_000495 CCCCC/C=C\CC1OC1C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A18 compound treatment 0.061 -0.0101 -1.2 -1.1952 -1.0 34 Bio2_000496 CCCCCCCCCCCCCCCC(=O)N[C@H](CN1CCOCC1)[C@H](O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A19 compound treatment 0.073 0.00191 0.23 0.2266 1.0 1000003 Bio2_000497 CCCCC/C=C\C[C@@H](O)/C=C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A20 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 223 Bio2_000498 CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A21 compound treatment 0.076 0.00491 0.58 0.5821 1.0 46 Bio2_000499 CCCCC/C=C\C[C@H](O)/C=C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A22 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 268 Bio2_000500 CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A23 mock treatment 0.0855 0.0144 1.71 1.7078 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 A24 mock treatment 0.08 0.00891 1.06 1.0561 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B01 mock treatment 0.0635 -0.00759 -0.9 -0.899 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B02 mock treatment 0.0685 -0.00259 -0.31 -0.3066 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B03 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 1000048 Bio2_000501 CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B04 compound treatment 0.07 -0.00109 -0.13 -0.1288 -1.0 2139 Bio2_000502 O[C@H]1C=C2CCN3Cc4cc5OCOc5cc4[C@@H]([C@H]32)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B05 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 32 Bio2_000503 C/C(=C/1\C(=O)C2C3C(Cc4cccc5[nH]cc3c45)C(C)(C)N2C1=O)/O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B06 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 3000451 Bio2_000504 CC[C@@]1(O)C(=O)OCc2c1cc3-c4nc5cccc(O)c5cc4Cn3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B07 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 3000787 Bio2_000505 [O-][N+](=O)c1ccc(cc1)c2ccc(/C=N/N3CC(=O)NC3=O)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B08 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 2127 Bio2_000506 CC1(C)CCC2=C(O1)c3ccccc3C(=O)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B09 compound treatment 0.0685 -0.00259 -0.31 -0.3066 -1.0 35 Bio2_000507 CC1=Nc2ccc(Cl)cc2S(=O)(=O)N1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B10 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 3103826 Bio2_000508 C/C/1=C\CC[C@@]2(C)O[C@@H]2[C@H]3OC(=O)C(=C)[C@@H]3CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B11 compound treatment 0.074 0.00291 0.35 0.3451 1.0 3103827 Bio2_000509 N/C(=N\C(=O)c1nc(Cl)c(N)nc1N)/NCc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B12 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 1907748 Bio2_000510 CC(C)C[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B13 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 3000452 Bio2_000511 *CCN1C(=O)[C@H](OC(=O)C)[C@@H](Sc2ccccc12)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B14 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 3000453 Bio2_000512 C[C@@H]1CC2OC(=O)C(=C)C2[C@H](O)[C@@]3(C)[C@H]1C=CC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B15 compound treatment 0.069 -0.00209 -0.25 -0.2473 -1.0 357 Bio2_000513 Cc1cccc(CCN2CCC(CC2)C(=O)c3ccc(NS(=O)(=O)C)cc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B16 compound treatment 0.065 -0.00609 -0.72 -0.7213 -1.0 1000105 Bio2_000514 CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B17 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 39 Bio2_000515 Nc1c(S(=O)C(F)(F)F)c(C#N)nn1c2c(Cl)cc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B18 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 1907749 Bio2_000516 CCOC(=O)CN1C(=O)CC(C[C@@H](O)C2C[C@@H](C)C[C@H](C)C2=O)CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B19 compound treatment 0.076 0.00491 0.58 0.5821 1.0 359 Bio2_000517 FC(F)(F)COc1ccc(OCC(F)(F)F)c(c1)C(=O)NCC2CCCCN2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B20 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 1907750 Bio2_000518 CC[C@@H]1/C=C(\C)/C[C@H](C)C[C@H](OC)[C@H]2O[C@](O)([C@H](C)C[C@@H]2OC)C(=O)C(=O)N3CCCC[C@H]3C(=O)O[C@@H]([C@H](C)[C@@H](O)CC1=O)\C(=C\[C@@H]4CC[C@@H](O)[C@@H](C4)OC)\C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B21 compound treatment 0.076 0.00491 0.58 0.5821 1.0 41 Bio2_000519 OC(=O)c1ccccc1Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B22 compound treatment 0.074 0.00291 0.35 0.3451 1.0 2349 Bio2_000520 CC12CC=C3C(CCC4=CC(=O)C=CC43C)C2CC[C@@H]1C(=O)CN5CCN(CC5)c6cc(nc(n6)N7CCCC7)N8CCCC8 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B23 mock treatment 0.072 9.13E-4 0.11 0.1081 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 B24 mock treatment 0.065 -0.00609 -0.72 -0.7213 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C01 mock treatment 0.0735 0.00241 0.29 0.2859 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C02 mock treatment 0.074 0.00291 0.35 0.3451 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C03 compound treatment 0.0795 0.00841 1.0 0.9968 1.0 87 Bio2_000521 CCCCC/C=C\C[C@H](OO)/C=C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C04 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 264 Bio2_000522 CC/C=C\C/C=C\C/C=C\CCCCCCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C05 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 301 Bio2_000523 COCCCCCCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C06 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 233 Bio2_000524 CCCCCCCCCCC/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C07 compound treatment 0.08 0.00891 1.06 1.0561 1.0 61 Bio2_000525 CCCCC[C@H](O)/C=C/C=C\CCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C08 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 256 Bio2_000526 CCCCC/C=C\C/C=C\CCCCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C09 compound treatment 0.075 0.00391 0.46 0.4636 1.0 90 Bio2_000527 CCCCC[C@H](OO)/C=C/C=C\CCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C10 compound treatment 0.0795 0.00841 1.0 0.9968 1.0 221 Bio2_000528 CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C11 compound treatment 0.076 0.00491 0.58 0.5821 1.0 304 Bio2_000529 CCCCC[C@H](O)CC[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C12 compound treatment 0.074 0.00291 0.35 0.3451 1.0 260 Bio2_000530 CC/C=C\C/C=C\C/C=C\CCCCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C13 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 1000009 Bio2_000531 C/C(=C\C=C\C(=C/C(=O)O)\C)/C=C/C1=C(C)CCCC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C14 compound treatment 0.0715 4.13E-4 0.05 0.0489 1.0 1000007 Bio2_000532 CCCCCCCCCCCCCCCCOC[C@@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C15 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 149 Bio2_000533 CCCCC(=O)/C=C/C=C\CCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C16 compound treatment 0.074 0.00291 0.35 0.3451 1.0 55 Bio2_000534 CC(=CCC/C(=C/CC/C(=C/CSCC(=O)O)/C)/C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C17 compound treatment 0.075 0.00391 0.46 0.4636 1.0 143 Bio2_000535 CCCCCC1OC1C/C=C\C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C18 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 217 Bio2_000536 O[C@@H](COc1cccc(c1)C(F)(F)F)/C=C/[C@H]2[C@H](O)C[C@H](O)[C@@H]2C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C19 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 50 Bio2_000537 CCCCC[C@H](O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C20 compound treatment 0.075 0.00391 0.46 0.4636 1.0 231 Bio2_000538 CCCCC/C=C\C/C=C\C/C=C\CCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C21 compound treatment 0.075 0.00391 0.46 0.4636 1.0 89 Bio2_000539 CCCCC[C@H](OO)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C22 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 92 Bio2_000540 CCCCC/C=C\CC1OC1CCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C23 mock treatment 0.075 0.00391 0.46 0.4636 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 C24 mock treatment 0.074 0.00291 0.35 0.3451 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D01 mock treatment 0.07 -0.00109 -0.13 -0.1288 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D02 mock treatment 0.0715 4.13E-4 0.05 0.0489 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D03 compound treatment 0.074 0.00291 0.35 0.3451 1.0 43 Bio2_000541 Fc1ccc(cc1)C(N2CCN(C/C=C/c3ccccc3)CC2)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D04 compound treatment 0.074 0.00291 0.35 0.3451 1.0 1531 Bio2_000542 O=c1n([se]c2ccccc12)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D05 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 3104253 Bio2_000543 CC(CCCN1CCC2(CC1)N(C)CNC2=O)c3ccc(F)cc3.Fc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D06 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 1875 Bio2_000544 FC(F)(F)c1ccccc1n2ccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D07 compound treatment 0.087 0.0159 1.89 1.8855 1.0 3000569 Bio2_000545 Cc1cc(C(=O)c2ccccc2Cc3ccccc3)c(C)[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D08 compound treatment 0.076 0.00491 0.58 0.5821 1.0 2372 Bio2_000546 COc1cc(ccc1OC(F)F)c2ccc(=O)[nH]n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D09 compound treatment 0.079 0.00791 0.94 0.9376 1.0 70 Bio2_000547 CCCCC[C@H](O)CC(=O)CCc1ccc(O)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D10 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 3000570 Bio2_000548 CCCNc1ccccc1c2nc3[nH]nnc3c(=O)[nH]2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D11 compound treatment 0.0815 0.0104 1.23 1.2338 1.0 72 Bio2_000549 Cc1cnc(cn1)C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D12 compound treatment 0.0905 0.0194 2.3 2.3002 1.0 3000571 Bio2_000550 *C1=C[C@]2(CC)CCCN3CCc4c(C32)n1c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D13 compound treatment 0.0815 0.0104 1.23 1.2338 1.0 74 Bio2_000551 COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D14 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 2337 Bio2_000552 COc1cc2CCn3c(cc(=Nc4c(C)cc(C)cc4C)n(C)c3=O)-c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D15 compound treatment 0.0795 0.00841 1.0 0.9968 1.0 76 Bio2_000553 CC1(C)[C@@H](O)C[C@@H]2[C@]1(O)[C@H](O)C[C@@]3(C[C@@](C)(O)C4CC[C@H]3[C@@]2(C)O)[C@@H]4O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D16 compound treatment 0.076 0.00491 0.58 0.5821 1.0 1907751 Bio2_000554 CN/C(=N\c1ccc(cc1)C2=NNC(=O)CC2C)/NC#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D17 compound treatment 0.079 0.00791 0.94 0.9376 1.0 78 Bio2_000555 C[C@]1(Cc2cc(OCC(=O)O)c(Cl)c(Cl)c2C1=O)C3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D18 compound treatment 0.0825 0.0114 1.35 1.3523 1.0 1000092 Bio2_000556 COc1ccc(cc1OC2CCCC2)C3CNC(=O)C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D19 compound treatment 0.079 0.00791 0.94 0.9376 1.0 3103683 Bio2_000557 COc1ccccc1.CS[C@H](C)[C@H](OC(=O)C)C(=O)N(C)CCN(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D20 compound treatment 0.0785 0.00741 0.88 0.8783 1.0 2270 Bio2_000558 CCCCOc1cc(CC2CNC(=O)N2)ccc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D21 compound treatment 0.0805 0.00941 1.12 1.1153 1.0 362 Bio2_000559 CCN(CC)CC(=O)Nc1c(C)cccc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D22 compound treatment 0.075 0.00391 0.46 0.4636 1.0 1865 Bio2_000560 Clc1cccc(Nc2nnc(c3ccccc3)c4ccccc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D23 mock treatment 0.0775 0.00641 0.76 0.7598 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 D24 mock treatment 0.075 0.00391 0.46 0.4636 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E01 mock treatment 0.075 0.00391 0.46 0.4636 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E02 mock treatment 0.0755 0.00441 0.52 0.5229 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E03 compound treatment 0.0805 0.00941 1.12 1.1153 1.0 308 Bio2_000561 CCCCC/C=C/C=C/1\[C@@H](C/C=C\CCCC(=O)O)C=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E04 compound treatment 0.092 0.0209 2.48 2.4779 1.0 94 Bio2_000562 CCCCCC1OC1C/C=C\CCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E05 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 147 Bio2_000563 CCCCCC(=O)/C=C/C=C\C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E06 compound treatment 0.099 0.0279 3.31 3.3074 1.0 1000018 Bio2_000564 CCCCC/C=C\C[C@@H](O)/C=C/C=C/C=C\[C@@H](O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E07 compound treatment 0.0845 0.0134 1.59 1.5893 1.0 259 Bio2_000565 CCCCC(C)(C)[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E08 compound treatment 0.094 0.0229 2.71 2.7149 1.0 3000590 Bio2_000566 **(*)S[C@H](/C=C/C=C/C=C\C/C=C\CCCCC)[C@@H](O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E09 compound treatment 0.0825 0.0114 1.35 1.3523 1.0 272 Bio2_000567 OC(=O)CCCCCCCCCCCCCCCC#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E10 compound treatment 0.081 0.00991 1.17 1.1746 1.0 3000609 Bio2_000568 *C(=O)[C@H](CS)NS[C@H](/C=C/C=C/C=C\C/C=C\CCCCC)[C@@H](O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E11 compound treatment 0.1205 0.0494 5.85 5.8549 1.0 300 Bio2_000569 O[C@@H](CCc1ccccc1)/C=C/[C@H]2[C@H](O)CC(=O)[C@@H]2C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E12 compound treatment 0.0835 0.0124 1.47 1.4708 1.0 3000610 Bio2_000570 *[C@H](/C=C/C=C/C=C\C/C=C\CCCCC)[C@@H](O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E13 compound treatment 0.0785 0.00741 0.88 0.8783 1.0 109 Bio2_000571 CCCCCCCCCCCCCCCC(=O)OC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E14 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 22 Bio2_000572 CCCCC/C=C\C/C=C\CCCCCCCC(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E15 compound treatment 0.081 0.00991 1.17 1.1746 1.0 179 Bio2_000573 CCCCCCCCCCCCCCCCOC[C@H](CO)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E16 compound treatment 0.0805 0.00941 1.12 1.1153 1.0 270 Bio2_000574 CCCCC/C=C\C/C=C\CCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E17 compound treatment 0.077 0.00591 0.7 0.7006 1.0 81 Bio2_000575 CCCCCCCCCCCCCCCCOCC(COP(=O)(O)OCC[N+](C)(C)C)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E18 compound treatment 0.073 0.00191 0.23 0.2266 1.0 229 Bio2_000576 CC/C=C\C/C=C\C/C=C\CCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E19 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 183 Bio2_000577 CCCCCCCCCCCCCCCCOCC(CO)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E20 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 186 Bio2_000578 CCCCC[C@H](O)/C=C/C=C\C=C\C=C\[C@@H](O)[C@@H](O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E21 compound treatment 0.075 0.00391 0.46 0.4636 1.0 181 Bio2_000579 CCCCCCCCCCCCCCCCOCC(CO)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E22 compound treatment 0.0785 0.00741 0.88 0.8783 1.0 3000631 Bio2_000580 *P(=O)OC[C@H](NC(=O)CCCCCCCCCCCCCCC)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E23 mock treatment 0.0745 0.00341 0.4 0.4044 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 E24 mock treatment 0.0725 0.00141 0.17 0.1674 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F01 mock treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F02 mock treatment 0.07 -0.00109 -0.13 -0.1288 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F03 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 80 Bio2_000581 CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F04 compound treatment 0.077 0.00591 0.7 0.7006 1.0 3000632 Bio2_000582 *CCNS(=O)(=O)c1cccc2c(Cl)cccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F05 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 372 Bio2_000583 COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2cc(OC)c(OC)c(OC)c2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F06 compound treatment 0.0715 4.13E-4 0.05 0.0489 1.0 47 Bio2_000584 CC(=CCC/C(=C/CC/C(=C/CSC[C@H](NC(=O)C)C(=O)O)/C)/C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F07 compound treatment 0.0835 0.0124 1.47 1.4708 1.0 82 Bio2_000585 Nc1cc(nc(N)[n+]1[O-])N2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F08 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 3000633 Bio2_000586 Cc1ccc(C(=O)*2****o2)c3nc4c(C(=O)*5****o5)c(N)c(=O)c(C)c4oc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F09 compound treatment 0.079 0.00791 0.94 0.9376 1.0 84 Bio2_000587 Nc1cc(nc(N)[n+]1OS(=O)(=O)O)N2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F10 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 1907752 Bio2_000588 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCc1ccc(O)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F11 compound treatment 0.079 0.00791 0.94 0.9376 1.0 86 Bio2_000589 COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCN(C)Cc3ccccc3)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F12 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 331 Bio2_000590 COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F13 compound treatment 0.077 0.00591 0.7 0.7006 1.0 110 Bio2_000591 COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OC)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F14 compound treatment 0.083 0.0119 1.41 1.4115 1.0 333 Bio2_000592 NC(=S)/C(=C/c1ccc(O)c(O)c1)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F15 compound treatment 0.076 0.00491 0.58 0.5821 1.0 112 Bio2_000593 OC(=O)c1cccnc1Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F16 compound treatment 0.074 0.00291 0.35 0.3451 1.0 203 Bio2_000594 NC(=C(C#N)C#N)/C(=C/c1ccc2[nH]ccc2c1)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F17 compound treatment 0.078 0.00691 0.82 0.8191 1.0 907431 Bio2_000595 COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCCN3CCC(CC3)(c4ccccc4)c5ccccc5)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F18 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 3 Bio2_000596 Oc1ccc(/C=C(\C#N)/C(=O)NCc2ccccc2)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F19 compound treatment 0.075 0.00391 0.46 0.4636 1.0 115 Bio2_000597 COCCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC(C)C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F20 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 208 Bio2_000598 CC(C)(C)c1cc(/C=C(\C#N)/C(=S)N)cc(c1O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F21 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 117 Bio2_000599 CCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OC)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F22 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 2413 Bio2_000600 CC(C)CC(NC(=O)CNC(=O)C(C)(C)NC(=O)C(NC(=O)C(C)(C)NC(=O)C(CCC(=O)N)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C(C)NC(=O)C(C)(C)NC(=O)C1CCCN1C(=O)C(C)(C)NC(=O)C)C(C)C)C(=O)NC(C)(C)C(=O)N2CCCC2C(=O)NC(C(C)C)C(=O)NC(C)(C)C(=O)NC(C)(C)C(=O)NC(CCC(=O)O)C(=O)NC(CCC(=O)N)C(=O)NC(CO)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F23 mock treatment 0.0755 0.00441 0.52 0.5229 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 F24 mock treatment 0.072 9.13E-4 0.11 0.1081 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G01 mock treatment 0.0725 0.00141 0.17 0.1674 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G02 mock treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G03 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 83 Bio2_000601 CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G04 compound treatment 0.0715 4.13E-4 0.05 0.0489 1.0 191 Bio2_000602 CCCc1c(O)c(ccc1OCCCCc2nnn[nH]2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G05 compound treatment 0.076 0.00491 0.58 0.5821 1.0 173 Bio2_000603 CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](CO)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G06 compound treatment 0.074 0.00291 0.35 0.3451 1.0 3000641 Bio2_000604 *CCOP(=O)(O)OC[C@H](O)COCCCCCCCCCCCCCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G07 compound treatment 0.0885 0.0174 2.06 2.0632 1.0 177 Bio2_000605 CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCCCCCC/C=C\C/C=C\CCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G08 compound treatment 0.08 0.00891 1.06 1.0561 1.0 111 Bio2_000606 CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@@H](O)COP(=O)(O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G09 compound treatment 0.0785 0.00741 0.88 0.8783 1.0 175 Bio2_000607 CCCCCCCCCCCCCCCCCC(=O)OC[C@H](CO)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G10 compound treatment 0.0805 0.00941 1.12 1.1153 1.0 36 Bio2_000608 CCCCCCCCCCCCCC(=O)N[C@H](C)[C@@H](O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G11 compound treatment 0.08 0.00891 1.06 1.0561 1.0 102 Bio2_000609 C[C@H](CC[C@@H](O)C(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C\3/C[C@@H](O)CCC3=C)/CCC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G12 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 1000002 Bio2_000610 CCCCCCCCCCCCCC(=O)N[C@@H](C)[C@H](O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G13 compound treatment 0.081 0.00991 1.17 1.1746 1.0 98 Bio2_000611 C[C@H](CCCC(C)(C)O)[C@H]1CC[C@H]2/C(=C/C=C\3/C[C@@H](O)CCC3=C)/CCC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G14 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 227 Bio2_000612 CCCCCCCC/C=C\C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G15 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 118 Bio2_000613 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)OC(CO)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G16 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 8 Bio2_000614 CCCCCCCC/C=C\C/C=C\C/C=C\CCCC(=O)NCCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G17 compound treatment 0.086 0.0149 1.77 1.767 1.0 276 Bio2_000615 CCCCCCCCCCCCCCC(F)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G18 compound treatment 0.071 -8.73E-5 -0.01 -0.0103 -1.0 136 Bio2_000616 COC(C)(C)CCCC(C)C/C=C/C(=C/C(=O)O)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G19 compound treatment 0.073 0.00191 0.23 0.2266 1.0 274 Bio2_000617 CCCCCCCCCCCCC(O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G20 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 310 Bio2_000618 CCCCC(C)(O)C/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G21 compound treatment 0.075 0.00391 0.46 0.4636 1.0 130 Bio2_000619 C/C(=C\C=C\C(=C\C(=O)Nc1ccc(O)cc1)\C)/C=C/C2=C(C)CCCC2(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G22 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 309 Bio2_000620 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G23 mock treatment 0.0725 0.00141 0.17 0.1674 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 G24 mock treatment 0.07 -0.00109 -0.13 -0.1288 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H01 mock treatment 0.071 -8.73E-5 -0.01 -0.0103 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H02 mock treatment 0.0675 -0.00359 -0.43 -0.4251 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H03 compound treatment 0.071 -8.73E-5 -0.01 -0.0103 -1.0 119 Bio2_000621 OC(=O)c1ccccc1Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H04 compound treatment 0.077 0.00591 0.7 0.7006 1.0 556 Bio2_000622 COc1cc2ncc(nc2cc1OC)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H05 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 3001877 Bio2_000623 OC(=O)c1cc(O)ccc1NCCCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H06 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 3001878 Bio2_000624 Cc1[nH]c(=O)c([N+]#[C-])cc1c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H07 compound treatment 0.082 0.0109 1.29 1.293 1.0 2450 Bio2_000625 Oc1ccc(cc1n2c(=O)[nH]c3cc(ccc23)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H08 compound treatment 0.081 0.00991 1.17 1.1746 1.0 2080829 Bio2_000626 OCC1(CO)N2CCC(CC2)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H09 compound treatment 0.0795 0.00841 1.0 0.9968 1.0 124 Bio2_000627 CC(C)(O)[C@H]1O[C@H]2CC[C@]3(C)[C@]4(C)[C@H](Cc5c4[nH]c6ccccc56)CC[C@@]3(O)C2=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H10 compound treatment 0.0815 0.0104 1.23 1.2338 1.0 1907753 Bio2_000628 CC[C@@H]1[C@H](C)C[C@@H]2[C@H]3C[C@H]4CCC(=O)C5=C(O)[C@H](CCCNC(=O)/C=C\C[C@@H]4[C@H]3C=C[C@@H]12)NC5=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H11 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 126 Bio2_000629 CC1(C)Oc2ccc(C#N)cc2[C@@H](OC3=CC(=O)CC3)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H12 compound treatment 0.09 0.0189 2.24 2.241 1.0 354 Bio2_000630 Nc1ccc2C(=O)NC(=O)c3cccc1c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H13 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 128 Bio2_000631 CC(=C)[C@H]1O[C@H]2CC[C@]3(C)[C@]4(C)[C@@H](CC[C@@]3(O)[C@@]52O[C@@H]5[C@H]1O)[C@@H]6OC(C)(C)[C@H]7C[C@@H]8C(=C)Cc9c(Cl)cc%10[nH]c4c6c%10c9[C@@]87O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H14 compound treatment 0.077 0.00591 0.7 0.7006 1.0 445 Bio2_000632 NC(=O)c1cccc(N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H15 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 2474 Bio2_000633 Nc1nc(N)c(nc1Cl)C(=O)NC(=N)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H16 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 1907754 Bio2_000634 CO[C@H]1C[C@H](C)CC2=C(NCC=C)C(=O)C=C(NC(=O)/C(=C/C=C\[C@H](OC)[C@@H](OC(=O)N)/C(=C/[C@H](C)[C@H]1O)/C)/C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H17 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 153 Bio2_000635 CC1=CC=C(CC1)N(CC2=NCCN2)c3cccc(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H18 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 3001880 Bio2_000636 CC(=O)O[C@@H]1[C@@H](O)CN[C@@H]1Cc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H19 compound treatment 0.075 0.00391 0.46 0.4636 1.0 3001155 Bio2_000637 CC1(C)NC(=O)NC1=O.c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H20 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 154 Bio2_000638 C[C@@]1(CO)[C@H](O)CC[C@@]2(C)[C@H]1CC[C@H]3C[C@@H]4C[C@@]32CC[C@]4(O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H21 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 156 Bio2_000639 Fc1ccc(cc1)C(CCCN2CCC(CC2)n3c(=O)[nH]c4ccccc34)c5ccc(F)cc5Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H22 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 401 Bio2_000640 COc1cccc2c1cc([N+](=O)[O-])c3c(cc4OCOc4c23)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H23 mock treatment 0.073 0.00191 0.23 0.2266 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 H24 mock treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I01 mock treatment 0.0715 4.13E-4 0.05 0.0489 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I02 mock treatment 0.0675 -0.00359 -0.43 -0.4251 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I03 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 299 Bio2_000641 CCCCCCCCCCOCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I04 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 184 Bio2_000642 CCCCC/C=C\C/C=C\C=C\C=C\[C@@H](SCC(NC(=O)C)C(=O)O)[C@@H](O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I05 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 13 Bio2_000643 CCCCC/C=C\C/C=C\C/C=C\C=C\[C@@H](O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I06 compound treatment 0.0805 0.00941 1.12 1.1153 1.0 14 Bio2_000644 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I07 compound treatment 0.079 0.00791 0.94 0.9376 1.0 64 Bio2_000645 CCCCC/C=C\C/C=C\C/C=C\C=C\[C@H](CCCC(=O)O)OO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I08 compound treatment 0.0795 0.00841 1.0 0.9968 1.0 123 Bio2_000646 CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I09 compound treatment 0.086 0.0149 1.77 1.767 1.0 137 Bio2_000647 CCCCC/C=C\C/C=C\C/C=C\CC1OC1CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I10 compound treatment 0.0805 0.00941 1.12 1.1153 1.0 40 Bio2_000648 CCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I11 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 146 Bio2_000649 CCCCCC#CCC#CCC#CCC#CCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I12 compound treatment 0.0685 -0.00259 -0.31 -0.3066 -1.0 66 Bio2_000650 CCCCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I13 compound treatment 0.059 -0.0121 -1.43 -1.4322 -1.0 144 Bio2_000651 CCCCCCCCC#CCC#CCC#CCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I14 compound treatment 0.063 -0.00809 -0.96 -0.9583 -1.0 69 Bio2_000652 CCCCCCCC/C=C\CCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I15 compound treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 145 Bio2_000653 CCCCC/C=C\C/C=C\C/C=C\C=C\C(=O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I16 compound treatment 0.066 -0.00509 -0.6 -0.6028 -1.0 318 Bio2_000654 CCCCCCCCCCCCCCCC(=O)NCCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I17 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 120 Bio2_000655 O=Cc1c2[nH]c3ccccc3c2cc4[nH]c5ccccc5c14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I18 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 114 Bio2_000656 CCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)O)OC(=O)CCCCCCCCCCCCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I19 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 257 Bio2_000657 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CC(=O)CCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I20 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 190 Bio2_000658 CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1CCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I21 compound treatment 0.073 0.00191 0.23 0.2266 1.0 258 Bio2_000659 CCCCCCCCCCC/C=C\C(C)(C)/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I22 compound treatment 0.068 -0.00309 -0.37 -0.3658 -1.0 212 Bio2_000660 CCCCC[C@H](O)/C=C/[C@H]1C=CC(=O)[C@@H]1C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I23 mock treatment 0.068 -0.00309 -0.37 -0.3658 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 I24 mock treatment 0.065 -0.00609 -0.72 -0.7213 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J01 mock treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J02 mock treatment 0.069 -0.00209 -0.25 -0.2473 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J03 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 3104408 Bio2_000661 CC(N/C(=N\C#N)/Nc1ccncc1)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J04 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 1907755 Bio2_000662 COCc1nc2n(CC(C)C)c(=O)n(C)c(=O)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J05 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 2431 Bio2_000663 CCN(CC)CCNC(=O)c1ccc(N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J06 compound treatment 0.068 -0.00309 -0.37 -0.3658 -1.0 1907756 Bio2_000664 Clc1ccc2ncnc(NCc3ccc4OCOc4c3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J07 compound treatment 0.091 0.0199 2.36 2.3595 1.0 3104409 Bio2_000665 CCCNCC(O)COc1ccccc1.CC(=O)CCc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J08 compound treatment 0.078 0.00691 0.82 0.8191 1.0 155 Bio2_000666 CSCC[C@H](NC(=O)[C@H](Cc1ccccc1)NC[C@@H](NC[C@@H](N)CS)C(C)C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J09 compound treatment 0.077 0.00591 0.7 0.7006 1.0 161 Bio2_000667 COc1ccc2nccc(C(O)[C@H]3CC4CC[C@@H]3CC4C=C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J10 compound treatment 0.077 0.00591 0.7 0.7006 1.0 361 Bio2_000668 CC(C)(c1ccc(OCC2CO2)cc1)c3ccc(OCC4CO4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J11 compound treatment 0.073 0.00191 0.23 0.2266 1.0 1000050 Bio2_000669 COc1ccc2nccc([C@@H](O)[C@@H]3CC4CC[C@@H]3CC4C=C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J12 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 3103962 Bio2_000670 CO[C@H]1/C=C/C=C(\C)/C[C@@H](C)[C@H](O)[C@H](C)/C=C(\C)/C=C(\OC)/C(=O)O[C@@H]1[C@@H](C)[C@@H](O)[C@H](C)[C@H]2C[C@@H](O)[C@H](C)[C@H](O2)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J13 compound treatment 0.0715 4.13E-4 0.05 0.0489 1.0 907369 Bio2_000671 CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J14 compound treatment 0.069 -0.00209 -0.25 -0.2473 -1.0 3103963 Bio2_000672 CC(=O)OCOC(=O)CNc1ccccc1OCCOc2ccccc2NCC(=O)OCOC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J15 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 3103964 Bio2_000673 CC(C)[C@]1(O)[C@@H](OC(=O)c2ccc[nH]2)[C@]3(O)[C@]4(O)[C@]1(C)[C@]5(O)C[C@@]3(C)[C@@]6(O)CC[C@H](C)[C@@H](O)[C@]46O5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J16 compound treatment 0.0685 -0.00259 -0.31 -0.3066 -1.0 3103618 Bio2_000674 Cc1ccc2N=C3N(CCC3(O)C(=O)c2c1)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J17 compound treatment 0.07 -0.00109 -0.13 -0.1288 -1.0 165 Bio2_000675 OC(COc1cccc2[nH]c(C#N)cc12)CN3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J18 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 3001881 Bio2_000676 */C=C(/CC(=O)O)\C=C\[C@@H](C)C\C=C\CC/C=C/C=C\CC/C(=C\C=C(\*)/C)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J19 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 390 Bio2_000677 COc1ccc(CCCOC(Cn2ccnc2)c3ccc(OC)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J20 compound treatment 0.081 0.00991 1.17 1.1746 1.0 1000439 Bio2_000678 CNC(=O)[C@H]1O[C@H]([C@H](O)[C@@H]1O)n2cnc3c(NCc4ccc(I)cc4)ncnc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J21 compound treatment 0.073 0.00191 0.23 0.2266 1.0 193 Bio2_000679 COc1cc2CCN(C)[C@H]3Cc4ccc(OC)c(Oc5ccc(C[C@@H]6N(C)CCc7cc(OC)c(Oc(c1OC)c32)cc67)cc5)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J22 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 3104702 Bio2_000680 C[C@H]1CCC/C=C/C2C[C@H](O)C[C@H]2[C@H](O)/C=C/C(=O)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J23 mock treatment 0.0715 4.13E-4 0.05 0.0489 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 J24 mock treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K01 mock treatment 0.069 -0.00209 -0.25 -0.2473 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K02 mock treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K03 compound treatment 0.0665 -0.00459 -0.54 -0.5435 -1.0 139 Bio2_000681 CCCCC/C=C\C/C=C\CC1OC1C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K04 compound treatment 0.0675 -0.00359 -0.43 -0.4251 -1.0 214 Bio2_000682 CCCCC[C@H](O)/C=C/C1=C(CCCCCCC(=O)O)C(=O)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K05 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 1000033 Bio2_000683 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@H]1C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K06 compound treatment 0.0685 -0.00259 -0.31 -0.3066 -1.0 216 Bio2_000684 CCCCC[C@H](O)/C=C/C1=C(C/C=C\CCCC(=O)O)C(=O)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K07 compound treatment 0.073 0.00191 0.23 0.2266 1.0 57 Bio2_000685 CCCCC/C=C\C=C\[C@@H](O)CCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K08 compound treatment 0.07 -0.00109 -0.13 -0.1288 -1.0 218 Bio2_000686 CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@@H](O)CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K09 compound treatment 0.07 -0.00109 -0.13 -0.1288 -1.0 88 Bio2_000687 CCCCC/C=C\C=C\[C@H](CCCCCCCC(=O)O)OO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K10 compound treatment 0.069 -0.00209 -0.25 -0.2473 -1.0 220 Bio2_000688 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1CCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K11 compound treatment 0.0685 -0.00259 -0.31 -0.3066 -1.0 45 Bio2_000689 CCCCCCCC/C=C\CCCCCCCC(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K12 compound treatment 0.066 -0.00509 -0.6 -0.6028 -1.0 222 Bio2_000690 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)CC(=O)[C@@H]1C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K13 compound treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 1000028 Bio2_000691 CCCCC[C@H](O)/C=C/[C@H]1[C@@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K14 compound treatment 0.0655 -0.00559 -0.66 -0.662 -1.0 226 Bio2_000692 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1CCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K15 compound treatment 0.078 0.00691 0.82 0.8191 1.0 1000027 Bio2_000693 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H](O)[C@@H]1C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K16 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 224 Bio2_000694 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@H](O)[C@@H]1C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K17 compound treatment 0.0675 -0.00359 -0.43 -0.4251 -1.0 1000008 Bio2_000695 C/C(=C/C=C/C(=C/C(=O)O)/C)/C=C/C1=C(C)CCCC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K18 compound treatment 0.0785 0.00741 0.88 0.8783 1.0 3184 Bio2_000696 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2O/C(=C\CCCC(=O)O)/C[C@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K19 compound treatment 0.069 -0.00209 -0.25 -0.2473 -1.0 47 Bio2_000697 CC(=CCC/C(=C/CC/C(=C/CSC[C@H](NC(=O)C)C(=O)O)/C)/C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K20 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 267 Bio2_000698 CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K21 compound treatment 0.0685 -0.00259 -0.31 -0.3066 -1.0 266 Bio2_000699 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K22 compound treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 104 Bio2_000700 C/C(=C\C=C\C(=C\C(=O)O)\C)/C=C/C1=C(C)CCCC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K23 mock treatment 0.068 -0.00309 -0.37 -0.3658 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 K24 mock treatment 0.0665 -0.00459 -0.54 -0.5435 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L01 mock treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L02 mock treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L03 compound treatment 0.068 -0.00309 -0.37 -0.3658 -1.0 194 Bio2_000701 CCCCCCCC(=O)O[C@@H]1[C@@H](OC(=O)/C(=C\C)/C)C(=C2[C@@H]3OC(=O)[C@@](C)(O)[C@@]3(O)[C@H](C[C@](C)(OC(=O)C)[C@@H]12)OC(=O)CCC)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L04 compound treatment 0.074 0.00291 0.35 0.3451 1.0 407 Bio2_000702 [O-][N+](=O)c1cccc2c(Br)n[nH]c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L05 compound treatment 0.069 -0.00209 -0.25 -0.2473 -1.0 392 Bio2_000703 CCN(CC)CCCCCCCOC(=O)c1cc(OC)c(OC)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L06 compound treatment 0.07 -0.00109 -0.13 -0.1288 -1.0 3103965 Bio2_000704 Nc1ncnc2n(C3O[C@H]4COP(=O)(O)O[C@@H]4[C@@H]3O)c(Br)nc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L07 compound treatment 0.078 0.00691 0.82 0.8191 1.0 196 Bio2_000705 Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L08 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 3103966 Bio2_000706 NC1=NC2C(N=C(Br)N2C3O[C@H]4COP(=O)(O)O[C@@H]4[C@@H]3O)C(=O)N1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L09 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 198 Bio2_000707 CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L10 compound treatment 0.0715 4.13E-4 0.05 0.0489 1.0 404 Bio2_000708 CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L11 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 3103746 Bio2_000709 C1CCC(CC1)/N=C(\NC2C3CC4CC(C3)CC2C4)/N5CCOCC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L12 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 3001884 Bio2_000710 CCNC(=O)[C@@H]1O[C@@H]([C@@H](O)[C@H]1O)n2cnc3c(N)ncnc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L13 compound treatment 0.07 -0.00109 -0.13 -0.1288 -1.0 396 Bio2_000711 CN([C@H]1CCCC[C@@H]1N2CCCC2)C(=O)Cc3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L14 compound treatment 0.0685 -0.00259 -0.31 -0.3066 -1.0 373 Bio2_000712 CC(/C=C/c1cccc(Oc2ccc(F)cc2)c1)N(O)C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L15 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 1000056 Bio2_000713 COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L16 compound treatment 0.0715 4.13E-4 0.05 0.0489 1.0 3103967 Bio2_000714 CCCNC(=O)[C@H]1O[C@@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N2CCC[C@H]2C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L17 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 200 Bio2_000715 COc1ccc(cc1OC)C(=O)OC2CC[C@@]3(C)C4CCC5[C@@]3(C[C@@]6(O)C7CN8CC(C)CCC8[C@@](C)(O)[C@@]7(O)[C@@H](O)C[C@@]56O)O[C@@]42O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L18 compound treatment 0.079 0.00791 0.94 0.9376 1.0 1907757 Bio2_000716 Oc1ccc(NC2=C(C(=O)NC2=O)c3ccccc3[N+](=O)[O-])cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L19 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 202 Bio2_000717 COc1ccc(CCN(C)CCc2ccc(OC)c(OC)c2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L20 compound treatment 0.072 9.13E-4 0.11 0.1081 1.0 3103968 Bio2_000718 CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)OCc1ccccc1)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L21 compound treatment 0.076 0.00491 0.58 0.5821 1.0 3104544 Bio2_000719 CC(O)(C(=O)Nc1ccccc1)C(F)(F)F.CS(=O)(=O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L22 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 125 Bio2_000720 COc1cc(O)c2c(=O)c(OC)c(CC(C)OC(=O)Oc3ccc(O)cc3)c4c5c(CC(C)OC(=O)c6ccccc6)c(OC)c(=O)c7c(O)cc(OC)c(c1c24)c75 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L23 mock treatment 0.073 0.00191 0.23 0.2266 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 L24 mock treatment 0.068 -0.00309 -0.37 -0.3658 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M01 mock treatment 0.0685 -0.00259 -0.31 -0.3066 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M02 mock treatment 0.068 -0.00309 -0.37 -0.3658 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M03 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 53 Bio2_000721 CC(=CCC/C(=C/CSC[C@H](NC(=O)C)C(=O)O)/C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M04 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 189 Bio2_000722 CCCCCC(O)c1cccc(OCc2ccc3ccccc3n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M05 compound treatment 0.0715 4.13E-4 0.05 0.0489 1.0 51 Bio2_000723 CC(=CCC/C(=C/CC/C(=C/CC/C(=C/CSC[C@H](NC(=O)C)C(=O)O)/C)/C)/C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M06 compound treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 49 Bio2_000724 COC(=O)[C@@H](N)CSC/C=C(\C)/CC/C=C(\C)/CCC=C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M07 compound treatment 0.0715 4.13E-4 0.05 0.0489 1.0 116 Bio2_000725 Cc1c(nn(c1c2ccc(I)cc2)c3ccc(Cl)cc3Cl)C(=O)NN4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M08 compound treatment 0.084 0.0129 1.53 1.53 1.0 1000032 Bio2_000726 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@@H](N)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M09 compound treatment 0.071 -8.73E-5 -0.01 -0.0103 -1.0 132 Bio2_000727 CC1(C)CCC(C)(C)c2cc(ccc21)C(=O)Nc3ccc(cc3)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M10 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 3103969 Bio2_000728 OC(=O)CCC/C=C\CC1C(CNNC(=O)Nc2ccccc2)C3CCC1O3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M11 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 2 Bio2_000729 CCCCC/C=C\C/C=C\CCCCCCCC(=O)NCCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M12 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 3001885 Bio2_000730 CCCCCc1cc(O)c2C3C=C(CC[C@H]3C(C)(C)Oc2c1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M13 compound treatment 0.069 -0.00209 -0.25 -0.2473 -1.0 4 Bio2_000731 CCCCC/C=C\C/C=C\C/C=C\CCCCCCC(=O)NCCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M14 compound treatment 0.0675 -0.00359 -0.43 -0.4251 -1.0 134 Bio2_000732 C/C(=C\c1ccc(cc1)C(=O)O)/c2ccc3c(c2)C(C)(C)CCC3(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M15 compound treatment 0.071 -8.73E-5 -0.01 -0.0103 -1.0 316 Bio2_000733 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)NCCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M16 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 261 Bio2_000734 CCCCC[C@H](O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)[C@H]2CO[C@@H]1C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M17 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 6 Bio2_000735 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(=O)NCCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M18 compound treatment 0.069 -0.00209 -0.25 -0.2473 -1.0 3103970 Bio2_000736 CCCCC/C=C\CC(O)/C=C/c1cccc(CC(O)CCCCO)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M19 compound treatment 0.073 0.00191 0.23 0.2266 1.0 20 Bio2_000737 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M20 compound treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 18 Bio2_000738 Cc1c(C(=O)c2ccc3ccccc3c2)c4cccc5OC[C@@H](CN6CCOCC6)n1c54 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M21 compound treatment 0.0705 -5.87E-4 -0.07 -0.0696 -1.0 225 Bio2_000739 CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M22 compound treatment 0.071 -8.73E-5 -0.01 -0.0103 -1.0 138 Bio2_000740 Cc1cccc(Nc2cc(Cl)nc(SCC(=O)O)n2)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M23 mock treatment 0.071 -8.73E-5 -0.01 -0.0103 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 M24 mock treatment 0.0675 -0.00359 -0.43 -0.4251 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N01 mock treatment 0.071 -8.73E-5 -0.01 -0.0103 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N02 mock treatment 0.0715 4.13E-4 0.05 0.0489 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N03 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 1002014 Bio2_000741 Cc1ccc(cc1)S(=O)(=O)N[C@@H](Cc2ccccc2)C(=O)CCl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N04 compound treatment 0.078 0.00691 0.82 0.8191 1.0 3103971 Bio2_000742 COC[C@H]([C@@H](O)[C@@H](O)C(=O)NCC[C@@H](C)c1nc(/C=C/C[C@H]2OC3(C[C@H](O)[C@H]2C)OC([C@@H](C[C@@H](O)[C@@H](C)[C@@H](O)[C@@H](C)/C=C(\C)/C(=C/C=C/C(=C\C#N)/C)/C)OC)[C@@H](OP(=O)(O)O)C3(C)C)co1)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N05 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 2041 Bio2_000743 OC(=O)CNC(=O)C(CS)Cc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N06 compound treatment 0.086 0.0149 1.77 1.767 1.0 3001887 Bio2_000744 CC[C@@]1(O)C(=O)OCc2c1cc3Cc4nc5ccccc5cc4-n3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N07 compound treatment 0.0795 0.00841 1.0 0.9968 1.0 831924 Bio2_000745 O=C[C@@H]1CCCN1C(=O)[C@@H]2CCCN2C(=O)OCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N08 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 363 Bio2_000746 CC12C3CCC(O3)C2(C)C(=O)OC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N09 compound treatment 0.076 0.00491 0.58 0.5821 1.0 1907758 Bio2_000747 CCC(C)[C@H](NS(=O)(=O)c1cccc2ccccc12)C(=O)N[C@@H](Cc3c[nH]c4ccccc34)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N10 compound treatment 0.0965 0.0254 3.01 3.0112 1.0 446 Bio2_000748 COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N11 compound treatment 0.077 0.00591 0.7 0.7006 1.0 1891 Bio2_000749 Clc1oc(=O)c2ccccc2c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N12 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 377 Bio2_000750 Oc1cc2CCCN(Cc2cc1O)C(=S)NCCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N13 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 1907759 Bio2_000751 CC(C)[C@H](NC(=O)[C@@H](NC(=O)CNC(=O)OC(C)(C)C)C(C)C)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N14 compound treatment 0.0845 0.0134 1.59 1.5893 1.0 379 Bio2_000752 O[C@H]1CCN2C[C@H](O)[C@@H](O)[C@H](O)[C@@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N15 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 2060 Bio2_000753 CC(C)C[C@H](NC(=O)[C@@H](O)[C@H](N)Cc1ccccc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N16 compound treatment 0.085 0.0139 1.65 1.6485 1.0 3103975 Bio2_000754 CCCN(CCC)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCC)CCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N17 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 1907760 Bio2_000755 C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](Cc1ccccc1)C(=O)CCl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N18 compound treatment 0.075 0.00391 0.46 0.4636 1.0 391 Bio2_000756 Clc1ccc2NC(=O)CSC(c3ccccc3Cl)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N19 compound treatment 0.079 0.00791 0.94 0.9376 1.0 1907761 Bio2_000757 CC(C)[C@H](NC(=O)OCc1ccccc1)C(=O)N[C@@H](Cc2ccccc2)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N20 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 3001890 Bio2_000758 COc1ccc2c(c1)c(OC)[n+](C)c3c2ccc4cc5OCOc5cc43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N21 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 1907762 Bio2_000759 CCCC[C@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(C)C)NC(=O)C)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N22 compound treatment 0.075 0.00391 0.46 0.4636 1.0 1907763 Bio2_000760 Oc1ccc(/C=C/C(=O)OCCc2ccccc2)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N23 mock treatment 0.077 0.00591 0.7 0.7006 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 N24 mock treatment 0.0745 0.00341 0.4 0.4044 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O01 mock treatment 0.071 -8.73E-5 -0.01 -0.0103 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O02 mock treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O03 compound treatment 0.074 0.00291 0.35 0.3451 1.0 73 Bio2_000761 CCCCCCCCCCCCCCCCOC[C@H](COP(=O)(O)OCC[N+](C)(C)C)OC(=O)CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O04 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 338 Bio2_000762 Nc1ccncc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O05 compound treatment 0.086 0.0149 1.77 1.767 1.0 12 Bio2_000763 COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)N4CCOCC4)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O06 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 340 Bio2_000764 CCCCCC(O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O07 compound treatment 0.0785 0.00741 0.88 0.8783 1.0 305 Bio2_000765 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O08 compound treatment 0.078 0.00691 0.82 0.8191 1.0 1000039 Bio2_000766 CC[C@]1(COC)[C@H](O)C[C@H](OC)[C@@]2(C(C)C)C3C[C@@]4(O)[C@H](OC(=O)c5ccccc5)C3[C@](C[C@H](OC)C12)(OC(=O)C)[C@@H](O)C[C@@H]4OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O09 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 307 Bio2_000767 CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O10 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 24 Bio2_000768 CN(CCc1ccc(Cl)c(Cl)c1)CC(O)COc2ccc(NS(=O)(=O)C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O11 compound treatment 0.079 0.00791 0.94 0.9376 1.0 311 Bio2_000769 CCCCCCCCCCCCC/C=C/[C@@H](O)[C@H](CO)NC(=O)CCCCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O12 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 1000040 Bio2_000770 [N-2]C1(CC2CC3CC(C2)C1)C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O13 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 313 Bio2_000771 CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(=O)CCCCCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O14 compound treatment 0.1025 0.0314 3.72 3.7221 1.0 1000042 Bio2_000772 NC(=N)NC(=O)c1nc(Cl)c(N)nc1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O15 compound treatment 0.073 0.00191 0.23 0.2266 1.0 271 Bio2_000773 CCCCC[C@H](O)/C=C/[C@H]1[C@H](O)C[C@@H]2C/C(=C\CCCC(=O)O)/C[C@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O16 compound treatment 0.092 0.0209 2.48 2.4779 1.0 26 Bio2_000774 CCCCc1oc2ccccc2c1C(=O)c3cc(I)c(OCCN(CC)CC)c(I)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O17 compound treatment 0.074 0.00291 0.35 0.3451 1.0 140 Bio2_000775 CC1(COc2ccc(CC3SC(=O)NC3=O)cc2)CCCCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O18 compound treatment 0.083 0.0119 1.41 1.4115 1.0 28 Bio2_000776 CNc1ccc2oc(C[C@@H]3OC4(CC[C@@H]3C)O[C@H](C(C)C(=O)c5ccc[nH]5)[C@H](C)C[C@H]4C)nc2c1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O19 compound treatment 0.078 0.00691 0.82 0.8191 1.0 142 Bio2_000777 CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O20 compound treatment 0.0825 0.0114 1.35 1.3523 1.0 3103889 Bio2_000778 COC(=O)C1=C(C)NC(=C(O)C1c2ccccc2C(F)(F)F)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O21 compound treatment 0.0775 0.00641 0.76 0.7598 1.0 219 Bio2_000779 O[C@@H](COc1cccc(Cl)c1)/C=C/[C@H]2[C@H](O)C[C@H](O)[C@@H]2C/C=C\CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O22 compound treatment 0.08 0.00891 1.06 1.0561 1.0 3103678 Bio2_000780 N/C(=N\C(=O)c1nc(Cl)c(N)nc1N)/NCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O23 mock treatment 0.081 0.00991 1.17 1.1746 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 O24 mock treatment 0.076 0.00491 0.58 0.5821 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P01 mock treatment 0.0725 0.00141 0.17 0.1674 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P02 mock treatment 0.0695 -0.00159 -0.19 -0.1881 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P03 compound treatment 0.079 0.00791 0.94 0.9376 1.0 1907764 Bio2_000781 CCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)c2cccc(NC=O)c2OC)[C@@H](C)OC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P04 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 393 Bio2_000782 CC(C)NCC(O)c1ccc(N)c(C#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P05 compound treatment 0.077 0.00591 0.7 0.7006 1.0 2090 Bio2_000783 CCOC(=O)C(C#N)C1C(=C(N)Oc2ccc(Br)cc12)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P06 compound treatment 0.0745 0.00341 0.4 0.4044 1.0 157 Bio2_000784 COC(=O)CC[C@H](NC(=O)CNC(=O)c1ccc(/C=C/C(=O)OC)cc1)C(=O)N[C@@H](CC(C)C)C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P07 compound treatment 0.083 0.0119 1.41 1.4115 1.0 2020 Bio2_000785 CCCCCCCCCCC1=C(C)C(=O)C(=C(OC)C1=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P08 compound treatment 0.0765 0.00541 0.64 0.6414 1.0 395 Bio2_000786 C(Oc1ccccc1C2CC2)C3=NCCN3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P09 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 3103891 Bio2_000787 CC(=C)C1CC[C@@]2(CC[C@]3(C)[C@H](CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@]43C)[C@@H]12)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P10 compound treatment 0.0805 0.00941 1.12 1.1153 1.0 448 Bio2_000788 Clc1cccc(Cl)c1N=C2NCCN2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P11 compound treatment 0.075 0.00391 0.46 0.4636 1.0 1000476 Bio2_000789 C[C@@H](N(C)CC#C)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P12 compound treatment 0.0755 0.00441 0.52 0.5229 1.0 417 Bio2_000790 CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P13 compound treatment 0.071 -8.73E-5 -0.01 -0.0103 -1.0 410 Bio2_000791 CC(=N)NCc1cccc(CN)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P14 compound treatment 0.0735 0.00241 0.29 0.2859 1.0 3001893 Bio2_000792 COc1ccc(/C=C/C(=O)CC(=O)\C=C\c2cccc(O)c2OC)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P15 compound treatment 0.08 0.00891 1.06 1.0561 1.0 3001894 Bio2_000793 *[C@@H](C[C@@H](C)C[C@H](O)CCCC[C@@H](O)C[C@H](O)[C@H](C)N)[C@H](*)[C@H](C)CCCC.CC(=O)C[C@@H](CC(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P16 compound treatment 0.0725 0.00141 0.17 0.1674 1.0 421 Bio2_000794 C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@@H](O)CC2CC(=O)NC(=O)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P17 compound treatment 0.0815 0.0104 1.23 1.2338 1.0 2340 Bio2_000795 CC(C)[C@@]12O[C@H]2[C@@H]3O[C@]34[C@]5(O[C@H]5C[C@H]6C7=C(CC[C@@]64C)C(=O)OC7)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P18 compound treatment 0.0675 -0.00359 -0.43 -0.4251 -1.0 3001895 Bio2_000796 *C1N(C)C(=O)C(*)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C(=O)C(CC)NC(=O)C(C(O)C(C)C/C=C/C)N(C)C(=O)C(*)N(C)C1=O)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P19 compound treatment 0.0895 0.0184 2.18 2.1817 1.0 1907765 Bio2_000797 Cc1coc-2c1C(=O)C(=O)c3c4CCCC(C)(C)c4ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P20 compound treatment 0.074 0.00291 0.35 0.3451 1.0 397 Bio2_000798 CC1(C)C(C=C(Cl)Cl)C1C(=O)OC(C#N)c2cccc(Oc3ccccc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P21 compound treatment 0.067 -0.00409 -0.48 -0.4843 -1.0 3103893 Bio2_000799 C[C@H]([C@@H]1O[C@@H](C[C@@H]2CC[C@@H](C)[C@@]3(O[C@@](C)(C[C@H]3C)[C@H]4CC[C@](C)(O4)[C@@H]5O[C@H](C[C@@H]5C)[C@H]6O[C@@](O)(CO)[C@H](C)C[C@@H]6C)O2)CC[C@@H]1C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P22 compound treatment 0.0685 -0.00259 -0.31 -0.3066 -1.0 3103894 Bio2_000800 C[C@H]1[C@H]2[C@H](Cc3ccccc3)NC(=O)[C@@]42OC(=O)/C=C/[C@H](O)CCC[C@@H](C)C\C=C\[C@H]4[C@H](O)C1=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P23 mock treatment 0.0715 4.13E-4 0.05 0.0489 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.2128 P24 mock treatment 0.0595 -0.0116 -1.37 -1.373 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A01 mock treatment 0.092 0.0158 1.87 1.8733 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A02 mock treatment 0.087 0.0108 1.28 1.2808 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A03 compound treatment 0.083 0.00681 0.81 0.8069 1.0 678 NINDS_000001 NCC(CC(=O)O)c1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A04 compound treatment 0.0855 0.00931 1.1 1.1031 1.0 679 NINDS_000002 CC(=O)Nc1cc(ccc1O)[As](=O)(O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A05 compound treatment 0.0885 0.0123 1.46 1.4586 1.0 3173079 NINDS_000003 CC1(C)N[C@@H](C(=O)N1C2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A06 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 1587004 NINDS_000004 COc1ccc(cc1)C2Sc3ccccc3N(CCN(C)C)C(=O)C2OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A07 compound treatment 0.0855 0.00931 1.1 1.1031 1.0 681 NINDS_000005 CC(CN1c2ccccc2Sc3ccccc13)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A08 compound treatment 0.0895 0.0133 1.58 1.577 1.0 682 NINDS_000006 CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3C(=O)C[C@@]21C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A09 compound treatment 0.078 0.00181 0.21 0.2144 1.0 683 NINDS_000007 Cc1ncc([N+](=O)[O-])n1CCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A10 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 3173081 NINDS_000008 COCCc1ccc(OCC(O)CNC(C)C)cc1.OC(C(O)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A11 compound treatment 0.0825 0.00631 0.75 0.7476 1.0 684 NINDS_000009 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3OC(=O)CC)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A12 compound treatment 0.0795 0.00331 0.39 0.3921 1.0 3044526 NINDS_000010 NC(=N)N/N=C\c1c(Cl)cccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A13 compound treatment 0.08 0.00381 0.45 0.4514 1.0 686 NINDS_000011 C(Nc1ncnc2[nH]cnc12)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A14 compound treatment 0.0795 0.00331 0.39 0.3921 1.0 687 NINDS_000012 CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A15 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 3173083 NINDS_000013 CO[C@H]1[C@H](O)CC(=O)O[C@@H](C)C/C=C/C=C/[C@H](O[C@H]2CC[C@@H]([C@@H](C)O2)N(C)C)[C@H](C)C[C@H](CC=O)[C@@H]1O[C@@H]3O[C@H](C)[C@@H](O[C@H]4C[C@@](C)(O)[C@H](O)[C@H](C)O4)[C@@H]([C@H]3O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A16 compound treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 689 NINDS_000014 Cc1nnc(SCC2=C(N3[C@H](SC2)[C@H](NC(=O)Cn4cnnn4)C3=O)C(=O)O)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A17 compound treatment 0.07 -0.00619 -0.73 -0.7335 -1.0 690 NINDS_000015 CC(C)NCC(O)COc1ccccc1CC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A18 compound treatment 0.0795 0.00331 0.39 0.3921 1.0 691 NINDS_000016 CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](NC(=O)N3CCNC3=O)c4ccccc4)C(=O)N2C1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A19 compound treatment 0.084 0.00781 0.93 0.9254 1.0 692 NINDS_000017 CC(=O)Nc1nnc(s1)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A20 compound treatment 0.079 0.00281 0.33 0.3329 1.0 693 NINDS_000018 CCN(CC)CCOc1ccc-2c(c1)C(=O)c3cc(OCCN(CC)CC)ccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A21 compound treatment 0.0795 0.00331 0.39 0.3921 1.0 694 NINDS_000019 C[C@H]1CC2C3CC[C@](O)(C(=O)C)[C@@]3(C)C[C@H](O)[C@]2(F)C4(C)C=CC(=O)C=C14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A22 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 695 NINDS_000020 CC1CCC(CC1)NC(=O)N(CCCl)N=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A23 mock treatment 0.0835 0.00731 0.87 0.8661 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 A24 mock treatment 0.077 8.1E-4 0.1 0.0959 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B01 mock treatment 0.084 0.00781 0.93 0.9254 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B02 mock treatment 0.081 0.00481 0.57 0.5699 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B03 compound treatment 0.0845 0.00831 0.98 0.9846 1.0 696 NINDS_000021 Oc1cccc2Cc3cccc(O)c3C(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B04 compound treatment 0.085 0.00881 1.04 1.0438 1.0 697 NINDS_000022 Cn1c(=O)n(C)c2ncn(CC(O)CO)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B05 compound treatment 0.0835 0.00731 0.87 0.8661 1.0 351 NINDS_000023 CC(C)NCC(O)COc1cccc2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B06 compound treatment 0.082 0.00581 0.69 0.6884 1.0 698 NINDS_000024 NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)[C@H]3O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B07 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 699 NINDS_000025 OC(=O)CCC(=O)c1ccc(cc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B08 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 700 NINDS_000026 CN1C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B09 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 701 NINDS_000027 Nc1c(Br)cc(Br)cc1CNC2CCC(O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B10 compound treatment 0.079 0.00281 0.33 0.3329 1.0 702 NINDS_000028 CCCCCC(=O)O[C@@]1(CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@@]21C)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B11 compound treatment 0.0705 -0.00569 -0.67 -0.6743 -1.0 3104621 NINDS_000029 CC[C@H]/1CC[C@H]2O[C@@]3(CC[C@@H](C)[C@@H](C[C@H](C)O)O3)[C@H](C)[C@@H](OC(=O)/C=C/[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@H](C)[C@H](O)[C@@H](C)C(=O)[C@@](C)(O)[C@H](O)[C@@H](C)C\C=C\C=C1)[C@H]2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B12 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 703 NINDS_000030 OC[C@H]1O[C@@H](Oc2ccccc2CO)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B13 compound treatment 0.0905 0.0143 1.7 1.6955 1.0 704 NINDS_000031 CN(C)c1ccc(cc1)C(=C2C=CC(=[N+](C)C)C=C2)c3ccc(cc3)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B14 compound treatment 0.0715 -0.00469 -0.56 -0.5558 -1.0 3044607 NINDS_000032 Oc1cc2C(=O)Cc3c(O)c(O)cc4c(=O)oc(c1O)c2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B15 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 705 NINDS_000033 CC(Cc1cccc(c1)C(F)(F)F)NCCOC(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B16 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 404 NINDS_000034 CCCCNc1cc(cc(c1Oc2ccccc2)S(=O)(=O)N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B17 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 706 NINDS_000035 Nc1ccc(cc1)S(=O)(=O)Nc2cnc3ccccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B18 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 707 NINDS_000036 C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@@H]2[C@@H](C)O[C@H](C[C@@H]2O)O[C@@H]3[C@@H](C)O[C@H](C[C@@H]3O)O[C@H]4CC[C@@]5(C)[C@H](CCC6C5CC[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B19 compound treatment 0.08 0.00381 0.45 0.4514 1.0 2080198 NINDS_000037 CC(=O)C1=C(O)C2C3C(Cc4cccc5[nH]cc3c45)C(C)(C)N2C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B20 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 708 NINDS_000038 C1CNCCN1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B21 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 709 NINDS_000039 COc1ccc(CCN2CCC(CC2)Nc3nc4ccccc4n3Cc5ccc(F)cc5)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B22 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 710 NINDS_000040 CC(=O)OCC1=C(N2C(SC1)[C@H](NC(=O)CCCC(N)C(=O)O)C2=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B23 mock treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 B24 mock treatment 0.0775 0.00131 0.16 0.1552 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C01 mock treatment 0.0805 0.00431 0.51 0.5106 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C02 mock treatment 0.0825 0.00631 0.75 0.7476 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C03 compound treatment 0.0845 0.00831 0.98 0.9846 1.0 711 NINDS_000041 Oc1cccc(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C04 compound treatment 0.086 0.00981 1.16 1.1623 1.0 712 NINDS_000042 CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)CSc3ccncc3)C2=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C05 compound treatment 0.0895 0.0133 1.58 1.577 1.0 43 NINDS_000043 Fc1ccc(cc1)C(N2CCN(C/C=C/c3ccccc3)CC2)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C06 compound treatment 0.0815 0.00531 0.63 0.6291 1.0 3173091 NINDS_000044 NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)C(O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3OC4O[C@H](CN)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C07 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 714 NINDS_000045 CCN(CCCCOC(=O)c1ccc(OC)c(OC)c1)C(C)Cc2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C08 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 715 NINDS_000046 COc1c2ccoc2c(OC)c3oc(C)cc(=O)c13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C09 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 716 NINDS_000047 CN(C)CCC=C1c2ccccc2C=Cc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C10 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 717 NINDS_000048 OC(=O)c1ccccc1OP(=O)(O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C11 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 3173092 NINDS_000049 CN(C)CCOC(c1ccccc1)c2ccccc2.Cn1c(=O)n(C)c2nc(Cl)[nH]c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C12 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 2080598 NINDS_000050 C[C@H]1C[C@H](C)C(=O)[C@@H](C1)[C@H](O)CC2CC(=O)NC(=O)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C13 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 370 NINDS_000051 O=C1N(C2CCC(=O)NC2=O)C(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C14 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 718 NINDS_000052 Cn1c(=O)n(C)c2ncn(CCO)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C15 compound treatment 0.078 0.00181 0.21 0.2144 1.0 719 NINDS_000053 CN(CC#C)Cc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C16 compound treatment 0.08 0.00381 0.45 0.4514 1.0 720 NINDS_000054 Fc1c[nH]c(=O)[nH]c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C17 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 721 NINDS_000055 CO[C@H]1C[C@H](O[C@H]2[C@H](C)[C@@H](OC3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@@H](C)C[C@]4(CO4)C(=O)[C@H](C)[C@@H](O)[C@@H](C)[C@@H](C)OC(=O)[C@@H]2C)O[C@@H](C)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C18 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 722 NINDS_000056 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C19 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 723 NINDS_000057 CC(C)NCC(O)COc1ccc(CC(=O)N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C20 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 724 NINDS_000058 CCn1cc(C(=O)O)c(=O)c2ccc(C)nc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C21 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 725 NINDS_000059 CC(=C)[C@@H]1CCC(=CC1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C22 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 726 NINDS_000060 CCOC(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C23 mock treatment 0.0785 0.00231 0.27 0.2737 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 C24 mock treatment 0.08 0.00381 0.45 0.4514 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D01 mock treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D02 mock treatment 0.0795 0.00331 0.39 0.3921 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D03 compound treatment 0.084 0.00781 0.93 0.9254 1.0 727 NINDS_000061 CCN(CC)C(C)CN1c2ccccc2Sc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D04 compound treatment 0.084 0.00781 0.93 0.9254 1.0 3273 NINDS_000062 NNCCc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D05 compound treatment 0.0845 0.00831 0.98 0.9846 1.0 728 NINDS_000063 Cc1cc(nnc1NCCN2CCOCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D06 compound treatment 0.0805 0.00431 0.51 0.5106 1.0 729 NINDS_000064 OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O[C@@H]2O[C@H](CO)[C@H](O)[C@H](O)[C@H]2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D07 compound treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 3173210 NINDS_000065 CO/N=C(\C(=O)NC1[C@H]2SCC(=C(N2C1=O)C(=O)O)CSc3nc(=O)c(=O)[nH]n3C)/c4csc(N)n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D08 compound treatment 0.078 0.00181 0.21 0.2144 1.0 731 NINDS_000066 CSc1ccc2Sc3ccccc3N(CCC4CCCCN4C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D09 compound treatment 0.079 0.00281 0.33 0.3329 1.0 732 NINDS_000067 Oc1cc(cc([N+](=O)[O-])c1O)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D10 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 733 NINDS_000068 CC1(CC2CC3(C)C1)CC(N)(C2)C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D11 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 734 NINDS_000069 CCN(CC)CCNC(=O)c1cc(Cl)c(N)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D12 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 735 NINDS_000070 NNC(=O)c1ccncc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D13 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 736 NINDS_000071 COC(=O)C(N)CS 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D14 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 737 NINDS_000072 c1nc(cs1)c2nc3ccccc3[nH]2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D15 compound treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 738 NINDS_000073 CC(=O)Nc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D16 compound treatment 0.086 0.00981 1.16 1.1623 1.0 1000104 NINDS_000074 Cc1c(CCC(=O)O)c2cc3[nH]c(cc4nc(cc5[nH]c(cc1n2)c(C)c5C=C)c(C)c4C=C)c(C)c3CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D17 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 740 NINDS_000075 N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D18 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 741 NINDS_000076 Cc1ccccc1OCC(O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D19 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 742 NINDS_000077 C[C@@H]1[C@H](O)CC[C@@]2(C)[C@H]1CC[C@@]3(C)C2[C@H](O)C[C@H]4/C(=C(/CCC=C(C)C)\C(=O)O)/[C@H](C[C@@]43C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D20 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 743 NINDS_000078 CC(C)(C)NCC(O)c1cc(O)cc(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D21 compound treatment 0.0915 0.0153 1.81 1.814 1.0 26 NINDS_000079 CCCCc1oc2ccccc2c1C(=O)c3cc(I)c(OCCN(CC)CC)c(I)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D22 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 449 NINDS_000080 CC1=CC(=O)c2ccccc2C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D23 mock treatment 0.0785 0.00231 0.27 0.2737 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 D24 mock treatment 0.0815 0.00531 0.63 0.6291 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E01 mock treatment 0.0765 3.1E-4 0.04 0.0367 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E02 mock treatment 0.086 0.00981 1.16 1.1623 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E03 compound treatment 0.081 0.00481 0.57 0.5699 1.0 744 NINDS_000081 Cn1cnc2[nH]c(=O)n(C)c(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E04 compound treatment 0.0835 0.00731 0.87 0.8661 1.0 745 NINDS_000082 CC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCNC(=O)CCC(=O)N(O)CCCCCN 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E05 compound treatment 0.0835 0.00731 0.87 0.8661 1.0 746 NINDS_000083 C(N(Cc1ccccc1)c2ccccc2)C3=NCCN3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E06 compound treatment 0.0795 0.00331 0.39 0.3921 1.0 747 NINDS_000084 CCn1cc(C(=O)O)c(=O)c2cc(F)c(cc12)N3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E07 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 3043753 NINDS_000085 [O-][N+](=O)c1ccc(/C=N/N2CCOC2=O)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E08 compound treatment 0.079 0.00281 0.33 0.3329 1.0 749 NINDS_000086 NC(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E09 compound treatment 0.081 0.00481 0.57 0.5699 1.0 750 NINDS_000087 CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1OC2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)O[C@@H](C)[C@]2(O)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E10 compound treatment 0.0845 0.00831 0.98 0.9846 1.0 751 NINDS_000088 COc1cc(NS(=O)(=O)c2ccc(N)cc2)nc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E11 compound treatment 0.0805 0.00431 0.51 0.5106 1.0 752 NINDS_000089 CC1CCc2cc(F)cc3c(=O)c(cn1c23)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E12 compound treatment 0.079 0.00281 0.33 0.3329 1.0 753 NINDS_000090 O=C1C(CCS(=O)c2ccccc2)C(=O)N(N1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E13 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 3173213 NINDS_000091 COc1ccc(C[C@H](N)C(=O)N[C@H]2[C@@H](O)C(O[C@@H]2CO)n3cnc4c(ncnc34)N(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E14 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 1000105 NINDS_000092 CC(C)(Oc1ccc(CCNC(=O)c2ccc(Cl)cc2)cc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E15 compound treatment 0.079 0.00281 0.33 0.3329 1.0 755 NINDS_000093 CC(CN(C)C)CN1c2ccccc2CCc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E16 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 756 NINDS_000094 CCCCCCc1ccc(O)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E17 compound treatment 0.079 0.00281 0.33 0.3329 1.0 757 NINDS_000095 OC(=O)c1cn(C2CC2)c3cc(N4CCNCC4)c(F)cc3c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E18 compound treatment 0.078 0.00181 0.21 0.2144 1.0 758 NINDS_000096 CCCOc1ccc2nc(NC(=O)OC)[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E19 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 759 NINDS_000097 CC(=O)OCC1=C(N2[C@H](SC1)[C@H](NC(=O)Cc3cccs3)C2=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E20 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 760 NINDS_000098 N[C@@H]1CONC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E21 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 3173215 NINDS_000099 Cc1onc(c1C(=O)NC2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E22 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 762 NINDS_000100 COc1cccc(OC)c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E23 mock treatment 0.078 0.00181 0.21 0.2144 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 E24 mock treatment 0.08 0.00381 0.45 0.4514 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F01 mock treatment 0.0715 -0.00469 -0.56 -0.5558 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F02 mock treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F03 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 763 NINDS_000101 CCN(CC)CCCC(C)Nc1c2ccc(Cl)cc2nc3ccc(OC)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F04 compound treatment 0.0825 0.00631 0.75 0.7476 1.0 382 NINDS_000102 NCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F05 compound treatment 0.0825 0.00631 0.75 0.7476 1.0 764 NINDS_000103 Fc1ccc(cc1)C(=O)CCCN2CCC(=CC2)n3c(=O)[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F06 compound treatment 0.079 0.00281 0.33 0.3329 1.0 765 NINDS_000104 Oc1ccnc(S)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F07 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 766 NINDS_000105 CC12CCC3C(CCC4=CC(=O)CCC34C)C2CCC1(O)C#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F08 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 767 NINDS_000106 OC[C@H]1O[C@@H](OC[C@H]2O[C@@H](OC(C#N)c3ccccc3)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F09 compound treatment 0.078 0.00181 0.21 0.2144 1.0 768 NINDS_000107 C[N+](C)(C)CCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F10 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 769 NINDS_000108 CCCCOc1ccc(CC(=O)NO)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F11 compound treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 770 NINDS_000109 CC(CCc1ccccc1)NC(C)C(O)c2ccc(O)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F12 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 1000048 NINDS_000110 CC(C)COCC(CN(Cc1ccccc1)c2ccccc2)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F13 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 771 NINDS_000111 CN1CCC(=C2c3ccsc3C(=O)Cc4ccccc24)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F14 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 772 NINDS_000112 CCN1CCCC(C1)OC(=O)C(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F15 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 773 NINDS_000113 Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F16 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 464 NINDS_000114 CN(Cc1cnc2nc(N)nc(N)c2n1)c3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F17 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 774 NINDS_000115 OC(=O)C1=CCNCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F18 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 775 NINDS_000116 NCC(O)CC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F19 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 776 NINDS_000117 NNc1nncc2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F20 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 777 NINDS_000118 Oc1ccc(cc1)[C@@H]2CC(=O)c3c(O)cc(O)cc3O2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F21 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 778 NINDS_000119 Oc1c(I)cc(I)c2cccnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F22 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 779 NINDS_000120 CCN(CC)CCOC(=O)c1ccc(N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F23 mock treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 F24 mock treatment 0.0765 3.1E-4 0.04 0.0367 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G01 mock treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G02 mock treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G03 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 780 NINDS_000121 CC(C)NNC(=O)c1ccncc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G04 compound treatment 0.0805 0.00431 0.51 0.5106 1.0 3173217 NINDS_000122 CCN1C[C@@]2(COC)C3[C@@H](OC)[C@H]4[C@@H]1[C@@]3(C5C[C@@]6(O)[C@H](OC(=O)c7ccccc7)C5[C@]4(OC(=O)C)[C@@H](O)[C@@H]6OC)C(C[C@H]2O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G05 compound treatment 0.0885 0.0123 1.46 1.4586 1.0 782 NINDS_000123 CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)C=CC5(C)C4C(O)CC3(C)[C@@]2(O1)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G06 compound treatment 0.078 0.00181 0.21 0.2144 1.0 783 NINDS_000124 CO[C@@]12C[C@@H](COC(=O)c3cncc(Br)c3)CN(C)[C@@H]2Cc4cn(C)c5cccc1c45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G07 compound treatment 0.078 0.00181 0.21 0.2144 1.0 784 NINDS_000125 Nc1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G08 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 785 NINDS_000126 CC(CC(O)c1ccc(O)cc1)NCc2ccc(O)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G09 compound treatment 0.079 0.00281 0.33 0.3329 1.0 786 NINDS_000127 CN1CCN(CC(=O)N2c3ccccc3C(=O)Nc4cccnc24)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G10 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 1981222 NINDS_000128 CCN1CCN(C(=O)NC(C(=O)NC2C3SCC(=C(N3C2=O)C(=O)O)CSc4nnnn4C)c5ccc(O)cc5)C(=O)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G11 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 382 NINDS_000129 NCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G12 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 1000106 NINDS_000130 O=C(C1CCCCC1)N2CC3N(CCc4ccccc34)C(=O)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G13 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 789 NINDS_000131 C[N+]1(C)C2CC[C@H]1C[C@H](C2)OC(=O)C(O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G14 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 790 NINDS_000132 COc1ccc2[C@@H](OC(=O)c2c1OC)[C@@H]3N(C)CCc4cc5OCOc5cc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G15 compound treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 791 NINDS_000133 CC(C)Oc1ccc2c(=O)cc(oc2c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G16 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 792 NINDS_000134 COc1ccc2nccc([C@@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G17 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 793 NINDS_000135 CCN(CC)CCOC(=O)C(C1CCCCC1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G18 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 794 NINDS_000136 Nc1cc(c[nH]c1=O)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G19 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 795 NINDS_000137 CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)O[C@@H]2[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G20 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 796 NINDS_000138 Cc1ccc(C)c(OCCCC(C)(C)C(=O)O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G21 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 797 NINDS_000139 CC[C@]1(CC[C@@H](O1)[C@]2(C)CCC3(C[C@H](O)[C@@H](C)[C@H](O3)[C@H](C)[C@@H](OC)[C@H](C)C(=O)O)O2)C4O[C@H](C[C@@H]4C)C5O[C@@](O)(CC)[C@H](C)C[C@@H]5C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G22 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 798 NINDS_000140 CCCCCCOc1ccccc1C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G23 mock treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 G24 mock treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H01 mock treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H02 mock treatment 0.0765 3.1E-4 0.04 0.0367 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H03 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 799 NINDS_000141 Cc1nnc(NS(=O)(=O)c2ccc(N)cc2)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H04 compound treatment 0.0805 0.00431 0.51 0.5106 1.0 800 NINDS_000142 C[C@](N)(Cc1ccc(O)c(O)c1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H05 compound treatment 0.082 0.00581 0.69 0.6884 1.0 801 NINDS_000143 CN(C)CC/C=C/1\c2ccccc2Sc3ccc(Cl)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H06 compound treatment 0.082 0.00581 0.69 0.6884 1.0 802 NINDS_000144 Oc1ccc2C(=O)c3c(O)ccc(O)c3C(=O)c2c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H07 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 803 NINDS_000145 CCc1cc(ccn1)C(=S)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H08 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 804 NINDS_000146 COc1c(C)c2COC(=O)c2c(O)c1C/C=C(\C)/CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H09 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 805 NINDS_000147 CCc1cccc2c3CCOC(CC)(CC(=O)O)c3[nH]c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H10 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 806 NINDS_000148 OC(=O)C1CCCNC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H11 compound treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 807 NINDS_000149 CCCc1ncc(C[n+]2ccccc2C)c(N)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H12 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 1000107 NINDS_000150 CC(=O)O[C@]1(CCC2C3CCC4=CC(=O)CC[C@@H]4C3CC[C@@]21C)C#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H13 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 809 NINDS_000151 CNCCC=C1c2ccccc2CCc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H14 compound treatment 0.07 -0.00619 -0.73 -0.7335 -1.0 810 NINDS_000152 CCCCC[C@@H]1[C@@H](OC(=O)CC(C)C)[C@H](C)OC(=O)[C@@H](NC(=O)c2cccc(NC=O)c2O)[C@@H](C)OC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H15 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 811 NINDS_000153 CC(=O)[C@H]1CCC2C3CC=C4C[C@@H](O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H16 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 812 NINDS_000154 COC1=CC(=O)C[C@@H](C)[C@@]21Oc3c(C2=O)c(OC)cc(OC)c3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H17 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 813 NINDS_000155 CC(=O)O[C@H]1CCC2C3CCc4cc(OC(=O)C)ccc4C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H18 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 814 NINDS_000156 Clc1ccc(COC(Cn2ccnc2)c3ccc(Cl)cc3Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H19 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 815 NINDS_000157 CCN(CC)C(=O)c1cccc(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H20 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 816 NINDS_000158 Cc1cc(cc(C)c1CC2=NCCN2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H21 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 3173342 NINDS_000159 CO/N=C(/C(=O)NC1C2SCC(=C(N2C1=O)C(=O)O)COC(=O)N)\c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H22 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 82 NINDS_000160 Nc1cc(nc(N)[n+]1[O-])N2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H23 mock treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 H24 mock treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I01 mock treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I02 mock treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I03 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 818 NINDS_000161 CCC1(CC)C(=O)NC=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I04 compound treatment 0.0795 0.00331 0.39 0.3921 1.0 819 NINDS_000162 CCN(CC)CCOC(=O)C1(CCCCC1)C2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I05 compound treatment 0.078 0.00181 0.21 0.2144 1.0 820 NINDS_000163 Oc1ccc(Cl)c2cccnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I06 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 821 NINDS_000164 O=C1NS(=O)(=O)c2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I07 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 822 NINDS_000165 CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I08 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 2081029 NINDS_000166 CN/C(=N\C#N)/NCCSCc1nc[nH]c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I09 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 824 NINDS_000167 CC[C@]1(CCCN2CCc3c4[C@@H]21)C[C@@](O)(C(=O)OC)n4c5ccccc35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I10 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 825 NINDS_000168 CC(Cc1ccc(O)c(O)c1)(NN)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I11 compound treatment 0.07 -0.00619 -0.73 -0.7335 -1.0 826 NINDS_000169 CC1(C)O[C@@H]2CC3C4C[C@H](F)C5=CC(=O)CC[C@]5(C)C4[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I12 compound treatment 0.0675 -0.00869 -1.03 -1.0297 -1.0 1000036 NINDS_000170 CC[C@H]1CN2CCc3cc(OC)c(OC)cc3C2C[C@@H]1CC4NCCc5cc(OC)c(OC)cc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I13 compound treatment 0.0615 -0.0147 -1.74 -1.7407 -1.0 827 NINDS_000171 CCCCC1(COC(=O)CCC(=O)O)C(=O)N(N(C1=O)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I14 compound treatment 0.0695 -0.00669 -0.79 -0.7928 -1.0 3173346 NINDS_000172 CC[C@H](C1OC(CC)(C[C@@H]1C)C2CC[C@](O)(CC)[C@H](C)O2)C(=O)C(C)[C@@H](O)[C@H](C)CCc3ccc(C)c(O)c3C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I15 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 829 NINDS_000173 CC(C)c1c(O)c(O)c(C=O)c2c(O)c(c(C)cc12)c3c(C)cc4c(C(C)C)c(O)c(O)c(C=O)c4c3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I16 compound treatment 0.071 -0.00519 -0.62 -0.615 -1.0 362 NINDS_000174 CCN(CC)CC(=O)Nc1c(C)cccc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I17 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 830 NINDS_000175 COc1ccc(CN(CCN(C)C)c2ccccn2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I18 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 831 NINDS_000176 Nc1nccs1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I19 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 832 NINDS_000177 CCCn1c(=O)n(CCC)c2[nH]c(nc2c1=O)C3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I20 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 833 NINDS_000178 CC(C)(C)NC[C@@H](O)COc1nsnc1N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I21 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 834 NINDS_000179 CC(C[N+](C)(C)C)OC(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I22 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 835 NINDS_000180 CC(=O)OC1CN2CCC1CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I23 mock treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 I24 mock treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J01 mock treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J02 mock treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J03 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 836 NINDS_000181 CNC(C)C(O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J04 compound treatment 0.079 0.00281 0.33 0.3329 1.0 1000042 NINDS_000182 NC(=N)NC(=O)c1nc(Cl)c(N)nc1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J05 compound treatment 0.0805 0.00431 0.51 0.5106 1.0 837 NINDS_000183 CCOc1ccc2NC(C)(C)C=C(C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J06 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 838 NINDS_000184 COc1ccc(C(=O)c2ccccc2)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J07 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 839 NINDS_000185 Nc1nc2n(COCCO)cnc2c(=O)[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J08 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 840 NINDS_000186 CCOc1ccc2ccccc2c1NC(=O)[C@H]3[C@H]4SC(C)(C)C(N4C3=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J09 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 841 NINDS_000187 C/C(=C(/CCOP(=O)(O)O)\SC(=O)c1ccccc1)/N(Cc2cnc(C)nc2N)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J10 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 842 NINDS_000188 Cn1cc[nH]c1=S 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J11 compound treatment 0.07 -0.00619 -0.73 -0.7335 -1.0 1000108 NINDS_000189 NC(=O)c1ccc[n+](c1)[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](O)[C@@H]3O)n4cnc5c(N)ncnc45)[C@@H](O)[C@H]2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J12 compound treatment 0.0705 -0.00569 -0.67 -0.6743 -1.0 844 NINDS_000190 CNCCCN1c2ccccc2CCc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J13 compound treatment 0.0675 -0.00869 -1.03 -1.0297 -1.0 1000109 NINDS_000191 Nc1ncnc2n(cnc12)[C@@H]3O[C@H](CO)[C@@H](O)[C@@H]3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J14 compound treatment 0.071 -0.00519 -0.62 -0.615 -1.0 846 NINDS_000192 Cc1nc2sccn2c(=O)c1CCN3CCC(=C(c4ccc(F)cc4)c5ccc(F)cc5)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J15 compound treatment 0.0715 -0.00469 -0.56 -0.5558 -1.0 847 NINDS_000193 CC(=CCC/C(=C/CO)/C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J16 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 848 NINDS_000194 CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@@]21C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J17 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 3045136 NINDS_000195 CC[C@H](C)C(=O)O[C@H]1CCC=C2C=C[C@H](C)C(CCC3C[C@@H](O)CC(=O)O3)[C@@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J18 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 850 NINDS_000196 Clc1cccc(c1)N2CCN(CCCn3nc4ccccn4c3=O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J19 compound treatment 0.0705 -0.00569 -0.67 -0.6743 -1.0 1635952 NINDS_000197 Cn1nnnc1SCC2=C(N3C(SC2)C(NC(=O)C(O)c4ccccc4)C3=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J20 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 822 NINDS_000198 CN(C)C(=O)Oc1cccc(c1)[N+](C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J21 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 852 NINDS_000199 CCOc1ccc(Cc2nccc3cc(OCC)c(OCC)cc23)cc1OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J22 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 1000110 NINDS_000200 CO[C@H]1[C@@H](C[C@@H]2CN3CCc4c([nH]c5cc(OC)ccc45)[C@@H]3C[C@@H]2[C@@H]1C(=O)OC)OC(=O)c6cc(OC)c(OC)c(OC)c6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J23 mock treatment 0.071 -0.00519 -0.62 -0.615 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 J24 mock treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K01 mock treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K02 mock treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K03 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 3045140 NINDS_000201 CC(C)[N+]1(C)C2CC[C@@H]1C[C@H](C2)OC(=O)C(CO)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K04 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 3173462 NINDS_000202 C[C@H](COc1ccccc1)N[C@@H](C)[C@H](O)c2ccc(O)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K05 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 856 NINDS_000203 Cn1c(=O)n(C)c2nc[nH]c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K06 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 857 NINDS_000204 O=C(OCc1ccccc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K07 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 858 NINDS_000205 OCC(O)CN1CCN(CC1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K08 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 859 NINDS_000206 CC(=O)O[C@@]1(CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5C[C@@H]5[C@]4(C)C3CC[C@@]21C)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K09 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 860 NINDS_000207 CN(C)C(=O)Oc1ccc[n+](C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K10 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 861 NINDS_000208 C[C@H](CS)C(=O)N1CCC[C@H]1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K11 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 862 NINDS_000209 CCCCCCCCCCCCCCCC[N+](C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K12 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 863 NINDS_000210 CN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K13 compound treatment 0.0695 -0.00669 -0.79 -0.7928 -1.0 864 NINDS_000211 Oc1noc2CNCCc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K14 compound treatment 0.0715 -0.00469 -0.56 -0.5558 -1.0 196 NINDS_000212 Cc1ccc(cc1)S(=O)(=O)NC(=O)NN2CCCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K15 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 865 NINDS_000213 Cc1ccc(cc1)C(=O)c2ccc(CC(=O)O)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K16 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 866 NINDS_000214 Cc1c(cc(cc1[N+](=O)[O-])[N+](=O)[O-])C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K17 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 80 NINDS_000215 CN(C)C(=O)C(CCN1CCC(O)(CC1)c2ccc(Cl)cc2)(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K18 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 867 NINDS_000216 Nc1ccc(cc1)S(=O)(=O)Nc2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K19 compound treatment 0.0705 -0.00569 -0.67 -0.6743 -1.0 868 NINDS_000217 CNC1(CCCCC1=O)c2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K20 compound treatment 0.0695 -0.00669 -0.79 -0.7928 -1.0 869 NINDS_000218 CCC1(C)CC(=O)NC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K21 compound treatment 0.0705 -0.00569 -0.67 -0.6743 -1.0 870 NINDS_000219 OC(=O)/C(=C/c1ccc(O)cc1)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K22 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 871 NINDS_000220 Clc1ccc(CSC(Cn2ccnc2)c3ccc(Cl)cc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K23 mock treatment 0.071 -0.00519 -0.62 -0.615 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 K24 mock treatment 0.0715 -0.00469 -0.56 -0.5558 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L01 mock treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L02 mock treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L03 compound treatment 0.078 0.00181 0.21 0.2144 1.0 872 NINDS_000221 CCN(CC)CCOC(=O)C(c1ccccc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L04 compound treatment 0.079 0.00281 0.33 0.3329 1.0 873 NINDS_000222 Nc1nc(=O)c2N(C=O)C(CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)CNc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L05 compound treatment 0.079 0.00281 0.33 0.3329 1.0 874 NINDS_000223 CC(C)CC(NC(=O)CCN)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L06 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 3173466 NINDS_000224 [O-][N+](=O)c1ccc(/C=N/N2CC(=O)NC2=O)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L07 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 876 NINDS_000225 CN(C)[C@H]1[C@@H]2[C@@H](O)[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)cccc4[C@@]3(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L08 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 877 NINDS_000226 CC(C)(Oc1ccc(Cl)cc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L09 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 878 NINDS_000227 CC(=O)NS(=O)(=O)c1ccc(N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L10 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 3173468 NINDS_000228 COc1ccc2nccc([C@H](O)[C@H]3C[C@@H]4CCN3C[C@@H]4C=C)c2c1.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L11 compound treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 3263 NINDS_000229 CNC(C)(C)Cc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L12 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 879 NINDS_000230 NC[C@H](O)c1ccc(O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L13 compound treatment 0.0715 -0.00469 -0.56 -0.5558 -1.0 3045196 NINDS_000231 CC1(C)S[C@@H]2[C@H](NC(=O)[C@@H](N)c3ccc(O)cc3)C(=O)N2[C@H]1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L14 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 881 NINDS_000232 CC12C[C@H](O)C3C(CCC4=CC(=O)CCC34C)C2CC[C@]1(O)C(=O)COP(=O)(O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L15 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 882 NINDS_000233 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)CN(C)[C@H](C)[C@@H](O)[C@]1(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L16 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 883 NINDS_000234 CC(Oc1ccccc1)C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L17 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 884 NINDS_000235 CN(C)CCC(c1ccccc1)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L18 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 885 NINDS_000236 Clc1ccc2Oc3ccccc3N=C(N4CCNCC4)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L19 compound treatment 0.0705 -0.00569 -0.67 -0.6743 -1.0 886 NINDS_000237 O[C@@H]([C@H]1C[C@@H]2CCN1C[C@@H]2C=C)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L20 compound treatment 0.071 -0.00519 -0.62 -0.615 -1.0 3173471 NINDS_000238 C[C@@]12CCC3C(CCc4cc(O)ccc34)C2CC[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L21 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 887 NINDS_000239 COc1ccc(NS(=O)(=O)c2ccc(N)cc2)nn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L22 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 888 NINDS_000240 CC(C)[N+](C)(CCC(C(=O)N)(c1ccccc1)c2ccccc2)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L23 mock treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 L24 mock treatment 0.0775 0.00131 0.16 0.1552 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M01 mock treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M02 mock treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M03 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 889 NINDS_000241 NC(=O)c1cnccn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M04 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 890 NINDS_000242 COc1ccc2cc(ccc2c1)[C@H](C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M05 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 891 NINDS_000243 CC(=O)OCC(=O)[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M06 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 892 NINDS_000244 C[n+]1c2cc(N)ccc2cc3ccc(N)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M07 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 893 NINDS_000245 NCC(O)c1ccc(O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M08 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 894 NINDS_000246 ClCCN(CCCl)P1(=O)NCCCO1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M09 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 895 NINDS_000247 C[C@@H]1O[C@@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2Oc3cc(O)c4C(=O)C[C@H](Oc4c3)c5ccc(O)cc5)[C@H](O)[C@H](O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M10 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 896 NINDS_000248 COc1ccccc1OCC(O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M11 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 897 NINDS_000249 CCCCCCCCCCCCCCCC(=O)OC/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M12 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 898 NINDS_000250 CCOC(=O)C(Cc1ccc(O)cc1)NC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M13 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 1011303 NINDS_000251 CN1CCc2cccc-3c2C1Cc4ccc(O)c(O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M14 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 900 NINDS_000252 CN1C(=C(O)c2sccc2S1(=O)=O)C(=O)Nc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M15 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 901 NINDS_000253 CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)ccc(Cl)c4[C@@]3(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M16 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 3173593 NINDS_000254 CN1CCCN=C1/C=C/c2cccs2.OC(=O)c1cc2ccccc2c(Cc3c(O)c(cc4ccccc34)C(=O)O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M17 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 902 NINDS_000255 OC(=O)c1cc2cc(Cc3cccnc3)ccc2o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M18 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 3173594 NINDS_000256 CO[C@H]1C[C@H](C)CC2=C(OC)C(=O)C=C(NC(=O)/C(=C/C=C\[C@@H](OC)[C@H](OC(=O)N)/C(=C/[C@H](C)[C@H]1O)/C)/C)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M19 compound treatment 0.0715 -0.00469 -0.56 -0.5558 -1.0 903 NINDS_000257 COC(=O)Nc1nc2ccc(Sc3ccccc3)cc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M20 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 368 NINDS_000258 CC/C(=C(\c1ccccc1)/c2ccc(OCCN(C)C)cc2)/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M21 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 904 NINDS_000259 NC(=O)CN1CCCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M22 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 905 NINDS_000260 CO[C@@H]1[C@@H](OC(=O)N)[C@@H](O)[C@H](Oc2ccc3c(O)c(NC(=O)c4ccc(O)c(CC=C(C)C)c4)c(=O)oc3c2C)OC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M23 mock treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 M24 mock treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N01 mock treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N02 mock treatment 0.0765 3.1E-4 0.04 0.0367 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N03 compound treatment 0.079 0.00281 0.33 0.3329 1.0 906 NINDS_000261 N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N04 compound treatment 0.0795 0.00331 0.39 0.3921 1.0 907 NINDS_000262 OC(=O)c1cc(O)c2cccc(O)c2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N05 compound treatment 0.08 0.00381 0.45 0.4514 1.0 3173595 NINDS_000263 C[C@H]1OC(OC/2CC3O[C@@](O)(CC(O)C3C(=O)O)CC(O)C(O)CCC(O)CC(O)CC(O)CC(=O)O[C@@H](C)C(C)[C@H](O)[C@@H](C)/C=C/C=C/CC\C=C\C=C\C=C\C=C2)[C@@H](O)[C@@H](N)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N06 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 3045298 NINDS_000264 C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N07 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 909 NINDS_000265 COc1ccc2cc3-c4cc5OCOc5cc4CC[n+]3cc2c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N08 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 910 NINDS_000266 CN1CC(CNC(=O)OCc2ccccc2)C[C@@H]3C1Cc4cn(C)c5cccc3c45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N09 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 911 NINDS_000267 CCCCCC(C)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N10 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 912 NINDS_000268 CCCc1cc(=O)[nH]c(=S)[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N11 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 913 NINDS_000269 O[C@H]1[C@@H](O)[C@@H](O[C@@H]1COP(=O)(O)OP(=O)(O)OP(=O)(O)O)n2ccc(=O)[nH]c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N12 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 914 NINDS_000270 OC[C@H]1O[C@@H](OC2c3cccc(O)c3C(=O)c4c(O)cc(CO)cc24)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N13 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 2797 NINDS_000271 COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N14 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 915 NINDS_000272 OC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N15 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 471 NINDS_000273 CCCC(CCC)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N16 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 917 NINDS_000274 NS(=O)(=O)c1cc2c(NC(Cc3ccccc3)NS2(=O)=O)cc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N17 compound treatment 0.0775 0.00131 0.16 0.1552 1.0 918 NINDS_000275 CC1Nc2cc(Cl)c(cc2C(=O)N1c3ccccc3C)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N18 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 919 NINDS_000276 COc1cc(ccc1c2nc3cccnc3[nH]2)S(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N19 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 112 NINDS_000277 OC(=O)c1cccnc1Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N20 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 920 NINDS_000278 CCN1CCCC1CNC(=O)c2cc(ccc2OC)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N21 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 921 NINDS_000279 NCCCC(N)CC(=O)NCC1NC(=O)C(CO)NC(=O)C(N)CNC(=O)C(NC(=O)/C(=C/NC(=O)N)/NC1=O)C2CCNC(=N)N2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N22 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 922 NINDS_000280 CCCCC(CC)CN1CN(CC(CC)CCCC)CC(C)(N)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N23 mock treatment 0.077 8.1E-4 0.1 0.0959 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 N24 mock treatment 0.0775 0.00131 0.16 0.1552 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O01 mock treatment 0.0705 -0.00569 -0.67 -0.6743 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O02 mock treatment 0.073 -0.00319 -0.38 -0.378 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O03 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 923 NINDS_000281 NC(=O)NC1NC(=O)NC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O04 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 924 NINDS_000282 NC(=N)NC(=N)Nc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O05 compound treatment 0.078 0.00181 0.21 0.2144 1.0 925 NINDS_000283 C[C@@H]([C@H](O)c1ccccc1)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O06 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 926 NINDS_000284 Oc1cccc2C(=O)c3cccc(O)c3C(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O07 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 927 NINDS_000285 CN1CCC[C@@H]1CCO[C@](C)(c2ccccc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O08 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 928 NINDS_000286 CC(=O)O[Hg]c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O09 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 3173600 NINDS_000287 Oc1ccc2C[C@H]3N(CC=C)CC[C@]4(C5Oc1c24)[C@@]3(O)CCC5=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O10 compound treatment 0.0715 -0.00469 -0.56 -0.5558 -1.0 930 NINDS_000288 CC(CN1CCCCC1)C(=O)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O11 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 931 NINDS_000289 NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O12 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 932 NINDS_000290 NCCCCC(N)C(=O)NC(Cc1ccc(O)cc1)C(=O)NC(CCCCN)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O13 compound treatment 0.0705 -0.00569 -0.67 -0.6743 -1.0 933 NINDS_000291 CN1C2C[C@@H](C[C@H]1[C@H]3OC32)OC(=O)[C@H](CO)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O14 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 1001531 NINDS_000292 COc1cc(cc(OC)c1OC)[C@H]2[C@@H]3[C@H](COC3=O)[C@@H](O)c4cc5OCOc5cc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O15 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 934 NINDS_000293 Cc1cc(C)nc(NS(=O)(=O)c2ccc(N)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O16 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 935 NINDS_000294 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O17 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 936 NINDS_000295 OCC(O)COC(=O)c1ccccc1Nc2ccnc3cc(Cl)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O18 compound treatment 0.0755 -6.9E-4 -0.08 -0.0818 -1.0 937 NINDS_000296 CCC(=O)c1ccc2Sc3ccccc3N(CC(C)N(C)C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O19 compound treatment 0.0745 -0.00169 -0.2 -0.2003 -1.0 938 NINDS_000297 Cc1ccc(cc1)/C(=C\CN2CCCC2)/c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O20 compound treatment 0.0765 3.1E-4 0.04 0.0367 1.0 939 NINDS_000298 Cc1cccc(Nc2ccccc2C(=O)O)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O21 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 940 NINDS_000299 CC(C)CC1NC(=O)CNC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O22 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 941 NINDS_000300 CC(=O)Oc1cccc(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O23 mock treatment 0.079 0.00281 0.33 0.3329 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 O24 mock treatment 0.08 0.00381 0.45 0.4514 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P01 mock treatment 0.0695 -0.00669 -0.79 -0.7928 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P02 mock treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P03 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 942 NINDS_000301 OC(=O)c1ccccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P04 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 943 NINDS_000302 CCCCC1C(=O)N(N(C1=O)c2ccc(O)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P05 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 944 NINDS_000303 Nc1ccc(cc1)S(=O)(=O)Nc2ccnn2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P06 compound treatment 0.0725 -0.00369 -0.44 -0.4373 -1.0 945 NINDS_000304 C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P07 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 946 NINDS_000305 OCCNC(=O)Cn1ccnc1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P08 compound treatment 0.072 -0.00419 -0.5 -0.4965 -1.0 3173722 NINDS_000306 NCC[C@@H](O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@H]1O[C@H]3O[C@H](CO)[C@@H](O)[C@H](N)C3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P09 compound treatment 0.073 -0.00319 -0.38 -0.378 -1.0 948 NINDS_000307 O=C1C(C(=O)c2ccccc12)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P10 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 465 NINDS_000308 NCCc1c[nH]cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P11 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 949 NINDS_000309 OC(=O)c1cc(O)c2ccccc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P12 compound treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 950 NINDS_000310 Oc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P13 compound treatment 0.0735 -0.00269 -0.32 -0.3188 -1.0 1000111 NINDS_000311 OC(=O)CCCCC1SCC2NC(=O)NC12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P14 compound treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 3256 NINDS_000312 CCN(CCCc1ccccc1)CCCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P15 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 110 NINDS_000313 COC(=O)C1=C(C)NC(=C(C1c2ccccc2[N+](=O)[O-])C(=O)OC)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P16 compound treatment 0.0785 0.00231 0.27 0.2737 1.0 952 NINDS_000314 CC(C)(S)[C@@H](N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P17 compound treatment 0.077 8.1E-4 0.1 0.0959 1.0 953 NINDS_000315 C[C@H](N)[C@H](O)c1ccc(O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P18 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 954 NINDS_000316 CC1(C)S[C@@H]2[C@H](NC(=O)Cc3ccccc3)C(=O)N2[C@H]1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P19 compound treatment 0.075 -0.00119 -0.14 -0.1411 -1.0 955 NINDS_000317 CCN(CC)CCNC(=O)c1cc(Br)c(N)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P20 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 956 NINDS_000318 CCn1nc(C(=O)O)c(=O)c2cc3OCOc3cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P21 compound treatment 0.076 -1.9E-4 -0.02 -0.0226 -1.0 957 NINDS_000319 NC(COC(=O)C=[N+]=[N-])C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P22 compound treatment 0.0795 0.00331 0.39 0.3921 1.0 958 NINDS_000320 NC(=O)NC(=O)Cc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P23 mock treatment 0.0775 0.00131 0.16 0.1552 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.500 P24 mock treatment 0.074 -0.00219 -0.26 -0.2595 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A01 mock treatment 0.09 0.0159 1.89 1.8855 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A02 mock treatment 0.08 0.00591 0.7 0.7006 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A03 compound treatment 0.077 0.00291 0.35 0.3451 1.0 959 NINDS_000321 COc1ccc(Cc2nccc3cc(OC)c(OC)cc23)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A04 compound treatment 0.079 0.00491 0.58 0.5821 1.0 960 NINDS_000322 C1N2CN3CN1CN(C2)C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A05 compound treatment 0.0895 0.0154 1.83 1.8263 1.0 3173724 NINDS_000323 COc1ccc2C(OC(=O)c2c1OC)[C@@H]3N(C)CCc4cc5OCOc5c(OC)c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A06 compound treatment 0.064 -0.0101 -1.2 -1.1952 -1.0 962 NINDS_000324 CCC1(C(=O)NCNC1=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A07 compound treatment 0.08 0.00591 0.7 0.7006 1.0 3173725 NINDS_000325 CCN1CCN(C(=O)NC(C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4)C(=O)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A08 compound treatment 0.0785 0.00441 0.52 0.5229 1.0 964 NINDS_000326 CN(C)N=Nc1[nH]cnc1C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A09 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 3173726 NINDS_000327 NNC(=O)c1ccncc1.Nc1ccc(C(=O)O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A10 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 965 NINDS_000328 C(C1=NCCN1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A11 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 966 NINDS_000329 OC[C@@H]1OC(=O)[C@@H](O)[C@H](O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A12 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 967 NINDS_000330 C/C(=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C)/C=C/C=C(\C)/C=C/C2=C(C)CCCC2(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A13 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 968 NINDS_000331 CCCCC1C(=O)N(N(C1=O)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A14 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 969 NINDS_000332 CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A15 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 970 NINDS_000333 CC1(C)O[C@]2(C)CC[C@H]1CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A16 compound treatment 0.075 9.13E-4 0.11 0.1081 1.0 971 NINDS_000334 CN(C(=S)Oc1ccc2ccccc2c1)c3cccc(C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A17 compound treatment 0.0665 -0.00759 -0.9 -0.899 -1.0 972 NINDS_000335 CN(C)S(=O)(=O)c1ccc2Sc3ccccc3/C(=C\CCN4CCN(C)CC4)/c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A18 compound treatment 0.075 9.13E-4 0.11 0.1081 1.0 973 NINDS_000336 COc1ccc(cc1)C2C(=O)c3ccccc3C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A19 compound treatment 0.095 0.0209 2.48 2.4779 1.0 1000112 NINDS_000337 CC(=O)O[C@H]1[C@@H](O)C2C(C)(C)CC[C@H](O)[C@]2(C)[C@@]3(O)C(=O)C[C@@](C)(O[C@]13C)C=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A20 compound treatment 0.077 0.00291 0.35 0.3451 1.0 975 NINDS_000338 CCN(CC)CCOC(=O)C(CC1CCCO1)Cc2cccc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A21 compound treatment 0.076 0.00191 0.23 0.2266 1.0 3173729 NINDS_000339 CNC(=O)Oc1ccc2N(C)[C@H]3N(C)CC[C@@]3(C)c2c1.OC(=O)c1ccccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A22 compound treatment 0.076 0.00191 0.23 0.2266 1.0 977 NINDS_000340 C[C@@]12C[C@H](O)[C@@]3(F)C(CCC4=CC(=O)C=C[C@@]43C)C2C[C@@H](O)[C@]1(O)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A23 mock treatment 0.0805 0.00641 0.76 0.7598 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 A24 mock treatment 0.077 0.00291 0.35 0.3451 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B01 mock treatment 0.081 0.00691 0.82 0.8191 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B02 mock treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B03 compound treatment 0.081 0.00691 0.82 0.8191 1.0 198 NINDS_000341 CCCCNC(=O)NS(=O)(=O)c1ccc(C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B04 compound treatment 0.08 0.00591 0.7 0.7006 1.0 978 NINDS_000342 COC(=O)C(C)C[N+](C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B05 compound treatment 0.0805 0.00641 0.76 0.7598 1.0 417 NINDS_000343 CN1CCN(CC1)C2=Nc3cc(Cl)ccc3Nc4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B06 compound treatment 0.077 0.00291 0.35 0.3451 1.0 3045266 NINDS_000344 S=C1CC=CC=[N+]1O[Zn]On2ccccc2=S 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B07 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 980 NINDS_000345 C[C@@H]1[C@H]2[C@H](O)[C@H]3[C@H](N(C)C)C(=C(C(=O)N)C(=O)[C@@]3(O)C(=C2C(=O)c4c(O)cccc14)O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B08 compound treatment 0.0815 0.00741 0.88 0.8783 1.0 981 NINDS_000346 CCCCCCCCCCCCCCCC[n+]1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B09 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 982 NINDS_000347 CC(=O)Oc1ccc(cc1)C(c2ccc(OC(=O)C)cc2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B10 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 983 NINDS_000348 NCCCS(=O)(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B11 compound treatment 0.0675 -0.00659 -0.78 -0.7805 -1.0 984 NINDS_000349 C[C@H]1CC2C3CC[C@H](C(=O)C)[C@@]3(C)C[C@H](O)C2[C@@]4(C)CCC(=O)C=C14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B12 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 985 NINDS_000350 Nc1ccc(C(=O)O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B13 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 986 NINDS_000351 CN1CC(=O)NC1=N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B14 compound treatment 0.068 -0.00609 -0.72 -0.7213 -1.0 987 NINDS_000352 CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B15 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 988 NINDS_000353 COc1ccc2[nH]cc(CCNC(=O)C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B16 compound treatment 0.0685 -0.00559 -0.66 -0.662 -1.0 446 NINDS_000354 COc1cc(CNC(=O)CCCC/C=C/C(C)C)ccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B17 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 989 NINDS_000355 NC(=N)NCCCCNC(=N)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B18 compound treatment 0.077 0.00291 0.35 0.3451 1.0 990 NINDS_000356 CCN(CC)CCOCCOC(=O)C1(CCCC1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B19 compound treatment 0.0795 0.00541 0.64 0.6414 1.0 991 NINDS_000357 CC[C@@H](CO)NC(=O)[C@H]1CN(C)[C@@H]2Cc3c[nH]c4cccc(C2=C1)c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B20 compound treatment 0.0685 -0.00559 -0.66 -0.662 -1.0 992 NINDS_000358 CC[C@H]1[C@@H](Cc2cncn2C)COC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B21 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 993 NINDS_000359 CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B22 compound treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 994 NINDS_000360 N[C@@H](CCONC(=N)N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B23 mock treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 B24 mock treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C01 mock treatment 0.079 0.00491 0.58 0.5821 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C02 mock treatment 0.0775 0.00341 0.4 0.4044 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C03 compound treatment 0.081 0.00691 0.82 0.8191 1.0 995 NINDS_000361 CCC[C@@H]1C[C@H](N(C)C1)C(=O)N[C@@H]([C@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C04 compound treatment 0.0835 0.00941 1.12 1.1153 1.0 996 NINDS_000362 NCCc1cc(O)c(O)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C05 compound treatment 0.0865 0.0124 1.47 1.4708 1.0 997 NINDS_000363 NCc1ccc(cc1)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C06 compound treatment 0.0825 0.00841 1.0 0.9968 1.0 998 NINDS_000364 CCCCCCCCNC(C)C(O)c1ccc(SC(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C07 compound treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 999 NINDS_000365 CCn1cc(C(=O)O)c(=O)c2cc(F)c(N3CCNC(C)C3)c(F)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C08 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1000 NINDS_000366 NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C(Cl)Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C09 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1001 NINDS_000367 CN(C)CCOC(=O)COc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C10 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1002 NINDS_000368 CN(C)CCOC(c1ccccc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C11 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 347 NINDS_000369 CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C12 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 3173852 NINDS_000370 COc1ccc(CCC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO)C(O)[C@H](O)C3O[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)cc2O)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C13 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1004 NINDS_000371 Oc1ccc2c(=O)cc(oc2c1O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C14 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1005 NINDS_000372 OC(CCN1CCCCC1)(C2CCCCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C15 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1006 NINDS_000373 Nc1ccn(C2O[C@H](CO)[C@@H](O)[C@@H]2O)c(=O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C16 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 1000113 NINDS_000374 CC1CC2C3CCC4=CC(=O)C=CC4(C)[C@@]3(F)C(O)CC2(C)[C@@]1(O)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C17 compound treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 349 NINDS_000375 COc1cc2nc(nc(N)c2cc1OC)N3CCN(CC3)C(=O)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C18 compound treatment 0.076 0.00191 0.23 0.2266 1.0 1008 NINDS_000376 OC1CCCCC1N2CCC(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C19 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1009 NINDS_000377 C[N+]1(C)C2CC(CC1C3OC32)OC(=O)[C@@H](CO)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C20 compound treatment 0.077 0.00291 0.35 0.3451 1.0 1010 NINDS_000378 COc1ccc(CN(CCN(C)C)c2ncccn2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C21 compound treatment 0.0775 0.00341 0.4 0.4044 1.0 1011 NINDS_000379 C[N+](C)(C)CC#CCN1CCCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C22 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1012 NINDS_000380 Cc1cc2cc3c(C)cc(=O)oc3c(C)c2o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C23 mock treatment 0.0785 0.00441 0.52 0.5229 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 C24 mock treatment 0.0795 0.00541 0.64 0.6414 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D01 mock treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D02 mock treatment 0.076 0.00191 0.23 0.2266 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D03 compound treatment 0.078 0.00391 0.46 0.4636 1.0 1013 NINDS_000381 Cc1ccc(O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D04 compound treatment 0.0805 0.00641 0.76 0.7598 1.0 3173855 NINDS_000382 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)/C(=N\OCOCCOC)/[C@H](C)[C@@H](O)[C@]1(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D05 compound treatment 0.083 0.00891 1.06 1.0561 1.0 3471725 NINDS_000383 CC1(C)SC2C(NC(=O)C(N=C)c3ccccc3)C(=O)N2C1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D06 compound treatment 0.0795 0.00541 0.64 0.6414 1.0 1016 NINDS_000384 CN1CCOC(c2ccccc2)c3ccccc3C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D07 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1017 NINDS_000385 CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D08 compound treatment 0.075 9.13E-4 0.11 0.1081 1.0 2117626 NINDS_000386 Fc1ccc(cc1)C(CCCN2CCC(CC2)n3c(=O)[nH]c4ccccc34)c5ccc(F)cc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D09 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1018 NINDS_000387 COc1ccc2C[C@H]3[C@@H]4CCCC[C@@]4(CCN3C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D10 compound treatment 0.075 9.13E-4 0.11 0.1081 1.0 1019 NINDS_000388 NC(=O)N1c2ccccc2C=Cc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D11 compound treatment 0.076 0.00191 0.23 0.2266 1.0 3173857 NINDS_000389 NC(=N)c1ccc(OCCCCCOc2ccc(cc2)C(=N)N)cc1.OCCS(=O)(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D12 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1021 NINDS_000390 CO[C@@H]1[C@@H](O)[C@H](C)O[C@@H](O[C@H]2CC[C@@]3(C)[C@H](CCC4C3CC[C@]5(C)C(CC[C@]45O)C6=CC(=O)OC6)C2)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D13 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1022 NINDS_000391 COc1cc(OC)c2ccc(=O)oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D14 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1023 NINDS_000392 CN[C@H](CC(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D15 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1024 NINDS_000393 c1ccc2c(c1)sc3ccccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D16 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 3173859 NINDS_000394 CC(C)CC(=O)OC1C(O[C@@H]2C[C@H]([C@H]3CC[C@]4(CC5CC[C@H]4[C@]3(C)C2)[C@@H](O)C5=C)C(=O)O)OC(CO)C(OS(=O)(=O)O)C1OS(=O)(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D17 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1026 NINDS_000395 CC(=O)NC(Cc1ccccc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D18 compound treatment 0.075 9.13E-4 0.11 0.1081 1.0 3264 NINDS_000396 Cn1nnnc1SCC2=C(N3C(SC2)C(NC(=O)C(OC=O)c4ccccc4)C3=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D19 compound treatment 0.0785 0.00441 0.52 0.5229 1.0 935 NINDS_000397 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D20 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 3173860 NINDS_000398 O[C@H]1CC[C@@]2(O)[C@H]3Cc4ccc(O)c5OC1[C@]2(CCN3CC6CCC6)c54 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D21 compound treatment 0.079 0.00491 0.58 0.5821 1.0 1000056 NINDS_000399 COc1ccc(CCN(C)CCCC(C#N)(C(C)C)c2ccc(OC)c(OC)c2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D22 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1028 NINDS_000400 Oc1ccc(cc1)C(=C2C=CC(=O)C=C2)c3ccc(O)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D23 mock treatment 0.079 0.00491 0.58 0.5821 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 D24 mock treatment 0.0835 0.00941 1.12 1.1153 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E01 mock treatment 0.0755 0.00141 0.17 0.1674 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E02 mock treatment 0.077 0.00291 0.35 0.3451 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E03 compound treatment 0.0795 0.00541 0.64 0.6414 1.0 1029 NINDS_000401 CC(C(=O)O)c1ccc(cc1)N2Cc3ccccc3C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E04 compound treatment 0.0815 0.00741 0.88 0.8783 1.0 915 NINDS_000402 OC(=O)Cc1ccccc1Nc2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E05 compound treatment 0.084 0.00991 1.17 1.1746 1.0 1031 NINDS_000403 COc1ccc(cc1)C(=O)N2CCCC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E06 compound treatment 0.078 0.00391 0.46 0.4636 1.0 1000114 NINDS_000404 CCN(CC)CCCC(C)Nc1ccnc2cc(Cl)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E07 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1033 NINDS_000405 CC(Cc1ccc(O)cc1)NCC(O)c2cc(O)cc(O)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E08 compound treatment 0.077 0.00291 0.35 0.3451 1.0 1034 NINDS_000406 CC(=O)N[C@@H](CCC(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E09 compound treatment 0.0785 0.00441 0.52 0.5229 1.0 1035 NINDS_000407 Cc1cccc(CN2CCN(CC2)C(c3ccccc3)c4ccc(Cl)cc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E10 compound treatment 0.076 0.00191 0.23 0.2266 1.0 1036 NINDS_000408 CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2CCC[C@H]2C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E11 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1037 NINDS_000409 CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)c3ccc(O)cc3)C2=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E12 compound treatment 0.0775 0.00341 0.4 0.4044 1.0 1038 NINDS_000410 O=C1CCCN1CC#CCN2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E13 compound treatment 0.076 0.00191 0.23 0.2266 1.0 1039 NINDS_000411 CC[C@]1(CCCN2CCc3c4[C@@H]21)CC(=O)n4c5ccccc35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E14 compound treatment 0.0865 0.0124 1.47 1.4708 1.0 1040 NINDS_000412 CC(C)CC1NC(=O)C(CCCN)NC(=O)C(NC(=O)C(Cc2ccc(O)cc2)NC(=O)C(CCC(=O)O)NC(=O)C(CC(=O)O)NC(=O)C(Cc3ccccc3)NC(=O)C(Cc4ccccc4)NC(=O)C5CCCN5C(=O)C(Cc6ccccc6)NC1=O)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E15 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1041 NINDS_000413 CN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E16 compound treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 1000115 NINDS_000414 COC(=O)[C@@H]1[C@@H](O)CC[C@@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E17 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1043 NINDS_000415 O[Hg]c1c(O)c(Br)cc2c(c3ccccc3C(=O)O)c4cc(Br)c(=O)cc4oc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E18 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1044 NINDS_000416 C[C@H](CCC(=O)O)[C@H]1CCC2C3[C@@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E19 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1045 NINDS_000417 C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E20 compound treatment 0.075 9.13E-4 0.11 0.1081 1.0 1046 NINDS_000418 CC1C2C(CC3C4CC[C@H]5C[C@@H](O)CC[C@]5(C)C4CC(=O)[C@]23C)OC61CCC(C)CO6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E21 compound treatment 0.0775 0.00341 0.4 0.4044 1.0 1047 NINDS_000419 CN(C)CCCN1c2ccccc2Sc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E22 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1048 NINDS_000420 CCn1cc(C(=O)O)c(=O)c2cc(F)c(nc12)N3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E23 mock treatment 0.0785 0.00441 0.52 0.5229 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 E24 mock treatment 0.082 0.00791 0.94 0.9376 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F01 mock treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F02 mock treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F03 compound treatment 0.076 0.00191 0.23 0.2266 1.0 1049 NINDS_000421 Oc1cc2oc(cc(=O)c2cc1O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F04 compound treatment 0.078 0.00391 0.46 0.4636 1.0 1050 NINDS_000422 Nc1ccc(cc1)S(=O)(=O)Nc2cnnc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F05 compound treatment 0.082 0.00791 0.94 0.9376 1.0 1051 NINDS_000423 CC(=O)Oc1ccc(Cl)c2cccnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F06 compound treatment 0.0785 0.00441 0.52 0.5229 1.0 1052 NINDS_000424 CC[C@H]1CN2CCC1C[C@@H]2[C@@H](O)c3ccnc4ccc(OC)cc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F07 compound treatment 0.076 0.00191 0.23 0.2266 1.0 1053 NINDS_000425 COc1cc(cc(OC)c1OC)C(=O)NCc2ccc(OCCN(C)C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F08 compound treatment 0.083 0.00891 1.06 1.0561 1.0 1054 NINDS_000426 CC(C)(C)CC(C)(C)c1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F09 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1055 NINDS_000427 CC(C)(C)NCC(O)COc1cccc2C[C@@H](O)[C@@H](O)Cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F10 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1056 NINDS_000428 Nc1nc2nc[nH]c2c(=S)[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F11 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1057 NINDS_000429 OC(CCN1CCCC1)(C2CCCCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F12 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1058 NINDS_000430 C[C@@]12CCC3C(CCC4=Cc5oncc5C[C@]34C)C2CC[C@@]1(O)C#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F13 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1059 NINDS_000431 CN(C)CC/C=C\1/c2ccccc2COc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F14 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1060 NINDS_000432 CN1CCC(=C2c3ccccc3Sc4ccccc24)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F15 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1061 NINDS_000433 Nc1nc(N)c2nc(c(N)nc2n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F16 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1062 NINDS_000434 COc1ccccc1OCC(O)COC(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F17 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1063 NINDS_000435 CC(CNCCc1ccc(O)c(O)c1)Cc2cccc(O)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F18 compound treatment 0.077 0.00291 0.35 0.3451 1.0 1064 NINDS_000436 [O-][N+](=O)O[C@@H]1CO[C@@H]2[C@H](CO[C@H]12)O[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F19 compound treatment 0.075 9.13E-4 0.11 0.1081 1.0 1065 NINDS_000437 CN1C(CC(O)c2ccccc2)CCCC1CC(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F20 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1066 NINDS_000438 OC1OCC=C2OC(=O)C=C12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F21 compound treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 1067 NINDS_000439 CO[C@]1(NC(=O)CSCC#N)C2SCC(=C(N2C1=O)C(=O)O)CSc3nnnn3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F22 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 1068 NINDS_000440 CN/C(=C\[N+](=O)[O-])/NCCSCc1ccc(CN(C)C)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F23 mock treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 F24 mock treatment 0.077 0.00291 0.35 0.3451 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G01 mock treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G02 mock treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G03 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1000045 NINDS_000441 CC(=O)O[C@@H]1C2=C(C)[C@H](C[C@@](O)([C@@H](OC(=O)c3ccccc3)C4[C@@]5(CO[C@@H]5C[C@H](O)[C@@]4(C)C1=O)OC(=O)C)C2(C)C)OC(=O)[C@H](O)[C@@H](NC(=O)c6ccccc6)c7ccccc7 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G04 compound treatment 0.079 0.00491 0.58 0.5821 1.0 1069 NINDS_000442 CCCN1C[C@H](CSC)C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G05 compound treatment 0.081 0.00691 0.82 0.8191 1.0 1070 NINDS_000443 CCC(C(CC)c1ccc(O)cc1)c2ccc(O)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G06 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1000116 NINDS_000444 CC(=O)CC(c1ccccc1)c2c(O)c3ccccc3oc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G07 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1000117 NINDS_000445 CC(=O)[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G08 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1073 NINDS_000446 CC(N)C(=O)NC(Cc1ccccc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G09 compound treatment 0.076 0.00191 0.23 0.2266 1.0 3173981 NINDS_000447 CCOC(=O)OC(C)OC(=O)C1N2C(SC1(C)C)C(NC(=O)[C@H](N)c3ccccc3)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G10 compound treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 1075 NINDS_000448 CCN(Cc1ccncc1)C(=O)C(CO)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G11 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1076 NINDS_000449 Cc1cccc(C)c1NC2=NCCCS2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G12 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1077 NINDS_000450 CN(C)[C@H]1[C@@H]2C[C@@H]3Cc4c(ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G13 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1000118 NINDS_000451 CN[C@@H](C)[C@@H](O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G14 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1079 NINDS_000452 N[C@@H](Cc1ccc(O)c(O)c1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G15 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 1080 NINDS_000453 N[C@H](Cc1ccccc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G16 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1081 NINDS_000454 Cc1c(N)c(=O)n(c2ccccc2)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G17 compound treatment 0.0775 0.00341 0.4 0.4044 1.0 1082 NINDS_000455 CN(Cc1cc(Br)cc(Br)c1N)C2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G18 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1083 NINDS_000456 C(C1=NCCN1)c2cccc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G19 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1000119 NINDS_000457 N[C@@H](Cc1c[nH]c2ccccc12)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G20 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 3173985 NINDS_000458 CO[C@H]1CC(O[C@H]/2[C@@H](C)\C=C\C=C\3/CO[C@@H]4CC(=C[C@@H](C(=O)O[C@H]5C[C@@H](C\C=C2/C)O[C@@]6(CC[C@H](C)[C@H](O6)C7CCCCC7)C5)[C@@]43O)C)O[C@@H](C)C1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G21 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 1086 NINDS_000459 CC(C)C(=O)Nc1ccc([N+](=O)[O-])c(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G22 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1087 NINDS_000460 Oc1ccc(Cl)cc1Cc2cc(Cl)ccc2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G23 mock treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 G24 mock treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H01 mock treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H02 mock treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H03 compound treatment 0.076 0.00191 0.23 0.2266 1.0 836 NINDS_000461 CNC(C)C(O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H04 compound treatment 0.082 0.00791 0.94 0.9376 1.0 1088 NINDS_000462 CCN(CC)CCOc1ccc(cc1)/C(=C(\Cl)/c2ccccc2)/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H05 compound treatment 0.081 0.00691 0.82 0.8191 1.0 3044782 NINDS_000463 NC(=N)N.OC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H06 compound treatment 0.076 0.00191 0.23 0.2266 1.0 1090 NINDS_000464 CCC[C@@H]1C[C@H](N(C)C1)C(=O)NC(C(C)Cl)C2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H07 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1091 NINDS_000465 CCc1cn(C2OCC(O)C2CO)c(=O)nc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H08 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1092 NINDS_000466 CC1(C)S[C@@H]2[C@H](NC(=O)[C@H](N)c3ccccc3)C(=O)N2[C@H]1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H09 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1093 NINDS_000467 NCCC(O)C(=O)N[C@@H]1C[C@H](N)[C@@H](O[C@H]2O[C@H](CN)[C@@H](O)[C@H](O)[C@H]2N)[C@H](OC3O[C@H](CO)[C@H](O)[C@H]3O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H10 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 1094 NINDS_000468 COc1cnc(NS(=O)(=O)c2ccc(N)cc2)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H11 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1095 NINDS_000469 NC(CO)C(=O)NNCc1ccc(O)c(O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H12 compound treatment 0.075 9.13E-4 0.11 0.1081 1.0 1096 NINDS_000470 C[N+](C)(C)CC(O)CC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H13 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 1097 NINDS_000471 OC(=O)c1cc(=O)c2ccccc2o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H14 compound treatment 0.068 -0.00609 -0.72 -0.7213 -1.0 1098 NINDS_000472 C[C@@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C2CC[C@]1(O)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H15 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 1099 NINDS_000473 CC(=O)NCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H16 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 1100 NINDS_000474 CC(CCc1ccccc1)NCC(O)c2ccc(O)c(c2)C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H17 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1101 NINDS_000475 CCCC1O[C@@H]2CC3C4CCC5=CC(=O)C=CC5(C)C4[C@@H](O)CC3(C)[C@@]2(O1)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H18 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1102 NINDS_000476 CC(C(=O)O)c1ccc(cc1)C(=O)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H19 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 3471036 NINDS_000477 OC(=O)C1=C(C[n+]2ccccc2)CSC3C(NC(=O)Cc4cccs4)C(=O)N31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H20 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 1104 NINDS_000478 C[C@H](CCC(=O)O)[C@H]1CCC2C3C(CC(=O)[C@]12C)[C@@]4(C)CCC(=O)CC4CC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H21 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 3044756 NINDS_000479 CC(CN(C)C)CN1c2ccccc2Sc3ccccc13.OC(C(O)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H22 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 1105 NINDS_000480 CCN(CC)CCNc1ccc(CO)c2sc3ccccc3c(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H23 mock treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 H24 mock treatment 0.0755 0.00141 0.17 0.1674 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I01 mock treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I02 mock treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I03 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 74 NINDS_000481 COc1ccc(Cl)cc1C(=O)NCCc2ccc(cc2)S(=O)(=O)NC(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I04 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1106 NINDS_000482 CCC(=O)c1c(O)cc(O)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I05 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1107 NINDS_000483 OC(=O)CN1CCNC1=N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I06 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 1108 NINDS_000484 Cc1cc(=O)n(c2ccccc2)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I07 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 353 NINDS_000485 Oc1cc(O)c2c(=O)c(O)c(oc2c1)c3ccc(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I08 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 1000121 NINDS_000486 C/C(=C\CO)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I09 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 1110 NINDS_000487 C[C@H]1CC2C3CC[C@](OC(=O)C)(C(=O)C)[C@@]3(C)CCC2[C@@]4(C)CCC(=O)C=C14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I10 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 1111 NINDS_000488 CCC(C)C1NC(=O)C(CCNCS(=O)(=O)O)NC(=O)C(CCNC(=O)C(NC(=O)C(CCNCS(=O)(=O)O)NC(=O)C(CCNCS(=O)(=O)O)NC(=O)C(NC1=O)C(C)CC)C(C)O)NC(=O)C(CCNCS(=O)(=O)O)NC(=O)C(NC(=O)C(CCNCS(=O)(=O)O)NC(=O)CCCCC(C)C)C(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I11 compound treatment 0.068 -0.00609 -0.72 -0.7213 -1.0 1112 NINDS_000489 CC(C)N(CCC(C(=O)N)(c1ccccc1)c2ccccn2)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I12 compound treatment 0.063 -0.0111 -1.31 -1.3137 -1.0 1113 NINDS_000490 COc1ccc2n(C(=O)c3ccc(Cl)cc3)c(C)c(CC(=O)OCC(=O)O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I13 compound treatment 0.0565 -0.0176 -2.08 -2.0839 -1.0 1114 NINDS_000491 NS(=O)(=O)c1cc2c(N=C(CSCc3ccccc3)NS2(=O)=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I14 compound treatment 0.0645 -0.00959 -1.14 -1.136 -1.0 1115 NINDS_000492 C[C@@]12CCC3C(CCC4=C3CCC(=O)C4)C2CC[C@@]1(O)C#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I15 compound treatment 0.0685 -0.00559 -0.66 -0.662 -1.0 1116 NINDS_000493 S=c1[nH]cnc2nc[nH]c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I16 compound treatment 0.0675 -0.00659 -0.78 -0.7805 -1.0 1117 NINDS_000494 Nc1nc(=O)c2nc(CNc3ccc(cc3)C(=O)N[C@@H](CCC(=O)O)C(=O)O)cnc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I17 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 2549 NINDS_000495 C[n+]1cc2c3OCOc3ccc2c4ccc5cc6OCOc6cc5c14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I18 compound treatment 0.093 0.0189 2.24 2.241 1.0 3174099 NINDS_000496 Nc1cccc(c1)C(=C2C=CC(=N)C=C2)c3cccc(N)c3.OC(=O)c1cc2ccccc2c(Cc3c(O)c(cc4ccccc34)C(=O)O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I19 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 2069294 NINDS_000497 C[C@@H]1CC2C3C[C@H](F)C4=CC(=O)C=CC4(C)C3(F)[C@@H](O)CC2(C)C1C(=O)COC(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I20 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 1119 NINDS_000498 CSCCC(NC=O)C(=O)NC(Cc1ccccc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I21 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 3174101 NINDS_000499 CN1CCc2c(C1)c3ccccc3n2Cc4ccccc4.OS(=O)(=O)c1cccc2c(cccc12)S(=O)(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I22 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 1120 NINDS_000500 Oc1ccc(cc1[N+](=O)[O-])[As](=O)(O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I23 mock treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 I24 mock treatment 0.0745 4.13E-4 0.05 0.0489 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J01 mock treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J02 mock treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J03 compound treatment 0.075 9.13E-4 0.11 0.1081 1.0 1000122 NINDS_000501 O[C@@H]([C@@H]1C[C@@H]2CCN1C[C@@H]2C=C)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J04 compound treatment 0.0785 0.00441 0.52 0.5229 1.0 1122 NINDS_000502 N(=Nc1ccccc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J05 compound treatment 0.078 0.00391 0.46 0.4636 1.0 3174102 NINDS_000503 OCCOCCN1CCN(CC1)C(c2ccccc2)c3ccc(Cl)cc3.OC(=O)c1cc2ccccc2c(Cc3c(O)c(cc4ccccc34)C(=O)O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J06 compound treatment 0.082 0.00791 0.94 0.9376 1.0 1123 NINDS_000504 Cc1ccc(Cl)c(Nc2ccccc2C(=O)O)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J07 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1124 NINDS_000505 CN1C2CC[C@@H]1C[C@H](C2)OC(=O)[C@H](CO)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J08 compound treatment 0.0685 -0.00559 -0.66 -0.662 -1.0 1125 NINDS_000506 CCOC(=O)NNc1nncc2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J09 compound treatment 0.068 -0.00609 -0.72 -0.7213 -1.0 1126 NINDS_000507 O=C1NC(=O)C(N1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J10 compound treatment 0.0685 -0.00559 -0.66 -0.662 -1.0 1127 NINDS_000508 CC1Cc2ccccc2N1NC(=O)c3ccc(Cl)c(c3)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J11 compound treatment 0.067 -0.00709 -0.84 -0.8398 -1.0 3174103 NINDS_000509 C/C/1=C\CC[C@@]2(C)OC2[C@H]3OC(=O)C(=C)[C@@H]3CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J12 compound treatment 0.0695 -0.00459 -0.54 -0.5435 -1.0 1129 NINDS_000510 CCn1cc(C(=O)O)c(=O)c2cnc(nc12)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J13 compound treatment 0.065 -0.00909 -1.08 -1.0768 -1.0 1130 NINDS_000511 OCCN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J14 compound treatment 0.065 -0.00909 -1.08 -1.0768 -1.0 1131 NINDS_000512 NS(=O)(=O)c1cc2c(NCNS2(=O)=O)cc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J15 compound treatment 0.0685 -0.00559 -0.66 -0.662 -1.0 1132 NINDS_000513 CCCNC(=O)NS(=O)(=O)c1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J16 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1133 NINDS_000514 CCC(=O)OC1CCC2C3CCc4cc(O)ccc4C3CCC12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J17 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1134 NINDS_000515 CN1C[C@H](CO)C=C2[C@H]1Cc3c[nH]c4cccc2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J18 compound treatment 0.1515 0.0774 9.17 9.1726 1.0 1135 NINDS_000516 OCCNCCNc1ccc(NCCNCCO)c2C(=O)c3c(O)ccc(O)c3C(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J19 compound treatment 0.067 -0.00709 -0.84 -0.8398 -1.0 1136 NINDS_000517 C[C@@]12C[C@H](O)C3C(CCC4=CC(=O)CC[C@]34C)C2CC[C@]1(O)C(=O)COC(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J20 compound treatment 0.0675 -0.00659 -0.78 -0.7805 -1.0 1137 NINDS_000518 CC(=O)Oc1ccc2C3CCC4(C)C(CCC4=O)C3CCc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J21 compound treatment 0.0695 -0.00459 -0.54 -0.5435 -1.0 1138 NINDS_000519 CC/C(=C(/CC)\c1ccc(O)cc1)/c2ccc(O)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J22 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 1139 NINDS_000520 C[C@@]12CCC3C(CCc4cc(O)ccc34)C2CC[C@@]1(O)C#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J23 mock treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 J24 mock treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K01 mock treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K02 mock treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K03 compound treatment 0.0775 0.00341 0.4 0.4044 1.0 3174105 NINDS_000521 CN(C)c1ccc2[n+](C)c(/C=C/c3cc(C)n(c3C)c4ccccc4)ccc2c1.OC(=O)c1cc2ccccc2c(Cc3c(O)c(cc4ccccc34)C(=O)O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K04 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1140 NINDS_000522 CC(=O)OC/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)CCCC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K05 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1141 NINDS_000523 CN1C2CCC1CC(C2)OC(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K06 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1142 NINDS_000524 Cc1cn([C@H]2C[C@H](N=[N+]=[N-])[C@@H](CO)O2)c(=O)[nH]c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K07 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 3174106 NINDS_000525 CN(C)CCCO[C@H]1[C@H](OC2OC(C)(C)O[C@H]12)C(O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K08 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1144 NINDS_000526 O=C1NCC2(CCN(CCc3ccccc3)CC2)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K09 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 3174107 NINDS_000527 CN[C@@H]1C(O)[C@@H](O[C@H]2[C@H](N)C[C@H](N)[C@@H](O[C@H]3OC(=CC[C@H]3N)CN)[C@@H]2O)OC[C@]1(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K10 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 1146 NINDS_000528 Nc1ccc(cc1)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K11 compound treatment 0.0685 -0.00559 -0.66 -0.662 -1.0 1147 NINDS_000529 COc1c2ccoc2cc3oc(=O)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K12 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 3174108 NINDS_000530 CC(=O)N[C@H](CS)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K13 compound treatment 0.068 -0.00609 -0.72 -0.7213 -1.0 1149 NINDS_000531 CN(N=O)C(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K14 compound treatment 0.0685 -0.00559 -0.66 -0.662 -1.0 1150 NINDS_000532 OC(=O)CCCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K15 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1151 NINDS_000533 CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(O)c(C)c(C)c2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K16 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 1152 NINDS_000534 CN(C)CCN(Cc1ccccc1)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K17 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 3174220 NINDS_000535 CO[C@@H]1C[C@@H](C[C@H]2CC[C@H](C)[C@@H](O2)[C@@H](C)C(=O)O)O[C@]3(O[C@@](C)(C[C@H]3C)[C@H]4CC[C@](C)(O4)C5O[C@H](C[C@@H]5C)C6O[C@@](O)(CO)[C@H](C)C[C@@H]6C)[C@@H]1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K18 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 1154 NINDS_000536 O=C1CC2OCC=C3CN4CC[C@]56C4C[C@@H]3[C@@H]2C6N1c7ccccc75 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K19 compound treatment 0.066 -0.00809 -0.96 -0.9583 -1.0 1155 NINDS_000537 Nc1ccc(cc1)S(=O)(=O)NC(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K20 compound treatment 0.068 -0.00609 -0.72 -0.7213 -1.0 1156 NINDS_000538 OC(=O)c1cc(O)ccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K21 compound treatment 0.0675 -0.00659 -0.78 -0.7805 -1.0 3055 NINDS_000539 NC(=N)NCCN1CCCCCCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K22 compound treatment 0.0685 -0.00559 -0.66 -0.662 -1.0 86 NINDS_000540 COC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCCN(C)Cc3ccccc3)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K23 mock treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 K24 mock treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L01 mock treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L02 mock treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L03 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1157 NINDS_000541 CC(=O)N1CCN(CC1)c2ccc(OCC3CO[C@@](Cn4ccnc4)(O3)c5ccc(Cl)cc5Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L04 compound treatment 0.0785 0.00441 0.52 0.5229 1.0 1158 NINDS_000542 C(C(C1CCCCC1)C2CCCCC2)C3CCCCN3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L05 compound treatment 0.077 0.00291 0.35 0.3451 1.0 1159 NINDS_000543 Nc1ccc(cc1)S(=O)(=O)Nc2ncccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L06 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1160 NINDS_000544 OC[C@@H](NC(=O)C(Cl)Cl)[C@H](O)c1ccc(cc1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L07 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 3045799 NINDS_000545 NC(=Nc1nc(CSCC/C(=N\S(=O)(=O)N)/N)cs1)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L08 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1162 NINDS_000546 Cc1c(NC(=O)c2cccnc2)c(=O)n(c3ccccc3)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L09 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1163 NINDS_000547 Oc1ccc2C[C@H]3N(CC4CC4)CCC5([C@H]6Oc1c25)[C@@]3(O)CCC6=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L10 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 1164 NINDS_000548 CCN(CC)C(=O)N1CCN(C)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L11 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1000123 NINDS_000549 CC(=O)OCC(=O)[C@@]1(O)[C@@H](CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L12 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 3174224 NINDS_000550 CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C2=O)c4c(O)c(\C=N/N5CCN(C)CC5)c(NC(=O)/C(=C\C=C\C(C)[C@H](O)[C@@H](C)[C@@H](O)[C@@H](C)[C@@H](OC(=O)C)[C@@H]1C)/C)c(O)c4c(O)c3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L13 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1167 NINDS_000551 NCCCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L14 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1168 NINDS_000552 CC12CCC3C(CCc4cc(OCc5ccccc5)ccc34)C2C[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L15 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1169 NINDS_000553 C[C@@]12CCC3C(CCC4=CC(=O)CC[C@H]34)C2CC[C@@]1(O)C#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L16 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1170 NINDS_000554 CC(=O)OCC(=O)[C@]12OC(C)(C)O[C@@H]2C[C@H]3C4C[C@H](F)C5=CC(=O)C=CC5(C)[C@@]4(F)[C@@H](O)C[C@@]31C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L17 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1171 NINDS_000555 CC(=O)Oc1ccccc1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L18 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 430 NINDS_000556 NC(=O)NO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L19 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1172 NINDS_000557 CC(C)OC(=O)C(C)(C)Oc1ccc(cc1)C(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L20 compound treatment 0.0675 -0.00659 -0.78 -0.7805 -1.0 1000124 NINDS_000558 CN1C2CCC1CC(C2)OC(=O)C(CO)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L21 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1174 NINDS_000559 CN(C)CCCN1c2ccccc2CCc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L22 compound treatment 0.0695 -0.00459 -0.54 -0.5435 -1.0 1175 NINDS_000560 Nc1ccc(cc1)S(=O)(=O)Nc2nccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L23 mock treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 L24 mock treatment 0.079 0.00491 0.58 0.5821 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M01 mock treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M02 mock treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M03 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1176 NINDS_000561 CC[C@@H](CO)NCCN[C@@H](CC)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M04 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 3174226 NINDS_000562 CC[N+](C)(C)Cc1ccc(Br)cc1.Cc1ccc(cc1)S(=O)(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M05 compound treatment 0.076 0.00191 0.23 0.2266 1.0 1177 NINDS_000563 Cc1ccnc(NS(=O)(=O)c2ccc(N)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M06 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 3174227 NINDS_000564 CC[C@@H]1[C@@H](O)N2[C@H]3C[C@@]45C(O)C3[C@@H]1CC2[C@@H]5N(C)c6ccccc64 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M07 compound treatment 0.0775 0.00341 0.4 0.4044 1.0 1179 NINDS_000565 CC12CC[C@H]3C(CCc4cc(O)ccc34)[C@@H]2CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M08 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1180 NINDS_000566 Fc1ccc(cc1)C(=O)CCCN2CCC3(CC2)N(CNC3=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M09 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1181 NINDS_000567 Cc1cc(c(O)c(C)c1CC2=NCCN2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M10 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 3471107 NINDS_000568 NC(=O)c1cc[n+](CC2=C(N3C(SC2)C(NC(=O)C(c4ccccc4)S(=O)(=O)O)C3=O)C(=O)O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M11 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 3174228 NINDS_000569 CN[C@H]1C(O)C(O)C(CO)OC1OC2[C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](NC(=N)N)[C@@H](O)[C@@H]3NC(=N)N)OC(C)[C@]2(O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M12 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1184 NINDS_000570 Nc1ncnc2n(cnc12)C3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M13 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 1000126 NINDS_000571 C[C@H](CCC(=O)O)[C@H]1CCC2C3[C@H](O)C[C@@H]4C[C@H](O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M14 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 338 NINDS_000572 Nc1ccncc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M15 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 1186 NINDS_000573 Nc1ccc(cc1)S(=O)(=O)c2ccc(N)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M16 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1187 NINDS_000574 C[C@@]12CCC3C(CCc4cc(OS(=O)(=O)O)ccc34)C2CC[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M17 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1188 NINDS_000575 NS(=O)(=O)c1cc(C(=O)O)c(NCc2ccco2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M18 compound treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 1189 NINDS_000576 CO[C@]1(NC(=O)Cc2cccs2)[C@H]3SCC(=C(N3C1=O)C(=O)O)COC(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M19 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 1190 NINDS_000577 Nc1c2C(O)CCCc2nc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M20 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1191 NINDS_000578 Oc1c(Cl)cc(Cl)c2cccnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M21 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 1192 NINDS_000579 Cc1noc(NS(=O)(=O)c2ccc(N)cc2)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M22 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1193 NINDS_000580 CCOc1ccc(NC(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M23 mock treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 M24 mock treatment 0.075 9.13E-4 0.11 0.1081 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N01 mock treatment 0.0745 4.13E-4 0.05 0.0489 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N02 mock treatment 0.0745 4.13E-4 0.05 0.0489 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N03 compound treatment 0.077 0.00291 0.35 0.3451 1.0 41 NINDS_000581 OC(=O)c1ccccc1Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N04 compound treatment 0.079 0.00491 0.58 0.5821 1.0 1194 NINDS_000582 CC(=O)N=c1sc(nn1C)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N05 compound treatment 0.0785 0.00441 0.52 0.5229 1.0 1195 NINDS_000583 C[C@@]12CCC3C(CC[C@]4(O)C[C@@H](O)CC[C@]34C=O)[C@@]2(O)CCC1C5=CC(=O)OC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N06 compound treatment 0.076 0.00191 0.23 0.2266 1.0 1196 NINDS_000584 CCCOc1ccccc1c2nc3[nH]nnc3c(=O)[nH]2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N07 compound treatment 0.078 0.00391 0.46 0.4636 1.0 3174345 NINDS_000585 CN(C)[C@H]1[C@@H]2[C@@H](O)[C@@H]3C(=C)c4c(Cl)ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N.OC(=O)c1cc(ccc1O)S(=O)(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N08 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1198 NINDS_000586 Cn1cnc([N+](=O)[O-])c1Sc2[nH]cnc3ncnc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N09 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1199 NINDS_000587 CSCCC(NC=O)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N10 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1200 NINDS_000588 NC1C[C@H]1c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N11 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1201 NINDS_000589 COc1cc(Cc2cnc(N)nc2N)cc(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N12 compound treatment 0.077 0.00291 0.35 0.3451 1.0 1202 NINDS_000590 COc1ccc2CN(C)CC[C@]34C=C[C@H](O)C[C@@H]4Oc1c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N13 compound treatment 0.0755 0.00141 0.17 0.1674 1.0 1203 NINDS_000591 CN(C)[C@H]1[C@@H]2[C@@H](O)[C@@H]3C(=C)c4cccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N14 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1204 NINDS_000592 CN1C[C@@H](C[C@H]2[C@H]1Cc3c[nH]c4cccc2c34)C(=O)N[C@]5(C)O[C@@]6(O)[C@@H]7CCCN7C(=O)[C@H](Cc8ccccc8)N6C5=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N15 compound treatment 0.076 0.00191 0.23 0.2266 1.0 818 NINDS_000593 CCC1(CC)C(=O)NC=CC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N16 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1205 NINDS_000594 CC(=CCC1=C(O)C(=O)c2ccccc2C1=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N17 compound treatment 0.0775 0.00341 0.4 0.4044 1.0 1206 NINDS_000595 CC(=C)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N18 compound treatment 0.0775 0.00341 0.4 0.4044 1.0 1207 NINDS_000596 CN(C)CCC(c1ccc(Cl)cc1)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N19 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 1208 NINDS_000597 CNC[C@H](O)c1cccc(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N20 compound treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 1209 NINDS_000598 CC(C(=O)O)c1cccc(c1)C(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N21 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1210 NINDS_000599 CC(C)(C)c1cc(SC(C)(C)Sc2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C)cc(c1O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N22 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1211 NINDS_000600 CON 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N23 mock treatment 0.0765 0.00241 0.29 0.2859 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 N24 mock treatment 0.078 0.00391 0.46 0.4636 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O01 mock treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O02 mock treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O03 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1212 NINDS_000601 CC/1=C(CC(=O)O)c2cc(F)ccc2\C1=C/c3ccc(cc3)S(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O04 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1213 NINDS_000602 CNCCc1ccccn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O05 compound treatment 0.078 0.00391 0.46 0.4636 1.0 1214 NINDS_000603 CCOC(=O)Nc1c[n+](no1)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O06 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1215 NINDS_000604 CC(NCCC(c1ccccc1)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O07 compound treatment 0.0765 0.00241 0.29 0.2859 1.0 1216 NINDS_000605 C[C@@]12CCC3C(CCc4cc(O)ccc34)C2C[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O08 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 1000127 NINDS_000606 CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)C=C[C@]5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O09 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1218 NINDS_000607 CCCCNc1ccc(cc1)C(=O)OCCN(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O10 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1219 NINDS_000608 CC[C@@]12CCC3C(CCC4=CC(=O)CC[C@H]34)C2CC[C@@]1(O)C#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O11 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1220 NINDS_000609 CN1CCc2cc3OCOc3cc2[C@H]1[C@@H]4OC(=O)c5c6OCOc6ccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O12 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1221 NINDS_000610 CN(C)CCOC(=O)C(c1ccccc1)C2(O)CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O13 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1222 NINDS_000611 Cn1cnc2n(C)c(=O)[nH]c(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O14 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1223 NINDS_000612 CCCC(=O)Nc1ccc(OCC(O)CNC(C)C)c(c1)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O15 compound treatment 0.09 0.0159 1.89 1.8855 1.0 1224 NINDS_000613 C[C@@]12CCC3C(CCc4cc(O)ccc34)C2CC[C@@H]1OC(=O)CCC5CCCC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O16 compound treatment 0.079 0.00491 0.58 0.5821 1.0 1225 NINDS_000614 Oc1cc(O)c2c(=O)cc(oc2c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O17 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 3046099 NINDS_000615 NC[C@@H]1O[C@H](OC2[C@@H](O)[C@H](O[C@@H]3[C@H](N)[C@@H](O)C[C@H](N)[C@H]3O[C@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O18 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1227 NINDS_000616 NCCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O19 compound treatment 0.075 9.13E-4 0.11 0.1081 1.0 1228 NINDS_000617 CC[Hg]Sc1ccccc1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O20 compound treatment 0.077 0.00291 0.35 0.3451 1.0 28 NINDS_000618 CNc1ccc2oc(C[C@@H]3OC4(CC[C@@H]3C)O[C@H](C(C)C(=O)c5ccc[nH]5)[C@H](C)C[C@H]4C)nc2c1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O21 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 121 NINDS_000619 OC(=O)c1cc(ccc1NCCCc2ccccc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O22 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 1229 NINDS_000620 CC(=O)N[C@H]1[C@@H](O)C[C@](O)(O[C@@H]1C(O)[C@H](O)CO)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O23 mock treatment 0.077 0.00291 0.35 0.3451 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 O24 mock treatment 0.076 0.00191 0.23 0.2266 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P01 mock treatment 0.0675 -0.00659 -0.78 -0.7805 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P02 mock treatment 0.067 -0.00709 -0.84 -0.8398 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P03 compound treatment 0.0675 -0.00659 -0.78 -0.7805 -1.0 1000128 NINDS_000621 CCCCC(=O)OC1(C(C)CC2C3CCC4=CC(=O)C=CC4(C)[C@@]3(F)[C@@H](O)CC21C)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P04 compound treatment 0.07 -0.00409 -0.48 -0.4843 -1.0 1231 NINDS_000622 CC(C)C[C@H](NC(=O)C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P05 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 1232 NINDS_000623 OC1=C(O)C(=O)C(=C(O)C1=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P06 compound treatment 0.069 -0.00509 -0.6 -0.6028 -1.0 436 NINDS_000624 CN(C)CCCN1c2ccccc2Sc3ccc(Cl)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P07 compound treatment 0.0725 -0.00159 -0.19 -0.1881 -1.0 1233 NINDS_000625 CO[C@@H]1[C@@H](O)[C@H](C)O[C@H](O[C@H]2CC[C@@]3(C=O)[C@H](CCC4C3CC[C@]5(C)[C@H](CC[C@]45O)C6=CC(=O)OC6)C2)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P08 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 1234 NINDS_000626 C[C@H]1CC2C3CC[C@](O)(C(=O)CO)[C@@]3(C)C[C@H](O)C2[C@@]4(C)C=CC(=O)C=C14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P09 compound treatment 0.071 -0.00309 -0.37 -0.3658 -1.0 1235 NINDS_000627 CCOC(=O)CCCCCCCCCCCCC1CCC=C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P10 compound treatment 0.0735 -5.87E-4 -0.07 -0.0696 -1.0 1236 NINDS_000628 OCc1cc2c(cn1)[nH]c3ccccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P11 compound treatment 0.0715 -0.00259 -0.31 -0.3066 -1.0 1237 NINDS_000629 CC(=O)Nc1ccc(OC(=O)c2ccccc2O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P12 compound treatment 0.08 0.00591 0.7 0.7006 1.0 1238 NINDS_000630 Oc1c(Cl)cc(Cl)c(Cl)c1Cc2c(O)c(Cl)cc(Cl)c2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P13 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1239 NINDS_000631 C1CCN2C[C@H]3C[C@H](CN4CCCC[C@H]34)[C@@H]2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P14 compound treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 1240 NINDS_000632 CCCCOc1ccc(cc1)C(=O)CCN2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P15 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1241 NINDS_000633 NC(=N)NS(=O)(=O)c1ccc(N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P16 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1242 NINDS_000634 CN(CS(=O)(=O)O)c1c(C)n(C)n(c2ccccc2)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P17 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1243 NINDS_000635 OC[C@H]1OC(C[C@H]1O)n2cc(F)c(=O)[nH]c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P18 compound treatment 0.074 -8.73E-5 -0.01 -0.0103 -1.0 1244 NINDS_000636 C[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P19 compound treatment 0.073 -0.00109 -0.13 -0.1288 -1.0 3046112 NINDS_000637 CC1(C)O[C@@H]2CC3C4CCC5=CC(=O)CCC5(C)C4(F)C(O)CC3(C)[C@@]2(O1)C(=O)CCl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P20 compound treatment 0.0745 4.13E-4 0.05 0.0489 1.0 1246 NINDS_000638 CC[N+]1(C)CCCC(C1)OC(=O)C(O)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P21 compound treatment 0.077 0.00291 0.35 0.3451 1.0 1247 NINDS_000639 Oc1c(Cl)cc(Cl)cc1Sc2cc(Cl)cc(Cl)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P22 compound treatment 0.072 -0.00209 -0.25 -0.2473 -1.0 1000060 NINDS_000640 COC(=O)C1[C@@H](O)CC[C@H]2CN3CCc4c([nH]c5ccccc45)[C@@H]3C[C@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P23 mock treatment 0.0705 -0.00359 -0.43 -0.4251 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.501 P24 mock treatment 0.0635 -0.0106 -1.25 -1.2545 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A01 mock treatment 0.095 0.0197 2.33 2.3312 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A02 mock treatment 0.0875 0.0122 1.44 1.4426 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A03 compound treatment 0.0815 0.00617 0.73 0.7316 1.0 1248 NINDS_000641 C[C@@]12CCC3C(CCc4cc(OC(=O)CCC(=O)O)ccc34)C2CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A04 compound treatment 0.0835 0.00817 0.97 0.9686 1.0 1249 NINDS_000642 C[N+](C)(C)CC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A05 compound treatment 0.095 0.0197 2.33 2.3312 1.0 1250 NINDS_000643 COc1cc(C)c2c(=O)cc(oc2c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A06 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1251 NINDS_000644 C[C@@H]1O[C@@H](OC[C@H]2O[C@@H](Oc3c(oc4cc(O)cc(O)c4c3=O)c5ccc(O)c(O)c5)[C@H](O)[C@@H](O)[C@@H]2O)[C@H](O)[C@H](O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A07 compound treatment 0.085 0.00967 1.15 1.1463 1.0 1252 NINDS_000645 CC(C)NCC(O)c1cc(O)cc(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A08 compound treatment 0.0855 0.0102 1.21 1.2056 1.0 1253 NINDS_000646 C[C@H]1OC=C2C(=C(C(=O)O)C(=O)C(=C2[C@@H]1C)C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A09 compound treatment 0.081 0.00567 0.67 0.6724 1.0 1254 NINDS_000647 O[C@H]1Cc2c(O)cc(O)cc2O[C@@H]1c3ccc(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A10 compound treatment 0.0785 0.00317 0.38 0.3762 1.0 1255 NINDS_000648 NC(=O)c1ccc(cc1Cl)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A11 compound treatment 0.081 0.00567 0.67 0.6724 1.0 1256 NINDS_000649 Cc1cc(NS(=O)(=O)c2ccc(N)cc2)no1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A12 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1257 NINDS_000650 CC[N+](CC)(CC)CCOc1cccc(OCC[N+](CC)(CC)CC)c1OCC[N+](CC)(CC)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A13 compound treatment 0.0815 0.00617 0.73 0.7316 1.0 1258 NINDS_000651 CCn1cc(C(=O)O)c(=O)c2cnc(nc12)N3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A14 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1259 NINDS_000652 CCc1nc(N)nc(N)c1c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A15 compound treatment 0.08 0.00467 0.55 0.5539 1.0 1260 NINDS_000653 N[C@@H](Cc1ccc(cc1)N(CCCl)CCCl)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A16 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1261 NINDS_000654 OC1(CCN(CCCC(=O)c2ccc(F)cc2)CC1)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A17 compound treatment 0.079 0.00367 0.44 0.4354 1.0 1262 NINDS_000655 NC[C@H]1CC[C@@H](CC1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A18 compound treatment 0.0845 0.00917 1.09 1.0871 1.0 1263 NINDS_000656 C[C@@H]1CC[C@H]2[C@@H](C)C(=O)O[C@@H]3O[C@@]4(C)CC[C@@H]1[C@@]23OO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A19 compound treatment 0.082 0.00667 0.79 0.7909 1.0 1264 NINDS_000657 OCc1ccccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A20 compound treatment 0.0795 0.00417 0.49 0.4946 1.0 1265 NINDS_000658 Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4c(Cl)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A21 compound treatment 0.0815 0.00617 0.73 0.7316 1.0 1266 NINDS_000659 CCn1cc(C(=O)O)c(=O)c2cc3OCOc3cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A22 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1267 NINDS_000660 CC(=O)Nc1ccc(O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A23 mock treatment 0.086 0.0107 1.26 1.2648 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 A24 mock treatment 0.0775 0.00217 0.26 0.2577 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B01 mock treatment 0.0815 0.00617 0.73 0.7316 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B02 mock treatment 0.0765 0.00117 0.14 0.1392 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B03 compound treatment 0.081 0.00567 0.67 0.6724 1.0 1268 NINDS_000661 CN1C(=C(O)c2ccccc2S1(=O)=O)C(=O)Nc3cc(C)on3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B04 compound treatment 0.0805 0.00517 0.61 0.6131 1.0 1269 NINDS_000662 CC(=O)N[C@@H](CC(=O)O)C(=O)N[C@@H](CCC(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B05 compound treatment 0.079 0.00367 0.44 0.4354 1.0 1270 NINDS_000663 C[N+](C)(C)CCCCCC[N+](C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B06 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1271 NINDS_000664 CC(=O)OC(CC(=O)O)[N+](C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B07 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 1272 NINDS_000665 Clc1ccccc1C(c2ccccc2)(c3ccccc3)n4ccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B08 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1273 NINDS_000666 C[C@@]12CC(=O)C3C(CCC4=CC(=O)C=C[C@]34C)C2CC[C@]1(O)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B09 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 1274 NINDS_000667 C1CN2C[C@@H](N=C2S1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B10 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 1275 NINDS_000668 CC(=O)NCCc1c[nH]c2ccc(O)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B11 compound treatment 0.068 -0.00733 -0.87 -0.868 -1.0 1000129 NINDS_000669 CC1(C)[C@H](CC[C@@]2(C)C1CC[C@]3(C)C2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@]43C)C(=O)O)OC(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B12 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1277 NINDS_000670 C[C@H]1O[C@H](C[C@H](O)[C@@H]1O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](OC(=O)C)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)O[C@H]5CC[C@@]6(C)C(CCC7C6C[C@@H](O)[C@]8(C)[C@H](CC[C@]78O)C9=CC(=O)OC9)C5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B13 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1278 NINDS_000671 COc1ccc(cc1O)c2cc(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@H](C)[C@@H](O)[C@H](O)[C@@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B14 compound treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 1279 NINDS_000672 N[C@@H]([C@@H]1CC(=NO1)Cl)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B15 compound treatment 0.0695 -0.00583 -0.69 -0.6903 -1.0 1280 NINDS_000673 NCCNC(=O)c1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B16 compound treatment 0.0695 -0.00583 -0.69 -0.6903 -1.0 3174477 NINDS_000674 CN[C@H](CC(C)C)C(=O)NC1[C@H](O)c2ccc(Oc3cc4cc(Oc5ccc(cc5Cl)[C@@H](O)[C@@H]6CC(=O)C(NC(=O)[C@@H]4NC(=O)[C@H](CC(=O)N)NC1=O)c7ccc(O)c(c7)-c8c(O)cc(O)cc8[C@@H](NC6=O)C(=O)O)c3O[C@@H]9OC(CO)[C@@H](O)[C@H](O)[C@H]9O[C@H]%10C[C@](C)(N)[C@H](O)[C@H](C)O%10)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B17 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1282 NINDS_000675 NS(=O)(=O)c1cc2c(N=CNS2(=O)=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B18 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 3046211 NINDS_000676 CCC(C)[C@H]1O[C@@]2(C[C@@H]3C[C@@H](C/C=C(\C)/[C@@H](OC4C[C@H](OC)C(O[C@H]5C[C@H](OC)[C@@H](O)[C@H](C)O5)[C@H](C)O4)[C@@H](C)/C=C/C=C/6\CO[C@@H]7[C@H](O)C(=C[C@@H](C(=O)O3)[C@@]76O)C)O2)C=C[C@@H]1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B19 compound treatment 0.0785 0.00317 0.38 0.3762 1.0 1284 NINDS_000677 OC(=O)CN(CC(=O)O)Cc1cc2c(c3ccccc3C(=O)O)c4cc(CN(CC(=O)O)CC(=O)O)c(=O)cc4oc2cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B20 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1285 NINDS_000678 CC[C@@]1(O)C[C@H](OC2CC(C(OC3CC(O)C(OC4CCC(=O)C(C)O4)C(C)O3)C(C)O2)N(C)C)c5c(O)c6C(=O)c7c(O)cccc7C(=O)c6cc5[C@H]1C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B21 compound treatment 0.07 -0.00533 -0.63 -0.631 -1.0 1286 NINDS_000679 Cc1cc(ccc1OCCOCC[N+](C)(C)Cc2ccccc2)C(C)(C)CC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B22 compound treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 1287 NINDS_000680 CC(=O)C1CCC2C3CC=C4CC(CC[C@]4(C)C3CC[C@]12C)OS(=O)(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B23 mock treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 B24 mock treatment 0.072 -0.00333 -0.39 -0.394 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C01 mock treatment 0.083 0.00767 0.91 0.9094 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C02 mock treatment 0.082 0.00667 0.79 0.7909 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C03 compound treatment 0.0835 0.00817 0.97 0.9686 1.0 1288 NINDS_000681 CC[C@@]1(O)C[C@H](O[C@H]2C[C@@H]([C@H](O)[C@H](C)O2)N(C)C)c3c(O)c4C(=O)c5c(O)cccc5C(=O)c4cc3[C@H]1C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C04 compound treatment 0.0865 0.0112 1.32 1.3241 1.0 1289 NINDS_000682 C[C@@]12C[C@H](O)C3C(CCC4=CC(=O)C=C[C@]34C)C2CC[C@]1(O)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C05 compound treatment 0.088 0.0127 1.5 1.5018 1.0 1290 NINDS_000683 OC(=O)c1ccc(cc1)S(=O)(=O)N(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C06 compound treatment 0.0815 0.00617 0.73 0.7316 1.0 1291 NINDS_000684 CCCN(CCC)C(=O)C(CCC(=O)O)NC(=O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C07 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1292 NINDS_000685 O=c1[nH]cnc2[nH]ncc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C08 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1293 NINDS_000686 CC(=O)OCC[N+](C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C09 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1294 NINDS_000687 CCN(CC)Cc1ccc(Nc2ccnc3cc(Cl)ccc23)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C10 compound treatment 0.076 6.75E-4 0.08 0.0799 1.0 1295 NINDS_000688 OC(=O)CCCc1ccc(cc1)N(CCCl)CCCl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C11 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 2550 NINDS_000689 O[C@@H]([C@@H](COC(=O)CCC(=O)O)NC(=O)C(Cl)Cl)c1ccc(cc1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C12 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1000131 NINDS_000690 C1CCN2CC3C[C@@H](CN4CCCC[C@H]34)[C@@H]2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C13 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 3174481 NINDS_000691 CNC[C@@H](O)c1ccc(O)c(O)c1.OC(C(O)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C14 compound treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 1297 NINDS_000692 COc1cc(CC=C)ccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C15 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1298 NINDS_000693 CS(=O)(=O)Nc1ccc(cc1Oc2ccccc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C16 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1299 NINDS_000694 Nc1ccc(cc1)C(=O)NCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C17 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1300 NINDS_000695 OC(=O)c1cccnc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C18 compound treatment 0.0765 0.00117 0.14 0.1392 1.0 1301 NINDS_000696 OCCN(CCO)c1nc(N2CCCCC2)c3nc(nc(N4CCCCC4)c3n1)N(CCO)CCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C19 compound treatment 0.0795 0.00417 0.49 0.4946 1.0 1302 NINDS_000697 CC(C)CC1N2C(=O)[C@](NC(=O)C3CN(C)[C@@H]4Cc5c(Br)[nH]c6cccc(C4=C3)c56)(OC2(O)[C@@H]7CCCN7C1=O)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C20 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1303 NINDS_000698 C[N+]1(CCC2CC1)CC2OC(=O)C(O)(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C21 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1304 NINDS_000699 ClC1=C(Cl)C2(Cl)C3C4CC(C5OC54)C3C1(Cl)C2(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C22 compound treatment 0.076 6.75E-4 0.08 0.0799 1.0 1305 NINDS_000700 CCOC(=O)O[C@H]([C@H]1C[C@@H]2CCN1C[C@@H]2C=C)c3ccnc4ccc(OC)cc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C23 mock treatment 0.0785 0.00317 0.38 0.3762 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 C24 mock treatment 0.079 0.00367 0.44 0.4354 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D01 mock treatment 0.0765 0.00117 0.14 0.1392 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D02 mock treatment 0.079 0.00367 0.44 0.4354 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D03 compound treatment 0.0795 0.00417 0.49 0.4946 1.0 3046265 NINDS_000701 Cl[C@H]1[C@H](Cl)[C@@H](Cl)[C@@H](Cl)[C@H](Cl)[C@H]1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D04 compound treatment 0.083 0.00767 0.91 0.9094 1.0 935 NINDS_000702 CC[C@H]1OC(=O)[C@H](C)[C@@H](O[C@H]2C[C@@](C)(OC)[C@@H](O)[C@H](C)O2)[C@H](C)[C@@H](O[C@@H]3O[C@H](C)C[C@@H]([C@H]3O)N(C)C)[C@](C)(O)C[C@@H](C)C(=O)[C@H](C)[C@@H](O)[C@]1(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D05 compound treatment 0.088 0.0127 1.5 1.5018 1.0 1307 NINDS_000703 ClC(Cl)C(c1ccc(Cl)cc1)c2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D06 compound treatment 0.08 0.00467 0.55 0.5539 1.0 1308 NINDS_000704 CCCSc1ccc2nc(NC(=O)OC)[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D07 compound treatment 0.076 6.75E-4 0.08 0.0799 1.0 3046268 NINDS_000705 Cc1cc(C2CCCCC2)n(O)c(=O)c1.NCCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D08 compound treatment 0.0765 0.00117 0.14 0.1392 1.0 1310 NINDS_000706 NC(=O)c1ccc[n+](c1)[C@@H]2O[C@H](COP(=O)(O)OP(=O)(O)OC[C@H]3O[C@H]([C@H](OP(=O)(O)O)[C@@H]3O)n4cnc5c(N)ncnc45)[C@@H](O)[C@H]2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D09 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1311 NINDS_000707 C[C@@]12CCC3C(CC[C@@H]4C[C@H](O)CC[C@@]43C)C2CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D10 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1312 NINDS_000708 C[As](=O)(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D11 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1313 NINDS_000709 Oc1ccc(Cl)cc1C(=O)Nc2ccc(cc2Cl)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D12 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1314 NINDS_000710 CCOC(=O)[C@H](CCc1ccccc1)N[C@@H](C)C(=O)N2Cc3ccccc3C[C@H]2C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D13 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1315 NINDS_000711 COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D14 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1316 NINDS_000712 CC(C)(C)NCC(O)c1ccccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D15 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 3046321 NINDS_000713 Nc1ncnc2n(cnc12)C3OC(CO)[C@H](O)C3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D16 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1317 NINDS_000714 Fc1ccc(cc1)C(c2ccccc2)(c3ccccc3F)n4ccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D17 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1318 NINDS_000715 CN(C(=O)CN(CCO)CC(=O)N(C)C(C)(C)Cc1ccccc1)C(C)(C)Cc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D18 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1319 NINDS_000716 NCCCCN 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D19 compound treatment 0.0785 0.00317 0.38 0.3762 1.0 445 NINDS_000717 NC(=O)c1cccc(N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D20 compound treatment 0.081 0.00567 0.67 0.6724 1.0 2114344 NINDS_000718 CC1=C(O)C(=O)C=C2C1=CC=C3[C@@]2(C)CC[C@@]4(C)[C@@H]5C[C@@](C)(CC[C@]5(C)CC[C@]34C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D21 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1321 NINDS_000719 Cc1cc(=O)[nH]c(=S)[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D22 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1322 NINDS_000720 COc1cc2ccc(=O)oc2cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D23 mock treatment 0.078 0.00267 0.32 0.3169 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 D24 mock treatment 0.082 0.00667 0.79 0.7909 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E01 mock treatment 0.0785 0.00317 0.38 0.3762 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E02 mock treatment 0.08 0.00467 0.55 0.5539 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E03 compound treatment 0.081 0.00567 0.67 0.6724 1.0 1323 NINDS_000721 CC1COc2c(N3CCN(C)CC3)c(F)cc4c(=O)c(cn1c24)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E04 compound treatment 0.0965 0.0212 2.51 2.509 1.0 1324 NINDS_000722 CCCCC(CC)CNC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NCC(CC)CCCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E05 compound treatment 0.0855 0.0102 1.21 1.2056 1.0 1325 NINDS_000723 NC1(CCCC1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E06 compound treatment 0.08 0.00467 0.55 0.5539 1.0 1000132 NINDS_000724 CC1(C)C2CCC1(C)C(=O)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E07 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1327 NINDS_000725 C[N+](C)(C)CCOC(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E08 compound treatment 0.08 0.00467 0.55 0.5539 1.0 1328 NINDS_000726 OC(CCN1CCCCC1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E09 compound treatment 0.0795 0.00417 0.49 0.4946 1.0 1329 NINDS_000727 NC(Cc1cc(I)c(Oc2ccc(O)c(I)c2)c(I)c1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E10 compound treatment 0.0765 0.00117 0.14 0.1392 1.0 1330 NINDS_000728 ClCCN(CCCl)CCCl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E11 compound treatment 0.0785 0.00317 0.38 0.3762 1.0 1331 NINDS_000729 CC(=O)CCCCn1c(=O)n(C)c2ncn(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E12 compound treatment 0.08 0.00467 0.55 0.5539 1.0 451 NINDS_000730 Cn1cnc2n(C)c(=O)n(C)c(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E13 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1332 NINDS_000731 NS(=O)(=O)c1cc(ccc1Cl)C2(O)NC(=O)c3ccccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E14 compound treatment 0.076 6.75E-4 0.08 0.0799 1.0 1333 NINDS_000732 CCC(C)CCCCC(=O)NC(CCN)C(=O)NC(C(C)O)C(=O)NC(CCN)C(=O)NC1CCNC(=O)C(NC(=O)C(CCN)NC(=O)C(CCN)NC(=O)C(CC(C)C)NC(=O)C(Cc2ccccc2)NC(=O)C(CCN)NC1=O)C(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E15 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1334 NINDS_000733 C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COP(=O)(O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E16 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1335 NINDS_000734 COc1cccc(C(=O)c2ccccc2O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E17 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1336 NINDS_000735 CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)O)c3ccccc3)C(=O)N2[C@H]1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E18 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1337 NINDS_000736 Cc1onc(c1C(=O)N[C@H]2[C@H]3SC(C)(C)[C@@H](N3C2=O)C(=O)O)c4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E19 compound treatment 0.079 0.00367 0.44 0.4354 1.0 1338 NINDS_000737 CCCC(C(=O)OCCN(CC)CC)(c1ccccc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E20 compound treatment 0.0765 0.00117 0.14 0.1392 1.0 1339 NINDS_000738 CCN(CC)CCNC(=O)c1cc(ccc1OC)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E21 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1340 NINDS_000739 CC1=C(N2[C@H](SC1)[C@H](NC(=O)[C@H](N)C3=CCC=CC3)C2=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E22 compound treatment 0.076 6.75E-4 0.08 0.0799 1.0 1341 NINDS_000740 CC(=O)OCC(COC(=O)C)OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E23 mock treatment 0.078 0.00267 0.32 0.3169 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 E24 mock treatment 0.079 0.00367 0.44 0.4354 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F01 mock treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F02 mock treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F03 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1342 NINDS_000741 CN(C)C(=S)SSC(=S)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F04 compound treatment 0.0795 0.00417 0.49 0.4946 1.0 1343 NINDS_000742 COC1=CC(C)[C@@H]2C[C@H]3OC(=O)C[C@H]4C(=C(OC)C(=O)C([C@@]34C)[C@@]2(C)C1=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F05 compound treatment 0.0835 0.00817 0.97 0.9686 1.0 1344 NINDS_000743 CCCC(=O)O[C@@]1(CCC2[C@@H]3CCC4=CC(=O)CC[C@]4(C)C3[C@@H](O)C[C@@]21C)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F06 compound treatment 0.0795 0.00417 0.49 0.4946 1.0 1000133 NINDS_000744 C[C@@]12CCC3C(CCC4=CC(=O)CC[C@]34C)C2CC[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F07 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1346 NINDS_000745 CCN(CC)CCNC(=O)COc1ccc(OC)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F08 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1347 NINDS_000746 CC1=CCCC2(C)CCC3C(OC(=O)C3=C)C12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F09 compound treatment 0.076 6.75E-4 0.08 0.0799 1.0 1348 NINDS_000747 Clc1ccc(OCC(=O)N2CCN(Cc3ccc4OCOc4c3)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F10 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 3046390 NINDS_000748 CCC(=O)O[C@H]1CCC2C3CCC4=CC(=O)CC[C@]4(C)C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F11 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 924 NINDS_000749 NC(=N)NC(=N)Nc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F12 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 3172708 NINDS_000750 CCC(C)C(=O)O[C@H]1[C@H](O)C2C(CN3CC(C)CCC3[C@@]2(C)O)C4C[C@]5(O[C@@]6(O)C7C(OC(=O)C)[C@@H](OC(=O)C)C5[C@@]41O)[C@@]7(C)CCC6OC(=O)C(C)(O)C(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F13 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1350 NINDS_000751 COC(=O)Nc1nc2cc(ccc2[nH]1)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F14 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1351 NINDS_000752 Cc1cc(N)c2ccccc2[n+]1CCCCCCCCCC[n+]3c(C)cc(N)c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F15 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1352 NINDS_000753 COc1cc2CC[C@H](NC(=O)C)c3cc(=O)c(OC)ccc3-c2c(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F16 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1353 NINDS_000754 COC(=O)/C(=C/1\OC(=O)C(C1=O)c2ccccc2)/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F17 compound treatment 0.0765 0.00117 0.14 0.1392 1.0 1354 NINDS_000755 OS(=O)(=O)CCS 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F18 compound treatment 0.0785 0.00317 0.38 0.3762 1.0 1355 NINDS_000756 CC(C)(O)[C@@H]1[C@H]2OC(=O)[C@@H]1[C@]3(O)C[C@H]4O[C@]45C(=O)O[C@H]2[C@@]53C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F19 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1356 NINDS_000757 Oc1cccc2cccnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F20 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1357 NINDS_000758 CCCCN1CCCCC1C(=O)Nc2c(C)cccc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F21 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1358 NINDS_000759 CN(CCCl)CCCl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F22 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1359 NINDS_000760 C[C@H]1C2C(CC3C4CC=C5CC(O)CCC5(C)C4CCC23C)O[C@@]61CCC(C)CN6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F23 mock treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 F24 mock treatment 0.0755 1.75E-4 0.02 0.0207 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G01 mock treatment 0.0765 0.00117 0.14 0.1392 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G02 mock treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G03 compound treatment 0.079 0.00367 0.44 0.4354 1.0 1360 NINDS_000761 Clc1ccc(NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)Nc2ccc(Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G04 compound treatment 0.082 0.00667 0.79 0.7909 1.0 1361 NINDS_000762 Clc1cc(Cl)c(OCC#CI)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G05 compound treatment 0.0805 0.00517 0.61 0.6131 1.0 1362 NINDS_000763 COc1c2occc2cc3ccc(=O)oc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G06 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1363 NINDS_000764 CCOC(=O)CCC(=O)O[C@@H]1[C@H](C[C@@H](C)O[C@H]1O[C@@H]2[C@@H](C)[C@H](O[C@H]3C[C@@](C)(OC)[C@@H](O)[C@H](C)O3)[C@@H](C)C(=O)O[C@H](CC)[C@@](C)(O)[C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@]2(C)O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G07 compound treatment 0.076 6.75E-4 0.08 0.0799 1.0 1364 NINDS_000765 OC(=O)/C(=C/c1cccc(O)c1)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G08 compound treatment 0.0765 0.00117 0.14 0.1392 1.0 1365 NINDS_000766 CN(C)CCC=C1c2ccccc2CCc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G09 compound treatment 0.0765 0.00117 0.14 0.1392 1.0 3172713 NINDS_000767 CO/N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)COC(=O)C)\c3csc(N)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G10 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1367 NINDS_000768 Cc1cc(O)ccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G11 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1368 NINDS_000769 CCC(C)C(N)C1=NC(CS1)C(=O)NC(CC(C)C)C(=O)NC(CCC(=O)O)C(=O)NC(C(C)CC)C(=O)NCCCCC2NC(=O)C(CC(=O)N)NC(=O)C(CC(=O)O)NC(=O)C(Cc3c[nH]cn3)NC(=O)C(Cc4ccccc4)NC(=O)C(NC(=O)C(CCCN)NC2=O)C(C)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G12 compound treatment 0.0765 0.00117 0.14 0.1392 1.0 3172714 NINDS_000770 C[n+]1ccccc1/C=N/O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G13 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1370 NINDS_000771 C/C=C(/C(=C/C)/c1ccc(O)cc1)\c2ccc(O)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G14 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1371 NINDS_000772 CN(C)c1nc(nc(n1)N(C)C)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G15 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1372 NINDS_000773 OC(=O)c1cccnc1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G16 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 448 NINDS_000774 Clc1cccc(Cl)c1N=C2NCCN2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G17 compound treatment 0.0795 0.00417 0.49 0.4946 1.0 1373 NINDS_000775 CC(C)(C)CC(C)(C)c1ccc(OCCOCC[N+](C)(C)Cc2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G18 compound treatment 0.0785 0.00317 0.38 0.3762 1.0 1374 NINDS_000776 Oc1c(Br)cc(Br)c2cccnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G19 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1001324 NINDS_000777 OC(=O)CN(CCN(CC(=O)O)CC(=O)O)CC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G20 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 3172716 NINDS_000778 NC(=O)N/N=C/c1ccc(o1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G21 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1377 NINDS_000779 CC1(C)S[C@@H]2[C@H](NC(=O)COc3ccccc3)C(=O)N2[C@H]1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G22 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1378 NINDS_000780 NCCc1ccc(O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G23 mock treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 G24 mock treatment 0.072 -0.00333 -0.39 -0.394 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H01 mock treatment 0.076 6.75E-4 0.08 0.0799 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H02 mock treatment 0.076 6.75E-4 0.08 0.0799 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H03 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1000134 NINDS_000781 Nc1ccn(C2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H04 compound treatment 0.0815 0.00617 0.73 0.7316 1.0 1380 NINDS_000782 NC(=O)c1ncn(n1)[C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H05 compound treatment 0.082 0.00667 0.79 0.7909 1.0 1381 NINDS_000783 Nc1ccc(cc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H06 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1382 NINDS_000784 OCCS 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H07 compound treatment 0.079 0.00367 0.44 0.4354 1.0 1383 NINDS_000785 CC[C@H]([C@H]1CC[C@H](C)[C@@H](O1)[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@H]2OC3(O[C@@]4(CC[C@](C)(O4)[C@H]5CC[C@](O)(CC)[C@H](C)O5)[C@H](O)C=C3)[C@H](C)C[C@@H]2C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H08 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 3045655 NINDS_000786 CC(=O)[C@@]1(O)CCC2C3C=C(Cl)C4=CC(=O)[C@@H]5CC5[C@]4(C)C3CC[C@@]21C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H09 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1384 NINDS_000787 COC(=O)[C@@H](N1CCc2sccc2C1)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H10 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1385 NINDS_000788 C(/C=C/N1CCN(CC1)C(c2ccccc2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H11 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1386 NINDS_000789 CN1CC(c2ccccc2)c3cccc(N)c3C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H12 compound treatment 0.0785 0.00317 0.38 0.3762 1.0 1387 NINDS_000790 OC(C1CCCCN1)c2cc(nc3c(cccc23)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H13 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1388 NINDS_000791 Cc1cc(Nc2ccccc2C(=O)O)ccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H14 compound treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 1389 NINDS_000792 CCOC(=O)N1CCC(=C2c3ccc(Cl)cc3CCc4cccnc24)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H15 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 3045662 NINDS_000793 CC(N)C(O)c1cccc(O)c1.OC(C(O)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H16 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1390 NINDS_000794 CC(C)(C)NCC(O)c1cc(Cl)c(N)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H17 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1391 NINDS_000795 CC(N)C(O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H18 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 3172720 NINDS_000796 CNC(C)[C@@H]1CC[C@@H](N)[C@@H](OC2[C@@H](N)C[C@@H](N)[C@H](OC3OC[C@](C)(O)[C@H](NC)[C@H]3O)[C@H]2O)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H19 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1393 NINDS_000797 CN(C)CCCN1c2ccccc2CCc3ccc(Cl)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H20 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 360 NINDS_000798 Oc1ccc(cc1)c2cc(=O)c3c(O)cc(O)cc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H21 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1394 NINDS_000799 BrCCC(=O)N1CCN(CC1)C(=O)CCBr 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H22 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1395 NINDS_000800 CC(COc1ccccc1)N(CCCl)Cc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H23 mock treatment 0.074 -0.00133 -0.16 -0.157 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 H24 mock treatment 0.072 -0.00333 -0.39 -0.394 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I01 mock treatment 0.078 0.00267 0.32 0.3169 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I02 mock treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I03 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1396 NINDS_000801 Cc1cc(O)cc(C)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I04 compound treatment 0.0785 0.00317 0.38 0.3762 1.0 1397 NINDS_000802 CC(C)[N+](C)(CCOC(=O)C1c2ccccc2Oc3ccccc13)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I05 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1398 NINDS_000803 CC(C)CCCC(C)CCCC(C)CCCC1(C)CCc2c(C)c(OC(=O)C)c(C)c(C)c2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I06 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1000135 NINDS_000804 CC(C(=O)O)c1ccc(c(F)c1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I07 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1400 NINDS_000805 CC(C)[C@@H](C)/C=C/[C@@H](C)C1CC[C@H]2\C(=C\C=C/3\C[C@@H](O)CCC3=C)\CCC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I08 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 2551 NINDS_000806 COc1cc(NC(C)CCCN)c2ncccc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I09 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 3046406 NINDS_000807 Cc1ccc(cc1)N(CC2=NCCN2)c3cccc(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I10 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1401 NINDS_000808 CN(C)CCCN1c2ccccc2Sc3ccc(cc13)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I11 compound treatment 0.07 -0.00533 -0.63 -0.631 -1.0 1402 NINDS_000809 CC[N+](C)(C)c1cccc(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I12 compound treatment 0.067 -0.00833 -0.99 -0.9865 -1.0 1403 NINDS_000810 COC(=O)C1=CCCN(C)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I13 compound treatment 0.0605 -0.0148 -1.76 -1.7567 -1.0 1404 NINDS_000811 Nc1ccc(N=Nc2ccccc2)c(N)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I14 compound treatment 0.068 -0.00733 -0.87 -0.868 -1.0 1000136 NINDS_000812 CC12CCC3C(=CCc4cc(O)ccc34)C2CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I15 compound treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 1406 NINDS_000813 NC(=O)c1cc(cc(c1)[N+](=O)[O-])[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I16 compound treatment 0.0695 -0.00583 -0.69 -0.6903 -1.0 1407 NINDS_000814 NC(COCc1ccccc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I17 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1408 NINDS_000815 NC1(CC2CC3CC(C2)C1)C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I18 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1409 NINDS_000816 CCCC(C)(COC(=O)N)COC(=O)NC(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I19 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1410 NINDS_000817 S=P(N1CC1)(N2CC2)N3CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I20 compound treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 1411 NINDS_000818 COc1ccc(cc1)/C(=C(\c2ccc(OC)cc2)/c3cccc(OC)c3)/Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I21 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1412 NINDS_000819 CN(C)CCOC(c1ccc(Cl)cc1)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I22 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 1413 NINDS_000820 CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I23 mock treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 I24 mock treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J01 mock treatment 0.074 -0.00133 -0.16 -0.157 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J02 mock treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J03 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1414 NINDS_000821 CC(=O)NO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J04 compound treatment 0.079 0.00367 0.44 0.4354 1.0 142 NINDS_000822 CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J05 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1415 NINDS_000823 FC(F)(F)c1cccc(c1)N2CCNCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J06 compound treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 1416 NINDS_000824 Cn1c(=O)n(C)c2[nH]c(nc2c1=O)C3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J07 compound treatment 0.0765 0.00117 0.14 0.1392 1.0 1417 NINDS_000825 CCCCCCCCCCCCC[N+](C)(C)Cc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J08 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 383 NINDS_000826 CC[C@@]1(O)C(=O)OCc2c1cc3-c4nc5ccccc5cc4Cn3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J09 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 1418 NINDS_000827 CN(C)[C@H]1[C@@H]2C[C@H]3C(=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N)C(=O)c4c(O)cccc4[C@@]3(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J10 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 1419 NINDS_000828 NCCSSCCN 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J11 compound treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 1420 NINDS_000829 COc1ccc2[C@@H](OC(=O)c2c1OC)[C@H]3N(C)CCc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J12 compound treatment 0.069 -0.00633 -0.75 -0.7495 -1.0 1421 NINDS_000830 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J13 compound treatment 0.068 -0.00733 -0.87 -0.868 -1.0 1422 NINDS_000831 CC1(C)O[C@@H]2C[C@H]3C4C[C@H](F)C5=CC(=O)C=CC5(C)[C@@]4(F)[C@@H](O)C[C@]3(C)[C@@]2(O1)C(=O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J14 compound treatment 0.068 -0.00733 -0.87 -0.868 -1.0 3172845 NINDS_000832 CCC(C)C(=O)O[C@H]1[C@H](O)C2C(CN3CC(C)CCC3[C@@]2(C)O)C4C[C@]5(O[C@@]6(O)C7C(OC(=O)C)[C@@H](OC(=O)C)C5[C@@]41O)[C@@]7(C)CCC6OC(=O)C(C)(O)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J15 compound treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 1424 NINDS_000833 CCCC(=O)Nc1ncnc2n(cnc12)C3O[C@@H]4COP(=O)(O)O[C@H]4[C@H]3OC(=O)CCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J16 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1425 NINDS_000834 CC(N)COc1c(C)cccc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J17 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1426 NINDS_000835 ClCCNC(=O)N(CCCl)N=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J18 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 3172846 NINDS_000836 NC(CO)(CO)CO.OC(=O)C1CCn2c(ccc12)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J19 compound treatment 0.07 -0.00533 -0.63 -0.631 -1.0 1428 NINDS_000837 CC(C)NCC(O)COc1cccc2[nH]ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J20 compound treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 1429 NINDS_000838 CCCCOC(=O)c1ccc(N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J21 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1430 NINDS_000839 CCC(=O)OCC(=O)C1(OC(=O)CC)C(C)CC2C3CCC4=CC(=O)C=CC4(C)C3(Cl)C(O)CC21C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J22 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 1431 NINDS_000840 Clc1ccc(cc1)C(OCCN2CCCCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J23 mock treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 J24 mock treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K01 mock treatment 0.074 -0.00133 -0.16 -0.157 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K02 mock treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K03 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1432 NINDS_000841 CN(C)CCOC(C)(c1ccccc1)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K04 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1433 NINDS_000842 CS(=O)(=O)c1ccc(cc1)[C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K05 compound treatment 0.077 0.00167 0.2 0.1984 1.0 437 NINDS_000843 CN1CCN(CCCN2c3ccccc3Sc4ccc(cc24)C(F)(F)F)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K06 compound treatment 0.07 -0.00533 -0.63 -0.631 -1.0 1434 NINDS_000844 CN1CCN2C(C1)c3ccccc3Cc4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K07 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1435 NINDS_000845 CN1[C@@H]2CC(O)C1CC(C2)OC(=O)[C@H](CO)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K08 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1436 NINDS_000846 CCCNC(C)C(=O)Nc1ccccc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K09 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1437 NINDS_000847 CS(=O)(=O)OCCCCOS(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K10 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1438 NINDS_000848 CC(C(=O)O)c1cccc(Oc2ccccc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K11 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 1439 NINDS_000849 CSCCC(N)C(=O)NC(CC(C)C)C(=O)NC(Cc1ccccc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K12 compound treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 1440 NINDS_000850 COc1ccc2cc(CCC(=O)C)ccc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K13 compound treatment 0.07 -0.00533 -0.63 -0.631 -1.0 1441 NINDS_000851 CN1CCC(CC1)OC(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K14 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1442 NINDS_000852 CC(=O)NC1SCCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K15 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1443 NINDS_000853 CN(C)CCOC(c1ccccc1)c2ccccc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K16 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1444 NINDS_000854 C1CN=C(N1)C2CCCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K17 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 336 NINDS_000855 COc1ccc(C[C@H]2NC[C@H](O)[C@H]2OC(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K18 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1445 NINDS_000856 C/C=C(/C)\C(=O)O[C@H]1CC[C@@]2(C)[C@@H]3CC[C@@H]4[C@@]2(C[C@@]5(O)[C@@H]6CN7C[C@@H](C)CC[C@H]7[C@@](C)(O)[C@@]6(O)[C@@H](O)C[C@@]45O)O[C@@]31O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K19 compound treatment 0.07 -0.00533 -0.63 -0.631 -1.0 1446 NINDS_000857 OC(COc1cccc2oc(cc(=O)c12)C(=O)O)COc3cccc4oc(cc(=O)c34)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K20 compound treatment 0.0695 -0.00583 -0.69 -0.6903 -1.0 1447 NINDS_000858 NC(=O)c1ccccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K21 compound treatment 0.069 -0.00633 -0.75 -0.7495 -1.0 3172849 NINDS_000859 CN1CCC[C@H]1c2cccnc2.OC(C(O)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K22 compound treatment 0.0685 -0.00683 -0.81 -0.8087 -1.0 1448 NINDS_000860 OC(=O)c1cc(N=Nc2ccc(cc2)S(=O)(=O)Nc3ccccn3)ccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K23 mock treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 K24 mock treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L01 mock treatment 0.074 -0.00133 -0.16 -0.157 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L02 mock treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L03 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1449 NINDS_000861 CN1[C@@H](CCC1=O)c2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L04 compound treatment 0.079 0.00367 0.44 0.4354 1.0 1450 NINDS_000862 NCCc1c[nH]c2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L05 compound treatment 0.079 0.00367 0.44 0.4354 1.0 1451 NINDS_000863 CN(C)[C@H]1[C@@H]2C[C@@H]3[C@H](O)c4c(Cl)ccc(O)c4C(=O)C3=C(O)[C@]2(O)C(=O)C(=C1O)C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L06 compound treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 1452 NINDS_000864 CCCCN(CCCC)CCCOC(=O)c1ccc(N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L07 compound treatment 0.077 0.00167 0.2 0.1984 1.0 3172851 NINDS_000865 C[C@@H]1CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]2(C)[C@@]1(O)C(=O)COC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L08 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1453 NINDS_000866 CN1CCCN=C1/C=C/c2sccc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L09 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1454 NINDS_000867 C[C@H]1O[C@H](C[C@H](O)[C@@H]1O)O[C@@H]2[C@@H](C)O[C@H](C[C@@H]2O)O[C@@H]3[C@@H](C)O[C@H](C[C@@H]3O)O[C@H]4CC[C@@]5(C)[C@H](CCC6C5C[C@@H](O)[C@]7(C)[C@H](CC[C@]67O)C8=CC(=O)OC8)C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L10 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1455 NINDS_000868 CC(=O)OCC(=O)[C@@]1(O)CCC2C3CCC4=CC(=O)C=CC4(C)C3[C@@H](O)C[C@@]21C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L11 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1456 NINDS_000869 CC(C)[C@@H](C)/C=C/[C@@H](C)C1CC[C@H]2\C(=C\C=C\3/C[C@@H](O)CC[C@@H]3C)\CCC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L12 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1457 NINDS_000870 CC(=O)OCC(=O)[C@]12OC3(CCCC3)O[C@@H]2CC4C5CCC6=CC(=O)C=C[C@]6(C)[C@@]5(F)[C@@H](O)C[C@@]41C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L13 compound treatment 0.082 0.00667 0.79 0.7909 1.0 3172968 NINDS_000871 CCC1NC(=O)C(C(O)C(C)C/C=C/C)N(C)C(=O)C(C(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(CC(C)C)N(C)C(=O)C(C)NC(=O)C(C)NC(=O)C(CC(C)C)N(C)C(=O)C(NC(=O)C(CC(C)C)N(C)C(=O)CN(C)C1=O)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L14 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 3045683 NINDS_000872 C[N+]1(CCCCC[N+]2(C)CCCC2)CCCC1.OC(C(O)C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L15 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1458 NINDS_000873 NC(Cc1ccc(Cl)cc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L16 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1459 NINDS_000874 OC1CCN(CCCN2c3ccccc3Sc4ccc(C#N)cc24)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L17 compound treatment 0.0785 0.00317 0.38 0.3762 1.0 3172969 NINDS_000875 CC(CNC(=O)CCC/1(C)C(CC(=O)N)C2N([Co]C[C@H]3OC([C@H](O)[C@@H]3O)n4cnc5c(N)ncnc45)\C1=C(\C)/C/6=N/C(=C\C\7=N/C(=C(/C)\C8=NC2(C)C(C)(CC(=O)N)C8CCC(=O)N)/C(C)(CC(=O)N)C7CCC(=O)N)/C(C)(C)C6CCC(=O)C)OP(=O)(O)O[C@H]9[C@@H](O)C(O[C@@H]9CO)n%10cnc%11cc(C)c(C)cc%10%11 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L18 compound treatment 0.0765 0.00117 0.14 0.1392 1.0 1461 NINDS_000876 CN1CCCN=C1COC(=O)C(O)(C2CCCCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L19 compound treatment 0.0705 -0.00483 -0.57 -0.5718 -1.0 1462 NINDS_000877 CC1C(CCC(C)(C)N1C)OC(=O)C(O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L20 compound treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 1463 NINDS_000878 COc1ccc(cc1)c2cc(=O)c3c(O)cc(O)cc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L21 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 1464 NINDS_000879 CC(=O)OCC(=O)[C@@]1(O)CC[C@H]2C3CCC4=CC(=O)CCC4(C)[C@@]3(F)[C@@H](O)CC21C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L22 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1465 NINDS_000880 OCCN1CCN(CCCN2c3ccccc3Sc4ccc(Cl)cc24)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L23 mock treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 L24 mock treatment 0.077 0.00167 0.2 0.1984 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M01 mock treatment 0.074 -0.00133 -0.16 -0.157 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M02 mock treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M03 compound treatment 0.076 6.75E-4 0.08 0.0799 1.0 1466 NINDS_000881 NCCCCC(N)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CCCCN)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M04 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1467 NINDS_000882 CCCCOc1ccc(OCCCN2CCOCC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M05 compound treatment 0.088 0.0127 1.5 1.5018 1.0 1468 NINDS_000883 CCCCC(=O)O[C@H]1CCC2C3CCc4cc(O)ccc4C3CC[C@]12C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M06 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1469 NINDS_000884 CCC1(CCC(=O)NC1=O)c2ccc(N)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M07 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1470 NINDS_000885 N[C@@H](Cc1ccc(O)cc1)C(=O)N[C@H](CCCNC(=N)N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M08 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1471 NINDS_000886 CN1C(c2ccc(Cl)cc2)S(=O)(=O)CCC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M09 compound treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 1000138 NINDS_000887 CC(C)Cc1ccc(cc1)C(C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M10 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1473 NINDS_000888 CC1(C)[C@@H](O)CC[C@@]2(C)C1CC[C@]3(C)C2C(=O)C=C4[C@@H]5C[C@](C)(CC[C@]5(C)CC[C@]43C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M11 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 3172973 NINDS_000889 COC(=O)[C@@]1(O)OC[C@]2(C3[C@H]4OC[C@@]3([C@@H](C[C@@H]2OC(=O)/C(=C/C)/C)OC(=O)C)C(=O)OC)[C@@H]1[C@@](C)([C@@H]4O)C56O[C@@]6(C)[C@H]7C[C@@H]5OC8OC=C[C@]78O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M12 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1475 NINDS_000890 Cl[Pt]Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M13 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1476 NINDS_000891 CNCCCC1(CCC2c3ccccc31)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M14 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 1477 NINDS_000892 O=C1O[Pt]OC(=O)C21CCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M15 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1478 NINDS_000893 Cc1ccc(cc1)c2cc(nn2c3ccc(cc3)S(=O)(=O)N)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M16 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1479 NINDS_000894 CC(C)NCC(O)c1ccc(O)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M17 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1480 NINDS_000895 Clc1ccc2oc(=O)[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M18 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1481 NINDS_000896 Oc1c(Cc2c(O)c3ccccc3oc2=O)c(=O)oc4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M19 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1482 NINDS_000897 CN1CCc2cc3OCOc3cc2C1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M20 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 3000787 NINDS_000898 [O-][N+](=O)c1ccc(cc1)c2ccc(/C=N/N3CC(=O)NC3=O)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M21 compound treatment 0.07 -0.00533 -0.63 -0.631 -1.0 1484 NINDS_000899 CCC(C)C(N)C(=O)N1CCCC1C(=O)NC(C(C)CC)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M22 compound treatment 0.07 -0.00533 -0.63 -0.631 -1.0 1485 NINDS_000900 CCC(=C)C(=O)c1ccc(OCC(=O)O)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M23 mock treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 M24 mock treatment 0.074 -0.00133 -0.16 -0.157 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N01 mock treatment 0.076 6.75E-4 0.08 0.0799 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N02 mock treatment 0.076 6.75E-4 0.08 0.0799 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N03 compound treatment 0.079 0.00367 0.44 0.4354 1.0 1486 NINDS_000901 CC(C)NCC(O)COc1ccc(NC(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N04 compound treatment 0.0805 0.00517 0.61 0.6131 1.0 1487 NINDS_000902 CCC(Cc1c(I)cc(I)c(N)c1I)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N05 compound treatment 0.079 0.00367 0.44 0.4354 1.0 104 NINDS_000903 C/C(=C\C=C\C(=C\C(=O)O)\C)/C=C/C1=C(C)CCCC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N06 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1488 NINDS_000904 NS(=O)(=O)c1cc2c(NC(NS2(=O)=O)C3CC4CC3C=C4)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N07 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 3172974 NINDS_000905 C[C@@H]1O[C@@H](O[C@H]2C[C@@H](O)[C@]3(CO)C4[C@H](O)C[C@]5(C)[C@H](CC[C@]5(O)C4CC[C@]3(O)C2)C6=CC(=O)OC6)[C@H](O)[C@H](O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N08 compound treatment 0.076 6.75E-4 0.08 0.0799 1.0 1489 NINDS_000906 CCCNCC(O)COc1ccccc1C(=O)CCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N09 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1490 NINDS_000907 NCC1OC(OC2C(N)CC(N)C(OC3OC(CO)C(O)C(N)C3O)C2O)C(N)C(O)C1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N10 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 3045773 NINDS_000908 CCC(=O)O[C@@H](OP(=O)(CCCCc1ccccc1)CC(=O)N2C[C@@H](C[C@H]2C(=O)O)C3CCCCC3)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N11 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1000139 NINDS_000909 CO[C@]1(NC(=O)C(C(=O)O)c2ccc(O)cc2)[C@H]3OCC(=C(N3C1=O)C(=O)O)CSc4nnnn4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N12 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1493 NINDS_000910 CCC(=O)O[C@@]1([C@@H](C)CC2C3CCC4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@@]21C)C(=O)CCl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N13 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1494 NINDS_000911 C1CN(CCN1)c2ccc3ccccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N14 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1495 NINDS_000912 OC(=O)CCCCC1CCSS1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N15 compound treatment 0.0785 0.00317 0.38 0.3762 1.0 1496 NINDS_000913 CSc1ccc2Sc3ccccc3CC(N4CCN(C)CC4)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N16 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1497 NINDS_000914 NC[C@H]1O[C@H](O[C@@H]2[C@@H](N)C[C@@H](N)[C@H](O)C2O[C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)[C@H](N)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N17 compound treatment 0.0795 0.00417 0.49 0.4946 1.0 1498 NINDS_000915 OC(=O)P(=O)(O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N18 compound treatment 0.0775 0.00217 0.26 0.2577 1.0 1499 NINDS_000916 Cc1oncc1C(=O)Nc2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N19 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1500 NINDS_000917 C[C@@H]1OC(Oc2c(oc3cc(O)cc(O)c3c2=O)c4ccc(O)c(O)c4)[C@H](O)[C@H](O)[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N20 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1501 NINDS_000918 NCCc1ccc(O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N21 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1502 NINDS_000919 OC(=O)c1c2ccccc2cc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N22 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1503 NINDS_000920 Cc1c(CS(=O)c2nc3ccccc3[nH]2)nccc1OCC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N23 mock treatment 0.0765 0.00117 0.14 0.1392 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 N24 mock treatment 0.0755 1.75E-4 0.02 0.0207 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O01 mock treatment 0.072 -0.00333 -0.39 -0.394 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O02 mock treatment 0.069 -0.00633 -0.75 -0.7495 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O03 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1504 NINDS_000921 O=C1CC2(CCCC2)CC(=O)N1CCCCN3CCN(CC3)c4ncccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O04 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1505 NINDS_000922 CC(C)Cn1c(=O)n(C)c(=O)c2[nH]cnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O05 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1506 NINDS_000923 OCc1cc(=O)c(O)co1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O06 compound treatment 0.0715 -0.00383 -0.45 -0.4533 -1.0 1507 NINDS_000924 CC(N)CCCC(C)(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O07 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1508 NINDS_000925 CSCCC(NC=O)C(=O)NC(C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O08 compound treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 142 NINDS_000926 CCOC(=O)C(C)(C)Oc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O09 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1509 NINDS_000927 Cn1c(COC(=O)N)ncc1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O10 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1510 NINDS_000928 CN(C)CCN(Cc1cccs1)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O11 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1511 NINDS_000929 Oc1ccc(cc1)C2(OC(=O)c3ccccc32)c4ccc(O)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O12 compound treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 1512 NINDS_000930 CC(C)NCC(O)c1ccc2ccccc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O13 compound treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 2431 NINDS_000931 CCN(CC)CCNC(=O)c1ccc(N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O14 compound treatment 0.07 -0.00533 -0.63 -0.631 -1.0 1513 NINDS_000932 CCOC(=O)c1ccc(N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O15 compound treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 1514 NINDS_000933 CC1OC1P(=O)(O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O16 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 3173095 NINDS_000934 CC(Oc1ccccc1)C(=O)NC2[C@H]3SC(C)(C)C(N3C2=O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O17 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1515 NINDS_000935 CC[C@@H]1[C@@H](Cc2cccn2C)COC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O18 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1516 NINDS_000936 Nc1c2CCCCc2nc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O19 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1517 NINDS_000937 CCC1(NC(=O)N(C)C1=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O20 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1518 NINDS_000938 OC(=O)c1cc(ccc1O)c2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O21 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1519 NINDS_000939 CC1(C)OC(=O)NC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O22 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1520 NINDS_000940 CC[n+]1c(c2ccccc2)c3cc(N)ccc3c4ccc(N)cc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O23 mock treatment 0.077 0.00167 0.2 0.1984 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 O24 mock treatment 0.0775 0.00217 0.26 0.2577 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P01 mock treatment 0.063 -0.0123 -1.46 -1.4604 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P02 mock treatment 0.071 -0.00433 -0.51 -0.5125 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P03 compound treatment 0.072 -0.00333 -0.39 -0.394 -1.0 1000140 NINDS_000941 CC[C@@H]1OC(OC(C(NC(=O)c2nc(nc(N)c2C)C(CC(=O)N)NCC(N)C(=O)N)C(=O)NC(C)C(O)C(C)C(=O)NC(C(C)O)C(=O)NCCc3nc(cs3)c4nc(cs4)C(=O)NCCCCNC(=N)N)c5c[nH]cn5)[C@@H](O[C@H]6O[C@H](CO)[C@@H](O)[C@H](OC(=O)N)[C@@H]6O)[C@@H](C)[C@@H]1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P04 compound treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 1522 NINDS_000942 CCN(CCO)CCCC(C)Nc1ccnc2cc(Cl)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P05 compound treatment 0.0695 -0.00583 -0.69 -0.6903 -1.0 1523 NINDS_000943 CC(C)(C)NCC(O)c1ccc(O)c(CO)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P06 compound treatment 0.0695 -0.00583 -0.69 -0.6903 -1.0 1524 NINDS_000944 CC(C)Nc1c(C)n(C)n(c2ccccc2)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P07 compound treatment 0.078 0.00267 0.32 0.3169 1.0 1525 NINDS_000945 CC(CNC(=O)c1ccccc1)C(=O)OCC(=O)[C@]23OC(C)(C)O[C@@H]3CC4C5CCC6=CC(=O)C=C[C@]6(C)[C@@]5(F)[C@@H](O)C[C@@]42C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P08 compound treatment 0.074 -0.00133 -0.16 -0.157 -1.0 1526 NINDS_000946 CC1CCCC(C)N1NC(=O)c2ccc(Cl)c(c2)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P09 compound treatment 0.079 0.00367 0.44 0.4354 1.0 1527 NINDS_000947 COc1cc2OC[C@H]3Oc4c5C[C@@H](Oc5ccc4C(=O)[C@H]3c2cc1OC)C(=C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P10 compound treatment 0.0725 -0.00283 -0.33 -0.3348 -1.0 1528 NINDS_000948 NC(=O)c1ncn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P11 compound treatment 0.0745 -8.25E-4 -0.1 -0.0978 -1.0 1529 NINDS_000949 COc1cc(NS(=O)(=O)c2ccc(N)cc2)ncn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P12 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1530 NINDS_000950 COc1ccc2c3CCN=C(C)c3[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P13 compound treatment 0.079 0.00367 0.44 0.4354 1.0 1531 NINDS_000951 O=c1n([se]c2ccccc12)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P14 compound treatment 0.0735 -0.00183 -0.22 -0.2163 -1.0 1532 NINDS_000952 OC[C@H]1O[C@H](Oc2cc3ccc(=O)oc3cc2O)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P15 compound treatment 0.076 6.75E-4 0.08 0.0799 1.0 1533 NINDS_000953 Cc1cc(CC(=O)O)n(C)c1C(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P16 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1534 NINDS_000954 O=C(/C=C/C=C/c1ccc2OCOc2c1)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P17 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1535 NINDS_000955 COc1ccc(OC)c(c1)C(O)CNC(=O)CN 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P18 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1000141 NINDS_000956 OC[C@H]1O[C@@H](Oc2cc3ccc(=O)oc3cc2O)[C@H](O)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P19 compound treatment 0.0755 1.75E-4 0.02 0.0207 1.0 1537 NINDS_000957 NC(Cc1ccc(F)cc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P20 compound treatment 0.077 0.00167 0.2 0.1984 1.0 1538 NINDS_000958 Oc1ccc(c(O)c1)c2oc3cc(O)cc(O)c3c(=O)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P21 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1539 NINDS_000959 C[C@H]1C(=O)O[C@@H]2CCN3CC=C(COC(=O)[C@](C)(O)[C@]1(C)O)[C@H]23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P22 compound treatment 0.075 -3.25E-4 -0.04 -0.0386 -1.0 1000142 NINDS_000960 CC1(C)[C@@H](O)CC[C@@]2(C)C1CC[C@]3(C)C2C(=O)C=C4[C@H]5C[C@](C)(CC[C@]5(C)CC[C@]43C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P23 mock treatment 0.0755 1.75E-4 0.02 0.0207 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.502 P24 mock treatment 0.073 -0.00233 -0.28 -0.2755 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A01 mock treatment 0.093 0.0173 2.04 2.0441 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A02 mock treatment 0.0825 0.00675 0.8 0.7999 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A03 compound treatment 0.081 0.00525 0.62 0.6222 1.0 1541 NINDS_000961 CC(C)C(NC(=O)OCc1ccccc1)C(=O)NC(C)C(=O)NC(CC(=O)O)C(=O)OC(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A04 mock treatment 0.085 0.00925 1.1 1.0961 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A05 compound treatment 0.091 0.0153 1.81 1.8071 1.0 1542 NINDS_000962 CNC(C)Cc1ccc2OCOc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A06 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A07 compound treatment 0.0835 0.00775 0.92 0.9184 1.0 1543 NINDS_000963 CCC(=O)C(CC(C)N(C)C)(c1ccccc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A08 mock treatment 0.0835 0.00775 0.92 0.9184 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A09 compound treatment 0.081 0.00525 0.62 0.6222 1.0 1544 NINDS_000964 CC(N)Cc1ccc2OCOc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A10 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A11 compound treatment 0.0785 0.00275 0.33 0.3259 1.0 1545 NINDS_000965 OC1N=C(c2ccccc2Cl)c3cc(Cl)ccc3NC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A12 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A13 compound treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 1546 NINDS_000966 CNC(C)C(=O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A14 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A15 compound treatment 0.076 2.51E-4 0.03 0.0297 1.0 1547 NINDS_000967 CN1C(=O)CN=C(c2ccccc2)c3cc(Cl)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A16 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A17 compound treatment 0.071 -0.00475 -0.56 -0.5627 -1.0 1548 NINDS_000968 CN1C2CCC1C(C(C2)OC(=O)c3ccccc3)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A18 mock treatment 0.0815 0.00575 0.68 0.6814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A19 compound treatment 0.086 0.0103 1.21 1.2146 1.0 3173101 NINDS_000969 CO[C@@]1(CC[C@]23C[C@@H]1C(C)(O)C(C)(C)C)[C@@H]4Oc5c6c(C[C@H]3N(CC7CC7)CC[C@@]462)ccc5O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A20 mock treatment 0.083 0.00725 0.86 0.8592 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A21 compound treatment 0.078 0.00225 0.27 0.2667 1.0 1550 NINDS_000970 CC(C)CC1(CC=C)C(=O)NC(=O)NC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A22 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A23 mock treatment 0.086 0.0103 1.21 1.2146 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 A24 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B01 mock treatment 0.083 0.00725 0.86 0.8592 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B02 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B03 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B04 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B05 mock treatment 0.082 0.00625 0.74 0.7407 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B06 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B07 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B08 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B09 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B10 mock treatment 0.0685 -0.00725 -0.86 -0.859 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B11 mock treatment 0.0675 -0.00825 -0.98 -0.9774 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B12 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B13 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B14 mock treatment 0.0705 -0.00525 -0.62 -0.622 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B15 mock treatment 0.068 -0.00775 -0.92 -0.9182 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B16 mock treatment 0.067 -0.00875 -1.04 -1.0367 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B17 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B18 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B19 mock treatment 0.0805 0.00475 0.56 0.5629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B20 mock treatment 0.071 -0.00475 -0.56 -0.5627 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B21 mock treatment 0.0665 -0.00925 -1.1 -1.0959 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B22 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B23 mock treatment 0.07 -0.00575 -0.68 -0.6812 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 B24 mock treatment 0.0685 -0.00725 -0.86 -0.859 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C01 mock treatment 0.082 0.00625 0.74 0.7407 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C02 mock treatment 0.083 0.00725 0.86 0.8592 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C03 compound treatment 0.084 0.00825 0.98 0.9776 1.0 1551 NINDS_000971 CCCCCc1cc(O)c(C2CC(=CCC2C(=C)C)C)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C04 mock treatment 0.0865 0.0108 1.27 1.2739 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C05 compound treatment 0.093 0.0173 2.04 2.0441 1.0 1552 NINDS_000972 CCCCCc1cc(O)c-2c(OC(C)(C)c3ccc(C)cc32)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C06 mock treatment 0.084 0.00825 0.98 0.9776 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C07 compound treatment 0.077 0.00125 0.15 0.1482 1.0 1553 NINDS_000973 [O-][N+](=O)c1ccc2NC(=O)CN=C(c3ccccc3Cl)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C08 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C09 compound treatment 0.076 2.51E-4 0.03 0.0297 1.0 1554 NINDS_000974 CCOC(=O)C1C2CCC(CC1OC(=O)c3ccccc3)N2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C10 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C11 compound treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 1555 NINDS_000975 COC(=O)C1C2CCC(CC1OC(=O)c3ccccc3)N2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C12 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C13 compound treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 1556 NINDS_000976 COc1ccc2C[C@@H]3C4C=C[C@H](O)[C@@H]5Oc1c2[C@@]54CCN3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C14 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C15 compound treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 1557 NINDS_000977 CCCCCc1cc(O)c2C3C=C(C)CCC3C(C)(C)Oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C16 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C17 compound treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 1558 NINDS_000978 CCCCCc1cc(O)c2C3CC(=CCC3C(C)(C)Oc2c1)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C18 mock treatment 0.078 0.00225 0.27 0.2667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C19 compound treatment 0.0785 0.00275 0.33 0.3259 1.0 1559 NINDS_000979 Clc1ccc2NC(=O)CN=C(c3ccccc3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C20 mock treatment 0.0785 0.00275 0.33 0.3259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C21 compound treatment 0.078 0.00225 0.27 0.2667 1.0 1560 NINDS_000980 CCNC(C)Cc1cccc(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C22 mock treatment 0.078 0.00225 0.27 0.2667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C23 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 C24 mock treatment 0.082 0.00625 0.74 0.7407 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D01 mock treatment 0.078 0.00225 0.27 0.2667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D02 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D03 mock treatment 0.0815 0.00575 0.68 0.6814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D04 mock treatment 0.084 0.00825 0.98 0.9776 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D05 mock treatment 0.0865 0.0108 1.27 1.2739 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D06 mock treatment 0.0825 0.00675 0.8 0.7999 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D07 mock treatment 0.0775 0.00175 0.21 0.2075 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D08 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D09 mock treatment 0.0775 0.00175 0.21 0.2075 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D10 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D11 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D12 mock treatment 0.0775 0.00175 0.21 0.2075 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D13 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D14 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D15 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D16 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D17 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D18 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D19 mock treatment 0.0805 0.00475 0.56 0.5629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D20 mock treatment 0.0795 0.00375 0.44 0.4444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D21 mock treatment 0.0805 0.00475 0.56 0.5629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D22 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D23 mock treatment 0.081 0.00525 0.62 0.6222 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 D24 mock treatment 0.086 0.0103 1.21 1.2146 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E01 mock treatment 0.0795 0.00375 0.44 0.4444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E02 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E03 compound treatment 0.0825 0.00675 0.8 0.7999 1.0 1561 NINDS_000981 CN1C(=O)CN=C(c2ccccc2F)c3cc(ccc13)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E04 mock treatment 0.0855 0.00975 1.16 1.1554 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E05 compound treatment 0.0865 0.0108 1.27 1.2739 1.0 1562 NINDS_000982 CN1CC[C@]23[C@H]4Oc5c3c(C[C@@H]1C2CCC4=O)ccc5O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E06 mock treatment 0.0825 0.00675 0.8 0.7999 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E07 compound treatment 0.0805 0.00475 0.56 0.5629 1.0 1563 NINDS_000983 CCOC(=O)C1(CCN(C)CC1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E08 mock treatment 0.0795 0.00375 0.44 0.4444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E09 compound treatment 0.0815 0.00575 0.68 0.6814 1.0 1564 NINDS_000984 COc1cc(CCN)cc(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E10 mock treatment 0.078 0.00225 0.27 0.2667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E11 compound treatment 0.0805 0.00475 0.56 0.5629 1.0 1565 NINDS_000985 CN1CC[C@]23[C@H]4Oc5c3c(C[C@@H]1C2C=C[C@H]4O)ccc5O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E12 mock treatment 0.0805 0.00475 0.56 0.5629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E13 compound treatment 0.079 0.00325 0.39 0.3852 1.0 1566 NINDS_000986 OC1N=C(c2ccccc2)c3cc(Cl)ccc3NC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E14 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E15 compound treatment 0.078 0.00225 0.27 0.2667 1.0 1567 NINDS_000987 CCC1(C(=O)NC(=O)NC1=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E16 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E17 compound treatment 0.079 0.00325 0.39 0.3852 1.0 1568 NINDS_000988 CNC(C)Cc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E18 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E19 compound treatment 0.078 0.00225 0.27 0.2667 1.0 1569 NINDS_000989 CN1C(=O)C(O)N=C(c2ccccc2)c3cc(Cl)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E20 mock treatment 0.078 0.00225 0.27 0.2667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E21 compound treatment 0.079 0.00325 0.39 0.3852 1.0 1570 NINDS_000990 CCCC(C)C1(CC=C)C(=O)NC(=NC1=O)S 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E22 mock treatment 0.078 0.00225 0.27 0.2667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E23 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 E24 mock treatment 0.0805 0.00475 0.56 0.5629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F01 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F02 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F03 mock treatment 0.0785 0.00275 0.33 0.3259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F04 mock treatment 0.082 0.00625 0.74 0.7407 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F05 mock treatment 0.0855 0.00975 1.16 1.1554 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F06 mock treatment 0.081 0.00525 0.62 0.6222 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F07 mock treatment 0.0785 0.00275 0.33 0.3259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F08 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F09 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F10 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F11 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F12 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F13 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F14 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F15 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F16 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F17 mock treatment 0.078 0.00225 0.27 0.2667 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F18 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F19 mock treatment 0.0775 0.00175 0.21 0.2075 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F20 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F21 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F22 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F23 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 F24 mock treatment 0.0795 0.00375 0.44 0.4444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G01 mock treatment 0.0775 0.00175 0.21 0.2075 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G02 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G03 compound treatment 0.078 0.00225 0.27 0.2667 1.0 1571 NINDS_000991 CC(N)Cc1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G04 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G05 compound treatment 0.081 0.00525 0.62 0.6222 1.0 1572 NINDS_000992 CCCC(C)C1(CC)C(=O)NC(=NC1=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G06 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G07 compound treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 1573 NINDS_000993 CCCC(C)C1(CC)C(=O)NC(=NC1=O)S 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G08 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G09 compound treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 1574 NINDS_000994 CCC1(CCC(C)C)C(=O)NC(=O)NC1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G10 mock treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G11 compound treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 1575 NINDS_000995 CNC1=Nc2ccc(Cl)cc2C(=[N+]([O-])C1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G12 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G13 compound treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 1576 NINDS_000996 CC(=CCc1c(O)c2c(=O)c(coc2c3C=CC(C)(C)Oc13)c4ccc(O)c(O)c4)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G14 mock treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G15 compound treatment 0.0915 0.0158 1.87 1.8663 1.0 1577 NINDS_000997 OCC(S)CS 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G16 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G17 compound treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 1578 NINDS_000998 CC1=NCCc2c1[nH]c3cc(O)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G18 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G19 compound treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 1579 NINDS_000999 CC(Cc1ccc(O)c(O)c1)C(C)Cc2ccc(O)c(O)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G20 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G21 compound treatment 0.071 -0.00475 -0.56 -0.5627 -1.0 1000143 NINDS_001000 NC(Cn1ccc(=O)c(O)c1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G22 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G23 mock treatment 0.071 -0.00475 -0.56 -0.5627 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 G24 mock treatment 0.072 -0.00375 -0.44 -0.4442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H01 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H02 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H03 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H04 mock treatment 0.082 0.00625 0.74 0.7407 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H05 mock treatment 0.0835 0.00775 0.92 0.9184 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H06 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H07 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H08 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H09 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H10 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H11 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H12 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H13 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H14 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H15 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H16 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H17 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H18 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H19 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H20 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H21 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H22 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H23 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 H24 mock treatment 0.0785 0.00275 0.33 0.3259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I01 mock treatment 0.0785 0.00275 0.33 0.3259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I02 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I03 compound treatment 0.0775 0.00175 0.21 0.2075 1.0 3103678 NINDS_001001 N/C(=N\C(=O)c1nc(Cl)c(N)nc1N)/NCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I04 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I05 compound treatment 0.079 0.00325 0.39 0.3852 1.0 1581 NINDS_001002 CNC(=N)NCCCC(N)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I06 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I07 compound treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 1582 NINDS_001003 O=C1CCO1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I08 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I09 compound treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 1583 NINDS_001004 COc1ccc(/C=C/c2cc(O)cc(O[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)c2)cc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I10 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I11 compound treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 1584 NINDS_001005 NCCCCC(N)C(=O)NCC(=O)NC(Cc1c[nH]cn1)C(=O)NC(CCCCN)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I12 mock treatment 0.068 -0.00775 -0.92 -0.9182 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I13 compound treatment 0.0615 -0.0142 -1.69 -1.6884 -1.0 1585 NINDS_001006 CC(C)c1ccc(C)c2ccc(C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I14 mock treatment 0.068 -0.00775 -0.92 -0.9182 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I15 compound treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 1586 NINDS_001007 NCCCCNCCCN 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I16 mock treatment 0.071 -0.00475 -0.56 -0.5627 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I17 compound treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 1587 NINDS_001008 NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)[C@H](O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3O[C@@H]4O[C@H](CO)[C@@H](O)C[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O[C@H]5O[C@H](CO)[C@@H](O)[C@H](O)[C@@H]5O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I18 mock treatment 0.072 -0.00375 -0.44 -0.4442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I19 compound treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 1588 NINDS_001009 CC(=O)C1C(=O)C=C2Oc3c(c(O)c(C)c(O)c3C(=O)C)C2(C)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I20 mock treatment 0.071 -0.00475 -0.56 -0.5627 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I21 compound treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 1589 NINDS_001010 CC(C)CC(NC(=O)C(Cc1ccccc1)NC(=O)CNC(=O)CNC(=O)C(N)Cc2ccc(O)cc2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I22 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I23 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 I24 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J01 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J02 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J03 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J04 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J05 mock treatment 0.0805 0.00475 0.56 0.5629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J06 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J07 mock treatment 0.0775 0.00175 0.21 0.2075 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J08 mock treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J09 mock treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J10 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J11 mock treatment 0.0705 -0.00525 -0.62 -0.622 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J12 mock treatment 0.07 -0.00575 -0.68 -0.6812 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J13 mock treatment 0.069 -0.00675 -0.8 -0.7997 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J14 mock treatment 0.069 -0.00675 -0.8 -0.7997 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J15 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J16 mock treatment 0.071 -0.00475 -0.56 -0.5627 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J17 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J18 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J19 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J20 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J21 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J22 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J23 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 J24 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K01 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K02 mock treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K03 compound treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 1590 NINDS_001011 CC(C)(C)c1ccc(cc1)C(O)CCCN2CCC(CC2)C(O)(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K04 mock treatment 0.0775 0.00175 0.21 0.2075 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K05 compound treatment 0.0775 0.00175 0.21 0.2075 1.0 1591 NINDS_001012 CC(C)C[C@@H](NC(=O)OCC1c2ccccc2-c3ccccc13)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K06 mock treatment 0.072 -0.00375 -0.44 -0.4442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K07 compound treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 1000144 NINDS_001013 CN[C@@H]1[C@H](O)[C@H](NC)[C@H]2O[C@]3(O)[C@@H](O[C@H](C)CC3=O)OC2[C@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K08 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K09 compound treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 3173223 NINDS_001014 NC[C@@H]1O[C@H](O[C@H]2[C@@H](O)C(O[C@@H]3[C@@H](O)[C@H](N)C[C@H](N)[C@H]3OC4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4N)O[C@@H]2CO)[C@H](N)[C@@H](O)[C@@H]1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K10 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K11 compound treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 382 NINDS_001015 NCCCCCCNS(=O)(=O)c1cccc2c(Cl)cccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K12 mock treatment 0.0695 -0.00625 -0.74 -0.7405 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K13 compound treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 1594 NINDS_001016 N[C@@H](CCCNC(=N)N[N+](=O)[O-])C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K14 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K15 compound treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 1595 NINDS_001017 CCCCCCCCCCCCCCCCCC(=O)OC(CC(=O)O)C[N+](C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K16 mock treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K17 compound treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 419 NINDS_001018 CC1=NN(C(=O)C1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K18 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K19 compound treatment 0.07 -0.00575 -0.68 -0.6812 -1.0 1596 NINDS_001019 CCOc1ccccc1OCC2CNCCO2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K20 mock treatment 0.0695 -0.00625 -0.74 -0.7405 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K21 compound treatment 0.0705 -0.00525 -0.62 -0.622 -1.0 1597 NINDS_001020 CC(=CCCC1(C)Oc2c(CC=C(C)C)c3OC4(C5CC6C=C4C(=O)c3c(O)c2C=C1)C(C/C=C(/C)\C(=O)O)(OC5(C)C)C6=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K22 mock treatment 0.0705 -0.00525 -0.62 -0.622 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K23 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 K24 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L01 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L02 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L03 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L04 mock treatment 0.0795 0.00375 0.44 0.4444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L05 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L06 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L07 mock treatment 0.0795 0.00375 0.44 0.4444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L08 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L09 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L10 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L11 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L12 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L13 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L14 mock treatment 0.072 -0.00375 -0.44 -0.4442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L15 mock treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L16 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L17 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L18 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L19 mock treatment 0.072 -0.00375 -0.44 -0.4442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L20 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L21 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L22 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L23 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 L24 mock treatment 0.081 0.00525 0.62 0.6222 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M01 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M02 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M03 compound treatment 0.0765 7.51E-4 0.09 0.089 1.0 1598 NINDS_001021 NCC1CCC(N)C(OC2C(N)CC(N)C(OC3OC(CO)C(O)C(N)C3O)C2O)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M04 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M05 compound treatment 0.078 0.00225 0.27 0.2667 1.0 1599 NINDS_001022 C=CCc1ccc2OCOc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M06 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M07 compound treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 592 NINDS_001023 Oc1ccc(cc1)c2coc3cc(O)ccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M08 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M09 compound treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 1600 NINDS_001024 CCCCC[C@H](CC(=O)NO)C(=O)N[C@@H](C(C)C)C(=O)N1CCC[C@H]1CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M10 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M11 compound treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 1601 NINDS_001025 COc1c(OC)c2ccc(=O)oc2c3ccoc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M12 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M13 compound treatment 0.0765 7.51E-4 0.09 0.089 1.0 422 NINDS_001026 Oc1cccc2C(=O)C=CC(=O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M14 mock treatment 0.071 -0.00475 -0.56 -0.5627 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M15 compound treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 1602 NINDS_001027 COc1ccc(cc1)c2coc3cc(O)cc(O)c3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M16 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M17 compound treatment 0.076 2.51E-4 0.03 0.0297 1.0 1603 NINDS_001028 OC(=O)CCC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2nccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M18 mock treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M19 compound treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 1604 NINDS_001029 OC(=O)c1ccccc1C(=O)Nc2ccc(cc2)S(=O)(=O)Nc3nccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M20 mock treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M21 compound treatment 0.0715 -0.00425 -0.5 -0.5035 -1.0 1605 NINDS_001030 OC(Cn1cncn1)(Cn2cncn2)c3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M22 mock treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M23 mock treatment 0.073 -0.00275 -0.33 -0.3258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 M24 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N01 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N02 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N03 mock treatment 0.0805 0.00475 0.56 0.5629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N04 mock treatment 0.0815 0.00575 0.68 0.6814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N05 mock treatment 0.0805 0.00475 0.56 0.5629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N06 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N07 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N08 mock treatment 0.0775 0.00175 0.21 0.2075 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N09 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N10 mock treatment 0.0775 0.00175 0.21 0.2075 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N11 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N12 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N13 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N14 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N15 mock treatment 0.0785 0.00275 0.33 0.3259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N16 mock treatment 0.0795 0.00375 0.44 0.4444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N17 mock treatment 0.0805 0.00475 0.56 0.5629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N18 mock treatment 0.079 0.00325 0.39 0.3852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N19 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N20 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N21 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N22 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N23 mock treatment 0.0785 0.00275 0.33 0.3259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 N24 mock treatment 0.0785 0.00275 0.33 0.3259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O01 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O02 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O03 compound treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 1606 NINDS_001031 NS(=O)(=O)c1cc2c(NC(CSCC=C)NS2(=O)=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O04 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O05 compound treatment 0.078 0.00225 0.27 0.2667 1.0 1607 NINDS_001032 CC[C@H](C)C(=O)O[C@H]1C[C@@H](C)C=C2C=C[C@H](C)[C@H](CC[C@@H]3C[C@@H](O)CC(=O)O3)[C@@H]12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O06 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O07 compound treatment 0.078 0.00225 0.27 0.2667 1.0 1594 NINDS_001033 N[C@@H](CCCNC(=N)N[N+](=O)[O-])C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O08 mock treatment 0.072 -0.00375 -0.44 -0.4442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O09 compound treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 3046992 NINDS_001034 CO[C@]12[C@@H]3NC3CN2C4=C([C@@H]1COC(=O)N)C(=O)C(=C(C)C4=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O10 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O11 compound treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 3250 NINDS_001035 CCCCCCCCCCCCCCCCCCOCC(O)CO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O12 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O13 compound treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 1317 NINDS_001036 Fc1ccc(cc1)C(c2ccccc2)(c3ccccc3F)n4ccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O14 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O15 compound treatment 0.075 -7.49E-4 -0.09 -0.0888 -1.0 1608 NINDS_001037 NCCCC[C@H](N[C@@H](CCc1ccccc1)C(=O)O)C(=O)N2CCC[C@H]2C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O16 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O17 compound treatment 0.078 0.00225 0.27 0.2667 1.0 1609 NINDS_001038 CC(=O)O[C@@H]1CC2C(C)(C)C(=O)C=C[C@]2(C)C3CC[C@@]4(C)[C@@H](OC(=O)[C@H]5O[C@]54[C@]13C)c6ccoc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O18 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O19 compound treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 1610 NINDS_001039 COc1ccc(cc1O)[C@@H]2CC(=O)c3c(O)cc(O)cc3O2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O20 mock treatment 0.077 0.00125 0.15 0.1482 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O21 compound treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 3173349 NINDS_001040 CO[C@@H]1C[C@@H](CC[C@H]1O)/C=C(\C)/[C@H]2OC(=O)[C@@H]3CCCCN3C(=O)C(=O)[C@]4(O)O[C@@H]([C@H](C[C@H]4C)OC)[C@H](C[C@@H](C)C\C(=C\[C@@H](CC=C)C(=O)C[C@H](O)[C@H]2C)\C)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O22 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O23 mock treatment 0.0795 0.00375 0.44 0.4444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 O24 mock treatment 0.08 0.00425 0.5 0.5037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P01 mock treatment 0.0725 -0.00325 -0.38 -0.385 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P02 mock treatment 0.0695 -0.00625 -0.74 -0.7405 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P03 mock treatment 0.068 -0.00775 -0.92 -0.9182 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P04 mock treatment 0.0635 -0.0122 -1.45 -1.4514 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P05 mock treatment 0.0675 -0.00825 -0.98 -0.9774 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P06 mock treatment 0.067 -0.00875 -1.04 -1.0367 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P07 mock treatment 0.0745 -0.00125 -0.15 -0.148 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P08 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P09 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P10 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P11 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P12 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P13 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P14 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P15 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P16 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P17 mock treatment 0.0765 7.51E-4 0.09 0.089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P18 mock treatment 0.0755 -2.49E-4 -0.03 -0.0295 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P19 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P20 mock treatment 0.076 2.51E-4 0.03 0.0297 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P21 mock treatment 0.074 -0.00175 -0.21 -0.2073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P22 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P23 mock treatment 0.0735 -0.00225 -0.27 -0.2665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.503 P24 mock treatment 0.07 -0.00575 -0.68 -0.6812 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A01 compound treatment 0.078 0.004 0.47 0.474 1.0 2122573 Peakdale1_000001 Cc1nc2ncccc2cc1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A02 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122574 Peakdale1_000002 FC(F)(F)c1nc2ccncc2cc1C(=O)NCc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A03 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122575 Peakdale1_000003 CNC(=O)c1cc2cccnc2nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A04 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122576 Peakdale1_000004 FC(F)(F)c1cccc(CNC(=O)c2cc3cnccc3nc2C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A05 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122577 Peakdale1_000005 CN(C)C(=O)c1cc2cccnc2nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A06 compound treatment 0.065 -0.009 -1.07 -1.0664 -1.0 2122578 Peakdale1_000006 COc1ccccc1CNC(=O)c2cc3cnccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A07 compound treatment 0.073 -0.001 -0.12 -0.1185 -1.0 2122579 Peakdale1_000007 CCOC(=O)c1cc2cccnc2nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A08 compound treatment 0.073 -0.001 -0.12 -0.1185 -1.0 2122580 Peakdale1_000008 COc1cccc(CCN2CCCC2)c1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A09 compound treatment 0.068 -0.006 -0.71 -0.7109 -1.0 2122581 Peakdale1_000009 Cc1nc2ncccc2cc1C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A10 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122582 Peakdale1_000010 COc1cccc(CCN2CCCC2)c1NC(=O)c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A11 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122583 Peakdale1_000011 Cc1nc2ncccc2cc1C(=O)NCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A12 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122584 Peakdale1_000012 COc1cccc(CCN2CCCC2)c1NC(=O)c3cc(OC)c(OC)c(OC)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A13 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122585 Peakdale1_000013 Cc1nc2ncccc2cc1C(=O)NCc3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A14 compound treatment 0.068 -0.006 -0.71 -0.7109 -1.0 2122586 Peakdale1_000014 COc1ccc(cc1)S(=O)(=O)Nc2c(CCN3CCCC3)cccc2OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A15 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122587 Peakdale1_000015 Cc1nc2ncccc2cc1C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A16 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122588 Peakdale1_000016 COc1ccccc1NC(=O)Nc2c(CCN3CCCC3)cccc2OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A17 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122589 Peakdale1_000017 OC(=O)c1cc2cccnc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A18 compound treatment 0.066 -0.008 -0.95 -0.9479 -1.0 2122590 Peakdale1_000018 Cc1cc(C)nc(Nc2ccc(N)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A19 compound treatment 0.076 0.002 0.24 0.237 1.0 2122591 Peakdale1_000019 CON(C)C(=O)c1cc2cccnc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A20 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122592 Peakdale1_000020 CN(c1ccc(N)cc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A21 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122593 Peakdale1_000021 CCOC(=O)c1cc2cccnc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A22 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122594 Peakdale1_000022 CCN(c1ccc(N)cc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A23 mock treatment 0.086 0.012 1.42 1.4219 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 A24 mock treatment 0.0845 0.0105 1.24 1.2441 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B01 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122595 Peakdale1_000023 Cc1cc(C)nc(Sc2ccc(O)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B02 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122596 Peakdale1_000024 FC(F)(F)c1nc2ccsc2cc1C(=O)NC(=O)Nc3ncccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B03 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122597 Peakdale1_000025 Cc1cc(C)nc(Sc2ccc(OC(=O)C3CC3)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B04 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122598 Peakdale1_000026 FC(F)(F)c1nc2ccsc2cc1c3ncc(o3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B05 compound treatment 0.073 -0.001 -0.12 -0.1185 -1.0 2122599 Peakdale1_000027 Cc1cc(C)nc(Sc2ccc(OC(=O)c3ccccc3C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B06 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122600 Peakdale1_000028 FC(F)(F)c1nc2ccsc2cc1C(=O)NCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B07 compound treatment 0.076 0.002 0.24 0.237 1.0 2122601 Peakdale1_000029 CN(C)C(=O)Oc1ccc(Sc2nc(C)cc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B08 compound treatment 0.071 -0.003 -0.36 -0.3555 -1.0 2104908 Peakdale1_000030 FC(F)(F)c1nc2ccsc2cc1C(=O)NCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B09 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122602 Peakdale1_000031 CC(C)Oc1ccc(Sc2nc(C)cc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B10 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122603 Peakdale1_000032 FC(F)(F)c1nc2ccsc2cc1C(=O)NCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B11 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122604 Peakdale1_000033 CCCCOc1ccc(Sc2nc(C)cc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B12 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2104909 Peakdale1_000034 FC(F)(F)c1cccc(CNC(=O)c2cc3sccc3nc2C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B13 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122605 Peakdale1_000035 Cc1cc(C)nc(Sc2ccc(OCC3OCCO3)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B14 compound treatment 0.076 0.002 0.24 0.237 1.0 2122606 Peakdale1_000036 CN(Cc1ccccc1)C(=O)c2cc3sccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B15 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122607 Peakdale1_000037 Cc1cc(C)nc(Sc2ccc(OCC3CCCCO3)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B16 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122608 Peakdale1_000038 CN(Cc1ccc(Cl)cc1)C(=O)c2cc3sccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B17 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122609 Peakdale1_000039 Cc1cc(C)nc(Sc2ccc(OS(=O)(=O)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B18 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122610 Peakdale1_000040 FC(F)(F)c1nc2ccsc2cc1C(=O)NCc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B19 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122611 Peakdale1_000041 COc1cc(OC)nc(Oc2ccccc2C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B20 compound treatment 0.076 0.002 0.24 0.237 1.0 2122612 Peakdale1_000042 FC(F)(F)c1nc2ccsc2cc1C(=O)NCC(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B21 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122613 Peakdale1_000043 COc1cc(OC)nc(Oc2cccc(c2)C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B22 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122614 Peakdale1_000044 FC(F)(F)c1nc2ccsc2cc1C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B23 mock treatment 0.075 0.001 0.12 0.1185 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 B24 mock treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C01 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122615 Peakdale1_000045 CN(C)C(=O)c1cc2cccnc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C02 compound treatment 0.0755 0.0015 0.18 0.1777 1.0 2122616 Peakdale1_000046 Cc1cc(C)nc(Nc2ccc(NC(=O)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C03 compound treatment 0.0805 0.0065 0.77 0.7702 1.0 2122617 Peakdale1_000047 FC(F)(F)c1cccc(NC(=O)Nc2cc3cccnc3nc2C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C04 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122618 Peakdale1_000048 CN(c1ccc(NC(=O)C(C)(C)C)cc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C05 compound treatment 0.078 0.004 0.47 0.474 1.0 2122619 Peakdale1_000049 FC(F)(F)c1nc2ncccc2cc1C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C06 compound treatment 0.0755 0.0015 0.18 0.1777 1.0 2122620 Peakdale1_000050 CCN(c1ccc(NC(=O)C(C)(C)C)cc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C07 compound treatment 0.086 0.012 1.42 1.4219 1.0 2122621 Peakdale1_000051 FC(F)(F)c1nc2ncccc2cc1C(=O)NCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C08 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122622 Peakdale1_000052 CSc1nc2N(CCc2c(Cl)n1)C3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C09 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122623 Peakdale1_000053 FC(F)(F)c1nc2ncccc2cc1C(=O)NCc3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C10 compound treatment 0.076 0.002 0.24 0.237 1.0 2122624 Peakdale1_000054 CSc1nc2N(CCc2c(Cl)n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C11 compound treatment 0.0815 0.0075 0.89 0.8887 1.0 2122625 Peakdale1_000055 FC(F)(F)c1cccc(CNC(=O)c2cc3cccnc3nc2C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C12 compound treatment 0.0765 0.0025 0.3 0.2962 1.0 2122626 Peakdale1_000056 CSc1nc2N(CCc2c(Cl)n1)c3cc(C)cc(C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C13 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122627 Peakdale1_000057 CC(C)Oc1cccc(NC(=O)c2cc3cccnc3nc2C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C14 compound treatment 0.073 -0.001 -0.12 -0.1185 -1.0 2122628 Peakdale1_000058 CSc1nc2N(CCc2c(Cl)n1)c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C15 compound treatment 0.076 0.002 0.24 0.237 1.0 2122629 Peakdale1_000059 OC(=O)c1ccc2cccnc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C16 compound treatment 0.0825 0.0085 1.01 1.0072 1.0 2122630 Peakdale1_000060 COc1ccc(cc1)N2CCc3c2nc(SC)nc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C17 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122631 Peakdale1_000061 CCOC(=O)c1ccc2cccnc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C18 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122632 Peakdale1_000062 CC(=O)N(c1ccccc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C19 compound treatment 0.078 0.004 0.47 0.474 1.0 2122633 Peakdale1_000063 NC(=O)c1ccc2cccnc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C20 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122634 Peakdale1_000064 CC(=O)N(c1ccc(Cl)cc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C21 compound treatment 0.078 0.004 0.47 0.474 1.0 2122635 Peakdale1_000065 C=CCNC(=O)c1ccc2cccnc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C22 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122636 Peakdale1_000066 CC(=O)N(c1cc(Cl)cc(Cl)c1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C23 mock treatment 0.077 0.003 0.36 0.3555 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 C24 mock treatment 0.078 0.004 0.47 0.474 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D01 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122637 Peakdale1_000067 COc1cc(OC)nc(Oc2cccc(F)c2C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D02 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122638 Peakdale1_000068 Cc1cccc(C)c1NC(=O)c2cc3sccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D03 compound treatment 0.0735 -5.0E-4 -0.06 -0.0592 -1.0 2122639 Peakdale1_000069 COc1cc(OC)nc(Oc2cccc(OC)c2C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D04 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122640 Peakdale1_000070 Fc1ccc(NC(=O)c2cc3sccc3nc2C(F)(F)F)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D05 compound treatment 0.073 -0.001 -0.12 -0.1185 -1.0 2122641 Peakdale1_000071 COC(=O)c1c(Cl)cccc1Oc2nc(OC)cc(OC)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D06 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122642 Peakdale1_000072 FC(F)(F)c1nc2ccsc2cc1C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D07 compound treatment 0.0885 0.0145 1.72 1.7181 1.0 2122643 Peakdale1_000073 COc1cc(OC)nc(Oc2cccnc2C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D08 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122644 Peakdale1_000074 CN(C(=O)c1cc2sccc2nc1C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D09 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122645 Peakdale1_000075 COc1cc(OC)nc(OC(C(C)C)C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D10 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122646 Peakdale1_000076 CN(C(=O)c1cc2sccc2nc1C(F)(F)F)c3c(C)cccc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D11 compound treatment 0.0895 0.0155 1.84 1.8366 1.0 2122647 Peakdale1_000077 CCC(C)C(Oc1nc(OC)cc(OC)n1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D12 compound treatment 0.081 0.007 0.83 0.8294 1.0 2122648 Peakdale1_000078 CN(C(=O)c1cc2sccc2nc1C(F)(F)F)c3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D13 compound treatment 0.0895 0.0155 1.84 1.8366 1.0 2122649 Peakdale1_000079 COc1cc(OC)nc(Sc2ccccc2C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D14 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122650 Peakdale1_000080 CN(C(=O)c1cc2sccc2nc1C(F)(F)F)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D15 compound treatment 0.084 0.01 1.18 1.1849 1.0 2122651 Peakdale1_000081 COc1nc(Oc2ccccc2C(=O)O)nc(OC)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D16 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122652 Peakdale1_000082 NNC(=O)c1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D17 compound treatment 0.083 0.009 1.07 1.0664 1.0 2122653 Peakdale1_000083 CC(=O)On1ccc2ccc(cc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D18 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122654 Peakdale1_000084 FC(F)(F)c1nc2ccsc2cc1C(=O)NNC=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D19 compound treatment 0.0815 0.0075 0.89 0.8887 1.0 2122655 Peakdale1_000085 CS(=O)(=O)c1ccc2ccn(OC(=O)c3ccccc3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D20 compound treatment 0.0795 0.0055 0.65 0.6517 1.0 2122656 Peakdale1_000086 CC(=O)NNC(=O)c1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D21 compound treatment 0.0805 0.0065 0.77 0.7702 1.0 2122657 Peakdale1_000087 CCNC(=O)On1ccc2ccc(cc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D22 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122658 Peakdale1_000088 CC(C)(C)C(=O)NNC(=O)c1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D23 mock treatment 0.0765 0.0025 0.3 0.2962 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 D24 mock treatment 0.078 0.004 0.47 0.474 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E01 compound treatment 0.0735 -5.0E-4 -0.06 -0.0592 -1.0 2122659 Peakdale1_000089 O=C(Nc1ccccc1)c2ccc3cccnc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E02 compound treatment 0.076 0.002 0.24 0.237 1.0 2122660 Peakdale1_000090 CSc1ccc(cc1)N(C(=O)C)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E03 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122661 Peakdale1_000091 O=C(Nc1cccnc1)c2ccc3cccnc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E04 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122662 Peakdale1_000092 COC(=O)N(c1ccccc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E05 compound treatment 0.078 0.004 0.47 0.474 1.0 2122663 Peakdale1_000093 FC(F)(F)c1cccc(NC(=O)c2ccc3cccnc3n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E06 compound treatment 0.0815 0.0075 0.89 0.8887 1.0 2122664 Peakdale1_000094 COC(=O)N(c1ccc(Cl)cc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E07 compound treatment 0.0895 0.0155 1.84 1.8366 1.0 2122665 Peakdale1_000095 FC(F)(F)c1cccc(CNC(=O)c2ccc3cccnc3n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E08 compound treatment 0.0815 0.0075 0.89 0.8887 1.0 2122666 Peakdale1_000096 COC(=O)N(c1cc(Cl)cc(Cl)c1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E09 compound treatment 0.082 0.008 0.95 0.9479 1.0 2122667 Peakdale1_000097 OC(=O)c1ccc2cnccc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E10 compound treatment 0.0855 0.0115 1.36 1.3626 1.0 2122668 Peakdale1_000098 COC(=O)N(c1ccc(SC)cc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E11 compound treatment 0.0975 0.0235 2.78 2.7845 1.0 2122669 Peakdale1_000099 COC(=O)c1ccc2cnccc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E12 compound treatment 0.081 0.007 0.83 0.8294 1.0 2122670 Peakdale1_000100 Cc1cc(C)nc(n1)N(C(=O)C2CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E13 compound treatment 0.0805 0.0065 0.77 0.7702 1.0 2122671 Peakdale1_000101 C=CCNC(=O)c1ccc2cnccc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E14 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122672 Peakdale1_000102 Cc1cc(C)nc(n1)N(C(=O)C2CC2)c3c(C)cccc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E15 compound treatment 0.084 0.01 1.18 1.1849 1.0 2122673 Peakdale1_000103 O=C(Nc1ccccc1)c2ccc3cnccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E16 compound treatment 0.0855 0.0115 1.36 1.3626 1.0 2122674 Peakdale1_000104 Cc1cc(C)nc(n1)N(C(=O)C2CC2)c3ccccc3C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E17 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122675 Peakdale1_000105 FC(F)(F)c1cccc(NC(=O)c2ccc3cnccc3n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E18 compound treatment 0.0755 0.0015 0.18 0.1777 1.0 2122676 Peakdale1_000106 Cc1cc(C)nc(n1)N(C(=O)C2CC2)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E19 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122677 Peakdale1_000107 COc1ccccc1CNC(=O)c2ccc3cnccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E20 compound treatment 0.084 0.01 1.18 1.1849 1.0 2122678 Peakdale1_000108 Cc1cc(C)nc(n1)N(C(=O)C2CC2)c3cc(ccc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E21 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122679 Peakdale1_000109 CC(=O)c1cc2cnccc2nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E22 compound treatment 0.076 0.002 0.24 0.237 1.0 2122680 Peakdale1_000110 Cc1cc(C)nc(n1)N(C(=O)C2CC2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E23 mock treatment 0.0755 0.0015 0.18 0.1777 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 E24 mock treatment 0.076 0.002 0.24 0.237 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F01 compound treatment 0.071 -0.003 -0.36 -0.3555 -1.0 2122681 Peakdale1_000111 CN(C)C(=O)On1ccc2ccc(cc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F02 compound treatment 0.07 -0.004 -0.47 -0.474 -1.0 2122682 Peakdale1_000112 FC(F)(F)c1nc2ccsc2cc1C(=O)NNC(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F03 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122683 Peakdale1_000113 CS(=O)(=O)c1ccc2ccn(OC(=O)Nc3ccccc3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F04 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122684 Peakdale1_000114 FC(F)(F)c1nc2ccsc2cc1C(=O)NNC(=S)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F05 compound treatment 0.081 0.007 0.83 0.8294 1.0 2122685 Peakdale1_000115 COn1ccc2ccc(cc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F06 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122686 Peakdale1_000116 COC(=O)Nc1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F07 compound treatment 0.0825 0.0085 1.01 1.0072 1.0 2122687 Peakdale1_000117 CS(=O)(=O)c1ccc2ccn(OCC#C)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F08 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122688 Peakdale1_000118 CNC(=O)Nc1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F09 compound treatment 0.082 0.008 0.95 0.9479 1.0 2122689 Peakdale1_000119 CCOC(=O)CCOn1ccc2ccc(cc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F10 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122690 Peakdale1_000120 CN(C)C(=O)Nc1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F11 compound treatment 0.083 0.009 1.07 1.0664 1.0 2122691 Peakdale1_000121 CS(=O)(=O)c1ccc2ccn(OC/C=C/c3ccccc3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F12 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122692 Peakdale1_000122 CON(C)C(=O)Nc1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F13 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122693 Peakdale1_000123 CS(=O)(=O)c1ccc2ccn(OCc3c(Cl)cccc3Cl)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F14 compound treatment 0.0815 0.0075 0.89 0.8887 1.0 2122694 Peakdale1_000124 CCSC(=O)Nc1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F15 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122695 Peakdale1_000125 COc1ccc(COn2ccc3ccc(cc23)S(=O)(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F16 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122696 Peakdale1_000126 CS(=O)(=O)c1ccc2n(Cc3ccccc3)cnc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F17 compound treatment 0.092 0.018 2.13 2.1328 1.0 2122697 Peakdale1_000127 CS(=O)(=O)c1ccc2ccn(OCc3nc4ccccc4[nH]3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F18 compound treatment 0.0755 0.0015 0.18 0.1777 1.0 2122698 Peakdale1_000128 CS(=O)(=O)c1ccc2n(Cc3ccccc3)c(nc2c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F19 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122699 Peakdale1_000129 CC(=O)Nc1cc(ccc1F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F20 compound treatment 0.078 0.004 0.47 0.474 1.0 2122700 Peakdale1_000130 CCOC(=O)Cc1nc2cc(ccc2n1Cc3ccccc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F21 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122701 Peakdale1_000131 CS(=O)(=O)c1ccc(F)c(NC(=O)c2ccccc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F22 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122702 Peakdale1_000132 CC(C)n1cnc2cc(ccc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F23 mock treatment 0.074 0.0 0.0 -1.0 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 F24 mock treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G01 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122703 Peakdale1_000133 CN(C)/C=C/C(=O)c1cc2cnccc2nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G02 compound treatment 0.066 -0.008 -0.95 -0.9479 -1.0 2122704 Peakdale1_000134 Cc1cc(C)nc(n1)N(C(=O)C2CC2)c3cccc(Cl)c3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G03 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122705 Peakdale1_000135 Cc1nc2ccncc2cc1c3ccnc(n3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G04 compound treatment 0.0685 -0.0055 -0.65 -0.6517 -1.0 2122706 Peakdale1_000136 Cc1cc(C)nc(n1)N(C(=O)C2CC2)c3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G05 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122707 Peakdale1_000137 CC(=O)c1cc2cnccc2[nH]c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G06 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122708 Peakdale1_000138 Cc1cc(C)nc(n1)N(C(=O)C2CC2)c3ccc(OC(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G07 compound treatment 0.0925 0.0185 2.19 2.1921 1.0 2122709 Peakdale1_000139 CN(C)/C=C/C(=O)c1cc2cnccc2[nH]c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G08 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122710 Peakdale1_000140 CSc1nc(C)cc(Nc2ccccc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G09 compound treatment 0.078 0.004 0.47 0.474 1.0 2122711 Peakdale1_000141 O=c1[nH]c2ccncc2cc1c3ccnc(n3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G10 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 1132114 Peakdale1_000142 COc1nc(Nc2ccccc2)nc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G11 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122712 Peakdale1_000143 COC(OC)c1ccc2cnccc2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G12 compound treatment 0.086 0.012 1.42 1.4219 1.0 2122713 Peakdale1_000144 COc1nc(Nc2ccccc2F)nc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G13 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122714 Peakdale1_000145 Cc1cc(C)nc(Nc2ccccc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G14 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122715 Peakdale1_000146 COc1nc(Nc2ccccc2Cl)nc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G15 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122716 Peakdale1_000147 Cc1cc(C)nc(Nc2ccccc2C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G16 compound treatment 0.071 -0.003 -0.36 -0.3555 -1.0 1402668 Peakdale1_000148 CCOC(=O)c1cn2c(n1)sc3ccccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G17 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122717 Peakdale1_000149 Cc1cc(C)nc(Nc2ccc(cc2)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G18 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122718 Peakdale1_000150 OCc1cn2c(n1)sc3ccccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G19 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122719 Peakdale1_000151 COC(=O)c1ccc(Nc2nc(C)cc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G20 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 1097652 Peakdale1_000152 OC(=O)c1cn2c(n1)sc3ccccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G21 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122720 Peakdale1_000153 Cc1cc(C)nc(Nc2ccc(cc2)[N+](=O)[O-])n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G22 compound treatment 0.071 -0.003 -0.36 -0.3555 -1.0 2122721 Peakdale1_000154 OCCCNC(=O)c1cn2c(n1)sc3ccccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G23 mock treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 G24 mock treatment 0.067 -0.007 -0.83 -0.8294 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H01 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122722 Peakdale1_000155 CC(C)(C)c1ccc(cc1)C(=O)Nc2cc(ccc2F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H02 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122723 Peakdale1_000156 CC(C)n1c(nc2cc(ccc12)S(=O)(=O)C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H03 compound treatment 0.071 -0.003 -0.36 -0.3555 -1.0 2122724 Peakdale1_000157 CS(=O)(=O)c1ccc(F)c(NC(=O)c2cccc(c2)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H04 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122725 Peakdale1_000158 CS(=O)(=O)c1ccc2n(Cc3ccccc3)c(=O)c(=O)[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H05 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122726 Peakdale1_000159 CS(=O)(=O)c1ccc(F)c(NC(=O)c2c(Cl)cccc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H06 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122727 Peakdale1_000160 CCOC(=O)Cn1c(=O)c(=O)n(Cc2ccccc2)c3ccc(cc13)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H07 compound treatment 0.0945 0.0205 2.43 2.429 1.0 2122728 Peakdale1_000161 CS(=O)(=O)c1ccc(F)c(NC(=O)Nc2ccccc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H08 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122729 Peakdale1_000162 CC(C)n1c(=O)c(=O)n(Cc2cccc(c2)C(F)(F)F)c3cc(ccc13)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H09 compound treatment 0.09 0.016 1.9 1.8958 1.0 2122730 Peakdale1_000163 CS(=O)(=O)c1ccc(F)c(NC(=O)Nc2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H10 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122731 Peakdale1_000164 CC(C)n1c(=O)c(=O)[nH]c2cc(ccc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H11 compound treatment 0.083 0.009 1.07 1.0664 1.0 2122732 Peakdale1_000165 CS(=O)(=O)c1ccc(F)c(NC(=O)CCC(=O)O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H12 compound treatment 0.0875 0.0135 1.6 1.5996 1.0 2122733 Peakdale1_000166 CCOC(=O)Cn1c(=O)c(=O)n(C(C)C)c2ccc(cc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H13 compound treatment 0.086 0.012 1.42 1.4219 1.0 2122734 Peakdale1_000167 CS(=O)(=O)c1ccc(F)c(c1)N2C(=O)CCC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H14 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122735 Peakdale1_000168 OC(=O)c1ccccc1c2ccc3cccnc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H15 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122736 Peakdale1_000169 CS(=O)(=O)c1ccc(F)c(c1)N2C(=O)C=CC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H16 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122737 Peakdale1_000170 OC(=O)c1ccccc1c2ccc3cnccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H17 compound treatment 0.082 0.008 0.95 0.9479 1.0 2122738 Peakdale1_000171 CC(C)N(C(=O)COc1nc(C)cc(C)n1)c2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H18 compound treatment 0.0735 -5.0E-4 -0.06 -0.0592 -1.0 2122739 Peakdale1_000172 CC1(C)OC(C)(C)c2nc3ncccc3cc21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H19 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122740 Peakdale1_000173 CC(C)N(C(=O)COc1nc(C)cc(C)n1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H20 compound treatment 0.078 0.004 0.47 0.474 1.0 2122741 Peakdale1_000174 CC1(C)OC(C)(C)c2nc3ccncc3cc21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H21 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122742 Peakdale1_000175 Cc1cc(C)nc(OCc2ccccc2C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H22 compound treatment 0.076 0.002 0.24 0.237 1.0 2122743 Peakdale1_000176 Fc1ccccc1c2ccc3cccnc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H23 mock treatment 0.0755 0.0015 0.18 0.1777 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 H24 mock treatment 0.073 -0.001 -0.12 -0.1185 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I01 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122744 Peakdale1_000177 CC(C)Oc1ccc(Nc2nc(C)cc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I02 compound treatment 0.0685 -0.0055 -0.65 -0.6517 -1.0 2122745 Peakdale1_000178 O=C(NCC1CCCO1)c2cn3c(n2)sc4ccccc43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I03 compound treatment 0.0675 -0.0065 -0.77 -0.7702 -1.0 2122746 Peakdale1_000179 Cc1cc(C)nc(Nc2ccc(OC(F)(F)F)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I04 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122747 Peakdale1_000180 O=C(N1CCCC1)c2cn3c(n2)sc4ccccc43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I05 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122748 Peakdale1_000181 Cc1cc(C)nc(Nc2ccc(Cl)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I06 compound treatment 0.07 -0.004 -0.47 -0.474 -1.0 2122749 Peakdale1_000182 CC(C)(C)NC(=O)c1cn2c(n1)sc3ccccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I07 compound treatment 0.076 0.002 0.24 0.237 1.0 2122750 Peakdale1_000183 Cc1cc(C)nc(Nc2cccc(Cl)c2Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I08 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122751 Peakdale1_000184 CON(C)C(=O)c1cn2c(n1)sc3ccccc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I09 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122752 Peakdale1_000185 Cc1cc(C)nc(Nc2cc(Cl)cc(Cl)c2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I10 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122753 Peakdale1_000186 CCOc1ccc(NC(=O)c2cn3c(n2)sc4ccccc43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I11 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122754 Peakdale1_000187 Cc1cc(C)nc(Nc2cc(ccc2Cl)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I12 compound treatment 0.0685 -0.0055 -0.65 -0.6517 -1.0 2122755 Peakdale1_000188 O=C(N1CCOCC1)c2cn3c(n2)sc4ccccc43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I13 compound treatment 0.0595 -0.0145 -1.72 -1.7181 -1.0 2122756 Peakdale1_000189 Cc1cc(C)nc(Nc2c(C)cccc2C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I14 compound treatment 0.0655 -0.0085 -1.01 -1.0072 -1.0 2122757 Peakdale1_000190 Cc1cc(C)nc(Sc2ccc(NC(=O)CCl)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I15 compound treatment 0.0735 -5.0E-4 -0.06 -0.0592 -1.0 2122758 Peakdale1_000191 CSc1ccc(Nc2nc(C)cc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I16 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122759 Peakdale1_000192 Cc1cc(C)nc(Sc2ccc(NC(=O)c3ccc(cc3)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I17 compound treatment 0.071 -0.003 -0.36 -0.3555 -1.0 2122760 Peakdale1_000193 CN(C)S(=O)(=O)c1ccc(Nc2nc(C)cc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I18 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122761 Peakdale1_000194 Cc1cc(C)nc(Sc2ccc(NC(=O)CSC(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I19 compound treatment 0.073 -0.001 -0.12 -0.1185 -1.0 2122762 Peakdale1_000195 COC(=O)c1sccc1Nc2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I20 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122763 Peakdale1_000196 Cc1cc(C)nc(Sc2ccc(NC(=O)NC(=O)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I21 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122764 Peakdale1_000197 COC(=O)c1ccc(cc1)N(C)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I22 compound treatment 0.07 -0.004 -0.47 -0.474 -1.0 2122765 Peakdale1_000198 Cc1cc(C)nc(Sc2ccc(NC(=O)NC(=O)c3c(F)cccc3F)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I23 mock treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 I24 mock treatment 0.068 -0.006 -0.71 -0.7109 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J01 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122766 Peakdale1_000199 Cc1cc(C)nc(OCc2ccccc2Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J02 compound treatment 0.0685 -0.0055 -0.65 -0.6517 -1.0 2122767 Peakdale1_000200 C1Cc2nc3ccncc3cc2CN1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J03 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122768 Peakdale1_000201 COC(=O)c1ccccc1Oc2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J04 compound treatment 0.0815 0.0075 0.89 0.8887 1.0 2122769 Peakdale1_000202 CN1CCc2nc3ccncc3cc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J05 compound treatment 0.078 0.004 0.47 0.474 1.0 2122770 Peakdale1_000203 COC(=O)c1cccc(Oc2nc(C)cc(C)n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J06 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122771 Peakdale1_000204 CCCN1CCc2nc3ccncc3cc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J07 compound treatment 0.0895 0.0155 1.84 1.8366 1.0 2122772 Peakdale1_000205 COC(=O)c1ccc(Oc2nc(C)cc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J08 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122773 Peakdale1_000206 CC(=O)N1CCc2nc3ccncc3cc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J09 compound treatment 0.0885 0.0145 1.72 1.7181 1.0 2122774 Peakdale1_000207 COC(=O)c1sccc1Oc2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J10 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122775 Peakdale1_000208 CCNC(=O)N1CCc2nc3ccncc3cc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J11 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122776 Peakdale1_000209 COc1cc(OC)nc(Oc2ccccc2c3ccn(C)n3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J12 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122777 Peakdale1_000210 OC(=O)CCC(=O)N1CCc2nc3ccncc3cc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J13 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122778 Peakdale1_000211 COc1cc(OC)nc(Oc2ccccc2c3ccno3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J14 compound treatment 0.076 0.002 0.24 0.237 1.0 2122779 Peakdale1_000212 C(N1CCc2nc3ccncc3cc2C1)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J15 compound treatment 0.071 -0.003 -0.36 -0.3555 -1.0 2122780 Peakdale1_000213 COc1cc(OC)nc(Oc2ccccc2c3noc(C)n3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J16 compound treatment 0.0795 0.0055 0.65 0.6517 1.0 2122781 Peakdale1_000214 C(Cc1ccccc1)N2CCc3nc4ccncc4cc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J17 compound treatment 0.076 0.002 0.24 0.237 1.0 2122782 Peakdale1_000215 COc1cc(OC)nc(Oc2ccccc2c3nnco3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J18 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122783 Peakdale1_000216 FC(F)(F)c1ccc(nc1)N2CCc3nc4ccncc4cc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J19 compound treatment 0.095 0.021 2.49 2.4883 1.0 2122784 Peakdale1_000217 COc1cc(OC)nc(Oc2ccccc2c3ccnc(C)n3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J20 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122785 Peakdale1_000218 CC(C)n1c(S)nc2cc(ccc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J21 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122786 Peakdale1_000219 OC(=O)/C=C/c1ccc2OC(F)(F)Oc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J22 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122787 Peakdale1_000220 CSc1nc2cc(ccc2n1C(C)C)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J23 mock treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 J24 mock treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K01 compound treatment 0.0675 -0.0065 -0.77 -0.7702 -1.0 2122788 Peakdale1_000221 CN(c1ccc(cc1)[N+](=O)[O-])c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K02 compound treatment 0.068 -0.006 -0.71 -0.7109 -1.0 2122789 Peakdale1_000222 COc1cccc(OC)c1C(=O)Nc2ccc(Sc3nc(C)cc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K03 compound treatment 0.068 -0.006 -0.71 -0.7109 -1.0 2122790 Peakdale1_000223 CC(C)Oc1ccc(cc1)N(C)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K04 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122791 Peakdale1_000224 Cc1cc(C)nc(Sc2ccc(NS(=O)(=O)c3ccccc3Cl)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K05 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122792 Peakdale1_000225 CN(c1ccc(OC(F)(F)F)cc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K06 compound treatment 0.0675 -0.0065 -0.77 -0.7702 -1.0 2122793 Peakdale1_000226 Cc1cc(C)nc(Sc2cccc(N)c2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K07 compound treatment 0.0735 -5.0E-4 -0.06 -0.0592 -1.0 2122794 Peakdale1_000227 CN(C)S(=O)(=O)c1ccc(cc1)N(C)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K08 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122795 Peakdale1_000228 CCOC(=O)Nc1cccc(Sc2nc(C)cc(C)n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K09 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122796 Peakdale1_000229 CCN(c1ccc(cc1)C(=O)OC)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K10 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122797 Peakdale1_000230 CN(C)C(=O)Nc1cccc(Sc2nc(C)cc(C)n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K11 compound treatment 0.0755 0.0015 0.18 0.1777 1.0 2122798 Peakdale1_000231 CCN(c1ccc(cc1)[N+](=O)[O-])c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K12 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122799 Peakdale1_000232 Cc1cc(C)nc(Sc2cccc(NC(=O)C(C)(C)C)c2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K13 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122800 Peakdale1_000233 CCN(c1ccc(OC(C)C)cc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K14 compound treatment 0.068 -0.006 -0.71 -0.7109 -1.0 2122801 Peakdale1_000234 Cc1cc(C)nc(Sc2ccc(N)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K15 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122802 Peakdale1_000235 CCN(c1ccc(OC(F)(F)F)cc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K16 compound treatment 0.068 -0.006 -0.71 -0.7109 -1.0 2122803 Peakdale1_000236 Cc1cc(C)nc(Sc2ccc(NC(=O)OC(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K17 compound treatment 0.0675 -0.0065 -0.77 -0.7702 -1.0 2122804 Peakdale1_000237 CCN(c1ccc(cc1)S(=O)(=O)N(C)C)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K18 compound treatment 0.0785 0.0045 0.53 0.5332 1.0 2122805 Peakdale1_000238 Cc1cc(C)nc(Sc2ccc(NC(=O)NC(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K19 compound treatment 0.0735 -5.0E-4 -0.06 -0.0592 -1.0 2122806 Peakdale1_000239 Fc1c2CCN(C(=O)c3ccccc3)c2c(F)c(F)c1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K20 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122807 Peakdale1_000240 Cc1cc(C)nc(Sc2ccc(NC(=O)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K21 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122808 Peakdale1_000241 CC(C)(C)c1ccc(cc1)C(=O)N2CCc3c2c(F)c(F)c(F)c3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K22 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122809 Peakdale1_000242 C1Cc2nc3ncccc3cc2CN1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K23 mock treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 K24 mock treatment 0.069 -0.005 -0.59 -0.5925 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L01 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122810 Peakdale1_000243 Fc1ccc(NC(=O)/C=C/c2ccc3OC(F)(F)Oc3c2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L02 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122811 Peakdale1_000244 CC(C)n1c(SCC=C)nc2cc(ccc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L03 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122812 Peakdale1_000245 CS(=O)(=O)c1ccc(NC(=O)/C=C/c2ccc3OC(F)(F)Oc3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L04 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122813 Peakdale1_000246 CC(C)n1c(SCC#C)nc2cc(ccc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L05 compound treatment 0.0755 0.0015 0.18 0.1777 1.0 2122814 Peakdale1_000247 FC1(F)Oc2ccc(/C=C/C(=O)N3CCc4ccccc34)cc2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L06 compound treatment 0.1035 0.0295 3.5 3.4955 1.0 2122815 Peakdale1_000248 CCOC(=O)CSc1nc2cc(ccc2n1C(C)C)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L07 compound treatment 0.081 0.007 0.83 0.8294 1.0 2122816 Peakdale1_000249 FC1(F)Oc2ccc(/C=C/C(=O)NCCN3CCOCC3)cc2O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L08 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122817 Peakdale1_000250 COC(=O)c1ccc(CSc2nc3cc(ccc3n2C(C)C)S(=O)(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L09 compound treatment 0.081 0.007 0.83 0.8294 1.0 2122818 Peakdale1_000251 CC(NC(=O)/C=C/c1ccc2OC(F)(F)Oc2c1)C(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L10 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122819 Peakdale1_000252 CC(C)n1c(SCC(=O)Nc2c(C)cccc2C)nc3cc(ccc13)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L11 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122820 Peakdale1_000253 CS(=O)(=O)c1ccc2ccn(Oc3cc(c(cn3)C(F)(F)F)C(F)(F)F)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L12 compound treatment 0.082 0.008 0.95 0.9479 1.0 2122821 Peakdale1_000254 CS(=O)(=O)c1ccc2n(Cc3ccccc3)c(S)nc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L13 compound treatment 0.0765 0.0025 0.3 0.2962 1.0 2122822 Peakdale1_000255 CS(=O)(=O)c1ccc2ccn(OCC(=O)N)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L14 compound treatment 0.081 0.007 0.83 0.8294 1.0 2122823 Peakdale1_000256 CCOC(=O)CSc1nc2cc(ccc2n1Cc3ccccc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L15 compound treatment 0.0795 0.0055 0.65 0.6517 1.0 2122824 Peakdale1_000257 CC(C)N(C(C)C)C(=O)COn1ccc2ccc(cc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L16 compound treatment 0.07 -0.004 -0.47 -0.474 -1.0 2122825 Peakdale1_000258 COCCn1c(=O)c(=O)[nH]c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L17 compound treatment 0.0835 0.0095 1.13 1.1257 1.0 2122826 Peakdale1_000259 CS(=O)(=O)c1ccc2ccn(OCC(=O)N3CCOCC3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L18 compound treatment 0.07 -0.004 -0.47 -0.474 -1.0 2122827 Peakdale1_000260 COCCn1c(=O)c(=O)n(C)c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L19 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122828 Peakdale1_000261 CC1CC(C)CN(C1)C(=O)COn2ccc3ccc(cc23)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L20 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122829 Peakdale1_000262 COCCn1c(=O)c(=O)n(CC=C)c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L21 compound treatment 0.078 0.004 0.47 0.474 1.0 2122830 Peakdale1_000263 CCOC(=O)C1CSCCN1C(=O)COn2ccc3ccc(cc23)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L22 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122831 Peakdale1_000264 COCCn1c(=O)c(=O)n(CC#C)c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L23 mock treatment 0.0755 0.0015 0.18 0.1777 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 L24 mock treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M01 compound treatment 0.068 -0.006 -0.71 -0.7109 -1.0 2122832 Peakdale1_000265 COc1cccc(C(=O)N2CCc3c2c(F)c(F)c(F)c3F)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M02 compound treatment 0.068 -0.006 -0.71 -0.7109 -1.0 2122833 Peakdale1_000266 CN1CCc2nc3ncccc3cc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M03 compound treatment 0.0675 -0.0065 -0.77 -0.7702 -1.0 2122834 Peakdale1_000267 COc1cc(cc(OC)c1OC)C(=O)N2CCc3c2c(F)c(F)c(F)c3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M04 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122835 Peakdale1_000268 C(N1CCc2nc3ncccc3cc2C1)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M05 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122836 Peakdale1_000269 Fc1ccc(C(=O)N2CCc3c2c(F)c(F)c(F)c3F)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M06 compound treatment 0.076 0.002 0.24 0.237 1.0 2122837 Peakdale1_000270 C(Cc1ccccc1)N2CCc3nc4ncccc4cc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M07 compound treatment 0.078 0.004 0.47 0.474 1.0 2122838 Peakdale1_000271 OC(=O)CCC(=O)N1CCc2c1c(F)c(F)c(F)c2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M08 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122839 Peakdale1_000272 OC(=O)CCC(=O)N1CCc2nc3ncccc3cc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M09 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122840 Peakdale1_000273 CON(C)C(=O)N1CCc2c1c(F)c(F)c(F)c2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M10 compound treatment 0.0915 0.0175 2.07 2.0736 1.0 2122841 Peakdale1_000274 CC(=O)N1CCc2nc3ncccc3cc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M11 compound treatment 0.073 -0.001 -0.12 -0.1185 -1.0 2122842 Peakdale1_000275 CCN(CC)C(=O)N1CCc2c1c(F)c(F)c(F)c2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M12 compound treatment 0.088 0.014 1.66 1.6589 1.0 2122843 Peakdale1_000276 FC(F)(F)c1cccc(c1)C(=O)N2CCc3nc4ncccc4cc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M13 compound treatment 0.0805 0.0065 0.77 0.7702 1.0 2122844 Peakdale1_000277 COc1ccccc1NC(=O)N2CCc3c2c(F)c(F)c(F)c3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M14 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122845 Peakdale1_000278 CC(=O)Oc1ccccc1C(=O)N2CCc3nc4ncccc4cc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M15 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122846 Peakdale1_000279 COc1ccc(cc1)S(=O)(=O)N2CCc3c2c(F)c(F)c(F)c3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M16 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122847 Peakdale1_000280 Oc1ccccc1C(=O)N2CCc3nc4ncccc4cc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M17 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122848 Peakdale1_000281 Cc1nc2ccncc2cc1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M18 compound treatment 0.0765 0.0025 0.3 0.2962 1.0 2122849 Peakdale1_000282 CCOC(=O)NC(=S)N1CCc2nc3ncccc3cc2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M19 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122850 Peakdale1_000283 CCOC(=O)c1cc2cnccc2nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M20 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122851 Peakdale1_000284 c1cc2sc3ccccc3n2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M21 compound treatment 0.071 -0.003 -0.36 -0.3555 -1.0 2122852 Peakdale1_000285 Cc1nc2ccncc2cc1C(=O)NCC#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M22 compound treatment 0.0805 0.0065 0.77 0.7702 1.0 2122853 Peakdale1_000286 FC(F)(F)C(=O)c1ccc2sc3ccccc3n12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M23 mock treatment 0.073 -0.001 -0.12 -0.1185 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 M24 mock treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N01 compound treatment 0.067 -0.007 -0.83 -0.8294 -1.0 2122854 Peakdale1_000287 Cc1cccc(C)c1NC(=O)COn2ccc3ccc(cc23)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N02 compound treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 2122855 Peakdale1_000288 COCCn1c(=O)c(=O)n(CC(=O)C)c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N03 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122856 Peakdale1_000289 CN(C(=O)COn1ccc2ccc(cc12)S(=O)(=O)C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N04 compound treatment 0.072 -0.002 -0.24 -0.237 -1.0 2122857 Peakdale1_000290 CCOC(=O)Cn1c(=O)c(=O)n(CCOC)c2ccc(cc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N05 compound treatment 0.073 -0.001 -0.12 -0.1185 -1.0 2122858 Peakdale1_000291 CS(=O)(=O)c1ccc2ccn(OCC(=O)N3CCc4ccccc34)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N06 compound treatment 0.0835 0.0095 1.13 1.1257 1.0 2122859 Peakdale1_000292 COCCn1c(=O)c(=O)n(CC(=O)N2CCc3ccccc23)c4cc(ccc14)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N07 compound treatment 0.08 0.006 0.71 0.7109 1.0 2122860 Peakdale1_000293 CS(=O)(=O)c1ccc(/C=C/C(=O)O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N08 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122861 Peakdale1_000294 COCCn1c(=O)c(=O)n(Cc2ccc(Cl)cc2)c3cc(ccc13)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N09 compound treatment 0.0865 0.0125 1.48 1.4811 1.0 2122862 Peakdale1_000295 CS(=O)(=O)c1ccc(/C=C/C(=O)Nc2ccc(F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N10 compound treatment 0.0865 0.0125 1.48 1.4811 1.0 2122863 Peakdale1_000296 COCCn1c(=O)c(=O)n(Cc2cccc(c2)C(F)(F)F)c3cc(ccc13)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N11 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122864 Peakdale1_000297 CS(=O)(=O)c1ccc(/C=C/C(=O)Nc2ccc(F)cc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N12 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122865 Peakdale1_000298 COCCn1c(=O)c(=O)n(Cc2ccc(cc2)C(=O)OC)c3cc(ccc13)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N13 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122866 Peakdale1_000299 CS(=O)(=O)c1ccc(/C=C/C(=O)Nc2cccc(c2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N14 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122867 Peakdale1_000300 CC(C)n1c(=O)c(=O)[nH]c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N15 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122868 Peakdale1_000301 CC(C)(C)c1ccc(NC(=O)/C=C/c2ccc(cc2)S(=O)(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N16 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122869 Peakdale1_000302 CC(C)n1c(=O)c(=O)n(C)c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N17 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122870 Peakdale1_000303 CS(=O)(=O)c1ccc(/C=C/C(=O)Nc2ccccn2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N18 compound treatment 0.0765 0.0025 0.3 0.2962 1.0 2122871 Peakdale1_000304 CC(C)n1c(=O)c(=O)n(CC=C)c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N19 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122872 Peakdale1_000305 CS(=O)(=O)c1ccc(/C=C/C(=O)NCCN2CCOCC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N20 compound treatment 0.076 0.002 0.24 0.237 1.0 2122873 Peakdale1_000306 CC(C)n1c(=O)c(=O)n(CC#C)c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N21 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122874 Peakdale1_000307 CS(=O)(=O)c1ccc2ccn(OCCO)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N22 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122875 Peakdale1_000308 CC(C)n1c(=O)c(=O)n(CC(=O)C)c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N23 mock treatment 0.0785 0.0045 0.53 0.5332 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 N24 mock treatment 0.0775 0.0035 0.41 0.4147 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O01 compound treatment 0.0705 -0.0035 -0.41 -0.4147 -1.0 2122876 Peakdale1_000309 Cc1nc2ccncc2cc1C(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O02 compound treatment 0.0615 -0.0125 -1.48 -1.4811 -1.0 2122877 Peakdale1_000310 O=C(NC1CCCCC1)c2ccc3sc4ccccc4n23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O03 compound treatment 0.068 -0.006 -0.71 -0.7109 -1.0 2122878 Peakdale1_000311 Cc1nc2ccncc2cc1C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O04 compound treatment 0.0775 0.0035 0.41 0.4147 1.0 2122879 Peakdale1_000312 O=C(N1CCCC1)c2ccc3sc4ccccc4n23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O05 compound treatment 0.071 -0.003 -0.36 -0.3555 -1.0 2122880 Peakdale1_000313 Cc1nc2ccncc2cc1C(=O)NCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O06 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122881 Peakdale1_000314 O=C(NCC1CCCO1)c2ccc3sc4ccccc4n23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O07 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122882 Peakdale1_000315 Cc1nc2ccncc2cc1C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O08 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122883 Peakdale1_000316 O=C(NCC#C)c1ccc2sc3ccccc3n12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O09 compound treatment 0.073 -0.001 -0.12 -0.1185 -1.0 2122884 Peakdale1_000317 OC(=O)c1cc2cnccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O10 compound treatment 0.085 0.011 1.3 1.3034 1.0 2122885 Peakdale1_000318 Oc1ccccc1c2ccc3cccnc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O11 compound treatment 0.069 -0.005 -0.59 -0.5925 -1.0 2122886 Peakdale1_000319 CCOC(=O)c1cc2cnccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O12 compound treatment 0.089 0.015 1.78 1.7774 1.0 2122887 Peakdale1_000320 Oc1ccc(Cl)cc1c2ccc3cccnc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O13 compound treatment 0.074 0.0 0.0 -1.0 -1.0 2122888 Peakdale1_000321 FC(F)(F)c1nc2ccncc2cc1C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O14 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122889 Peakdale1_000322 Cc1cc(C)c(c(O)c1)c2ccc3cccnc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O15 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122890 Peakdale1_000323 FC(F)(F)c1nc2ccncc2cc1C(=O)NCC#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O16 compound treatment 0.0885 0.0145 1.72 1.7181 1.0 2122891 Peakdale1_000324 c1ccc(nc1)c2ccc3cccnc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O17 compound treatment 0.076 0.002 0.24 0.237 1.0 2122892 Peakdale1_000325 FC(F)(F)c1nc2ccncc2cc1C(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O18 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122893 Peakdale1_000326 CC(=O)Oc1ccccc1c2ccc3cccnc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O19 compound treatment 0.0755 0.0015 0.18 0.1777 1.0 2122894 Peakdale1_000327 FC(F)(F)c1nc2ccncc2cc1C(=O)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O20 compound treatment 0.078 0.004 0.47 0.474 1.0 2122895 Peakdale1_000328 O=C(Nc1ccccc1)Oc2ccccc2c3ccc4cccnc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O21 compound treatment 0.079 0.005 0.59 0.5925 1.0 2122896 Peakdale1_000329 COc1ccc(NC(=O)c2cc3cnccc3nc2C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O22 compound treatment 0.081 0.007 0.83 0.8294 1.0 2122897 Peakdale1_000330 Cc1cc(C)nc(Oc2ccccc2c3ccc4cccnc4n3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O23 mock treatment 0.0815 0.0075 0.89 0.8887 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 O24 mock treatment 0.079 0.005 0.59 0.5925 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P01 compound treatment 0.063 -0.011 -1.3 -1.3034 -1.0 2122898 Peakdale1_000331 CC(C)(C)OC(=O)COn1ccc2ccc(cc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P02 compound treatment 0.0665 -0.0075 -0.89 -0.8887 -1.0 2122899 Peakdale1_000332 CCOC(=O)Cn1c(=O)c(=O)n(C(C)C)c2ccc(cc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P03 compound treatment 0.0735 -5.0E-4 -0.06 -0.0592 -1.0 2122900 Peakdale1_000333 CS(=O)(=O)c1ccc2ccn(OCC3CO3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P04 compound treatment 0.0715 -0.0025 -0.3 -0.2962 -1.0 2122901 Peakdale1_000334 CC(C)n1c(=O)c(=O)n(CC(=O)N2CCc3ccccc23)c4cc(ccc14)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P05 compound treatment 0.075 0.001 0.12 0.1185 1.0 2122902 Peakdale1_000335 CS(=O)(=O)c1ccc2ccn(OCC3CCCCO3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P06 compound treatment 0.077 0.003 0.36 0.3555 1.0 2122903 Peakdale1_000336 CC(C)n1c(=O)c(=O)n(Cc2ccc(Cl)cc2)c3cc(ccc13)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P07 compound treatment 0.084 0.01 1.18 1.1849 1.0 2122904 Peakdale1_000337 OC(=O)c1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P08 compound treatment 0.078 0.004 0.47 0.474 1.0 2122905 Peakdale1_000338 CC(C)n1c(=O)c(=O)n(Cc2cccc(c2)C(F)(F)F)c3cc(ccc13)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P09 compound treatment 0.0845 0.0105 1.24 1.2441 1.0 2122906 Peakdale1_000339 CCOC(=O)c1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P10 compound treatment 0.082 0.008 0.95 0.9479 1.0 2122907 Peakdale1_000340 COC(=O)c1ccc(Cn2c(=O)c(=O)n(C(C)C)c3ccc(cc23)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P11 compound treatment 0.0835 0.0095 1.13 1.1257 1.0 2122908 Peakdale1_000341 NC(=O)c1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P12 compound treatment 0.083 0.009 1.07 1.0664 1.0 2122909 Peakdale1_000342 Fc1c(F)c(F)c2c(CC#N)c[nH]c2c1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P13 compound treatment 0.0865 0.0125 1.48 1.4811 1.0 2122910 Peakdale1_000343 CNC(=O)c1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P14 compound treatment 0.0735 -5.0E-4 -0.06 -0.0592 -1.0 2122911 Peakdale1_000344 OC(=O)Cc1c[nH]c2c(F)c(F)c(F)c(F)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P15 compound treatment 0.076 0.002 0.24 0.237 1.0 2122912 Peakdale1_000345 FC(F)(F)c1nc2ccsc2cc1C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P16 compound treatment 0.0725 -0.0015 -0.18 -0.1777 -1.0 2122913 Peakdale1_000346 CCN(CC)C(=O)Cc1c[nH]c2c(F)c(F)c(F)c(F)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P17 compound treatment 0.0745 5.0E-4 0.06 0.0592 1.0 2122914 Peakdale1_000347 CC(C)NC(=O)c1cc2sccc2nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P18 compound treatment 0.0885 0.0145 1.72 1.7181 1.0 2122915 Peakdale1_000348 COCCNC(=O)Cc1c[nH]c2c(F)c(F)c(F)c(F)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P19 compound treatment 0.081 0.007 0.83 0.8294 1.0 2122916 Peakdale1_000349 FC(F)(F)c1nc2ccsc2cc1C(=O)NC(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P20 compound treatment 0.071 -0.003 -0.36 -0.3555 -1.0 2079952 Peakdale1_000350 Fc1c(F)c(F)c2c(CC(=O)NCCN3CCOCC3)c[nH]c2c1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P21 compound treatment 0.0765 0.0025 0.3 0.2962 1.0 2122917 Peakdale1_000351 FC(F)(F)c1nc2ccsc2cc1C(=O)NC(=O)Nc3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P22 compound treatment 0.0755 0.0015 0.18 0.1777 1.0 2122918 Peakdale1_000352 COCCNC(C)c1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P23 mock treatment 0.0695 -0.0045 -0.53 -0.5332 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.518 P24 mock treatment 0.061 -0.013 -1.54 -1.5404 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A01 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2122919 Peakdale1_000353 COCCN(C(C)c1ccc(cc1)S(=O)(=O)C)C(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A02 compound treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 2122920 Peakdale1_000354 CC[C@@H](CO)NC(=O)c1cc2cc(ccc2[nH]1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A03 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2122921 Peakdale1_000355 CCNC(=O)N(CC1CCCO1)C(C)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A04 compound treatment 0.077 0.00277 0.33 0.3287 1.0 2122922 Peakdale1_000356 CS(=O)(=O)c1ccc2[nH]c(cc2c1)C(=O)NC3CCSC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A05 compound treatment 0.0715 -0.00273 -0.32 -0.323 -1.0 2122923 Peakdale1_000357 CC(N(CC1CCCO1)C(=O)c2ccccc2)c3ccc(cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A06 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2122924 Peakdale1_000358 CS(=O)(=O)c1ccc2[nH]c(cc2c1)C(=O)N3CCN(CC3)c4ncccc4C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A07 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2122925 Peakdale1_000359 COCCN(CCOc1ccc(cc1)S(=O)(=O)C)C(=O)c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A08 compound treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 2122926 Peakdale1_000360 CON(C)C(=O)c1cc2cc(ccc2[nH]1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A09 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2122927 Peakdale1_000361 COCCN(CCOc1ccc(cc1)S(=O)(=O)C)C(=O)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A10 compound treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 2122928 Peakdale1_000362 CN(C)CCC(O)c1ccc(cc1)S(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A11 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2122929 Peakdale1_000363 COCCN(CCOc1ccc(cc1)S(=O)(=O)C)S(=O)(=O)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A12 compound treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 2122930 Peakdale1_000364 CN(C)CCC(O)c1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A13 compound treatment 0.0725 -0.00173 -0.2 -0.2045 -1.0 2122931 Peakdale1_000365 CCCCCCOc1ccc(cc1N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A14 compound treatment 0.0715 -0.00273 -0.32 -0.323 -1.0 2122932 Peakdale1_000366 CS(=O)(=O)c1ccc(cc1)C(O)CCN2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A15 compound treatment 0.0715 -0.00273 -0.32 -0.323 -1.0 2122933 Peakdale1_000367 CCCCCCOc1ccc(cc1NC(=O)C(C)(C)C)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A16 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2122934 Peakdale1_000368 CN(C)CCC(Oc1ccc(cc1)S(=O)(=O)C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A17 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2122935 Peakdale1_000369 CCCCCCOc1ccc(cc1NC(=O)c2ccccc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A18 compound treatment 0.0665 -0.00773 -0.92 -0.9154 -1.0 2122936 Peakdale1_000370 CN(C)CCC(OC(=O)c1ccccc1)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A19 compound treatment 0.0725 -0.00173 -0.2 -0.2045 -1.0 2122937 Peakdale1_000371 CCCCCCOc1ccc(cc1NC(=O)c2ccc(cc2)C(F)(F)F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A20 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2122938 Peakdale1_000372 CN(C)CCC(Oc1ccc(F)cc1)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A21 compound treatment 0.0765 0.00227 0.27 0.2695 1.0 2122939 Peakdale1_000373 CCCCCCOc1ccc(cc1NS(=O)(=O)c2cccc(c2)C(F)(F)F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A22 compound treatment 0.0795 0.00527 0.62 0.6249 1.0 2122940 Peakdale1_000374 CN(C)CCC(Oc1ccc(cc1)C(F)(F)F)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A23 mock treatment 0.09 0.0158 1.87 1.8691 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 A24 mock treatment 0.079 0.00477 0.57 0.5657 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B01 compound treatment 0.068 -0.00623 -0.74 -0.7377 -1.0 2122941 Peakdale1_000375 O=C(NCCN1CCOCC1)c2ccc3cc[nH]c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B02 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2122942 Peakdale1_000376 COc1cc(OC)nc(OC(CCCN2CCOCC2)c3ccc(F)cc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B03 compound treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 2122943 Peakdale1_000377 O=C(N[C@@H]1CCCCNC1=O)c2ccc3cc[nH]c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B04 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2122944 Peakdale1_000378 Fc1ccc(cc1)C(CCCN2CCOCC2)OC(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B05 compound treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 2122945 Peakdale1_000379 CC(C)(C)OC(=O)[C@@H]1CCCN1C(=O)c2ccc3cc[nH]c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B06 compound treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 2122946 Peakdale1_000380 Fc1ccc(cc1)C(=O)CCNC(=O)OCC#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B07 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2122947 Peakdale1_000381 FC(F)(F)c1cccnc1N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B08 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2122948 Peakdale1_000382 Fc1ccc(cc1)C(=O)CCNC(=O)NCCN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B09 compound treatment 0.0685 -0.00573 -0.68 -0.6785 -1.0 2122949 Peakdale1_000383 CON(C)C(=O)c1ccc2cc[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B10 compound treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 2122950 Peakdale1_000384 COc1ccccc1CNC(=O)NCCC(=O)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B11 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2122951 Peakdale1_000385 COC(=O)CCCNC(=O)c1ccc2cc[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B12 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2122952 Peakdale1_000386 Fc1ccc(cc1)C(=O)CCNC(=O)Nc2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B13 compound treatment 0.072 -0.00223 -0.26 -0.2637 -1.0 2122953 Peakdale1_000387 COc1ccc(NCc2ccc3N(C)CCc3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B14 compound treatment 0.072 -0.00223 -0.26 -0.2637 -1.0 2122954 Peakdale1_000388 CC(C)N(C(C)C)C(=O)NCCC(=O)c1ccc(F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B15 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2122955 Peakdale1_000389 COc1ccc(cc1)N(Cc2ccc3N(C)CCc3c2)C(=O)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B16 compound treatment 0.066 -0.00823 -0.97 -0.9747 -1.0 2122956 Peakdale1_000390 CN1CCN(CC1)C(=O)NCCC(=O)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B17 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2122957 Peakdale1_000391 COc1ccc(cc1)N(Cc2ccc3N(C)CCc3c2)C(=O)c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B18 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2122958 Peakdale1_000392 O=C(CCNC(=O)N1CCc2ccccc12)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B19 compound treatment 0.08 0.00577 0.68 0.6842 1.0 2122959 Peakdale1_000393 COc1ccc(cc1)N(Cc2ccc3N(C)CCc3c2)S(=O)(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B20 compound treatment 0.0785 0.00427 0.51 0.5064 1.0 2122960 Peakdale1_000394 c1[nH]nc(c1c2ccnc3ccccc23)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B21 compound treatment 0.102 0.0278 3.29 3.291 1.0 2122961 Peakdale1_000395 CN1CCc2cc(CN(CC3CCCO3)C(=O)C(C)(C)C)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B22 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2122962 Peakdale1_000396 CC(C)(C)C(=O)n1cc(c(n1)c2ccccn2)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B23 mock treatment 0.0775 0.00327 0.39 0.388 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 B24 mock treatment 0.076 0.00177 0.21 0.2102 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C01 compound treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 2122963 Peakdale1_000397 CCCCCCOc1ccc(cc1NC(=O)Nc2ccccc2OC)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C02 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2122964 Peakdale1_000398 Fc1ccc2NCCc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C03 compound treatment 0.077 0.00277 0.33 0.3287 1.0 2122965 Peakdale1_000399 CCCCCCOc1ccc(cc1NC(=O)C2CC2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C04 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2122966 Peakdale1_000400 Fc1ccc2N(CCc2c1)C(=O)C3CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C05 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2122967 Peakdale1_000401 CS(=O)(=O)c1ccc(Oc2ccc(Cl)cc2)c(NC(=O)C3CC3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C06 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2122968 Peakdale1_000402 Fc1ccc2N(CCc2c1)C(=O)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C07 compound treatment 0.0825 0.00827 0.98 0.9804 1.0 2122969 Peakdale1_000403 CC(C)(C)c1ccc(Oc2ccc(cc2NC(=O)C3CC3)S(=O)(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C08 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2122970 Peakdale1_000404 CC(C)(C)c1ccc(cc1)C(=O)N2CCc3cc(F)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C09 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2122971 Peakdale1_000405 CS(=O)(=O)c1ccc(Oc2ccc(Oc3ccccc3)cc2)c(NC(=O)C4CC4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C10 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2122972 Peakdale1_000406 COc1ccccc1NC(=O)N2CCc3cc(F)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C11 compound treatment 0.0765 0.00227 0.27 0.2695 1.0 2122973 Peakdale1_000407 CS(=O)(=O)c1ccc(Oc2ccc(NC(=O)C3CC3)cc2)c(NC(=O)C4CC4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C12 compound treatment 0.085 0.0108 1.28 1.2766 1.0 2122974 Peakdale1_000408 Nc1ccccc1SCC(=O)N2CCc3cc(F)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C13 compound treatment 0.0845 0.0103 1.22 1.2174 1.0 2122975 Peakdale1_000409 CCOC(=O)c1nc(oc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C14 compound treatment 0.0775 0.00327 0.39 0.388 1.0 2122976 Peakdale1_000410 CCNC(=O)Nc1ccccc1SCC(=O)N2CCc3cc(F)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C15 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2122977 Peakdale1_000411 OC(=O)c1nc(oc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C16 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2122978 Peakdale1_000412 Cc1cc(C)nc(SCC(=O)N2CCc3cc(F)ccc23)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C17 compound treatment 0.079 0.00477 0.57 0.5657 1.0 2122979 Peakdale1_000413 CNC(=O)c1nc(oc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C18 compound treatment 0.0765 0.00227 0.27 0.2695 1.0 2122980 Peakdale1_000414 Fc1ccc2N(CCc2c1)C(=O)CSc3nc4ccccc4[nH]3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C19 compound treatment 0.0795 0.00527 0.62 0.6249 1.0 2122981 Peakdale1_000415 FC(F)(F)c1oc(nc1C(=O)NCC=C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C20 compound treatment 0.0765 0.00227 0.27 0.2695 1.0 2122982 Peakdale1_000416 COc1ccc(cc1)S(=O)(=O)N2CCc3cc(F)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C21 compound treatment 0.0795 0.00527 0.62 0.6249 1.0 2122983 Peakdale1_000417 COCCNC(=O)c1nc(oc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C22 compound treatment 0.0775 0.00327 0.39 0.388 1.0 2122984 Peakdale1_000418 OC(=O)CCC(=O)N1CCc2cc(F)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C23 mock treatment 0.0755 0.00127 0.15 0.151 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 C24 mock treatment 0.079 0.00477 0.57 0.5657 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D01 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2122985 Peakdale1_000419 CN1CCc2cc(CN(CC3CCCO3)C(=O)c4ccccc4)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D02 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2122986 Peakdale1_000420 CCNC(=O)n1cc(c(n1)c2ccccn2)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D03 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2122987 Peakdale1_000421 CN1CCc2cc(CN(CC3CCCO3)C(=O)NC(=O)C(C)(C)C)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D04 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2122988 Peakdale1_000422 Cc1ccc(cc1)S(=O)(=O)NC(=O)n2cc(c(n2)c3ccccn3)c4ccnc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D05 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2122989 Peakdale1_000423 CSc1ncc(c(n1)c2ccc(cc2)C(F)(F)F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D06 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2122990 Peakdale1_000424 Cc1ncc(c(n1)c2ccccn2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D07 compound treatment 0.11 0.0358 4.24 4.2389 1.0 2122991 Peakdale1_000425 CS(=O)(=O)c1cnc(nc1c2ccc(cc2)C(F)(F)F)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D08 compound treatment 0.08 0.00577 0.68 0.6842 1.0 2122992 Peakdale1_000426 FC(F)(F)c1cccc(c1)S(=O)(=O)c2cnc(nc2c3ccccn3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D09 compound treatment 0.0925 0.0183 2.17 2.1653 1.0 2122993 Peakdale1_000427 CS(=O)(=O)c1cnc(N)nc1c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D10 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2122994 Peakdale1_000428 Nc1ncc(c(n1)c2ccccn2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D11 compound treatment 0.084 0.00977 1.16 1.1581 1.0 2122995 Peakdale1_000429 CC(C)(C)C(=O)NC(=O)Nc1ncc(c(n1)c2ccc(cc2)C(F)(F)F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D12 compound treatment 0.0805 0.00627 0.74 0.7434 1.0 2122996 Peakdale1_000430 Cc1ncc(c(n1)c2cccnc2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D13 compound treatment 0.083 0.00877 1.04 1.0397 1.0 1525492 Peakdale1_000431 OC(=O)CCN1CCc2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D14 compound treatment 0.08 0.00577 0.68 0.6842 1.0 2122997 Peakdale1_000432 FC(F)(F)c1cccc(c1)S(=O)(=O)c2cnc(nc2c3cccnc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D15 compound treatment 0.0825 0.00827 0.98 0.9804 1.0 2122998 Peakdale1_000433 COCCNC(=O)CCN1CCc2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D16 compound treatment 0.081 0.00677 0.8 0.8027 1.0 2122999 Peakdale1_000434 Nc1ncc(c(n1)c2cccnc2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D17 compound treatment 0.0815 0.00727 0.86 0.8619 1.0 2123000 Peakdale1_000435 O=C(CCN1CCc2ccccc12)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D18 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123001 Peakdale1_000436 Cc1ncc(c(n1)c2ccncc2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D19 compound treatment 0.079 0.00477 0.57 0.5657 1.0 2123002 Peakdale1_000437 O=C(CCN1CCc2ccccc12)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D20 compound treatment 0.0795 0.00527 0.62 0.6249 1.0 2123003 Peakdale1_000438 FC(F)(F)c1cccc(c1)S(=O)(=O)c2cnc(nc2c3ccncc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D21 compound treatment 0.0875 0.0133 1.57 1.5729 1.0 2123004 Peakdale1_000439 FC(F)(F)c1cccc(CNC(=O)CCN2CCc3ccccc23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D22 compound treatment 0.0775 0.00327 0.39 0.388 1.0 2123005 Peakdale1_000440 Nc1ncc(c(n1)c2ccncc2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D23 mock treatment 0.0775 0.00327 0.39 0.388 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 D24 mock treatment 0.0785 0.00427 0.51 0.5064 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E01 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2123006 Peakdale1_000441 CCC(CO)NC(=O)c1nc(oc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E02 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123007 Peakdale1_000442 CON(C)C(=O)CCC(=O)N1CCc2cc(F)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E03 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123008 Peakdale1_000443 FC(F)(F)c1oc(nc1C(=O)NCCN2CCOCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E04 compound treatment 0.0765 0.00227 0.27 0.2695 1.0 2123009 Peakdale1_000444 Fc1ccc2N(CCc2c1)C(=O)CCC(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E05 compound treatment 0.077 0.00277 0.33 0.3287 1.0 2123010 Peakdale1_000445 FC(F)(F)c1oc(nc1C(=O)Nc2ccccn2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E06 compound treatment 0.0905 0.0163 1.93 1.9283 1.0 2123011 Peakdale1_000446 Fc1ccc2N(CCc2c1)C(=O)CCC(=O)NC3CCSC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E07 compound treatment 0.0855 0.0113 1.34 1.3359 1.0 2123012 Peakdale1_000447 FC(F)(F)c1oc(nc1C(=O)NCc2cccnc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E08 compound treatment 0.079 0.00477 0.57 0.5657 1.0 2123013 Peakdale1_000448 Fc1ccc2N(CCc2c1)C(=O)CCC(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E09 compound treatment 0.081 0.00677 0.8 0.8027 1.0 2123014 Peakdale1_000449 CON(C)C(=O)c1nc(oc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E10 compound treatment 0.0805 0.00627 0.74 0.7434 1.0 2123015 Peakdale1_000450 CN(C)S(=O)(=O)c1ccc2NCCc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E11 compound treatment 0.083 0.00877 1.04 1.0397 1.0 1267936 Peakdale1_000451 Cc1cc(C)nc(Nc2ccccc2C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E12 compound treatment 0.0825 0.00827 0.98 0.9804 1.0 2123016 Peakdale1_000452 CC(O)CC(=O)N1CCc2cc(ccc12)S(=O)(=O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E13 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2123017 Peakdale1_000453 COC(=O)c1ccccc1Nc2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E14 compound treatment 0.08 0.00577 0.68 0.6842 1.0 2123018 Peakdale1_000454 CN(C)S(=O)(=O)c1ccc2N(CCc2c1)C(=O)CC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E15 compound treatment 0.081 0.00677 0.8 0.8027 1.0 2123019 Peakdale1_000455 Cc1cc(C)nc(Nc2cccc(c2)C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E16 compound treatment 0.082 0.00777 0.92 0.9212 1.0 2123020 Peakdale1_000456 CN(C)S(=O)(=O)c1ccc2N(CCc2c1)C(=O)c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E17 compound treatment 0.085 0.0108 1.28 1.2766 1.0 2123021 Peakdale1_000457 COC(=O)c1cccc(Nc2nc(C)cc(C)n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E18 compound treatment 0.0765 0.00227 0.27 0.2695 1.0 2123022 Peakdale1_000458 CN(C)S(=O)(=O)c1ccc2N(CCc2c1)C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E19 compound treatment 0.08 0.00577 0.68 0.6842 1.0 2123023 Peakdale1_000459 Cc1cc(C)nc(Nc2ccc(cc2)C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E20 compound treatment 0.0795 0.00527 0.62 0.6249 1.0 2123024 Peakdale1_000460 CN(C)S(=O)(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E21 compound treatment 0.084 0.00977 1.16 1.1581 1.0 2123025 Peakdale1_000461 COC(=O)c1ccccc1N(C)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E22 compound treatment 0.077 0.00277 0.33 0.3287 1.0 2123026 Peakdale1_000462 CN(C)S(=O)(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)NCC(=C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E23 mock treatment 0.076 0.00177 0.21 0.2102 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 E24 mock treatment 0.0755 0.00127 0.15 0.151 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F01 compound treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 2123027 Peakdale1_000463 O=C(CCN1CCc2ccccc12)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F02 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123028 Peakdale1_000464 CS(=O)c1cnc(nc1c2ccc(cc2)C(F)(F)F)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F03 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123029 Peakdale1_000465 CC(=O)N1CCc2cccc(NC(=O)CCC(=O)O)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F04 compound treatment 0.0725 -0.00173 -0.2 -0.2045 -1.0 2123030 Peakdale1_000466 CS(=O)c1cnc(nc1c2ccc(cc2)C(F)(F)F)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F05 compound treatment 0.092 0.0178 2.11 2.1061 1.0 2123031 Peakdale1_000467 CC(Sc1nc(C)cc(C)n1)C(=O)Nc2cccc3CCN(C(=O)C)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F06 compound treatment 0.0725 -0.00173 -0.2 -0.2045 -1.0 2123032 Peakdale1_000468 CS(=O)c1cnc(N)nc1c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F07 compound treatment 0.09 0.0158 1.87 1.8691 1.0 2123033 Peakdale1_000469 CC(=O)N1CCc2cccc(NC(=O)Nc3ccc(F)cc3F)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F08 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2123034 Peakdale1_000470 CC1(C)CC(NCc2ccccc2)c3cccn31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F09 compound treatment 0.0815 0.00727 0.86 0.8619 1.0 2123035 Peakdale1_000471 CC(=O)N1CCc2cccc(NS(=O)(=O)c3ccc(cc3)S(=O)(=O)C)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F10 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123036 Peakdale1_000472 CC1(C)CC(NCCc2ccccc2)c3cccn31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F11 compound treatment 0.0795 0.00527 0.62 0.6249 1.0 2123037 Peakdale1_000473 COCCN(CCCN1CCc2ccccc12)C(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F12 compound treatment 0.0785 0.00427 0.51 0.5064 1.0 2123038 Peakdale1_000474 COc1ccccc1CNC2CC(C)(C)n3cccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F13 compound treatment 0.0795 0.00527 0.62 0.6249 1.0 2123039 Peakdale1_000475 COCCN(CCCN1CCc2ccccc12)C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F14 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123040 Peakdale1_000476 COc1ccc(NC2CC(C)(C)n3cccc23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F15 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123041 Peakdale1_000477 CCNC(=O)N(CCCN1CCc2ccccc12)CCOC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F16 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2123042 Peakdale1_000478 CC1(C)CC(NCc2cccc(c2)C(F)(F)F)c3cccn31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F17 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123043 Peakdale1_000479 COCCN(CCCN1CCc2ccccc12)C(=O)Nc3ccccc3C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F18 compound treatment 0.0825 0.00827 0.98 0.9804 1.0 2123044 Peakdale1_000480 CC1(C)CC(NCc2ccncc2)c3cccn31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F19 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123045 Peakdale1_000481 Cc1cc(C)nc(OC(Cc2ccncn2)c3ccc(cc3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F20 compound treatment 0.0765 0.00227 0.27 0.2695 1.0 2123046 Peakdale1_000482 CC1(C)CC(NCc2cccnc2)c3cccn31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F21 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123047 Peakdale1_000483 COc1cc(OC)nc(OC(Cc2ccncn2)c3ccc(cc3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F22 compound treatment 0.0875 0.0133 1.57 1.5729 1.0 2123048 Peakdale1_000484 CC(=O)N(Cc1ccccc1)C2CC(C)(C)n3cccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F23 mock treatment 0.075 7.74E-4 0.09 0.0917 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 F24 mock treatment 0.0745 2.74E-4 0.03 0.0325 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G01 compound treatment 0.068 -0.00623 -0.74 -0.7377 -1.0 2123049 Peakdale1_000485 CN(c1cccc(c1)C(=O)O)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G02 compound treatment 0.066 -0.00823 -0.97 -0.9747 -1.0 2123050 Peakdale1_000486 CN(C)S(=O)(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G03 compound treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 2123051 Peakdale1_000487 COC(=O)c1cccc(c1)N(C)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G04 compound treatment 0.0685 -0.00573 -0.68 -0.6785 -1.0 2123052 Peakdale1_000488 CN(C)S(=O)(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)NC3CCSC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G05 compound treatment 0.069 -0.00523 -0.62 -0.6192 -1.0 2123053 Peakdale1_000489 CN(c1ccc(cc1)C(=O)O)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G06 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123054 Peakdale1_000490 CN(C)S(=O)(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)N3CCN(C)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G07 compound treatment 0.084 0.00977 1.16 1.1581 1.0 2123055 Peakdale1_000491 CCOC(=O)C(O)c1ccc2OCCc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G08 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2080022 Peakdale1_000492 CN1CCC(CC1)Nc2ccc3N(CCc3c2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G09 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2123056 Peakdale1_000493 CCOC(=O)C(Oc1nc(C)cc(C)n1)c2ccc3OCCc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G10 compound treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 2080036 Peakdale1_000494 CN1CCC(CC1)N(C(=O)C2CC2)c3ccc4N(CCc4c3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G11 compound treatment 0.0785 0.00427 0.51 0.5064 1.0 2123057 Peakdale1_000495 CCOC(=O)C(Oc1nc(OC)cc(OC)n1)c2ccc3OCCc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G12 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2080063 Peakdale1_000496 CN1CCC(CC1)N(C(=O)c2ccc(cc2)C(F)(F)F)c3ccc4N(CCc4c3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G13 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123058 Peakdale1_000497 CCOC(=O)C(Oc1ncc(Cl)cn1)c2ccc3OCCc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G14 compound treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 2123059 Peakdale1_000498 CCNC(=O)N(C1CCN(C)CC1)c2ccc3N(CCc3c2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G15 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123060 Peakdale1_000499 COC(=O)CNC(=O)c1nc(C)oc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G16 compound treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 2123061 Peakdale1_000500 CCCN1CCC(CC1)Nc2ccc3N(CCc3c2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G17 compound treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 2123062 Peakdale1_000501 COC(=O)CCCNC(=O)c1nc(C)oc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G18 compound treatment 0.0685 -0.00573 -0.68 -0.6785 -1.0 2123063 Peakdale1_000502 CCCN1CCC(CC1)N(C(=O)C(C)(C)C)c2ccc3N(CCc3c2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G19 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2123064 Peakdale1_000503 Cc1nc(C(=O)NOCC(=O)OC(C)(C)C)c(o1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G20 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123065 Peakdale1_000504 CCCN1CCC(CC1)N(C(=O)c2cccc(c2)C(F)(F)F)c3ccc4N(CCc4c3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G21 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123066 Peakdale1_000505 Cc1nc(C(=O)NC(CCC(=O)OCC=C)C(=O)OCC=C)c(o1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G22 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2079917 Peakdale1_000506 CCCN1CCC(CC1)N(C(=O)c2cccs2)c3ccc4N(CCc4c3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G23 mock treatment 0.0715 -0.00273 -0.32 -0.323 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 G24 mock treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H01 compound treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 2123067 Peakdale1_000507 Oc1nc(c2ccc(cc2)C(F)(F)F)c(cc1C#N)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H02 compound treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 2123068 Peakdale1_000508 CCNC(=O)N(Cc1ccccc1)C2CC(C)(C)n3cccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H03 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123069 Peakdale1_000509 Oc1nc(c2ccncc2)c(cc1C#N)c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H04 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123070 Peakdale1_000510 CC1(C)CC(N(Cc2ccccc2)C(=O)Nc3ccc(F)cc3F)c4cccn41 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H05 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2123071 Peakdale1_000511 CSc1ncc(c2cnc3ccccc3n2)c(n1)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H06 compound treatment 0.077 0.00277 0.33 0.3287 1.0 2123072 Peakdale1_000512 FC(F)(F)c1ccc(cc1)c2n[nH]cc2c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H07 compound treatment 0.0835 0.00927 1.1 1.0989 1.0 2123073 Peakdale1_000513 Nc1ncc(c2cnc3ccccc3n2)c(n1)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H08 compound treatment 0.084 0.00977 1.16 1.1581 1.0 2123074 Peakdale1_000514 CC(C)(C)C(=O)n1cc(c(n1)c2ccc(cc2)C(F)(F)F)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H09 compound treatment 0.0905 0.0163 1.93 1.9283 1.0 2123075 Peakdale1_000515 Nc1ncc(c2ccncn2)c(n1)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H10 compound treatment 0.0815 0.00727 0.86 0.8619 1.0 2123076 Peakdale1_000516 CCNC(=O)n1cc(c(n1)c2ccc(cc2)C(F)(F)F)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H11 compound treatment 0.0955 0.0213 2.52 2.5208 1.0 2123077 Peakdale1_000517 CC(=O)Nc1ncc(c2ccncn2)c(n1)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H12 compound treatment 0.0925 0.0183 2.17 2.1653 1.0 2123078 Peakdale1_000518 Cc1ccc(cc1)S(=O)(=O)NC(=O)n2cc(c(n2)c3ccc(cc3)C(F)(F)F)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H13 compound treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 2123079 Peakdale1_000519 CC(C)(C)C(=O)NC(=O)Nc1ncc(c2ccncn2)c(n1)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H14 compound treatment 0.087 0.0128 1.51 1.5136 1.0 2123080 Peakdale1_000520 c1[nH]nc(c1c2ccncn2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H15 compound treatment 0.0805 0.00627 0.74 0.7434 1.0 2123081 Peakdale1_000521 FC(F)(F)c1ccc(cc1)c2nc(ncc2c3ccncn3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H16 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123082 Peakdale1_000522 CC(C)(C)C(=O)n1cc(c(n1)c2ccccc2)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H17 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123083 Peakdale1_000523 CSc1ncc(c2ccncn2)c(n1)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H18 compound treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 2123084 Peakdale1_000524 CCNC(=O)n1cc(c(n1)c2ccccc2)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H19 compound treatment 0.077 0.00277 0.33 0.3287 1.0 2123085 Peakdale1_000525 OC(=O)CCOC(Cc1cnccn1)c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H20 compound treatment 0.0825 0.00827 0.98 0.9804 1.0 2123086 Peakdale1_000526 Cc1ccc(cc1)S(=O)(=O)NC(=O)n2cc(c(n2)c3ccccc3)c4ccncn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H21 compound treatment 0.0825 0.00827 0.98 0.9804 1.0 2123087 Peakdale1_000527 CC(C)(C)NC(=O)CCOC(Cc1cnccn1)c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H22 compound treatment 0.0775 0.00327 0.39 0.388 1.0 2123088 Peakdale1_000528 Cc1ccc(cc1)S(=O)(=O)c2cnc(C)nc2c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H23 mock treatment 0.0745 2.74E-4 0.03 0.0325 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 H24 mock treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I01 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123089 Peakdale1_000529 COC(=O)CNC(=O)c1nc(oc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I02 compound treatment 0.0685 -0.00573 -0.68 -0.6785 -1.0 2123090 Peakdale1_000530 CCCN1CCC(CC1)N(C(=O)Nc2ccccc2)c3ccc4N(CCc4c3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I03 compound treatment 0.068 -0.00623 -0.74 -0.7377 -1.0 2123091 Peakdale1_000531 FC(F)(F)c1oc(nc1C(=O)NC2CCSC2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I04 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123092 Peakdale1_000532 CS(=O)c1ccc2NCCc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I05 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123093 Peakdale1_000533 COC(=O)c1cc(cs1)c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I06 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123094 Peakdale1_000534 CS(=O)c1ccc2N(CCc2c1)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I07 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123095 Peakdale1_000535 COc1ccc(cc1)c2csc(c2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I08 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123096 Peakdale1_000536 CS(=O)c1ccc2N(CCc2c1)C(=O)CSc3nc(C)cc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I09 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123097 Peakdale1_000537 COCCNC(=O)c1cc(cs1)c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I10 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123098 Peakdale1_000538 CC(=O)N1CCc2cc(ccc12)S(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I11 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123099 Peakdale1_000539 COc1ccc(cc1)c2csc(c2)C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I12 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123100 Peakdale1_000540 CS(=O)c1ccc2N(CCc2c1)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I13 compound treatment 0.0575 -0.0167 -1.98 -1.9818 -1.0 2123101 Peakdale1_000541 COc1ccc(cc1)c2csc(c2)C(=O)NC(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I14 compound treatment 0.0855 0.0113 1.34 1.3359 1.0 2123102 Peakdale1_000542 CS(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I15 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123103 Peakdale1_000543 COc1ccc(cc1)c2csc(c2)C(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I16 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123104 Peakdale1_000544 CS(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)NCC(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I17 compound treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 2123105 Peakdale1_000545 COc1ccc(cc1)c2csc(c2)C(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I18 compound treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 2079940 Peakdale1_000546 CC(=O)N1CCc2cc(NC3CCN(Cc4ccccc4)CC3)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I19 compound treatment 0.083 0.00877 1.04 1.0397 1.0 2123106 Peakdale1_000547 COc1ccc(cc1)c2csc(c2)C(=O)Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I20 compound treatment 0.072 -0.00223 -0.26 -0.2637 -1.0 2123107 Peakdale1_000548 CC(=O)N1CCc2cc(ccc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)C5CC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I21 compound treatment 0.0725 -0.00173 -0.2 -0.2045 -1.0 2123108 Peakdale1_000549 COc1ccc(cc1)c2csc(c2)C(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I22 compound treatment 0.0715 -0.00273 -0.32 -0.323 -1.0 2123109 Peakdale1_000550 CC(=O)N1CCc2cc(ccc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)/C=C/c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I23 mock treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 I24 mock treatment 0.0685 -0.00573 -0.68 -0.6785 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J01 compound treatment 0.0685 -0.00573 -0.68 -0.6785 -1.0 2123110 Peakdale1_000551 CCC(CO)NC(=O)CCOC(Cc1cnccn1)c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J02 compound treatment 0.0685 -0.00573 -0.68 -0.6785 -1.0 2123111 Peakdale1_000552 Cc1ccc(cc1)S(=O)(=O)c2cnc(N)nc2c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J03 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123112 Peakdale1_000553 FC(F)(F)c1ccc(cc1)C(Cc2cnccn2)OCCC(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J04 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123113 Peakdale1_000554 Cc1ccc(cc1)S(=O)(=O)c2cnc(nc2c3ccncc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J05 compound treatment 0.0715 -0.00273 -0.32 -0.323 -1.0 2123114 Peakdale1_000555 FC(F)(F)c1ccc(cc1)C(Cc2cnccn2)OCCC(=O)NC3CCSC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J06 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123115 Peakdale1_000556 Cc1ccc(cc1)S(=O)(=O)c2cnc(nc2c3ccncc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J07 compound treatment 0.077 0.00277 0.33 0.3287 1.0 2123116 Peakdale1_000557 CON(C)C(=O)CCOC(Cc1cnccn1)c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J08 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123117 Peakdale1_000558 Cc1ccc(cc1)S(=O)(=O)c2cnc(C)nc2c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J09 compound treatment 0.08 0.00577 0.68 0.6842 1.0 2123118 Peakdale1_000559 FC(F)(F)c1ccc(cc1)C(Cc2cnccn2)OCCC(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J10 compound treatment 0.0775 0.00327 0.39 0.388 1.0 2123119 Peakdale1_000560 Cc1ccc(cc1)S(=O)(=O)c2cnc(nc2c3cccnc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J11 compound treatment 0.0825 0.00827 0.98 0.9804 1.0 2123120 Peakdale1_000561 CC(C)(C)OC(=O)C1CCCN1C(=O)CCOC(Cc2cnccn2)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J12 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123121 Peakdale1_000562 Cc1ccc(cc1)S(=O)(=O)c2cnc(nc2c3cccnc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J13 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2123122 Peakdale1_000563 FC(F)(F)c1ccc(cc1)c2n[nH]cc2c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J14 compound treatment 0.069 -0.00523 -0.62 -0.6192 -1.0 2123123 Peakdale1_000564 Cc1ccc(cc1)S(=O)(=O)c2cnc(N)nc2c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J15 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123124 Peakdale1_000565 CCNC(=O)n1cc(c(n1)c2ccc(cc2)C(F)(F)F)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J16 compound treatment 0.069 -0.00523 -0.62 -0.6192 -1.0 2123125 Peakdale1_000566 Cc1ccc(cc1)S(=O)(=O)c2cnc(nc2c3ccccn3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J17 compound treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 2123126 Peakdale1_000567 CC(C)(C)C(=O)n1cc(c(n1)c2ccc(cc2)C(F)(F)F)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J18 compound treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 2123127 Peakdale1_000568 Cc1ccc(cc1)S(=O)(=O)c2cnc(nc2c3ccccn3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J19 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2123128 Peakdale1_000569 Cc1ccc(cc1)S(=O)(=O)NC(=O)n2cc(c(n2)c3ccc(cc3)C(F)(F)F)c4ccncn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J20 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123129 Peakdale1_000570 CCOC(CNc1ccc(cn1)C(F)(F)F)(OCC)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J21 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123130 Peakdale1_000571 CS(=O)(=O)c1cnc(N)nc1c2cccc(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J22 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123131 Peakdale1_000572 CCOC(CNC(=O)c1cccc(c1)S(=O)(=O)C)(OCC)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J23 mock treatment 0.072 -0.00223 -0.26 -0.2637 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 J24 mock treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K01 compound treatment 0.068 -0.00623 -0.74 -0.7377 -1.0 2123132 Peakdale1_000573 CC(=O)OCC(=O)c1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K02 compound treatment 0.0675 -0.00673 -0.8 -0.7969 -1.0 2123133 Peakdale1_000574 CC(=O)N1CCc2cc(ccc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K03 compound treatment 0.068 -0.00623 -0.74 -0.7377 -1.0 2123134 Peakdale1_000575 CS(=O)(=O)c1ccc(cc1)C(=O)COC(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K04 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123135 Peakdale1_000576 CC(=O)N1CCc2cc(ccc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)Nc5ccccc5C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K05 compound treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 2123136 Peakdale1_000577 CS(=O)(=O)c1ccc(cc1)C(=O)COC(=O)C(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K06 compound treatment 0.0685 -0.00573 -0.68 -0.6785 -1.0 2123137 Peakdale1_000578 CC(=O)N1CCc2cc(ccc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)Nc5ccc(F)cc5F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K07 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123138 Peakdale1_000579 COC(=O)c1ccccc1SCC(=O)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K08 compound treatment 0.0715 -0.00273 -0.32 -0.323 -1.0 2123139 Peakdale1_000580 COc1ccc(cc1)S(=O)(=O)N(C2CCN(Cc3ccccc3)CC2)c4ccc5N(CCc5c4)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K09 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2123140 Peakdale1_000581 COC(=O)c1ccccc1S(=O)CC(=O)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K10 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123141 Peakdale1_000582 OC(=O)c1cc(C(=O)O)c(nc1O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K11 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2080001 Peakdale1_000583 CN(C)CCC(=O)c1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K12 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123142 Peakdale1_000584 OC(=O)c1cc(C(=O)O)c(nc1O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K13 compound treatment 0.068 -0.00623 -0.74 -0.7377 -1.0 2123143 Peakdale1_000585 CS(=O)(=O)c1ccc(cc1)C(=O)CCN2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K14 compound treatment 0.068 -0.00623 -0.74 -0.7377 -1.0 2123144 Peakdale1_000586 OC(=O)c1cc(C(=O)O)c(nc1O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K15 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123145 Peakdale1_000587 COc1cc(nc(OC)n1)C(=O)NCC(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K16 compound treatment 0.069 -0.00523 -0.62 -0.6192 -1.0 2123146 Peakdale1_000588 OC(=O)c1cc(C(=O)O)c(nc1O)c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K17 compound treatment 0.077 0.00277 0.33 0.3287 1.0 2123147 Peakdale1_000589 CCOC(=O)C(C)NC(=O)c1cc(OC)nc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K18 compound treatment 0.067 -0.00723 -0.86 -0.8562 -1.0 2123148 Peakdale1_000590 COc1cc(cc(OC)c1OC)c2nc(O)c(cc2C(=O)O)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K19 compound treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 2123149 Peakdale1_000591 CCOC(=O)C(CC(C)C)NC(=O)c1cc(OC)nc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K20 compound treatment 0.089 0.0148 1.75 1.7506 1.0 2123150 Peakdale1_000592 CN(C)S(=O)(=O)c1cccc2CCNc21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K21 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123151 Peakdale1_000593 COC(=O)C(C)(C)NC(=O)c1cc(OC)nc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K22 compound treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 2123152 Peakdale1_000594 CCNC(=O)N1CCc2cccc(c12)S(=O)(=O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K23 mock treatment 0.0715 -0.00273 -0.32 -0.323 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 K24 mock treatment 0.069 -0.00523 -0.62 -0.6192 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L01 compound treatment 0.0685 -0.00573 -0.68 -0.6785 -1.0 2123153 Peakdale1_000595 CS(=O)(=O)c1cnc(nc1c2cccc(F)c2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L02 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123154 Peakdale1_000596 CCOC(CNC(=O)c1ccc2cc[nH]c2c1)(OCC)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L03 compound treatment 0.069 -0.00523 -0.62 -0.6192 -1.0 2123155 Peakdale1_000597 CSc1ncc(c(n1)c2cccc(F)c2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L04 compound treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 2123156 Peakdale1_000598 CCOC(CNC(=O)c1ccc2ccccc2n1)(OCC)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L05 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123157 Peakdale1_000599 CC(=O)Nc1ncc(c(n1)c2ccc(cc2)C(F)(F)F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L06 compound treatment 0.085 0.0108 1.28 1.2766 1.0 2123158 Peakdale1_000600 CCOC(CNS(=O)(=O)c1ccc(cc1)S(=O)(=O)C)(OCC)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L07 compound treatment 0.091 0.0168 1.99 1.9876 1.0 2123159 Peakdale1_000601 CS(=O)(=O)c1cc(C#N)c(O)nc1c2cccc(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L08 compound treatment 0.093 0.0188 2.22 2.2246 1.0 2123160 Peakdale1_000602 CCOC(CNC(=O)Nc1cccc(c1)C(F)(F)F)(OCC)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L09 compound treatment 0.089 0.0148 1.75 1.7506 1.0 2123161 Peakdale1_000603 c1[nH]nc(c1c2ccncn2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L10 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2123162 Peakdale1_000604 CCOC(CNc1ncccc1C(F)(F)F)(OCC)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L11 compound treatment 0.0845 0.0103 1.22 1.2174 1.0 2123163 Peakdale1_000605 CC(C)(C)C(=O)n1cc(c(n1)c2ccncc2)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L12 compound treatment 0.0775 0.00327 0.39 0.388 1.0 2123164 Peakdale1_000606 CCOC(CNc1nc(OC)cc(OC)n1)(OCC)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L13 compound treatment 0.092 0.0178 2.11 2.1061 1.0 2123165 Peakdale1_000607 CCNC(=O)n1cc(c(n1)c2ccncc2)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L14 compound treatment 0.0785 0.00427 0.51 0.5064 1.0 2123166 Peakdale1_000608 CCOC(CNS(=O)(=O)c1ccccc1S(=O)(=O)C)(OCC)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L15 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123167 Peakdale1_000609 Cc1ccc(cc1)S(=O)(=O)NC(=O)n2cc(c(n2)c3ccncc3)c4ccncn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L16 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123168 Peakdale1_000610 CCOC(CNC(=O)c1c(OC)cccc1OC)(OCC)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L17 compound treatment 0.09 0.0158 1.87 1.8691 1.0 2123169 Peakdale1_000611 c1[nH]nc(c1c2ccncn2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L18 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123170 Peakdale1_000612 CCOC(CNC(=O)C(c1ccccc1)c2ccccc2)(OCC)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L19 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123171 Peakdale1_000613 CC(C)(C)C(=O)n1cc(c(n1)c2cccnc2)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L20 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123172 Peakdale1_000614 CCOC(CNC(=O)c1cccs1)(OCC)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L21 compound treatment 0.072 -0.00223 -0.26 -0.2637 -1.0 2123173 Peakdale1_000615 CCNC(=O)n1cc(c(n1)c2cccnc2)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L22 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123174 Peakdale1_000616 CCOC(CNC(=O)Nc1ccccc1OC)(OCC)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L23 mock treatment 0.0755 0.00127 0.15 0.151 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 L24 mock treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M01 compound treatment 0.066 -0.00823 -0.97 -0.9747 -1.0 2123175 Peakdale1_000617 COc1cc(nc(OC)n1)C(=O)N2CCCC2C(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M02 compound treatment 0.0665 -0.00773 -0.92 -0.9154 -1.0 2123176 Peakdale1_000618 COc1ccccc1NC(=O)N2CCc3cccc(c23)S(=O)(=O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M03 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2123177 Peakdale1_000619 Cc1cc(C)nc(Oc2ccc(NC(=O)/C=C\C(=O)O)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M04 compound treatment 0.068 -0.00623 -0.74 -0.7377 -1.0 2123178 Peakdale1_000620 CN(C)S(=O)(=O)c1cccc2CCN(C(=O)Nc3ccccc3C(F)(F)F)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M05 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123179 Peakdale1_000621 C/C(=C/C(=O)Nc1ccc(Oc2nc(C)cc(C)n2)cc1)/C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M06 compound treatment 0.069 -0.00523 -0.62 -0.6192 -1.0 2123180 Peakdale1_000622 CN(C)S(=O)(=O)c1cccc2CCN(C(=O)Nc3ccc(F)cc3F)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M07 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2123181 Peakdale1_000623 Cc1cc(C)nc(Sc2ccc(NC(=O)/C=C\C(=O)O)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M08 compound treatment 0.0725 -0.00173 -0.2 -0.2045 -1.0 2123182 Peakdale1_000624 C/C(=N/N1CCc2ccccc12)/C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M09 compound treatment 0.092 0.0178 2.11 2.1061 1.0 2123183 Peakdale1_000625 C/C(=C/C(=O)Nc1ccc(Sc2nc(C)cc(C)n2)cc1)/C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M10 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123184 Peakdale1_000626 CCOC(=O)/C(=N\N1CCc2ccccc12)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M11 compound treatment 0.0935 0.0193 2.28 2.2838 1.0 2123185 Peakdale1_000627 Cc1cc(C)nc(Sc2ccc(Cl)nn2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M12 compound treatment 0.082 0.00777 0.92 0.9212 1.0 2123186 Peakdale1_000628 COC(=O)CNC(=O)/C(=N\N1CCc2ccccc12)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M13 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123187 Peakdale1_000629 COc1nc(OC)nc(Sc2nc(C)cc(C)n2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M14 compound treatment 0.0945 0.0203 2.4 2.4023 1.0 2123188 Peakdale1_000630 C/C(=N/N1CCc2ccccc12)/C(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M15 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123189 Peakdale1_000631 COC(=O)c1ccc(Sc2nc(C)cc(C)n2)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M16 compound treatment 0.0685 -0.00573 -0.68 -0.6785 -1.0 2123190 Peakdale1_000632 C/C(=N/N1CCc2ccccc12)/C(=O)NC3CCSC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M17 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123191 Peakdale1_000633 CC(C)Oc1ccc(CSc2nc(C)cc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M18 compound treatment 0.0695 -0.00473 -0.56 -0.56 -1.0 2123192 Peakdale1_000634 C/C(=N/N1CCc2ccccc12)/C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M19 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123193 Peakdale1_000635 COC(=O)c1ccccc1CSc2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M20 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123194 Peakdale1_000636 CN(C)S(=O)(=O)c1cccc2CCN(C(=O)C)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M21 compound treatment 0.0725 -0.00173 -0.2 -0.2045 -1.0 2123195 Peakdale1_000637 CC(C)N(C(=O)CSc1nc(C)cc(C)n1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M22 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2123196 Peakdale1_000638 CN(C)S(=O)(=O)c1cccc2CCN(C(=O)CCC(=O)O)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M23 mock treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 M24 mock treatment 0.072 -0.00223 -0.26 -0.2637 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N01 compound treatment 0.066 -0.00823 -0.97 -0.9747 -1.0 2123197 Peakdale1_000639 Clc1ccccc1c2n[nH]cc2c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N02 compound treatment 0.069 -0.00523 -0.62 -0.6192 -1.0 2123198 Peakdale1_000640 CCOC(CNC(=O)NS(=O)(=O)c1ccc(C)cc1)(OCC)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N03 compound treatment 0.082 0.00777 0.92 0.9212 1.0 2123199 Peakdale1_000641 CC(C)(C)C(=O)n1cc(c(n1)c2ccccc2Cl)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N04 compound treatment 0.0715 -0.00273 -0.32 -0.323 -1.0 2123200 Peakdale1_000642 CN(C)C1c2cccn2-c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N05 compound treatment 0.0825 0.00827 0.98 0.9804 1.0 2123201 Peakdale1_000643 CCNC(=O)n1cc(c(n1)c2ccccc2Cl)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N06 compound treatment 0.082 0.00777 0.92 0.9212 1.0 2079977 Peakdale1_000644 C1CN(CCO1)C2c3cccn3-c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N07 compound treatment 0.096 0.0218 2.58 2.58 1.0 2123202 Peakdale1_000645 Cc1ccc(cc1)S(=O)(=O)NC(=O)n2cc(c(n2)c3ccccc3Cl)c4ccncn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N08 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2123203 Peakdale1_000646 CN1CCN(CC1)C2c3cccn3-c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N09 compound treatment 0.0835 0.00927 1.1 1.0989 1.0 2123204 Peakdale1_000647 CC(C)(CC(=O)O)n1cccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N10 compound treatment 0.083 0.00877 1.04 1.0397 1.0 2123205 Peakdale1_000648 OC(CS(=O)(=O)c1ccc(cc1)n2cccc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N11 compound treatment 0.088 0.0138 1.63 1.6321 1.0 2123206 Peakdale1_000649 COCCNC(=O)CC(C)(C)n1cccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N12 compound treatment 0.098 0.0238 2.82 2.817 1.0 2123207 Peakdale1_000650 COc1ccc(cc1)C(=O)Nc2ccc(Sc3nc(C)cc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N13 compound treatment 0.083 0.00877 1.04 1.0397 1.0 2123208 Peakdale1_000651 CC(C)(CC(=O)NC1CCSC1=O)n2cccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N14 compound treatment 0.0855 0.0113 1.34 1.3359 1.0 2123209 Peakdale1_000652 Cc1cc(C)nc(Sc2ccc(NC(=O)c3ccc(OC(F)(F)F)cc3)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N15 compound treatment 0.095 0.0208 2.46 2.4615 1.0 2123210 Peakdale1_000653 COc1ccc(NC(=O)CC(C)(C)n2cccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N16 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123211 Peakdale1_000654 CN(C(=O)c1ccc(cc1)C(C)(C)C)c2ccc(Sc3nc(C)cc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N17 compound treatment 0.0825 0.00827 0.98 0.9804 1.0 2123212 Peakdale1_000655 COc1ccccc1CNC(=O)CC(C)(C)n2cccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N18 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123213 Peakdale1_000656 CCc1c(C)nc(Sc2ccc(NC(=O)c3ccc(cc3)C(C)(C)C)cc2)nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N19 compound treatment 0.094 0.0198 2.34 2.343 1.0 2123214 Peakdale1_000657 CC(C)(CC(=O)NCc1cccc(c1)C(F)(F)F)n2cccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N20 compound treatment 0.0795 0.00527 0.62 0.6249 1.0 2123215 Peakdale1_000658 COc1cc(OC)nc(Sc2ccc(NC(=O)c3ccc(cc3)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N21 compound treatment 0.0765 0.00227 0.27 0.2695 1.0 2123216 Peakdale1_000659 CON(C)C(=O)CC(C)(C)n1cccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N22 compound treatment 0.084 0.00977 1.16 1.1581 1.0 2123217 Peakdale1_000660 Cc1cc(C)nc(Sc2ccc(NC(=O)c3ccc(cc3)C(F)(F)F)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N23 mock treatment 0.0785 0.00427 0.51 0.5064 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 N24 mock treatment 0.0785 0.00427 0.51 0.5064 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O01 compound treatment 0.0675 -0.00673 -0.8 -0.7969 -1.0 2123218 Peakdale1_000661 CC(=O)Nc1cc2CCCCCCCCCc(c1)c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O02 compound treatment 0.065 -0.00923 -1.09 -1.0932 -1.0 2123219 Peakdale1_000662 CN(C)S(=O)(=O)c1cccc2CCN(C(=O)CCC(=O)NCc3cccc(c3)C(F)(F)F)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O03 compound treatment 0.069 -0.00523 -0.62 -0.6192 -1.0 2123220 Peakdale1_000663 c1cc2ccc3cccnc3c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O04 compound treatment 0.068 -0.00623 -0.74 -0.7377 -1.0 2123221 Peakdale1_000664 CN(C)S(=O)(=O)c1cccc2CCN(C(=O)/C=C/c3ccccc3)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O05 compound treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 2123222 Peakdale1_000665 COC(=O)[C@@]1(N=[N+]=[N-])[C@@H](O)Cc2ccccc21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O06 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123223 Peakdale1_000666 COC(=O)CSC(C)C(=O)N1CCc2cccc(c12)S(=O)(=O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O07 compound treatment 0.077 0.00277 0.33 0.3287 1.0 2123224 Peakdale1_000667 CC(C)Oc1ccc(NC(=O)c2cc3cccnc3nc2C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O08 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2123225 Peakdale1_000668 COC(=O)CS(=O)C(C)C(=O)N1CCc2cccc(c12)S(=O)(=O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O09 compound treatment 0.0705 -0.00373 -0.44 -0.4415 -1.0 2123226 Peakdale1_000669 COC(=O)c1cnc(Oc2cccc3cccnc23)cc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O10 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123227 Peakdale1_000670 CN(C)S(=O)(=O)c1cccc2CCN(C(=O)c3cccc(c3)C(F)(F)F)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O11 compound treatment 0.073 -0.00123 -0.15 -0.1452 -1.0 2123228 Peakdale1_000671 CCOC(=O)c1cc2cccc(NC(=O)C(C)(C)C)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O12 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2123229 Peakdale1_000672 COc1cccc(OC)c1C(=O)N2CCc3cccc(c23)S(=O)(=O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O13 compound treatment 0.07 -0.00423 -0.5 -0.5007 -1.0 2123230 Peakdale1_000673 CCOC(=O)c1cc2cccc(NC(=O)c3cccc(c3)C(F)(F)F)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O14 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2123231 Peakdale1_000674 CC(=O)N1CCc2cc(NC3CCN(CCc4ccccc4)CC3)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O15 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2123232 Peakdale1_000675 CCOC(=O)c1cc2cccc(NC(=O)c3c(OC)cccc3OC)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O16 compound treatment 0.072 -0.00223 -0.26 -0.2637 -1.0 2123233 Peakdale1_000676 CC(=O)N1CCc2cc(ccc12)N(C3CCN(CCc4ccccc4)CC3)C(=O)C5CC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O17 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123234 Peakdale1_000677 CCOC(=O)c1cc2cccc(NC(=O)c3ccccc3OC(=O)C)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O18 compound treatment 0.0745 2.74E-4 0.03 0.0325 1.0 2123235 Peakdale1_000678 CC(=O)N1CCc2cc(ccc12)N(C3CCN(CCc4ccccc4)CC3)C(=O)/C=C/c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O19 compound treatment 0.081 0.00677 0.8 0.8027 1.0 2123236 Peakdale1_000679 CCOC(=O)c1cc2cccc(NS(=O)(=O)c3ccc(OC)cc3)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O20 compound treatment 0.076 0.00177 0.21 0.2102 1.0 2123237 Peakdale1_000680 CC(=O)N1CCc2cc(ccc12)N(C3CCN(CCc4ccccc4)CC3)C(=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O21 compound treatment 0.081 0.00677 0.8 0.8027 1.0 2123238 Peakdale1_000681 CS(=O)(=O)c1ccc2[nH]c(cc2c1)C(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O22 compound treatment 0.079 0.00477 0.57 0.5657 1.0 2123239 Peakdale1_000682 COc1ccccc1NC(=O)N(C2CCN(CCc3ccccc3)CC2)c4ccc5N(CCc5c4)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O23 mock treatment 0.081 0.00677 0.8 0.8027 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 O24 mock treatment 0.0785 0.00427 0.51 0.5064 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P01 compound treatment 0.0785 0.00427 0.51 0.5064 1.0 2123240 Peakdale1_000683 CN(C(=O)CC(C)(C)n1cccc1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P02 compound treatment 0.0545 -0.0197 -2.34 -2.3373 -1.0 2123241 Peakdale1_000684 CCSc1ccc(cc1)C(=O)Nc2ccc(Sc3nc(C)cc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P03 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2123242 Peakdale1_000685 CN(Cc1ncccc1Oc2nc(C)cc(C)n2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P04 compound treatment 0.065 -0.00923 -1.09 -1.0932 -1.0 2123243 Peakdale1_000686 CCN(C(=O)c1ccc(cc1)C(C)(C)C)c2ccc(Sc3nc(C)cc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P05 compound treatment 0.0785 0.00427 0.51 0.5064 1.0 2123244 Peakdale1_000687 COc1cc(OC)nc(Oc2cccnc2CN(C)c3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P06 compound treatment 0.0655 -0.00873 -1.03 -1.0339 -1.0 2123245 Peakdale1_000688 COc1cc(OC)nc(Sc2ccc(NC(=O)Cc3ccccc3)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P07 compound treatment 0.092 0.0178 2.11 2.1061 1.0 2123246 Peakdale1_000689 COc1ccc(cc1)N(C)Cc2ncccc2Oc3nc(OC)cc(OC)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P08 compound treatment 0.08 0.00577 0.68 0.6842 1.0 2123247 Peakdale1_000690 COc1nc(Sc2ccc(NC(=O)c3ccc(cc3)C(C)(C)C)cc2)nc4OCCc41 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P09 compound treatment 0.0835 0.00927 1.1 1.0989 1.0 2123248 Peakdale1_000691 CCNC(=O)Oc1cccnc1CN(C)c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P10 compound treatment 0.0775 0.00327 0.39 0.388 1.0 2123249 Peakdale1_000692 CCSc1ccc(cc1)C(=O)Nc2ccc(Sc3nc4OCCc4c(OC)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P11 compound treatment 0.0855 0.0113 1.34 1.3359 1.0 2123250 Peakdale1_000693 CC(C)N(CCCC(O)c1ccc(F)cc1)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P12 compound treatment 0.085 0.0108 1.28 1.2766 1.0 2123251 Peakdale1_000694 CS(=O)c1cnc(nc1c2ccc(cc2)C(F)(F)F)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P13 compound treatment 0.083 0.00877 1.04 1.0397 1.0 2123252 Peakdale1_000695 CC(C)N(CCCC(O)c1ccc(F)cc1)C(=O)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P14 compound treatment 0.075 7.74E-4 0.09 0.0917 1.0 2123253 Peakdale1_000696 CS(=O)(=O)c1cnc(nc1c2ccc(Cl)cc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P15 compound treatment 0.077 0.00277 0.33 0.3287 1.0 2123254 Peakdale1_000697 CCNC(=O)N(CCCC(O)c1ccc(F)cc1)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P16 compound treatment 0.074 -2.26E-4 -0.03 -0.0268 -1.0 2123255 Peakdale1_000698 CS(=O)(=O)c1cnc(nc1c2cccc(F)c2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P17 compound treatment 0.078 0.00377 0.45 0.4472 1.0 2123256 Peakdale1_000699 COc1ccccc1NC(=O)N(CCCC(O)c2ccc(F)cc2)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P18 compound treatment 0.071 -0.00323 -0.38 -0.3822 -1.0 2123257 Peakdale1_000700 FC(F)(F)c1ccc(cc1)c2nc(ncc2c3ccncn3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P19 compound treatment 0.0865 0.0123 1.45 1.4544 1.0 2123258 Peakdale1_000701 CNCCC(O)c1ccc(F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P20 compound treatment 0.0755 0.00127 0.15 0.151 1.0 2123259 Peakdale1_000702 Clc1ccccc1c2nc(ncc2c3ccncn3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P21 compound treatment 0.0725 -0.00173 -0.2 -0.2045 -1.0 2123260 Peakdale1_000703 OC(CCCN1CCOCC1)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P22 compound treatment 0.079 0.00477 0.57 0.5657 1.0 2123261 Peakdale1_000704 FC(F)(F)c1cccc(c1)S(=O)(=O)c2cnc(nc2c3ccncc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P23 mock treatment 0.0735 -7.26E-4 -0.09 -0.086 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.519 P24 mock treatment 0.067 -0.00723 -0.86 -0.8562 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A01 compound treatment 0.0815 0.00778 0.92 0.9222 1.0 2123262 Peakdale1_000705 Cc1ccc(cc1)S(=O)(=O)c2cnc(nc2c3cccnc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A02 compound treatment 0.0685 -0.00522 -0.62 -0.6181 -1.0 2123263 Peakdale1_000706 FC(F)(F)c1ccc(cc1)C(=O)N(C(=O)c2ccc(cc2)C(F)(F)F)c3nccc4cccnc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A03 compound treatment 0.081 0.00728 0.86 0.863 1.0 2123264 Peakdale1_000707 Nc1ncc(c2nc3ccccc3o2)c(n1)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A04 compound treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 2123265 Peakdale1_000708 FC(F)(F)c1cccc(c1)C(=O)N(C(=O)c2cccc(c2)C(F)(F)F)c3nccc4cccnc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A05 compound treatment 0.0705 -0.00322 -0.38 -0.3811 -1.0 2123266 Peakdale1_000709 Cc1ncc(c2nc3ccccc3o2)c(n1)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A06 compound treatment 0.0715 -0.00222 -0.26 -0.2627 -1.0 2123267 Peakdale1_000710 OC(=O)CCC(=O)Nc1nccc2cccnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A07 compound treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 2123268 Peakdale1_000711 c1ccc(nc1)c2ncc(c3nc4ccccc4o3)c(n2)c5ccncc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A08 compound treatment 0.094 0.0203 2.4 2.4034 1.0 2123269 Peakdale1_000712 CC(C)(C)C(=O)NC(=O)Nc1nccc2cccnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A09 compound treatment 0.076 0.00228 0.27 0.2706 1.0 2123270 Peakdale1_000713 c1ccc2oc(nc2c1)c3cnc(nc3c4ccncc4)c5cccnc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A10 compound treatment 0.091 0.0173 2.05 2.0479 1.0 2123271 Peakdale1_000714 FC(F)(F)c1ccccc1NC(=O)Nc2nccc3cccnc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A11 compound treatment 0.0775 0.00378 0.45 0.4483 1.0 2123272 Peakdale1_000715 c1ccc2oc(nc2c1)c3cnc(nc3c4ccncc4)c5ccncc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A12 compound treatment 0.088 0.0143 1.69 1.6924 1.0 2123273 Peakdale1_000716 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2nccc3cccnc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A13 compound treatment 0.076 0.00228 0.27 0.2706 1.0 2123274 Peakdale1_000717 Oc1nc(c2ccncc2)c(cc1C#N)c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A14 compound treatment 0.0715 -0.00222 -0.26 -0.2627 -1.0 2123275 Peakdale1_000718 CCC(=O)Nc1ccc2[nH]c(C)cc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A15 compound treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 2123276 Peakdale1_000719 c1[nH]nc(c1c2nc3ccccc3o2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A16 compound treatment 0.0915 0.0178 2.11 2.1071 1.0 2123277 Peakdale1_000720 CCNC(=O)Nc1ccc2[nH]c(C)cc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A17 compound treatment 0.069 -0.00472 -0.56 -0.5589 -1.0 2123278 Peakdale1_000721 CC(C)(C)C(=O)n1cc(c2nc3ccccc3o2)c(n1)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A18 compound treatment 0.0865 0.0128 1.51 1.5147 1.0 2123279 Peakdale1_000722 Cc1cc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A19 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123280 Peakdale1_000723 CCNC(=O)n1cc(c2nc3ccccc3o2)c(n1)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A20 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 1404909 Peakdale1_000724 Cc1cc2cc(NC(=O)c3cccs3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A21 compound treatment 0.075 0.00128 0.15 0.1521 1.0 2123281 Peakdale1_000725 Cc1ccc(cc1)S(=O)(=O)NC(=O)n2cc(c3nc4ccccc4o3)c(n2)c5ccncc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A22 compound treatment 0.0825 0.00878 1.04 1.0407 1.0 2123282 Peakdale1_000726 CN1CCC(CC1)Nc2ccc3CCN(C(=O)C)c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A23 mock treatment 0.0885 0.0148 1.75 1.7517 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 A24 mock treatment 0.083 0.00928 1.1 1.1 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B01 compound treatment 0.067 -0.00672 -0.8 -0.7959 -1.0 2123283 Peakdale1_000727 CS(=O)(=O)c1cnc(nc1c2ccccc2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B02 compound treatment 0.067 -0.00672 -0.8 -0.7959 -1.0 2123284 Peakdale1_000728 CS(=O)(=O)c1ccc(CNS(=O)(=O)c2ccc3oc(=O)ccc3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B03 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123285 Peakdale1_000729 CS(=O)(=O)c1cnc(nc1c2ccccc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B04 compound treatment 0.0705 -0.00322 -0.38 -0.3811 -1.0 2123286 Peakdale1_000730 CC(C)Oc1ccc(NS(=O)(=O)c2ccc3oc(=O)ccc3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B05 compound treatment 0.0705 -0.00322 -0.38 -0.3811 -1.0 2123287 Peakdale1_000731 CS(=O)(=O)c1cnc(nc1c2ccc(cc2)C(F)(F)F)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B06 compound treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 2123288 Peakdale1_000732 Cc1c(NS(=O)(=O)c2ccc3oc(=O)ccc3c2)cccc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B07 compound treatment 0.077 0.00328 0.39 0.389 1.0 2123289 Peakdale1_000733 CS(=O)(=O)c1cnc(nc1c2ccc(cc2)C(F)(F)F)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B08 compound treatment 0.0755 0.00178 0.21 0.2113 1.0 2123290 Peakdale1_000734 CS(=O)(=O)c1ccc(NS(=O)(=O)c2ccc3oc(=O)ccc3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B09 compound treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 2123291 Peakdale1_000735 CS(=O)(=O)c1cnc(nc1c2cccc(c2)C(F)(F)F)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B10 compound treatment 0.073 -7.17E-4 -0.08 -0.0849 -1.0 2123292 Peakdale1_000736 CS(=O)(=O)c1ccc(NS(=O)(=O)c2ccc3oc(=O)ccc3c2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B11 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123293 Peakdale1_000737 CS(=O)(=O)c1cnc(nc1c2cccc(c2)C(F)(F)F)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B12 compound treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 2123294 Peakdale1_000738 CN(C)S(=O)(=O)c1ccc(NS(=O)(=O)c2ccc3oc(=O)ccc3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B13 compound treatment 0.072 -0.00172 -0.2 -0.2034 -1.0 2123295 Peakdale1_000739 CS(=O)(=O)c1cnc(nc1c2cccc(c2)C(F)(F)F)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B14 compound treatment 0.0795 0.00578 0.69 0.6853 1.0 2123296 Peakdale1_000740 CN(C)S(=O)(=O)c1ccc(cc1)N(Cc2ccccc2)S(=O)(=O)c3ccc4oc(=O)ccc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B15 compound treatment 0.0705 -0.00322 -0.38 -0.3811 -1.0 2123297 Peakdale1_000741 CS(=O)(=O)c1cnc(nc1c2ccccc2C(F)(F)F)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B16 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123298 Peakdale1_000742 Cc1ccnc(Sc2ccc(NS(=O)(=O)c3ccc4oc(=O)ccc4c3)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B17 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123299 Peakdale1_000743 COc1cnc(nc1c2ccccc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B18 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123300 Peakdale1_000744 CN(c1nc(C)cc(C)n1)S(=O)(=O)c2ccc3oc(=O)ccc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B19 compound treatment 0.08 0.00628 0.74 0.7445 1.0 2123301 Peakdale1_000745 COc1cnc(nc1c2ccccc2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B20 compound treatment 0.08 0.00628 0.74 0.7445 1.0 2123302 Peakdale1_000746 CC(=O)N1CCc2cc(NS(=O)(=O)c3ccc4oc(=O)ccc4c3)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B21 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123303 Peakdale1_000747 COc1cnc(nc1c2ccccc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B22 compound treatment 0.0775 0.00378 0.45 0.4483 1.0 2123304 Peakdale1_000748 Cc1ccc2N(CCc2c1)S(=O)(=O)c3ccc4oc(=O)ccc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B23 mock treatment 0.0775 0.00378 0.45 0.4483 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 B24 mock treatment 0.0775 0.00378 0.45 0.4483 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C01 compound treatment 0.073 -7.17E-4 -0.08 -0.0849 -1.0 2123305 Peakdale1_000749 CCOC(CNC(=O)c1cccc(N)c1)(OCC)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C02 compound treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 2079981 Peakdale1_000750 CN1CCC(CC1)N(C(=O)c2ccc(cc2)C(F)(F)F)c3ccc4CCN(C(=O)C)c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C03 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123306 Peakdale1_000751 CCOC(CNC(=O)c1cccc(NC(=O)C(C)(C)C)c1)(OCC)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C04 compound treatment 0.0715 -0.00222 -0.26 -0.2627 -1.0 2123307 Peakdale1_000752 CN1CCC(CC1)N(C(=O)c2cccs2)c3ccc4CCN(C(=O)C)c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C05 compound treatment 0.083 0.00928 1.1 1.1 1.0 2123308 Peakdale1_000753 CCOC(CNC(=O)c1cccc(NC(=O)c2ccc(cc2)C(F)(F)F)c1)(OCC)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C06 compound treatment 0.073 -7.17E-4 -0.08 -0.0849 -1.0 2123309 Peakdale1_000754 CS(=O)(=O)c1ccc(CCC(=O)O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C07 compound treatment 0.0815 0.00778 0.92 0.9222 1.0 2123310 Peakdale1_000755 CCOC(CNC(=O)c1cccc(NC(=O)C(c2ccccc2)c3ccccc3)c1)(OCC)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C08 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123311 Peakdale1_000756 CC(=C)CNC(=O)CCc1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C09 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123312 Peakdale1_000757 CCOC(CNC(=O)c1cccc(NC(=O)c2cccs2)c1)(OCC)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C10 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123313 Peakdale1_000758 CS(=O)(=O)c1ccc(CCC(=O)NCCN2CCOCC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C11 compound treatment 0.077 0.00328 0.39 0.389 1.0 2123314 Peakdale1_000759 CCOC(CNC(=O)c1cccc(NS(=O)(=O)c2ccccc2S(=O)(=O)C)c1)(OCC)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C12 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123315 Peakdale1_000760 CS(=O)(=O)c1ccc(CCC(=O)NCC2CCCO2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C13 compound treatment 0.0795 0.00578 0.69 0.6853 1.0 2123316 Peakdale1_000761 CCOC(CNC(=O)c1cccc(NC(=O)Nc2ccccc2C(F)(F)F)c1)(OCC)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C14 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123317 Peakdale1_000762 CS(=O)(=O)c1ccc(CCC(=O)NCc2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C15 compound treatment 0.0805 0.00678 0.8 0.8038 1.0 2123318 Peakdale1_000763 CCOC(CNC(=O)c1cccc(NC(=O)NS(=O)(=O)c2ccc(C)cc2)c1)(OCC)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C16 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123319 Peakdale1_000764 CS(=O)(=O)c1ccc(CCC(=O)Nc2ccc(cc2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C17 compound treatment 0.0905 0.0168 1.99 1.9887 1.0 2123320 Peakdale1_000765 O=C1CCNCCN1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C18 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123321 Peakdale1_000766 COc1cccc(NC(=O)CCc2ccc(cc2)S(=O)(=O)C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C19 compound treatment 0.0795 0.00578 0.69 0.6853 1.0 1030543 Peakdale1_000767 O=C1CCN(Cc2ccccc2)CCN1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C20 compound treatment 0.0755 0.00178 0.21 0.2113 1.0 2123322 Peakdale1_000768 CC(=O)N1CCc2cc(NC3CCN(CC3)C(=O)C)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C21 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123323 Peakdale1_000769 O=C(/C=C/c1ccccc1)N2CCNC(=O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C22 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123324 Peakdale1_000770 CCC(=O)N(C1CCN(CC1)C(=O)C)c2ccc3N(CCc3c2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C23 mock treatment 0.077 0.00328 0.39 0.389 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 C24 mock treatment 0.0785 0.00478 0.57 0.5668 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D01 compound treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 2123325 Peakdale1_000771 COc1cnc(nc1c2ccc(cc2)C(F)(F)F)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D02 compound treatment 0.066 -0.00772 -0.91 -0.9143 -1.0 2123326 Peakdale1_000772 CS(=O)(=O)c1ccc2N(CCc2c1)S(=O)(=O)c3ccc4oc(=O)ccc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D03 compound treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 2123327 Peakdale1_000773 COc1cnc(nc1c2ccc(cc2)C(F)(F)F)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D04 compound treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 2123328 Peakdale1_000774 CC(C)(C)c1cc2cc(NC(=O)C3CC3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D05 compound treatment 0.072 -0.00172 -0.2 -0.2034 -1.0 2123329 Peakdale1_000775 COc1cnc(nc1c2ccc(cc2)C(F)(F)F)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D06 compound treatment 0.0805 0.00678 0.8 0.8038 1.0 2123330 Peakdale1_000776 CC(C)(C)c1cc2cc(NC(=O)c3ccc(cc3)C(F)(F)F)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D07 compound treatment 0.0855 0.0118 1.4 1.3962 1.0 2123331 Peakdale1_000777 COc1cnc(nc1c2cccc(c2)C(F)(F)F)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D08 compound treatment 0.0815 0.00778 0.92 0.9222 1.0 2123332 Peakdale1_000778 CC(C)(C)c1cc2cc(NC(=O)c3cc(Cl)nc(Cl)c3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D09 compound treatment 0.0935 0.0198 2.34 2.3441 1.0 2123333 Peakdale1_000779 COc1cnc(nc1c2cccc(c2)C(F)(F)F)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D10 compound treatment 0.085 0.0113 1.34 1.337 1.0 2123334 Peakdale1_000780 COc1cc(cc(OC)c1OC)C(=O)Nc2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D11 compound treatment 0.094 0.0203 2.4 2.4034 1.0 2123335 Peakdale1_000781 COc1cnc(nc1c2cccc(c2)C(F)(F)F)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D12 compound treatment 0.0885 0.0148 1.75 1.7517 1.0 2123336 Peakdale1_000782 CC(C)(C)c1cc2cc(NC(=O)c3ccc(cc3)S(=O)(=O)C)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D13 compound treatment 0.112 0.0383 4.54 4.5362 1.0 2123337 Peakdale1_000783 FC(F)(F)S(=O)(=O)c1cccc(NC2CCNCC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D14 compound treatment 0.0865 0.0128 1.51 1.5147 1.0 2123338 Peakdale1_000784 CC(C)(C)c1cc2cc(NC(=O)c3ccc(cc3)S(=O)(=O)C(F)(F)F)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D15 compound treatment 0.0835 0.00978 1.16 1.1592 1.0 2123339 Peakdale1_000785 CC(=O)N1CCC(CC1)Nc2cccc(c2)S(=O)(=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D16 compound treatment 0.0815 0.00778 0.92 0.9222 1.0 2123340 Peakdale1_000786 CC(C)(C)c1cc2cc(NC(=O)c3cccs3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D17 compound treatment 0.1095 0.0358 4.24 4.24 1.0 2123341 Peakdale1_000787 COc1cc(cc(OC)c1OC)C(=O)N2CCC(CC2)Nc3cccc(c3)S(=O)(=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D18 compound treatment 0.076 0.00228 0.27 0.2706 1.0 2123342 Peakdale1_000788 CCNC(=O)Nc1ccc2[nH]c(cc2c1)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D19 compound treatment 0.1025 0.0288 3.41 3.4105 1.0 2123343 Peakdale1_000789 FC(F)(F)S(=O)(=O)c1cccc(NC2CCN(CC2)C(=O)Nc3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D20 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123344 Peakdale1_000790 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D21 compound treatment 0.088 0.0143 1.69 1.6924 1.0 2123345 Peakdale1_000791 CCC(=O)N(C1CCN(CC1)C(=O)C)c2cccc(c2)S(=O)(=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D22 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123346 Peakdale1_000792 CC(=O)N1CCC(CC1)Nc2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D23 mock treatment 0.076 0.00228 0.27 0.2706 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 D24 mock treatment 0.0765 0.00278 0.33 0.3298 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E01 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123347 Peakdale1_000793 O=C(C(c1ccccc1)c2ccccc2)N3CCNC(=O)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E02 compound treatment 0.0715 -0.00222 -0.26 -0.2627 -1.0 2123348 Peakdale1_000794 CC(=O)N1CCc2cc(ccc12)N(C3CCN(CC3)C(=O)C)C(=O)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E03 compound treatment 0.076 0.00228 0.27 0.2706 1.0 1017342 Peakdale1_000795 C(N1CCCNCC1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E04 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123349 Peakdale1_000796 CC(=O)N1CCc2cc(ccc12)N(C3CCN(CC3)C(=O)C)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E05 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123350 Peakdale1_000797 FC(F)(F)c1ccc(nc1)N2CCCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E06 compound treatment 0.0845 0.0108 1.28 1.2777 1.0 2123351 Peakdale1_000798 CC(=O)N1CCc2cc(ccc12)N(C3CCN(CC3)C(=O)C)C(=O)c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E07 compound treatment 0.0875 0.0138 1.63 1.6332 1.0 2080024 Peakdale1_000799 COc1ccc(cc1)S(=O)(=O)N2CCCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E08 compound treatment 0.0805 0.00678 0.8 0.8038 1.0 2123352 Peakdale1_000800 CC(=O)N1CCc2cc(ccc12)N(C3CCN(CC3)C(=O)C)C(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E09 compound treatment 0.0815 0.00778 0.92 0.9222 1.0 2080038 Peakdale1_000801 COc1cccc(OC)c1C(=O)N2CCCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E10 compound treatment 0.0835 0.00978 1.16 1.1592 1.0 2123353 Peakdale1_000802 CCNC(=O)N(C1CCN(CC1)C(=O)C)c2ccc3N(CCc3c2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E11 compound treatment 0.086 0.0123 1.46 1.4555 1.0 2123354 Peakdale1_000803 CS(=O)(=O)c1cccc(c1)C(=O)N2CCCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E12 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123355 Peakdale1_000804 CC(N)c1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E13 compound treatment 0.096 0.0223 2.64 2.6404 1.0 2123356 Peakdale1_000805 OC(=O)CCC(=O)N1CCCN(Cc2ccccc2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E14 compound treatment 0.0795 0.00578 0.69 0.6853 1.0 2123357 Peakdale1_000806 CC(NC(=O)C1CC1)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E15 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123358 Peakdale1_000807 Fc1ccc(NC(=O)N2CCCN(Cc3ccccc3)CC2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E16 compound treatment 0.0795 0.00578 0.69 0.6853 1.0 2123359 Peakdale1_000808 CC(NC(=O)c1cccc(c1)C(F)(F)F)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E17 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123360 Peakdale1_000809 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E18 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123361 Peakdale1_000810 CC(NC(=O)c1cccs1)c2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E19 compound treatment 0.0755 0.00178 0.21 0.2113 1.0 2123362 Peakdale1_000811 c1ccc(nc1)c2ncc(c3ccncn3)c(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E20 compound treatment 0.075 0.00128 0.15 0.1521 1.0 2123363 Peakdale1_000812 CCNC(=O)NC(C)c1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E21 compound treatment 0.082 0.00828 0.98 0.9815 1.0 2123364 Peakdale1_000813 c1cncc(c1)c2ncc(c3ccncn3)c(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E22 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123365 Peakdale1_000814 OC(=O)CSc1cnccc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E23 mock treatment 0.075 0.00128 0.15 0.1521 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 E24 mock treatment 0.0765 0.00278 0.33 0.3298 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F01 compound treatment 0.0715 -0.00222 -0.26 -0.2627 -1.0 2123366 Peakdale1_000815 CC(=O)N1CCC(CC1)N(C(=O)c2ccccc2)c3cccc(c3)S(=O)(=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F02 compound treatment 0.0665 -0.00722 -0.86 -0.8551 -1.0 2123367 Peakdale1_000816 CCC(=O)N(C1CCN(CC1)C(=O)C)c2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F03 compound treatment 0.0855 0.0118 1.4 1.3962 1.0 2123368 Peakdale1_000817 CCOC(=O)c1cc2cccc(NS(=O)(=O)c3ccccc3)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F04 compound treatment 0.0685 -0.00522 -0.62 -0.6181 -1.0 2123369 Peakdale1_000818 CC(=O)N1CCC(CC1)N(C(=O)c2ccc(cc2)C(F)(F)F)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F05 compound treatment 0.08 0.00628 0.74 0.7445 1.0 2123370 Peakdale1_000819 CCOC(=O)c1cc2cccc(NS(=O)(=O)c3ccc(C)cc3)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F06 compound treatment 0.0715 -0.00222 -0.26 -0.2627 -1.0 2123371 Peakdale1_000820 COc1cc(cc(OC)c1OC)C(=O)N(C2CCN(CC2)C(=O)C)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F07 compound treatment 0.0835 0.00978 1.16 1.1592 1.0 2123372 Peakdale1_000821 CCOC(=O)c1cc2cccc(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F08 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123373 Peakdale1_000822 CC(=O)N1CCC(CC1)N(C(=O)c2ccc(cc2)S(=O)(=O)C)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F09 compound treatment 0.0815 0.00778 0.92 0.9222 1.0 2123374 Peakdale1_000823 CCOC(=O)c1cc2cccc(NS(=O)(=O)c3ccc(Cl)cc3)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F10 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123375 Peakdale1_000824 CC(=O)N1CCC(CC1)N(C(=O)c2cccs2)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F11 compound treatment 0.0835 0.00978 1.16 1.1592 1.0 2123376 Peakdale1_000825 CCOC(=O)c1cc2cccc(NS(=O)(=O)c3cccc(c3)C(F)(F)F)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F12 compound treatment 0.075 0.00128 0.15 0.1521 1.0 2123377 Peakdale1_000826 O=C(c1ccccc1)c2cnc(nc2c3ccccc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F13 compound treatment 0.0955 0.0218 2.58 2.5811 1.0 2123378 Peakdale1_000827 CCOC(=O)c1cc2cccc(NS(=O)(=O)c3ccc(OC(F)(F)F)cc3)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F14 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123379 Peakdale1_000828 O=C(c1ccccc1)c2cnc(nc2c3ccccc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F15 compound treatment 0.076 0.00228 0.27 0.2706 1.0 2123380 Peakdale1_000829 CCOC(=O)c1cc2cccc(NS(=O)(=O)c3ccccc3S(=O)(=O)C)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F16 compound treatment 0.0805 0.00678 0.8 0.8038 1.0 2123381 Peakdale1_000830 Clc1ccc(cc1)C(=O)c2cnc(nc2c3ccc(Cl)cc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F17 compound treatment 0.0875 0.0138 1.63 1.6332 1.0 2123382 Peakdale1_000831 CCOC(=O)c1cc2cccc(NS(=O)(=O)c3ccc(cc3)S(=O)(=O)C)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F18 compound treatment 0.083 0.00928 1.1 1.1 1.0 2123383 Peakdale1_000832 Clc1ccc(cc1)C(=O)c2cnc(nc2c3ccc(Cl)cc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F19 compound treatment 0.094 0.0203 2.4 2.4034 1.0 2123384 Peakdale1_000833 CCOC(=O)c1cc2cccc(NS(=O)(=O)c3cccs3)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F20 compound treatment 0.0775 0.00378 0.45 0.4483 1.0 2123385 Peakdale1_000834 Clc1ccc(cc1)C(=O)c2cnc(nc2c3ccc(Cl)cc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F21 compound treatment 0.0815 0.00778 0.92 0.9222 1.0 2123386 Peakdale1_000835 CCOC(=O)c1cc2cnccc2nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F22 compound treatment 0.073 -7.17E-4 -0.08 -0.0849 -1.0 2123387 Peakdale1_000836 OC(=O)c1cc(cs1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F23 mock treatment 0.073 -7.17E-4 -0.08 -0.0849 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 F24 mock treatment 0.072 -0.00172 -0.2 -0.2034 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G01 compound treatment 0.068 -0.00572 -0.68 -0.6774 -1.0 2123388 Peakdale1_000837 c1cncc(c1)c2nc(ncc2c3ccncn3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G02 compound treatment 0.061 -0.0127 -1.51 -1.5068 -1.0 2123389 Peakdale1_000838 FC(F)(F)c1ccncc1SCC(=O)NCCN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G03 compound treatment 0.0765 0.00278 0.33 0.3298 1.0 2123390 Peakdale1_000839 c1ccc(nc1)c2ncc(c3ccncn3)c(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G04 compound treatment 0.063 -0.0107 -1.27 -1.2698 -1.0 2123391 Peakdale1_000840 FC(F)(F)c1ccncc1SCC(=O)NCCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G05 compound treatment 0.0925 0.0188 2.23 2.2256 1.0 2123392 Peakdale1_000841 c1cncc(c1)c2ncc(c3ccncn3)c(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G06 compound treatment 0.067 -0.00672 -0.8 -0.7959 -1.0 2123393 Peakdale1_000842 FC(F)(F)c1ccncc1SCC(=O)NCc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G07 compound treatment 0.098 0.0243 2.88 2.8773 1.0 2123394 Peakdale1_000843 c1cc(ccn1)c2ncc(c3ccncn3)c(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G08 compound treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 2123395 Peakdale1_000844 FC(F)(F)c1ccncc1SCC(=O)NCc2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G09 compound treatment 0.091 0.0173 2.05 2.0479 1.0 2123396 Peakdale1_000845 FC(F)(F)c1ccc(cc1)c2n[nH]cc2c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G10 compound treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 2123397 Peakdale1_000846 FC(F)(F)c1ccncc1SCC(=O)NC2CCSC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G11 compound treatment 0.099 0.0253 3.0 2.9958 1.0 2123398 Peakdale1_000847 CC(C)(C)C(=O)n1cc(c(n1)c2ccc(cc2)C(F)(F)F)c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G12 compound treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 2123399 Peakdale1_000848 FC(F)(F)c1ccncc1SCC(=O)NN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G13 compound treatment 0.082 0.00828 0.98 0.9815 1.0 2123400 Peakdale1_000849 CCNC(=O)n1cc(c(n1)c2ccc(cc2)C(F)(F)F)c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G14 compound treatment 0.083 0.00928 1.1 1.1 1.0 2123401 Peakdale1_000850 FC(F)(F)c1ccncc1SCC(=O)NOCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G15 compound treatment 0.0815 0.00778 0.92 0.9222 1.0 2123402 Peakdale1_000851 Cc1ccc(cc1)S(=O)(=O)NC(=O)n2cc(c(n2)c3ccc(cc3)C(F)(F)F)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G16 compound treatment 0.0675 -0.00622 -0.74 -0.7366 -1.0 2123403 Peakdale1_000852 CON(C)C(=O)CSc1cnccc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G17 compound treatment 0.101 0.0273 3.23 3.2328 1.0 2123404 Peakdale1_000853 c1[nH]nc(c1c2cnccn2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G18 compound treatment 0.0665 -0.00722 -0.86 -0.8551 -1.0 2123405 Peakdale1_000854 FC(F)(F)c1ccncc1SCC(=O)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G19 compound treatment 0.088 0.0143 1.69 1.6924 1.0 2123406 Peakdale1_000855 CCNC(=O)n1cc(c(n1)c2ccncc2)c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G20 compound treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 2123407 Peakdale1_000856 OC(=O)CCC(=O)N1CCNC(=O)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G21 compound treatment 0.0865 0.0128 1.51 1.5147 1.0 2123408 Peakdale1_000857 Cc1ccc(cc1)S(=O)(=O)NC(=O)n2cc(c(n2)c3ccncc3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G22 compound treatment 0.072 -0.00172 -0.2 -0.2034 -1.0 2123409 Peakdale1_000858 COC(=O)CCN1CCNC(=O)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G23 mock treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 G24 mock treatment 0.069 -0.00472 -0.56 -0.5589 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H01 compound treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 2123410 Peakdale1_000859 CCOC(=O)c1cc2cnccc2nc1c3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H02 compound treatment 0.065 -0.00872 -1.03 -1.0328 -1.0 2123411 Peakdale1_000860 COCCNC(=O)c1cc(cs1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H03 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123412 Peakdale1_000861 CCOC(=O)c1cc2cnccc2nc1c3ccccc3OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H04 compound treatment 0.069 -0.00472 -0.56 -0.5589 -1.0 2079966 Peakdale1_000862 Clc1ccc(cc1)c2csc(c2)C(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H05 compound treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 2123413 Peakdale1_000863 CCOC(=O)c1cc2cnccc2nc1c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H06 compound treatment 0.0705 -0.00322 -0.38 -0.3811 -1.0 2123414 Peakdale1_000864 Clc1ccc(cc1)c2csc(c2)C(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H07 compound treatment 0.084 0.0103 1.22 1.2185 1.0 2123415 Peakdale1_000865 CCOC(=O)c1cc2cnccc2nc1c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H08 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123416 Peakdale1_000866 Clc1ccc(cc1)c2csc(c2)C(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H09 compound treatment 0.08 0.00628 0.74 0.7445 1.0 2123417 Peakdale1_000867 CCOC(=O)c1cc2cnccc2nc1c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H10 compound treatment 0.076 0.00228 0.27 0.2706 1.0 2123418 Peakdale1_000868 Clc1ccc(cc1)c2csc(c2)C(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H11 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123419 Peakdale1_000869 COC(=O)c1cc2cnccc2nc1c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H12 compound treatment 0.0855 0.0118 1.4 1.3962 1.0 2123420 Peakdale1_000870 Clc1ccc(cc1)c2csc(c2)C(=O)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H13 compound treatment 0.076 0.00228 0.27 0.2706 1.0 2123421 Peakdale1_000871 CCOC(=O)c1cc2cnccc2nc1c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H14 compound treatment 0.0835 0.00978 1.16 1.1592 1.0 2123422 Peakdale1_000872 CC1CCN(CC1)C(=O)c2cc(cs2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H15 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123423 Peakdale1_000873 COC(=O)c1cc2cnccc2nc1c3ccccc3C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H16 compound treatment 0.084 0.0103 1.22 1.2185 1.0 2123424 Peakdale1_000874 Clc1ccc(cc1)c2csc(c2)C(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H17 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123425 Peakdale1_000875 OC(=O)c1ccc(CCN2CCCC2)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H18 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123426 Peakdale1_000876 CC1CN(CC(C)O1)C(=O)c2cc(cs2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H19 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123427 Peakdale1_000877 COC(=O)c1ccc(CCN2CCCC2)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H20 compound treatment 0.1185 0.0448 5.31 5.3064 1.0 2079979 Peakdale1_000878 CN1CCN(CC1)C(=O)c2cc(cs2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H21 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123428 Peakdale1_000879 O=C(NCCc1ccccc1)c2ccc(CCN3CCCC3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H22 compound treatment 0.1 0.0263 3.11 3.1143 1.0 2123429 Peakdale1_000880 COc1cc(OC)nc(CSc2ccc(N)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H23 mock treatment 0.075 0.00128 0.15 0.1521 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 H24 mock treatment 0.074 2.83E-4 0.03 0.0336 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I01 compound treatment 0.0685 -0.00522 -0.62 -0.6181 -1.0 2123430 Peakdale1_000881 Nc1ncc(c2cnccn2)c(n1)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I02 compound treatment 0.063 -0.0107 -1.27 -1.2698 -1.0 2123431 Peakdale1_000882 COc1cccc(OC)c1CNC(=O)CCC(=O)N2CCNC(=O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I03 compound treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 2123432 Peakdale1_000883 FC(F)(F)c1ccc(cc1)c2nc(ncc2c3cnccn3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I04 compound treatment 0.064 -0.00972 -1.15 -1.1513 -1.0 2123433 Peakdale1_000884 O=C(CCC(=O)N1CCNC(=O)CC1)N2CCc3ccccc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I05 compound treatment 0.075 0.00128 0.15 0.1521 1.0 2123434 Peakdale1_000885 FC(F)(F)c1ccc(cc1)c2nc(ncc2c3cnccn3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I06 compound treatment 0.0765 0.00278 0.33 0.3298 1.0 2123435 Peakdale1_000886 COc1cccc(OC)c1CNC(=O)CN 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I07 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123436 Peakdale1_000887 FC(F)(F)c1ccc(cc1)c2nc(ncc2c3cnccn3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I08 compound treatment 0.0775 0.00378 0.45 0.4483 1.0 2123437 Peakdale1_000888 COc1cccc(OC)c1CNC(=O)CNC(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I09 compound treatment 0.0875 0.0138 1.63 1.6332 1.0 2123438 Peakdale1_000889 c1cncc(c1)c2ncc(c3ccncc3)c(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I10 compound treatment 0.0825 0.00878 1.04 1.0407 1.0 2123439 Peakdale1_000890 COc1cccc(OC)c1CNC(=O)CNC(=O)C(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I11 compound treatment 0.086 0.0123 1.46 1.4555 1.0 2123440 Peakdale1_000891 c1cncc(c1)c2nc(ncc2c3ccncc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I12 compound treatment 0.0765 0.00278 0.33 0.3298 1.0 2123441 Peakdale1_000892 COc1cccc(OC)c1CNC(=O)CNC(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I13 compound treatment 0.0635 -0.0102 -1.21 -1.2106 -1.0 2123442 Peakdale1_000893 c1ccc(nc1)c2ncc(c3ccncc3)c(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I14 compound treatment 0.0885 0.0148 1.75 1.7517 1.0 2123443 Peakdale1_000894 COc1cccc(OC)c1CNC(=O)CNS(=O)(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I15 compound treatment 0.077 0.00328 0.39 0.389 1.0 2123444 Peakdale1_000895 c1cncc(c1)c2ncc(c3ccncc3)c(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I16 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123445 Peakdale1_000896 COc1cccc(OC)c1CNC(=O)CNC(=O)c2cn3c(n2)sc4ccccc43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I17 compound treatment 0.0865 0.0128 1.51 1.5147 1.0 2123446 Peakdale1_000897 c1cc(ccn1)c2cnc(nc2c3ccncc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I18 compound treatment 0.076 0.00228 0.27 0.2706 1.0 2123447 Peakdale1_000898 COc1cccc(OC)c1CNC(=O)CNC(=O)c2cnccc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I19 compound treatment 0.0775 0.00378 0.45 0.4483 1.0 2123448 Peakdale1_000899 Fc1ccc(cc1)c2nc(ncc2c3ccncn3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I20 compound treatment 0.08 0.00628 0.74 0.7445 1.0 2123449 Peakdale1_000900 COc1cccc(OC)c1CN2CCC(=O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I21 compound treatment 0.0795 0.00578 0.69 0.6853 1.0 2123450 Peakdale1_000901 Fc1ccc(cc1)c2nc(ncc2c3ccncn3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I22 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123451 Peakdale1_000902 COc1cccc(OC)c1CN2CCC(CC2)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I23 mock treatment 0.069 -0.00472 -0.56 -0.5589 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 I24 mock treatment 0.0675 -0.00622 -0.74 -0.7366 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J01 compound treatment 0.069 -0.00472 -0.56 -0.5589 -1.0 2079944 Peakdale1_000903 FC(F)(F)c1cccc(CNC(=O)c2ccc(CCN3CCCC3)nc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J02 compound treatment 0.064 -0.00972 -1.15 -1.1513 -1.0 2123452 Peakdale1_000904 COc1cc(OC)nc(CSc2ccc(NC(=O)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J03 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123453 Peakdale1_000905 CN(C)S(=O)(=O)c1ccc(NC(=O)c2ccccc2S(=O)(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J04 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123454 Peakdale1_000906 COc1cc(OC)nc(CSc2ccc(NC(=O)c3ccc(cc3)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J05 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123455 Peakdale1_000907 CC(C)Oc1cccc(NC(=O)c2ccccc2S(=O)(=O)C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J06 compound treatment 0.0675 -0.00622 -0.74 -0.7366 -1.0 2123456 Peakdale1_000908 CCSc1ccc(cc1)C(=O)Nc2ccc(SCc3nc(OC)cc(OC)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J07 compound treatment 0.079 0.00528 0.63 0.626 1.0 2123457 Peakdale1_000909 CC(=O)N1CCc2cc(NC(=O)c3ccccc3S(=O)(=O)C)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J08 compound treatment 0.089 0.0153 1.81 1.8109 1.0 2123458 Peakdale1_000910 COc1cc(OC)nc(CSc2ccc(NC(=O)c3ccc(cc3)[N+](=O)[O-])cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J09 compound treatment 0.089 0.0153 1.81 1.8109 1.0 2123459 Peakdale1_000911 CCOC(=O)c1cc2cccc(NC(=O)c3ccccc3S(=O)(=O)C)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J10 compound treatment 0.0765 0.00278 0.33 0.3298 1.0 2123460 Peakdale1_000912 COc1cc(OC)nc(CSc2ccc(NC(=O)C(c3ccccc3)c4ccccc4)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J11 compound treatment 0.0805 0.00678 0.8 0.8038 1.0 2123461 Peakdale1_000913 CS(=O)(=O)c1ccc(CNC(=O)c2ccccc2S(=O)(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J12 compound treatment 0.073 -7.17E-4 -0.08 -0.0849 -1.0 2123462 Peakdale1_000914 COc1cc(OC)nc(CSc2ccc(NC(=O)c3ccc(cc3)c4ccccc4)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J13 compound treatment 0.0675 -0.00622 -0.74 -0.7366 -1.0 2123463 Peakdale1_000915 CS(=O)(=O)c1ccccc1C(=O)NCc2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J14 compound treatment 0.0665 -0.00722 -0.86 -0.8551 -1.0 2123464 Peakdale1_000916 COc1cc(OC)nc(CSc2ccc(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J15 compound treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 1531434 Peakdale1_000917 CS(=O)(=O)N1CCc2cc(N)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J16 compound treatment 0.0675 -0.00622 -0.74 -0.7366 -1.0 2123465 Peakdale1_000918 COc1cc(OC)nc(CSc2ccc(NC(=O)Nc3ccccc3C(F)(F)F)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J17 compound treatment 0.0815 0.00778 0.92 0.9222 1.0 2123466 Peakdale1_000919 CC(C)(C)C(=O)Nc1ccc2N(CCc2c1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J18 compound treatment 0.0675 -0.00622 -0.74 -0.7366 -1.0 2123467 Peakdale1_000920 COc1cc(OC)nc(CSc2ccc(NC(=O)NS(=O)(=O)c3ccc(C)cc3)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J19 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123468 Peakdale1_000921 CS(=O)(=O)N1CCc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J20 compound treatment 0.072 -0.00172 -0.2 -0.2034 -1.0 2123469 Peakdale1_000922 CN1CCC(CC1)Nc2ccc3N(CCc3c2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J21 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123470 Peakdale1_000923 COc1ccc(cc1)S(=O)(=O)Nc2ccc3N(CCc3c2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J22 compound treatment 0.072 -0.00172 -0.2 -0.2034 -1.0 2123471 Peakdale1_000924 CCC(=O)N(C1CCN(C)CC1)c2ccc3N(CCc3c2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J23 mock treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 J24 mock treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K01 compound treatment 0.0675 -0.00622 -0.74 -0.7366 -1.0 2123472 Peakdale1_000925 Fc1ccc(cc1)c2nc(ncc2c3ccncn3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K02 compound treatment 0.0615 -0.0122 -1.45 -1.4476 -1.0 2080065 Peakdale1_000926 COc1cccc(OC)c1CN2CCC(CC2)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K03 compound treatment 0.065 -0.00872 -1.03 -1.0328 -1.0 2123473 Peakdale1_000927 CS(=O)(=O)c1cccc(c1)C(=O)NCCCN2CCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K04 compound treatment 0.0635 -0.0102 -1.21 -1.2106 -1.0 2123474 Peakdale1_000928 COc1cccc(OC)c1CN2CCC(CC2)N(CCc3ccccc3)C(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K05 compound treatment 0.065 -0.00872 -1.03 -1.0328 -1.0 2123475 Peakdale1_000929 Cc1ncccc1C(=O)NCCCN2CCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K06 compound treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 2123476 Peakdale1_000930 COc1cccc(OC)c1CN2CCC(CC2)N(CCc3ccccc3)C(=O)Nc4ccc(F)cc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K07 compound treatment 0.072 -0.00172 -0.2 -0.2034 -1.0 2123477 Peakdale1_000931 O=C(NCCCN1CCc2ccccc12)c3ccc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K08 compound treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 2123478 Peakdale1_000932 COc1cccc(OC)c1CN2CCC(CC2)N(C(=O)Nc3ccccc3C(F)(F)F)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K09 compound treatment 0.082 0.00828 0.98 0.9815 1.0 2123479 Peakdale1_000933 COc1ccccc1NC(=O)NCCCN2CCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K10 compound treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 2079919 Peakdale1_000934 COc1cccc(OC)c1CN2CCC(CC2)N(C(=O)c3cccc(c3)C(F)(F)F)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K11 compound treatment 0.0775 0.00378 0.45 0.4483 1.0 2123480 Peakdale1_000935 Cc1ccc(cc1)S(=O)(=O)NC(=O)NCCCN2CCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K12 compound treatment 0.0655 -0.00822 -0.97 -0.9736 -1.0 2123481 Peakdale1_000936 COc1cccc(OC)c1CN2CCC(CC2)OC(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K13 compound treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 2123482 Peakdale1_000937 CS(=O)(=O)c1ccc(cc1)S(=O)(=O)NCCCN2CCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K14 compound treatment 0.0655 -0.00822 -0.97 -0.9736 -1.0 2123483 Peakdale1_000938 CCCNC1CCN(Cc2c(OC)cccc2OC)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K15 compound treatment 0.0675 -0.00622 -0.74 -0.7366 -1.0 2123484 Peakdale1_000939 c1cncc(c1)c2nc(ncc2c3cnccn3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K16 compound treatment 0.076 0.00228 0.27 0.2706 1.0 2123485 Peakdale1_000940 CCCN(CCC(=O)OC)C1CCN(Cc2c(OC)cccc2OC)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K17 compound treatment 0.0715 -0.00222 -0.26 -0.2627 -1.0 2123486 Peakdale1_000941 c1cncc(c1)c2ncc(c3cnccn3)c(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K18 compound treatment 0.09 0.0163 1.93 1.9294 1.0 2123487 Peakdale1_000942 CCCN(C1CCN(Cc2c(OC)cccc2OC)CC1)C(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K19 compound treatment 0.083 0.00928 1.1 1.1 1.0 2123488 Peakdale1_000943 c1ccc(nc1)c2ncc(c3cnccn3)c(n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K20 compound treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 2123489 Peakdale1_000944 CCCN(C1CCN(Cc2c(OC)cccc2OC)CC1)C(=O)NCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K21 compound treatment 0.076 0.00228 0.27 0.2706 1.0 2123490 Peakdale1_000945 c1cnc(cn1)c2cnc(nc2c3ccncc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K22 compound treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 2123491 Peakdale1_000946 CCCN(C1CCN(Cc2c(OC)cccc2OC)CC1)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K23 mock treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 K24 mock treatment 0.068 -0.00572 -0.68 -0.6774 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L01 compound treatment 0.068 -0.00572 -0.68 -0.6774 -1.0 2123492 Peakdale1_000947 CCNC(=O)Nc1ccc2N(CCc2c1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L02 compound treatment 0.0645 -0.00922 -1.09 -1.0921 -1.0 2123493 Peakdale1_000948 CN1CCC(CC1)N(C(=O)c2cccc(c2)C(F)(F)F)c3ccc4N(CCc4c3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L03 compound treatment 0.0665 -0.00722 -0.86 -0.8551 -1.0 2123494 Peakdale1_000949 CS(=O)(=O)N1CCc2cc(NC(=O)Nc3ccc(F)cc3F)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L04 compound treatment 0.0605 -0.0132 -1.57 -1.566 -1.0 2123495 Peakdale1_000950 CCNC(=O)N(C1CCN(C)CC1)c2ccc3N(CCc3c2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L05 compound treatment 0.067 -0.00672 -0.8 -0.7959 -1.0 2123496 Peakdale1_000951 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2ccc3N(CCc3c2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L06 compound treatment 0.076 0.00228 0.27 0.2706 1.0 2123497 Peakdale1_000952 CN1CCC(CC1)N(C(=O)Nc2ccc(F)cc2F)c3ccc4N(CCc4c3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L07 compound treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 2123498 Peakdale1_000953 CN1CCN(CC1)c2ccc(cc2N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L08 compound treatment 0.0875 0.0138 1.63 1.6332 1.0 2123499 Peakdale1_000954 CN1CCC(CC1)N(C(=O)NS(=O)(=O)c2ccc(C)cc2)c3ccc4N(CCc4c3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L09 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123500 Peakdale1_000955 CN1CCN(CC1)c2ccc(cc2NC(=O)C(C)(C)C)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L10 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123501 Peakdale1_000956 CCCN1CCC(CC1)Nc2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L11 compound treatment 0.083 0.00928 1.1 1.1 1.0 2123502 Peakdale1_000957 CN1CCN(CC1)c2ccc(cc2NC(=O)c3ccccc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L12 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123503 Peakdale1_000958 CCCN1CCC(CC1)N(C(=O)CC)c2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L13 compound treatment 0.091 0.0173 2.05 2.0479 1.0 2123504 Peakdale1_000959 CN1CCN(CC1)c2ccc(cc2NC(=O)c3ccc(cc3)C(F)(F)F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L14 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2080004 Peakdale1_000960 CCCN1CCC(CC1)N(C(=O)C2CC2)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L15 compound treatment 0.0885 0.0148 1.75 1.7517 1.0 2123505 Peakdale1_000961 CN1CCN(CC1)c2ccc(cc2NC(=O)c3ccccc3Cl)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L16 compound treatment 0.0775 0.00378 0.45 0.4483 1.0 2080029 Peakdale1_000962 CCCN1CCC(CC1)N(C(=O)c2cccc(c2)C(F)(F)F)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L17 compound treatment 0.097 0.0233 2.76 2.7588 1.0 2123506 Peakdale1_000963 CN1CCN(CC1)c2ccc(cc2NC(=O)c3cccs3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L18 compound treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 2123507 Peakdale1_000964 CCCN1CCC(CC1)N(C(=O)c2ccc(cc2)S(=O)(=O)C)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L19 compound treatment 0.101 0.0273 3.23 3.2328 1.0 2123508 Peakdale1_000965 CCNC(=O)Nc1cc(ccc1N2CCN(C)CC2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L20 compound treatment 0.0765 0.00278 0.33 0.3298 1.0 2123509 Peakdale1_000966 CCCN1CCC(CC1)N(C(=O)c2ccccc2Cl)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L21 compound treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 2123510 Peakdale1_000967 CN1CCN(CC1)c2ccc(cc2NC(=O)NS(=O)(=O)c3ccc(C)cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L22 compound treatment 0.072 -0.00172 -0.2 -0.2034 -1.0 2123511 Peakdale1_000968 CCCN1CCC(CC1)N(C(=O)c2cc(Cl)nc(Cl)c2)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L23 mock treatment 0.0745 7.83E-4 0.09 0.0928 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 L24 mock treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M01 compound treatment 0.0665 -0.00722 -0.86 -0.8551 -1.0 2123512 Peakdale1_000969 c1cncc(c1)c2ncc(c3cnccn3)c(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M02 compound treatment 0.059 -0.0147 -1.74 -1.7438 -1.0 2123513 Peakdale1_000970 COc1cccc(OC)c1CN2CCC(N)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M03 compound treatment 0.1035 0.0298 3.53 3.529 1.0 2123514 Peakdale1_000971 c1ccc(nc1)c2ncc(c3cnccn3)c(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M04 compound treatment 0.059 -0.0147 -1.74 -1.7438 -1.0 2123515 Peakdale1_000972 CNC1CCN(Cc2c(OC)cccc2OC)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M05 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123516 Peakdale1_000973 CS(=O)(=O)c1ccc2NCCc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M06 compound treatment 0.0635 -0.0102 -1.21 -1.2106 -1.0 2123517 Peakdale1_000974 COc1cccc(OC)c1CN2CCC(CC2)NC(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M07 compound treatment 0.0905 0.0168 1.99 1.9887 1.0 2123518 Peakdale1_000975 CC(C)(C)C(=O)N1CCc2cc(ccc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M08 compound treatment 0.0755 0.00178 0.21 0.2113 1.0 2123519 Peakdale1_000976 COc1cccc(OC)c1CN2CCC(CC2)N(C)C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M09 compound treatment 0.07 -0.00372 -0.44 -0.4404 -1.0 2123520 Peakdale1_000977 CS(=O)(=O)c1ccc2N(CCc2c1)C(=O)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M10 compound treatment 0.0765 0.00278 0.33 0.3298 1.0 2123521 Peakdale1_000978 COc1cccc(OC)c1CN2CCC(CC2)N(C)C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M11 compound treatment 0.089 0.0153 1.81 1.8109 1.0 2123522 Peakdale1_000979 CS(=O)(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M12 compound treatment 0.069 -0.00472 -0.56 -0.5589 -1.0 2123523 Peakdale1_000980 COc1cccc(OC)c1CN2CCC(CC2)N(C)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M13 compound treatment 0.083 0.00928 1.1 1.1 1.0 2123524 Peakdale1_000981 COCCNC(=O)CCC(=O)N1CCc2cc(ccc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M14 compound treatment 0.0705 -0.00322 -0.38 -0.3811 -1.0 2123525 Peakdale1_000982 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M15 compound treatment 0.0835 0.00978 1.16 1.1592 1.0 2123526 Peakdale1_000983 CC(=C)CNC(=O)CCC(=O)N1CCc2cc(ccc12)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M16 compound treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 2123527 Peakdale1_000984 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)NCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M17 compound treatment 0.0915 0.0178 2.11 2.1071 1.0 2123528 Peakdale1_000985 CS(=O)(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M18 compound treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 2123529 Peakdale1_000986 COC(=O)C(CSc1cc(Cl)nc(Cl)c1)NC(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M19 compound treatment 0.0955 0.0218 2.58 2.5811 1.0 2123530 Peakdale1_000987 CS(=O)(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M20 compound treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 2123531 Peakdale1_000988 COC(=O)C(CCSc1cc(Cl)nc(Cl)c1)NC(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M21 compound treatment 0.0895 0.0158 1.87 1.8702 1.0 2123532 Peakdale1_000989 CS(=O)(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)NC3CCSC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M22 compound treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 2123533 Peakdale1_000990 OC(=O)CSc1cc(Cl)nc(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M23 mock treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 M24 mock treatment 0.0705 -0.00322 -0.38 -0.3811 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N01 compound treatment 0.065 -0.00872 -1.03 -1.0328 -1.0 2123534 Peakdale1_000991 CS(=O)(=O)c1ccc(CN(Cc2ccccn2)C(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N02 compound treatment 0.0655 -0.00822 -0.97 -0.9736 -1.0 2123535 Peakdale1_000992 CC(C)(C)c1cc2cc(NC3CCN(Cc4ccccc4)CC3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N03 compound treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 2123536 Peakdale1_000993 CS(=O)(=O)c1ccc(CN(Cc2ccccn2)C(=O)c3cccs3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N04 compound treatment 0.057 -0.0167 -1.98 -1.9808 -1.0 2123537 Peakdale1_000994 CCC(=O)N(C1CCN(Cc2ccccc2)CC1)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N05 compound treatment 0.0655 -0.00822 -0.97 -0.9736 -1.0 2123538 Peakdale1_000995 CS(=O)(=O)c1ccc(CN(Cc2ccccn2)C(=O)c3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N06 compound treatment 0.0805 0.00678 0.8 0.8038 1.0 2123539 Peakdale1_000996 CC(C)(C)c1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5ccc(cc5)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N07 compound treatment 0.0865 0.0128 1.51 1.5147 1.0 2123540 Peakdale1_000997 CS(=O)(=O)c1ccc(CN(Cc2ccccn2)C(=O)c3cc(Cl)nc(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N08 compound treatment 0.0755 0.00178 0.21 0.2113 1.0 2123541 Peakdale1_000998 CC(C)(C)c1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5ccc(cc5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N09 compound treatment 0.093 0.0193 2.28 2.2849 1.0 2123542 Peakdale1_000999 Cc1ccc(cc1)S(=O)(=O)NC(=O)N(Cc2ccc(cc2)S(=O)(=O)C)Cc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N10 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123543 Peakdale1_001000 CC(C)(C)c1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5cc(Cl)nc(Cl)c5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N11 compound treatment 0.085 0.0113 1.34 1.337 1.0 2123544 Peakdale1_001001 CS(=O)(=O)c1ccc(cc1)N(Cc2ccccn2)C(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N12 compound treatment 0.0765 0.00278 0.33 0.3298 1.0 2123545 Peakdale1_001002 CC(C)(C)c1cc2cc(NC3CCNCC3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N13 compound treatment 0.09 0.0163 1.93 1.9294 1.0 2123546 Peakdale1_001003 CS(=O)(=O)c1ccc(cc1)N(Cc2ccccn2)C(=O)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N14 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123547 Peakdale1_001004 CC(C)(C)c1cc2cc(NC3CCN(CC3)C(=O)c4ccccc4Cl)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N15 compound treatment 0.0775 0.00378 0.45 0.4483 1.0 2123548 Peakdale1_001005 CS(=O)(=O)c1ccc(cc1)N(Cc2ccccn2)C(=O)c3cc(Cl)nc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N16 compound treatment 0.0885 0.0148 1.75 1.7517 1.0 2123549 Peakdale1_001006 CC(C)(C)c1cc2cc(NC3CCN(CC3)C(=O)c4cccc(c4)C(F)(F)F)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N17 compound treatment 0.1005 0.0268 3.17 3.1736 1.0 2123550 Peakdale1_001007 CCCCc1ccc(cc1)C(=O)Nc2ccc(Sc3nc(C)cc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N18 compound treatment 0.089 0.0153 1.81 1.8109 1.0 2123551 Peakdale1_001008 CC(C)(C)c1cc2cc(NC3CCN(CC3)C(=O)c4ccc(cc4)S(=O)(=O)C)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N19 compound treatment 0.075 0.00128 0.15 0.1521 1.0 2123552 Peakdale1_001009 CCCCCCCc1ccc(cc1)C(=O)Nc2ccc(Sc3nc(C)cc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N20 compound treatment 0.073 -7.17E-4 -0.08 -0.0849 -1.0 2123553 Peakdale1_001010 OC(c1ccccc1)c2cnc(nc2c3ccccc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N21 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123554 Peakdale1_001011 Cc1cc(C)nc(Sc2ccc(NC(=O)c3ccc(cc3)c4ccccc4)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N22 compound treatment 0.073 -7.17E-4 -0.08 -0.0849 -1.0 2123555 Peakdale1_001012 OC(c1ccc(Cl)cc1)c2cnc(nc2c3ccc(Cl)cc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N23 mock treatment 0.075 0.00128 0.15 0.1521 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 N24 mock treatment 0.0745 7.83E-4 0.09 0.0928 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O01 compound treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 2123556 Peakdale1_001013 CS(=O)(=O)c1ccc2N(CCc2c1)C(=O)CCC(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O02 compound treatment 0.0595 -0.0142 -1.68 -1.6845 -1.0 2123557 Peakdale1_001014 COC(=O)CSc1cc(Cl)nc(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O03 compound treatment 0.071 -0.00272 -0.32 -0.3219 -1.0 2123558 Peakdale1_001015 CC(=O)N1CCc2ccc(NC3CCN(Cc4ccccc4)CC3)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O04 compound treatment 0.056 -0.0177 -2.1 -2.0992 -1.0 2123559 Peakdale1_001016 COCCNC(=O)CSc1cc(Cl)nc(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O05 compound treatment 0.0795 0.00578 0.69 0.6853 1.0 2123560 Peakdale1_001017 CC(=O)N1CCc2ccc(cc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O06 compound treatment 0.0705 -0.00322 -0.38 -0.3811 -1.0 2123561 Peakdale1_001018 Clc1cc(SCC(=O)NN2CCOCC2)cc(Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O07 compound treatment 0.098 0.0243 2.88 2.8773 1.0 2123562 Peakdale1_001019 CC(=O)N1CCc2ccc(cc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5cccc(c5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O08 compound treatment 0.0735 -2.17E-4 -0.03 -0.0257 -1.0 2123563 Peakdale1_001020 Clc1cc(SCC(=O)NCCc2ccccc2)cc(Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O09 compound treatment 0.0715 -0.00222 -0.26 -0.2627 -1.0 2123564 Peakdale1_001021 CC(=O)N1CCc2ccc(cc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)/C=C/c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O10 compound treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 2123565 Peakdale1_001022 FC(F)(F)c1cccc(CNC(=O)CSc2cc(Cl)nc(Cl)c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O11 compound treatment 0.072 -0.00172 -0.2 -0.2034 -1.0 2123566 Peakdale1_001023 CC(=O)N1CCc2ccc(cc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O12 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123567 Peakdale1_001024 Clc1cc(SCC(=O)NNc2ccccc2)cc(Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O13 compound treatment 0.0715 -0.00222 -0.26 -0.2627 -1.0 2123568 Peakdale1_001025 CCNC(=O)N(C1CCN(Cc2ccccc2)CC1)c3ccc4CCN(C(=O)C)c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O14 compound treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 2123569 Peakdale1_001026 CON(C)C(=O)CSc1cc(Cl)nc(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O15 compound treatment 0.088 0.0143 1.69 1.6924 1.0 2123570 Peakdale1_001027 Nc1nccc2cccnc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O16 compound treatment 0.069 -0.00472 -0.56 -0.5589 -1.0 2123571 Peakdale1_001028 CNCCC(Oc1ncccc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O17 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123572 Peakdale1_001029 FC(F)(F)c1ccc(cc1)C(=O)Nc2nccc3cccnc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O18 compound treatment 0.077 0.00328 0.39 0.389 1.0 2123573 Peakdale1_001030 CNCCC(Oc1ccc(cn1)C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O19 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123574 Peakdale1_001031 O=C(N(C(=O)c1ccccc1)c2nccc3cccnc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O20 compound treatment 0.077 0.00328 0.39 0.389 1.0 2123575 Peakdale1_001032 CNCCC(Sc1ccccn1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O21 compound treatment 0.0795 0.00578 0.69 0.6853 1.0 2123576 Peakdale1_001033 CC(C)(C)c1ccc(cc1)C(=O)N(C(=O)c2ccc(cc2)C(C)(C)C)c3nccc4cccnc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O22 compound treatment 0.0785 0.00478 0.57 0.5668 1.0 2123577 Peakdale1_001034 CS(=O)(=O)c1cnc(nc1c2ccccc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O23 mock treatment 0.078 0.00428 0.51 0.5075 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 O24 mock treatment 0.076 0.00228 0.27 0.2706 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P01 compound treatment 0.0755 0.00178 0.21 0.2113 1.0 2123578 Peakdale1_001035 CCCCOc1ccc(cc1)C(=O)Nc2ccc(Sc3nc(C)cc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P02 compound treatment 0.0595 -0.0142 -1.68 -1.6845 -1.0 2123579 Peakdale1_001036 COc1ccc(cc1)c2csc(c2)C(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P03 compound treatment 0.075 0.00128 0.15 0.1521 1.0 2123580 Peakdale1_001037 CC(C)Oc1ccc(cc1)C(=O)Nc2ccc(Sc3nc(C)cc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P04 compound treatment 0.0565 -0.0172 -2.04 -2.04 -1.0 2123581 Peakdale1_001038 COc1ccc(cc1)c2csc(c2)C(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P05 compound treatment 0.0655 -0.00822 -0.97 -0.9736 -1.0 2123582 Peakdale1_001039 Cc1cc(C)nc(Sc2ccc(NC(=O)c3ccc(cc3)S(=O)(=O)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P06 compound treatment 0.0695 -0.00422 -0.5 -0.4996 -1.0 2123583 Peakdale1_001040 COc1ccc(cc1)c2csc(c2)C(=O)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P07 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123584 Peakdale1_001041 Cc1cc(C)nc(Sc2ccc(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P08 compound treatment 0.0815 0.00778 0.92 0.9222 1.0 2123585 Peakdale1_001042 COc1ccc(cc1)c2csc(c2)C(=O)N3CCC(C)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P09 compound treatment 0.0775 0.00378 0.45 0.4483 1.0 2123586 Peakdale1_001043 Cc1ccnc(Sc2ccc(N)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P10 compound treatment 0.078 0.00428 0.51 0.5075 1.0 2123587 Peakdale1_001044 COc1ccc(cc1)c2csc(c2)C(=O)N3CCN(C)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P11 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123588 Peakdale1_001045 Cc1ccnc(Sc2ccc(NC(=O)c3ccc(cc3)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P12 compound treatment 0.0705 -0.00322 -0.38 -0.3811 -1.0 2123589 Peakdale1_001046 COc1ccc(cc1)c2csc(c2)C(=O)N3CC(C)OC(C)C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P13 compound treatment 0.066 -0.00772 -0.91 -0.9143 -1.0 2123590 Peakdale1_001047 CCN(C(=O)c1ccc(cc1)C(C)(C)C)c2ccc(Sc3nccc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P14 compound treatment 0.067 -0.00672 -0.8 -0.7959 -1.0 2123591 Peakdale1_001048 COc1cc(OC)nc(n1)c2ccc(N)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P15 compound treatment 0.0745 7.83E-4 0.09 0.0928 1.0 2123592 Peakdale1_001049 CCCCCCCc1ccc(cc1)C(=O)Nc2ccc(Sc3nccc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P16 compound treatment 0.0705 -0.00322 -0.38 -0.3811 -1.0 2123593 Peakdale1_001050 COc1cc(OC)nc(n1)c2ccc(NC(=O)C(C)(C)C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P17 compound treatment 0.0645 -0.00922 -1.09 -1.0921 -1.0 2123594 Peakdale1_001051 CCSc1ccc(cc1)C(=O)Nc2ccc(Sc3nccc(C)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P18 compound treatment 0.0595 -0.0142 -1.68 -1.6845 -1.0 2123595 Peakdale1_001052 COc1cc(OC)nc(n1)c2ccc(NC(=O)c3ccc(cc3)C(C)(C)C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P19 compound treatment 0.077 0.00328 0.39 0.389 1.0 2123596 Peakdale1_001053 Cc1ccnc(Sc2ccc(NC(=O)c3ccc(cc3)S(=O)(=O)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P20 compound treatment 0.074 2.83E-4 0.03 0.0336 1.0 2123597 Peakdale1_001054 COc1cc(OC)nc(n1)c2ccc(NC(=O)c3cccc(c3)C(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P21 compound treatment 0.0725 -0.00122 -0.14 -0.1442 -1.0 2123598 Peakdale1_001055 Cc1ccnc(Sc2ccc(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P22 compound treatment 0.066 -0.00772 -0.91 -0.9143 -1.0 2123599 Peakdale1_001056 COc1cc(OC)nc(n1)c2ccc(NC(=O)Nc3ccc(F)cc3F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P23 mock treatment 0.0715 -0.00222 -0.26 -0.2627 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.520 P24 mock treatment 0.056 -0.0177 -2.1 -2.0992 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A01 compound treatment 0.0805 0.00728 0.86 0.863 1.0 2123600 Peakdale1_001057 COc1cc(OC)nc(n1)c2ccc(NC(=O)c3ccc(F)cc3Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A02 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123601 Peakdale1_001058 O=C(NCCc1ccccc1)/C=C/c2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A03 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123602 Peakdale1_001059 COc1cc(OC)nc(n1)c2ccc(NC(=O)C(c3ccccc3)c4ccccc4)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A04 compound treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 2123603 Peakdale1_001060 Clc1ccc(CNC(=O)/C=C/c2cc3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A05 compound treatment 0.0815 0.00828 0.98 0.9815 1.0 2123604 Peakdale1_001061 COc1cc(OC)nc(n1)c2ccc(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A06 compound treatment 0.066 -0.00722 -0.86 -0.8551 -1.0 2123605 Peakdale1_001062 O=C(/C=C/c1cc2cccc3CCCn(c1=O)c32)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A07 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123606 Peakdale1_001063 COc1cc(OC)nc(n1)c2ccc(NC(=O)NS(=O)(=O)c3ccc(C)cc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A08 compound treatment 0.071 -0.00222 -0.26 -0.2627 -1.0 2123607 Peakdale1_001064 O=C(/C=C/c1cc2cccc3CCCn(c1=O)c32)N4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A09 compound treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 2123608 Peakdale1_001065 CC(=O)N1CCc2ccc(NS(=O)(=O)c3ccccc3)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A10 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123609 Peakdale1_001066 FC(F)(F)c1cccc(NCc2cc3cccc4CCCn(c2=O)c43)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A11 compound treatment 0.071 -0.00222 -0.26 -0.2627 -1.0 2123610 Peakdale1_001067 CC(=O)N1CCc2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A12 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123611 Peakdale1_001068 CCC(=O)N(Cc1cc2cccc3CCCn(c1=O)c32)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A13 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123612 Peakdale1_001069 CC(=O)N1CCc2ccc(NS(=O)(=O)c3cccc(c3)C(F)(F)F)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A14 compound treatment 0.071 -0.00222 -0.26 -0.2627 -1.0 2123613 Peakdale1_001070 FC(F)(F)c1cccc(c1)N(Cc2cc3cccc4CCCn(c2=O)c43)C(=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A15 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123614 Peakdale1_001071 CC(=O)N1CCc2ccc(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A16 compound treatment 0.074 7.83E-4 0.09 0.0928 1.0 2123615 Peakdale1_001072 CS(=O)(=O)c1ccc(cc1)C(=O)N(Cc2cc3cccc4CCCn(c2=O)c43)c5cccc(c5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A17 compound treatment 0.0705 -0.00272 -0.32 -0.3219 -1.0 2123616 Peakdale1_001073 CC(=O)N1CCc2ccc(NS(=O)(=O)c3ccc4oc(=O)ccc4c3)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A18 compound treatment 0.0625 -0.0107 -1.27 -1.2698 -1.0 2123617 Peakdale1_001074 FC(F)(F)c1cccc(c1)N(Cc2cc3cccc4CCCn(c2=O)c43)C(=O)c5ccco5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A19 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123618 Peakdale1_001075 CC(=O)N1CCc2cc(NS(=O)(=O)c3ccccc3S(=O)(=O)C)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A20 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123619 Peakdale1_001076 FC(F)(F)c1cccc(c1)N(Cc2cc3cccc4CCCn(c2=O)c43)C(=O)c5cc(Cl)nc(Cl)c5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A21 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123620 Peakdale1_001077 CC(=O)N1CCc2cc(NS(=O)(=O)c3cccc(c3)C(F)(F)F)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A22 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123621 Peakdale1_001078 FC(F)(F)c1cccc(c1)N(Cc2cc3cccc4CCCn(c2=O)c43)S(=O)(=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A23 mock treatment 0.0875 0.0143 1.69 1.6924 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 A24 mock treatment 0.077 0.00378 0.45 0.4483 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B01 compound treatment 0.068 -0.00522 -0.62 -0.6181 -1.0 2123622 Peakdale1_001079 COc1ccc(cc1)S(=O)(=O)NCCSCc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B02 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123623 Peakdale1_001080 COC(=O)c1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B03 compound treatment 0.0705 -0.00272 -0.32 -0.3219 -1.0 2123624 Peakdale1_001081 O=C(NCCSCc1cc2cccc3CCCn(c1=O)c32)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B04 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123625 Peakdale1_001082 Cc1c(NC(=O)c2cc3cccc4CCCn(c2=O)c43)cccc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B05 compound treatment 0.068 -0.00522 -0.62 -0.6181 -1.0 2123626 Peakdale1_001083 CCNC(=O)NCCSCc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B06 compound treatment 0.0665 -0.00672 -0.8 -0.7959 -1.0 2123627 Peakdale1_001084 CN(C)S(=O)(=O)c1ccc(NC(=O)c2cc3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B07 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123628 Peakdale1_001085 COc1ccccc1NC(=O)NCCSCc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B08 compound treatment 0.067 -0.00622 -0.74 -0.7366 -1.0 2123629 Peakdale1_001086 O=C(Nc1ccncc1)c2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B09 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123630 Peakdale1_001087 CC(=O)NCCS(=O)(=O)Cc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B10 compound treatment 0.068 -0.00522 -0.62 -0.6181 -1.0 2123631 Peakdale1_001088 COc1cc(OC)nc(NC(=O)c2cc3cccc4CCCn(c2=O)c43)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B11 compound treatment 0.0775 0.00428 0.51 0.5075 1.0 2123632 Peakdale1_001089 O=C(NCCS(=O)(=O)Cc1cc2cccc3CCCn(c1=O)c32)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B12 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123633 Peakdale1_001090 COC(=O)c1sccc1NC(=O)c2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B13 compound treatment 0.071 -0.00222 -0.26 -0.2627 -1.0 2123634 Peakdale1_001091 O=C(NCCS(=O)(=O)Cc1cc2cccc3CCCn(c1=O)c32)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B14 compound treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 2123635 Peakdale1_001092 CC(=O)N1CCc2cc(NC(=O)c3cc4cccc5CCCn(c3=O)c54)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B15 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123636 Peakdale1_001093 Clc1cccc(c1)C(=O)NCCS(=O)(=O)Cc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B16 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123637 Peakdale1_001094 CCC(=O)N(CCSCc1cc2cccc3CCCn(c1=O)c32)Cc4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B17 compound treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 2123638 Peakdale1_001095 Fc1cccc(F)c1C(=O)NCCS(=O)(=O)Cc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B18 compound treatment 0.07 -0.00322 -0.38 -0.3811 -1.0 2123639 Peakdale1_001096 O=C(N(CCSCc1cc2cccc3CCCn(c1=O)c32)Cc4ccccn4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B19 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123640 Peakdale1_001097 FC(F)(F)c1ccc(cc1)C(=O)NCCS(=O)(=O)Cc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B20 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123641 Peakdale1_001098 FC(F)(F)c1cccc(c1)C(=O)N(CCSCc2cc3cccc4CCCn(c2=O)c43)Cc5ccccn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B21 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123642 Peakdale1_001099 COc1cc(OC)nc(CSCCN)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B22 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123643 Peakdale1_001100 Clc1cc(cc(Cl)n1)C(=O)N(CCSCc2cc3cccc4CCCn(c2=O)c43)Cc5ccccn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B23 mock treatment 0.0765 0.00328 0.39 0.389 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 B24 mock treatment 0.074 7.83E-4 0.09 0.0928 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C01 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123644 Peakdale1_001101 CC(=O)N1CCc2cc(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C02 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123645 Peakdale1_001102 FC(F)(F)c1cccc(c1)N(Cc2cc3cccc4CCCn(c2=O)c43)S(=O)(=O)c5ccc(Cl)cc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C03 compound treatment 0.0785 0.00528 0.63 0.626 1.0 2123646 Peakdale1_001103 CC(=O)N1CCc2cc(ccc12)N(C3CCN(CC3)C(=O)C)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C04 compound treatment 0.079 0.00578 0.69 0.6853 1.0 2123647 Peakdale1_001104 Cc1ccc(cc1)S(=O)(=O)NC(=O)N(Cc2cc3cccc4CCCn(c2=O)c43)c5cccc(c5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C05 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123648 Peakdale1_001105 CC(=O)N1CCc2cc(ccc12)N(C3CCN(CC3)C(=O)C)S(=O)(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C06 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123649 Peakdale1_001106 O=Cc1cc2cccc3CCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C07 compound treatment 0.081 0.00778 0.92 0.9222 1.0 2123650 Peakdale1_001107 CC(=O)N1CCc2ccc(cc12)N(C3CCN(Cc4ccccc4)CC3)S(=O)(=O)c5ccc(cc5)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C08 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123651 Peakdale1_001108 O=c1c(C#N)cc2cccc3CCn1c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C09 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123652 Peakdale1_001109 COc1ccc(cc1)S(=O)(=O)N(C2CCN(Cc3ccccc3)CC2)c4ccc5CCN(C(=O)C)c5c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C10 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123653 Peakdale1_001110 OC(=O)c1cc2cccc3CCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C11 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123654 Peakdale1_001111 COc1ccc(cc1)S(=O)(=O)N2CCc3ccc(NS(=O)(=O)c4ccccc4)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C12 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123655 Peakdale1_001112 NC(=O)c1cc2cccc3CCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C13 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123656 Peakdale1_001113 COc1ccc(cc1)S(=O)(=O)N2CCc3ccc(NS(=O)(=O)c4ccc(cc4)C(C)(C)C)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C14 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123657 Peakdale1_001114 NC(=S)c1cc2cccc3CCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C15 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123658 Peakdale1_001115 COc1ccc(cc1)S(=O)(=O)N2CCc3ccc(NS(=O)(=O)c4cccc(c4)C(F)(F)F)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C16 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123659 Peakdale1_001116 NNC(=O)c1cc2cccc3CCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C17 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123660 Peakdale1_001117 COc1ccc(cc1)S(=O)(=O)N2CCc3ccc(NC(=O)c4cccs4)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C18 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123661 Peakdale1_001118 O=C(NC1CCSC1=O)c2cc3cccc4CCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C19 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123662 Peakdale1_001119 COc1ccc(cc1)S(=O)(=O)N2CCc3ccc(NC(=O)Nc4ccc(Cl)cc4)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C20 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123663 Peakdale1_001120 FC(F)(F)c1cccc(CNC(=O)c2cc3cccc4CCn(c2=O)c43)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C21 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123664 Peakdale1_001121 FC(F)(F)c1cccc(c1)S(=O)(=O)Nc2ccc3CCN(c3c2)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C22 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123665 Peakdale1_001122 O=C(NCc1cccnc1)c2cc3cccc4CCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C23 mock treatment 0.0755 0.00228 0.27 0.2706 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 C24 mock treatment 0.077 0.00378 0.45 0.4483 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D01 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123666 Peakdale1_001123 COc1cc(OC)nc(CSCCNC(=O)c2cccs2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D02 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123667 Peakdale1_001124 O=C(N(CCSCc1cc2cccc3CCCn(c1=O)c32)Cc4ccccn4)c5ccco5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D03 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123668 Peakdale1_001125 COc1cc(OC)nc(CSCCNC(=O)c2ccc(cc2)C(C)(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D04 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123669 Peakdale1_001126 COc1ccc(cc1)S(=O)(=O)N(CCSCc2cc3cccc4CCCn(c2=O)c43)Cc5ccccn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D05 compound treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 2123670 Peakdale1_001127 COc1cc(OC)nc(CSCCNC(=O)c2cccc(c2)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D06 compound treatment 0.0915 0.0183 2.17 2.1664 1.0 2123671 Peakdale1_001128 CCNC(=O)N(CCSCc1cc2cccc3CCCn(c1=O)c32)Cc4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D07 compound treatment 0.0855 0.0123 1.46 1.4555 1.0 2123672 Peakdale1_001129 COc1cc(OC)nc(CSCCNC(=O)c2c(F)cccc2F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D08 compound treatment 0.083 0.00978 1.16 1.1592 1.0 2123673 Peakdale1_001130 CC(C)(C)c1ccc(cc1)C(=O)N2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D09 compound treatment 0.086 0.0128 1.51 1.5147 1.0 2123674 Peakdale1_001131 COc1cc(OC)nc(CSCCNC(=O)c2c(OC)cccc2OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D10 compound treatment 0.0775 0.00428 0.51 0.5075 1.0 2123675 Peakdale1_001132 FC(F)(F)c1cccc(c1)C(=O)N2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D11 compound treatment 0.082 0.00878 1.04 1.0407 1.0 2123676 Peakdale1_001133 COc1cc(OC)nc(CSCCNC(=O)C(c2ccccc2)c3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D12 compound treatment 0.091 0.0178 2.11 2.1071 1.0 2123677 Peakdale1_001134 Fc1cccc(F)c1C(=O)N2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D13 compound treatment 0.0805 0.00728 0.86 0.863 1.0 2123678 Peakdale1_001135 COc1cc(OC)nc(CSCCNC(=O)c2ccc(cc2Cl)S(=O)(=O)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D14 compound treatment 0.0795 0.00628 0.74 0.7445 1.0 2123679 Peakdale1_001136 Clc1cc(cc(Cl)n1)C(=O)N2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D15 compound treatment 0.0785 0.00528 0.63 0.626 1.0 2123680 Peakdale1_001137 COc1cc(OC)nc(CSCCNS(=O)(=O)c2ccc(C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D16 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123681 Peakdale1_001138 O=C(N1CCN(Cc2cc3cccc4CCCn(c2=O)c43)CC1)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D17 compound treatment 0.0795 0.00628 0.74 0.7445 1.0 2123682 Peakdale1_001139 COc1cc(OC)nc(n1)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D18 compound treatment 0.091 0.0178 2.11 2.1071 1.0 2123683 Peakdale1_001140 O=c1c(CN2CCN(CC2)S(=O)(=O)c3ccccc3)cc4cccc5CCCn1c54 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D19 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123684 Peakdale1_001141 COc1cc(OC)nc(n1)c2c(F)cccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D20 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123685 Peakdale1_001142 COc1ccc(cc1)S(=O)(=O)N2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D21 compound treatment 0.079 0.00578 0.69 0.6853 1.0 2123686 Peakdale1_001143 COc1cc(OC)nc(n1)c2ccc(cc2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D22 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123687 Peakdale1_001144 Clc1cccc(NC(=O)N2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D23 mock treatment 0.075 0.00178 0.21 0.2113 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 D24 mock treatment 0.077 0.00378 0.45 0.4483 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E01 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123688 Peakdale1_001145 COc1ccc(cc1)S(=O)(=O)Nc2ccc3CCN(c3c2)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E02 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123689 Peakdale1_001146 O=C(NCC1CCCO1)c2cc3cccc4CCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E03 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123690 Peakdale1_001147 CC(C)(C)C(=O)Nc1ccc2CCN(c2c1)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E04 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123691 Peakdale1_001148 O=C(NCCN1CCOCC1)c2cc3cccc4CCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E05 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123692 Peakdale1_001149 Clc1ccc(cc1)S(=O)(=O)N2CCc3ccc(NC(=O)C4CC4)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E06 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123693 Peakdale1_001150 O=C(NCCc1ccccc1)c2cc3cccc4CCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E07 compound treatment 0.0905 0.0173 2.05 2.0479 1.0 2123694 Peakdale1_001151 FC(F)(F)c1cccc(c1)S(=O)(=O)Nc2ccc3CCN(c3c2)S(=O)(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E08 compound treatment 0.0775 0.00428 0.51 0.5075 1.0 2123695 Peakdale1_001152 CON(C)C(=O)c1cc2cccc3CCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E09 compound treatment 0.088 0.0148 1.75 1.7517 1.0 2123696 Peakdale1_001153 COc1ccc(cc1)S(=O)(=O)Nc2ccc3CCN(c3c2)S(=O)(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E10 compound treatment 0.081 0.00778 0.92 0.9222 1.0 2123697 Peakdale1_001154 O=C(N1CCN(CC1)C(c2ccccc2)c3ccccc3)c4cc5cccc6CCn(c4=O)c65 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E11 compound treatment 0.083 0.00978 1.16 1.1592 1.0 2123698 Peakdale1_001155 CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2ccc3CCN(c3c2)S(=O)(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E12 compound treatment 0.0795 0.00628 0.74 0.7445 1.0 2123699 Peakdale1_001156 O=C(N1CCc2ccccc2C1)c3cc4cccc5CCn(c3=O)c54 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E13 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123700 Peakdale1_001157 COC(=O)c1ccccc1SCc2nc(OC)cc(OC)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E14 compound treatment 0.099 0.0258 3.06 3.0551 1.0 2123701 Peakdale1_001158 O=Cc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E15 compound treatment 0.081 0.00778 0.92 0.9222 1.0 2123702 Peakdale1_001159 COc1cc(OC)nc(CSc2nc(C)cc(C)n2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E16 compound treatment 0.0815 0.00828 0.98 0.9815 1.0 2123703 Peakdale1_001160 O=c1c(C#N)cc2cccc3CCCn1c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E17 compound treatment 0.0795 0.00628 0.74 0.7445 1.0 2123704 Peakdale1_001161 Cc1cc(C)nc(SCc2nc(OCC(F)(F)F)cc(OCC(F)(F)F)n2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E18 compound treatment 0.074 7.83E-4 0.09 0.0928 1.0 2123705 Peakdale1_001162 OC(=O)c1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E19 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123706 Peakdale1_001163 COc1cc(OC)nc(CSc2nc3ccccc3[nH]2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E20 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123707 Peakdale1_001164 OCc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E21 compound treatment 0.082 0.00878 1.04 1.0407 1.0 2123708 Peakdale1_001165 COc1cc(OC)nc(CSc2ccc(NC(=O)CCl)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E22 compound treatment 0.079 0.00578 0.69 0.6853 1.0 2123709 Peakdale1_001166 O/N=C/c1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E23 mock treatment 0.075 0.00178 0.21 0.2113 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 E24 mock treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F01 compound treatment 0.071 -0.00222 -0.26 -0.2627 -1.0 2123710 Peakdale1_001167 COc1cc(OC)nc(n1)c2ccc(cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F02 compound treatment 0.07 -0.00322 -0.38 -0.3811 -1.0 2123711 Peakdale1_001168 CCNC(=O)NCCSCc1nc(OC)cc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F03 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123712 Peakdale1_001169 COc1cc(OC)nc(n1)C(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F04 compound treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 2123713 Peakdale1_001170 COc1cc(OC)nc(CSCCNC(=S)Nc2ccccc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F05 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123714 Peakdale1_001171 COc1cc(OC)nc(n1)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F06 compound treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 2123715 Peakdale1_001172 COc1cc(OC)nc(CSCCNC(=O)Nc2ccc(Cl)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F07 compound treatment 0.079 0.00578 0.69 0.6853 1.0 2123716 Peakdale1_001173 COc1cc(OC)nc(n1)c2ccc(Cl)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F08 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123717 Peakdale1_001174 COc1cc(OC)nc(CSCCNC(=O)Nc2ccc(F)cc2F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F09 compound treatment 0.0785 0.00528 0.63 0.626 1.0 2123718 Peakdale1_001175 COc1cc(OC)nc(n1)c2cc(Cl)nc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F10 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123719 Peakdale1_001176 COc1cc(OC)nc(CSCCNC(=O)NS(=O)(=O)c2ccc(C)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F11 compound treatment 0.095 0.0218 2.58 2.5811 1.0 2123720 Peakdale1_001177 COc1ccc(cn1)c2nc(OC)cc(OC)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F12 compound treatment 0.0805 0.00728 0.86 0.863 1.0 2123721 Peakdale1_001178 O=S(=O)(N(C1CC1)C2CCNCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F13 compound treatment 0.0955 0.0223 2.64 2.6404 1.0 2123722 Peakdale1_001179 COc1cc(OC)nc(n1)c2cc(Cl)nc(OC)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F14 compound treatment 0.085 0.0118 1.4 1.3962 1.0 2123723 Peakdale1_001180 O=C(N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F15 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123724 Peakdale1_001181 COc1cc(OC)nc(COc2ccc(cc2)C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F16 compound treatment 0.074 7.83E-4 0.09 0.0928 1.0 2123725 Peakdale1_001182 Clc1ccccc1C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F17 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123726 Peakdale1_001183 COc1cc(OC)nc(COc2ccc(cc2)C(=O)NCC3CCCO3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F18 compound treatment 0.074 7.83E-4 0.09 0.0928 1.0 2123727 Peakdale1_001184 FC(F)(F)c1ccc(cc1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F19 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123728 Peakdale1_001185 COc1cc(OC)nc(COc2ccc(cc2)C(=O)NCCN3CCOCC3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F20 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123729 Peakdale1_001186 O=C(C(c1ccccc1)c2ccccc2)N3CCC(CC3)N(C4CC4)S(=O)(=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F21 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123730 Peakdale1_001187 COc1cc(OC)nc(COc2ccc(cc2)C(=O)NC(C)c3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F22 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123731 Peakdale1_001188 O=C(N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F23 mock treatment 0.0735 2.83E-4 0.03 0.0336 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 F24 mock treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G01 compound treatment 0.071 -0.00222 -0.26 -0.2627 -1.0 2123732 Peakdale1_001189 COc1cc(OC)nc(CSc2ccc(NC(=O)CSc3nc(C)cc(C)n3)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G02 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123733 Peakdale1_001190 NC(=O)c1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G03 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123734 Peakdale1_001191 COc1cc(OC)nc(n1)c2cccc(N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G04 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123735 Peakdale1_001192 NNC(=O)c1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G05 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123736 Peakdale1_001193 COc1cc(OC)nc(n1)c2cccc(NC(=O)c3ccc(cc3)C(C)(C)C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G06 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123737 Peakdale1_001194 CC(=C)CNC(=O)c1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G07 compound treatment 0.0885 0.0153 1.81 1.8109 1.0 2123738 Peakdale1_001195 COc1cc(OC)nc(n1)c2cccc(NC(=O)C(c3ccccc3)c4ccccc4)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G08 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123739 Peakdale1_001196 O=C(NC1CCCCC1)c2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G09 compound treatment 0.074 7.83E-4 0.09 0.0928 1.0 2123740 Peakdale1_001197 COc1cc(OC)nc(n1)c2cccc(NC(=O)c3ccc(cc3)c4ccccc4)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G10 compound treatment 0.079 0.00578 0.69 0.6853 1.0 2123741 Peakdale1_001198 O=C(NC1CCSC1=O)c2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G11 compound treatment 0.0855 0.0123 1.46 1.4555 1.0 2123742 Peakdale1_001199 COc1cc(OC)nc(n1)c2cccc(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G12 compound treatment 0.0795 0.00628 0.74 0.7445 1.0 2123743 Peakdale1_001200 O=C(NCc1ccncc1)c2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G13 compound treatment 0.0895 0.0163 1.93 1.9294 1.0 2123744 Peakdale1_001201 COc1cc(OC)nc(n1)c2cccc(NC(=O)NS(=O)(=O)c3ccc(C)cc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G14 compound treatment 0.079 0.00578 0.69 0.6853 1.0 2123745 Peakdale1_001202 Clc1ccc(CNC(=O)c2cc3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G15 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123746 Peakdale1_001203 COc1cc(OC)nc(n1)c2cccc(NC(=S)Nc3ccccc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G16 compound treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 2123747 Peakdale1_001204 O=C(NCCc1ccccc1)c2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G17 compound treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 2123748 Peakdale1_001205 COc1cc(OC)nc(n1)c2cccc(NC(=O)CCl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G18 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123749 Peakdale1_001206 O=C(NCCN1CCOCC1)c2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G19 compound treatment 0.081 0.00778 0.92 0.9222 1.0 2123750 Peakdale1_001207 COc1cc(OC)nc(n1)c2cccc(NC(=O)CSc3nc(C)cc(C)n3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G20 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123751 Peakdale1_001208 O=C(N1CCN(Cc2ccccc2)CC1)c3cc4cccc5CCCn(c3=O)c54 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G21 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123752 Peakdale1_001209 Nc1ccc(SCc2nc(OCC(F)(F)F)cc(OCC(F)(F)F)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G22 compound treatment 0.074 7.83E-4 0.09 0.0928 1.0 2123753 Peakdale1_001210 COc1cc(OC)nc(CSCC(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G23 mock treatment 0.074 7.83E-4 0.09 0.0928 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 G24 mock treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H01 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123754 Peakdale1_001211 COc1cc(OC)nc(COc2ccc(cc2)C(=O)N3CC(C)OC(C)C3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H02 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123755 Peakdale1_001212 Clc1cc(cc(Cl)n1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H03 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123756 Peakdale1_001213 COc1cc(OC)nc(COc2ccc(cc2)C(=O)N3CCN(CC(=O)N4CCOCC4)CC3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H04 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123757 Peakdale1_001214 COc1ccc(cc1)S(=O)(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H05 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123758 Peakdale1_001215 COc1cc(OC)nc(COc2ccc(cc2)C(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H06 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123759 Peakdale1_001216 Fc1ccc(NC(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccccc4)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H07 compound treatment 0.0855 0.0123 1.46 1.4555 1.0 2123760 Peakdale1_001217 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H08 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123761 Peakdale1_001218 Clc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H09 compound treatment 0.085 0.0118 1.4 1.3962 1.0 2123762 Peakdale1_001219 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H10 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123763 Peakdale1_001220 CCC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H11 compound treatment 0.0785 0.00528 0.63 0.626 1.0 2123764 Peakdale1_001221 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H12 compound treatment 0.0805 0.00728 0.86 0.863 1.0 2123765 Peakdale1_001222 Clc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)/C=C/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H13 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123766 Peakdale1_001223 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H14 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123767 Peakdale1_001224 FC(F)(F)c1cccc(c1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H15 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123768 Peakdale1_001225 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H16 compound treatment 0.0815 0.00828 0.98 0.9815 1.0 2123769 Peakdale1_001226 CC(=O)Oc1ccccc1C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H17 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123770 Peakdale1_001227 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)c3c(F)cccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H18 compound treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 2123771 Peakdale1_001228 Clc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H19 compound treatment 0.0845 0.0113 1.34 1.337 1.0 2123772 Peakdale1_001229 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)c3ccc(cc3Cl)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H20 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123773 Peakdale1_001230 Clc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)c4cc(Cl)nc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H21 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123774 Peakdale1_001231 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)c3cc(Cl)nc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H22 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123775 Peakdale1_001232 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H23 mock treatment 0.0745 0.00128 0.15 0.1521 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 H24 mock treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I01 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123776 Peakdale1_001233 CC(C)(C)c1ccc(cc1)C(=O)Nc2ccc(SCc3nc(OCC(F)(F)F)cc(OCC(F)(F)F)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I02 compound treatment 0.0675 -0.00572 -0.68 -0.6774 -1.0 2123777 Peakdale1_001234 COc1cc(OC)nc(CSCC(=O)NCC2CCCO2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I03 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123778 Peakdale1_001235 FC(F)(F)COc1cc(OCC(F)(F)F)nc(CSc2ccc(NC(=O)C(c3ccccc3)c4ccccc4)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I04 compound treatment 0.0705 -0.00272 -0.32 -0.3219 -1.0 2123779 Peakdale1_001236 COc1cc(OC)nc(CSCC(=O)NCCN2CCOCC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I05 compound treatment 0.07 -0.00322 -0.38 -0.3811 -1.0 2123780 Peakdale1_001237 FC(F)(F)COc1cc(OCC(F)(F)F)nc(CSc2ccc(NC(=O)c3ccc(cc3)c4ccccc4)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I06 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123781 Peakdale1_001238 COc1cc(OC)nc(CSCC(=O)NC(C)c2ccccc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I07 compound treatment 0.0785 0.00528 0.63 0.626 1.0 2123782 Peakdale1_001239 CC(C)(C)c1ccc(cc1)S(=O)(=O)Nc2ccc(SCc3nc(OCC(F)(F)F)cc(OCC(F)(F)F)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I08 compound treatment 0.081 0.00778 0.92 0.9222 1.0 2123783 Peakdale1_001240 COc1cc(OC)nc(CSCC(=O)N(C(C)C)C(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I09 compound treatment 0.086 0.0128 1.51 1.5147 1.0 2123784 Peakdale1_001241 FC(F)(F)COc1cc(OCC(F)(F)F)nc(CSc2ccc(NC(=O)Nc3ccccc3)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I10 compound treatment 0.0895 0.0163 1.93 1.9294 1.0 2123785 Peakdale1_001242 COc1cc(OC)nc(CSCC(=O)N2CC(C)OC(C)C2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I11 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123786 Peakdale1_001243 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2ccc(SCc3nc(OCC(F)(F)F)cc(OCC(F)(F)F)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I12 compound treatment 0.0665 -0.00672 -0.8 -0.7959 -1.0 2123787 Peakdale1_001244 COc1cc(OC)nc(CSCC(=O)N2CCN(CC(=O)N3CCOCC3)CC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I13 compound treatment 0.0585 -0.0147 -1.74 -1.7438 -1.0 2123788 Peakdale1_001245 Fc1ccc(NC(=O)Nc2ccc(SCc3nc(OCC(F)(F)F)cc(OCC(F)(F)F)n3)cc2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I14 compound treatment 0.0645 -0.00872 -1.03 -1.0328 -1.0 2123789 Peakdale1_001246 COc1cc(OC)nc(CSCC(=O)N2CCN(Cc3ccccc3)CC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I15 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123790 Peakdale1_001247 CC(C)(C)c1cc2cc(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I16 compound treatment 0.067 -0.00622 -0.74 -0.7366 -1.0 2123791 Peakdale1_001248 COc1cc(OC)nc(CN2CCC(C)CC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I17 compound treatment 0.0845 0.0113 1.34 1.337 1.0 2123792 Peakdale1_001249 COc1ccc(cc1)S(=O)(=O)Nc2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I18 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123793 Peakdale1_001250 COc1cc(OC)nc(CN2CC(C)OC(C)C2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I19 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123794 Peakdale1_001251 CC(C)(C)c1cc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I20 compound treatment 0.0775 0.00428 0.51 0.5075 1.0 2123795 Peakdale1_001252 COc1cc(OC)nc(CN2CCN(CC2)C(c3ccccc3)c4ccccc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I21 compound treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 2123796 Peakdale1_001253 CC(C)(C)c1cc2cc(NS(=O)(=O)c3cccc(c3)C(F)(F)F)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I22 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123797 Peakdale1_001254 COc1cc(OC)nc(CN2CCN(Cc3ccccc3)CC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I23 mock treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 I24 mock treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J01 compound treatment 0.068 -0.00522 -0.62 -0.6181 -1.0 2123798 Peakdale1_001255 CCNC(=O)N1CCN(CC1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J02 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123799 Peakdale1_001256 Clc1ccc(NC(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J03 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123800 Peakdale1_001257 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J04 compound treatment 0.07 -0.00322 -0.38 -0.3811 -1.0 2123801 Peakdale1_001258 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J05 compound treatment 0.071 -0.00222 -0.26 -0.2627 -1.0 2123802 Peakdale1_001259 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCN(CC2)c3nc(C)cc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J06 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123803 Peakdale1_001260 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)c4ccccc4C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J07 compound treatment 0.081 0.00778 0.92 0.9222 1.0 2123804 Peakdale1_001261 Cc1cc(C)nc(n1)N2CCN(CC2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J08 compound treatment 0.074 7.83E-4 0.09 0.0928 1.0 2123805 Peakdale1_001262 CC(C)(C)c1ccc(cc1)C(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J09 compound treatment 0.077 0.00378 0.45 0.4483 1.0 1712002 Peakdale1_001263 Cc1cc(C)nc(n1)N2CCN(CC2)c3nc(C)cc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J10 compound treatment 0.081 0.00778 0.92 0.9222 1.0 2123806 Peakdale1_001264 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J11 compound treatment 0.074 7.83E-4 0.09 0.0928 1.0 2123807 Peakdale1_001265 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J12 compound treatment 0.068 -0.00522 -0.62 -0.6181 -1.0 2123808 Peakdale1_001266 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)c4cc(Cl)nc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J13 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123809 Peakdale1_001267 COCCNC(=O)CCC(=O)N1CCN(CC1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J14 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123810 Peakdale1_001268 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J15 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123811 Peakdale1_001269 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)CCC(=O)NCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J16 compound treatment 0.0675 -0.00572 -0.68 -0.6774 -1.0 2123812 Peakdale1_001270 CCNC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J17 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123813 Peakdale1_001271 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)CCC(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J18 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123814 Peakdale1_001272 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J19 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123815 Peakdale1_001273 CC(NC(=O)CCC(=O)N1CCN(CC1)c2nc(C)cc(C)n2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J20 compound treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 2123816 Peakdale1_001274 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J21 compound treatment 0.088 0.0148 1.75 1.7517 1.0 2123817 Peakdale1_001275 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)CCC(=O)NC3CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J22 compound treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 2123818 Peakdale1_001276 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J23 mock treatment 0.07 -0.00322 -0.38 -0.3811 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 J24 mock treatment 0.07 -0.00322 -0.38 -0.3811 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K01 compound treatment 0.0675 -0.00572 -0.68 -0.6774 -1.0 2123819 Peakdale1_001277 CC(C)(C)c1cc2cc(NS(=O)(=O)c3ccc4oc(=O)ccc4c3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K02 compound treatment 0.0665 -0.00672 -0.8 -0.7959 -1.0 2123820 Peakdale1_001278 COc1cc(OC)nc(CN(C)Cc2ccccc2Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K03 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123821 Peakdale1_001279 CC(C)(C)c1cc2cc(NCc3ccccn3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K04 compound treatment 0.07 -0.00322 -0.38 -0.3811 -1.0 2123822 Peakdale1_001280 COCc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K05 compound treatment 0.07 -0.00322 -0.38 -0.3811 -1.0 2123823 Peakdale1_001281 CCC(=O)N(Cc1ccccn1)c2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K06 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123824 Peakdale1_001282 FC(F)(F)c1cccc(COCc2cc3cccc4CCCn(c2=O)c43)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K07 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123825 Peakdale1_001283 CC(C)(C)c1cc2cc(ccc2[nH]1)N(Cc3ccccn3)C(=O)c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K08 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123826 Peakdale1_001284 O=c1c(COCc2ccccc2)cc3cccc4CCCn1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K09 compound treatment 0.0705 -0.00272 -0.32 -0.3219 -1.0 2123827 Peakdale1_001285 CC(C)(C)c1cc2cc(ccc2[nH]1)N(Cc3ccccn3)C(=O)c4ccc(cc4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K10 compound treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 2123828 Peakdale1_001286 O=c1c(COCc2ccccn2)cc3cccc4CCCn1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K11 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123829 Peakdale1_001287 CC(C)(C)c1cc2cc(ccc2[nH]1)N(Cc3ccccn3)C(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K12 compound treatment 0.067 -0.00622 -0.74 -0.7366 -1.0 2123830 Peakdale1_001288 Cc1cc(C)nc(OCc2cc3cccc4CCCn(c2=O)c43)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K13 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123831 Peakdale1_001289 CC(C)(C)c1cc2cc(ccc2[nH]1)N(Cc3ccccn3)C(=O)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K14 compound treatment 0.0675 -0.00572 -0.68 -0.6774 -1.0 2123832 Peakdale1_001290 COc1cc(OC)nc(OCc2cc3cccc4CCCn(c2=O)c43)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K15 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123833 Peakdale1_001291 CC(C)(C)c1cc2cc(ccc2[nH]1)N(Cc3ccccn3)S(=O)(=O)c4ccc(cc4)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K16 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123834 Peakdale1_001292 CC(=O)OCc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K17 compound treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 2123835 Peakdale1_001293 CS(=O)(=O)N1CCc2cc(NC3CCN(Cc4ccccc4)CC3)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K18 compound treatment 0.068 -0.00522 -0.62 -0.6181 -1.0 2123836 Peakdale1_001294 O=C(OCc1cc2cccc3CCCn(c1=O)c32)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K19 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123837 Peakdale1_001295 CCNC(=O)N(C1CCN(Cc2ccccc2)CC1)c3ccc4N(CCc4c3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K20 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123838 Peakdale1_001296 CCNC(=O)OCc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K21 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123839 Peakdale1_001297 COc1ccccc1NC(=O)N(C2CCN(Cc3ccccc3)CC2)c4ccc5N(CCc5c4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K22 compound treatment 0.0885 0.0153 1.81 1.8109 1.0 2123840 Peakdale1_001298 O=C(Nc1ccccc1)OCc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K23 mock treatment 0.068 -0.00522 -0.62 -0.6181 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 K24 mock treatment 0.0675 -0.00572 -0.68 -0.6774 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L01 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123841 Peakdale1_001299 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)CCC(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L02 compound treatment 0.07 -0.00322 -0.38 -0.3811 -1.0 2123842 Peakdale1_001300 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(N)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L03 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123843 Peakdale1_001301 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)CCC(=O)NN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L04 compound treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 2123844 Peakdale1_001302 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)C(C)(C)C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L05 compound treatment 0.0805 0.00728 0.86 0.863 1.0 2123845 Peakdale1_001303 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)CCC(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L06 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123846 Peakdale1_001304 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4ccccc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L07 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123847 Peakdale1_001305 CON(C)C(=O)CCC(=O)N1CCN(CC1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L08 compound treatment 0.0785 0.00528 0.63 0.626 1.0 2123848 Peakdale1_001306 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4cccc(c4)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L09 compound treatment 0.081 0.00778 0.92 0.9222 1.0 2123849 Peakdale1_001307 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)CCC(=O)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L10 compound treatment 0.0825 0.00928 1.1 1.1 1.0 2123850 Peakdale1_001308 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4ccccc4OC(=O)C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L11 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123851 Peakdale1_001309 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)CCC(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L12 compound treatment 0.074 7.83E-4 0.09 0.0928 1.0 2123852 Peakdale1_001310 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)C(c4ccccc4)c5ccccc5)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L13 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123853 Peakdale1_001311 Cc1cc(C)nc(n1)N2CCN(CC2)C(=O)CCC(=O)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L14 compound treatment 0.0795 0.00628 0.74 0.7445 1.0 2123854 Peakdale1_001312 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4ccco4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L15 compound treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 2123855 Peakdale1_001313 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L16 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123856 Peakdale1_001314 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4cc(Cl)nc(Cl)c4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L17 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123857 Peakdale1_001315 CCCN1CCC(CC1)N(C2CC2)C(=O)c3c(F)cccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L18 compound treatment 0.0705 -0.00272 -0.32 -0.3219 -1.0 2123858 Peakdale1_001316 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)NCC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L19 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2080051 Peakdale1_001317 CCCN1CCC(CC1)N(C2CC2)C(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L20 compound treatment 0.0705 -0.00272 -0.32 -0.3219 -1.0 2123859 Peakdale1_001318 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)Nc4ccc(F)cc4F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L21 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123860 Peakdale1_001319 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L22 compound treatment 0.071 -0.00222 -0.26 -0.2627 -1.0 2123861 Peakdale1_001320 CC(C)(C)C(=O)NC1CCN2CCCc3cccc1c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L23 mock treatment 0.0735 2.83E-4 0.03 0.0336 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 L24 mock treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M01 compound treatment 0.067 -0.00622 -0.74 -0.7366 -1.0 2123862 Peakdale1_001321 Cc1ccc(cc1)S(=O)(=O)NC(=O)N(C2CCN(Cc3ccccc3)CC2)c4ccc5N(CCc5c4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M02 compound treatment 0.068 -0.00522 -0.62 -0.6181 -1.0 2123863 Peakdale1_001322 OC(=O)CSCc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M03 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123864 Peakdale1_001323 CC(=O)N(C1CCN(Cc2ccccc2)CC1)c3ccc4N(CCc4c3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M04 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123865 Peakdale1_001324 NC(=O)CSCc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M05 compound treatment 0.07 -0.00322 -0.38 -0.3811 -1.0 2123866 Peakdale1_001325 CS(=O)(=O)N1CCc2cc(ccc12)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M06 compound treatment 0.088 0.0148 1.75 1.7517 1.0 2123867 Peakdale1_001326 COCCNC(=O)CSCc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M07 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123868 Peakdale1_001327 CC(=O)N1CCC(CC1)Nc2ccc3N(CCc3c2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M08 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123869 Peakdale1_001328 Clc1cccc(CNC(=O)CSCc2cc3cccc4CCCn(c2=O)c43)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M09 compound treatment 0.08 0.00678 0.8 0.8038 1.0 2123870 Peakdale1_001329 COc1ccccc1NC(=O)N(C2CCN(CC2)C(=O)C)c3ccc4N(CCc4c3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M10 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123871 Peakdale1_001330 O=C(CSCc1cc2cccc3CCCn(c1=O)c32)NCc4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M11 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123872 Peakdale1_001331 CCC(=O)N(C1CCN(CC1)C(=O)C)c2ccc3N(CCc3c2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M12 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123873 Peakdale1_001332 O=C(CSCc1cc2cccc3CCCn(c1=O)c32)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M13 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123874 Peakdale1_001333 CC(=O)N1CCC(CC1)N(C(=O)c2cccs2)c3ccc4N(CCc4c3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M14 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123875 Peakdale1_001334 O=C(CSCc1cc2cccc3CCCn(c1=O)c32)NC4CCSC4=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M15 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123876 Peakdale1_001335 COc1ccc(NCc2cc3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M16 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123877 Peakdale1_001336 O=C(CSCc1cc2cccc3CCCn(c1=O)c32)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M17 compound treatment 0.079 0.00578 0.69 0.6853 1.0 2123878 Peakdale1_001337 CCC(=O)N(Cc1cc2cccc3CCCn(c1=O)c32)c4ccc(OC)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M18 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123879 Peakdale1_001338 O=C(CSCc1cc2cccc3CCCn(c1=O)c32)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M19 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123880 Peakdale1_001339 COc1ccc(cc1)N(Cc2cc3cccc4CCCn(c2=O)c43)C(=O)c5ccc(cc5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M20 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123881 Peakdale1_001340 O=C(CSCc1cc2cccc3CCCn(c1=O)c32)N4CCc5ccccc5C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M21 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123882 Peakdale1_001341 COc1ccc(cc1)N(Cc2cc3cccc4CCCn(c2=O)c43)C(=O)c5c(F)cccc5F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M22 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123883 Peakdale1_001342 Cc1cccc(OCc2cc3cccc4CCCn(c2=O)c43)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M23 mock treatment 0.071 -0.00222 -0.26 -0.2627 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 M24 mock treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N01 compound treatment 0.0675 -0.00572 -0.68 -0.6774 -1.0 2123884 Peakdale1_001343 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(Cl)nc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N02 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123885 Peakdale1_001344 O=C(NC1CCN2CCCc3cccc1c23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N03 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123886 Peakdale1_001345 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N04 compound treatment 0.0715 -0.00172 -0.2 -0.2034 -1.0 2123887 Peakdale1_001346 CC(C)(C)c1ccc(cc1)C(=O)NC2CCN3CCCc4cccc2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N05 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123888 Peakdale1_001347 CCCN1CCC(CC1)N(C2CC2)C(=O)NS(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N06 compound treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 2123889 Peakdale1_001348 Fc1cccc(F)c1C(=O)NC2CCN3CCCc4cccc2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N07 compound treatment 0.079 0.00578 0.69 0.6853 1.0 2123890 Peakdale1_001349 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N08 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123891 Peakdale1_001350 CC(=O)Oc1ccccc1C(=O)NC2CCN3CCCc4cccc2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N09 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123892 Peakdale1_001351 CC(C)(C)C(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N10 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123893 Peakdale1_001352 O=C(NC1CCN2CCCc3cccc1c23)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N11 compound treatment 0.0825 0.00928 1.1 1.1 1.0 2123894 Peakdale1_001353 O=C(C1CC1)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N12 compound treatment 0.084 0.0108 1.28 1.2777 1.0 2123895 Peakdale1_001354 Clc1cc(cc(Cl)n1)C(=O)NC2CCN3CCCc4cccc2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N13 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123896 Peakdale1_001355 FC(F)(F)c1ccc(cc1)C(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N14 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123897 Peakdale1_001356 O=C(NC1CCN2CCCc3cccc1c23)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N15 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123898 Peakdale1_001357 COc1cccc(OC)c1C(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N16 compound treatment 0.095 0.0218 2.58 2.5811 1.0 2123899 Peakdale1_001358 Fc1ccc(NC(=O)NC2CCN3CCCc4cccc2c34)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N17 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123900 Peakdale1_001359 O=C(N(C1CC1)C2CCN(Cc3ccccc3)CC2)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N18 compound treatment 0.0865 0.0133 1.57 1.5739 1.0 2123901 Peakdale1_001360 Cc1ccc(cc1)S(=O)(=O)NC(=O)NC2CCN3CCCc4cccc2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N19 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123902 Peakdale1_001361 Clc1cc(cc(Cl)n1)C(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N20 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123903 Peakdale1_001362 COc1cc(OC)nc(n1)C(Sc2ccc(N)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N21 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123904 Peakdale1_001363 O=S(=O)(N(C1CC1)C2CCN(Cc3ccccc3)CC2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N22 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123905 Peakdale1_001364 COc1cc(OC)nc(n1)C(Sc2ccc(NC(=O)c3cccc(c3)C(F)(F)F)cc2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N23 mock treatment 0.077 0.00378 0.45 0.4483 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 N24 mock treatment 0.0735 2.83E-4 0.03 0.0336 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O01 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123906 Peakdale1_001365 COc1ccc(cc1)N(Cc2cc3cccc4CCCn(c2=O)c43)C(=O)c5cc(Cl)nc(Cl)c5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O02 compound treatment 0.0655 -0.00772 -0.91 -0.9143 -1.0 2123907 Peakdale1_001366 COc1ccc(OCc2cc3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O03 compound treatment 0.0675 -0.00572 -0.68 -0.6774 -1.0 2123908 Peakdale1_001367 COc1ccc(cc1)N(Cc2cc3cccc4CCCn(c2=O)c43)C(=O)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O04 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123909 Peakdale1_001368 O=c1c(COc2cccnc2)cc3cccc4CCCn1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O05 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123910 Peakdale1_001369 COc1ccc(cc1)N(Cc2cc3cccc4CCCn(c2=O)c43)S(=O)(=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O06 compound treatment 0.072 -0.00122 -0.14 -0.1442 -1.0 2123911 Peakdale1_001370 COC(=O)c1ncccc1OCc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O07 compound treatment 0.0765 0.00328 0.39 0.389 1.0 2123912 Peakdale1_001371 COc1ccc(cc1)N(Cc2cc3cccc4CCCn(c2=O)c43)C(=O)NS(=O)(=O)c5ccc(C)cc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O08 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123913 Peakdale1_001372 O=c1c(CSc2ccccn2)cc3cccc4CCCn1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O09 compound treatment 0.071 -0.00222 -0.26 -0.2627 -1.0 2123914 Peakdale1_001373 CCNC(=O)N(Cc1cc2cccc3CCCn(c1=O)c32)c4ccc(OC)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O10 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123915 Peakdale1_001374 Cc1cc(C)nc(SCc2cc3cccc4CCCn(c2=O)c43)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O11 compound treatment 0.074 7.83E-4 0.09 0.0928 1.0 2123916 Peakdale1_001375 OC(=O)/C=C/c1cc2cccc3CCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O12 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123917 Peakdale1_001376 CC(=O)NCCSCc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O13 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123918 Peakdale1_001377 O=C(NCCc1ccccc1)/C=C/c2cc3cccc4CCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O14 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123919 Peakdale1_001378 O=C(NCCSCc1cc2cccc3CCCn(c1=O)c32)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O15 compound treatment 0.0785 0.00528 0.63 0.626 1.0 2123920 Peakdale1_001379 FC(F)(F)c1cccc(CNC(=O)/C=C/c2cc3cccc4CCn(c2=O)c43)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O16 compound treatment 0.0695 -0.00372 -0.44 -0.4404 -1.0 2123921 Peakdale1_001380 FC(F)(F)c1ccc(cc1)C(=O)NCCSCc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O17 compound treatment 0.078 0.00478 0.57 0.5668 1.0 2123922 Peakdale1_001381 O=C(/C=C/c1cc2cccc3CCn(c1=O)c32)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O18 compound treatment 0.069 -0.00422 -0.5 -0.4996 -1.0 2123923 Peakdale1_001382 CS(=O)(=O)c1cccc(c1)C(=O)NCCSCc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O19 compound treatment 0.085 0.0118 1.4 1.3962 1.0 2123924 Peakdale1_001383 O=C(/C=C/c1cc2cccc3CCn(c1=O)c32)N4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O20 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123925 Peakdale1_001384 Clc1cc(cc(Cl)n1)C(=O)NCCSCc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O21 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123926 Peakdale1_001385 OC(=O)/C=C/c1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O22 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123927 Peakdale1_001386 O=c1c(CSCCNS(=O)(=O)c2ccccc2)cc3cccc4CCCn1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O23 mock treatment 0.0815 0.00828 0.98 0.9815 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 O24 mock treatment 0.0755 0.00228 0.27 0.2706 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P01 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123928 Peakdale1_001387 CCNC(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P02 compound treatment 0.0725 -7.17E-4 -0.08 -0.0849 -1.0 2123929 Peakdale1_001388 COc1cc(OC)nc(n1)C(Sc2ccc(NC(=O)c3c(F)cccc3F)cc2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P03 compound treatment 0.0745 0.00128 0.15 0.1521 1.0 2123930 Peakdale1_001389 Fc1ccc(NC(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P04 compound treatment 0.0825 0.00928 1.1 1.1 1.0 2123931 Peakdale1_001390 COc1cc(OC)nc(n1)C(Sc2ccc(NC(=O)c3c(OC)cccc3OC)cc2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P05 compound treatment 0.0735 2.83E-4 0.03 0.0336 1.0 2123932 Peakdale1_001391 Cc1ccc(cc1)S(=O)(=O)NC(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P06 compound treatment 0.0805 0.00728 0.86 0.863 1.0 2123933 Peakdale1_001392 COc1cc(OC)nc(n1)C(Sc2ccc(NC(=O)c3ccc(Cl)nc3)cc2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P07 compound treatment 0.0795 0.00628 0.74 0.7445 1.0 2123934 Peakdale1_001393 CCC(=O)N(C1CC1)C2CCN(CC2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P08 compound treatment 0.073 -2.17E-4 -0.03 -0.0257 -1.0 2123935 Peakdale1_001394 COc1cc(OC)nc(n1)C(Sc2ccc(NC(=O)c3cccs3)cc2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P09 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123936 Peakdale1_001395 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P10 compound treatment 0.076 0.00278 0.33 0.3298 1.0 2123937 Peakdale1_001396 COc1cc(OC)nc(n1)C(Sc2ccc(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)cc2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P11 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123938 Peakdale1_001397 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P12 compound treatment 0.0775 0.00428 0.51 0.5075 1.0 2123939 Peakdale1_001398 COc1cc(OC)nc(n1)C(SCCN)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P13 compound treatment 0.0685 -0.00472 -0.56 -0.5589 -1.0 2123940 Peakdale1_001399 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P14 compound treatment 0.084 0.0108 1.28 1.2777 1.0 2123941 Peakdale1_001400 COC(=O)C1CCCCC1C(=O)NCCSC(c2ccccc2)c3nc(OC)cc(OC)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P15 compound treatment 0.0755 0.00228 0.27 0.2706 1.0 2123942 Peakdale1_001401 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)c3cc(Cl)nc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P16 compound treatment 0.0845 0.0113 1.34 1.337 1.0 2123943 Peakdale1_001402 COc1cc(OC)nc(n1)C(SCCNC(=O)c2c(F)cccc2F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P17 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123944 Peakdale1_001403 CC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P18 compound treatment 0.075 0.00178 0.21 0.2113 1.0 2123945 Peakdale1_001404 COc1cc(OC)nc(n1)C(SCCNC(=O)c2ccc(cc2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P19 compound treatment 0.0885 0.0153 1.81 1.8109 1.0 2123946 Peakdale1_001405 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)Nc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P20 compound treatment 0.083 0.00978 1.16 1.1592 1.0 2123947 Peakdale1_001406 COc1cc(OC)nc(n1)C(SCCNC(=O)c2ccc(Cl)nc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P21 compound treatment 0.0835 0.0103 1.22 1.2185 1.0 2123948 Peakdale1_001407 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)NS(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P22 compound treatment 0.077 0.00378 0.45 0.4483 1.0 2123949 Peakdale1_001408 COc1cc(OC)nc(n1)C(SCCNC(=O)c2c(OC)cccc2OC)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P23 mock treatment 0.0735 2.83E-4 0.03 0.0336 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.521 P24 mock treatment 0.06 -0.0132 -1.57 -1.566 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A01 compound treatment 0.0765 0.00308 0.37 0.365 1.0 2123950 Peakdale1_001409 COc1cc(OC)nc(n1)C(SCCNC(=O)c2ccco2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A02 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2123951 Peakdale1_001410 COc1cc(OC)nc(n1)c2ccc(cc2)C(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A03 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2123952 Peakdale1_001411 COc1cc(OC)nc(n1)C(SCCNC(=O)Nc2ccc(F)cc2F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A04 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2123953 Peakdale1_001412 COc1cc(OC)nc(n1)c2ccc(cc2)C(=O)N3CCN(CC3)c4nc(C)cc(C)n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A05 compound treatment 0.067 -0.00642 -0.76 -0.7606 -1.0 2123954 Peakdale1_001413 COc1cc(OC)nc(n1)C(Sc2ncc(C(=O)O)n2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A06 compound treatment 0.065 -0.00842 -1.0 -0.9976 -1.0 2123955 Peakdale1_001414 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3ccccc3C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A07 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2123956 Peakdale1_001415 COC(=O)c1cnc(SC(c2ccccc2)c3nc(OC)cc(OC)n3)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A08 compound treatment 0.077 0.00358 0.42 0.4243 1.0 2123957 Peakdale1_001416 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3ccccc3C(=O)NC4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A09 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2123958 Peakdale1_001417 COc1cc(OC)nc(n1)C(Sc2ccccn2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A10 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2123959 Peakdale1_001418 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3ccccc3C(=O)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A11 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2123960 Peakdale1_001419 COc1cc(OC)nc(n1)C(Sc2nc(C)cc(C)n2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A12 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2123961 Peakdale1_001420 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3ccccc3C(=O)NCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A13 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2123962 Peakdale1_001421 COc1cc(OC)nc(n1)C(Sc2nc3ccccc3[nH]2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A14 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2123963 Peakdale1_001422 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3ccccc3C(=O)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A15 compound treatment 0.067 -0.00642 -0.76 -0.7606 -1.0 2123964 Peakdale1_001423 COC(=O)c1ccccc1OC(c2ccccc2)c3nc(OC)cc(OC)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A16 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2123965 Peakdale1_001424 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3ccccc3C(=O)NCCc4ccc(cc4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A17 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2123966 Peakdale1_001425 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CSCCNC(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A18 compound treatment 0.0645 -0.00892 -1.06 -1.0569 -1.0 2123967 Peakdale1_001426 COc1ccccc1CNC(=O)c2ccccc2OCC(=O)N(C3CC3)C4CCN(CC4)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A19 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2123968 Peakdale1_001427 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CSCCNC(=O)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A20 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2123969 Peakdale1_001428 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3ccccc3C(=O)NCc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A21 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2123970 Peakdale1_001429 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CSCCNC(=O)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A22 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2123971 Peakdale1_001430 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3ccccc3C(=O)NCc4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A23 mock treatment 0.085 0.0116 1.37 1.3722 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 A24 mock treatment 0.0795 0.00608 0.72 0.7205 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B01 compound treatment 0.0665 -0.00692 -0.82 -0.8199 -1.0 2123972 Peakdale1_001431 COC(=O)c1cc(nc(n1)N2CCOCC2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B02 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2123973 Peakdale1_001432 Clc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B03 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2123974 Peakdale1_001433 O=C(NC1CC1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B04 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2123975 Peakdale1_001434 Clc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)NCc4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B05 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2123976 Peakdale1_001435 O=C(N1CCOCC1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B06 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2123977 Peakdale1_001436 Clc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)N4CCN(CC4)C(c5ccccc5)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B07 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 2123978 Peakdale1_001437 O=C(NCCN1CCOCC1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B08 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2123979 Peakdale1_001438 CCCN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B09 compound treatment 0.0665 -0.00692 -0.82 -0.8199 -1.0 2123980 Peakdale1_001439 O=C(NCCc1ccccc1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B10 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 2123981 Peakdale1_001440 CCCN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B11 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2123982 Peakdale1_001441 FC(F)(F)c1cccc(CNC(=O)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B12 compound treatment 0.0825 0.00908 1.08 1.076 1.0 2123983 Peakdale1_001442 CCCN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NC3CCSC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B13 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2123984 Peakdale1_001443 Clc1ccc(CNC(=O)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B14 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2123985 Peakdale1_001444 CCCN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B15 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2123986 Peakdale1_001445 O=C(N1CCc2ccccc2C1)c3cc(nc(n3)N4CCOCC4)N5CCOCC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B16 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 2123987 Peakdale1_001446 CCCN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B17 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2123988 Peakdale1_001447 CON(C)C(=O)c1cc(nc(n1)N2CCOCC2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B18 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2123989 Peakdale1_001448 CCCN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B19 compound treatment 0.077 0.00358 0.42 0.4243 1.0 2123990 Peakdale1_001449 Cc1ncc(c(n1)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B20 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2123991 Peakdale1_001450 CCCN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NCc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B21 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2123992 Peakdale1_001451 CS(=O)(=O)c1cnc(nc1c2cc(nc(n2)N3CCOCC3)N4CCOCC4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B22 compound treatment 0.079 0.00558 0.66 0.6613 1.0 2123993 Peakdale1_001452 CCCN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B23 mock treatment 0.0785 0.00508 0.6 0.602 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 B24 mock treatment 0.076 0.00258 0.31 0.3058 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C01 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2123994 Peakdale1_001453 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CSCCNC(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C02 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2123995 Peakdale1_001454 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3ccccc3C(=O)N4CCc5ccccc5C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C03 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2123996 Peakdale1_001455 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CSCCNC(=O)c3cc(Cl)nc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C04 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2123997 Peakdale1_001456 CN(C)c1cc(nc(n1)N(C)C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C05 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2123998 Peakdale1_001457 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CSCCNC(=O)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C06 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2123999 Peakdale1_001458 COC(=O)c1cc(nc(n1)N(C)C)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C07 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2124000 Peakdale1_001459 COc1ccc(cc1)S(=O)(=O)NCCSCC(=O)N(C2CC2)C3CCN(CC3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C08 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124001 Peakdale1_001460 COCCNC(=O)c1cc(nc(n1)N(C)C)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C09 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124002 Peakdale1_001461 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CSCCNC(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C10 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124003 Peakdale1_001462 CN(C)c1cc(nc(n1)N(C)C)C(=O)NC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C11 compound treatment 0.076 0.00258 0.31 0.3058 1.0 2124004 Peakdale1_001463 COc1cc(OC)nc(CSCCNC(=O)CCl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C12 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124005 Peakdale1_001464 CN(C)c1cc(nc(n1)N(C)C)C(=O)NCC2CCCO2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C13 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124006 Peakdale1_001465 CON(C)CC(=O)NCCSCc1nc(OC)cc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C14 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2124007 Peakdale1_001466 CN(C)c1cc(nc(n1)N(C)C)C(=O)NCCN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C15 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124008 Peakdale1_001467 COc1cc(OC)nc(CSCCNC(=O)CN2CCc3ccccc3C2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C16 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124009 Peakdale1_001468 CN(C)c1cc(nc(n1)N(C)C)C(=O)NCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C17 compound treatment 0.0805 0.00708 0.84 0.839 1.0 2124010 Peakdale1_001469 COc1cc(OC)nc(CSCCNC(=O)CN2CCN(CC2)C(c3ccccc3)c4ccccc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C18 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 2124011 Peakdale1_001470 CN(C)c1cc(nc(n1)N(C)C)C(=O)NCCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C19 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124012 Peakdale1_001471 COc1cc(OC)nc(CSCCNC(=O)C2CCCCC2C(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C20 compound treatment 0.08 0.00658 0.78 0.7797 1.0 2124013 Peakdale1_001472 CN(C)C(=O)c1cc(nc(n1)N(C)C)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C21 compound treatment 0.0765 0.00308 0.37 0.365 1.0 2124014 Peakdale1_001473 COC(=O)C1CCCCC1C(=O)NCCSCc2nc(OC)cc(OC)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C22 compound treatment 0.0775 0.00408 0.48 0.4835 1.0 2124015 Peakdale1_001474 CON(C)C(=O)c1cc(nc(n1)N(C)C)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C23 mock treatment 0.075 0.00158 0.19 0.1873 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 C24 mock treatment 0.0765 0.00308 0.37 0.365 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D01 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124016 Peakdale1_001475 CS(=O)(=O)c1cnc(N)nc1c2cc(nc(n2)N3CCOCC3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D02 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124017 Peakdale1_001476 CCCN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D03 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124018 Peakdale1_001477 Cc1nc(c(C)[nH]1)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D04 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2124019 Peakdale1_001478 CCCN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D05 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2124020 Peakdale1_001479 Cc1[nH]cnc1c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D06 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2124021 Peakdale1_001480 COc1cc(OC)nc(n1)C(N2CCNCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D07 compound treatment 0.083 0.00958 1.14 1.1352 1.0 2124022 Peakdale1_001481 Cc1nc(c(C)[nH]1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D08 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124023 Peakdale1_001482 COc1cc(OC)nc(n1)C(N2CCN(CC2)C(=O)c3cccc(c3)C(F)(F)F)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D09 compound treatment 0.0765 0.00308 0.37 0.365 1.0 2124024 Peakdale1_001483 Cc1nc(c(C)[nH]1)c2cc(Cl)cc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D10 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124025 Peakdale1_001484 COc1cc(OC)nc(n1)C(N2CCN(CC2)C(=O)c3c(F)cccc3F)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D11 compound treatment 0.0785 0.00508 0.6 0.602 1.0 2124026 Peakdale1_001485 CC(C)NC(=O)c1cccc2cc[nH]c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D12 compound treatment 0.0795 0.00608 0.72 0.7205 1.0 2124027 Peakdale1_001486 COc1cc(OC)nc(n1)C(N2CCN(CC2)C(=O)c3cc(OC)c(OC)c(OC)c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D13 compound treatment 0.0765 0.00308 0.37 0.365 1.0 2124028 Peakdale1_001487 O=C(NCC1CCCO1)c2cccc3cc[nH]c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D14 compound treatment 0.0775 0.00408 0.48 0.4835 1.0 2124029 Peakdale1_001488 COc1cc(OC)nc(n1)C(N2CCN(CC2)C(=O)c3ccc(cc3)c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D15 compound treatment 0.08 0.00658 0.78 0.7797 1.0 2124030 Peakdale1_001489 O=C(NCCc1ccccc1)c2cccc3cc[nH]c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D16 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 2124031 Peakdale1_001490 CCNC(=O)N1CCN(CC1)C(c2ccccc2)c3nc(OC)cc(OC)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D17 compound treatment 0.085 0.0116 1.37 1.3722 1.0 2080067 Peakdale1_001491 O=C(NCCN1CCOCC1)c2cccc3cc[nH]c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D18 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124032 Peakdale1_001492 COc1cc(OC)nc(n1)C(N2CCN(CC2)C(=O)Nc3ccccc3OC)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D19 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2124033 Peakdale1_001493 FC(F)(F)c1cccc(CNC(=O)c2cccc3cc[nH]c23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D20 compound treatment 0.077 0.00358 0.42 0.4243 1.0 2124034 Peakdale1_001494 COc1cc(OC)nc(n1)C(N2CCN(CC2)C(=O)NS(=O)(=O)c3ccc(C)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D21 compound treatment 0.0835 0.0101 1.19 1.1945 1.0 2124035 Peakdale1_001495 CS(=O)(=O)c1ccc(CNC(=O)c2cccc3cc[nH]c23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D22 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2124036 Peakdale1_001496 CC(C)(C)C(=O)N1CCN(CC1)C(=O)c2ccc3cc[nH]c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D23 mock treatment 0.074 5.81E-4 0.07 0.0688 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 D24 mock treatment 0.077 0.00358 0.42 0.4243 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E01 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124037 Peakdale1_001497 COc1cc(OC)nc(CSCCNC(=O)C2CCCCC2C(=O)N3CCN(CC(=O)N4CCOCC4)CC3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E02 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124038 Peakdale1_001498 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCc3ccccc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E03 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124039 Peakdale1_001499 COc1cc(OC)nc(CSCCNC(=O)C(Sc2ccccn2)c3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E04 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2124040 Peakdale1_001500 CC1CN(CC(C)O1)C(=O)c2cc(nc(n2)N(C)C)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E05 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124041 Peakdale1_001501 COc1cc(OC)nc(CSc2ncc(C(=O)O)n2C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E06 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124042 Peakdale1_001502 CN(C)c1cc(nc(n1)N(C)C)C(=O)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E07 compound treatment 0.0835 0.0101 1.19 1.1945 1.0 2124043 Peakdale1_001503 COC(=O)c1cnc(SCc2nc(OC)cc(OC)n2)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E08 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124044 Peakdale1_001504 COc1ccc(NC(=O)c2cc(nc(n2)N(C)C)N(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E09 compound treatment 0.0795 0.00608 0.72 0.7205 1.0 2124045 Peakdale1_001505 COc1cc(OC)nc(CSc2ncc(C(=O)NCc3cccc(c3)C(F)(F)F)n2C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E10 compound treatment 0.0775 0.00408 0.48 0.4835 1.0 2124046 Peakdale1_001506 COc1cc(NC(=O)c2cc(nc(n2)N(C)C)N(C)C)cc(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E11 compound treatment 0.0825 0.00908 1.08 1.076 1.0 2124047 Peakdale1_001507 COc1cc(OC)nc(CSc2ncc(C(=O)NCc3ccc(Cl)cc3)n2C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E12 compound treatment 0.079 0.00558 0.66 0.6613 1.0 2124048 Peakdale1_001508 CN(C)c1cc(nc(n1)N(C)C)C(=O)Nc2ccc(cc2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E13 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 2124049 Peakdale1_001509 COc1cc(OC)nc(CSc2ncc(C(=O)N3CCc4ccccc4C3)n2C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E14 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2124050 Peakdale1_001510 CCN(C(=O)c1cc(nc(n1)N(C)C)N(C)C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E15 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2124051 Peakdale1_001511 COc1cc(OC)nc(CSc2ncc(C(=O)N3CCN(CC(=O)N4CCOCC4)CC3)n2C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E16 compound treatment 0.079 0.00558 0.66 0.6613 1.0 2124052 Peakdale1_001512 COc1ccc(cc1)N(C)C(=O)c2cc(nc(n2)N(C)C)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E17 compound treatment 0.077 0.00358 0.42 0.4243 1.0 2124053 Peakdale1_001513 COc1cc(OC)nc(CSc2ncc(C(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5)n2C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E18 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124054 Peakdale1_001514 CCN(C(=O)c1cc(nc(n1)N(C)C)N(C)C)c2cc(OC)cc(OC)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E19 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124055 Peakdale1_001515 COc1cc(OC)nc(CSc2ncc(C(=O)N3CCN(CC3)c4nc(C)cc(C)n4)n2C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E20 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124056 Peakdale1_001516 CN(C)c1cc(nc(n1)N(C)C)C(=O)N(C)c2ccc(cc2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E21 compound treatment 0.076 0.00258 0.31 0.3058 1.0 2124057 Peakdale1_001517 COc1cc(OC)nc(CCC(=O)O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E22 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124058 Peakdale1_001518 CNC(=S)NNC(=O)c1cc(nc(n1)N(C)C)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E23 mock treatment 0.0735 8.06E-5 0.01 0.0096 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 E24 mock treatment 0.074 5.81E-4 0.07 0.0688 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F01 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124059 Peakdale1_001519 O=C(NCc1ccccn1)c2cccc3cc[nH]c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F02 compound treatment 0.0685 -0.00492 -0.58 -0.5829 -1.0 2124060 Peakdale1_001520 O=C(C(c1ccccc1)c2ccccc2)N3CCN(CC3)C(=O)c4ccc5cc[nH]c5c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F03 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124061 Peakdale1_001521 O=C(N1CCc2ccccc2C1)c3cccc4cc[nH]c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F04 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124062 Peakdale1_001522 Oc1ccccc1C(=O)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F05 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2124063 Peakdale1_001523 O=C(N1CCN(CC1)C(c2ccccc2)c3ccccc3)c4cccc5cc[nH]c45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F06 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124064 Peakdale1_001524 CC(=O)Oc1ccccc1C(=O)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F07 compound treatment 0.0785 0.00508 0.6 0.602 1.0 2079921 Peakdale1_001525 OC(=O)C1N(Cc2ccccc2-n3cccc13)C4CCNCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F08 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124065 Peakdale1_001526 FC(F)(F)c1cccc(c1)C(=O)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F09 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124066 Peakdale1_001527 CC(=O)N1CCC(CC1)N2Cc3ccccc3-n4cccc4C2C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F10 compound treatment 0.0815 0.00808 0.96 0.9575 1.0 2124067 Peakdale1_001528 Fc1cccc(F)c1C(=O)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F11 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2124068 Peakdale1_001529 CC(=O)N1CCC(CC1)N2Cc3ccccc3-n4cccc4C2C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F12 compound treatment 0.081 0.00758 0.9 0.8982 1.0 2124069 Peakdale1_001530 CC(C)(C)c1ccc(cc1)C(=O)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F13 compound treatment 0.0765 0.00308 0.37 0.365 1.0 2124070 Peakdale1_001531 CCN(CC)C(=O)C1N(Cc2ccccc2-n3cccc13)C4CCN(CC4)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F14 compound treatment 0.0785 0.00508 0.6 0.602 1.0 2124071 Peakdale1_001532 COc1cc(cc(OC)c1OC)C(=O)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F15 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124072 Peakdale1_001533 CC(=O)N1CCC(CC1)N2Cc3ccccc3-n4cccc4C2C(=O)NCc5cccc(c5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F16 compound treatment 0.0865 0.0131 1.55 1.5499 1.0 2124073 Peakdale1_001534 Clc1cc(cc(Cl)n1)C(=O)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F17 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124074 Peakdale1_001535 CC(=O)N1CCC(CC1)N2Cc3ccccc3-n4cccc4C2c5ccco5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F18 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124075 Peakdale1_001536 O=C(N1CCN(CC1)C(=O)c2ccc3cc[nH]c3c2)c4ccc(cc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F19 compound treatment 0.0895 0.0161 1.91 1.9054 1.0 2124076 Peakdale1_001537 Cc1[nH]c2c(NC(=O)C3CC3)cccc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F20 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124077 Peakdale1_001538 CN1CCN(CC1)C(=O)c2ccc3cc[nH]c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F21 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124078 Peakdale1_001539 Cc1[nH]c2c(NC(=O)C(c3ccccc3)c4ccccc4)cccc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F22 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124079 Peakdale1_001540 O=C(N1CCN(Cc2ccccc2)CC1)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F23 mock treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 F24 mock treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G01 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124080 Peakdale1_001541 COC(=O)CCc1nc(OC)cc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G02 compound treatment 0.067 -0.00642 -0.76 -0.7606 -1.0 2124081 Peakdale1_001542 CN(C)c1cc(nc(n1)N(C)C)c2nnc(S)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G03 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124082 Peakdale1_001543 COCCNC(=O)CCc1nc(OC)cc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G04 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124083 Peakdale1_001544 CSc1nnc(c2cc(nc(n2)N(C)C)N(C)C)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G05 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124084 Peakdale1_001545 COc1cc(OC)nc(CCC(=O)NCc2cccc(c2)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G06 compound treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 2124085 Peakdale1_001546 CN(C)c1cc(nc(n1)N(C)C)c2nnc(SCC=C)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G07 compound treatment 0.079 0.00558 0.66 0.6613 1.0 2124086 Peakdale1_001547 COc1cc(OC)nc(CCC(=O)N2CCN(CC2)C(c3ccccc3)c4ccccc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G08 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124087 Peakdale1_001548 CN(C)c1cc(nc(n1)N(C)C)c2nnc(SCC#C)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G09 compound treatment 0.0765 0.00308 0.37 0.365 1.0 2124088 Peakdale1_001549 COc1cc(OC)nc(CCC(=O)NCCN2CCOCC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G10 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124089 Peakdale1_001550 CN(C)c1cc(nc(n1)N(C)C)c2nnc(SCc3cccc(c3)C(F)(F)F)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G11 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 2124090 Peakdale1_001551 CON(C)C(=O)CCc1nc(OC)cc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G12 compound treatment 0.079 0.00558 0.66 0.6613 1.0 2124091 Peakdale1_001552 CN(C)c1cc(nc(n1)N(C)C)c2nnc(SCc3ccccn3)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G13 compound treatment 0.085 0.0116 1.37 1.3722 1.0 2124092 Peakdale1_001553 COc1cc(OC)nc(CCC(=O)N2CCN(CC(=O)N3CCOCC3)CC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G14 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 2124093 Peakdale1_001554 CN(C)c1cc(nc(n1)N(C)C)c2nnc(SCc3noc(n3)C(C)(C)C)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G15 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2124094 Peakdale1_001555 O=C(CCC(=O)NC1CCN2CCCc3cccc1c23)NC4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G16 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124095 Peakdale1_001556 CN(C)c1cc(nc(n1)N(C)C)c2nnc(SCC(=O)c3ccc(Cl)cc3)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G17 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124096 Peakdale1_001557 Clc1ccc(CNC(=O)CCC(=O)NC2CCN3CCCc4cccc2c34)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G18 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124097 Peakdale1_001558 CN(C)c1cc(nc(n1)N(C)C)c2nnc(SCC(=O)N(C)Cc3ccccc3)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G19 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124098 Peakdale1_001559 O=C(CCC(=O)NN1CCOCC1)NC2CCN3CCCc4cccc2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G20 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124099 Peakdale1_001560 COc1cc(OC)nc(n1)C(N2CCCCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G21 compound treatment 0.076 0.00258 0.31 0.3058 1.0 2124100 Peakdale1_001561 O=C(CCC(=O)NC1CCN2CCCc3cccc1c23)NCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G22 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124101 Peakdale1_001562 COc1cc(OC)nc(n1)C(N2CC(C)OC(C)C2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G23 mock treatment 0.0735 8.06E-5 0.01 0.0096 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 G24 mock treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H01 compound treatment 0.0665 -0.00692 -0.82 -0.8199 -1.0 2124102 Peakdale1_001563 Cc1[nH]c2c(NC(=O)c3cccc(c3)C(F)(F)F)cccc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H02 compound treatment 0.066 -0.00742 -0.88 -0.8791 -1.0 2124103 Peakdale1_001564 O=C(N1CCN(CC1)C(c2ccccc2)c3ccccc3)c4ccc5cc[nH]c5c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H03 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124104 Peakdale1_001565 COc1cc(cc(OC)c1OC)C(=O)Nc2cccc3c(C)c(C)[nH]c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H04 compound treatment 0.067 -0.00642 -0.76 -0.7606 -1.0 2124105 Peakdale1_001566 Fc1ccc(cc1)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H05 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124106 Peakdale1_001567 Cc1[nH]c2c(NC(=O)c3cc(Cl)nc(Cl)c3)cccc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H06 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124107 Peakdale1_001568 OC(=O)CCC(=O)N1CCN(CC1)C(=O)c2cc(nc(n2)N3CCOCC3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H07 compound treatment 0.0825 0.00908 1.08 1.076 1.0 2124108 Peakdale1_001569 Cc1[nH]c2c(NC(=O)c3cccs3)cccc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H08 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2124109 Peakdale1_001570 O=C(CCC(=O)N1CCN(CC1)C(=O)c2cc(nc(n2)N3CCOCC3)N4CCOCC4)NC5CC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H09 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2124110 Peakdale1_001571 CCNC(=O)Nc1cccc2c(C)c(C)[nH]c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H10 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124111 Peakdale1_001572 CON(C)C(=O)CCC(=O)N1CCN(CC1)C(=O)c2cc(nc(n2)N3CCOCC3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H11 compound treatment 0.076 0.00258 0.31 0.3058 1.0 2124112 Peakdale1_001573 Cc1[nH]c2c(NC(=O)Nc3ccc(F)cc3F)cccc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H12 compound treatment 0.08 0.00658 0.78 0.7797 1.0 2124113 Peakdale1_001574 COc1cc(OC)nc(CN2CCNCC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H13 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124114 Peakdale1_001575 COc1ccc(cc1)S(=O)(=O)Nc2cccc3c(C)c(C)[nH]c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H14 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2124115 Peakdale1_001576 COc1cc(OC)nc(CN2CCN(CC2)C=O)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H15 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124116 Peakdale1_001577 Cc1[nH]c2c(NS(=O)(=O)c3ccc4oc(=O)ccc4c3)cccc2c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H16 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124117 Peakdale1_001578 COc1cc(OC)nc(CN2CCN(CC2)C(=O)c3cccc(c3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H17 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2124118 Peakdale1_001579 O=C(N1CCNCC1)c2ccc3cc[nH]c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H18 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2124119 Peakdale1_001580 COc1cc(OC)nc(CN2CCN(CC2)C(=O)c3ccc(cc3)C(C)(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H19 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124120 Peakdale1_001581 CCNC(=O)N1CCN(CC1)C(=O)c2ccc3cc[nH]c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H20 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 2124121 Peakdale1_001582 COc1cc(OC)nc(CN2CCN(CC2)C(=O)c3cc(OC)c(OC)c(OC)c3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H21 compound treatment 0.0765 0.00308 0.37 0.365 1.0 2124122 Peakdale1_001583 Fc1ccc(NC(=O)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H22 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124123 Peakdale1_001584 COc1cc(OC)nc(CN2CCN(CC2)C(=O)NS(=O)(=O)c3ccc(C)cc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H23 mock treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 H24 mock treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I01 compound treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 2124124 Peakdale1_001585 CON(C)C(=O)CCC(=O)NC1CCN2CCCc3cccc1c23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I02 compound treatment 0.066 -0.00742 -0.88 -0.8791 -1.0 2124125 Peakdale1_001586 COc1cc(OC)nc(n1)C(N2CCc3ccccc3C2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I03 compound treatment 0.0665 -0.00692 -0.82 -0.8199 -1.0 2124126 Peakdale1_001587 O=C(CCC(=O)N1CCOCC1)NC2CCN3CCCc4cccc2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I04 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2124127 Peakdale1_001588 COc1cc(OC)nc(n1)C(N2CCN(CC(=O)N3CCOCC3)CC2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I05 compound treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 2124128 Peakdale1_001589 O=C(CCC(=O)N1CCc2ccccc2C1)NC3CCN4CCCc5cccc3c45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I06 compound treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 2124129 Peakdale1_001590 COc1cc(OC)nc(n1)C(N2CCN(CC2)C(c3ccccc3)c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I07 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2124130 Peakdale1_001591 O=C1CCC(=O)N1C2CCN3CCCc4cccc2c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I08 compound treatment 0.076 0.00258 0.31 0.3058 1.0 2124131 Peakdale1_001592 COc1cc(OC)nc(n1)C(N2CCN(CC2)C=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I09 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124132 Peakdale1_001593 Cn1c(=O)cc(Sc2ccccc2)[nH]c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I10 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124133 Peakdale1_001594 COc1cc(OC)nc(n1)C(N2CCN(CC2)c3nc(C)cc(C)n3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I11 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124134 Peakdale1_001595 Cn1c(=O)cc(Sc2ccccc2)n(Cc3ccccc3)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I12 compound treatment 0.066 -0.00742 -0.88 -0.8791 -1.0 2124135 Peakdale1_001596 COc1cc(OC)nc(n1)c2sc3ccccc3c2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I13 compound treatment 0.059 -0.0144 -1.71 -1.7086 -1.0 2124136 Peakdale1_001597 Cn1c(=O)cc(Sc2ccccc2)n(CC(=O)c3ccc(Cl)cc3)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I14 compound treatment 0.0635 -0.00992 -1.18 -1.1753 -1.0 2124137 Peakdale1_001598 COc1c(sc2ccccc12)c3nc(OC)cc(OC)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I15 compound treatment 0.0805 0.00708 0.84 0.839 1.0 2124138 Peakdale1_001599 Cn1c(=O)cc(Sc2ccccc2)n(Cc3cccc(c3)C(F)(F)F)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I16 compound treatment 0.0685 -0.00492 -0.58 -0.5829 -1.0 2124139 Peakdale1_001600 COc1cc(OC)nc(n1)c2sc3ccccc3c2OCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I17 compound treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 2124140 Peakdale1_001601 Cn1c(=O)cc([nH]c1=O)N2CCN(CC2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I18 compound treatment 0.0685 -0.00492 -0.58 -0.5829 -1.0 2124141 Peakdale1_001602 COc1cc(OC)nc(n1)c2sc3ccccc3c2OCC#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I19 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124142 Peakdale1_001603 Cn1c(=O)cc([nH]c1=O)N2CCN(CC2)C(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I20 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124143 Peakdale1_001604 COc1cc(OC)nc(n1)c2sc3ccccc3c2OCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I21 compound treatment 0.081 0.00758 0.9 0.8982 1.0 2124144 Peakdale1_001605 COc1cc(OC)nc(n1)C2CCCCC2C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I22 compound treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 2124145 Peakdale1_001606 COC(=O)COc1c(sc2ccccc12)c3nc(OC)cc(OC)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I23 mock treatment 0.0685 -0.00492 -0.58 -0.5829 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 I24 mock treatment 0.066 -0.00742 -0.88 -0.8791 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J01 compound treatment 0.067 -0.00642 -0.76 -0.7606 -1.0 2124146 Peakdale1_001607 Clc1ccc(CNC(=S)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J02 compound treatment 0.066 -0.00742 -0.88 -0.8791 -1.0 2124147 Peakdale1_001608 COc1cc(OC)nc(CN2CCN(Cc3nc(OC)cc(OC)n3)CC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J03 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2124148 Peakdale1_001609 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J04 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2124149 Peakdale1_001610 COc1ccccc1CN(C(=O)C(c2ccccc2)c3ccccc3)c4ccc5[nH]c(cc5c4)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J05 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124150 Peakdale1_001611 COc1ccc(cc1)S(=O)(=O)N2CCN(CC2)C(=O)c3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J06 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124151 Peakdale1_001612 COc1ccccc1CN(C(=O)c2ccc(cc2)C(F)(F)F)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J07 compound treatment 0.0795 0.00608 0.72 0.7205 1.0 2124152 Peakdale1_001613 CCC(=O)N(Cc1ccc(cc1)S(=O)(=O)C)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J08 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124153 Peakdale1_001614 COc1ccccc1CN(c2ccc3[nH]c(cc3c2)C(C)(C)C)S(=O)(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J09 compound treatment 0.079 0.00558 0.66 0.6613 1.0 2124154 Peakdale1_001615 CS(=O)(=O)c1ccc(CN(C2CCN(Cc3ccccc3)CC2)C(=O)C(c4ccccc4)c5ccccc5)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J10 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2124155 Peakdale1_001616 COc1ccccc1CN(C(=O)c2cc(Cl)nc(Cl)c2)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J11 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124156 Peakdale1_001617 CS(=O)(=O)c1ccc(CN(C2CCN(Cc3ccccc3)CC2)C(=O)c4cccc(c4)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J12 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124157 Peakdale1_001618 COc1ccccc1CN(C(=O)c2ccco2)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J13 compound treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 2124158 Peakdale1_001619 COc1cc(cc(OC)c1OC)C(=O)N(Cc2ccc(cc2)S(=O)(=O)C)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J14 compound treatment 0.066 -0.00742 -0.88 -0.8791 -1.0 2124159 Peakdale1_001620 CCNC(=O)N(Cc1ccccc1OC)c2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J15 compound treatment 0.076 0.00258 0.31 0.3058 1.0 2124160 Peakdale1_001621 CS(=O)(=O)c1ccc(CN(C2CCN(Cc3ccccc3)CC2)C(=O)c4cc(Cl)nc(Cl)c4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J16 compound treatment 0.066 -0.00742 -0.88 -0.8791 -1.0 2124161 Peakdale1_001622 COc1ccccc1CN(C(=O)Nc2ccc(F)cc2F)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J17 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2124162 Peakdale1_001623 CS(=O)(=O)c1ccc(CN(C2CCN(Cc3ccccc3)CC2)C(=O)c4ccco4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J18 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124163 Peakdale1_001624 CCC(=O)N(Cc1cccc(Cl)c1)c2ccc3[nH]c(cc3c2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J19 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124164 Peakdale1_001625 CCNC(=O)N(Cc1ccc(cc1)S(=O)(=O)C)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J20 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 2124165 Peakdale1_001626 CC(C)(C)c1cc2cc(ccc2[nH]1)N(Cc3cccc(Cl)c3)C(=O)c4ccccc4C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J21 compound treatment 0.0775 0.00408 0.48 0.4835 1.0 2124166 Peakdale1_001627 CS(=O)(=O)c1ccc(CN(C2CCN(Cc3ccccc3)CC2)C(=O)Nc4ccc(F)cc4F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J22 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2124167 Peakdale1_001628 CC(C)(C)c1cc2cc(ccc2[nH]1)N(Cc3cccc(Cl)c3)C(=O)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J23 mock treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 J24 mock treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K01 compound treatment 0.0655 -0.00792 -0.94 -0.9384 -1.0 2124168 Peakdale1_001629 COC(=O)C1CCCCC1c2nc(OC)cc(OC)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K02 compound treatment 0.0635 -0.00992 -1.18 -1.1753 -1.0 2124169 Peakdale1_001630 COc1cc(OC)nc(n1)c2sc3ccccc3c2OCC4CCCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K03 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2124170 Peakdale1_001631 COc1cc(OC)nc(n1)C2CCCCC2C(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K04 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124171 Peakdale1_001632 COc1cc(OC)nc(n1)c2sc3ccccc3c2OCc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K05 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124172 Peakdale1_001633 COc1cc(OC)nc(n1)C2CCCCC2C(=O)NC(C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K06 compound treatment 0.0655 -0.00792 -0.94 -0.9384 -1.0 2124173 Peakdale1_001634 COc1cc(OC)nc(n1)c2sc3ccccc3c2OCc4ccc(C#N)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K07 compound treatment 0.086 0.0126 1.49 1.4907 1.0 2124174 Peakdale1_001635 COc1cc(OC)nc(n1)C2CCCCC2C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K08 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2124175 Peakdale1_001636 COc1cc(OC)nc(n1)c2sc3ccccc3c2OCc4noc(n4)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K09 compound treatment 0.08 0.00658 0.78 0.7797 1.0 2124176 Peakdale1_001637 COc1cc(OC)nc(n1)C2CCCCC2C(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K10 compound treatment 0.0775 0.00408 0.48 0.4835 1.0 2124177 Peakdale1_001638 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCN(CC2)C(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K11 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124178 Peakdale1_001639 COc1cc(OC)nc(n1)C2CCCCC2C(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K12 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2124179 Peakdale1_001640 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCN(CC2)C(=O)c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K13 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124180 Peakdale1_001641 COc1cc(OC)nc(n1)C2CCCCC2C(=O)NCc3ccccc3OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K14 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124181 Peakdale1_001642 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCN(CC2)C(=O)c3c(F)cccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K15 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124182 Peakdale1_001643 COc1cc(nc(OC)n1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K16 compound treatment 0.0795 0.00608 0.72 0.7205 1.0 2124183 Peakdale1_001644 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCN(CC2)C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K17 compound treatment 0.0755 0.00208 0.25 0.2465 1.0 1100965 Peakdale1_001645 COC(=O)c1cc(OC)nc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K18 compound treatment 0.065 -0.00842 -1.0 -0.9976 -1.0 2124184 Peakdale1_001646 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCN(CC2)C(=O)c3cc(Cl)nc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K19 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2124185 Peakdale1_001647 COc1cc(nc(OC)n1)C(=O)NC2CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K20 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2124186 Peakdale1_001648 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCN(CC2)C(=O)c3ccc(cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K21 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124187 Peakdale1_001649 COc1cc(nc(OC)n1)C(=O)NCC2CCCO2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K22 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124188 Peakdale1_001650 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCNCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K23 mock treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 K24 mock treatment 0.067 -0.00642 -0.76 -0.7606 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L01 compound treatment 0.0665 -0.00692 -0.82 -0.8199 -1.0 2124189 Peakdale1_001651 CS(=O)(=O)c1ccc(CN(C2CCN(Cc3ccccc3)CC2)S(=O)(=O)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L02 compound treatment 0.067 -0.00642 -0.76 -0.7606 -1.0 2124190 Peakdale1_001652 COc1ccc(cc1)S(=O)(=O)N(Cc2cccc(Cl)c2)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L03 compound treatment 0.065 -0.00842 -1.0 -0.9976 -1.0 2124191 Peakdale1_001653 COc1ccc(cc1)S(=O)(=O)N(Cc2ccc(cc2)S(=O)(=O)C)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L04 compound treatment 0.0665 -0.00692 -0.82 -0.8199 -1.0 2124192 Peakdale1_001654 COc1ccccc1NC(=O)N(Cc2cccc(Cl)c2)c3ccc4[nH]c(cc4c3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L05 compound treatment 0.0995 0.0261 3.09 3.0903 1.0 2124193 Peakdale1_001655 CS(=O)(=O)c1ccc(CN(Cc2cccc(c2)C(F)(F)F)C(=O)C(c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L06 compound treatment 0.067 -0.00642 -0.76 -0.7606 -1.0 2124194 Peakdale1_001656 Cc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L07 compound treatment 0.085 0.0116 1.37 1.3722 1.0 2124195 Peakdale1_001657 CS(=O)(=O)c1ccc(CN(Cc2cccc(c2)C(F)(F)F)C(=O)c3ccc(cc3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L08 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124196 Peakdale1_001658 Clc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L09 compound treatment 0.099 0.0256 3.03 3.0311 1.0 2124197 Peakdale1_001659 CS(=O)(=O)c1ccc(CN(Cc2cccc(c2)C(F)(F)F)C(=O)c3cccs3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L10 compound treatment 0.076 0.00258 0.31 0.3058 1.0 2124198 Peakdale1_001660 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L11 compound treatment 0.0875 0.0141 1.67 1.6684 1.0 2124199 Peakdale1_001661 CS(=O)(=O)c1ccc(CN(Cc2cccc(c2)C(F)(F)F)C(=O)c3cc(Cl)nc(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L12 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124200 Peakdale1_001662 COc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L13 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2124201 Peakdale1_001663 COc1ccccc1NC(=O)N(Cc2ccc(cc2)S(=O)(=O)C)Cc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L14 compound treatment 0.0665 -0.00692 -0.82 -0.8199 -1.0 2124202 Peakdale1_001664 CS(=O)(=O)c1ccccc1S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L15 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2124203 Peakdale1_001665 CS(=O)(=O)c1ccc(CN(Cc2cccc(c2)C(F)(F)F)S(=O)(=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L16 compound treatment 0.085 0.0116 1.37 1.3722 1.0 2124204 Peakdale1_001666 [O-][N+](=O)c1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L17 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2124205 Peakdale1_001667 CCN1Cc2ccccc2-n3cccc3C1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L18 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2124206 Peakdale1_001668 CC(=O)Nc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L19 compound treatment 0.0805 0.00708 0.84 0.839 1.0 2124207 Peakdale1_001669 CC(C)N1Cc2ccccc2-n3cccc3C1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L20 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124208 Peakdale1_001670 FC(F)(F)c1cccc(c1)C(=O)N(Cc2ccc(Cl)cc2)Cc3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L21 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2079946 Peakdale1_001671 OC(=O)C1N(Cc2ccccc2)Cc3ccccc3-n4cccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L22 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124209 Peakdale1_001672 Fc1cccc(F)c1C(=O)N(Cc2ccc(Cl)cc2)Cc3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L23 mock treatment 0.074 5.81E-4 0.07 0.0688 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 L24 mock treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M01 compound treatment 0.0645 -0.00892 -1.06 -1.0569 -1.0 2124210 Peakdale1_001673 COc1cc(nc(OC)n1)C(=O)NN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M02 compound treatment 0.0655 -0.00792 -0.94 -0.9384 -1.0 2124211 Peakdale1_001674 CCNC(=O)N1CCN(CC1)C(=O)c2cc(nc(n2)N(C)C)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M03 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124212 Peakdale1_001675 COc1cc(nc(OC)n1)C(=O)NCCN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M04 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2124213 Peakdale1_001676 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCN(CC2)C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M05 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124214 Peakdale1_001677 COc1cc(nc(OC)n1)C(=O)NCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M06 compound treatment 0.067 -0.00642 -0.76 -0.7606 -1.0 2124215 Peakdale1_001678 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCN(CC2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M07 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2124216 Peakdale1_001679 COc1cc(nc(OC)n1)C(=O)NCCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M08 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124217 Peakdale1_001680 CN(C)c1cc(nc(n1)N(C)C)C(=O)N2CCN(CC2)C(=S)NCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M09 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124218 Peakdale1_001681 CON(C)C(=O)c1cc(OC)nc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M10 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2124219 Peakdale1_001682 COCCNC(=O)c1ccccc1OCc2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M11 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2124220 Peakdale1_001683 COc1cc(nc(OC)n1)C(=O)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M12 compound treatment 0.0685 -0.00492 -0.58 -0.5829 -1.0 2124221 Peakdale1_001684 CS(=O)(=O)c1ccc(COc2ccccc2C(=O)NCC3CCCO3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M13 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124222 Peakdale1_001685 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COCC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M14 compound treatment 0.066 -0.00742 -0.88 -0.8791 -1.0 2124223 Peakdale1_001686 CS(=O)(=O)c1ccc(COc2ccccc2C(=O)NCCN3CCOCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M15 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124224 Peakdale1_001687 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M16 compound treatment 0.0685 -0.00492 -0.58 -0.5829 -1.0 2124225 Peakdale1_001688 CS(=O)(=O)c1ccc(COc2ccccc2C(=O)N3CCN(CC3)C=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M17 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2124226 Peakdale1_001689 COc1ccc(OCC(=O)N(C2CC2)C3CCN(CC3)C(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M18 compound treatment 0.0685 -0.00492 -0.58 -0.5829 -1.0 2124227 Peakdale1_001690 CS(=O)(=O)c1ccc(COc2ccccc2C(=O)NCc3ccncc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M19 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2124228 Peakdale1_001691 CC(=O)Nc1ccccc1OCC(=O)N(C2CC2)C3CCN(CC3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M20 compound treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 2124229 Peakdale1_001692 CS(=O)(=O)c1ccc(COc2ccccc2C(=O)Nc3ccccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M21 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124230 Peakdale1_001693 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M22 compound treatment 0.0675 -0.00592 -0.7 -0.7014 -1.0 2124231 Peakdale1_001694 CC(C)(C)C(=O)Nc1ccccc1SCc2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M23 mock treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 M24 mock treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N01 compound treatment 0.065 -0.00842 -1.0 -0.9976 -1.0 2124232 Peakdale1_001695 OC(=O)C1N(Cc2cccnc2)Cc3ccccc3-n4cccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N02 compound treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 2124233 Peakdale1_001696 COc1cc(cc(OC)c1OC)C(=O)N(Cc2ccc(Cl)cc2)Cc3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N03 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124234 Peakdale1_001697 COC(=O)CCC(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N04 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124235 Peakdale1_001698 Clc1ccc(CN(Cc2ccc3cc[nH]c3c2)C(=O)C(c4ccccc4)c5ccccc5)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N05 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2124236 Peakdale1_001699 COCCNC(=O)CCC(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N06 compound treatment 0.069 -0.00442 -0.52 -0.5236 -1.0 2124237 Peakdale1_001700 Clc1ccc(CN(Cc2ccc3cc[nH]c3c2)C(=O)c4ccco4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N07 compound treatment 0.083 0.00958 1.14 1.1352 1.0 2124238 Peakdale1_001701 O=C(CCC(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2)NC4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N08 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124239 Peakdale1_001702 COc1ccc(cc1)S(=O)(=O)N(Cc2ccc(Cl)cc2)Cc3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N09 compound treatment 0.0875 0.0141 1.67 1.6684 1.0 2124240 Peakdale1_001703 O=C(CCC(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N10 compound treatment 0.0825 0.00908 1.08 1.076 1.0 2124241 Peakdale1_001704 FC(F)(F)c1ccccc1NC(=O)N(Cc2ccc(Cl)cc2)Cc3ccc4cc[nH]c4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N11 compound treatment 0.081 0.00758 0.9 0.8982 1.0 2124242 Peakdale1_001705 O=C(CCC(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2)NCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N12 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124243 Peakdale1_001706 COCCNC(=O)c1cc2cccc(NS(=O)(=O)c3ccc(OC)cc3)c2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N13 compound treatment 0.0795 0.00608 0.72 0.7205 1.0 2124244 Peakdale1_001707 O=C(CCC(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N14 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124245 Peakdale1_001708 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N15 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124246 Peakdale1_001709 COc1ccccc1CNC(=O)CCC(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N16 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2124247 Peakdale1_001710 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)NCc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N17 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124248 Peakdale1_001711 O=C(CCC(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2)NCc4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N18 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124249 Peakdale1_001712 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)NCc4ccccc4OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N19 compound treatment 0.0835 0.0101 1.19 1.1945 1.0 2124250 Peakdale1_001713 CN(C)C(=O)CCC(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N20 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124251 Peakdale1_001714 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)NCc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N21 compound treatment 0.0745 0.00108 0.13 0.128 1.0 2124252 Peakdale1_001715 CN1CCN(CC1)C(=O)CCC(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N22 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124253 Peakdale1_001716 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)NCc4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N23 mock treatment 0.077 0.00358 0.42 0.4243 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 N24 mock treatment 0.075 0.00158 0.19 0.1873 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O01 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2124254 Peakdale1_001717 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COc3cncc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O02 compound treatment 0.0645 -0.00892 -1.06 -1.0569 -1.0 2124255 Peakdale1_001718 CS(=O)(=O)c1ccc(CSc2ccccc2NC(=O)c3ccco3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O03 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2124256 Peakdale1_001719 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)COCc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O04 compound treatment 0.066 -0.00742 -0.88 -0.8791 -1.0 2124257 Peakdale1_001720 CS(=O)(=O)c1ccc(CSc2ccccc2NC(=O)c3cc(Cl)nc(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O05 compound treatment 0.0705 -0.00292 -0.35 -0.3459 -1.0 2124258 Peakdale1_001721 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CSc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O06 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2124259 Peakdale1_001722 CS(=O)(=O)c1ccc(CSc2ccccc2NC(=O)Nc3ccccc3C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O07 compound treatment 0.0775 0.00408 0.48 0.4835 1.0 2124260 Peakdale1_001723 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CSc3nc(C)cc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O08 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124261 Peakdale1_001724 COc1ccc(cc1)S(=O)(=O)Nc2ccccc2SCc3ccc(cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O09 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124262 Peakdale1_001725 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CSc3nc4ccccc4[nH]3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O10 compound treatment 0.081 0.00758 0.9 0.8982 1.0 2124263 Peakdale1_001726 CS(=O)(=O)c1ccc(CSCCNC(=O)C2CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O11 compound treatment 0.07 -0.00342 -0.41 -0.4052 -1.0 2124264 Peakdale1_001727 COc1cc(OC)nc(n1)c2ccc(cc2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O12 compound treatment 0.09 0.0166 1.96 1.9646 1.0 2124265 Peakdale1_001728 CS(=O)(=O)c1ccc(CSCCNC(=O)c2ccco2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O13 compound treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 2124266 Peakdale1_001729 COC(=O)c1ccc(cc1)c2nc(OC)cc(OC)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O14 compound treatment 0.0785 0.00508 0.6 0.602 1.0 2124267 Peakdale1_001730 CS(=O)(=O)c1ccc(CSCCNC(=O)c2c(F)cccc2F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O15 compound treatment 0.0765 0.00308 0.37 0.365 1.0 2124268 Peakdale1_001731 COc1cc(OC)nc(n1)c2ccc(cc2)C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O16 compound treatment 0.0805 0.00708 0.84 0.839 1.0 2124269 Peakdale1_001732 CS(=O)(=O)c1ccc(CSCCNC(=O)c2cc(Cl)nc(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O17 compound treatment 0.079 0.00558 0.66 0.6613 1.0 2124270 Peakdale1_001733 COc1cc(OC)nc(n1)c2ccc(cc2)C(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O18 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124271 Peakdale1_001734 COc1ccccc1NC(=O)NCCSCc2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O19 compound treatment 0.0785 0.00508 0.6 0.602 1.0 2124272 Peakdale1_001735 COc1cc(OC)nc(n1)c2ccc(cc2)C(=O)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O20 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2124273 Peakdale1_001736 CS(=O)(=O)c1ccc(CSCCNS(=O)(=O)c2cccc(c2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O21 compound treatment 0.074 5.81E-4 0.07 0.0688 1.0 2124274 Peakdale1_001737 COc1cc(OC)nc(n1)c2ccc(cc2)C(=O)N3CCN(CC(=O)N4CCOCC4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O22 compound treatment 0.0765 0.00308 0.37 0.365 1.0 2124275 Peakdale1_001738 OC(=O)c1cc(nc(n1)N2CCOCC2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O23 mock treatment 0.0805 0.00708 0.84 0.839 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 O24 mock treatment 0.076 0.00258 0.31 0.3058 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P01 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124276 Peakdale1_001739 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P02 compound treatment 0.068 -0.00542 -0.64 -0.6421 -1.0 2124277 Peakdale1_001740 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)N(C)Cc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P03 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2124278 Peakdale1_001741 COCCNC(=O)CCC(=O)N(C1CC1)C2CCN(CC2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P04 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124279 Peakdale1_001742 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)N4CCN(C)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P05 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124280 Peakdale1_001743 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P06 compound treatment 0.0775 0.00408 0.48 0.4835 1.0 2124281 Peakdale1_001744 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)N4CCN(CC4)C(c5ccccc5)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P07 compound treatment 0.078 0.00458 0.54 0.5428 1.0 2124282 Peakdale1_001745 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P08 compound treatment 0.0685 -0.00492 -0.58 -0.5829 -1.0 2124283 Peakdale1_001746 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P09 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2124284 Peakdale1_001747 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P10 compound treatment 0.088 0.0146 1.73 1.7277 1.0 2124285 Peakdale1_001748 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)N4CC(C)OC(C)C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P11 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124286 Peakdale1_001749 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P12 compound treatment 0.0735 8.06E-5 0.01 0.0096 1.0 2124287 Peakdale1_001750 COc1ccc(cc1)S(=O)(=O)Nc2cccc3cc([nH]c23)C(=O)N4CCc5ccccc5C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P13 compound treatment 0.071 -0.00242 -0.29 -0.2867 -1.0 2124288 Peakdale1_001751 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CCC(=O)NCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P14 compound treatment 0.0725 -9.19E-4 -0.11 -0.1089 -1.0 2124289 Peakdale1_001752 Cn1cc(cn1)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P15 compound treatment 0.075 0.00158 0.19 0.1873 1.0 2124290 Peakdale1_001753 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CCC(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P16 compound treatment 0.0765 0.00308 0.37 0.365 1.0 2124291 Peakdale1_001754 C(Cn1cc(cn1)c2ccncc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P17 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124292 Peakdale1_001755 OC(=O)CCC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P18 compound treatment 0.0665 -0.00692 -0.82 -0.8199 -1.0 2124293 Peakdale1_001756 Clc1ccc(Cn2cc(cn2)c3ccncc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P19 compound treatment 0.0775 0.00408 0.48 0.4835 1.0 2124294 Peakdale1_001757 COCCNC(=O)CCC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P20 compound treatment 0.072 -0.00142 -0.17 -0.1682 -1.0 2124295 Peakdale1_001758 CS(=O)(=O)c1ccc(Cn2cc(cn2)c3ccncc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P21 compound treatment 0.0715 -0.00192 -0.23 -0.2274 -1.0 2124296 Peakdale1_001759 Clc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P22 compound treatment 0.0695 -0.00392 -0.46 -0.4644 -1.0 2124297 Peakdale1_001760 FC(F)(F)c1cccc(Cn2cc(cn2)c3ccncc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P23 mock treatment 0.073 -4.19E-4 -0.05 -0.0497 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.522 P24 mock treatment 0.057 -0.0164 -1.95 -1.9455 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A01 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124298 Peakdale1_001761 C(c1ccccn1)n2cc(cn2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A02 compound treatment 0.072 -0.001 -0.12 -0.1185 -1.0 2124299 Peakdale1_001762 CN1CCN(Cc2ccnc(Cl)c2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A03 compound treatment 0.0795 0.0065 0.77 0.7702 1.0 2124300 Peakdale1_001763 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A04 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124301 Peakdale1_001764 Clc1cc(CN2CCN(Cc3ccccc3)CC2)ccn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A05 compound treatment 0.071 -0.002 -0.24 -0.237 -1.0 2124302 Peakdale1_001765 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A06 compound treatment 0.066 -0.007 -0.83 -0.8294 -1.0 2124303 Peakdale1_001766 FC(F)(F)c1cccc(c1)N2CCN(Cc3ccnc(Cl)c3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A07 compound treatment 0.078 0.005 0.59 0.5925 1.0 2124304 Peakdale1_001767 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A08 compound treatment 0.072 -0.001 -0.12 -0.1185 -1.0 2124305 Peakdale1_001768 Fc1ccc(cc1)N2CCN(Cc3ccnc(Cl)c3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A09 compound treatment 0.077 0.004 0.47 0.474 1.0 2124306 Peakdale1_001769 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A10 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124307 Peakdale1_001770 Clc1cc(CN2CCN(CC2)C(c3ccccc3)c4ccccc4)ccn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A11 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124308 Peakdale1_001771 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A12 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124309 Peakdale1_001772 Cc1cc(C)nc(n1)N2CCN(Cc3ccnc(Cl)c3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A13 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124310 Peakdale1_001773 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A14 compound treatment 0.0675 -0.0055 -0.65 -0.6517 -1.0 2124311 Peakdale1_001774 CC(C)(C)c1ccc(Cn2cc(cn2)c3nc4ccccc4o3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A15 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124312 Peakdale1_001775 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A16 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124313 Peakdale1_001776 FC(F)(F)c1cccc(Cn2cc(cn2)c3nc4ccccc4o3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A17 compound treatment 0.0665 -0.0065 -0.77 -0.7702 -1.0 2124314 Peakdale1_001777 CC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A18 compound treatment 0.062 -0.011 -1.3 -1.3034 -1.0 2124315 Peakdale1_001778 Clc1ccc(Cn2cc(cn2)c3nc4ccccc4o3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A19 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124316 Peakdale1_001779 CC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A20 compound treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 2124317 Peakdale1_001780 CS(=O)(=O)c1ccc(Cn2cc(cn2)c3nc4ccccc4o3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A21 compound treatment 0.068 -0.005 -0.59 -0.5925 -1.0 2124318 Peakdale1_001781 COc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A22 compound treatment 0.077 0.004 0.47 0.474 1.0 2124319 Peakdale1_001782 C(c1ccccn1)n2cc(cn2)c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A23 mock treatment 0.086 0.013 1.54 1.5404 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 A24 mock treatment 0.0775 0.0045 0.53 0.5332 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B01 compound treatment 0.066 -0.007 -0.83 -0.8294 -1.0 2124320 Peakdale1_001783 COc1cc(OC)nc(OC(Cc2ccncc2)c3ccc(cc3)C(C)(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B02 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124321 Peakdale1_001784 COc1ccc(cc1)c2cnn(Cc3cccc(c3)C(F)(F)F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B03 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124322 Peakdale1_001785 COc1cc(OC)nc(OC(Cc2ccncn2)c3ccc(cc3)C(C)(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B04 compound treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 2124323 Peakdale1_001786 COc1ccc(cc1)c2cnn(Cc3ccc(Cl)cc3Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B05 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124324 Peakdale1_001787 COc1cc(OC)nc(OC(Cc2ccnc3ccccc23)c4ccc(cc4)C(C)(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B06 compound treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 2124325 Peakdale1_001788 Cc1ccc(cc1)c2cnn(Cc3ccccc3Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B07 compound treatment 0.075 0.002 0.24 0.237 1.0 2124326 Peakdale1_001789 COc1cc(OC)nc(OC(Cc2nc3ccccc3o2)c4ccc(cc4)C(C)(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B08 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124327 Peakdale1_001790 Cc1ccc(cc1)c2cnn(Cc3ccc(cc3)C(C)(C)C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B09 compound treatment 0.064 -0.009 -1.07 -1.0664 -1.0 2124328 Peakdale1_001791 C(Cn1cc(cn1)c2ccncn2)OCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B10 compound treatment 0.0625 -0.0105 -1.24 -1.2441 -1.0 2124329 Peakdale1_001792 OC(=O)c1ccc(cc1)n2cc(cn2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B11 compound treatment 0.077 0.004 0.47 0.474 1.0 2124330 Peakdale1_001793 FC(F)(F)c1cccc(COCCn2cc(cn2)c3ccncn3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B12 compound treatment 0.0825 0.0095 1.13 1.1257 1.0 2124331 Peakdale1_001794 COCCNC(=O)c1ccc(cc1)n2cc(cn2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B13 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124332 Peakdale1_001795 CC(C)(C)c1ccc(COCCn2cc(cn2)c3ccncn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B14 compound treatment 0.0665 -0.0065 -0.77 -0.7702 -1.0 2124333 Peakdale1_001796 Clc1ccc(cc1)c2cnn(c2)c3ccc(cc3)C(=O)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B15 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124334 Peakdale1_001797 Clc1ccc(COCCn2cc(cn2)c3ccncn3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B16 compound treatment 0.0695 -0.0035 -0.41 -0.4147 -1.0 2124335 Peakdale1_001798 Clc1ccc(cc1)c2cnn(c2)c3ccc(cc3)C(=O)NCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B17 compound treatment 0.0835 0.0105 1.24 1.2441 1.0 2124336 Peakdale1_001799 COc1cc(OC)nc(OC(Cc2ccncc2)c3ccc(cc3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B18 compound treatment 0.0675 -0.0055 -0.65 -0.6517 -1.0 2124337 Peakdale1_001800 Clc1ccc(cc1)c2cnn(c2)c3ccc(cc3)C(=O)NCc4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B19 compound treatment 0.079 0.006 0.71 0.7109 1.0 2124338 Peakdale1_001801 COc1cc(OC)nc(OC(Cc2cnccn2)c3ccc(cc3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B20 compound treatment 0.0745 0.0015 0.18 0.1777 1.0 2124339 Peakdale1_001802 COc1ccccc1CNC(=O)c2ccc(cc2)n3cc(cn3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B21 compound treatment 0.0795 0.0065 0.77 0.7702 1.0 2124340 Peakdale1_001803 COc1cc(OC)nc(OC(Cc2ccnc3ccccc23)c4ccc(cc4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B22 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124341 Peakdale1_001804 OC(=O)c1ccc(cc1)n2cc(cn2)c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B23 mock treatment 0.0755 0.0025 0.3 0.2962 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 B24 mock treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C01 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124342 Peakdale1_001805 CC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C02 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124343 Peakdale1_001806 OC(=O)c1ccc(OCc2ccnc(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C03 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124344 Peakdale1_001807 CC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C04 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124345 Peakdale1_001808 COC(=O)c1ccc(OCc2ccnc(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C05 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124346 Peakdale1_001809 CC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C06 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124347 Peakdale1_001810 Clc1cc(COc2ccc(cc2)C(=O)NCC3CCCO3)ccn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C07 compound treatment 0.0925 0.0195 2.31 2.3106 1.0 2124348 Peakdale1_001811 CC(=O)Nc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C08 compound treatment 0.078 0.005 0.59 0.5925 1.0 2124349 Peakdale1_001812 Clc1ccc(CNC(=O)c2ccc(OCc3ccnc(Cl)c3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C09 compound treatment 0.09 0.017 2.01 2.0143 1.0 2124350 Peakdale1_001813 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)c4ccccc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C10 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124351 Peakdale1_001814 FC(F)(F)c1cccc(CNC(=O)c2ccc(OCc3ccnc(Cl)c3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C11 compound treatment 0.087 0.014 1.66 1.6589 1.0 2124352 Peakdale1_001815 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)c4ccc(cc4)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C12 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124353 Peakdale1_001816 CON(C)C(=O)c1ccc(OCc2ccnc(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C13 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124354 Peakdale1_001817 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)c4c(F)cccc4F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C14 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124355 Peakdale1_001818 FC(F)(F)c1cccc(c1)N2CCN(CC2)C(=O)c3ccc(OCc4ccnc(Cl)c4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C15 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124356 Peakdale1_001819 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)C(c4ccccc4)c5ccccc5)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C16 compound treatment 0.075 0.002 0.24 0.237 1.0 2124357 Peakdale1_001820 CC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NS(=O)(=O)c4ccccc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C17 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124358 Peakdale1_001821 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)c4cccs4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C18 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124359 Peakdale1_001822 CC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NS(=O)(=O)c4ccc(C)cc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C19 compound treatment 0.0775 0.0045 0.53 0.5332 1.0 2124360 Peakdale1_001823 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NS(=O)(=O)c4cccc(c4)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C20 compound treatment 0.0745 0.0015 0.18 0.1777 1.0 2124361 Peakdale1_001824 COc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(CC4)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C21 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124362 Peakdale1_001825 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NS(=O)(=O)c4ccc(NC(=O)C)cc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C22 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124363 Peakdale1_001826 CC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NS(=O)(=O)c4ccc(Cl)cc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C23 mock treatment 0.073 0.0 0.0 -1.0 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 C24 mock treatment 0.0775 0.0045 0.53 0.5332 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D01 compound treatment 0.069 -0.004 -0.47 -0.474 -1.0 2124364 Peakdale1_001827 COc1cc(OC)nc(OC(Cc2ccc3ccccc3n2)c4ccc(cc4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D02 compound treatment 0.0675 -0.0055 -0.65 -0.6517 -1.0 2124365 Peakdale1_001828 CCCNC(=O)c1ccc(cc1)n2cc(cn2)c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D03 compound treatment 0.071 -0.002 -0.24 -0.237 -1.0 2124366 Peakdale1_001829 COc1cc(OC)nc(OC(Cc2cnc3ccccc3n2)c4ccc(cc4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D04 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124367 Peakdale1_001830 FC(F)(F)c1cccc(CNC(=O)c2ccc(cc2)n3cc(cn3)c4cnccn4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D05 compound treatment 0.075 0.002 0.24 0.237 1.0 2124368 Peakdale1_001831 COc1cc(OC)nc(OC(Cc2nc3ccccc3o2)c4ccc(cc4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D06 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124369 Peakdale1_001832 O=C(NCc1ccccn1)c2ccc(cc2)n3cc(cn3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D07 compound treatment 0.0865 0.0135 1.6 1.5996 1.0 2124370 Peakdale1_001833 Cc1cc(C)nc(OC(Cc2ccncc2)c3ccc(cc3)C(C)(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D08 compound treatment 0.081 0.008 0.95 0.9479 1.0 2124371 Peakdale1_001834 CN1CCN(CC1)C(=O)c2ccc(cc2)n3cc(cn3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D09 compound treatment 0.077 0.004 0.47 0.474 1.0 2124372 Peakdale1_001835 Cc1cc(C)nc(OC(Cc2ccncn2)c3ccc(cc3)C(C)(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D10 compound treatment 0.0775 0.0045 0.53 0.5332 1.0 2124373 Peakdale1_001836 O=C(N1CCOCC1)c2ccc(cc2)n3cc(cn3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D11 compound treatment 0.086 0.013 1.54 1.5404 1.0 2124374 Peakdale1_001837 Cc1cc(C)nc(OC(Cc2ccnc3ccccc23)c4ccc(cc4)C(C)(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D12 compound treatment 0.08 0.007 0.83 0.8294 1.0 2124375 Peakdale1_001838 OC(=O)c1ccc(cc1)n2cc(cn2)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D13 compound treatment 0.0805 0.0075 0.89 0.8887 1.0 2124376 Peakdale1_001839 Cc1cc(C)nc(OC(Cc2nc3ccccc3o2)c4ccc(cc4)C(C)(C)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D14 compound treatment 0.0835 0.0105 1.24 1.2441 1.0 2124377 Peakdale1_001840 CC(C)NC(=O)c1ccc(cc1)n2cc(cn2)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D15 compound treatment 0.088 0.015 1.78 1.7774 1.0 2124378 Peakdale1_001841 Cc1cc(C)nc(OC(Cc2ccncc2)c3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D16 compound treatment 0.0775 0.0045 0.53 0.5332 1.0 2124379 Peakdale1_001842 O=C(NCC1CCCO1)c2ccc(cc2)n3cc(cn3)c4ccnc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D17 compound treatment 0.09 0.017 2.01 2.0143 1.0 2124380 Peakdale1_001843 Cc1cc(C)nc(OC(Cc2cnccn2)c3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D18 compound treatment 0.0745 0.0015 0.18 0.1777 1.0 2124381 Peakdale1_001844 O=C(NCCN1CCOCC1)c2ccc(cc2)n3cc(cn3)c4ccnc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D19 compound treatment 0.082 0.009 1.07 1.0664 1.0 2124382 Peakdale1_001845 Cc1cc(C)nc(OC(Cc2ccncn2)c3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D20 compound treatment 0.0775 0.0045 0.53 0.5332 1.0 2124383 Peakdale1_001846 O=C(NCCc1ccccc1)c2ccc(cc2)n3cc(cn3)c4ccnc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D21 compound treatment 0.0805 0.0075 0.89 0.8887 1.0 2124384 Peakdale1_001847 Cc1cc(C)nc(OC(Cc2ccc3ccccc3n2)c4ccccc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D22 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124385 Peakdale1_001848 Cc1cc2cc(NS(=O)(=O)c3ccccc3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D23 mock treatment 0.074 0.001 0.12 0.1185 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 D24 mock treatment 0.077 0.004 0.47 0.474 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E01 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124386 Peakdale1_001849 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NS(=O)(=O)c4ccc(OC)cc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E02 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124387 Peakdale1_001850 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(CC4)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E03 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124388 Peakdale1_001851 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)NCC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E04 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124389 Peakdale1_001852 Clc1ccc(cc1)c2cnn(CCOCc3ccccc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E05 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124390 Peakdale1_001853 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)Nc4ccccc4OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E06 compound treatment 0.0875 0.0145 1.72 1.7181 1.0 2124391 Peakdale1_001854 CC(C)(C)c1ccc(COCCn2cc(cn2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E07 compound treatment 0.0885 0.0155 1.84 1.8366 1.0 2124392 Peakdale1_001855 OC(=O)c1ccc(OCc2cccc(Cl)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E08 compound treatment 0.0785 0.0055 0.65 0.6517 1.0 2124393 Peakdale1_001856 FC(F)(F)c1cccc(COCCn2cc(cn2)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E09 compound treatment 0.0775 0.0045 0.53 0.5332 1.0 2124394 Peakdale1_001857 COC(=O)c1ccc(OCc2cccc(Cl)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E10 compound treatment 0.087 0.014 1.66 1.6589 1.0 2124395 Peakdale1_001858 Clc1ccc(cc1)c2cnn(CCOCc3ccccc3Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E11 compound treatment 0.0805 0.0075 0.89 0.8887 1.0 2124396 Peakdale1_001859 COCCNC(=O)c1ccc(OCc2cccc(Cl)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E12 compound treatment 0.0805 0.0075 0.89 0.8887 1.0 2124397 Peakdale1_001860 CC(C)n1cc(cn1)c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E13 compound treatment 0.08 0.007 0.83 0.8294 1.0 2124398 Peakdale1_001861 Clc1cccc(COc2ccc(cc2)C(=O)NC3CC3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E14 compound treatment 0.0885 0.0155 1.84 1.8366 1.0 2124399 Peakdale1_001862 CC(C)n1cc(cn1)c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E15 compound treatment 0.0805 0.0075 0.89 0.8887 1.0 2124400 Peakdale1_001863 Clc1cccc(COc2ccc(cc2)C(=O)NCCc3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E16 compound treatment 0.0845 0.0115 1.36 1.3626 1.0 2124401 Peakdale1_001864 CC(C)n1cc(cn1)c2cnccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E17 compound treatment 0.079 0.006 0.71 0.7109 1.0 2124402 Peakdale1_001865 FC(F)(F)c1cccc(CNC(=O)c2ccc(OCc3cccc(Cl)n3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E18 compound treatment 0.085 0.012 1.42 1.4219 1.0 2124403 Peakdale1_001866 CC(C)n1cc(cn1)c2ccncn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E19 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124404 Peakdale1_001867 Cc1ccc(CNC(=O)c2ccc(OCc3cccc(Cl)n3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E20 compound treatment 0.075 0.002 0.24 0.237 1.0 2124405 Peakdale1_001868 CC(C)n1cc(cn1)c2ccc3ccccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E21 compound treatment 0.077 0.004 0.47 0.474 1.0 2124406 Peakdale1_001869 Clc1cccc(COc2ccc(cc2)C(=O)NN3CCOCC3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E22 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124407 Peakdale1_001870 CC(C)n1cc(cn1)c2cnc3ccccc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E23 mock treatment 0.074 0.001 0.12 0.1185 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 E24 mock treatment 0.074 0.001 0.12 0.1185 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F01 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124408 Peakdale1_001871 Cc1cc(C)nc(OC(Cc2cnc3ccccc3n2)c4ccccc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F02 compound treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 2124409 Peakdale1_001872 Cc1cc2cc(NS(=O)(=O)c3ccc(C)cc3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F03 compound treatment 0.071 -0.002 -0.24 -0.237 -1.0 2124410 Peakdale1_001873 Cc1cc(C)nc(OC(Cc2nc3ccccc3o2)c4ccccc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F04 compound treatment 0.071 -0.002 -0.24 -0.237 -1.0 2124411 Peakdale1_001874 COc1ccc(cc1)S(=O)(=O)Nc2ccc3[nH]c(C)cc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F05 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124412 Peakdale1_001875 Cc1cc(C)nc(OC(Cc2ccncc2)c3ccc(cc3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F06 compound treatment 0.083 0.01 1.18 1.1849 1.0 2124413 Peakdale1_001876 Cc1cc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F07 compound treatment 0.085 0.012 1.42 1.4219 1.0 2124414 Peakdale1_001877 Cc1cc(C)nc(OC(Cc2cnccn2)c3ccc(cc3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F08 compound treatment 0.0825 0.0095 1.13 1.1257 1.0 2124415 Peakdale1_001878 Cc1cc2cc(NS(=O)(=O)c3cccc(c3)C(F)(F)F)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F09 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124416 Peakdale1_001879 Cc1cc(C)nc(OC(Cc2ccnc3ccccc23)c4ccc(cc4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F10 compound treatment 0.089 0.016 1.9 1.8958 1.0 2124417 Peakdale1_001880 Cc1cc2cc(NS(=O)(=O)c3ccccc3S(=O)(=O)C)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F11 compound treatment 0.08 0.007 0.83 0.8294 1.0 2124418 Peakdale1_001881 Cc1cc(C)nc(OC(Cc2ccc3ccccc3n2)c4ccc(cc4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F12 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124419 Peakdale1_001882 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc3[nH]c(C)cc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F13 compound treatment 0.082 0.009 1.07 1.0664 1.0 2124420 Peakdale1_001883 Cc1cc(C)nc(OC(Cc2cnc3ccccc3n2)c4ccc(cc4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F14 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2079958 Peakdale1_001884 CCC(=O)N(C1CCN(CCc2ccccc2)CC1)c3ccc4[nH]c(C)cc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F15 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124421 Peakdale1_001885 COc1cc(OC)nc(OC(Cc2ccncn2)c3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F16 compound treatment 0.077 0.004 0.47 0.474 1.0 2124422 Peakdale1_001886 Cc1cc2cc(ccc2[nH]1)N(C3CCN(CCc4ccccc4)CC3)C(=O)c5ccc(cc5)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F17 compound treatment 0.0745 0.0015 0.18 0.1777 1.0 2124423 Peakdale1_001887 COc1cc(OC)nc(OC(Cc2cnccn2)c3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F18 compound treatment 0.0745 0.0015 0.18 0.1777 1.0 2124424 Peakdale1_001888 Cc1cc2cc(ccc2[nH]1)N(C3CCN(CCc4ccccc4)CC3)C(=O)c5cccc(c5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F19 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124425 Peakdale1_001889 COc1cc(OC)nc(OC(Cc2ccc3ccccc3n2)c4ccccc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F20 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124426 Peakdale1_001890 Cc1cc2cc(ccc2[nH]1)N(C3CCN(CCc4ccccc4)CC3)C(=O)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F21 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124427 Peakdale1_001891 COc1cc(OC)nc(OC(Cc2cnc3ccccc3n2)c4ccccc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F22 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124428 Peakdale1_001892 OC(=O)c1ccc(cc1)n2cc(cn2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F23 mock treatment 0.073 0.0 0.0 -1.0 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 F24 mock treatment 0.072 -0.001 -0.12 -0.1185 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G01 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124429 Peakdale1_001893 CN1CCN(CC1)C(=O)c2ccc(OCc3cccc(Cl)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G02 compound treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 2124430 Peakdale1_001894 CC(C)n1cc(cn1)c2cnc3ccccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G03 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124431 Peakdale1_001895 CC1CN(CC(C)O1)C(=O)c2ccc(OCc3cccc(Cl)n3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G04 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124432 Peakdale1_001896 CC(C)n1cc(cn1)c2nc3ccccc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G05 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124433 Peakdale1_001897 CCNC(=O)N1CCN(Cc2cccc(Cl)n2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G06 compound treatment 0.0785 0.0055 0.65 0.6517 1.0 2124434 Peakdale1_001898 CN1CCC(CC1)N(C2CC2)C(=O)/C=C/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G07 compound treatment 0.0805 0.0075 0.89 0.8887 1.0 2124435 Peakdale1_001899 FC(F)(F)c1ccccc1NC(=O)N2CCN(Cc3cccc(Cl)n3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G08 compound treatment 0.079 0.006 0.71 0.7109 1.0 2124436 Peakdale1_001900 CN1CCC(CC1)N(C2CC2)C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G09 compound treatment 0.077 0.004 0.47 0.474 1.0 2124437 Peakdale1_001901 Fc1ccc(NC(=O)N2CCN(Cc3cccc(Cl)n3)CC2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G10 compound treatment 0.089 0.016 1.9 1.8958 1.0 2124438 Peakdale1_001902 CN1CCC(CC1)N(C2CC2)C(=O)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G11 compound treatment 0.0745 0.0015 0.18 0.1777 1.0 2124439 Peakdale1_001903 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCN(Cc3cccc(Cl)n3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G12 compound treatment 0.0775 0.0045 0.53 0.5332 1.0 2124440 Peakdale1_001904 CN1CCC(CC1)N(C2CC2)C(=O)c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G13 compound treatment 0.0785 0.0055 0.65 0.6517 1.0 2124441 Peakdale1_001905 Clc1ccc(CNC(=S)N2CCN(Cc3cccc(Cl)n3)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G14 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124442 Peakdale1_001906 CN1CCC(CC1)N(C2CC2)C(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G15 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124443 Peakdale1_001907 CCOC(=O)NC(=S)N1CCN(Cc2cccc(Cl)n2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G16 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124444 Peakdale1_001908 CN1CCC(CC1)N(C2CC2)C(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G17 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124445 Peakdale1_001909 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCN(Cc3cccc(Cl)n3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G18 compound treatment 0.08 0.007 0.83 0.8294 1.0 2124446 Peakdale1_001910 COc1ccccc1NC(=O)N(C2CC2)C3CCN(C)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G19 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124447 Peakdale1_001911 COc1ccc(cc1)S(=O)(=O)N2CCN(Cc3cccc(Cl)n3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G20 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124448 Peakdale1_001912 CN1CCC(CC1)N(C2CC2)C(=O)NS(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G21 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124449 Peakdale1_001913 CC(C)(C)c1ccc(cc1)C(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G22 compound treatment 0.077 0.004 0.47 0.474 1.0 2124450 Peakdale1_001914 O=c1c(COCc2ccc(C#N)cc2)cc3cccc4CCCn1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G23 mock treatment 0.073 0.0 0.0 -1.0 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 G24 mock treatment 0.071 -0.002 -0.24 -0.237 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H01 compound treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 2124451 Peakdale1_001915 COc1cc(OC)nc(OC(Cc2nc3ccccc3o2)c4ccccc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H02 compound treatment 0.0665 -0.0065 -0.77 -0.7702 -1.0 2124452 Peakdale1_001916 COCCNC(=O)c1ccc(cc1)n2cc(cn2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H03 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124453 Peakdale1_001917 COc1ccc(cc1)C(Cc2ccncc2)Oc3nc(C)cc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H04 compound treatment 0.0695 -0.0035 -0.41 -0.4147 -1.0 2124454 Peakdale1_001918 O=C(NCCN1CCOCC1)c2ccc(cc2)n3cc(cn3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H05 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124455 Peakdale1_001919 COc1ccc(cc1)C(Cc2cnccn2)Oc3nc(C)cc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H06 compound treatment 0.083 0.01 1.18 1.1849 1.0 2124456 Peakdale1_001920 COc1ccccc1CNC(=O)c2ccc(cc2)n3cc(cn3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H07 compound treatment 0.0865 0.0135 1.6 1.5996 1.0 2124457 Peakdale1_001921 COc1ccc(cc1)C(Cc2ccncn2)Oc3nc(C)cc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H08 compound treatment 0.077 0.004 0.47 0.474 1.0 2124458 Peakdale1_001922 O=C(NCc1ccccn1)c2ccc(cc2)n3cc(cn3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H09 compound treatment 0.08 0.007 0.83 0.8294 1.0 2124459 Peakdale1_001923 COc1ccc(cc1)C(Cc2ccncn2)Oc3nc(OC)cc(OC)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H10 compound treatment 0.075 0.002 0.24 0.237 1.0 2124460 Peakdale1_001924 CN1CCN(CC1)C(=O)c2ccc(cc2)n3cc(cn3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H11 compound treatment 0.084 0.011 1.3 1.3034 1.0 2124461 Peakdale1_001925 COc1ccc(cc1)C(Cc2ccc3ccccc3n2)Oc4nc(C)cc(C)n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H12 compound treatment 0.081 0.008 0.95 0.9479 1.0 2124462 Peakdale1_001926 O=C(N1CCc2ccccc2C1)c3ccc(cc3)n4cc(cn4)c5ccncc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H13 compound treatment 0.087 0.014 1.66 1.6589 1.0 2124463 Peakdale1_001927 COc1ccc(cc1)C(Cc2ccc3ccccc3n2)Oc4nc(OC)cc(OC)n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H14 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124464 Peakdale1_001928 OC(=O)c1ccc(cc1)n2cc(cn2)c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H15 compound treatment 0.0835 0.0105 1.24 1.2441 1.0 2124465 Peakdale1_001929 COc1ccc(cc1)C(Cc2cnc3ccccc3n2)Oc4nc(C)cc(C)n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H16 compound treatment 0.071 -0.002 -0.24 -0.237 -1.0 2124466 Peakdale1_001930 CCCNC(=O)c1ccc(cc1)n2cc(cn2)c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H17 compound treatment 0.094 0.021 2.49 2.4883 1.0 2124467 Peakdale1_001931 COc1ccc(cc1)C(Cc2cnc3ccccc3n2)Oc4nc(OC)cc(OC)n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H18 compound treatment 0.0745 0.0015 0.18 0.1777 1.0 2124468 Peakdale1_001932 O=C(NCC1CCCO1)c2ccc(cc2)n3cc(cn3)c4nc5ccccc5o4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H19 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124469 Peakdale1_001933 COc1cc(OC)nc(n1)N2CCN(C)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H20 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124470 Peakdale1_001934 Clc1ccc(CNC(=O)c2ccc(cc2)n3cc(cn3)c4nc5ccccc5o4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H21 compound treatment 0.078 0.005 0.59 0.5925 1.0 2124471 Peakdale1_001935 COc1cc(OC)nc(n1)N2CCN(CC2)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H22 compound treatment 0.079 0.006 0.71 0.7109 1.0 2124472 Peakdale1_001936 O=C(NCCc1ccccc1)c2ccc(cc2)n3cc(cn3)c4nc5ccccc5o4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H23 mock treatment 0.0735 5.0E-4 0.06 0.0592 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 H24 mock treatment 0.07 -0.003 -0.36 -0.3555 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I01 compound treatment 0.0695 -0.0035 -0.41 -0.4147 -1.0 2124473 Peakdale1_001937 FC(F)(F)c1cccc(c1)C(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I02 compound treatment 0.0675 -0.0055 -0.65 -0.6517 -1.0 2124474 Peakdale1_001938 CC(C)(C)c1ccc(COCc2cc3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I03 compound treatment 0.0675 -0.0055 -0.65 -0.6517 -1.0 2124475 Peakdale1_001939 COc1cc(cc(OC)c1OC)C(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I04 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124476 Peakdale1_001940 Cc1ccc(COCc2cc3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I05 compound treatment 0.0695 -0.0035 -0.41 -0.4147 -1.0 2124477 Peakdale1_001941 O=C(Nc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3)C(c5ccccc5)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I06 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124478 Peakdale1_001942 Clc1ccc(COCc2cc3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I07 compound treatment 0.0775 0.0045 0.53 0.5332 1.0 2124479 Peakdale1_001943 O=C(Nc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3)c5ccco5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I08 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124480 Peakdale1_001944 FC(F)(F)c1cc(COCc2cc3cccc4CCCn(c2=O)c43)cc(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I09 compound treatment 0.072 -0.001 -0.12 -0.1185 -1.0 2124481 Peakdale1_001945 Clc1cc(cc(Cl)n1)C(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I10 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124482 Peakdale1_001946 Clc1ccc(COCc2cc3cccc4CCCn(c2=O)c43)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I11 compound treatment 0.084 0.011 1.3 1.3034 1.0 2124483 Peakdale1_001947 O=S(=O)(Nc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I12 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124484 Peakdale1_001948 FC(F)(F)c1cccc(c1)C(=O)OCc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I13 compound treatment 0.066 -0.007 -0.83 -0.8294 -1.0 2124485 Peakdale1_001949 FC(F)(F)c1cccc(c1)S(=O)(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I14 compound treatment 0.0635 -0.0095 -1.13 -1.1257 -1.0 2124486 Peakdale1_001950 O=C(OCc1cc2cccc3CCCn(c1=O)c32)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I15 compound treatment 0.077 0.004 0.47 0.474 1.0 2124487 Peakdale1_001951 COc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I16 compound treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 2124488 Peakdale1_001952 CON(C)C(=O)CCC(=O)N1CCN(CC1)C(=O)c2cccc(Cl)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I17 compound treatment 0.0805 0.0075 0.89 0.8887 1.0 2124489 Peakdale1_001953 Fc1ccc(NC(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I18 compound treatment 0.0885 0.0155 1.84 1.8366 1.0 2124490 Peakdale1_001954 CN1CCN(CC1)C(=O)CCC(=O)N2CCN(CC2)C(=O)c3cccc(Cl)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I19 compound treatment 0.078 0.005 0.59 0.5925 1.0 2124491 Peakdale1_001955 COCCNC(=O)c1ccc([N+](=O)[O-])c(c1)c2cnn(c2)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I20 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124492 Peakdale1_001956 Clc1ccc(CNC(=O)CCC(=O)N2CCN(CC2)C(=O)c3cccc(Cl)n3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I21 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124493 Peakdale1_001957 CC(C)n1cc(cn1)c2cc(ccc2[N+](=O)[O-])C(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I22 compound treatment 0.0775 0.0045 0.53 0.5332 1.0 2124494 Peakdale1_001958 FC(F)(F)c1cccc(CNC(=O)CCC(=O)N2CCN(CC2)C(=O)c3cccc(Cl)n3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I23 mock treatment 0.068 -0.005 -0.59 -0.5925 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 I24 mock treatment 0.0655 -0.0075 -0.89 -0.8887 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J01 compound treatment 0.068 -0.005 -0.59 -0.5925 -1.0 2124495 Peakdale1_001959 COc1cc(OC)nc(n1)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J02 compound treatment 0.068 -0.005 -0.59 -0.5925 -1.0 2124496 Peakdale1_001960 O=C(NCc1ccncc1)c2ccc(cc2)n3cc(cn3)c4nc5ccccc5o4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J03 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124497 Peakdale1_001961 COc1cc(OC)nc(n1)N2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J04 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124498 Peakdale1_001962 O=C(N1CCOCC1)c2ccc(cc2)n3cc(cn3)c4nc5ccccc5o4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J05 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124499 Peakdale1_001963 COc1cc(OC)nc(n1)N2CCN(CC2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J06 compound treatment 0.077 0.004 0.47 0.474 1.0 2124500 Peakdale1_001964 OC(=O)c1ccc(cc1)n2cc(cn2)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J07 compound treatment 0.0785 0.0055 0.65 0.6517 1.0 2124501 Peakdale1_001965 COc1cc(OC)nc(n1)N2CCN(CC2)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J08 compound treatment 0.078 0.005 0.59 0.5925 1.0 2124502 Peakdale1_001966 C=CCNC(=O)c1ccc(cc1)n2cc(cn2)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J09 compound treatment 0.0785 0.0055 0.65 0.6517 1.0 2124503 Peakdale1_001967 COc1cc(OC)nc(OC(Cc2ccncn2)c3cccc(c3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J10 compound treatment 0.0775 0.0045 0.53 0.5332 1.0 2124504 Peakdale1_001968 CS(=O)(=O)c1ccc(CNC(=O)c2ccc(cc2)n3cc(cn3)c4ccncn4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J11 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124505 Peakdale1_001969 COc1cc(OC)nc(OC(Cc2cnccn2)c3cccc(c3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J12 compound treatment 0.082 0.009 1.07 1.0664 1.0 2124506 Peakdale1_001970 O=C(NCCc1ccccc1)c2ccc(cc2)n3cc(cn3)c4ccncn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J13 compound treatment 0.0665 -0.0065 -0.77 -0.7702 -1.0 2124507 Peakdale1_001971 COc1cc(OC)nc(OC(Cc2ccnc3ccccc23)c4cccc(c4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J14 compound treatment 0.0885 0.0155 1.84 1.8366 1.0 2124508 Peakdale1_001972 O=C(N1CCN(Cc2ccccc2)CC1)c3ccc(cc3)n4cc(cn4)c5ccncn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J15 compound treatment 0.071 -0.002 -0.24 -0.237 -1.0 2124509 Peakdale1_001973 COc1cc(OC)nc(OC(Cc2ccc3ccccc3n2)c4cccc(c4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J16 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124510 Peakdale1_001974 CC1CN(CC(C)O1)C(=O)c2ccc(cc2)n3cc(cn3)c4ccncn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J17 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124511 Peakdale1_001975 COc1cc(OC)nc(OC(Cc2cnc3ccccc3n2)c4cccc(c4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J18 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124512 Peakdale1_001976 CCC(=O)N(C1CCN(Cc2ccccc2)CC1)c3ccc4[nH]c(C)cc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J19 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124513 Peakdale1_001977 Cc1cc(C)nc(OC(Cc2ccncc2)c3cccc(c3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J20 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124514 Peakdale1_001978 Cc1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J21 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124515 Peakdale1_001979 Cc1cc(C)nc(OC(Cc2ccncn2)c3cccc(c3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J22 compound treatment 0.072 -0.001 -0.12 -0.1185 -1.0 2124516 Peakdale1_001980 Cc1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5cccc(c5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J23 mock treatment 0.07 -0.003 -0.36 -0.3555 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 J24 mock treatment 0.069 -0.004 -0.47 -0.474 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K01 compound treatment 0.067 -0.006 -0.71 -0.7109 -1.0 2124517 Peakdale1_001981 CC(C)n1cc(cn1)c2cc(ccc2[N+](=O)[O-])C(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K02 compound treatment 0.0655 -0.0075 -0.89 -0.8887 -1.0 2124518 Peakdale1_001982 COCCNC(=O)c1ccc(nc1)c2cnn(c2)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K03 compound treatment 0.0665 -0.0065 -0.77 -0.7702 -1.0 2124519 Peakdale1_001983 CC(C)n1cc(cn1)c2cc(ccc2[N+](=O)[O-])C(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K04 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124520 Peakdale1_001984 CC(C)n1cc(cn1)c2ccc(cn2)C(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K05 compound treatment 0.071 -0.002 -0.24 -0.237 -1.0 2124521 Peakdale1_001985 COc1ccccc1CNC(=O)c2ccc([N+](=O)[O-])c(c2)c3cnn(c3)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K06 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124522 Peakdale1_001986 CC(C)n1cc(cn1)c2ccc(cn2)C(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K07 compound treatment 0.078 0.005 0.59 0.5925 1.0 2124523 Peakdale1_001987 CC(C)n1cc(cn1)c2cc(ccc2[N+](=O)[O-])C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K08 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124524 Peakdale1_001988 CC(C)n1cc(cn1)c2ccc(cn2)C(=O)NCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K09 compound treatment 0.078 0.005 0.59 0.5925 1.0 2124525 Peakdale1_001989 CC(C)n1cc(cn1)c2cc(ccc2[N+](=O)[O-])C(=O)NCc3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K10 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124526 Peakdale1_001990 CC(C)n1cc(cn1)c2ccc(cn2)C(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K11 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124527 Peakdale1_001991 CC(C)n1cc(cn1)c2cc(ccc2[N+](=O)[O-])C(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K12 compound treatment 0.0695 -0.0035 -0.41 -0.4147 -1.0 2124528 Peakdale1_001992 CC(C)n1cc(cn1)c2ccc(cn2)C(=O)NCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K13 compound treatment 0.068 -0.005 -0.59 -0.5925 -1.0 2124529 Peakdale1_001993 C(c1ccccc1)n2cc(cn2)c3ccc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K14 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124530 Peakdale1_001994 CC(C)n1cc(cn1)c2ccc(cn2)C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K15 compound treatment 0.068 -0.005 -0.59 -0.5925 -1.0 2124531 Peakdale1_001995 Clc1ccccc1Cn2cc(cn2)c3ccc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K16 compound treatment 0.0795 0.0065 0.77 0.7702 1.0 2124532 Peakdale1_001996 CC(C)n1cc(cn1)c2ccc(cn2)C(=O)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K17 compound treatment 0.069 -0.004 -0.47 -0.474 -1.0 2124533 Peakdale1_001997 FC(F)(F)c1cccc(Cn2cc(cn2)c3ccc4ccccc4n3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K18 compound treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 2124534 Peakdale1_001998 CC(C)n1cc(cn1)c2ccc(cn2)C(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K19 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124535 Peakdale1_001999 CS(=O)(=O)c1ccc(Cn2cc(cn2)c3ccc4ccccc4n3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K20 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124536 Peakdale1_002000 CC(C)n1cc(cn1)c2ccc(cn2)C(=O)NCc3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K21 compound treatment 0.075 0.002 0.24 0.237 1.0 2124537 Peakdale1_002001 CC(C)n1cc(cn1)c2ccc(cc2NC(=O)C(C)(C)C)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K22 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124538 Peakdale1_002002 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)C(C)(C)C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K23 mock treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 K24 mock treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L01 compound treatment 0.0675 -0.0055 -0.65 -0.6517 -1.0 2124539 Peakdale1_002003 Cc1cc(C)nc(OC(Cc2cnccn2)c3cccc(c3)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L02 compound treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 2124540 Peakdale1_002004 Cc1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5ccc(cc5)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L03 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124541 Peakdale1_002005 Cc1cc(C)nc(OC(Cc2ccnc3ccccc23)c4cccc(c4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L04 compound treatment 0.068 -0.005 -0.59 -0.5925 -1.0 2124542 Peakdale1_002006 Cc1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)C(=O)C(c5ccccc5)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L05 compound treatment 0.069 -0.004 -0.47 -0.474 -1.0 2124543 Peakdale1_002007 Cc1cc(C)nc(OC(Cc2ccc3ccccc3n2)c4cccc(c4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L06 compound treatment 0.072 -0.001 -0.12 -0.1185 -1.0 2079961 Peakdale1_002008 CCCN1CCC(CC1)N(C2CC2)C(=O)c3cccc(NC(=O)c4ccc(cc4)C(C)(C)C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L07 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124544 Peakdale1_002009 Cc1cc(C)nc(OC(Cc2cnc3ccccc3n2)c4cccc(c4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L08 compound treatment 0.0845 0.0115 1.36 1.3626 1.0 2124545 Peakdale1_002010 CCCN1CCC(CC1)N(C2CC2)C(=O)c3cccc(NC(=O)c4ccc(cc4)C(F)(F)F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L09 compound treatment 0.0785 0.0055 0.65 0.6517 1.0 2124546 Peakdale1_002011 Cc1cc(C)nc(OC(Cc2cnc3ccccc3n2)c4cc(cc(c4)C(F)(F)F)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L10 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124547 Peakdale1_002012 CCCN1CCC(CC1)N(C2CC2)C(=O)c3cccc(NC(=O)c4ccc(cc4)[N+](=O)[O-])c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L11 compound treatment 0.077 0.004 0.47 0.474 1.0 2124548 Peakdale1_002013 Cc1cc(C)nc(OC(Cc2nc3ccccc3o2)c4cccc(c4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L12 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124549 Peakdale1_002014 CCCN1CCC(CC1)N(C2CC2)C(=O)c3cccc(NC(=O)c4ccc(Cl)cc4Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L13 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124550 Peakdale1_002015 FC(F)(F)c1ccccc1c2n[nH]cc2c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L14 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124551 Peakdale1_002016 CCCN1CCC(CC1)N(C2CC2)C(=O)c3cccc(NC(=O)c4ccc(cc4)S(=O)(=O)C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L15 compound treatment 0.086 0.013 1.54 1.5404 1.0 2124552 Peakdale1_002017 FC(F)(F)c1ccccc1c2n[nH]cc2c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L16 compound treatment 0.0695 -0.0035 -0.41 -0.4147 -1.0 2124553 Peakdale1_002018 CCCN1CCC(CC1)N(C2CC2)C(=O)c3cccc(NC(=O)c4cc(OC)c(OC)c(OC)c4)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L17 compound treatment 0.08 0.007 0.83 0.8294 1.0 2124554 Peakdale1_002019 FC(F)(F)c1ccc(cc1)c2n[nH]cc2c3ccc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L18 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124555 Peakdale1_002020 CCCN1CCC(CC1)N(C2CC2)C(=O)c3cccc(NC(=O)C(c4ccccc4)c5ccccc5)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L19 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124556 Peakdale1_002021 FC(F)(F)c1ccc(cc1)c2n[nH]cc2c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L20 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124557 Peakdale1_002022 CCCN1CCC(CC1)N(C2CC2)C(=O)c3cccc(NC(=O)c4ccc(Cl)nc4)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L21 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124558 Peakdale1_002023 FC(F)(F)c1ccc(cc1)c2n[nH]cc2c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L22 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124559 Peakdale1_002024 c1[nH]nc(c1c2ccncc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L23 mock treatment 0.074 0.001 0.12 0.1185 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 L24 mock treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M01 compound treatment 0.0665 -0.0065 -0.77 -0.7702 -1.0 2124560 Peakdale1_002025 COc1ccc(cc1)S(=O)(=O)Nc2cc(ccc2c3cnn(c3)C(C)C)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M02 compound treatment 0.067 -0.006 -0.71 -0.7109 -1.0 2124561 Peakdale1_002026 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)c4ccccc4Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M03 compound treatment 0.068 -0.005 -0.59 -0.5925 -1.0 2124562 Peakdale1_002027 CC(C)n1cc(cn1)c2ccc(cc2NC(=O)c3cccc(c3)C(F)(F)F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M04 compound treatment 0.0675 -0.0055 -0.65 -0.6517 -1.0 2124563 Peakdale1_002028 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)c4ccc(cc4)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M05 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124564 Peakdale1_002029 CC(C)n1cc(cn1)c2ccc(cc2NC(=O)c3ccco3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M06 compound treatment 0.067 -0.006 -0.71 -0.7109 -1.0 2124565 Peakdale1_002030 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)C(c4ccccc4)c5ccccc5)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M07 compound treatment 0.0855 0.0125 1.48 1.4811 1.0 2124566 Peakdale1_002031 CC(C)n1cc(cn1)c2ccc(cc2NC(=O)C(c3ccccc3)c4ccccc4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M08 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124567 Peakdale1_002032 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)c4ccco4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M09 compound treatment 0.0945 0.0215 2.55 2.5475 1.0 2124568 Peakdale1_002033 CC(C)n1cc(cn1)c2ccc(cc2NC(=O)c3ccccc3NC(=O)C)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M10 compound treatment 0.0835 0.0105 1.24 1.2441 1.0 2124569 Peakdale1_002034 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)NS(=O)(=O)c4ccc(C)cc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M11 compound treatment 0.075 0.002 0.24 0.237 1.0 2124570 Peakdale1_002035 CCNC(=O)Nc1cc(ccc1c2cnn(c2)C(C)C)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M12 compound treatment 0.072 -0.001 -0.12 -0.1185 -1.0 2124571 Peakdale1_002036 c1[nH]nc(c1c2ccnc3ccccc23)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M13 compound treatment 0.069 -0.004 -0.47 -0.474 -1.0 2124572 Peakdale1_002037 CC(C)n1cc(cn1)c2ccc(cc2NC(=O)Nc3ccc(F)cc3F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M14 compound treatment 0.0675 -0.0055 -0.65 -0.6517 -1.0 2124573 Peakdale1_002038 CC(C)(C)C(=O)n1cc(c(n1)c2ccncc2)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M15 compound treatment 0.0695 -0.0035 -0.41 -0.4147 -1.0 2124574 Peakdale1_002039 CN1CCN(Cc2cccc(Cl)n2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M16 compound treatment 0.069 -0.004 -0.47 -0.474 -1.0 2124575 Peakdale1_002040 CCNC(=O)n1cc(c(n1)c2ccncc2)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M17 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124576 Peakdale1_002041 Clc1cccc(CN2CCN(Cc3ccccc3)CC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M18 compound treatment 0.0675 -0.0055 -0.65 -0.6517 -1.0 2124577 Peakdale1_002042 c1[nH]nc(c1c2ccnc3ccccc23)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M19 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124578 Peakdale1_002043 Fc1ccc(cc1)N2CCN(Cc3cccc(Cl)n3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M20 compound treatment 0.0695 -0.0035 -0.41 -0.4147 -1.0 2124579 Peakdale1_002044 CC(C)(C)C(=O)n1cc(c(n1)c2cccnc2)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M21 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124580 Peakdale1_002045 FC(F)(F)c1cccc(c1)N2CCN(Cc3cccc(Cl)n3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M22 compound treatment 0.0695 -0.0035 -0.41 -0.4147 -1.0 2124581 Peakdale1_002046 CCNC(=O)n1cc(c(n1)c2cccnc2)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M23 mock treatment 0.073 0.0 0.0 -1.0 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 M24 mock treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N01 compound treatment 0.0655 -0.0075 -0.89 -0.8887 -1.0 2124582 Peakdale1_002047 FC(F)(F)c1ccc(cc1)c2n[nH]cc2c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N02 compound treatment 0.0675 -0.0055 -0.65 -0.6517 -1.0 2124583 Peakdale1_002048 c1[nH]nc(c1c2ccncc2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N03 compound treatment 0.069 -0.004 -0.47 -0.474 -1.0 2124584 Peakdale1_002049 c1n[nH]cc1c2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N04 compound treatment 0.068 -0.005 -0.59 -0.5925 -1.0 2124585 Peakdale1_002050 c1[nH]nc(c1c2ccc3ccccc3n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N05 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124586 Peakdale1_002051 c1n[nH]cc1c2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N06 compound treatment 0.085 0.012 1.42 1.4219 1.0 2124587 Peakdale1_002052 c1[nH]nc(c1c2ccc3ccccc3n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N07 compound treatment 0.08 0.007 0.83 0.8294 1.0 2124588 Peakdale1_002053 c1n[nH]cc1c2ccncn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N08 compound treatment 0.0805 0.0075 0.89 0.8887 1.0 2124589 Peakdale1_002054 c1[nH]nc(c1c2cnc3ccccc3n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N09 compound treatment 0.086 0.013 1.54 1.5404 1.0 2124590 Peakdale1_002055 c1n[nH]cc1c2cnccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N10 compound treatment 0.0755 0.0025 0.3 0.2962 1.0 2124591 Peakdale1_002056 c1[nH]nc(c1c2cnc3ccccc3n2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N11 compound treatment 0.0855 0.0125 1.48 1.4811 1.0 2124592 Peakdale1_002057 c1n[nH]cc1c2ccnc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N12 compound treatment 0.0845 0.0115 1.36 1.3626 1.0 2124593 Peakdale1_002058 c1[nH]nc(c1c2cnccn2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N13 compound treatment 0.0805 0.0075 0.89 0.8887 1.0 2124594 Peakdale1_002059 c1n[nH]cc1c2ccc3ccccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N14 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124595 Peakdale1_002060 c1[nH]nc(c1c2nc3ccccc3o2)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N15 compound treatment 0.0885 0.0155 1.84 1.8366 1.0 2124596 Peakdale1_002061 c1n[nH]cc1c2cnc3ccccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N16 compound treatment 0.072 -0.001 -0.12 -0.1185 -1.0 2124597 Peakdale1_002062 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)Cc4ccc(Cl)cc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N17 compound treatment 0.079 0.006 0.71 0.7109 1.0 2124598 Peakdale1_002063 c1n[nH]cc1c2nc3ccccc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N18 compound treatment 0.071 -0.002 -0.24 -0.237 -1.0 2124599 Peakdale1_002064 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)/C=C/c4ccccc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N19 compound treatment 0.0925 0.0195 2.31 2.3106 1.0 2124600 Peakdale1_002065 c1[nH]nc(c1c2ccncc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N20 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124601 Peakdale1_002066 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4ccc(cc4)C(C)(C)C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N21 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124602 Peakdale1_002067 c1[nH]nc(c1c2cnccn2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N22 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124603 Peakdale1_002068 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4ccc(cc4)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N23 mock treatment 0.075 0.002 0.24 0.237 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 N24 mock treatment 0.073 0.0 0.0 -1.0 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O01 compound treatment 0.069 -0.004 -0.47 -0.474 -1.0 2124604 Peakdale1_002069 Clc1cccc(CN2CCN(CC2)C(c3ccccc3)c4ccccc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O02 compound treatment 0.065 -0.008 -0.95 -0.9479 -1.0 2124605 Peakdale1_002070 C(Cn1cc(cn1)c2ccc3ccccc3n2)OCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O03 compound treatment 0.0685 -0.0045 -0.53 -0.5332 -1.0 2124606 Peakdale1_002071 Clc1cccc(CN2CCN(Cc3cccc(Cl)n3)CC2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O04 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124607 Peakdale1_002072 CC(C)(C)c1ccc(COCCn2cc(cn2)c3ccc4ccccc4n3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O05 compound treatment 0.0695 -0.0035 -0.41 -0.4147 -1.0 2124608 Peakdale1_002073 Cc1cc(C)nc(n1)N2CCN(Cc3cccc(Cl)n3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O06 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124609 Peakdale1_002074 FC(F)(F)c1cccc(COCCn2cc(cn2)c3ccc4ccccc4n3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O07 compound treatment 0.086 0.013 1.54 1.5404 1.0 2124610 Peakdale1_002075 CC(C)n1cc(cn1)c2ccccc2NC(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O08 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124611 Peakdale1_002076 Clc1ccc(COCCn2cc(cn2)c3ccc4ccccc4n3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O09 compound treatment 0.0725 -5.0E-4 -0.06 -0.0592 -1.0 2124612 Peakdale1_002077 CC(C)n1cc(cn1)c2ccccc2NC(=O)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O10 compound treatment 0.076 0.003 0.36 0.3555 1.0 2124613 Peakdale1_002078 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O11 compound treatment 0.069 -0.004 -0.47 -0.474 -1.0 2124614 Peakdale1_002079 CC(C)n1cc(cn1)c2ccccc2NC(=O)c3c(F)cccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O12 compound treatment 0.072 -0.001 -0.12 -0.1185 -1.0 2124615 Peakdale1_002080 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O13 compound treatment 0.071 -0.002 -0.24 -0.237 -1.0 2124616 Peakdale1_002081 CC(C)n1cc(cn1)c2ccccc2NC(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O14 compound treatment 0.0825 0.0095 1.13 1.1257 1.0 2124617 Peakdale1_002082 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O15 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124618 Peakdale1_002083 CC(C)n1cc(cn1)c2ccccc2NC(=O)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O16 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124619 Peakdale1_002084 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O17 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124620 Peakdale1_002085 CC(C)n1cc(cn1)c2ccccc2NS(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O18 compound treatment 0.07 -0.003 -0.36 -0.3555 -1.0 2124621 Peakdale1_002086 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O19 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124622 Peakdale1_002087 COc1ccc(cc1)S(=O)(=O)Nc2ccccc2c3cnn(c3)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O20 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124623 Peakdale1_002088 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O21 compound treatment 0.074 0.001 0.12 0.1185 1.0 2124624 Peakdale1_002089 CC(C)n1cc(cn1)c2ccccc2NC(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O22 compound treatment 0.078 0.005 0.59 0.5925 1.0 2124625 Peakdale1_002090 COc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(C)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O23 mock treatment 0.0805 0.0075 0.89 0.8887 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 O24 mock treatment 0.076 0.003 0.36 0.3555 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P01 compound treatment 0.069 -0.004 -0.47 -0.474 -1.0 2124626 Peakdale1_002091 c1[nH]nc(c1c2ccnc3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P02 compound treatment 0.068 -0.005 -0.59 -0.5925 -1.0 2124627 Peakdale1_002092 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4cc(cc(c4)C(F)(F)F)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P03 compound treatment 0.075 0.002 0.24 0.237 1.0 2124628 Peakdale1_002093 c1[nH]nc(c1c2cnc3ccccc3n2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P04 compound treatment 0.0705 -0.0025 -0.3 -0.2962 -1.0 2124629 Peakdale1_002094 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4ccc(Cl)cc4Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P05 compound treatment 0.078 0.005 0.59 0.5925 1.0 2124630 Peakdale1_002095 c1[nH]nc(c1c2nc3ccccc3o2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P06 compound treatment 0.072 -0.001 -0.12 -0.1185 -1.0 2124631 Peakdale1_002096 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4ccc(cc4)S(=O)(=O)C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P07 compound treatment 0.0815 0.0085 1.01 1.0072 1.0 2124632 Peakdale1_002097 FC(F)(F)c1cccc(c1)c2n[nH]cc2c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P08 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124633 Peakdale1_002098 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4ccc(cc4)[N+](=O)[O-])cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P09 compound treatment 0.0785 0.0055 0.65 0.6517 1.0 2124634 Peakdale1_002099 FC(F)(F)c1cccc(c1)c2n[nH]cc2c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P10 compound treatment 0.077 0.004 0.47 0.474 1.0 2124635 Peakdale1_002100 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4cc(OC)c(OC)c(OC)c4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P11 compound treatment 0.0785 0.0055 0.65 0.6517 1.0 2124636 Peakdale1_002101 FC(F)(F)c1cccc(c1)c2n[nH]cc2c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P12 compound treatment 0.0775 0.0045 0.53 0.5332 1.0 2124637 Peakdale1_002102 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)c4ccc(Cl)nc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P13 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124638 Peakdale1_002103 FC(F)(F)c1cccc(c1)c2n[nH]cc2c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P14 compound treatment 0.0735 5.0E-4 0.06 0.0592 1.0 2124639 Peakdale1_002104 CCCN1CCC(CC1)N(C(=O)CC)c2ccc3[nH]c(C)cc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P15 compound treatment 0.079 0.006 0.71 0.7109 1.0 2124640 Peakdale1_002105 FC(F)(F)c1cccc(c1)c2n[nH]cc2c3ccc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P16 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124641 Peakdale1_002106 CCCN1CCC(CC1)N(C(=O)c2ccccc2)c3ccc4[nH]c(C)cc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P17 compound treatment 0.0715 -0.0015 -0.18 -0.1777 -1.0 2124642 Peakdale1_002107 FC(F)(F)c1cccc(c1)c2n[nH]cc2c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P18 compound treatment 0.071 -0.002 -0.24 -0.237 -1.0 2124643 Peakdale1_002108 CCCN1CCC(CC1)N(C(=O)C(c2ccccc2)c3ccccc3)c4ccc5[nH]c(C)cc5c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P19 compound treatment 0.0765 0.0035 0.41 0.4147 1.0 2124644 Peakdale1_002109 FC(F)(F)c1cccc(c1)c2n[nH]cc2c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P20 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124645 Peakdale1_002110 CCCN1CCC(CC1)N(C(=O)c2cc(Cl)nc(Cl)c2)c3ccc4[nH]c(C)cc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P21 compound treatment 0.073 0.0 0.0 -1.0 -1.0 2124646 Peakdale1_002111 COc1ccc(cc1)c2cnn(Cc3ccccc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P22 compound treatment 0.077 0.004 0.47 0.474 1.0 2124647 Peakdale1_002112 CCC(=O)N(C1CCN(CC1)C(=O)C)c2ccc3[nH]c(C)cc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P23 mock treatment 0.0745 0.0015 0.18 0.1777 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.523 P24 mock treatment 0.064 -0.009 -1.07 -1.0664 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A01 compound treatment 0.075 0.0025 0.3 0.2962 1.0 2124648 Peakdale1_002113 CC(=O)N1CCC(CC1)N(C(=O)/C=C/c2ccccc2)c3ccc4[nH]c(C)cc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A02 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124649 Peakdale1_002114 CCNC(=O)Nc1cccc2CCN(C(=O)C)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A03 compound treatment 0.077 0.0045 0.53 0.5332 1.0 2124650 Peakdale1_002115 CC(=O)N1CCC(CC1)N(C(=O)c2ccc(cc2)C(F)(F)F)c3ccc4[nH]c(C)cc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A04 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124651 Peakdale1_002116 CC(=O)N1CCc2cccc(NC(=O)C3CC3)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A05 compound treatment 0.0675 -0.005 -0.59 -0.5925 -1.0 2124652 Peakdale1_002117 CS(=O)(=O)c1ccc(CN(C(=O)c2ccc(Cl)cc2)c3ccccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A06 compound treatment 0.0615 -0.011 -1.3 -1.3034 -1.0 2124653 Peakdale1_002118 CC(=O)N1CCc2cccc(NC(=O)c3ccc(cc3)C(F)(F)F)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A07 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124654 Peakdale1_002119 CC(C)(C)c1ccc(cc1)C(=O)N(Cc2ccc(cc2)S(=O)(=O)C)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A08 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124655 Peakdale1_002120 CC(=O)N1CCc2cccc(NC(=O)c3cc(Cl)nc(Cl)c3)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A09 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124656 Peakdale1_002121 COc1cc(cc(OC)c1OC)C(=O)N(Cc2ccc(cc2)S(=O)(=O)C)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A10 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124657 Peakdale1_002122 CC(=O)N1CCc2cccc(NC(=O)C(c3ccccc3)c4ccccc4)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A11 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124658 Peakdale1_002123 CS(=O)(=O)c1ccc(CN(C(=O)c2ccc(cc2)C(F)(F)F)c3ccccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A12 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124659 Peakdale1_002124 CC(=O)N1CCc2cccc(NC(=O)NS(=O)(=O)c3ccc(C)cc3)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A13 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124660 Peakdale1_002125 CS(=O)(=O)c1ccc(CN(C(=O)c2cccc(c2)C(F)(F)F)c3ccccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A14 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124661 Peakdale1_002126 CC(=O)N1CCc2cccc(NS(=O)(=O)c3cccc(c3)C(F)(F)F)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A15 compound treatment 0.0685 -0.004 -0.47 -0.474 -1.0 2124662 Peakdale1_002127 CS(=O)(=O)c1ccc(CN(C(=O)c2ccccc2C(F)(F)F)c3ccccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A16 compound treatment 0.0695 -0.003 -0.36 -0.3555 -1.0 2124663 Peakdale1_002128 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2cccc3CCN(C(=O)C)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A17 compound treatment 0.0695 -0.003 -0.36 -0.3555 -1.0 2124664 Peakdale1_002129 CS(=O)(=O)c1ccc(CN(C(=O)c2ccc(Cl)nc2)c3ccccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A18 compound treatment 0.0615 -0.011 -1.3 -1.3034 -1.0 2124665 Peakdale1_002130 CCC(C)(C)c1cc2cc(NS(=O)(=O)c3ccccc3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A19 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124666 Peakdale1_002131 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A20 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124667 Peakdale1_002132 CCC(C)(C)c1cc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A21 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124668 Peakdale1_002133 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3C(=O)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A22 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124669 Peakdale1_002134 CCC(C)(C)c1cc2cc(NS(=O)(=O)c3cccc(c3)C(F)(F)F)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A23 mock treatment 0.081 0.0085 1.01 1.0072 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 A24 mock treatment 0.0775 0.005 0.59 0.5925 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B01 compound treatment 0.0685 -0.004 -0.47 -0.474 -1.0 2124670 Peakdale1_002135 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccccc3NC(=O)Nc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B02 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124671 Peakdale1_002136 CS(=O)(=O)c1cnc(nc1c2cccc(F)c2)c3ccc(O)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B03 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124672 Peakdale1_002137 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2ccccc2c3cnn(c3)c4ccc(cc4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B04 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124673 Peakdale1_002138 CS(=O)(=O)c1cnc(nc1c2cccc(c2)C(F)(F)F)c3ccc(O)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B05 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124674 Peakdale1_002139 Nc1ncc(c2ccnc3ccccc23)c(n1)c4ccc(nc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B06 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124675 Peakdale1_002140 CS(=O)(=O)c1cnc(nc1c2ccc(Cl)cc2)c3ccc(O)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B07 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124676 Peakdale1_002141 FC(F)(F)c1ccc(cn1)c2nc(ncc2c3ccnc4ccccc34)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B08 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124677 Peakdale1_002142 Nc1ncc(c2cnc3ccccc3n2)c(n1)c4ccc(nc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B09 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124678 Peakdale1_002143 FC(F)(F)c1ccc(cn1)c2nc(ncc2c3ccnc4ccccc34)c5ccccn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B10 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124679 Peakdale1_002144 FC(F)(F)c1ccc(cn1)c2nc(ncc2c3cnc4ccccc4n3)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B11 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124680 Peakdale1_002145 FC(F)(F)c1ccc(cn1)c2ncc(c3ccnc4ccccc34)c(n2)c5ccc(nc5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B12 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124681 Peakdale1_002146 FC(F)(F)c1ccc(cn1)c2nc(ncc2c3cnc4ccccc4n3)c5ccccn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B13 compound treatment 0.0625 -0.01 -1.18 -1.1849 -1.0 2124682 Peakdale1_002147 Clc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B14 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124683 Peakdale1_002148 FC(F)(F)c1ccc(cn1)c2ncc(c3cnc4ccccc4n3)c(n2)c5ccc(nc5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B15 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124684 Peakdale1_002149 CN1CCN(CC1)c2ncc(cn2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B16 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124685 Peakdale1_002150 COc1ccc(cc1)c2cnc(=O)n(Cc3ccccc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B17 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2079882 Peakdale1_002151 Clc1ccc(cc1)c2cnc(nc2)N3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B18 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124686 Peakdale1_002152 COc1ccc(cc1)c2cnc(=O)n(Cc3ccc(cc3)C(C)(C)C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B19 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124687 Peakdale1_002153 Fc1ccc(cc1)N2CCN(CC2)c3ncc(cn3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B20 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124688 Peakdale1_002154 COc1ccc(cc1)c2cnc(=O)n(Cc3cccc(c3)C(F)(F)F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B21 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124689 Peakdale1_002155 FC(F)(F)c1cccc(c1)N2CCN(CC2)c3ncc(cn3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B22 compound treatment 0.0765 0.004 0.47 0.474 1.0 2124690 Peakdale1_002156 COc1ccc(cc1)c2cnc(=O)n(Cc3ccc(Cl)cc3Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B23 mock treatment 0.073 5.0E-4 0.06 0.0592 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 B24 mock treatment 0.0695 -0.003 -0.36 -0.3555 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C01 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124691 Peakdale1_002157 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3C(=O)NCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C02 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124692 Peakdale1_002158 CCC(C)(C)c1cc2cc(NS(=O)(=O)c3ccc(cc3)[N+](=O)[O-])ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C03 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124693 Peakdale1_002159 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3C(=O)NCCOC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C04 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124694 Peakdale1_002160 CCC(C)(C)c1cc2cc(NS(=O)(=O)c3ccc(OC)cc3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C05 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124695 Peakdale1_002161 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3C(=O)NCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C06 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124696 Peakdale1_002162 CCC(C)(C)c1cc2cc(NS(=O)(=O)c3ccccc3S(=O)(=O)C)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C07 compound treatment 0.0805 0.008 0.95 0.9479 1.0 2124697 Peakdale1_002163 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3C(=O)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C08 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124698 Peakdale1_002164 CCC(C)(C)c1cc2cc(NS(=O)(=O)c3ccc(C)cc3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C09 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124699 Peakdale1_002165 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3C(=O)NCc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C10 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124700 Peakdale1_002166 CCC(C)(C)c1cc2cc(NS(=O)(=O)c3ccc(NC(=O)C)cc3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C11 compound treatment 0.0775 0.005 0.59 0.5925 1.0 2124701 Peakdale1_002167 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3C(=O)NCc4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C12 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124702 Peakdale1_002168 CCC(C)(C)c1cc2cc(NS(=O)(=O)c3ccc4oc(=O)ccc4c3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C13 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124703 Peakdale1_002169 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3C(=O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C14 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124704 Peakdale1_002170 CCC(C)(C)c1cc2cc(NC(=O)C(C)(C)C)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C15 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124705 Peakdale1_002171 CCCN1CCC(CC1)N(C2CC2)C(=O)Nc3ccccc3C(=O)N4CCc5ccccc5C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C16 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124706 Peakdale1_002172 CCC(C)(C)c1cc2cc(NC(=O)/C=C/c3ccccc3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C17 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124707 Peakdale1_002173 COCCNC(=O)Cc1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C18 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124708 Peakdale1_002174 CCC(C)(C)c1cc2cc(NC(=O)c3ccc(cc3)C(C)(C)C)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C19 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124709 Peakdale1_002175 CS(=O)(=O)c1ccc(CC(=O)NCC2CCCO2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C20 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124710 Peakdale1_002176 CCC(C)(C)c1cc2cc(NC(=O)c3c(F)cccc3F)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C21 compound treatment 0.075 0.0025 0.3 0.2962 1.0 2124711 Peakdale1_002177 CS(=O)(=O)c1ccc(CC(=O)NCCN2CCOCC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C22 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124712 Peakdale1_002178 CCC(C)(C)c1cc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C23 mock treatment 0.074 0.0015 0.18 0.1777 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 C24 mock treatment 0.076 0.0035 0.41 0.4147 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D01 compound treatment 0.0665 -0.006 -0.71 -0.7109 -1.0 2124713 Peakdale1_002179 Clc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D02 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124714 Peakdale1_002180 FC(F)(F)c1ccc(cn1)c2n[nH]cc2c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D03 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124715 Peakdale1_002181 OC(=O)c1ccccc1NC(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D04 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124716 Peakdale1_002182 FC(F)(F)c1ccc(cn1)c2n[nH]cc2c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D05 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124717 Peakdale1_002183 COCCNC(=O)c1ccccc1NC(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D06 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124718 Peakdale1_002184 FC(F)(F)c1ccc(cn1)c2n[nH]cc2c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D07 compound treatment 0.0855 0.013 1.54 1.5404 1.0 2124719 Peakdale1_002185 O=C(Nc1ccccc1C(=O)NCc2ccccn2)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D08 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124720 Peakdale1_002186 FC(F)(F)c1ccc(cn1)c2n[nH]cc2c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D09 compound treatment 0.078 0.0055 0.65 0.6517 1.0 2124721 Peakdale1_002187 FC(F)(F)c1cccc(CNC(=O)c2ccccc2NC(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D10 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124722 Peakdale1_002188 FC(F)(F)c1ccc(cn1)c2n[nH]cc2c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D11 compound treatment 0.0805 0.008 0.95 0.9479 1.0 2124723 Peakdale1_002189 CS(=O)(=O)c1ccc(CCNC(=O)c2ccccc2NC(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D12 compound treatment 0.0765 0.004 0.47 0.474 1.0 2124724 Peakdale1_002190 FC(F)(F)c1ccc(cn1)c2n[nH]cc2c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D13 compound treatment 0.079 0.0065 0.77 0.7702 1.0 2124725 Peakdale1_002191 O=C(Nc1ccccc1C(=O)N2CCN(CC2)C(c3ccccc3)c4ccccc4)N(C5CC5)C6CCN(Cc7ccccc7)CC6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D14 compound treatment 0.078 0.0055 0.65 0.6517 1.0 2124726 Peakdale1_002192 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)Nc4ccccc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D15 compound treatment 0.0795 0.007 0.83 0.8294 1.0 2124727 Peakdale1_002193 COc1ccc(cc1)c2cnn(c2)c3ccc(NC(=O)C(C)(C)C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D16 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124728 Peakdale1_002194 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)Nc4ccc(F)cc4F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D17 compound treatment 0.083 0.0105 1.24 1.2441 1.0 2124729 Peakdale1_002195 COc1ccc(cc1)c2cnn(c2)c3ccc(NC(=O)c4ccc(cc4)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D18 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124730 Peakdale1_002196 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)Nc4cccc(c4)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D19 compound treatment 0.0765 0.004 0.47 0.474 1.0 2124731 Peakdale1_002197 COc1ccc(cc1)c2cnn(c2)c3ccc(NC(=O)c4cc(Cl)nc(Cl)c4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D20 compound treatment 0.079 0.0065 0.77 0.7702 1.0 2124732 Peakdale1_002198 CN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D21 compound treatment 0.0795 0.007 0.83 0.8294 1.0 2124733 Peakdale1_002199 COc1ccc(cc1)c2cnn(c2)c3ccc(NC(=O)C(c4ccccc4)c5ccccc5)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D22 compound treatment 0.0795 0.007 0.83 0.8294 1.0 2124734 Peakdale1_002200 COc1cc(OC)nc(n1)N2CCNCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D23 mock treatment 0.074 0.0015 0.18 0.1777 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 D24 mock treatment 0.0755 0.003 0.36 0.3555 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E01 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124735 Peakdale1_002201 CS(=O)(=O)c1ccc(CC(=O)NCCc2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E02 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124736 Peakdale1_002202 CCC(C)(C)c1cc2cc(NC(=O)C(c3ccccc3)c4ccccc4)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E03 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124737 Peakdale1_002203 CS(=O)(=O)c1ccc(CC(=O)NCc2cccc(c2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E04 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124738 Peakdale1_002204 CCC(C)(C)c1cc2cc(NC(=O)c3cccs3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E05 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124739 Peakdale1_002205 CS(=O)(=O)c1ccc(CC(=O)NCc2ccccn2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E06 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124740 Peakdale1_002206 CCC(C)(C)c1cc2cc(NC(=O)c3cc(Cl)nc(Cl)c3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E07 compound treatment 0.081 0.0085 1.01 1.0072 1.0 2124741 Peakdale1_002207 CN(C)C(=O)Cc1ccc(cc1)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E08 compound treatment 0.076 0.0035 0.41 0.4147 1.0 2124742 Peakdale1_002208 CCNC(=O)Nc1ccc2[nH]c(cc2c1)C(C)(C)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E09 compound treatment 0.0795 0.007 0.83 0.8294 1.0 2124743 Peakdale1_002209 CN1CCC(CC1)N(C2CC2)C(=O)Cc3ccc(cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E10 compound treatment 0.079 0.0065 0.77 0.7702 1.0 2124744 Peakdale1_002210 CCC(C)(C)c1cc2cc(NC(=O)Nc3cccc(Cl)c3)ccc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E11 compound treatment 0.0805 0.008 0.95 0.9479 1.0 2124745 Peakdale1_002211 CS(=O)(=O)c1ccc(CC(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E12 compound treatment 0.0895 0.017 2.01 2.0143 1.0 2124746 Peakdale1_002212 CCC(=O)N(C1CCN(Cc2ccccc2)CC1)c3ccc4[nH]c(cc4c3)C(C)(C)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E13 compound treatment 0.085 0.0125 1.48 1.4811 1.0 2124747 Peakdale1_002213 CN(Cc1ccccc1)C(=O)Cc2ccc(cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E14 compound treatment 0.0785 0.006 0.71 0.7109 1.0 2124748 Peakdale1_002214 CCC(C)(C)c1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5ccc(cc5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E15 compound treatment 0.0795 0.007 0.83 0.8294 1.0 2124749 Peakdale1_002215 CS(=O)(=O)c1ccc(CC(=O)N2CCc3ccccc3C2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E16 compound treatment 0.085 0.0125 1.48 1.4811 1.0 2124750 Peakdale1_002216 CCC(C)(C)c1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)C(=O)C(c5ccccc5)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E17 compound treatment 0.0835 0.011 1.3 1.3034 1.0 2124751 Peakdale1_002217 CS(=O)(=O)c1ccc(CC(=O)N2CCN(CC2)C(c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E18 compound treatment 0.081 0.0085 1.01 1.0072 1.0 2124752 Peakdale1_002218 CCC(C)(C)c1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5cc(Cl)nc(Cl)c5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E19 compound treatment 0.0765 0.004 0.47 0.474 1.0 2124753 Peakdale1_002219 CC(C)(C)c1ccc(cc1)c2n[nH]cc2c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E20 compound treatment 0.0765 0.004 0.47 0.474 1.0 2124754 Peakdale1_002220 CCNC(=O)N(C1CCN(Cc2ccccc2)CC1)c3ccc4[nH]c(cc4c3)C(C)(C)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E21 compound treatment 0.0765 0.004 0.47 0.474 1.0 2124755 Peakdale1_002221 CC(C)(C)c1ccc(cc1)c2n[nH]cc2c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E22 compound treatment 0.075 0.0025 0.3 0.2962 1.0 2124756 Peakdale1_002222 CCC(C)(C)c1cc2cc(ccc2[nH]1)N(C3CCN(Cc4ccccc4)CC3)S(=O)(=O)c5ccc(NC(=O)C)cc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E23 mock treatment 0.074 0.0015 0.18 0.1777 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 E24 mock treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F01 compound treatment 0.0695 -0.003 -0.36 -0.3555 -1.0 2124757 Peakdale1_002223 COc1ccc(cc1)c2cnn(c2)c3ccc(NS(=O)(=O)c4ccccc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F02 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124758 Peakdale1_002224 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F03 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124759 Peakdale1_002225 COc1ccc(cc1)c2cnn(c2)c3ccc(NS(=O)(=O)c4ccc(Cl)cc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F04 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124760 Peakdale1_002226 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)c3cc(OC)c(OC)c(OC)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F05 compound treatment 0.0775 0.005 0.59 0.5925 1.0 2124761 Peakdale1_002227 COc1ccc(cc1)c2cnn(c2)c3ccc(NC(=O)NS(=O)(=O)c4ccc(C)cc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F06 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124762 Peakdale1_002228 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)Nc3ccccc3OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F07 compound treatment 0.0845 0.012 1.42 1.4219 1.0 2124763 Peakdale1_002229 COc1ccc(cc1)c2cnn(c2)c3ccc(NC(=O)Nc4cccc(c4)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F08 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124764 Peakdale1_002230 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F09 compound treatment 0.082 0.0095 1.13 1.1257 1.0 2124765 Peakdale1_002231 COCCNC(=O)c1ccc(nc1)c2cnn(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F10 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124766 Peakdale1_002232 COc1cc(OC)nc(n1)N2CCN(CC2)C(=S)Nc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F11 compound treatment 0.0805 0.008 0.95 0.9479 1.0 2124767 Peakdale1_002233 Cn1cc(cn1)c2ccc(cn2)C(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F12 compound treatment 0.0765 0.004 0.47 0.474 1.0 2124768 Peakdale1_002234 COc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3nc(OC)cc(OC)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F13 compound treatment 0.078 0.0055 0.65 0.6517 1.0 2124769 Peakdale1_002235 Cn1cc(cn1)c2ccc(cn2)C(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F14 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124770 Peakdale1_002236 COc1cc(OC)nc(n1)N2CCN(CC2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F15 compound treatment 0.075 0.0025 0.3 0.2962 1.0 2124771 Peakdale1_002237 Cn1cc(cn1)c2ccc(cn2)C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F16 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124772 Peakdale1_002238 CCNC(=O)c1cc(=O)oc2cc(OCc3ccc(Cl)cc3)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F17 compound treatment 0.0765 0.004 0.47 0.474 1.0 2124773 Peakdale1_002239 Cn1cc(cn1)c2ccc(cn2)C(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F18 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124774 Peakdale1_002240 COCCNC(=O)c1cc(=O)oc2cc(OCc3ccccc3)ccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F19 compound treatment 0.075 0.0025 0.3 0.2962 1.0 2124775 Peakdale1_002241 Cn1cc(cn1)c2ccc(cn2)C(=O)NCc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F20 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124776 Peakdale1_002242 Clc1ccc(COc2ccc3c(cc(=O)oc3c2)C(=O)NCC4CCCO4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F21 compound treatment 0.078 0.0055 0.65 0.6517 1.0 2124777 Peakdale1_002243 CN(C)C(=O)c1ccc(nc1)c2cnn(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F22 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124778 Peakdale1_002244 O=C(NCCN1CCOCC1)c2cc(=O)oc3cc(OCc4ccccc4)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F23 mock treatment 0.074 0.0015 0.18 0.1777 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 F24 mock treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G01 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124779 Peakdale1_002245 CC(C)(C)c1ccc(cc1)c2n[nH]cc2c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G02 compound treatment 0.0675 -0.005 -0.59 -0.5925 -1.0 2124780 Peakdale1_002246 CCCN1CCC(CC1)N(C(=O)CC)c2ccc3[nH]c(cc3c2)C(C)(C)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G03 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124781 Peakdale1_002247 CC(C)(C)c1ccc(cc1)c2n[nH]cc2c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G04 compound treatment 0.082 0.0095 1.13 1.1257 1.0 2124782 Peakdale1_002248 CCCN1CCC(CC1)N(C(=O)c2ccccc2)c3ccc4[nH]c(cc4c3)C(C)(C)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G05 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124783 Peakdale1_002249 CC(C)(C)c1ccc(cc1)c2n[nH]cc2c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G06 compound treatment 0.0805 0.008 0.95 0.9479 1.0 2124784 Peakdale1_002250 CCCN1CCC(CC1)N(C(=O)c2ccc(cc2)C(C)(C)C)c3ccc4[nH]c(cc4c3)C(C)(C)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G07 compound treatment 0.08 0.0075 0.89 0.8887 1.0 2124785 Peakdale1_002251 Cc1[nH]c2c(cccc2c1C)N(C3CCN(Cc4ccccc4)CC3)C(=O)Nc5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G08 compound treatment 0.0775 0.005 0.59 0.5925 1.0 2124786 Peakdale1_002252 CCCN1CCC(CC1)N(C(=O)C(c2ccccc2)c3ccccc3)c4ccc5[nH]c(cc5c4)C(C)(C)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G09 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124787 Peakdale1_002253 Cc1[nH]c2c(cccc2c1C)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5cccc(c5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G10 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124788 Peakdale1_002254 CCCN1CCC(CC1)N(c2ccc3[nH]c(cc3c2)C(C)(C)CC)S(=O)(=O)c4ccc(OC)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G11 compound treatment 0.077 0.0045 0.53 0.5332 1.0 2124789 Peakdale1_002255 Cc1[nH]c2c(cccc2c1C)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5cc(Cl)nc(Cl)c5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G12 compound treatment 0.077 0.0045 0.53 0.5332 1.0 2124790 Peakdale1_002256 CCCN1CCC(CC1)N(C(=O)Nc2cccc(c2)C(F)(F)F)c3ccc4[nH]c(cc4c3)C(C)(C)CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G13 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124791 Peakdale1_002257 Cc1[nH]c2c(cccc2c1C)N(C3CCN(Cc4ccccc4)CC3)C(=O)c5ccco5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G14 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124792 Peakdale1_002258 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G15 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124793 Peakdale1_002259 COc1ccccc1NC(=O)N(C2CCN(C)CC2)c3cccc4c(C)c(C)[nH]c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G16 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124794 Peakdale1_002260 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G17 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124795 Peakdale1_002261 CN1CCC(CC1)N(C(=O)c2ccc(cc2)C(C)(C)C)c3cccc4c(C)c(C)[nH]c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G18 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124796 Peakdale1_002262 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G19 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124797 Peakdale1_002263 CN1CCC(CC1)N(C(=O)c2cc(Cl)nc(Cl)c2)c3cccc4c(C)c(C)[nH]c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G20 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124798 Peakdale1_002264 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G21 compound treatment 0.0825 0.01 1.18 1.1849 1.0 1631964 Peakdale1_002265 C1CC(CCN1)c2c[nH]c3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G22 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124799 Peakdale1_002266 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G23 mock treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 G24 mock treatment 0.0705 -0.002 -0.24 -0.237 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H01 compound treatment 0.0675 -0.005 -0.59 -0.5925 -1.0 2124800 Peakdale1_002267 CC1CCN(CC1)C(=O)c2ccc(nc2)c3cnn(C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H02 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124801 Peakdale1_002268 O=C(NCc1cccnc1)c2cc(=O)oc3cc(OCc4ccccc4)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H03 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124802 Peakdale1_002269 Cn1cc(cn1)c2ccc(cn2)C(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H04 compound treatment 0.0695 -0.003 -0.36 -0.3555 -1.0 2124803 Peakdale1_002270 Clc1ccc(COc2ccc3c(cc(=O)oc3c2)C(=O)N4CCOCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H05 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124804 Peakdale1_002271 Cn1cc(cn1)c2ccc(cn2)C(=O)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H06 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124805 Peakdale1_002272 CN1CCN(CC1)C(=O)c2cc(=O)oc3cc(OCc4ccc(Cl)cc4)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H07 compound treatment 0.082 0.0095 1.13 1.1257 1.0 2124806 Peakdale1_002273 Nc1ncc(c2ccncn2)c(n1)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H08 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124807 Peakdale1_002274 O=C(N1CCN(CC1)c2ccccn2)c3cc(=O)oc4cc(OCc5ccccc5)ccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H09 compound treatment 0.087 0.0145 1.72 1.7181 1.0 2124808 Peakdale1_002275 Cc1ncc(c2ccncn2)c(n1)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H10 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124809 Peakdale1_002276 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)Nc4ccccc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H11 compound treatment 0.0825 0.01 1.18 1.1849 1.0 2124810 Peakdale1_002277 FC(F)(F)c1ccc(cn1)c2nc(ncc2c3ccncn3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H12 compound treatment 0.082 0.0095 1.13 1.1257 1.0 2124811 Peakdale1_002278 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)Nc4cccc(Cl)c4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H13 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124812 Peakdale1_002279 FC(F)(F)c1ccc(cn1)c2nc(ncc2c3ccncn3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H14 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124813 Peakdale1_002280 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)Nc4ccccc4C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H15 compound treatment 0.077 0.0045 0.53 0.5332 1.0 2124814 Peakdale1_002281 FC(F)(F)c1ccc(cn1)c2ncc(c3ccncn3)c(n2)c4ccc(nc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H16 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124815 Peakdale1_002282 CCCN1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccc(NC(=O)Nc4ccc(F)cc4F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H17 compound treatment 0.0775 0.005 0.59 0.5925 1.0 2124816 Peakdale1_002283 Clc1ccc(cc1)c2cnc(nc2)N3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H18 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124817 Peakdale1_002284 O=C(Nc1ccccc1)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H19 compound treatment 0.0915 0.019 2.25 2.2513 1.0 2124818 Peakdale1_002285 CC(C)(C)C(=O)N1CCN(CC1)c2ncc(cn2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H20 compound treatment 0.076 0.0035 0.41 0.4147 1.0 2124819 Peakdale1_002286 COc1ccccc1NC(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H21 compound treatment 0.0785 0.006 0.71 0.7109 1.0 2124820 Peakdale1_002287 Fc1cccc(F)c1C(=O)N2CCN(CC2)c3ncc(cn3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H22 compound treatment 0.079 0.0065 0.77 0.7702 1.0 2124821 Peakdale1_002288 [O-][N+](=O)c1ccc(NC(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H23 mock treatment 0.073 5.0E-4 0.06 0.0592 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 H24 mock treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I01 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124822 Peakdale1_002289 O=C(N1CCC(CC1)c2c[nH]c3ccccc23)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I02 compound treatment 0.0685 -0.004 -0.47 -0.474 -1.0 2124823 Peakdale1_002290 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccnc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I03 compound treatment 0.0685 -0.004 -0.47 -0.474 -1.0 2124824 Peakdale1_002291 Oc1ccccc1C(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I04 compound treatment 0.0685 -0.004 -0.47 -0.474 -1.0 2124825 Peakdale1_002292 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I05 compound treatment 0.0675 -0.005 -0.59 -0.5925 -1.0 2124826 Peakdale1_002293 CC(=O)Oc1ccccc1C(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I06 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124827 Peakdale1_002294 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I07 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124828 Peakdale1_002295 COc1cc(cc(OC)c1OC)C(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I08 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124829 Peakdale1_002296 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I09 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124830 Peakdale1_002297 FC(F)(F)c1cccc(c1)C(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I10 compound treatment 0.075 0.0025 0.3 0.2962 1.0 2124831 Peakdale1_002298 COCCNC(=O)c1ccc(nc1)c2cnn(c2)c3ccc(cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I11 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124832 Peakdale1_002299 Fc1cccc(F)c1C(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I12 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124833 Peakdale1_002300 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I13 compound treatment 0.0615 -0.011 -1.3 -1.3034 -1.0 2124834 Peakdale1_002301 CC(C)(C)c1ccc(cc1)C(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I14 compound treatment 0.075 0.0025 0.3 0.2962 1.0 2124835 Peakdale1_002302 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)NCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I15 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124836 Peakdale1_002303 Clc1ccc(C(=O)N2CCC(CC2)c3c[nH]c4ccccc34)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I16 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124837 Peakdale1_002304 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I17 compound treatment 0.0835 0.011 1.3 1.3034 1.0 2124838 Peakdale1_002305 O=C(C(c1ccccc1)c2ccccc2)N3CCC(CC3)c4c[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I18 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124839 Peakdale1_002306 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)NCc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I19 compound treatment 0.075 0.0025 0.3 0.2962 1.0 2124840 Peakdale1_002307 CS(=O)(=O)N1CCC(CC1)c2c[nH]c3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I20 compound treatment 0.08 0.0075 0.89 0.8887 1.0 2124841 Peakdale1_002308 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)NCc4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I21 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124842 Peakdale1_002309 FC(F)(F)c1cccc(c1)S(=O)(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I22 compound treatment 0.0835 0.011 1.3 1.3034 1.0 2124843 Peakdale1_002310 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)N4CCc5ccccc5C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I23 mock treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 I24 mock treatment 0.066 -0.0065 -0.77 -0.7702 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J01 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124844 Peakdale1_002311 Clc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)C(=O)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J02 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124845 Peakdale1_002312 FC(F)(F)c1ccccc1NC(=O)Nc2ccc(cc2)S(=O)(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J03 compound treatment 0.0695 -0.003 -0.36 -0.3555 -1.0 2124846 Peakdale1_002313 Clc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)C(=O)c4cc(Cl)nc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J04 compound treatment 0.077 0.0045 0.53 0.5332 1.0 2124847 Peakdale1_002314 FC(F)(F)c1cccc(c1)c2cc(=O)oc3cc(OCc4ccccn4)ccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J05 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124848 Peakdale1_002315 Clc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J06 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124849 Peakdale1_002316 O=c1cc(c2ccncc2)c3ccc(OCc4ccccn4)cc3o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J07 compound treatment 0.086 0.0135 1.6 1.5996 1.0 2124850 Peakdale1_002317 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ncc(cn3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J08 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124851 Peakdale1_002318 O=c1cc(c2ccccn2)c3ccc(OCc4ccccn4)cc3o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J09 compound treatment 0.0795 0.007 0.83 0.8294 1.0 2124852 Peakdale1_002319 CCNC(=O)N1CCN(CC1)c2ncc(cn2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J10 compound treatment 0.078 0.0055 0.65 0.6517 1.0 2124853 Peakdale1_002320 O=c1cc(c2cccnc2)c3ccc(OCc4ccccn4)cc3o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J11 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124854 Peakdale1_002321 FC(F)(F)c1cccc(NC(=O)N2CCN(CC2)c3ncc(cn3)c4ccc(Cl)cc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J12 compound treatment 0.081 0.0085 1.01 1.0072 1.0 2124855 Peakdale1_002322 COc1cc(OC)nc(Oc2ccc3c(cc(=O)oc3c2)c4cccc(c4)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J13 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124856 Peakdale1_002323 Cn1c(cc2cc(ccc12)S(=O)(=O)C)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J14 compound treatment 0.0685 -0.004 -0.47 -0.474 -1.0 2124857 Peakdale1_002324 COc1cc(OC)nc(Oc2ccc3c(cc(=O)oc3c2)c4ccncc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J15 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124858 Peakdale1_002325 COCCNC(=O)c1cc2cc(ccc2n1C)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J16 compound treatment 0.0795 0.007 0.83 0.8294 1.0 2124859 Peakdale1_002326 COc1cc(OC)nc(Oc2ccc3c(cc(=O)oc3c2)c4ccccn4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J17 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124860 Peakdale1_002327 Cn1c(cc2cc(ccc12)S(=O)(=O)C)C(=O)NCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J18 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124861 Peakdale1_002328 COc1cc(OC)nc(Oc2ccc3c(cc(=O)oc3c2)c4cccnc4)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J19 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124862 Peakdale1_002329 Cn1c(cc2cc(ccc12)S(=O)(=O)C)C(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J20 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124863 Peakdale1_002330 CC(C)(C)C(=O)Nc1ccccc1C(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J21 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124864 Peakdale1_002331 Cn1c(cc2cc(ccc12)S(=O)(=O)C)C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J22 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124865 Peakdale1_002332 CC(=O)Oc1ccccc1C(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J23 mock treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 J24 mock treatment 0.0665 -0.006 -0.71 -0.7109 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K01 compound treatment 0.066 -0.0065 -0.77 -0.7702 -1.0 2124866 Peakdale1_002333 COc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K02 compound treatment 0.0655 -0.007 -0.83 -0.8294 -1.0 2124867 Peakdale1_002334 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccc(cn3)C(=O)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K03 compound treatment 0.081 0.0085 1.01 1.0072 1.0 2124868 Peakdale1_002335 O=c1ccc2cc(ccc2o1)S(=O)(=O)N3CCC(CC3)c4c[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K04 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124869 Peakdale1_002336 CN1CCN(CC1)C(=O)c2ccc(nc2)c3cnn(c3)c4ccc(cc4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K05 compound treatment 0.0795 0.007 0.83 0.8294 1.0 2124870 Peakdale1_002337 CS(=O)(=O)c1cnc(nc1c2ccccc2)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K06 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124871 Peakdale1_002338 CCNC(=O)N1CCC(CC1)c2c[nH]c3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K07 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124872 Peakdale1_002339 CS(=O)(=O)c1cnc(nc1c2cccc(F)c2)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K08 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124873 Peakdale1_002340 Clc1ccc(CNC(=S)N2CCC(CC2)c3c[nH]c4ccccc34)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K09 compound treatment 0.0795 0.007 0.83 0.8294 1.0 2124874 Peakdale1_002341 CS(=O)(=O)c1cnc(nc1c2ccc(Cl)cc2)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K10 compound treatment 0.087 0.0145 1.72 1.7181 1.0 2124875 Peakdale1_002342 FC(F)(F)c1ccccc1NC(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K11 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124876 Peakdale1_002343 CS(=O)(=O)c1cnc(nc1c2ccccc2C(F)(F)F)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K12 compound treatment 0.065 -0.0075 -0.89 -0.8887 -1.0 2124877 Peakdale1_002344 Fc1ccc(NC(=O)N2CCC(CC2)c3c[nH]c4ccccc34)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K13 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124878 Peakdale1_002345 CS(=O)(=O)c1cnc(nc1c2cccc(c2)C(F)(F)F)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K14 compound treatment 0.0695 -0.003 -0.36 -0.3555 -1.0 2124879 Peakdale1_002346 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)c3ccccc3N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K15 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124880 Peakdale1_002347 CS(=O)(=O)c1cnc(nc1c2ccc(cc2)C(F)(F)F)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K16 compound treatment 0.0695 -0.003 -0.36 -0.3555 -1.0 2124881 Peakdale1_002348 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)c3ccccc3NC(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K17 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124882 Peakdale1_002349 COc1ccc(cc1)c2n[nH]cc2c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K18 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124883 Peakdale1_002350 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)c3ccccc3NC(=O)c4ccc(cc4)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K19 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124884 Peakdale1_002351 COc1ccc(cc1)c2n[nH]cc2c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K20 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124885 Peakdale1_002352 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)c3ccccc3NC(=O)c4c(F)cccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K21 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124886 Peakdale1_002353 COc1ccc(cc1)c2n[nH]cc2c3ccncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K22 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124887 Peakdale1_002354 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)c3ccccc3NS(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K23 mock treatment 0.0695 -0.003 -0.36 -0.3555 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 K24 mock treatment 0.0675 -0.005 -0.59 -0.5925 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L01 compound treatment 0.0675 -0.005 -0.59 -0.5925 -1.0 2124888 Peakdale1_002355 Cn1c(cc2cc(ccc12)S(=O)(=O)C)C(=O)NCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L02 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124889 Peakdale1_002356 COc1cc(cc(OC)c1OC)C(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L03 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124890 Peakdale1_002357 Cn1c(cc2cc(ccc12)S(=O)(=O)C)C(=O)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L04 compound treatment 0.0665 -0.006 -0.71 -0.7109 -1.0 2124891 Peakdale1_002358 CC(C)(C)c1ccc(cc1)C(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L05 compound treatment 0.0675 -0.005 -0.59 -0.5925 -1.0 2124892 Peakdale1_002359 Cn1c(cc2cc(ccc12)S(=O)(=O)C)C(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L06 compound treatment 0.09 0.0175 2.07 2.0736 1.0 2124893 Peakdale1_002360 FC(F)(F)c1cccc(c1)C(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L07 compound treatment 0.076 0.0035 0.41 0.4147 1.0 2124894 Peakdale1_002361 CC(C)(C)C(=O)Nc1ccc(cc1)n2cc(cn2)c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L08 compound treatment 0.078 0.0055 0.65 0.6517 1.0 2124895 Peakdale1_002362 Fc1cccc(F)c1C(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L09 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124896 Peakdale1_002363 O=C(Nc1ccc(cc1)n2cc(cn2)c3cnccn3)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L10 compound treatment 0.087 0.0145 1.72 1.7181 1.0 2124897 Peakdale1_002364 Clc1ccc(C(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L11 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124898 Peakdale1_002365 Fc1cccc(F)c1C(=O)Nc2ccc(cc2)n3cc(cn3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L12 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124899 Peakdale1_002366 O=C(Nc1ccccc1C(=O)N2CCC(CC2)c3c[nH]c4ccccc34)c5ccc(cc5)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L13 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124900 Peakdale1_002367 O=C(Nc1ccc(cc1)n2cc(cn2)c3cnccn3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L14 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124901 Peakdale1_002368 O=C(Nc1ccccc1C(=O)N2CCC(CC2)c3c[nH]c4ccccc34)C(c5ccccc5)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L15 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124902 Peakdale1_002369 Clc1cc(cc(Cl)n1)C(=O)Nc2ccc(cc2)n3cc(cn3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L16 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124903 Peakdale1_002370 O=C(Nc1ccccc1C(=O)N2CCC(CC2)c3c[nH]c4ccccc34)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L17 compound treatment 0.079 0.0065 0.77 0.7702 1.0 2124904 Peakdale1_002371 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)n3cc(cn3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L18 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124905 Peakdale1_002372 O=c1c(CN2CCNCC2)cc3cccc4CCCn1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L19 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124906 Peakdale1_002373 FC(F)(F)c1ccccc1NC(=O)Nc2ccc(cc2)n3cc(cn3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L20 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124907 Peakdale1_002374 CN1CCN(Cc2cc3cccc4CCCn(c2=O)c43)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L21 compound treatment 0.077 0.0045 0.53 0.5332 1.0 2124908 Peakdale1_002375 COc1ccc(cc1)c2cnc(nc2)N3CCN(C)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L22 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124909 Peakdale1_002376 O=c1c(CN2CCN(Cc3ccccc3)CC2)cc4cccc5CCCn1c54 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L23 mock treatment 0.074 0.0015 0.18 0.1777 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 L24 mock treatment 0.0695 -0.003 -0.36 -0.3555 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M01 compound treatment 0.066 -0.0065 -0.77 -0.7702 -1.0 2124910 Peakdale1_002377 COc1ccc(cc1)c2n[nH]cc2c3ccc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M02 compound treatment 0.065 -0.0075 -0.89 -0.8887 -1.0 2124911 Peakdale1_002378 COc1ccc(cc1)S(=O)(=O)Nc2ccccc2C(=O)N3CCN(CC3)c4nc(OC)cc(OC)n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M03 compound treatment 0.066 -0.0065 -0.77 -0.7702 -1.0 2124912 Peakdale1_002379 COc1ccc(cc1)c2n[nH]cc2c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M04 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124913 Peakdale1_002380 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)c3ccccc3NC(=O)Nc4ccc(F)cc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M05 compound treatment 0.067 -0.0055 -0.65 -0.6517 -1.0 2124914 Peakdale1_002381 Cc1[nH]c2c(cccc2c1C)N(Cc3cccc(Cl)c3)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M06 compound treatment 0.0665 -0.006 -0.71 -0.7109 -1.0 2124915 Peakdale1_002382 COc1cc(OC)nc(n1)N2CCN(CC2)C(=O)c3ccccc3NC(=O)NS(=O)(=O)c4ccc(C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M07 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124916 Peakdale1_002383 Cc1[nH]c2c(cccc2c1C)N(Cc3cccc(Cl)c3)C(=O)c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M08 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124917 Peakdale1_002384 FC(F)(F)c1ccc(cn1)c2ncc(c3ccncc3)c(n2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M09 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124918 Peakdale1_002385 OC(=O)COCCn1cc(cn1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M10 compound treatment 0.0885 0.016 1.9 1.8958 1.0 2124919 Peakdale1_002386 FC(F)(F)c1ccc(cn1)c2ncc(c3cnccn3)c(n2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M11 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124920 Peakdale1_002387 COCCNC(=O)COCCn1cc(cn1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M12 compound treatment 0.093 0.0205 2.43 2.429 1.0 2124921 Peakdale1_002388 FC(F)(F)c1ccc(cn1)c2ncc(c3ccncn3)c(n2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M13 compound treatment 0.0665 -0.006 -0.71 -0.7109 -1.0 2124922 Peakdale1_002389 Clc1ccc(cc1)c2cnn(CCOCC(=O)NCCN3CCOCC3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M14 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124923 Peakdale1_002390 FC(F)(F)c1ccc(cn1)c2ncc(c3ccnc4ccccc34)c(n2)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M15 compound treatment 0.0765 0.004 0.47 0.474 1.0 2124924 Peakdale1_002391 FC(F)(F)c1cccc(CNC(=O)COCCn2cc(cn2)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M16 compound treatment 0.084 0.0115 1.36 1.3626 1.0 2124925 Peakdale1_002392 FC(F)(F)c1ccc(cn1)c2ncc(c3ccc4ccccc4n3)c(n2)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M17 compound treatment 0.069 -0.0035 -0.41 -0.4147 -1.0 2124926 Peakdale1_002393 Clc1ccc(cc1)c2cnn(CCOCC(=O)NCc3cccnc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M18 compound treatment 0.0785 0.006 0.71 0.7109 1.0 2124927 Peakdale1_002394 FC(F)(F)c1ccc(cn1)c2ncc(c3cnc4ccccc4n3)c(n2)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M19 compound treatment 0.0855 0.013 1.54 1.5404 1.0 2124928 Peakdale1_002395 Clc1ccc(cc1)c2cnn(CCOCC(=O)N3CCN(Cc4ccccc4)CC3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M20 compound treatment 0.08 0.0075 0.89 0.8887 1.0 2124929 Peakdale1_002396 FC(F)(F)c1ccc(cn1)c2ncc(c3nc4ccccc4o3)c(n2)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M21 compound treatment 0.0825 0.01 1.18 1.1849 1.0 2124930 Peakdale1_002397 FC(F)(F)c1ccc(nc1)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M22 compound treatment 0.0825 0.01 1.18 1.1849 1.0 2124931 Peakdale1_002398 CN1CCC(CC1)N(C2CC2)C(=O)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M23 mock treatment 0.0725 0.0 0.0 -1.0 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 M24 mock treatment 0.0685 -0.004 -0.47 -0.474 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N01 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124932 Peakdale1_002399 COc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N02 compound treatment 0.0685 -0.004 -0.47 -0.474 -1.0 2124933 Peakdale1_002400 Fc1ccc(cc1)N2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N03 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124934 Peakdale1_002401 CCOC(=O)N1CCN(CC1)c2ncc(cn2)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N04 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124935 Peakdale1_002402 FC(F)(F)c1cccc(c1)N2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N05 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124936 Peakdale1_002403 COc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N06 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124937 Peakdale1_002404 O=c1c(CN2CCN(CC2)c3ccccn3)cc4cccc5CCCn1c54 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N07 compound treatment 0.0785 0.006 0.71 0.7109 1.0 2124938 Peakdale1_002405 COc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N08 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124939 Peakdale1_002406 OC(=O)C1CCN(CC1)c2ncc(cn2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N09 compound treatment 0.083 0.0105 1.24 1.2441 1.0 2124940 Peakdale1_002407 COc1ccc(cc1)c2cnc(nc2)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N10 compound treatment 0.0825 0.01 1.18 1.1849 1.0 2124941 Peakdale1_002408 COCCNC(=O)C1CCN(CC1)c2ncc(cn2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N11 compound treatment 0.091 0.0185 2.19 2.1921 1.0 2124942 Peakdale1_002409 Nc1ccccc1C(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N12 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124943 Peakdale1_002410 Clc1ccc(cc1)c2cnc(nc2)N3CCC(CC3)C(=O)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N13 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124944 Peakdale1_002411 CS(=O)(=O)Nc1ccccc1C(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N14 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124945 Peakdale1_002412 Clc1ccc(cc1)c2cnc(nc2)N3CCC(CC3)C(=O)NCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N15 compound treatment 0.0755 0.003 0.36 0.3555 1.0 2124946 Peakdale1_002413 FC(F)(F)c1cccc(c1)S(=O)(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N16 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124947 Peakdale1_002414 Clc1ccc(cc1)c2cnc(nc2)N3CCC(CC3)C(=O)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N17 compound treatment 0.0915 0.019 2.25 2.2513 1.0 2124948 Peakdale1_002415 COc1ccc(cc1)S(=O)(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N18 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124949 Peakdale1_002416 Clc1ccc(cc1)c2cnc(nc2)N3CCC(CC3)C(=O)NCc4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N19 compound treatment 0.088 0.0155 1.84 1.8366 1.0 2124950 Peakdale1_002417 CCNC(=O)Nc1ccccc1C(=O)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N20 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124951 Peakdale1_002418 FC(F)(F)c1cccc(CNC(=O)C2CCN(CC2)c3ncc(cn3)c4ccc(Cl)cc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N21 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124952 Peakdale1_002419 FC(F)(F)c1cccc(NC(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N22 compound treatment 0.079 0.0065 0.77 0.7702 1.0 2124953 Peakdale1_002420 CC1CCN(CC1)C(=O)C2CCN(CC2)c3ncc(cn3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N23 mock treatment 0.077 0.0045 0.53 0.5332 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 N24 mock treatment 0.078 0.0055 0.65 0.6517 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O01 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124954 Peakdale1_002421 C1CN(CCC1c2c[nH]c3ccccc23)c4ncccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O02 compound treatment 0.0615 -0.011 -1.3 -1.3034 -1.0 2124955 Peakdale1_002422 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O03 compound treatment 0.07 -0.0025 -0.3 -0.2962 -1.0 2124956 Peakdale1_002423 Cc1cc(C)nc(n1)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O04 compound treatment 0.066 -0.0065 -0.77 -0.7702 -1.0 2124957 Peakdale1_002424 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O05 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124958 Peakdale1_002425 COc1cc(OC)nc(n1)N2CCC(CC2)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O06 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124959 Peakdale1_002426 FC(F)(F)c1ccc(cn1)C(=O)N(C2CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O07 compound treatment 0.088 0.0155 1.84 1.8366 1.0 2124960 Peakdale1_002427 OC(=O)COCc1cc2cccc3CCCn(c1=O)c32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O08 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124961 Peakdale1_002428 CCC(=O)Nc1ccccc1c2cnn(c2)c3ccc(cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O09 compound treatment 0.0725 0.0 0.0 -1.0 -1.0 2124962 Peakdale1_002429 O=C(COCc1cc2cccc3CCCn(c1=O)c32)NCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O10 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124963 Peakdale1_002430 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccccc3NC(=O)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O11 compound treatment 0.0705 -0.002 -0.24 -0.237 -1.0 2124964 Peakdale1_002431 O=C(COCc1cc2cccc3CCCn(c1=O)c32)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O12 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124965 Peakdale1_002432 CC(C)(C)c1ccc(cc1)C(=O)Nc2ccccc2c3cnn(c3)c4ccc(cc4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O13 compound treatment 0.071 -0.0015 -0.18 -0.1777 -1.0 2124966 Peakdale1_002433 Clc1ccc(CNC(=O)COCc2cc3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O14 compound treatment 0.108 0.0355 4.21 4.2064 1.0 2124967 Peakdale1_002434 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccccc3NC(=O)c4c(F)cccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O15 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124968 Peakdale1_002435 CS(=O)(=O)c1ccc(CCNC(=O)COCc2cc3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O16 compound treatment 0.076 0.0035 0.41 0.4147 1.0 2124969 Peakdale1_002436 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccccc3NC(=O)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O17 compound treatment 0.088 0.0155 1.84 1.8366 1.0 2124970 Peakdale1_002437 O=C(COCc1cc2cccc3CCCn(c1=O)c32)NCc4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O18 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124971 Peakdale1_002438 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccccc3NC(=O)c4cc(Cl)nc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O19 compound treatment 0.08 0.0075 0.89 0.8887 1.0 2124972 Peakdale1_002439 O=CN1CCN(CC1)C(=O)COCc2cc3cccc4CCCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O20 compound treatment 0.0775 0.005 0.59 0.5925 1.0 2124973 Peakdale1_002440 CS(=O)(=O)c1ccc(cc1)n2cc(cn2)c3ccccc3NS(=O)(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O21 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124974 Peakdale1_002441 O=C(COCc1cc2cccc3CCCn(c1=O)c32)N4CCc5ccccc5C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O22 compound treatment 0.078 0.0055 0.65 0.6517 1.0 2124975 Peakdale1_002442 CC(=O)Nc1ccc(cc1)S(=O)(=O)Nc2ccccc2c3cnn(c3)c4ccc(cc4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O23 mock treatment 0.08 0.0075 0.89 0.8887 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 O24 mock treatment 0.077 0.0045 0.53 0.5332 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P01 compound treatment 0.051 -0.0215 -2.55 -2.5475 -1.0 2124976 Peakdale1_002443 Fc1ccc(NC(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P02 compound treatment 0.0625 -0.01 -1.18 -1.1849 -1.0 2124977 Peakdale1_002444 Clc1ccc(cc1)c2cnc(nc2)N3CCC(CC3)C(=O)N4CCc5ccccc5C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P03 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124978 Peakdale1_002445 Cc1ccc(cc1)S(=O)(=O)NC(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4c[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P04 compound treatment 0.073 5.0E-4 0.06 0.0592 1.0 2124979 Peakdale1_002446 Clc1ccc(cc1)c2cnc(nc2)N3CCC(CC3)C(=O)N4CCN(CC4)c5ccccn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P05 compound treatment 0.075 0.0025 0.3 0.2962 1.0 2124980 Peakdale1_002447 Nc1ncc(c2ccncc2)c(n1)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P06 compound treatment 0.077 0.0045 0.53 0.5332 1.0 2124981 Peakdale1_002448 Oc1ccc(cc1)c2ncc(c3ccncc3)c(n2)c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P07 compound treatment 0.0815 0.009 1.07 1.0664 1.0 2124982 Peakdale1_002449 FC(F)(F)c1ccc(cn1)c2nc(ncc2c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P08 compound treatment 0.076 0.0035 0.41 0.4147 1.0 2124983 Peakdale1_002450 Oc1ccc(cc1)c2ncc(c3cnccn3)c(n2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P09 compound treatment 0.079 0.0065 0.77 0.7702 1.0 2124984 Peakdale1_002451 FC(F)(F)c1ccc(cn1)c2nc(ncc2c3ccncc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P10 compound treatment 0.08 0.0075 0.89 0.8887 1.0 2124985 Peakdale1_002452 Oc1ccc(cc1)c2ncc(c3ccncn3)c(n2)c4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P11 compound treatment 0.0735 0.001 0.12 0.1185 1.0 2124986 Peakdale1_002453 FC(F)(F)c1ccc(cn1)c2ncc(c3ccncc3)c(n2)c4ccc(nc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P12 compound treatment 0.077 0.0045 0.53 0.5332 1.0 2124987 Peakdale1_002454 Oc1ccc(cc1)c2ncc(c3cnccn3)c(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P13 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124988 Peakdale1_002455 CC(C)(C)c1ccc(cc1)C(=O)Nc2ccccc2Sc3ncc(cn3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P14 compound treatment 0.077 0.0045 0.53 0.5332 1.0 2124989 Peakdale1_002456 Oc1ccc(cc1)c2ncc(c3ccc4ccccc4n3)c(n2)c5cccc(c5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P15 compound treatment 0.068 -0.0045 -0.53 -0.5332 -1.0 2124990 Peakdale1_002457 FC(F)(F)c1cccc(c1)C(=O)Nc2ccccc2Sc3ncc(cn3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P16 compound treatment 0.0715 -0.001 -0.12 -0.1185 -1.0 2124991 Peakdale1_002458 Oc1ccc(cc1)c2ncc(c3cnc4ccccc4n3)c(n2)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P17 compound treatment 0.087 0.0145 1.72 1.7181 1.0 2124992 Peakdale1_002459 Clc1ccc(cc1)c2cnc(Sc3ccccc3NC(=O)c4cc(Cl)nc(Cl)c4)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P18 compound treatment 0.0605 -0.012 -1.42 -1.4219 -1.0 2124993 Peakdale1_002460 Oc1ccc(cc1)c2ncc(c3cnc4ccccc4n3)c(n2)c5ccc(cc5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P19 compound treatment 0.072 -5.0E-4 -0.06 -0.0592 -1.0 2124994 Peakdale1_002461 Clc1ccc(cc1)c2cnc(Sc3ccccc3NC(=O)c4ccco4)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P20 compound treatment 0.0675 -0.005 -0.59 -0.5925 -1.0 2124995 Peakdale1_002462 CS(=O)c1cnc(nc1c2ccc(cc2)C(F)(F)F)c3ccc(O)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P21 compound treatment 0.074 0.0015 0.18 0.1777 1.0 2124996 Peakdale1_002463 CS(=O)(=O)c1cnc(nc1c2ccccc2)c3ccc(O)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P22 compound treatment 0.0745 0.002 0.24 0.237 1.0 2124997 Peakdale1_002464 Cc1ccc(cc1)S(=O)(=O)c2cnc(nc2c3cccnc3)c4ccc(O)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P23 mock treatment 0.073 5.0E-4 0.06 0.0592 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.524 P24 mock treatment 0.063 -0.0095 -1.13 -1.1257 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A01 compound treatment 0.077 0.00455 0.54 0.5388 1.0 2124998 Peakdale1_002465 FC(F)(F)c1ccc(cc1)c2nc(ncc2c3ccncc3)c4ccc(nc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A02 compound treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 2124999 Peakdale1_002466 COCCN(C1CCN(CC1)C(=O)c2ccccc2OC(=O)C)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A03 compound treatment 0.081 0.00855 1.01 1.0127 1.0 2125000 Peakdale1_002467 FC(F)(F)c1ccc(cn1)c2ncc(c3ccncc3)c(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A04 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125001 Peakdale1_002468 COCCN(C1CCN(CC1)C(=O)C(c2ccccc2)c3ccccc3)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A05 compound treatment 0.073 5.47E-4 0.06 0.0648 1.0 2125002 Peakdale1_002469 FC(F)(F)c1ccc(cn1)c2ncc(c3cnccn3)c(n2)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A06 compound treatment 0.066 -0.00645 -0.76 -0.7646 -1.0 2125003 Peakdale1_002470 COCCN(C1CCN(CC1)C(=O)c2cccs2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A07 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125004 Peakdale1_002471 Fc1ccc(cc1)c2nc(ncc2c3ccncn3)c4ccc(nc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A08 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125005 Peakdale1_002472 COCCN(C1CCN(CC1)S(=O)(=O)c2ccccc2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A09 compound treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 2125006 Peakdale1_002473 FC(F)(F)c1cccc(c1)c2nc(ncc2c3ccc4ccccc4n3)c5ccc(nc5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A10 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125007 Peakdale1_002474 COCCN(C1CCN(CC1)S(=O)(=O)c2ccc(OC)cc2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A11 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125008 Peakdale1_002475 FC(F)(F)c1ccc(cn1)c2ncc(c3ccnc4ccccc34)c(n2)c5ccccn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A12 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125009 Peakdale1_002476 COCCN(C1CCN(CC1)C(=O)C(C)(C)C)S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A13 compound treatment 0.0765 0.00405 0.48 0.4795 1.0 2125010 Peakdale1_002477 FC(F)(F)c1ccc(cc1)c2nc(ncc2c3cnc4ccccc4n3)c5ccc(nc5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A14 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125011 Peakdale1_002478 COCCN(C1CCN(CC1)C(=O)c2cccc(c2)C(F)(F)F)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A15 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125012 Peakdale1_002479 CC(C)(C)c1ccc(cc1)c2nc(ncc2c3nc4ccccc4o3)c5ccc(nc5)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A16 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125013 Peakdale1_002480 COCCN(C1CCN(CC1)C(=O)c2cc(OC)c(OC)c(OC)c2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A17 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125014 Peakdale1_002481 CS(=O)c1cnc(nc1c2ccc(cc2)C(F)(F)F)c3ccc(nc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A18 compound treatment 0.063 -0.00945 -1.12 -1.1201 -1.0 2125015 Peakdale1_002482 COCCN(C1CCN(CC1)C(=O)C(c2ccccc2)c3ccccc3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A19 compound treatment 0.075 0.00255 0.3 0.3018 1.0 2125016 Peakdale1_002483 FC(F)(F)c1cccc(c1)S(=O)(=O)c2cnc(nc2c3ccncc3)c4ccc(nc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A20 compound treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 2125017 Peakdale1_002484 COCCN(C1CCN(CC1)C(=O)c2ccc(Cl)nc2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A21 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125018 Peakdale1_002485 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)NC4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A22 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125019 Peakdale1_002486 COCCN(C1CCN(CC1)C(=O)c2ccco2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A23 mock treatment 0.084 0.0115 1.37 1.3682 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 A24 mock treatment 0.076 0.00355 0.42 0.4203 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B01 compound treatment 0.064 -0.00845 -1.0 -1.0016 -1.0 2125020 Peakdale1_002487 OC(=O)CCC(=O)N1CCC(CC1)c2nc(no2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B02 compound treatment 0.065 -0.00745 -0.88 -0.8831 -1.0 2125021 Peakdale1_002488 Clc1ccc(CNC(=O)CCC(=O)N2CCC(CC2)c3nc(no3)c4cccnc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B03 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125022 Peakdale1_002489 CCCNC(=O)CCC(=O)N1CCC(CC1)c2nc(no2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B04 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125023 Peakdale1_002490 COc1ccccc1CNC(=O)COCC(=O)N2CCC(CC2)c3nc(no3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B05 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125024 Peakdale1_002491 CN1CCN(CC1)C(=O)CCC(=O)N2CCC(CC2)c3nc(no3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B06 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125025 Peakdale1_002492 FC(F)(F)c1cccc(CNC(=O)CCC(=O)N2CCC(CC2)c3nc(no3)c4cccnc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B07 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125026 Peakdale1_002493 O=C(CCC(=O)N1CCC(CC1)c2nc(no2)c3cccs3)NCc4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B08 compound treatment 0.068 -0.00445 -0.53 -0.5277 -1.0 2125027 Peakdale1_002494 OC(=O)COCc1nc(no1)c2cnccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B09 compound treatment 0.066 -0.00645 -0.76 -0.7646 -1.0 2125028 Peakdale1_002495 O=C(CCC(=O)N1CCC(CC1)c2nc(no2)c3cccs3)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B10 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125029 Peakdale1_002496 Clc1ccc(CNC(=O)COCc2nc(no2)c3cnccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B11 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125030 Peakdale1_002497 Clc1cccc(CNC(=O)CCC(=O)N2CCC(CC2)c3nc(no3)c4cccs4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B12 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125031 Peakdale1_002498 O=C(COCc1nc(no1)c2cnccn2)N3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B13 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125032 Peakdale1_002499 Cc1cc(C)nc(n1)N2CCC(CC2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B14 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125033 Peakdale1_002500 OC(=O)CCCC(=O)N1CCC(CC1)c2nc(no2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B15 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125034 Peakdale1_002501 CCCNC(=O)C1CCN(CC1)c2nc(C)cc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B16 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125035 Peakdale1_002502 CN1CCN(CC1)C(=O)CCCC(=O)N2CCC(CC2)c3nc(no3)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B17 compound treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 2125036 Peakdale1_002503 Cc1cc(C)nc(n1)N2CCC(CC2)C(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B18 compound treatment 0.0645 -0.00795 -0.94 -0.9424 -1.0 2125037 Peakdale1_002504 FC(F)(F)c1cccc(c1)c2noc(n2)C3CCN(CC3)C(=O)CCCC(=O)NCc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B19 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125038 Peakdale1_002505 Cc1cc(C)nc(n1)N2CCC(CC2)C(=O)NCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B20 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125039 Peakdale1_002506 C1CC(CCN1)c2nc(no2)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B21 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125040 Peakdale1_002507 Cc1cc(C)nc(n1)N2CCC(CC2)C(=O)NCc3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B22 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125041 Peakdale1_002508 CC(C)(C)C(=O)N1CCC(CC1)c2nc(no2)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B23 mock treatment 0.073 5.47E-4 0.06 0.0648 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 B24 mock treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C01 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125042 Peakdale1_002509 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C02 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125043 Peakdale1_002510 COCCN(C1CCN(CC1)S(=O)(=O)c2ccccc2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C03 compound treatment 0.077 0.00455 0.54 0.5388 1.0 2125044 Peakdale1_002511 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C04 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125045 Peakdale1_002512 COCCN(C1CCN(CC1)S(=O)(=O)c2ccc(NC(=O)C)cc2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C05 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125046 Peakdale1_002513 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)NCc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C06 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125047 Peakdale1_002514 CCOc1ccc(cc1)c2ncc(c(n2)c3ccc(Cl)cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C07 compound treatment 0.079 0.00655 0.78 0.7757 1.0 2125048 Peakdale1_002515 FC(F)(F)c1cccc(CNC(=O)CCC(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4cccc(c4)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C08 compound treatment 0.0815 0.00905 1.07 1.072 1.0 2125049 Peakdale1_002516 CS(=O)(=O)c1cnc(nc1c2ccc(Cl)cc2)c3ccc(OCC4CCCCO4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C09 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125050 Peakdale1_002517 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)NCc4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C10 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125051 Peakdale1_002518 CS(=O)(=O)c1cnc(nc1c2ccc(Cl)cc2)c3ccc(OCc4ccccc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C11 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125052 Peakdale1_002519 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)N4CCN(CC4)C=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C12 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125053 Peakdale1_002520 CS(=O)(=O)c1cnc(nc1c2ccc(Cl)cc2)c3ccc(OCc4cccc(c4)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C13 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125054 Peakdale1_002521 FC(F)(F)c1cccc(c1)S(=O)(=O)N(C2CC2)C3CCN(CC3)C(=O)CCC(=O)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C14 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125055 Peakdale1_002522 CS(=O)(=O)c1cnc(nc1c2ccc(Cl)cc2)c3ccc(Oc4ccc(cn4)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C15 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2079938 Peakdale1_002523 CCCN(C1CCN(C)CC1)C(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C16 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125056 Peakdale1_002524 Cc1cc(C)nc(Oc2ccc(cc2)c3ncc(c(n3)c4ccc(Cl)cc4)S(=O)(=O)C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C17 compound treatment 0.081 0.00855 1.01 1.0127 1.0 2125057 Peakdale1_002525 CCCN(C1CCN(C)CC1)C(=O)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C18 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125058 Peakdale1_002526 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)c3ccccc3NC(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C19 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125059 Peakdale1_002527 CCCN(C1CCN(C)CC1)C(=O)c2c(F)cccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C20 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125060 Peakdale1_002528 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)c3ccccc3NC(=O)/C=C/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C21 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125061 Peakdale1_002529 CCCN(C1CCN(C)CC1)C(=O)c2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C22 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125062 Peakdale1_002530 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)c3ccccc3NC(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C23 mock treatment 0.0745 0.00205 0.24 0.2425 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 C24 mock treatment 0.0765 0.00405 0.48 0.4795 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D01 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125063 Peakdale1_002531 CC(NC(=O)C1CCN(CC1)c2nc(C)cc(C)n2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D02 compound treatment 0.0675 -0.00495 -0.59 -0.5869 -1.0 2125064 Peakdale1_002532 O=C(N1CCC(CC1)c2nc(no2)C(c3ccccc3)c4ccccc4)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D03 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125065 Peakdale1_002533 Cc1cc(C)nc(n1)N2CCC(CC2)C(=O)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D04 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125066 Peakdale1_002534 Nc1ccccc1C(=O)N2CCC(CC2)c3nc(no3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D05 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125067 Peakdale1_002535 Cc1cc(C)nc(n1)N2CCC(CC2)C(=O)NCc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D06 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125068 Peakdale1_002536 OC(=O)C1C(C2CC1C=C2)C(=O)N3CCC(CC3)c4nc(no4)c5cnccn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D07 compound treatment 0.0905 0.018 2.14 2.1384 1.0 2125069 Peakdale1_002537 Cc1cc(C)nc(n1)N2CCC(CC2)C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D08 compound treatment 0.076 0.00355 0.42 0.4203 1.0 2125070 Peakdale1_002538 CS(=O)(=O)c1ccc(cc1)c2noc(n2)C3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D09 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125071 Peakdale1_002539 Cc1cc(C)nc(n1)N2CCC(CC2)C(=O)NCCc3ccc(cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D10 compound treatment 0.075 0.00255 0.3 0.3018 1.0 2125072 Peakdale1_002540 CN(C)C(=O)N1CCC(CC1)c2nc(no2)c3ccc(cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D11 compound treatment 0.082 0.00955 1.13 1.1312 1.0 1431581 Peakdale1_002541 CN1CCC(CC1)NC2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D12 compound treatment 0.077 0.00455 0.54 0.5388 1.0 2125073 Peakdale1_002542 CCNC(=O)N1CCC(CC1)c2nc(no2)c3ccc(cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D13 compound treatment 0.0805 0.00805 0.95 0.9535 1.0 2125074 Peakdale1_002543 CN1CCC(CC1)N(C2CCN(Cc3ccccc3)CC2)C(=O)c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D14 compound treatment 0.0765 0.00405 0.48 0.4795 1.0 2125075 Peakdale1_002544 CS(=O)(=O)c1ccc(cc1)c2noc(n2)C3CCN(CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D15 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125076 Peakdale1_002545 CN1CCC(CC1)N(C2CCN(Cc3ccccc3)CC2)C(=O)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D16 compound treatment 0.0805 0.00805 0.95 0.9535 1.0 2125077 Peakdale1_002546 CS(=O)(=O)c1ccc(cc1)c2noc(n2)C3CCN(CC3)C(=O)c4c(F)cccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D17 compound treatment 0.0795 0.00705 0.83 0.835 1.0 2125078 Peakdale1_002547 CN1CCC(CC1)N(C2CCN(Cc3ccccc3)CC2)C(=O)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D18 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125079 Peakdale1_002548 C1CC(CCN1)c2nnc(o2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D19 compound treatment 0.0765 0.00405 0.48 0.4795 1.0 2125080 Peakdale1_002549 CN1CCC(CC1)N(C2CCN(Cc3ccccc3)CC2)C(=O)c4c(F)cccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D20 compound treatment 0.075 0.00255 0.3 0.3018 1.0 2125081 Peakdale1_002550 CC(C)(C)C(=O)N1CCC(CC1)c2nnc(o2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D21 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125082 Peakdale1_002551 CN1CCC(CC1)N(C2CCN(Cc3ccccc3)CC2)C(=O)/C=C/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D22 compound treatment 0.079 0.00655 0.78 0.7757 1.0 2125083 Peakdale1_002552 Cc1cc(C)cc(NC(=O)N2CCC(CC2)c3nnc(o3)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D23 mock treatment 0.074 0.00155 0.18 0.1833 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 D24 mock treatment 0.0755 0.00305 0.36 0.361 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E01 compound treatment 0.073 5.47E-4 0.06 0.0648 1.0 2125084 Peakdale1_002553 CCCN(C1CCN(C)CC1)C(=O)c2cc(OC)c(OC)c(OC)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E02 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125085 Peakdale1_002554 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)c3ccccc3NC(=O)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E03 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125086 Peakdale1_002555 CCCN(C1CCN(C)CC1)C(=O)C(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E04 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125087 Peakdale1_002556 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)c3ccccc3NC(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E05 compound treatment 0.0755 0.00305 0.36 0.361 1.0 2125088 Peakdale1_002557 CCCN(C1CCN(C)CC1)C(=O)Nc2ccccc2OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E06 compound treatment 0.079 0.00655 0.78 0.7757 1.0 2125089 Peakdale1_002558 CCOC(=O)C1CCN(CC1)c2ccc(cc2N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E07 compound treatment 0.0835 0.011 1.31 1.3089 1.0 2125090 Peakdale1_002559 CCCN(C1CCN(C)CC1)C(=O)NS(=O)(=O)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E08 compound treatment 0.0755 0.00305 0.36 0.361 1.0 2125091 Peakdale1_002560 CCOC(=O)C1CCN(CC1)c2ccc(cc2NC(=O)c3ccc(cc3)C(F)(F)F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E09 compound treatment 0.0765 0.00405 0.48 0.4795 1.0 2125092 Peakdale1_002561 CCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E10 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125093 Peakdale1_002562 CCOC(=O)C1CCN(CC1)c2ccc(cc2NC(=O)C(c3ccccc3)c4ccccc4)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E11 compound treatment 0.085 0.0125 1.49 1.4867 1.0 2125094 Peakdale1_002563 CCCN(C1CCN(C)CC1)S(=O)(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E12 compound treatment 0.1 0.0275 3.26 3.264 1.0 2125095 Peakdale1_002564 CCNC(=O)Nc1cc(ccc1N2CCC(CC2)C(=O)OCC)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E13 compound treatment 0.0825 0.01 1.19 1.1905 1.0 2125096 Peakdale1_002565 OC(=O)C1CCN(Cc2cc3cccc4CCCn(c2=O)c43)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E14 compound treatment 0.083 0.0105 1.25 1.2497 1.0 2125097 Peakdale1_002566 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E15 compound treatment 0.08 0.00755 0.89 0.8942 1.0 2125098 Peakdale1_002567 O=C(NC1CC1)C2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E16 compound treatment 0.094 0.0215 2.55 2.5531 1.0 2125099 Peakdale1_002568 CCCNC(=O)CCC(=O)N1CCC(CC1)c2nc(OC)cc(OC)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E17 compound treatment 0.0785 0.00605 0.72 0.7165 1.0 2125100 Peakdale1_002569 O=C(NCCN1CCOCC1)C2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E18 compound treatment 0.0805 0.00805 0.95 0.9535 1.0 2125101 Peakdale1_002570 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)CCC(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E19 compound treatment 0.073 5.47E-4 0.06 0.0648 1.0 2125102 Peakdale1_002571 FC(F)(F)c1cccc(CNC(=O)C2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E20 compound treatment 0.083 0.0105 1.25 1.2497 1.0 2125103 Peakdale1_002572 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)CCC(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E21 compound treatment 0.0755 0.00305 0.36 0.361 1.0 2125104 Peakdale1_002573 O=C(NCc1ccccn1)C2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E22 compound treatment 0.0765 0.00405 0.48 0.4795 1.0 2125105 Peakdale1_002574 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)CCC(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E23 mock treatment 0.0735 0.00105 0.12 0.124 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 E24 mock treatment 0.073 5.47E-4 0.06 0.0648 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F01 compound treatment 0.068 -0.00445 -0.53 -0.5277 -1.0 2125106 Peakdale1_002575 CC(C)Nc1nc(c2ccc(Cl)cc2)c(cc1C#N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F02 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125107 Peakdale1_002576 FC(F)(F)c1ccc(cc1)C(=O)N2CCC(CC2)c3nnc(o3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F03 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125108 Peakdale1_002577 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F04 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125109 Peakdale1_002578 Clc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3nnc(o3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F05 compound treatment 0.0765 0.00405 0.48 0.4795 1.0 2125110 Peakdale1_002579 CN1CCN(CC1)c2nc(c3ccc(Cl)cc3)c(cc2C#N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F06 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125111 Peakdale1_002580 C1Oc2ccc(cc2O1)c3noc(n3)C4CCNCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F07 compound treatment 0.0785 0.00605 0.72 0.7165 1.0 2125112 Peakdale1_002581 CC1CN(CC(C)O1)c2nc(c3ccc(Cl)cc3)c(cc2C#N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F08 compound treatment 0.0755 0.00305 0.36 0.361 1.0 2125113 Peakdale1_002582 CN(C)C(=O)N1CCC(CC1)c2nc(no2)c3ccc4OCOc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F09 compound treatment 0.077 0.00455 0.54 0.5388 1.0 2125114 Peakdale1_002583 COc1cccc(OC)c1Oc2nc(c3ccc(Cl)cc3)c(cc2C#N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F10 compound treatment 0.0755 0.00305 0.36 0.361 1.0 2125115 Peakdale1_002584 CC(C)(C)c1ccc(cc1)C(=O)N2CCC(CC2)c3nc(no3)c4ccc5OCOc5c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F11 compound treatment 0.078 0.00555 0.66 0.6572 1.0 2125116 Peakdale1_002585 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCN(CC3)c4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F12 compound treatment 0.0835 0.011 1.31 1.3089 1.0 2125117 Peakdale1_002586 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3nc(no3)c4ccc5OCOc5c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F13 compound treatment 0.078 0.00555 0.66 0.6572 1.0 2125118 Peakdale1_002587 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F14 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125119 Peakdale1_002588 CCNC(=O)N1CCC(CC1)c2nc(no2)C3(CC3)c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F15 compound treatment 0.0925 0.02 2.38 2.3754 1.0 2125120 Peakdale1_002589 CC(C)(C)C(=O)N1CCN(CC1)c2nc(c3ccc(Cl)cc3)c(cc2C#N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F16 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125121 Peakdale1_002590 CC(C)(C)C(=O)N1CCC(CC1)c2nc(no2)C3(CC3)c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F17 compound treatment 0.092 0.0195 2.32 2.3161 1.0 2125122 Peakdale1_002591 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCN(CC3)C(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F18 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125123 Peakdale1_002592 N#CCCN1CCC(CC1)c2nnc(o2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F19 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125124 Peakdale1_002593 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCN(CC3)C(=O)/C=C/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F20 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125125 Peakdale1_002594 C(C1OCCO1)N2CCC(CC2)c3nnc(o3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F21 compound treatment 0.0765 0.00405 0.48 0.4795 1.0 2125126 Peakdale1_002595 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCN(CC3)C(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F22 compound treatment 0.075 0.00255 0.3 0.3018 1.0 2125127 Peakdale1_002596 C(N1CCC(CC1)c2nnc(o2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F23 mock treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 F24 mock treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G01 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125128 Peakdale1_002597 O=CN1CCN(CC1)C(=O)C2CCN(Cc3cc4cccc5CCCn(c3=O)c54)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G02 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125129 Peakdale1_002598 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)CCC(=O)NCc3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G03 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125130 Peakdale1_002599 COCCNC(=O)CCC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G04 compound treatment 0.076 0.00355 0.42 0.4203 1.0 2125131 Peakdale1_002600 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)CCC(=O)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G05 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125132 Peakdale1_002601 O=C(CCC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3)NCCN4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G06 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125133 Peakdale1_002602 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)CCC(=O)N3CCN(CC3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G07 compound treatment 0.083 0.0105 1.25 1.2497 1.0 2125134 Peakdale1_002603 FC(F)(F)c1cccc(CNC(=O)CCC(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G08 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125135 Peakdale1_002604 CS(=O)(=O)c1ccc(N2CCC(CC2)C(=O)O)c(c1)n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G09 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125136 Peakdale1_002605 O=C(CCC(=O)N1CCC(CC1)N(C2CC2)S(=O)(=O)c3ccccc3)NCc4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G10 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125137 Peakdale1_002606 CNC(=O)C1CCN(CC1)c2ccc(cc2n3cccc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G11 compound treatment 0.076 0.00355 0.42 0.4203 1.0 2125138 Peakdale1_002607 CC1CCN(CC1)C(=O)CCC(=O)N2CCC(CC2)N(C3CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G12 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125139 Peakdale1_002608 CS(=O)(=O)c1ccc(N2CCC(CC2)C(=O)NCc3cccc(c3)C(F)(F)F)c(c1)n4cccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G13 compound treatment 0.0945 0.022 2.61 2.6123 1.0 2125140 Peakdale1_002609 O=C(CCC(=O)N1CCc2ccccc2C1)N3CCC(CC3)N(C4CC4)S(=O)(=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G14 compound treatment 0.0865 0.014 1.66 1.6644 1.0 2125141 Peakdale1_002610 Cc1ccc(cc1)c2noc(n2)C3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G15 compound treatment 0.086 0.0135 1.61 1.6052 1.0 2125142 Peakdale1_002611 CCC(=O)N(CCOC)C1CCN(C)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G16 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125143 Peakdale1_002612 Cc1ccc(cc1)c2noc(n2)C3CCN(CC3)C(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G17 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125144 Peakdale1_002613 COCCN(C1CCN(C)CC1)C(=O)c2ccco2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G18 compound treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 2125145 Peakdale1_002614 Cc1ccc(cc1)c2noc(n2)C3CCN(CC3)C(=O)Nc4cc(C)cc(C)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G19 compound treatment 0.073 5.47E-4 0.06 0.0648 1.0 2125146 Peakdale1_002615 COCCN(C1CCN(C)CC1)C(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G20 compound treatment 0.0785 0.00605 0.72 0.7165 1.0 2125147 Peakdale1_002616 Cc1ccc(cc1)c2noc(n2)C3CCN(CC3)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G21 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125148 Peakdale1_002617 COCCN(C1CCN(C)CC1)C(=O)c2ccc(cc2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G22 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125149 Peakdale1_002618 C1CC(CCN1)c2nc(no2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G23 mock treatment 0.0725 4.69E-5 0.01 0.0056 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 G24 mock treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H01 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125150 Peakdale1_002619 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCN(CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H02 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125151 Peakdale1_002620 OC(COc1ccccc1)CN2CCC(CC2)c3nnc(o3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H03 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125152 Peakdale1_002621 COc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3nc(c4ccc(Cl)cc4)c(cc3C#N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H04 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125153 Peakdale1_002622 FC(F)(F)c1cccc(CN2CCC(CC2)c3nnc(o3)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H05 compound treatment 0.082 0.00955 1.13 1.1312 1.0 2125154 Peakdale1_002623 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCN(CC3)C(=O)c4ccccc4C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H06 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125155 Peakdale1_002624 C=CCN1CCC(CC1)c2nc(no2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H07 compound treatment 0.0825 0.01 1.19 1.1905 1.0 2125156 Peakdale1_002625 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCN(CC3)C(=O)Nc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H08 compound treatment 0.0755 0.00305 0.36 0.361 1.0 2125157 Peakdale1_002626 N#CCCN1CCC(CC1)c2nc(no2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H09 compound treatment 0.0785 0.00605 0.72 0.7165 1.0 2125158 Peakdale1_002627 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCN(CC2)c3nc(c4ccc(Cl)cc4)c(cc3C#N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H10 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125159 Peakdale1_002628 OC(=O)CCN1CCC(CC1)c2nc(no2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H11 compound treatment 0.077 0.00455 0.54 0.5388 1.0 2125160 Peakdale1_002629 CN1CCC(CC1)NC2CCN(C)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H12 compound treatment 0.079 0.00655 0.78 0.7757 1.0 2125161 Peakdale1_002630 C(N1CCC(CC1)c2nc(no2)c3cnccn3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H13 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 1874151 Peakdale1_002631 CN1CCC(CC1)N(C2CCN(C)CC2)C(=O)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H14 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125162 Peakdale1_002632 CC(C)CN1CCC(CC1)c2nc(no2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H15 compound treatment 0.073 5.47E-4 0.06 0.0648 1.0 2125163 Peakdale1_002633 CN1CCC(CC1)N(C2CCN(C)CC2)C(=O)/C=C/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H16 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125164 Peakdale1_002634 Clc1ccccc1CN2CCC(CC2)c3nc(no3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H17 compound treatment 0.081 0.00855 1.01 1.0127 1.0 2125165 Peakdale1_002635 CN1CCC(CC1)N(C2CCN(C)CC2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H18 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125166 Peakdale1_002636 OC(COc1ccccc1)CN2CCC(CC2)c3nc(no3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H19 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125167 Peakdale1_002637 CN1CCC(CC1)N(C2CCN(C)CC2)C(=O)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H20 compound treatment 0.076 0.00355 0.42 0.4203 1.0 2125168 Peakdale1_002638 Fc1ccc(cc1)c2nnc(o2)C3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H21 compound treatment 0.076 0.00355 0.42 0.4203 1.0 2125169 Peakdale1_002639 CC1=NC2(CCNCC2)N=C1c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H22 compound treatment 0.0765 0.00405 0.48 0.4795 1.0 2125170 Peakdale1_002640 CCNC(=O)N1CCC(CC1)c2nnc(o2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H23 mock treatment 0.0735 0.00105 0.12 0.124 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 H24 mock treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I01 compound treatment 0.068 -0.00445 -0.53 -0.5277 -1.0 2125171 Peakdale1_002641 COCCN(C1CCN(C)CC1)C(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I02 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125172 Peakdale1_002642 CC(C)(C)C(=O)N1CCC(CC1)c2nc(no2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I03 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125173 Peakdale1_002643 COCCN(C1CCN(C)CC1)C(=O)C(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I04 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125174 Peakdale1_002644 O=C(/C=C/c1ccccc1)N2CCC(CC2)c3nc(no3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I05 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125175 Peakdale1_002645 COCCN(C1CCN(C)CC1)C(=O)Nc2ccccc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I06 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125176 Peakdale1_002646 O=C(N1CCC(CC1)c2nc(no2)c3ccncc3)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I07 compound treatment 0.075 0.00255 0.3 0.3018 1.0 2125177 Peakdale1_002647 COCCN(C1CCN(C)CC1)S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I08 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125178 Peakdale1_002648 COc1cc(cc(OC)c1OC)C(=O)N2CCC(CC2)c3nc(no3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I09 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125179 Peakdale1_002649 COCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I10 compound treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 2125180 Peakdale1_002650 Fc1cccc(F)c1C(=O)N2CCC(CC2)c3nc(no3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I11 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125181 Peakdale1_002651 COCCN(C1CCN(C)CC1)C(=O)NS(=O)(=O)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I12 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125182 Peakdale1_002652 O=S(=O)(N1CCC(CC1)c2nc(no2)c3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I13 compound treatment 0.0555 -0.017 -2.01 -2.0088 -1.0 2125183 Peakdale1_002653 CCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(N)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I14 compound treatment 0.066 -0.00645 -0.76 -0.7646 -1.0 2125184 Peakdale1_002654 CCNC(=O)N1CCC(CC1)c2nc(no2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I15 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125185 Peakdale1_002655 CCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(NC(=O)C(C)(C)C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I16 compound treatment 0.085 0.0125 1.49 1.4867 1.0 2125186 Peakdale1_002656 FC(F)(F)c1cccc(NC(=O)N2CCC(CC2)c3nc(no3)c4ccncc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I17 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125187 Peakdale1_002657 CCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(NC(=O)c3ccccc3C(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I18 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125188 Peakdale1_002658 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)c3nc(no3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I19 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125189 Peakdale1_002659 CCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(NC(=O)c3ccco3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I20 compound treatment 0.0815 0.00905 1.07 1.072 1.0 2125190 Peakdale1_002660 C1CC(CCN1)c2nc(no2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I21 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125191 Peakdale1_002661 CCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(NC(=O)C(c3ccccc3)c4ccccc4)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I22 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125192 Peakdale1_002662 CC(C)(C)c1ccc(cc1)C(=O)N2CCC(CC2)c3nc(no3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I23 mock treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 I24 mock treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J01 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125193 Peakdale1_002663 COc1cc(cc(OC)c1OC)C(=O)N2CCC3(CC2)N=C(C)C(=N3)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J02 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125194 Peakdale1_002664 CN(C)C(=O)N1CCC(CC1)c2nnc(o2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J03 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125195 Peakdale1_002665 CC1=NC2(CCN(CC2)C(=O)c3ccc(Cl)nc3)N=C1c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J04 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125196 Peakdale1_002666 Fc1ccc(cc1)c2nnc(o2)C3CCN(Cc4ccccc4Cl)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J05 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125197 Peakdale1_002667 CC1=NC2(CCN(CC2)S(=O)(=O)c3ccc(Cl)cc3)N=C1c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J06 compound treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 2125198 Peakdale1_002668 Fc1ccc(cc1)c2nnc(o2)C3CCN(CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J07 compound treatment 0.0755 0.00305 0.36 0.361 1.0 2125199 Peakdale1_002669 CC1=NC2(CCN(CC2)C(=O)Nc3ccc(F)cc3F)N=C1c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J08 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125200 Peakdale1_002670 Fc1ccc(cc1)c2nnc(o2)C3CCN(CC3)C(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J09 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125201 Peakdale1_002671 CC1=NC2(CCN(CC2)C(=S)Nc3ccccc3)N=C1c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J10 compound treatment 0.087 0.0145 1.72 1.7237 1.0 2125202 Peakdale1_002672 COc1cc(OC)nc(n1)c2nnc(SCc3ccccc3)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J11 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125203 Peakdale1_002673 CC1=NC2(CCN(CC2)c3ccc(cn3)C(F)(F)F)N=C1c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J12 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125204 Peakdale1_002674 COc1cc(OC)nc(n1)c2nnc(SCc3ccc(Cl)cc3)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J13 compound treatment 0.0675 -0.00495 -0.59 -0.5869 -1.0 2125205 Peakdale1_002675 CC1=NC2(CCN(CC(O)COc3ccccc3)CC2)N=C1c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J14 compound treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 2125206 Peakdale1_002676 COc1cc(OC)nc(n1)c2nnc(SCc3cccc(c3)C(F)(F)F)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J15 compound treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 2125207 Peakdale1_002677 OC(=O)C1CCN(CC1)c2ccc(cn2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J16 compound treatment 0.068 -0.00445 -0.53 -0.5277 -1.0 2125208 Peakdale1_002678 COc1cc(OC)nc(n1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J17 compound treatment 0.08 0.00755 0.89 0.8942 1.0 2125209 Peakdale1_002679 CN1CCC(CC1)NC(=O)C2CCN(CC2)c3ccc(cn3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J18 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125210 Peakdale1_002680 CCOC(=O)c1nc(OC)cc(OC)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J19 compound treatment 0.085 0.0125 1.49 1.4867 1.0 2125211 Peakdale1_002681 CN1CCC(CC1)N(C2CC2)C(=O)C3CCN(CC3)c4ccc(cn4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J20 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125212 Peakdale1_002682 COc1cc(OC)nc(n1)C(=O)N2CCc3ccccc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J21 compound treatment 0.075 0.00255 0.3 0.3018 1.0 2125213 Peakdale1_002683 FC(F)(F)c1ccc(nc1)N2CCC(CC2)C(=O)Nc3ccc4oc(=O)ccc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J22 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125214 Peakdale1_002684 COc1cc(OC)nc(n1)C(=O)N2CCN(CC2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J23 mock treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 J24 mock treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K01 compound treatment 0.066 -0.00645 -0.76 -0.7646 -1.0 2125215 Peakdale1_002685 COCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(N)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K02 compound treatment 0.0645 -0.00795 -0.94 -0.9424 -1.0 2125216 Peakdale1_002686 O=C(C(c1ccccc1)c2ccccc2)N3CCC(CC3)c4nc(no4)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K03 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125217 Peakdale1_002687 COCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(NC(=O)c3cc(OC)c(OC)c(OC)c3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K04 compound treatment 0.0675 -0.00495 -0.59 -0.5869 -1.0 2125218 Peakdale1_002688 O=C(N1CCC(CC1)c2nc(no2)c3cccs3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K05 compound treatment 0.0675 -0.00495 -0.59 -0.5869 -1.0 2125219 Peakdale1_002689 COCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(NC(=O)c3c(F)cccc3F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K06 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125220 Peakdale1_002690 Clc1cc(cc(Cl)n1)C(=O)N2CCC(CC2)c3nc(no3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K07 compound treatment 0.0825 0.01 1.19 1.1905 1.0 2125221 Peakdale1_002691 COCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(NC(=O)c3cccc(c3)C(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K08 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125222 Peakdale1_002692 O=S(=O)(N1CCC(CC1)c2nc(no2)c3cccs3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K09 compound treatment 0.083 0.0105 1.25 1.2497 1.0 2125223 Peakdale1_002693 COCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(NC(=O)C(c3ccccc3)c4ccccc4)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K10 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125224 Peakdale1_002694 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3nc(no3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K11 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125225 Peakdale1_002695 COCCN(C1CCN(C)CC1)S(=O)(=O)c2ccc(NC(=O)c3cccs3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K12 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125226 Peakdale1_002696 FC(F)(F)c1ccccc1NC(=O)N2CCC(CC2)c3nc(no3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K13 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125227 Peakdale1_002697 CCCNC(=O)CCC(=O)N(CCOC)C1CCN(C)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K14 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125228 Peakdale1_002698 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)c3nc(no3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K15 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125229 Peakdale1_002699 COCCN(C1CCN(C)CC1)C(=O)CCC(=O)NCCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K16 compound treatment 0.066 -0.00645 -0.76 -0.7646 -1.0 2125230 Peakdale1_002700 FC(F)(F)c1cccc(c1)c2noc(n2)C3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K17 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125231 Peakdale1_002701 COCCN(C1CCN(C)CC1)C(=O)CCC(=O)NCc2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K18 compound treatment 0.065 -0.00745 -0.88 -0.8831 -1.0 2125232 Peakdale1_002702 CC(C)(C)C(=O)N1CCC(CC1)c2nc(no2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K19 compound treatment 0.083 0.0105 1.25 1.2497 1.0 2125233 Peakdale1_002703 COCCN(C1CCN(C)CC1)C(=O)CCC(=O)NCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K20 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125234 Peakdale1_002704 COc1cc(cc(OC)c1OC)C(=O)N2CCC(CC2)c3nc(no3)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K21 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125235 Peakdale1_002705 COCCN(C1CCN(C)CC1)C(=O)CCC(=O)N2CCC(C)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K22 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125236 Peakdale1_002706 FC(F)(F)c1cccc(c1)c2noc(n2)C3CCN(CC3)C(=O)c4ccc(Cl)nc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K23 mock treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 K24 mock treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L01 compound treatment 0.0675 -0.00495 -0.59 -0.5869 -1.0 2125237 Peakdale1_002707 Cc1c(NC(=O)C2CCN(CC2)c3ccc(cn3)C(F)(F)F)cccc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L02 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125238 Peakdale1_002708 COc1cc(OC)nc(n1)C(=O)NCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L03 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125239 Peakdale1_002709 CC(=O)N1CCc2ccc(NC(=O)C3CCN(CC3)c4ccc(cn4)C(F)(F)F)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L04 compound treatment 0.066 -0.00645 -0.76 -0.7646 -1.0 2125240 Peakdale1_002710 COc1cc(OC)nc(n1)C(=O)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L05 compound treatment 0.0675 -0.00495 -0.59 -0.5869 -1.0 2125241 Peakdale1_002711 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)C3CCN(CC3)c4ccc(cn4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L06 compound treatment 0.068 -0.00445 -0.53 -0.5277 -1.0 2125242 Peakdale1_002712 COc1cc(OC)nc(n1)C(=O)N2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L07 compound treatment 0.077 0.00455 0.54 0.5388 1.0 2125243 Peakdale1_002713 FC(F)(F)c1ccc(nc1)N2CCC(CC2)C(=O)N(C3CC3)C4CCN(Cc5ccccc5)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L08 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125244 Peakdale1_002714 COc1cc(OC)nc(n1)C(=O)N2CCN(CC2)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L09 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125245 Peakdale1_002715 CN1CCN(CC1)c2ccc(cc2NC(=O)C3CCN(CC3)c4ccc(cn4)C(F)(F)F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L10 compound treatment 0.076 0.00355 0.42 0.4203 1.0 2125246 Peakdale1_002716 FC(F)(F)c1ccc(cc1)c2oc(cc2C(=O)NCc3cccnc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L11 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125247 Peakdale1_002717 FC(F)(F)c1ccc(nc1)N2CCC(CC2)C(=O)N3CCC(CC3)N(C4CC4)S(=O)(=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L12 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125248 Peakdale1_002718 COc1ccc(NC(=O)c2cc(oc2c3ccc(cc3)C(F)(F)F)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L13 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125249 Peakdale1_002719 CCCN1CCC(CC1)N(C2CC2)C(=O)c3ccc(NC(=O)C4CCN(CC4)c5ccc(cn5)C(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L14 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125250 Peakdale1_002720 FC(F)(F)c1ccc(cc1)c2oc(cc2C(=O)Nc3ccc(Cl)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L15 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125251 Peakdale1_002721 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2)N3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L16 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125252 Peakdale1_002722 CN(C1CCN(C)CC1)C(=O)c2cc(oc2c3ccc(cc3)C(F)(F)F)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L17 compound treatment 0.077 0.00455 0.54 0.5388 1.0 2125253 Peakdale1_002723 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2C(F)(F)F)N3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L18 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125254 Peakdale1_002724 FC(F)(F)c1ccc(cc1)c2oc(cc2C(=O)N3CCN(Cc4ccccc4)CC3)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L19 compound treatment 0.093 0.0205 2.43 2.4346 1.0 2125255 Peakdale1_002725 CC(C)(C)C(=O)N1CCN(CC1)c2nc(c3ccccc3)c(cc2C#N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L20 compound treatment 0.088 0.0155 1.84 1.8422 1.0 2125256 Peakdale1_002726 FC(F)(F)c1ccc(cc1)c2oc(cc2C(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L21 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125257 Peakdale1_002727 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2)N3CCN(CC3)C(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L22 compound treatment 0.073 5.47E-4 0.06 0.0648 1.0 2125258 Peakdale1_002728 COc1ccsc1CN(Cc2ccccc2)C(=O)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L23 mock treatment 0.0735 0.00105 0.12 0.124 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 L24 mock treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M01 compound treatment 0.066 -0.00645 -0.76 -0.7646 -1.0 2125259 Peakdale1_002729 COCCN(C1CCN(C)CC1)C(=O)CCC(=O)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M02 compound treatment 0.0655 -0.00695 -0.82 -0.8239 -1.0 2125260 Peakdale1_002730 FC(F)(F)c1cccc(c1)c2noc(n2)C3CCN(CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M03 compound treatment 0.0645 -0.00795 -0.94 -0.9424 -1.0 2125261 Peakdale1_002731 COCCN(C1CCN(C)CC1)C(=O)CCC(=O)N2CCc3ccccc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M04 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125262 Peakdale1_002732 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)c3nc(no3)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M05 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125263 Peakdale1_002733 COCCN(C1CCN(C)CC1)C(=O)CCC(=O)N2CCN(CC2)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M06 compound treatment 0.0655 -0.00695 -0.82 -0.8239 -1.0 2125264 Peakdale1_002734 COc1ccccc1NC(=O)N2CCC(CC2)c3nc(no3)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M07 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125265 Peakdale1_002735 Nc1ccc(cc1)S(=O)(=O)N2CCOC3CCCCC32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M08 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125266 Peakdale1_002736 C1CC(CCN1)c2nc(no2)c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M09 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125267 Peakdale1_002737 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCOC3CCCCC32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M10 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125268 Peakdale1_002738 FC(F)(F)c1ccc(cc1)C(=O)N2CCC(CC2)c3nc(no3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M11 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125269 Peakdale1_002739 OC(=O)CCC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCOC3CCCCC32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M12 compound treatment 0.0685 -0.00395 -0.47 -0.4684 -1.0 2125270 Peakdale1_002740 CC(C)(C)C(=O)N1CCC(CC1)c2nc(no2)c3cnccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M13 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125271 Peakdale1_002741 OC(=O)c1ccccc1C(=O)Nc2ccc(cc2)S(=O)(=O)N3CCOC4CCCCC43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M14 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125272 Peakdale1_002742 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)c3nc(no3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M15 compound treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 2125273 Peakdale1_002743 COc1cc(OC)nc(n1)C2CCNCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M16 compound treatment 0.073 5.47E-4 0.06 0.0648 1.0 2125274 Peakdale1_002744 Clc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3nc(no3)c4cnccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M17 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125275 Peakdale1_002745 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M18 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125276 Peakdale1_002746 Nc1ccccc1C(=O)N2CCC(CC2)c3nc(no3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M19 compound treatment 0.078 0.00555 0.66 0.6572 1.0 2125277 Peakdale1_002747 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)/C=C/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M20 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125278 Peakdale1_002748 O=C(Nc1ccccc1C(=O)N2CCC(CC2)c3nc(no3)c4ccncc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M21 compound treatment 0.07 -0.00245 -0.29 -0.2907 -1.0 2125279 Peakdale1_002749 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M22 compound treatment 0.0795 0.00705 0.83 0.835 1.0 2125280 Peakdale1_002750 COc1ccccc1NC(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4nc(no4)c5ccncc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M23 mock treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 M24 mock treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N01 compound treatment 0.0665 -0.00595 -0.71 -0.7054 -1.0 2125281 Peakdale1_002751 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2C(F)(F)F)N3CCN(CC3)C(=O)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N02 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125282 Peakdale1_002752 COc1ccsc1CN(Cc2ccccc2)C(=O)/C=C\C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N03 compound treatment 0.0875 0.015 1.78 1.7829 1.0 2125283 Peakdale1_002753 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2)N3CCN(CC3)C(=O)c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N04 compound treatment 0.069 -0.00345 -0.41 -0.4092 -1.0 2125284 Peakdale1_002754 COc1ccsc1CN(Cc2ccccc2)C(=O)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N05 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125285 Peakdale1_002755 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2)N3CCN(CC3)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N06 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125286 Peakdale1_002756 OC(=O)/C=C\C(=O)N1CCC(CC1)c2nnc(o2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N07 compound treatment 0.084 0.0115 1.37 1.3682 1.0 2125287 Peakdale1_002757 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2)N3CCN(CC3)C(=O)Nc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N08 compound treatment 0.0755 0.00305 0.36 0.361 1.0 2125288 Peakdale1_002758 OC(=O)CCC(=O)N1CCC(CC1)c2nnc(o2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N09 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125289 Peakdale1_002759 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2C(F)(F)F)N3CCN(CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N10 compound treatment 0.077 0.00455 0.54 0.5388 1.0 2125290 Peakdale1_002760 OC(=O)CCCC(=O)N1CCC(CC1)c2nnc(o2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N11 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125291 Peakdale1_002761 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2C(F)(F)F)N3CCN(CC3)C(=O)c4cc(Cl)nc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N12 compound treatment 0.0785 0.00605 0.72 0.7165 1.0 2125292 Peakdale1_002762 OC(=O)CSCC(=O)N1CCC(CC1)c2nnc(o2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N13 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125293 Peakdale1_002763 Cn1nc(N)c2cc(c(nc12)c3ccccc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N14 compound treatment 0.085 0.0125 1.49 1.4867 1.0 2125294 Peakdale1_002764 Nc1ccccc1C(=O)N2CCC(CC2)c3nnc(o3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N15 compound treatment 0.073 5.47E-4 0.06 0.0648 1.0 2125295 Peakdale1_002765 COC(=O)c1sc2nc(c3ccccc3)c(cc2c1N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N16 compound treatment 0.078 0.00555 0.66 0.6572 1.0 2125296 Peakdale1_002766 OC(=O)c1ccccc1C(=O)N2CCC(CC2)c3nnc(o3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N17 compound treatment 0.0825 0.01 1.19 1.1905 1.0 2125297 Peakdale1_002767 Cn1nc(N)c2cc(c(nc12)c3ccc(Cl)cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N18 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125298 Peakdale1_002768 OC(=O)C1C(C2CC1C=C2)C(=O)N3CCC(CC3)c4nnc(o4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N19 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125299 Peakdale1_002769 Cn1nc(N)c2cc(c(nc12)c3ccccc3C(F)(F)F)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N20 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125300 Peakdale1_002770 OC(=O)c1c2CNCCc2nc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N21 compound treatment 0.0815 0.00905 1.07 1.072 1.0 2125301 Peakdale1_002771 COC(=O)c1sc2nc(c3ccc(Cl)cc3)c(cc2c1N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N22 compound treatment 0.073 5.47E-4 0.06 0.0648 1.0 1228124 Peakdale1_002772 CN1CCc2nc3ccccc3c(C(=O)O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N23 mock treatment 0.0775 0.00505 0.6 0.598 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 N24 mock treatment 0.074 0.00155 0.18 0.1833 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O01 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125302 Peakdale1_002773 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)c3c(F)cccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O02 compound treatment 0.0655 -0.00695 -0.82 -0.8239 -1.0 2125303 Peakdale1_002774 CCC(=O)Nc1ccccc1C(=O)N2CCC(CC2)c3nc(no3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O03 compound treatment 0.0745 0.00205 0.24 0.2425 1.0 2125304 Peakdale1_002775 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)c3cc(OC)c(OC)c(OC)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O04 compound treatment 0.067 -0.00545 -0.65 -0.6461 -1.0 2125305 Peakdale1_002776 FC(F)(F)c1ccc(cc1)C(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4nc(no4)c5ccncc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O05 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125306 Peakdale1_002777 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O06 compound treatment 0.085 0.0125 1.49 1.4867 1.0 2125307 Peakdale1_002778 Clc1ccc(cc1)S(=O)(=O)Nc2ccccc2C(=O)N3CCC(CC3)c4nc(no4)c5ccncc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O07 compound treatment 0.079 0.00655 0.78 0.7757 1.0 2125308 Peakdale1_002779 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O08 compound treatment 0.073 5.47E-4 0.06 0.0648 1.0 2125309 Peakdale1_002780 C1CC(CCN1)c2nc(no2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O09 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125310 Peakdale1_002781 CCNC(=O)N1CCC(CC1)c2nc(OC)cc(OC)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O10 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 2125311 Peakdale1_002782 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3nc(no3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O11 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125312 Peakdale1_002783 COc1cc(OC)nc(n1)C2CCN(CC2)C(=O)Nc3cc(C)cc(C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O12 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125313 Peakdale1_002784 O=C(C(c1ccccc1)c2ccccc2)N3CCC(CC3)c4nc(no4)c5cccnc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O13 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125314 Peakdale1_002785 COc1cc(OC)nc(n1)C2CCN(CC2)S(=O)(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O14 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125315 Peakdale1_002786 Clc1cccc(NC(=O)N2CCC(CC2)c3nc(no3)c4cccnc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O15 compound treatment 0.08 0.00755 0.89 0.8942 1.0 2125316 Peakdale1_002787 COc1cc(OC)nc(n1)C2CCN(CC2)S(=O)(=O)c3ccc(NC(=O)C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O16 compound treatment 0.0875 0.015 1.78 1.7829 1.0 2125317 Peakdale1_002788 CS(=O)(=O)c1cnc(nc1c2cccc(c2)C(F)(F)F)c3ccc(OCC#C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O17 compound treatment 0.075 0.00255 0.3 0.3018 1.0 2125318 Peakdale1_002789 CCC(=O)N1CCC(CC1)N(CCOC)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O18 compound treatment 0.074 0.00155 0.18 0.1833 1.0 2125319 Peakdale1_002790 CS(=O)(=O)c1cnc(nc1c2cccc(c2)C(F)(F)F)c3ccc(OCC4OCCO4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O19 compound treatment 0.081 0.00855 1.01 1.0127 1.0 2125320 Peakdale1_002791 COCCN(C1CCN(CC1)C(=O)/C=C/c2ccccc2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O20 compound treatment 0.077 0.00455 0.54 0.5388 1.0 2125321 Peakdale1_002792 CS(=O)(=O)c1cnc(nc1c2cccc(c2)C(F)(F)F)c3ccc(OCc4ccc(Cl)cc4Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O21 compound treatment 0.0765 0.00405 0.48 0.4795 1.0 2125322 Peakdale1_002793 COCCN(C1CCN(CC1)C(=O)c2ccc(cc2)C(F)(F)F)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O22 compound treatment 0.079 0.00655 0.78 0.7757 1.0 2125323 Peakdale1_002794 CS(=O)(=O)c1ccc(COc2ccc(cc2)c3ncc(c(n3)c4cccc(c4)C(F)(F)F)S(=O)(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O23 mock treatment 0.0805 0.00805 0.95 0.9535 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 O24 mock treatment 0.077 0.00455 0.54 0.5388 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P01 compound treatment 0.072 -4.53E-4 -0.05 -0.0537 -1.0 2125324 Peakdale1_002795 COC(=O)c1sc2nc(c3ccccc3C(F)(F)F)c(cc2c1N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P02 compound treatment 0.0695 -0.00295 -0.35 -0.3499 -1.0 1398234 Peakdale1_002796 OC(=O)c1c2CN(Cc3ccccc3)CCc2nc4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P03 compound treatment 0.078 0.00555 0.66 0.6572 1.0 2125325 Peakdale1_002797 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2)N3CCN(CC3)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P04 compound treatment 0.071 -0.00145 -0.17 -0.1722 -1.0 2125326 Peakdale1_002798 CC(=O)N1CCc2nc3ccccc3c(C(=O)O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P05 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125327 Peakdale1_002799 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCN(CC3)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P06 compound treatment 0.0705 -0.00195 -0.23 -0.2314 -1.0 2125328 Peakdale1_002800 CC(C)(C)C(=O)N1CCc2nc3ccccc3c(C(=O)O)c2C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P07 compound treatment 0.0845 0.012 1.43 1.4274 1.0 2125329 Peakdale1_002801 CS(=O)(=O)c1cc(C#N)c(nc1c2ccccc2)N3CCN(CC3)C(=O)CCC(=O)NCc4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P08 compound treatment 0.0785 0.00605 0.72 0.7165 1.0 2125330 Peakdale1_002802 OC(=O)c1c2CN(CCc2nc3ccccc13)C(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P09 compound treatment 0.0795 0.00705 0.83 0.835 1.0 2125331 Peakdale1_002803 COCCNC(=O)CCC(=O)N1CCN(CC1)c2nc(c3ccc(Cl)cc3)c(cc2C#N)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P10 compound treatment 0.079 0.00655 0.78 0.7757 1.0 2125332 Peakdale1_002804 OC(=O)c1c2CN(CCc2nc3ccccc13)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P11 compound treatment 0.0785 0.00605 0.72 0.7165 1.0 2125333 Peakdale1_002805 CS(=O)(=O)c1cc(C#N)c(nc1c2ccc(Cl)cc2)N3CCN(CC3)C(=O)CCC(=O)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P12 compound treatment 0.0965 0.024 2.85 2.8493 1.0 2125334 Peakdale1_002806 COc1ccc(cc1)S(=O)(=O)N2CCc3nc4ccccc4c(C(=O)O)c3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P13 compound treatment 0.0755 0.00305 0.36 0.361 1.0 2125335 Peakdale1_002807 OC(=O)CCC(=O)N1CCC(CC1)c2nc(no2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P14 compound treatment 0.09 0.0175 2.08 2.0791 1.0 2125336 Peakdale1_002808 OC(CN1CCc2nc3ccccc3c(C(=O)O)c2C1)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P15 compound treatment 0.0765 0.00405 0.48 0.4795 1.0 2125337 Peakdale1_002809 OC(=O)COCC(=O)N1CCC(CC1)c2nc(no2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P16 compound treatment 0.096 0.0235 2.79 2.7901 1.0 2125338 Peakdale1_002810 OC(COc1ccccc1)CN2CCc3nc4ccccc4c(C(=O)O)c3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P17 compound treatment 0.081 0.00855 1.01 1.0127 1.0 2125339 Peakdale1_002811 CNC(=O)COCC(=O)N1CCC(CC1)c2nc(no2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P18 compound treatment 0.0775 0.00505 0.6 0.598 1.0 2125340 Peakdale1_002812 OC(=O)/C=C\C(=O)N1CCC(CC1)N2C(=O)Cc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P19 compound treatment 0.087 0.0145 1.72 1.7237 1.0 2125341 Peakdale1_002813 OC(=O)c1ccccc1C(=O)N2CCC(CC2)c3nc(no3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P20 compound treatment 0.0725 4.69E-5 0.01 0.0056 1.0 2125342 Peakdale1_002814 OC(=O)CCC(=O)N1CCC(CC1)N2C(=O)Cc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P21 compound treatment 0.075 0.00255 0.3 0.3018 1.0 2125343 Peakdale1_002815 O=C(COCC(=O)N1CCC(CC1)c2nc(no2)c3cccnc3)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P22 compound treatment 0.0735 0.00105 0.12 0.124 1.0 2125344 Peakdale1_002816 OC(=O)CCCC(=O)N1CCC(CC1)N2C(=O)Cc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P23 mock treatment 0.0715 -9.53E-4 -0.11 -0.1129 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.525 P24 mock treatment 0.0625 -0.00995 -1.18 -1.1793 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A01 compound treatment 0.0915 0.021 2.49 2.4921 1.0 1344833 MixCom1_000001 Cc1cccc(Cl)c1NC(=S)NCCc2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A02 compound treatment 0.073 0.00253 0.3 0.3 1.0 1787937 MixCom1_000002 [O-][N+](=O)c1ccc(cc1)S(=O)(=O)N2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A03 compound treatment 0.074 0.00353 0.42 0.4185 1.0 2069348 MixCom1_000003 CC(NC(=S)Nc1ccc(Cl)cc1)c2ccc(C)cc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A04 compound treatment 0.083 0.0125 1.48 1.4849 1.0 1273756 MixCom1_000004 NNC(=O)Cc1ccc(Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A05 compound treatment 0.089 0.0185 2.2 2.1959 1.0 1179794 MixCom1_000005 O=S(=O)(N1CCN(CCOc2ccccc2)CC1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A06 compound treatment 0.057 -0.0135 -1.6 -1.5958 -1.0 1371255 MixCom1_000006 OC(=O)c1cccnc1Oc2ccc3OCOc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A07 compound treatment 0.0945 0.024 2.85 2.8476 1.0 1339310 MixCom1_000007 Fc1cccc(Cl)c1CN2CCC(CC2)NC(=O)c3c(F)cccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A08 compound treatment 0.094 0.0235 2.79 2.7883 1.0 1113154 MixCom1_000008 COc1ccc(cc1)C(CC(=O)O)CC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A09 compound treatment 0.0925 0.022 2.61 2.6106 1.0 2069349 MixCom1_000009 CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)c2ccccc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A10 compound treatment 0.0865 0.016 1.9 1.8997 1.0 1510751 MixCom1_000010 Nc1nnc(SCCO)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A11 compound treatment 0.084 0.0135 1.6 1.6034 1.0 2069350 MixCom1_000011 Nc1nc(=S)ss1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A12 compound treatment 0.086 0.0155 1.84 1.8404 1.0 2069351 MixCom1_000012 O=C1NN=C(CC1c2ccccc2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A13 compound treatment 0.082 0.0115 1.37 1.3665 1.0 1009987 MixCom1_000013 Nc1nc(S)nc(S)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A14 compound treatment 0.099 0.0285 3.38 3.3808 1.0 1019912 MixCom1_000014 O=C(N1C=Cc2ccccc2C1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A15 compound treatment 0.081 0.0105 1.25 1.248 1.0 1008346 MixCom1_000015 OC(C(=O)c1ccco1)c2ccco2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A16 compound treatment 0.0895 0.019 2.26 2.2551 1.0 1002188 MixCom1_000016 O=C1NC(C(=N1)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A17 compound treatment 0.0765 0.00603 0.71 0.7148 1.0 1949267 MixCom1_000017 CC(=O)Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A18 compound treatment 0.0895 0.019 2.26 2.2551 1.0 1602342 MixCom1_000018 CCOc1ccc(C(=O)N)c(SCC(=O)O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A19 compound treatment 0.0785 0.00803 0.95 0.9517 1.0 2069352 MixCom1_000019 COC(=O)CS(=O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A20 compound treatment 0.0735 0.00303 0.36 0.3593 1.0 1005579 MixCom1_000020 CN1CSC(=S)N(C)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A21 compound treatment 0.0695 -9.68E-4 -0.11 -0.1147 -1.0 1042325 MixCom1_000021 CC(=O)Nc1ccccc1NC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A22 compound treatment 0.059 -0.0115 -1.36 -1.3588 -1.0 2069353 MixCom1_000022 CCCCCCCCCCCCCCCCCC1N=CCN1CCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A23 mock treatment 0.0715 0.00103 0.12 0.1223 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 A24 mock treatment 0.068 -0.00247 -0.29 -0.2924 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B01 compound treatment 0.0835 0.013 1.54 1.5442 1.0 2079645 MixCom1_000023 OC(=O)CSCC(=O)N1CCC(CC1)N2C(=O)Cc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B02 compound treatment 0.079 0.00853 1.01 1.011 1.0 2079646 MixCom1_000024 CCCN1CCC(CC1)N(C2CC2)C(=O)COCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B03 compound treatment 0.0825 0.012 1.43 1.4257 1.0 2079647 MixCom1_000025 OC(=O)c1ccccc1C(=O)N2CCC(CC2)N3C(=O)Cc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B04 compound treatment 0.073 0.00253 0.3 0.3 1.0 2079648 MixCom1_000026 OC(=O)/C=C\C(=O)N(C1CC1)C2CCN(CCc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B05 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2079649 MixCom1_000027 Nc1ccccc1C(=O)N2CCC(CC2)N3C(=O)Cc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B06 compound treatment 0.069 -0.00147 -0.17 -0.1739 -1.0 2079650 MixCom1_000028 OC(=O)CCC(=O)N(C1CC1)C2CCN(CCc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B07 compound treatment 0.0915 0.021 2.49 2.4921 1.0 2079651 MixCom1_000029 O=C1Cc2ccccc2N1C3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B08 compound treatment 0.087 0.0165 1.96 1.9589 1.0 2079652 MixCom1_000030 OC(=O)COCC(=O)N(C1CC1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B09 compound treatment 0.077 0.00653 0.77 0.774 1.0 2079653 MixCom1_000031 O=C1Cc2ccccc2N1C3CCN(CCC#N)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B10 compound treatment 0.0755 0.00503 0.6 0.5963 1.0 2079654 MixCom1_000032 OC(=O)CCCC(=O)N(C1CC1)C2CCN(CCc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B11 compound treatment 0.0765 0.00603 0.71 0.7148 1.0 2079655 MixCom1_000033 OC(COc1ccccc1)CN2CCC(CC2)N3C(=O)Cc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B12 compound treatment 0.0745 0.00403 0.48 0.4778 1.0 2079656 MixCom1_000034 OC(=O)COCC(=O)N(C1CC1)C2CCN(CCc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B13 compound treatment 0.075 0.00453 0.54 0.537 1.0 2079657 MixCom1_000035 CC(C)(C)C(=O)N1CCC(CC1)N2C(=O)Cc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B14 compound treatment 0.073 0.00253 0.3 0.3 1.0 2079658 MixCom1_000036 CN1CCC(CC1)N2CCC(CC2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B15 compound treatment 0.0695 -9.68E-4 -0.11 -0.1147 -1.0 2079659 MixCom1_000037 O=C(N1CCC(CC1)N2C(=O)Cc3ccccc23)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B16 compound treatment 0.0715 0.00103 0.12 0.1223 1.0 2079660 MixCom1_000038 CN1CCC(CC1)N2CCC(CC2)C(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B17 compound treatment 0.076 0.00553 0.66 0.6555 1.0 2079661 MixCom1_000039 Clc1ccccc1C(=O)N2CCC(CC2)N3C(=O)Cc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B18 compound treatment 0.0865 0.016 1.9 1.8997 1.0 2079662 MixCom1_000040 CN1CCC(CC1)N2CCC(CC2)C(=O)NCc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B19 compound treatment 0.0695 -9.68E-4 -0.11 -0.1147 -1.0 2079663 MixCom1_000041 O=C1Cc2ccccc2N1C3CCN(CC3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B20 compound treatment 0.0595 -0.011 -1.3 -1.2996 -1.0 2079664 MixCom1_000042 CCCCCCCCCCCCNC(=O)C1CCN(CC1)C2CCN(C)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B21 compound treatment 0.058 -0.0125 -1.48 -1.4773 -1.0 2079665 MixCom1_000043 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCC(CC2)N3C(=O)Cc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B22 compound treatment 0.0575 -0.013 -1.54 -1.5365 -1.0 2079666 MixCom1_000044 CN1CCC(CC1)N(C2CCN(Cc3ccccc3)CC2)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B23 mock treatment 0.0585 -0.012 -1.42 -1.4181 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 B24 mock treatment 0.056 -0.0145 -1.71 -1.7143 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C01 compound treatment 0.0905 0.02 2.37 2.3736 1.0 2069354 MixCom1_000045 Cc1cccc(Cl)c1NC(=S)NCc2ccncc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C02 compound treatment 0.087 0.0165 1.96 1.9589 1.0 1210757 MixCom1_000046 Nc1ccc(cc1)S(=O)(=O)N2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C03 compound treatment 0.083 0.0125 1.48 1.4849 1.0 1297952 MixCom1_000047 O=C1N(CN(CCC#N)CCc2ccccn2)C(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C04 compound treatment 0.0915 0.021 2.49 2.4921 1.0 1077740 MixCom1_000048 CC(=O)Nc1c(C)cc(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C05 compound treatment 0.096 0.0255 3.03 3.0253 1.0 1698722 MixCom1_000049 Cc1ccc(cc1)S(=O)(=O)N2CCN(CCOc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C06 compound treatment 0.0895 0.019 2.26 2.2551 1.0 2069355 MixCom1_000050 COc1ccc(cc1)c2n[nH]cc2/C=N/NC(=S)NC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C07 compound treatment 0.09 0.0195 2.31 2.3144 1.0 2069356 MixCom1_000051 CC(C)(C)c1ccc(cc1)C(=O)NNC(=S)Nc2ccc3OCOc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C08 compound treatment 0.087 0.0165 1.96 1.9589 1.0 1356512 MixCom1_000052 Cc1sc(NC(=O)CCC(=O)O)nc1c2ccc(C)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C09 compound treatment 0.0835 0.013 1.54 1.5442 1.0 1201410 MixCom1_000053 CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)c2c(F)cccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C10 compound treatment 0.0865 0.016 1.9 1.8997 1.0 2069357 MixCom1_000054 Cc1ccc(Sc2ccc(cc2/C=C/3\SC(=S)NC3=O)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C11 compound treatment 0.085 0.0145 1.72 1.7219 1.0 1019305 MixCom1_000055 CN(C)c1ccc(SC#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C12 compound treatment 0.0835 0.013 1.54 1.5442 1.0 2069358 MixCom1_000056 O=C1CCC(=NN1)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C13 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2069359 MixCom1_000057 CC(=O)Nc1ccc(cc1C(F)(F)F)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C14 compound treatment 0.085 0.0145 1.72 1.7219 1.0 1004616 MixCom1_000058 Oc1ccc2ccccc2c1CN3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C15 compound treatment 0.0845 0.014 1.66 1.6627 1.0 2069360 MixCom1_000059 CCC(=O)c1c(OC)cc(OC)cc1C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C16 compound treatment 0.081 0.0105 1.25 1.248 1.0 2069361 MixCom1_000060 [O-][N+](=O)c1ccc2cc(Br)c3ccccc3c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C17 compound treatment 0.0835 0.013 1.54 1.5442 1.0 1039729 MixCom1_000061 CCc1ccccc1NC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C18 compound treatment 0.0885 0.018 2.14 2.1366 1.0 2069362 MixCom1_000062 CC(C)C(=O)Nc1ccc(cc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C19 compound treatment 0.0755 0.00503 0.6 0.5963 1.0 2069363 MixCom1_000063 COc1ccc2cc(ccc2c1)/C(=N/O)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C20 compound treatment 0.078 0.00753 0.89 0.8925 1.0 2069364 MixCom1_000064 CN(C)c1ccc(/C=N/NC(=S)N)c(O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C21 compound treatment 0.0725 0.00203 0.24 0.2408 1.0 1183869 MixCom1_000065 CC(=O)Nc1cc(Cl)c(Cl)cc1NC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C22 compound treatment 0.074 0.00353 0.42 0.4185 1.0 1722884 MixCom1_000066 CCc1ccc(NCN2C(=O)c3ccccc3C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C23 mock treatment 0.071 5.32E-4 0.06 0.0631 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 C24 mock treatment 0.0725 0.00203 0.24 0.2408 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D01 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2079667 MixCom1_000067 Cc1ccc(cc1)S(=O)(=O)NC(=O)N2CCC(CC2)N3C(=O)Cc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D02 compound treatment 0.0825 0.012 1.43 1.4257 1.0 2079668 MixCom1_000068 CN1CCC(CC1)N(C2CCN(Cc3ccccc3)CC2)C(=O)c4ccccc4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D03 compound treatment 0.0825 0.012 1.43 1.4257 1.0 2079669 MixCom1_000069 CCNC(=O)N1CCC(CC1)N2C(=O)Cc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D04 compound treatment 0.089 0.0185 2.2 2.1959 1.0 2079670 MixCom1_000070 CN1CCC(CC1)N(C2CCN(Cc3ccccc3)CC2)C(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D05 compound treatment 0.09 0.0195 2.31 2.3144 1.0 2079671 MixCom1_000071 CS(=O)(=O)c1ccc2n(C3CCNCC3)c(nc2c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D06 compound treatment 0.0845 0.014 1.66 1.6627 1.0 2079672 MixCom1_000072 CN1CCC(CC1)N(C2CCN(Cc3ccccc3)CC2)C(=O)c4cc(cc(c4)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D07 compound treatment 0.0905 0.02 2.37 2.3736 1.0 2079673 MixCom1_000073 CC(C)(C)C(=O)N1CCC(CC1)n2c(nc3cc(ccc23)S(=O)(=O)C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D08 compound treatment 0.0895 0.019 2.26 2.2551 1.0 2079674 MixCom1_000074 C(NCc1ccc2OCCc2c1)C3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D09 compound treatment 0.088 0.0175 2.08 2.0774 1.0 2079675 MixCom1_000075 CS(=O)(=O)c1ccc2n(C3CCN(CC3)C(=O)c4ccc(cc4)C(F)(F)F)c(nc2c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D10 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079676 MixCom1_000076 OC(=O)C1CCN(Cc2ccc3OCCc3c2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D11 compound treatment 0.0875 0.017 2.02 2.0182 1.0 2079677 MixCom1_000077 CS(=O)(=O)c1ccc2n(C3CCN(CC3)C(=O)c4ccc(Cl)cc4)c(nc2c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D12 compound treatment 0.088 0.0175 2.08 2.0774 1.0 2079678 MixCom1_000078 C(N(Cc1ccc2OCCc2c1)C3CC3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D13 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079679 MixCom1_000079 CS(=O)(=O)c1ccc2n(C3CCN(CC3)C(=O)Cc4cc(F)cc(F)c4)c(nc2c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D14 compound treatment 0.0865 0.016 1.9 1.8997 1.0 2079680 MixCom1_000080 CCOC(=O)C1CCN(Cc2ccc3OCCc3c2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D15 compound treatment 0.0835 0.013 1.54 1.5442 1.0 2079681 MixCom1_000081 CS(=O)(=O)c1ccc2n(C3CCN(CC3)C(=O)c4ccc(Cl)nc4)c(nc2c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D16 compound treatment 0.092 0.0215 2.55 2.5514 1.0 2079682 MixCom1_000082 COc1ccc(CN(Cc2ccc3OCCc3c2)C4CC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D17 compound treatment 0.0915 0.021 2.49 2.4921 1.0 2079683 MixCom1_000083 CS(=O)(=O)c1ccc2n(C3CCN(CC3)S(=O)(=O)c4ccc(Cl)cc4)c(nc2c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D18 compound treatment 0.086 0.0155 1.84 1.8404 1.0 2079684 MixCom1_000084 CC(=O)N1CCC(CC1)N(Cc2ccc3OCCc3c2)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D19 compound treatment 0.0765 0.00603 0.71 0.7148 1.0 2079685 MixCom1_000085 COc1ccc(cc1)S(=O)(=O)N2CCC(CC2)n3c(nc4cc(ccc34)S(=O)(=O)C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D20 compound treatment 0.0815 0.011 1.31 1.3072 1.0 2079686 MixCom1_000086 O=C1Cc2ccccc2N1C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D21 compound treatment 0.0755 0.00503 0.6 0.5963 1.0 2079687 MixCom1_000087 CN1CCC(CC1)N(C2CCN(CCc3ccccc3)CC2)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D22 compound treatment 0.076 0.00553 0.66 0.6555 1.0 2079688 MixCom1_000088 COc1ccccc1/C=C/2\C(=O)N(C3CCN(Cc4ccccc4)CC3)c5ccccc25 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D23 mock treatment 0.071 5.32E-4 0.06 0.0631 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 D24 mock treatment 0.0735 0.00303 0.36 0.3593 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E01 compound treatment 0.0815 0.011 1.31 1.3072 1.0 2069365 MixCom1_000089 FC(F)(F)c1cccc(NC(=S)N(CCC#N)Cc2ccccc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E02 compound treatment 0.084 0.0135 1.6 1.6034 1.0 2069366 MixCom1_000090 CCCCc1ccc(NC(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E03 compound treatment 0.0845 0.014 1.66 1.6627 1.0 1565677 MixCom1_000091 CCN(CC)c1ccc(NCN2C(=O)c3ccccc3C2=O)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E04 compound treatment 0.089 0.0185 2.2 2.1959 1.0 1235554 MixCom1_000092 OC(=O)c1cccnc1Oc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E05 compound treatment 0.0925 0.022 2.61 2.6106 1.0 1618731 MixCom1_000093 Clc1ccccc1S(=O)(=O)N2CCN(CCOc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E06 compound treatment 0.0845 0.014 1.66 1.6627 1.0 2069367 MixCom1_000094 Cn1cnc(c1)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E07 compound treatment 0.093 0.0225 2.67 2.6698 1.0 1246976 MixCom1_000095 CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E08 compound treatment 0.0915 0.021 2.49 2.4921 1.0 1126518 MixCom1_000096 Cc1ccc(CSc2nnc(N)s2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E09 compound treatment 0.0885 0.018 2.14 2.1366 1.0 2069368 MixCom1_000097 CNc1ccc(cc1[N+](=O)[O-])C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E10 compound treatment 0.0865 0.016 1.9 1.8997 1.0 2069369 MixCom1_000098 [O-][N+](=O)c1ccc(Sc2ccc(Cl)cc2)c(/C=C\3/SC(=S)NC3=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E11 compound treatment 0.0905 0.02 2.37 2.3736 1.0 2069370 MixCom1_000099 CSc1nnc(S)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E12 compound treatment 0.095 0.0245 2.91 2.9068 1.0 2069371 MixCom1_000100 Clc1c[nH]c(=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E13 compound treatment 0.0915 0.021 2.49 2.4921 1.0 2069372 MixCom1_000101 CC(=O)Nc1ccc(I)cc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E14 compound treatment 0.083 0.0125 1.48 1.4849 1.0 1014052 MixCom1_000102 N#CC(N1CCCCC1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E15 compound treatment 0.092 0.0215 2.55 2.5514 1.0 1035271 MixCom1_000103 CC(=O)Nc1ccc(OCC=C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E16 compound treatment 0.094 0.0235 2.79 2.7883 1.0 1696626 MixCom1_000104 Cc1cc(cc(C)c1O)C2(CCCCC2)c3cc(C)c(O)c(C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E17 compound treatment 0.0875 0.017 2.02 2.0182 1.0 2069373 MixCom1_000105 CC(=O)Nc1ccc(Br)cc1OC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E18 compound treatment 0.086 0.0155 1.84 1.8404 1.0 1526931 MixCom1_000106 OC(=O)c1ccccc1C(=O)c2cc(Cl)cc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E19 compound treatment 0.09 0.0195 2.31 2.3144 1.0 2069374 MixCom1_000107 C/C(=N\O)/c1ccc2c(c1)C(C)(C)CCC2(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E20 compound treatment 0.08 0.00953 1.13 1.1295 1.0 1056662 MixCom1_000108 Cc1ccc(cc1)S(=O)(=O)OCC(C)(C)COS(=O)(=O)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E21 compound treatment 0.079 0.00853 1.01 1.011 1.0 1016071 MixCom1_000109 CS(=O)(=O)Nc1ccccc1NS(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E22 compound treatment 0.0735 0.00303 0.36 0.3593 1.0 1008547 MixCom1_000110 OCCN(CCO)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E23 mock treatment 0.0725 0.00203 0.24 0.2408 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 E24 mock treatment 0.0745 0.00403 0.48 0.4778 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F01 compound treatment 0.077 0.00653 0.77 0.774 1.0 2079689 MixCom1_000111 CN1CCC(CC1)N(C2CCN(CCc3ccccc3)CC2)C(=O)c4ccc(cc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F02 compound treatment 0.0765 0.00603 0.71 0.7148 1.0 2079690 MixCom1_000112 O=C/1N(C2CCN(Cc3ccccc3)CC2)c4ccccc4\C1=C\c5ccccn5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F03 compound treatment 0.078 0.00753 0.89 0.8925 1.0 2079691 MixCom1_000113 CN1CCC(CC1)N(C2CCN(CCc3ccccc3)CC2)C(=O)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F04 compound treatment 0.084 0.0135 1.6 1.6034 1.0 2079692 MixCom1_000114 NC(=O)CCc1ccc2OCCc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F05 compound treatment 0.0905 0.02 2.37 2.3736 1.0 2079693 MixCom1_000115 CN1CCC(CC1)N(C2CCN(CCc3ccccc3)CC2)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F06 compound treatment 0.086 0.0155 1.84 1.8404 1.0 2079694 MixCom1_000116 O=C(CCc1ccc2OCCc2c1)Nc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F07 compound treatment 0.0915 0.021 2.49 2.4921 1.0 2079695 MixCom1_000117 OC(=O)CCc1nc(no1)c2cnccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F08 compound treatment 0.086 0.0155 1.84 1.8404 1.0 2079696 MixCom1_000118 CN1CCN(CC1)C(=O)CCc2ccc3OCCc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F09 compound treatment 0.0935 0.023 2.73 2.7291 1.0 2079697 MixCom1_000119 CCCNC(=O)CCc1nc(no1)c2cnccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F10 compound treatment 0.088 0.0175 2.08 2.0774 1.0 2079698 MixCom1_000120 O=C(CCc1ccc2OCCc2c1)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F11 compound treatment 0.0845 0.014 1.66 1.6627 1.0 2079699 MixCom1_000121 O=C(CCc1nc(no1)c2cnccn2)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F12 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079700 MixCom1_000122 COc1ccc(OC)c(NC(=O)CCc2ccc3OCCc3c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F13 compound treatment 0.089 0.0185 2.2 2.1959 1.0 2079701 MixCom1_000123 FC(F)(F)c1cccc(CNC(=O)CCc2nc(no2)c3cnccn3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F14 compound treatment 0.081 0.0105 1.25 1.248 1.0 2079702 MixCom1_000124 CN1CCC(CC1)N(C2CC2)C(=O)CCc3ccc4OCCc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F15 compound treatment 0.093 0.0225 2.67 2.6698 1.0 2079703 MixCom1_000125 O=C(CCc1nc(no1)c2cnccn2)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F16 compound treatment 0.0835 0.013 1.54 1.5442 1.0 2079704 MixCom1_000126 Clc1ccc(NC(=O)CCc2ccc3OCCc3c2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F17 compound treatment 0.0945 0.024 2.85 2.8476 1.0 2079705 MixCom1_000127 OC(=O)CCCc1nc(no1)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F18 compound treatment 0.0995 0.029 3.44 3.44 1.0 2079706 MixCom1_000128 Fc1ccc(cc1)N2CCN(CC2)C(=O)CCc3ccc4OCCc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F19 compound treatment 0.075 0.00453 0.54 0.537 1.0 2079707 MixCom1_000129 CCCNC(=O)CCCc1nc(no1)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F20 compound treatment 0.0755 0.00503 0.6 0.5963 1.0 2079708 MixCom1_000130 OC(=O)C1CCN(Cc2ccc(s2)c3cccs3)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F21 compound treatment 0.0745 0.00403 0.48 0.4778 1.0 2079709 MixCom1_000131 O=C(CCCc1nc(no1)c2cccs2)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F22 compound treatment 0.0715 0.00103 0.12 0.1223 1.0 2079710 MixCom1_000132 C(N1CCc2ccccc2C1)c3ccc(s3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F23 mock treatment 0.069 -0.00147 -0.17 -0.1739 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 F24 mock treatment 0.0705 3.23E-5 0.0 0.0038 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G01 compound treatment 0.0835 0.013 1.54 1.5442 1.0 2069375 MixCom1_000133 O=C1N(CN(CCC#N)Cc2ccccc2)C(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G02 compound treatment 0.0785 0.00803 0.95 0.9517 1.0 2069376 MixCom1_000134 CCCCc1ccc(NC(=O)C)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G03 compound treatment 0.08 0.00953 1.13 1.1295 1.0 2069377 MixCom1_000135 Clc1ccc(NC(=S)N(CCC#N)C2CCCCC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G04 compound treatment 0.0875 0.017 2.02 2.0182 1.0 1183843 MixCom1_000136 CCCCc1ccc(cc1)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G05 compound treatment 0.0885 0.018 2.14 2.1366 1.0 1456855 MixCom1_000137 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCN(CCOc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G06 compound treatment 0.0825 0.012 1.43 1.4257 1.0 1698633 MixCom1_000138 Cc1c(Cl)cc(F)cc1S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G07 compound treatment 0.091 0.0205 2.43 2.4329 1.0 1363199 MixCom1_000139 CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)Nc2ccc(OCc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G08 compound treatment 0.0885 0.018 2.14 2.1366 1.0 2069378 MixCom1_000140 Clc1ccc(CSc2nnc(s2)n3cccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G09 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2069379 MixCom1_000141 CC(C)Nc1ccc(cc1[N+](=O)[O-])C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G10 compound treatment 0.085 0.0145 1.72 1.7219 1.0 2069380 MixCom1_000142 CS/C(=N\C#N)/NCCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G11 compound treatment 0.0835 0.013 1.54 1.5442 1.0 1035181 MixCom1_000143 Cc1ccc(cc1)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G12 compound treatment 0.085 0.0145 1.72 1.7219 1.0 2069381 MixCom1_000144 N#CC1(CCCCC1)NNC2(CCCCC2)C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G13 compound treatment 0.084 0.0135 1.6 1.6034 1.0 2069382 MixCom1_000145 CC(=O)Nc1ccc(C#N)cc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G14 compound treatment 0.1 0.0295 3.5 3.4993 1.0 1044849 MixCom1_000146 N#CC(N1CCOCC1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G15 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2069383 MixCom1_000147 OC(=O)c1ccccc1C(=O)c2cc(cc(c2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G16 compound treatment 0.092 0.0215 2.55 2.5514 1.0 1030489 MixCom1_000148 CC1C(=C(C)NC(=C1C(=O)C)C)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G17 compound treatment 0.0975 0.027 3.2 3.2031 1.0 2069384 MixCom1_000149 CC(=O)Nc1ccc(C#N)cc1OC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G18 compound treatment 0.0915 0.021 2.49 2.4921 1.0 2069385 MixCom1_000150 CC(NCc1ccccc1)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G19 compound treatment 0.0735 0.00303 0.36 0.3593 1.0 1079214 MixCom1_000151 CC(=O)Nc1ccc2CCCCc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G20 compound treatment 0.0705 3.23E-5 0.0 0.0038 1.0 2069386 MixCom1_000152 Cc1cc(C)c([N+](=O)[O-])c(C)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G21 compound treatment 0.077 0.00653 0.77 0.774 1.0 2069387 MixCom1_000153 Cc1nc2cc(Cl)c(Cl)cc2[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G22 compound treatment 0.0695 -9.68E-4 -0.11 -0.1147 -1.0 1110132 MixCom1_000154 OC(=O)CCN1C(=O)c2ccccc2C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G23 mock treatment 0.068 -0.00247 -0.29 -0.2924 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 G24 mock treatment 0.0705 3.23E-5 0.0 0.0038 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H01 compound treatment 0.081 0.0105 1.25 1.248 1.0 2079711 MixCom1_000155 Clc1ccc(CNC(=O)CCCc2nc(no2)c3cccs3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H02 compound treatment 0.0795 0.00903 1.07 1.0702 1.0 2079712 MixCom1_000156 CCOC(=O)C1CCN(Cc2ccc(s2)c3cccs3)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H03 compound treatment 0.0815 0.011 1.31 1.3072 1.0 2079713 MixCom1_000157 Clc1cccc(c1)N2CCN(CC2)C(=O)CCCc3nc(no3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H04 compound treatment 0.0865 0.016 1.9 1.8997 1.0 2079714 MixCom1_000158 Fc1ccc(cc1)N2CCN(Cc3ccc(s3)c4cccs4)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H05 compound treatment 0.095 0.0245 2.91 2.9068 1.0 2079715 MixCom1_000159 CN1CCC(CC1)N2C(=O)Cc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H06 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2079716 MixCom1_000160 Clc1ccccc1C(=O)N(Cc2ccc(s2)c3cccs3)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H07 compound treatment 0.0975 0.027 3.2 3.2031 1.0 2079717 MixCom1_000161 CN1CCC(CC1)N2C(=O)/C(=C\c3ccc(Cl)cc3)/c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H08 compound treatment 0.0865 0.016 1.9 1.8997 1.0 2079718 MixCom1_000162 Clc1ccc(cn1)C(=O)N(Cc2ccc(s2)c3cccs3)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H09 compound treatment 0.0935 0.023 2.73 2.7291 1.0 2079719 MixCom1_000163 COc1ccccc1/C=C/2\C(=O)N(C3CCN(C)CC3)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H10 compound treatment 0.0815 0.011 1.31 1.3072 1.0 2079720 MixCom1_000164 CC(=O)Oc1ccccc1C(=O)N(Cc2ccc(s2)c3cccs3)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H11 compound treatment 0.0895 0.019 2.26 2.2551 1.0 2079721 MixCom1_000165 CN1CCC(CC1)N2C(=O)/C(=C\c3cccnc3)/c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H12 compound treatment 0.086 0.0155 1.84 1.8404 1.0 2079722 MixCom1_000166 FC(F)(F)c1cccc(c1)C(=O)N(Cc2ccc(s2)c3cccs3)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H13 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079723 MixCom1_000167 CN1CCC(CC1)N2C(=O)/C(=C\c3ccco3)/c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H14 compound treatment 0.0805 0.01 1.19 1.1887 1.0 2079724 MixCom1_000168 C(N1CCN(CC1)C(c2ccccc2)c3ccccc3)c4ccc(s4)c5cccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H15 compound treatment 0.1 0.0295 3.5 3.4993 1.0 2079725 MixCom1_000169 C(NC1CC1)c2ccc3OCCc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H16 compound treatment 0.091 0.0205 2.43 2.4329 1.0 2079726 MixCom1_000170 OC(=O)C1CCN(Cc2ccccn2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H17 compound treatment 0.089 0.0185 2.2 2.1959 1.0 2079727 MixCom1_000171 OC(=O)/C=C\C(=O)N(Cc1ccc2OCCc2c1)C3CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H18 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079728 MixCom1_000172 O=C(NC1CCCCC1)C2CCN(Cc3ccccn3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H19 compound treatment 0.0815 0.011 1.31 1.3072 1.0 2079729 MixCom1_000173 OC(=O)CCC(=O)N(Cc1ccc2OCCc2c1)C3CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H20 compound treatment 0.0735 0.00303 0.36 0.3593 1.0 2079730 MixCom1_000174 O=C(C1CCN(Cc2ccccn2)CC1)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H21 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2079731 MixCom1_000175 Clc1ccc(cc1)C(=O)N(Cc2ccc3OCCc3c2)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H22 compound treatment 0.081 0.0105 1.25 1.248 1.0 2079732 MixCom1_000176 FC(F)(F)c1cccc(CNC(=O)C2CCN(Cc3ccccn3)CC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H23 mock treatment 0.0705 3.23E-5 0.0 0.0038 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 H24 mock treatment 0.0715 0.00103 0.12 0.1223 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I01 compound treatment 0.084 0.0135 1.6 1.6034 1.0 2069388 MixCom1_000177 O=C1N(CN(CCC#N)C2CCCCC2)C(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I02 compound treatment 0.0805 0.01 1.19 1.1887 1.0 1049619 MixCom1_000178 CN(C(=S)N)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I03 compound treatment 0.082 0.0115 1.37 1.3665 1.0 2069389 MixCom1_000179 CCN(CCC#N)C(=S)Nc1cccc2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I04 compound treatment 0.0845 0.014 1.66 1.6627 1.0 1466450 MixCom1_000180 COC(=O)c1ccc(OC)c(OC2CCCC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I05 compound treatment 0.086 0.0155 1.84 1.8404 1.0 1337971 MixCom1_000181 Fc1ccc(c(F)c1)S(=O)(=O)N2CCN(CCOc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I06 compound treatment 0.0765 0.00603 0.71 0.7148 1.0 2069390 MixCom1_000182 N/C(=N\O)/Cc1ccc(F)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I07 compound treatment 0.085 0.0145 1.72 1.7219 1.0 1531113 MixCom1_000183 CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)Nc2cc(Cl)cc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I08 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2069391 MixCom1_000184 [O-][N+](=O)c1ccc(CSc2nnc(s2)n3cccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I09 compound treatment 0.0845 0.014 1.66 1.6627 1.0 2069392 MixCom1_000185 Cn1c(=S)[nH]c2cc(ccc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I10 compound treatment 0.0815 0.011 1.31 1.3072 1.0 2069393 MixCom1_000186 CCCSc1ccc([N+](=O)[O-])c(/N=C(/NCCS(=O)(=O)O)\NC(=O)OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I11 compound treatment 0.0825 0.012 1.43 1.4257 1.0 1114641 MixCom1_000187 OC(=O)CCC(=O)c1ccc(F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I12 compound treatment 0.0775 0.00703 0.83 0.8333 1.0 1008972 MixCom1_000188 OCC1(CO)CCCC(CO)(CO)C1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I13 compound treatment 0.077 0.00653 0.77 0.774 1.0 2069394 MixCom1_000189 CC(=O)c1ccc(C#N)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I14 compound treatment 0.077 0.00653 0.77 0.774 1.0 1386343 MixCom1_000190 OCCN(CCO)C(C#N)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I15 compound treatment 0.086 0.0155 1.84 1.8404 1.0 1109655 MixCom1_000191 CC(=O)OCC(=O)c1ccc(Br)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I16 compound treatment 0.0895 0.019 2.26 2.2551 1.0 2069395 MixCom1_000192 C(COc1ccccn1)Oc2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I17 compound treatment 0.084 0.0135 1.6 1.6034 1.0 2069396 MixCom1_000193 OC(=O)c1ccc(C(=O)O)c(OC(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I18 compound treatment 0.088 0.0175 2.08 2.0774 1.0 1720440 MixCom1_000194 CCOC(=O)C1=C(C)NC(=C(C1C)C(=O)OCC)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I19 compound treatment 0.0865 0.016 1.9 1.8997 1.0 2069397 MixCom1_000195 CC(=O)Nc1ccc2CCCc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I20 compound treatment 0.098 0.0275 3.26 3.2623 1.0 1013653 MixCom1_000196 [O-][N+](=O)c1ccc(N2CCCCC2)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I21 compound treatment 0.0705 3.23E-5 0.0 0.0038 1.0 2069398 MixCom1_000197 CC(=O)Nc1ccc(Cl)cc1OC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I22 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2069399 MixCom1_000198 CCCCCCCCCCCC1=NCCN1CCO 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I23 mock treatment 0.0665 -0.00397 -0.47 -0.4701 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 I24 mock treatment 0.071 5.32E-4 0.06 0.0631 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J01 compound treatment 0.081 0.0105 1.25 1.248 1.0 2079733 MixCom1_000199 OC(=O)c1ccccc1C(=O)N(Cc2ccc3OCCc3c2)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J02 compound treatment 0.081 0.0105 1.25 1.248 1.0 2079734 MixCom1_000200 OC(=O)C1CCN(Cc2ccncc2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J03 compound treatment 0.0845 0.014 1.66 1.6627 1.0 2079735 MixCom1_000201 COc1ccc(cc1)S(=O)(=O)N(Cc2ccc3OCCc3c2)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J04 compound treatment 0.0875 0.017 2.02 2.0182 1.0 2079736 MixCom1_000202 CC(NC(=O)C1CCN(Cc2ccncc2)CC1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J05 compound treatment 0.0935 0.023 2.73 2.7291 1.0 2079737 MixCom1_000203 FC(F)(F)c1ccc(cc1)C(=O)N(Cc2ccc3OCCc3c2)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J06 compound treatment 0.09 0.0195 2.31 2.3144 1.0 2079738 MixCom1_000204 Clc1ccc(CNC(=O)C2CCN(Cc3ccncc3)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J07 compound treatment 0.094 0.0235 2.79 2.7883 1.0 2079739 MixCom1_000205 CC(=O)Nc1ccc(cc1)S(=O)(=O)N(Cc2ccc3OCCc3c2)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J08 compound treatment 0.085 0.0145 1.72 1.7219 1.0 2079740 MixCom1_000206 O=C(C1CCN(Cc2ccncc2)CC1)N3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J09 compound treatment 0.085 0.0145 1.72 1.7219 1.0 2079741 MixCom1_000207 Cc1ccc(cc1)S(=O)(=O)NC(=O)N(Cc2ccc3OCCc3c2)C4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J10 compound treatment 0.0835 0.013 1.54 1.5442 1.0 2079742 MixCom1_000208 OC(=O)C1CCN(Cc2cccnc2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J11 compound treatment 0.082 0.0115 1.37 1.3665 1.0 2079743 MixCom1_000209 CC1=NC2(CCN(CC2)C(=O)c3ccccc3N)N=C1c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J12 compound treatment 0.081 0.0105 1.25 1.248 1.0 2079744 MixCom1_000210 O=C(NCCc1ccccc1)C2CCN(Cc3cccnc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J13 compound treatment 0.0795 0.00903 1.07 1.0702 1.0 2079745 MixCom1_000211 CCNC(=O)Nc1ccccc1C(=O)N2CCC3(CC2)N=C(C)C(=N3)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J14 compound treatment 0.078 0.00753 0.89 0.8925 1.0 2079746 MixCom1_000212 Clc1cccc(CNC(=O)C2CCN(Cc3cccnc3)CC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J15 compound treatment 0.0835 0.013 1.54 1.5442 1.0 2079747 MixCom1_000213 CC1=NC2(CCN(CC2)C(=O)c3ccccc3NC(=O)C(C)(C)C)N=C1c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J16 compound treatment 0.08 0.00953 1.13 1.1295 1.0 2079748 MixCom1_000214 CCCCCCCCCCCCNC(=O)C1CCN(Cc2cccnc2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J17 compound treatment 0.108 0.0375 4.45 4.4472 1.0 2079749 MixCom1_000215 CC1=NC2(CCN(CC2)C(=O)c3ccccc3NS(=O)(=O)C)N=C1c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J18 compound treatment 0.081 0.0105 1.25 1.248 1.0 2079750 MixCom1_000216 O=C(C1CCN(Cc2cccnc2)CC1)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J19 compound treatment 0.094 0.0235 2.79 2.7883 1.0 2079751 MixCom1_000217 COc1cc(OC)nc(n1)c2n[nH]c(=S)n2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J20 compound treatment 0.0725 0.00203 0.24 0.2408 1.0 2079752 MixCom1_000218 CCCN1CCC(CC1)N2CCC(CC2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J21 compound treatment 0.0785 0.00803 0.95 0.9517 1.0 2079753 MixCom1_000219 COc1cc(OC)nc(n1)c2n[nH]c(=S)n2CC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J22 compound treatment 0.0705 3.23E-5 0.0 0.0038 1.0 2079754 MixCom1_000220 CCCN1CCC(CC1)N2CCC(CC2)C(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J23 mock treatment 0.07 -4.68E-4 -0.06 -0.0554 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 J24 mock treatment 0.0715 0.00103 0.12 0.1223 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K01 compound treatment 0.082 0.0115 1.37 1.3665 1.0 2069400 MixCom1_000221 CCN(C(=S)Nc1cccc(c1)C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K02 compound treatment 0.079 0.00853 1.01 1.011 1.0 2069401 MixCom1_000222 CC(C)c1ccccc1NC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K03 compound treatment 0.0805 0.01 1.19 1.1887 1.0 1266374 MixCom1_000223 O=C(N1CCN(CCOc2ccccc2)CC1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K04 compound treatment 0.0865 0.016 1.9 1.8997 1.0 2069402 MixCom1_000224 CC(=O)Nc1ccc(Cl)cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K05 compound treatment 0.084 0.0135 1.6 1.6034 1.0 1159261 MixCom1_000225 O=C(Nc1ccc2ccccc2c1)N3CCCN(CCOc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K06 compound treatment 0.0755 0.00503 0.6 0.5963 1.0 2069403 MixCom1_000226 NC(=O)Cc1ccc(F)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K07 compound treatment 0.0985 0.028 3.32 3.3215 1.0 1700453 MixCom1_000227 CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K08 compound treatment 0.085 0.0145 1.72 1.7219 1.0 2069404 MixCom1_000228 CN(C)/C=N/c1nnc(SCc2ccc(cc2)[N+](=O)[O-])s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K09 compound treatment 0.0845 0.014 1.66 1.6627 1.0 1435466 MixCom1_000229 CN(CCOC(=O)c1ccc(Cl)cc1)c2nc3cc(Cl)ccc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K10 compound treatment 0.0845 0.014 1.66 1.6627 1.0 1088064 MixCom1_000230 CC1=C(C(=O)Nc2ccccc2)S(=O)(=O)CCO1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K11 compound treatment 0.088 0.0175 2.08 2.0774 1.0 1016457 MixCom1_000231 CC1(C)CCC(C)(C)c2cc3c(cc21)C(C)(C)CCC3(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K12 compound treatment 0.08 0.00953 1.13 1.1295 1.0 2069405 MixCom1_000232 CC1=N/C(=C\c2cccc(c2)[N+](=O)[O-])/C(=O)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K13 compound treatment 0.0825 0.012 1.43 1.4257 1.0 2069406 MixCom1_000233 FC(F)(F)c1cccc(c1)C(=O)CC#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K14 compound treatment 0.082 0.0115 1.37 1.3665 1.0 1007168 MixCom1_000234 CN(C)Cc1c(O)ccc2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K15 compound treatment 0.093 0.0225 2.67 2.6698 1.0 2069407 MixCom1_000235 CC(=O)Nc1ccc(OC(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K16 compound treatment 0.078 0.00753 0.89 0.8925 1.0 1075367 MixCom1_000236 CC(C)(C)c1ccc(cc1)C(=O)C2CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K17 compound treatment 0.1095 0.039 4.62 4.6249 1.0 1063399 MixCom1_000237 CC(=O)Nc1ccc(cc1C(=O)O)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K18 compound treatment 0.0955 0.025 2.97 2.9661 1.0 1298979 MixCom1_000238 CCOC(=O)c1nc(sc1C(=O)OCC)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K19 compound treatment 0.0985 0.028 3.32 3.3215 1.0 2069408 MixCom1_000239 CC(=O)Nc1ccc(C)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K20 compound treatment 0.0705 3.23E-5 0.0 0.0038 1.0 2069409 MixCom1_000240 Clc1ccc(NC(=S)NCc2ccccc2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K21 compound treatment 0.07 -4.68E-4 -0.06 -0.0554 -1.0 1777053 MixCom1_000241 [O-][N+](=O)c1ccc(cc1)S(=O)(=O)N2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K22 compound treatment 0.068 -0.00247 -0.29 -0.2924 -1.0 2069410 MixCom1_000242 O/N=C\c1c[nH]c2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K23 mock treatment 0.067 -0.00347 -0.41 -0.4109 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 K24 mock treatment 0.069 -0.00147 -0.17 -0.1739 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L01 compound treatment 0.0815 0.011 1.31 1.3072 1.0 2079755 MixCom1_000243 CCCn1c(n[nH]c1=S)c2nc(OC)cc(OC)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L02 compound treatment 0.079 0.00853 1.01 1.011 1.0 2079756 MixCom1_000244 CCCN1CCC(CC1)N2CCC(CC2)C(=O)NCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L03 compound treatment 0.082 0.0115 1.37 1.3665 1.0 2079757 MixCom1_000245 COc1cc(OC)nc(n1)c2n[nH]c(=S)n2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L04 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079758 MixCom1_000246 CCCN1CCC(CC1)N2CCC(CC2)C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L05 compound treatment 0.0925 0.022 2.61 2.6106 1.0 2079759 MixCom1_000247 COc1cc(OC)nc(n1)c2n[nH]c(=S)n2c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L06 compound treatment 0.077 0.00653 0.77 0.774 1.0 2079760 MixCom1_000248 CCCN1CCC(CC1)N2CCC(CC2)C(=O)NC(C)c3ccc(cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L07 compound treatment 0.0935 0.023 2.73 2.7291 1.0 2079761 MixCom1_000249 O/C=C(\C=O)/c1cc(F)cc(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L08 compound treatment 0.092 0.0215 2.55 2.5514 1.0 2079762 MixCom1_000250 CCCN1CCC(CC1)N2CCC(CC2)C(=O)N3CCN(CC3)C(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L09 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079763 MixCom1_000251 Fc1cc(F)cc(c1)c2cn[nH]c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L10 compound treatment 0.0875 0.017 2.02 2.0182 1.0 2079764 MixCom1_000252 Fc1ccc(cc1)N2CCN(CC2)C3CCNCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L11 compound treatment 0.0885 0.018 2.14 2.1366 1.0 2079765 MixCom1_000253 Cn1cc(cn1)c2cc(F)cc(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L12 compound treatment 0.1025 0.032 3.8 3.7955 1.0 1341399 MixCom1_000254 CC(=O)N1CCC(CC1)N2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L13 compound treatment 0.0895 0.019 2.26 2.2551 1.0 2079766 MixCom1_000255 OCCn1cc(cn1)c2cc(F)cc(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L14 compound treatment 0.104 0.0335 3.97 3.9732 1.0 2079767 MixCom1_000256 OC(=O)/C=C\C(=O)N1CCC(CC1)N2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L15 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2079768 MixCom1_000257 Fc1cc(F)cc(c1)c2cnn(c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L16 compound treatment 0.092 0.0215 2.55 2.5514 1.0 2079769 MixCom1_000258 OC(=O)CCCC(=O)N1CCC(CC1)N2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L17 compound treatment 0.0875 0.017 2.02 2.0182 1.0 2079770 MixCom1_000259 OC(=O)c1cccc(c1)n2cc(cn2)c3cc(F)cc(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L18 compound treatment 0.086 0.0155 1.84 1.8404 1.0 2079771 MixCom1_000260 OC(=O)COCC(=O)N1CCC(CC1)N2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L19 compound treatment 0.075 0.00453 0.54 0.537 1.0 2079772 MixCom1_000261 OC(=O)c1ccc(cc1)n2cc(cn2)c3cc(F)cc(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L20 compound treatment 0.07 -4.68E-4 -0.06 -0.0554 -1.0 2079773 MixCom1_000262 Cc1ccccc1C(=O)N2CCC(CC2)N3CCN(CC3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L21 compound treatment 0.095 0.0245 2.91 2.9068 1.0 2079774 MixCom1_000263 CCNC(=O)N(C1CC1)C2CCN(CCc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L22 compound treatment 0.077 0.00653 0.77 0.774 1.0 2079775 MixCom1_000264 Fc1ccc(cc1)N2CCN(CC2)C3CCN(CC3)C(=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L23 mock treatment 0.0705 3.23E-5 0.0 0.0038 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 L24 mock treatment 0.072 0.00153 0.18 0.1816 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M01 compound treatment 0.081 0.0105 1.25 1.248 1.0 1430441 MixCom1_000265 CCN(C(=S)Nc1ccc(OC)cc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M02 compound treatment 0.0805 0.01 1.19 1.1887 1.0 2069411 MixCom1_000266 CCCc1ccc(cc1)/C(=N/O)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M03 compound treatment 0.0905 0.02 2.37 2.3736 1.0 1367521 MixCom1_000267 Clc1ccccc1c2cnoc2C(=O)N3CCN(CCOc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M04 compound treatment 0.086 0.0155 1.84 1.8404 1.0 2069412 MixCom1_000268 Cc1ccc(C(=O)c2cc(Cl)cc(Cl)c2)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M05 compound treatment 0.083 0.0125 1.48 1.4849 1.0 1578471 MixCom1_000269 Fc1cccc(Cl)c1CN2CCC(CC2)NC(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M06 compound treatment 0.078 0.00753 0.89 0.8925 1.0 1489129 MixCom1_000270 Cc1sc(N)nc1c2ccc(C)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M07 compound treatment 0.087 0.0165 1.96 1.9589 1.0 1286673 MixCom1_000271 CC(C)(C)OC(=O)NC1CCN(CC1)C(=O)Nc2ccc(F)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M08 compound treatment 0.0835 0.013 1.54 1.5442 1.0 2069413 MixCom1_000272 CCOC(=O)CSc1nnc(N)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M09 compound treatment 0.0815 0.011 1.31 1.3072 1.0 2069414 MixCom1_000273 Cn1c(S)ncc1c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M10 compound treatment 0.0825 0.012 1.43 1.4257 1.0 2069415 MixCom1_000274 CC(=O)C1=C(C)OC(=C(C#N)C1c2ccco2)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M11 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2069416 MixCom1_000275 FC(F)(F)c1cccc(CSc2nnc(S)s2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M12 compound treatment 0.0795 0.00903 1.07 1.0702 1.0 1026284 MixCom1_000276 NC(c1ccccc1)c2c(O)ccc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M13 compound treatment 0.0795 0.00903 1.07 1.0702 1.0 2069417 MixCom1_000277 CC(=O)Nc1ccc(OC(F)(F)F)cc1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M14 compound treatment 0.0785 0.00803 0.95 0.9517 1.0 1031546 MixCom1_000278 [O-][N+](=O)c1cccc(c1)C(OC(=O)c2ccccc2)C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M15 compound treatment 0.0805 0.01 1.19 1.1887 1.0 1002353 MixCom1_000279 CC(=O)Nc1ccccc1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M16 compound treatment 0.0825 0.012 1.43 1.4257 1.0 2069418 MixCom1_000280 OC(C1CC1)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M17 compound treatment 0.0835 0.013 1.54 1.5442 1.0 2069419 MixCom1_000281 CC(=O)Nc1ccccc1OC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M18 compound treatment 0.083 0.0125 1.48 1.4849 1.0 1666852 MixCom1_000282 OCc1cc(=O)c(O)c(CO)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M19 compound treatment 0.072 0.00153 0.18 0.1816 1.0 2069420 MixCom1_000283 Brc1ccccc1NC(=O)Nc2ccccc2Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M20 compound treatment 0.069 -0.00147 -0.17 -0.1739 -1.0 2069421 MixCom1_000284 Brc1ccc(NC(=S)NCc2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M21 compound treatment 0.07 -4.68E-4 -0.06 -0.0554 -1.0 1027080 MixCom1_000285 Nc1ccc(cc1)S(=O)(=O)N2CCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M22 compound treatment 0.068 -0.00247 -0.29 -0.2924 -1.0 1026358 MixCom1_000286 CCCC(CC(=O)O)(C(=O)O)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M23 mock treatment 0.0685 -0.00197 -0.23 -0.2332 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 M24 mock treatment 0.0695 -9.68E-4 -0.11 -0.1147 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N01 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2079776 MixCom1_000287 CC(C)(C)C(=O)N(C1CC1)C2CCN(CCc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N02 compound treatment 0.0815 0.011 1.31 1.3072 1.0 2079777 MixCom1_000288 Fc1ccc(cc1)N2CCN(CC2)C3CCN(CC3)S(=O)(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N03 compound treatment 0.0995 0.029 3.44 3.44 1.0 2079778 MixCom1_000289 O=C(N(C1CC1)C2CCN(CCc3ccccc3)CC2)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N04 compound treatment 0.0945 0.024 2.85 2.8476 1.0 2079779 MixCom1_000290 CC(=O)Nc1ccc(cc1)S(=O)(=O)N2CCC(CC2)N3CCN(CC3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N05 compound treatment 0.09 0.0195 2.31 2.3144 1.0 2079780 MixCom1_000291 O=C(/C=C/c1ccccc1)N(C2CC2)C3CCN(CCc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N06 compound treatment 0.0785 0.00803 0.95 0.9517 1.0 2079781 MixCom1_000292 OC(=O)C1CCCN(C1)c2ccc(cn2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N07 compound treatment 0.1055 0.035 4.15 4.151 1.0 2079782 MixCom1_000293 O=S(=O)(N(C1CC1)C2CCN(CCc3ccccc3)CC2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N08 compound treatment 0.0915 0.021 2.49 2.4921 1.0 2079783 MixCom1_000294 CNC(=O)C1CCCN(C1)c2ccc(cn2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N09 compound treatment 0.087 0.0165 1.96 1.9589 1.0 2079784 MixCom1_000295 Cc1cc(C)cc(NC(=O)N(C2CC2)C3CCN(CCc4ccccc4)CC3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N10 compound treatment 0.085 0.0145 1.72 1.7219 1.0 2079785 MixCom1_000296 FC(F)(F)c1ccc(nc1)N2CCCC(C2)C(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N11 compound treatment 0.085 0.0145 1.72 1.7219 1.0 2079786 MixCom1_000297 FC(F)(F)c1cccc(c1)C(=O)N(C2CC2)C3CCN(CCc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N12 compound treatment 0.0895 0.019 2.26 2.2551 1.0 2079787 MixCom1_000298 FC(F)(F)c1ccc(nc1)N2CCCC(C2)C(=O)NCc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N13 compound treatment 0.091 0.0205 2.43 2.4329 1.0 2079788 MixCom1_000299 Clc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CCc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N14 compound treatment 0.0845 0.014 1.66 1.6627 1.0 2079789 MixCom1_000300 COC(=O)C1CCN(CC1)C(=O)C2CCCN(C2)c3ccc(cn3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N15 compound treatment 0.092 0.0215 2.55 2.5514 1.0 2079790 MixCom1_000301 CC(=O)Nc1ccc(cc1)S(=O)(=O)N(C2CC2)C3CCN(CCc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N16 compound treatment 0.087 0.0165 1.96 1.9589 1.0 2079791 MixCom1_000302 CCCCCCCCCCCCNC(=O)C1CCCN(C1)c2ccc(cn2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N17 compound treatment 0.1005 0.03 3.56 3.5585 1.0 2079792 MixCom1_000303 Fc1cc(F)cc(c1)c2cnoc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N18 compound treatment 0.089 0.0185 2.2 2.1959 1.0 2079793 MixCom1_000304 CN1CCC(CC1)N2CCCC(C2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N19 compound treatment 0.0925 0.022 2.61 2.6106 1.0 2079794 MixCom1_000305 Clc1ccc(cc1)c2cnoc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N20 compound treatment 0.0735 0.00303 0.36 0.3593 1.0 2079795 MixCom1_000306 CCCN1CCC(CC1)N2CCCC(C2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N21 compound treatment 0.083 0.0125 1.48 1.4849 1.0 2079796 MixCom1_000307 c1nocc1c2nc3ccccc3o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N22 compound treatment 0.073 0.00253 0.3 0.3 1.0 2079797 MixCom1_000308 CN1CCC(CC1)N2CCCC(C2)C(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N23 mock treatment 0.074 0.00353 0.42 0.4185 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 N24 mock treatment 0.0735 0.00303 0.36 0.3593 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O01 compound treatment 0.08 0.00953 1.13 1.1295 1.0 2069422 MixCom1_000309 CCN(C(=S)Nc1c(C)cccc1C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O02 compound treatment 0.077 0.00653 0.77 0.774 1.0 2069423 MixCom1_000310 CCCc1ccc(NC(=O)C)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O03 compound treatment 0.077 0.00653 0.77 0.774 1.0 1211065 MixCom1_000311 Clc1ccc(cc1)C(=O)N2CCN(CCOc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O04 compound treatment 0.08 0.00953 1.13 1.1295 1.0 1281850 MixCom1_000312 CC(=O)NCc1cccnc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O05 compound treatment 0.083 0.0125 1.48 1.4849 1.0 1140212 MixCom1_000313 Fc1cccc(Cl)c1CN2CCC(CC2)NC(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O06 compound treatment 0.0765 0.00603 0.71 0.7148 1.0 2069424 MixCom1_000314 C/C(=N\Cc1ccccc1)/c2ccccc2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O07 compound treatment 0.086 0.0155 1.84 1.8404 1.0 1181278 MixCom1_000315 CCCCc1ccc(NC(=O)N2CCC(CC2)NC(=O)OC(C)(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O08 compound treatment 0.0785 0.00803 0.95 0.9517 1.0 2069425 MixCom1_000316 CCCCCCSc1nnc(N)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O09 compound treatment 0.086 0.0155 1.84 1.8404 1.0 1716032 MixCom1_000317 NC(=O)C(C(=O)N)c1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O10 compound treatment 0.0805 0.01 1.19 1.1887 1.0 2069426 MixCom1_000318 O=C1CC(C=C1Nc2ccccc2)N3CCN(CC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O11 compound treatment 0.083 0.0125 1.48 1.4849 1.0 1554557 MixCom1_000319 Nc1nc(=N)nc(S)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O12 compound treatment 0.081 0.0105 1.25 1.248 1.0 1170762 MixCom1_000320 CCC(CC)(c1cc(C)c(O)c(C)c1)c2cc(C)c(O)c(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O13 compound treatment 0.0775 0.00703 0.83 0.8333 1.0 2069427 MixCom1_000321 FC(F)(F)Oc1ccccc1NCN2C(=O)CCC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O14 compound treatment 0.0765 0.00603 0.71 0.7148 1.0 2069428 MixCom1_000322 CC(C(Nc1ccccc1)c2ccccc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O15 compound treatment 0.081 0.0105 1.25 1.248 1.0 2069429 MixCom1_000323 COC(=O)Nc1cc(Cl)cc(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O16 compound treatment 0.0825 0.012 1.43 1.4257 1.0 1257530 MixCom1_000324 OCC(O)COc1ccc(Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O17 compound treatment 0.0835 0.013 1.54 1.5442 1.0 1053294 MixCom1_000325 O=C(CC#N)N1CCCCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O18 compound treatment 0.077 0.00653 0.77 0.774 1.0 1083221 MixCom1_000326 Cc1cc(C)cc(OCCC#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O19 compound treatment 0.076 0.00553 0.66 0.6555 1.0 2069430 MixCom1_000327 CCOC(=O)c1c[nH]c2c(OC(F)(F)F)cccc2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O20 compound treatment 0.069 -0.00147 -0.17 -0.1739 -1.0 1136526 MixCom1_000328 CCC(=O)Oc1c(C)cc(O)c2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O21 compound treatment 0.072 0.00153 0.18 0.1816 1.0 1026723 MixCom1_000329 [O-][N+](=O)c1ccc(cc1)S(=O)(=O)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O22 compound treatment 0.0745 0.00403 0.48 0.4778 1.0 1416824 MixCom1_000330 O=c1cc(c2ccccc2)c3ccccc3[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O23 mock treatment 0.0725 0.00203 0.24 0.2408 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 O24 mock treatment 0.069 -0.00147 -0.17 -0.1739 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P01 compound treatment 0.0795 0.00903 1.07 1.0702 1.0 2079798 MixCom1_000331 c1nc(co1)c2ccnc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P02 compound treatment 0.063 -0.00747 -0.88 -0.8849 -1.0 2079799 MixCom1_000332 OC(=O)C1CCN(CC1)C2CCN(CCc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P03 compound treatment 0.072 0.00153 0.18 0.1816 1.0 2079800 MixCom1_000333 c1nocc1c2ccc(cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P04 compound treatment 0.07 -4.68E-4 -0.06 -0.0554 -1.0 2079801 MixCom1_000334 OC(=O)C1CCCN(C1)C2CCN(CCc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P05 compound treatment 0.077 0.00653 0.77 0.774 1.0 2079802 MixCom1_000335 OC(=O)C1CCN(CC1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P06 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079803 MixCom1_000336 CCNC(=O)C1CCCN(C1)C2CCN(CCc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P07 compound treatment 0.092 0.0215 2.55 2.5514 1.0 2079804 MixCom1_000337 CC(C)NC(=O)C1CCN(CC1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P08 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079805 MixCom1_000338 O=C(C1CCCN(C1)C2CCN(CCc3ccccc3)CC2)N4CCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P09 compound treatment 0.086 0.0155 1.84 1.8404 1.0 2079806 MixCom1_000339 O=C(NCCc1ccccc1)C2CCN(CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P10 compound treatment 0.087 0.0165 1.96 1.9589 1.0 2079807 MixCom1_000340 CCCCNC(=O)C1CCN(CC1)C2CCN(CCc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P11 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079808 MixCom1_000341 COc1ccccc1CNC(=O)C2CCN(CC2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P12 compound treatment 0.0925 0.022 2.61 2.6106 1.0 2079809 MixCom1_000342 CCCCCCCCCCCCNC(=O)C1CCCN(C1)C2CCN(CCC)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P13 compound treatment 0.089 0.0185 2.2 2.1959 1.0 2079810 MixCom1_000343 CN1CCC(CC1)N(C2CC2)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P14 compound treatment 0.091 0.0205 2.43 2.4329 1.0 2079811 MixCom1_000344 COc1cc(OC)nc(n1)N2CCC(CC2)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P15 compound treatment 0.0805 0.01 1.19 1.1887 1.0 2079812 MixCom1_000345 CN1CCC(CC1)N(C2CC2)C(=O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P16 compound treatment 0.0825 0.012 1.43 1.4257 1.0 2079813 MixCom1_000346 COc1cc(OC)nc(n1)N2CCC(CC2)C(=O)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P17 compound treatment 0.097 0.0265 3.14 3.1438 1.0 2079814 MixCom1_000347 CN1CCC(CC1)N(C2CC2)C(=O)COCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P18 compound treatment 0.0855 0.015 1.78 1.7812 1.0 2079815 MixCom1_000348 COc1cc(OC)nc(n1)N2CCC(CC2)C(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P19 compound treatment 0.088 0.0175 2.08 2.0774 1.0 2079816 MixCom1_000349 CCCN1CCC(CC1)N(C2CC2)C(=O)/C=C\C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P20 compound treatment 0.0765 0.00603 0.71 0.7148 1.0 2079817 MixCom1_000350 COc1cc(OC)nc(n1)N2CCC(CC2)C(=O)NCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P21 compound treatment 0.086 0.0155 1.84 1.8404 1.0 2079818 MixCom1_000351 CC(=O)N1CCC(CC1)N(C2CC2)C(=O)CCCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P22 compound treatment 0.077 0.00653 0.77 0.774 1.0 2079819 MixCom1_000352 COc1cc(OC)nc(n1)N2CCC(CC2)C(=O)NCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P23 mock treatment 0.0775 0.00703 0.83 0.8333 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.541 P24 mock treatment 0.0695 -9.68E-4 -0.11 -0.1147 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A01 mock treatment 0.088 0.0118 1.39 1.3946 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A02 mock treatment 0.077 7.7E-4 0.09 0.0912 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A03 compound treatment 0.077 7.7E-4 0.09 0.0912 1.0 1907783 MixCom2_000001 ClC1=C(N2CCC(CC2)C(=O)N3CCOCC3)C(=O)c4ccccc4C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A04 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970020 MixCom2_000002 CC(CCOC(=O)NNC(=O)c1snnc1c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A05 compound treatment 0.0905 0.0143 1.69 1.6908 1.0 1907784 MixCom2_000003 COC(=O)CC(NS(=O)(=O)c1cccs1)c2cccc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A06 compound treatment 0.0625 -0.0137 -1.63 -1.6269 -1.0 1970021 MixCom2_000004 Cn1cccc1C(=O)NNC(=O)OCCc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A07 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1907785 MixCom2_000005 COc1ccc(cc1)C(CC(=O)N2CCN(C)CC2)NC(=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A08 compound treatment 0.0885 0.0123 1.45 1.4539 1.0 1970022 MixCom2_000006 CN1CCCC1CCOC(=O)NNC(=O)c2sc(nc2C)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A09 compound treatment 0.072 -0.00423 -0.5 -0.5012 -1.0 1907786 MixCom2_000007 COC(=O)CC(NC(=O)c1cccc(Cl)c1)c2cccc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A10 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970023 MixCom2_000008 Cc1cccc(CCOC(=O)NNC(=O)c2ccc(F)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A11 compound treatment 0.0715 -0.00473 -0.56 -0.5605 -1.0 1907787 MixCom2_000009 COc1ccc(cc1)C(CC(=O)N2CCCCC2)NC(=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A12 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1970024 MixCom2_000010 COc1ccc(cc1)N2CCN(CC2C)C(=O)OCCN3CCN(Cc4cc5OCOc5c(OC)c4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A13 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1907788 MixCom2_000011 CNC(=S)NNC(=O)c1csc(n1)n2nc(C)cc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A14 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970025 MixCom2_000012 CC(C)(C)OC(=O)N(CCOC(=O)NC1CCN(Cc2ccccc2)C1)Cc3cc4ccccc4c5ccccc35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A15 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1907789 MixCom2_000013 Cc1cc(n(n1)c2nc(cs2)C(=O)N/N=C/c3cccnc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A16 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970026 MixCom2_000014 [O-][N+](=O)c1ccc(NCCNC(=O)OCc2nc(cs2)c3ccc(Cl)cc3)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A17 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1907790 MixCom2_000015 CCNC(=S)NNC(=O)c1csc(n1)n2nc(C)cc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A18 compound treatment 0.069 -0.00723 -0.86 -0.8567 -1.0 1970027 MixCom2_000016 Cc1ccc(CCOC(=O)NNC(=O)c2csc(n2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A19 compound treatment 0.077 7.7E-4 0.09 0.0912 1.0 1459959 MixCom2_000017 Fc1cccc(COc2cc(NC(=O)C3CC3)c(Cl)cc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A20 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970028 MixCom2_000018 Cc1cc(C)c(CCOC(=O)N2CCN(CC2)c3ccc(cn3)C(F)(F)F)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A21 compound treatment 0.072 -0.00423 -0.5 -0.5012 -1.0 1907791 MixCom2_000019 Cc1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A22 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1970029 MixCom2_000020 COc1cc(Br)c(CN2CCN(CC2)C(=O)OCC3CC4CC3C=C4)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A23 mock treatment 0.08 0.00377 0.45 0.4467 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 A24 mock treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B01 mock treatment 0.0865 0.0103 1.22 1.2169 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B02 mock treatment 0.0795 0.00327 0.39 0.3874 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B03 compound treatment 0.0845 0.00827 0.98 0.9799 1.0 1970030 MixCom2_000021 COCc1nc2ccc(Br)cc2c3C(=O)N(CCCN4CCCC4=O)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B04 compound treatment 0.0855 0.00927 1.1 1.0984 1.0 1970031 MixCom2_000022 O=C(N1CCN(CC1)c2ccccc2)c3ccc(s3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B05 compound treatment 0.0815 0.00527 0.62 0.6244 1.0 1970032 MixCom2_000023 Cc1ccc(s1)C(=O)NN2C(=O)c3c(C2=O)c4cc(Cl)ccc4nc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B06 compound treatment 0.0835 0.00727 0.86 0.8614 1.0 1970033 MixCom2_000024 Cc1nc(cn1CCC(=O)N2CCN(C/C=C/c3ccccc3)CC2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B07 compound treatment 0.077 7.7E-4 0.09 0.0912 1.0 1970034 MixCom2_000025 CCN(CC)c1ccc(cc1)C(=O)NN2C(=O)c3c(C2=O)c4cc(C)ccc4nc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B08 compound treatment 0.0815 0.00527 0.62 0.6244 1.0 1970035 MixCom2_000026 CN(C)c1ccc(CNC(=O)c2cc(=O)n([nH]2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B09 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1970036 MixCom2_000027 COCc1nc2ccccc2c3C(=O)N(CCC4CCCN4C)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B10 compound treatment 0.069 -0.00723 -0.86 -0.8567 -1.0 1970037 MixCom2_000028 NC(=O)C(Cc1ccc(O)cc1)NC(=O)CCC(=O)Nc2ccc(Br)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B11 compound treatment 0.079 0.00277 0.33 0.3282 1.0 1970038 MixCom2_000029 COCC(Cc1ccccc1)N2C(=O)c3c(C2=O)c4cc(C)ccc4nc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B12 compound treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 1970039 MixCom2_000030 FC(F)(F)c1cccc(c1)C(=O)NNC(=O)c2ccc3nsnc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B13 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1970040 MixCom2_000031 O=C1N(C2CCCCNC2=O)C(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B14 compound treatment 0.07 -0.00623 -0.74 -0.7382 -1.0 1970041 MixCom2_000032 COC(=O)CCCCC(=O)NNC(=O)c1ccco1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B15 compound treatment 0.0715 -0.00473 -0.56 -0.5605 -1.0 1970042 MixCom2_000033 CC(C)c1nc2ccc(F)cc2c3C(=O)N(NC(=O)CC4(CC5CC6CC(C5)C4)C6)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B16 compound treatment 0.0695 -0.00673 -0.8 -0.7975 -1.0 1970043 MixCom2_000034 COc1cc(CCNC(=O)c2cc(C)n(C)n2)cc(OC)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B17 compound treatment 0.0715 -0.00473 -0.56 -0.5605 -1.0 1970044 MixCom2_000035 Clc1cc2OCOc2cc1CN3CCC(C3)N4C(=O)c5ccccc5C4=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B18 compound treatment 0.0695 -0.00673 -0.8 -0.7975 -1.0 1970045 MixCom2_000036 COC(=O)CCCC(=O)NNC(=O)c1sc(SC)c2c1CCCC32SCCS3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B19 compound treatment 0.0825 0.00627 0.74 0.7429 1.0 1970046 MixCom2_000037 CC(C)c1nc2ccc(F)cc2c3C(=O)N(Cc4nc5ccccc5[nH]4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B20 compound treatment 0.079 0.00277 0.33 0.3282 1.0 1970047 MixCom2_000038 CCN(CCNC(=O)CCC(=O)c1ccccc1)c2cccc(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B21 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970048 MixCom2_000039 COCc1nc2ccc(C)cc2c3C(=O)N(NC(=O)c4ccc5OCOc5c4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B22 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970049 MixCom2_000040 CCN1CC(CN1CC)NC(=O)c2ccoc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B23 mock treatment 0.077 7.7E-4 0.09 0.0912 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 B24 mock treatment 0.071 -0.00523 -0.62 -0.6197 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C01 mock treatment 0.085 0.00877 1.04 1.0391 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C02 mock treatment 0.082 0.00577 0.68 0.6837 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C03 compound treatment 0.0845 0.00827 0.98 0.9799 1.0 1700977 MixCom2_000041 CC(C)(C)C(=O)n1cc(CCN2CCS(=O)(=O)CC2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C04 compound treatment 0.0865 0.0103 1.22 1.2169 1.0 1970050 MixCom2_000042 CCCN(CCC)S(=O)(=O)c1ccc(cc1)C(=O)NNC(=O)OCCCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C05 compound treatment 0.0895 0.0133 1.57 1.5723 1.0 1907792 MixCom2_000043 Fc1ccc(cc1)c2ccnn2c3nc(cs3)c4ccc(Br)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C06 compound treatment 0.0835 0.00727 0.86 0.8614 1.0 1970051 MixCom2_000044 COc1ccccc1CCOC(=O)NCCN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C07 compound treatment 0.085 0.00877 1.04 1.0391 1.0 1907793 MixCom2_000045 Cc1ccc(C)n1c2ccsc2c3cc4nccc(c5ccc(C)cc5)n4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C08 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970052 MixCom2_000046 O=C(Cc1csc(n1)c2ccccc2)NNC(=O)OCc3cccc(Oc4ccccc4)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C09 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1907794 MixCom2_000047 CC(C)CC(=O)c1c[nH]c(c1)C(=O)NCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C10 compound treatment 0.084 0.00777 0.92 0.9206 1.0 1970053 MixCom2_000048 OC1CCCN(C1)C(=O)OCCc2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C11 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1907795 MixCom2_000049 COc1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCCCn3ccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C12 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970054 MixCom2_000050 CCN(Cc1ccncc1)C(=O)C(COC(=O)N2CCN(CC2)c3sc(cc3[N+](=O)[O-])S(=O)(=O)N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C13 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1562281 MixCom2_000051 CC(C)CC(=O)c1c[nH]c(c1)C(=O)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C14 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1970055 MixCom2_000052 CC1CC1COC(=O)NNC(=O)CC2Sc3ccccc3NC2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C15 compound treatment 0.0785 0.00227 0.27 0.269 1.0 1525424 MixCom2_000053 COc1ccc(CNC(=O)c2cc(c[nH]2)C(=O)c3ccc(OC)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C16 compound treatment 0.0785 0.00227 0.27 0.269 1.0 1970056 MixCom2_000054 CC(C)(C)c1cc([nH]n1)C(=O)NNC(=O)OCCN2CCN(Cc3cc4ccccc4o3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C17 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1467365 MixCom2_000055 CN(CCOc1ccc(cc1)c2ccn(n2)c3ncccn3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C18 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970057 MixCom2_000056 CC(CCOC(=O)NCc1ccc(Cl)cc1Cl)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C19 compound treatment 0.077 7.7E-4 0.09 0.0912 1.0 1907796 MixCom2_000057 CCOC(=O)c1cnn(c2nc(cs2)c3ccc(C)cc3)c1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C20 compound treatment 0.077 7.7E-4 0.09 0.0912 1.0 1970058 MixCom2_000058 CC(CNC(=O)OCC#Cc1ccccc1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C21 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1907797 MixCom2_000059 CCOC(=O)c1cnn(c2nc(cs2)c3ccc(F)cc3)c1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C22 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970059 MixCom2_000060 Fc1ccc(COC(=O)N2CCN(CC2)c3ccccc3Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C23 mock treatment 0.0795 0.00327 0.39 0.3874 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 C24 mock treatment 0.0835 0.00727 0.86 0.8614 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D01 mock treatment 0.0775 0.00127 0.15 0.1505 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D02 mock treatment 0.078 0.00177 0.21 0.2097 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D03 compound treatment 0.0815 0.00527 0.62 0.6244 1.0 1970060 MixCom2_000061 COCc1nc2ccc(Br)cc2c3C(=O)N(CC4(O)CCCCC4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D04 compound treatment 0.0835 0.00727 0.86 0.8614 1.0 1970061 MixCom2_000062 O=C(CCC(=O)c1ccccc1)NC2CCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D05 compound treatment 0.084 0.00777 0.92 0.9206 1.0 1970062 MixCom2_000063 Cc1nc2ccc(Cl)cc2c3C(=O)N(Cc4ccccc4OC(F)(F)F)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D06 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1970063 MixCom2_000064 CCn1c2ccccc2c3cc(CN4CCN(CC4)C(=O)c5cccnc5Oc6ccc(C)cc6)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D07 compound treatment 0.0965 0.0203 2.4 2.4018 1.0 1970064 MixCom2_000065 CCN(CCN1C(=O)c2c(C1=O)c3cc(C)ccc3nc2C)c4cccc(C)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D08 compound treatment 0.085 0.00877 1.04 1.0391 1.0 1970065 MixCom2_000066 CC(=O)N1CCN(CC1)C(=O)CCC(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D09 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970066 MixCom2_000067 COCc1nc2ccccc2c3C(=O)N(NC(=O)C4(CCC4)c5ccc(Cl)cc5)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D10 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970067 MixCom2_000068 CSc1ncc(C(=O)NNC(=O)OCc2ccc(F)cc2Cl)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D11 compound treatment 0.083 0.00677 0.8 0.8022 1.0 1970068 MixCom2_000069 Cc1ccc2nc(C)c3C(=O)N(NC(=O)c4ccccc4Cl)C(=O)c3c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D12 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970069 MixCom2_000070 COc1cc(OC)c(CN2CCC(C2)NC(=O)c3ccc(cc3)n4nc(cc4C(C)(C)C)C(C)(C)C)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D13 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970070 MixCom2_000071 CN(C)c1ccc(cc1)C(=O)NN2C(=O)c3ccccc3C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D14 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1970071 MixCom2_000072 CC(C)(C)OC(=O)NC(CC1CCCCC1)C(=O)NNC(=O)c2ccco2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D15 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970072 MixCom2_000073 CC(C)c1nc2ccc(F)cc2c3C(=O)N(NC(=O)c4cc(n[nH]4)C(C)(C)C)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D16 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1970073 MixCom2_000074 Cn1c(CCC(=O)NNC(=O)Cc2ccsc2)nc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D17 compound treatment 0.0905 0.0143 1.69 1.6908 1.0 1970074 MixCom2_000075 COc1cc(nc2ccccc12)C(=O)NN3C(=O)c4ccccc4C3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D18 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970075 MixCom2_000076 Clc1ccc(cc1)S(=O)(=O)N(CCC(=O)NNC(=O)c2ccccc2c3ccccc3)Cc4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D19 compound treatment 0.081 0.00477 0.57 0.5652 1.0 1970076 MixCom2_000077 CC(C)c1nc2ccc(F)cc2c3C(=O)N(Cc4ccccc4OC(F)(F)F)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D20 compound treatment 0.083 0.00677 0.8 0.8022 1.0 1970077 MixCom2_000078 CC(C)(C)OC(=O)NC(CCCCNC(=O)c1cccnc1)C(=O)NNC(=O)C(Cc2c[nH]cn2)NC(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D21 compound treatment 0.081 0.00477 0.57 0.5652 1.0 1970078 MixCom2_000079 COCc1nc2ccc(C)cc2c3C(=O)N(NC(=O)C(=O)N4CCCc5ccccc45)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D22 compound treatment 0.079 0.00277 0.33 0.3282 1.0 1970079 MixCom2_000080 FC(F)(F)c1cccc(c1)N2CCN(CC2)C(=O)CCc3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D23 mock treatment 0.08 0.00377 0.45 0.4467 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 D24 mock treatment 0.082 0.00577 0.68 0.6837 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E01 mock treatment 0.079 0.00277 0.33 0.3282 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E02 mock treatment 0.079 0.00277 0.33 0.3282 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E03 compound treatment 0.082 0.00577 0.68 0.6837 1.0 1907798 MixCom2_000081 FC(F)(F)c1cc(nc2cc(nn12)c3ccc(Cl)c(Cl)c3)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E04 compound treatment 0.088 0.0118 1.39 1.3946 1.0 1970080 MixCom2_000082 COc1ccc(CCCOC(=O)NNC(=O)C2CN(C)CCN2C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E05 compound treatment 0.086 0.00977 1.16 1.1576 1.0 1907799 MixCom2_000083 Cc1onc(c1C(=O)N2CCN=C(C=C2)C(F)(F)Cl)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E06 compound treatment 0.0855 0.00927 1.1 1.0984 1.0 1970081 MixCom2_000084 CC(C)C(NC(=O)OCCc1cccc(Cl)c1)C(=O)OCc2ccc(cc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E07 compound treatment 0.079 0.00277 0.33 0.3282 1.0 1907800 MixCom2_000085 CC(C)(C)c1ccc(cc1)S(=O)(=O)N2CCN=C(C=C2)C(F)(F)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E08 compound treatment 0.08 0.00377 0.45 0.4467 1.0 1970082 MixCom2_000086 CSc1sc(cc1c2nc(C)cs2)C(=O)NNC(=O)OCCN3C(=O)c4ccccc4C3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E09 compound treatment 0.0785 0.00227 0.27 0.269 1.0 1907801 MixCom2_000087 Cc1cc(C)c(c(C)c1)S(=O)(=O)N2CCN=C(C=C2)C(F)(F)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E10 compound treatment 0.081 0.00477 0.57 0.5652 1.0 1970083 MixCom2_000088 CCOc1ccsc1C(=O)NNC(=O)OCCC2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E11 compound treatment 0.077 7.7E-4 0.09 0.0912 1.0 1907802 MixCom2_000089 FC(F)(Cl)C1=NCCN(C=C1)C(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E12 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1970084 MixCom2_000090 CCn1c2ccccc2c3cc(CN4CCN(CC4)C(=O)OCc5cccc(c5)C(F)(F)F)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E13 compound treatment 0.078 0.00177 0.21 0.2097 1.0 1397671 MixCom2_000091 COc1ccc(Oc2ncc(CN3CCN(CC3)c4ccccc4)s2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E14 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970085 MixCom2_000092 Cc1nc(sc1C(=O)NNC(=O)OCc2ccc(/C=C/c3ccccc3)cc2)c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E15 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1708198 MixCom2_000093 Brc1ccc(Oc2ncc(Cn3ccc4ccccc34)s2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E16 compound treatment 0.081 0.00477 0.57 0.5652 1.0 1970086 MixCom2_000094 COc1ccc(CN2CCCC(COC(=O)N3CCN(CC3)c4cc(nc5cc(nn45)C(C)(C)C)C(F)(F)F)C2)cc1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E17 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1433082 MixCom2_000095 C(c1cnc(s1)N2CCN(CC2)c3ccccc3)n4ccc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E18 compound treatment 0.089 0.0128 1.51 1.5131 1.0 1970087 MixCom2_000096 O=C(NNC(=O)c1snnc1c2ccccc2)OCCCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E19 compound treatment 0.089 0.0128 1.51 1.5131 1.0 1535695 MixCom2_000097 Cc1ccc(C)n1c2ccsc2c3cc4nccc(CCc5ccccc5)n4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E20 compound treatment 0.0855 0.00927 1.1 1.0984 1.0 1970088 MixCom2_000098 CCC#CCOC(=O)NNC(=O)Cc1ccc(OC)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E21 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1254989 MixCom2_000099 Fc1ccccc1C(=O)n2cc(c3ccc(Cl)nn3)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E22 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1970089 MixCom2_000100 Fc1ccc(/C=C/C(=O)NNC(=O)OCC2CC2(Cl)Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E23 mock treatment 0.0795 0.00327 0.39 0.3874 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 E24 mock treatment 0.0795 0.00327 0.39 0.3874 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F01 mock treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F02 mock treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F03 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1970090 MixCom2_000101 COCc1nc2ccc(Br)cc2c3C(=O)N(NC(=O)c4ccc(cc4)N(C)C)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F04 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1970091 MixCom2_000102 COCCC(=O)N1CCN(CC1)c2ccc(cc2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F05 compound treatment 0.0885 0.0123 1.45 1.4539 1.0 1970092 MixCom2_000103 Cc1nc2ccc(Cl)cc2c3C(=O)N(CCN4CCCC4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F06 compound treatment 0.079 0.00277 0.33 0.3282 1.0 1970093 MixCom2_000104 Fc1ccc(cc1)C(=O)CCC(=O)NCC2COc3ccccc3O2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F07 compound treatment 0.078 0.00177 0.21 0.2097 1.0 1970094 MixCom2_000105 Cc1ccc2nc(C)c3C(=O)N(Cc4ccccn4)C(=O)c3c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F08 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1970095 MixCom2_000106 COc1ccc(cc1OC)C(=O)NNC(=O)c2ccoc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F09 compound treatment 0.0835 0.00727 0.86 0.8614 1.0 1970096 MixCom2_000107 COCc1nc2ccccc2c3C(=O)N(Cc4ccc(C)o4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F10 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1970097 MixCom2_000108 Cc1nn(c(C)c1CN2CCC(C2)NC(=O)c3ccccc3c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F11 compound treatment 0.09 0.0138 1.63 1.6316 1.0 1970098 MixCom2_000109 Cc1ccc2nc(C)c3C(=O)N(NC(=O)c4ccccc4C)C(=O)c3c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F12 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970099 MixCom2_000110 CC(=O)Nc1ccc(cc1NC(=O)C)C(=O)NCCOc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F13 compound treatment 0.09 0.0138 1.63 1.6316 1.0 1861039 MixCom2_000111 CC(C)(C)c1ccc(cc1)C(=O)NN2C(=O)c3ccccc3C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F14 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970100 MixCom2_000112 Cc1ccc(Oc2ncccc2C(=O)NNC(=O)C(Cc3c[nH]cn3)NC(=O)OC(C)(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F15 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1970101 MixCom2_000113 O=C1N(CCN2CCCCCC2)C(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F16 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1970102 MixCom2_000114 CCCCCCc1ccc(cc1)C(=O)N2CCN(CC2)c3ccc(cn3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F17 compound treatment 0.0925 0.0163 1.93 1.9278 1.0 1970103 MixCom2_000115 CC(=O)NC(Cc1ccccc1)C(=O)NN2C(=O)c3ccccc3C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F18 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970104 MixCom2_000116 Fc1cc(F)cc(c1)C(=O)NNC(=O)c2ccco2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F19 compound treatment 0.081 0.00477 0.57 0.5652 1.0 1970105 MixCom2_000117 CC(C)c1nc2ccc(F)cc2c3C(=O)N(CCN4CCCC4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F20 compound treatment 0.0915 0.0153 1.81 1.8093 1.0 1970106 MixCom2_000118 CC(C)NC(=O)CN1CCN(CC1)C(=O)c2ccoc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F21 compound treatment 0.077 7.7E-4 0.09 0.0912 1.0 1970107 MixCom2_000119 COCc1nc2ccc(C)cc2c3C(=O)N(NC(=O)C4CCCNC4=O)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F22 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970108 MixCom2_000120 FC(F)(F)Oc1cccc(CNC(=O)c2ccc3[nH]nnc3c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F23 mock treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 F24 mock treatment 0.0765 2.7E-4 0.03 0.032 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G01 mock treatment 0.0775 0.00127 0.15 0.1505 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G02 mock treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G03 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1907803 MixCom2_000121 CCCCCCCc1ccc(cc1)C2NC(=S)NC3=C2C(=O)c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G04 compound treatment 0.083 0.00677 0.8 0.8022 1.0 1970109 MixCom2_000122 COc1ccc2ccccc2c1CN3CCN(CC3)C(=O)OCc4ccccc4OC(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G05 compound treatment 0.0825 0.00627 0.74 0.7429 1.0 1410645 MixCom2_000123 Oc1cc2OCOc2cc1C(N3CCCC3)c4ccc(Br)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G06 compound treatment 0.078 0.00177 0.21 0.2097 1.0 1970110 MixCom2_000124 Clc1ccccc1N2CCN(CC2)C(=O)OCC3CC4CCC3C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G07 compound treatment 0.085 0.00877 1.04 1.0391 1.0 1907804 MixCom2_000125 CC1C(c2ccc(Br)cc2)c3cc4OCOc4cc3OC1(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G08 compound treatment 0.08 0.00377 0.45 0.4467 1.0 1970111 MixCom2_000126 COc1cc(Br)c(CN2CCN(CC2)C(=O)OCCCl)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G09 compound treatment 0.082 0.00577 0.68 0.6837 1.0 1662730 MixCom2_000127 Cc1ccc(cc1)C(=O)n2ccc(n2)c3ccc(cc3)n4cnc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G10 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1970112 MixCom2_000128 Cc1ccc(s1)C(=O)NNC(=O)OCCN2CCN(CCCN3c4ccccc4Sc5ccc(cc35)C(F)(F)F)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G11 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1907805 MixCom2_000129 Cc1ccc(N/C=C/C(=O)c2ccc(cc2)n3cnc4ccccc34)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G12 compound treatment 0.083 0.00677 0.8 0.8022 1.0 1970113 MixCom2_000130 Cc1ccc([N+](=O)[O-])c(COC(=O)NCCc2c[nH]c3ccc(Cl)cc23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G13 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1907806 MixCom2_000131 CC(C)(C)c1ccc(cc1)C(=O)N/N=C/c2cccn2c3nccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G14 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1970114 MixCom2_000132 COC(COC(=O)NNC(=O)/C=C/c1ccco1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G15 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1907807 MixCom2_000133 CCn1c(S)nnc1c2csc(n2)n3nc(C)cc3C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G16 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970115 MixCom2_000134 COc1ccc(CN2CCCC(COC(=O)N3CCN(CC3)C(=O)Cc4ccc(Br)cc4)C2)cc1OCc5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G17 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1907808 MixCom2_000135 Cc1cc(n(n1)c2nc(cs2)c3nnc(S)n3CC=C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G18 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970116 MixCom2_000136 CCOC(=O)C(Cc1ccccc1)NC(=O)OCCCc2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G19 compound treatment 0.0815 0.00527 0.62 0.6244 1.0 1553301 MixCom2_000137 COc1ccc(cc1)N2CCN(CC2)c3nc(cs3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G20 compound treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 1970117 MixCom2_000138 Clc1cc(ccn1)C(=O)NNC(=O)OC/C=C/COCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G21 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1261718 MixCom2_000139 Cc1ccc(cc1)S(=O)(=O)c2cnc3c(cnn3c2N)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G22 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970118 MixCom2_000140 CC(C)c1nc2ccccc2c3C(=O)N(NC(=O)c4cccc(C)c4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G23 mock treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 G24 mock treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H01 mock treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H02 mock treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H03 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1970119 MixCom2_000141 COCc1nc2ccc(Br)cc2c3C(=O)N(NC(=O)c4cnc(SC)n4C)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H04 compound treatment 0.083 0.00677 0.8 0.8022 1.0 1970120 MixCom2_000142 Cn1cccc1C(=O)NNC(=O)c2ccoc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H05 compound treatment 0.09 0.0138 1.63 1.6316 1.0 1970121 MixCom2_000143 Cc1nc2ccc(Cl)cc2c3C(=O)N(CC(O)c4ccccc4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H06 compound treatment 0.0785 0.00227 0.27 0.269 1.0 1970122 MixCom2_000144 Cc1cc(no1)c2onc(C)c2C(=O)NNC(=O)C(C3CCCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H07 compound treatment 0.0865 0.0103 1.22 1.2169 1.0 1970123 MixCom2_000145 CCn1c2ccccc2c3cc(CN4CCC(C4)N5C(=O)c6c(C5=O)c7cc(C)ccc7nc6C)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H08 compound treatment 0.08 0.00377 0.45 0.4467 1.0 1970124 MixCom2_000146 CCCCCCNC(=O)CCc1c[nH]c2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H09 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970125 MixCom2_000147 COCc1nc2ccccc2c3C(=O)N(CCOc4ccc(OC)cc4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H10 compound treatment 0.0785 0.00227 0.27 0.269 1.0 1970126 MixCom2_000148 CCn1c2ccccc2c3cc(CN4CCN(CC4)C(=O)c5cc(C)c([N+](=O)[O-])c(C)c5)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H11 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970127 MixCom2_000149 CCOc1cccc(c1)C(=O)NN2C(=O)c3c(C2=O)c4cc(C)ccc4nc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H12 compound treatment 0.082 0.00577 0.68 0.6837 1.0 1970128 MixCom2_000150 COC(=O)CCCC(=O)N1CCC(CC1)C(O)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H13 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1970129 MixCom2_000151 Fc1cccc(F)c1C(=O)Nc2ccccc2C(=O)NN3C(=O)c4ccccc4C3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H14 compound treatment 0.079 0.00277 0.33 0.3282 1.0 1970130 MixCom2_000152 Cc1nn(c(C)c1CN2CCC(C2)NC(=O)CCN(Cc3ccco3)S(=O)(=O)c4cccc5nsnc45)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H15 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970131 MixCom2_000153 O=C(NN1C(=O)c2ccccc2C1=O)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H16 compound treatment 0.072 -0.00423 -0.5 -0.5012 -1.0 1970132 MixCom2_000154 CC(C)C(NC(=O)Cc1c[nH]c2ccccc12)C(=O)NCCNC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H17 compound treatment 0.0885 0.0123 1.45 1.4539 1.0 1970133 MixCom2_000155 CC1CCCCN1CCCN2C(=O)c3ccccc3C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H18 compound treatment 0.083 0.00677 0.8 0.8022 1.0 1970134 MixCom2_000156 CC(C)(C)OC(=O)NC(CC1CCCCC1)C(=O)NNC(=O)c2ccc3nsnc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H19 compound treatment 0.079 0.00277 0.33 0.3282 1.0 1970135 MixCom2_000157 CC(C)c1nc2ccc(F)cc2c3C(=O)N(CC(O)c4ccccc4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H20 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970136 MixCom2_000158 CC(O)CNC(=O)CCc1c[nH]c2ccccc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H21 compound treatment 0.0825 0.00627 0.74 0.7429 1.0 1970137 MixCom2_000159 COCc1nc2ccc(C)cc2c3C(=O)N(NC(=O)c4sccc4N(C)C)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H22 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970138 MixCom2_000160 CC(C)NC(=O)CN1CCN(CC1)C(=O)C2Cc3ccccc3CN2C(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H23 mock treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 H24 mock treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I01 mock treatment 0.0785 0.00227 0.27 0.269 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I02 mock treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I03 compound treatment 0.08 0.00377 0.45 0.4467 1.0 1128388 MixCom2_000161 Cc1ccc(C)n1c2ccsc2c3cc4ncc(c(N)n4n3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I04 compound treatment 0.08 0.00377 0.45 0.4467 1.0 1970139 MixCom2_000162 COC(=O)C(Cc1c[nH]c2ccccc12)NC(=O)OCCn3nc(cc3c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I05 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1907809 MixCom2_000163 ClC1=C(N2CCC(CC2)C(=O)NC3CCCC3)C(=O)c4ccccc4C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I06 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1970140 MixCom2_000164 Clc1ccccc1N2CCN(CC2)C(=O)OCCc3ccccc3Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I07 compound treatment 0.081 0.00477 0.57 0.5652 1.0 1605572 MixCom2_000165 CC(C)(C)S(=O)(=O)c1cnc2c(cnn2c1N)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I08 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1970141 MixCom2_000166 OC1CCCN(C1)C(=O)OCCc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I09 compound treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 1907810 MixCom2_000167 COC(=O)CC(NC(=O)Nc1cccc(Cl)c1)c2cccc(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I10 compound treatment 0.082 0.00577 0.68 0.6837 1.0 1970142 MixCom2_000168 Cc1cc(no1)c2onc(C)c2COC(=O)N3CCN(CC3)c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I11 compound treatment 0.0715 -0.00473 -0.56 -0.5605 -1.0 1524704 MixCom2_000169 Cc1c(CS(=O)(=O)c2ccc(C)cc2)[nH]c(=O)n1c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I12 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1970143 MixCom2_000170 Oc1ccc2[nH]cc(CCNC(=O)OCc3c(F)ccc(F)c3F)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I13 compound treatment 0.0715 -0.00473 -0.56 -0.5605 -1.0 1907811 MixCom2_000171 CN(N1C(=O)C2C3OC(C=C3)C2C1=O)c4ncc(cc4Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I14 compound treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 1970144 MixCom2_000172 CSc1sc(cc1c2nc(C)cs2)C(=O)NNC(=O)OCC3CCC(=O)N3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I15 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1907812 MixCom2_000173 N#Cc1c(SCc2ccccc2)nc(c3ccccc3)c4CCCCc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I16 compound treatment 0.07 -0.00623 -0.74 -0.7382 -1.0 1970145 MixCom2_000174 COc1cc(COC(=O)N2CCN(CC2)c3ccc(cc3)C(F)(F)F)ccc1OCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I17 compound treatment 0.0955 0.0193 2.28 2.2833 1.0 1907813 MixCom2_000175 Fc1ccc(CSc2nc(c3ccccc3)c4CCCCc4c2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I18 compound treatment 0.0715 -0.00473 -0.56 -0.5605 -1.0 1970146 MixCom2_000176 CC(C)(C)OC(=O)C(Cc1ccc(OC(C)(C)C)cc1)NC(=O)OCCCCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I19 compound treatment 0.0845 0.00827 0.98 0.9799 1.0 1548341 MixCom2_000177 COC(=O)c1ccc(c(NC(=O)c2ccco2)c1)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I20 compound treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 1970147 MixCom2_000178 Fc1cccc(CCOC(=O)NNC(=O)CNC(=O)c2c(F)cccc2F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I21 compound treatment 0.0905 0.0143 1.69 1.6908 1.0 1484756 MixCom2_000179 COC(=O)c1ccc(N2CCN(CC2)c3ccccc3)c(NC(=O)C4CC4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I22 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1970148 MixCom2_000180 CC(C)c1nc2ccccc2c3C(=O)N(NC(=O)c4cccc(C)c4O)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I23 mock treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 I24 mock treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J01 mock treatment 0.077 7.7E-4 0.09 0.0912 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J02 mock treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J03 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1970149 MixCom2_000181 COCc1nc2ccc(C)cc2c3C(=O)N(CCCn4ccnc4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J04 compound treatment 0.0825 0.00627 0.74 0.7429 1.0 1970150 MixCom2_000182 CC(C)(C)OC(=O)NCCCCC(=O)N1CCN(C/C=C/c2ccccc2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J05 compound treatment 0.083 0.00677 0.8 0.8022 1.0 1970151 MixCom2_000183 Cc1nc2ccc(Cl)cc2c3C(=O)N(NC(=O)CC4(CC5CC6CC(C5)C4)C6)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J06 compound treatment 0.079 0.00277 0.33 0.3282 1.0 1970152 MixCom2_000184 COc1cc(CN2CCC(C2)NC(=O)CNC(=O)c3ccccc3)cc4OCOc41 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J07 compound treatment 0.09 0.0138 1.63 1.6316 1.0 1970153 MixCom2_000185 Cc1ccc2nc(C)c3C(=O)N(NC(=O)/C=C/c4ccc(F)cc4Cl)C(=O)c3c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J08 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970154 MixCom2_000186 OC1(Cc2ccccc2)CCN(CC1)C(=O)c3ccc4[nH]nnc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J09 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970155 MixCom2_000187 COCc1nc2ccccc2c3C(=O)N(CC(=O)Nc4ccc5ccccc5c4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J10 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1970156 MixCom2_000188 COC(=O)CCc1c(C)nn(c1C)c2ccc(cc2)C(=O)NC(Cc3ccccc3)C(=O)OCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J11 compound treatment 0.072 -0.00423 -0.5 -0.5012 -1.0 1970157 MixCom2_000189 CC(Oc1ccc(OC(F)(F)F)cc1)C(=O)NN2C(=O)c3c(C2=O)c4cc(C)ccc4nc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J12 compound treatment 0.071 -0.00523 -0.62 -0.6197 -1.0 1970158 MixCom2_000190 Cc1sc(nc1CC(=O)NNC(=O)c2cnn(c2C(F)(F)F)c3ccc(cc3)[N+](=O)[O-])c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J13 compound treatment 0.071 -0.00523 -0.62 -0.6197 -1.0 1970159 MixCom2_000191 Clc1ncn(Cc2nc(cs2)C(=O)NN3C(=O)c4ccccc4C3=O)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J14 compound treatment 0.082 0.00577 0.68 0.6837 1.0 1970160 MixCom2_000192 Fc1ccc(cc1)C(=O)CCC(=O)N2CCN(CC2)C(=O)Cc3ccc(F)c(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J15 compound treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 1935349 MixCom2_000193 O=C(NN1C(=O)c2ccccc2C1=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J16 compound treatment 0.072 -0.00423 -0.5 -0.5012 -1.0 1970161 MixCom2_000194 OC(C1CCN(CC1)C(=O)CCCCCNC(=O)OCc2ccccc2)(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J17 compound treatment 0.077 7.7E-4 0.09 0.0912 1.0 1970162 MixCom2_000195 O=C1N(C2CCN(Cc3ccccc3)C2)C(=O)c4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J18 compound treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 1970163 MixCom2_000196 COc1cccc(CN2CCC(C2)NC(=O)CC(NC(=O)OC(C)(C)C)c3ccc(F)cc3)c1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J19 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970164 MixCom2_000197 CC(C)c1nc2ccc(F)cc2c3C(=O)N(NC(=O)Cc4ccccc4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J20 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1970165 MixCom2_000198 O=C(NCCc1ccncc1)c2ccc3[nH]nnc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J21 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970166 MixCom2_000199 COCc1nc2ccc(C)cc2c3C(=O)N(NC(=O)c4csc(C)n4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J22 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970167 MixCom2_000200 CC1CC(CC(C)(C)C1)NC(=O)c2ccc(s2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J23 mock treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 J24 mock treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K01 mock treatment 0.0765 2.7E-4 0.03 0.032 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K02 mock treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K03 compound treatment 0.0825 0.00627 0.74 0.7429 1.0 1577056 MixCom2_000201 COc1ccc(cc1)C(=O)NCCN2CCN(CC2)C(=O)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K04 compound treatment 0.0785 0.00227 0.27 0.269 1.0 1970168 MixCom2_000202 CCn1c2ccccc2c3cc(CN(CCOC(=O)NC(Cc4cn(cn4)C(c5ccccc5)(c6ccccc6)c7ccccc7)C(=O)OC)C(=O)OC(C)(C)C)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K05 compound treatment 0.0855 0.00927 1.1 1.0984 1.0 1907814 MixCom2_000203 ClC1=C(NC(=O)OC2CCCCCCC2)C(=O)c3ccccc3C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K06 compound treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 1970169 MixCom2_000204 Clc1ccccc1N2CCN(CC2)C(=O)OCC3CC4CC3C=C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K07 compound treatment 0.0825 0.00627 0.74 0.7429 1.0 1907815 MixCom2_000205 FC(F)(F)c1cccc(c1)C(=O)n2nccc2c3ccc4OCOc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K08 compound treatment 0.082 0.00577 0.68 0.6837 1.0 1970170 MixCom2_000206 COc1ccccc1CCOC(=O)NNC(=O)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K09 compound treatment 0.082 0.00577 0.68 0.6837 1.0 1119315 MixCom2_000207 Oc1cc2OCOc2cc1C(N3CCCC3)c4ccc(Cl)c(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K10 compound treatment 0.0785 0.00227 0.27 0.269 1.0 1970171 MixCom2_000208 COc1ccc(CN2CCCCC2COC(=O)N3CCN(CC3)c4ccc(cc4)C(F)(F)F)cc1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K11 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1133756 MixCom2_000209 CC1C(c2ccc(Cl)c(Cl)c2)c3cc4OCOc4cc3OC1(C)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K12 compound treatment 0.0825 0.00627 0.74 0.7429 1.0 1970172 MixCom2_000210 COc1ccc2ccccc2c1CN3CCN(CC3)C(=O)OCc4ccc(OC(F)F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K13 compound treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 1907816 MixCom2_000211 COc1ccc(OC)c(c1)C2C(C)C(C)(O)Oc3cc4OCOc4cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K14 compound treatment 0.0825 0.00627 0.74 0.7429 1.0 1970173 MixCom2_000212 Fc1cccc(Cl)c1CN2CCC(C2)NC(=O)OCCN3CNC(=S)NC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K15 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1907817 MixCom2_000213 Cc1cc(n2nc(c(Cl)c2n1)c3cnn(C)c3C(F)(F)F)C(F)(F)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K16 compound treatment 0.077 7.7E-4 0.09 0.0912 1.0 1970174 MixCom2_000214 NS(=O)(=O)c1cc([N+](=O)[O-])c(s1)N2CCN(CC2)C(=O)OCc3cccc(OCc4ccccc4)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K17 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1606077 MixCom2_000215 CN1CCN(CC1)c2ccc(NS(=O)(=O)c3ccc(Cl)cc3)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K18 compound treatment 0.08 0.00377 0.45 0.4467 1.0 1970175 MixCom2_000216 Clc1ccc(CNC(=O)OCCCCCc2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K19 compound treatment 0.0705 -0.00573 -0.68 -0.679 -1.0 1907818 MixCom2_000217 CN1CCN(CC1)c2ccc(NC(=O)c3ccc(cc3)C(F)(F)F)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K20 compound treatment 0.0715 -0.00473 -0.56 -0.5605 -1.0 1970176 MixCom2_000218 COc1ccc(cc1)C(=O)NNC(=O)OCCC2=CCC3CC2C3(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K21 compound treatment 0.0705 -0.00573 -0.68 -0.679 -1.0 1907819 MixCom2_000219 FC(F)(F)c1cccc(c1)C(=O)Nc2ccc(C#Cc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K22 compound treatment 0.071 -0.00523 -0.62 -0.6197 -1.0 1970177 MixCom2_000220 CC(C)c1nc2ccccc2c3C(=O)N(NC(=O)c4ccc5OCOc5c4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K23 mock treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 K24 mock treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L01 mock treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L02 mock treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L03 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970178 MixCom2_000221 COCc1nc2ccc(C)cc2c3C(=O)N(CCc4c[nH]c5ccccc45)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L04 compound treatment 0.0815 0.00527 0.62 0.6244 1.0 1970179 MixCom2_000222 FC(F)(F)c1cccc(NC(=O)C(=O)NNC(=O)c2ccc3[nH]nnc3c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L05 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1970180 MixCom2_000223 CCCc1nc2ccccc2c3C(=O)N(CCN(CC)CC)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L06 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1970181 MixCom2_000224 CC(C)(C)OC(=O)N1CCC(CC1)C(=O)NNC(=O)c2ccco2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L07 compound treatment 0.08 0.00377 0.45 0.4467 1.0 1970182 MixCom2_000225 Cc1ccc2nc(C)c3C(=O)N(C4CCN(Cc5ccccc5Sc6ccc(Cl)cc6)C4)C(=O)c3c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L08 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970183 MixCom2_000226 CC(=O)c1ccc(cc1)N2CCN(CC2)C(=O)C3Cc4ccccc4CN3C(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L09 compound treatment 0.082 0.00577 0.68 0.6837 1.0 1970184 MixCom2_000227 Cc1nn(c(C)c1CN2CCC(C2)N3C(=O)c4c(C3=O)c5cc(C)ccc5nc4C)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L10 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970185 MixCom2_000228 Cc1oc(nc1CC(=O)NC(CCCNC(=O)OCc2ccccc2)C(=O)OCc3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L11 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970186 MixCom2_000229 O=C1CCCN1CCCN2C(=O)c3ccccc3C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L12 compound treatment 0.084 0.00777 0.92 0.9206 1.0 1970187 MixCom2_000230 CC(=O)c1ccc(cc1)N2CCN(CC2)C(=O)c3cccnc3Oc4ccc(C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L13 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970188 MixCom2_000231 CCOc1ccc(cc1)C(=O)NN2C(=O)c3c(C2=O)c4cc(F)ccc4nc3C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L14 compound treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 1970189 MixCom2_000232 CCn1c2ccccc2c3cc(CN4CCN(CC4)C(=O)CCCCC(=O)OC)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L15 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970190 MixCom2_000233 COc1ccc(CN2C(=O)c3ccccc3C2=O)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L16 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1970191 MixCom2_000234 O=C(N1CCN(CC1)c2cnccn2)c3ccc(cc3)n4nc(cc4c5ccccc5)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L17 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1970192 MixCom2_000235 CC(C)c1nc2ccc(F)cc2c3C(=O)N(CCc4c[nH]cn4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L18 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970193 MixCom2_000236 COc1cccc(CN2CCC(C2)NC(=O)CCN(Cc3ccco3)S(=O)(=O)c4cccc5nsnc45)c1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L19 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970194 MixCom2_000237 COCc1nc2ccc(C)cc2c3C(=O)N(Cc4c(OC)cc(OC)cc4OC)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L20 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1970195 MixCom2_000238 O=C(NNC(=O)c1ccc(s1)c2ccccn2)OCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L21 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970196 MixCom2_000239 CCCc1nc2ccccc2c3C(=O)N(Cc4ccccn4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L22 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970197 MixCom2_000240 Cc1nc(cn1CCC(=O)NNC(=O)c2ccc3nsnc3c2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L23 mock treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 L24 mock treatment 0.079 0.00277 0.33 0.3282 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M01 mock treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M02 mock treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M03 compound treatment 0.078 0.00177 0.21 0.2097 1.0 1245758 MixCom2_000241 Clc1ccc(cc1Cl)C(=O)Nc2ccc(C#Cc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M04 compound treatment 0.078 0.00177 0.21 0.2097 1.0 1970198 MixCom2_000242 CC(C)(C)OC(=O)N(CCOC(=O)N1CCN(CC1)c2ccccc2C#N)Cc3cc4ccccc4c5ccccc35 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M05 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1907820 MixCom2_000243 Clc1ccc(cc1)S(=O)(=O)Nc2ccc(C#Cc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M06 compound treatment 0.072 -0.00423 -0.5 -0.5012 -1.0 1970199 MixCom2_000244 Cc1csc(C(=O)NNC(=O)OCc2ccc(F)cc2Cl)c1n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M07 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1452233 MixCom2_000245 Fc1ccc(cc1)S(=O)(=O)Nc2ccc(C#Cc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M08 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1970200 MixCom2_000246 CCOC(=O)N1CCN(CC1)C(=O)OCCc2cccc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M09 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1907821 MixCom2_000247 Clc1ccc(/C=C/2\C(=O)N(N=C2c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M10 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1970201 MixCom2_000248 [O-][N+](=O)c1cc(CN2CCCCC2COC(=O)N3CCCC3C(=O)OCc4ccccc4)ccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M11 compound treatment 0.08 0.00377 0.45 0.4467 1.0 1907822 MixCom2_000249 FC(F)(F)c1cccc(c1)C(=O)OCn2ncc(Cl)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M12 compound treatment 0.0905 0.0143 1.69 1.6908 1.0 1970202 MixCom2_000250 COc1cc(CN2CCC(C2)NC(=O)OCCn3nc(cc3c4ccccc4)c5ccccc5)cc6OCOc61 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M13 compound treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 1907823 MixCom2_000251 FC(F)(F)c1ccc(cc1)C(=O)OCn2ncc(Cl)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M14 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970203 MixCom2_000252 O=C(NCCCn1ccnc1)OCc2ccc(C#Cc3ccccc3)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M15 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1907824 MixCom2_000253 CC(C)(C)c1cc(cc(c1O)C(C)(C)C)C(OCC#C)C(=O)OCC#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M16 compound treatment 0.081 0.00477 0.57 0.5652 1.0 1970204 MixCom2_000254 Fc1cccc(Cl)c1COC(=O)N2CCN(CC2)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M17 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1907825 MixCom2_000255 CCN(CC)CCNC(=O)c1cc2cc(Br)ccc2s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M18 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970205 MixCom2_000256 CC(C)(C)c1ccc(COC(=O)NC(CSCc2ccccc2)C(=O)Nc3ccc4ccccc4c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M19 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1907826 MixCom2_000257 FC(F)(F)c1ccc2sc(cc2c1)C(=O)NCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M20 compound treatment 0.0905 0.0143 1.69 1.6908 1.0 1970206 MixCom2_000258 COc1ccc2[nH]cc(CCNC(=O)OCC3CC4CCC3C4)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M21 compound treatment 0.0865 0.0103 1.22 1.2169 1.0 1907827 MixCom2_000259 Cc1ccc(C)n1c2ccsc2c3cc4nc(C)c(c(N)n4n3)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M22 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970207 MixCom2_000260 CC(C)c1nc2ccccc2c3C(=O)N(NC(=O)C(=O)N4CCCc5ccccc45)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M23 mock treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 M24 mock treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N01 mock treatment 0.0765 2.7E-4 0.03 0.032 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N02 mock treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N03 compound treatment 0.08 0.00377 0.45 0.4467 1.0 1970208 MixCom2_000261 CCN1CCCC1CN2C(=O)c3c(C2=O)c4cc(C)ccc4nc3COC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N04 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1970209 MixCom2_000262 CC(=O)c1ccc(cc1)N2CCN(CC2)C(=O)C(COC(C)(C)C)NC(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N05 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1970210 MixCom2_000263 CCN(CC)CCN1C(=O)c2c(C1=O)c3cc(C)ccc3nc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N06 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1970211 MixCom2_000264 Cc1cc(nn1C)C(=O)NCc2ccc(cc2)S(=O)(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N07 compound treatment 0.082 0.00577 0.68 0.6837 1.0 1970212 MixCom2_000265 O=C(NN1C(=O)C2C(C3CCC2C=C3)C1=O)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N08 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970213 MixCom2_000266 Cn1cccc1C(=O)NNC(=O)c2ccc(s2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N09 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970214 MixCom2_000267 CCOc1ccccc1CN2C(=O)c3c(C2=O)c4cc(C)ccc4nc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N10 compound treatment 0.087 0.0108 1.28 1.2761 1.0 1970215 MixCom2_000268 CC1(C)C2CCC1(C)C(O)C2CC(=O)N3CCC(CC3)C(O)(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N11 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970216 MixCom2_000269 OC1(CN2C(=O)c3ccccc3C2=O)CCCCC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N12 compound treatment 0.089 0.0128 1.51 1.5131 1.0 1970217 MixCom2_000270 O=C(CCN(Cc1ccco1)S(=O)(=O)c2cccc3nsnc23)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N13 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970218 MixCom2_000271 CC(C)c1nc2ccc(F)cc2c3C(=O)N(NC(=O)c4cncc(Br)c4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N14 compound treatment 0.083 0.00677 0.8 0.8022 1.0 1970219 MixCom2_000272 Cc1ccc(cc1)C(=O)NC(CCCCNC(=O)OCc2ccccc2)C(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N15 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1970220 MixCom2_000273 O=C1N(CCc2ccncc2)C(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N16 compound treatment 0.0825 0.00627 0.74 0.7429 1.0 1970221 MixCom2_000274 CC(C)(C)c1cc(n(n1)c2ccc(cc2)C(=O)NC(CO)Cc3ccc(Cl)cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N17 compound treatment 0.079 0.00277 0.33 0.3282 1.0 1970222 MixCom2_000275 CC(C)c1nc2ccc(F)cc2c3C(=O)N(NC(=O)c4ccc(C)s4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N18 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970223 MixCom2_000276 COC(=O)CCCCC(=O)NNC(=O)C(Cc1c[nH]cn1)NC(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N19 compound treatment 0.085 0.00877 1.04 1.0391 1.0 1970224 MixCom2_000277 COCc1nc2ccc(C)cc2c3C(=O)N(CC4CCCO4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N20 compound treatment 0.079 0.00277 0.33 0.3282 1.0 1970225 MixCom2_000278 CC(C)(C)OC(=O)C(Cc1ccc(OC(C)(C)C)cc1)NC(=O)c2cc(=O)n([nH]2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N21 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970226 MixCom2_000279 Cc1[nH]c2ccccc2c1SCC(=O)NN3C(=O)c4c(C3=O)c5cc(C)ccc5nc4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N22 compound treatment 0.0785 0.00227 0.27 0.269 1.0 1970227 MixCom2_000280 COC(=O)CCCCC(=O)N1CCN(CC1)c2ccc(cc2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N23 mock treatment 0.077 7.7E-4 0.09 0.0912 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 N24 mock treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O01 mock treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O02 mock treatment 0.068 -0.00823 -0.98 -0.9752 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O03 compound treatment 0.072 -0.00423 -0.5 -0.5012 -1.0 1907828 MixCom2_000281 Cc1nc2cc(nn2c(N)c1c3ccccc3)c4ccc(Cl)c(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O04 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1913199 MixCom2_000282 COc1ccc2[nH]cc(CCNC(=O)OCCCl)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O05 compound treatment 0.0785 0.00227 0.27 0.269 1.0 1907829 MixCom2_000283 NNC(=O)c1cn2c(ccc3c(cc(nc32)C(F)(F)F)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O06 compound treatment 0.0715 -0.00473 -0.56 -0.5605 -1.0 1970228 MixCom2_000284 COc1ccc(CC(=O)NNC(=O)OCC2CC2(Cl)Cl)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O07 compound treatment 0.0795 0.00327 0.39 0.3874 1.0 1907830 MixCom2_000285 FC(F)(F)c1cc(c2ccc3nc(cn3c2n1)c4ccccc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O08 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970229 MixCom2_000286 COc1cccc(CCOC(=O)N2CCC(CC2)C(=O)N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O09 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1907831 MixCom2_000287 FCCCSc1nc(c2ccc(Cl)cc2)c3CCCCc3c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O10 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970230 MixCom2_000288 COc1cc(CN2CCN(CCOC(=O)NCc3ccc(F)c(Cl)c3)CC2)cc4OCOc41 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O11 compound treatment 0.071 -0.00523 -0.62 -0.6197 -1.0 1907832 MixCom2_000289 FC(F)(F)c1cc(c2ccc3nc(cn3c2n1)c4nnco4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O12 compound treatment 0.091 0.0148 1.75 1.7501 1.0 1970231 MixCom2_000290 CCn1c2ccccc2c3cc(CN(CCOC(=O)N4CCN(CC4)C(=O)c5ccc(F)cc5Cl)C(=O)OC(C)(C)C)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O13 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1907833 MixCom2_000291 CCOC(=O)C1=C(C)N=C2SCCC(=O)N2C1c3cccc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O14 compound treatment 0.072 -0.00423 -0.5 -0.5012 -1.0 1970232 MixCom2_000292 COc1ccc(COC(=O)NNC(=O)c2noc(C)c2c3csc(C)n3)c(Cl)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O15 compound treatment 0.073 -0.00323 -0.38 -0.3827 -1.0 1907834 MixCom2_000293 Fc1ccc(cc1)c2cn3c(ccc4c(cc(nc43)C(F)(F)F)C(F)(F)F)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O16 compound treatment 0.0715 -0.00473 -0.56 -0.5605 -1.0 1970233 MixCom2_000294 FC(F)(F)c1ccccc1COC(=O)NCCc2c[nH]c3ccc(Cl)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O17 compound treatment 0.074 -0.00223 -0.26 -0.2643 -1.0 1907835 MixCom2_000295 Fc1ccc(CSc2nc(c3CCCc3c2C#N)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O18 compound treatment 0.072 -0.00423 -0.5 -0.5012 -1.0 1970234 MixCom2_000296 Cc1nn(c(C)c1CN2CCC(C2)NC(=O)OCCCCc3ccc(cc3)[N+](=O)[O-])c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O19 compound treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 1907836 MixCom2_000297 Cc1ccc(cc1)c2nc(SCc3ccc(F)cc3)c(C#N)c4CCCCc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O20 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1970235 MixCom2_000298 COc1ccc2[nH]cc(CCNC(=O)OCCc3ccccc3Br)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O21 compound treatment 0.0665 -0.00973 -1.15 -1.1529 -1.0 1907837 MixCom2_000299 Cc1ccc(cc1)c2nc(SCCC(=C(F)F)F)c(C#N)c3CCCCc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O22 compound treatment 0.0715 -0.00473 -0.56 -0.5605 -1.0 1970236 MixCom2_000300 CC(C)c1nc2ccccc2c3C(=O)N(NC(=O)C4CCCNC4=O)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O23 mock treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 O24 mock treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P01 mock treatment 0.0705 -0.00573 -0.68 -0.679 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P02 mock treatment 0.0575 -0.0187 -2.22 -2.2193 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P03 compound treatment 0.07 -0.00623 -0.74 -0.7382 -1.0 1970237 MixCom2_000301 Cc1nc2ccc(Cl)cc2c3C(=O)N(CCc4c[nH]cn4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P04 compound treatment 0.0805 0.00427 0.51 0.5059 1.0 1970238 MixCom2_000302 CC1=NN(C(=O)C1)c2ccc(cc2)C(=O)N3CCC(CC3)C(O)(c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P05 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970239 MixCom2_000303 Cc1ccc2nc(C)c3C(=O)N(C(=O)c3c2c1)c4ccccc4N5CCCCC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P06 compound treatment 0.069 -0.00723 -0.86 -0.8567 -1.0 1970240 MixCom2_000304 O=C(NCCCC(NC(=O)c1ccccc1COC(=O)c2ccccc2)C(=O)OCc3ccccc3)OCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P07 compound treatment 0.072 -0.00423 -0.5 -0.5012 -1.0 1970241 MixCom2_000305 COCc1nc2ccccc2c3C(=O)N(CCN4CCOCC4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P08 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970242 MixCom2_000306 CC(Cc1ccc(Cl)cc1)NC(=O)c2cc(=O)n([nH]2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P09 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1970243 MixCom2_000307 COc1ccc(CN2C(=O)c3c(C2=O)c4cc(C)ccc4nc3C)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P10 compound treatment 0.075 -0.00123 -0.15 -0.1458 -1.0 1970244 MixCom2_000308 OS(=O)(=O)c1cccc(c1)C(=O)N2CCN(Cc3ccc(OCC=C)cc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P11 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970245 MixCom2_000309 CCN(CC)CCCC(C)N1C(=O)c2ccccc2C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P12 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1970246 MixCom2_000310 CN(C)CCCNC(=O)CCC(=O)c1ccc(F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P13 compound treatment 0.076 -2.3E-4 -0.03 -0.0273 -1.0 1970247 MixCom2_000311 CC(C)c1nc2ccc(F)cc2c3C(=O)N(NC(=O)c4sc(nc4C)n5cccc5)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P14 compound treatment 0.0745 -0.00173 -0.21 -0.205 -1.0 1970248 MixCom2_000312 CC(=O)c1ccc(cc1)N2CCN(CC2)C(=O)C3CCN(CC3)C(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P15 compound treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 1970249 MixCom2_000313 O=C(NN1C(=O)c2ccccc2C1=O)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P16 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970250 MixCom2_000314 CC(=O)Nc1ccc(cc1NC(=O)C)C(=O)N2CCN(CC2)c3nccnc3C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P17 compound treatment 0.078 0.00177 0.21 0.2097 1.0 1970251 MixCom2_000315 CSc1ccc(cc1)C(=O)NN2C(=O)c3c(C2=O)c4cc(F)ccc4nc3C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P18 compound treatment 0.0765 2.7E-4 0.03 0.032 1.0 1970252 MixCom2_000316 CC(C)C(NC(=O)c1ccc(C)cc1)C(=O)OCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P19 compound treatment 0.0775 0.00127 0.15 0.1505 1.0 1970253 MixCom2_000317 COCc1nc2ccc(C)cc2c3C(=O)N(NC(=O)c4cccc(C)c4)C(=O)c31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P20 compound treatment 0.0755 -7.3E-4 -0.09 -0.0865 -1.0 1970254 MixCom2_000318 Cc1cc(no1)c2onc(C)c2C(=O)NNC(=O)C(CCCCNC(=O)c3cccnc3)NC(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P21 compound treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 1970255 MixCom2_000319 COc1cscc1C(=O)NN2C(=O)c3c(C2=O)c4cc(C)ccc4nc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P22 compound treatment 0.0725 -0.00373 -0.44 -0.442 -1.0 1970256 MixCom2_000320 Cc1ccc(cc1)C(=O)NC(CCCCNC(=O)OCc2ccccc2)C(=O)OCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P23 mock treatment 0.0735 -0.00273 -0.32 -0.3235 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.567 P24 mock treatment 0.0655 -0.0107 -1.27 -1.2714 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A01 mock treatment 0.0895 0.0133 1.57 1.5705 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A02 mock treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A03 compound treatment 0.079 0.00275 0.33 0.3263 1.0 1713246 Bionet1_000401 Clc1ccc(Oc2ccc(c3ccnn3c4ccccc4)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A04 compound treatment 0.0805 0.00425 0.5 0.5041 1.0 1908051 Bionet1_000402 CN(C)S(=O)(=O)Oc1ccc(cc1)C(=O)Nc2cccc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A05 compound treatment 0.089 0.0128 1.51 1.5112 1.0 1333379 Bionet1_000403 Clc1cccc(Cl)c1Cn2cccc(NC(=O)c3ccccc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A06 compound treatment 0.069 -0.00725 -0.86 -0.8586 -1.0 1908052 Bionet1_000404 CN(C)S(=O)(=O)Oc1ccc(cc1)C(=O)Nc2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A07 compound treatment 0.081 0.00475 0.56 0.5633 1.0 1645116 Bionet1_000405 CC(C)(C)C(=O)Nc1cccn(Cc2c(Cl)cccc2Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A08 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908053 Bionet1_000406 CN(C)S(=O)(=O)Oc1ccc(cc1)C(=O)Nc2cc(Cl)ccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A09 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908054 Bionet1_000407 FC(F)(F)C(=O)Nc1cccn(Cc2c(Cl)cccc2Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A10 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908055 Bionet1_000408 COc1ccc(NC(=O)c2ccc(OS(=O)(=O)N(C)C)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A11 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1185767 Bionet1_000409 Cc1ccc(cc1)C(=O)Nc2cccn(Cc3c(Cl)cccc3Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A12 compound treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 1908056 Bionet1_000410 CN(C)S(=O)(=O)Oc1ccccc1C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A13 compound treatment 0.0665 -0.00975 -1.15 -1.1548 -1.0 1563361 Bionet1_000411 CCCCC(=O)Nc1cccn(Cc2c(Cl)cccc2Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A14 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908057 Bionet1_000412 CN(C)S(=O)(=O)Oc1ccccc1C(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A15 compound treatment 0.0665 -0.00975 -1.15 -1.1548 -1.0 1525668 Bionet1_000413 CC(C)CC(=O)Nc1cccn(Cc2c(Cl)cccc2Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A16 compound treatment 0.0615 -0.0147 -1.75 -1.7473 -1.0 1908058 Bionet1_000414 CN(C)S(=O)(=O)Oc1ccccc1C(=O)Nc2cccc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A17 compound treatment 0.0685 -0.00775 -0.92 -0.9178 -1.0 1273797 Bionet1_000415 CCN(CC)C(=O)c1cc(Cl)cn(Cc2c(Cl)cccc2Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A18 compound treatment 0.069 -0.00725 -0.86 -0.8586 -1.0 1908059 Bionet1_000416 CN(C)S(=O)(=O)Oc1ccccc1C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A19 compound treatment 0.0775 0.00125 0.15 0.1486 1.0 1221672 Bionet1_000417 CN(C)CCNC(=O)c1cc(Cl)cn(Cc2ccc(Cl)cc2)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A20 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908060 Bionet1_000418 COc1ccc(NC(=O)c2ccccc2OS(=O)(=O)N(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A21 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1691757 Bionet1_000419 Clc1ccc(NC(=O)c2cn(c3ccccc3)c(=O)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A22 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908061 Bionet1_000420 Clc1ccc(CO/N=C\NC(=S)Nc2ccccc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A23 mock treatment 0.0825 0.00625 0.74 0.741 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 A24 mock treatment 0.071 -0.00525 -0.62 -0.6216 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B01 mock treatment 0.0835 0.00725 0.86 0.8595 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B02 mock treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B03 compound treatment 0.08 0.00375 0.44 0.4448 1.0 1908062 Bionet1_000421 Clc1ccc(COn2c(nc3ccccc23)c4ccccc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B04 compound treatment 0.0875 0.0113 1.33 1.3335 1.0 1602414 Bionet1_000422 Fc1ccccc1c2nnc3c4ccccc4nc(Oc5ccccc5)n23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B05 compound treatment 0.081 0.00475 0.56 0.5633 1.0 1908063 Bionet1_000423 Fc1cccc(Cl)c1COn2c(nc3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B06 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1908064 Bionet1_000424 Cc1cc(C)cc(COn2c(nc3ncccc23)c4ccc(Cl)cc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B07 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908065 Bionet1_000425 FC(F)(F)c1cccc(COn2c(nc3ccccc23)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B08 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1908066 Bionet1_000426 Clc1ccc(/C=N/Nc2nc(Cl)nc3ccccc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B09 compound treatment 0.0705 -0.00575 -0.68 -0.6808 -1.0 1908067 Bionet1_000427 Clc1ccc(COn2c(nc3ccccc23)c4ccccc4Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B10 compound treatment 0.071 -0.00525 -0.62 -0.6216 -1.0 1908068 Bionet1_000428 Clc1nc(N/N=C/c2ccc(Br)cc2)c3ccccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B11 compound treatment 0.065 -0.0112 -1.33 -1.3325 -1.0 1908069 Bionet1_000429 Clc1ccc(cc1)c2nc3ccccc3n2OCc4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B12 compound treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 1908070 Bionet1_000430 Clc1nc2ccccc2c3nnc(c4ccc(Br)cc4)n13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B13 compound treatment 0.0685 -0.00775 -0.92 -0.9178 -1.0 1908071 Bionet1_000431 Clc1ccc(COn2c(nc3ccccc23)c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B14 compound treatment 0.0685 -0.00775 -0.92 -0.9178 -1.0 1661291 Bionet1_000432 Fc1ccccc1c2nnc3c4ccccc4nc(Nc5ccccc5)n23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B15 compound treatment 0.067 -0.00925 -1.1 -1.0956 -1.0 1908072 Bionet1_000433 Fc1cccc(Cl)c1COn2c(nc3ccccc23)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B16 compound treatment 0.0645 -0.0117 -1.39 -1.3918 -1.0 1908073 Bionet1_000434 Cc1cc(C)cc(COn2c(nc3ccc(Cl)cc23)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B17 compound treatment 0.0715 -0.00475 -0.56 -0.5624 -1.0 1908074 Bionet1_000435 Cc1ccc(cc1)c2nc3ccccc3n2OCc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B18 compound treatment 0.0705 -0.00575 -0.68 -0.6808 -1.0 1908075 Bionet1_000436 Cn1nc(c(COC(=O)Nc2ccc(Cl)cc2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B19 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1908076 Bionet1_000437 Cc1ccc(cc1)c2nc3ccccc3n2OCc4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B20 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908077 Bionet1_000438 Cn1nc(c(COC(=O)c2ccc(Cl)cc2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B21 compound treatment 0.0715 -0.00475 -0.56 -0.5624 -1.0 1908078 Bionet1_000439 Cc1ccc(cc1)c2nc3ccccc3n2OCc4c(F)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B22 compound treatment 0.069 -0.00725 -0.86 -0.8586 -1.0 1908079 Bionet1_000440 Cn1nc(c(COC(=O)Nc2cccc(Cl)c2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B23 mock treatment 0.0705 -0.00575 -0.68 -0.6808 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 B24 mock treatment 0.069 -0.00725 -0.86 -0.8586 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C01 mock treatment 0.083 0.00675 0.8 0.8003 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C02 mock treatment 0.084 0.00775 0.92 0.9188 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C03 compound treatment 0.084 0.00775 0.92 0.9188 1.0 1134484 Bionet1_000441 Clc1ccc(NC(=O)c2cn(Cc3cccnc3)c(=O)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C04 compound treatment 0.085 0.00875 1.04 1.0373 1.0 1908080 Bionet1_000442 CS/C(=C(/C(=O)\C=C\c1ccccc1)\c2ccccc2)/Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C05 compound treatment 0.0885 0.0123 1.45 1.452 1.0 1908081 Bionet1_000443 FC(F)(F)Oc1ccc(NNC(=O)c2c(Cl)cccc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C06 compound treatment 0.0905 0.0143 1.69 1.689 1.0 1908082 Bionet1_000444 COc1ccc(cc1)C2CC(=O)C(=C(Nc3ccccc3)S2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C07 compound treatment 0.0815 0.00525 0.62 0.6225 1.0 1908083 Bionet1_000445 FC(F)(F)Oc1ccc(NNC(=O)c2ccc(Cl)cc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C08 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908084 Bionet1_000446 Cc1ccc(cc1)C2CC(=O)C(=C(Nc3ccccc3)S2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C09 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1908085 Bionet1_000447 FC(F)(F)Oc1ccc(NNC(=O)c2ccccc2C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C10 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1908086 Bionet1_000448 FC(F)(F)c1nnc2c(Sc3ccccc3)nc4ccc(Cl)cc4n12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C11 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1732143 Bionet1_000449 CC(C)OC(=O)c1cc(Cl)c(=O)n(Cc2ccc(Cl)cc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C12 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908087 Bionet1_000450 C1CN(CCN1C(c2ccccc2)c3ccccc3)C4=Nc5ccccc5CS4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C13 compound treatment 0.0775 0.00125 0.15 0.1486 1.0 1908088 Bionet1_000451 CCCCOC(=O)c1cc(Cl)c(=O)n(Cc2ccc(Cl)cc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C14 compound treatment 0.0685 -0.00775 -0.92 -0.9178 -1.0 1908089 Bionet1_000452 CN(C)S(=O)(=O)Oc1ccccc1C(=O)Nc2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C15 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1206331 Bionet1_000453 Clc1ccc(Cn2cc(cc(Cl)c2=O)C(=O)OCC#C)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C16 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908090 Bionet1_000454 CN(C)S(=O)(=O)Oc1ccccc1C(=O)Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C17 compound treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 1241150 Bionet1_000455 Clc1ccc(C(=O)Oc2cccnc2I)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C18 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1908091 Bionet1_000456 CN(C)S(=O)(=O)Oc1ccccc1C(=O)Nc2ccc(cc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C19 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1908092 Bionet1_000457 [O-][N+](=O)c1ccc(NC(=O)Oc2cccnc2I)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C20 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1908093 Bionet1_000458 CN(C)S(=O)(=O)Oc1cccc(c1)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C21 compound treatment 0.0775 0.00125 0.15 0.1486 1.0 1908094 Bionet1_000459 [O-][N+](=O)c1ccc(CONC(=O)N/C=N/OCc2ccc(cc2)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C22 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908095 Bionet1_000460 CN(C)S(=O)(=O)Oc1cccc(c1)C(=O)Nc2cccc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C23 mock treatment 0.0765 2.54E-4 0.03 0.0301 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 C24 mock treatment 0.0795 0.00325 0.39 0.3856 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D01 mock treatment 0.0785 0.00225 0.27 0.2671 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D02 mock treatment 0.0775 0.00125 0.15 0.1486 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D03 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1908096 Bionet1_000461 COc1ccc(cc1)c2nc3ccccc3n2OCc4c(Cl)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D04 compound treatment 0.0835 0.00725 0.86 0.8595 1.0 1908097 Bionet1_000462 Cc1ccc(COn2c(nc3ccc(cc23)[N+](=O)[O-])c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D05 compound treatment 0.0845 0.00825 0.98 0.978 1.0 1908098 Bionet1_000463 COc1ccc(cc1)c2nc3ccccc3n2OCc4ccc(Cl)c(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D06 compound treatment 0.082 0.00575 0.68 0.6818 1.0 1908099 Bionet1_000464 Cc1cc(C)cc(COn2c(nc3ccc(cc23)[N+](=O)[O-])c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D07 compound treatment 0.08 0.00375 0.44 0.4448 1.0 1590670 Bionet1_000465 COC(=O)c1nn(c2ccccc2)c(=O)cc1Sc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D08 compound treatment 0.096 0.0198 2.34 2.3406 1.0 1908100 Bionet1_000466 CCOC(=O)C(C)On1c(nc2ccc(cc12)[N+](=O)[O-])c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D09 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1141529 Bionet1_000467 COC(=O)c1nn(c2ccc(OC)cc2)c(=O)cc1Sc3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D10 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908101 Bionet1_000468 Cc1ccc(COn2c(nc3ccc(cc23)[N+](=O)[O-])c4cccc(Cl)c4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D11 compound treatment 0.0825 0.00625 0.74 0.741 1.0 1908102 Bionet1_000469 COC(=O)c1sc2cc(=O)n(nc2c1O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D12 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908103 Bionet1_000470 CCOC(=O)CSc1nc(Cc2ccc(Cl)cc2)nc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D13 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1310906 Bionet1_000471 COC(=O)c1nn(c2ccc(OC)cc2)c(=O)cc1Sc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D14 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1728366 Bionet1_000472 Clc1ccc(Cc2nc(NCc3ccccc3)c4ccccc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D15 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1330713 Bionet1_000473 COC(=O)CSc1cc(=O)n(nc1C(=O)OC)c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D16 compound treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 1663469 Bionet1_000474 Clc1ccc(c2nnc3c4ccccc4nc(N5CCCCC5)n23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D17 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908104 Bionet1_000475 COC(=O)c1sc2cc(=O)n(nc2c1N)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D18 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1700185 Bionet1_000476 Clc1ccc(cc1Cl)c2nnc3c4ccccc4nc(N5CCOCC5)n23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D19 compound treatment 0.079 0.00275 0.33 0.3263 1.0 1489949 Bionet1_000477 COC(=O)c1nn(c2ccc(OC)cc2)c(=O)cc1Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D20 compound treatment 0.0775 0.00125 0.15 0.1486 1.0 1908105 Bionet1_000478 CN1C(=O)N(C)C(=O)C(=CNNc2ncc(cc2Cl)C(F)(F)F)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D21 compound treatment 0.0795 0.00325 0.39 0.3856 1.0 1625642 Bionet1_000479 COc1ccc(cc1)n2nc(C(=O)NN)c(Sc3ccc(C)cc3)cc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D22 compound treatment 0.0775 0.00125 0.15 0.1486 1.0 1908106 Bionet1_000480 Cc1snc(SCc2ncc(cc2Cl)C(F)(F)F)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D23 mock treatment 0.0795 0.00325 0.39 0.3856 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 D24 mock treatment 0.081 0.00475 0.56 0.5633 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E01 mock treatment 0.078 0.00175 0.21 0.2078 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E02 mock treatment 0.0845 0.00825 0.98 0.978 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E03 compound treatment 0.082 0.00575 0.68 0.6818 1.0 1908107 Bionet1_000481 Clc1ccc(NC(=O)c2cc(Cl)c(=O)n(Cc3ccccc3)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E04 compound treatment 0.0845 0.00825 0.98 0.978 1.0 1908108 Bionet1_000482 CN(C)S(=O)(=O)Oc1cccc(c1)C(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E05 compound treatment 0.089 0.0128 1.51 1.5112 1.0 1657485 Bionet1_000483 Clc1cc(cn(Cc2ccccc2)c1=O)C(=O)NCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E06 compound treatment 0.08 0.00375 0.44 0.4448 1.0 1908109 Bionet1_000484 CN(C)S(=O)(=O)Oc1cccc(c1)C(=O)Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E07 compound treatment 0.083 0.00675 0.8 0.8003 1.0 1712706 Bionet1_000485 Fc1ccc(NC(=O)c2cc(Cl)c(=O)n(Cc3ccccc3)c2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E08 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1908110 Bionet1_000486 CN(C)S(=O)(=O)Oc1cccc(c1)C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E09 compound treatment 0.0825 0.00625 0.74 0.741 1.0 1169784 Bionet1_000487 Clc1ccc(Cn2cc(cc(Cl)c2=O)C(=O)Nc3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E10 compound treatment 0.0775 0.00125 0.15 0.1486 1.0 1908111 Bionet1_000488 COc1ccc(NC(=O)c2cccc(OS(=O)(=O)N(C)C)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E11 compound treatment 0.0825 0.00625 0.74 0.741 1.0 1447132 Bionet1_000489 Clc1ccc(Cn2cc(cc(Cl)c2=O)C(=O)NCc3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E12 compound treatment 0.0935 0.0173 2.04 2.0444 1.0 1908112 Bionet1_000490 CN(C)S(=O)(=O)Oc1cccc(c1)C(=O)Nc2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E13 compound treatment 0.079 0.00275 0.33 0.3263 1.0 1442566 Bionet1_000491 CN(C)CCNC(=O)c1cc(Cl)c(=O)n(Cc2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E14 compound treatment 0.084 0.00775 0.92 0.9188 1.0 1908113 Bionet1_000492 CN(C)S(=O)(=O)Oc1ccc(cc1Cl)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E15 compound treatment 0.0775 0.00125 0.15 0.1486 1.0 1666594 Bionet1_000493 Clc1ccc(Cn2cc(cc(Cl)c2=O)C(=O)N3CCOCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E16 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908114 Bionet1_000494 CN(C)S(=O)(=O)Oc1ccc(cc1Cl)C(=O)Nc2cccc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E17 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1644458 Bionet1_000495 CN1CCN(CC1)C(=O)c2cc(Cl)c(=O)n(Cc3ccc(Cl)cc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E18 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908115 Bionet1_000496 CN(C)S(=O)(=O)Oc1ccc(cc1Cl)C(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E19 compound treatment 0.0775 0.00125 0.15 0.1486 1.0 1517230 Bionet1_000497 Clc1ccc(NC(=O)CC(=O)Nc2ccc(Cl)cc2Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E20 compound treatment 0.0775 0.00125 0.15 0.1486 1.0 1908116 Bionet1_000498 CN(C)S(=O)(=O)Oc1ccc(Cl)cc1C(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E21 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1908117 Bionet1_000499 CNC(=S)NNC(=O)c1cccn(Cc2cccc(c2)C(F)(F)F)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E22 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908118 Bionet1_000500 FC(F)(F)c1nnc2c(Sc3ccc(Cl)cc3)nc4ccccc4n12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E23 mock treatment 0.079 0.00275 0.33 0.3263 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 E24 mock treatment 0.0795 0.00325 0.39 0.3856 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F01 mock treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F02 mock treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F03 compound treatment 0.089 0.0128 1.51 1.5112 1.0 1908119 Bionet1_000501 COC(=O)c1nn(c2cccc(c2)C(F)(F)F)c(=O)cc1Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F04 compound treatment 0.0805 0.00425 0.5 0.5041 1.0 1908120 Bionet1_000502 CC(C)C(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)c(Cl)c2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F05 compound treatment 0.0835 0.00725 0.86 0.8595 1.0 1726222 Bionet1_000503 COC(=O)c1nn(c2ccc(Cl)cc2)c(=O)cc1Oc3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F06 compound treatment 0.079 0.00275 0.33 0.3263 1.0 1908121 Bionet1_000504 FC(F)(F)c1cccc(CN2C(=O)/C(=N\OC(=O)C3CC3)/c4ccccc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F07 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1658078 Bionet1_000505 COC(=O)c1nn(c2ccc(OC)cc2)c(=O)cc1Oc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F08 compound treatment 0.085 0.00875 1.04 1.0373 1.0 1908122 Bionet1_000506 ClCC(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2Cl)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F09 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1622633 Bionet1_000507 COC(=O)c1nn(c2ccc(Cl)cc2)c(=O)cc1Sc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F10 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908123 Bionet1_000508 CC(C)C(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2Cl)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F11 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1247584 Bionet1_000509 Clc1ccc(c(Cl)c1)n2nc(C#N)c(Oc3ccccc3)cc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F12 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1908124 Bionet1_000510 CCC(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2Cl)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F13 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1140024 Bionet1_000511 COC(=O)c1nn(c2ccc(Cl)cc2)c(=O)cc1Oc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F14 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908125 Bionet1_000512 N/C(=N\Nc1ncc(cc1Cl)C(F)(F)F)/CSc2ccccn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F15 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1720398 Bionet1_000513 COC(=O)c1nn(c2ccc(Cl)cc2)c(=O)cc1Sc3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F16 compound treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 1908126 Bionet1_000514 Fc1cccc(Cl)c1COn2c(nc3ccc(Cl)cc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F17 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1273407 Bionet1_000515 COC(=O)c1nn(c2ccccc2)c(=O)cc1Oc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F18 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908127 Bionet1_000516 Cc1ccc(CN2C(=O)/C(=N\OC(=O)CCCCl)/c3ccccc23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F19 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1368159 Bionet1_000517 COC(=O)c1nn(c2ccc(Cl)cc2)c(=O)cc1Sc3ncccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F20 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1908128 Bionet1_000518 CC(C)CC(=O)O/N=C/1\C(=O)N(Cc2ccc(C)cc2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F21 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1908129 Bionet1_000519 COC(=O)c1nn(c2ccc(Cl)cc2)c(=O)cc1Sc3cccc[n+]3[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F22 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908130 Bionet1_000520 CCCCC(=O)O/N=C/1\C(=O)N(Cc2ccc(C)cc2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F23 mock treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 F24 mock treatment 0.077 7.54E-4 0.09 0.0893 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G01 mock treatment 0.0815 0.00525 0.62 0.6225 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G02 mock treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G03 compound treatment 0.1195 0.0433 5.13 5.1252 1.0 1908131 Bionet1_000521 CNC(=S)NNC(=O)c1cccn(Cc2ccc(Cl)c(Cl)c2)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G04 compound treatment 0.0825 0.00625 0.74 0.741 1.0 1908132 Bionet1_000522 COc1ccc(Sc2nc3ccccc3n4c(nnc24)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G05 compound treatment 0.102 0.0258 3.05 3.0516 1.0 1908133 Bionet1_000523 Cn1c(S)nnc1c2cccn(Cc3cccc(c3)C(F)(F)F)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G06 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908134 Bionet1_000524 Nc1c(cnn1c2ccc(Cc3ccc(Cl)cc3Cl)nn2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G07 compound treatment 0.079 0.00275 0.33 0.3263 1.0 1908135 Bionet1_000525 Cn1c(S)nnc1c2cccn(Cc3ccc(Cl)c(Cl)c3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G08 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1117855 Bionet1_000526 COc1ccc(NC(=O)c2cccn(Cc3ccccc3Cl)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G09 compound treatment 0.118 0.0418 4.95 4.9474 1.0 1908136 Bionet1_000527 CNC(=S)NNC(=O)c1cccn(Cc2ccc(Cl)cc2Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G10 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1471885 Bionet1_000528 COc1ccc(NC(=O)c2cccn(Cc3ccccc3Cl)c2=O)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G11 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1908137 Bionet1_000529 CCNC(=S)NNC(=O)c1cccn(Cc2ccc(Cl)cc2Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G12 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908138 Bionet1_000530 Cn1nc(c(/C=N/O)c1SCc2ccccc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G13 compound treatment 0.0865 0.0103 1.21 1.215 1.0 1599000 Bionet1_000531 CCn1c(S)nnc1c2cccn(Cc3ccc(Cl)cc3Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G14 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908139 Bionet1_000532 Cn1nc(c(/C=N/O)c1SCc2ccc(Cl)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G15 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1553217 Bionet1_000533 Sc1nnc(c2cccn(Cc3ccc(Cl)cc3Cl)c2=O)n1CC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G16 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908140 Bionet1_000534 Cn1nc(c(/C=N/O)c1SCc2ccc(cc2)C(C)(C)C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G17 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908141 Bionet1_000535 CSc1nnc(c2cccn(Cc3ccc(Cl)cc3Cl)c2=O)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G18 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908142 Bionet1_000536 CO/N=C/c1c(Sc2ccccc2C(=O)OC)n(C)nc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G19 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908143 Bionet1_000537 [O-][N+](=O)/C(=C/Nc1cc(Cl)cc(Cl)c1)/C2OC(=O)c3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G20 compound treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 1908144 Bionet1_000538 COC(=O)c1ccccc1Sc2c(/C=N/O)c(nn2C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G21 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908145 Bionet1_000539 [O-][N+](=O)/C(=C/Nc1cccc(c1)C(F)(F)F)/C2OC(=O)c3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G22 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1703282 Bionet1_000540 Clc1ccc(cc1)C(=O)NCC(=O)N2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G23 mock treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 G24 mock treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H01 mock treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H02 mock treatment 0.0835 0.00725 0.86 0.8595 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H03 compound treatment 0.0815 0.00525 0.62 0.6225 1.0 1908146 Bionet1_000541 C/C(=C/C(=O)c1c(C)nn(c1O)c2nc(cs2)c3ccc(C)cc3)/O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H04 compound treatment 0.084 0.00775 0.92 0.9188 1.0 1908147 Bionet1_000542 Cc1ccc(CN2C(=O)/C(=N\OC(=O)C(C)(C)CCl)/c3ccccc23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H05 compound treatment 0.083 0.00675 0.8 0.8003 1.0 1908148 Bionet1_000543 Cc1cc(c2c(C)nn(c2O)c3ccccc3)n(n1)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H06 compound treatment 0.079 0.00275 0.33 0.3263 1.0 1908149 Bionet1_000544 ClCC(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H07 compound treatment 0.081 0.00475 0.56 0.5633 1.0 1908150 Bionet1_000545 Cc1cc(c2c(C)nn(c2O)c3ccc(Cl)cc3)n(n1)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H08 compound treatment 0.0795 0.00325 0.39 0.3856 1.0 1908151 Bionet1_000546 ClCCCC(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H09 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1908152 Bionet1_000547 COc1ccc(cc1)c2csc(n2)n3nc(C)c(C(=O)/C=C(/C)\O)c3O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H10 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908153 Bionet1_000548 CC(C)CC(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H11 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1908154 Bionet1_000549 Cc1cc(c2c(C)nn(c2O)c3ccc(Cl)cc3)n(n1)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H12 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1908155 Bionet1_000550 [O-][N+](=O)c1ccc2N(Cc3ccc(Cl)cc3Cl)C(=O)C(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H13 compound treatment 0.082 0.00575 0.68 0.6818 1.0 1908156 Bionet1_000551 Cc1cc(c2c(C)nn(c2O)c3nc(cs3)c4ccccc4)n(n1)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H14 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908157 Bionet1_000552 CCCCC(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H15 compound treatment 0.0835 0.00725 0.86 0.8595 1.0 1908158 Bionet1_000553 C/C(=C/C(=O)c1c(C)nn(c1O)c2nc(cs2)c3ccc(Cl)cc3)/O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H16 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908159 Bionet1_000554 FC(F)(F)c1cnc(N2CCN(CC2)c3ccc(Cl)nn3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H17 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908160 Bionet1_000555 COc1ccc(cc1)c2nc3ccccc3n2OCc4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H18 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908161 Bionet1_000556 O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2Cl)c3ccc(cc13)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H19 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1908162 Bionet1_000557 COc1ccc(cc1)c2nc3ccccc3n2OCc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H20 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908163 Bionet1_000558 CCCCC(=O)O/N=C/1\C(=O)N(Cc2cccc(Cl)c2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H21 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908164 Bionet1_000559 COc1ccc(cc1)c2nc3ccccc3n2OCc4c(F)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H22 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908165 Bionet1_000560 ClCCC(=O)O/N=C/1\C(=O)N(Cc2cccc(Cl)c2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H23 mock treatment 0.077 7.54E-4 0.09 0.0893 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 H24 mock treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I01 mock treatment 0.079 0.00275 0.33 0.3263 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I02 mock treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I03 compound treatment 0.0975 0.0213 2.52 2.5184 1.0 1908166 Bionet1_000561 [O-][N+](=O)/C(=C/Nc1ccc(Oc2ccccc2)cc1)/C3OC(=O)c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I04 compound treatment 0.0795 0.00325 0.39 0.3856 1.0 1908167 Bionet1_000562 COc1ccc(cc1)C(=O)NCC(=O)NCCOC(=O)c2ccccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I05 compound treatment 0.0845 0.00825 0.98 0.978 1.0 1908168 Bionet1_000563 Clc1ccc(CO/N=C/NC(=O)C2CCN(CC2)c3ncccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I06 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908169 Bionet1_000564 CC/1=NN(C(=O)\C1=N/Nc2cccc(c2)C(F)(F)F)C3=NCCS3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I07 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908170 Bionet1_000565 CC(C)(C)c1ccc(N/C=C(\C2OC(=O)c3ccccc23)/[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I08 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908171 Bionet1_000566 Clc1ccc(cc1Cl)N2C(=O)CSC23C(=O)Nc4ccccc43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I09 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908172 Bionet1_000567 Clc1cccc(Cn2cc(Cl)cc(C(=O)Nc3ccccc3)c2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I10 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908173 Bionet1_000568 FC(F)(F)c1cccc(c1)N2C(=O)CSC23C(=O)Nc4ccccc43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I11 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908174 Bionet1_000569 Clc1ccc(cc1)C(=O)C[n+]2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I12 compound treatment 0.068 -0.00825 -0.98 -0.9771 -1.0 1333462 Bionet1_000570 O=C1CSC2(N1c3ccccc3)C(=O)N(Cc4ccccc4)c5ccccc52 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I13 compound treatment 0.0625 -0.0137 -1.63 -1.6288 -1.0 1908175 Bionet1_000571 Clc1ccc(C(=O)C[n+]2ccccc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I14 compound treatment 0.068 -0.00825 -0.98 -0.9771 -1.0 1908176 Bionet1_000572 Clc1ccc(cc1)n2cc(COC(=O)Nc3cccc(Cl)c3)nn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I15 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1003505 Bionet1_000573 [O-][N+](=O)c1ccc(cc1)C(=O)C[n+]2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I16 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908177 Bionet1_000574 FC(F)(F)c1cccc(NC(=O)OCc2cn(nn2)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I17 compound treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 1908178 Bionet1_000575 CNC(=S)NNC(=O)c1ccc(=O)n(Cc2cccc(c2)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I18 compound treatment 0.071 -0.00525 -0.62 -0.6216 -1.0 1908179 Bionet1_000576 Clc1ccc(NC(=O)OCc2cn(nn2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I19 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908180 Bionet1_000577 FC(F)(F)c1cccc(Cn2cc(ccc2=O)c3nnc(S)n3CC=C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I20 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908181 Bionet1_000578 Clc1ccc(cc1)n2cc(COC(=O)C(Cl)(Cl)Cl)nn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I21 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908182 Bionet1_000579 FC(F)(F)c1cccc(Cn2cc(ccc2=O)c3nnc(S)o3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I22 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908183 Bionet1_000580 Clc1ccc(cc1)n2cc(COC(=O)c3ccc(Cl)cc3Cl)nn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I23 mock treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 I24 mock treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J01 mock treatment 0.0855 0.00925 1.1 1.0965 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J02 mock treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J03 compound treatment 0.0835 0.00725 0.86 0.8595 1.0 1908184 Bionet1_000581 COc1ccc(cc1)c2nc3ccccc3n2OCc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J04 compound treatment 0.0865 0.0103 1.21 1.215 1.0 1908185 Bionet1_000582 Cc1ccc(cc1)S(=O)(=O)Nc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J05 compound treatment 0.081 0.00475 0.56 0.5633 1.0 1908186 Bionet1_000583 Clc1ccc(cc1)c2nc3ncccc3n2OCc4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J06 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1908187 Bionet1_000584 CC(=O)N(OCc1ccc(Cl)cc1)/C=C\2/N=C(OC2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J07 compound treatment 0.079 0.00275 0.33 0.3263 1.0 1726544 Bionet1_000585 Clc1ccc(COn2c(nc3ncccc23)c4ccccc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J08 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908188 Bionet1_000586 FC(F)(F)c1cnc(OCCNC(=O)Cc2ccccc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J09 compound treatment 0.0835 0.00725 0.86 0.8595 1.0 1908189 Bionet1_000587 FC(F)(F)c1cccc(COn2c(nc3ncccc23)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J10 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908190 Bionet1_000588 FC(F)(F)c1cnc(N2CCN(CC2)c3ccc(C#N)cc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J11 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908191 Bionet1_000589 Clc1ccc(cc1)c2nc3ncccc3n2OCc4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J12 compound treatment 0.071 -0.00525 -0.62 -0.6216 -1.0 1908192 Bionet1_000590 [O-][N+](=O)c1cccnc1N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J13 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908193 Bionet1_000591 Cc1ccc(cc1)c2nc3ncccc3n2OCc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J14 compound treatment 0.0695 -0.00675 -0.8 -0.7993 -1.0 1908194 Bionet1_000592 FC(F)(F)c1cnc(N2CCN(CC2)c3cccc(Cl)n3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J15 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1908195 Bionet1_000593 Cc1ccc(cc1)c2nc3ncccc3n2OCc4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J16 compound treatment 0.071 -0.00525 -0.62 -0.6216 -1.0 1908196 Bionet1_000594 NC(=O)c1ccc(cc1)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J17 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908197 Bionet1_000595 Cc1ccc(cc1)c2nc3ncccc3n2OCc4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J18 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908198 Bionet1_000596 CN(C)/C=N/NC(=O)CN1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J19 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1687610 Bionet1_000597 COc1ccc(cc1)c2nc3ncccc3n2OCc4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J20 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908199 Bionet1_000598 O/N=C/1\C(=O)N(Cc2ccc(Cl)c(Cl)c2)c3ccc(Cl)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J21 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1557171 Bionet1_000599 COc1ccc(cc1)c2nc3ncccc3n2OCc4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J22 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908200 Bionet1_000600 Cc1onc(c1C(=O)NC(=S)NC(=O)N)c2c(F)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J23 mock treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 J24 mock treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K01 mock treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K02 mock treatment 0.0825 0.00625 0.74 0.741 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K03 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1908201 Bionet1_000601 CCNC(=S)NNC(=O)c1ccc(=O)n(Cc2cccc(c2)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K04 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1908202 Bionet1_000602 FC(F)(F)c1cccc(c1)C(=O)OCc2cn(nn2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K05 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1908203 Bionet1_000603 CCn1c(S)nnc1c2ccc(=O)n(Cc3cccc(c3)C(F)(F)F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K06 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908204 Bionet1_000604 Clc1ccc(cc1Cl)n2cc(COC(=O)Nc3ccccc3)nn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K07 compound treatment 0.095 0.0188 2.22 2.2222 1.0 1908205 Bionet1_000605 CNC(=S)NNC(=O)c1ccc(=O)n(Cc2ccc(Cl)cc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K08 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908206 Bionet1_000606 Cc1ccc(NC(=O)OCc2cn(nn2)c3ccc(Cl)c(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K09 compound treatment 0.081 0.00475 0.56 0.5633 1.0 1255396 Bionet1_000607 Cn1c(S)nnc1c2ccc(=O)n(Cc3ccc(Cl)cc3Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K10 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908207 Bionet1_000608 Clc1cccc(NC(=O)OCc2cn(nn2)c3ccc(Cl)c(Cl)c3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K11 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1672425 Bionet1_000609 Sc1nnc(c2ccc(=O)n(Cc3ccc(Cl)cc3Cl)c2)n1CC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K12 compound treatment 0.071 -0.00525 -0.62 -0.6216 -1.0 1234090 Bionet1_000610 COc1ccc(cc1)C(=O)OCc2cn(nn2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K13 compound treatment 0.071 -0.00525 -0.62 -0.6216 -1.0 1908208 Bionet1_000611 CSc1nnc(c2cccn(Cc3ccc(Cl)c(Cl)c3)c2=O)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K14 compound treatment 0.0715 -0.00475 -0.56 -0.5624 -1.0 1908209 Bionet1_000612 Clc1ccc(cc1Cl)n2cc(COC(=O)C(Cl)(Cl)Cl)nn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K15 compound treatment 0.0705 -0.00575 -0.68 -0.6808 -1.0 1024527 Bionet1_000613 COc1ccc(cc1)C(=O)C[n+]2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K16 compound treatment 0.071 -0.00525 -0.62 -0.6216 -1.0 1742367 Bionet1_000614 Cc1cccc(c1)C(=O)NCC(=O)N2CCN(CC2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K17 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908210 Bionet1_000615 [O-][N+](=O)c1cccc(c1)C(=O)C[n+]2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K18 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1422775 Bionet1_000616 COc1ccc(cc1)C(=O)NCC(=O)N2CCN(CC2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K19 compound treatment 0.071 -0.00525 -0.62 -0.6216 -1.0 1908211 Bionet1_000617 CCOC(=O)/C(=C\C(=C(\N)/N1CCN(CC1)c2ccc(OC)cc2)\C#N)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K20 compound treatment 0.07 -0.00625 -0.74 -0.7401 -1.0 1908212 Bionet1_000618 COC(=O)C(NC(=O)c1ccccc1)/C=N/OCc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K21 compound treatment 0.07 -0.00625 -0.74 -0.7401 -1.0 1708814 Bionet1_000619 CCOC(=O)c1cc(C#N)c([nH]c1=O)N2CCN(CC2)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K22 compound treatment 0.0695 -0.00675 -0.8 -0.7993 -1.0 1908213 Bionet1_000620 COC(=O)c1sc2ncccc2c1OCc3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K23 mock treatment 0.0715 -0.00475 -0.56 -0.5624 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 K24 mock treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L01 mock treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L02 mock treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L03 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1908214 Bionet1_000621 Cc1ccc(COn2c(nc3ncccc23)c4ccc(Cl)cc4Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L04 compound treatment 0.0805 0.00425 0.5 0.5041 1.0 1908215 Bionet1_000622 Cc1onc(c1C(=O)Nc2nc(=O)[nH]s2)c3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L05 compound treatment 0.0805 0.00425 0.5 0.5041 1.0 1908216 Bionet1_000623 COc1ccc(N/C(=N\C=[N+](C)C)/SC)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L06 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908217 Bionet1_000624 Cc1ccc2N(Cc3ccc(Cl)cc3)C(=O)/C(=N\OC(=O)CCCl)/c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L07 compound treatment 0.0795 0.00325 0.39 0.3856 1.0 1908218 Bionet1_000625 CS/C(=N/C=[N+](C)C)/Nc1c(C)cccc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L08 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908219 Bionet1_000626 CCCCC(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2)c3ccc(C)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L09 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908220 Bionet1_000627 CN(C)/C=N/C(=O)c1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L10 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908221 Bionet1_000628 CC(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2)c3ccc(Cl)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L11 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1908222 Bionet1_000629 Cc1ccc(NC(=O)c2cccn(Cc3cccc(c3)C(F)(F)F)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L12 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908223 Bionet1_000630 ClCC(=O)O/N=C/1\C(=O)N(Cc2ccc(Cl)cc2)c3ccc(Cl)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L13 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1908224 Bionet1_000631 Cc1ccccc1NC(=O)c2cccn(Cc3cccc(c3)C(F)(F)F)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L14 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908225 Bionet1_000632 CC(=O)O/N=C/1\C(=O)N(Cc2cccc(c2)C(F)(F)F)c3ccc(Cl)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L15 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908226 Bionet1_000633 Cc1ccc(NC(=O)c2cccn(Cc3cccc(c3)C(F)(F)F)c2=O)cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L16 compound treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 1908227 Bionet1_000634 CN(C)/C=C(\C#N)/c1nn2c(cc(nc2c1C#N)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L17 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908228 Bionet1_000635 Cc1cccc(NC(=O)c2cccn(Cc3cccc(c3)C(F)(F)F)c2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L18 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1908229 Bionet1_000636 Cc1cc(C)n2nc(/C(=C/c3ccc(Cl)cc3Cl)/C#N)c(C#N)c2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L19 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908230 Bionet1_000637 Cc1ccc(NC(=O)c2cccn(Cc3cccc(c3)C(F)(F)F)c2=O)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L20 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908231 Bionet1_000638 FC(F)(F)c1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L21 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908232 Bionet1_000639 Clc1ccc2nc(c3ccccc3)n(OCc4ccccc4Cl)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L22 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908233 Bionet1_000640 FC(F)(F)c1ccccc1C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L23 mock treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 L24 mock treatment 0.0785 0.00225 0.27 0.2671 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M01 mock treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M02 mock treatment 0.0775 0.00125 0.15 0.1486 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M03 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1908234 Bionet1_000641 ClCCCC(=O)Nc1cccn(Cc2c(Cl)cccc2Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M04 compound treatment 0.079 0.00275 0.33 0.3263 1.0 1908235 Bionet1_000642 COC(=O)c1sc2ncccc2c1OCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M05 compound treatment 0.0825 0.00625 0.74 0.741 1.0 1908236 Bionet1_000643 FC(F)(F)c1ccc(=O)n(Cc2ccc(cc2)C(=O)Nc3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M06 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908237 Bionet1_000644 COC(=O)c1sc2ncccc2c1OCc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M07 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1908238 Bionet1_000645 FC(F)(F)c1ccc(=O)n(Cc2ccc(NC(=O)N3CCOCC3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M08 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1908239 Bionet1_000646 COC(=O)c1sc2ncccc2c1OCc3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M09 compound treatment 0.0865 0.0103 1.21 1.215 1.0 1908240 Bionet1_000647 CC(C)(C)NC(=O)Nc1ccc(Cn2cc(ccc2=O)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M10 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908241 Bionet1_000648 Cn1nc(c(C#N)c1S(=O)(=O)c2ccc(Cl)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M11 compound treatment 0.0825 0.00625 0.74 0.741 1.0 1908242 Bionet1_000649 FC(F)(F)c1ccc(=O)n(Cc2ccc(NC(=O)Nc3ccccc3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M12 compound treatment 0.073 -0.00325 -0.38 -0.3846 -1.0 1908243 Bionet1_000650 CO/N=C/C1C(=O)N(OCc2ccc(Cl)cc2Cl)C(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M13 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908244 Bionet1_000651 COC(=O)CSC(=O)Nc1ccc(Cn2cc(ccc2=O)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M14 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908245 Bionet1_000652 COC(=O)C(NC(=O)c1ccccc1)/C=N/OCc2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M15 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908246 Bionet1_000653 Clc1ccc(Sc2ccc(Cc3ccc(Cl)cc3Cl)nn2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M16 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908247 Bionet1_000654 COC(=O)C(NC(=O)c1ccccc1)/C=N/OCc2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M17 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908248 Bionet1_000655 Clc1cccc(Sc2ccc(Cc3ccc(Cl)cc3Cl)nn2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M18 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908249 Bionet1_000656 COC(=O)C(NC(=O)c1ccccc1)/C=N/OCc2ccc(cc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M19 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908250 Bionet1_000657 Clc1ccc(Cc2ccc(SCc3ccccc3)nn2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M20 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1908251 Bionet1_000658 COC(=O)C(NC(=O)c1ccccc1)/C=N/OCc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M21 compound treatment 0.071 -0.00525 -0.62 -0.6216 -1.0 1908252 Bionet1_000659 Fc1ccc(NC(=S)N/C=N\OCc2ccc(Cl)cc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M22 compound treatment 0.0715 -0.00475 -0.56 -0.5624 -1.0 1908253 Bionet1_000660 COC(=O)c1ccccc1S(=O)(=O)c2c(C#N)c(nn2C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M23 mock treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 M24 mock treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N01 mock treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N02 mock treatment 0.0775 0.00125 0.15 0.1486 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N03 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1908254 Bionet1_000661 Clc1cccc(COn2c(nc3ccc(Cl)cc23)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N04 compound treatment 0.0865 0.0103 1.21 1.215 1.0 1908255 Bionet1_000662 ClC(Cl)(Cl)C(=O)c1cc(c[nH]1)C(=O)c2ccccc2Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N05 compound treatment 0.0815 0.00525 0.62 0.6225 1.0 1908256 Bionet1_000663 Clc1ccc(COn2c(nc3ccc(Cl)cc23)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N06 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1908257 Bionet1_000664 Fc1ccc(C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N07 compound treatment 0.088 0.0118 1.39 1.3927 1.0 1908258 Bionet1_000665 CCOC(=O)COn1c(nc2ccc(Cl)cc12)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N08 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908259 Bionet1_000666 Clc1ccsc1C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N09 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908260 Bionet1_000667 CCOC(=O)C(C)On1c(nc2ccc(Cl)cc12)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N10 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1426038 Bionet1_000668 Clc1ccc(C(=O)c2c[nH]c(NC(=O)Nc3ccccc3)c2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N11 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1908261 Bionet1_000669 COc1ccc(COn2c(nc3ccc(Cl)cc23)c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N12 compound treatment 0.0795 0.00325 0.39 0.3856 1.0 1908262 Bionet1_000670 Clc1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N13 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1908263 Bionet1_000671 Cc1ccc(COn2c(nc3ccc(Cl)cc23)c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N14 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908264 Bionet1_000672 Clc1ccc(C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N15 compound treatment 0.08 0.00375 0.44 0.4448 1.0 1566066 Bionet1_000673 CCOC(=O)COn1c(nc2ccc(Cl)cc12)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N16 compound treatment 0.079 0.00275 0.33 0.3263 1.0 1908265 Bionet1_000674 Cc1onc(c1C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N17 compound treatment 0.0805 0.00425 0.5 0.5041 1.0 1706192 Bionet1_000675 COc1ccc(Nc2nc3ccccc3c4nnc(c5ccccc5F)n24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N18 compound treatment 0.0785 0.00225 0.27 0.2671 1.0 1908266 Bionet1_000676 Cn1cc(cc1C(=O)C(Cl)(Cl)Cl)C(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N19 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1908267 Bionet1_000677 [O-][N+](=O)c1ccc2nc(c3ccc(Cl)cc3)n(OCc4ccccc4)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N20 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1908268 Bionet1_000678 Clc1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NNc3cccc(Cl)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N21 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908269 Bionet1_000679 COc1ccc(cc1)c2nc3ccc(Cl)cc3n2OCc4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N22 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1908270 Bionet1_000680 Clc1ccccc1C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N23 mock treatment 0.0775 0.00125 0.15 0.1486 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 N24 mock treatment 0.0765 2.54E-4 0.03 0.0301 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O01 mock treatment 0.0715 -0.00475 -0.56 -0.5624 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O02 mock treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O03 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908271 Bionet1_000681 Cc1nn(c(N)c1c2cccc(c2)C(F)(F)F)c3cccc(c3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O04 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1908272 Bionet1_000682 Cn1nc(c(C#N)c1S(=O)(=O)Cc2cccc(c2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O05 compound treatment 0.0805 0.00425 0.5 0.5041 1.0 1908273 Bionet1_000683 FC(F)(F)c1cccc(N/C=C\2/C=NN(C2=O)c3cccc(Cl)n3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O06 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1908274 Bionet1_000684 Cn1nc(c(C#N)c1S(=O)(=O)Cc2ccc(cc2)C(C)(C)C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O07 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1908275 Bionet1_000685 Clc1ccc(CON/C=C\2/C=NN(C2=O)c3cccc(Cl)n3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O08 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908276 Bionet1_000686 Cn1nc(c(C#N)c1S(=O)(=O)c2cccc(c2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O09 compound treatment 0.072 -0.00425 -0.5 -0.5031 -1.0 1168349 Bionet1_000687 Clc1cccc(Cl)c1Cn2n(c3ccccc3)c4ncccc4c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O10 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1493607 Bionet1_000688 Clc1ccc(cc1)N2CCN(CC2)c3ncnc4c5ccccc5[nH]c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O11 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908277 Bionet1_000689 CN(C)S(=O)(=O)Oc1ccc(cc1)C(=O)Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O12 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1677052 Bionet1_000690 COc1ccc(cc1)N2CCN(CC2)c3ncnc4c5ccccc5[nH]c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O13 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908278 Bionet1_000691 CN(C)S(=O)(=O)Oc1ccc(cc1)C(=O)Nc2ccc(cc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O14 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1908279 Bionet1_000692 Cc1ccc(cc1)S(=O)(=O)NC(=O)OCc2cn(nn2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O15 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908280 Bionet1_000693 CN(C)S(=O)(=O)Oc1ccc(cc1)C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O16 compound treatment 0.075 -0.00125 -0.15 -0.1476 -1.0 1323356 Bionet1_000694 Nc1nn(cc1c2ccc(Cl)cc2)c3ncnc4c5ccccc5[nH]c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O17 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908281 Bionet1_000695 CN(C)S(=O)(=O)Oc1ccc(cc1)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O18 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908282 Bionet1_000696 Clc1ccc(/C=N/Nc2ncnc3c4ccccc4[nH]c23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O19 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908283 Bionet1_000697 CN(C)S(=O)(=O)Oc1ccc(cc1)C(=O)Nc2cccc(Cl)c2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O20 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1908284 Bionet1_000698 Clc1cccc(Cl)c1COn2c(nc3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O21 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908285 Bionet1_000699 CN(C)S(=O)(=O)Oc1ccc(cc1)C(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O22 compound treatment 0.0735 -0.00275 -0.33 -0.3254 -1.0 1908286 Bionet1_000700 Clc1ccc(COn2c(nc3ccccc23)c4ccccc4)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O23 mock treatment 0.0785 0.00225 0.27 0.2671 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 O24 mock treatment 0.0795 0.00325 0.39 0.3856 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P01 mock treatment 0.0685 -0.00775 -0.92 -0.9178 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P02 mock treatment 0.0675 -0.00875 -1.04 -1.0363 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P03 compound treatment 0.0685 -0.00775 -0.92 -0.9178 -1.0 1908287 Bionet1_000701 COc1ccc(cc1)c2nc3ccc(Cl)cc3n2OCc4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P04 compound treatment 0.069 -0.00725 -0.86 -0.8586 -1.0 1908288 Bionet1_000702 Fc1ccc(C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P05 compound treatment 0.0695 -0.00675 -0.8 -0.7993 -1.0 1908289 Bionet1_000703 COc1ccc(cc1)c2nc3ccc(Cl)cc3n2OCc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P06 compound treatment 0.092 0.0158 1.87 1.8667 1.0 1908290 Bionet1_000704 Fc1cccc(F)c1C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P07 compound treatment 0.081 0.00475 0.56 0.5633 1.0 1908291 Bionet1_000705 COc1ccc(cc1)c2nc3ccc(Cl)cc3n2OCc4ccc(C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P08 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908292 Bionet1_000706 Clc1cccc(Cl)c1C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P09 compound treatment 0.0755 -7.46E-4 -0.09 -0.0884 -1.0 1908293 Bionet1_000707 COc1ccc(cc1)c2nc3ccc(Cl)cc3n2OCc4cc(C)cc(C)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P10 compound treatment 0.0745 -0.00175 -0.21 -0.2069 -1.0 1908294 Bionet1_000708 Cn1cc(cc1C(=O)C(Cl)(Cl)Cl)C(=O)c2cccc(Cl)c2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P11 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908295 Bionet1_000709 CCOC(=O)COn1c(nc2ccc(cc12)[N+](=O)[O-])c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P12 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1908296 Bionet1_000710 Clc1cccc(C(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P13 compound treatment 0.077 7.54E-4 0.09 0.0893 1.0 1908297 Bionet1_000711 Cc1ccc(COn2c(nc3ccc(cc23)[N+](=O)[O-])c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P14 compound treatment 0.0725 -0.00375 -0.44 -0.4439 -1.0 1908298 Bionet1_000712 CN(C)CCCNC(=O)c1cc(c[nH]1)C(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P15 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908299 Bionet1_000713 COc1ccc(COn2c(nc3ccc(Cl)cc23)c4ccc(OC)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P16 compound treatment 0.076 -2.46E-4 -0.03 -0.0292 -1.0 1375498 Bionet1_000714 CCOC(=O)c1ccccc1c2csc(Nc3ccc(Cl)c(Cl)c3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P17 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1908300 Bionet1_000715 CCOC(=O)C(C)On1c(nc2ccc(cc12)[N+](=O)[O-])c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P18 compound treatment 0.078 0.00175 0.21 0.2078 1.0 1908301 Bionet1_000716 CCOC(=O)c1ccccc1c2csc(NC(=O)c3ccc(F)cc3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P19 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908302 Bionet1_000717 [O-][N+](=O)c1ccc2nc(c3ccccc3)n(OCc4ccc(Cl)cc4)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P20 compound treatment 0.0765 2.54E-4 0.03 0.0301 1.0 1908303 Bionet1_000718 FC(F)(F)Oc1ccc(NC(=O)c2csc(n2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P21 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1599721 Bionet1_000719 COc1ccc(Oc2nc3ccccc3c4nnc(c5ccccc5F)n24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P22 compound treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 1908304 Bionet1_000720 Cc1nc(sc1C(=O)Nc2cccc(c2)C(F)(F)F)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P23 mock treatment 0.074 -0.00225 -0.27 -0.2661 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.569 P24 mock treatment 0.066 -0.0102 -1.21 -1.2141 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A01 mock treatment 0.087 0.0107 1.27 1.2719 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A02 mock treatment 0.0825 0.00623 0.74 0.7387 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A03 compound treatment 0.0825 0.00623 0.74 0.7387 1.0 1442469 Bionet1_000721 Cc1nc(sc1C(=O)Nc2ccc(Cl)c(Cl)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A04 compound treatment 0.083 0.00673 0.8 0.798 1.0 1675922 Bionet1_000722 Cc1ccc(cc1)S(=O)(=O)CCCS(=O)(=O)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A05 compound treatment 0.089 0.0127 1.51 1.5089 1.0 1908305 Bionet1_000723 Cc1nc(sc1C(=O)Nc2ccc(OC(F)(F)F)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A06 compound treatment 0.0695 -0.00677 -0.8 -0.8017 -1.0 1908306 Bionet1_000724 CCNc1nc(Oc2c(Cl)cccc2Cl)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A07 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908307 Bionet1_000725 FC(F)(F)c1cnc(NC(=S)NC(=O)c2ccccc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A08 compound treatment 0.0795 0.00323 0.38 0.3832 1.0 1908308 Bionet1_000726 CCNc1nc(Sc2ccc(Cl)cc2Cl)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A09 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908309 Bionet1_000727 [O-][N+](=O)c1cc(ccc1n2cncn2)C(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A10 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908310 Bionet1_000728 CCNc1nc(SCc2ccc(Cl)c(Cl)c2)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A11 compound treatment 0.077 7.34E-4 0.09 0.087 1.0 1908311 Bionet1_000729 COc1ccc(NC(=O)c2ccc(c(c2)[N+](=O)[O-])n3cncn3)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A12 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908312 Bionet1_000730 CCNc1nc(Sc2ccc(Cl)c(Cl)c2)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A13 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1908313 Bionet1_000731 Cc1c(Cl)cccc1NC(=O)c2ccc(c(c2)[N+](=O)[O-])n3cccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A14 compound treatment 0.0705 -0.00577 -0.68 -0.6832 -1.0 1908314 Bionet1_000732 CCNc1nc(Oc2cc(Cl)cc(Cl)c2)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A15 compound treatment 0.069 -0.00727 -0.86 -0.8609 -1.0 1908315 Bionet1_000733 FC(F)(F)c1cnc(Nc2nc(cs2)c3ccc(Cl)cc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A16 compound treatment 0.067 -0.00927 -1.1 -1.0979 -1.0 1908316 Bionet1_000734 CCNc1nc(Oc2ccc(Cl)cc2Cl)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A17 compound treatment 0.0665 -0.00977 -1.16 -1.1571 -1.0 1600344 Bionet1_000735 CCOC(=O)c1ccccc1c2csc(NC(=O)c3ccc(OC)cc3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A18 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1129864 Bionet1_000736 CC(C)(C)c1ccc(CS(=O)(=O)CCCS(=O)(=O)c2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A19 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908317 Bionet1_000737 CN(C)/C=N/C(=O)N1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A20 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1908318 Bionet1_000738 CCNc1nc(SCc2ccc(cc2)C(C)(C)C)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A21 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1548652 Bionet1_000739 Fc1ccc(NC(=O)c2csc(n2)c3ccc(Cl)cc3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A22 compound treatment 0.071 -0.00527 -0.62 -0.6239 -1.0 1908319 Bionet1_000740 FC(F)(F)c1cnc(N2CCN(CC2)C(=O)CN3CCOCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A23 mock treatment 0.077 7.34E-4 0.09 0.087 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 A24 mock treatment 0.067 -0.00927 -1.1 -1.0979 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B01 mock treatment 0.0835 0.00723 0.86 0.8572 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B02 mock treatment 0.0825 0.00623 0.74 0.7387 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B03 compound treatment 0.0825 0.00623 0.74 0.7387 1.0 1908320 Bionet1_000741 O=C(CCSSCCC(=O)Nc1ccccc1)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B04 compound treatment 0.1395 0.0632 7.49 7.4926 1.0 1908321 Bionet1_000742 Cc1cc(C)n(n1)c2nnc(nn2)N3CCN(CC3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B05 compound treatment 0.0825 0.00623 0.74 0.7387 1.0 1908322 Bionet1_000743 Cc1cc(C)cc(OC(F)(F)C(=O)Nc2cc(Cl)cc(Cl)c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B06 compound treatment 0.097 0.0207 2.46 2.4568 1.0 1603190 Bionet1_000744 O=S(=O)(C1CON(Cc2ccccc2)C1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B07 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908323 Bionet1_000745 Cc1cc(C)cc(OC(F)(F)C(=O)Nc2ccc(OC(F)(F)F)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B08 compound treatment 0.084 0.00773 0.92 0.9164 1.0 1330374 Bionet1_000746 O=C(CON1C(=O)c2ccccc2C1=O)N3CCN(CC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B09 compound treatment 0.071 -0.00527 -0.62 -0.6239 -1.0 1908324 Bionet1_000747 COc1ccc(OC(F)(F)C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B10 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908325 Bionet1_000748 CC(=O)c1ccc(cc1)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B11 compound treatment 0.0705 -0.00577 -0.68 -0.6832 -1.0 1908326 Bionet1_000749 COC(=O)c1ccccc1NC(=O)C(F)(F)Oc2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B12 compound treatment 0.071 -0.00527 -0.62 -0.6239 -1.0 1908327 Bionet1_000750 C/C(=N\O)/c1ccc(cc1)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B13 compound treatment 0.0685 -0.00777 -0.92 -0.9201 -1.0 1908328 Bionet1_000751 COc1ccc(OC(F)(F)C(=O)Nc2c(Cl)cccc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B14 compound treatment 0.068 -0.00827 -0.98 -0.9794 -1.0 1908329 Bionet1_000752 Cn1cc(cc1/C=C(\C#N)/c2ccccn2)C(=O)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B15 compound treatment 0.07 -0.00627 -0.74 -0.7424 -1.0 1908330 Bionet1_000753 COC(=O)c1ccccc1NC(=O)C(F)(F)Oc2ccc(cc2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B16 compound treatment 0.0685 -0.00777 -0.92 -0.9201 -1.0 1908331 Bionet1_000754 FC(F)(F)c1cc(c2ccc(Sc3nc[nH]n3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B17 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908332 Bionet1_000755 CC(C)(C)c1ccc(OC(F)(F)C(=O)Nc2ccc(Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B18 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1702138 Bionet1_000756 COc1ccc(cc1OC)c2cn(nc2C)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B19 compound treatment 0.079 0.00273 0.32 0.324 1.0 1908333 Bionet1_000757 CON/C=N/C(=O)C1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B20 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908334 Bionet1_000758 CO/N=C/C(C)C(=O)c1ccc2c(Br)c(OC)ccc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B21 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908335 Bionet1_000759 CC(C)(C)c1ccc(OC(F)(F)C(=O)Nc2cc(Cl)cc(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B22 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908336 Bionet1_000760 COc1ccc(cc1OC)c2nnn3c2nc(N)c4ncc(cc43)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B23 mock treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 B24 mock treatment 0.0695 -0.00677 -0.8 -0.8017 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C01 mock treatment 0.084 0.00773 0.92 0.9164 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C02 mock treatment 0.082 0.00573 0.68 0.6795 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C03 compound treatment 0.084 0.00773 0.92 0.9164 1.0 1908337 Bionet1_000761 FC(F)(F)Oc1ccc(NC(=O)c2csc(n2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C04 compound treatment 0.085 0.00873 1.03 1.0349 1.0 1908338 Bionet1_000762 FC(F)(F)c1cnc(N2CCN(CC2)c3nc(CCl)cs3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C05 compound treatment 0.088 0.0117 1.39 1.3904 1.0 1908339 Bionet1_000763 Fc1ccc(NC(=O)c2csc(n2)c3cccc(c3)C(F)(F)F)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C06 compound treatment 0.0835 0.00723 0.86 0.8572 1.0 1440891 Bionet1_000764 Nc1c(C#N)c(COc2ccc(Cl)cc2Cl)nc(=O)n1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C07 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908340 Bionet1_000765 FC(F)(F)c1cccc(c1)c2nc(cs2)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C08 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1908341 Bionet1_000766 Clc1ccc(Nc2nc(Cn3cncn3)nn2c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C09 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908342 Bionet1_000767 COC(=O)c1ccc(cc1)c2nc(cs2)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C10 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908343 Bionet1_000768 Fc1ccc(Sc2ccc(NC(=O)c3cccc(c3)C(F)(F)F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C11 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908344 Bionet1_000769 Cc1nc(sc1C(=O)Nc2ccc(F)cc2F)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C12 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908345 Bionet1_000770 CCOC(=O)CSc1ccc(cn1)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C13 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1538007 Bionet1_000771 O=C(Nc1ccccc1)c2ccc(cc2)c3nc(cs3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C14 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908346 Bionet1_000772 CCOC(=O)CSc1ccc(cn1)C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C15 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1190182 Bionet1_000773 Fc1ccc(NC(=O)c2ccc(cc2)c3nc(cs3)c4ccccc4)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C16 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1132001 Bionet1_000774 CCC(C)S(=O)(=O)c1ccc(cn1)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C17 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908347 Bionet1_000775 CN(C)C(=O)c1ccc(cc1)c2nc(cs2)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C18 compound treatment 0.077 7.34E-4 0.09 0.087 1.0 1134836 Bionet1_000776 Cc1ccc(Sc2ccc(NC(=O)c3ccc(Cl)cc3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C19 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1367743 Bionet1_000777 Clc1ccc(c2csc(n2)c3ccc(cc3)C(=O)NCC=C)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C20 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1439191 Bionet1_000778 CCCCS(=O)(=O)c1ccc(cn1)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C21 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1599031 Bionet1_000779 Fc1ccc(NC(=O)c2ccc(cc2)c3nc(cs3)c4ccc(F)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C22 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908348 Bionet1_000780 Cc1ccc(Sc2ccc(NC(=O)c3cccc(c3)C(F)(F)F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C23 mock treatment 0.078 0.00173 0.21 0.2055 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 C24 mock treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D01 mock treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D02 mock treatment 0.0785 0.00223 0.26 0.2648 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D03 compound treatment 0.079 0.00273 0.32 0.324 1.0 1908349 Bionet1_000781 FC(F)(F)c1cnc(N2CCN(CC2)c3c[nH]c(=O)[nH]c3=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D04 compound treatment 0.0905 0.0142 1.69 1.6866 1.0 1908350 Bionet1_000782 Nc1nc2c(nnn2c3cc(cnc13)C(F)(F)F)c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D05 compound treatment 0.0845 0.00823 0.98 0.9757 1.0 1908351 Bionet1_000783 CSc1sn(C(=O)NS(=O)(=O)c2ccc(C)cc2)c(=O)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D06 compound treatment 0.0845 0.00823 0.98 0.9757 1.0 1908352 Bionet1_000784 Nc1nc2c(nnn2c3cc(cnc13)C(F)(F)F)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D07 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908353 Bionet1_000785 Cc1onc(c1C(=O)NOCCOc2ccccc2)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D08 compound treatment 0.0855 0.00923 1.09 1.0942 1.0 1908354 Bionet1_000786 Nc1nc2c(nnn2c3cc(cnc13)C(F)(F)F)c4c(F)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D09 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908355 Bionet1_000787 FC(F)(F)c1cccc(OCCON2C(=O)c3ccccc3C2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D10 compound treatment 0.0805 0.00423 0.5 0.5017 1.0 1908356 Bionet1_000788 CCOC(=O)c1sc(=S)sc1SCc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D11 compound treatment 0.077 7.34E-4 0.09 0.087 1.0 1214859 Bionet1_000789 Cc1ccc(NC(=O)N2CCOC32CCN(CC3)c4ncccn4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D12 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908357 Bionet1_000790 CCOC(=O)c1sc(=S)sc1SCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D13 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908358 Bionet1_000791 COc1ccc(cc1)C(=O)N2CCOC32CCN(CC3)c4ccc(cc4)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D14 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1130635 Bionet1_000792 CCOC(=O)c1sc(=S)sc1SCc2cccc(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D15 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1723867 Bionet1_000793 Clc1ccc(C(=O)N2CCOC32CCN(CC3)c4ncccn4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D16 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1355653 Bionet1_000794 Clc1ccc(COc2ccsc2NC(=O)Nc3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D17 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1253955 Bionet1_000795 COc1ccc(cc1)C(=O)N2CCOC32CCN(CC3)c4ncccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D18 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908359 Bionet1_000796 CN(C)c1nnc(o1)/C(=C/c2cc(cn2C)C(=O)c3cccc(Cl)c3)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D19 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1908360 Bionet1_000797 COc1ccc(N/C=C(\C#N)/C(=O)N/C=N/OCc2ccc(cc2)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D20 compound treatment 0.077 7.34E-4 0.09 0.087 1.0 1908361 Bionet1_000798 Cn1cc(cc1/C=C(\C#N)/C(=O)c2ccccc2)C(=O)c3c(F)cccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D21 compound treatment 0.079 0.00273 0.32 0.324 1.0 1908362 Bionet1_000799 FC(F)(F)c1cccc(c1)N2CCN(CC2)c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D22 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908363 Bionet1_000800 COC(=O)c1c(N)sc2CN(CCc12)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D23 mock treatment 0.079 0.00273 0.32 0.324 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 D24 mock treatment 0.081 0.00473 0.56 0.561 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E01 mock treatment 0.079 0.00273 0.32 0.324 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E02 mock treatment 0.0795 0.00323 0.38 0.3832 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E03 compound treatment 0.081 0.00473 0.56 0.561 1.0 1908364 Bionet1_000801 N/C(=N\NC(=O)c1ccc(Cl)cc1)/CSc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E04 compound treatment 0.0845 0.00823 0.98 0.9757 1.0 1669123 Bionet1_000802 Cc1ccc(cc1)S(=O)(=O)c2ccc(NC(=O)c3ccc(Cl)cc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E05 compound treatment 0.0845 0.00823 0.98 0.9757 1.0 1908365 Bionet1_000803 N/C(=N\NC(=O)c1ccc(Cl)cc1)/COc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E06 compound treatment 0.08 0.00373 0.44 0.4425 1.0 1146305 Bionet1_000804 Cc1ccc(Sc2ccc(NC(=O)c3c(F)cccc3F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E07 compound treatment 0.079 0.00273 0.32 0.324 1.0 1908366 Bionet1_000805 Cc1c(Cl)cccc1NC(=O)c2ccc(c(c2)[N+](=O)[O-])n3cncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E08 compound treatment 0.078 0.00173 0.21 0.2055 1.0 1528774 Bionet1_000806 Fc1ccc(Sc2ccc(NC(=O)c3ccc(Cl)cc3Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E09 compound treatment 0.0795 0.00323 0.38 0.3832 1.0 1908367 Bionet1_000807 COc1ccc(NC(=O)c2ccc(c(c2)[N+](=O)[O-])n3cncn3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E10 compound treatment 0.077 7.34E-4 0.09 0.087 1.0 1482424 Bionet1_000808 Clc1ccc(cc1Cl)c2ccnc3nc(nn23)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E11 compound treatment 0.079 0.00273 0.32 0.324 1.0 1908368 Bionet1_000809 COc1ccc(NC(=O)c2ccc(c(c2)[N+](=O)[O-])n3cccn3)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E12 compound treatment 0.079 0.00273 0.32 0.324 1.0 1433181 Bionet1_000810 CC(Oc1ccc(Cl)cc1Cl)c2ccnc3nc(nn23)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E13 compound treatment 0.077 7.34E-4 0.09 0.087 1.0 1908369 Bionet1_000811 COc1ccc(NC(=O)c2ccc(c(c2)[N+](=O)[O-])n3cccn3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E14 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1681221 Bionet1_000812 C1CN(CCN1c2nc3nccc(c4ccccc4)n3n2)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E15 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908370 Bionet1_000813 CCOC(=O)c1c(NC(=O)Nc2ccc(Cl)cc2)[nH]cc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E16 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1733643 Bionet1_000814 COc1ccc(cc1)c2ccnc3nc(nn23)N4CCN(CC4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E17 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1369019 Bionet1_000815 Brc1ccc(NC(=O)c2csc(n2)c3ccncc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E18 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1681135 Bionet1_000816 Fc1ccc(cc1)c2ccnc3nc(nn23)N4CCN(CC4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E19 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908371 Bionet1_000817 Cc1nc(sc1C(=O)Nc2cccc(c2)C(F)(F)F)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E20 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908372 Bionet1_000818 Fc1ccc(cc1)c2ccnc3nc(SCc4c(F)cccc4Cl)nn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E21 compound treatment 0.0775 0.00123 0.15 0.1463 1.0 1908373 Bionet1_000819 Cc1nc(sc1C(=O)Nc2ccc(cc2)C(F)(F)F)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E22 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1908374 Bionet1_000820 Fc1cccc(Cl)c1CSc2nc3nccc(/C=C\c4ccccc4)n3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E23 mock treatment 0.078 0.00173 0.21 0.2055 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 E24 mock treatment 0.0775 0.00123 0.15 0.1463 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F01 mock treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F02 mock treatment 0.0765 2.34E-4 0.03 0.0278 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F03 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908375 Bionet1_000821 CN(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F04 compound treatment 0.081 0.00473 0.56 0.561 1.0 1908376 Bionet1_000822 Nc1sc2CN(CCc2c1C#N)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F05 compound treatment 0.0835 0.00723 0.86 0.8572 1.0 1908377 Bionet1_000823 CN(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CC2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F06 compound treatment 0.082 0.00573 0.68 0.6795 1.0 1908378 Bionet1_000824 Cn1c(CNS(=O)(=O)c2ccc(Cl)cc2)nnc1SCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F07 compound treatment 0.077 7.34E-4 0.09 0.087 1.0 1908379 Bionet1_000825 CN(C)c1nc(cc(n1)C(F)(F)F)N2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F08 compound treatment 0.0805 0.00423 0.5 0.5017 1.0 1168738 Bionet1_000826 COC(=O)CSc1nnc(CNS(=O)(=O)c2ccc(Cl)cc2)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F09 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1297873 Bionet1_000827 Clc1ccc(cc1Cl)N2CCN(CC2)c3nnnn3c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F10 compound treatment 0.0815 0.00523 0.62 0.6202 1.0 1908380 Bionet1_000828 CSc1nnc(CNS(=O)(=O)c2ccc(Br)cc2)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F11 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1229343 Bionet1_000829 Clc1ccc(cc1Cl)N2CCN(CC2)c3cnc4ccccc4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F12 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1666889 Bionet1_000830 CCC(C)Sc1nnc(CNS(=O)(=O)c2ccc(F)cc2)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F13 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908381 Bionet1_000831 Cn1nc(c(C#N)c1N2CCN(CC2)c3ccc(F)cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F14 compound treatment 0.071 -0.00527 -0.62 -0.6239 -1.0 1908382 Bionet1_000832 [O-][N+](=O)c1ccc(cc1)N2CCc3nn(cc3C2)c4cccc(Cl)n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F15 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908383 Bionet1_000833 Cn1nc(c(C#N)c1N2CCN(CC2)c3ccccc3F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F16 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908384 Bionet1_000834 COc1ccc(NC(=O)CS(=O)(=O)c2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F17 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908385 Bionet1_000835 COc1cccc(c1)N2CCN(CC2)c3c(C#N)c(nn3C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F18 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908386 Bionet1_000836 COc1ccc(NC(=O)CS(=O)c2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F19 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1908387 Bionet1_000837 CCOC(=O)NC(=O)c1cn(OCc2ccc(Cl)cc2)c(=O)[nH]c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F20 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908388 Bionet1_000838 COc1ccc(NC(=O)CS(=O)c2cccc(c2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F21 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1908389 Bionet1_000839 FC(F)(F)c1cccc(c1)C(=O)OCCn2cc(C#N)c(=O)[nH]c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F22 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908390 Bionet1_000840 COc1ccc(NC(=O)CS(=O)(=O)c2cccc(c2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F23 mock treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 F24 mock treatment 0.075 -0.00127 -0.15 -0.15 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G01 mock treatment 0.077 7.34E-4 0.09 0.087 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G02 mock treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G03 compound treatment 0.0775 0.00123 0.15 0.1463 1.0 1908391 Bionet1_000841 COC(=O)c1ccc(cc1)c2nc(cs2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G04 compound treatment 0.08 0.00373 0.44 0.4425 1.0 1908392 Bionet1_000842 Fc1cccc(Cl)c1CSc2nc3nccc(c4ccccn4)n3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G05 compound treatment 0.082 0.00573 0.68 0.6795 1.0 1908393 Bionet1_000843 Cc1nc(sc1C(=O)Nc2ccc(Br)cc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G06 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908394 Bionet1_000844 C(Sc1nc2nccc(/C=C\c3ccccc3)n2n1)/C=C/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G07 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1353051 Bionet1_000845 CCOC(=O)c1cc([nH]c1N2CCN(CC2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G08 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1908395 Bionet1_000846 Fc1ccc(cc1)c2ccnc3nc(SC/C=C/c4ccccc4)nn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G09 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1599578 Bionet1_000847 COc1ccc(cc1)N2CCN(CC2)c3[nH]c(cc3C#N)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G10 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908396 Bionet1_000848 COc1ccc(cc1)c2cnc3nc(SC/C=C/c4ccccc4)nn3c2N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G11 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908397 Bionet1_000849 Cc1nc(sc1C(=O)Nc2ccc(OC(F)(F)F)cc2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G12 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1908398 Bionet1_000850 Nc1c(cnc2nc(SC/C=C/c3ccccc3)nn12)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G13 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908399 Bionet1_000851 CNC(=O)c1ccc(cc1)c2nc(cs2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G14 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1908400 Bionet1_000852 COc1ccc(cc1)c2ccnc3nc(SC/C=C/c4ccccc4)nn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G15 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1908401 Bionet1_000853 FC(F)(F)c1cccc(c1)c2csc(n2)c3ccc(cc3)C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G16 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1908402 Bionet1_000854 CN(C)/C=C/C(=O)c1cccc(Oc2ncc(cc2Cl)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G17 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1179349 Bionet1_000855 CCOC(=O)c1cc([nH]c1N2CCOCC2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G18 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1908403 Bionet1_000856 CO/N=C/C(=C\Nc1ccc(Cl)cc1)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G19 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1152475 Bionet1_000857 Clc1ccc(cc1)c2csc(n2)c3ccc(cc3)C(=O)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G20 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908404 Bionet1_000858 FC(F)(F)c1cccc(N/C=C/c2ncc(cc2Cl)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G21 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908405 Bionet1_000859 CN(C)CCCNC(=O)c1ccc(cc1)c2nc(cs2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G22 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908406 Bionet1_000860 FC(F)(F)c1cnc(C/C=N\OCc2c(Cl)cccc2Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G23 mock treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 G24 mock treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H01 mock treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H02 mock treatment 0.0775 0.00123 0.15 0.1463 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H03 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1908407 Bionet1_000861 C/C(=N\Nc1ncc(cc1Cl)C(F)(F)F)/c2cn(C)c(=O)n(C)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H04 compound treatment 0.084 0.00773 0.92 0.9164 1.0 1908408 Bionet1_000862 COc1ccc(NC(=O)CSc2ccc(Br)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H05 compound treatment 0.083 0.00673 0.8 0.798 1.0 1197912 Bionet1_000863 COc1ccc(cc1)n2cc(C#N)c(=O)n(Cc3ccc(F)cc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H06 compound treatment 0.0885 0.0122 1.45 1.4497 1.0 1908409 Bionet1_000864 COc1ccc(NC(=O)CS(=O)(=O)c2ccc(Br)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H07 compound treatment 0.08 0.00373 0.44 0.4425 1.0 1908410 Bionet1_000865 CN(c1ncc(cc1Cl)C(F)(F)F)n2cc(C(=O)C)c(=O)[nH]c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H08 compound treatment 0.0795 0.00323 0.38 0.3832 1.0 1908411 Bionet1_000866 Clc1ccc(NC(=O)C/C=N\OCc2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H09 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1908412 Bionet1_000867 CC(=O)c1cn(CCNc2ncc(cc2Cl)C(F)(F)F)c(=O)[nH]c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H10 compound treatment 0.082 0.00573 0.68 0.6795 1.0 1908413 Bionet1_000868 Clc1ccc(NC(=O)C/C=N\OCc2ccc(Cl)cc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H11 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908414 Bionet1_000869 CN1CCN(CC1)n2cc(C(=O)C)c(=O)n(Cc3ccc(F)cc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H12 compound treatment 0.077 7.34E-4 0.09 0.087 1.0 1908415 Bionet1_000870 [O-][N+](=O)c1ccc(CO/N=C\CC(=O)Nc2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H13 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908416 Bionet1_000871 CC(=O)c1cn(Cc2ccccc2)c(=O)n(Cc3ccc(F)cc3)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H14 compound treatment 0.0705 -0.00577 -0.68 -0.6832 -1.0 1908417 Bionet1_000872 Clc1ccc(NC(=O)C/C=N\OC(=O)Nc2ccccc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H15 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908418 Bionet1_000873 CC(=O)c1cn(c2ccc(Cl)cc2)c(=O)n(Cc3ccc(F)cc3)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H16 compound treatment 0.0705 -0.00577 -0.68 -0.6832 -1.0 1908419 Bionet1_000874 Clc1ccc(NC(=O)C/C=N\OCc2c(Cl)cccc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H17 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908420 Bionet1_000875 Cn1c(=O)c(C#N)cn(CCNc2ncc(cc2Cl)C(F)(F)F)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H18 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908421 Bionet1_000876 [O-][N+](=O)c1ccc(CO/N=C\CC(=O)Nc2ccc(Br)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H19 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1908422 Bionet1_000877 FC(F)(F)c1cnc(NCCn2cc(C#N)c(=O)[nH]c2=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H20 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908423 Bionet1_000878 Fc1ccc(NC(=O)C/C=N\OCc2ccc(Cl)cc2Cl)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H21 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1908424 Bionet1_000879 CCOC(=O)NC(=O)/C(=C\NNc1ncc(cc1Cl)C(F)(F)F)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H22 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908425 Bionet1_000880 Fc1ccc(NC(=O)C/C=N\OCc2ccc(Cl)c(Cl)c2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H23 mock treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 H24 mock treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I01 mock treatment 0.079 0.00273 0.32 0.324 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I02 mock treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I03 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1153565 Bionet1_000881 CNC(=O)c1ccc(cc1)c2nc(cs2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I04 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1908426 Bionet1_000882 FC(F)(F)c1cnc(/C=C/Nc2ccccc2Oc3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I05 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1317106 Bionet1_000883 Clc1ccc(cc1Cl)c2csc(n2)c3ccc(cc3)C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I06 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908427 Bionet1_000884 CO/N=C/C(=C\Nc1ccccc1)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I07 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908428 Bionet1_000885 CCOC(=O)c1cc([nH]c1NNC(=O)c2ccccc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I08 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908429 Bionet1_000886 CO/N=C/C(=C\Nc1ccc(F)cc1)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I09 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1601031 Bionet1_000887 CCOC(=O)c1cc([nH]c1Nc2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I10 compound treatment 0.07 -0.00627 -0.74 -0.7424 -1.0 1908430 Bionet1_000888 CO/N=C/C(=C\Nc1ccc(OC)cc1)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I11 compound treatment 0.069 -0.00727 -0.86 -0.8609 -1.0 1908431 Bionet1_000889 CCOC(=O)c1cc([nH]c1Nc2ccc(C)cc2)c3cccc(c3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I12 compound treatment 0.066 -0.0103 -1.22 -1.2164 -1.0 1908432 Bionet1_000890 FC(F)(F)c1cnc(C(C#N)c2c(Cl)cccc2Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I13 compound treatment 0.0605 -0.0158 -1.87 -1.8681 -1.0 1266304 Bionet1_000891 O=C(c1cc(C#N)c([nH]1)N2CCN(CC2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I14 compound treatment 0.065 -0.0113 -1.33 -1.3349 -1.0 1908433 Bionet1_000892 COc1ccc(cc1OC)C(C#N)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I15 compound treatment 0.0695 -0.00677 -0.8 -0.8017 -1.0 1908434 Bionet1_000893 CCOC(=O)C(=CNc1c[nH]c(C)c1C(=O)c2ccccc2)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I16 compound treatment 0.069 -0.00727 -0.86 -0.8609 -1.0 1908435 Bionet1_000894 NC(=O)C(c1cccc(c1)C(F)(F)F)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I17 compound treatment 0.071 -0.00527 -0.62 -0.6239 -1.0 1908436 Bionet1_000895 CCOC(=O)C(=CNc1cn(C)c(C)c1C(=O)c2ccccc2)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I18 compound treatment 0.07 -0.00627 -0.74 -0.7424 -1.0 1908437 Bionet1_000896 COc1ccc(cc1OC)C(C(=O)N)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I19 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1430706 Bionet1_000897 O=C(c1cc(C#N)c([nH]1)N2CCN(CC2)c3ccccn3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I20 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1908438 Bionet1_000898 FC(F)(F)c1cnc(C(C#N)c2ccc(Cl)cc2Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I21 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1710693 Bionet1_000899 CCOC(=O)c1cc([nH]c1Nc2ccc(Cl)cc2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I22 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1908439 Bionet1_000900 NC(=O)C(c1ncc(cc1Cl)C(F)(F)F)c2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I23 mock treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 I24 mock treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J01 mock treatment 0.077 7.34E-4 0.09 0.087 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J02 mock treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J03 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1908440 Bionet1_000901 Cn1c(ccc1/C(=C/c2ccc(Cl)cc2)/C#N)C(=O)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J04 compound treatment 0.0875 0.0112 1.33 1.3312 1.0 1908441 Bionet1_000902 Fc1ccc(NC(=O)C/C=N\OCc2c(Cl)cccc2Cl)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J05 compound treatment 0.08 0.00373 0.44 0.4425 1.0 1908442 Bionet1_000903 COC(=O)C(NS(=O)(=O)c1cccc(c1)C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J06 compound treatment 0.0815 0.00523 0.62 0.6202 1.0 1908443 Bionet1_000904 CSc1nc(NC(=O)C/C=N\OCc2ccc(cc2)[N+](=O)[O-])nn1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J07 compound treatment 0.078 0.00173 0.21 0.2055 1.0 1514688 Bionet1_000905 CS(=O)(=O)c1ccc(C(=O)Nc2ccc(cc2)N3CCCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J08 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908444 Bionet1_000906 Clc1ccc(cc1)S(=O)(=O)C/C=N/OCc2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J09 compound treatment 0.084 0.00773 0.92 0.9164 1.0 1151626 Bionet1_000907 CCCCC(=O)Nc1ccc(cc1)N2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J10 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1908445 Bionet1_000908 Clc1ccc(OC(=O)C/C=N\OCc2c(Cl)cccc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J11 compound treatment 0.0705 -0.00577 -0.68 -0.6832 -1.0 1908446 Bionet1_000909 FC(F)(F)c1cccc(c1)C(=O)Nc2ccccc2N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J12 compound treatment 0.069 -0.00727 -0.86 -0.8609 -1.0 1908447 Bionet1_000910 COc1ccc(OC(=O)C/C=N\OCc2c(Cl)cccc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J13 compound treatment 0.068 -0.00827 -0.98 -0.9794 -1.0 1418952 Bionet1_000911 CS(=O)(=O)c1ccc(C(=O)Nc2ccccc2N3CCOCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J14 compound treatment 0.067 -0.00927 -1.1 -1.0979 -1.0 1908448 Bionet1_000912 Clc1ccc(cc1)c2nnc(COc3ccc(Cl)cc3Cl)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J15 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908449 Bionet1_000913 Cc1nc(nn1c2ccc(cc2)[N+](=O)[O-])C(=O)Nc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J16 compound treatment 0.069 -0.00727 -0.86 -0.8609 -1.0 1908450 Bionet1_000914 CC(C)(N1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F)C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J17 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1349482 Bionet1_000915 Cc1nc(nn1c2ccc(Cl)cc2)C(=O)Nc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J18 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1908451 Bionet1_000916 COc1cccc2C=C(COc12)C(=O)Nc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J19 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1908452 Bionet1_000917 Cc1nc(nn1c2ccc(cc2)[N+](=O)[O-])C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J20 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908453 Bionet1_000918 COc1cccc2C=C(COc12)C(=O)Nc3ccc(OC(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J21 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908454 Bionet1_000919 Cc1nc(nn1c2ccc(cc2)[N+](=O)[O-])C(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J22 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908455 Bionet1_000920 COc1cccc2C=C(COc12)C(=O)NCc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J23 mock treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 J24 mock treatment 0.083 0.00673 0.8 0.798 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K01 mock treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K02 mock treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K03 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908456 Bionet1_000921 Cn1nc(c(CO)c1Sc2ccc(Br)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K04 compound treatment 0.078 0.00173 0.21 0.2055 1.0 1908457 Bionet1_000922 NC(=O)C(c1ccc(Cl)cc1Cl)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K05 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908458 Bionet1_000923 CC(=O)OCc1c(nn(C)c1S(=O)(=O)c2ccc(Cl)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K06 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1908459 Bionet1_000924 FC(F)(F)c1cnc(N2CCC(CC2)C(=O)N3CCCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K07 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908460 Bionet1_000925 Cn1nc(c(CO)c1S(=O)(=O)c2ccc(Cl)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K08 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908461 Bionet1_000926 FC(F)(F)c1cnc(N2CCC(CC2)C(=O)N3CCOCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K09 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1908462 Bionet1_000927 Cn1nc(c(CO)c1S(=O)(=O)c2ccc(Br)cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K10 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908463 Bionet1_000928 FC(F)(F)c1cnc(N2CCC(CC2)C(=O)N3CCCCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K11 compound treatment 0.071 -0.00527 -0.62 -0.6239 -1.0 1908464 Bionet1_000929 Cc1ccnc(N/C=C(/NC(=O)c2ccccc2)\C(=O)N/N=C\c3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K12 compound treatment 0.0685 -0.00777 -0.92 -0.9201 -1.0 1908465 Bionet1_000930 CN(CCO)C(=O)C1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K13 compound treatment 0.0685 -0.00777 -0.92 -0.9201 -1.0 1908466 Bionet1_000931 FC(F)(F)c1cnc(CON2C(=O)c3ccccc3C2=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K14 compound treatment 0.069 -0.00727 -0.86 -0.8609 -1.0 1908467 Bionet1_000932 CN1CCN(CC1)C(=O)C2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K15 compound treatment 0.0695 -0.00677 -0.8 -0.8017 -1.0 1908468 Bionet1_000933 Cn1c(SCc2ccccc2)nnc1c3csc(n3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K16 compound treatment 0.07 -0.00627 -0.74 -0.7424 -1.0 1378992 Bionet1_000934 Cc1ccc(cc1)S(=O)(=O)c2ccc(NC(=O)c3c(F)cccc3F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K17 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908469 Bionet1_000935 Clc1ccc(CSc2nnc(o2)c3csc(n3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K18 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908470 Bionet1_000936 Fc1ccc(cc1)C(=O)Nc2ccc(Sc3cccc(c3)C(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K19 compound treatment 0.0695 -0.00677 -0.8 -0.8017 -1.0 1908471 Bionet1_000937 CN(C)c1nc(Sc2ccc(Cl)c(Cl)c2)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K20 compound treatment 0.0695 -0.00677 -0.8 -0.8017 -1.0 1908472 Bionet1_000938 COC(=O)/C(=C\Nc1ccc(Cl)cc1Cl)/NC(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K21 compound treatment 0.0695 -0.00677 -0.8 -0.8017 -1.0 1908473 Bionet1_000939 CN(C)c1nc(Sc2ccc(Br)cc2)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K22 compound treatment 0.071 -0.00527 -0.62 -0.6239 -1.0 1908474 Bionet1_000940 COC(=O)/C(=C\Nc1ccc(OC)cc1)/NC(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K23 mock treatment 0.071 -0.00527 -0.62 -0.6239 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 K24 mock treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L01 mock treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L02 mock treatment 0.081 0.00473 0.56 0.561 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L03 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1908475 Bionet1_000941 COc1ccc(NC(=O)c2nc(C)n(n2)c3ccc(cc3)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L04 compound treatment 0.0845 0.00823 0.98 0.9757 1.0 1908476 Bionet1_000942 COc1ccc2OCC(=Cc2c1)C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L05 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1908477 Bionet1_000943 Clc1ccc(CC(=O)c2c[nH]c(c2)C(=O)C(Cl)(Cl)Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L06 compound treatment 0.0805 0.00423 0.5 0.5017 1.0 1908478 Bionet1_000944 Cc1ccc(cc1)n2cc3CN(CCc3n2)c4ncc(cc4Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L07 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1908479 Bionet1_000945 CCOC(=O)c1c(N)onc1OCCOC(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L08 compound treatment 0.0825 0.00623 0.74 0.7387 1.0 1908480 Bionet1_000946 CSc1nnc(CNS(=O)(=O)c2ccc(Cl)cc2)n1CC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L09 compound treatment 0.084 0.00773 0.92 0.9164 1.0 1908481 Bionet1_000947 CCOC(=O)c1c(N)onc1OCCOC(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L10 compound treatment 0.08 0.00373 0.44 0.4425 1.0 1908482 Bionet1_000948 Clc1ccc(cc1)S(=O)(=O)NCc2nnc(SCC=C)n2CC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L11 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1908483 Bionet1_000949 FC(F)(F)c1cnc(NCCNC2=CC(=O)c3ccccc3C2=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L12 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1908484 Bionet1_000950 CCn1c(SCC=C)nnc1C(C)NS(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L13 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908485 Bionet1_000951 CCOC(=O)c1c(N)onc1OCCOC(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L14 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1908486 Bionet1_000952 CCn1c(SC)nnc1C(C)NS(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L15 compound treatment 0.0705 -0.00577 -0.68 -0.6832 -1.0 1631585 Bionet1_000953 CC(C)CC(NS(=O)(=O)c1ccc(F)cc1)C(=O)Nc2ccc(C)c(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L16 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908487 Bionet1_000954 CN(C)S(=O)(=O)Oc1ccsc1C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L17 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1479836 Bionet1_000955 CC(NS(=O)(=O)c1ccc(F)cc1)C(=O)Nc2ccc(C)c(C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L18 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1908488 Bionet1_000956 CN(C)S(=O)(=O)Oc1ccsc1C(=O)Nc2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L19 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1177965 Bionet1_000957 CC(NS(=O)(=O)c1ccc(F)cc1)C(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L20 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1908489 Bionet1_000958 CN(C)S(=O)(=O)Oc1ccsc1C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L21 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1383336 Bionet1_000959 CC(C)C(NS(=O)(=O)c1ccc(Cl)cc1)C(=O)Nc2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L22 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1908490 Bionet1_000960 CN(C)S(=O)(=O)Oc1ccsc1C(=O)Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L23 mock treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 L24 mock treatment 0.078 0.00173 0.21 0.2055 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M01 mock treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M02 mock treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M03 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908491 Bionet1_000961 CN(C)c1nc(Oc2cccc(Cl)c2Cl)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M04 compound treatment 0.0775 0.00123 0.15 0.1463 1.0 1908492 Bionet1_000962 COC(=O)/C(=C\Nc1ccccc1)/NC(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M05 compound treatment 0.077 7.34E-4 0.09 0.087 1.0 1908493 Bionet1_000963 CN(C)c1nc(Oc2c(Cl)cccc2Cl)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M06 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1908494 Bionet1_000964 COC(=O)/C(=C\Nc1ccc(OC)cc1)/NC(=O)c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M07 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908495 Bionet1_000965 CN(C)/C=N\NC(=O)/C(=C\Nc1nccc(C)n1)/NC(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M08 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1397124 Bionet1_000966 Cc1cccc(c1)C(=O)Nc2ccc(Sc3ccccc3Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M09 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908496 Bionet1_000967 FC(F)(F)Oc1ccc(NC(=O)c2nc(Cn3cncn3)n[nH]2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M10 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908497 Bionet1_000968 FC(F)(F)c1cccc(c1)C(=O)Nc2ccc(cc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M11 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908498 Bionet1_000969 CCc1cccc(CC)c1NC(=O)C(F)(F)Oc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M12 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1465528 Bionet1_000970 Clc1ccc(C(=O)Nc2ccc(cc2)N3CCOCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M13 compound treatment 0.0705 -0.00577 -0.68 -0.6832 -1.0 1908499 Bionet1_000971 FC(F)(F)c1cccc(OC(F)(F)C(=O)Nc2c(Cl)cccc2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M14 compound treatment 0.0695 -0.00677 -0.8 -0.8017 -1.0 1345249 Bionet1_000972 CS(=O)(=O)c1ccc(C(=O)Nc2ccc(cc2)N3CCOCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M15 compound treatment 0.071 -0.00527 -0.62 -0.6239 -1.0 1908500 Bionet1_000973 Cc1ccc(NC(=O)C(F)(F)Oc2cccc(c2)C(F)(F)F)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M16 compound treatment 0.0725 -0.00377 -0.45 -0.4462 -1.0 1908501 Bionet1_000974 CN1CCN(CC1)c2ccc(NC(=O)c3cccc(c3)C(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M17 compound treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 1908502 Bionet1_000975 FC(F)(F)c1ccc(NC(=O)C(F)(F)Oc2cccc(c2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M18 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1423200 Bionet1_000976 Fc1ccc(cc1)C(=O)Nc2ccc(cc2)N3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M19 compound treatment 0.0715 -0.00477 -0.56 -0.5647 -1.0 1908503 Bionet1_000977 Fc1ccc(OC(F)(F)C(=O)Nc2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M20 compound treatment 0.071 -0.00527 -0.62 -0.6239 -1.0 1908504 Bionet1_000978 ClC(Cl)C(=O)Nc1ccc(cc1)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M21 compound treatment 0.069 -0.00727 -0.86 -0.8609 -1.0 1908505 Bionet1_000979 Fc1ccc(OC(F)(F)C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M22 compound treatment 0.07 -0.00627 -0.74 -0.7424 -1.0 1908506 Bionet1_000980 O/N=C(\Sc1ccc(Cl)cc1)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M23 mock treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 M24 mock treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N01 mock treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N02 mock treatment 0.087 0.0107 1.27 1.2719 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N03 compound treatment 0.079 0.00273 0.32 0.324 1.0 1908507 Bionet1_000981 Cc1nc(nn1c2ccc(Cl)cc2)C(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N04 compound treatment 0.081 0.00473 0.56 0.561 1.0 1908508 Bionet1_000982 CN(C)S(=O)(=O)Oc1ccsc1C(=O)Nc2ccc(cc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N05 compound treatment 0.0805 0.00423 0.5 0.5017 1.0 1119468 Bionet1_000983 Cc1nc(nn1c2ccc(Cl)cc2)C(=O)Nc3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N06 compound treatment 0.082 0.00573 0.68 0.6795 1.0 1908509 Bionet1_000984 CN(C)S(=O)(=O)Oc1ccsc1C(=O)Nc2cccc(Cl)c2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N07 compound treatment 0.08 0.00373 0.44 0.4425 1.0 1908510 Bionet1_000985 Cc1nc(nn1c2cccc(c2)C(F)(F)F)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N08 compound treatment 0.0815 0.00523 0.62 0.6202 1.0 1908511 Bionet1_000986 CN(C)/C=C(/C(=O)c1ccc(Cl)cc1)\S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N09 compound treatment 0.082 0.00573 0.68 0.6795 1.0 1908512 Bionet1_000987 Cc1nc(nn1c2cccc(c2)C(F)(F)F)C(=O)Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N10 compound treatment 0.0805 0.00423 0.5 0.5017 1.0 1456380 Bionet1_000988 Clc1ccc(cc1)c2c(cnn2c3ccccc3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N11 compound treatment 0.078 0.00173 0.21 0.2055 1.0 1908513 Bionet1_000989 Cc1nc(nn1c2cccc(c2)C(F)(F)F)C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N12 compound treatment 0.079 0.00273 0.32 0.324 1.0 1908514 Bionet1_000990 CN(C)/C=C(/C(=O)c1ccc(F)cc1)\S(=O)(=O)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N13 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1908515 Bionet1_000991 Cc1nc(nn1c2cccc(c2)C(F)(F)F)C(=O)Nc3ccc(F)c(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N14 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1638945 Bionet1_000992 COc1ccc(cc1)c2c(cnn2c3ccccc3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N15 compound treatment 0.0805 0.00423 0.5 0.5017 1.0 1206788 Bionet1_000993 Cc1nc(nn1c2ccc(F)cc2F)C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N16 compound treatment 0.078 0.00173 0.21 0.2055 1.0 1732410 Bionet1_000994 Fc1ccc(cc1)c2c(cnn2c3ccccc3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N17 compound treatment 0.08 0.00373 0.44 0.4425 1.0 1908516 Bionet1_000995 Cc1nc(nn1c2ccc(F)cc2F)C(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N18 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1908517 Bionet1_000996 CN(C)/C=C(/C(=O)c1ccc(Cl)c(Cl)c1)\S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N19 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1319951 Bionet1_000997 Cc1nc(nn1c2ccc(F)cc2F)C(=O)Nc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N20 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908518 Bionet1_000998 CN(C)/C=C(/C(=O)c1ccccc1Cl)\S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N21 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908519 Bionet1_000999 Cc1nc(nn1c2ccc(F)cc2)C(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N22 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908520 Bionet1_001000 OC1CON(C1)C(=O)CN2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N23 mock treatment 0.0765 2.34E-4 0.03 0.0278 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 N24 mock treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O01 mock treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O02 mock treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O03 compound treatment 0.077 7.34E-4 0.09 0.087 1.0 1908521 Bionet1_001001 Cc1ccc(NC(=O)C(F)(F)Oc2ccc(Cl)cc2C)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O04 compound treatment 0.0795 0.00323 0.38 0.3832 1.0 1908522 Bionet1_001002 O/N=C(/Nc1ccc(Cl)cc1)\c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O05 compound treatment 0.0795 0.00323 0.38 0.3832 1.0 1322362 Bionet1_001003 Clc1ccc(C(C#N)c2ccc(Sc3ccccc3)nn2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O06 compound treatment 0.0775 0.00123 0.15 0.1463 1.0 1908523 Bionet1_001004 FC(F)(F)c1cnc(C2=C(COC2=O)c3ccc(Cl)cc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O07 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1522054 Bionet1_001005 NC(=O)C(c1ccc(Sc2ccccc2)nn1)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O08 compound treatment 0.136 0.0597 7.08 7.0779 1.0 1908524 Bionet1_001006 CC(=O)C(/C=N/OCc1ccc(cc1)[N+](=O)[O-])C(=O)Nc2nccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O09 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1157065 Bionet1_001007 Clc1ccc(C(C#N)c2ccc(Nc3ccccc3)nn2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O10 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1908525 Bionet1_001008 COC(=O)/C(=C\Nc1cccc(c1)C(F)(F)F)/NC(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O11 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1908526 Bionet1_001009 CCc1cccc(CC)c1NC(=O)C(F)(F)Oc2ccc(Cl)cc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O12 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1908527 Bionet1_001010 COC(=O)/C(=C\Nc1ccc(Oc2ccccc2)cc1)/NC(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O13 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908528 Bionet1_001011 NOCC(=O)N1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O14 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1609013 Bionet1_001012 Fc1cccc(F)c1C(=O)Nc2ccc(Sc3ccccc3Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O15 compound treatment 0.079 0.00273 0.32 0.324 1.0 1908529 Bionet1_001013 NC(=O)NOCC(=O)N1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O16 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1384508 Bionet1_001014 Fc1ccc(cc1)C(=O)Nc2ccc(Sc3ccccc3Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O17 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1288104 Bionet1_001015 CN(C)c1nc(N2CCN(CC2)c3c(C)cccc3C)c(C#N)c(=O)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O18 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1133579 Bionet1_001016 Fc1ccc(cc1)C(=O)Nc2ccc(cc2)S(=O)(=O)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O19 compound treatment 0.0745 -0.00177 -0.21 -0.2092 -1.0 1908530 Bionet1_001017 Clc1ccc(cc1)S(=O)CCCCS(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O20 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908531 Bionet1_001018 Clc1ccccc1Sc2ccc(NC(=O)C(Cl)(Cl)Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O21 compound treatment 0.073 -0.00327 -0.39 -0.3869 -1.0 1908532 Bionet1_001019 CCNc1nc(Sc2ccc(Br)cc2)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O22 compound treatment 0.072 -0.00427 -0.51 -0.5054 -1.0 1908533 Bionet1_001020 O=C(CCSSCCC(=O)NCc1ccccc1)NCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O23 mock treatment 0.0775 0.00123 0.15 0.1463 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 O24 mock treatment 0.0795 0.00323 0.38 0.3832 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P01 mock treatment 0.0735 -0.00277 -0.33 -0.3277 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P02 mock treatment 0.0685 -0.00777 -0.92 -0.9201 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P03 compound treatment 0.068 -0.00827 -0.98 -0.9794 -1.0 1551657 Bionet1_001021 Cc1nc(nn1c2ccc(F)cc2)C(=O)Nc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P04 compound treatment 0.0865 0.0102 1.21 1.2127 1.0 1466673 Bionet1_001022 CS(=O)(=O)c1cnn(c1c2ccc(Cl)c(Cl)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P05 compound treatment 0.0695 -0.00677 -0.8 -0.8017 -1.0 1478102 Bionet1_001023 Cc1nc(nn1c2ccc(Cl)cc2Cl)C(=O)Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P06 compound treatment 0.0685 -0.00777 -0.92 -0.9201 -1.0 1908534 Bionet1_001024 C/C(=N\Oc1ccc2c(cc(nc2n1)C(F)(F)F)C(F)(F)F)/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P07 compound treatment 0.078 0.00173 0.21 0.2055 1.0 1712053 Bionet1_001025 Cc1nc(nn1c2ccc(Cl)cc2Cl)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P08 compound treatment 0.0815 0.00523 0.62 0.6202 1.0 1908535 Bionet1_001026 FC(F)(F)c1cnc(N2CCc3nc(ncc3C2)c4ccccc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P09 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1300978 Bionet1_001027 Cc1nc(nn1c2ccc(Cl)cc2Cl)C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P10 compound treatment 0.0835 0.00723 0.86 0.8572 1.0 1908536 Bionet1_001028 Cc1nc(c(s1)C(=O)NC(=O)Nc2cccc(c2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P11 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1143904 Bionet1_001029 Cc1nc(nn1c2cc(Cl)ccc2Cl)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P12 compound treatment 0.0755 -7.66E-4 -0.09 -0.0907 -1.0 1908537 Bionet1_001030 Cc1nc(c(s1)C(=O)NC(=O)Nc2ccc(Cl)cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P13 compound treatment 0.075 -0.00127 -0.15 -0.15 -1.0 1200195 Bionet1_001031 Cc1nc(nn1c2cc(Cl)ccc2Cl)C(=O)Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P14 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908538 Bionet1_001032 CN(NC(=O)Nc1ccc(Cl)cc1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P15 compound treatment 0.0765 2.34E-4 0.03 0.0278 1.0 1908539 Bionet1_001033 FC(F)(F)c1cccc(c1)S(=O)(=O)c2snnc2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P16 compound treatment 0.0775 0.00123 0.15 0.1463 1.0 1908540 Bionet1_001034 CN(C)/C=N/C(=O)C(c1ccccc1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P17 compound treatment 0.0775 0.00123 0.15 0.1463 1.0 1908541 Bionet1_001035 Brc1ccc(cc1)S(=O)(=O)c2snnc2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P18 compound treatment 0.079 0.00273 0.32 0.324 1.0 1908542 Bionet1_001036 O/N=C/NC(=O)C(c1ccccc1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P19 compound treatment 0.076 -2.66E-4 -0.03 -0.0315 -1.0 1908543 Bionet1_001037 Clc1ccc(cc1Cl)S(=O)(=O)c2snnc2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P20 compound treatment 0.0785 0.00223 0.26 0.2648 1.0 1908544 Bionet1_001038 O/N=C/NC(=O)C(c1ccc(Cl)cc1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P21 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1256303 Bionet1_001039 Cc1nc(nn1c2cc(Cl)ccc2Cl)C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P22 compound treatment 0.074 -0.00227 -0.27 -0.2685 -1.0 1908545 Bionet1_001040 Clc1cccc(NN/C(=N\C(=O)Nc2ccccc2)/Cn3cncn3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P23 mock treatment 0.0765 2.34E-4 0.03 0.0278 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.570 P24 mock treatment 0.0655 -0.0108 -1.28 -1.2756 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A01 mock treatment 0.0945 0.0181 2.14 2.1433 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A02 mock treatment 0.0845 0.00809 0.96 0.9584 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A03 compound treatment 0.0865 0.0101 1.2 1.1954 1.0 1908546 Bionet1_001041 Clc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A04 compound treatment 0.0845 0.00809 0.96 0.9584 1.0 1633996 Bionet1_001042 COc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A05 compound treatment 0.091 0.0146 1.73 1.7286 1.0 1146805 Bionet1_001043 Clc1cccc(Cl)c1Cn2c(ccc(C#N)c2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A06 compound treatment 0.063 -0.0134 -1.59 -1.5891 -1.0 1908547 Bionet1_001044 COc1ccc(cc1)c2ccc(C#N)c(OC(=O)c3c(Cl)cccc3Cl)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A07 compound treatment 0.08 0.00359 0.43 0.4252 1.0 1908548 Bionet1_001045 FC(F)(F)c1cccc(Cn2c(ccc(C#N)c2=O)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A08 compound treatment 0.086 0.00959 1.14 1.1362 1.0 1438828 Bionet1_001046 OC(CSc1ccc(F)cc1)(c2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A09 compound treatment 0.0805 0.00409 0.48 0.4845 1.0 1324721 Bionet1_001047 Brc1ccc(cc1)N2C(=O)CS(=O)(=O)C(C2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A10 compound treatment 0.0785 0.00209 0.25 0.2475 1.0 1908549 Bionet1_001048 COc1cccc(c1)c2ccc(C#N)c(OC(=O)c3c(Cl)cccc3Cl)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A11 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1241380 Bionet1_001049 Clc1ccc(cc1)N2C(=O)CS(=O)(=O)C(C2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A12 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1908550 Bionet1_001050 COc1cccc(c1)c2ccc(C#N)c(OC(=O)c3ccc(Cl)cc3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A13 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1210179 Bionet1_001051 Clc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A14 compound treatment 0.068 -0.00841 -1.0 -0.9967 -1.0 1908551 Bionet1_001052 COc1cccc(c1)c2ccc(C#N)c(OC(=O)c3cccc(c3)C(F)(F)F)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A15 compound treatment 0.0685 -0.00791 -0.94 -0.9374 -1.0 1908552 Bionet1_001053 FC(F)(F)c1ccc(Cn2c(ccc(C#N)c2=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A16 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1908553 Bionet1_001054 COc1cccc(c1)c2ccc(C#N)c(OC(=O)c3ccc(F)cc3F)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A17 compound treatment 0.068 -0.00841 -1.0 -0.9967 -1.0 1250294 Bionet1_001055 Clc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A18 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908554 Bionet1_001056 FC(F)(F)c1cccc(c1)c2ccc(C#N)c(Oc3cccc(Cl)c3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A19 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1573085 Bionet1_001057 COc1ccc(Cn2c(ccc(C#N)c2=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A20 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1455913 Bionet1_001058 Clc1ccc(NC(=O)C2CCCN2S(=O)(=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A21 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1333412 Bionet1_001059 Clc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A22 compound treatment 0.073 -0.00341 -0.4 -0.4042 -1.0 1588053 Bionet1_001060 Clc1ccc(cc1)S(=O)(=O)N2CCCC2C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A23 mock treatment 0.0795 0.00309 0.37 0.366 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 A24 mock treatment 0.0775 0.00109 0.13 0.129 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B01 mock treatment 0.085 0.00859 1.02 1.0177 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B02 mock treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B03 compound treatment 0.0845 0.00809 0.96 0.9584 1.0 1638075 Bionet1_001061 Fc1cc(F)c(NC(=O)c2cccn(Cc3ccccc3)c2=O)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B04 compound treatment 0.0815 0.00509 0.6 0.603 1.0 1908555 Bionet1_001062 Clc1cccc(n1)N2N=C/C(=C/Nc3ccc(Oc4ccccc4)cc3)/C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B05 compound treatment 0.0825 0.00609 0.72 0.7215 1.0 1908556 Bionet1_001063 CCOC(=O)NC(=O)C(/C=N\OCCOc1cccc(c1)C(F)(F)F)C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B06 compound treatment 0.073 -0.00341 -0.4 -0.4042 -1.0 1908557 Bionet1_001064 CO/N=C/NC(=O)C(c1ccccc1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B07 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1908558 Bionet1_001065 Nc1c(sc2ncc(C#N)cc12)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B08 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908559 Bionet1_001066 Clc1ccc(NC(=O)/N=C(/Cn2cncn2)\NNc3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B09 compound treatment 0.069 -0.00741 -0.88 -0.8782 -1.0 1908560 Bionet1_001067 Clc1ccc(CSc2snnc2c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B10 compound treatment 0.0655 -0.0109 -1.29 -1.2929 -1.0 1908561 Bionet1_001068 Sc1nnc(CNS(=O)(=O)c2ccc(Br)cc2)n1CC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B11 compound treatment 0.0635 -0.0129 -1.53 -1.5299 -1.0 1908562 Bionet1_001069 Clc1ccc(CS(=O)(=O)c2snnc2c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B12 compound treatment 0.07 -0.00641 -0.76 -0.7597 -1.0 1908563 Bionet1_001070 CCn1c(S)nnc1CNS(=O)(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B13 compound treatment 0.0695 -0.00691 -0.82 -0.8189 -1.0 1908564 Bionet1_001071 FC(F)(F)c1cccc(CS(=O)(=O)c2snnc2c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B14 compound treatment 0.0655 -0.0109 -1.29 -1.2929 -1.0 1908565 Bionet1_001072 CCn1c(CNS(=O)(=O)c2ccc(Br)cc2)nnc1SC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B15 compound treatment 0.068 -0.00841 -1.0 -0.9967 -1.0 1908566 Bionet1_001073 Clc1ccccc1CS(=O)(=O)c2snnc2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B16 compound treatment 0.0625 -0.0139 -1.65 -1.6484 -1.0 1908567 Bionet1_001074 FC(F)(F)c1nc(/C=C/Nc2cccc(c2)C(F)(F)F)sc1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B17 compound treatment 0.0655 -0.0109 -1.29 -1.2929 -1.0 1197982 Bionet1_001075 Cc1nc(nn1c2cc(Cl)ccc2Cl)C(=O)Nc3ccc(F)c(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B18 compound treatment 0.065 -0.0114 -1.35 -1.3521 -1.0 1908568 Bionet1_001076 CN1C(=NS(=O)(=O)c2ccccc12)Nc3nc(C)cc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B19 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1616006 Bionet1_001077 Cc1nc(nn1c2cc(Cl)ccc2Cl)C(=O)Nc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B20 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908569 Bionet1_001078 FC(F)(F)c1cnc2cc(sc2c1)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B21 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1908570 Bionet1_001079 Fc1ccc(Sc2snnc2c3ccc(Cl)cc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B22 compound treatment 0.073 -0.00341 -0.4 -0.4042 -1.0 1323845 Bionet1_001080 Cc1cc(C)c(C#N)c(OC(=O)c2c(Cl)cc(Cl)cc2Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B23 mock treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 B24 mock treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C01 mock treatment 0.0835 0.00709 0.84 0.8399 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C02 mock treatment 0.0835 0.00709 0.84 0.8399 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C03 compound treatment 0.085 0.00859 1.02 1.0177 1.0 1723417 Bionet1_001081 Clc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C04 compound treatment 0.0885 0.0121 1.43 1.4324 1.0 1223342 Bionet1_001082 Fc1ccc(cc1)S(=O)(=O)N2CCCC2C(=O)Nc3ccc(F)c(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C05 compound treatment 0.0905 0.0141 1.67 1.6694 1.0 1298207 Bionet1_001083 Clc1ccc(cc1)C2SCC(=O)N(C2=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C06 compound treatment 0.0825 0.00609 0.72 0.7215 1.0 1658525 Bionet1_001084 Fc1ccc(cc1)S(=O)(=O)N2CCCC2C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C07 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1908571 Bionet1_001085 Clc1ccc(cc1)c2nn(cc2n3cncn3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C08 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908572 Bionet1_001086 OCc1cnc(S)n1CCNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C09 compound treatment 0.0685 -0.00791 -0.94 -0.9374 -1.0 1908573 Bionet1_001087 CSc1cccc(N/C=C/c2onc(c2C#N)c3ccccc3Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C10 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1132556 Bionet1_001088 Cn1c(CS(=O)(=O)c2ccccc2)cnc1SCc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C11 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908574 Bionet1_001089 COc1ccccc1N/C=C/c2onc(c2C#N)c3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C12 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908575 Bionet1_001090 CNC(=S)NNC(=O)c1sccc1OCc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C13 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1908576 Bionet1_001091 Cc1snc(SCc2n[nH]c(COc3ccc(F)cc3)n2)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C14 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1908577 Bionet1_001092 Cn1c(S)nnc1c2sccc2OCc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C15 compound treatment 0.068 -0.00841 -1.0 -0.9967 -1.0 1908578 Bionet1_001093 Cc1noc(/C=C/c2ccc(o2)c3ccc(Cl)cc3Cl)c1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C16 compound treatment 0.071 -0.00541 -0.64 -0.6412 -1.0 1908579 Bionet1_001094 CSc1nnc(c2sccc2OCc3ccc(Cl)cc3Cl)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C17 compound treatment 0.07 -0.00641 -0.76 -0.7597 -1.0 1362191 Bionet1_001095 Clc1ccc(c2ccc(Cc3n[nH]c(=O)c4ccccc34)o2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C18 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1908580 Bionet1_001096 CNC(=S)NNC(=O)c1sccc1OCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C19 compound treatment 0.0765 8.87E-5 0.01 0.0105 1.0 1908581 Bionet1_001097 CO/N=C\NC(=O)c1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C20 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908582 Bionet1_001098 Cn1c(S)nnc1c2sccc2OCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C21 compound treatment 0.083 0.00659 0.78 0.7807 1.0 1908583 Bionet1_001099 CCOC(=O)C(Cc1ccc(cc1)C(=O)OC)(NC(=O)C)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C22 compound treatment 0.0785 0.00209 0.25 0.2475 1.0 1908584 Bionet1_001100 CSc1nnc(c2sccc2OCc3cccc(c3)C(F)(F)F)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C23 mock treatment 0.08 0.00359 0.43 0.4252 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 C24 mock treatment 0.0805 0.00409 0.48 0.4845 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D01 mock treatment 0.0765 8.87E-5 0.01 0.0105 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D02 mock treatment 0.0795 0.00309 0.37 0.366 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D03 compound treatment 0.0895 0.0131 1.55 1.5509 1.0 1908585 Bionet1_001101 Clc1ccc(c2nnsc2SCc3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D04 compound treatment 0.085 0.00859 1.02 1.0177 1.0 1908586 Bionet1_001102 CN(C)/C=C(/c1ncc(cc1Cl)C(F)(F)F)\S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D05 compound treatment 0.0855 0.00909 1.08 1.0769 1.0 1908587 Bionet1_001103 Clc1ccc(cc1)c2nnsc2Sc3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D06 compound treatment 0.0815 0.00509 0.6 0.603 1.0 1908588 Bionet1_001104 CO/N=C/C(c1ncc(cc1Cl)C(F)(F)F)S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D07 compound treatment 0.0765 8.87E-5 0.01 0.0105 1.0 1525588 Bionet1_001105 Cc1nc(nn1c2cc(Cl)cc(Cl)c2)C(=O)Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D08 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1347380 Bionet1_001106 COc1ccc(NC(=O)CS(=O)(=O)Cc2ccc(Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D09 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1381444 Bionet1_001107 Cc1nc(nn1c2cc(Cl)cc(Cl)c2)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D10 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908589 Bionet1_001108 FC(F)(F)c1cccc(NC(=O)CS(=O)Cc2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D11 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1908590 Bionet1_001109 Clc1ccc(c2nnsc2Sc3ccccc3Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D12 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1908591 Bionet1_001110 FC(F)(F)c1cccc(NC(=O)CS(=O)c2cccc(Cl)c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D13 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1238011 Bionet1_001111 Cc1nc(nn1c2cc(Cl)cc(Cl)c2)C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D14 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908592 Bionet1_001112 FC(F)(F)c1cnc(/C=C(\C#N)/C(=O)Nc2ccc(Cl)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D15 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1416561 Bionet1_001113 COc1ccc(NC(=O)c2nc(C)n(n2)c3cc(Cl)cc(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D16 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1908593 Bionet1_001114 FC(F)(F)c1cccc(c1)S(=O)CC(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D17 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1702956 Bionet1_001115 Cc1nc(nn1c2cc(Cl)cc(Cl)c2)C(=O)Nc3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D18 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908594 Bionet1_001116 FC(F)(F)c1cccc(NC(=O)CS(=O)(=O)Cc2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D19 compound treatment 0.08 0.00359 0.43 0.4252 1.0 1328682 Bionet1_001117 Cc1nc(nn1c2cc(Cl)cc(Cl)c2)C(=O)Nc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D20 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908595 Bionet1_001118 COc1ccc(cc1)S(=O)(=O)CC(=O)Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D21 compound treatment 0.0805 0.00409 0.48 0.4845 1.0 1382939 Bionet1_001119 Cc1nc(nn1c2cc(Cl)cc(Cl)c2)C(=O)Nc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D22 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1908596 Bionet1_001120 FC(F)(F)c1cccc(NC(=O)CS(=O)(=O)c2cccc(Cl)c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D23 mock treatment 0.08 0.00359 0.43 0.4252 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 D24 mock treatment 0.0825 0.00609 0.72 0.7215 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E01 mock treatment 0.078 0.00159 0.19 0.1882 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E02 mock treatment 0.0815 0.00509 0.6 0.603 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E03 compound treatment 0.0825 0.00609 0.72 0.7215 1.0 1908597 Bionet1_001121 CCCNS(=O)(=O)c1cccn1c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E04 compound treatment 0.0855 0.00909 1.08 1.0769 1.0 1908598 Bionet1_001122 Sc1nnc([nH]1)c2sccc2OCc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E05 compound treatment 0.0865 0.0101 1.2 1.1954 1.0 1908599 Bionet1_001123 [O-][N+](=O)/C(=C\Nc1cccc(c1)C(F)(F)F)/S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E06 compound treatment 0.0835 0.00709 0.84 0.8399 1.0 1908600 Bionet1_001124 CSc1nnc([nH]1)c2sccc2OCc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E07 compound treatment 0.08 0.00359 0.43 0.4252 1.0 1908601 Bionet1_001125 Cc1c(Cl)cccc1N/C=C(\[N+](=O)[O-])/S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E08 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908602 Bionet1_001126 COC(=O)CC(=NNc1ncc(cc1Cl)C(F)(F)F)CC(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E09 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908603 Bionet1_001127 [O-][N+](=O)/C(=C\Nc1ccc(Br)cc1)/S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E10 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908604 Bionet1_001128 CN(c1ncc(cc1Cl)C(F)(F)F)n2cc(C#N)c3ccccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E11 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1908605 Bionet1_001129 [O-][N+](=O)/C(=C\Nc1ccc(Oc2ccccc2)cc1)/S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E12 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1366469 Bionet1_001130 OC(CS(=O)(=O)Cc1ccccc1)(c2ccc(F)cc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E13 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908606 Bionet1_001131 [O-][N+](=O)/C(=C\Nc1ccc(Cl)c(Cl)c1)/S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E14 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1367991 Bionet1_001132 OC(CSc1ccc(Cl)cc1)(c2ccc(F)cc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E15 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908607 Bionet1_001133 COC(=O)c1cccc(N/C=C(\[N+](=O)[O-])/S(=O)(=O)c2ccccc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E16 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1520724 Bionet1_001134 OC(CSCc1ccccc1)(c2ccc(F)cc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E17 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908608 Bionet1_001135 [O-][N+](=O)/C(=C\Nc1ccc(cc1)C(F)(F)F)/S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E18 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1636688 Bionet1_001136 OC(CSCc1ccc(Cl)cc1)(c2ccc(F)cc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E19 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908609 Bionet1_001137 CN(C)S(=O)(=O)c1cccn1c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E20 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1179101 Bionet1_001138 Cc1cccc(SCC(O)(c2ccc(Cl)cc2)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E21 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908610 Bionet1_001139 CN(C)/C=N/S(=O)(=O)c1cccn1c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E22 compound treatment 0.0765 8.87E-5 0.01 0.0105 1.0 1148662 Bionet1_001140 OC(CS(=O)c1ccc(Cl)cc1)(c2ccc(F)cc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E23 mock treatment 0.079 0.00259 0.31 0.3067 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 E24 mock treatment 0.079 0.00259 0.31 0.3067 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F01 mock treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F02 mock treatment 0.073 -0.00341 -0.4 -0.4042 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F03 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908611 Bionet1_001141 Fc1ccc(cc1)c2nnsc2Sc3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F04 compound treatment 0.081 0.00459 0.54 0.5437 1.0 1908612 Bionet1_001142 Clc1ccc(cc1Cl)S(=O)(=O)CC(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F05 compound treatment 0.0855 0.00909 1.08 1.0769 1.0 1908613 Bionet1_001143 Clc1ccc(CSc2snnc2c3ccc(Cl)cc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F06 compound treatment 0.083 0.00659 0.78 0.7807 1.0 1908614 Bionet1_001144 Clc1ccccc1CS(=O)(=O)CC(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F07 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908615 Bionet1_001145 [O-][N+](=O)c1ccc(NN2C3CCC2c4c(O3)ccc5ccccc45)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F08 compound treatment 0.09 0.0136 1.61 1.6101 1.0 1908616 Bionet1_001146 FC(F)(F)c1cccc(c1)S(=O)(=O)CC(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F09 compound treatment 0.0785 0.00209 0.25 0.2475 1.0 1908617 Bionet1_001147 N/C(=N/OC(=O)Nc1ccccc1)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F10 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908618 Bionet1_001148 FC(F)(F)c1cccc(c1)c2nnnn2c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F11 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908619 Bionet1_001149 N/C(=N/OC(=O)Nc1ccc(Cl)cc1)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F12 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1908620 Bionet1_001150 [O-][N+](=O)c1ccc(cc1)N2CCC(CC2)OC(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F13 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908621 Bionet1_001151 FC(F)(F)c1cnc(c(Cl)c1)n2ccc(=O)n(CCc3ccccc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F14 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908622 Bionet1_001152 COc1ccc(cc1)C(=O)OC2CCN(CC2)c3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F15 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1908623 Bionet1_001153 Cc1nc(ncc1C(=O)Nc2ncc(cc2Cl)C(F)(F)F)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F16 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1908624 Bionet1_001154 Cc1ccc(cc1)C(=O)ON=C2CCN(CC2)c3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F17 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908625 Bionet1_001155 Cc1nn(cc1C(=O)Nc2ncc(cc2Cl)C(F)(F)F)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F18 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1908626 Bionet1_001156 COc1ccc(cc1)C(=O)ON=C2CCN(CC2)c3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F19 compound treatment 0.0765 8.87E-5 0.01 0.0105 1.0 1908627 Bionet1_001157 FC(F)(F)c1cccc(c1)C(=O)Nc2ccc(CSc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F20 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1266791 Bionet1_001158 CC(C)N(C(C)C)C(=O)CS(=O)(=O)c1ccc(Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F21 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908628 Bionet1_001159 Clc1ccc(cc1)C(=O)Nc2ccc(CSc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F22 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1583340 Bionet1_001160 Brc1ccc(cc1)N2C(=O)CSC(C2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F23 mock treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 F24 mock treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G01 mock treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G02 mock treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G03 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908629 Bionet1_001161 FC(F)(F)c1cnc(c(Cl)c1)n2cccc2S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G04 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1908630 Bionet1_001162 CC(=O)c1ccccc1NS(=O)(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G05 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908631 Bionet1_001163 FC(F)(F)c1cnc(Sc2ccccc2n3cccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G06 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1506840 Bionet1_001164 OC(CSc1ccc(Cl)c(Cl)c1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G07 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1908632 Bionet1_001165 CCC(=O)Nc1ccccc1Sc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G08 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1249374 Bionet1_001166 OC(CS(=O)c1ccc(Cl)c(Cl)c1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G09 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908633 Bionet1_001167 FC(F)(F)c1cnc(Sc2ccccc2NC(=O)CCl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G10 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1908634 Bionet1_001168 [O-][N+](=O)c1cc(F)ccc1Oc2ccsc2C(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G11 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908635 Bionet1_001169 FC(F)(F)c1cnc(c2ncc3c(Cl)cc(cn23)C(F)(F)F)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G12 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1908636 Bionet1_001170 CCC(C)(C)NC(=O)c1sccc1Oc2ccc(F)cc2[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G13 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908637 Bionet1_001171 OS(=O)(=O)c1ccc(Cc2ncc(cc2Cl)C(F)(F)F)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G14 compound treatment 0.069 -0.00741 -0.88 -0.8782 -1.0 1908638 Bionet1_001172 [O-][N+](=O)c1cc(F)ccc1Oc2ccsc2C(=O)Nc3ccc(F)c(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G15 compound treatment 0.0705 -0.00591 -0.7 -0.7004 -1.0 1908639 Bionet1_001173 NS(=O)(=O)c1ccc(Cc2ncc(cc2Cl)C(F)(F)F)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G16 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1908640 Bionet1_001174 CC(C)(NC(=O)c1sccc1Oc2ccc([N+](=O)[O-])c(c2)C(F)(F)F)C#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G17 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1376726 Bionet1_001175 OC(CS(=O)(=O)c1ccc(Cl)cc1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G18 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1682048 Bionet1_001176 OC(CNCc1cccc(Cl)c1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G19 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1908641 Bionet1_001177 OC(CSc1ccc(Br)cc1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G20 compound treatment 0.071 -0.00541 -0.64 -0.6412 -1.0 1280596 Bionet1_001178 OC(CNCc1ccc(Cl)cc1Cl)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G21 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1655282 Bionet1_001179 OC(CS(=O)c1ccc(Cl)cc1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G22 compound treatment 0.0705 -0.00591 -0.7 -0.7004 -1.0 1349629 Bionet1_001180 COc1ccccc1CNCC(O)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G23 mock treatment 0.071 -0.00541 -0.64 -0.6412 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 G24 mock treatment 0.0695 -0.00691 -0.82 -0.8189 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H01 mock treatment 0.078 0.00159 0.19 0.1882 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H02 mock treatment 0.0765 8.87E-5 0.01 0.0105 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H03 compound treatment 0.0785 0.00209 0.25 0.2475 1.0 1908642 Bionet1_001181 Clc1cc(Cl)cc(c1)C(=O)Nc2ccc(CSc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H04 compound treatment 0.0825 0.00609 0.72 0.7215 1.0 1908643 Bionet1_001182 CN(C)/C=C(/C(=O)c1ccc(Cl)cc1Cl)\S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H05 compound treatment 0.0835 0.00709 0.84 0.8399 1.0 1908644 Bionet1_001183 Fc1ccc(C(=O)Nc2ccc(CSc3ccccc3)cc2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H06 compound treatment 0.0785 0.00209 0.25 0.2475 1.0 1908645 Bionet1_001184 CN(C)c1ncc(c(n1)c2ccccc2Cl)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H07 compound treatment 0.0805 0.00409 0.48 0.4845 1.0 1908646 Bionet1_001185 FC(F)(F)c1ccc(cc1)C(=O)Nc2ccc(CSc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H08 compound treatment 0.0785 0.00209 0.25 0.2475 1.0 1908647 Bionet1_001186 Fc1ccc(cc1)S(=O)(=O)CC(=O)Nc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H09 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1908648 Bionet1_001187 Clc1ccc(SCc2ccc(NC(=O)c3ccccc3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H10 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1908649 Bionet1_001188 Clc1ccc(NC(=O)CS(=O)(=O)c2ccccc2Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H11 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908650 Bionet1_001189 Fc1cccc(F)c1C(=O)Nc2ccc(CSc3ccc(Cl)cc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H12 compound treatment 0.078 0.00159 0.19 0.1882 1.0 1908651 Bionet1_001190 Clc1cccc(c1)S(=O)(=O)CC(=O)Nc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H13 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1908652 Bionet1_001191 NS(=O)(=O)c1ccc(CCNc2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H14 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1908653 Bionet1_001192 Clc1ccc(NC(=O)CS(=O)c2ccccc2Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H15 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908654 Bionet1_001193 CC(=O)CC(=O)N1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H16 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908655 Bionet1_001194 Cc1ncc(c(n1)c2ccc(Cl)cc2Cl)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H17 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908656 Bionet1_001195 Fc1ccc(SCc2ccc(NC(=O)c3c(F)cccc3F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H18 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1285561 Bionet1_001196 COc1ccc(cc1)S(=O)CC(=O)Nc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H19 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1908657 Bionet1_001197 Fc1ccc(SCc2ccc(NC(=O)c3ccc(F)cc3F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H20 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908658 Bionet1_001198 FC(F)(F)c1cccc(c1)S(=O)CC(=O)Nc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H21 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908659 Bionet1_001199 Fc1ccc(SCc2ccc(NC(=O)c3ccc(Cl)cc3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H22 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1743168 Bionet1_001200 COc1ccc(cc1)S(=O)(=O)CC(=O)Nc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H23 mock treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 H24 mock treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I01 mock treatment 0.0795 0.00309 0.37 0.366 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I02 mock treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I03 compound treatment 0.0785 0.00209 0.25 0.2475 1.0 1273474 Bionet1_001201 OC(CS(=O)(=O)Cc1ccccc1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I04 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1742621 Bionet1_001202 COc1ccc(CNCC(O)(c2ccccc2)c3ccccc3)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I05 compound treatment 0.0805 0.00409 0.48 0.4845 1.0 1394231 Bionet1_001203 Cc1cccc(c1)S(=O)(=O)CC(O)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I06 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1405447 Bionet1_001204 OC(CNCc1ccccc1)(c2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I07 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1343725 Bionet1_001205 OC(CS(=O)(=O)c1cccc(Cl)c1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I08 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1400968 Bionet1_001206 Cc1ccc(CNCC(O)(c2ccc(Cl)cc2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I09 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1290011 Bionet1_001207 OC(CSCc1ccc(Cl)cc1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I10 compound treatment 0.0705 -0.00591 -0.7 -0.7004 -1.0 1245817 Bionet1_001208 OC(CNCc1ccc(F)cc1)(c2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I11 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1471810 Bionet1_001209 OC(CSc1c(Cl)cccc1Cl)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I12 compound treatment 0.067 -0.00941 -1.12 -1.1151 -1.0 1480312 Bionet1_001210 OC(CNCc1ccccc1F)(c2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I13 compound treatment 0.0595 -0.0169 -2.0 -2.0038 -1.0 1245223 Bionet1_001211 OC(CS(=O)c1c(Cl)cccc1Cl)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I14 compound treatment 0.0655 -0.0109 -1.29 -1.2929 -1.0 1281121 Bionet1_001212 OC(CN1CCOCC1)(c2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I15 compound treatment 0.0695 -0.00691 -0.82 -0.8189 -1.0 1535297 Bionet1_001213 OC(CS(=O)Cc1ccc(Cl)cc1)(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I16 compound treatment 0.069 -0.00741 -0.88 -0.8782 -1.0 1908660 Bionet1_001214 CS(=O)(=O)c1ccccc1Oc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I17 compound treatment 0.073 -0.00341 -0.4 -0.4042 -1.0 1127818 Bionet1_001215 OC(CSCc1ccccc1)(c2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I18 compound treatment 0.0705 -0.00591 -0.7 -0.7004 -1.0 1908661 Bionet1_001216 CN(c1ncc(cc1Cl)C(F)(F)F)n2cc(C(=O)N)c3ccccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I19 compound treatment 0.0765 8.87E-5 0.01 0.0105 1.0 1908662 Bionet1_001217 Brc1ccc(Sc2nc(ccc2C#N)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I20 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1908663 Bionet1_001218 FC(F)(F)c1ccc(N/C=C/c2onc(c2C#N)c3ccccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I21 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908664 Bionet1_001219 FC(F)(F)c1cccc(Sc2nc(ccc2C#N)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I22 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908665 Bionet1_001220 Clc1ccccc1N/C=C/c2onc(c2C#N)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I23 mock treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 I24 mock treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J01 mock treatment 0.0765 8.87E-5 0.01 0.0105 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J02 mock treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J03 compound treatment 0.078 0.00159 0.19 0.1882 1.0 1908666 Bionet1_001221 Cc1sc(nc1OC(=O)c2ccc(Cl)c(Cl)c2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J04 compound treatment 0.081 0.00459 0.54 0.5437 1.0 1908667 Bionet1_001222 O=S(=O)(c1ccccc1)c2cnc(nc2c3ccccc3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J05 compound treatment 0.0805 0.00409 0.48 0.4845 1.0 1908668 Bionet1_001223 Cc1sc(nc1OC(=O)c2ccc(Cl)cc2Cl)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J06 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908669 Bionet1_001224 O=S(=O)(c1ccccc1)c2cnc(nc2c3ccccc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J07 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1908670 Bionet1_001225 Cc1sc(nc1OC(=O)c2cc(Cl)cc(Cl)c2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J08 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908671 Bionet1_001226 CN(C)/C=C(/C(=O)c1ccccc1)\S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J09 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908672 Bionet1_001227 Cc1sc(nc1OC(=O)c2ccc(cc2)C(F)(F)F)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J10 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908673 Bionet1_001228 Clc1ccc(cc1)S(=O)(=O)CC(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J11 compound treatment 0.073 -0.00341 -0.4 -0.4042 -1.0 1908674 Bionet1_001229 Cc1sc(nc1OC(=O)c2ccc(Cl)cc2Cl)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J12 compound treatment 0.0695 -0.00691 -0.82 -0.8189 -1.0 1908675 Bionet1_001230 CN(C)c1ncc(c(n1)c2ccccc2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J13 compound treatment 0.069 -0.00741 -0.88 -0.8782 -1.0 1908676 Bionet1_001231 Cc1sc(nc1OC(=O)c2ccc(Cl)c(Cl)c2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J14 compound treatment 0.07 -0.00641 -0.76 -0.7597 -1.0 1532686 Bionet1_001232 Clc1ccc(CN2C(=O)CSC(C2=O)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J15 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908677 Bionet1_001233 Cc1sc(nc1OC(=O)c2cc(Cl)cc(Cl)c2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J16 compound treatment 0.07 -0.00641 -0.76 -0.7597 -1.0 1908678 Bionet1_001234 FC(F)(F)c1ccc(cc1)N2C(=O)CSC(C2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J17 compound treatment 0.0815 0.00509 0.6 0.603 1.0 1908679 Bionet1_001235 Cc1sc(nc1OC(=O)c2cccc(c2)C(F)(F)F)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J18 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1244794 Bionet1_001236 Brc1ccc(cc1)N2C(=O)CS(=O)C(C2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J19 compound treatment 0.1065 0.0301 3.57 3.5652 1.0 1908680 Bionet1_001237 Cc1sc(nc1OC(=O)c2ccc(Cl)cc2Cl)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J20 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1516221 Bionet1_001238 Clc1ccc(N2C(=O)CSC(C2=O)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J21 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908681 Bionet1_001239 Cc1sc(nc1OC(=O)c2cccc(c2)C(F)(F)F)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J22 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1908682 Bionet1_001240 FC(F)(F)c1cnc(NCC2CC(=NO2)C(=O)N3CCOCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J23 mock treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 J24 mock treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K01 mock treatment 0.077 5.89E-4 0.07 0.0698 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K02 mock treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K03 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1254773 Bionet1_001241 Clc1ccc(CSc2nc(ccc2C#N)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K04 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1908683 Bionet1_001242 Cc1cc(O)ccc1N/C=C/c2onc(c2C#N)c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K05 compound treatment 0.0785 0.00209 0.25 0.2475 1.0 1908684 Bionet1_001243 FC(F)(F)c1cccc(Oc2nc(ccc2C#N)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K06 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908685 Bionet1_001244 CC(Oc1ccc(Cl)cc1)c2ccnn2S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K07 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1451789 Bionet1_001245 Clc1ccc(Cn2c(ccc(C#N)c2=O)c3ccc(Cl)c(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K08 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1908686 Bionet1_001246 Clc1cccc(Cl)c1CO/N=C\NC(=S)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K09 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1725966 Bionet1_001247 Clc1ccc(cc1Cl)c2ccc(C#N)c(=O)n2Cc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K10 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1908687 Bionet1_001248 CC(=O)c1ccccc1NS(=O)(=O)c2cc(Cl)c(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K11 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1908688 Bionet1_001249 [O-][N+](=O)c1ccc(Oc2ccsc2C(=O)Nc3ccccc3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K12 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1446155 Bionet1_001250 CC1CN(CC(O)(c2ccc(Cl)cc2)c3ccc(Cl)cc3)CC(C)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K13 compound treatment 0.071 -0.00541 -0.64 -0.6412 -1.0 1908689 Bionet1_001251 [O-][N+](=O)c1ccc(Oc2ccsc2C(=O)Nc3ccc(F)cc3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K14 compound treatment 0.073 -0.00341 -0.4 -0.4042 -1.0 1563283 Bionet1_001252 CN1CCN(CC(O)(c2ccc(Cl)cc2)c3ccc(Cl)cc3)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K15 compound treatment 0.0705 -0.00591 -0.7 -0.7004 -1.0 1908690 Bionet1_001253 CN(C(=O)c1sccc1Oc2ccc(cc2F)[N+](=O)[O-])c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K16 compound treatment 0.071 -0.00541 -0.64 -0.6412 -1.0 1908691 Bionet1_001254 COc1cnc(nc1Sc2cccc(c2)C(F)(F)F)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K17 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908692 Bionet1_001255 [O-][N+](=O)c1ccc(Oc2ccsc2C(=O)Nc3ccccc3F)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K18 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1908693 Bionet1_001256 Fc1ccc(NC(=O)c2cnc(nc2c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K19 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1908694 Bionet1_001257 CCOC(CNC(=O)c1sccc1Oc2ccc(cc2F)[N+](=O)[O-])OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K20 compound treatment 0.0695 -0.00691 -0.82 -0.8189 -1.0 1908695 Bionet1_001258 Clc1ccc(NC(=O)c2cnc(nc2c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K21 compound treatment 0.07 -0.00641 -0.76 -0.7597 -1.0 1908696 Bionet1_001259 [O-][N+](=O)c1cc(F)ccc1Oc2ccsc2C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K22 compound treatment 0.0695 -0.00691 -0.82 -0.8189 -1.0 1908697 Bionet1_001260 O=C(Nc1ccccc1)c2cnc(nc2c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K23 mock treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 K24 mock treatment 0.071 -0.00541 -0.64 -0.6412 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L01 mock treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L02 mock treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L03 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908698 Bionet1_001261 Cc1sc(nc1OC(=O)c2ccc(Cl)c(Cl)c2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L04 compound treatment 0.0805 0.00409 0.48 0.4845 1.0 1908699 Bionet1_001262 C/[N+](=C/c1c(OCc2ccc(Cl)cc2Cl)ccc3ccccc13)/[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L05 compound treatment 0.0905 0.0141 1.67 1.6694 1.0 1908700 Bionet1_001263 Cc1sc(nc1OC(=O)c2cccc(Cl)c2Cl)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L06 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908701 Bionet1_001264 CN(C)/C=N/C(=O)C1=NOC(CNc2ncc(cc2Cl)C(F)(F)F)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L07 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908702 Bionet1_001265 FC(F)(F)c1cnc(NCCNC(=O)Nc2ccc(Cl)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L08 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908703 Bionet1_001266 FC(F)(F)c1cnc(NCC2CC(=NO2)C(=O)NC3CC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L09 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908704 Bionet1_001267 CN(C)c1ccc(/C=N\CCNc2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L10 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908705 Bionet1_001268 FC(F)(F)c1cnc(NCC2CC(=NO2)C(=O)Nc3cccnc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L11 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1908706 Bionet1_001269 FC(F)(F)c1cnc(NCCNC(=O)c2ccc(Cl)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L12 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1908707 Bionet1_001270 ON/C=N/C(=O)C1=NOC(CNc2ncc(cc2Cl)C(F)(F)F)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L13 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908708 Bionet1_001271 Cc1nc(ncc1C(=O)Nc2ncc(cc2Cl)C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L14 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1908709 Bionet1_001272 CON/C=N/C(=O)C1=NOC(CNc2ncc(cc2Cl)C(F)(F)F)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L15 compound treatment 0.0765 8.87E-5 0.01 0.0105 1.0 1908710 Bionet1_001273 Cc1sc(nc1OC(=O)c2cccc(Cl)c2Cl)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L16 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1908711 Bionet1_001274 CN(C)/C=C/C(=O)C1=NOC(CNc2ncc(cc2Cl)C(F)(F)F)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L17 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1908712 Bionet1_001275 Cc1sc(nc1OC(=O)c2cccc(c2)C(F)(F)F)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L18 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908713 Bionet1_001276 Nc1nccc(n1)C2=NOC(CNc3ncc(cc3Cl)C(F)(F)F)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L19 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908714 Bionet1_001277 Cc1sc(nc1OCc2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L20 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1908715 Bionet1_001278 CCOC(=O)C1=NOC(CNc2ncc(cc2Cl)C(F)(F)F)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L21 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908716 Bionet1_001279 COC(=O)c1ccc(cc1)c2nc(OCc3ccc(Cl)cc3)c(C)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L22 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908717 Bionet1_001280 CS(=O)(=O)c1cnc(nc1c2ccc(Cl)c(Cl)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L23 mock treatment 0.0765 8.87E-5 0.01 0.0105 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 L24 mock treatment 0.0785 0.00209 0.25 0.2475 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M01 mock treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M02 mock treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M03 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1908718 Bionet1_001281 [O-][N+](=O)c1cc(F)ccc1Oc2ccsc2C(=O)Nc3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M04 compound treatment 0.08 0.00359 0.43 0.4252 1.0 1908719 Bionet1_001282 Fc1ccc(NC(=O)c2cnc(nc2c3ccccc3)c4ccccc4)cc1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M05 compound treatment 0.078 0.00159 0.19 0.1882 1.0 1908720 Bionet1_001283 [O-][N+](=O)c1cc(F)ccc1Oc2ccsc2C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M06 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1587015 Bionet1_001284 Clc1ccc(CNC(=O)c2cnc(nc2c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M07 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908721 Bionet1_001285 CN(C(=O)c1sccc1Oc2ccc(F)cc2[N+](=O)[O-])c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M08 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908722 Bionet1_001286 CC(=O)c1cc(NC(=O)c2ccc(C)cc2)c(=O)n(Cc3ccccc3)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M09 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908723 Bionet1_001287 [O-][N+](=O)c1cc(F)ccc1Oc2ccsc2C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M10 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1908724 Bionet1_001288 CC(=O)c1cc(NC(=O)c2ccc(Cl)cc2)c(=O)n(Cc3ccco3)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M11 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1273341 Bionet1_001289 OC1=C(C2NCCc3ccccc23)C(=O)CC(C1)c4c(F)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M12 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1651792 Bionet1_001290 Clc1cccc(c1)C(=O)Nc2cc3C(=O)CCCc3n(Cc4ccco4)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M13 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1298481 Bionet1_001291 O=C(CC1NCCc2ccccc12)Nc3ccc(Oc4ccccc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M14 compound treatment 0.072 -0.00441 -0.52 -0.5227 -1.0 1908725 Bionet1_001292 Cn1nc(c(C(=O)Nc2cccc(c2)C(F)(F)F)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M15 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1187392 Bionet1_001293 Clc1ccccc1n2ncc3C(=O)N4CCc5ccccc5C4Cc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M16 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908726 Bionet1_001294 Cn1nc(c(C(=O)Nc2ccc(OC(F)(F)F)cc2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M17 compound treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 1908727 Bionet1_001295 Fc1ccc(Sc2nc(ccc2C#N)c3ccc(Cl)c(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M18 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908728 Bionet1_001296 COc1ccc(OC)c(NC(=O)c2c(Cl)n(C)nc2C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M19 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1908729 Bionet1_001297 Clc1cccc(Sc2nc(ccc2C#N)c3ccc(Cl)c(Cl)c3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M20 compound treatment 0.073 -0.00341 -0.4 -0.4042 -1.0 1908730 Bionet1_001298 Cn1nc(c(C(=O)Nc2ccc(Cl)c(Cl)c2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M21 compound treatment 0.0715 -0.00491 -0.58 -0.5819 -1.0 1294695 Bionet1_001299 Clc1ccc(cc1Cl)c2ccc(C#N)c(Oc3ccccc3Cl)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M22 compound treatment 0.0725 -0.00391 -0.46 -0.4634 -1.0 1908731 Bionet1_001300 Cn1nc(c(C(=O)NCc2ccc(Cl)cc2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M23 mock treatment 0.074 -0.00241 -0.29 -0.2857 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 M24 mock treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N01 mock treatment 0.0775 0.00109 0.13 0.129 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N02 mock treatment 0.0775 0.00109 0.13 0.129 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N03 compound treatment 0.081 0.00459 0.54 0.5437 1.0 1908732 Bionet1_001301 CCOC(=O)NCCN1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N04 compound treatment 0.083 0.00659 0.78 0.7807 1.0 1908733 Bionet1_001302 Fc1ccc(cc1)c2ccc(C#N)c(OC(=O)c3c(Cl)cccc3Cl)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N05 compound treatment 0.0825 0.00609 0.72 0.7215 1.0 1908734 Bionet1_001303 NC(=O)NCCN1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N06 compound treatment 0.0765 8.87E-5 0.01 0.0105 1.0 1908735 Bionet1_001304 [O-][N+](=O)c1ccc(Oc2ccsc2C(=O)Nc3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N07 compound treatment 0.0815 0.00509 0.6 0.603 1.0 1908736 Bionet1_001305 FC(F)(F)c1cnc(c(Cl)c1)n2ccc(=O)n(Cc3ccccc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N08 compound treatment 0.0785 0.00209 0.25 0.2475 1.0 1908737 Bionet1_001306 CC(=O)Nc1ccc(NC(=O)c2sccc2Oc3ccc(cc3)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N09 compound treatment 0.078 0.00159 0.19 0.1882 1.0 1908738 Bionet1_001307 CN(OC(=O)c1ccc(C)cc1)/C=C/C(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N10 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908739 Bionet1_001308 [O-][N+](=O)c1ccccc1Oc2ccsc2C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N11 compound treatment 0.078 0.00159 0.19 0.1882 1.0 1569330 Bionet1_001309 Fc1cccc(n1)N2CCC3(CC2)OCCN3C(=O)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N12 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908740 Bionet1_001310 COc1ccc(OC)c(NC(=O)c2sccc2Oc3ccccc3[N+](=O)[O-])c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N13 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1610039 Bionet1_001311 O=S(=O)(C1CON(C1c2ccccc2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N14 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1908741 Bionet1_001312 [O-][N+](=O)c1ccccc1Oc2ccsc2C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N15 compound treatment 0.08 0.00359 0.43 0.4252 1.0 1908742 Bionet1_001313 FC(F)(F)c1cccc(SCc2ccc(NC(=O)c3ccccc3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N16 compound treatment 0.0855 0.00909 1.08 1.0769 1.0 1908743 Bionet1_001314 Cc1c(Cl)cccc1NC(=O)c2sccc2Oc3ccccc3[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N17 compound treatment 0.084 0.00759 0.9 0.8992 1.0 1908744 Bionet1_001315 FC(F)(F)c1cccc(SCc2ccc(NC(=O)c3cccs3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N18 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908745 Bionet1_001316 CN(C(=O)c1sccc1Oc2ccccc2[N+](=O)[O-])c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N19 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908746 Bionet1_001317 Cc1ccc(SCc2ccc(NC(=O)c3c(F)cccc3F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N20 compound treatment 0.078 0.00159 0.19 0.1882 1.0 1229369 Bionet1_001318 Clc1ccc(cc1)C2SCC(=O)N(C2=O)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N21 compound treatment 0.081 0.00459 0.54 0.5437 1.0 1287997 Bionet1_001319 CCOC(=O)CC1N(CCNC1=O)S(=O)(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N22 compound treatment 0.078 0.00159 0.19 0.1882 1.0 1540177 Bionet1_001320 Clc1ccc(cc1)C2C(=O)N(C(=O)CS2=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N23 mock treatment 0.0795 0.00309 0.37 0.366 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 N24 mock treatment 0.0785 0.00209 0.25 0.2475 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O01 mock treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O02 mock treatment 0.071 -0.00541 -0.64 -0.6412 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O03 compound treatment 0.083 0.00659 0.78 0.7807 1.0 1908747 Bionet1_001321 Fc1ccc(Oc2nc(ccc2C#N)c3ccc(Cl)c(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O04 compound treatment 0.08 0.00359 0.43 0.4252 1.0 1640810 Bionet1_001322 O=C(N1CCSCC1)c2cnc(nc2c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O05 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908748 Bionet1_001323 FC(F)(F)c1cccc(c1)c2ccc(C#N)c(=O)n2Cc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O06 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1908749 Bionet1_001324 [O-][N+](=O)c1ccc(cc1)N2CCC(=NNc3nc4ccccc4[nH]c3=O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O07 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1908750 Bionet1_001325 [O-][N+](=O)c1ccc(Cn2c(ccc(C#N)c2=O)c3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O08 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908751 Bionet1_001326 [O-][N+](=O)c1cccnc1N2CCC(=NNc3nc4ccccc4[nH]c3=O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O09 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1288621 Bionet1_001327 Fc1ccc(cc1)c2ccc(C#N)c(Oc3ccc(Cl)c(Cl)c3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O10 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908752 Bionet1_001328 Clc1ccc(CO/N=C/2\CCSC3=C2c4ccccc4C3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O11 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1307904 Bionet1_001329 Fc1ccc(cc1)c2ccc(C#N)c(Oc3cccc(Cl)c3Cl)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O12 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1908753 Bionet1_001330 [O-][N+](=O)c1ccc(cc1)N2CCC(=NOCc3ccc(Cl)cc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O13 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1908754 Bionet1_001331 Fc1ccc(Oc2nc(ccc2C#N)c3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O14 compound treatment 0.0755 -9.11E-4 -0.11 -0.108 -1.0 1908755 Bionet1_001332 CCOC(=O)c1cc(C(=O)OCC)c(NNC(=O)c2ccncc2)nc1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O15 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1908756 Bionet1_001333 COc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O16 compound treatment 0.0885 0.0121 1.43 1.4324 1.0 1908757 Bionet1_001334 CCOC(=O)c1cc(C(=O)OCC)c2nnc(c3ccncc3)n2c1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O17 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1276453 Bionet1_001335 COc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O18 compound treatment 0.078 0.00159 0.19 0.1882 1.0 1319091 Bionet1_001336 CCOC(=O)c1cc(C(=O)OCC)c2nnc(c3ccc(Cl)cc3)n2c1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O19 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1908758 Bionet1_001337 COc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O20 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1908759 Bionet1_001338 Cc1[nH]cc(Br)c(=O)c1Oc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O21 compound treatment 0.0765 8.87E-5 0.01 0.0105 1.0 1908760 Bionet1_001339 Clc1ccc(c2ccc(/C=C/3\OC(=O)c4ccccc34)o2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O22 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1550875 Bionet1_001340 Cc1c(OCc2c(F)cccc2Cl)c(=O)ccn1Cc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O23 mock treatment 0.08 0.00359 0.43 0.4252 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 O24 mock treatment 0.08 0.00359 0.43 0.4252 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P01 mock treatment 0.073 -0.00341 -0.4 -0.4042 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P02 mock treatment 0.057 -0.0194 -2.3 -2.3 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P03 compound treatment 0.0745 -0.00191 -0.23 -0.2265 -1.0 1520633 Bionet1_001341 CCOC(=O)CC1N(CCNC1=O)S(=O)(=O)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P04 compound treatment 0.0735 -0.00291 -0.34 -0.345 -1.0 1908761 Bionet1_001342 Fc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P05 compound treatment 0.067 -0.00941 -1.12 -1.1151 -1.0 1590329 Bionet1_001343 CCOC(=O)CC1N(CCNC1=O)S(=O)(=O)c2ccc(NC(=O)C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P06 compound treatment 0.07 -0.00641 -0.76 -0.7597 -1.0 1469037 Bionet1_001344 Clc1ccc(cc1Cl)N2C(=O)CS(=O)C(C2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P07 compound treatment 0.075 -0.00141 -0.17 -0.1672 -1.0 1908762 Bionet1_001345 CCOC(=O)CC1N(CCNC1=O)S(=O)(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P08 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1342855 Bionet1_001346 Fc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P09 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1497979 Bionet1_001347 CCOC(=O)CC1N(CCNC1=O)S(=O)(=O)c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P10 compound treatment 0.0765 8.87E-5 0.01 0.0105 1.0 1158365 Bionet1_001348 Fc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P11 compound treatment 0.076 -4.11E-4 -0.05 -0.0487 -1.0 1908763 Bionet1_001349 CCOC(=O)CC1N(CCNC1=O)C(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P12 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1339555 Bionet1_001350 Fc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P13 compound treatment 0.083 0.00659 0.78 0.7807 1.0 1395153 Bionet1_001351 CCOC(=O)CC1N(CCNC1=O)C(=O)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P14 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1908764 Bionet1_001352 Fc1ccc(cc1)c2ccc(C#N)c(=O)n2Cc3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P15 compound treatment 0.0815 0.00509 0.6 0.603 1.0 1356900 Bionet1_001353 CCOC(=O)CC1N(CCNC1=O)C(=O)c2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P16 compound treatment 0.078 0.00159 0.19 0.1882 1.0 1908765 Bionet1_001354 FC(F)(F)c1ccc(cc1)N2C(=O)CSC(C2=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P17 compound treatment 0.079 0.00259 0.31 0.3067 1.0 1246095 Bionet1_001355 CCOC(=O)CC1N(CCNC1=O)C(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P18 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1908766 Bionet1_001356 C/C(=C\C(=O)Nc1ccccc1Cl)/N2CCN(CC2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P19 compound treatment 0.0775 0.00109 0.13 0.129 1.0 1201963 Bionet1_001357 CCOC(=O)CC1N(CCNC1=O)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P20 compound treatment 0.0795 0.00309 0.37 0.366 1.0 1196283 Bionet1_001358 CCOC(=O)c1cc(C(=O)OCC)c(=O)n(NC(=O)c2ccccc2)c1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P21 compound treatment 0.077 5.89E-4 0.07 0.0698 1.0 1420464 Bionet1_001359 CCOC(=O)CC1N(CCNC1=O)S(=O)(=O)c2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P22 compound treatment 0.0765 8.87E-5 0.01 0.0105 1.0 1335658 Bionet1_001360 CCOC(=O)c1cc(C(=O)OCC)c(=O)n(NC(=O)c2cccnc2)c1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P23 mock treatment 0.077 5.89E-4 0.07 0.0698 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.571 P24 mock treatment 0.068 -0.00841 -1.0 -0.9967 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A01 mock treatment 0.0815 0.00661 0.78 0.7836 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A02 mock treatment 0.0765 0.00161 0.19 0.1911 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A03 compound treatment 0.0795 0.00461 0.55 0.5466 1.0 1277576 Bionet1_001361 Cc1ccc(Cn2ccc(=O)c(OCc3c(F)cccc3Cl)c2C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A04 compound treatment 0.078 0.00311 0.37 0.3688 1.0 1274478 Bionet1_001362 COC(=O)c1ccc(CN2C(=O)C(C)N(C(=O)C3CC3)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A05 compound treatment 0.0815 0.00661 0.78 0.7836 1.0 1645956 Bionet1_001363 Cc1c(OCc2c(F)cccc2Cl)c(=O)ccn1Cc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A06 compound treatment 0.0675 -0.00739 -0.88 -0.8753 -1.0 1692094 Bionet1_001364 CC(C)n1cnc2c(NS(=O)(=O)c3ccc(C)cc3)c(C)c(C)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A07 compound treatment 0.062 -0.0129 -1.53 -1.527 -1.0 1908767 Bionet1_001365 Clc1ccc(Cn2c(/C=C/c3ccccc3)nc4ccccc24)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A08 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1698919 Bionet1_001366 CC(C)n1cnc2c(NS(=O)(=O)c3ccc(Cl)cc3)c(C)c(C)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A09 compound treatment 0.0575 -0.0174 -2.06 -2.0602 -1.0 1908768 Bionet1_001367 Clc1cccc(Cl)c1Cn2c(/C=C/c3ccccc3)nc4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A10 compound treatment 0.0595 -0.0154 -1.82 -1.8232 -1.0 1273999 Bionet1_001368 CC(C)n1cnc2c(NS(=O)(=O)c3ccc(F)cc3)c(C)c(C)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A11 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1908769 Bionet1_001369 CC(C)(C)c1ccc(Cn2c(/C=C/c3ccccc3)nc4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A12 compound treatment 0.0575 -0.0174 -2.06 -2.0602 -1.0 1245414 Bionet1_001370 CC(C)n1cnc2c(NS(=O)(=O)c3ccccc3Cl)c(C)c(C)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A13 compound treatment 0.06 -0.0149 -1.76 -1.764 -1.0 1908770 Bionet1_001371 Cc1cc2nc(/C=C/c3ccccc3)n(Cc4cccc(F)c4)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A14 compound treatment 0.0615 -0.0134 -1.59 -1.5862 -1.0 1233334 Bionet1_001372 COc1ccc(Cn2cc(cc(C#N)c2=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A15 compound treatment 0.0615 -0.0134 -1.59 -1.5862 -1.0 1908771 Bionet1_001373 Cc1cc2nc(/C=C/c3ccccc3)n(Cc4ccc(cc4)C(C)(C)C)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A16 compound treatment 0.0595 -0.0154 -1.82 -1.8232 -1.0 1702974 Bionet1_001374 Clc1ccc(cc1)c2cc(C#N)c(=O)n(Cc3ccc(Cl)cc3Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A17 compound treatment 0.0555 -0.0194 -2.3 -2.2972 -1.0 1908772 Bionet1_001375 COc1cccc(Cn2c(/C=C/c3ccccc3)nc4cc(C)c(C)cc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A18 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1908773 Bionet1_001376 Cc1cccc(Cn2cnc3c(NS(=O)(=O)C(F)(F)F)c(C)c(C)cc23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A19 compound treatment 0.0795 0.00461 0.55 0.5466 1.0 1908774 Bionet1_001377 Cc1cc2nc(/C=C/c3ccccc3)n(Cc4ccc(C#N)cc4)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A20 compound treatment 0.078 0.00311 0.37 0.3688 1.0 1320477 Bionet1_001378 CCCn1cnc2c(NS(=O)(=O)c3ccc(OC)cc3)c(C)c(C)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A21 compound treatment 0.0805 0.00561 0.67 0.6651 1.0 1908775 Bionet1_001379 Cc1cc2nc(/C=C/c3ccccc3)n(Cc4ccc(Cl)cc4)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A22 compound treatment 0.08 0.00511 0.61 0.6058 1.0 1477659 Bionet1_001380 CCCn1cnc2c(NS(=O)(=O)c3ccc(F)cc3)c(C)c(C)cc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A23 mock treatment 0.092 0.0171 2.03 2.0277 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 A24 mock treatment 0.0805 0.00561 0.67 0.6651 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B01 mock treatment 0.0785 0.00361 0.43 0.4281 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B02 mock treatment 0.078 0.00311 0.37 0.3688 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B03 compound treatment 0.084 0.00911 1.08 1.0798 1.0 1535596 Bionet1_001381 Cc1nn(C)c(Oc2ccc(Cl)cc2)c1C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B04 compound treatment 0.0795 0.00461 0.55 0.5466 1.0 1908776 Bionet1_001382 [O-][N+](=O)c1ccc(CSc2ncc(cn2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B05 compound treatment 0.083 0.00811 0.96 0.9613 1.0 1908777 Bionet1_001383 Cc1nn(C)c(Oc2cccc(c2)C(F)(F)F)c1C(=O)Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B06 compound treatment 0.0775 0.00261 0.31 0.3096 1.0 1908778 Bionet1_001384 Clc1ccc(cc1)c2cnc(SCc3ccc(Cl)cc3Cl)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B07 compound treatment 0.0605 -0.0144 -1.7 -1.7047 -1.0 1908779 Bionet1_001385 Cc1nn(C)c(Sc2ccc(Cl)cc2)c1C(=O)Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B08 compound treatment 0.0595 -0.0154 -1.82 -1.8232 -1.0 1136799 Bionet1_001386 CN(C)C(=O)Oc1c(C)cc(cc1C)C(=O)CSc2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B09 compound treatment 0.0615 -0.0134 -1.59 -1.5862 -1.0 1908780 Bionet1_001387 Cc1nn(C)c(Sc2ccc(Cl)cc2)c1C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B10 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1572137 Bionet1_001388 CN(C)C(=S)Oc1c(C)cc(cc1C)C(=O)CSc2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B11 compound treatment 0.058 -0.0169 -2.0 -2.001 -1.0 1908781 Bionet1_001389 Cc1nn(C)c(Sc2cccc(Cl)c2)c1C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B12 compound treatment 0.059 -0.0159 -1.88 -1.8825 -1.0 1477329 Bionet1_001390 CN(C)C(=O)Oc1c(C)cc(cc1C)C(=O)CSc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B13 compound treatment 0.059 -0.0159 -1.88 -1.8825 -1.0 1908782 Bionet1_001391 Cc1nn(C)c(Sc2cccc(Cl)c2)c1C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B14 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1305385 Bionet1_001392 CN(C)C(=S)Oc1c(C)cc(cc1C)C(=O)CSc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B15 compound treatment 0.0585 -0.0164 -1.94 -1.9417 -1.0 1162146 Bionet1_001393 Clc1ccc(Sc2nnc(Cc3ccccc3)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B16 compound treatment 0.056 -0.0189 -2.24 -2.2379 -1.0 1506007 Bionet1_001394 CN(C)C(=O)Oc1c(C)cc(cc1C)C(=O)CS(=O)(=O)c2ccc(C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B17 compound treatment 0.056 -0.0189 -2.24 -2.2379 -1.0 1421362 Bionet1_001395 COc1ccc(CNc2nnc(Cc3ccccc3)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B18 compound treatment 0.0565 -0.0184 -2.18 -2.1787 -1.0 1596612 Bionet1_001396 CN(C)C(=O)Oc1c(C)cc(cc1C)C(=O)CS(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B19 compound treatment 0.0835 0.00861 1.02 1.0205 1.0 1369090 Bionet1_001397 CC(O)(CS(=O)(=O)c1ccccc1)C(=O)Nc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B20 compound treatment 0.0795 0.00461 0.55 0.5466 1.0 1332510 Bionet1_001398 CN(C)C(=O)Oc1c(C)cc(cc1C)C(=O)CS(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B21 compound treatment 0.079 0.00411 0.49 0.4873 1.0 1569787 Bionet1_001399 CC(O)(CSc1ccc(Cl)cc1)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B22 compound treatment 0.0805 0.00561 0.67 0.6651 1.0 1654914 Bionet1_001400 CN(C)C(=O)Oc1c(C)cc(cc1C)C(=O)CS(=O)(=O)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B23 mock treatment 0.081 0.00611 0.72 0.7243 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 B24 mock treatment 0.0775 0.00261 0.31 0.3096 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C01 mock treatment 0.072 -0.00289 -0.34 -0.3421 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C02 mock treatment 0.0775 0.00261 0.31 0.3096 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C03 compound treatment 0.0805 0.00561 0.67 0.6651 1.0 1908783 Bionet1_001401 COC(=O)c1ccc(Cn2c(/C=C/c3ccccc3)nc4cc(C)c(C)cc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C04 compound treatment 0.077 0.00211 0.25 0.2504 1.0 1908784 Bionet1_001402 CC1=CSC2=[N+](CC(=O)c3ccc(Cl)cc3)CCN12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C05 compound treatment 0.081 0.00611 0.72 0.7243 1.0 1908785 Bionet1_001403 Clc1ccc(/C=C/c2nc3ccccc3n2Cc4ccccc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C06 compound treatment 0.0705 -0.00439 -0.52 -0.5198 -1.0 1325136 Bionet1_001404 Clc1cccc(Cl)c1Cn2cc(cc(C#N)c2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C07 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1908786 Bionet1_001405 Cc1ccc(Cn2c(/C=C/c3ccc(Cl)cc3Cl)nc4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C08 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1908787 Bionet1_001406 FC(F)(F)c1cccc(Cn2cc(cc(C#N)c2=O)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C09 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1908788 Bionet1_001407 COc1cnc(nc1Sc2ccc(Cl)cc2Cl)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C10 compound treatment 0.062 -0.0129 -1.53 -1.527 -1.0 1718993 Bionet1_001408 Clc1ccc(cc1)c2cc(C#N)c(=O)n(Cc3ccc(Cl)c(Cl)c3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C11 compound treatment 0.0615 -0.0134 -1.59 -1.5862 -1.0 1908789 Bionet1_001409 CCOC(=O)Cn1c(/C=C/c2ccc(Cl)cc2Cl)nc3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C12 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1730545 Bionet1_001410 Clc1ccc(cc1)c2cc(C#N)c(=O)n(Cc3c(Cl)cccc3Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C13 compound treatment 0.0605 -0.0144 -1.7 -1.7047 -1.0 1908790 Bionet1_001411 COc1cccc(Cn2c(/C=C/c3ccccc3Cl)nc4ccccc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C14 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1908791 Bionet1_001412 FC(F)(F)c1cccc(Cn2cc(cc(C#N)c2=O)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C15 compound treatment 0.06 -0.0149 -1.76 -1.764 -1.0 1908792 Bionet1_001413 Fc1cccc(Cl)c1Cn2c(/C=C/c3ccccc3Cl)nc4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C16 compound treatment 0.0585 -0.0164 -1.94 -1.9417 -1.0 1150783 Bionet1_001414 Clc1cccc(Cn2cc(cc(C#N)c2=O)c3cccc(Cl)c3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C17 compound treatment 0.0575 -0.0174 -2.06 -2.0602 -1.0 1908793 Bionet1_001415 Clc1cccc(Cn2c(/C=C/c3ccccc3Cl)nc4ccccc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C18 compound treatment 0.0595 -0.0154 -1.82 -1.8232 -1.0 1633434 Bionet1_001416 Clc1cccc(c1)c2cc(C#N)c(=O)n(Cc3ccc(Cl)cc3Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C19 compound treatment 0.077 0.00211 0.25 0.2504 1.0 1908794 Bionet1_001417 Fc1cccc(Cn2c(/C=C/c3ccccc3Cl)nc4ccccc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C20 compound treatment 0.0815 0.00661 0.78 0.7836 1.0 1123613 Bionet1_001418 COc1ccc(Sc2ncc(cc2C#N)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C21 compound treatment 0.0825 0.00761 0.9 0.9021 1.0 1908795 Bionet1_001419 Clc1ccc(Cn2c(/C=C/c3ccccc3Cl)nc4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C22 compound treatment 0.0785 0.00361 0.43 0.4281 1.0 1326244 Bionet1_001420 Clc1ccc(cc1)c2cnc(Sc3ccccc3Cl)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C23 mock treatment 0.0855 0.0106 1.26 1.2575 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 C24 mock treatment 0.084 0.00911 1.08 1.0798 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D01 mock treatment 0.071 -0.00389 -0.46 -0.4606 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D02 mock treatment 0.0735 -0.00139 -0.16 -0.1644 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D03 compound treatment 0.078 0.00311 0.37 0.3688 1.0 1908796 Bionet1_001421 CC(O)(CS(=O)(=O)c1ccccc1)C(=O)Nc2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D04 compound treatment 0.0765 0.00161 0.19 0.1911 1.0 1544202 Bionet1_001422 CN(C)C(=O)Oc1c(C)cc(cc1C)C(=O)CS(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D05 compound treatment 0.079 0.00411 0.49 0.4873 1.0 1908797 Bionet1_001423 CC(O)(CS(=O)(=O)C1CCCCC1)C(=O)Nc2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D06 compound treatment 0.073 -0.00189 -0.22 -0.2236 -1.0 1179427 Bionet1_001424 CN(C)C(=O)Oc1c(C)cc(cc1C)C(=O)CS(=O)c2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D07 compound treatment 0.066 -0.00889 -1.05 -1.053 -1.0 1908798 Bionet1_001425 COc1ccc(SCC(C)(O)C(=O)Nc2ccc(cc2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D08 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1908799 Bionet1_001426 COc1ccc(cc1OC)C(=O)NCCSc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D09 compound treatment 0.065 -0.00989 -1.17 -1.1715 -1.0 1224308 Bionet1_001427 COc1cccc(Cn2cnc3c(NS(=O)(=O)C)c(C)c(C)cc23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D10 compound treatment 0.0645 -0.0104 -1.23 -1.2308 -1.0 1908800 Bionet1_001428 COc1cc(cc(OC)c1OC)C(=O)NCCSc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D11 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1723827 Bionet1_001429 Cc1cccc(Cn2c(nc3cc(C)c(C)cc23)c4cccnc4Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D12 compound treatment 0.067 -0.00789 -0.93 -0.9345 -1.0 1908801 Bionet1_001430 Clc1ccc(Sc2ncccc2c3nc4ccccc4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D13 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1337830 Bionet1_001431 Cc1cc2nc(c3cccnc3Cl)n(Cc4ccccc4Cl)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D14 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1908802 Bionet1_001432 FC(F)(F)c1cccc(Sc2ncccc2c3nc4ccccc4s3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D15 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1622607 Bionet1_001433 Cc1cc2nc(c3cccnc3Cl)n(Cc4ccc(F)cc4)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D16 compound treatment 0.0665 -0.00839 -0.99 -0.9938 -1.0 1908803 Bionet1_001434 COc1ccc(Cn2c(nc3ccccc23)c4ccc(Cl)nc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D17 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1460082 Bionet1_001435 Cc1ccccc1Cn2c(nc3cc(C)c(C)cc23)c4cccnc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D18 compound treatment 0.0615 -0.0134 -1.59 -1.5862 -1.0 1908804 Bionet1_001436 FC(F)(F)c1cccc(Cn2c(nc3ccccc23)c4ccc(Cl)nc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D19 compound treatment 0.0765 0.00161 0.19 0.1911 1.0 1678707 Bionet1_001437 Cc1cc2nc(c3cccnc3Cl)n(Cc4ccccc4F)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D20 compound treatment 0.08 0.00511 0.61 0.6058 1.0 1611698 Bionet1_001438 COC(=O)c1c(C(=O)OC)c2CSCn2c1c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D21 compound treatment 0.083 0.00811 0.96 0.9613 1.0 1477920 Bionet1_001439 Clc1ccc(Oc2nnc(Cc3ccccc3)c4ccccc24)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D22 compound treatment 0.082 0.00711 0.84 0.8428 1.0 1580425 Bionet1_001440 COC(=O)c1c(C(=O)OC)c2CS(=O)(=O)Cn2c1c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D23 mock treatment 0.087 0.0121 1.44 1.4353 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 D24 mock treatment 0.09 0.0151 1.79 1.7907 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E01 mock treatment 0.073 -0.00189 -0.22 -0.2236 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E02 mock treatment 0.0745 -3.87E-4 -0.05 -0.0459 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E03 compound treatment 0.079 0.00411 0.49 0.4873 1.0 1908805 Bionet1_001441 Clc1ccccc1/C=C/c2nc3ccccc3n2Cc4cccc(C#N)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E04 compound treatment 0.0795 0.00461 0.55 0.5466 1.0 1480589 Bionet1_001442 Clc1ccc(cc1)c2cnc(Sc3cccc(Cl)c3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E05 compound treatment 0.0785 0.00361 0.43 0.4281 1.0 1908806 Bionet1_001443 FC(F)(F)c1cnc(C(c2nc[nH]n2)c3ccc(Cl)cc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E06 compound treatment 0.074 -8.87E-4 -0.11 -0.1051 -1.0 1274264 Bionet1_001444 Clc1ccc(Sc2ncc(cc2C#N)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E07 compound treatment 0.068 -0.00689 -0.82 -0.8161 -1.0 1908807 Bionet1_001445 COc1cnc(nc1Oc2ccc(Cl)c3ccccc23)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E08 compound treatment 0.068 -0.00689 -0.82 -0.8161 -1.0 1447550 Bionet1_001446 Clc1ccc(cc1)c2cnc(Sc3c(Cl)cccc3Cl)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E09 compound treatment 0.07 -0.00489 -0.58 -0.5791 -1.0 1908808 Bionet1_001447 COc1cnc(SCc2ccc(Cl)cc2)nc1Sc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E10 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1908809 Bionet1_001448 FC(F)(F)c1cccc(Oc2ncc(cc2C#N)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E11 compound treatment 0.065 -0.00989 -1.17 -1.1715 -1.0 1908810 Bionet1_001449 COc1cnc(SCc2ccc(Cl)cc2)nc1Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E12 compound treatment 0.065 -0.00989 -1.17 -1.1715 -1.0 1282964 Bionet1_001450 Clc1cccc(c1)c2cc(C#N)c(=O)n(Cc3c(Cl)cccc3Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E13 compound treatment 0.0645 -0.0104 -1.23 -1.2308 -1.0 1908811 Bionet1_001451 COc1cnc(SCc2ccc(Cl)cc2)nc1Oc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E14 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1908812 Bionet1_001452 FC(F)(F)c1cccc(Oc2ncc(cc2C#N)c3cccc(Cl)c3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E15 compound treatment 0.062 -0.0129 -1.53 -1.527 -1.0 1908813 Bionet1_001453 CCOC(=O)CSc1ncc(OC)c(Sc2ccc(Cl)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E16 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1139505 Bionet1_001454 Clc1ccc(NC(=O)N2OCC3COc4ccc5ccccc5c4C32)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E17 compound treatment 0.065 -0.00989 -1.17 -1.1715 -1.0 1908814 Bionet1_001455 CCOC(=O)CSc1ncc(OC)c(Sc2ccc(OC)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E18 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1457321 Bionet1_001456 Clc1ccc(cc1)C(=O)N2OCC3COc4ccc5ccccc5c4C32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E19 compound treatment 0.0765 0.00161 0.19 0.1911 1.0 1908815 Bionet1_001457 CCOC(=O)CSc1ncc(OC)c(Oc2ccc(Cl)c(Cl)c2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E20 compound treatment 0.0775 0.00261 0.31 0.3096 1.0 1172613 Bionet1_001458 O=C(NC(=S)N1OC[C@@H]2COc3ccc4ccccc4c3[C@@H]21)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E21 compound treatment 0.0805 0.00561 0.67 0.6651 1.0 1908816 Bionet1_001459 CCOC(=O)CSc1ncc(OC)c(Oc2cccc(c2)[N+](=O)[O-])n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E22 compound treatment 0.0775 0.00261 0.31 0.3096 1.0 1908817 Bionet1_001460 CN1C(=O)N(C)C(=O)C(=Cc2c(OCC=C)ccc3ccccc23)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E23 mock treatment 0.0855 0.0106 1.26 1.2575 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 E24 mock treatment 0.081 0.00611 0.72 0.7243 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F01 mock treatment 0.0705 -0.00439 -0.52 -0.5198 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F02 mock treatment 0.071 -0.00389 -0.46 -0.4606 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F03 compound treatment 0.0755 6.13E-4 0.07 0.0726 1.0 1908818 Bionet1_001461 Cc1cc2nc(c3cccnc3Cl)n(Cc4cccc(Cl)c4)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F04 compound treatment 0.0755 6.13E-4 0.07 0.0726 1.0 1464474 Bionet1_001462 COC(=O)c1c(C(=O)OC)c2CS(=O)Cn2c1c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F05 compound treatment 0.0765 0.00161 0.19 0.1911 1.0 1595639 Bionet1_001463 Cc1cc2nc(c3cccnc3Cl)n(Cc4c(F)cccc4Cl)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F06 compound treatment 0.071 -0.00389 -0.46 -0.4606 -1.0 1697406 Bionet1_001464 COC(=O)c1c(C(=O)OC)c2CS(=O)(=O)Cn2c1c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F07 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1497567 Bionet1_001465 COc1cccc(Cn2c(nc3cc(C)c(C)cc23)c4cccnc4Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F08 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1456538 Bionet1_001466 COC(=O)c1c(C(=O)OC)c2CS(=O)Cn2c1c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F09 compound treatment 0.071 -0.00389 -0.46 -0.4606 -1.0 1299705 Bionet1_001467 COc1ccc(Sc2nnc(Cc3ccccc3)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F10 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1410089 Bionet1_001468 COC(=O)c1c(C(=O)OC)c2CSCn2c1c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F11 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1908819 Bionet1_001469 COc1ccc(Oc2cccc3C(/C(=C/N(C)C)/C(=O)c32)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F12 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1288290 Bionet1_001470 COC(=O)c1c(C(=O)OC)c2CS(=O)Cn2c1c3cccc(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F13 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1908820 Bionet1_001471 CN(C)c1ccc(/C=C/C=C\2/C(c3ccccc3C2=O)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F14 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1908821 Bionet1_001472 COC(=O)c1c(C(=O)OC)c2CSCn2c1c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F15 compound treatment 0.0725 -0.00239 -0.28 -0.2828 -1.0 1908822 Bionet1_001473 COc1ccc(/C=C\2/C(c3ccccc3C2=O)c4ccccc4)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F16 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1339872 Bionet1_001474 Clc1ccc(Sc2ccc(nn2)C(C#N)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F17 compound treatment 0.0645 -0.0104 -1.23 -1.2308 -1.0 1908823 Bionet1_001475 OC1CC(c2cccc(Oc3cccc(c3)C(F)(F)F)c12)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F18 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1511401 Bionet1_001476 NC(=O)C(c1ccc(Cl)cc1)c2ccc(Sc3ccccc3)nn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F19 compound treatment 0.0775 0.00261 0.31 0.3096 1.0 1908824 Bionet1_001477 Fc1cccc2C(/C(=C\Nc3ccc(Cl)cc3)/C(=O)c21)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F20 compound treatment 0.076 0.00111 0.13 0.1319 1.0 1330119 Bionet1_001478 NC(=O)C(c1ccc(Cl)cc1)c2ccc(Sc3ccc(Cl)cc3)nn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F21 compound treatment 0.0755 6.13E-4 0.07 0.0726 1.0 1908825 Bionet1_001479 Fc1cccc2C(/C(=C\Nc3cccc(c3)C(F)(F)F)/C(=O)c21)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F22 compound treatment 0.075 1.13E-4 0.01 0.0134 1.0 1908826 Bionet1_001480 C/C(=N\OCc1ccc(cc1)[N+](=O)[O-])/CCS(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F23 mock treatment 0.0795 0.00461 0.55 0.5466 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 F24 mock treatment 0.083 0.00811 0.96 0.9613 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G01 mock treatment 0.0695 -0.00539 -0.64 -0.6383 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G02 mock treatment 0.0675 -0.00739 -0.88 -0.8753 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G03 compound treatment 0.0715 -0.00339 -0.4 -0.4013 -1.0 1908827 Bionet1_001481 CCOC(=O)CSc1ncc(OC)c(Oc2ccc(OC)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G04 compound treatment 0.072 -0.00289 -0.34 -0.3421 -1.0 1908828 Bionet1_001482 Cn1c2OC[C@H]3COc4ccc5ccccc5c4[C@H]3c2c(=O)n(C)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G05 compound treatment 0.075 1.13E-4 0.01 0.0134 1.0 1908829 Bionet1_001483 CCOC(=O)C(C)Sc1ncc(OC)c(Sc2ccc(Cl)cc2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G06 compound treatment 0.069 -0.00589 -0.7 -0.6976 -1.0 1256704 Bionet1_001484 Clc1ccc(cc1Cl)C(=O)N2OC[C@@H]3COc4ccc5ccccc5c4[C@@H]32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G07 compound treatment 0.076 0.00111 0.13 0.1319 1.0 1908830 Bionet1_001485 Clc1ccc(SCCNC(=O)c2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G08 compound treatment 0.06 -0.0149 -1.76 -1.764 -1.0 1908831 Bionet1_001486 O=C(CN1CCOCC1)N2OC[C@@H]3COc4ccc5ccccc5c4[C@@H]32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G09 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1187364 Bionet1_001487 Cc1ccc(Cn2ccc(=O)c(OCc3c(Cl)cccc3Cl)c2C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G10 compound treatment 0.0585 -0.0164 -1.94 -1.9417 -1.0 1908832 Bionet1_001488 OC[C@H]1COc2ccc3ccccc3c2[C@H]1NC(=O)Nc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G11 compound treatment 0.0605 -0.0144 -1.7 -1.7047 -1.0 1336601 Bionet1_001489 Cc1c(OCc2c(Cl)cccc2Cl)c(=O)ccn1Cc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G12 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1576493 Bionet1_001490 Clc1ccc(cc1)C2N[C@H]3[C@@H](CO2)COc4ccc5ccccc5c34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G13 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1674938 Bionet1_001491 Cc1c(OCc2ccccc2)c(=O)ccn1Cc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G14 compound treatment 0.0575 -0.0174 -2.06 -2.0602 -1.0 1908833 Bionet1_001492 COc1cccc2[C@@H]([C@H](CO)COc12)N(C)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G15 compound treatment 0.0575 -0.0174 -2.06 -2.0602 -1.0 1406416 Bionet1_001493 Cc1c(OCc2ccccc2)c(=O)ccn1Cc3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G16 compound treatment 0.0595 -0.0154 -1.82 -1.8232 -1.0 1556426 Bionet1_001494 COc1cccc(c1)C2OC[C@@H]3COc4ccc5ccccc5c4[C@@H]3N2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G17 compound treatment 0.0585 -0.0164 -1.94 -1.9417 -1.0 1661200 Bionet1_001495 Cc1c(OCc2ccc(F)cc2)c(=O)ccn1Cc3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G18 compound treatment 0.0575 -0.0174 -2.06 -2.0602 -1.0 1908834 Bionet1_001496 O=C(N1OCC2COc3ccc4ccccc4c3C21)C5(CC6CC7CC(C6)C5)C7 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G19 compound treatment 0.0715 -0.00339 -0.4 -0.4013 -1.0 1908835 Bionet1_001497 FC(F)(F)c1cccc(c1)C(=O)Nc2ncc3CCc4ccccc4-c3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G20 compound treatment 0.071 -0.00389 -0.46 -0.4606 -1.0 1908836 Bionet1_001498 CCCCCCCCCCC(=O)c1c[nH]c(c1)C(=O)C(Cl)(Cl)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G21 compound treatment 0.0715 -0.00339 -0.4 -0.4013 -1.0 1648314 Bionet1_001499 Clc1ccc(NC(=O)Nc2ncc3CCc4ccccc4-c3n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G22 compound treatment 0.0735 -0.00139 -0.16 -0.1644 -1.0 1908837 Bionet1_001500 FC(F)(F)c1cnc(SC2CC(=O)N(C2=O)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G23 mock treatment 0.075 1.13E-4 0.01 0.0134 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 G24 mock treatment 0.07 -0.00489 -0.58 -0.5791 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H01 mock treatment 0.072 -0.00289 -0.34 -0.3421 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H02 mock treatment 0.0725 -0.00239 -0.28 -0.2828 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H03 compound treatment 0.076 0.00111 0.13 0.1319 1.0 1908838 Bionet1_001501 [O-][N+](=O)c1ccccc1N/C=C/2\C(c3cccc(F)c3C2=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H04 compound treatment 0.077 0.00211 0.25 0.2504 1.0 1908839 Bionet1_001502 FC(F)(F)c1cnc(SC(C#N)c2ccc(Cl)cc2Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H05 compound treatment 0.08 0.00511 0.61 0.6058 1.0 1908840 Bionet1_001503 Fc1cccc2C(/C(=C\Nc3cccc(C#N)c3)/C(=O)c21)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H06 compound treatment 0.0735 -0.00139 -0.16 -0.1644 -1.0 1908841 Bionet1_001504 FC(F)(F)c1cnc(SC(C#N)c2ccc(Cl)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H07 compound treatment 0.071 -0.00389 -0.46 -0.4606 -1.0 1691069 Bionet1_001505 O=C1CC(c2cccc(N3CCN(CC3)c4ccccc4)c12)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H08 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1335558 Bionet1_001506 Clc1ccc(CNc2nnc(Cc3ccccc3)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H09 compound treatment 0.067 -0.00789 -0.93 -0.9345 -1.0 1520476 Bionet1_001507 Fc1ccc(cc1)N2CCN(CC2)c3cccc4C(CC(=O)c43)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H10 compound treatment 0.066 -0.00889 -1.05 -1.053 -1.0 1908842 Bionet1_001508 FC(F)(F)c1cccc(c1)c2nc(no2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H11 compound treatment 0.065 -0.00989 -1.17 -1.1715 -1.0 1908843 Bionet1_001509 CN(C)/C=C\1/C(c2cccc(Oc3ccc(Cl)cc3)c2C1=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H12 compound treatment 0.0695 -0.00539 -0.64 -0.6383 -1.0 1908844 Bionet1_001510 FC(F)(F)c1cnc(c(Cl)c1)c2cnc(Oc3ccccc3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H13 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1908845 Bionet1_001511 FC(F)(F)c1cccc(Oc2cccc3C(CC(=O)c32)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H14 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1908846 Bionet1_001512 Clc1cccc(c1)c2cnc(SCc3ccc(Cl)c(Cl)c3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H15 compound treatment 0.066 -0.00889 -1.05 -1.053 -1.0 1908847 Bionet1_001513 CN(C)/C=C/1\CCc2c(cc(c3ccccc3)n2c4ccc(C)cc4)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H16 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1908848 Bionet1_001514 Cn1c(SCc2ccc(Cl)c(Cl)c2)nc(cc1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H17 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1908849 Bionet1_001515 Clc1ccc(cc1)C(=O)c2oc3ccccc3c2CBr 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H18 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1908850 Bionet1_001516 Cn1c(SCc2ccc(Cl)cc2Cl)nc(cc1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H19 compound treatment 0.0765 0.00161 0.19 0.1911 1.0 1380683 Bionet1_001517 Clc1ccc(cc1)C(=O)c2oc3ccccc3c2CSc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H20 compound treatment 0.0765 0.00161 0.19 0.1911 1.0 1908851 Bionet1_001518 Cn1c(SCc2c(Cl)cccc2Cl)nc(cc1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H21 compound treatment 0.079 0.00411 0.49 0.4873 1.0 1736174 Bionet1_001519 Cc1ccc(cc1)S(=O)(=O)Cc2c(oc3ccccc23)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H22 compound treatment 0.076 0.00111 0.13 0.1319 1.0 1908852 Bionet1_001520 Cn1c(SCc2ccc(cc2)C(C)(C)C)nc(cc1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H23 mock treatment 0.081 0.00611 0.72 0.7243 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 H24 mock treatment 0.0765 0.00161 0.19 0.1911 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I01 mock treatment 0.074 -8.87E-4 -0.11 -0.1051 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I02 mock treatment 0.071 -0.00389 -0.46 -0.4606 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I03 compound treatment 0.0745 -3.87E-4 -0.05 -0.0459 -1.0 1308297 Bionet1_001521 Clc1cccc(NC(=O)Nc2ncc3CCc4ccccc4-c3n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I04 compound treatment 0.073 -0.00189 -0.22 -0.2236 -1.0 1908853 Bionet1_001522 COc1ccc(cc1)C(CCC#N)(C#N)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I05 compound treatment 0.072 -0.00289 -0.34 -0.3421 -1.0 1295409 Bionet1_001523 CC1N(C(=O)c2ccccc2)c3ccccc3N(Cc4cccc(Cl)c4)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I06 compound treatment 0.075 1.13E-4 0.01 0.0134 1.0 1908854 Bionet1_001524 COc1ccc(cc1)C2(CCC(=O)NC2=O)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I07 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1140364 Bionet1_001525 CC1N(C(=O)c2ccccc2)c3ccccc3N(Cc4cccc(F)c4)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I08 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1592764 Bionet1_001526 CC(O)(CS(=O)(=O)c1ccccc1)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I09 compound treatment 0.0665 -0.00839 -0.99 -0.9938 -1.0 1579010 Bionet1_001527 COc1cccc(CN2C(=O)C(C)N(C(=O)c3ccccc3)c4ccccc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I10 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1250843 Bionet1_001528 CC(O)(CS(=O)(=O)C1CCCCC1)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I11 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1354171 Bionet1_001529 CC1N(C(=O)c2ccccc2)c3ccccc3N(Cc4ccccc4Cl)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I12 compound treatment 0.0595 -0.0154 -1.82 -1.8232 -1.0 1394922 Bionet1_001530 CC(O)(CS(=O)c1ccc(Cl)cc1)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I13 compound treatment 0.0515 -0.0234 -2.77 -2.7711 -1.0 1391776 Bionet1_001531 CC1N(C(=O)c2ccccc2)c3ccccc3N(Cc4ccccc4)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I14 compound treatment 0.0565 -0.0184 -2.18 -2.1787 -1.0 1420403 Bionet1_001532 CC(O)(CS(=O)(=O)c1cccc(Cl)c1)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I15 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1908855 Bionet1_001533 COc1cnc(nc1Sc2c(Cl)cccc2Cl)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I16 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1255363 Bionet1_001534 Cc1ccc(cc1)S(=O)(=O)CC(C)(O)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I17 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1908856 Bionet1_001535 FC(F)(F)c1cccc(NC(=O)Nc2ncc3CCc4ccccc4-c3n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I18 compound treatment 0.0605 -0.0144 -1.7 -1.7047 -1.0 1687284 Bionet1_001536 COc1ccc(cc1)S(=O)(=O)CC(C)(O)C(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I19 compound treatment 0.075 1.13E-4 0.01 0.0134 1.0 1683343 Bionet1_001537 Cc1cc2n(C)cnc2c(NS(=O)(=O)c3ccc(Cl)cc3)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I20 compound treatment 0.073 -0.00189 -0.22 -0.2236 -1.0 1908857 Bionet1_001538 CC(O)(CS(=O)(=O)c1ccccc1)C(=O)Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I21 compound treatment 0.0735 -0.00139 -0.16 -0.1644 -1.0 1340803 Bionet1_001539 Cc1cc2n(C)cnc2c(NS(=O)(=O)c3cc(Cl)ccc3Cl)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I22 compound treatment 0.074 -8.87E-4 -0.11 -0.1051 -1.0 1908858 Bionet1_001540 COc1cnc(SCc2ccc(Cl)c(Cl)c2)nc1Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I23 mock treatment 0.076 0.00111 0.13 0.1319 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 I24 mock treatment 0.075 1.13E-4 0.01 0.0134 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J01 mock treatment 0.0715 -0.00339 -0.4 -0.4013 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J02 mock treatment 0.0705 -0.00439 -0.52 -0.5198 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J03 compound treatment 0.0755 6.13E-4 0.07 0.0726 1.0 1539254 Bionet1_001541 Clc1ccccc1SCc2c(oc3ccccc23)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J04 compound treatment 0.0735 -0.00139 -0.16 -0.1644 -1.0 1908859 Bionet1_001542 FC(F)(F)c1cccc(c1)c2cnc(SCc3ccc(Cl)cc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J05 compound treatment 0.073 -0.00189 -0.22 -0.2236 -1.0 1158460 Bionet1_001543 Clc1ccc(SCc2c(oc3ccccc23)C(=O)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J06 compound treatment 0.0685 -0.00639 -0.76 -0.7568 -1.0 1908860 Bionet1_001544 COC(=O)c1ccc(CSc2nc(cc(=O)n2C)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J07 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1570403 Bionet1_001545 COc1ccc(SCc2c(oc3ccccc23)C(=O)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J08 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1908861 Bionet1_001546 Cn1c(SCc2cccc(c2)C(F)(F)F)nc(cc1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J09 compound treatment 0.0665 -0.00839 -0.99 -0.9938 -1.0 1451234 Bionet1_001547 Cc1ccccc1SCc2c(oc3ccccc23)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J10 compound treatment 0.0645 -0.0104 -1.23 -1.2308 -1.0 1908862 Bionet1_001548 Cn1c(SCc2c(F)cccc2Cl)nc(cc1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J11 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1658679 Bionet1_001549 COc1ccc(cc1)S(=O)Cc2c(oc3ccccc23)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J12 compound treatment 0.062 -0.0129 -1.53 -1.527 -1.0 1908863 Bionet1_001550 Cc1cccc(CSc2ncc(cn2)c3cccc(c3)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J13 compound treatment 0.06 -0.0149 -1.76 -1.764 -1.0 1908864 Bionet1_001551 Clc1cccc(c1)c2cnn(c2)c3ccc(Cl)c(Cl)c3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J14 compound treatment 0.06 -0.0149 -1.76 -1.764 -1.0 1908865 Bionet1_001552 FC(F)(F)c1cccc(c1)c2cnc(SCc3ccccc3Cl)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J15 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1908866 Bionet1_001553 Clc1snnc1CO/N=C\C2C(=O)CC(CC2=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J16 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1908867 Bionet1_001554 FC(F)(F)c1cccc(c1)c2cnc(SCc3cccc(Cl)c3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J17 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1908868 Bionet1_001555 FC(F)(F)c1cccc(c1)c2cc(C#N)c(=O)n(Cc3ccc(Cl)cc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J18 compound treatment 0.061 -0.0139 -1.65 -1.6455 -1.0 1908869 Bionet1_001556 Fc1ccc(CSc2ncc(cn2)c3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J19 compound treatment 0.072 -0.00289 -0.34 -0.3421 -1.0 1908870 Bionet1_001557 COc1ccc(Cn2cc(cc(C#N)c2=O)c3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J20 compound treatment 0.0715 -0.00339 -0.4 -0.4013 -1.0 1189944 Bionet1_001558 COC(=O)c1c(C(=O)OC)c2CSCn2c1c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J21 compound treatment 0.0745 -3.87E-4 -0.05 -0.0459 -1.0 1908871 Bionet1_001559 Cc1ccc(Cn2cc(cc(C#N)c2=O)c3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J22 compound treatment 0.0735 -0.00139 -0.16 -0.1644 -1.0 1735124 Bionet1_001560 COC(=O)c1c(C(=O)OC)c2CS(=O)Cn2c1c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J23 mock treatment 0.074 -8.87E-4 -0.11 -0.1051 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 J24 mock treatment 0.0725 -0.00239 -0.28 -0.2828 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K01 mock treatment 0.07 -0.00489 -0.58 -0.5791 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K02 mock treatment 0.0665 -0.00839 -0.99 -0.9938 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K03 compound treatment 0.0705 -0.00439 -0.52 -0.5198 -1.0 1908872 Bionet1_001561 Cc1cc2n(C)cnc2c(NS(=O)(=O)c3cccc(c3)C(F)(F)F)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K04 compound treatment 0.0715 -0.00339 -0.4 -0.4013 -1.0 1908873 Bionet1_001562 FC(F)(F)c1cnc(c(Cl)c1)C(C#N)(N2CCOCC2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K05 compound treatment 0.0715 -0.00339 -0.4 -0.4013 -1.0 1412047 Bionet1_001563 Cc1cc2n(C)cnc2c(NS(=O)(=O)c3ccc(cc3)C(C)(C)C)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K06 compound treatment 0.0685 -0.00639 -0.76 -0.7568 -1.0 1368529 Bionet1_001564 COc1ccc(Cn2cnc3c(NS(=O)(=O)C)c(C)c(C)cc23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K07 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1642363 Bionet1_001565 Cc1cc2n(C)cnc2c(NS(=O)(=O)c3ccccc3Cl)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K08 compound treatment 0.062 -0.0129 -1.53 -1.527 -1.0 1908874 Bionet1_001566 FC(F)(F)c1cnc(c(Cl)c1)C(C#N)(N2CCOCC2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K09 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1908875 Bionet1_001567 FC(F)(F)c1cccc(c1)c2nnnn2c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K10 compound treatment 0.0645 -0.0104 -1.23 -1.2308 -1.0 1908876 Bionet1_001568 FC(F)(F)c1cnc(c(Cl)c1)C(C#N)(N2CCOCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K11 compound treatment 0.066 -0.00889 -1.05 -1.053 -1.0 1908877 Bionet1_001569 Brc1ccc(SCCN2C(=O)c3ccccc3C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K12 compound treatment 0.062 -0.0129 -1.53 -1.527 -1.0 1908878 Bionet1_001570 Clc1cccc(Cl)c1CON/C=N/OCc2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K13 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1908879 Bionet1_001571 FC(F)(F)c1cccc(c1)n2nnnc2c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K14 compound treatment 0.0605 -0.0144 -1.7 -1.7047 -1.0 1908880 Bionet1_001572 Fc1ccccc1C(C#N)(N2CCOCC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K15 compound treatment 0.0605 -0.0144 -1.7 -1.7047 -1.0 1172509 Bionet1_001573 Clc1ccc(cc1)S(=O)(=O)CCNC(=O)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K16 compound treatment 0.0615 -0.0134 -1.59 -1.5862 -1.0 1908881 Bionet1_001574 COc1ccc(cc1)C(=O)n2cc(cn2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K17 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1412820 Bionet1_001575 Cc1ccc(SCC(=O)Nc2ncc3CCc4ccccc4-c3n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K18 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1908882 Bionet1_001576 CO/N=C/NC(=O)C(c1ccc(F)cc1)c2cccc(c2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K19 compound treatment 0.07 -0.00489 -0.58 -0.5791 -1.0 1908883 Bionet1_001577 Fc1ccc(cc1)C(=O)NCCSc2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K20 compound treatment 0.0695 -0.00539 -0.64 -0.6383 -1.0 1908884 Bionet1_001578 FC(F)(F)c1cnc(c2cnn(c2)C(=O)c3cccnc3Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K21 compound treatment 0.069 -0.00589 -0.7 -0.6976 -1.0 1908885 Bionet1_001579 Fc1ccc(cc1)C(=O)NCCS(=O)(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K22 compound treatment 0.0695 -0.00539 -0.64 -0.6383 -1.0 1908886 Bionet1_001580 FC(F)(F)c1cnc(c(Cl)c1)n2cccc2C(=O)NCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K23 mock treatment 0.0755 6.13E-4 0.07 0.0726 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 K24 mock treatment 0.074 -8.87E-4 -0.11 -0.1051 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L01 mock treatment 0.069 -0.00589 -0.7 -0.6976 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L02 mock treatment 0.07 -0.00489 -0.58 -0.5791 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L03 compound treatment 0.072 -0.00289 -0.34 -0.3421 -1.0 1908887 Bionet1_001581 Fc1ccc(Cn2cc(cc(C#N)c2=O)c3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L04 compound treatment 0.072 -0.00289 -0.34 -0.3421 -1.0 1613963 Bionet1_001582 COC(=O)c1c(C(=O)OC)c2CS(=O)(=O)Cn2c1c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L05 compound treatment 0.0725 -0.00239 -0.28 -0.2828 -1.0 1908888 Bionet1_001583 FC(F)(F)c1cccc(c1)c2cc(C#N)c(=O)n(Cc3cccc(Cl)c3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L06 compound treatment 0.069 -0.00589 -0.7 -0.6976 -1.0 1908889 Bionet1_001584 COc1ccc(Sc2ncccc2c3nc4ccccc4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L07 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1908890 Bionet1_001585 FC(F)(F)c1cccc(c1)c2cc(C#N)c(=O)n(Cc3ccccc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L08 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1908891 Bionet1_001586 Clc1ccc(Cn2c(nc3ccccc23)c4ccc(Cl)nc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L09 compound treatment 0.065 -0.00989 -1.17 -1.1715 -1.0 1908892 Bionet1_001587 FC(F)(F)c1cccc(c1)c2cnc(Oc3ccccc3Cl)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L10 compound treatment 0.0665 -0.00839 -0.99 -0.9938 -1.0 1366968 Bionet1_001588 Clc1ccc(Cn2c(nc3ccccc23)c4ccc(Cl)nc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L11 compound treatment 0.0665 -0.00839 -0.99 -0.9938 -1.0 1908893 Bionet1_001589 FC(F)(F)c1cccc(c1)c2cnc(Oc3ccc(Cl)cc3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L12 compound treatment 0.0665 -0.00839 -0.99 -0.9938 -1.0 1908894 Bionet1_001590 Clc1ccc(cn1)c2nc3ccccc3n2Cc4ccc(Cl)c(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L13 compound treatment 0.065 -0.00989 -1.17 -1.1715 -1.0 1908895 Bionet1_001591 Fc1ccc(Oc2ncc(cc2C#N)c3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L14 compound treatment 0.062 -0.0129 -1.53 -1.527 -1.0 1728237 Bionet1_001592 COC(=O)c1c(C(=O)OC)c2CSCn2c1c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L15 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1908896 Bionet1_001593 Fc1ccc(Oc2ncc(cc2C#N)c3cccc(c3)C(F)(F)F)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L16 compound treatment 0.062 -0.0129 -1.53 -1.527 -1.0 1385890 Bionet1_001594 COC(=O)c1c(C(=O)OC)c2CS(=O)Cn2c1c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L17 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1908897 Bionet1_001595 FC(F)(F)c1cccc(c1)c2cnc(Sc3ccccc3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L18 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1226627 Bionet1_001596 COC(=O)c1c(C(=O)OC)c2CS(=O)(=O)Cn2c1c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L19 compound treatment 0.0705 -0.00439 -0.52 -0.5198 -1.0 1908898 Bionet1_001597 FC(F)(F)c1cccc(c1)c2cnc(Sc3cccc(Cl)c3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L20 compound treatment 0.079 0.00411 0.49 0.4873 1.0 1608690 Bionet1_001598 COC(=O)c1c(C(=O)OC)c2CS(=O)(=O)Cn2c1c3cccc(C)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L21 compound treatment 0.0745 -3.87E-4 -0.05 -0.0459 -1.0 1908899 Bionet1_001599 FC(F)(F)c1cccc(c1)c2cnc(Sc3ccc(Cl)cc3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L22 compound treatment 0.0745 -3.87E-4 -0.05 -0.0459 -1.0 1322334 Bionet1_001600 COC(=O)c1c(C(=O)OC)c2CS(=O)Cn2c1c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L23 mock treatment 0.0805 0.00561 0.67 0.6651 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 L24 mock treatment 0.084 0.00911 1.08 1.0798 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M01 mock treatment 0.069 -0.00589 -0.7 -0.6976 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M02 mock treatment 0.0685 -0.00639 -0.76 -0.7568 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M03 compound treatment 0.073 -0.00189 -0.22 -0.2236 -1.0 1908900 Bionet1_001601 Clc1ccccc1C(=O)NCCSc2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M04 compound treatment 0.072 -0.00289 -0.34 -0.3421 -1.0 1908901 Bionet1_001602 FC(F)(F)c1cnc(c(Cl)c1)n2cccc2C(=O)NCc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M05 compound treatment 0.0705 -0.00439 -0.52 -0.5198 -1.0 1908902 Bionet1_001603 CO/N=C/C(=N\Nc1ccc(OC)cc1)/C(=O)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M06 compound treatment 0.067 -0.00789 -0.93 -0.9345 -1.0 1908903 Bionet1_001604 FC(F)(F)c1cnc(c(Cl)c1)n2cc(cc2C#N)C(=O)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M07 compound treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 1908904 Bionet1_001605 CO/N=C/C(=N\Nc1ccc(OC)cc1)/C(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M08 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1908905 Bionet1_001606 FC(F)(F)c1cnc(c(Cl)c1)n2cccc2NC(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M09 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1261702 Bionet1_001607 Clc1ccc(SCC(=O)Nc2ncc3CCc4ccccc4-c3n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M10 compound treatment 0.0625 -0.0124 -1.47 -1.4677 -1.0 1908906 Bionet1_001608 Nc1nc(Br)c2c(F)cccc2c1c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M11 compound treatment 0.066 -0.00889 -1.05 -1.053 -1.0 1908907 Bionet1_001609 CO/N=C/C(=N\Nc1ccc(C)c(C)c1)/C(=O)c2ccc(cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M12 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1642271 Bionet1_001610 Nc1nc(Br)c2c(Cl)cccc2c1c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M13 compound treatment 0.0635 -0.0114 -1.35 -1.3493 -1.0 1908908 Bionet1_001611 CO/N=C/C(=N/Nc1ccc(OC)cc1)/C(=O)c2ccc(cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M14 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1908909 Bionet1_001612 COc1ccc(NC(=O)c2cccn2c3ncc(cc3Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M15 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1256977 Bionet1_001613 OC(CNCc1ccc(Cl)cc1)(c2ccc(F)cc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M16 compound treatment 0.0675 -0.00739 -0.88 -0.8753 -1.0 1908910 Bionet1_001614 Cc1cc(C)cc(NC(=O)c2cccn2c3ncc(cc3Cl)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M17 compound treatment 0.062 -0.0129 -1.53 -1.527 -1.0 1666388 Bionet1_001615 Cc1ccc(CNCC(O)(c2ccc(F)cc2)c3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M18 compound treatment 0.064 -0.0109 -1.29 -1.29 -1.0 1908911 Bionet1_001616 FC(F)(F)c1cc(c2ccc(nc2n1)C(C#N)c3ccccc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M19 compound treatment 0.0695 -0.00539 -0.64 -0.6383 -1.0 1300997 Bionet1_001617 COc1ccc(CNCC(O)(c2ccc(F)cc2)c3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M20 compound treatment 0.0855 0.0106 1.26 1.2575 1.0 1146484 Bionet1_001618 NC(=O)C(c1ccc(Cl)cc1)c2ccc(cc2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M21 compound treatment 0.072 -0.00289 -0.34 -0.3421 -1.0 1701509 Bionet1_001619 COc1ccccc1CNCC(O)(c2ccc(F)cc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M22 compound treatment 0.0745 -3.87E-4 -0.05 -0.0459 -1.0 1908912 Bionet1_001620 O/N=C/NC(=O)C(c1ccc(Cl)cc1)c2ccc(cc2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M23 mock treatment 0.078 0.00311 0.37 0.3688 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 M24 mock treatment 0.079 0.00411 0.49 0.4873 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N01 mock treatment 0.07 -0.00489 -0.58 -0.5791 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N02 mock treatment 0.0715 -0.00339 -0.4 -0.4013 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N03 compound treatment 0.0745 -3.87E-4 -0.05 -0.0459 -1.0 1908913 Bionet1_001621 COc1ccccc1Sc2ncc(cc2C#N)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N04 compound treatment 0.0765 0.00161 0.19 0.1911 1.0 1717312 Bionet1_001622 COC(=O)c1c(C(=O)OC)c2CS(=O)(=O)Cn2c1c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N05 compound treatment 0.074 -8.87E-4 -0.11 -0.1051 -1.0 1908914 Bionet1_001623 FC(F)(F)c1cc(c2ccc(nc2n1)N3CCC(=O)CC3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N06 compound treatment 0.0735 -0.00139 -0.16 -0.1644 -1.0 1520882 Bionet1_001624 COC(=O)c1c(C(=O)OC)c2CSCn2c1c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N07 compound treatment 0.066 -0.00889 -1.05 -1.053 -1.0 1908915 Bionet1_001625 FC(F)(F)c1nnc2c(nc3ccc(Cl)cc3n12)N4CCC(=O)CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N08 compound treatment 0.0685 -0.00639 -0.76 -0.7568 -1.0 1908916 Bionet1_001626 FC(F)(F)c1cnc(Sc2nc3nccc(c4ccco4)n3n2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N09 compound treatment 0.076 0.00111 0.13 0.1319 1.0 1908917 Bionet1_001627 C(O/N=C\1/CCCc2c1cc(c3ccccc3)n2c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N10 compound treatment 0.078 0.00311 0.37 0.3688 1.0 1908918 Bionet1_001628 COC(=O)c1sccc1OC(C)c2ccnc3nc(nn23)n4cccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N11 compound treatment 0.0675 -0.00739 -0.88 -0.8753 -1.0 1908919 Bionet1_001629 COc1cc(cc(OC)c1OC)C(=O)NCCSc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N12 compound treatment 0.069 -0.00589 -0.7 -0.6976 -1.0 1908920 Bionet1_001630 CC(Oc1ccc(cc1)C(C)(C)C)c2ccnc3nc(/N=C/N(C)C)nn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N13 compound treatment 0.0675 -0.00739 -0.88 -0.8753 -1.0 1908921 Bionet1_001631 COc1cccc(c1)C(=O)NCCSc2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N14 compound treatment 0.0705 -0.00439 -0.52 -0.5198 -1.0 1908922 Bionet1_001632 CC(Oc1ccc(cc1)[N+](=O)[O-])c2ccnc3nc(/N=C/N(C)C)nn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N15 compound treatment 0.067 -0.00789 -0.93 -0.9345 -1.0 1345358 Bionet1_001633 O=C1c2ccccc2-c3nnc(cc13)c4ccc(Oc5ccccc5)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N16 compound treatment 0.07 -0.00489 -0.58 -0.5791 -1.0 1908923 Bionet1_001634 CO/N=C/Nc1nc2nccc(C(C)Oc3ccc(cc3)[N+](=O)[O-])n2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N17 compound treatment 0.067 -0.00789 -0.93 -0.9345 -1.0 1908924 Bionet1_001635 CN(C)/C=N\c1nc2nccc(c3ccc(Oc4ccccc4)cc3)n2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N18 compound treatment 0.0645 -0.0104 -1.23 -1.2308 -1.0 1908925 Bionet1_001636 CO/N=C/Nc1nc2nccc(C(C)Oc3ccc(Cl)cc3C)n2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N19 compound treatment 0.0765 0.00161 0.19 0.1911 1.0 1908926 Bionet1_001637 CN(C)/C=N/c1nc2ncc(c(\N=C\N(C)C)n2n1)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N20 compound treatment 0.078 0.00311 0.37 0.3688 1.0 1908927 Bionet1_001638 CO/N=C/Nc1nc2nccc(C(C)Oc3ccc(cc3)C(C)(C)C)n2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N21 compound treatment 0.078 0.00311 0.37 0.3688 1.0 1908928 Bionet1_001639 COc1ccc(cc1)c2cnc3nc(/N=C/N(C)C)nn3c2/N=C/N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N22 compound treatment 0.079 0.00411 0.49 0.4873 1.0 1908929 Bionet1_001640 CC(Oc1ccc(OC(C)C(=O)/C=C/N(C)C)cc1)C(=O)/C=C/N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N23 mock treatment 0.0815 0.00661 0.78 0.7836 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 N24 mock treatment 0.081 0.00611 0.72 0.7243 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O01 mock treatment 0.0685 -0.00639 -0.76 -0.7568 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O02 mock treatment 0.068 -0.00689 -0.82 -0.8161 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O03 compound treatment 0.0725 -0.00239 -0.28 -0.2828 -1.0 1473133 Bionet1_001641 COc1ccc(CNCC(O)(c2ccc(F)cc2)c3ccc(F)cc3)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O04 compound treatment 0.0735 -0.00139 -0.16 -0.1644 -1.0 1233894 Bionet1_001642 Clc1ccc(C(C#N)c2ccc(cc2)C(=O)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O05 compound treatment 0.0715 -0.00339 -0.4 -0.4013 -1.0 1344327 Bionet1_001643 OC(CNCc1ccc(F)cc1)(c2ccc(F)cc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O06 compound treatment 0.0705 -0.00439 -0.52 -0.5198 -1.0 1677560 Bionet1_001644 NC(=O)C(c1ccc(cc1)C(=O)c2ccccc2)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O07 compound treatment 0.065 -0.00989 -1.17 -1.1715 -1.0 1580259 Bionet1_001645 OC(CNCc1ccc(Cl)cc1)(c2ccccc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O08 compound treatment 0.0645 -0.0104 -1.23 -1.2308 -1.0 1908930 Bionet1_001646 FC(F)(F)c1cnc(c(Cl)c1)C2(CCC(=O)NC2=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O09 compound treatment 0.068 -0.00689 -0.82 -0.8161 -1.0 1644110 Bionet1_001647 COc1ccc(CNCC(O)(c2ccccc2)c3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O10 compound treatment 0.067 -0.00789 -0.93 -0.9345 -1.0 1207820 Bionet1_001648 Fc1ccc(cc1)C(=O)c2ccc(cc2)C(C#N)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O11 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1489678 Bionet1_001649 OC(CNCc1ccc(Cl)cc1Cl)(c2ccccc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O12 compound treatment 0.068 -0.00689 -0.82 -0.8161 -1.0 1517547 Bionet1_001650 Fc1ccc(cc1)C(=O)c2ccc(cc2)C(C#N)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O13 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1132342 Bionet1_001651 OC(CNCc1ccc(Cl)c(Cl)c1)(c2ccccc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O14 compound treatment 0.0675 -0.00739 -0.88 -0.8753 -1.0 1286508 Bionet1_001652 NC(=O)C(c1ccc(Br)cc1)c2ccc(cc2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O15 compound treatment 0.067 -0.00789 -0.93 -0.9345 -1.0 1175998 Bionet1_001653 COc1ccccc1CNCC(O)(c2ccccc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O16 compound treatment 0.0675 -0.00739 -0.88 -0.8753 -1.0 1908931 Bionet1_001654 Fc1ccc(cc1)C(=O)c2ccc(cc2)C(C#N)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O17 compound treatment 0.0675 -0.00739 -0.88 -0.8753 -1.0 1174626 Bionet1_001655 CC1N(C(=O)c2ccc(F)cc2)c3ccccc3N(Cc4ccc(C#N)cc4)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O18 compound treatment 0.0675 -0.00739 -0.88 -0.8753 -1.0 1359301 Bionet1_001656 Cc1onc(c1NC(=O)Nc2c(C)onc2c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O19 compound treatment 0.076 0.00111 0.13 0.1319 1.0 1656400 Bionet1_001657 CC1N(C(=O)c2ccc(F)cc2)c3ccccc3N(Cc4ccccc4F)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O20 compound treatment 0.0785 0.00361 0.43 0.4281 1.0 1908932 Bionet1_001658 Cc1nn(C)c(Sc2ccc(Cl)cc2)c1C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O21 compound treatment 0.0735 -0.00139 -0.16 -0.1644 -1.0 1908933 Bionet1_001659 CC1N(C(=O)C2CC2)c3ccccc3N(Cc4ccc(cc4)[N+](=O)[O-])C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O22 compound treatment 0.078 0.00311 0.37 0.3688 1.0 1256882 Bionet1_001660 Cc1nn(C)c(Oc2ccc(Cl)cc2)c1C(=O)Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O23 mock treatment 0.081 0.00611 0.72 0.7243 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 O24 mock treatment 0.0825 0.00761 0.9 0.9021 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P01 mock treatment 0.065 -0.00989 -1.17 -1.1715 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P02 mock treatment 0.0645 -0.0104 -1.23 -1.2308 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P03 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1908934 Bionet1_001661 CO/N=C/Nc1nc2nccc(c3ccc(Oc4ccccc4)cc3)n2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P04 compound treatment 0.065 -0.00989 -1.17 -1.1715 -1.0 1908935 Bionet1_001662 CCNC(=O)Nc1ccccc1Sc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P05 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1313795 Bionet1_001663 Cc1ccc(cc1)c2cc(C#N)c(=O)n(Cc3c(Cl)cccc3Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P06 compound treatment 0.066 -0.00889 -1.05 -1.053 -1.0 1908936 Bionet1_001664 O=C(c1ccccc1)c2ccc(cc2)C3(CCC(=O)NC3=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P07 compound treatment 0.0665 -0.00839 -0.99 -0.9938 -1.0 1587719 Bionet1_001665 Cc1ccc(cc1)c2cc(C#N)c(=O)n(Cc3ccc(Cl)c(Cl)c3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P08 compound treatment 0.0665 -0.00839 -0.99 -0.9938 -1.0 1406062 Bionet1_001666 Fc1ccc(Cn2cc(ccc2=O)C(=O)Nc3ccc(Cl)cc3)cc1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P09 compound treatment 0.0655 -0.00939 -1.11 -1.1123 -1.0 1908937 Bionet1_001667 Cc1ccc(cc1)c2cc(C#N)c(=O)n(Cc3cccc(c3)C(F)(F)F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P10 compound treatment 0.0645 -0.0104 -1.23 -1.2308 -1.0 1693527 Bionet1_001668 Cc1ccc(NC(=O)c2ccc(=O)n(Cc3ccc(F)c(F)c3)c2)cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P11 compound treatment 0.071 -0.00389 -0.46 -0.4606 -1.0 1181820 Bionet1_001669 CN(C)C(=O)Oc1c(C)cc(cc1C)C(=O)CSc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P12 compound treatment 0.075 1.13E-4 0.01 0.0134 1.0 1170430 Bionet1_001670 COC(=O)c1ccccc1NC(=O)c2ccc(=O)n(Cc3ccc(F)c(F)c3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P13 compound treatment 0.066 -0.00889 -1.05 -1.053 -1.0 1414407 Bionet1_001671 CN(C)C(=S)Oc1c(C)cc(cc1C)C(=O)CSc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P14 compound treatment 0.066 -0.00889 -1.05 -1.053 -1.0 1908938 Bionet1_001672 COC(=O)c1cccn(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P15 compound treatment 0.0665 -0.00839 -0.99 -0.9938 -1.0 1908939 Bionet1_001673 Cc1cc(cc(C)c1O)C(=O)CS(=O)(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P16 compound treatment 0.0645 -0.0104 -1.23 -1.2308 -1.0 1908940 Bionet1_001674 CN(C(=O)c1cccn(Cc2ccc(cc2)C(F)(F)F)c1=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P17 compound treatment 0.067 -0.00789 -0.93 -0.9345 -1.0 1908941 Bionet1_001675 Cc1cc(cc(C)c1O)C(=O)CS(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P18 compound treatment 0.0695 -0.00539 -0.64 -0.6383 -1.0 1908942 Bionet1_001676 FC(F)(F)c1ccc(Cn2cccc(C(=O)Nc3ccccc3)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P19 compound treatment 0.0725 -0.00239 -0.28 -0.2828 -1.0 1908943 Bionet1_001677 Clc1ccc(cc1)c2cnc(SCc3ccc(Cl)c(Cl)c3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P20 compound treatment 0.077 0.00211 0.25 0.2504 1.0 1908944 Bionet1_001678 CNC(=O)c1cccn(Cc2cc(cc(c2)C(F)(F)F)C(F)(F)F)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P21 compound treatment 0.0745 -3.87E-4 -0.05 -0.0459 -1.0 1908945 Bionet1_001679 FC(F)(F)c1cccc(CSc2ncc(cn2)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P22 compound treatment 0.0705 -0.00439 -0.52 -0.5198 -1.0 1908946 Bionet1_001680 CN1CCN(CC1)C(=O)c2cccn(Cc3ccc(cc3)C(F)(F)F)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P23 mock treatment 0.072 -0.00289 -0.34 -0.3421 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.572 P24 mock treatment 0.063 -0.0119 -1.41 -1.4085 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A01 mock treatment 0.0925 0.0175 2.07 2.0745 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A02 mock treatment 0.0855 0.0105 1.25 1.2451 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A03 compound treatment 0.085 0.01 1.19 1.1858 1.0 1908947 Bionet1_001681 FC(F)(F)c1ccc(Cn2cccc(C(=O)N3CCOCC3)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A04 compound treatment 0.086 0.011 1.3 1.3043 1.0 1908948 Bionet1_001682 Nc1ccc(Oc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A05 compound treatment 0.095 0.02 2.37 2.3707 1.0 1908949 Bionet1_001683 FC(F)(F)c1ccc(Cn2cccc(C(=O)NCc3ccccc3)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A06 compound treatment 0.0695 -0.00549 -0.65 -0.6508 -1.0 1908950 Bionet1_001684 CO/N=C\Cc1snc(Sc2ncc(cc2Cl)C(F)(F)F)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A07 compound treatment 0.0795 0.00451 0.53 0.5341 1.0 1908951 Bionet1_001685 FC(F)(F)c1ccc(Cn2cccc(C(=O)Nc3cccnc3)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A08 compound treatment 0.0825 0.00751 0.89 0.8896 1.0 1229496 Bionet1_001686 Clc1ccc(cc1)S(=O)(=O)Nc2ccc(Oc3ncccn3)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A09 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1908952 Bionet1_001687 FC(F)(F)c1ccc(Cn2cc(ccc2=O)C(=O)Nc3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A10 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1715222 Bionet1_001688 Fc1ccc(cc1)S(=O)(=O)Nc2ccc(Oc3ncccn3)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A11 compound treatment 0.0775 0.00251 0.3 0.2972 1.0 1318775 Bionet1_001689 CCCSc1cc(=O)n(nc1C(=O)Nc2cccc(Cl)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A12 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1908953 Bionet1_001690 FC(F)(F)c1cccc(c1)C(=O)Nc2ccc(Oc3ncccn3)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A13 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1693496 Bionet1_001691 CCCSc1cc(=O)n(nc1C(=O)Nc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A14 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1908954 Bionet1_001692 CC(C)NC(=O)c1cnc(Sc2ncc(cc2Cl)C(F)(F)F)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A15 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1908955 Bionet1_001693 NC(=O)c1ccc(n(Cc2ccc(Cl)c(Cl)c2)c1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A16 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1908956 Bionet1_001694 CCCNC(=O)c1cnc(Sc2ncc(cc2Cl)C(F)(F)F)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A17 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1908957 Bionet1_001695 NC(=O)c1ccc(n(Cc2ccc(cc2)C(F)(F)F)c1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A18 compound treatment 0.077 0.00201 0.24 0.2379 1.0 1908958 Bionet1_001696 COC(=O)c1cnc(Sc2ncc(cc2Cl)C(F)(F)F)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A19 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1908959 Bionet1_001697 Cc1ccc(NC(=O)c2cccn(Cc3ccc(cc3)C(F)(F)F)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A20 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1908960 Bionet1_001698 CC(c1nnc(S)n1c2ccccc2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A21 compound treatment 0.0845 0.00951 1.13 1.1266 1.0 1908961 Bionet1_001699 NC(=O)c1ccc(n(Cc2cccc(c2)C(F)(F)F)c1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A22 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1908962 Bionet1_001700 CSc1nnc(C(C)c2ncc(cc2Cl)C(F)(F)F)n1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A23 mock treatment 0.0825 0.00751 0.89 0.8896 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 A24 mock treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B01 mock treatment 0.0845 0.00951 1.13 1.1266 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B02 mock treatment 0.0775 0.00251 0.3 0.2972 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B03 compound treatment 0.084 0.00901 1.07 1.0674 1.0 1734321 Bionet1_001701 CC(O)(CS(=O)(=O)Cc1ccc(Cl)cc1Cl)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B04 compound treatment 0.0835 0.00851 1.01 1.0081 1.0 1908963 Bionet1_001702 COc1ccc(cc1)c2cc(n[nH]2)C3CCN(Cc4ccc(cc4)[N+](=O)[O-])CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B05 compound treatment 0.085 0.01 1.19 1.1858 1.0 1408080 Bionet1_001703 CC(O)(CS(=O)(=O)Cc1ccc(Cl)cc1Cl)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B06 compound treatment 0.0775 0.00251 0.3 0.2972 1.0 1908964 Bionet1_001704 [O-][N+](=O)c1ccc(CN2CCC(CC2)c3cc([nH]n3)c4ccco4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B07 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1248384 Bionet1_001705 CC(O)(CS(=O)(=O)Cc1ccccc1)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B08 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1583003 Bionet1_001706 Cc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3cc([nH]n3)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B09 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1312341 Bionet1_001707 CC(O)(CS(=O)(=O)Cc1ccc(Cl)cc1)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B10 compound treatment 0.0695 -0.00549 -0.65 -0.6508 -1.0 1677585 Bionet1_001708 Clc1cccc(NC(=O)N2CCC(CC2)c3cc([nH]n3)c4ccco4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B11 compound treatment 0.068 -0.00699 -0.83 -0.8285 -1.0 1251378 Bionet1_001709 CC(O)(CS(=O)(=O)Cc1ccc(Cl)cc1)c2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B12 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1908965 Bionet1_001710 N(/N=C(\C(=N/Nc1ccccc1)\c2ccccc2)/c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B13 compound treatment 0.068 -0.00699 -0.83 -0.8285 -1.0 1430279 Bionet1_001711 COc1ccc(CS(=O)(=O)CC(C)(O)c2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B14 compound treatment 0.0655 -0.00949 -1.12 -1.1247 -1.0 1908966 Bionet1_001712 CCOC(=O)C1=NOC(CNC(=O)C2CCN(CC2)c3ncccn3)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B15 compound treatment 0.0635 -0.0115 -1.36 -1.3617 -1.0 1619236 Bionet1_001713 CC(O)(CS(=O)(=O)Cc1ccccc1Cl)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B16 compound treatment 0.0685 -0.00649 -0.77 -0.7692 -1.0 1908967 Bionet1_001714 FC(F)(F)c1cnc(Sc2nccn2c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B17 compound treatment 0.067 -0.00799 -0.95 -0.947 -1.0 1654437 Bionet1_001715 COC(=O)c1cccnc1N2CCN(CC2)C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B18 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1908968 Bionet1_001716 CN(NC(=S)NC(=O)c1ccccc1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B19 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1908969 Bionet1_001717 COC(=O)c1ccccc1Sc2c(CO)c(nn2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B20 compound treatment 0.0685 -0.00649 -0.77 -0.7692 -1.0 1377112 Bionet1_001718 COc1ccc(cc1)C(=O)N2CCOC32CCN(CC3)c4ccc(Cl)nn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B21 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1412512 Bionet1_001719 Clc1ccc(CSc2nc(c([nH]2)c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B22 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1908970 Bionet1_001720 CC(=O)C1=NOC(CNC(=O)c2c(C)onc2c3ccccc3Cl)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B23 mock treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 B24 mock treatment 0.065 -0.00999 -1.18 -1.184 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C01 mock treatment 0.0815 0.00651 0.77 0.7711 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C02 mock treatment 0.0815 0.00651 0.77 0.7711 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C03 compound treatment 0.084 0.00901 1.07 1.0674 1.0 1908971 Bionet1_001721 CN(C)C(=O)c1cc(Cl)cn(Cc2ccc(cc2)C(F)(F)F)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C04 compound treatment 0.0845 0.00951 1.13 1.1266 1.0 1908972 Bionet1_001722 CC(c1nnc(SCC=C)n1C)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C05 compound treatment 0.088 0.013 1.54 1.5413 1.0 1707687 Bionet1_001723 Cc1cc2nc(c3ccc(Cl)nc3)n(Cc4ccc(Cl)cc4)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C06 compound treatment 0.0815 0.00651 0.77 0.7711 1.0 1908973 Bionet1_001724 Sc1nnc(CSCc2c(Cl)cccc2Cl)n1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C07 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1250698 Bionet1_001725 COc1ccc(Cn2c(nc3cc(C)c(C)cc23)c4ccc(Cl)nc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C08 compound treatment 0.077 0.00201 0.24 0.2379 1.0 1292960 Bionet1_001726 CC(C)(C)c1ccc(COc2ccsc2C(=O)Nc3ccccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C09 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1385613 Bionet1_001727 Cc1ccc(Cn2c(nc3cc(C)c(C)cc23)c4ccc(Cl)nc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C10 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1908974 Bionet1_001728 CCn1c(S)nnc1CS(=O)Cc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C11 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1908975 Bionet1_001729 CCOC(=O)Cn1c(nc2cc(Cl)c(Cl)cc12)c3cccnc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C12 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1908976 Bionet1_001730 Sc1nnc(CSCc2ccc(Cl)cc2Cl)n1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C13 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1908977 Bionet1_001731 FC(F)(F)c1cccc(Cn2nnnc2c3cc(Cl)cc(Cl)c3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C14 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1908978 Bionet1_001732 CSc1nnc(CSCc2ccc(Cl)cc2Cl)n1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C15 compound treatment 0.0695 -0.00549 -0.65 -0.6508 -1.0 1282281 Bionet1_001733 Cc1c(oc2c(Br)cc(Br)cc12)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C16 compound treatment 0.068 -0.00699 -0.83 -0.8285 -1.0 1908979 Bionet1_001734 CCn1c(S)nnc1CS(=O)Cc2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C17 compound treatment 0.0695 -0.00549 -0.65 -0.6508 -1.0 1182767 Bionet1_001735 Cc1c(oc2ccc(Br)cc12)C(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C18 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1242855 Bionet1_001736 COc1ccc(COc2ccsc2C(=O)Nc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C19 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1346812 Bionet1_001737 Cc1c(oc2ccc(Br)cc12)C(=O)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C20 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1222750 Bionet1_001738 Oc1cc(nc(=O)n1Cc2ccccc2)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C21 compound treatment 0.0835 0.00851 1.01 1.0081 1.0 1092671 Bionet1_001739 COC(=O)c1c(C(=O)OC)c2CCCn2c1c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C22 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1549187 Bionet1_001740 Oc1cc(nc(=O)n1Cc2ccccc2)C(=O)Nc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C23 mock treatment 0.076 0.00101 0.12 0.1194 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 C24 mock treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D01 mock treatment 0.076 0.00101 0.12 0.1194 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D02 mock treatment 0.0775 0.00251 0.3 0.2972 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D03 compound treatment 0.0795 0.00451 0.53 0.5341 1.0 1716876 Bionet1_001741 Cn1c(SCc2ccccc2)nc(c1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D04 compound treatment 0.0825 0.00751 0.89 0.8896 1.0 1908980 Bionet1_001742 CCOC(=O)/C=C(\C)/NCCNc1ncc(cc1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D05 compound treatment 0.084 0.00901 1.07 1.0674 1.0 1382998 Bionet1_001743 CCCn1c(SCc2ccccc2)nc(c1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D06 compound treatment 0.081 0.00601 0.71 0.7119 1.0 1908981 Bionet1_001744 Cc1ccc(cc1)c2nnc(C)c(Sc3c(Cl)cccc3Cl)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D07 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1331294 Bionet1_001745 C=CCn1c(SCc2ccccc2)nc(c1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D08 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1908982 Bionet1_001746 Cc1ccc(cc1)c2nnc(C)c(Sc3cccc(c3)C(F)(F)F)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D09 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1182579 Bionet1_001747 C#CCn1c(SCc2ccccc2)nc(c1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D10 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1345564 Bionet1_001748 CCOC(=O)n1c(=O)n(Cc2ccc(Cl)cc2Cl)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D11 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1908983 Bionet1_001749 Cn1nc(c(COC(=O)c2ccc(Cl)c(Cl)c2)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D12 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1494248 Bionet1_001750 CCOC(=O)n1c(=O)n(Cc2ccc(Cl)c(Cl)c2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D13 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1908984 Bionet1_001751 Cn1nc(c(COC(=O)c2ccc(Cl)cc2Cl)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D14 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1238936 Bionet1_001752 CCOC(=O)n1c(=O)n(Cc2c(Cl)cccc2Cl)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D15 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1908985 Bionet1_001753 Cn1nc(c(COC(=O)c2ccc(cc2)[N+](=O)[O-])c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D16 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1908986 Bionet1_001754 CS(=O)(=O)c1ccccc1c2nnc(o2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D17 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1908987 Bionet1_001755 Cn1c(SCc2ccc(Cl)cc2)nc(c1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D18 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1908988 Bionet1_001756 Clc1ccc(CSc2ccccc2c3nnc(o3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D19 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1908989 Bionet1_001757 Cn1nc(c(CO)c1Sc2ccc(Br)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D20 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1908990 Bionet1_001758 Cc1ccc(cc1)c2nnc(o2)c3ccccc3SCc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D21 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1908991 Bionet1_001759 Cc1ccc(Oc2c(COC(=O)CCl)c(nn2C)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D22 compound treatment 0.077 0.00201 0.24 0.2379 1.0 1908992 Bionet1_001760 O=S(=O)(Cc1ccccc1)c2ccccc2c3nnc(o3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D23 mock treatment 0.0785 0.00351 0.42 0.4157 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 D24 mock treatment 0.0825 0.00751 0.89 0.8896 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E01 mock treatment 0.0785 0.00351 0.42 0.4157 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E02 mock treatment 0.079 0.00401 0.47 0.4749 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E03 compound treatment 0.081 0.00601 0.71 0.7119 1.0 1908993 Bionet1_001761 COC(=O)c1c(C(=O)OC)c2CCCn2c1c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E04 compound treatment 0.0835 0.00851 1.01 1.0081 1.0 1375946 Bionet1_001762 Oc1cc(nc(=O)n1Cc2ccccc2)C(=O)Nc3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E05 compound treatment 0.088 0.013 1.54 1.5413 1.0 1908994 Bionet1_001763 Cc1ccn2c(=O)nc(SCc3cccc(c3)C(F)(F)F)nc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E06 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1534835 Bionet1_001764 Oc1cc(nc(=O)n1Cc2ccccc2)C(=O)Nc3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E07 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1908995 Bionet1_001765 CN(C)/C=N/c1nc(N2CCN(CC2)c3ccccn3)c(C#N)cc1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E08 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1515561 Bionet1_001766 Oc1cc(nc(=O)n1Cc2ccccc2)C(=O)Nc3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E09 compound treatment 0.0775 0.00251 0.3 0.2972 1.0 1908996 Bionet1_001767 CC1=C(CC(=O)c2sccc2Br)C(=O)c3ccccc3C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E10 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1908997 Bionet1_001768 Oc1cc(nc(=O)n1Cc2ccccc2)C(=O)Nc3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E11 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1908998 Bionet1_001769 Clc1cccc(CNCCNCc2cccc(Cl)c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E12 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1908999 Bionet1_001770 Oc1cc(nc(=O)n1Cc2ccccc2)C(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E13 compound treatment 0.0775 0.00251 0.3 0.2972 1.0 1909000 Bionet1_001771 FC(F)(F)c1cccc(Sc2nc3ccccc3nc2C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E14 compound treatment 0.0805 0.00551 0.65 0.6526 1.0 1488811 Bionet1_001772 OC(CSc1ccc(Cl)cc1)CN2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E15 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1909001 Bionet1_001773 CC(C)NS(=O)(=O)c1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E16 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1909002 Bionet1_001774 OC(CSc1cccc(c1)C(F)(F)F)CN2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E17 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1909003 Bionet1_001775 CCCNS(=O)(=O)c1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E18 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1375708 Bionet1_001776 OC(CSc1cccc(Cl)c1)CN2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E19 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1909004 Bionet1_001777 N/C(=C(\C=C(C#N)C#N)/C#N)/N1CCN(CC1)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E20 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1659409 Bionet1_001778 OC(CSc1ccccc1Cl)CN2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E21 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1909005 Bionet1_001779 CN(C)/C=N/c1nc(N2CCN(CC2)c3cccc(Cl)n3)c(C#N)cc1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E22 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1477976 Bionet1_001780 OC(CSc1ccc(Cl)cc1)CN2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E23 mock treatment 0.0775 0.00251 0.3 0.2972 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 E24 mock treatment 0.077 0.00201 0.24 0.2379 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F01 mock treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F02 mock treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F03 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1909006 Bionet1_001781 Cn1nc(c(CO)c1Sc2cccc(c2)C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F04 compound treatment 0.0795 0.00451 0.53 0.5341 1.0 1909007 Bionet1_001782 Cc1ccc(CSc2ccccc2c3nnc(o3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F05 compound treatment 0.082 0.00701 0.83 0.8304 1.0 1909008 Bionet1_001783 Cn1nc(c(COC(=O)Nc2ccc(Cl)cc2)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F06 compound treatment 0.0795 0.00451 0.53 0.5341 1.0 1909009 Bionet1_001784 Cc1ccc(CSc2ccccc2c3nnc(o3)c4ccc(C)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F07 compound treatment 0.077 0.00201 0.24 0.2379 1.0 1909010 Bionet1_001785 CC(C)(C)c1ccc(CSc2nc(c([nH]2)c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F08 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1909011 Bionet1_001786 Cc1ccc(CSc2ccccc2c3nnc(o3)c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F09 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1909012 Bionet1_001787 Cn1nc(c(CO)c1Sc2c(Cl)cccc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F10 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1909013 Bionet1_001788 Cc1ccc(CS(=O)c2ccccc2c3nnc(o3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F11 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1909014 Bionet1_001789 COCc1c(Sc2c(Cl)cccc2Cl)n(C)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F12 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1909015 Bionet1_001790 Cc1ccc(CS(=O)(=O)c2ccccc2c3nnc(o3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F13 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1909016 Bionet1_001791 Cn1nc(c(COCc2c(Cl)cccc2Cl)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F14 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1909017 Bionet1_001792 CNC(=O)c1cnn(c2nc(cs2)c3ccc(Cl)cc3)c1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F15 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1909018 Bionet1_001793 CN(C)c1nnnn1c2ccc(Oc3ncc(cc3Cl)C(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F16 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1909019 Bionet1_001794 CNC(=O)c1cnn(c2nc(cs2)c3ccccc3)c1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F17 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1909020 Bionet1_001795 CN(C)c1nnnn1c2cccc(Oc3ncc(cc3Cl)C(F)(F)F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F18 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1909021 Bionet1_001796 FC(F)(F)c1c(cnn1c2nc(cs2)c3ccccc3)C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F19 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1909022 Bionet1_001797 CN(C)c1nnnn1c2ccccc2Oc3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F20 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1909023 Bionet1_001798 COc1ccc(cc1)C(=O)NCCSc2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F21 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1909024 Bionet1_001799 CN(C)/C=N/c1nnc(s1)\C(=C\c2ccc(Cl)cc2Cl)\C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F22 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1909025 Bionet1_001800 Clc1ccc(SCCNC(=O)c2ccc(Cl)cc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F23 mock treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 F24 mock treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G01 mock treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G02 mock treatment 0.071 -0.00399 -0.47 -0.473 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G03 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1390729 Bionet1_001801 Cc1c(oc2c(Cl)cc(Cl)cc12)C(=O)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G04 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1288139 Bionet1_001802 OC(CSc1ccc(F)cc1)CN2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G05 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1909026 Bionet1_001803 Cc1c(oc2c(Cl)cc(Cl)cc12)C(=O)c3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G06 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1650823 Bionet1_001804 OC(CSc1cccc(Cl)c1)CN2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G07 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1507563 Bionet1_001805 Cc1cc2nc([nH]c2cc1C)C(Cc3ccccc3)NC(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G08 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1693783 Bionet1_001806 Cc1ccc(SCC(O)CN2CCN(CC2)c3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G09 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1214826 Bionet1_001807 COc1cccc(c1)C(=O)NC(Cc2ccccc2)c3nc4ccccc4[nH]3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G10 compound treatment 0.069 -0.00599 -0.71 -0.71 -1.0 1304653 Bionet1_001808 Cc1ccc(SCC(O)CN2CCN(CC2)c3ccccc3F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G11 compound treatment 0.07 -0.00499 -0.59 -0.5915 -1.0 1524482 Bionet1_001809 COc1cccc(c1)C(=O)NC(Cc2ccccc2)c3nc4cc(C)ccc4[nH]3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G12 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1469852 Bionet1_001810 OC(CSc1ccc(F)cc1)CN2CCN(CC2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G13 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1650256 Bionet1_001811 Fc1ccccc1C(=O)NC(Cc2ccccc2)c3nc4ccccc4[nH]3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G14 compound treatment 0.068 -0.00699 -0.83 -0.8285 -1.0 1430519 Bionet1_001812 OC(CSc1ccccc1Cl)CN2CCN(CC2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G15 compound treatment 0.068 -0.00699 -0.83 -0.8285 -1.0 1304217 Bionet1_001813 Cc1cc2nc([nH]c2cc1C)C(Cc3ccccc3)NC(=O)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G16 compound treatment 0.068 -0.00699 -0.83 -0.8285 -1.0 1194683 Bionet1_001814 OC(CSc1ccccc1Cl)CN2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G17 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1415859 Bionet1_001815 CC(C)C(NC(=O)c1ccc(Cl)cc1Cl)c2nc3ccccc3[nH]2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G18 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1909027 Bionet1_001816 CCCCSc1nnc(CNS(=O)(=O)c2ccc(Cl)cc2)n1CC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G19 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1711863 Bionet1_001817 Clc1ccc(Cn2c(nc3ccccc23)c4cccnc4Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G20 compound treatment 0.0695 -0.00549 -0.65 -0.6508 -1.0 1909028 Bionet1_001818 CCn1c(CNS(=O)(=O)c2ccc(Cl)cc2)nnc1SCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G21 compound treatment 0.069 -0.00599 -0.71 -0.71 -1.0 1909029 Bionet1_001819 Clc1ccc(Cn2c(nc3ccccc23)c4cccnc4Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G22 compound treatment 0.0675 -0.00749 -0.89 -0.8877 -1.0 1409296 Bionet1_001820 OC(CSc1ccc(Cl)cc1)CN2CCN(CC2)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G23 mock treatment 0.069 -0.00599 -0.71 -0.71 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 G24 mock treatment 0.0675 -0.00749 -0.89 -0.8877 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H01 mock treatment 0.076 0.00101 0.12 0.1194 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H02 mock treatment 0.0755 5.08E-4 0.06 0.0602 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H03 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1909030 Bionet1_001821 CO/N=C/Nc1nnc(s1)/C(=C/c2ccc(Cl)cc2Cl)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H04 compound treatment 0.0805 0.00551 0.65 0.6526 1.0 1909031 Bionet1_001822 FC(F)(F)c1cccc(c1)c2cc3ccccc3nc2Oc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H05 compound treatment 0.0825 0.00751 0.89 0.8896 1.0 1909032 Bionet1_001823 COc1ccc(/C=C(\C#N)/c2nnc(\N=C\Nc3ccc(Cl)cc3)s2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H06 compound treatment 0.077 0.00201 0.24 0.2379 1.0 1909033 Bionet1_001824 FC(F)(F)c1cccc(c1)c2cc3ccccc3nc2Oc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H07 compound treatment 0.0825 0.00751 0.89 0.8896 1.0 1909034 Bionet1_001825 [O-][N+](=O)C(/C=N/OCc1c(F)cccc1Cl)S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H08 compound treatment 0.077 0.00201 0.24 0.2379 1.0 1909035 Bionet1_001826 Fc1ccc(Oc2nc3ccccc3cc2c4cccc(c4)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H09 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1909036 Bionet1_001827 Clc1cccc(Cl)c1CSc2nccc(/C=C/c3cccs3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H10 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1909037 Bionet1_001828 Cc1cc(C)cc(Oc2nc3ccccc3cc2c4cccc(c4)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H11 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1909038 Bionet1_001829 FC(F)(F)c1cnc(Sc2nccc(/C=C/c3cccs3)n2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H12 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1909039 Bionet1_001830 COc1ccc(Oc2nc3ccccc3cc2c4cccc(c4)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H13 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1909040 Bionet1_001831 Cc1nc(c(s1)C(=O)NCc2cccc(c2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H14 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1508829 Bionet1_001832 Cc1ccc(C)c(SCc2nc3ccccc3c(=O)n2c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H15 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1909041 Bionet1_001833 CN(C)/C=C(\C#N)/C(=O)CSc1ncc(cc1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H16 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1909042 Bionet1_001834 CCOC(=O)CN(c1ccccc1)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H17 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1716227 Bionet1_001835 Clc1ccc(cc1)c2onc3ccc(cc23)c4ccnn4c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H18 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1909043 Bionet1_001836 COc1ccc(cc1)S(=O)(=O)N(CC(=O)NC(C)(C)C#C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H19 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1321454 Bionet1_001837 CCOC(=O)c1nocc1C(=O)c2ccc3noc(c4ccc(Cl)cc4)c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H20 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1553649 Bionet1_001838 COc1ccc(cc1)S(=O)(=O)N(CC(=O)Nc2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H21 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1909044 Bionet1_001839 C/C(=C(/C#N)\C(=O)N)/Nc1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H22 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1187229 Bionet1_001840 COc1ccc(cc1)S(=O)(=O)N(CC(=O)N2CCCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H23 mock treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 H24 mock treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I01 mock treatment 0.078 0.00301 0.36 0.3564 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I02 mock treatment 0.0755 5.08E-4 0.06 0.0602 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I03 compound treatment 0.0955 0.0205 2.43 2.43 1.0 1909045 Bionet1_001841 COc1cccc(Cn2c(nc3ccccc23)c4cccnc4Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I04 compound treatment 0.081 0.00601 0.71 0.7119 1.0 1384369 Bionet1_001842 OC(CSc1ccc(Cl)c(Cl)c1)CN2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I05 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1477856 Bionet1_001843 Clc1cccc(Cl)c1Cn2c(nc3ccccc23)c4cccnc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I06 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1909046 Bionet1_001844 CCOC(=O)C1=C(C)N(Cc2ccc(Cl)cc2Cl)c3ccccc3S1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I07 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1165855 Bionet1_001845 Fc1cccc(Cl)c1Cn2c(nc3ccccc23)c4cccnc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I08 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1909047 Bionet1_001846 CCOC(=O)C1=C(C)N(Cc2c(Cl)cccc2Cl)c3ccccc3S1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I09 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1909048 Bionet1_001847 Clc1cccc(Cn2c(nc3ccccc23)c4cccnc4Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I10 compound treatment 0.069 -0.00599 -0.71 -0.71 -1.0 1909049 Bionet1_001848 CCOC(=O)C1=C(C)N(Cc2c(F)cccc2Cl)c3ccccc3S1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I11 compound treatment 0.067 -0.00799 -0.95 -0.947 -1.0 1909050 Bionet1_001849 Clc1ccc(Cn2c(nc3ccccc23)c4cccnc4Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I12 compound treatment 0.064 -0.011 -1.3 -1.3025 -1.0 1909051 Bionet1_001850 CCOC(=O)C1=C(C)N(Cc2ccccc2Cl)c3ccccc3S1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I13 compound treatment 0.058 -0.017 -2.01 -2.0134 -1.0 1909052 Bionet1_001851 FC(F)(F)c1cccc(Cn2c(nc3ccccc23)c4cccnc4Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I14 compound treatment 0.065 -0.00999 -1.18 -1.184 -1.0 1909053 Bionet1_001852 CCOC(=O)C1=C(C)N(Cc2cc(Cl)ccc2Cl)c3ccccc3S1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I15 compound treatment 0.07 -0.00499 -0.59 -0.5915 -1.0 1909054 Bionet1_001853 FC(F)(F)c1ccc(Cn2c(nc3ccccc23)c4cccnc4Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I16 compound treatment 0.067 -0.00799 -0.95 -0.947 -1.0 1909055 Bionet1_001854 FC(F)(F)c1cnc(/C(=N/Nc2ccccc2)/c3cccnc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I17 compound treatment 0.07 -0.00499 -0.59 -0.5915 -1.0 1182447 Bionet1_001855 CC(C)C(NC(=O)c1ccccc1Cl)c2nc3cc(C)c(C)cc3[nH]2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I18 compound treatment 0.069 -0.00599 -0.71 -0.71 -1.0 1909056 Bionet1_001856 CN1CCN(CC1)c2cc(cnc2C(=O)c3ccc(cc3)[N+](=O)[O-])C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I19 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1652329 Bionet1_001857 Cc1ccc(SCc2nc3ccccc3n2CC(=O)Nc4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I20 compound treatment 0.069 -0.00599 -0.71 -0.71 -1.0 1909057 Bionet1_001858 [O-][N+](=O)c1ccc(cc1)C(=O)c2ncc(cc2N3CCOCC3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I21 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1909058 Bionet1_001859 COc1ccc(NC(=O)CS(=O)c2ccc(Br)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I22 compound treatment 0.069 -0.00599 -0.71 -0.71 -1.0 1909059 Bionet1_001860 FC(F)(F)c1cnc(C(=O)c2ccc(Cl)cc2)c(c1)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I23 mock treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 I24 mock treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J01 mock treatment 0.076 0.00101 0.12 0.1194 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J02 mock treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J03 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1909060 Bionet1_001861 CN(C)/C=C/c1nc(C)c(C#N)c(c1C#N)c2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J04 compound treatment 0.0815 0.00651 0.77 0.7711 1.0 1376871 Bionet1_001862 CN(C)C(=O)CN(c1ccccc1)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J05 compound treatment 0.0805 0.00551 0.65 0.6526 1.0 1909061 Bionet1_001863 CN(C)/C=C/c1c(C#N)c(=O)ncn1N(C)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J06 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1909062 Bionet1_001864 Clc1ccc(cc1)S(=O)(=O)N(CC(=O)NCC=C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J07 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1909063 Bionet1_001865 COc1ccc(CCn2cnc(=O)c(C#N)c2/C=C/N(C)C)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J08 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1389648 Bionet1_001866 Fc1ccc(NC(=O)CN(c2ccccc2)S(=O)(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J09 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1909064 Bionet1_001867 C/C(=N/Nc1ccccc1F)/c2ccc3noc(c4ccc(F)cc4)c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J10 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1529841 Bionet1_001868 O=C(CN(c1ccccc1)S(=O)(=O)c2ccccc2)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J11 compound treatment 0.069 -0.00599 -0.71 -0.71 -1.0 1909065 Bionet1_001869 Fc1ccc(cc1)c2onc3ccc(cc23)c4ccn(n4)c5cccc(F)c5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J12 compound treatment 0.0675 -0.00749 -0.89 -0.8877 -1.0 1554895 Bionet1_001870 CN(C)C(=O)CN(c1ccccc1)S(=O)(=O)c2cc(Cl)ccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J13 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1909066 Bionet1_001871 Fc1ccc(cc1)c2onc3ccc(cc23)c4ccn(n4)c5ccccc5F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J14 compound treatment 0.0685 -0.00649 -0.77 -0.7692 -1.0 1416296 Bionet1_001872 Fc1ccc(cc1)S(=O)(=O)N(CC(=O)N2CCCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J15 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1909067 Bionet1_001873 FC(F)(F)c1cnc(NCCNc2cc[nH]c(=O)c2C#N)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J16 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1200806 Bionet1_001874 Fc1ccc(cc1)S(=O)(=O)N(CC(=O)N2CCOCC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J17 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1909068 Bionet1_001875 CCOC(=O)C(Cc1ccc(COC)cc1)(NC(=O)C)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J18 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1352110 Bionet1_001876 O=C(CN(c1ccccc1)S(=O)(=O)c2ccccc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J19 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1255082 Bionet1_001877 Fc1ccc(cc1)c2onc3ccc(cc23)c4ccnc(n4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J20 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1513922 Bionet1_001878 COc1ccc(NC(=O)CN(c2ccccc2)S(=O)(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J21 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1909069 Bionet1_001879 COC(=O)C1(NOC2C1C(=O)N(C2=O)c3ccc(Cl)cc3)C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J22 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1446800 Bionet1_001880 O=C(CN(c1ccccc1)S(=O)(=O)c2ccccc2)NCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J23 mock treatment 0.0695 -0.00549 -0.65 -0.6508 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 J24 mock treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K01 mock treatment 0.0755 5.08E-4 0.06 0.0602 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K02 mock treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K03 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1721912 Bionet1_001881 Fc1ccccc1NC(=O)Cn2c(CSc3ccccc3)nc4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K04 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1909070 Bionet1_001882 FC(F)(F)c1cnc(C(=O)c2ccc(Cl)cc2)c(c1)N3CCCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K05 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1330692 Bionet1_001883 O=C(Cn1c(CSc2ccccc2)nc3ccccc13)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K06 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1909071 Bionet1_001884 FC(F)(F)c1cnc(C(=O)c2ccc(Cl)cc2)c(c1)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K07 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1909072 Bionet1_001885 Cc1cccn2c(=O)nc(SCc3cccc(c3)C(F)(F)F)nc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K08 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1909073 Bionet1_001886 FC(F)(F)c1cnc(C(=O)c2ccccc2)c(c1)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K09 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1909074 Bionet1_001887 Cc1ccc2nc(SCc3cccc(c3)C(F)(F)F)nc(=O)n2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K10 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1909075 Bionet1_001888 O/N=C(\c1ccc(Cl)cc1Cl)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K11 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1909076 Bionet1_001889 COc1nc(N)c(cc1C#N)S(=O)(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K12 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1909077 Bionet1_001890 FC(F)(F)c1cnc2c(nnc(c3ccccc3)c2c1)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K13 compound treatment 0.069 -0.00599 -0.71 -0.71 -1.0 1909078 Bionet1_001891 Nc1nc(cc(c1C#N)c2c(Cl)cccc2Cl)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K14 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1909079 Bionet1_001892 COc1ccc(cc1)N2CCN(CC2)/C(=C/C#N)/NC(=O)Nc3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K15 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1909080 Bionet1_001893 Nc1nc(cc(c1C#N)c2ccc(Cl)cc2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K16 compound treatment 0.07 -0.00499 -0.59 -0.5915 -1.0 1909081 Bionet1_001894 CN(N/C(=C/C#N)/NC(=O)NC(C)(C)C)c1ncc(cc1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K17 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1909082 Bionet1_001895 Nc1nc(cc(c1C#N)c2ccc(Cl)cc2)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K18 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1909083 Bionet1_001896 CN(NC(=O)NC(=O)c1c[nH]nc1C)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K19 compound treatment 0.069 -0.00599 -0.71 -0.71 -1.0 1490824 Bionet1_001897 COc1ccc(cc1)c2cc(nc(N)c2C#N)c3ccc(OC)c(OC)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K20 compound treatment 0.0675 -0.00749 -0.89 -0.8877 -1.0 1909084 Bionet1_001898 [O-][N+](=O)c1ccc(cc1)N2CCC3(CC2)NCCc4c3[nH]c5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K21 compound treatment 0.069 -0.00599 -0.71 -0.71 -1.0 1729259 Bionet1_001899 COc1ccc(cc1)c2c(C)c(nc(N)c2C#N)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K22 compound treatment 0.067 -0.00799 -0.95 -0.947 -1.0 1909085 Bionet1_001900 CCOC(=O)/C(=C(/N)\N1CCN(CC1)c2ccc(OC)cc2)/SC#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K23 mock treatment 0.0695 -0.00549 -0.65 -0.6508 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 K24 mock treatment 0.07 -0.00499 -0.59 -0.5915 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L01 mock treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L02 mock treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L03 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1909086 Bionet1_001901 CCOC(=O)C1=NOC2C1C(=O)N(C2=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L04 compound treatment 0.079 0.00401 0.47 0.4749 1.0 1909087 Bionet1_001902 FC(F)(F)c1nnc(NS(=O)(=O)c2cccc(c2)C(F)(F)F)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L05 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1909088 Bionet1_001903 CCOC(=O)C1=NOC2C1C(=O)N(C2=O)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L06 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1715321 Bionet1_001904 Clc1ccc(Oc2nc3ccccc3cc2c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L07 compound treatment 0.079 0.00401 0.47 0.4749 1.0 1909089 Bionet1_001905 COc1ccc(CO/N=C(/C)\c2ccc3noc(c4ccccc4)c3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L08 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1189417 Bionet1_001906 COc1ccc(Oc2nc3ccccc3cc2c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L09 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1909090 Bionet1_001907 COc1ccc(N/C=C/C(=O)c2ccc3noc(c4ccccc4)c3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L10 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1132092 Bionet1_001908 Cc1cc(C)cc(Oc2nc3ccccc3cc2c4ccc(Cl)cc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L11 compound treatment 0.0795 0.00451 0.53 0.5341 1.0 1909091 Bionet1_001909 Clc1ccc(CSc2ccsc2C(=O)Nc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L12 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1909092 Bionet1_001910 Cc1ccc(CNS(=O)(=O)NCc2ccc(Cl)cc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L13 compound treatment 0.08 0.00501 0.59 0.5934 1.0 1909093 Bionet1_001911 Cc1ccc(NC(=O)c2sccc2SCc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L14 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1909094 Bionet1_001912 Cc1ccc(CNS(=O)(=O)NCc2cccc(c2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L15 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1430573 Bionet1_001913 COC(=O)CS(=O)(=O)c1ccsc1C(=O)Nc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L16 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1584425 Bionet1_001914 COc1ccc(CNS(=O)(=O)NCc2ccc(OC)c(OC)c2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L17 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1909095 Bionet1_001915 Clc1cccc(Cl)c1CSc2ccsc2C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L18 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1909096 Bionet1_001916 Fc1ccccc1CNS(=O)(=O)NCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L19 compound treatment 0.07 -0.00499 -0.59 -0.5915 -1.0 1909097 Bionet1_001917 CNC(=O)c1sccc1S(=O)(=O)Cc2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L20 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1222053 Bionet1_001918 COc1ccc(CNS(=O)(=O)NCc2ccc(C)cc2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L21 compound treatment 0.077 0.00201 0.24 0.2379 1.0 1616476 Bionet1_001919 COC(=O)CS(=O)(=O)c1ccsc1C(=O)Nc2ccc(F)c(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L22 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1582662 Bionet1_001920 COc1ccc(CNS(=O)(=O)NCc2ccc(OC)c(OC)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L23 mock treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 L24 mock treatment 0.0765 0.00151 0.18 0.1787 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M01 mock treatment 0.0755 5.08E-4 0.06 0.0602 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M02 mock treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M03 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1909098 Bionet1_001921 Cc1c(nc(N)c(C#N)c1c2ccccc2Cl)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M04 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1909099 Bionet1_001922 CN1O[C@H]2[C@@H]([C@H]1c3ccccc3)C(=O)N(C2=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M05 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1909100 Bionet1_001923 FC(F)(F)c1cnc(c2cnn(c2)c3ccccc3Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M06 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1909101 Bionet1_001924 CN1O[C@H]2[C@@H]([C@H]1c3ccccc3)C(=O)N(C2=O)c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M07 compound treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 1909102 Bionet1_001925 CO/N=C/c1c(N)c(sc1Nc2ccccc2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M08 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1909103 Bionet1_001926 O=C1[C@H]2ON(Cc3ccccc3)[C@@H]([C@H]2C(=O)N1Cc4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M09 compound treatment 0.073 -0.00199 -0.24 -0.236 -1.0 1909104 Bionet1_001927 Clc1cccc(Cl)c1CSc2nccc(/C=C/c3ccccc3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M10 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1909105 Bionet1_001928 CN(NC(=O)NC(=O)c1cn(C)nc1C)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M11 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1909106 Bionet1_001929 FC(F)(F)c1cnc(Sc2nccc(/C=C/c3ccccc3)n2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M12 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1581123 Bionet1_001930 CCOC(=O)c1c(n2cccc2)c3ccccc3n1Cc4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M13 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1909107 Bionet1_001931 CCOC(=O)c1sc(=S)sc1SCC(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M14 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1909108 Bionet1_001932 CCOC(=O)NC(=O)/C(=C\Nc1c([nH]c2ccccc12)C(=O)OCC)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M15 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1909109 Bionet1_001933 Clc1ccc(N/C=C/2\C(=O)CC3N(CCc4ccccc34)C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M16 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1909110 Bionet1_001934 Cc1nn(C(=O)c2ccccc2)c(C)c1CS(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M17 compound treatment 0.08 0.00501 0.59 0.5934 1.0 1909111 Bionet1_001935 FC(F)(F)c1cnc(CS/C=C\C(=O)c2ccc(Cl)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M18 compound treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 1909112 Bionet1_001936 Cc1nn(c(C)c1CS(=O)(=O)c2ccccc2)S(=O)(=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M19 compound treatment 0.0695 -0.00549 -0.65 -0.6508 -1.0 1909113 Bionet1_001937 FC(F)(F)c1cnc(S/C=C\C(=O)c2ccc(Cl)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M20 compound treatment 0.0705 -0.00449 -0.53 -0.5323 -1.0 1909114 Bionet1_001938 Cc1nn(C(=O)c2cccnc2)c(C)c1CS(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M21 compound treatment 0.0685 -0.00649 -0.77 -0.7692 -1.0 1909115 Bionet1_001939 FC(F)(F)c1cnc(c(Cl)c1)c2cnc3cc(nn3c2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M22 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1909116 Bionet1_001940 Clc1ccc(cn1)c2nc3cc(Cl)c(Cl)cc3n2Cc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M23 mock treatment 0.071 -0.00399 -0.47 -0.473 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 M24 mock treatment 0.072 -0.00299 -0.35 -0.3545 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N01 mock treatment 0.076 0.00101 0.12 0.1194 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N02 mock treatment 0.0775 0.00251 0.3 0.2972 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N03 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1235719 Bionet1_001941 Clc1ccccc1CSc2nc(c([nH]2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N04 compound treatment 0.08 0.00501 0.59 0.5934 1.0 1129547 Bionet1_001942 COc1ccc(CNS(=O)(=O)NCc2ccc(Cl)cc2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N05 compound treatment 0.0795 0.00451 0.53 0.5341 1.0 1283265 Bionet1_001943 Fc1ccc(CSc2nc(c([nH]2)c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N06 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1909117 Bionet1_001944 CC(C)(C)c1ccc(cc1)S(=O)(=O)Oc2ccc(cc2)c3csnn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N07 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1522118 Bionet1_001945 COc1ccc(CSc2nc(c([nH]2)c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N08 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1909118 Bionet1_001946 COC(=O)N/N=C(/C)\c1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N09 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1909119 Bionet1_001947 Cn1c(SCc2ccccc2Cl)nc(c1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N10 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1909120 Bionet1_001948 FC(F)(F)c1cnc(Oc2ccc(cc2)c3csnn3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N11 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1649621 Bionet1_001949 Cn1c(SCc2ccc(F)cc2)nc(c1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N12 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1909121 Bionet1_001950 Clc1ccc(cc1)S(=O)(=O)Oc2ccc(cc2)c3csnn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N13 compound treatment 0.08 0.00501 0.59 0.5934 1.0 1679641 Bionet1_001951 Fc1ccc(CSc2nc(c(c3ccccc3)n2CC#C)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N14 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1909122 Bionet1_001952 Clc1ccc(/C=C/C(=O)c2ccc(Br)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N15 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1551171 Bionet1_001953 COc1ccc(CSc2nc(c(c3ccccc3)n2C)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N16 compound treatment 0.08 0.00501 0.59 0.5934 1.0 1909123 Bionet1_001954 Clc1ccc(cc1)S(=O)(=O)Oc2ccccc2c3csnn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N17 compound treatment 0.0815 0.00651 0.77 0.7711 1.0 1909124 Bionet1_001955 Cn1nc(c(CSc2c(Cl)cccc2Cl)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N18 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1909125 Bionet1_001956 Nc1cccc(Cl)c1NCCNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N19 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1909126 Bionet1_001957 Cn1nc(c(CSc2ccc(Br)cc2)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N20 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1909127 Bionet1_001958 [O-][N+](=O)c1cc(Cl)ccc1NCCNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N21 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1909128 Bionet1_001959 Cn1nc(c(CSc2cccc(Cl)c2Cl)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N22 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1909129 Bionet1_001960 Nc1cc(Cl)ccc1NCCNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N23 mock treatment 0.0755 5.08E-4 0.06 0.0602 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 N24 mock treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O01 mock treatment 0.077 0.00201 0.24 0.2379 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O02 mock treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O03 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1909130 Bionet1_001961 FC(F)(F)c1cc(Cl)c(=S)n(/C=C/C(=O)c2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O04 compound treatment 0.0775 0.00251 0.3 0.2972 1.0 1414452 Bionet1_001962 Clc1cc2nc(c3ccc(=O)[nH]c3)n(Cc4ccccc4)c2cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O05 compound treatment 0.079 0.00401 0.47 0.4749 1.0 1909131 Bionet1_001963 Cc1nn2cc(cnc2c1Br)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O06 compound treatment 0.0805 0.00551 0.65 0.6526 1.0 1219734 Bionet1_001964 Cc1ccccc1Cn2c(nc3cc(Cl)c(Cl)cc23)c4ccc(=O)[nH]c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O07 compound treatment 0.0835 0.00851 1.01 1.0081 1.0 1909132 Bionet1_001965 FC(F)(F)c1cnc(c(Cl)c1)c2cnc3c(cnn3c2)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O08 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1195809 Bionet1_001966 Fc1ccccc1Cn2c(nc3cc(Cl)c(Cl)cc23)c4ccc[nH]c4=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O09 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1909133 Bionet1_001967 FC(F)(F)c1cccc(NC(=O)N2CCc3ccccc3C2CC#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O10 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1641154 Bionet1_001968 Fc1cccc(Cn2c(nc3cc(Cl)c(Cl)cc23)c4ccc[nH]c4=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O11 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1318947 Bionet1_001969 Clc1ccc(NC(=O)N2CCc3ccccc3C2CC#N)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O12 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1493154 Bionet1_001970 Fc1ccc(Cn2c(nc3cc(Cl)c(Cl)cc23)c4ccc[nH]c4=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O13 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1909134 Bionet1_001971 FC(F)(F)c1ccc(NC(=O)N2CCc3ccccc3C2CC#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O14 compound treatment 0.0775 0.00251 0.3 0.2972 1.0 1389046 Bionet1_001972 Cc1ccccc1Cn2c(nc3cc(Cl)c(Cl)cc23)c4ccc[nH]c4=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O15 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1909135 Bionet1_001973 COC(=O)c1sc2ncc(cc2c1N)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O16 compound treatment 0.077 0.00201 0.24 0.2379 1.0 1207705 Bionet1_001974 CC(O)(CS(=O)(=O)c1ccc(Br)cc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O17 compound treatment 0.0775 0.00251 0.3 0.2972 1.0 1909136 Bionet1_001975 CC(C(=O)Nc1ccc(Cl)cc1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O18 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1437669 Bionet1_001976 Cc1ccc(Cn2c(nc3cc(Cl)c(Cl)cc23)c4ccc[nH]c4=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O19 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1909137 Bionet1_001977 COC(=O)C/1=C(C)NC(=O)\C1=C/Nc2ccc(Oc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O20 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1277226 Bionet1_001978 CC(O)(CS(=O)(=O)Cc1ccc(Cl)cc1)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O21 compound treatment 0.0725 -0.00249 -0.3 -0.2953 -1.0 1909138 Bionet1_001979 CN(C)/C=C/c1snc(Sc2ncc(cc2Cl)C(F)(F)F)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O22 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1604510 Bionet1_001980 COc1ccc(CS(=O)(=O)CC(C)(O)c2ccc(Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O23 mock treatment 0.079 0.00401 0.47 0.4749 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 O24 mock treatment 0.079 0.00401 0.47 0.4749 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P01 mock treatment 0.0735 -0.00149 -0.18 -0.1768 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P02 mock treatment 0.065 -0.00999 -1.18 -1.184 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P03 compound treatment 0.07 -0.00499 -0.59 -0.5915 -1.0 1502958 Bionet1_001981 Fc1ccc(NC(=O)Cc2sc(nc2c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P04 compound treatment 0.0625 -0.0125 -1.48 -1.4802 -1.0 1909139 Bionet1_001982 FC(F)(F)c1cnc(NCCn2c(=O)cc(Cl)[nH]c2=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P05 compound treatment 0.0715 -0.00349 -0.41 -0.4138 -1.0 1220479 Bionet1_001983 O=C(Cc1sc(nc1c2ccccc2)c3ccccc3)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P06 compound treatment 0.071 -0.00399 -0.47 -0.473 -1.0 1909140 Bionet1_001984 [O-][N+](=O)c1cccnc1NCCNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P07 compound treatment 0.08 0.00501 0.59 0.5934 1.0 1563165 Bionet1_001985 Cc1ccc(CSc2nc(c([nH]2)c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P08 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1909141 Bionet1_001986 Nc1cccnc1NCCNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P09 compound treatment 0.076 0.00101 0.12 0.1194 1.0 1909142 Bionet1_001987 [O-][N+](=O)c1ccc(CSc2nc(c([nH]2)c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P10 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1909143 Bionet1_001988 Nc1cccnc1N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P11 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1635916 Bionet1_001989 Cn1c(SCc2cccc(F)c2)nc(c1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P12 compound treatment 0.0775 0.00251 0.3 0.2972 1.0 1909144 Bionet1_001990 [O-][N+](=O)c1ccccc1NCCNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P13 compound treatment 0.0755 5.08E-4 0.06 0.0602 1.0 1121458 Bionet1_001991 Fc1cccc(CSc2nc(c(c3ccccc3)n2CC#C)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P14 compound treatment 0.0765 0.00151 0.18 0.1787 1.0 1909145 Bionet1_001992 Nc1ccccc1NCCNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P15 compound treatment 0.078 0.00301 0.36 0.3564 1.0 1176989 Bionet1_001993 Cc1ccc(CSc2nc(c(c3ccccc3)n2C)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P16 compound treatment 0.077 0.00201 0.24 0.2379 1.0 1909146 Bionet1_001994 FC(F)(F)c1cnc(NCCn2c(=O)c(=O)[nH]c3cccnc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P17 compound treatment 0.0785 0.00351 0.42 0.4157 1.0 1625015 Bionet1_001995 CCCn1c(SCc2ccc(C)cc2)nc(c1c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P18 compound treatment 0.0795 0.00451 0.53 0.5341 1.0 1909147 Bionet1_001996 NNc1nc2cccnc2n(CCNc3ncc(cc3Cl)C(F)(F)F)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P19 compound treatment 0.0745 -4.92E-4 -0.06 -0.0583 -1.0 1507806 Bionet1_001997 Cc1ccc(CSc2nc(c(c3ccccc3)n2CC=C)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P20 compound treatment 0.0775 0.00251 0.3 0.2972 1.0 1909148 Bionet1_001998 [O-][N+](=O)c1ccc(cc1)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P21 compound treatment 0.074 -9.92E-4 -0.12 -0.1175 -1.0 1557672 Bionet1_001999 Cc1ccc(CSc2nc(c(c3ccccc3)n2CC#C)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P22 compound treatment 0.075 7.94E-6 0.0 9.0E-4 1.0 1909149 Bionet1_002000 Nc1cc(ccc1NCCNc2ncc(cc2Cl)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P23 mock treatment 0.076 0.00101 0.12 0.1194 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.573 P24 mock treatment 0.0685 -0.00649 -0.77 -0.7692 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A01 mock treatment 0.093 0.0147 1.75 1.7463 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A02 mock treatment 0.0875 0.00924 1.09 1.0946 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A03 compound treatment 0.084 0.00574 0.68 0.6799 1.0 1909150 Bionet1_002001 Nc1ccc(cc1)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A04 compound treatment 0.084 0.00574 0.68 0.6799 1.0 1660363 Bionet1_002002 Clc1ccccc1c2nc(c(CC(=O)NCC=C)s2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A05 compound treatment 0.091 0.0127 1.51 1.5093 1.0 1909151 Bionet1_002003 NC(=O)Nc1ccc(cc1)N2CCN(CC2)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A06 compound treatment 0.069 -0.00926 -1.1 -1.0974 -1.0 1416546 Bionet1_002004 Clc1ccc(SCC(=O)Nc2nc(cs2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A07 compound treatment 0.083 0.00474 0.56 0.5614 1.0 1214913 Bionet1_002005 CN(C)C(=O)CN(c1ccc(Cl)cc1)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A08 compound treatment 0.0835 0.00524 0.62 0.6207 1.0 1241292 Bionet1_002006 Cc1ccc(SCC(=O)Nc2nc(cs2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A09 compound treatment 0.0805 0.00224 0.27 0.2652 1.0 1909152 Bionet1_002007 Clc1ccc(cc1)N(CC(=O)NCC=C)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A10 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1642983 Bionet1_002008 Clc1ccc(cc1)c2csc(NC(=O)CSc3cccc(Cl)c3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A11 compound treatment 0.083 0.00474 0.56 0.5614 1.0 1909153 Bionet1_002009 CN(C)C(=O)CN(c1cccc(c1)C(F)(F)F)S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A12 compound treatment 0.082 0.00374 0.44 0.4429 1.0 1326719 Bionet1_002010 Clc1ccc(cc1)c2csc(NC(=O)CSc3ccccc3Cl)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A13 compound treatment 0.0885 0.0102 1.21 1.2131 1.0 1460525 Bionet1_002011 CN(C)C(=O)CN(c1ccc(Cl)cc1)S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A14 compound treatment 0.081 0.00274 0.32 0.3244 1.0 1593558 Bionet1_002012 Cc1cccc(SCC(=O)Nc2nc(cs2)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A15 compound treatment 0.0775 -7.62E-4 -0.09 -0.0903 -1.0 1909154 Bionet1_002013 Clc1ccc(cc1)N(CC(=O)NCC=C)S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A16 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1539388 Bionet1_002014 Cc1ccc(SCC(=O)Nc2nc(cs2)c3ccccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A17 compound treatment 0.072 -0.00626 -0.74 -0.742 -1.0 1698139 Bionet1_002015 Clc1ccc(cc1)N(CC(=O)N2CCOCC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A18 compound treatment 0.0885 0.0102 1.21 1.2131 1.0 1433634 Bionet1_002016 Clc1ccc(SCC(=O)Nc2nc(cs2)c3ccccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A19 compound treatment 0.083 0.00474 0.56 0.5614 1.0 1267968 Bionet1_002017 Cc1cccc(C)c1NC(=O)CN(c2ccccn2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A20 compound treatment 0.3275 0.249 29.53 29.5322 1.0 1557783 Bionet1_002018 Fc1ccc(cc1)c2csc(NC(=O)CSc3ccc(Cl)cc3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A21 compound treatment 0.211 0.133 15.73 15.7282 1.0 1551285 Bionet1_002019 O=C(CN(c1ccccn1)S(=O)(=O)c2ccccc2)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A22 compound treatment 0.0825 0.00424 0.5 0.5022 1.0 1510003 Bionet1_002020 Cc1ccc(SCC(=O)Nc2nc(cs2)c3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A23 mock treatment 0.0865 0.00824 0.98 0.9761 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 A24 mock treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B01 mock treatment 0.0845 0.00624 0.74 0.7392 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B02 mock treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B03 compound treatment 0.084 0.00574 0.68 0.6799 1.0 1909155 Bionet1_002021 [O-][N+](=O)c1cc(ccc1n2c3ccccc3c4ccccc24)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B04 compound treatment 0.083 0.00474 0.56 0.5614 1.0 1909156 Bionet1_002022 [O-][N+](=O)c1cccc(Cl)c1NCCNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B05 compound treatment 0.0885 0.0102 1.21 1.2131 1.0 1909157 Bionet1_002023 CC(C)(C)c1cc(/C=N\NC(=O)Nc2ccccc2)cc(c1O)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B06 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1605306 Bionet1_002024 COc1ccc(cc1)c2nc(nc(N3CCN(C)CC3)c2C#N)c4cccc(C)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B07 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1909158 Bionet1_002025 COC(=O)/C(=C/N(C)C)/C(=O)N1CCN(CC1)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B08 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1909159 Bionet1_002026 Fc1ccc(/C=C\2/SC(=S)N(N3C(=O)C4C5CC(C=C5)C4C3=O)C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B09 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1909160 Bionet1_002027 CCOC(=O)c1noc(C)c1C(=O)Nc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B10 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1909161 Bionet1_002028 COc1cccc(/C=C/2\SC(=S)N(N3C(=O)CCCC3=O)C2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B11 compound treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 1909162 Bionet1_002029 Cc1onc(C(=O)NN)c1C(=O)Nc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B12 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1909163 Bionet1_002030 FC(F)(F)c1cccc(OCCO/N=C/c2sc3ccccc3c2Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B13 compound treatment 0.071 -0.00726 -0.86 -0.8605 -1.0 1236971 Bionet1_002031 Cc1onc(c2ccnn2c3ccc(C)cc3)c1C(=O)Nc4nccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B14 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1909164 Bionet1_002032 COc1ccccc1/C=C/2\SC(=S)N(N3C(=O)CCCC3=O)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B15 compound treatment 0.0725 -0.00576 -0.68 -0.6827 -1.0 1909165 Bionet1_002033 COc1ccc(N/C=C/C(=O)c2noc(C)c2C(=O)Nc3nccs3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B16 compound treatment 0.0705 -0.00776 -0.92 -0.9197 -1.0 1909166 Bionet1_002034 COc1ccc(cc1)c2nc(nc(Cl)c2C#N)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B17 compound treatment 0.071 -0.00726 -0.86 -0.8605 -1.0 1909167 Bionet1_002035 FC(F)(F)c1ccc(NC(=O)CC(=O)Nc2ccc(cc2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B18 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1909168 Bionet1_002036 CN(C)c1nc(N(C)C)n(n1)S(=O)(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B19 compound treatment 0.085 0.00674 0.8 0.7984 1.0 1909169 Bionet1_002037 FC(F)(F)c1ccccc1NC(=O)CC(=O)Nc2ccccc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B20 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1909170 Bionet1_002038 CN(C)c1nc(N(C)C)n(n1)S(=O)(=O)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B21 compound treatment 0.0865 0.00824 0.98 0.9761 1.0 1909171 Bionet1_002039 CN(C)C=C(C(=O)Nc1ccccc1Cl)C(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B22 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1909172 Bionet1_002040 C/C(=N/Nc1nc(cs1)c2sccc2Cl)/c3c(O)cc(C)oc3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B23 mock treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 B24 mock treatment 0.0725 -0.00576 -0.68 -0.6827 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C01 mock treatment 0.0855 0.00724 0.86 0.8576 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C02 mock treatment 0.089 0.0107 1.27 1.2724 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C03 compound treatment 0.086 0.00774 0.92 0.9169 1.0 1909173 Bionet1_002041 CC(=O)c1cc(C#N)c(SCc2ccc(Cl)c(Cl)c2)nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C04 compound treatment 0.0885 0.0102 1.21 1.2131 1.0 1909174 Bionet1_002042 FC(F)(F)c1cnc(C#N)c(c1)S(=O)(=O)Cc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C05 compound treatment 0.0915 0.0132 1.57 1.5686 1.0 1909175 Bionet1_002043 CC(=O)c1cc(C#N)c(SCc2cccc(c2)C(F)(F)F)nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C06 compound treatment 0.0855 0.00724 0.86 0.8576 1.0 1909176 Bionet1_002044 NC(=O)c1ncc(cc1S(=O)(=O)c2ccc(cn2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C07 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1909177 Bionet1_002045 CC(=O)c1cc(C#N)c(SCc2ccc(Cl)cc2Cl)nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C08 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1909178 Bionet1_002046 CCC(=O)Nc1ccc(Sc2cc(cnc2C#N)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C09 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1452833 Bionet1_002047 Fc1ccc(cc1)S(=O)(=O)N(CC(=O)Nc2ccccc2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C10 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1909179 Bionet1_002048 NC(=O)c1ncc(cc1Oc2cccc(c2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C11 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1639653 Bionet1_002049 COC(=O)c1cc(C#N)c(Oc2cc(Cl)c(Cl)cc2Cl)nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C12 compound treatment 0.073 -0.00526 -0.62 -0.6235 -1.0 1909180 Bionet1_002050 FC(F)(F)c1cnc(c2nc[nH]n2)c(Sc3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C13 compound treatment 0.0905 0.0122 1.45 1.4501 1.0 1909181 Bionet1_002051 CCOC(=O)c1cnn(c2nc(cs2)c3ccc(OC)cc3)c1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C14 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1909182 Bionet1_002052 Fc1ccc(cc1)N2CCN(CC2)c3cc(cnc3C#N)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C15 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1909183 Bionet1_002053 CNC(=O)c1cnn(c2nc(cs2)c3ccc(OC)cc3)c1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C16 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1909184 Bionet1_002054 NC(=O)c1ncc(cc1Oc2ccc(cc2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C17 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1909185 Bionet1_002055 FC(F)(F)c1ccc(cc1)C2=NNC(=O)C(C2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C18 compound treatment 0.088 0.00974 1.15 1.1539 1.0 1909186 Bionet1_002056 CN(C)/C=C/C(=O)c1ccc(Oc2cc(cnc2C#N)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C19 compound treatment 0.081 0.00274 0.32 0.3244 1.0 1909187 Bionet1_002057 COc1ccc(NC(=O)/C(=C(/Cl)\SCc2ccc(C)cc2)/Cl)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C20 compound treatment 0.081 0.00274 0.32 0.3244 1.0 1909188 Bionet1_002058 COC(=O)c1c(noc1/C(=C/N(C)C)/C(=O)C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C21 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1909189 Bionet1_002059 COc1ccc(CS/C(=C(/Cl)\C(=O)Nc2ccc(OC)nc2)/Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C22 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1909190 Bionet1_002060 FC(F)(F)c1cccc(c1)N2CCN(CC2)c3cc(cnc3C#N)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C23 mock treatment 0.0805 0.00224 0.27 0.2652 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 C24 mock treatment 0.0815 0.00324 0.38 0.3837 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D01 mock treatment 0.0785 2.38E-4 0.03 0.0282 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D02 mock treatment 0.084 0.00574 0.68 0.6799 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D03 compound treatment 0.083 0.00474 0.56 0.5614 1.0 1909191 Bionet1_002061 CO/N=C/C(C(=O)Nc1ccccc1Cl)C(=O)Nc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D04 compound treatment 0.088 0.00974 1.15 1.1539 1.0 1909192 Bionet1_002062 CC(=O)CC(=O)c1c(C)nn(c1O)c2nc(cs2)c3sccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D05 compound treatment 0.0885 0.0102 1.21 1.2131 1.0 1909193 Bionet1_002063 CN(C)C=C(C(=O)Nc1ccc(F)cc1F)C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D06 compound treatment 0.0825 0.00424 0.5 0.5022 1.0 1909194 Bionet1_002064 Fc1ccc(cc1)N2CCN(CC2)c3[nH]c(cc3C#N)c4sccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D07 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1909195 Bionet1_002065 CO/N=C/C(C(=O)Nc1ccc(F)cc1F)C(=O)Nc2ccc(F)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D08 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1909196 Bionet1_002066 Fc1ccc(cc1)n2nc(C#N)c(=O)n(Cc3ccc(cc3)C(F)(F)F)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D09 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1909197 Bionet1_002067 CC(=O)OCc1c(Sc2ccccc2Cl)n(C)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D10 compound treatment 0.0845 0.00624 0.74 0.7392 1.0 1909198 Bionet1_002068 Cc1ccc(cc1)n2cc(cn2)c3nn(c4cc(C)cc(C)c4)c(=O)n(C)c3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D11 compound treatment 0.0925 0.0142 1.69 1.6871 1.0 1909199 Bionet1_002069 Cc1cccc(C)c1n2c(CCl)nc3c(Cl)cc(Cl)cc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D12 compound treatment 0.0805 0.00224 0.27 0.2652 1.0 1909200 Bionet1_002070 COC(=O)C1CCN(CC1)c2[nH]c(cc2C#N)c3sccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D13 compound treatment 0.084 0.00574 0.68 0.6799 1.0 1175235 Bionet1_002071 Clc1ccc(SCC(=O)Nc2nc(cs2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D14 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1909201 Bionet1_002072 COC(=O)C1CCN(CC1)c2[nH]c(cc2C#N)c3sccc3Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D15 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1318903 Bionet1_002073 Clc1cccc(SCc2nc3ccccc3c(=O)n2c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D16 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1909202 Bionet1_002074 COC(=O)C1CCN(CC1)c2[nH]c(cc2C(=O)OC)c3sccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D17 compound treatment 0.106 0.0277 3.29 3.2867 1.0 1526136 Bionet1_002075 Clc1cccc(SCC(=O)Nc2nc(cs2)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D18 compound treatment 0.0835 0.00524 0.62 0.6207 1.0 1909203 Bionet1_002076 Cn1c(=O)c(nn(c2ccc(F)cc2F)c1=O)C(=O)CBr 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D19 compound treatment 0.082 0.00374 0.44 0.4429 1.0 1647762 Bionet1_002077 Clc1ccc(c2csc(NC(=O)CSc3ccccc3)n2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D20 compound treatment 0.0835 0.00524 0.62 0.6207 1.0 1909204 Bionet1_002078 Cn1c(=O)c(nn(c2ccc(Cl)cc2)c1=O)c3ccnn3c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D21 compound treatment 0.089 0.0107 1.27 1.2724 1.0 1220284 Bionet1_002079 Clc1ccc(cc1)c2csc(NC(=O)CSc3ccccc3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D22 compound treatment 0.0825 0.00424 0.5 0.5022 1.0 1440353 Bionet1_002080 Cn1c(=O)c(nn(c2ccc(F)cc2F)c1=O)c3csc(n3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D23 mock treatment 0.0825 0.00424 0.5 0.5022 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 D24 mock treatment 0.0855 0.00724 0.86 0.8576 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E01 mock treatment 0.0805 0.00224 0.27 0.2652 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E02 mock treatment 0.0805 0.00224 0.27 0.2652 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E03 compound treatment 0.085 0.00674 0.8 0.7984 1.0 1909205 Bionet1_002081 COc1ccc(NC(=O)/C(=C(/Cl)\S(=O)Cc2ccccc2)/Cl)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E04 compound treatment 0.0875 0.00924 1.09 1.0946 1.0 1909206 Bionet1_002082 FC(F)(F)c1cnc(C#N)c(Oc2ccc(Cl)c3cccnc23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E05 compound treatment 0.0885 0.0102 1.21 1.2131 1.0 1909207 Bionet1_002083 COc1ccc(NC(=O)/C(=C(/Cl)\S(=O)Cc2ccc(C)cc2)/Cl)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E06 compound treatment 0.089 0.0107 1.27 1.2724 1.0 1909208 Bionet1_002084 COC(=O)c1c(noc1c2cnc(N)nc2C(F)(F)F)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E07 compound treatment 0.082 0.00374 0.44 0.4429 1.0 1909209 Bionet1_002085 Cc1ccc(SCCC(=O)NCCSc2ccc(Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E08 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1909210 Bionet1_002086 COC(=O)c1c(noc1c2cnc(N)nc2C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E09 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1909211 Bionet1_002087 Clc1ccc(SCCNC(=O)CCSc2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E10 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1909212 Bionet1_002088 COc1ccc(cc1)N2CCN(CC2)c3cc(cnc3C#N)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E11 compound treatment 0.0825 0.00424 0.5 0.5022 1.0 1909213 Bionet1_002089 Clc1cccc(Cl)c1SCC(=O)NCCSc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E12 compound treatment 0.0935 0.0152 1.81 1.8056 1.0 1909214 Bionet1_002090 CN(C)/C=C(\C(=O)C(F)(F)F)/c1onc(c1C#N)c2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E13 compound treatment 0.1045 0.0262 3.11 3.109 1.0 1909215 Bionet1_002091 Clc1cccc(Cl)c1SCCC(=O)NCCSc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E14 compound treatment 0.082 0.00374 0.44 0.4429 1.0 1909216 Bionet1_002092 COC(=O)C1CC(Cl)CN1S(=O)(=O)c2ccc(OC)c(OC)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E15 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1909217 Bionet1_002093 O=C(CCS(=O)(=O)c1ccccc1)NCCS(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E16 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1909218 Bionet1_002094 NNC(=O)C1=NOC2COC3(CCN(CC3)c4ccc(cc4)[N+](=O)[O-])OCC21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E17 compound treatment 0.0915 0.0132 1.57 1.5686 1.0 1909219 Bionet1_002095 Fc1ccc(cc1)S(=O)(=O)CC(=O)NCCS(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E18 compound treatment 0.0825 0.00424 0.5 0.5022 1.0 1909220 Bionet1_002096 CN(N1C(=O)C2ON=C(C2C1=O)C(=O)C)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E19 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1909221 Bionet1_002097 COC(=O)c1ccccc1SC(C)C(=O)NCCSc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E20 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1909222 Bionet1_002098 CCOC(=O)C1=NOC2COC3(CCN(CC3)c4ncccn4)OCC21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E21 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1909223 Bionet1_002099 Clc1ccc(Sc2ccccc2CSc3ccccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E22 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1909224 Bionet1_002100 CN(NS(=O)(=O)c1ccc(Cl)cc1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E23 mock treatment 0.081 0.00274 0.32 0.3244 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 E24 mock treatment 0.0815 0.00324 0.38 0.3837 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F01 mock treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F02 mock treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F03 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1457569 Bionet1_002101 Cc1ccccc1SCC(=O)Nc2nc(cs2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F04 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1909225 Bionet1_002102 Cn1c(=O)c(nn(c2ccc(Cl)cc2)c1=O)c3ccnc(n3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F05 compound treatment 0.0905 0.0122 1.45 1.4501 1.0 1690949 Bionet1_002103 Cc1ccc(cc1)S(=O)(=O)CC(=O)Nc2nc(cs2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F06 compound treatment 0.0825 0.00424 0.5 0.5022 1.0 1460474 Bionet1_002104 Cn1c(=O)c(nn(c2cc(Cl)cc(Cl)c2)c1=O)c3csc(N)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F07 compound treatment 0.083 0.00474 0.56 0.5614 1.0 1523184 Bionet1_002105 Clc1ccc(cc1)S(=O)(=O)CC(=O)Nc2nc(cs2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F08 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1909226 Bionet1_002106 CN(C)/C=C/C(=O)c1nn(c2cccc(c2)C(F)(F)F)c(=O)n(C)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F09 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1414598 Bionet1_002107 Cc1cccc(c1)S(=O)(=O)CC(=O)Nc2nc(cs2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F10 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1909227 Bionet1_002108 C=CCOc1ccccc1/C=C/2\C(=O)N(N=C2c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F11 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1217857 Bionet1_002109 Clc1ccc(cc1)c2csc(NC(=O)CS(=O)(=O)c3ccccc3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F12 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1909228 Bionet1_002110 CN(C)/C=C\C(=O)c1nn(c2ccc(cc2)C(F)(F)F)c(=O)n(C)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F13 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1327423 Bionet1_002111 COc1ccc(SCC(=O)Nc2nc(cs2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F14 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1909229 Bionet1_002112 [O-][N+](=O)c1ccc(Cn2c(=O)c(C#N)nn(c3ccc(F)cc3)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F15 compound treatment 0.0855 0.00724 0.86 0.8576 1.0 1909230 Bionet1_002113 CC(=O)c1cccc(NS(=O)(=O)c2ccc(Br)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F16 compound treatment 0.0845 0.00624 0.74 0.7392 1.0 1255507 Bionet1_002114 Fc1ccc(cc1)n2nc(C#N)c(=O)n(Cc3ccc(Cl)cc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F17 compound treatment 0.091 0.0127 1.51 1.5093 1.0 1909231 Bionet1_002115 FC(F)(F)c1nnc(NC(=O)CSc2ccc(Br)cc2)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F18 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1432583 Bionet1_002116 Fc1cccc(F)c1n2nc(C#N)c(=O)n(Cc3ccc(Cl)cc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F19 compound treatment 0.087 0.00874 1.04 1.0354 1.0 1909232 Bionet1_002117 FC(F)(F)c1nnc(NC(=O)CSc2ccc(Cl)cc2)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F20 compound treatment 0.085 0.00674 0.8 0.7984 1.0 1909233 Bionet1_002118 FC(F)(F)c1cccc(c1)C(=O)Nc2nc(cs2)c3sccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F21 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1909234 Bionet1_002119 FC(F)(F)c1nnc(NC(=O)CSc2ccccc2Cl)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F22 compound treatment 0.084 0.00574 0.68 0.6799 1.0 1322477 Bionet1_002120 Cc1ccc(cc1)S(=O)(=O)CCNC(=O)Cc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F23 mock treatment 0.0775 -7.62E-4 -0.09 -0.0903 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 F24 mock treatment 0.08 0.00174 0.21 0.2059 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G01 mock treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G02 mock treatment 0.074 -0.00426 -0.5 -0.505 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G03 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1909235 Bionet1_002121 FC(F)(F)c1cccc(CN2N=C(CCC2=O)/C=C/c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G04 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1239262 Bionet1_002122 COC(=O)C1CSC(N1C(=O)Nc2ccc(Cl)cc2)C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G05 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1909236 Bionet1_002123 Clc1ccc(CN2N=C(CCC2=O)/C=C/c3ccccc3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G06 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1909237 Bionet1_002124 COc1ccc(cc1)S(=O)(=O)NN(C)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G07 compound treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 1909238 Bionet1_002125 CC(C)c1ccc(/C=C/C2=NN(Cc3cccc(c3)C(F)(F)F)C(=O)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G08 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1489822 Bionet1_002126 COC(=O)C1CSC(N1C(=O)Nc2ccc(Cl)c(Cl)c2)C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G09 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1909239 Bionet1_002127 Cc1ccc(/C=C/C2=NN(Cc3ccc(Cl)c(Cl)c3)C(=O)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G10 compound treatment 0.073 -0.00526 -0.62 -0.6235 -1.0 1909240 Bionet1_002128 CC(=O)C1=NOC2COC3(CCN(CC3)c4ccc(cc4)[N+](=O)[O-])OCC21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G11 compound treatment 0.0725 -0.00576 -0.68 -0.6827 -1.0 1428207 Bionet1_002129 Cc1ccc(Sc2ccc(C#N)cc2NC(=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G12 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1485122 Bionet1_002130 COC(=O)C1SCC2N1C(=O)CN(Cc3ccc(Cl)cc3)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G13 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1281515 Bionet1_002131 Cc1ccc(Sc2ccc(C#N)cc2NC(=O)c3ccccc3C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G14 compound treatment 0.0725 -0.00576 -0.68 -0.6827 -1.0 1909241 Bionet1_002132 COC(=O)c1ccccc1N/C=C/c2nccc3c2cnc4c(C#N)cnn43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G15 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1185688 Bionet1_002133 Cc1ccc(Sc2ccc(C#N)cc2NC(=O)c3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G16 compound treatment 0.081 0.00274 0.32 0.3244 1.0 1909242 Bionet1_002134 CCOC(=O)/C(=C\N(C)C)/Sc1ncc(cc1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G17 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1247894 Bionet1_002135 COc1cccc(c1)C(=O)Nc2cc(C#N)ccc2Sc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G18 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1590978 Bionet1_002136 CCOC(=O)CN1C(=C(C(CC1=O)c2ccc(Cl)cc2)C(=O)OCC)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G19 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1527802 Bionet1_002137 Clc1ccc(Sc2ccc(C#N)cc2NC(=O)c3ccccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G20 compound treatment 0.072 -0.00626 -0.74 -0.742 -1.0 1909243 Bionet1_002138 COc1ccc(OC)c(N/C=C/c2nccc3c2cnc4c(C#N)cnn43)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G21 compound treatment 0.072 -0.00626 -0.74 -0.742 -1.0 1556695 Bionet1_002139 Clc1ccc(Sc2ccc(C#N)cc2NC(=O)c3ccc(Cl)nc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G22 compound treatment 0.072 -0.00626 -0.74 -0.742 -1.0 1909244 Bionet1_002140 FC(F)(F)c1ccc(N/C=C/c2nccc3c2cnc4c(C#N)cnn43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G23 mock treatment 0.072 -0.00626 -0.74 -0.742 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 G24 mock treatment 0.07 -0.00826 -0.98 -0.979 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H01 mock treatment 0.076 -0.00226 -0.27 -0.268 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H02 mock treatment 0.0785 2.38E-4 0.03 0.0282 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H03 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1909245 Bionet1_002141 FC(F)(F)c1nnc(NC(=O)CSc2cccc(Cl)c2)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H04 compound treatment 0.0835 0.00524 0.62 0.6207 1.0 1909246 Bionet1_002142 Cc1ccc(CC(=O)NCCSc2ccc(Br)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H05 compound treatment 0.093 0.0147 1.75 1.7463 1.0 1909247 Bionet1_002143 FC(F)(F)c1nnc(NC(=O)CSc2cccc(Cl)c2Cl)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H06 compound treatment 0.0855 0.00724 0.86 0.8576 1.0 1694109 Bionet1_002144 Clc1ccc(CC(=O)NCCS(=O)(=O)c2ccc(Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H07 compound treatment 0.089 0.0107 1.27 1.2724 1.0 1909248 Bionet1_002145 COC(=O)c1ccccc1SCC(=O)Nc2nnc(s2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H08 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1217604 Bionet1_002146 Cc1ccc(CC(=O)NCCS(=O)c2ccc(Br)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H09 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1909249 Bionet1_002147 COc1ccc(cc1)S(=O)(=O)CC(=O)Nc2nnc(s2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H10 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1411721 Bionet1_002148 Cc1ccc(CC(=O)NCCS(=O)(=O)c2ccc(Br)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H11 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1909250 Bionet1_002149 FC(F)(F)c1nnc(NC(=O)CS(=O)(=O)c2cccc(Cl)c2)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H12 compound treatment 0.0805 0.00224 0.27 0.2652 1.0 1909251 Bionet1_002150 Cc1ccc(Oc2ncccc2/C=N/OCc3ccc(Cl)cc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H13 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1909252 Bionet1_002151 Cc1ccc(cc1)S(=O)(=O)CC(=O)Nc2nnc(s2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H14 compound treatment 0.0735 -0.00476 -0.56 -0.5642 -1.0 1909253 Bionet1_002152 Cc1ccc(Oc2ncccc2/C=N/OCc3ccc(Cl)c(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H15 compound treatment 0.11 0.0317 3.76 3.7607 1.0 1909254 Bionet1_002153 FC(F)(F)c1nnc(NC(=O)CSc2cc(Cl)ccc2Cl)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H16 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1909255 Bionet1_002154 Clc1ccc(CO/N=C/c2cccnc2Sc3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H17 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1909256 Bionet1_002155 CCOC(=O)c1nnc(nc1Sc2ccc(OC)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H18 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1909257 Bionet1_002156 Clc1ccc(CO/N=C/c2cccnc2Sc3ccccc3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H19 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1909258 Bionet1_002157 CCOC(=O)c1nnc(nc1Sc2ccccc2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H20 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1618073 Bionet1_002158 Cc1ccc(Sc2ncccc2COC(=O)Nc3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H21 compound treatment 0.0925 0.0142 1.69 1.6871 1.0 1909259 Bionet1_002159 CCOC(=O)c1nnc(nc1Sc2cc(C)ccc2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H22 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1489075 Bionet1_002160 Cc1ccc(Sc2ncccc2COC(=O)Nc3cccc(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H23 mock treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 H24 mock treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I01 mock treatment 0.081 0.00274 0.32 0.3244 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I02 mock treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I03 compound treatment 0.0805 0.00224 0.27 0.2652 1.0 1909260 Bionet1_002161 COc1ccc(NC(=O)/C(=C(/Cl)\SCc2ccccc2)/Cl)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I04 compound treatment 0.0865 0.00824 0.98 0.9761 1.0 1909261 Bionet1_002162 Ic1ccc(N/C=C/C(=O)c2ccc3ccccc3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I05 compound treatment 0.0805 0.00224 0.27 0.2652 1.0 1909262 Bionet1_002163 CC1(C)CN(C1=O)c2ccc(Oc3ncc(cc3Cl)C(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I06 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1177842 Bionet1_002164 COC(=O)C(CC(=O)c1ccc(Cl)cc1)c2cccc(Cl)c2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I07 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1909263 Bionet1_002165 CC(=C)C(=O)Nc1ccc(Oc2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I08 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1472974 Bionet1_002166 COC(=O)C(CC(=O)c1ccc(Cl)cc1)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I09 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1909264 Bionet1_002167 CC1(C)CN(C1=O)c2ccc(cc2)C(=O)C/C=N/OCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I10 compound treatment 0.073 -0.00526 -0.62 -0.6235 -1.0 1570637 Bionet1_002168 COC(=O)C(CC(=O)c1ccc(Cl)cc1)c2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I11 compound treatment 0.0725 -0.00576 -0.68 -0.6827 -1.0 1909265 Bionet1_002169 CC1(C)CN(C1=O)c2ccc(cc2)C(=O)/C=C/c3cccc(Br)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I12 compound treatment 0.0685 -0.00976 -1.16 -1.1567 -1.0 1909266 Bionet1_002170 Clc1ccc(cc1)C2=NNC(=O)C(C2)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I13 compound treatment 0.0625 -0.0158 -1.87 -1.8676 -1.0 1909267 Bionet1_002171 CC1(C)CN(C1=O)c2cccc(Oc3ncc(cc3Cl)C(F)(F)F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I14 compound treatment 0.0695 -0.00876 -1.04 -1.0382 -1.0 1909268 Bionet1_002172 Clc1ccc(cc1)C2=NNC(=O)C(C2)c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I15 compound treatment 0.0725 -0.00576 -0.68 -0.6827 -1.0 1236270 Bionet1_002173 CC1(C)CN(C1=O)c2ccc(cc2)c3ccnn3c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I16 compound treatment 0.0715 -0.00676 -0.8 -0.8012 -1.0 1909269 Bionet1_002174 Clc1ccc(cc1)C2CC(=NNC2=O)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I17 compound treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 1909270 Bionet1_002175 C(Sc1ccccc1)c2cc(nc(n2)c3ccccc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I18 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1909271 Bionet1_002176 Clc1ccc(cc1)C2CC(=NNC2=O)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I19 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1909272 Bionet1_002177 CSc1cc(CSc2ccc(Cl)cc2)nc(n1)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I20 compound treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 1909273 Bionet1_002178 Clc1ccc(cc1)C2=NNC(=O)C(C2)c3cccc(Br)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I21 compound treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 1909274 Bionet1_002179 CSc1cc(CS(=O)(=O)c2ccccc2)nc(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I22 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1909275 Bionet1_002180 FC(F)(F)c1cnc(c(Cl)c1)n2cc(c3c[nH][nH]c3=O)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I23 mock treatment 0.076 -0.00226 -0.27 -0.268 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 I24 mock treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J01 mock treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J02 mock treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J03 compound treatment 0.081 0.00274 0.32 0.3244 1.0 1909276 Bionet1_002181 CCOC(=O)c1nnc(nc1Sc2ccccc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J04 compound treatment 0.0935 0.0152 1.81 1.8056 1.0 1405036 Bionet1_002182 Cc1ccc(Sc2ncccc2COC(=O)NC3CCCCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J05 compound treatment 0.0835 0.00524 0.62 0.6207 1.0 1909277 Bionet1_002183 CCOC(=O)c1nnc(nc1Sc2ccc(C)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J06 compound treatment 0.082 0.00374 0.44 0.4429 1.0 1459348 Bionet1_002184 Cc1ccc(Sc2ncccc2COC(=O)Nc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J07 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1909278 Bionet1_002185 CCOC(=O)c1nnc(nc1Sc2ccc(F)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J08 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1626986 Bionet1_002186 Clc1ccc(NC(=O)c2ccccc2Sc3ccccc3C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J09 compound treatment 0.084 0.00574 0.68 0.6799 1.0 1909279 Bionet1_002187 CCOC(=O)c1nnc(nc1Sc2ccccc2C(=O)OC)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J10 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1909280 Bionet1_002188 FC(F)(F)c1cccc(NC(=O)c2ccccc2Sc3ccccc3C#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J11 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1909281 Bionet1_002189 CCOC(=O)c1nnc(nc1Oc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J12 compound treatment 0.072 -0.00626 -0.74 -0.742 -1.0 1161119 Bionet1_002190 COc1ccc(NC(=O)c2ccccc2Sc3ccccc3C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J13 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1909282 Bionet1_002191 CCOC(=O)c1nnc(nc1Oc2cccc(c2)C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J14 compound treatment 0.072 -0.00626 -0.74 -0.742 -1.0 1222321 Bionet1_002192 Clc1ccc(NC(=O)c2ccccc2S(=O)c3ccccc3C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J15 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1909283 Bionet1_002193 CCOC(=O)c1nnc(nc1Oc2c(Cl)cccc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J16 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1703051 Bionet1_002194 Clc1ccc(NC(=O)c2ccccc2S(=O)(=O)c3ccccc3C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J17 compound treatment 0.083 0.00474 0.56 0.5614 1.0 1909284 Bionet1_002195 CCOC(=O)c1nnc(nc1Oc2ccccc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J18 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1315840 Bionet1_002196 COc1ccc(NC(=O)c2ccccc2S(=O)c3ccccc3C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J19 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1909285 Bionet1_002197 CCOC(=O)c1nnc(nc1Oc2ccc(OC)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J20 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1208169 Bionet1_002198 COc1ccc(NC(=O)c2ccccc2S(=O)(=O)c3ccccc3C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J21 compound treatment 0.082 0.00374 0.44 0.4429 1.0 1909286 Bionet1_002199 CCOC(=O)c1nnc(nc1Oc2ccccc2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J22 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1536537 Bionet1_002200 O=C(Nc1ccccc1)c2ccccc2S(=O)(=O)c3ccccc3C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J23 mock treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 J24 mock treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K01 mock treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K02 mock treatment 0.076 -0.00226 -0.27 -0.268 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K03 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1909287 Bionet1_002201 O=S(=O)(Cc1cc(nc(n1)c2ccccn2)N3CCOCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K04 compound treatment 0.0825 0.00424 0.5 0.5022 1.0 1909288 Bionet1_002202 NC(=O)Cc1cn(c2ncc(cc2Cl)C(F)(F)F)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K05 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1137727 Bionet1_002203 O=S(=O)(Cc1cc(nc(n1)c2ccncc2)N3CCCCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K06 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1909289 Bionet1_002204 COC(=O)C1CCN(CC1)c2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K07 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1240316 Bionet1_002205 C(Sc1ccccc1)c2cc(nc(n2)c3ccncc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K08 compound treatment 0.073 -0.00526 -0.62 -0.6235 -1.0 1619521 Bionet1_002206 COc1ccc(cc1)C2CC(=O)C(CS(=O)(=O)c3ccccc3)C(=O)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K09 compound treatment 0.073 -0.00526 -0.62 -0.6235 -1.0 1163902 Bionet1_002207 Clc1ccc(cc1Cl)C(=O)Nc2ccc(Sc3ccccc3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K10 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1909290 Bionet1_002208 ClC1=C(CS(=O)(=O)c2ccccc2)C(=O)CC(C1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K11 compound treatment 0.0725 -0.00576 -0.68 -0.6827 -1.0 1909291 Bionet1_002209 FC(F)(F)c1cccc(c1)C(=O)Nc2ccc(Sc3ccccc3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K12 compound treatment 0.0715 -0.00676 -0.8 -0.8012 -1.0 1909292 Bionet1_002210 C/[N+](=C/c1cn(c2ncc(cc2Cl)C(F)(F)F)c3ccccc13)/[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K13 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1507420 Bionet1_002211 Clc1ccc(cc1)C(=O)Nc2ccc(Sc3ccccc3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K14 compound treatment 0.072 -0.00626 -0.74 -0.742 -1.0 1909293 Bionet1_002212 NC(=O)C(=O)c1cn(c2ncc(cc2Cl)C(F)(F)F)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K15 compound treatment 0.072 -0.00626 -0.74 -0.742 -1.0 1909294 Bionet1_002213 Clc1ccc(cc1)S(=O)Cc2cc(nc(n2)c3ccccn3)N4CCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K16 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1909295 Bionet1_002214 FC(F)(F)c1cnc(c(Cl)c1)n2cc(C=C(C#N)C#N)c3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K17 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1723501 Bionet1_002215 Clc1cc(Cl)cc(c1)C(=O)Nc2ccc(Sc3ccccc3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K18 compound treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 1909296 Bionet1_002216 CO/N=C\c1cn(c2ncc(cc2Cl)C(F)(F)F)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K19 compound treatment 0.073 -0.00526 -0.62 -0.6235 -1.0 1909297 Bionet1_002217 Clc1ccc(SCc2cc(nc(n2)c3ccccc3)N4CCCCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K20 compound treatment 0.071 -0.00726 -0.86 -0.8605 -1.0 1909298 Bionet1_002218 CCOC(=O)/C=C\c1cn(c2ncc(cc2Cl)C(F)(F)F)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K21 compound treatment 0.0715 -0.00676 -0.8 -0.8012 -1.0 1287437 Bionet1_002219 Cc1ccc(Sc2ccc(NC(=O)c3ccc(F)cc3)cc2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K22 compound treatment 0.0715 -0.00676 -0.8 -0.8012 -1.0 1909299 Bionet1_002220 CC(=O)/C=C\c1cn(c2ncc(cc2Cl)C(F)(F)F)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K23 mock treatment 0.073 -0.00526 -0.62 -0.6235 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 K24 mock treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L01 mock treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L02 mock treatment 0.0795 0.00124 0.15 0.1467 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L03 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1909300 Bionet1_002221 CCOC(=O)c1nnc(nc1Sc2ccccc2)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L04 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1909301 Bionet1_002222 Cc1ccc(CO/N=C\2/c3ccccc3-c4nnc(cc24)c5ccc(C)cc5)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L05 compound treatment 0.0805 0.00224 0.27 0.2652 1.0 1909302 Bionet1_002223 CCOC(=O)c1nnc(nc1Sc2ccccc2Cl)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L06 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1258226 Bionet1_002224 Clc1ccc(cc1)C(=O)c2c[nH]cc2c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L07 compound treatment 0.0855 0.00724 0.86 0.8576 1.0 1909303 Bionet1_002225 CCOC(=O)c1nnc(nc1Sc2cccc(Cl)c2)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L08 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1909304 Bionet1_002226 Clc1ccc(cc1)C(=O)c2c[nH]cc2c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L09 compound treatment 0.083 0.00474 0.56 0.5614 1.0 1909305 Bionet1_002227 CCOC(=O)c1nnc(nc1Sc2ccc(Cl)cc2)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L10 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1909306 Bionet1_002228 Clc1ccc(cc1)C(=O)c2c[nH]cc2c3cccc(Br)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L11 compound treatment 0.0775 -7.62E-4 -0.09 -0.0903 -1.0 1909307 Bionet1_002229 CCOC(=O)c1nnc(nc1Oc2ccccc2Cl)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L12 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1909308 Bionet1_002230 Clc1ccc(cc1)C(=O)c2c[nH]cc2c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L13 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1403197 Bionet1_002231 Cn1nc(c(C(O)C#Cc2ccccc2)c1Sc3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L14 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1909309 Bionet1_002232 Clc1ccc(cc1)C(=O)c2c[nH]cc2c3cccc(Cl)c3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L15 compound treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 1909310 Bionet1_002233 CCCCC#CC(O)c1c(Sc2ccc(C)cc2)n(C)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L16 compound treatment 0.081 0.00274 0.32 0.3244 1.0 1291198 Bionet1_002234 COc1ccc(cc1OC)C(=O)c2c[nH]cc2c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L17 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1909311 Bionet1_002235 CCCCC#CC(O)c1c(Sc2ccccc2)n(C)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L18 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1909312 Bionet1_002236 CSCc1cc(Sc2ccc(Cl)cc2)nc(n1)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L19 compound treatment 0.081 0.00274 0.32 0.3244 1.0 1909313 Bionet1_002237 Cc1ccc(Sc2c(C(O)c3cccs3)c(nn2C)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L20 compound treatment 0.0775 -7.62E-4 -0.09 -0.0903 -1.0 1909314 Bionet1_002238 CS(=O)(=O)Cc1cc(Sc2ccc(Cl)cc2)nc(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L21 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1909315 Bionet1_002239 CCOC(=O)c1nnc(nc1Oc2ccc(OC)cc2)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L22 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1728928 Bionet1_002240 CSc1cc(c2ccccc2)n(Cc3ccc(Cl)cc3)c(=O)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L23 mock treatment 0.0785 2.38E-4 0.03 0.0282 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 L24 mock treatment 0.08 0.00174 0.21 0.2059 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M01 mock treatment 0.0775 -7.62E-4 -0.09 -0.0903 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M02 mock treatment 0.09 0.0117 1.39 1.3908 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M03 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1546846 Bionet1_002241 Cc1ccc(Sc2ccc(NC(=O)c3ccccc3C)cc2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M04 compound treatment 0.0805 0.00224 0.27 0.2652 1.0 1909316 Bionet1_002242 [O-][N+](=O)/C=C\c1cn(c2ncc(cc2Cl)C(F)(F)F)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M05 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1243374 Bionet1_002243 Cc1ccc(Sc2ccc(NC(=O)c3ccccc3Cl)cc2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M06 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1632338 Bionet1_002244 Clc1ccc(nn1)N2CCC(CC2)C(=O)NCC3CC4CCCCN4O3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M07 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1635382 Bionet1_002245 Fc1ccc(cc1)C(=O)Nc2ccc(Sc3ccc(Cl)cc3)c(C#N)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M08 compound treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 1909317 Bionet1_002246 Cc1c(Br)c2ccccc2n1c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M09 compound treatment 0.0735 -0.00476 -0.56 -0.5642 -1.0 1909318 Bionet1_002247 CN(C)c1cc(CS(=O)c2ccc(Cl)cc2)nc(n1)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M10 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1909319 Bionet1_002248 FC(F)(F)c1cnc(c(Cl)c1)n2cc(Br)c3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M11 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1449907 Bionet1_002249 Cc1ccccc1Sc2ccc(NC(=O)c3ccc(F)cc3)cc2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M12 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1568934 Bionet1_002250 Clc1ccc(cc1)C2CC(=O)C(CS(=O)(=O)c3ccccc3)C(=O)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M13 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1443702 Bionet1_002251 Cc1ccccc1Sc2ccc(NC(=O)c3ccccc3Cl)cc2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M14 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1909320 Bionet1_002252 CN(C)/C=C/C(=O)c1cn(c2ncc(cc2Cl)C(F)(F)F)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M15 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1154525 Bionet1_002253 Cc1ccccc1Sc2ccc(NC(=O)c3cccc(Cl)c3)cc2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M16 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1909321 Bionet1_002254 NNC(=O)Cc1cn(c2ncc(cc2Cl)C(F)(F)F)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M17 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1297917 Bionet1_002255 Cc1ccc(Sc2ccc(NC(=O)c3cccc(C)c3)cc2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M18 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1909322 Bionet1_002256 FC(F)(F)Oc1ccc(N/C=C\2/CCN(C2=O)c3ncccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M19 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1229272 Bionet1_002257 COc1ccc(Sc2ccc(NC(=O)c3ccccc3Cl)cc2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M20 compound treatment 0.073 -0.00526 -0.62 -0.6235 -1.0 1909323 Bionet1_002258 COc1ccc(/C=C(\C#N)/c2ccc(s2)C(=O)c3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M21 compound treatment 0.0735 -0.00476 -0.56 -0.5642 -1.0 1643147 Bionet1_002259 COc1ccc(Sc2ccc(NC(=O)c3c(F)cccc3F)cc2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M22 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1909324 Bionet1_002260 COc1ccc(/C=C(\C#N)/c2ccc(s2)C(=O)c3ccc(OC)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M23 mock treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 M24 mock treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N01 mock treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N02 mock treatment 0.0775 -7.62E-4 -0.09 -0.0903 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N03 compound treatment 0.081 0.00274 0.32 0.3244 1.0 1909325 Bionet1_002261 Brc1ccc(Sc2nc3ccccc3cc2c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N04 compound treatment 0.0825 0.00424 0.5 0.5022 1.0 1909326 Bionet1_002262 CSc1cc(c2ccccc2)n(Cc3cccc(c3)C(F)(F)F)c(=O)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N05 compound treatment 0.094 0.0157 1.86 1.8648 1.0 1909327 Bionet1_002263 Clc1ccc(Sc2nc3ccccc3cc2c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N06 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1703342 Bionet1_002264 CSc1cc(c2ccccc2)n(Cc3ccc(cc3)C(C)(C)C)c(=O)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N07 compound treatment 0.082 0.00374 0.44 0.4429 1.0 1460201 Bionet1_002265 Fc1ccc(Sc2nc3ccccc3cc2c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N08 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1144549 Bionet1_002266 CSc1cc(c2ccc(Cl)cc2)n(Cc3ccc(F)cc3)c(=O)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N09 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1629546 Bionet1_002267 COc1ccc(Sc2nc3ccccc3cc2c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N10 compound treatment 0.0775 -7.62E-4 -0.09 -0.0903 -1.0 1450985 Bionet1_002268 CSc1cc(c2ccc(Cl)cc2)n(Cc3ccc(C)cc3)c(=O)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N11 compound treatment 0.0805 0.00224 0.27 0.2652 1.0 1909328 Bionet1_002269 Clc1ccc(cc1)c2cc3ccccc3nc2Sc4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N12 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1208224 Bionet1_002270 CSc1cc(c2ccc(Cl)cc2)n(Cc3ccccc3C)c(=O)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N13 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1909329 Bionet1_002271 Clc1ccc(cc1)c2cc3ccccc3nc2Sc4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N14 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1119335 Bionet1_002272 CSc1cc(c2ccc(Cl)cc2)n(Cc3ccccc3)c(=O)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N15 compound treatment 0.084 0.00574 0.68 0.6799 1.0 1909330 Bionet1_002273 Clc1ccc(Cl)c(Sc2nc3ccccc3cc2c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N16 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1479016 Bionet1_002274 CCOC(=O)Cn1c(cc(SC)c(C#N)c1=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N17 compound treatment 0.083 0.00474 0.56 0.5614 1.0 1909331 Bionet1_002275 Clc1ccc(Sc2nc3ccccc3cc2c4ccccc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N18 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1173778 Bionet1_002276 CSc1cc(c2ccccc2)n(Cc3cccc(F)c3)c(=O)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N19 compound treatment 0.0935 0.0152 1.81 1.8056 1.0 1909332 Bionet1_002277 Cc1ccc(cc1)c2cc3ccccc3nc2Sc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N20 compound treatment 0.082 0.00374 0.44 0.4429 1.0 1523934 Bionet1_002278 CSc1cc(c2ccccc2)n(Cc3ccccc3Cl)c(=O)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N21 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1909333 Bionet1_002279 Cc1ccc(cc1)c2cc3ccccc3nc2Sc4c(Cl)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N22 compound treatment 0.0805 0.00224 0.27 0.2652 1.0 1909334 Bionet1_002280 CC(Sc1ncc(cc1Cl)C(F)(F)F)c2ccnc3c(C#N)cnn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N23 mock treatment 0.0815 0.00324 0.38 0.3837 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 N24 mock treatment 0.0785 2.38E-4 0.03 0.0282 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O01 mock treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O02 mock treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O03 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1567916 Bionet1_002281 Cc1ccc(cc1)S(=O)c2ccc(NC(=O)c3ccccc3Cl)cc2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O04 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1909335 Bionet1_002282 CN(C)c1ccc(/C=C(\C#N)/c2ccc(s2)C(=O)c3ccccc3F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O05 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1677425 Bionet1_002283 Cc1ccc(cc1)S(=O)(=O)c2ccc(NC(=O)c3ccccc3C)cc2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O06 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1909336 Bionet1_002284 Cc1ccsc1/C=C(\C#N)/c2ccc(s2)C(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O07 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1909337 Bionet1_002285 CC(C)c1ccc(/C=C/c2ccc(=O)n(Cc3cccc(c3)C(F)(F)F)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O08 compound treatment 0.0725 -0.00576 -0.68 -0.6827 -1.0 1909338 Bionet1_002286 Fc1ccc(cc1)C(=O)c2ccc(s2)/C(=C/c3ccc(Cl)cc3)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O09 compound treatment 0.074 -0.00426 -0.5 -0.505 -1.0 1909339 Bionet1_002287 Cc1ccc(/C=C/c2ccc(=O)n(Cc3ccc(cc3)C(C)(C)C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O10 compound treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 1909340 Bionet1_002288 Fc1ccccc1C(=O)c2ccc(s2)/C(=C/c3ccc(Cl)cc3)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O11 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1909341 Bionet1_002289 Cc1ccc(/C=C/c2ccc(=O)n(Cc3ccc(Cl)cc3Cl)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O12 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1909342 Bionet1_002290 FC(F)(F)c1cnc(Oc2ccc(NC(=O)CCCCl)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O13 compound treatment 0.075 -0.00326 -0.39 -0.3865 -1.0 1313798 Bionet1_002291 COC(=O)c1cc(C#N)c(NCc2ccc(Cl)cc2Cl)nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O14 compound treatment 0.077 -0.00126 -0.15 -0.1495 -1.0 1909343 Bionet1_002292 FC(F)(F)c1cnc(Oc2cccc(NC(=O)CCCCl)c2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O15 compound treatment 0.0755 -0.00276 -0.33 -0.3273 -1.0 1354365 Bionet1_002293 CCOC(=O)c1cc(C#N)c(Sc2ccccc2)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O16 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1909344 Bionet1_002294 Cc1ccc(cc1)n2cc(c(n2)C(F)(F)F)c3ccc4ccccc4c3[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O17 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1909345 Bionet1_002295 CCOC(=O)c1cc(C#N)c(Sc2ccc(Cl)cc2)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O18 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1625467 Bionet1_002296 CCOC(=O)c1sc(NC(=O)Nc2ccccc2)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O19 compound treatment 0.0775 -7.62E-4 -0.09 -0.0903 -1.0 1305867 Bionet1_002297 CCOC(=O)c1cc(C#N)c(Sc2ccc(OC)cc2)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O20 compound treatment 0.079 7.38E-4 0.09 0.0875 1.0 1909346 Bionet1_002298 CCOC(=O)C(=CNc1nc(cs1)c2ccc(Cl)cc2)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O21 compound treatment 0.0745 -0.00376 -0.45 -0.4457 -1.0 1909347 Bionet1_002299 FC(F)(F)c1cccc(Cn2nc(/C=C/c3ccccc3)ccc2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O22 compound treatment 0.076 -0.00226 -0.27 -0.268 -1.0 1909348 Bionet1_002300 Cc1ccc(SCc2ccc(CSc3ccc(C)cc3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O23 mock treatment 0.0815 0.00324 0.38 0.3837 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 O24 mock treatment 0.0805 0.00224 0.27 0.2652 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P01 mock treatment 0.072 -0.00626 -0.74 -0.742 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P02 mock treatment 0.07 -0.00826 -0.98 -0.979 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P03 compound treatment 0.071 -0.00726 -0.86 -0.8605 -1.0 1909349 Bionet1_002301 Cc1ccc(cc1)c2cc3ccccc3nc2Sc4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P04 compound treatment 0.072 -0.00626 -0.74 -0.742 -1.0 1159528 Bionet1_002302 CC1(C)CC(=O)C2=C(C1)Nc3ccccc3NC2c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P05 compound treatment 0.064 -0.0143 -1.69 -1.6899 -1.0 1909350 Bionet1_002303 Cc1ccc(cc1)c2cc3ccccc3nc2Sc4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P06 compound treatment 0.073 -0.00526 -0.62 -0.6235 -1.0 1909351 Bionet1_002304 CC1(C)CC(=O)C2=C(C1)Nc3ccccc3NC2c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P07 compound treatment 0.083 0.00474 0.56 0.5614 1.0 1663387 Bionet1_002305 CC1CN(CC(C)O1)c2nc3ccccc3cc2c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P08 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1081417 Bionet1_002306 CC1(C)CC(=O)C2=C(C1)Nc3ccccc3NC2c4ccc(cc4)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P09 compound treatment 0.0815 0.00324 0.38 0.3837 1.0 1909352 Bionet1_002307 FC(F)(F)c1cccc(c1)c2cc3ccccc3nc2N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P10 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1572032 Bionet1_002308 Cc1cc2NC(C3=C(CCCC3=O)Nc2cc1C)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P11 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1909353 Bionet1_002309 Fc1ccc(OCc2ncc(cn2)c3ncc(cc3Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P12 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1462066 Bionet1_002310 Cc1cc2NC(C3=C(CCCC3=O)Nc2cc1C)c4ccc(Br)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P13 compound treatment 0.0795 0.00124 0.15 0.1467 1.0 1486895 Bionet1_002311 Clc1ccc(CN2CCC(CC2)c3cc([nH]n3)c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P14 compound treatment 0.0765 -0.00176 -0.21 -0.2088 -1.0 1909354 Bionet1_002312 Cc1cc2NC(C3=C(CCCC3=O)Nc2cc1C)c4ccc(cc4)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P15 compound treatment 0.08 0.00174 0.21 0.2059 1.0 1652067 Bionet1_002313 CCOC(=O)c1cnc2c(cc(Cl)cc2c1O)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P16 compound treatment 0.078 -2.62E-4 -0.03 -0.031 -1.0 1187202 Bionet1_002314 Cc1cc2NC(C3=C(CCCC3=O)Nc2cc1C)c4cccc(Br)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P17 compound treatment 0.081 0.00274 0.32 0.3244 1.0 1909355 Bionet1_002315 FC(F)(F)c1cnc(c(Cl)c1)C(C#N)(N2CCOCC2)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P18 compound treatment 0.0785 2.38E-4 0.03 0.0282 1.0 1303113 Bionet1_002316 Cc1ccc(cc1)C2Nc3cc(C)c(C)cc3NC4=C2C(=O)CC(C)(C)C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P19 compound treatment 0.0885 0.0102 1.21 1.2131 1.0 1909356 Bionet1_002317 [O-][N+](=O)c1ccc(CN2CCC(CC2)c3cc([nH]n3)c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P20 compound treatment 0.0825 0.00424 0.5 0.5022 1.0 1909357 Bionet1_002318 C/C(=N\Nc1ccc(OC(F)(F)F)cc1)/C(=N/O)/C(=O)Nc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P21 compound treatment 0.0775 -7.62E-4 -0.09 -0.0903 -1.0 1909358 Bionet1_002319 FC(F)(F)c1cc(N/N=C\2/C(=O)OC(=O)c3ccccc23)ccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P22 compound treatment 0.092 0.0137 1.63 1.6278 1.0 1563610 Bionet1_002320 COc1ccc(cc1)C2Nc3cc(C)c(C)cc3NC4=C2C(=O)CC(C)(C)C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P23 mock treatment 0.0775 -7.62E-4 -0.09 -0.0903 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.574 P24 mock treatment 0.071 -0.00726 -0.86 -0.8605 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A01 mock treatment 0.092 0.0154 1.82 1.8206 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A02 mock treatment 0.0845 0.00787 0.93 0.9319 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A03 compound treatment 0.085 0.00837 0.99 0.9912 1.0 1909359 Bionet1_002321 Fc1ccccc1CO/N=C/CC(=O)c2cnc(s2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A04 compound treatment 0.0875 0.0109 1.29 1.2874 1.0 1909360 Bionet1_002322 CC1=C(C(NC(=S)N1)c2ccc(Cl)cc2)C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A05 compound treatment 0.0905 0.0139 1.64 1.6429 1.0 1909361 Bionet1_002323 COc1ccc(cc1)S(=O)(=O)n2ccc(n2)c3cnc(s3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A06 compound treatment 0.066 -0.0106 -1.26 -1.2601 -1.0 1909362 Bionet1_002324 CC1=C(C(NC(=S)N1)c2c(F)cccc2Cl)C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A07 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1909363 Bionet1_002325 O=S(=O)(c1cccs1)n2ccc(n2)c3cnc(s3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A08 compound treatment 0.084 0.00737 0.87 0.8727 1.0 1909364 Bionet1_002326 CC1=C(C(N2C(=O)CSC2=N1)c3ccc(Cl)cc3)C(=O)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A09 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909365 Bionet1_002327 O=S(=O)(c1ccccc1)n2ccc(n2)c3cnc(s3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A10 compound treatment 0.0715 -0.00513 -0.61 -0.6084 -1.0 1452419 Bionet1_002328 CCOC(=O)C1=C(C)NC2=C(C1c3ccc(OC)cc3)C(=O)CC(C)(C)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A11 compound treatment 0.069 -0.00763 -0.9 -0.9047 -1.0 1909366 Bionet1_002329 Fc1ccc(cc1)S(=O)(=O)n2ccc(n2)c3cnc(s3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A12 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1228507 Bionet1_002330 CCOC(=O)c1c(C)nc2CC(C)(C)CC(=O)c2c1c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A13 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1743309 Bionet1_002331 COc1ccc(cc1)C(=O)n2ccc(n2)c3cnc(s3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A14 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909367 Bionet1_002332 CN(C)/C=C(\c1ccc(Cl)cc1)/S(=O)(=O)\C=C\c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A15 compound treatment 0.0795 0.00287 0.34 0.3395 1.0 1909368 Bionet1_002333 FC(F)(F)c1ccc(Oc2ccc(NC(=O)C3CC3)cc2Cl)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A16 compound treatment 0.0685 -0.00813 -0.96 -0.9639 -1.0 1909369 Bionet1_002334 COc1ccc(/C=C/C(=O)NC(=S)Nc2ccc(F)cc2C)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A17 compound treatment 0.0795 0.00287 0.34 0.3395 1.0 1909370 Bionet1_002335 Cc1c(sc(C#N)c1c2ccccc2)C(=O)N/C=N/OCc3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A18 compound treatment 0.081 0.00437 0.52 0.5172 1.0 1909371 Bionet1_002336 Cc1ccc(cc1)c2nc(ncc2N=Nc3cccc(C)c3C)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A19 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1909372 Bionet1_002337 COc1cc(NC(=O)c2ccccc2CC[N+](=O)[O-])cc(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A20 compound treatment 0.0775 8.65E-4 0.1 0.1025 1.0 1909373 Bionet1_002338 CCOC(=O)C1=C(NC2=C(C1c3ccc(F)cc3)C(=O)CCC2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A21 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1909374 Bionet1_002339 [O-][N+](=O)CCc1ccccc1NC(=O)N2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A22 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909375 Bionet1_002340 O=c1n(c(SCc2ccccc2)nc3ccsc13)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A23 mock treatment 0.0825 0.00587 0.69 0.695 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 A24 mock treatment 0.0815 0.00487 0.58 0.5765 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B01 mock treatment 0.0835 0.00687 0.81 0.8134 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B02 mock treatment 0.0895 0.0129 1.52 1.5244 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B03 compound treatment 0.0805 0.00387 0.46 0.458 1.0 1909376 Bionet1_002341 CS(=O)c1ccccc1c2nc(no2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B04 compound treatment 0.087 0.0104 1.23 1.2282 1.0 1909377 Bionet1_002342 Clc1ccc(Cn2nc(/C=C/c3ccccc3)ccc2=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B05 compound treatment 0.088 0.0114 1.35 1.3466 1.0 1909378 Bionet1_002343 CS(=O)(=O)c1ccccc1c2nc(no2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B06 compound treatment 0.0835 0.00687 0.81 0.8134 1.0 1909379 Bionet1_002344 CCOC(=O)c1cc(C#N)c(Sc2ccccc2Cl)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B07 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1503315 Bionet1_002345 CC(C)(C)c1ccc(cc1)c2noc(n2)c3ccccc3S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B08 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1135151 Bionet1_002346 CCOC(=O)c1cc(C#N)c(Oc2cc(C)cc(C)c2)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B09 compound treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 1909380 Bionet1_002347 CS(=O)c1ccccc1c2nc(no2)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B10 compound treatment 0.0655 -0.0111 -1.32 -1.3194 -1.0 1554904 Bionet1_002348 CCOC(=O)c1cc(C#N)c(Oc2ccc(F)cc2)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B11 compound treatment 0.068 -0.00863 -1.02 -1.0232 -1.0 1909381 Bionet1_002349 CS(=O)(=O)c1ccccc1c2nc(no2)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B12 compound treatment 0.0715 -0.00513 -0.61 -0.6084 -1.0 1909382 Bionet1_002350 CCOC(=O)c1cc(C#N)c(Oc2ccccc2OC)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B13 compound treatment 0.066 -0.0106 -1.26 -1.2601 -1.0 1909383 Bionet1_002351 COc1ccc(cc1)C(=O)O/N=C/2\C(=O)N(c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B14 compound treatment 0.068 -0.00863 -1.02 -1.0232 -1.0 1651941 Bionet1_002352 CCOC(=O)c1cc(C#N)c(Oc2ccc(Cl)cc2C)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B15 compound treatment 0.0665 -0.0101 -1.2 -1.2009 -1.0 1909384 Bionet1_002353 Cc1ccc(cc1)C(=O)O/N=C/2\C(=O)N(c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B16 compound treatment 0.0655 -0.0111 -1.32 -1.3194 -1.0 1227034 Bionet1_002354 O=S(=O)(Cc1cc(nc(n1)c2ccncc2)N3CCOCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B17 compound treatment 0.069 -0.00763 -0.9 -0.9047 -1.0 1909385 Bionet1_002355 Clc1ccc(cc1)C(=O)O/N=C/2\C(=O)N(c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B18 compound treatment 0.0705 -0.00613 -0.73 -0.7269 -1.0 1458986 Bionet1_002356 O=S(Cc1cc(nc(n1)c2ccccc2)N3CCOCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B19 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909386 Bionet1_002357 Clc1ccccc1C(=O)O/N=C/2\C(=O)N(c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B20 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1718922 Bionet1_002358 CCOC(=O)c1cc(C#N)c(NCc2ccccc2)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B21 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909387 Bionet1_002359 Cc1ccccc1C(=O)O/N=C/2\C(=O)N(c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B22 compound treatment 0.0705 -0.00613 -0.73 -0.7269 -1.0 1175752 Bionet1_002360 CCOC(=O)c1cc(C#N)c(nc1c2ccccc2)N(C)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B23 mock treatment 0.071 -0.00563 -0.67 -0.6677 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 B24 mock treatment 0.068 -0.00863 -1.02 -1.0232 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C01 mock treatment 0.081 0.00437 0.52 0.5172 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C02 mock treatment 0.083 0.00637 0.75 0.7542 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C03 compound treatment 0.084 0.00737 0.87 0.8727 1.0 1909388 Bionet1_002361 [O-][N+](=O)CCc1ccccc1NC(=O)Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C04 compound treatment 0.086 0.00937 1.11 1.1097 1.0 1909389 Bionet1_002362 FC(F)(F)c1cccc(Sc2nnc(cc2C#N)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C05 compound treatment 0.089 0.0124 1.47 1.4651 1.0 1909390 Bionet1_002363 CCOc1ccccc1N2CCN(CC2)c3cc(Cl)nc(SC)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C06 compound treatment 0.0825 0.00587 0.69 0.695 1.0 1909391 Bionet1_002364 Cc1ccc(cc1)c2nc(C)ncc2N=Nc3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C07 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909392 Bionet1_002365 CSc1nc(Cl)cc(n1)N2CCN(CC2)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C08 compound treatment 0.0935 0.0169 2.0 1.9983 1.0 1909393 Bionet1_002366 COc1ccc(N=Nc2cnc(nc2c3ccc(OC)cc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C09 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1413630 Bionet1_002367 Cc1cc(nc(SCc2ccc(Cl)cc2Cl)n1)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C10 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1909394 Bionet1_002368 COc1ccc(N=Nc2cnc(nc2c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C11 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1909395 Bionet1_002369 Clc1ccc(CSCc2cc(Cl)nc(n2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C12 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909396 Bionet1_002370 COc1ccc(N=Nc2cnc(nc2c3ccccc3)c4ccncc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C13 compound treatment 0.0685 -0.00813 -0.96 -0.9639 -1.0 1909397 Bionet1_002371 Cc1nc(CSc2ccc(Cl)cc2)cc(OCc3cccc(Cl)c3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C14 compound treatment 0.066 -0.0106 -1.26 -1.2601 -1.0 1909398 Bionet1_002372 Cc1cccc(N=Nc2cnc(nc2c3cccs3)c4ccncc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C15 compound treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 1909399 Bionet1_002373 Cc1nc(CS(=O)(=O)c2ccccc2)cc(Sc3ccc(Cl)cc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C16 compound treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 1909400 Bionet1_002374 Cc1cccc(N=Nc2cnc(nc2c3cccs3)c4ccccn4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C17 compound treatment 0.0725 -0.00413 -0.49 -0.4899 -1.0 1909401 Bionet1_002375 Cc1ccc(Sc2cc(CS(=O)(=O)c3ccccc3)nc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C18 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1909402 Bionet1_002376 Clc1ccc(N=Nc2cnc(nc2c3cccs3)c4cccnc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C19 compound treatment 0.0775 8.65E-4 0.1 0.1025 1.0 1909403 Bionet1_002377 Cc1nc(CS(=O)(=O)c2ccccc2)cc(Sc3ccccc3Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C20 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1552166 Bionet1_002378 CCOC(=O)c1cc(nnc1Sc2ccc(F)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C21 compound treatment 0.079 0.00237 0.28 0.2802 1.0 1909404 Bionet1_002379 COc1ccc(Sc2cc(CS(=O)(=O)c3ccccc3)nc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C22 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909405 Bionet1_002380 COc1ccc(cc1)c2nc(ncc2N=Nc3ccc(F)cc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C23 mock treatment 0.077 3.65E-4 0.04 0.0433 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 C24 mock treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D01 mock treatment 0.0775 8.65E-4 0.1 0.1025 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D02 mock treatment 0.0795 0.00287 0.34 0.3395 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D03 compound treatment 0.0815 0.00487 0.58 0.5765 1.0 1909406 Bionet1_002381 Clc1ccc(CO/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D04 compound treatment 0.0835 0.00687 0.81 0.8134 1.0 1591763 Bionet1_002382 CCOC(=O)c1cc(C#N)c(NCc2ccc(Cl)cc2)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D05 compound treatment 0.0865 0.00987 1.17 1.1689 1.0 1909407 Bionet1_002383 Fc1cccc(Cl)c1CO/N=C/2\C(=O)N(c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D06 compound treatment 0.0915 0.0149 1.76 1.7614 1.0 1232522 Bionet1_002384 CCOC(=O)c1cc(C#N)c(NCc2ccccc2OC)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D07 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909408 Bionet1_002385 CC(C)(C)c1ccc(CO/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D08 compound treatment 0.087 0.0104 1.23 1.2282 1.0 1313129 Bionet1_002386 CCOC(=O)c1cc(C#N)c(NCc2cccc(Cl)c2)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D09 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909409 Bionet1_002387 FC(F)(F)c1cccc(CO/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D10 compound treatment 0.0875 0.0109 1.29 1.2874 1.0 1456466 Bionet1_002388 CCOC(=O)c1cc(C#N)c(NCc2ccc(C)cc2)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D11 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1909410 Bionet1_002389 Clc1cccc(Cl)c1CO/N=C\2/C(=O)N(c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D12 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1909411 Bionet1_002390 FC(F)(F)c1cc(Nc2nnnc3ccccc23)cc(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D13 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1909412 Bionet1_002391 On1c(nc2ccc(Br)cc2c1=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D14 compound treatment 0.077 3.65E-4 0.04 0.0433 1.0 1909413 Bionet1_002392 O=S(Cc1cc(Oc2ccccc2)nc(n1)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D15 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1240287 Bionet1_002393 On1c(nc2ccc(Br)cc2c1=O)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D16 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1909414 Bionet1_002394 [O-][N+](=O)c1ccc(Oc2nc(nc3ccccc23)C(F)(F)F)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D17 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1734265 Bionet1_002395 On1c(nc2ccc(Br)cc2c1=O)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D18 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1909415 Bionet1_002396 FC(F)(F)c1nc(N/N=C/c2ccc(Cl)cc2)c3ccccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D19 compound treatment 0.079 0.00237 0.28 0.2802 1.0 1312519 Bionet1_002397 On1c(nc2ccc(Br)cc2c1=O)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D20 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909416 Bionet1_002398 [O-][N+](=O)c1cccc(/C=N/Nc2nc(nc3ccccc23)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D21 compound treatment 0.081 0.00437 0.52 0.5172 1.0 1719573 Bionet1_002399 On1c(nc2ccc(Br)cc2c1=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D22 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909417 Bionet1_002400 [O-][N+](=O)c1cccc(c1)c2nnc3c4ccccc4nc(n23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D23 mock treatment 0.08 0.00337 0.4 0.3987 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 D24 mock treatment 0.084 0.00737 0.87 0.8727 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E01 mock treatment 0.0805 0.00387 0.46 0.458 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E02 mock treatment 0.0825 0.00587 0.69 0.695 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E03 compound treatment 0.0845 0.00787 0.93 0.9319 1.0 1183316 Bionet1_002401 Cc1nc(CS(=O)(=O)c2ccc(Cl)cc2)cc(n1)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E04 compound treatment 0.094 0.0174 2.06 2.0576 1.0 1909418 Bionet1_002402 Cc1ccc(cc1)c2nc(N)ncc2N=Nc3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E05 compound treatment 0.087 0.0104 1.23 1.2282 1.0 1909419 Bionet1_002403 COc1cc(c(Cl)cc1Cl)n2nnnc2c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E06 compound treatment 0.083 0.00637 0.75 0.7542 1.0 1909420 Bionet1_002404 Cc1nn(nc1C(=O)Nc2ccc(Br)cc2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E07 compound treatment 0.083 0.00637 0.75 0.7542 1.0 1909421 Bionet1_002405 COc1cc(NC(=O)c2cccc(c2)C(F)(F)F)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E08 compound treatment 0.0795 0.00287 0.34 0.3395 1.0 1658815 Bionet1_002406 Cc1snc2sc(C(=O)c3ccc(Br)cc3)c(N)c12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E09 compound treatment 0.081 0.00437 0.52 0.5172 1.0 1727351 Bionet1_002407 CC(C)Oc1cc(NC(=O)c2ccc(Cl)c(Cl)c2)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E10 compound treatment 0.0775 8.65E-4 0.1 0.1025 1.0 1250104 Bionet1_002408 Cc1cc(C)n(Cc2ccccc2)c(=O)c1S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E11 compound treatment 0.0825 0.00587 0.69 0.695 1.0 1909422 Bionet1_002409 COc1cc(c(Cl)cc1Cl)n2nnnc2c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E12 compound treatment 0.079 0.00237 0.28 0.2802 1.0 1649533 Bionet1_002410 Cc1cc(C)n(Cc2ccc(Cl)cc2)c(=O)c1S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E13 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909423 Bionet1_002411 COc1cc(c(Cl)cc1Cl)n2nnnc2c3c(F)cccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E14 compound treatment 0.084 0.00737 0.87 0.8727 1.0 1163023 Bionet1_002412 Cc1cc(C)c(c(SCc2ccccc2)n1)S(=O)(=O)c3ccccc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E15 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909424 Bionet1_002413 COCCOc1cc(NC(=O)c2ccccc2Cl)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E16 compound treatment 0.083 0.00637 0.75 0.7542 1.0 1909425 Bionet1_002414 CCCCSc1nc(C)cc(C)c1S(=O)(=O)c2ccccc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E17 compound treatment 0.092 0.0154 1.82 1.8206 1.0 1909426 Bionet1_002415 COCCOc1cc(NC(=O)c2cccc(OC)c2)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E18 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1562043 Bionet1_002416 Cc1cc([nH]c(=O)c1S(=O)(=O)c2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E19 compound treatment 0.079 0.00237 0.28 0.2802 1.0 1133687 Bionet1_002417 CCOC(=O)COc1cc(NC(=O)c2ccc(OC)cc2)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E20 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1280487 Bionet1_002418 CC(C)CSc1nc(C)cc(C)c1S(=O)(=O)c2ccccc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E21 compound treatment 0.0805 0.00387 0.46 0.458 1.0 1909427 Bionet1_002419 CC(C)Oc1cc(c(Cl)cc1Cl)n2nnnc2c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E22 compound treatment 0.077 3.65E-4 0.04 0.0433 1.0 1145208 Bionet1_002420 Cc1cc(C)c(c(Oc2ccccc2)n1)S(=O)(=O)c3ccccc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E23 mock treatment 0.0785 0.00187 0.22 0.221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 E24 mock treatment 0.0775 8.65E-4 0.1 0.1025 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F01 mock treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F02 mock treatment 0.077 3.65E-4 0.04 0.0433 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F03 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1710801 Bionet1_002421 CCOC(=O)COc1cc(N2C(=O)CSCC2=O)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F04 compound treatment 0.0805 0.00387 0.46 0.458 1.0 1909428 Bionet1_002422 COc1ccc(cc1)C(=O)NN(C)c2nc(nc3ccccc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F05 compound treatment 0.0865 0.00987 1.17 1.1689 1.0 1335341 Bionet1_002423 Clc1cc(Cl)c(cc1OCc2ccccc2)N3C(=O)CSCC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F06 compound treatment 0.081 0.00437 0.52 0.5172 1.0 1909429 Bionet1_002424 FC(F)(F)c1nc(NNC(=O)c2ccc(Cl)cc2)c3ccccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F07 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1909430 Bionet1_002425 COCCOc1cc(N2C(=O)CSCC2=O)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F08 compound treatment 0.0835 0.00687 0.81 0.8134 1.0 1909431 Bionet1_002426 CN(NC(=O)c1ccccc1F)c2nc(nc3ccccc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F09 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909432 Bionet1_002427 Clc1ccc(CO/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F10 compound treatment 0.0775 8.65E-4 0.1 0.1025 1.0 1460281 Bionet1_002428 O=S(=O)(N1CCN(CC1)c2ccccn2)c3ccc(s3)c4csnn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F11 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909433 Bionet1_002429 COc1ccc(CO/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F12 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909434 Bionet1_002430 COc1ccc(OS(=O)(=O)c2ccc(s2)c3csnn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F13 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909435 Bionet1_002431 Clc1cccc(CO/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F14 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1909436 Bionet1_002432 CC(C)(C)c1ccc(OS(=O)(=O)c2ccc(s2)c3csnn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F15 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909437 Bionet1_002433 COc1ccnc(Oc2ccc(F)cc2)c1C(=O)N/C=N/OCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F16 compound treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 1909438 Bionet1_002434 Clc1ccc(OS(=O)(=O)c2ccc(s2)c3csnn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F17 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1166185 Bionet1_002435 COc1ccnc(Nc2ccc(I)cc2)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F18 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1909439 Bionet1_002436 Cc1cc(C)cc(OS(=O)(=O)c2ccc(s2)c3csnn3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F19 compound treatment 0.077 3.65E-4 0.04 0.0433 1.0 1737568 Bionet1_002437 COc1ccnc(N2CCN(CC2)C(c3ccccc3)c4ccccc4)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F20 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1909440 Bionet1_002438 CC(=O)Nc1cccc(OS(=O)(=O)c2ccc(s2)c3csnn3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F21 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909441 Bionet1_002439 COc1ccnc(N/C=N/OCc2cccc(c2)C(F)(F)F)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F22 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909442 Bionet1_002440 NC(=O)C(c1ccc(Cl)cc1)c2nc3ccccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F23 mock treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 F24 mock treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G01 mock treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G02 mock treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G03 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1909443 Bionet1_002441 COCCOc1cc(c(Cl)cc1Cl)n2nnnc2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G04 compound treatment 0.077 3.65E-4 0.04 0.0433 1.0 1433540 Bionet1_002442 Cc1cc(C)c(c(NCc2ccccc2)n1)S(=O)(=O)c3ccccc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G05 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909444 Bionet1_002443 COCCOc1cc(c(Cl)cc1Cl)n2nnnc2c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G06 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1274557 Bionet1_002444 Cc1ccccc1S(=O)(=O)c2c(C)c(c(C)nc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G07 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909445 Bionet1_002445 COCCOc1cc(c(Cl)cc1Cl)n2nnnc2c3cccc(OC)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G08 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1332850 Bionet1_002446 Cc1cc(C)c(c(OCCN2CCOCC2)n1)S(=O)(=O)c3ccccc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G09 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1171195 Bionet1_002447 COc1cc(c(Cl)cc1Cl)n2c(S)nc3ccccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G10 compound treatment 0.0715 -0.00513 -0.61 -0.6084 -1.0 1909446 Bionet1_002448 COc1cccc(c1)C(=O)O/N=C/c2ccc(Sc3ccc(C)cc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G11 compound treatment 0.0715 -0.00513 -0.61 -0.6084 -1.0 1169258 Bionet1_002449 COc1cc(c(Cl)cc1Cl)n2c(SC)nc3ccccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G12 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1909447 Bionet1_002450 Cc1ccc(Oc2ccc(/C=N/OCc3ccc(Cl)cc3Cl)cn2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G13 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1514662 Bionet1_002451 COc1cc(c(Cl)cc1Cl)n2c(SCC=C)nc3ccccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G14 compound treatment 0.0715 -0.00513 -0.61 -0.6084 -1.0 1909448 Bionet1_002452 Fc1ccc(CO/N=C/c2ccc(Sc3ccc(Cl)cc3)nc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G15 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909449 Bionet1_002453 COc1cc(NS(=O)(=O)c2ccc(Cl)cc2)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G16 compound treatment 0.0705 -0.00613 -0.73 -0.7269 -1.0 1909450 Bionet1_002454 COc1ccc(cc1)C(=O)O/N=C/c2ccc(Sc3ccc(Cl)cc3)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G17 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909451 Bionet1_002455 COc1cc(NS(=O)(=O)c2ccc(F)cc2)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G18 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1909452 Bionet1_002456 Cc1ccc(Sc2ccc(/C=N/OC(=O)c3ccccc3Cl)cn2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G19 compound treatment 0.0815 0.00487 0.58 0.5765 1.0 1215028 Bionet1_002457 CC(C)Oc1cc(NS(=O)(=O)c2ccc(Cl)cc2)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G20 compound treatment 0.0705 -0.00613 -0.73 -0.7269 -1.0 1909453 Bionet1_002458 CC(C)CC(=O)O/N=C/c1ccc(nc1)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G21 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1909454 Bionet1_002459 Clc1ccc(CSCc2cc(nc(n2)c3ccccc3)N4CCCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G22 compound treatment 0.0815 0.00487 0.58 0.5765 1.0 1909455 Bionet1_002460 CSc1ccccc1c2nnc(SCc3ccc(Cl)cc3Cl)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G23 mock treatment 0.07 -0.00663 -0.79 -0.7862 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 G24 mock treatment 0.0675 -0.00913 -1.08 -1.0824 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H01 mock treatment 0.077 3.65E-4 0.04 0.0433 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H02 mock treatment 0.078 0.00137 0.16 0.1617 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H03 compound treatment 0.08 0.00337 0.4 0.3987 1.0 1909456 Bionet1_002461 COc1ccnc(N/C=N/OCCOc2cccc(c2)C(F)(F)F)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H04 compound treatment 0.0835 0.00687 0.81 0.8134 1.0 1909457 Bionet1_002462 CCn1ncc(NCCNc2ncc(cc2Cl)C(F)(F)F)c(Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H05 compound treatment 0.0835 0.00687 0.81 0.8134 1.0 1469928 Bionet1_002463 COc1ccnc(Oc2ccc(cc2)S(=O)(=O)N3CCOCC3)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H06 compound treatment 0.08 0.00337 0.4 0.3987 1.0 1183788 Bionet1_002464 COc1ccc(cc1)n2ncc(ON3C(=O)CCC3=O)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H07 compound treatment 0.082 0.00537 0.64 0.6357 1.0 1909458 Bionet1_002465 COc1ccnc(N/C=N/OCc2cccc(Cl)c2Cl)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H08 compound treatment 0.089 0.0124 1.47 1.4651 1.0 1543954 Bionet1_002466 COc1ccc(cc1)n2ncc(N(C)CCOC(=O)C3CC3)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H09 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909459 Bionet1_002467 COc1ccnc(N2CCN(CC2)c3cccc(c3)C(F)(F)F)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H10 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1601814 Bionet1_002468 COc1ccc(cc1)n2ncc(NCCc3ccccn3)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H11 compound treatment 0.077 3.65E-4 0.04 0.0433 1.0 1330160 Bionet1_002469 COc1ccnc(Oc2ccc(cc2)S(=O)(=O)NC(C)(C)C)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H12 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909460 Bionet1_002470 CN(CCO)c1cnn(c2ncc(cc2Cl)C(F)(F)F)c(=O)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H13 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1909461 Bionet1_002471 COc1ccnc(c1C#N)n2cccc2/C=N/OCc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H14 compound treatment 0.0725 -0.00413 -0.49 -0.4899 -1.0 1909462 Bionet1_002472 FC(F)(F)c1cnc(c(Cl)c1)n2ncc(N3CCNCC3)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H15 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909463 Bionet1_002473 COc1cccc(CO/N=C/c2cccn2c3nccc(OC)c3C#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H16 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1909464 Bionet1_002474 FC(F)(F)c1cnc(c(Cl)c1)n2nccc2c3sccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H17 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1909465 Bionet1_002475 COc1ccnc(c1C#N)n2cccc2/C=N/OCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H18 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1401731 Bionet1_002476 Clc1ccc(c(Cl)c1)n2ncc(N3CCC(=O)CC3)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H19 compound treatment 0.0805 0.00387 0.46 0.458 1.0 1909466 Bionet1_002477 COc1ccnc(c1C#N)n2cccc2/C=N/OCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H20 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1238514 Bionet1_002478 COc1ccc(cc1)n2ncc(N3CCC(CC3)C(=O)N)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H21 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909467 Bionet1_002479 CO/N=C/NC(=O)c1c(OC)ccnc1Oc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H22 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909468 Bionet1_002480 FC(F)(F)c1cnc(c(Cl)c1)n2ncc(N3CCOCC3)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H23 mock treatment 0.077 3.65E-4 0.04 0.0433 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 H24 mock treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I01 mock treatment 0.0795 0.00287 0.34 0.3395 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I02 mock treatment 0.078 0.00137 0.16 0.1617 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I03 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909469 Bionet1_002481 CN(C)c1cc(CSCc2ccc(Cl)cc2)nc(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I04 compound treatment 0.08 0.00337 0.4 0.3987 1.0 1471760 Bionet1_002482 CS(=O)c1ccccc1COC(=O)Nc2cc(Cl)cc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I05 compound treatment 0.079 0.00237 0.28 0.2802 1.0 1296388 Bionet1_002483 Sc1nccn1c2cc(OCc3ccccc3)c(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I06 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1909470 Bionet1_002484 CS(=O)(=O)c1ccccc1COC(=O)Nc2cc(Cl)cc(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I07 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1490195 Bionet1_002485 COc1cc(c(Cl)cc1Cl)n2ccnc2SCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I08 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909471 Bionet1_002486 CSc1ccccc1c2nnc(SCc3ccc(Cl)c(Cl)c3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I09 compound treatment 0.0725 -0.00413 -0.49 -0.4899 -1.0 1705425 Bionet1_002487 CSc1nccn1c2cc(OCc3ccccc3)c(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I10 compound treatment 0.0695 -0.00713 -0.85 -0.8454 -1.0 1909472 Bionet1_002488 CSc1ccccc1c2nnc(SCc3ccc(cc3)C(C)(C)C)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I11 compound treatment 0.0695 -0.00713 -0.85 -0.8454 -1.0 1909473 Bionet1_002489 COCCOc1cc(NS(=O)(=O)c2ccccc2)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I12 compound treatment 0.0655 -0.0111 -1.32 -1.3194 -1.0 1909474 Bionet1_002490 FC(F)(F)c1cccc(NC(=O)NNC(=O)C2Cc3cncn3C(=O)N2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I13 compound treatment 0.0605 -0.0161 -1.91 -1.9118 -1.0 1209136 Bionet1_002491 CS(=O)(=O)Cc1cc(NCc2ccccc2)nc(n1)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I14 compound treatment 0.0675 -0.00913 -1.08 -1.0824 -1.0 1669035 Bionet1_002492 CCOC(=O)Cc1ncccc1C(=O)Nc2ccc(Oc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I15 compound treatment 0.082 0.00537 0.64 0.6357 1.0 1909475 Bionet1_002493 CS(=O)(=O)Cc1cc(Sc2ccccc2)nc(n1)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I16 compound treatment 0.0695 -0.00713 -0.85 -0.8454 -1.0 1909476 Bionet1_002494 CCOC(=O)Cc1ncccc1C(=O)Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I17 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1909477 Bionet1_002495 CSCc1cc(Sc2ccc(Cl)cc2)nc(n1)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I18 compound treatment 0.071 -0.00563 -0.67 -0.6677 -1.0 1909478 Bionet1_002496 CCOC(=O)Cc1ncccc1C(=O)Nc2ccc(OC(F)(F)F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I19 compound treatment 0.077 3.65E-4 0.04 0.0433 1.0 1909479 Bionet1_002497 COc1cc(NS(=O)(=O)c2cccc(c2)C(F)(F)F)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I20 compound treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 1722980 Bionet1_002498 COc1ccc(NC(=O)CC(=O)Nc2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I21 compound treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 1909480 Bionet1_002499 CN(NC(=O)Nc1ccc(Cl)cc1)c2nc3ccccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I22 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1466830 Bionet1_002500 Clc1ccc(NC(=O)CC(=O)Nc2ccc(Cl)c(Cl)c2)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I23 mock treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 I24 mock treatment 0.0725 -0.00413 -0.49 -0.4899 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J01 mock treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J02 mock treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J03 compound treatment 0.0815 0.00487 0.58 0.5765 1.0 1909481 Bionet1_002501 COc1ccnc(Oc2ccccc2)c1C(=O)N/C=N/OCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J04 compound treatment 0.081 0.00437 0.52 0.5172 1.0 1909482 Bionet1_002502 CN1C(=O)N(C)C(=O)C(=Cc2c(C)nn(c2OCC=C)c3ccccc3)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J05 compound treatment 0.0815 0.00487 0.58 0.5765 1.0 1909483 Bionet1_002503 COc1ccnc(Oc2ccccc2)c1C(=O)N/C=N/OCc3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J06 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1327076 Bionet1_002504 COc1ccc(cc1)N2CCN(CC2)c3cc(O)n(C4CCCCC4)c(=O)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J07 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909484 Bionet1_002505 COc1ccc(cc1)N2C(=O)/C(=C/c3ccc(cc3)C(C)C)/NC2=S 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J08 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1653614 Bionet1_002506 Oc1cc(nc(=O)n1C2CCCCC2)N3CCN(CC3)c4cccc(Cl)n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J09 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909485 Bionet1_002507 CCOC(=O)CNC(=S)NNc1ncc(cc1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J10 compound treatment 0.0725 -0.00413 -0.49 -0.4899 -1.0 1909486 Bionet1_002508 Clc1ccsc1C(=O)c2conc2c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J11 compound treatment 0.0775 8.65E-4 0.1 0.1025 1.0 1909487 Bionet1_002509 FC(F)(F)c1nc2ccccc2nc1SCC(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J12 compound treatment 0.07 -0.00663 -0.79 -0.7862 -1.0 1909488 Bionet1_002510 Clc1ccc(/C=C/C(=O)c2sccc2Br)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J13 compound treatment 0.069 -0.00763 -0.9 -0.9047 -1.0 1909489 Bionet1_002511 FC(F)(F)c1ccc(N/C=C(\C=C\C#N)/S(=O)(=O)c2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J14 compound treatment 0.069 -0.00763 -0.9 -0.9047 -1.0 1909490 Bionet1_002512 CS(=O)c1ccc(NC(=O)c2cccc(c2)C(F)(F)F)cc1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J15 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1909491 Bionet1_002513 COC(=O)/C=C/C(=C\Nc1ccc(OC)cc1)/S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J16 compound treatment 0.071 -0.00563 -0.67 -0.6677 -1.0 1624052 Bionet1_002514 CSc1ccc(NC(=O)c2ccccc2C(=O)c3ccc(F)cc3)cc1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J17 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909492 Bionet1_002515 COC(=O)c1ccccc1N/C=C/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J18 compound treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 1656894 Bionet1_002516 CS(=O)(=O)c1ccc(NC(=O)c2cc(Cl)ccc2Cl)cc1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J19 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909493 Bionet1_002517 COC(=O)/C=C/C(=C\Nc1ccc(F)cc1)/S(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J20 compound treatment 0.0715 -0.00513 -0.61 -0.6084 -1.0 1559389 Bionet1_002518 CS(=O)(=O)c1ccc(NC(=O)c2cc(F)c(F)cc2Cl)cc1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J21 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909494 Bionet1_002519 Cc1cc(C)c(CSC(C)(C)CNC(=O)c2cccc(c2)[N+](=O)[O-])c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J22 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1121925 Bionet1_002520 CS(=O)c1ccc(NC(=O)c2ccc(Cl)cc2Cl)cc1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J23 mock treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 J24 mock treatment 0.071 -0.00563 -0.67 -0.6677 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K01 mock treatment 0.0795 0.00287 0.34 0.3395 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K02 mock treatment 0.082 0.00537 0.64 0.6357 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K03 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1909495 Bionet1_002521 FC(F)(F)c1nc2ccccc2nc1N/N=C/c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K04 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909496 Bionet1_002522 CN(/N=C/C1CC(=O)NC(=C1C#N)C)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K05 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1909497 Bionet1_002523 FC(F)(F)c1nc2ccccc2nc1N/N=C/c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K06 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1909498 Bionet1_002524 FC(F)(F)c1cccc(CO/N=C\2/COc3ccc4ccccc4c23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K07 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909499 Bionet1_002525 FC(F)(F)c1nc2ccccc2n3c(nnc13)c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K08 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1909500 Bionet1_002526 FC(F)(F)c1cccc(OCCO/N=C\2/COc3ccc4ccccc4c23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K09 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1909501 Bionet1_002527 Cc1ccc(cc1)S(=O)(=O)NNc2nc3ccccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K10 compound treatment 0.0725 -0.00413 -0.49 -0.4899 -1.0 1279015 Bionet1_002528 Clc1ccc(cc1Cl)c2cnc3c(NC(=O)c4cccs4)cccn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K11 compound treatment 0.0715 -0.00513 -0.61 -0.6084 -1.0 1909502 Bionet1_002529 CN(NC(=O)c1ccccc1C)c2nc3ccccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K12 compound treatment 0.0705 -0.00613 -0.73 -0.7269 -1.0 1909503 Bionet1_002530 FC(F)(F)c1cccc(N/C=C/2\Oc3ccc4ccccc4c3C2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K13 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1909504 Bionet1_002531 CN(NC(=O)c1ccc(Cl)cc1)c2nc3ccccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K14 compound treatment 0.07 -0.00663 -0.79 -0.7862 -1.0 1909505 Bionet1_002532 COC(=O)c1ccncc1C(=O)NN(C)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K15 compound treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 1909506 Bionet1_002533 FC(F)(F)c1nc2ccccc2nc1NNC(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K16 compound treatment 0.0715 -0.00513 -0.61 -0.6084 -1.0 1909507 Bionet1_002534 CC1=C(CCC(=O)N1Cc2ccccc2)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K17 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1909508 Bionet1_002535 Cc1ccc(/C=N/Nc2ccc3c(cc(nc3n2)C(F)(F)F)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K18 compound treatment 0.0725 -0.00413 -0.49 -0.4899 -1.0 1412030 Bionet1_002536 COc1ccc(NC(=O)C2=C(C)N(Cc3ccccc3)C(=O)CC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K19 compound treatment 0.071 -0.00563 -0.67 -0.6677 -1.0 1909509 Bionet1_002537 FC(F)(F)c1cc(c2ccc(N/N=C/c3ccccc3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K20 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1448704 Bionet1_002538 CCOC(=O)C1=C(C)N(CCN2C(=C(CCC2=O)C(=O)OCC)C)C(=O)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K21 compound treatment 0.069 -0.00763 -0.9 -0.9047 -1.0 1909510 Bionet1_002539 FC(F)(F)c1cc(c2ccc(N/N=C/c3ccco3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K22 compound treatment 0.0705 -0.00613 -0.73 -0.7269 -1.0 1909511 Bionet1_002540 COc1ccc(cc1)C(=O)/C(=N/Nc2ccc(cc2)C(F)(F)F)/C=N/N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K23 mock treatment 0.0715 -0.00513 -0.61 -0.6084 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 K24 mock treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L01 mock treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L02 mock treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L03 compound treatment 0.077 3.65E-4 0.04 0.0433 1.0 1909512 Bionet1_002541 Cc1cc(C)c(CSC(C)(C)CNc2ncccc2[N+](=O)[O-])c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L04 compound treatment 0.083 0.00637 0.75 0.7542 1.0 1909513 Bionet1_002542 Clc1ccc(SCc2cc(nc(n2)c3ccccn3)N4CCOCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L05 compound treatment 0.082 0.00537 0.64 0.6357 1.0 1456431 Bionet1_002543 COc1ccc(cc1)C(=O)NCC(C)(C)SCc2c(C)cc(C)cc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L06 compound treatment 0.081 0.00437 0.52 0.5172 1.0 1909514 Bionet1_002544 Clc1ccc(SCc2cc(nc(n2)c3ccccn3)N4CCCCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L07 compound treatment 0.0805 0.00387 0.46 0.458 1.0 1575550 Bionet1_002545 Cc1cc(C)c(CSC(C)(C)CN2C(=O)Cc3ccccc3C2=O)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L08 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1503571 Bionet1_002546 O=S(=O)(Cc1cc(nc(n1)c2ccccc2)N3CCOCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L09 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909515 Bionet1_002547 FC(F)(F)c1cnc(N/N=C/c2ccc(Cl)cc2Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L10 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1373707 Bionet1_002548 O=S(=O)(Cc1cc(nc(n1)c2ccccc2)N3CCCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L11 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909516 Bionet1_002549 FC(F)(F)c1cc(Cl)c2nnc(c3ccc(Cl)cc3Cl)n2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L12 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1909517 Bionet1_002550 Clc1ccc(SCc2cc(nc(n2)c3ccccc3)N4CCOCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L13 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1681168 Bionet1_002551 COc1ccc(cc1)S(=O)(=O)NCC(C)(C)SCc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L14 compound treatment 0.0725 -0.00413 -0.49 -0.4899 -1.0 1909518 Bionet1_002552 Clc1ccc(SCc2cc(nc(n2)c3ccccc3)N4CCCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L15 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1727227 Bionet1_002553 CC(C)(CNS(=O)(=O)c1ccc(F)cc1)SCc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L16 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1909519 Bionet1_002554 FC(F)(F)c1ccc(Sc2ccc(Br)cc2)c(C#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L17 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909520 Bionet1_002555 CC(C)(CNc1ccc(cn1)[N+](=O)[O-])SCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L18 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1213145 Bionet1_002556 O=S(=O)(Cc1cc(nc(n1)c2cccnc2)N3CCOCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L19 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1909521 Bionet1_002557 CC(C)(CNC(=O)Nc1ccccc1)SCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L20 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1230193 Bionet1_002558 O=S(=O)(Cc1cc(nc(n1)c2cccnc2)N3CCCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L21 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1209182 Bionet1_002559 COc1ccc(cc1)S(=O)(=O)NCC(C)(C)SCc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L22 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1441862 Bionet1_002560 Clc1ccc(Oc2ccc(cn2)C(=O)NC3CCSC3=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L23 mock treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 L24 mock treatment 0.079 0.00237 0.28 0.2802 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M01 mock treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M02 mock treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M03 compound treatment 0.077 3.65E-4 0.04 0.0433 1.0 1909522 Bionet1_002561 FC(F)(F)c1cc(c2ccc(N/N=C/c3cccs3)nc2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M04 compound treatment 0.082 0.00537 0.64 0.6357 1.0 1909523 Bionet1_002562 Cc1ccc(cc1)C(=O)/C(=N/Nc2cc(Cl)cc(Cl)c2)/C=N/O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M05 compound treatment 0.079 0.00237 0.28 0.2802 1.0 1909524 Bionet1_002563 FC(F)(F)c1cc(c2ccc3nnc(c4cccs4)n3c2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M06 compound treatment 0.0775 8.65E-4 0.1 0.1025 1.0 1909525 Bionet1_002564 Cc1cccc(N/N=C(\C=N\N)/C(=O)c2ccc(Br)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M07 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1909526 Bionet1_002565 FC(F)(F)c1ccc(/C=N/Nc2nc3ccccc3nc2C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M08 compound treatment 0.0735 -0.00313 -0.37 -0.3715 -1.0 1909527 Bionet1_002566 N/N=C/C(=N/Nc1ccc(Cl)cc1)/C(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M09 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1909528 Bionet1_002567 Fc1cccc(Cl)c1/C=N/Nc2nc3ccccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M10 compound treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 1909529 Bionet1_002568 CC(=O)/C(=C/Nc1ccc(I)cc1)/c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M11 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1909530 Bionet1_002569 FC(F)(F)c1cc(c2ccc3nnc(c4ccccc4)n3c2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M12 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909531 Bionet1_002570 CCSc1nnc(c2cccn(Cc3ccc(Cl)cc3Cl)c2=O)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M13 compound treatment 0.071 -0.00563 -0.67 -0.6677 -1.0 1909532 Bionet1_002571 FC(F)(F)c1nc2ccccc2nc1N/N=C/c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M14 compound treatment 0.071 -0.00563 -0.67 -0.6677 -1.0 1909533 Bionet1_002572 CC(=O)/C(=C\Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F)/c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M15 compound treatment 0.0775 8.65E-4 0.1 0.1025 1.0 1909534 Bionet1_002573 Cc1ccc(cc1)c2nnc3ccc4c(cc(nc4n23)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M16 compound treatment 0.083 0.00637 0.75 0.7542 1.0 1909535 Bionet1_002574 COc1ccc(cc1OC)/C(=C\Nc2ccc(Cl)cc2Cl)/C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M17 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1909536 Bionet1_002575 FC(F)(F)c1nc2ccccc2nc1N/N=C/c3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M18 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1909537 Bionet1_002576 CCOC(=O)c1ccc(N/C=C(\C(=O)C)/c2ccc(OC)c(OC)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M19 compound treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 1909538 Bionet1_002577 FC(F)(F)c1cc(c2ccc3nnc(n4cccc4)n3c2n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M20 compound treatment 0.0775 8.65E-4 0.1 0.1025 1.0 1909539 Bionet1_002578 COc1ccc(cc1OC)/C(=C/Nc2ccc(Oc3ccccc3)cc2)/C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M21 compound treatment 0.071 -0.00563 -0.67 -0.6677 -1.0 1909540 Bionet1_002579 Fc1cccc(Cl)c1c2nnc3c(cc4cccnc4n23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M22 compound treatment 0.0715 -0.00513 -0.61 -0.6084 -1.0 1909541 Bionet1_002580 COc1ccc(cc1OC)/C(=C/Nc2ccc(cc2)C(F)(F)F)/C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M23 mock treatment 0.0725 -0.00413 -0.49 -0.4899 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 M24 mock treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N01 mock treatment 0.0785 0.00187 0.22 0.221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N02 mock treatment 0.079 0.00237 0.28 0.2802 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N03 compound treatment 0.0795 0.00287 0.34 0.3395 1.0 1738874 Bionet1_002581 CC(C)(CNS(=O)(=O)c1ccc(Cl)cc1)SCc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N04 compound treatment 0.095 0.0184 2.18 2.1761 1.0 1909542 Bionet1_002582 CSc1nnc(C)c(/C=C/Nc2cc(cc(c2)C(F)(F)F)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N05 compound treatment 0.081 0.00437 0.52 0.5172 1.0 1909543 Bionet1_002583 FC(F)(F)c1cnc(N/N=C/C(=O)c2ccc(Cl)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N06 compound treatment 0.082 0.00537 0.64 0.6357 1.0 1909544 Bionet1_002584 Cc1nnc(SCC=C)nc1/C=C/Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N07 compound treatment 0.0815 0.00487 0.58 0.5765 1.0 1367731 Bionet1_002585 CC(C)(CNC(=O)c1c(Cl)cccc1Cl)SCc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N08 compound treatment 0.089 0.0124 1.47 1.4651 1.0 1909545 Bionet1_002586 Cc1nnc(SCC=C)nc1/C=C/NOCc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N09 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1909546 Bionet1_002587 CC(C)(CNC(=O)c1cccc(c1)[N+](=O)[O-])SCc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N10 compound treatment 0.0805 0.00387 0.46 0.458 1.0 1909547 Bionet1_002588 FC(F)(F)c1cccc(Oc2ccc(cn2)C(=O)NC3CCSC3=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N11 compound treatment 0.085 0.00837 0.99 0.9912 1.0 1909548 Bionet1_002589 Oc1nc(cc(c1C#N)c2ccc(Cl)cc2Cl)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N12 compound treatment 0.081 0.00437 0.52 0.5172 1.0 1909549 Bionet1_002590 CCCSc1nnc(C)c(/C=C/Nc2cccc(c2)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N13 compound treatment 0.0805 0.00387 0.46 0.458 1.0 1909550 Bionet1_002591 Cc1ccc(cc1)c2cc(c(C#N)c(O)n2)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N14 compound treatment 0.077 3.65E-4 0.04 0.0433 1.0 1909551 Bionet1_002592 COc1ccc(N/C=C/c2nc(SCc3ccccc3)nnc2C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N15 compound treatment 0.08 0.00337 0.4 0.3987 1.0 1909552 Bionet1_002593 Cc1ccc(cc1)c2cc(nc(O)c2C#N)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N16 compound treatment 0.0795 0.00287 0.34 0.3395 1.0 1909553 Bionet1_002594 Cc1nnc(SCc2ccccc2)nc1/C=C/Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N17 compound treatment 0.082 0.00537 0.64 0.6357 1.0 1909554 Bionet1_002595 CNC(=O)CSCC(=O)Nc1cc(OC(C)C)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N18 compound treatment 0.0805 0.00387 0.46 0.458 1.0 1909555 Bionet1_002596 Cc1nnc(SCc2ccccc2)nc1/C=C/Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N19 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909556 Bionet1_002597 CNC(=O)CS(=O)CC(=O)Nc1cc(OC(C)C)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N20 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1909557 Bionet1_002598 Cc1nnc(SCc2ccccc2)nc1/C=C/NOCc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N21 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909558 Bionet1_002599 CNC(=O)CS(=O)(=O)CC(=O)Nc1cc(OC(C)C)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N22 compound treatment 0.077 3.65E-4 0.04 0.0433 1.0 1909559 Bionet1_002600 COc1ccc(N/C=C/c2nc(SCc3ccc(Cl)cc3)nnc2C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N23 mock treatment 0.0785 0.00187 0.22 0.221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 N24 mock treatment 0.077 3.65E-4 0.04 0.0433 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O01 mock treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O02 mock treatment 0.0725 -0.00413 -0.49 -0.4899 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O03 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909560 Bionet1_002601 FC(F)(F)c1nc2ccccc2n3c(nnc13)c4c(Cl)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O04 compound treatment 0.0795 0.00287 0.34 0.3395 1.0 1909561 Bionet1_002602 COc1ccc(cc1OC)/C(=C/Nc2cccc(Br)c2)/C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O05 compound treatment 0.0815 0.00487 0.58 0.5765 1.0 1909562 Bionet1_002603 COc1ccc(cc1)C(=O)NNc2nc3ccccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O06 compound treatment 0.086 0.00937 1.11 1.1097 1.0 1909563 Bionet1_002604 COc1ccc(N/C=C(\C(=O)C)/c2ccc(OC)c(OC)c2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O07 compound treatment 0.0805 0.00387 0.46 0.458 1.0 1909564 Bionet1_002605 [O-][N+](=O)c1cc(/C=N/Nc2nc3ccccc3nc2C(F)(F)F)ccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O08 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1909565 Bionet1_002606 CC1(C)NC(=NC(=C1)/C=C/c2c(Cl)cccc2Cl)SCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O09 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1909566 Bionet1_002607 [O-][N+](=O)c1cc(ccc1Cl)c2nnc3c(nc4ccccc4n23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O10 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1909567 Bionet1_002608 CC1(C)NC(=NC(=C1)/C=C/c2ccc(Cl)cc2Cl)SCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O11 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909568 Bionet1_002609 COc1ccc(cc1)C(=O)NN(C)c2nc3ccccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O12 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909569 Bionet1_002610 CC(C)SC1=NC(=CC(C)(C)N1)/C=C/c2c(Cl)cccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O13 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909570 Bionet1_002611 CN(NC(=O)c1ccc(C)cc1)c2nc3ccccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O14 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909571 Bionet1_002612 CC(C)SC1=NC(=CC(C)(C)N1)/C=C/c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O15 compound treatment 0.089 0.0124 1.47 1.4651 1.0 1909572 Bionet1_002613 COc1ccc(cc1)C2=CC(=O)N(Nc3ncc(cc3Cl)C(F)(F)F)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O16 compound treatment 0.0805 0.00387 0.46 0.458 1.0 1319319 Bionet1_002614 COc1cc(c(Cl)cc1Cl)n2c(S)nc3cc(Cl)ccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O17 compound treatment 0.079 0.00237 0.28 0.2802 1.0 1909573 Bionet1_002615 COc1ccc(cc1)C2=CC(=O)N(Nc3ccc(Cl)cc3Cl)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O18 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1510896 Bionet1_002616 COc1cc(c(Cl)cc1Cl)n2c(S)nc3ccc(C)cc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O19 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909574 Bionet1_002617 Clc1ccc(cc1)C2=CC(=O)N(Nc3ccc(Cl)cc3Cl)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O20 compound treatment 0.0775 8.65E-4 0.1 0.1025 1.0 1443260 Bionet1_002618 CC(C)Oc1cc(c(Cl)cc1Cl)n2c(S)nc3ccccc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O21 compound treatment 0.07 -0.00663 -0.79 -0.7862 -1.0 1909575 Bionet1_002619 CN(NS(=O)(=O)c1ccccc1)c2nc3ccccc3nc2C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O22 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1909576 Bionet1_002620 CCOC(=O)CSc1nnc(c2ccccc2SC)n1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O23 mock treatment 0.0785 0.00187 0.22 0.221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 O24 mock treatment 0.0795 0.00287 0.34 0.3395 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P01 mock treatment 0.071 -0.00563 -0.67 -0.6677 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P02 mock treatment 0.073 -0.00363 -0.43 -0.4307 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P03 compound treatment 0.072 -0.00463 -0.55 -0.5492 -1.0 1909577 Bionet1_002621 CC(C)Oc1cc(NC(=O)CSCC(=O)N(C)C)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P04 compound treatment 0.074 -0.00263 -0.31 -0.3122 -1.0 1909578 Bionet1_002622 Cc1ccc(N/C=C/c2nc(SCc3ccc(Cl)cc3)nnc2C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P05 compound treatment 0.0745 -0.00213 -0.25 -0.253 -1.0 1909579 Bionet1_002623 CC(C)Oc1cc(NC(=O)CS(=O)CC(=O)N(C)C)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P06 compound treatment 0.0695 -0.00713 -0.85 -0.8454 -1.0 1909580 Bionet1_002624 Cc1nnc(SCc2ccc(Cl)cc2)nc1/C=C/Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P07 compound treatment 0.082 0.00537 0.64 0.6357 1.0 1909581 Bionet1_002625 CNC(=O)CSCC(=O)Nc1cc(OCCOC)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P08 compound treatment 0.085 0.00837 0.99 0.9912 1.0 1909582 Bionet1_002626 CSc1nnc(C)c(/C=C/NOCc2ccc(Cl)cc2Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P09 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909583 Bionet1_002627 CNC(=O)CS(=O)CC(=O)Nc1cc(OCCOC)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P10 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1228714 Bionet1_002628 Clc1ccc(CC(=O)NCCS(=O)c2ccc(Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P11 compound treatment 0.0765 -1.35E-4 -0.02 -0.016 -1.0 1909584 Bionet1_002629 COCCOc1cc(NC(=O)CSCC(=O)N(C)C)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P12 compound treatment 0.0785 0.00187 0.22 0.221 1.0 1909585 Bionet1_002630 CSc1nnc(C)c(/C=C/NOCc2cccc(Cl)c2Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P13 compound treatment 0.082 0.00537 0.64 0.6357 1.0 1909586 Bionet1_002631 CCN(CC)C(=O)CSCC(=O)Nc1cc(OC)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P14 compound treatment 0.075 -0.00163 -0.19 -0.1937 -1.0 1909587 Bionet1_002632 Fc1ccc(/C=C/2\SC(=S)N(N3C(=O)c4ccccc4C3=O)C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P15 compound treatment 0.079 0.00237 0.28 0.2802 1.0 1909588 Bionet1_002633 CCN(CC)C(=O)CS(=O)CC(=O)Nc1cc(OC)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P16 compound treatment 0.078 0.00137 0.16 0.1617 1.0 1724601 Bionet1_002634 COc1cccc(c1)c2nc(nc(N3CCN(C)CC3)c2C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P17 compound treatment 0.0915 0.0149 1.76 1.7614 1.0 1909589 Bionet1_002635 COc1cc(NC(=S)NC(=O)c2csnn2)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P18 compound treatment 0.08 0.00337 0.4 0.3987 1.0 1537313 Bionet1_002636 CN1CCN(CC1)c2nc(nc(c2C#N)c3ccc(C)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P19 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1909590 Bionet1_002637 Cn1nc(c(/C=N/O)c1Sc2ccc(cc2)C(C)(C)C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P20 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1702113 Bionet1_002638 CN1CCN(CC1)c2nc(nc(c2C#N)c3ccc(F)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P21 compound treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 1909591 Bionet1_002639 Cn1nc(c(/C=N/O)c1Sc2cccc(c2)C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P22 compound treatment 0.0755 -0.00113 -0.13 -0.1345 -1.0 1548153 Bionet1_002640 COc1ccccc1c2nc(nc(N3CCN(C)CC3)c2C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P23 mock treatment 0.076 -6.35E-4 -0.08 -0.0752 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.575 P24 mock treatment 0.0705 -0.00613 -0.73 -0.7269 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A01 mock treatment 0.09 0.0138 1.64 1.641 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A02 mock treatment 0.0845 0.00835 0.99 0.9893 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A03 compound treatment 0.086 0.00985 1.17 1.167 1.0 1333022 Bionet1_002641 CC(C)c1ccc(cc1)C2Nc3cc(C)c(C)cc3NC4=C2C(=O)CC(C)(C)C4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A04 compound treatment 0.084 0.00785 0.93 0.9301 1.0 1909592 Bionet1_002642 Cn1nc(c(C#N)c1Sc2cccc(c2)C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A05 compound treatment 0.091 0.0148 1.76 1.7595 1.0 1144365 Bionet1_002643 Cc1cc2NC(C3=C(CC(C)(C)CC3=O)Nc2cc1C)c4cccc(O)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A06 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909593 Bionet1_002644 Cn1nc(c(/C=N/O)c1Sc2ccc(Br)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A07 compound treatment 0.082 0.00585 0.69 0.6931 1.0 1411009 Bionet1_002645 CCOC(=O)c1cc(nnc1Sc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A08 compound treatment 0.1005 0.0243 2.89 2.8851 1.0 1909594 Bionet1_002646 CNc1cc(CSC)nc(SCc2ccc(Cl)c(Cl)c2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A09 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909595 Bionet1_002647 CC(C)C(NC(=O)c1sc(C)nc1C(F)(F)F)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A10 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1227541 Bionet1_002648 CSCc1cc(NCC=C)nc(SCc2ccc(Cl)c(Cl)c2)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A11 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909596 Bionet1_002649 CC(C(=O)c1c[nH]c(c1)C(=O)NCC=C)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A12 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1909597 Bionet1_002650 CO/N=C/c1c(Sc2ccc(Cl)cc2)n(C)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A13 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909598 Bionet1_002651 FC(F)(F)c1cnc(CCC(=O)N2CCN(CC2)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A14 compound treatment 0.07 -0.00615 -0.73 -0.7288 -1.0 1909599 Bionet1_002652 CNc1cc(CSC)nc(SCc2ccc(Cl)cc2Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A15 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909600 Bionet1_002653 CN(C)c1nc(N(C)C)n(n1)S(=O)(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A16 compound treatment 0.067 -0.00915 -1.08 -1.0843 -1.0 1909601 Bionet1_002654 CSCc1cc(nc(SCc2ccc(Cl)cc2Cl)n1)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A17 compound treatment 0.0655 -0.0107 -1.26 -1.262 -1.0 1909602 Bionet1_002655 [O-][N+](=O)c1ccc(cc1)N2CCc3c(C#N)c(sc3C2)n4cccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A18 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909603 Bionet1_002656 CO/N=C/c1c(Sc2ccccc2C(=O)OC)n(C)nc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A19 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1909604 Bionet1_002657 CC1(OCCO1)c2ccc([N+](=O)[O-])c(CS(=O)(=O)c3ccccc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A20 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1909605 Bionet1_002658 Cn1nc(c(C#N)c1Sc2ccc(Br)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A21 compound treatment 0.07 -0.00615 -0.73 -0.7288 -1.0 1909606 Bionet1_002659 CN(C)/C=C/C(=O)c1ccc([N+](=O)[O-])c(CS(=O)(=O)c2ccccc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A22 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1909607 Bionet1_002660 Oc1nc(cc(c1C#N)c2ccc(Cl)cc2)c3cccc(Br)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A23 mock treatment 0.0865 0.0103 1.23 1.2263 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 A24 mock treatment 0.0725 -0.00365 -0.43 -0.4326 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B01 mock treatment 0.0845 0.00835 0.99 0.9893 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B02 mock treatment 0.083 0.00685 0.81 0.8116 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B03 compound treatment 0.082 0.00585 0.69 0.6931 1.0 1723442 Bionet1_002661 CC(C)Nc1nc(SCc2ccc(C)cc2)nc(c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B04 compound treatment 0.0875 0.0113 1.34 1.3448 1.0 1909608 Bionet1_002662 Cn1nc(c(/C=N/OCc2ccc(Cl)cc2Cl)c1O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B05 compound treatment 0.084 0.00785 0.93 0.9301 1.0 1909609 Bionet1_002663 Cc1ccc(N/N=C/2\C(=O)N(CN3CCOCC3)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B06 compound treatment 0.081 0.00485 0.57 0.5746 1.0 1909610 Bionet1_002664 Cn1nc(c(/C=N/OCc2ccc(Cl)cc2Cl)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B07 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1909611 Bionet1_002665 Clc1ccc(N/N=C/2\C(=O)N(CN3CCOCC3)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B08 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1909612 Bionet1_002666 CCOc1ccc(Br)cc1/C=C/c2nc3ccccc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B09 compound treatment 0.0705 -0.00565 -0.67 -0.6696 -1.0 1909613 Bionet1_002667 Clc1ccccc1N/N=C/2\C(=O)N(CN3CCOCC3)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B10 compound treatment 0.064 -0.0122 -1.44 -1.4397 -1.0 1909614 Bionet1_002668 Cn1nc(c(CCl)c1Sc2ccc(Br)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B11 compound treatment 0.07 -0.00615 -0.73 -0.7288 -1.0 1909615 Bionet1_002669 Fc1ccc(N/N=C/2\C(=O)N(CN3CCOCC3)c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B12 compound treatment 0.0705 -0.00565 -0.67 -0.6696 -1.0 1909616 Bionet1_002670 Cc1ccc(cc1)c2cc3ccccc3nc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B13 compound treatment 0.0725 -0.00365 -0.43 -0.4326 -1.0 1909617 Bionet1_002671 CO/N=C(/CS(=O)(=O)c1ccc(Cl)cc1)\c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B14 compound treatment 0.0655 -0.0107 -1.26 -1.262 -1.0 1909618 Bionet1_002672 C/C(=N\Oc1cccc(O/N=C(\C)/c2ccc(F)cc2)n1)/c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B15 compound treatment 0.0685 -0.00765 -0.91 -0.9065 -1.0 1909619 Bionet1_002673 CO/N=C(/CS(=O)Cc1ccc(Cl)cc1)\c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B16 compound treatment 0.069 -0.00715 -0.85 -0.8473 -1.0 1909620 Bionet1_002674 FC(F)(F)c1ccc(N/N=C(/N=Nc2ccc(cc2)C(F)(F)F)\C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B17 compound treatment 0.0655 -0.0107 -1.26 -1.262 -1.0 1909621 Bionet1_002675 CO/N=C(/CS(=O)(=O)Cc1ccc(Cl)cc1)\c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B18 compound treatment 0.066 -0.0102 -1.2 -1.2028 -1.0 1527210 Bionet1_002676 COC(=O)Cc1c(sc(NC(=O)c2ccccc2)c1C(=O)OC)C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B19 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909622 Bionet1_002677 CO/N=C(/CS(=O)(=O)c1ccc(OC)cc1)\c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B20 compound treatment 0.07 -0.00615 -0.73 -0.7288 -1.0 1909623 Bionet1_002678 CN(C)/C=C/C(=C\C(=O)C(F)(F)F)/Nc1ccc(Br)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B21 compound treatment 0.071 -0.00515 -0.61 -0.6103 -1.0 1909624 Bionet1_002679 CO/N=C(\CS(=O)Cc1ccc(OC)cc1)/c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B22 compound treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 1909625 Bionet1_002680 COc1ccc(/C=C\2/N(Cc3ccccc3)C(=O)CN(C(=O)C)C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B23 mock treatment 0.068 -0.00815 -0.97 -0.9658 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 B24 mock treatment 0.0695 -0.00665 -0.79 -0.7881 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C01 mock treatment 0.0835 0.00735 0.87 0.8708 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C02 mock treatment 0.083 0.00685 0.81 0.8116 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C03 compound treatment 0.1105 0.0343 4.07 4.07 1.0 1909626 Bionet1_002681 CC1(OCCO1)c2ccc([N+](=O)[O-])c(CS(=O)(=O)c3ccc(Cl)cc3)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C04 compound treatment 0.091 0.0148 1.76 1.7595 1.0 1909627 Bionet1_002682 Oc1nc(cc(c1C#N)c2ccc(Cl)cc2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C05 compound treatment 0.089 0.0128 1.52 1.5225 1.0 1909628 Bionet1_002683 CCOC(=O)/C(=C(\O)/C(=C/c1ccccc1)/NC(=O)c2ccccc2)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C06 compound treatment 0.0865 0.0103 1.23 1.2263 1.0 1909629 Bionet1_002684 Oc1nc(cc(c1C#N)c2ccc(Cl)cc2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C07 compound treatment 0.0795 0.00335 0.4 0.3968 1.0 1909630 Bionet1_002685 CC(=O)c1ccc([N+](=O)[O-])c(CS(=O)(=O)c2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C08 compound treatment 0.0785 0.00235 0.28 0.2784 1.0 1909631 Bionet1_002686 Oc1nc(cc(c1C#N)c2ccc(Cl)cc2)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C09 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909632 Bionet1_002687 Fc1ccc(cc1)S(=O)(=O)NCCNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C10 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1909633 Bionet1_002688 Oc1nc(cc(c1C#N)c2ccccc2C(F)(F)F)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C11 compound treatment 0.0785 0.00235 0.28 0.2784 1.0 1909634 Bionet1_002689 CCOC(=O)c1[nH]c2ccccc2c1NC(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C12 compound treatment 0.073 -0.00315 -0.37 -0.3733 -1.0 1909635 Bionet1_002690 COc1ccc(Sc2nc(SC)nc(c2C#N)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C13 compound treatment 0.08 0.00385 0.46 0.4561 1.0 1909636 Bionet1_002691 COC(=O)c1ccc([N+](=O)[O-])c(CS(=O)(=O)c2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C14 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1909637 Bionet1_002692 CSc1nc(Sc2ccc(Cl)cc2)c(C#N)c(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C15 compound treatment 0.0715 -0.00465 -0.55 -0.5511 -1.0 1909638 Bionet1_002693 NNC(=O)c1ccc([N+](=O)[O-])c(CS(=O)(=O)c2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C16 compound treatment 0.092 0.0158 1.88 1.878 1.0 1909639 Bionet1_002694 CSc1nc(Sc2cccc(Cl)c2)c(C#N)c(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C17 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1909640 Bionet1_002695 COC(=O)c1ccc(c(CS(=O)(=O)c2ccc(Cl)cc2)c1)n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C18 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1909641 Bionet1_002696 FC(F)(F)c1cccc(/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C19 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909642 Bionet1_002697 FC(F)(F)c1cnc(c(Cl)c1)n2cc3CCc4ccccc4-c3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C20 compound treatment 0.0865 0.0103 1.23 1.2263 1.0 1909643 Bionet1_002698 FC(F)(F)c1ccc(/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C21 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909644 Bionet1_002699 CCOC(=O)c1ccc([N+](=O)[O-])c(CS(=O)(=O)c2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C22 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1909645 Bionet1_002700 FC(F)(F)c1ccccc1/N=C/2\C(=O)N(c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C23 mock treatment 0.0805 0.00435 0.52 0.5153 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 C24 mock treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D01 mock treatment 0.0785 0.00235 0.28 0.2784 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D02 mock treatment 0.0785 0.00235 0.28 0.2784 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D03 compound treatment 0.0815 0.00535 0.63 0.6338 1.0 1909646 Bionet1_002701 CO/N=C(\CS(=O)(=O)Cc1ccc(OC)cc1)/c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D04 compound treatment 0.0905 0.0143 1.7 1.7002 1.0 1909647 Bionet1_002702 CCOC(OCC)c1ccc(/C=C/C(=O)c2ccc(Br)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D05 compound treatment 0.0865 0.0103 1.23 1.2263 1.0 1909648 Bionet1_002703 Cn1nc(c(/C=N/c2ccc(F)c(Cl)c2F)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D06 compound treatment 0.081 0.00485 0.57 0.5746 1.0 1909649 Bionet1_002704 COc1ccc(N=Nc2cnc(nc2c3ccc(OC)cc3)c4ccccn4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D07 compound treatment 0.0845 0.00835 0.99 0.9893 1.0 1909650 Bionet1_002705 Cn1nc(c(/C=N/c2cccc(c2)C(F)(F)F)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D08 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1909651 Bionet1_002706 Clc1ccccc1N=Nc2cnc(nc2c3ccccc3)c4ccncc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D09 compound treatment 0.0815 0.00535 0.63 0.6338 1.0 1909652 Bionet1_002707 CN(NC(=O)c1cccc(c1)C(F)(F)F)c2c(C#N)c(nn2C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D10 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1909653 Bionet1_002708 Clc1ccc(N=Nc2cnc(nc2c3ccco3)c4cccnc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D11 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909654 Bionet1_002709 CN(NC(=O)c1ccc(Cl)cc1Cl)c2c(C#N)c(nn2C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D12 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909655 Bionet1_002710 CC(=O)N1CC(=O)N(Cc2ccccc2)/C(=C/c3ccc(F)cc3)/C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D13 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909656 Bionet1_002711 CN(NS(=O)(=O)c1ccccc1)c2c(C#N)c(nn2C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D14 compound treatment 0.0875 0.0113 1.34 1.3448 1.0 1909657 Bionet1_002712 CN(C)c1ccc(/C=C\2/N(Cc3ccccc3)C(=O)CN(C(=O)C)C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D15 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1677095 Bionet1_002713 COc1ccc(cc1)N(Cc2ccccc2)C(=O)c3ccc(Cl)nc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D16 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909658 Bionet1_002714 COc1ccc(cc1)c2nc(ncc2N=Nc3ccc(F)cc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D17 compound treatment 0.0785 0.00235 0.28 0.2784 1.0 1675002 Bionet1_002715 COc1ccc(cc1)N(Cc2ccccc2)C(=O)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D18 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1719087 Bionet1_002716 Nc1nc(Cn2cncn2)nc(N)c1Cc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D19 compound treatment 0.0795 0.00335 0.4 0.3968 1.0 1909659 Bionet1_002717 CO/N=C(/CS(=O)c1ccccc1C(=O)OC)\c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D20 compound treatment 0.0795 0.00335 0.4 0.3968 1.0 1909660 Bionet1_002718 COc1ccc(cc1)C2CC2/C(=N/OC(=O)c3ccc(cc3)[N+](=O)[O-])/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D21 compound treatment 0.0805 0.00435 0.52 0.5153 1.0 1909661 Bionet1_002719 CO/N=C(/CSc1ccc(Br)cc1)\c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D22 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909662 Bionet1_002720 Clc1ccc(C2CC2C(=O)c3ccc(Br)cc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D23 mock treatment 0.079 0.00285 0.34 0.3376 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 D24 mock treatment 0.0805 0.00435 0.52 0.5153 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E01 mock treatment 0.0795 0.00335 0.4 0.3968 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E02 mock treatment 0.081 0.00485 0.57 0.5746 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E03 compound treatment 0.087 0.0108 1.29 1.2855 1.0 1227893 Bionet1_002721 Nc1ccc(cc1CS(=O)(=O)c2ccc(Cl)cc2)C(=O)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E04 compound treatment 0.0855 0.00935 1.11 1.1078 1.0 1909663 Bionet1_002722 O=C/1N(c2ccccc2\C1=N\c3ccc(Oc4ccccc4)cc3)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E05 compound treatment 0.087 0.0108 1.29 1.2855 1.0 1909664 Bionet1_002723 NC(=O)c1ccc([N+](=O)[O-])c(CS(=O)(=O)c2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E06 compound treatment 0.081 0.00485 0.57 0.5746 1.0 1909665 Bionet1_002724 Clc1ccc(N/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E07 compound treatment 0.083 0.00685 0.81 0.8116 1.0 1909666 Bionet1_002725 Clc1ccc(cc1)S(=O)(=O)Cc2cc(C#N)ccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E08 compound treatment 0.0895 0.0133 1.58 1.5817 1.0 1909667 Bionet1_002726 Clc1cc(Cl)cc(N/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E09 compound treatment 0.0895 0.0133 1.58 1.5817 1.0 1909668 Bionet1_002727 Clc1ccc(cc1)S(=O)(=O)c2snnc2C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E10 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909669 Bionet1_002728 Clc1ccc(Cl)c(N/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E11 compound treatment 0.0865 0.0103 1.23 1.2263 1.0 1909670 Bionet1_002729 Clc1ccc(cc1)S(=O)c2snnc2C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E12 compound treatment 0.081 0.00485 0.57 0.5746 1.0 1909671 Bionet1_002730 [O-][N+](=O)c1ccc(N/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E13 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1315741 Bionet1_002731 Clc1ccc(cc1)S(=O)c2snnc2C(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E14 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1909672 Bionet1_002732 CSc1nc(Sc2ccc(Cl)cc2)c(C#N)c(n1)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E15 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1678768 Bionet1_002733 Clc1ccc(cc1)S(=O)c2snnc2C(=O)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E16 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909673 Bionet1_002734 CSc1nc(Sc2cccc(C)c2)c(C#N)c(n1)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E17 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909674 Bionet1_002735 Clc1ccc(Sc2snnc2C(=O)OC3CCCCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E18 compound treatment 0.073 -0.00315 -0.37 -0.3733 -1.0 1909675 Bionet1_002736 Oc1nc(SCc2ccccc2Cl)nc(c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E19 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1646308 Bionet1_002737 Clc1ccc(cc1)S(=O)(=O)c2snnc2C(=O)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E20 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909676 Bionet1_002738 Oc1nc(SCc2cccc(c2)C(F)(F)F)nc(c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E21 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1739634 Bionet1_002739 Clc1ccc(cc1)S(=O)(=O)c2snnc2C(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E22 compound treatment 0.09 0.0138 1.64 1.641 1.0 1909677 Bionet1_002740 Cc1ccc(cc1)c2nc(SCc3ccccc3)nc(Cl)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E23 mock treatment 0.0775 0.00135 0.16 0.1599 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 E24 mock treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F01 mock treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F02 mock treatment 0.088 0.0118 1.4 1.404 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F03 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909678 Bionet1_002741 CO/N=C(/CS(=O)c1ccc(Br)cc1)\c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F04 compound treatment 0.081 0.00485 0.57 0.5746 1.0 1909679 Bionet1_002742 O/N=C(/C1CC1c2ccc(Cl)cc2)\c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F05 compound treatment 0.084 0.00785 0.93 0.9301 1.0 1909680 Bionet1_002743 FC(F)(F)c1cccc(CC(=O)Nc2ccc(Oc3ccccc3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F06 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909681 Bionet1_002744 Cc1ccc(cc1)C2CC2/C(=N/OC(=O)c3ccc(C)cc3)/c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F07 compound treatment 0.087 0.0108 1.29 1.2855 1.0 1909682 Bionet1_002745 Clc1ccc(CN/C(=N\c2ccccc2)/NC3CCCCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F08 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1909683 Bionet1_002746 Cc1ccc(cc1)C2CC2/C(=N/OC(=O)c3ccc(F)cc3)/c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F09 compound treatment 0.0825 0.00635 0.75 0.7523 1.0 1339515 Bionet1_002747 Fc1ccc(cc1)C(=O)N2CCN3C(=O)c4ccccc4C23c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F10 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1909684 Bionet1_002748 Cc1ccc(cc1)C2CC2/C(=N/OC(=O)c3ccco3)/c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F11 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1720705 Bionet1_002749 Cc1ccc(cc1)C(=O)N2CCN3C(=O)c4ccccc4C23c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F12 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1909685 Bionet1_002750 COc1ccc(cc1)C2CC2/C(=N/OC(=O)c3ccc(C)cc3)/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F13 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909686 Bionet1_002751 Cn1nc(c(C(=O)Nc2ccc(cc2)C(F)(F)F)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F14 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909687 Bionet1_002752 COc1ccc(cc1)C2CC2/C(=N/OC(=O)c3cccs3)/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F15 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909688 Bionet1_002753 Cn1nc(c(C(=O)Nc2ccc(Cl)c(Cl)c2)c1Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F16 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909689 Bionet1_002754 COc1ccc(cc1)C2CC2/C(=N/OC(=O)c3ccc(C)cc3)/c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F17 compound treatment 0.085 0.00885 1.05 1.0485 1.0 1909690 Bionet1_002755 CN(C)/C=N\C(=O)c1sc2cc(cnc2c1c3cccs3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F18 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909691 Bionet1_002756 Cc1onc(c1C(=O)Oc2cc(no2)c3ccccc3)c4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F19 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1909692 Bionet1_002757 FC(F)(F)c1cnc2c(c3cccs3)c(sc2c1)c4nc[nH]n4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F20 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1909693 Bionet1_002758 CCOC(=O)C1=NNC2C1C(=O)N(C2=O)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F21 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1909694 Bionet1_002759 Cc1ccc(C)n1c2ccc(C#Cc3ccc(cc3)n4c(C)ccc4C)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F22 compound treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 1909695 Bionet1_002760 CCOC(=O)C1=NNC2C1C(=O)N(C2=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F23 mock treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 F24 mock treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G01 mock treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G02 mock treatment 0.072 -0.00415 -0.49 -0.4918 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G03 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909696 Bionet1_002761 Clc1ccc(cc1)S(=O)(=O)c2snnc2C(=O)OC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G04 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909697 Bionet1_002762 Clc1ccccc1CSc2nc(Cl)c(C#N)c(n2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G05 compound treatment 0.0805 0.00435 0.52 0.5153 1.0 1909698 Bionet1_002763 CCOC(=O)C1C(N=C(N=C1O)c2ccccc2)c3ccc(cc3)C(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G06 compound treatment 0.072 -0.00415 -0.49 -0.4918 -1.0 1909699 Bionet1_002764 Clc1ccc(CN2C(=O)/C(=N\Nc3ccccc3)/c4ccccc24)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G07 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1909700 Bionet1_002765 CCOC(=O)C1C(N=C(N=C1O)c2ccccc2)c3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G08 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1909701 Bionet1_002766 FC(F)(F)c1cccc(CN2C(=O)/C(=N/Nc3ccccc3)/c4ccccc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G09 compound treatment 0.082 0.00585 0.69 0.6931 1.0 1909702 Bionet1_002767 CCOC(=O)C1C(N=C(N=C1O)c2ccccc2)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G10 compound treatment 0.0705 -0.00565 -0.67 -0.6696 -1.0 1909703 Bionet1_002768 Clc1ccc(N/N=C/2\C(=O)N(c3ccccc23)c4ccccc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G11 compound treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 1449119 Bionet1_002769 OC(c1c[nH]cc1c2c(Cl)cccc2Cl)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G12 compound treatment 0.0725 -0.00365 -0.43 -0.4326 -1.0 1909704 Bionet1_002770 Oc1nc(SCc2c(Cl)cccc2Cl)nc(c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G13 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1909705 Bionet1_002771 COCc1cc(nc(n1)c2ccccc2)N3CCN(CC3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G14 compound treatment 0.069 -0.00715 -0.85 -0.8473 -1.0 1909706 Bionet1_002772 Cc1ccccc1CN2C(=O)N(Cc3cccc(c3)C(F)(F)F)C(=O)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G15 compound treatment 0.0695 -0.00665 -0.79 -0.7881 -1.0 1909707 Bionet1_002773 COCc1cc(Sc2cccc(Cl)c2Cl)nc(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G16 compound treatment 0.07 -0.00615 -0.73 -0.7288 -1.0 1909708 Bionet1_002774 COc1ccc(CN2C(=O)N(Cc3ccccc3C)C(=O)C2=O)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G17 compound treatment 0.0825 0.00635 0.75 0.7523 1.0 1909709 Bionet1_002775 COCc1cc(Sc2c(Cl)cccc2Cl)nc(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G18 compound treatment 0.071 -0.00515 -0.61 -0.6103 -1.0 1909710 Bionet1_002776 Fc1ccc(CN2C(=O)N(Cc3ccc(Cl)cc3Cl)C(=O)C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G19 compound treatment 0.072 -0.00415 -0.49 -0.4918 -1.0 1909711 Bionet1_002777 COCc1cc(Sc2ccc(Cl)cc2Cl)nc(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G20 compound treatment 0.068 -0.00815 -0.97 -0.9658 -1.0 1909712 Bionet1_002778 Cc1ccc(CN2C(=O)N(Cc3ccc(Cl)cc3Cl)C(=O)C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G21 compound treatment 0.068 -0.00815 -0.97 -0.9658 -1.0 1909713 Bionet1_002779 COCc1cc(Sc2ccc(Br)cc2)nc(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G22 compound treatment 0.086 0.00985 1.17 1.167 1.0 1909714 Bionet1_002780 COc1ccccc1CN2C(=O)N(Cc3c(F)cccc3Cl)C(=O)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G23 mock treatment 0.0695 -0.00665 -0.79 -0.7881 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 G24 mock treatment 0.065 -0.0112 -1.32 -1.3213 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H01 mock treatment 0.077 8.49E-4 0.1 0.1006 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H02 mock treatment 0.086 0.00985 1.17 1.167 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H03 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909715 Bionet1_002781 FC(F)(F)c1cnc2c(c3cccs3)c(sc2c1)C(=O)NCC#C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H04 compound treatment 0.082 0.00585 0.69 0.6931 1.0 1909716 Bionet1_002782 CCOC(=O)C1=NNC2C1C(=O)N(C2=O)c3ccsc3C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H05 compound treatment 0.083 0.00685 0.81 0.8116 1.0 1909717 Bionet1_002783 Cn1c(S)nnc1c2sc3cc(cnc3c2c4cccs4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H06 compound treatment 0.0795 0.00335 0.4 0.3968 1.0 1909718 Bionet1_002784 Clc1ccc(c(Cl)c1)S(=O)(=O)Oc2cc(no2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H07 compound treatment 0.083 0.00685 0.81 0.8116 1.0 1909719 Bionet1_002785 FC(F)(F)c1cnc(c2cc(on2)C(=O)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H08 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909720 Bionet1_002786 CCOC(=O)C1=NOC(C1)C(=O)NN(C)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H09 compound treatment 0.081 0.00485 0.57 0.5746 1.0 1909721 Bionet1_002787 Cn1c(S)nnc1c2sc3cc(cnc3c2c4ccccc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H10 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909722 Bionet1_002788 CCOC(=O)C1C(C1C(=O)Nc2cccc(c2)C(F)(F)F)C(=O)NN 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H11 compound treatment 0.08 0.00385 0.46 0.4561 1.0 1909723 Bionet1_002789 Cn1c(S)nnc1c2sc3cc(cnc3c2c4cccnc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H12 compound treatment 0.0805 0.00435 0.52 0.5153 1.0 1909724 Bionet1_002790 CCOC(=O)C1C2C1C(=O)N(N(C)c3ncc(cc3Cl)C(F)(F)F)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H13 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1909725 Bionet1_002791 Cn1c(S)nnc1c2sc3cc(cnc3c2c4ccccn4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H14 compound treatment 0.0835 0.00735 0.87 0.8708 1.0 1909726 Bionet1_002792 CCOC(=O)C1C(C1C(=O)N2CCCC2)C(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H15 compound treatment 0.0785 0.00235 0.28 0.2784 1.0 1909727 Bionet1_002793 CSc1nnc([nH]1)c2sc3cc(cnc3c2c4cccs4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H16 compound treatment 0.073 -0.00315 -0.37 -0.3733 -1.0 1909728 Bionet1_002794 CCOC(=O)C1C(C1C(=O)OCC)C(=O)Nc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H17 compound treatment 0.0795 0.00335 0.4 0.3968 1.0 1909729 Bionet1_002795 FC(F)(F)c1cnc2c(c(sc2c1)C(=O)N3CCOCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H18 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1909730 Bionet1_002796 CCOC(=O)C1C(C1C(=O)Nc2cccc(c2)C(F)(F)F)C(=O)NC(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H19 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909731 Bionet1_002797 CN(C)/C=N/C(=O)c1sc2cc(cnc2c1c3ccccc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H20 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1909732 Bionet1_002798 [O-][N+](=O)c1ccc(cc1)N2CCN(CCOC(=O)Nc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H21 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909733 Bionet1_002799 FC(F)(F)c1cccc(c1)C(=O)n2sc(NC(=O)c3ccccc3)nc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H22 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909734 Bionet1_002800 [O-][N+](=O)c1ccc(cc1)N2CCN(CCOC(=O)c3ccc(F)cc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H23 mock treatment 0.0765 3.49E-4 0.04 0.0414 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 H24 mock treatment 0.073 -0.00315 -0.37 -0.3733 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I01 mock treatment 0.0805 0.00435 0.52 0.5153 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I02 mock treatment 0.078 0.00185 0.22 0.2191 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I03 compound treatment 0.0795 0.00335 0.4 0.3968 1.0 1909735 Bionet1_002801 COCc1cc(SCc2ccc(Cl)cc2Cl)nc(n1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I04 compound treatment 0.084 0.00785 0.93 0.9301 1.0 1909736 Bionet1_002802 [O-][N+](=O)c1ccc(CN2C(=O)N(Cc3ccccc3Cl)C(=O)C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I05 compound treatment 0.0905 0.0143 1.7 1.7002 1.0 1909737 Bionet1_002803 [O-][N+](=O)c1ccc(cc1)C(=O)OCc2ccc(Oc3ccccc3)c(c2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I06 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909738 Bionet1_002804 Clc1cccc(CN2C(=O)N(Cc3c(Cl)cccc3Cl)C(=O)C2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I07 compound treatment 0.091 0.0148 1.76 1.7595 1.0 1909739 Bionet1_002805 [O-][N+](=O)c1cc(COC(=O)Nc2ccc(Cl)cc2)ccc1Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I08 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1909740 Bionet1_002806 Clc1cccc(CN2C(=O)N(Cc3cccc(Cl)c3)C(=O)C2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I09 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1909741 Bionet1_002807 Cc1ccc(Oc2ccc(COC(=O)c3ccc(Cl)cc3)cc2[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I10 compound treatment 0.0715 -0.00465 -0.55 -0.5511 -1.0 1909742 Bionet1_002808 Clc1cccc(CN2C(=O)N(CCOc3ccccc3)C(=O)C2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I11 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1909743 Bionet1_002809 [O-][N+](=O)c1cc(COC(=O)c2ccc(Cl)cc2)ccc1Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I12 compound treatment 0.068 -0.00815 -0.97 -0.9658 -1.0 1909744 Bionet1_002810 COc1ccccc1CN2C(=O)N(CC(=O)c3ccc(F)cc3)C(=O)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I13 compound treatment 0.066 -0.0102 -1.2 -1.2028 -1.0 1909745 Bionet1_002811 [O-][N+](=O)c1cc(COC(=O)Nc2cccc(Cl)c2)ccc1Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I14 compound treatment 0.067 -0.00915 -1.08 -1.0843 -1.0 1909746 Bionet1_002812 Clc1ccccc1C(=O)CN2C(=O)N(Cc3ccccc3)C(=O)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I15 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1909747 Bionet1_002813 Fc1ccc(NC(=O)c2nnsc2Sc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I16 compound treatment 0.0995 0.0233 2.77 2.7666 1.0 1909748 Bionet1_002814 O=C(CN1C(=O)N(Cc2ccccc2)C(=O)C1=O)c3ccc(cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I17 compound treatment 0.092 0.0158 1.88 1.878 1.0 1909749 Bionet1_002815 Fc1ccc(NC(=O)c2nnsc2Sc3ccc(Cl)cc3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I18 compound treatment 0.071 -0.00515 -0.61 -0.6103 -1.0 1909750 Bionet1_002816 Cc1cc(C)c(CN2C(=O)N(Cc3ccccc3F)C(=O)C2=O)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I19 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1909751 Bionet1_002817 Fc1ccc(NC(=O)c2nnsc2S(=O)(=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I20 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909752 Bionet1_002818 CCOC(=O)CN1C(=O)N(Cc2ccc(Cl)cc2Cl)C(=O)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I21 compound treatment 0.0725 -0.00365 -0.43 -0.4326 -1.0 1909753 Bionet1_002819 Clc1ccccc1/C=C/NC(=O)OCc2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I22 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909754 Bionet1_002820 CCOC(=O)CN1C(=O)N(Cc2ccc(cc2)C(F)(F)F)C(=O)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I23 mock treatment 0.073 -0.00315 -0.37 -0.3733 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 I24 mock treatment 0.072 -0.00415 -0.49 -0.4918 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J01 mock treatment 0.0765 3.49E-4 0.04 0.0414 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J02 mock treatment 0.077 8.49E-4 0.1 0.1006 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J03 compound treatment 0.0805 0.00435 0.52 0.5153 1.0 1497526 Bionet1_002821 Cc1ccc(cc1)C(=O)Nc2nc(=O)n(s2)C(=O)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J04 compound treatment 0.0815 0.00535 0.63 0.6338 1.0 1909755 Bionet1_002822 [O-][N+](=O)c1ccc(cc1)N2CCN(CCOC(=O)c3cccc(Cl)c3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J05 compound treatment 0.0815 0.00535 0.63 0.6338 1.0 1283584 Bionet1_002823 Cc1ccc(cc1)C(=O)Nc2nc(=O)n(s2)C(=O)c3ccccc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J06 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909756 Bionet1_002824 CN(NS(=O)(=O)c1ccc(F)cc1)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J07 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909757 Bionet1_002825 CC(C)(C)/C(=N\OC(=O)NC1CCCCC1)/COc2ccccc2[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J08 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909758 Bionet1_002826 FC(F)(F)c1cccc(c1)N2C(=O)CC(C2=O)c3c[nH]c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J09 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1909759 Bionet1_002827 Cc1ccc(OC/C(=N/OC(=O)NC2CCCCC2)/C(C)(C)C)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J10 compound treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 1632313 Bionet1_002828 CC(=O)Nc1ccc(Sc2ccccc2C(=O)Nc3ccc(F)cc3)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J11 compound treatment 0.0805 0.00435 0.52 0.5153 1.0 1556791 Bionet1_002829 Clc1ccc(cc1)c2cc(COc3cc(Cl)cc(Cl)c3)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J12 compound treatment 0.0785 0.00235 0.28 0.2784 1.0 1909760 Bionet1_002830 COc1ccc2[nH]cc(C3CC(=O)N(C3=O)c4cccc(c4)C(F)(F)F)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J13 compound treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 1705222 Bionet1_002831 Clc1ccccc1c2cc(COc3cc(Cl)c(Cl)cc3Cl)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J14 compound treatment 0.07 -0.00615 -0.73 -0.7288 -1.0 1508650 Bionet1_002832 Clc1ccc(N2C(=O)CC(C2=O)c3c[nH]c4ccccc34)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J15 compound treatment 0.081 0.00485 0.57 0.5746 1.0 1239805 Bionet1_002833 Clc1cc(Cl)c(OCc2cc(no2)c3ccccc3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J16 compound treatment 0.0715 -0.00465 -0.55 -0.5511 -1.0 1399121 Bionet1_002834 O=c1ccn(nc1c2ccn(n2)C3CCS(=O)(=O)C3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J17 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1384706 Bionet1_002835 COc1ccc(cc1)c2cc(COc3cc(Cl)c(Cl)cc3Cl)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J18 compound treatment 0.072 -0.00415 -0.49 -0.4918 -1.0 1492859 Bionet1_002836 Cc1ccc(cc1)C(=O)n2ccc(n2)c3nn(ccc3=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J19 compound treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 1281653 Bionet1_002837 Clc1ccc(cc1)c2cc(COc3cc(Cl)c(Cl)cc3Cl)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J20 compound treatment 0.073 -0.00315 -0.37 -0.3733 -1.0 1693854 Bionet1_002838 Fc1ccc(cc1)C(=O)n2ccc(n2)c3nn(ccc3=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J21 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1119437 Bionet1_002839 COc1ccc(cc1)c2cc(COc3ccc(Cl)c(Cl)c3)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J22 compound treatment 0.073 -0.00315 -0.37 -0.3733 -1.0 1909761 Bionet1_002840 FC(F)(F)c1cccc(c1)n2ccc(=O)c(n2)c3ccn(n3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J23 mock treatment 0.0705 -0.00565 -0.67 -0.6696 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 J24 mock treatment 0.066 -0.0102 -1.2 -1.2028 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K01 mock treatment 0.079 0.00285 0.34 0.3376 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K02 mock treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K03 compound treatment 0.0785 0.00235 0.28 0.2784 1.0 1576316 Bionet1_002841 Cc1ccc(Sc2ncccc2COC(=O)Nc3c(C)cccc3C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K04 compound treatment 0.081 0.00485 0.57 0.5746 1.0 1909762 Bionet1_002842 Cc1cccc(CN2C(=O)N(OCc3cccc(Cl)c3)C(=O)C2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K05 compound treatment 0.08 0.00385 0.46 0.4561 1.0 1506044 Bionet1_002843 Cc1ccccc1NC(=O)OCc2cccnc2Oc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K06 compound treatment 0.0725 -0.00365 -0.43 -0.4326 -1.0 1909763 Bionet1_002844 CCOC(=O)CN1C(=O)N(Cc2ccc(Cl)c(Cl)c2)C(=O)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K07 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1367652 Bionet1_002845 Clc1ccc(Sc2ncccc2COC(=O)Nc3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K08 compound treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 1909764 Bionet1_002846 CCOC(=O)CN1C(=O)N(Cc2c(Cl)cccc2Cl)C(=O)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K09 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1328691 Bionet1_002847 Clc1ccc(Sc2ncccc2COC(=O)NC3CCCCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K10 compound treatment 0.088 0.0118 1.4 1.404 1.0 1909765 Bionet1_002848 COc1ccc(CN2C(=O)N(Cc3ccc(Cl)cc3)C(=O)C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K11 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1909766 Bionet1_002849 COc1ccc(COC(=O)N/C=C/c2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K12 compound treatment 0.071 -0.00515 -0.61 -0.6103 -1.0 1909767 Bionet1_002850 COc1ccc(CN2C(=O)N(Cc3ccc(Cl)cc3)C(=O)C2=O)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K13 compound treatment 0.0955 0.0193 2.29 2.2927 1.0 1909768 Bionet1_002851 Clc1ccc(CNC(=O)N/C=C/c2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K14 compound treatment 0.082 0.00585 0.69 0.6931 1.0 1909769 Bionet1_002852 FC(F)(F)c1cccc(CN2C(=O)N(Cc3ccc(Cl)cc3)C(=O)C2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K15 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1909770 Bionet1_002853 Clc1cccc(CNC(=O)N/C=C/c2ccc(Cl)c(Cl)c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K16 compound treatment 0.0715 -0.00465 -0.55 -0.5511 -1.0 1909771 Bionet1_002854 CCOC(=O)c1sc2nccc(N(C)C)c2c1N/C=N/OCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K17 compound treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 1422768 Bionet1_002855 Cc1ccccc1NC(=O)OCc2cccnc2Sc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K18 compound treatment 0.0835 0.00735 0.87 0.8708 1.0 1909772 Bionet1_002856 CN(C)c1ccnc(c1C#N)n2cccc2/C=N/OCc3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K19 compound treatment 0.0695 -0.00665 -0.79 -0.7881 -1.0 1665165 Bionet1_002857 COc1ccccc1CNc2cc(CSc3ccc(Cl)cc3)nc(C)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K20 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909773 Bionet1_002858 CN(C)c1ccnc(c1C#N)n2cccc2/C=N/OCc3cccc(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K21 compound treatment 0.0705 -0.00565 -0.67 -0.6696 -1.0 1909774 Bionet1_002859 Cc1nc(CSc2ccccc2)cc(OCc3ccc(Cl)cc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K22 compound treatment 0.07 -0.00615 -0.73 -0.7288 -1.0 1909775 Bionet1_002860 COc1ccccc1CO/N=C/c2cccn2c3nccc(N(C)C)c3C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K23 mock treatment 0.071 -0.00515 -0.61 -0.6103 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 K24 mock treatment 0.07 -0.00615 -0.73 -0.7288 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L01 mock treatment 0.0775 0.00135 0.16 0.1599 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L02 mock treatment 0.0765 3.49E-4 0.04 0.0414 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L03 compound treatment 0.0845 0.00835 0.99 0.9893 1.0 1909776 Bionet1_002861 Clc1ccc(NC(=O)OCCNS(=O)(=O)c2ccc(Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L04 compound treatment 0.084 0.00785 0.93 0.9301 1.0 1239273 Bionet1_002862 Clc1ccc(cc1)n2ccc(=O)c(n2)c3ccn(n3)C(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L05 compound treatment 0.0805 0.00435 0.52 0.5153 1.0 1189276 Bionet1_002863 Cc1ccc(cc1)n2ncc(Cl)c(Oc3ccc4ccccc4c3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L06 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1349583 Bionet1_002864 Clc1ccc(cc1)n2ccc(=O)c(n2)c3ccn(n3)C(=O)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L07 compound treatment 0.1015 0.0253 3.0 3.0036 1.0 1909777 Bionet1_002865 COc1ccc(/C=C(\C#N)/c2nc(cs2)c3ccc(Cl)cc3)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L08 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909778 Bionet1_002866 Fc1ccccc1n2ccc(n2)c3nn(ccc3=O)c4cccc(c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L09 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909779 Bionet1_002867 COc1ccc(cc1)c2csc(n2)/C(=C/c3ccc(OC)c(OC)c3)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L10 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1344113 Bionet1_002868 CN(N)c1nc(cc(C)c1S(=O)(=O)c2ccc(C)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L11 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909780 Bionet1_002869 COc1ccc(/C=C(\C#N)/c2nc(cs2)c3ccc(F)cc3)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L12 compound treatment 0.0845 0.00835 0.99 0.9893 1.0 1909781 Bionet1_002870 COc1cccc(c1)C(=O)NN(C)c2nc(C)cc(C)c2S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L13 compound treatment 0.085 0.00885 1.05 1.0485 1.0 1909782 Bionet1_002871 C/C(=N\OCc1cccc(c1)C(F)(F)F)/c2sc3ncnn3c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L14 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909783 Bionet1_002872 CN(NC(=O)c1c(F)cccc1F)c2nc(C)cc(C)c2S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L15 compound treatment 0.08 0.00385 0.46 0.4561 1.0 1909784 Bionet1_002873 Cc1c(sc2ncnn12)C(=O)CSCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L16 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1909785 Bionet1_002874 Cc1ccc(Sc2[nH]c(nc2/C=N/Nc3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L17 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909786 Bionet1_002875 CN(N1C(=O)C2C3CC(C=C3)C2C1=O)c4ncc(cc4Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L18 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1909787 Bionet1_002876 Cc1ccc(Sc2[nH]c(nc2/C=N/c3ccc(C)c(C)c3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L19 compound treatment 0.0725 -0.00365 -0.43 -0.4326 -1.0 1463955 Bionet1_002877 COc1ccc(NC(=O)c2ccccc2Sc3ccc(NC(=O)C)nc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L20 compound treatment 0.073 -0.00315 -0.37 -0.3733 -1.0 1909788 Bionet1_002878 CN(NC(=O)C(C)(C)C)c1nc(cc(C)c1S(=O)(=O)C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L21 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1621763 Bionet1_002879 COc1ccc(cc1)C2CC(Cn3cc(C#N)c(=O)n(C)c3=O)ON2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L22 compound treatment 0.0725 -0.00365 -0.43 -0.4326 -1.0 1909789 Bionet1_002880 CN(NC(=O)C1CC1)c2nc(cc(C)c2S(=O)(=O)C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L23 mock treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 L24 mock treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M01 mock treatment 0.0775 0.00135 0.16 0.1599 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M02 mock treatment 0.0765 3.49E-4 0.04 0.0414 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M03 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909790 Bionet1_002881 Cc1nc(CSc2ccccc2)cc(OCc3ccc(Cl)cc3Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M04 compound treatment 0.08 0.00385 0.46 0.4561 1.0 1909791 Bionet1_002882 CN(C)c1ccnc(c1C#N)n2cccc2/C=N/OCc3ccc(F)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M05 compound treatment 0.0795 0.00335 0.4 0.3968 1.0 1233696 Bionet1_002883 Cc1nc(CSc2ccc(Cl)cc2)cc(NCc3ccc(Cl)cc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M06 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909792 Bionet1_002884 CN(C)C(=C(C#N)C#N)C/C=N/Nc1ncc(cc1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M07 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1660394 Bionet1_002885 Cc1nc(CS(=O)c2ccc(Cl)cc2)cc(n1)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M08 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1909793 Bionet1_002886 CN(C)C(=C(C#N)C#N)/C=C/Nc1cc(cc(c1)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M09 compound treatment 0.072 -0.00415 -0.49 -0.4918 -1.0 1909794 Bionet1_002887 COc1ccc(SCc2c(Cl)n(C)nc2CSc3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M10 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1909795 Bionet1_002888 CN(C)C(=C(C#N)C#N)/C=C/Nc1ccc(I)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M11 compound treatment 0.0805 0.00435 0.52 0.5153 1.0 1724480 Bionet1_002889 COc1ccc(Oc2cc(CS(=O)c3ccc(Cl)cc3)nc(C)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M12 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1909796 Bionet1_002890 CN(C)c1ccnc(Nc2ccc(I)cc2)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M13 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1258850 Bionet1_002891 Cc1nc(CSc2ccc(Cl)cc2)cc(NCc3ccccc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M14 compound treatment 0.082 0.00585 0.69 0.6931 1.0 1909797 Bionet1_002892 CN(C)C(=C(C#N)C#N)C/C=N/OCC(=O)N1CCN(CC1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M15 compound treatment 0.0955 0.0193 2.29 2.2927 1.0 1269012 Bionet1_002893 Cc1nc(CSc2ccc(Cl)cc2)cc(NCc3ccccc3Cl)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M16 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1909798 Bionet1_002894 CN(C)C(=C(C#N)C#N)C/C=N/OCCOc1cccc(c1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M17 compound treatment 0.08 0.00385 0.46 0.4561 1.0 1909799 Bionet1_002895 COc1cccc(c1)n2nc(c3ccnn3c4ccccc4)c(=O)n(C)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M18 compound treatment 0.0975 0.0213 2.53 2.5297 1.0 1909800 Bionet1_002896 Cc1ccc(CN2C(=O)/C(=N/Nc3ccc(Cl)cc3)/c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M19 compound treatment 0.073 -0.00315 -0.37 -0.3733 -1.0 1909801 Bionet1_002897 COc1cccc(c1)n2nc(c3ccnn3c4ccc(C)cc4)c(=O)n(C)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M20 compound treatment 0.087 0.0108 1.29 1.2855 1.0 1909802 Bionet1_002898 Cc1ccc(CN2C(=O)/C(=N/Nc3cccc(F)c3)/c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M21 compound treatment 0.0885 0.0123 1.46 1.4633 1.0 1909803 Bionet1_002899 COc1cccc(c1)n2nc(c3ccnn3c4ccc(F)cc4)c(=O)n(C)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M22 compound treatment 0.072 -0.00415 -0.49 -0.4918 -1.0 1909804 Bionet1_002900 CSc1nc(/C=C/c2ccc(C)cc2)cc(\C=C/c3ccc(C)cc3)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M23 mock treatment 0.0725 -0.00365 -0.43 -0.4326 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 M24 mock treatment 0.0735 -0.00265 -0.31 -0.3141 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N01 mock treatment 0.0765 3.49E-4 0.04 0.0414 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N02 mock treatment 0.082 0.00585 0.69 0.6931 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N03 compound treatment 0.0805 0.00435 0.52 0.5153 1.0 1909805 Bionet1_002901 FC(F)(F)c1cccc(c1)C(=O)Nc2ccc(I)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N04 compound treatment 0.0835 0.00735 0.87 0.8708 1.0 1402942 Bionet1_002902 COc1ccc(cc1)S(=O)(=O)NCc2cc(no2)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N05 compound treatment 0.0815 0.00535 0.63 0.6338 1.0 1909806 Bionet1_002903 CCOC(=O)NC(=O)/C(=C/Nc1ccc(I)cn1)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N06 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909807 Bionet1_002904 Clc1ccc(cc1)S(=O)(=O)NCc2cc(no2)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N07 compound treatment 0.0825 0.00635 0.75 0.7523 1.0 1408542 Bionet1_002905 COc1ccc(NC(=O)Nc2ccc(I)cn2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N08 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1540478 Bionet1_002906 COc1ccc(cc1)c2cc(CNS(=O)(=O)c3ccc(F)cc3)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N09 compound treatment 0.083 0.00685 0.81 0.8116 1.0 1909808 Bionet1_002907 Ic1ccc(NC(=S)NC(=O)c2ccccc2)nc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N10 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1732565 Bionet1_002908 Cc1cc(nc(Cl)c1S(=O)(=O)c2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N11 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1737757 Bionet1_002909 Clc1ccc(cc1)c2cnc3ccc(I)cn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N12 compound treatment 0.099 0.0228 2.71 2.7074 1.0 1357422 Bionet1_002910 Cc1cccc(Cl)c1S(=O)(=O)NCc2cc(no2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N13 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1909809 Bionet1_002911 Fc1ccc(cc1)c2csc(Nc3ccc(I)cn3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N14 compound treatment 0.0805 0.00435 0.52 0.5153 1.0 1909810 Bionet1_002912 Clc1ccc(cc1)c2cc(CNS(=O)(=O)c3ccc(Cl)cc3)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N15 compound treatment 0.0905 0.0143 1.7 1.7002 1.0 1731679 Bionet1_002913 CC(=O)Nc1ccc(Sc2ccccc2C(=O)NCCc3ccccc3)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N16 compound treatment 0.0815 0.00535 0.63 0.6338 1.0 1260919 Bionet1_002914 COc1ccc(CS(=O)c2nc(C)cc(C)c2S(=O)(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N17 compound treatment 0.0805 0.00435 0.52 0.5153 1.0 1909811 Bionet1_002915 COCCCNC(=O)c1ccccc1Sc2ccc(NC(=O)C)nc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N18 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1185968 Bionet1_002916 COc1ccc(CS(=O)(=O)c2nc(C)cc(C)c2S(=O)(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N19 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1120589 Bionet1_002917 CC(=O)Nc1ccc(Sc2ncccc2C(=O)Nc3ccc(F)cc3)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N20 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1909812 Bionet1_002918 Clc1cccc(c1Cl)S(=O)(=O)NCc2cc(no2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N21 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1608181 Bionet1_002919 COc1ccc(NC(=O)c2cccnc2Sc3ccc(NC(=O)C)nc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N22 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1131498 Bionet1_002920 COc1ccc(OC)c(c1)S(=O)(=O)NCc2cc(no2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N23 mock treatment 0.078 0.00185 0.22 0.2191 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 N24 mock treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O01 mock treatment 0.077 8.49E-4 0.1 0.1006 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O02 mock treatment 0.071 -0.00515 -0.61 -0.6103 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O03 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909813 Bionet1_002921 CN(C)c1ccc(/C=N/NC(=O)c2[nH]c3ccccc3c2c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O04 compound treatment 0.0785 0.00235 0.28 0.2784 1.0 1622811 Bionet1_002922 CC(C)Nc1nc(SCc2ccccc2)nc(c1C#N)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O05 compound treatment 0.08 0.00385 0.46 0.4561 1.0 1909814 Bionet1_002923 N/C(=C(/C#N)\C(=S)Nc1ccccc1)/N2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O06 compound treatment 0.0835 0.00735 0.87 0.8708 1.0 1679707 Bionet1_002924 Cc1ccc(cc1)c2nc(SCc3ccccc3)nc(NCC=C)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O07 compound treatment 0.0785 0.00235 0.28 0.2784 1.0 1909815 Bionet1_002925 FC(F)(F)c1c(c2ccccc2)c3cc(Cl)ccc3n1Cc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O08 compound treatment 0.0725 -0.00365 -0.43 -0.4326 -1.0 1635316 Bionet1_002926 CCN(CC)c1nc(SCc2ccccc2)nc(c1C#N)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O09 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909816 Bionet1_002927 [O-][N+](=O)c1ccc(Cn2c(C#N)c(c3ccccc3)c4cc(Cl)ccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O10 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909817 Bionet1_002928 CNc1nc(SCc2ccccc2Cl)nc(c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O11 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1909818 Bionet1_002929 [O-][N+](=O)CCc1ccccc1C(=O)NNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O12 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909819 Bionet1_002930 Clc1ccccc1CSc2nc(NCC=C)c(C#N)c(n2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O13 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1909820 Bionet1_002931 FC(F)(F)c1cnc(Cc2ccc(s2)C(=O)CCl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O14 compound treatment 0.09 0.0138 1.64 1.641 1.0 1909821 Bionet1_002932 CCCNc1nc(SCc2ccccc2Cl)nc(c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O15 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909822 Bionet1_002933 Clc1ccc(CO/N=C/CC(=O)c2cnc(s2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O16 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1909823 Bionet1_002934 CC(C)Nc1nc(SCc2ccccc2Cl)nc(c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O17 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909824 Bionet1_002935 Cc1ccc(CO/N=C/CC(=O)c2cnc(s2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O18 compound treatment 0.0785 0.00235 0.28 0.2784 1.0 1909825 Bionet1_002936 Cc1ccc(CN2C(=O)/C(=N/Nc3ccc(cc3)[N+](=O)[O-])/c4ccccc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O19 compound treatment 0.076 -1.51E-4 -0.02 -0.0179 -1.0 1909826 Bionet1_002937 Fc1ccc(CO/N=C/CC(=O)c2cnc(s2)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O20 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909827 Bionet1_002938 CN1C(=O)/C(=N/Nc2c(Cl)cc(cc2Cl)C(F)(F)F)/c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O21 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909828 Bionet1_002939 FC(F)(F)c1cccc(N/C=C/C(=O)c2cnc(s2)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O22 compound treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 1269128 Bionet1_002940 Cc1ccc(CSc2nc(NCC=C)c(C#N)c(n2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O23 mock treatment 0.078 0.00185 0.22 0.2191 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 O24 mock treatment 0.0765 3.49E-4 0.04 0.0414 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P01 mock treatment 0.0765 3.49E-4 0.04 0.0414 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P02 mock treatment 0.067 -0.00915 -1.08 -1.0843 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P03 compound treatment 0.0705 -0.00565 -0.67 -0.6696 -1.0 1483630 Bionet1_002941 CC(=O)Nc1ccc(Sc2ncccc2C(=O)Nc3cc(C)cc(C)c3)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P04 compound treatment 0.0675 -0.00865 -1.03 -1.025 -1.0 1909829 Bionet1_002942 Cc1cc(C)c(c(n1)S(=O)(=O)c2ccc(Cl)cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P05 compound treatment 0.071 -0.00515 -0.61 -0.6103 -1.0 1584531 Bionet1_002943 CC(=O)Nc1ccc(Sc2ccccc2C(=O)N3CCOCC3)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P06 compound treatment 0.0685 -0.00765 -0.91 -0.9065 -1.0 1909830 Bionet1_002944 Cc1cc(C)c(c(Sc2ccc(Cl)cc2)n1)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P07 compound treatment 0.0835 0.00735 0.87 0.8708 1.0 1909831 Bionet1_002945 FC(F)(F)c1cnc(NCC(CC#N)OC(=O)c2ccco2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P08 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1909832 Bionet1_002946 Cc1cc(nc(Sc2ccc(Cl)cc2)c1S(=O)(=O)C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P09 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909833 Bionet1_002947 COc1ccc(cc1)C2CC(Cn3cc(C(=O)C)c(=O)[nH]c3=O)ON2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P10 compound treatment 0.079 0.00285 0.34 0.3376 1.0 1613633 Bionet1_002948 Cc1ccc(cc1)S(=O)(=O)c2c(C)cc(nc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P11 compound treatment 0.08 0.00385 0.46 0.4561 1.0 1909834 Bionet1_002949 C/C(=C/C(=O)Nc1ccc(I)cn1)/N2CCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P12 compound treatment 0.0795 0.00335 0.4 0.3968 1.0 1909835 Bionet1_002950 Cc1cc(nc(O)c1S(=O)(=O)Cc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P13 compound treatment 0.0775 0.00135 0.16 0.1599 1.0 1909836 Bionet1_002951 CC(=O)c1noc(C)c1C(=O)Nc2ccc(I)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P14 compound treatment 0.0825 0.00635 0.75 0.7523 1.0 1909837 Bionet1_002952 Cc1cc(nc(Cl)c1S(=O)(=O)Cc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P15 compound treatment 0.0835 0.00735 0.87 0.8708 1.0 1909838 Bionet1_002953 CO/N=C(\C)/c1noc(C)c1C(=O)Nc2ccc(I)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P16 compound treatment 0.0795 0.00335 0.4 0.3968 1.0 1909839 Bionet1_002954 Cc1ccc(Sc2nc(C)cc(C)c2S(=O)(=O)c3ccc(C)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P17 compound treatment 0.078 0.00185 0.22 0.2191 1.0 1909840 Bionet1_002955 FC(F)(F)c1cnc(NCCN2C(=O)C3C4CC(C=C4)C3C2=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P18 compound treatment 0.077 8.49E-4 0.1 0.1006 1.0 1233216 Bionet1_002956 Cc1ccc(cc1)S(=O)c2nc(C)cc(C)c2S(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P19 compound treatment 0.0755 -6.51E-4 -0.08 -0.0771 -1.0 1909841 Bionet1_002957 Cc1cc(nc(SCc2ccc(Cl)c(Cl)c2)c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P20 compound treatment 0.0765 3.49E-4 0.04 0.0414 1.0 1124505 Bionet1_002958 Sc1nnc(Cc2sc(nc2c3ccccc3)c4ccccc4)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P21 compound treatment 0.075 -0.00115 -0.14 -0.1364 -1.0 1909842 Bionet1_002959 FC(F)(F)c1cccc(/N=C/c2nc([nH]c2Cl)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P22 compound treatment 0.074 -0.00215 -0.25 -0.2548 -1.0 1227960 Bionet1_002960 CSc1nnc(Cc2sc(nc2c3ccccc3)c4ccccc4)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P23 mock treatment 0.0745 -0.00165 -0.2 -0.1956 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.576 P24 mock treatment 0.0665 -0.00965 -1.14 -1.1435 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A01 mock treatment 0.0815 0.00923 1.09 1.0932 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A02 mock treatment 0.0725 2.26E-4 0.03 0.0268 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A03 compound treatment 0.08 0.00773 0.92 0.9154 1.0 1909843 Bionet1_002961 CC(OC(=O)c1cccc(c1)C(F)(F)F)c2sc3ncnn3c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A04 compound treatment 0.0885 0.0162 1.92 1.9226 1.0 1909844 Bionet1_002962 Fc1ccc(NC(=O)c2ccc(=O)n(Cc3cccc(Cl)c3)c2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A05 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909845 Bionet1_002963 COC(=O)c1nn(c(Sc2ccc(OC)cc2)c1/C=N/O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A06 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1909846 Bionet1_002964 FC(F)(F)c1ccc(NC(=O)c2ccc(=O)n(Cc3ccccc3)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A07 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1909847 Bionet1_002965 COC(=O)c1nn(c(Sc2ccc(Cl)cc2)c1/C=N/O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A08 compound treatment 0.0835 0.0112 1.33 1.3301 1.0 1177140 Bionet1_002966 CN(C(=O)c1ccc(=O)n(Cc2c(Cl)cccc2Cl)c1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A09 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1909848 Bionet1_002967 COC(=O)c1nn(c(Sc2ccc(C)cc2)c1/C=N/O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A10 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1408555 Bionet1_002968 Fc1cccc(Cl)c1Cn2cccc(C(=O)Nc3ccccc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A11 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1909849 Bionet1_002969 COC(=O)c1nn(c(Sc2ccccc2)c1/C=N/O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A12 compound treatment 0.077 0.00473 0.56 0.56 1.0 1557351 Bionet1_002970 Fc1ccc(cc1)c2nn(c3ccc(Cl)cc3)c(=O)c4cc(F)ccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A13 compound treatment 0.0805 0.00823 0.97 0.9747 1.0 1909850 Bionet1_002971 COC(=O)c1cc(c2ccc(Cl)cc2)n(n1)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A14 compound treatment 0.0755 0.00323 0.38 0.3822 1.0 1909851 Bionet1_002972 COC(=O)C(C)NC(=O)CNS(=O)(=O)c1ccc(Br)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A15 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1909852 Bionet1_002973 COC(=O)c1cc(c2ccc(Cl)cc2)n(n1)c3cc(Cl)ccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A16 compound treatment 0.086 0.0137 1.63 1.6264 1.0 1611406 Bionet1_002974 Cc1cc(c2ccccc2)n(CC#C)c(=O)c1S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A17 compound treatment 0.079 0.00673 0.8 0.7969 1.0 1909853 Bionet1_002975 COC(=O)c1cc(c2ccc(Cl)cc2)n(n1)c3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A18 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1728286 Bionet1_002976 CCn1c(cc(C)c(c1=O)S(=O)(=O)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A19 compound treatment 0.08 0.00773 0.92 0.9154 1.0 1909854 Bionet1_002977 COC(=O)c1cc(c2ccc(Cl)cc2)n(n1)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A20 compound treatment 0.08 0.00773 0.92 0.9154 1.0 1909855 Bionet1_002978 Fc1ccc(C(=O)Nc2ccc(CS(=O)c3ccccc3)cc2)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A21 compound treatment 0.0795 0.00723 0.86 0.8562 1.0 1909856 Bionet1_002979 Clc1ccccc1c2csc(NC(=O)CN3CCSCC3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A22 compound treatment 0.0825 0.0102 1.21 1.2117 1.0 1909857 Bionet1_002980 Clc1ccc(cc1)S(=O)Cc2ccc(NC(=O)c3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A23 mock treatment 0.0915 0.0192 2.28 2.2781 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 A24 mock treatment 0.083 0.0107 1.27 1.2709 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B01 mock treatment 0.066 -0.00627 -0.74 -0.7434 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B02 mock treatment 0.073 7.26E-4 0.09 0.086 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B03 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1909858 Bionet1_002981 COc1ccc(cc1)C(=O)n2ccc(n2)c3ccc(Oc4ncccn4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B04 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909859 Bionet1_002982 Cc1ccc(Oc2cc(Oc3ccc(C)cc3)nc(n2)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B05 compound treatment 0.071 -0.00127 -0.15 -0.151 -1.0 1690382 Bionet1_002983 Cc1cccc(c1)C(=O)n2ccc(n2)c3ccc(Oc4ncccn4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B06 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1909860 Bionet1_002984 Cc1ccc(Sc2cc(nc(n2)c3ccccc3)N4CCOCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B07 compound treatment 0.077 0.00473 0.56 0.56 1.0 1909861 Bionet1_002985 Nc1c(cnc2nc(SCCC(=C(F)F)F)nn12)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B08 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1909862 Bionet1_002986 Cc1ccc(Oc2cc(Sc3ccc(C)cc3)nc(n2)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B09 compound treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 1909863 Bionet1_002987 [O-][N+](=O)c1ccc(CC(C#N)(C#N)c2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B10 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1605807 Bionet1_002988 Clc1ccc(SC2CCS(=O)(=O)c3sccc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B11 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1909864 Bionet1_002989 Nc1c(cnc2nc(SCCC(=C(F)F)F)nn12)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B12 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1130924 Bionet1_002990 Brc1ccc(SC2CCS(=O)(=O)c3sccc23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B13 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1909865 Bionet1_002991 Oc1ccccc1c2occc2C(=O)N/N=C/c3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B14 compound treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 1634902 Bionet1_002992 Clc1ccc(Cl)c(SC2CCS(=O)(=O)c3sccc23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B15 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1909866 Bionet1_002993 FC(=C(F)CCSc1ccccc1C(=O)Nc2ccc(Cl)cc2)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B16 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1909867 Bionet1_002994 COc1cccc(Sc2cc(nc(n2)c3ccccc3)N4CCOCC4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B17 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1909868 Bionet1_002995 Nc1nc(Nc2ccc(Cl)cc2)sc1C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B18 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1909869 Bionet1_002996 Clc1ccc(Sc2cc(nc(n2)c3ccccc3)N4CCOCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B19 compound treatment 0.08 0.00773 0.92 0.9154 1.0 1732093 Bionet1_002997 Nc1nc(Nc2ccc(Cl)cc2)sc1C(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B20 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1909870 Bionet1_002998 Cc1nc2sccn2c1c3nnc(SCc4cccc(c4)C(F)(F)F)o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B21 compound treatment 0.077 0.00473 0.56 0.56 1.0 1641010 Bionet1_002999 Nc1nc(Nc2ccc(Cl)cc2)sc1C(=O)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B22 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1464512 Bionet1_003000 COc1ccc(Sc2nccc(c2C#N)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B23 mock treatment 0.08 0.00773 0.92 0.9154 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 B24 mock treatment 0.0755 0.00323 0.38 0.3822 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C01 mock treatment 0.074 0.00173 0.2 0.2045 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C02 mock treatment 0.0755 0.00323 0.38 0.3822 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C03 compound treatment 0.077 0.00473 0.56 0.56 1.0 1909871 Bionet1_003001 COC(=O)c1cc(c2ccc(Cl)c(Cl)c2)n(n1)c3cccc(C)c3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C04 compound treatment 0.0825 0.0102 1.21 1.2117 1.0 1909872 Bionet1_003002 Cc1c(Cl)cccc1NC(=O)c2ccc(c(c2)[N+](=O)[O-])n3ccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C05 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909873 Bionet1_003003 COC(=O)c1cc(c2ccc(Cl)c(Cl)c2)n(n1)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C06 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1526532 Bionet1_003004 CNC(=O)c1cc(c2ccc(Cl)cc2)n(n1)c3cc(Cl)ccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C07 compound treatment 0.0825 0.0102 1.21 1.2117 1.0 1909874 Bionet1_003005 COC(=O)c1cc(c2ccc(Cl)c(Cl)c2)n(n1)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C08 compound treatment 0.077 0.00473 0.56 0.56 1.0 1909875 Bionet1_003006 COc1cccc2C=C(COc12)C(=O)Nc3cc(Cl)ccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C09 compound treatment 0.0775 0.00523 0.62 0.6192 1.0 1909876 Bionet1_003007 COC(=O)c1cc(c2ccc(Cl)c(Cl)c2)n(n1)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C10 compound treatment 0.075 0.00273 0.32 0.323 1.0 1345448 Bionet1_003008 COc1ccc(cc1)C2C(CN3CCCCC3)C(=O)N2c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C11 compound treatment 0.0765 0.00423 0.5 0.5007 1.0 1909877 Bionet1_003009 CN(CC(=O)Nc1nc(cs1)c2ccc(Cl)cc2)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C12 compound treatment 0.075 0.00273 0.32 0.323 1.0 1909878 Bionet1_003010 CO/N=C(/CN1CCN(CC1)c2ccccc2F)\c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C13 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909879 Bionet1_003011 COC(=O)c1cc(c2ccccc2Cl)n(n1)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C14 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1909880 Bionet1_003012 CN(C)C(=O)c1cc(c2ccc(Cl)cc2)n(n1)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C15 compound treatment 0.075 0.00273 0.32 0.323 1.0 1909881 Bionet1_003013 COC(=O)c1cc(NC(=O)c2cccc(Cl)c2)c(=O)oc1/C=C/N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C16 compound treatment 0.091 0.0187 2.22 2.2188 1.0 1909882 Bionet1_003014 Clc1ccc(cc1)C(=O)Nc2ccc(/C=C/c3nc4ccccc4s3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C17 compound treatment 0.0765 0.00423 0.5 0.5007 1.0 1909883 Bionet1_003015 CCOC(=O)c1cc(on1)c2oc(=O)c(NC(=O)c3ccccc3)cc2C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C18 compound treatment 0.075 0.00273 0.32 0.323 1.0 1909884 Bionet1_003016 CCOC(=O)COn1c(nc2ccc(cc12)[N+](=O)[O-])c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C19 compound treatment 0.0895 0.0172 2.04 2.0411 1.0 1909885 Bionet1_003017 COC(=O)c1cc(NC(=O)c2ccccc2)c(=O)oc1/C=C/Nc3nccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C20 compound treatment 0.0845 0.0122 1.45 1.4486 1.0 1909886 Bionet1_003018 Cc1ccc(cc1)S(=O)c2snnc2c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C21 compound treatment 0.084 0.0117 1.39 1.3894 1.0 1306022 Bionet1_003019 O=C(Nc1cc2c(=O)n(ccc2oc1=O)c3nccs3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C22 compound treatment 0.0795 0.00723 0.86 0.8562 1.0 1909887 Bionet1_003020 Clc1ccc(NC(=O)C2=Cc3cc(Cl)ccc3OC2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C23 mock treatment 0.0765 0.00423 0.5 0.5007 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 C24 mock treatment 0.0775 0.00523 0.62 0.6192 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D01 mock treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D02 mock treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D03 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1231570 Bionet1_003021 CC(C)(C)Nc1nc(N)c(s1)C(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D04 compound treatment 0.0755 0.00323 0.38 0.3822 1.0 1909888 Bionet1_003022 FC(F)(F)c1cccc(Sc2nccc(c2C#N)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D05 compound treatment 0.075 0.00273 0.32 0.323 1.0 1909889 Bionet1_003023 Nc1nc(Nc2ccc(Cl)cc2)sc1C(=O)c3cccc(c3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D06 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1384292 Bionet1_003024 Clc1ccc(cc1)c2ccnc(Oc3ccc(Cl)c(Cl)c3)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D07 compound treatment 0.0865 0.0142 1.69 1.6856 1.0 1434967 Bionet1_003025 COc1ccc(OCc2cnc(OCc3ccc(Cl)c(Cl)c3)s2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D08 compound treatment 0.078 0.00573 0.68 0.6785 1.0 1909890 Bionet1_003026 FC(F)(F)c1cccc(Oc2nccc(c2C#N)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D09 compound treatment 0.079 0.00673 0.8 0.7969 1.0 1508756 Bionet1_003027 Clc1ncc(COc2ccc(cc2)S(=O)(=O)N3CCOCC3)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D10 compound treatment 0.077 0.00473 0.56 0.56 1.0 1909891 Bionet1_003028 COc1ccc(CSc2nccc(c2C#N)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D11 compound treatment 0.0825 0.0102 1.21 1.2117 1.0 1909892 Bionet1_003029 FC(=C(F)CCSc1ncccc1C(=O)Nc2ccc(F)cc2)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D12 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1909893 Bionet1_003030 Cc1ccc(cc1)S(=O)(=O)c2cc(nc(n2)c3ccccc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D13 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1909894 Bionet1_003031 CCNC(=O)NNC(=O)COc1ccc2c(C(=O)OCC)c3ccccn3c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D14 compound treatment 0.078 0.00573 0.68 0.6785 1.0 1287949 Bionet1_003032 COc1ccc(cc1)c2c(Oc3ccc(F)cc3)c4ccc(OC)cc4s2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D15 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1909895 Bionet1_003033 Clc1cc(Cl)c(N/N=C/2\CCS(=O)(=O)c3sccc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D16 compound treatment 0.0775 0.00523 0.62 0.6192 1.0 1734112 Bionet1_003034 COc1ccc(Oc2nc(C)cc(C)c2S(=O)(=O)c3ccc(C)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D17 compound treatment 0.0825 0.0102 1.21 1.2117 1.0 1909896 Bionet1_003035 Clc1ccc(Cl)c(N/N=C/2\CCS(=O)(=O)c3sccc23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D18 compound treatment 0.075 0.00273 0.32 0.323 1.0 1577130 Bionet1_003036 COc1ccccc1Oc2nc(cc(C)c2S(=O)(=O)C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D19 compound treatment 0.079 0.00673 0.8 0.7969 1.0 1909897 Bionet1_003037 Clc1ccc(N/N=C/2\CCS(=O)(=O)c3sccc23)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D20 compound treatment 0.079 0.00673 0.8 0.7969 1.0 1168505 Bionet1_003038 Cc1cc(nc(Oc2ccc(cc2)C(C)(C)C)c1S(=O)(=O)C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D21 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1307758 Bionet1_003039 Cc1ccc(CSc2nc(N3CCOCC3)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D22 compound treatment 0.0765 0.00423 0.5 0.5007 1.0 1909898 Bionet1_003040 Fc1ccc(cc1)c2ccnc(Sc3ccc(Br)cc3)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D23 mock treatment 0.076 0.00373 0.44 0.4415 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 D24 mock treatment 0.0755 0.00323 0.38 0.3822 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E01 mock treatment 0.0765 0.00423 0.5 0.5007 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E02 mock treatment 0.078 0.00573 0.68 0.6785 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E03 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1909899 Bionet1_003041 O=C1C2C(/C=C/c3ccccc3)N4CSCC4C2C(=O)N1c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E04 compound treatment 0.0815 0.00923 1.09 1.0932 1.0 1164709 Bionet1_003042 Fc1ccc(cc1)c2nn(c3ccc(F)cc3)c(=O)c4cc(F)ccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E05 compound treatment 0.078 0.00573 0.68 0.6785 1.0 1605788 Bionet1_003043 Clc1cccc(c1)C2C3C(C4CSCN24)C(=O)N(C3=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E06 compound treatment 0.0915 0.0192 2.28 2.2781 1.0 1909900 Bionet1_003044 FC(F)(F)COC(=O)c1ccc(nc1)N2CCN(CC2)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E07 compound treatment 0.0855 0.0132 1.57 1.5671 1.0 1909901 Bionet1_003045 CNc1nnc(s1)C2=NOC(CNc3ncc(cc3Cl)C(F)(F)F)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E08 compound treatment 0.088 0.0157 1.86 1.8634 1.0 1909902 Bionet1_003046 FC(F)(F)COC(=O)c1ccc(nc1)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E09 compound treatment 0.0805 0.00823 0.97 0.9747 1.0 1909903 Bionet1_003047 Fc1cccc(F)c1C(=O)NCCONC(=O)c2c(F)cccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E10 compound treatment 0.0805 0.00823 0.97 0.9747 1.0 1909904 Bionet1_003048 FC(F)(F)c1nn(c(c1OCc2ccccc2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E11 compound treatment 0.082 0.00973 1.15 1.1524 1.0 1909905 Bionet1_003049 Clc1ccc(cc1)C(=O)NCCONC(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E12 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1587334 Bionet1_003050 CCOC(=O)c1nn(c2ccccc2)c(=O)cc1SC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E13 compound treatment 0.08 0.00773 0.92 0.9154 1.0 1909906 Bionet1_003051 COc1ccc(cc1)N2CCN(CC2)c3ccc4nnc(n4n3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E14 compound treatment 0.0815 0.00923 1.09 1.0932 1.0 1404442 Bionet1_003052 Cc1ccc(Sc2ccc(NC(=O)c3cccnc3Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E15 compound treatment 0.0865 0.0142 1.69 1.6856 1.0 1909907 Bionet1_003053 CC(C)(C)NC(=O)C1Cc2ccccc2CN1c3ncccc3[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E16 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1645118 Bionet1_003054 COc1ccc(COc2ccsc2C(=O)Nc3ccc(F)cc3F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E17 compound treatment 0.085 0.0127 1.51 1.5079 1.0 1655032 Bionet1_003055 COc1ccc(NC(=O)N2Cc3ccccc3CC2C(=O)NC(C)(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E18 compound treatment 0.0975 0.0252 2.99 2.989 1.0 1144993 Bionet1_003056 Cc1ccc(cc1)S(=O)(=O)c2ccc(NC(=O)c3ccc(F)cc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E19 compound treatment 0.0775 0.00523 0.62 0.6192 1.0 1259874 Bionet1_003057 CC(=O)N1C(Cc2ccccc2)C(=O)N(C(Cc3ccccc3)C1=O)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E20 compound treatment 0.077 0.00473 0.56 0.56 1.0 1909908 Bionet1_003058 Cc1ccc(cc1)S(=O)(=O)c2ccc(NC(=O)C(Cl)Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E21 compound treatment 0.0765 0.00423 0.5 0.5007 1.0 1681730 Bionet1_003059 COc1ccc(cc1)C(=O)N2Cc3ccccc3CC2C(=O)NC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E22 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1909909 Bionet1_003060 ClCC(=O)Nc1ccc(cc1)S(=O)(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E23 mock treatment 0.0755 0.00323 0.38 0.3822 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 E24 mock treatment 0.0745 0.00223 0.26 0.2637 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F01 mock treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F02 mock treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F03 compound treatment 0.078 0.00573 0.68 0.6785 1.0 1467003 Bionet1_003061 Cc1ccc(CSc2nc(N3CCCCC3)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F04 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1909910 Bionet1_003062 Fc1ccc(cc1)c2ccnc(Sc3c(Cl)cccc3Cl)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F05 compound treatment 0.0775 0.00523 0.62 0.6192 1.0 1909911 Bionet1_003063 Clc1ccc(cc1)C(=O)O/N=C/2\CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F06 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1168816 Bionet1_003064 COC(=O)c1ccccc1Sc2nccc(c2C#N)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F07 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1909912 Bionet1_003065 Clc1ccc(cc1Cl)C(=O)O/N=C/2\CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F08 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909913 Bionet1_003066 Cc1ccc(C/N=C/c2ccc(O)c(Cc3c(F)cccc3Cl)c2O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F09 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1909914 Bionet1_003067 COc1cccc(c1)C(=O)O/N=C/2\CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F10 compound treatment 0.0755 0.00323 0.38 0.3822 1.0 1909915 Bionet1_003068 COc1cccc(C/N=C/c2ccc(O)c(Cc3c(F)cccc3Cl)c2O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F11 compound treatment 0.0805 0.00823 0.97 0.9747 1.0 1909916 Bionet1_003069 Clc1cccc(c1)C(=O)O/N=C/2\CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F12 compound treatment 0.0765 0.00423 0.5 0.5007 1.0 1909917 Bionet1_003070 Oc1ccc(/C=N/Cc2ccco2)c(O)c1Cc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F13 compound treatment 0.077 0.00473 0.56 0.56 1.0 1909918 Bionet1_003071 Clc1ccc(C(=O)O/N=C/2\CCS(=O)(=O)c3sccc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F14 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909919 Bionet1_003072 COC(=O)c1ccc(N2CCN(CC(=O)c3ccc(C)cc3)CC2)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F15 compound treatment 0.0765 0.00423 0.5 0.5007 1.0 1326935 Bionet1_003073 CN1CCN(CC1)c2nc(SCc3ccc(C)cc3)nc4CCCCc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F16 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909920 Bionet1_003074 COC(=O)c1ccc(N2CCN(CC2)c3ccc(F)cc3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F17 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909921 Bionet1_003075 FC(F)(F)c1ccccc1C(=O)O/N=C/2\CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F18 compound treatment 0.075 0.00273 0.32 0.323 1.0 1909922 Bionet1_003076 COC(=O)c1ccc(N2CCN(CC2)c3ccc(cc3)[N+](=O)[O-])c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F19 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1484324 Bionet1_003077 CC1CN(CC(C)O1)c2nc(SCc3ccc(C)cc3)nc4CCCCc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F20 compound treatment 0.0755 0.00323 0.38 0.3822 1.0 1909923 Bionet1_003078 COC(=O)c1ccc(N2CCN(CC2)C(=O)c3ccc(OC)cc3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F21 compound treatment 0.0755 0.00323 0.38 0.3822 1.0 1502191 Bionet1_003079 Cc1ccc(CSc2nc(Oc3ccc(C)cc3)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F22 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1909924 Bionet1_003080 COC(=O)c1ccc(N2CCN(CC2)c3ccc(Cl)cc3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F23 mock treatment 0.0735 0.00123 0.15 0.1452 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 F24 mock treatment 0.0725 2.26E-4 0.03 0.0268 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G01 mock treatment 0.068 -0.00427 -0.51 -0.5064 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G02 mock treatment 0.071 -0.00127 -0.15 -0.151 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G03 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1301514 Bionet1_003081 CC(C)(C)NC(=O)C1Cc2ccccc2CN1C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G04 compound treatment 0.08 0.00773 0.92 0.9154 1.0 1179644 Bionet1_003082 COC(=O)c1ccccc1SCC(=O)c2cc(Cl)sc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G05 compound treatment 0.068 -0.00427 -0.51 -0.5064 -1.0 1909925 Bionet1_003083 O=C(NC(COC(=O)c1cccs1)c2ccccc2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G06 compound treatment 0.0825 0.0102 1.21 1.2117 1.0 1909926 Bionet1_003084 Clc1cc(C(=O)/C=C/Nc2ccc(Br)cc2)c(Cl)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G07 compound treatment 0.079 0.00673 0.8 0.7969 1.0 1122031 Bionet1_003085 CNC(=O)C(NS(=O)(=O)c1ccc(Br)cc1)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G08 compound treatment 0.0775 0.00523 0.62 0.6192 1.0 1909927 Bionet1_003086 FC(F)(F)Oc1ccc(N/C=C/C(=O)c2cc(Cl)sc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G09 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1909928 Bionet1_003087 O=C(NC(COC(=O)Nc1ccccc1)c2ccccc2)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G10 compound treatment 0.071 -0.00127 -0.15 -0.151 -1.0 1909929 Bionet1_003088 COc1ccc(N/C=C/C(=O)c2cc(Cl)sc2Cl)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G11 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1495650 Bionet1_003089 CNC(=O)C(NC(=O)c1c(C)onc1c2c(F)cccc2Cl)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G12 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1909930 Bionet1_003090 CC(=O)Oc1ccc(cc1)C(C#N)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G13 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1909931 Bionet1_003091 [O-][N+](=O)c1ccc(/C=N/NC(=O)C(CC2CCCCC2)n3cccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G14 compound treatment 0.068 -0.00427 -0.51 -0.5064 -1.0 1909932 Bionet1_003092 CS(=O)(=O)Oc1ccc(cc1)C(C#N)c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G15 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1909933 Bionet1_003093 CNC(=O)C(Nc1c(cc(cc1[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G16 compound treatment 0.0705 -0.00177 -0.21 -0.2102 -1.0 1909934 Bionet1_003094 CS(=O)(=O)Oc1ccc(Cc2ncc(cc2Cl)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G17 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1279440 Bionet1_003095 Cc1ccc(NC(=O)N2Cc3ccccc3CC2C(=O)NC(C)(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G18 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1909935 Bionet1_003096 Clc1cc(c(Cl)s1)c2ccnc(SCc3ccc(Cl)cc3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G19 compound treatment 0.071 -0.00127 -0.15 -0.151 -1.0 1734718 Bionet1_003097 CC(C)(C)NC(=O)C1Cc2ccccc2CN1C(=O)Nc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G20 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1909936 Bionet1_003098 FC(F)(F)c1cnc(Cc2ccc(Oc3ccc(Cl)nn3)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G21 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1176928 Bionet1_003099 CC(C)(C)NC(=O)C1Cc2ccccc2CN1C(=O)Nc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G22 compound treatment 0.0775 0.00523 0.62 0.6192 1.0 1909937 Bionet1_003100 Clc1ccc(cc1)C(=O)/C=C/c2ccc(o2)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G23 mock treatment 0.0705 -0.00177 -0.21 -0.2102 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 G24 mock treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H01 mock treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H02 mock treatment 0.073 7.26E-4 0.09 0.086 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H03 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1418682 Bionet1_003101 Cc1ccc(CSc2nc(Oc3ccc(Cl)cc3)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H04 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1909938 Bionet1_003102 COC(=O)c1ccc(N2CCN(CC2)c3ncccc3[N+](=O)[O-])c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H05 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1363624 Bionet1_003103 Cc1ccc(CSc2nc(Oc3cccc(Cl)c3)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H06 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1909939 Bionet1_003104 COC(=O)c1ccc(N2CCN(CC2)c3c(C)cccc3C)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H07 compound treatment 0.0845 0.0122 1.45 1.4486 1.0 1467517 Bionet1_003105 Cc1cccc(C)c1OC(=O)CN(c2ccccc2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H08 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1909940 Bionet1_003106 COC(=O)c1ccc(N2CCN(CC2)C(=O)c3cccs3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H09 compound treatment 0.0815 0.00923 1.09 1.0932 1.0 1909941 Bionet1_003107 Cc1ccc(CSc2nc(Sc3ccccc3)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H10 compound treatment 0.078 0.00573 0.68 0.6785 1.0 1212804 Bionet1_003108 COc1ccc(S(=O)N2CCN(Cc3ccccc3)CC2)c(OC)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H11 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1909942 Bionet1_003109 Cc1ccc(CSc2nc(Sc3cccc(C)c3)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H12 compound treatment 0.083 0.0107 1.27 1.2709 1.0 1238261 Bionet1_003110 COc1ccc(S(=O)N2CCN(CC2)c3ccccc3F)c(OC)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H13 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1909943 Bionet1_003111 COC(=O)CSc1nc(SCc2ccc(C)cc2)nc3CCCCc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H14 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1403051 Bionet1_003112 COc1ccc(S(=O)N2CCN(CC2)c3ccccn3)c(OC)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H15 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909944 Bionet1_003113 CSc1nc(Sc2ccc(Br)cc2)c3sccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H16 compound treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 1177814 Bionet1_003114 Brc1ccc(COc2ccc3c(C#N)c4ccccn4c3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H17 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909945 Bionet1_003115 Cc1ccc(CSc2nc(Sc3ccccc3N)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H18 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1585493 Bionet1_003116 CSc1nc(Oc2ccc(F)cc2)c3cnn(c4ccccc4)c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H19 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1728605 Bionet1_003117 CCOC(=O)c1cnc(SC)nc1Nc2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H20 compound treatment 0.0775 0.00523 0.62 0.6192 1.0 1909946 Bionet1_003118 FC(F)(F)c1cccc(c1)C(=O)OC2CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H21 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1909947 Bionet1_003119 CCOC(=O)c1cnc(SC)nc1Nc2ccc(cc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H22 compound treatment 0.075 0.00273 0.32 0.323 1.0 1483542 Bionet1_003120 Clc1ccc(C(=O)OC2CCS(=O)(=O)c3sccc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H23 mock treatment 0.0745 0.00223 0.26 0.2637 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 H24 mock treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I01 mock treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I02 mock treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I03 compound treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 1342233 Bionet1_003121 COC(=O)C(NS(=O)(=O)c1ccc(Br)cc1)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I04 compound treatment 0.0805 0.00823 0.97 0.9747 1.0 1909948 Bionet1_003122 [O-][N+](=O)c1ccc(cc1)/C(=N/Nc2ccccc2)/C=C/c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I05 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1909949 Bionet1_003123 FC(F)(F)c1cccc(CC(=O)OCC(=O)Nc2sccc2C#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I06 compound treatment 0.0765 0.00423 0.5 0.5007 1.0 1909950 Bionet1_003124 Cc1ccccc1CSc2nccc(n2)c3cc(Cl)sc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I07 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909951 Bionet1_003125 FC(F)(F)c1cnc(SCC(=O)Nc2sccc2C#N)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I08 compound treatment 0.075 0.00273 0.32 0.323 1.0 1909952 Bionet1_003126 Cc1ccc(CSc2nccc(n2)c3cc(Cl)sc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I09 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1711260 Bionet1_003127 COC(=O)c1ccsc1n2cc(C#N)c(=O)n(Cc3ccc(OC)cc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I10 compound treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 1909953 Bionet1_003128 [O-][N+](=O)c1cccnc1n2ncn(c3ccc(Br)cc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I11 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1909954 Bionet1_003129 Cc1ccc(c2ccc(cc2)S(=O)(=O)C)n1c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I12 compound treatment 0.0685 -0.00377 -0.45 -0.4472 -1.0 1909955 Bionet1_003130 Cc1cc(C)c(Cn2ncn(c3ccc(Br)cc3)c2=O)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I13 compound treatment 0.062 -0.0103 -1.22 -1.2174 -1.0 1909956 Bionet1_003131 COc1ccc(Oc2nc(cc(c2C#N)C(F)(F)F)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I14 compound treatment 0.066 -0.00627 -0.74 -0.7434 -1.0 1595238 Bionet1_003132 COc1cccc(Cn2ncn(c3ccc(Br)cc3)c2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I15 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1909957 Bionet1_003133 FC(F)(F)c1cc(nc(Sc2ccc(Cl)cc2)c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I16 compound treatment 0.067 -0.00527 -0.62 -0.6249 -1.0 1909958 Bionet1_003134 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1n2ncn(c3ccccn3)c2=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I17 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1909959 Bionet1_003135 FC(F)(F)c1cc(nc(Oc2ccc(Cl)cc2)c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I18 compound treatment 0.068 -0.00427 -0.51 -0.5064 -1.0 1909960 Bionet1_003136 Fc1ccc(N/N=C(\C=C\c2c(F)cccc2Cl)/c3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I19 compound treatment 0.082 0.00973 1.15 1.1524 1.0 1909961 Bionet1_003137 FC(F)(F)c1cc(nc(Oc2ccc3ccccc3c2)c1C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I20 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1448486 Bionet1_003138 COC(=O)Cc1c(sc(c1C(=O)OC)n2c(C)ccc2C)C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I21 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909962 Bionet1_003139 FC(F)(F)c1cc(nc(Sc2ccccc2)c1C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I22 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1909963 Bionet1_003140 Fc1ccc(cc1)N2N=C(CC2c3ccccc3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I23 mock treatment 0.0685 -0.00377 -0.45 -0.4472 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 I24 mock treatment 0.067 -0.00527 -0.62 -0.6249 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J01 mock treatment 0.068 -0.00427 -0.51 -0.5064 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J02 mock treatment 0.0705 -0.00177 -0.21 -0.2102 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J03 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1909964 Bionet1_003141 CCOC(=O)c1cnc(SC)nc1Nc2cc(ccc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J04 compound treatment 0.071 -0.00127 -0.15 -0.151 -1.0 1909965 Bionet1_003142 CO/N=C(/CNC(=O)c1ccc(Cl)cc1Cl)\c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J05 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1614077 Bionet1_003143 CCOC(=O)c1cnc(SC)nc1N2CCN(CC2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J06 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1620999 Bionet1_003144 Fc1ccccc1N2CCN(Cc3cc(on3)c4ccc(Cl)cc4)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J07 compound treatment 0.078 0.00573 0.68 0.6785 1.0 1909966 Bionet1_003145 Cn1nc(c2cc(sc12)c3nnc(S)n3c4ccccc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J08 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1909967 Bionet1_003146 Clc1ccc(Cl)c(OCc2cc(on2)c3ccccc3Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J09 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1909968 Bionet1_003147 CSc1nnc(c2cc3c(nn(C)c3s2)C(F)(F)F)n1c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J10 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1725628 Bionet1_003148 Fc1ccccc1N2CCN(Cc3cc(on3)c4ccccc4Cl)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J11 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1909969 Bionet1_003149 Cc1ccc(cc1)c2nnc(o2)c3cc4c(nn(C)c4s3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J12 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1909970 Bionet1_003150 [O-][N+](=O)c1cc(/C=N\OC(=O)c2c(F)cccc2F)ccc1N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J13 compound treatment 0.0675 -0.00477 -0.57 -0.5657 -1.0 1909971 Bionet1_003151 COc1cccc(c1)c2nnc(o2)c3cc4c(nn(C)c4s3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J14 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1909972 Bionet1_003152 Cc1ccc(cc1)C(=O)O/N=C\c2ccc(N3CCCCC3)c(c2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J15 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1909973 Bionet1_003153 Cn1nc(c2cc(sc12)c3nnc(SCC=C)n3C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J16 compound treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 1909974 Bionet1_003154 [O-][N+](=O)c1cc(/C=N\OC(=O)c2cccc(Cl)c2)ccc1N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J17 compound treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 1909975 Bionet1_003155 Cn1nc(c2cc(sc12)c3nnc(SCC#C)n3C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J18 compound treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 1909976 Bionet1_003156 [O-][N+](=O)c1cc(/C=N/OC(=O)c2cccs2)ccc1N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J19 compound treatment 0.075 0.00273 0.32 0.323 1.0 1909977 Bionet1_003157 CCCCSc1nnc(c2cc3c(nn(C)c3s2)C(F)(F)F)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J20 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1909978 Bionet1_003158 FC(F)(F)c1cccc(OCc2cc(on2)c3ccc(Cl)c(Cl)c3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J21 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1742697 Bionet1_003159 Clc1ccc(cc1)C(=O)Nc2ccc(oc2=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J22 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1644727 Bionet1_003160 COC(=O)c1sccc1OCc2cc(on2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J23 mock treatment 0.071 -0.00127 -0.15 -0.151 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 J24 mock treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K01 mock treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K02 mock treatment 0.0755 0.00323 0.38 0.3822 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K03 compound treatment 0.067 -0.00527 -0.62 -0.6249 -1.0 1565675 Bionet1_003161 COC(=O)c1cc(C#N)c(NCc2cc(no2)c3ccc(Cl)cc3)nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K04 compound treatment 0.0685 -0.00377 -0.45 -0.4472 -1.0 1909979 Bionet1_003162 COc1cccc(c1)C2=NN(C(C2)c3ccc(Cl)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K05 compound treatment 0.0685 -0.00377 -0.45 -0.4472 -1.0 1909980 Bionet1_003163 COc1ccc(cc1)c2cc(CNc3nc(C)c(cc3C#N)C(=O)C)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K06 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1909981 Bionet1_003164 Clc1ccc(cc1)N2N=C(CC2c3ccccc3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K07 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1535204 Bionet1_003165 Cc1ccc(c2ccc(cc2)S(=O)(=O)C)n1c3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K08 compound treatment 0.08 0.00773 0.92 0.9154 1.0 1408999 Bionet1_003166 COc1ccc(cc1)n2ccc(=O)c(Cc3c(Cl)cccc3Cl)c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K09 compound treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 1909982 Bionet1_003167 Fc1ccc(cc1)C(=O)Nc2ccc(/C=C/c3nc4ccccc4o3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K10 compound treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 1909983 Bionet1_003168 [O-][N+](=O)c1cccc(c1)N2N=C(CC2c3ccccc3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K11 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1909984 Bionet1_003169 FC(F)(F)c1cc(nc(N2CCOCC2)c1C#N)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K12 compound treatment 0.0685 -0.00377 -0.45 -0.4472 -1.0 1211145 Bionet1_003170 Clc1ccc(cc1)C2CN(CC2C(=O)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K13 compound treatment 0.0665 -0.00577 -0.68 -0.6842 -1.0 1909985 Bionet1_003171 CCN(CC)c1nc(cc(c1C#N)C(F)(F)F)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K14 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1712611 Bionet1_003172 Fc1ccccc1C2CN(CC2C(=O)c3ccc(Cl)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K15 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1909986 Bionet1_003173 COc1ccc(cc1)c2cc(CNC(=O)CN(C)Cc3ccccc3)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K16 compound treatment 0.0815 0.00923 1.09 1.0932 1.0 1617843 Bionet1_003174 COc1cccc(c1)C(=O)C2CN(CC2c3ccc(Cl)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K17 compound treatment 0.0805 0.00823 0.97 0.9747 1.0 1909987 Bionet1_003175 FC(F)(F)c1cc(nc(Sc2ccccc2)c1C#N)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K18 compound treatment 0.068 -0.00427 -0.51 -0.5064 -1.0 1223140 Bionet1_003176 COc1cc(NC(=S)NCc2cccc(Cl)c2)c(C#N)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K19 compound treatment 0.071 -0.00127 -0.15 -0.151 -1.0 1909988 Bionet1_003177 Cc1ccc(Sc2nc(nnc2c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K20 compound treatment 0.081 0.00873 1.03 1.0339 1.0 1521688 Bionet1_003178 Cc1c(Cc2c(Cl)cccc2Cl)c(=O)ccn1c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K21 compound treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 1909989 Bionet1_003179 Clc1ccc(Oc2nc(nnc2c3ccccc3)c4ccccc4)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K22 compound treatment 0.068 -0.00427 -0.51 -0.5064 -1.0 1130619 Bionet1_003180 CN(C)c1ccc(cc1)n2ccc(=O)c(Cc3c(Cl)cccc3Cl)c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K23 mock treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 K24 mock treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L01 mock treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L02 mock treatment 0.074 0.00173 0.2 0.2045 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L03 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1389763 Bionet1_003181 COCc1cc(nc(SCc2ccc(Cl)cc2)n1)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L04 compound treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 1909990 Bionet1_003182 [O-][N+](=O)c1cc(/C=N\OC(=O)c2ccc(F)cc2)ccc1N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L05 compound treatment 0.071 -0.00127 -0.15 -0.151 -1.0 1909991 Bionet1_003183 Cc1ccc(cc1)c2nnc(o2)c3c(Cl)n(C)nc3c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L06 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1909992 Bionet1_003184 Cc1ccc(cc1)C(=O)O/N=C\c2ccc(N3CCOCC3)c(c2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L07 compound treatment 0.075 0.00273 0.32 0.323 1.0 1909993 Bionet1_003185 Cn1nc(c(c1Cl)c2nnc(o2)c3ccc(Cl)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L08 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1909994 Bionet1_003186 [O-][N+](=O)c1cc(/C=N\OC(=O)c2ccccc2Cl)ccc1N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L09 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1909995 Bionet1_003187 COc1ccc(cc1)C(=O)OCc2cc(on2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L10 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1909996 Bionet1_003188 Clc1ccc(cc1)c2ccnc(Sc3cc(Cl)ccc3Cl)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L11 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1172634 Bionet1_003189 Clc1ccc(cc1)c2cc(COC(=O)c3ccc(Cl)cc3Cl)no2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L12 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1909997 Bionet1_003190 Clc1ccc(cc1)c2ccnc(Oc3cc(Cl)cc(Cl)c3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L13 compound treatment 0.0705 -0.00177 -0.21 -0.2102 -1.0 1909998 Bionet1_003191 FC(F)(F)c1cccc(c1)C(=O)OCc2cc(on2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L14 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1909999 Bionet1_003192 Clc1ccc(cc1)c2ccnc(Oc3cc(Cl)ccc3Cl)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L15 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1910000 Bionet1_003193 Fc1cccc(F)c1C(=O)OCc2cc(on2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L16 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1910001 Bionet1_003194 COc1cccc(Sc2nc(ncc2S(=O)(=O)C)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L17 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1910002 Bionet1_003195 Clc1ccc(cc1Cl)c2cc(COC(=O)c3cccs3)no2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L18 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1910003 Bionet1_003196 CS(=O)(=O)c1cnc(nc1Oc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L19 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1552964 Bionet1_003197 CS(=O)(=O)N(CC(=O)N1CCCCC1)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L20 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1910004 Bionet1_003198 CS(=O)(=O)c1cnc(nc1Sc2ccc(F)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L21 compound treatment 0.0755 0.00323 0.38 0.3822 1.0 1661730 Bionet1_003199 COc1cc(N(CC(=O)N2CCOCC2)S(=O)(=O)C)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L22 compound treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 1910005 Bionet1_003200 Cc1ccc(Sc2nc(ncc2S(=O)(=O)C)c3ccccc3)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L23 mock treatment 0.074 0.00173 0.2 0.2045 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 L24 mock treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M01 mock treatment 0.067 -0.00527 -0.62 -0.6249 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M02 mock treatment 0.0705 -0.00177 -0.21 -0.2102 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M03 compound treatment 0.0685 -0.00377 -0.45 -0.4472 -1.0 1910006 Bionet1_003201 Fc1ccc(Sc2nc(nnc2c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M04 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1421809 Bionet1_003202 COc1ccc(Cn2ccc(=O)c(Cc3c(Cl)cccc3Cl)c2C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M05 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1910007 Bionet1_003203 N#Cc1ccc(Oc2nc(nnc2c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M06 compound treatment 0.0755 0.00323 0.38 0.3822 1.0 1269073 Bionet1_003204 Cc1c(Cc2c(Cl)cccc2Cl)c(=O)ccn1Cc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M07 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1910008 Bionet1_003205 FC(F)(F)c1cccc(Oc2nc(nnc2c3ccccc3)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M08 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1910009 Bionet1_003206 CCOC(=O)c1c2ccc(OCc3ccc(cc3)[N+](=O)[O-])cc2n4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M09 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1910010 Bionet1_003207 [O-][N+](=O)c1ccc(CSc2ccsc2C(=O)Nc3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M10 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1308969 Bionet1_003208 CCOC(=O)c1c2ccc(OCc3ccc(F)cc3)cc2n4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M11 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1910011 Bionet1_003209 Cc1nn(c(N)c1c2cccc(c2)C(F)(F)F)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M12 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1375905 Bionet1_003210 Cc1c(Cc2c(Cl)cccc2Cl)c(=O)ccn1Cc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M13 compound treatment 0.07 -0.00227 -0.27 -0.2695 -1.0 1910012 Bionet1_003211 Clc1ccc(Cn2cccc(c3nnc(SCC=C)o3)c2=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M14 compound treatment 0.0845 0.0122 1.45 1.4486 1.0 1401614 Bionet1_003212 Cc1c(Cc2c(Cl)cccc2Cl)c(=O)ccn1Cc3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M15 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1175142 Bionet1_003213 OC(CN1CCN(CC1)c2ccccc2F)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M16 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1736523 Bionet1_003214 Cc1ccc(Cn2ccc(=O)c(Cc3c(Cl)cccc3Cl)c2C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M17 compound treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 1910013 Bionet1_003215 OC(CN1CCN(CC1)c2cccc(Cl)c2)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M18 compound treatment 0.0825 0.0102 1.21 1.2117 1.0 1631313 Bionet1_003216 Cc1c(Cc2c(Cl)cccc2Cl)c(=O)ccn1CCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M19 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1910014 Bionet1_003217 Cc1nn(C)c(Oc2cccc(Cl)c2)c1C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M20 compound treatment 0.0845 0.0122 1.45 1.4486 1.0 1219302 Bionet1_003218 Cc1c(Cc2c(Cl)cccc2Cl)c(=O)ccn1Cc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M21 compound treatment 0.0715 -7.74E-4 -0.09 -0.0917 -1.0 1910015 Bionet1_003219 Fc1ccc(cc1)N2CCN(CC3CN4C(=N3)c5ccccc5NC4=O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M22 compound treatment 0.0705 -0.00177 -0.21 -0.2102 -1.0 1660617 Bionet1_003220 CC(c1ccccc1)n2ccc(=O)c(Cc3c(Cl)cccc3Cl)c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M23 mock treatment 0.073 7.26E-4 0.09 0.086 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 M24 mock treatment 0.071 -0.00127 -0.15 -0.151 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N01 mock treatment 0.066 -0.00627 -0.74 -0.7434 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N02 mock treatment 0.0725 2.26E-4 0.03 0.0268 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N03 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1910016 Bionet1_003221 Cc1nc(nc2CCCc21)S(=O)(=O)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N04 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1910017 Bionet1_003222 CSc1nc(Oc2ccc3ccccc3c2)c4cnn(c5ccccc5)c4n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N05 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1910018 Bionet1_003223 Clc1ccc(C(=O)OCc2cc(on2)c3ccccc3Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N06 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1910019 Bionet1_003224 COc1ccc(CSc2ncc3CSc4ccc(C)cc4-c3n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N07 compound treatment 0.078 0.00573 0.68 0.6785 1.0 1910020 Bionet1_003225 FC(F)(F)c1cccc(c1)C(=O)OCc2cc(on2)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N08 compound treatment 0.075 0.00273 0.32 0.323 1.0 1910021 Bionet1_003226 Cc1ccc2SCc3cnc(SCc4cccc(c4)[N+](=O)[O-])nc3-c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N09 compound treatment 0.075 0.00273 0.32 0.323 1.0 1910022 Bionet1_003227 Clc1ccc(NC(=O)OCc2cc(on2)c3ccccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N10 compound treatment 0.0755 0.00323 0.38 0.3822 1.0 1910023 Bionet1_003228 Cc1ccc2SCc3cnc(SCc4ccc(cc4)C(C)(C)C)nc3-c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N11 compound treatment 0.0755 0.00323 0.38 0.3822 1.0 1910024 Bionet1_003229 Clc1ccc(NC(=O)OCc2cc(on2)c3ccccc3Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N12 compound treatment 0.075 0.00273 0.32 0.323 1.0 1910025 Bionet1_003230 Cc1cccc(CSc2ncc3CSc4ccc(C)cc4-c3n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N13 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1910026 Bionet1_003231 Fc1ccc(cc1)C(=O)OCc2cc(on2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N14 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1910027 Bionet1_003232 Cc1ccc2SCc3cnc(SCc4ccc(Cl)cc4)nc3-c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N15 compound treatment 0.075 0.00273 0.32 0.323 1.0 1910028 Bionet1_003233 Cc1ccc(NC(=O)OCc2cc(on2)c3ccc(Cl)c(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N16 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1910029 Bionet1_003234 CSc1nc(Sc2ccc(C)cc2)c3cnn(c4ccccc4)c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N17 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1910030 Bionet1_003235 Clc1ccc(NC(=O)OCc2cc(on2)c3ccc(Cl)c(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N18 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1910031 Bionet1_003236 CSc1nc(Sc2ccc(F)cc2)c3cnn(c4ccccc4)c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N19 compound treatment 0.077 0.00473 0.56 0.56 1.0 1910032 Bionet1_003237 Clc1ccc(NC(=O)OCc2cc(on2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N20 compound treatment 0.0755 0.00323 0.38 0.3822 1.0 1910033 Bionet1_003238 CSc1nc(Sc2ccccc2)c3cnn(c4ccccc4)c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N21 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1238924 Bionet1_003239 Cc1cccc(C)c1OC(=O)CN(c2ccc(Cl)cc2)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N22 compound treatment 0.075 0.00273 0.32 0.323 1.0 1910034 Bionet1_003240 CSc1nc(Sc2cccc(Cl)c2)c3cnn(c4ccccc4)c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N23 mock treatment 0.0775 0.00523 0.62 0.6192 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 N24 mock treatment 0.0775 0.00523 0.62 0.6192 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O01 mock treatment 0.073 7.26E-4 0.09 0.086 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O02 mock treatment 0.067 -0.00527 -0.62 -0.6249 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O03 compound treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 1910035 Bionet1_003241 Fc1ccccc1N2CCN(CC3CN4C(=N3)c5ccccc5NC4=O)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O04 compound treatment 0.0685 -0.00377 -0.45 -0.4472 -1.0 1910036 Bionet1_003242 Clc1ccc(CNS(=O)(=O)/C=C/c2ccc(Br)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O05 compound treatment 0.071 -0.00127 -0.15 -0.151 -1.0 1910037 Bionet1_003243 O=C1Nc2ccccc2C3=NC(CN4CCN(Cc5ccccc5)CC4)CN31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O06 compound treatment 0.08 0.00773 0.92 0.9154 1.0 1910038 Bionet1_003244 [O-][N+](=O)c1ccc(/C=C/S(=O)(=O)NCc2ccc(Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O07 compound treatment 0.077 0.00473 0.56 0.56 1.0 1218222 Bionet1_003245 Brc1ccc(CN2c3ccccc3Sc4cccnc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O08 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1910039 Bionet1_003246 Ic1ccc(cc1)S(=O)(=O)NCc2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O09 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1910040 Bionet1_003247 CNc1nc(nc(c1C#N)c2cccc(c2)C(F)(F)F)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O10 compound treatment 0.073 7.26E-4 0.09 0.086 1.0 1910041 Bionet1_003248 Clc1ccc(CNS(=O)(=O)/C=C/c2ccc3OCOc3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O11 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1910042 Bionet1_003249 Cn1nc(c(/C=N/OC(=O)CCl)c1Sc2ccccc2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O12 compound treatment 0.072 -2.74E-4 -0.03 -0.0325 -1.0 1574751 Bionet1_003250 Ic1ccc(cc1)S(=O)(=O)NCc2cccnc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O13 compound treatment 0.0735 0.00123 0.15 0.1452 1.0 1732198 Bionet1_003251 CC1CN(CC(C)O1)C(=O)c2cccn(Cc3c(Cl)cccc3Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O14 compound treatment 0.0805 0.00823 0.97 0.9747 1.0 1910043 Bionet1_003252 Clc1ccc(cc1)c2ccc(/C=C/S(=O)(=O)NCc3cccs3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O15 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1727413 Bionet1_003253 Clc1ccc(cc1)c2nn(c3ccc(Cl)cc3)c(=O)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O16 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1611664 Bionet1_003254 Ic1ccc(cc1)C(=O)NC2CCCCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O17 compound treatment 0.075 0.00273 0.32 0.323 1.0 1910044 Bionet1_003255 Fc1ccc(cc1)c2nn(c3ccc(OC(F)(F)F)cc3)c(=O)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O18 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1910045 Bionet1_003256 CN(N(S(=O)(=O)C)S(=O)(=O)C)c1c(C#N)c(nn1C)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O19 compound treatment 0.0775 0.00523 0.62 0.6192 1.0 1910046 Bionet1_003257 Fc1ccc(cc1)c2nn(c3ccc(cc3)C(F)(F)F)c(=O)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O20 compound treatment 0.0765 0.00423 0.5 0.5007 1.0 1910047 Bionet1_003258 CN(N1C(=O)c2ccncc2C1=O)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O21 compound treatment 0.0765 0.00423 0.5 0.5007 1.0 1910048 Bionet1_003259 Cc1nn(c2c(Cl)cc(cc2Cl)C(F)(F)F)c(=O)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O22 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1910049 Bionet1_003260 FC(F)(F)c1cccc(N/C=C/C(=O)c2ccc(Oc3ncccn3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O23 mock treatment 0.0815 0.00923 1.09 1.0932 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 O24 mock treatment 0.077 0.00473 0.56 0.56 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P01 mock treatment 0.0625 -0.00977 -1.16 -1.1581 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P02 mock treatment 0.0585 -0.0138 -1.63 -1.6321 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P03 compound treatment 0.0695 -0.00277 -0.33 -0.3287 -1.0 1259992 Bionet1_003261 CS(=O)(=O)N(CC(=O)Oc1ccc2ccccc2c1)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P04 compound treatment 0.0665 -0.00577 -0.68 -0.6842 -1.0 1910050 Bionet1_003262 CSc1nc(Sc2ccccc2Cl)c3cnn(c4ccccc4)c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P05 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1910051 Bionet1_003263 CCOC(=O)c1cnc(SC)nc1Sc2cc(Cl)ccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P06 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1910052 Bionet1_003264 Oc1nc(SCc2ccccc2)ncc1S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P07 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1910053 Bionet1_003265 CCOC(=O)c1cnc(SC)nc1Sc2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P08 compound treatment 0.0805 0.00823 0.97 0.9747 1.0 1910054 Bionet1_003266 Clc1ccc(cc1)C2=NC(N=C(S2)c3ccc(Cl)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P09 compound treatment 0.078 0.00573 0.68 0.6785 1.0 1910055 Bionet1_003267 CCOC(=O)c1cnc(SC)nc1Sc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P10 compound treatment 0.078 0.00573 0.68 0.6785 1.0 1254221 Bionet1_003268 Cc1ccc(cc1)c2nn(c3nc(nc(N)c23)c4ccc(C)cc4)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P11 compound treatment 0.0775 0.00523 0.62 0.6192 1.0 1910056 Bionet1_003269 CCOC(=O)c1cnc(SC)nc1Sc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P12 compound treatment 0.079 0.00673 0.8 0.7969 1.0 1556945 Bionet1_003270 Cc1ccc(cc1)C(=O)Nc2ncnc3n(nc(c4ccc(C)cc4)c23)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P13 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1532052 Bionet1_003271 COc1ccc(CN2CCn3ncc(C(=O)Nc4ccccc4)c3C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P14 compound treatment 0.0745 0.00223 0.26 0.2637 1.0 1371341 Bionet1_003272 CC(=O)N(C(=O)C)c1ncnc2n(nc(c3ccc(Cl)cc3)c12)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P15 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1170723 Bionet1_003273 COc1ccc(CN2CCn3ncc(C(=O)Nc4cccc(C)c4)c3C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P16 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1713837 Bionet1_003274 CCS(=O)(=O)c1ccc(C(=O)Nc2nccs2)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P17 compound treatment 0.0725 2.26E-4 0.03 0.0268 1.0 1910057 Bionet1_003275 COC(=O)c1nn(c(Cl)c1/C=N/OCc2ccc(F)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P18 compound treatment 0.069 -0.00327 -0.39 -0.388 -1.0 1910058 Bionet1_003276 CCOC(=O)/C=C\1/C(=O)N(Cc2ccc(Cl)c(Cl)c2)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P19 compound treatment 0.0785 0.00623 0.74 0.7377 1.0 1910059 Bionet1_003277 Cc1cccc2c(cc(Sc3ccc(Cl)cc3)nc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P20 compound treatment 0.076 0.00373 0.44 0.4415 1.0 1910060 Bionet1_003278 Cn1nc(c2cc(sc12)C(=O)Nc3ccc(F)cc3F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P21 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1910061 Bionet1_003279 Cc1cccc2c(cc(Oc3cccc(c3)C(F)(F)F)nc12)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P22 compound treatment 0.074 0.00173 0.2 0.2045 1.0 1910062 Bionet1_003280 COc1ccc(NC(=O)c2cc3c(nn(C)c3s2)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P23 mock treatment 0.062 -0.0103 -1.22 -1.2174 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.577 P24 mock treatment 0.0645 -0.00777 -0.92 -0.9212 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A01 mock treatment 0.077 0.0048 0.57 0.5682 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A02 mock treatment 0.075 0.0028 0.33 0.3312 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A03 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1143038 Bionet1_003281 Clc1ccc(CN2COc3c(C2)cc(Cl)c4cccnc34)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A04 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1910063 Bionet1_003282 Clc1ccc(CN2C(=O)CCSc3ccc(Cl)cc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A05 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1268704 Bionet1_003283 Clc1ccc(cc1)c2nc3ccccc3cc2Oc4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A06 compound treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 1910064 Bionet1_003284 CN1c2ccsc2/C(=N/NC(=O)c3ccc(F)cc3)/CS1(=O)=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A07 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1312774 Bionet1_003285 Cc1ccc(Oc2nc(SCc3ccc(Cl)cc3)nc4CCCCc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A08 compound treatment 0.0805 0.0083 0.98 0.9829 1.0 1910065 Bionet1_003286 Clc1ccc2SCCC(=O)N(Cc3c(Cl)cccc3Cl)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A09 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1910066 Bionet1_003287 CC(C)(C)Sc1nc(SCc2ccc(Cl)cc2)nc3CCCCc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A10 compound treatment 0.0805 0.0083 0.98 0.9829 1.0 1910067 Bionet1_003288 Fc1cccc(Cl)c1CN2C(=O)CCSc3ccc(Cl)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A11 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1910068 Bionet1_003289 COC(=O)CSc1nc(SCc2ccccc2Cl)nc3CCCCc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A12 compound treatment 0.0775 0.0053 0.63 0.6274 1.0 1332871 Bionet1_003290 COc1ccc(cc1)C(=O)CN2C(=O)CCSc3ccc(Cl)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A13 compound treatment 0.081 0.0088 1.04 1.0421 1.0 1277880 Bionet1_003291 CN(C)c1ncc(c(n1)N2CCCC2)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A14 compound treatment 0.078 0.0058 0.69 0.6867 1.0 1143218 Bionet1_003292 CN1c2ccsc2C(=C(C(=O)Nc3ccc(Cl)cc3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A15 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1564557 Bionet1_003293 O=S(=O)(c1ccccc1)c2cnc(nc2N3CCCCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A16 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1185545 Bionet1_003294 CN1c2ccsc2C(=C(C(=O)Nc3ccc(C)cc3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A17 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1584305 Bionet1_003295 CCN(CC)c1nc(ncc1S(=O)(=O)c2ccc(Cl)cc2)N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A18 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1683941 Bionet1_003296 CN1c2ccsc2C(=C(C(=O)Nc3c(C)cccc3C)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A19 compound treatment 0.08 0.0078 0.92 0.9236 1.0 1910069 Bionet1_003297 Clc1ncc(CO/N=C/CC(=O)c2ccc(Br)cc2)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A20 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1456773 Bionet1_003298 CN1c2ccsc2C(=C(C(=O)Nc3ccc(F)cc3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A21 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1910070 Bionet1_003299 Clc1ncc(COC(=O)c2ccc(I)cc2)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A22 compound treatment 0.0825 0.0103 1.22 1.2199 1.0 1418197 Bionet1_003300 CN1c2ccsc2C(=C(C(=S)Nc3ccccc3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A23 mock treatment 0.0925 0.0203 2.4 2.4048 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 A24 mock treatment 0.0815 0.0093 1.1 1.1014 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B01 mock treatment 0.0715 -7.05E-4 -0.08 -0.0835 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B02 mock treatment 0.074 0.0018 0.21 0.2127 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B03 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1239411 Bionet1_003301 Cn1nc(c(CN2CCN(CC2)c3ncccn3)c1Cl)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B04 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1910071 Bionet1_003302 [O-][N+](=O)c1cc(COc2ccc(F)cc2)ccc1Sc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B05 compound treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 1192236 Bionet1_003303 COc1ccc(Oc2c(cnn(c3ccc(C)cc3)c2=O)N4CCCCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B06 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1910072 Bionet1_003304 Cc1ccc(OCc2ccc(Sc3ccc(Cl)cc3)c(c2)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B07 compound treatment 0.078 0.0058 0.69 0.6867 1.0 1910073 Bionet1_003305 Clc1ccc(NC(=O)OCCNC(=O)c2cccc(Br)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B08 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910074 Bionet1_003306 Cc1cccc(OCc2ccc(Sc3ccc(Cl)cc3)c(c2)[N+](=O)[O-])c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B09 compound treatment 0.068 -0.0042 -0.5 -0.4982 -1.0 1910075 Bionet1_003307 O/N=C(/NC(=O)c1cccs1)\c2ccc(OCc3cnc(Cl)s3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B10 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910076 Bionet1_003308 Cc1ccc(Sc2ccc(COc3cccc(Cl)c3)cc2[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B11 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910077 Bionet1_003309 Cc1ccc(/C=N/NC(=O)c2c(O)c3cccc4CCCn(c2=O)c43)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B12 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1910078 Bionet1_003310 Cc1ccc(OCc2ccc(Sc3ccc(C)cc3)c(c2)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B13 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1711158 Bionet1_003311 CCOC(CCn1ccc(O)c(Cc2ccc(Cl)cc2)c1=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B14 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1910079 Bionet1_003312 Cc1ccc(Sc2ccc(COc3ccc(F)cc3)cc2[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B15 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910080 Bionet1_003313 Oc1c(C(=O)N/N=C/c2cccc(Cl)c2)c(=O)n3CCCc4cccc1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B16 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1587315 Bionet1_003314 Brc1ccc(cc1)n2c(cc3C(=O)CCCc32)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B17 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1563407 Bionet1_003315 CC(C)(C)c1ccccc1NC(=O)c2c(O)c3cccc4CCn(c2=O)c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B18 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910081 Bionet1_003316 ClC1=C(CCc2ccccc12)/C=N/OCc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B19 compound treatment 0.0775 0.0053 0.63 0.6274 1.0 1910082 Bionet1_003317 CCCCCCOc1ccc(/C=C/C(=O)Oc2ccc(CC(C)CC)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B20 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1221786 Bionet1_003318 COC(=O)c1sccc1NC(=O)COc2ccc(Cl)c3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B21 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1910083 Bionet1_003319 CCOC(=O)C1CCN(CC1)c2ncc(/C=N/NC(=O)c3ccncc3)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B22 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1910084 Bionet1_003320 COC(=O)c1sccc1NC(=O)COc2ccc(cc2Cl)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B23 mock treatment 0.079 0.0068 0.81 0.8051 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 B24 mock treatment 0.077 0.0048 0.57 0.5682 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C01 mock treatment 0.091 0.0188 2.23 2.227 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C02 mock treatment 0.0765 0.0043 0.51 0.5089 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C03 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1910085 Bionet1_003321 FC(F)(F)c1cnc(c(Cl)c1)n2cc(cc(Cl)c2=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C04 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1910086 Bionet1_003322 CC(C)(C)NC(=O)c1ccc(Sc2ccc(Cl)cc2)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C05 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1910087 Bionet1_003323 Clc1ccc(CO/N=C/Nc2ncnc3sccc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C06 compound treatment 0.0775 0.0053 0.63 0.6274 1.0 1910088 Bionet1_003324 [O-][N+](=O)c1cc(ccc1Sc2ccc(Cl)cc2)C(=O)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C07 compound treatment 0.084 0.0118 1.4 1.3976 1.0 1713117 Bionet1_003325 O=c1cc(c2ccccc2)n(o1)S(=O)(=O)c3ccc4ccccc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C08 compound treatment 0.0805 0.0083 0.98 0.9829 1.0 1910089 Bionet1_003326 [O-][N+](=O)c1cc(ccc1Sc2ccc(Cl)cc2)C(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C09 compound treatment 0.08 0.0078 0.92 0.9236 1.0 1306768 Bionet1_003327 COc1ccc(cc1OC)S(=O)(=O)n2oc(=O)cc2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C10 compound treatment 0.0795 0.0073 0.86 0.8644 1.0 1910090 Bionet1_003328 Cc1ccc(Sc2ccc(cc2[N+](=O)[O-])C(=O)N3CCOCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C11 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1910091 Bionet1_003329 Cc1ccc(/C=N/NC(=O)c2ccc(OCc3c(F)cccc3Cl)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C12 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1910092 Bionet1_003330 Cc1ccc(Sc2ccc(cc2[N+](=O)[O-])C(=O)NC3CCCCC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C13 compound treatment 0.08 0.0078 0.92 0.9236 1.0 1910093 Bionet1_003331 Clc1ccc(COc2ccc(cc2)C(=O)N/N=C/c3ccccc3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C14 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1910094 Bionet1_003332 COc1ccc(NC(=O)c2ccc(Sc3ccc(C)cc3)c(c2)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C15 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1569085 Bionet1_003333 Nc1c(C#N)c(Nc2ccccc2)sc1C(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C16 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1910095 Bionet1_003334 Cc1ccc(Sc2ccc(cc2[N+](=O)[O-])C(=O)Nc3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C17 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1910096 Bionet1_003335 CN(C)/C=C/C(=C\C(=O)C(F)(F)F)/Nc1ccc(cc1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C18 compound treatment 0.0795 0.0073 0.86 0.8644 1.0 1910097 Bionet1_003336 Cc1ccccc1NC(=O)c2ccc(Sc3ccc(Cl)cc3)c(c2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C19 compound treatment 0.0775 0.0053 0.63 0.6274 1.0 1602860 Bionet1_003337 CN(C)S(=O)(=O)c1ccc(Oc2ccc(cc2)S(=O)(=O)N(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C20 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1910098 Bionet1_003338 [O-][N+](=O)c1cc(ccc1Sc2ccc(Cl)cc2)C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C21 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1733864 Bionet1_003339 Clc1cc(Cl)c(OCc2ccccc2)c(Cl)c1OCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C22 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1910099 Bionet1_003340 [O-][N+](=O)c1cc(ccc1Sc2ccccc2)C(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C23 mock treatment 0.0755 0.0033 0.39 0.3904 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 C24 mock treatment 0.0775 0.0053 0.63 0.6274 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D01 mock treatment 0.073 7.95E-4 0.09 0.0942 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D02 mock treatment 0.0735 0.0013 0.15 0.1535 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D03 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1910100 Bionet1_003341 CC1CN(CC(C)O1)c2ncc(/C=N/NC(=O)c3ccccc3O)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D04 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1639700 Bionet1_003342 Cc1nn(C)c(Oc2ccccc2)c1CCNC(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D05 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910101 Bionet1_003343 C1CN(CCO1)c2ncc(/C=N/Nc3ccccc3Oc4ccccc4)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D06 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1534636 Bionet1_003344 Cc1nn(C)c(Oc2ccccc2)c1CCNS(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D07 compound treatment 0.0955 0.0233 2.76 2.7602 1.0 1910102 Bionet1_003345 O=C(N/N=C/c1cnc(s1)N2CCN(CC2)c3ccccc3)c4cccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D08 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1581523 Bionet1_003346 Cc1nn(C)c(Oc2ccccc2)c1CCNC(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D09 compound treatment 0.082 0.0098 1.16 1.1606 1.0 1910103 Bionet1_003347 Oc1c(C(=O)N/N=C/c2c[nH]c3ccccc23)c(=O)n4CCCc5cccc1c54 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D10 compound treatment 0.0875 0.0153 1.81 1.8123 1.0 1485173 Bionet1_003348 Cc1nn(C)c(Oc2ccccc2)c1CCNC(=O)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D11 compound treatment 0.086 0.0138 1.63 1.6346 1.0 1910104 Bionet1_003349 Oc1cccc(/C=N/NC(=O)c2c(O)c3cccc4CCCn(c2=O)c43)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D12 compound treatment 0.0825 0.0103 1.22 1.2199 1.0 1455182 Bionet1_003350 Cc1nn(C)c(Oc2ccccc2)c1CCNS(=O)(=O)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D13 compound treatment 0.0825 0.0103 1.22 1.2199 1.0 1910105 Bionet1_003351 FC(F)(F)c1ccc(cc1)C(=O)N/N=C/c2cnc(s2)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D14 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1910106 Bionet1_003352 Clc1ccc(N/N=C/2\CCS(=O)(=O)c3sccc23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D15 compound treatment 0.08 0.0078 0.92 0.9236 1.0 1910107 Bionet1_003353 FC(F)(F)c1cc(NC(=S)NC(=O)c2ccccc2)ccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D16 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1910108 Bionet1_003354 FC(F)(F)c1cccc(c1)C(=O)O/N=C/2\CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D17 compound treatment 0.087 0.0148 1.75 1.7531 1.0 1910109 Bionet1_003355 CC(C)c1ccc(Sc2ncnc3n(Cc4ccccc4)c(C)c(C)c23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D18 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1910110 Bionet1_003356 COc1ccc(cc1)C(=O)O/N=C/2\CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D19 compound treatment 0.078 0.0058 0.69 0.6867 1.0 1910111 Bionet1_003357 Cn1c2sc(cc2c3ccccc13)C(=O)NNC(=O)c4c(F)cccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D20 compound treatment 0.08 0.0078 0.92 0.9236 1.0 1910112 Bionet1_003358 Fc1cccc(F)c1C(=O)O/N=C/2\CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D21 compound treatment 0.08 0.0078 0.92 0.9236 1.0 1910113 Bionet1_003359 Cn1c2sc(cc2c3ccccc13)C(=O)NNC(=O)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D22 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1910114 Bionet1_003360 Cc1ccc(CSc2nc(Sc3ccc(C)cc3)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D23 mock treatment 0.077 0.0048 0.57 0.5682 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 D24 mock treatment 0.0785 0.0063 0.75 0.7459 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E01 mock treatment 0.0755 0.0033 0.39 0.3904 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E02 mock treatment 0.0775 0.0053 0.63 0.6274 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E03 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1910115 Bionet1_003361 COC(=O)c1ccc(Oc2c(cc(cc2[N+](=O)[O-])C(F)(F)F)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E04 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1910116 Bionet1_003362 [O-][N+](=O)c1cc(ccc1Sc2ccccc2)C(=O)Nc3ccc(F)cc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E05 compound treatment 0.0775 0.0053 0.63 0.6274 1.0 1910117 Bionet1_003363 Clc1ccc(COc2ccc(cc2)C(=O)N/N=C/c3ccco3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E06 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1910118 Bionet1_003364 COc1ccc(NC(=O)c2ccc(Sc3ccccc3)c(c2)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E07 compound treatment 0.0865 0.0143 1.69 1.6938 1.0 1910119 Bionet1_003365 CN(N1C(=O)c2cccc(O)c2C1=O)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E08 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1714600 Bionet1_003366 CN1c2ccsc2C(=C(C(=S)Nc3ccc(Cl)cc3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E09 compound treatment 0.082 0.0098 1.16 1.1606 1.0 1910120 Bionet1_003367 CN(N1C(=O)c2cccc(N)c2C1=O)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E10 compound treatment 0.0845 0.0123 1.46 1.4568 1.0 1161142 Bionet1_003368 CN1c2ccsc2C(=C(C(=S)Nc3ccc(C)cc3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E11 compound treatment 0.0855 0.0133 1.58 1.5753 1.0 1502713 Bionet1_003369 Nc1c(C#N)c(Nc2ccccc2)sc1C(=O)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E12 compound treatment 0.082 0.0098 1.16 1.1606 1.0 1910121 Bionet1_003370 C(Sc1nc(NC2CCCCC2)c3sccc3n1)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E13 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1179126 Bionet1_003371 COc1ccc(cc1)C2CC(=O)Nc3c2c(nn3c4ccccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E14 compound treatment 0.0805 0.0083 0.98 0.9829 1.0 1910122 Bionet1_003372 Clc1ccc(OCC(=O)NN=C(c2ccccc2)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E15 compound treatment 0.0805 0.0083 0.98 0.9829 1.0 1910123 Bionet1_003373 CCOC(=O)C1=C(C)N(N(C)c2ncc(cc2Cl)C(F)(F)F)C(=O)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E16 compound treatment 0.082 0.0098 1.16 1.1606 1.0 1910124 Bionet1_003374 COc1ccc(OCC(=O)NN=C(c2ccccc2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E17 compound treatment 0.0805 0.0083 0.98 0.9829 1.0 1302194 Bionet1_003375 O=C(c1sc(Nc2ccccc2)c(C#N)c1n3cccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E18 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1910125 Bionet1_003376 Cc1ccc(OCC(=O)NN=C(c2ccccc2)c3ccccc3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E19 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1910126 Bionet1_003377 N#CC1=C(Nc2ccccc2)SC=C(N=C1N3CCOCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E20 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910127 Bionet1_003378 O=C(COc1ccc2ccccc2c1)NN=C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E21 compound treatment 0.0775 0.0053 0.63 0.6274 1.0 1910128 Bionet1_003379 O=C(NC(=S)Nc1ccc(N=Nc2ccccc2)cc1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E22 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910129 Bionet1_003380 Clc1ccc(SCC(=O)NN=C(c2ccccc2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E23 mock treatment 0.075 0.0028 0.33 0.3312 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 E24 mock treatment 0.0745 0.0023 0.27 0.2719 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F01 mock treatment 0.0715 -7.05E-4 -0.08 -0.0835 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F02 mock treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F03 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1519261 Bionet1_003381 Clc1ccc(SCC2CSc3nc4ccccc4c(=O)n23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F04 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1910130 Bionet1_003382 Clc1ccc(cn1)C(=O)O/N=C/2\CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F05 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910131 Bionet1_003383 Cc1ccccc1C(=O)NNC(=O)c2cc3c(s2)n(C)c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F06 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1264965 Bionet1_003384 CN(C(=O)CN(c1ccc(Cl)cc1Cl)S(=O)(=O)C)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F07 compound treatment 0.0815 0.0093 1.1 1.1014 1.0 1910132 Bionet1_003385 Cc1cccc(c1)C(=O)NNC(=O)c2cc3c(s2)n(C)c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F08 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1298187 Bionet1_003386 CS(=O)(=O)N(CC(=O)N1CCOCC1)c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F09 compound treatment 0.0845 0.0123 1.46 1.4568 1.0 1910133 Bionet1_003387 Cc1ccc(cc1)C(=O)NNC(=O)c2cc3c(s2)n(C)c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F10 compound treatment 0.0835 0.0113 1.34 1.3384 1.0 1237863 Bionet1_003388 Cc1ccc(CSc2nc(Oc3cc(C)cc(C)c3)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F11 compound treatment 0.0805 0.0083 0.98 0.9829 1.0 1910134 Bionet1_003389 Cn1c2sc(cc2c3ccccc13)C(=O)NNC(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F12 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1735998 Bionet1_003390 Cc1ccc(CSc2nc(Oc3ccc(F)cc3F)c4CCCCc4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F13 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1220641 Bionet1_003391 Clc1ccc(SCC2CSc3nc4ccccc4c(=O)n23)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F14 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910135 Bionet1_003392 CSc1nc(Sc2ccc(Cl)cc2Cl)c3sccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F15 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1440657 Bionet1_003393 COc1ccc(cc1)c2cc(on2)C(=O)Nc3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F16 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910136 Bionet1_003394 CSc1nc(Sc2cccc(c2)C(F)(F)F)c3sccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F17 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910137 Bionet1_003395 OC(CS(=O)(=O)c1ccc(Cl)cc1)c2ccc(Cl)c(Cl)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F18 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1910138 Bionet1_003396 FC(F)(F)c1cccc(CO/N=C/Nc2ncnc3sccc23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F19 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1444095 Bionet1_003397 Clc1ccccc1SCC2CSc3nc4ccccc4c(=O)n23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F20 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910139 Bionet1_003398 FC(F)(F)c1cccc(OCCO/N=C/Nc2ncnc3sccc23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F21 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1434562 Bionet1_003399 Clc1cccc(SCC2CSc3nc4ccccc4c(=O)n23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F22 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1910140 Bionet1_003400 Clc1cccc(Cl)c1CO/N=C/Nc2ncnc3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F23 mock treatment 0.0735 0.0013 0.15 0.1535 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 F24 mock treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G01 mock treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G02 mock treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G03 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1910141 Bionet1_003401 Nc1cccc2C(=O)N(CCNc3ncc(cc3Cl)C(F)(F)F)C(=O)c21 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G04 compound treatment 0.069 -0.0032 -0.38 -0.3798 -1.0 1910142 Bionet1_003402 Cc1ccc(SCC(=O)NN=C(c2ccccc2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G05 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1910143 Bionet1_003403 Fc1ccc(COc2ccsc2C(=O)N/N=C/c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G06 compound treatment 0.069 -0.0032 -0.38 -0.3798 -1.0 1910144 Bionet1_003404 COc1cccc(SCC(=O)NN=C(c2ccccc2)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G07 compound treatment 0.081 0.0088 1.04 1.0421 1.0 1910145 Bionet1_003405 Cc1ccc(/C=N/NC(=O)c2sccc2OCc3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G08 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1910146 Bionet1_003406 Clc1ccc2SCCC(=Nc2c1)SCc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G09 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910147 Bionet1_003407 Fc1ccc(COc2ccsc2C(=O)N/N=C/c3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G10 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910148 Bionet1_003408 CC(C)(C)C(=O)Cn1ncc(Br)c(Br)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G11 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910149 Bionet1_003409 Cc1ccsc1/C=N/NC(=O)c2sccc2OCc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G12 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1910150 Bionet1_003410 Clc1ccc(CSC2=Nc3cc(Cl)ccc3SCC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G13 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910151 Bionet1_003411 Fc1ccc(COc2ccsc2C(=O)N/N=C/c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G14 compound treatment 0.0695 -0.0027 -0.32 -0.3205 -1.0 1910152 Bionet1_003412 Clc1cccc(CSC2=Nc3cc(Cl)ccc3SCC2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G15 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1910153 Bionet1_003413 Fc1ccc(COc2ccsc2C(=O)N/N=C/c3ccncc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G16 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1393961 Bionet1_003414 Clc1ccc(cc1)C(=O)Cn2ncc(N3CCCC3)c(Br)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G17 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1427809 Bionet1_003415 Oc1c(C(=O)NCc2ccc(F)cc2)c(=O)n3CCCc4cccc1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G18 compound treatment 0.0715 -7.05E-4 -0.08 -0.0835 -1.0 1910154 Bionet1_003416 COC(=O)c1ccc2SCC(=O)N(Cc3cccc(c3)C(F)(F)F)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G19 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1522331 Bionet1_003417 Oc1c(C(=O)Nc2cc(Cl)cc(Cl)c2)c(=O)n3CCCc4cccc1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G20 compound treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 1910155 Bionet1_003418 CN1c2ccccc2C(=C(C(=O)Nc3cccc(Cl)c3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G21 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1680892 Bionet1_003419 Clc1ccc(cc1)C(=O)CSc2nnc(SC3CCCC3)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G22 compound treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 1910156 Bionet1_003420 CN1c2ccccc2C(=C(C(=O)Nc3cccc(c3)C(F)(F)F)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G23 mock treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 G24 mock treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H01 mock treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H02 mock treatment 0.0755 0.0033 0.39 0.3904 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H03 compound treatment 0.0715 -7.05E-4 -0.08 -0.0835 -1.0 1358708 Bionet1_003421 Clc1cccc(SCC2CSc3nc4ccccc4c(=O)n23)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H04 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1910157 Bionet1_003422 FC(=C(F)CCSc1nc2ccsc2c(=O)n1c3ccccc3)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H05 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1457919 Bionet1_003423 Clc1ccc(Cl)c(SCC2CSc3nc4ccccc4c(=O)n23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H06 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910158 Bionet1_003424 COC(=O)/C(=C\Nc1ccccc1N)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H07 compound treatment 0.0855 0.0133 1.58 1.5753 1.0 1377998 Bionet1_003425 Clc1ccc(CSCC2CSc3nc4ccccc4c(=O)n23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H08 compound treatment 0.08 0.0078 0.92 0.9236 1.0 1027931 Bionet1_003426 Clc1ccc(OCCOc2ccc(Cl)cc2Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H09 compound treatment 0.0815 0.0093 1.1 1.1014 1.0 1910159 Bionet1_003427 Cc1ccc(cc1)S(=O)(=O)NNC(=O)c2cc3c(s2)n(C)c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H10 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1910160 Bionet1_003428 COc1cccc(CNS(=O)(=O)/C=C/c2ccc(OC)c(OC)c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H11 compound treatment 0.0795 0.0073 0.86 0.8644 1.0 1456037 Bionet1_003429 Clc1ccc(CSC2=CS(=O)(=O)c3ccccc3N2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H12 compound treatment 0.0865 0.0143 1.69 1.6938 1.0 1326910 Bionet1_003430 CCOC(=O)c1c2ccc(OCC(=O)NCc3ccco3)cc2n4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H13 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1910161 Bionet1_003431 Fc1cccc(Cl)c1CSC2=CS(=O)(=O)c3ccccc3N2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H14 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910162 Bionet1_003432 FC(F)(F)c1cccc(COc2ccc3c(C#N)c4ccccn4c3c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H15 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1910163 Bionet1_003433 Cn1c2sc(cc2c3ccccc13)C(=O)NNC(=O)Cc4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H16 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1910164 Bionet1_003434 FC(F)(F)c1cnc(Oc2ccc3c(C#N)c4ccccn4c3c2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H17 compound treatment 0.0825 0.0103 1.22 1.2199 1.0 1910165 Bionet1_003435 COC(=O)c1sccc1NC(=O)CSc2ccccc2C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H18 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1303648 Bionet1_003436 COc1ccc(NC(=O)COc2ccc3c(C#N)c4ccccn4c3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H19 compound treatment 0.0775 0.0053 0.63 0.6274 1.0 1910166 Bionet1_003437 COC(=O)c1sccc1NC(=O)CSc2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H20 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1127807 Bionet1_003438 CSc1nc(Oc2ccc(cc2)C(C)(C)C)c3cnn(c4ccccc4)c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H21 compound treatment 0.0795 0.0073 0.86 0.8644 1.0 1910167 Bionet1_003439 [O-][N+](=O)c1cc(CN2CCOCC2)ccc1Sc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H22 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1147845 Bionet1_003440 CCCCn1c(NC(=O)C(C)C)c(C#N)c(c1c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H23 mock treatment 0.0745 0.0023 0.27 0.2719 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 H24 mock treatment 0.0725 2.95E-4 0.03 0.035 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I01 mock treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I02 mock treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I03 compound treatment 0.069 -0.0032 -0.38 -0.3798 -1.0 1160435 Bionet1_003441 COc1cccc(Cn2ccc(O)c(Cc3ccc(Cl)cc3)c2=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I04 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1342213 Bionet1_003442 CN1c2ccccc2C(=C(C(=O)Nc3c(C)cccc3C)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I05 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1910168 Bionet1_003443 Oc1c(C(=O)Nc2cccc(c2)[N+](=O)[O-])c(=O)n3CCCc4cccc1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I06 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1282139 Bionet1_003444 CN1c2ccccc2C(=C(C(=O)Nc3ccc(Cl)cc3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I07 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1694746 Bionet1_003445 Oc1c(C(=O)Nc2cc(F)ccc2F)c(=O)n3CCCc4cccc1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I08 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910169 Bionet1_003446 CN1c2ccccc2C(=C(C(=O)Nc3ccc(Cl)c(Cl)c3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I09 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1609852 Bionet1_003447 COc1ccc(CCn2ccc(O)c(Cc3ccc(Cl)cc3)c2=O)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I10 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1910170 Bionet1_003448 Clc1ccc2SCCC(=Nc2c1)SCc3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I11 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910171 Bionet1_003449 Cc1ccc(COc2ccc(cc2)C(=O)N/N=C/C=C\c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I12 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1910172 Bionet1_003450 Clc1ccc(CSC2=Nc3cc(Cl)ccc3SCC2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I13 compound treatment 0.058 -0.0142 -1.68 -1.6831 -1.0 1910173 Bionet1_003451 [O-][N+](=O)c1ccc(CO/N=C/CC(=O)c2cc(no2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I14 compound treatment 0.065 -0.0072 -0.85 -0.8537 -1.0 1910174 Bionet1_003452 Cc1ccc(Sc2ccc(COC(=O)c3cccs3)cc2[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I15 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1910175 Bionet1_003453 CCOc1ccc(Br)cc1/C=N/NC(=O)c2ccccc2O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I16 compound treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 1910176 Bionet1_003454 [O-][N+](=O)c1cc(COC(=O)c2ccc(Cl)cc2)ccc1Sc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I17 compound treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 1910177 Bionet1_003455 Oc1ccccc1/C=N/NC(=O)c2ccc(OCc3c(F)cccc3Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I18 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1910178 Bionet1_003456 CCNC(=O)OCc1ccc(Sc2ccc(Cl)cc2)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I19 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1910179 Bionet1_003457 CC(C)(C)c1ccc(Oc2ccccc2/C=C/3\SC(=O)NC3=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I20 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1910180 Bionet1_003458 [O-][N+](=O)c1cc(COC(=O)Nc2ccc(F)cc2)ccc1Sc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I21 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1910181 Bionet1_003459 Clc1ncc(COc2ccc(/C=N/NC(=O)c3ccncc3)cc2)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I22 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1487542 Bionet1_003460 COC(=O)c1ccc2SCC(=O)N(Cc3ccc(Cl)cc3Cl)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I23 mock treatment 0.067 -0.0052 -0.62 -0.6167 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 I24 mock treatment 0.068 -0.0042 -0.5 -0.4982 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J01 mock treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J02 mock treatment 0.0735 0.0013 0.15 0.1535 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J03 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1910182 Bionet1_003461 [O-][N+](=O)c1cc(CN2CCCCC2)ccc1Sc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J04 compound treatment 0.0775 0.0053 0.63 0.6274 1.0 1426452 Bionet1_003462 Cc1c(C)n(Cc2ccccc2)c(NC(=O)c3ccccc3Cl)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J05 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1910183 Bionet1_003463 COC(=O)c1sccc1NC(=O)CSc2cccc(Cl)c2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J06 compound treatment 0.069 -0.0032 -0.38 -0.3798 -1.0 1646382 Bionet1_003464 Cc1c(C)n(Cc2ccccc2)c(NC(=O)c3cccc(Cl)c3)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J07 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1910184 Bionet1_003465 COC(=O)c1sccc1NC(=O)CSc2cc(Cl)ccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J08 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1910185 Bionet1_003466 CO/N=C(/CNS(=O)(=O)c1ccc(OC)cc1)\c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J09 compound treatment 0.078 0.0058 0.69 0.6867 1.0 1910186 Bionet1_003467 COC(=O)c1sccc1NC(=O)CN2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J10 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1498526 Bionet1_003468 Clc1cccc(Cl)c1SC2CCS(=O)(=O)c3sccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J11 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1910187 Bionet1_003469 FC(F)(F)c1ccc(cc1)C(=O)N/N=C/c2c[nH]nc2c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J12 compound treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 1390228 Bionet1_003470 Fc1ccc(Oc2cc(nc(n2)c3ccccc3)N4CCOCC4)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J13 compound treatment 0.068 -0.0042 -0.5 -0.4982 -1.0 1910188 Bionet1_003471 Oc1ccn(Cc2cccc(Cl)c2)c(=O)c1C/C=C/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J14 compound treatment 0.0695 -0.0027 -0.32 -0.3205 -1.0 1588462 Bionet1_003472 O=S(=O)(c1ccccc1)c2cnc(nc2N3CCCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J15 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910189 Bionet1_003473 Oc1ccn(Cc2cccc(c2)C(F)(F)F)c(=O)c1C/C=C/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J16 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1910190 Bionet1_003474 FC(F)(F)c1cccc(Sc2nccc(n2)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J17 compound treatment 0.0715 -7.05E-4 -0.08 -0.0835 -1.0 1910191 Bionet1_003475 CCOC(=O)/C(=C/N(C)C)/NC=C(C(=O)c1ccccc1)C(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J18 compound treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 1583381 Bionet1_003476 Cc1ccc(cc1)S(=O)(=O)c2cnc(nc2N3CCCCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J19 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1910192 Bionet1_003477 O=C(C(=CNc1cnc2ccccn2c1=O)C(=O)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J20 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1183782 Bionet1_003478 Cc1cc(Cl)ccc1Oc2nc(ncc2S(=O)(=O)C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J21 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910193 Bionet1_003479 O=C(N/N=C/c1cnc(s1)S(=O)(=O)c2ccccc2)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J22 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1427611 Bionet1_003480 CN1CCN(CC1)c2nc(ncc2S(=O)(=O)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J23 mock treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 J24 mock treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K01 mock treatment 0.069 -0.0032 -0.38 -0.3798 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K02 mock treatment 0.067 -0.0052 -0.62 -0.6167 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K03 compound treatment 0.067 -0.0052 -0.62 -0.6167 -1.0 1910194 Bionet1_003481 Clc1ncc(COc2ccc(/C=C\3/SC(=O)NC3=O)cc2)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K04 compound treatment 0.0675 -0.0047 -0.56 -0.5575 -1.0 1910195 Bionet1_003482 CC(Sc1ccc(C)cc1)C(=O)NN=C(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K05 compound treatment 0.0695 -0.0027 -0.32 -0.3205 -1.0 1194760 Bionet1_003483 O=C(C1CN(CC1C(=O)c2ccccc2)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K06 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1910196 Bionet1_003484 CC(Sc1ccccc1)C(=O)NN=C(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K07 compound treatment 0.078 0.0058 0.69 0.6867 1.0 1709080 Bionet1_003485 Cc1ccc(cc1)C(=O)C2CN(CC2C(=O)c3ccc(C)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K08 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1910197 Bionet1_003486 COc1cccc(SC(C)C(=O)NN=C(c2ccccc2)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K09 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1260235 Bionet1_003487 Oc1c(C(=O)NCc2cccc(Cl)c2)c(=O)n3CCCc4cccc1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K10 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910198 Bionet1_003488 CC(Sc1ccc(Cl)cc1)C(=O)NN=C(c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K11 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1910199 Bionet1_003489 CC(C)(C)c1cc(C#N)c(OCc2ccc(cc2)C(F)(F)F)c(C#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K12 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1910200 Bionet1_003490 CC1CN(CC(=O)NN=C(c2ccccc2)c3ccccc3)CC(C)O1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K13 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1910201 Bionet1_003491 CCCc1ccc(c(F)c1)c2ccc(cc2)C(=O)Cc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K14 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1910202 Bionet1_003492 O=C(CN1CCN(CC1)c2ncccn2)NN=C(c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K15 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1910203 Bionet1_003493 Brc1nc(Br)n(n1)C(=O)OCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K16 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1673550 Bionet1_003494 COc1ccc(OC)c(c1)n2c(C)ccc2c3ccc(cc3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K17 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1910204 Bionet1_003495 CC(C)(C)c1cc(C#N)c(OC(=O)c2ccc(cc2)C(F)(F)F)c(C#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K18 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1910205 Bionet1_003496 Cc1ccc(Sc2nc(cc(c2C#N)C(F)(F)F)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K19 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1910206 Bionet1_003497 Clc1ncc(COc2ccccc2/C=N/NC(=O)c3cccnc3)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K20 compound treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 1588099 Bionet1_003498 COC(=O)c1cc(C#N)c(NCc2cc(no2)c3ccc(OC)cc3)nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K21 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910207 Bionet1_003499 FC(F)(F)c1ccc(cc1)C(=O)N/N=C/c2ccccc2Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K22 compound treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 1910208 Bionet1_003500 CC(=O)c1cc(C#N)c(NCc2cc(no2)c3ccc(Cl)cc3)nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K23 mock treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 K24 mock treatment 0.0685 -0.0037 -0.44 -0.439 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L01 mock treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L02 mock treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L03 compound treatment 0.068 -0.0042 -0.5 -0.4982 -1.0 1910209 Bionet1_003501 Fc1ccc(cc1)c2n[nH]cc2/C=N\OCc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L04 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1910210 Bionet1_003502 COC(=O)c1sccc1Oc2nc(SC)nc3n(ncc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L05 compound treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 1910211 Bionet1_003503 COC(=O)c1ccc(/N=C/c2cnc(s2)S(=O)(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L06 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910212 Bionet1_003504 Cc1ccc2SCc3cnc(SCc4ccc(F)cc4)nc3-c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L07 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1910213 Bionet1_003505 Fc1ccc(cc1)c2n[nH]cc2/C=N\Nc3ccnc4cc(Cl)ccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L08 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1910214 Bionet1_003506 Cc1ccc2SCc3cnc(SCc4c(F)cccc4Cl)nc3-c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L09 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910215 Bionet1_003507 CN(C)/C=C/C(=O)C(Cc1c(Cl)cccc1Cl)C(=O)/C=C\N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L10 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1579848 Bionet1_003508 Cc1ccc(cc1)S(=O)(=O)c2cnc(nc2N3CCOCC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L11 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910216 Bionet1_003509 CN(C)/C=C/C(=O)C(Cc1c(F)cccc1Cl)C(=O)/C=C\N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L12 compound treatment 0.0695 -0.0027 -0.32 -0.3205 -1.0 1664188 Bionet1_003510 CCN(CC)c1nc(ncc1S(=O)(=O)c2ccc(C)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L13 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1542564 Bionet1_003511 Cc1ccccc1OCC2Cc3c(O2)nc(c(C#N)c3n4cccc4)n5cccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L14 compound treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 1910217 Bionet1_003512 CSc1nc(Oc2ccc3ccccc3c2)c4cnn(c5ccc(C)cc5)c4n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L15 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1494141 Bionet1_003513 CC(CO)Oc1ccc(cc1)c2ccc(c(F)c2)c3ccc(OC(C)CO)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L16 compound treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 1566962 Bionet1_003514 COc1cc2ncnc(Nc3ccc(Br)cc3)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L17 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1011790 Bionet1_003515 CCCCCCCCCCCCCCCCCC[n+]1ccccc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L18 compound treatment 0.069 -0.0032 -0.38 -0.3798 -1.0 1277018 Bionet1_003516 COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L19 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1910218 Bionet1_003517 CS(=O)(=O)/C(=C\c1cnc(s1)S(=O)(=O)c2ccccc2)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L20 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1473188 Bionet1_003518 COc1cc2ncnc(Nc3ccc(Cl)cc3Cl)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L21 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1910219 Bionet1_003519 FC(=C(F)CCSc1nc2nccc(c3ccc(F)cc3)n2n1)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L22 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1603939 Bionet1_003520 COc1cc2ncnc(Nc3ccc(Cl)c(Cl)c3)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L23 mock treatment 0.074 0.0018 0.21 0.2127 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 L24 mock treatment 0.069 -0.0032 -0.38 -0.3798 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M01 mock treatment 0.0675 -0.0047 -0.56 -0.5575 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M02 mock treatment 0.0695 -0.0027 -0.32 -0.3205 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M03 compound treatment 0.0675 -0.0047 -0.56 -0.5575 -1.0 1910220 Bionet1_003521 Cc1ccc(Oc2ccccc2/C=N/NC(=O)c3ccc(cc3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M04 compound treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 1910221 Bionet1_003522 CN(CC(=O)NCc1cc(no1)c2ccc(Cl)cc2)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M05 compound treatment 0.0715 -7.05E-4 -0.08 -0.0835 -1.0 1910222 Bionet1_003523 Oc1ccn(Nc2ncccc2[N+](=O)[O-])c(=O)c1Cc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M06 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1910223 Bionet1_003524 Cc1cc(Sc2cccc(c2)C(F)(F)F)nc3ccc(Cl)cc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M07 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1910224 Bionet1_003525 CSc1nc(N(C)NC(=O)c2ccc(Cl)cc2)c3ccccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M08 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1375673 Bionet1_003526 Cc1ccc(cc1)n2nc(cc2c3ccc(Cl)cc3)C(=O)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M09 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1910225 Bionet1_003527 CSc1nc(Sc2cc(Cl)ccc2Cl)c3ccccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M10 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910226 Bionet1_003528 Clc1ccccc1c2cc(on2)C(=O)NCc3cc(no3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M11 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1910227 Bionet1_003529 CSc1nc(Sc2ccc(Cl)cc2Cl)c3ccccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M12 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1910228 Bionet1_003530 COc1cccc(c1)C(=O)Nc2ccc(/C=C/c3nc4ccccc4o3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M13 compound treatment 0.068 -0.0042 -0.5 -0.4982 -1.0 1910229 Bionet1_003531 CSc1nc(Oc2cc(Cl)c(Cl)cc2Cl)c3ccccc3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M14 compound treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 1910230 Bionet1_003532 Fc1cccc(F)c1C(=O)Nc2ccc(/C=C/c3nc4ccccc4o3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M15 compound treatment 0.068 -0.0042 -0.5 -0.4982 -1.0 1910231 Bionet1_003533 CSc1nc(Oc2cc(Cl)c(Cl)cc2Cl)cc(n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M16 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1370465 Bionet1_003534 Fc1ccc(cc1)S(=O)(=O)N2C(COc3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M17 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1910232 Bionet1_003535 COc1ccc(CCOC(=O)Nc2cn(C)nc2C(F)(F)F)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M18 compound treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 1680960 Bionet1_003536 Cc1ccc(cc1)S(=O)(=O)N2C(COc3ccc(C)cc23)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M19 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1728119 Bionet1_003537 CC1COc2ccccc2N1S(=O)(=O)c3cc(Cl)ccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M20 compound treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 1518407 Bionet1_003538 Cc1ccc2OCC(N(c2c1)S(=O)(=O)c3ccc(F)cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M21 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1615505 Bionet1_003539 COc1ccc(cc1)S(=O)(=O)N2C(COc3ccccc23)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M22 compound treatment 0.0675 -0.0047 -0.56 -0.5575 -1.0 1585848 Bionet1_003540 COc1ccc(Oc2c(Cl)cnn(c3ccc(Cl)c(Cl)c3)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M23 mock treatment 0.0725 2.95E-4 0.03 0.035 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 M24 mock treatment 0.0705 -0.0017 -0.2 -0.202 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N01 mock treatment 0.068 -0.0042 -0.5 -0.4982 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N02 mock treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N03 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1910233 Bionet1_003541 FC(F)(F)c1cccc(c1)N2CCN(CC(=O)c3cccs3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N04 compound treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 1303887 Bionet1_003542 COc1cc2ncnc(Nc3ccc(cc3)N4CCOCC4)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N05 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910234 Bionet1_003543 COc1ccc(cc1)C2=NN(C(C2)c3ccc(Cl)cc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N06 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1412837 Bionet1_003544 COc1cc2ncnc(NCc3ccc(Cl)cc3Cl)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N07 compound treatment 0.08 0.0078 0.92 0.9236 1.0 1910235 Bionet1_003545 Fc1ccc(N2N=C(CC2c3ccccc3)c4ccc(Cl)cc4)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N08 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1910236 Bionet1_003546 COc1cc2ncnc(NCc3ccccc3C(F)(F)F)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N09 compound treatment 0.083 0.0108 1.28 1.2791 1.0 1910237 Bionet1_003547 CC(=O)Nc1ccc(cc1)C2CC(=NN2c3ccccc3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N10 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1736243 Bionet1_003548 Clc1ccc2c(Nc3ccc(I)cc3)ncnc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N11 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1910238 Bionet1_003549 COc1cccc(c1)C2=NN(C(C2)c3ccc(Cl)cc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N12 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1284145 Bionet1_003550 COc1cc2ncnc(NCc3ccc(Cl)c(Cl)c3)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N13 compound treatment 0.073 7.95E-4 0.09 0.0942 1.0 1910239 Bionet1_003551 COc1ccc(cc1)c2cnc3nc(SCCC(=C(F)F)F)nn3c2N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N14 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1646584 Bionet1_003552 COc1ccc(CNc2ncnc3cc(OC)c(OC)cc23)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N15 compound treatment 0.077 0.0048 0.57 0.5682 1.0 1910240 Bionet1_003553 FC(=C(F)CCSc1nc2nccc(/C=C\c3cccs3)n2n1)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N16 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1910241 Bionet1_003554 COc1cc2ncnc(NCc3cccc(c3)C(F)(F)F)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N17 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1463826 Bionet1_003555 Cc1ccc(cc1)C2CN(CC2C(=O)c3ccc(F)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N18 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1631243 Bionet1_003556 COc1ccc(CCNc2ncnc3cc(OC)c(OC)cc23)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N19 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1127217 Bionet1_003557 Clc1ccc(cc1)C2CN(CC2C(=O)c3cccs3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N20 compound treatment 0.0755 0.0033 0.39 0.3904 1.0 1398126 Bionet1_003558 COc1cc2ncnc(NCCc3ccc(cc3)S(=O)(=O)N)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N21 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910242 Bionet1_003559 COc1ccc(NC(=O)c2ccccc2SCCC(=C(F)F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N22 compound treatment 0.0795 0.0073 0.86 0.8644 1.0 1910243 Bionet1_003560 Clc1ccc(SCCNc2ncnc3cc(Cl)ccc23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N23 mock treatment 0.077 0.0048 0.57 0.5682 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 N24 mock treatment 0.075 0.0028 0.33 0.3312 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O01 mock treatment 0.072 -2.05E-4 -0.02 -0.0243 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O02 mock treatment 0.0665 -0.0057 -0.68 -0.676 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O03 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1353850 Bionet1_003561 CC(C)(C)C1COc2ccccc2N1S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O04 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1435481 Bionet1_003562 COc1ccc(Oc2c(cnn(c3ccc(C)cc3)c2=O)N4CCOCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O05 compound treatment 0.0775 0.0053 0.63 0.6274 1.0 1333895 Bionet1_003563 Clc1ccc(cc1)S(=O)(=O)N2C(COc3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O06 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1364036 Bionet1_003564 COc1ccc(Oc2c(Cl)cnn(c3cccc(C)c3C)c2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O07 compound treatment 0.078 0.0058 0.69 0.6867 1.0 1147999 Bionet1_003565 COc1ccc(cc1)S(=O)(=O)N2C(COc3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O08 compound treatment 0.078 0.0058 0.69 0.6867 1.0 1910244 Bionet1_003566 FC(F)(F)c1cc(nc(N2CCOCC2)c1C#N)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O09 compound treatment 0.075 0.0028 0.33 0.3312 1.0 1910245 Bionet1_003567 Cn1nc(OCC(O)CS(=O)(=O)c2ccc(Cl)cc2)cc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O10 compound treatment 0.0725 2.95E-4 0.03 0.035 1.0 1910246 Bionet1_003568 COC(=O)c1ccccc1Sc2nc(C)cc(c2C#N)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O11 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1510173 Bionet1_003569 CN1CCN(CC1)c2cnn(c3ccc(F)cc3)c(=O)c2Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O12 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1458590 Bionet1_003570 COc1ccc(cc1)C2C(CN3CCOCC3)C(=O)N2c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O13 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1515952 Bionet1_003571 CN(Cc1ccccc1)c2cnn(c3ccc(F)cc3)c(=O)c2Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O14 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910247 Bionet1_003572 COc1cccc(c1)C(=O)Nc2ccc(/C=C/c3nc4ccccc4s3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O15 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1248744 Bionet1_003573 OCc1cnc(n1Cc2ccccc2)S(=O)(=O)Cc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O16 compound treatment 0.0745 0.0023 0.27 0.2719 1.0 1698392 Bionet1_003574 CCS(=O)(=O)c1ccc(c2csc(n2)c3ccccc3)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O17 compound treatment 0.074 0.0018 0.21 0.2127 1.0 1910248 Bionet1_003575 Clc1ccc(cc1)c2cc(CS(=O)(=O)c3cccc(Cl)c3)on2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O18 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1388552 Bionet1_003576 CCS(=O)(=O)c1ccc(c2csc(n2)c3ccccn3)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O19 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1654004 Bionet1_003577 CC(C)(C)c1ccc(CN2C(=O)CCSc3ccc(Cl)cc23)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O20 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1329709 Bionet1_003578 CCS(=O)(=O)c1ccc(c2csc(n2)c3ccncc3)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O21 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1910249 Bionet1_003579 Clc1ccc2SCCC(=O)N(Cc3ccc(Cl)c(Cl)c3)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O22 compound treatment 0.0805 0.0083 0.98 0.9829 1.0 1910250 Bionet1_003580 Cc1ccc(cc1)n2ncc(Cl)c(Sc3ccc(Cl)cc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O23 mock treatment 0.08 0.0078 0.92 0.9236 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 O24 mock treatment 0.0745 0.0023 0.27 0.2719 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P01 mock treatment 0.053 -0.0192 -2.28 -2.2756 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P02 mock treatment 0.067 -0.0052 -0.62 -0.6167 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P03 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1910251 Bionet1_003581 FC(=C(F)CCSc1ncn(n1)c2ncc(cc2Cl)C(F)(F)F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P04 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1440383 Bionet1_003582 OC(CNc1ncnc2cc(Cl)ccc12)c3ccc4ccccc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P05 compound treatment 0.0695 -0.0027 -0.32 -0.3205 -1.0 1910252 Bionet1_003583 FC(=C(F)CCSc1ncccc1C(=O)NC2CCCCCCC2)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P06 compound treatment 0.067 -0.0052 -0.62 -0.6167 -1.0 1910253 Bionet1_003584 Cc1ccc(CSC/2=Nc3ccccc3\C2=N/Nc4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P07 compound treatment 0.079 0.0068 0.81 0.8051 1.0 1295777 Bionet1_003585 CCOC(=O)c1c2ccc(OCc3ccc(C)cc3)cc2n4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P08 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1910254 Bionet1_003586 N#Cc1cc(oc1/N=C/c2ccc(Oc3ccccc3)cc2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P09 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1436818 Bionet1_003587 COc1ccc2ccccc2c1S(=O)N3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P10 compound treatment 0.0785 0.0063 0.75 0.7459 1.0 1910255 Bionet1_003588 Brc1ccc(/C=N/c2oc(cc2C#N)c3ccccc3)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P11 compound treatment 0.0795 0.0073 0.86 0.8644 1.0 1910256 Bionet1_003589 COc1ccc2ccccc2c1S(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P12 compound treatment 0.078 0.0058 0.69 0.6867 1.0 1910257 Bionet1_003590 FC(F)(F)c1ccccc1C(=O)Nc2oc(cc2C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P13 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1147892 Bionet1_003591 COc1ccc2ccccc2c1S(=O)N3CCN(CC3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P14 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1910258 Bionet1_003592 Cc1ccc(cc1)S(=O)(=O)NNC(=O)c2cc3CCc4ccccc4-c3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P15 compound treatment 0.078 0.0058 0.69 0.6867 1.0 1521904 Bionet1_003593 COc1ccc2ccccc2c1S(=O)N3CCN(CC3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P16 compound treatment 0.0735 0.0013 0.15 0.1535 1.0 1910259 Bionet1_003594 Clc1ccc(/C=N/NC(=O)c2cc3CCc4ccccc4-c3s2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P17 compound treatment 0.0765 0.0043 0.51 0.5089 1.0 1237317 Bionet1_003595 CCOC(=O)c1c2ccc(OCc3c(F)cccc3Cl)cc2n4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P18 compound treatment 0.071 -0.0012 -0.14 -0.1428 -1.0 1910260 Bionet1_003596 FC(F)(F)c1cccc(/C=N/NC(=O)c2cc3CCc4ccccc4-c3s2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P19 compound treatment 0.081 0.0088 1.04 1.0421 1.0 1910261 Bionet1_003597 FC(=C(F)CCSc1ncccc1C(=O)NCc2ccccc2)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P20 compound treatment 0.076 0.0038 0.45 0.4497 1.0 1910262 Bionet1_003598 Fc1ccc(/C=N/NC(=O)c2cc3CCc4ccccc4-c3s2)cc1F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P21 compound treatment 0.07 -0.0022 -0.26 -0.2613 -1.0 1667164 Bionet1_003599 COC(=O)c1sccc1NC(=O)COc2ccsc2C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P22 compound treatment 0.0795 0.0073 0.86 0.8644 1.0 1446805 Bionet1_003600 COc1ccc(cc1)S(=O)(=O)N2CCN(CC2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P23 mock treatment 0.063 -0.0092 -1.09 -1.0907 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.578 P24 mock treatment 0.0625 -0.0097 -1.15 -1.1499 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A01 mock treatment 0.0775 0.00808 0.96 0.958 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A02 mock treatment 0.072 0.00258 0.31 0.3063 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A03 compound treatment 0.0775 0.00808 0.96 0.958 1.0 1376399 Bionet1_003601 Clc1ccc(cc1)S(=O)(=O)N2CCN(CC2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A04 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1910263 Bionet1_003602 FC(F)(F)c1cccc(c1)N2CCN(Cc3cnc(Cl)s3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A05 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1183828 Bionet1_003603 Clc1ccc(Cl)c(c1)S(=O)(=O)N2CCN(CC2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A06 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1910264 Bionet1_003604 COc1cc(Br)c(O)c(/C=N/Cc2ccc3OCOc3c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A07 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910265 Bionet1_003605 FC(F)(F)c1ccccc1C(=O)N2CCN(CC2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A08 compound treatment 0.0785 0.00908 1.08 1.0765 1.0 1910266 Bionet1_003606 COc1cc(Br)c(O)c(/C=N/c2ccc(cc2)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A09 compound treatment 0.0765 0.00708 0.84 0.8395 1.0 1910267 Bionet1_003607 FC(F)(F)c1ccccc1S(=O)(=O)N2CCN(CC2)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A10 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1910268 Bionet1_003608 COc1cc(Br)cc(/C=N/c2cccc(Br)c2)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A11 compound treatment 0.075 0.00558 0.66 0.6617 1.0 1350151 Bionet1_003609 Clc1cccc(C(=O)Nc2oc(cc2C#N)c3ccccc3)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A12 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1910269 Bionet1_003610 COc1cc(OC)cc(/N=C/c2cc(Br)cc(OC)c2O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A13 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910270 Bionet1_003611 FC(F)(F)c1cccc(CSc2nc(ccc2C#N)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A14 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1910271 Bionet1_003612 COC(=O)c1cccc(/N=C/c2cc(Br)cc(OC)c2O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A15 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1289590 Bionet1_003613 Clc1cccc(C(=O)N2CCN(CC2)C(=O)c3ccccc3)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A16 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1910272 Bionet1_003614 COc1cc(Br)c(O)c(/C=N/Cc2ccc(OC)c(OC)c2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A17 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1201217 Bionet1_003615 Clc1ccc(C(=O)N2CCN(CC2)C(=O)c3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A18 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1910273 Bionet1_003616 Oc1c(Br)cc(Br)cc1/C=N/Cc2ccc(F)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A19 compound treatment 0.0765 0.00708 0.84 0.8395 1.0 1213082 Bionet1_003617 COc1cc2ncnc(NCC(O)c3ccc4ccccc4c3)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A20 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1489756 Bionet1_003618 CN1OC(CC(=O)NCc2ccc(F)cc2)N(C1=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A21 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910274 Bionet1_003619 CCOC(=O)c1ccc(/N=C/c2ccccc2Oc3ccc(F)c(F)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A22 compound treatment 0.0805 0.0111 1.31 1.3134 1.0 1910275 Bionet1_003620 FC(F)(F)c1ccc2[nH]cc(c3ncc(cc3Cl)C(F)(F)F)c(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A23 mock treatment 0.085 0.0156 1.85 1.8466 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 A24 mock treatment 0.0805 0.0111 1.31 1.3134 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B01 mock treatment 0.0645 -0.00492 -0.58 -0.5824 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B02 mock treatment 0.0645 -0.00492 -0.58 -0.5824 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B03 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910276 Bionet1_003621 Cc1ccc(CSc2nnc(o2)c3cc4CCc5ccccc5-c4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B04 compound treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 1910277 Bionet1_003622 CCOC(=O)/C(=N\Nc1ccccc1[N+](=O)[O-])/NC(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B05 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1910278 Bionet1_003623 CCOC(=O)c1cnc2ccc(OC)cc2c1Nc3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B06 compound treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 1910279 Bionet1_003624 Cc1ccc(cc1)C(=O)Oc2ccc(cc2)c3nccc(n3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B07 compound treatment 0.075 0.00558 0.66 0.6617 1.0 1247702 Bionet1_003625 CCOC(=O)c1cnc2ccc(OC)cc2c1Nc3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B08 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1910280 Bionet1_003626 Fc1ccc(cc1)C(=O)Oc2ccc(cc2)c3nccc(n3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B09 compound treatment 0.0675 -0.00192 -0.23 -0.2269 -1.0 1910281 Bionet1_003627 Clc1ccc(cc1)C(=O)ON=C2CCN(CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B10 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1739750 Bionet1_003628 O=C(Cc1ccccc1)Oc2ccc(cc2)c3nccc(n3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B11 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1910282 Bionet1_003629 Fc1ccc(cc1)C(=O)ON=C2CCN(CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B12 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1910283 Bionet1_003630 Clc1ccc(cc1)C(=O)Oc2ccc(cc2)c3nccc(n3)c4ccccn4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B13 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910284 Bionet1_003631 Cc1ccc(cc1)C(=O)ON=C2CCN(CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B14 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910285 Bionet1_003632 CCCCCCCCS(=O)(=O)c1nnc(o1)c2ccc(OC)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B15 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910286 Bionet1_003633 Clc1cccc(c1)C(=O)ON=C2CCN(CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B16 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910287 Bionet1_003634 O=S(=O)(Oc1ccc(cc1)c2nccc(n2)c3ccccn3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B17 compound treatment 0.0805 0.0111 1.31 1.3134 1.0 1910288 Bionet1_003635 O=C(ON=C1CCN(CC1)S(=O)(=O)c2ccccc2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B18 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1910289 Bionet1_003636 CC(C)(C)c1ccc(cc1)c2nnc(SCc3ccc(cc3)[N+](=O)[O-])o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B19 compound treatment 0.085 0.0156 1.85 1.8466 1.0 1910290 Bionet1_003637 O=S(=O)(ON=C1CCN(CC1)S(=O)(=O)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B20 compound treatment 0.0765 0.00708 0.84 0.8395 1.0 1910291 Bionet1_003638 CC(C)(C)c1ccc(cc1)c2nnc(SCc3ccc(Cl)cc3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B21 compound treatment 0.0765 0.00708 0.84 0.8395 1.0 1910292 Bionet1_003639 Cc1ccn2c(/C=C(\C#N)/c3ccccn3)c(nc2c1)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B22 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1910293 Bionet1_003640 Fc1cccc(Cl)c1COc2ccc(C=C3C(=O)NC(=O)NC3=O)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B23 mock treatment 0.073 0.00358 0.42 0.4248 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 B24 mock treatment 0.076 0.00658 0.78 0.7802 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C01 mock treatment 0.0745 0.00508 0.6 0.6025 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C02 mock treatment 0.0705 0.00108 0.13 0.1285 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C03 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1217132 Bionet1_003641 CCOC(=O)c1ccc(NCc2ccccc2Oc3ccc(F)c(F)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C04 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1910294 Bionet1_003642 Fc1ccc(F)c2c(=O)c(c[nH]c12)c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C05 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1910295 Bionet1_003643 FC(F)(F)c1cnc(CC(=O)NCc2ccc(Cl)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C06 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1664882 Bionet1_003644 CN1OC(CC(=O)NCc2ccc(C)cc2)N(C1=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C07 compound treatment 0.078 0.00858 1.02 1.0172 1.0 1910296 Bionet1_003645 Cc1cccc(n1)n2cnc(c2)C(=O)N/N=C\c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C08 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910297 Bionet1_003646 Oc1ccn(CCc2c[nH]c3ccccc23)c(=O)c1C/C=C/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C09 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1910298 Bionet1_003647 COc1ccc(cc1)S(=O)(=O)NNC(=O)c2cn(cn2)c3cccc(C)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C10 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1910299 Bionet1_003648 Cc1ccc(cc1)C(C#N)c2ccc3c(cc(nc3n2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C11 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910300 Bionet1_003649 COc1cc(/C=N/NC(=O)c2cn(cn2)c3cccc(C)n3)ccc1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C12 compound treatment 0.08 0.0106 1.25 1.2542 1.0 1910301 Bionet1_003650 Fc1ccc(cc1)C(C#N)c2ccc3c(cc(nc3n2)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C13 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1910302 Bionet1_003651 OC(CN1CCN(CC1)C(c2ccccc2)c3ccccc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C14 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910303 Bionet1_003652 COC(=O)Cc1nnc2c3nnc(CC(=O)OC)n3c4ccccc4n12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C15 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1910304 Bionet1_003653 Oc1c(C(=O)Nc2ccc(cc2)C(F)(F)F)c(=O)n3CCCc4cccc1c43 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C16 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1910305 Bionet1_003654 CCOC(=O)c1cnc(nc1Oc2cccc(c2)C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C17 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1224256 Bionet1_003655 Oc1ccn(Cc2cccc(Cl)c2)c(=O)c1Cc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C18 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910306 Bionet1_003656 CCOC(=O)c1cnc(nc1Oc2ccc(OC)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C19 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1649511 Bionet1_003657 OCC(Cc1ccccc1)n2ccc(O)c(Cc3ccc(F)cc3)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C20 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910307 Bionet1_003658 CN1c2ccsc2/C(=N/NC(=O)c3c(F)cccc3F)/CS1(=O)=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C21 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910308 Bionet1_003659 O=C(Sc1nnc(SCCOc2ccccc2)s1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C22 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1910309 Bionet1_003660 CN1c2ccsc2/C(=N/NC(=O)c3ccc(Cl)cc3)/CS1(=O)=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C23 mock treatment 0.075 0.00558 0.66 0.6617 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 C24 mock treatment 0.0775 0.00808 0.96 0.958 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D01 mock treatment 0.066 -0.00342 -0.4 -0.4047 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D02 mock treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D03 compound treatment 0.0655 -0.00392 -0.46 -0.4639 -1.0 1910310 Bionet1_003661 COc1ccc(NC(=O)c2cc3CSc4ccc(C)cc4-c3s2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D04 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1910311 Bionet1_003662 O=C(Oc1ccc(cc1)c2nccc(n2)c3cccs3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D05 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1910312 Bionet1_003663 Cc1ccc2SCc3cc(sc3-c2c1)C(=O)Nc4ccc(F)cc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D06 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1459451 Bionet1_003664 Cc1cccc(c1)C(=O)Oc2ccc(cc2)c3nccc(n3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D07 compound treatment 0.0835 0.0141 1.67 1.6689 1.0 1910313 Bionet1_003665 Cc1ccc2SCc3cc(sc3-c2c1)C(=O)Nc4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D08 compound treatment 0.075 0.00558 0.66 0.6617 1.0 1730123 Bionet1_003666 O=C(Oc1ccc(cc1)c2nccc(n2)c3cccs3)C4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D09 compound treatment 0.078 0.00858 1.02 1.0172 1.0 1910314 Bionet1_003667 Cc1ccc2SCc3cc(sc3-c2c1)C(=O)Nc4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D10 compound treatment 0.0765 0.00708 0.84 0.8395 1.0 1910315 Bionet1_003668 CC(C)(C)c1ccc(cc1)C(=O)N/N=C/c2ccc(OCCCF)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D11 compound treatment 0.081 0.0116 1.37 1.3727 1.0 1910316 Bionet1_003669 Cc1ccc2SCc3cc(sc3-c2c1)C(=O)Nc4ccc(Cl)cc4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D12 compound treatment 0.082 0.0126 1.49 1.4912 1.0 1910317 Bionet1_003670 FCCCOc1ccc(/C=N/NC(=O)c2ccc(Cl)cc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D13 compound treatment 0.0815 0.0121 1.43 1.4319 1.0 1378719 Bionet1_003671 Cc1ccc2SCc3cc(sc3-c2c1)C(=O)Oc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D14 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1910318 Bionet1_003672 Clc1ccc(COc2ccc(/C=C\3/SC(=O)NC3=O)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D15 compound treatment 0.0805 0.0111 1.31 1.3134 1.0 1379260 Bionet1_003673 Cc1ccc2SCc3cc(sc3-c2c1)C(=O)Oc4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D16 compound treatment 0.075 0.00558 0.66 0.6617 1.0 1910319 Bionet1_003674 Brc1ccc(COc2ccc(/C=C\3/SC(=O)NC3=O)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D17 compound treatment 0.0845 0.0151 1.79 1.7874 1.0 1910320 Bionet1_003675 Fc1ccccc1N2CCN(CC(=O)Nc3nnc(s3)C(F)(F)F)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D18 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1645641 Bionet1_003676 O=C(NC1CCCCC1)Oc2ccc(cc2)c3nccc(n3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D19 compound treatment 0.086 0.0166 1.97 1.9651 1.0 1910321 Bionet1_003677 Fc1ccc(cc1)N2CCN(CC(=O)Nc3nnc(s3)C(F)(F)F)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D20 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1910322 Bionet1_003678 CN1C(=O)N(C)C(=O)C(=Cc2ccc(OCc3ccccc3)cc2)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D21 compound treatment 0.079 0.00958 1.14 1.1357 1.0 1910323 Bionet1_003679 Clc1ccccc1c2nc(no2)c3cc(oc3n4cccc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D22 compound treatment 0.0775 0.00808 0.96 0.958 1.0 1394938 Bionet1_003680 O=C(Oc1ccc(cc1)c2nccc(n2)c3cccs3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D23 mock treatment 0.075 0.00558 0.66 0.6617 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 D24 mock treatment 0.075 0.00558 0.66 0.6617 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E01 mock treatment 0.0715 0.00208 0.25 0.247 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E02 mock treatment 0.0725 0.00308 0.37 0.3655 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E03 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1387635 Bionet1_003681 Oc1ccn(Cc2ccc(F)cc2)c(=O)c1Cc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E04 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1910324 Bionet1_003682 CN1c2ccsc2/C(=N/NC(=O)Cc3cccs3)/CS1(=O)=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E05 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1254553 Bionet1_003683 CCOC(=O)C(Cc1c(F)cccc1Cl)c2ccnc3nc(N)nn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E06 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1910325 Bionet1_003684 COC(=O)c1sccc1Oc2cc(nc(SC)n2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E07 compound treatment 0.0825 0.0131 1.55 1.5504 1.0 1335360 Bionet1_003685 Oc1ccn(CCCN2CCOCC2)c(=O)c1Cc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E08 compound treatment 0.075 0.00558 0.66 0.6617 1.0 1910326 Bionet1_003686 CC(OC(=O)Nc1cccc(c1)C(F)(F)F)c2sc3ncnn3c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E09 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1151858 Bionet1_003687 Oc1ccn(CCc2ccccn2)c(=O)c1Cc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E10 compound treatment 0.078 0.00858 1.02 1.0172 1.0 1910327 Bionet1_003688 CC(OC(=O)NS(=O)(=O)c1ccc(C)cc1)c2sc3ncnn3c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E11 compound treatment 0.08 0.0106 1.25 1.2542 1.0 1525023 Bionet1_003689 CCOC(=O)C(Cc1c(F)cccc1Cl)c2ccnn2c3cccc(F)n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E12 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1910328 Bionet1_003690 COc1cccc(Sc2nc(SCc3ccccc3)nc4ccsc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E13 compound treatment 0.078 0.00858 1.02 1.0172 1.0 1229087 Bionet1_003691 Oc1ccn(Cc2cccc(Cl)c2)c(=O)c1Cc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E14 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1910329 Bionet1_003692 Cc1ccc(Sc2nc(SCc3ccccc3)nc4ccsc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E15 compound treatment 0.0805 0.0111 1.31 1.3134 1.0 1297010 Bionet1_003693 Oc1ccn(Cc2ccc3OCOc3c2)c(=O)c1Cc4c(F)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E16 compound treatment 0.0785 0.00908 1.08 1.0765 1.0 1910330 Bionet1_003694 COc1ccc(Oc2nc(SCc3ccccc3)nc4ccsc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E17 compound treatment 0.0785 0.00908 1.08 1.0765 1.0 1424403 Bionet1_003695 CN1CC(C(C1)C(=O)c2ccc(Cl)cc2)C(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E18 compound treatment 0.079 0.00958 1.14 1.1357 1.0 1910331 Bionet1_003696 Fc1ccc(Oc2nc(SCc3ccccc3)nc4ccsc24)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E19 compound treatment 0.0775 0.00808 0.96 0.958 1.0 1143157 Bionet1_003697 COc1ccc(cc1)C(=O)C2CN(C)CC2C(=O)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E20 compound treatment 0.0785 0.00908 1.08 1.0765 1.0 1910332 Bionet1_003698 Cc1ccc(Oc2nc(SCc3ccccc3)nc4ccsc24)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E21 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1291386 Bionet1_003699 COc1ccc(NC(=O)c2c(O)c3cccc4CCCn(c2=O)c43)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E22 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1910333 Bionet1_003700 C=CCSc1nc(Oc2ccc3ccccc3c2)c4sccc4n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E23 mock treatment 0.0755 0.00608 0.72 0.721 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 E24 mock treatment 0.072 0.00258 0.31 0.3063 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F01 mock treatment 0.0665 -0.00292 -0.35 -0.3454 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F02 mock treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F03 compound treatment 0.0685 -9.15E-4 -0.11 -0.1084 -1.0 1910334 Bionet1_003701 Nc1c(C#N)c(SCc2ccccc2)sc1C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F04 compound treatment 0.0685 -9.15E-4 -0.11 -0.1084 -1.0 1687952 Bionet1_003702 Clc1ccc(cc1)C(=O)Oc2ccc(cc2)c3nccc(n3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F05 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1910335 Bionet1_003703 COc1ccc(CSc2sc(C(=O)c3ccccc3)c(N)c2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F06 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910336 Bionet1_003704 Clc1ccc(N/N=C/c2ccc(OCc3ccccc3)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F07 compound treatment 0.078 0.00858 1.02 1.0172 1.0 1910337 Bionet1_003705 Cc1ccccc1CSc2sc(C(=O)c3ccccc3)c(N)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F08 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1910338 Bionet1_003706 CC(C)(C)c1ccc(N/N=C/c2ccc(OCc3ccccc3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F09 compound treatment 0.075 0.00558 0.66 0.6617 1.0 1910339 Bionet1_003707 Nc1c(C#N)c(SCC(=O)c2ccccc2)sc1C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F10 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1910340 Bionet1_003708 Clc1ccc(CO/N=C/c2ccc(OCc3ccccc3)cc2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F11 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1910341 Bionet1_003709 Nc1c(sc2sc(C(=O)c3ccccc3)c(N)c12)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F12 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910342 Bionet1_003710 COC(=O)c1cc2cc(NS(=O)(=O)c3ccc(C)cc3)ccc2s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F13 compound treatment 0.075 0.00558 0.66 0.6617 1.0 1910343 Bionet1_003711 Nc1c(C#N)c(SCc2cccc(F)c2)sc1C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F14 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910344 Bionet1_003712 CCOC(=O)c1cnn(c1n2cccc2C(=O)C(=O)NCC=C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F15 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1910345 Bionet1_003713 Nc1c(C#N)c(SCc2ccc(F)cc2)sc1C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F16 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1910346 Bionet1_003714 CCOC(=O)c1cnn(c1n2cccc2C(=O)C(=O)N(C)C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F17 compound treatment 0.0775 0.00808 0.96 0.958 1.0 1910347 Bionet1_003715 Cc1ccc(CSc2sc(C(=O)c3ccccc3)c(N)c2C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F18 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910348 Bionet1_003716 CC(C)Sc1nnc(c2cnn(c2n3cccc3)c4ccccc4)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F19 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1910349 Bionet1_003717 Nc1c(C#N)c(SCc2cccc(Cl)c2)sc1C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F20 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1910350 Bionet1_003718 CCSc1nnc(c2cnn(c2n3cccc3)c4ccccc4)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F21 compound treatment 0.0775 0.00808 0.96 0.958 1.0 1910351 Bionet1_003719 Nc1c(C#N)c(SCc2ccc(Cl)cc2)sc1C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F22 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910352 Bionet1_003720 FC(F)(F)c1cc(=O)n(nc1C(=O)Nc2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F23 mock treatment 0.0725 0.00308 0.37 0.3655 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 F24 mock treatment 0.071 0.00158 0.19 0.1878 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G01 mock treatment 0.0645 -0.00492 -0.58 -0.5824 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G02 mock treatment 0.0615 -0.00792 -0.94 -0.9379 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G03 compound treatment 0.065 -0.00442 -0.52 -0.5232 -1.0 1910353 Bionet1_003721 CC(=O)C(Cc1cnc(Cl)s1)(Cc2cnc(Cl)s2)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G04 compound treatment 0.064 -0.00542 -0.64 -0.6417 -1.0 1240057 Bionet1_003722 COC(=O)c1ccccc1Oc2nc(SCC=C)nc3ccsc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G05 compound treatment 0.064 -0.00542 -0.64 -0.6417 -1.0 1183374 Bionet1_003723 COc1ccc(CCn2ccc(O)c(Cc3ccccc3)c2=O)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G06 compound treatment 0.0645 -0.00492 -0.58 -0.5824 -1.0 1910354 Bionet1_003724 Cc1c(sc2ncnn12)/C(=N\O)/CSCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G07 compound treatment 0.0765 0.00708 0.84 0.8395 1.0 1227988 Bionet1_003725 Oc1ccn(Cc2ccc(Cl)cc2Cl)c(=O)c1Cc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G08 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1491407 Bionet1_003726 Clc1ccc(cc1)C(=O)CSc2nc3n(ncc3c(=O)[nH]2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G09 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910355 Bionet1_003727 Clc1cccc(C(=O)NNC(=O)c2sccc2n3cccc3)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G10 compound treatment 0.0675 -0.00192 -0.23 -0.2269 -1.0 1910356 Bionet1_003728 Clc1ccc(cc1)c2csc3nc4n(ncc4c(=O)n23)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G11 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1910357 Bionet1_003729 C/C(=N\OCc1ccc(Cl)cc1)/c2sc3nc4ccccc4n3c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G12 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1286687 Bionet1_003730 COc1ccc(cc1)C(=O)CSc2nc3n(ncc3c(=O)[nH]2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G13 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1376211 Bionet1_003731 COC(=O)CSc1nnc(s1)c2cc(c(O)c(c2)C(C)(C)C)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G14 compound treatment 0.0665 -0.00292 -0.35 -0.3454 -1.0 1492995 Bionet1_003732 O=C(CSc1nc2n(ncc2c(=O)[nH]1)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G15 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1445945 Bionet1_003733 CC(C)(C)c1cc(cc(c1O)C(C)(C)C)c2nnc(SCC=C)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G16 compound treatment 0.0685 -9.15E-4 -0.11 -0.1084 -1.0 1910358 Bionet1_003734 Brc1ccc(cc1)C2=Nn3c(nnc3SC2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G17 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1910359 Bionet1_003735 FC(F)(F)c1cccc(c1)n2ccc(=O)c(n2)C(=O)Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G18 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1161908 Bionet1_003736 Brc1cc(Br)c2oc(cc2c1)C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G19 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1910360 Bionet1_003737 COc1cccc(c1)C(=O)O/N=C(\C)/c2sc3nc4ccccc4n3c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G20 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1910361 Bionet1_003738 O/N=C(\c1cc2cc(Br)cc(Br)c2o1)/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G21 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1712484 Bionet1_003739 Clc1ccc(CN2CCN(CC2)c3nc4ccccc4s3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G22 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1910362 Bionet1_003740 COc1ccc(cc1)c2nnc(SCc3ccc(Cl)cc3Cl)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G23 mock treatment 0.0705 0.00108 0.13 0.1285 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 G24 mock treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H01 mock treatment 0.0665 -0.00292 -0.35 -0.3454 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H02 mock treatment 0.0655 -0.00392 -0.46 -0.4639 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H03 compound treatment 0.0665 -0.00292 -0.35 -0.3454 -1.0 1910363 Bionet1_003741 Nc1c(C#N)c(SCc2ccccc2Cl)sc1C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H04 compound treatment 0.0675 -0.00192 -0.23 -0.2269 -1.0 1910364 Bionet1_003742 FC(F)(F)c1cc(=O)n(nc1C(=O)Nc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H05 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1910365 Bionet1_003743 Nc1c(C#N)c(SCC(=O)c2ccc(F)cc2)sc1C(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H06 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910366 Bionet1_003744 FC(F)(F)c1cccc(NC(=O)C2CCC(=O)N2Cc3cccs3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H07 compound treatment 0.08 0.0106 1.25 1.2542 1.0 1910367 Bionet1_003745 Cc1cccn2c(/C=N/OC(=O)c3cccs3)c(nc12)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H08 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1910368 Bionet1_003746 FC(F)(F)c1cccc(NC(=O)C2CCC(=O)N2Cc3ccccc3Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H09 compound treatment 0.0785 0.00908 1.08 1.0765 1.0 1910369 Bionet1_003747 Cc1ccc(cc1)C(=O)O/N=C/c2c(nc3ccc(Cl)cn23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H10 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1448522 Bionet1_003748 Clc1ccc(NC(=O)C2CCC(=O)N2Cc3ccccc3Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H11 compound treatment 0.0765 0.00708 0.84 0.8395 1.0 1910370 Bionet1_003749 Cc1cccn2c(/C=N/OC(=O)C3CC3)c(nc12)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H12 compound treatment 0.079 0.00958 1.14 1.1357 1.0 1590698 Bionet1_003750 Clc1ccc(NC(=O)C2CCC(=O)N2Cc3ccccc3Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H13 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1910371 Bionet1_003751 O=C(NN=C1CCN(CC1)S(=O)(=O)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H14 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1910372 Bionet1_003752 FC(F)(F)c1ccc(NC(=O)C2CCC(=O)N2Cc3cccs3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H15 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1910373 Bionet1_003753 O=C(ON=C1CCN(CC1)S(=O)(=O)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H16 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1150108 Bionet1_003754 Clc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H17 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1910374 Bionet1_003755 CCOC(=O)c1cnc2c(C)cccc2c1Nc3ccc(OC(F)(F)F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H18 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1555155 Bionet1_003756 Fc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H19 compound treatment 0.0825 0.0131 1.55 1.5504 1.0 1910375 Bionet1_003757 Clc1ccc(cc1)C(=O)NN=C2CCN(CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H20 compound treatment 0.078 0.00858 1.02 1.0172 1.0 1452723 Bionet1_003758 Cc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H21 compound treatment 0.0815 0.0121 1.43 1.4319 1.0 1910376 Bionet1_003759 Fc1ccc(cc1)C(=O)NN=C2CCN(CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H22 compound treatment 0.075 0.00558 0.66 0.6617 1.0 1910377 Bionet1_003760 FC(F)(F)S(=O)(=O)N1CCC(CC1)c2nc3ccccc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H23 mock treatment 0.0725 0.00308 0.37 0.3655 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 H24 mock treatment 0.0705 0.00108 0.13 0.1285 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I01 mock treatment 0.0675 -0.00192 -0.23 -0.2269 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I02 mock treatment 0.064 -0.00542 -0.64 -0.6417 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I03 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1910378 Bionet1_003761 [O-][N+](=O)c1ccc(CN2CCN(CC2)c3nc4ccccc4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I04 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1455660 Bionet1_003762 CCOC(=O)COc1ccc(cc1)c2nccc(n2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I05 compound treatment 0.0655 -0.00392 -0.46 -0.4639 -1.0 1910379 Bionet1_003763 FC(F)(F)c1cccc(CN2CCN(CC2)c3nc4ccccc4s3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I06 compound treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 1910380 Bionet1_003764 COC(=O)COc1ccc(cc1)c2nccc(n2)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I07 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1332242 Bionet1_003765 Fc1cccc(Cl)c1CN2CCN(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I08 compound treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 1910381 Bionet1_003766 CCCCCCCc1ccc(CNc2ccc(cc2)C(=O)OCC)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I09 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1910382 Bionet1_003767 FC(F)(F)c1cccc(c1)C(=O)N2CCN(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I10 compound treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 1910383 Bionet1_003768 COc1ccc(cc1)C(=O)c2nnn(c2C)c3cc(Cl)cc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I11 compound treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 1673809 Bionet1_003769 Clc1ccc(cc1)C(=O)N2CCN(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I12 compound treatment 0.0645 -0.00492 -0.58 -0.5824 -1.0 1910384 Bionet1_003770 COC(=O)c1ccc(OCCCCCCOc2ccc(cc2)C(=O)OC)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I13 compound treatment 0.055 -0.0144 -1.71 -1.7081 -1.0 1379240 Bionet1_003771 COc1cccc(c1)C(=O)N2CCN(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I14 compound treatment 0.0625 -0.00692 -0.82 -0.8194 -1.0 1567386 Bionet1_003772 CC(C)(C)c1ccc(Oc2ccc(cc2)c3nc(N)c(C#N)c(C#N)c3C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I15 compound treatment 0.0665 -0.00292 -0.35 -0.3454 -1.0 1149384 Bionet1_003773 COc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I16 compound treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 1910385 Bionet1_003774 [O-][N+](=O)c1ccc(NCCc2c[nH]c3ccccc23)c(Br)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I17 compound treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 1147923 Bionet1_003775 O=S(=O)(N1CCN(CC1)c2nc3ccccc3s2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I18 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1910386 Bionet1_003776 CCOC(=O)C(CSC(=O)c1ccc(cc1)[N+](=O)[O-])NC(=O)OC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I19 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1173610 Bionet1_003777 Cc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I20 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1910387 Bionet1_003778 Brc1ccc(cc1)C(=O)CSc2nnc(o2)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I21 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1555729 Bionet1_003779 Clc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I22 compound treatment 0.0675 -0.00192 -0.23 -0.2269 -1.0 1910388 Bionet1_003780 COc1cc(Br)c(O)c(/C=N/NC(=O)c2cccnc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I23 mock treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 I24 mock treatment 0.065 -0.00442 -0.52 -0.5232 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J01 mock treatment 0.066 -0.00342 -0.4 -0.4047 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J02 mock treatment 0.065 -0.00442 -0.52 -0.5232 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J03 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1910389 Bionet1_003781 Cc1ccc(cc1)C(=O)NN=C2CCN(CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J04 compound treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 1696263 Bionet1_003782 COc1ccc(cc1)S(=O)(=O)N2CCC(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J05 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1910390 Bionet1_003783 O=C(NN=C1CCN(CC1)S(=O)(=O)c2ccccc2)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J06 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1491125 Bionet1_003784 O=S(=O)(N1CCC(CC1)c2nc3ccccc3s2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J07 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1910391 Bionet1_003785 CCOC(=O)c1cnc2ccc(cc2c1NCc3ccc(C)cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J08 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1422608 Bionet1_003786 O=S(=O)(Cc1ccccc1)N2CCC(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J09 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1910392 Bionet1_003787 CCOC(=O)c1cnc2ccc(cc2c1Nc3ccccc3F)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J10 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1412011 Bionet1_003788 Clc1ccc(cc1)S(=O)(=O)N2CCCC2c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J11 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910393 Bionet1_003789 Clc1ccc(cc1Cl)C(=O)Nc2ccc3sc4ccccc4c(=O)c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J12 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1202686 Bionet1_003790 Cc1ccc(cc1)S(=O)(=O)N2CCCC2c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J13 compound treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 1910394 Bionet1_003791 Clc1cccc(c1)C(=O)Nc2ccc3sc4ccccc4c(=O)c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J14 compound treatment 0.066 -0.00342 -0.4 -0.4047 -1.0 1334878 Bionet1_003792 COc1ccc(cc1)S(=O)(=O)N2CCCC2c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J15 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1910395 Bionet1_003793 COc1ccc(cc1)/C(=C/c2c(nc3c(C)cccn23)c4ccc(Cl)cc4)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J16 compound treatment 0.0675 -0.00192 -0.23 -0.2269 -1.0 1719153 Bionet1_003794 O=S(=O)(Cc1ccccc1)N2CCCC2c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J17 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1910396 Bionet1_003795 COc1cccc(c1)/C(=C/c2c(nc3c(C)cccn23)c4ccc(Cl)cc4)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J18 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1910397 Bionet1_003796 COc1cc(NC(=O)c2ccc(cc2)C(=O)C(F)(F)F)c(Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J19 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1910398 Bionet1_003797 COc1cccc(c1)/C(=C/c2c(nc3cc(C)ccn23)c4ccc(Cl)cc4)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J20 compound treatment 0.075 0.00558 0.66 0.6617 1.0 1910399 Bionet1_003798 CCOC(=O)c1nn(c2cccc(c2)C(F)(F)F)c(=O)cc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J21 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910400 Bionet1_003799 Cc1nc(sc1C(=O)/C=C/c2ccccc2[N+](=O)[O-])c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J22 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1910401 Bionet1_003800 CCOC(=O)c1nn(c2ccc(cc2)C(F)(F)F)c(=O)cc1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J23 mock treatment 0.07 5.85E-4 0.07 0.0693 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 J24 mock treatment 0.066 -0.00342 -0.4 -0.4047 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K01 mock treatment 0.065 -0.00442 -0.52 -0.5232 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K02 mock treatment 0.062 -0.00742 -0.88 -0.8786 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K03 compound treatment 0.0625 -0.00692 -0.82 -0.8194 -1.0 1910402 Bionet1_003801 Cc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ncccc3C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K04 compound treatment 0.0655 -0.00392 -0.46 -0.4639 -1.0 1910403 Bionet1_003802 COC(=O)c1ccc(/N=C/c2cc(OC)cc(Br)c2O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K05 compound treatment 0.0645 -0.00492 -0.58 -0.5824 -1.0 1269742 Bionet1_003803 Clc1cccc(c1)C(=O)N2CCC(CC2)c3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K06 compound treatment 0.066 -0.00342 -0.4 -0.4047 -1.0 1910404 Bionet1_003804 COc1cc(Br)c(O)c(/C=N/NC(=O)c2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K07 compound treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 1910405 Bionet1_003805 CC(C)(C)c1cc(O)cc(c1/C=N/Nc2cccc3cccnc23)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K08 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1910406 Bionet1_003806 Fc1ccccc1/C=C\2/C(OC(=O)Nc3ccccc3)C4CCN2CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K09 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910407 Bionet1_003807 CCOC(=O)C(=CNc1nc(cs1)c2ccc(C)cc2)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K10 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1910408 Bionet1_003808 COc1cc(Br)c(O)c(/C=N/Cc2ccc(Cl)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K11 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1910409 Bionet1_003809 Fc1ccc(SCc2ccc(CSc3ccc(F)cc3)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K12 compound treatment 0.0655 -0.00392 -0.46 -0.4639 -1.0 1910410 Bionet1_003810 COc1cccc2cc(oc12)/C(=N/NC(=O)c3ccc(cc3)C(F)(F)F)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K13 compound treatment 0.0655 -0.00392 -0.46 -0.4639 -1.0 1642102 Bionet1_003811 CC(C)(C)c1nc(NC(=O)Nc2ccccc2)sc1Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K14 compound treatment 0.0665 -0.00292 -0.35 -0.3454 -1.0 1910411 Bionet1_003812 COc1cccc2cc(oc12)/C(=N/Nc3ncc(cc3Cl)C(F)(F)F)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K15 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1370781 Bionet1_003813 Clc1ccc(NC(=O)Nc2nc(cs2)c3cccc4ccccc34)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K16 compound treatment 0.0665 -0.00292 -0.35 -0.3454 -1.0 1492345 Bionet1_003814 CC(C)(C)C(=O)Cn1ncc(N2CCOCC2)c(Br)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K17 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1571877 Bionet1_003815 CSc1nc(Sc2ccccc2)cc(n1)N3CCCc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K18 compound treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 1414611 Bionet1_003816 Clc1ccc(cc1)C(=O)Cn2ncc(N3CCOCC3)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K19 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910412 Bionet1_003817 CCOC(=O)C(=CNc1nc(cs1)c2ccc3ccccc3c2)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K20 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1391382 Bionet1_003818 Clc1ccc(cc1)C(=O)Cn2ncc(N3CCCC3)c(Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K21 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1441061 Bionet1_003819 Oc1ccn(CCc2c[nH]c3ccccc23)c(=O)c1Cc4c(F)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K22 compound treatment 0.0665 -0.00292 -0.35 -0.3454 -1.0 1910413 Bionet1_003820 CO/N=C(\Cn1ncc(N2CCOCC2)c(Cl)c1=O)/c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K23 mock treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 K24 mock treatment 0.0665 -0.00292 -0.35 -0.3454 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L01 mock treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L02 mock treatment 0.0655 -0.00392 -0.46 -0.4639 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L03 compound treatment 0.064 -0.00542 -0.64 -0.6417 -1.0 1910414 Bionet1_003821 Clc1ccc(Oc2ccccc2/C=C\3/SC(=O)NC3=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L04 compound treatment 0.066 -0.00342 -0.4 -0.4047 -1.0 1910415 Bionet1_003822 [O-][N+](=O)c1ccc2sc(cc2c1)C(=O)Nc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L05 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910416 Bionet1_003823 Clc1ccc(Oc2ccccc2C=C3C(=O)NC(=O)NC3=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L06 compound treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 1910417 Bionet1_003824 COC(=O)c1ccc(NC(=O)c2cc3cc(ccc3s2)[N+](=O)[O-])cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L07 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910418 Bionet1_003825 Fc1cc(Br)ccc1Oc2ccccc2/C=C/3\SC(=O)NC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L08 compound treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 1452589 Bionet1_003826 Clc1ncc(CC(Cc2cnc(Cl)s2)c3ccnc4ncnn34)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L09 compound treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 1910419 Bionet1_003827 Fc1cc(Oc2ccccc2/C=C/3\SC(=O)NC3=O)ccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L10 compound treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 1910420 Bionet1_003828 [O-][N+](=O)c1ccc(Oc2ccc(Cl)c(Cl)c2)c(Br)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L11 compound treatment 0.0715 0.00208 0.25 0.247 1.0 1910421 Bionet1_003829 CN1C(=O)N(C)C(=O)C(=Cc2ccccc2Oc3ccc(Cl)cc3)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L12 compound treatment 0.0685 -9.15E-4 -0.11 -0.1084 -1.0 1910422 Bionet1_003830 [O-][N+](=O)c1ccc(Oc2cc(Cl)cc(Cl)c2)c(Br)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L13 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1910423 Bionet1_003831 FC(F)(F)c1ccc(cc1)c2nnc(SCC(=O)c3ccc(Cl)cc3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L14 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910424 Bionet1_003832 COCCCNC(=O)/C=C/c1ccc(OCc2c(F)cccc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L15 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1910425 Bionet1_003833 COc1ccc(cc1)S(=O)(=O)Oc2ccc(c(F)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L16 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910426 Bionet1_003834 Fc1cccc(Cl)c1COc2ccc(/C=C/C(=O)N3CCOCC3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L17 compound treatment 0.0815 0.0121 1.43 1.4319 1.0 1910427 Bionet1_003835 Fc1cc(OC(=O)c2cccc(c2)C(F)(F)F)ccc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L18 compound treatment 0.08 0.0106 1.25 1.2542 1.0 1910428 Bionet1_003836 Fc1cccc(Cl)c1COc2ccc(/C=C/C(=O)NC3CCCC3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L19 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1364921 Bionet1_003837 COc1ccc(cc1)c2ccnc(n2)c3ccc(OC(=O)c4ccco4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L20 compound treatment 0.08 0.0106 1.25 1.2542 1.0 1910429 Bionet1_003838 Cc1ccccc1NC(=O)/C=C/c2ccc(OCc3c(F)cccc3Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L21 compound treatment 0.086 0.0166 1.97 1.9651 1.0 1910430 Bionet1_003839 COc1ccc(cc1)c2ccnc(n2)c3ccc(OC(=O)c4cccs4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L22 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910431 Bionet1_003840 O=C/1/C(=C/c2ccccc2)/CN(Cc3ccccc3)C\C1=C/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L23 mock treatment 0.074 0.00458 0.54 0.5432 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 L24 mock treatment 0.0675 -0.00192 -0.23 -0.2269 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M01 mock treatment 0.065 -0.00442 -0.52 -0.5232 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M02 mock treatment 0.0645 -0.00492 -0.58 -0.5824 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M03 compound treatment 0.063 -0.00642 -0.76 -0.7601 -1.0 1128240 Bionet1_003841 Oc1ccn(CCCn2ccnc2)c(=O)c1Cc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M04 compound treatment 0.0655 -0.00392 -0.46 -0.4639 -1.0 1324499 Bionet1_003842 Clc1cccc(Cl)c1SCC2CSc3nc4ccccc4c(=O)n23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M05 compound treatment 0.065 -0.00442 -0.52 -0.5232 -1.0 1712969 Bionet1_003843 CC(C)(Cn1ccc(O)c(Cc2ccccc2)c1=O)SCc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M06 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1123883 Bionet1_003844 COc1cccc(SCC2CSc3nc4ccccc4c(=O)n23)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M07 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1910432 Bionet1_003845 CCOC(=O)C(Cc1ccccc1)c2ccnc3nc(nn23)n4c(C)ccc4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M08 compound treatment 0.0685 -9.15E-4 -0.11 -0.1084 -1.0 1910433 Bionet1_003846 CN1c2ccccc2C(=C(C(=S)Nc3ccc(Cl)cc3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M09 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1494949 Bionet1_003847 Oc1ccn(C2CCCCCC2)c(=O)c1Cc3c(F)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M10 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1453081 Bionet1_003848 COc1ccccc1NC(=S)C2=C(O)c3ccccc3N(C)S2(=O)=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M11 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910434 Bionet1_003849 COC(=O)/C(=C\Nc1ccc(Cl)cc1)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M12 compound treatment 0.0685 -9.15E-4 -0.11 -0.1084 -1.0 1298145 Bionet1_003850 CN1c2ccccc2C(=C(C(=S)Nc3ccc(C)cc3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M13 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1910435 Bionet1_003851 FC(F)(F)c1cnc(c(Cl)c1)c2c[nH]c3ccc(Cl)cc3c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M14 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1168222 Bionet1_003852 CN1c2ccccc2C(=C(C(=S)Nc3ccc(F)c(Cl)c3)S1(=O)=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M15 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1910436 Bionet1_003853 COC(=O)/C(=C\Nc1cc(F)ccc1F)/c2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M16 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1910437 Bionet1_003854 Fc1cccc(Cl)c1CSC2=Nc3cc(Cl)ccc3SCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M17 compound treatment 0.081 0.0116 1.37 1.3727 1.0 1910438 Bionet1_003855 COc1ccc(Cn2ccc(O)c(C/C=C/c3ccccc3)c2=O)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M18 compound treatment 0.085 0.0156 1.85 1.8466 1.0 1910439 Bionet1_003856 COc1ccc(CSC2=Nc3cc(Cl)ccc3SCC2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M19 compound treatment 0.0765 0.00708 0.84 0.8395 1.0 1910440 Bionet1_003857 Oc1ccn(Cc2ccc(Cl)cc2Cl)c(=O)c1C/C=C/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M20 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1910441 Bionet1_003858 FC(F)(F)c1cccc(CSC2=CS(=O)(=O)c3ccccc3N2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M21 compound treatment 0.079 0.00958 1.14 1.1357 1.0 1211240 Bionet1_003859 COc1ccc(NC(=O)CC2ON(C)C(=O)N2c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M22 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1280568 Bionet1_003860 CC(C)(C)c1ccc(CSC2=CS(=O)(=O)c3ccccc3N2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M23 mock treatment 0.072 0.00258 0.31 0.3063 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 M24 mock treatment 0.069 -4.15E-4 -0.05 -0.0492 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N01 mock treatment 0.066 -0.00342 -0.4 -0.4047 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N02 mock treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N03 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1910442 Bionet1_003861 CC(=O)Nc1ccc(cc1)S(=O)(=O)Oc2ccc(c(F)c2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N04 compound treatment 0.0675 -0.00192 -0.23 -0.2269 -1.0 1910443 Bionet1_003862 CN1N=C/2C(CN(Cc3ccccc3)C\C2=C/c4ccccc4)C1c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N05 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1910444 Bionet1_003863 Fc1cc(OC(=O)c2cccc(Cl)c2Cl)ccc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N06 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1910445 Bionet1_003864 CN(C)/C=C\C(=O)c1nc2ccccc2n1Cc3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N07 compound treatment 0.0765 0.00708 0.84 0.8395 1.0 1362335 Bionet1_003865 OC(c1cc2cc(Br)cc(Br)c2o1)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N08 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1219502 Bionet1_003866 COc1ccc(cc1)c2cn3cc(I)ccc3n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N09 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1910446 Bionet1_003867 C/C(=N/NC(=O)c1cn(cn1)c2cccc(C)n2)/c3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N10 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1910447 Bionet1_003868 Fc1ccccc1/C=C\2/C(OC(=O)c3c(F)cccc3F)C4CCN2CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N11 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1489529 Bionet1_003869 CC(Oc1ccc(c(F)c1)c2ccccc2)c3ccn(n3)C(=O)C4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N12 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1327990 Bionet1_003870 COC(=O)c1ccc(cc1OC(=O)c2ccccc2Cl)n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N13 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1706126 Bionet1_003871 CCCc1ccc(c(F)c1)c2ccc(cc2)c3nocc3c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N14 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1910448 Bionet1_003872 [O-][N+](=O)c1ccc(cc1)C(=O)OC/2C3CCN(CC3)\C2=C/c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N15 compound treatment 0.08 0.0106 1.25 1.2542 1.0 1588140 Bionet1_003873 CCOC(=O)Cn1ccc(O)c(Cc2ccc(Cl)cc2Cl)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N16 compound treatment 0.0805 0.0111 1.31 1.3134 1.0 1361101 Bionet1_003874 COC(=O)c1cc(Br)c(NC(=O)c2cccs2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N17 compound treatment 0.0875 0.0181 2.14 2.1429 1.0 1224039 Bionet1_003875 Oc1ccn(CCc2ccccc2)c(=O)c1Cc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N18 compound treatment 0.079 0.00958 1.14 1.1357 1.0 1910449 Bionet1_003876 Oc1ccn(CC(F)(F)F)c(=O)c1Cc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N19 compound treatment 0.077 0.00758 0.9 0.8987 1.0 1211376 Bionet1_003877 Oc1ccn(Cc2ccncc2)c(=O)c1Cc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N20 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1712954 Bionet1_003878 CCC(=O)C(Cc1ccc(Cl)cc1Cl)c2ccnc3nc(N)nn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N21 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1361337 Bionet1_003879 Oc1ccn(Cc2ccc(Cl)cc2)c(=O)c1Cc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N22 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1626178 Bionet1_003880 Oc1nc2sc3ccccc3n2c(=O)c1C(=O)Nc4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N23 mock treatment 0.0775 0.00808 0.96 0.958 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 N24 mock treatment 0.078 0.00858 1.02 1.0172 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O01 mock treatment 0.072 0.00258 0.31 0.3063 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O02 mock treatment 0.0645 -0.00492 -0.58 -0.5824 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O03 compound treatment 0.067 -0.00242 -0.29 -0.2862 -1.0 1910450 Bionet1_003881 Cc1ccc(N/C=C(/c2ccc(Cl)nc2)\S(=O)(=O)c3ccccc3)cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O04 compound treatment 0.0675 -0.00192 -0.23 -0.2269 -1.0 1255091 Bionet1_003882 Clc1ccc(CSC2=CS(=O)(=O)c3ccccc3N2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O05 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910451 Bionet1_003883 FC(F)(F)c1ccc(cc1)C(=O)Nc2ccc(cc2)c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O06 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1910452 Bionet1_003884 Cn1c2sc(cc2c3ccccc13)C(=O)NNC(=O)c4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O07 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1316690 Bionet1_003885 COc1ccc(Oc2ccc(cc2)c3nc(N)c(C#N)c(C#N)c3C#N)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O08 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1910453 Bionet1_003886 CN1CCN(Cc2ccc(Sc3ccc(Cl)cc3)c(c2)[N+](=O)[O-])CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O09 compound treatment 0.0715 0.00208 0.25 0.247 1.0 3006735 Bionet1_003887 CN1CCOCC1.O=C1CC(C(=C(N1)[C-](C#N)C#N)C#N)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O10 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1910455 Bionet1_003888 [O-][N+](=O)c1cc(CN2CCOCC2)ccc1Sc3nc4ccccc4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O11 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1910456 Bionet1_003889 OC(CN(Cc1ccc(Cl)cc1)C(=O)Nc2cccc(F)c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O12 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1249045 Bionet1_003890 COC(=O)Cc1cc(OC)c(OC)cc1S(=O)(=O)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O13 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1141297 Bionet1_003891 Clc1ccc(cc1Cl)C(=O)Nc2ccc(cc2)c3nc4ccccc4o3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O14 compound treatment 0.0725 0.00308 0.37 0.3655 1.0 1910457 Bionet1_003892 COC(=O)c1sccc1NC(=O)CN2CCN(CC2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O15 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1331590 Bionet1_003893 Clc1ccc(C(=O)Nc2ccc(cc2)c3nc4ccccc4o3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O16 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1910458 Bionet1_003894 COC(=O)c1sccc1NC(=O)CN2CCN(CC2)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O17 compound treatment 0.082 0.0126 1.49 1.4912 1.0 1654630 Bionet1_003895 Clc1cccc(C(=O)Nc2ccc(cc2)c3nc4ccccc4o3)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O18 compound treatment 0.0775 0.00808 0.96 0.958 1.0 1704616 Bionet1_003896 COc1ccccc1C(=O)Nc2c(C#N)c(C)c(C)n2Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O19 compound treatment 0.0795 0.0101 1.19 1.1949 1.0 1910459 Bionet1_003897 Brc1ccc(cc1)C(=O)CSc2nnc(o2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O20 compound treatment 0.081 0.0116 1.37 1.3727 1.0 1910460 Bionet1_003898 FC(F)(F)c1ccccc1c2nnc(o2)c3cc4CCc5ccccc5-c4s3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O21 compound treatment 0.0755 0.00608 0.72 0.721 1.0 1910461 Bionet1_003899 O=C(CSc1nnc(o1)c2ccccc2)c3ccc(cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O22 compound treatment 0.0795 0.0101 1.19 1.1949 1.0 1910462 Bionet1_003900 Fc1ccc(CSc2nnc(o2)c3cc4CCc5ccccc5-c4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O23 mock treatment 0.081 0.0116 1.37 1.3727 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 O24 mock treatment 0.0765 0.00708 0.84 0.8395 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P01 mock treatment 0.0415 -0.0279 -3.31 -3.3077 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P02 mock treatment 0.053 -0.0164 -1.95 -1.945 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P03 compound treatment 0.0665 -0.00292 -0.35 -0.3454 -1.0 1739357 Bionet1_003901 Cn1cccc1C(=O)Nn2ccc(O)c(Cc3ccc(Cl)cc3Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P04 compound treatment 0.06 -0.00942 -1.12 -1.1156 -1.0 1687068 Bionet1_003902 Oc1nc2sc3ccccc3n2c(=O)c1C(=O)Nc4nc5ccccc5s4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P05 compound treatment 0.066 -0.00342 -0.4 -0.4047 -1.0 1910463 Bionet1_003903 CCOC(=O)C(Cc1ccc(Cl)cc1Cl)C(=O)/C=C/NCC(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P06 compound treatment 0.062 -0.00742 -0.88 -0.8786 -1.0 1910464 Bionet1_003904 FC(F)(F)c1cnc(CC(=O)NCc2ccc3OCOc3c2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P07 compound treatment 0.08 0.0106 1.25 1.2542 1.0 1383151 Bionet1_003905 CN1OC(CC(=O)Nc2cc(C)on2)N(C1=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P08 compound treatment 0.0745 0.00508 0.6 0.6025 1.0 1910465 Bionet1_003906 FC(F)(F)c1cccc(CNC(=O)Cc2ncc(cc2Cl)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P09 compound treatment 0.075 0.00558 0.66 0.6617 1.0 1470073 Bionet1_003907 CN1OC(CC(=O)NC2CCCCCC2)N(C1=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P10 compound treatment 0.071 0.00158 0.19 0.1878 1.0 1313971 Bionet1_003908 Oc1ccn(CCCN2CCOCC2)c(=O)c1Cc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P11 compound treatment 0.076 0.00658 0.78 0.7802 1.0 1546856 Bionet1_003909 CSc1cccc(c1)n2ccc(O)c(Cc3ccc(Cl)cc3Cl)c2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P12 compound treatment 0.074 0.00458 0.54 0.5432 1.0 1910466 Bionet1_003910 CCSc1ncc(/C=N/Nc2c(Cl)cc(Cl)cc2Cl)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P13 compound treatment 0.068 -0.00142 -0.17 -0.1677 -1.0 1910467 Bionet1_003911 Fc1cccc(CSc2nnc(o2)c3ccc(cc3)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P14 compound treatment 0.0735 0.00408 0.48 0.484 1.0 1910468 Bionet1_003912 CCSc1ncc(/C=N/Nc2c(Cl)cc(cc2Cl)C(F)(F)F)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P15 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1910469 Bionet1_003913 FC(F)(F)c1ccc(cc1)c2nnc(SCCOc3ccccc3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P16 compound treatment 0.072 0.00258 0.31 0.3063 1.0 1910470 Bionet1_003914 Clc1ccc(N/N=C/c2cnc(SCC=C)n2Cc3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P17 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910471 Bionet1_003915 COc1ccc(cc1)c2nnc(SCc3cccc(c3)C(F)(F)F)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P18 compound treatment 0.0695 8.47E-5 0.01 0.01 1.0 1401200 Bionet1_003916 CCS(=O)(=O)c1ccc(C(=O)Nc2ccccc2OC)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P19 compound treatment 0.08 0.0106 1.25 1.2542 1.0 1910472 Bionet1_003917 Fc1cccc(Cl)c1CSc2nnc(o2)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P20 compound treatment 0.073 0.00358 0.42 0.4248 1.0 1438845 Bionet1_003918 CCS(=O)(=O)c1ccc(C(=O)N2CCOCC2)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P21 compound treatment 0.0705 0.00108 0.13 0.1285 1.0 1910473 Bionet1_003919 Cc1ccc(cc1)C(=O)CSc2nnc(o2)c3ccc(cc3)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P22 compound treatment 0.07 5.85E-4 0.07 0.0693 1.0 1424958 Bionet1_003920 CCS(=O)(=O)c1ccc(C(=O)Nc2cccc(Cl)c2)c(Cl)c1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P23 mock treatment 0.062 -0.00742 -0.88 -0.8786 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.579 P24 mock treatment 0.054 -0.0154 -1.83 -1.8266 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A01 mock treatment 0.081 0.00921 1.09 1.0917 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A02 mock treatment 0.0875 0.0157 1.86 1.8618 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A03 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910703 Bionet1_004241 FC(F)(F)c1cccc(Oc2ccccc2/C=C\3/SC(=O)NC3=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A04 compound treatment 0.092 0.0202 2.4 2.3951 1.0 1910704 Bionet1_004242 Cc1ccc(CSc2nc(nnc2C(F)(F)F)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A05 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1910705 Bionet1_004243 FC(F)(F)c1ccccc1n2cc(nn2)C(=O)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A06 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1910706 Bionet1_004244 FC(F)(F)c1ccc(cc1)C(=O)N2CCN(CC2)c3ccc(C#N)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A07 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1163461 Bionet1_004245 CN1CCN(CC1)c2ccc(cc2)C(=O)c3cn(nn3)c4ccc(C)c(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A08 compound treatment 0.0835 0.0117 1.39 1.3879 1.0 1407957 Bionet1_004246 Clc1ccc(c(Cl)c1)S(=O)(=O)N2CCN(CC2)c3ccc(C#N)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A09 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1910707 Bionet1_004247 FC(F)(F)C(CN1CCCCC1)OC(=O)Nc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A10 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1206614 Bionet1_004248 Clc1cccc(c1Cl)S(=O)(=O)N2CCN(CC2)c3ccc(C#N)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A11 compound treatment 0.078 0.00621 0.74 0.7362 1.0 1910708 Bionet1_004249 Brc1ccc(CSC2=Nc3ccccc3C4=NC(=O)CN42)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A12 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1315919 Bionet1_004250 Clc1ccc(cc1Cl)S(=O)(=O)N2CCN(CC2)c3ccc(C#N)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A13 compound treatment 0.082 0.0102 1.21 1.2102 1.0 1910709 Bionet1_004251 Clc1ccc(CSC2=Nc3ccccc3C4=NC(=O)CN42)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A14 compound treatment 0.0705 -0.00129 -0.15 -0.1525 -1.0 1241057 Bionet1_004252 COc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ccc(C#N)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A15 compound treatment 0.075 0.00321 0.38 0.3807 1.0 1910710 Bionet1_004253 FC(F)(F)c1nc2cc(Cl)c(Cl)cc2nc1C(C#N)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A16 compound treatment 0.0805 0.00871 1.03 1.0324 1.0 1426382 Bionet1_004254 Clc1ccc(CC(=O)c2cc(C#N)n(Cc3cccc(Cl)c3)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A17 compound treatment 0.0795 0.00771 0.91 0.9139 1.0 1276216 Bionet1_004255 Clc1ccc(cc1)S(=O)(=O)N2CCN(CC2)c3ccc(C#N)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A18 compound treatment 0.0665 -0.00529 -0.63 -0.6264 -1.0 1910711 Bionet1_004256 COc1cc2N=C(SCc3ccc(C)cc3)N4CC(=O)N=C4c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A19 compound treatment 0.077 0.00521 0.62 0.6177 1.0 1910712 Bionet1_004257 Clc1ccc(cc1)C(=O)O/N=C/c2ccc(OCc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A20 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910713 Bionet1_004258 COc1cc2N=C(SCc3cccc(F)c3)N4CC(=O)N=C4c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A21 compound treatment 0.0835 0.0117 1.39 1.3879 1.0 1910714 Bionet1_004259 FC(F)(F)c1ccc(cc1)C(=O)O/N=C/c2ccc(OCc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A22 compound treatment 0.0795 0.00771 0.91 0.9139 1.0 1910715 Bionet1_004260 COc1cc2N=C(SCc3cccc(C)c3)N4CC(=O)N=C4c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A23 mock treatment 0.0865 0.0147 1.74 1.7434 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 A24 mock treatment 0.0825 0.0107 1.27 1.2694 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B01 mock treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B02 mock treatment 0.0755 0.00371 0.44 0.44 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B03 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910716 Bionet1_004261 COc1ccccc1/C=C(\C(=O)NCc2ccc(F)cc2)/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B04 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910717 Bionet1_004262 Clc1cccc(COc2ccc(C=C3C(=O)NC(=O)NC3=O)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B05 compound treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 1910718 Bionet1_004263 COc1cc(Br)cc(/C=N/c2ccc3nc(C)c(C)nc3c2)c1O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B06 compound treatment 0.087 0.0152 1.8 1.8026 1.0 1689914 Bionet1_004264 Cc1ccc(COc2ccc(cc2)c3nccc(n3)c4cccs4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B07 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1910719 Bionet1_004265 Cc1nc2ccc(NS(=O)(=O)c3cccc(c3)C(F)(F)F)cc2nc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B08 compound treatment 0.079 0.00721 0.85 0.8547 1.0 1910720 Bionet1_004266 CC(Oc1ccc(c(F)c1)c2ccccc2)c3ccn(n3)C(=O)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B09 compound treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 1498604 Bionet1_004267 CCOC(=O)NC(C1CCCC(C(=O)OCC)C1=O)c2ccccc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B10 compound treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 1544575 Bionet1_004268 COC(=O)Cc1c(O)ccn(CCc2ccc(cc2)S(=O)(=O)N)c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B11 compound treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 1910721 Bionet1_004269 COc1ccccc1/C=C(\C(=O)N2CCN(CC2)c3ccccc3)/c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B12 compound treatment 0.077 0.00521 0.62 0.6177 1.0 1910722 Bionet1_004270 COc1ccc(cc1)C2C(=C(N)Oc3c2c(C)nn3c4ccc(C)cc4)C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B13 compound treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 1910723 Bionet1_004271 COc1ccc(CNC(=O)/C(=C\c2ccccc2OC)/c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B14 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1910724 Bionet1_004272 COc1ccc(cc1)C2C(C#N)C(=O)Nc3c2c(C)nn3C4=NCCCN4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B15 compound treatment 0.0695 -0.00229 -0.27 -0.271 -1.0 1910725 Bionet1_004273 COc1ccccc1/C=C(\C(=O)NCc2ccc(C)cc2)/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B16 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1910726 Bionet1_004274 Cc1nc(sc1C(=O)/C=C/c2ccc(Cl)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B17 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1910727 Bionet1_004275 COc1ccccc1/C=C(/C(=O)NCCCn2ccnc2)\c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B18 compound treatment 0.0675 -0.00429 -0.51 -0.508 -1.0 1910728 Bionet1_004276 Cc1nn2c(cc(nc2c1Br)c3ccccc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B19 compound treatment 0.077 0.00521 0.62 0.6177 1.0 1910729 Bionet1_004277 Clc1ccc(cc1)C(=O)NNC(=O)C2Cc3c(O2)ccc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B20 compound treatment 0.075 0.00321 0.38 0.3807 1.0 1910730 Bionet1_004278 Fc1ccc(CNC(=O)/C=C/c2cc3OCOc3cc2Br)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B21 compound treatment 0.083 0.0112 1.33 1.3286 1.0 1910731 Bionet1_004279 Cc1ccc(cc1)S(=O)(=O)NNC(=O)C2Cc3c(O2)ccc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B22 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1910732 Bionet1_004280 COc1ccc(CNC(=O)/C=C/c2cc3OCOc3cc2Br)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B23 mock treatment 0.073 0.00121 0.14 0.1437 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 B24 mock treatment 0.0775 0.00571 0.68 0.6769 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C01 mock treatment 0.075 0.00321 0.38 0.3807 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C02 mock treatment 0.0755 0.00371 0.44 0.44 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C03 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1233450 Bionet1_004281 CCOC(=O)c1c(C)nn(c1C)c2ccc(NC(=O)Nc3ccccc3)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C04 compound treatment 0.0805 0.00871 1.03 1.0324 1.0 1910733 Bionet1_004282 COc1cc2N=C(SCC(=O)OC(C)(C)C)N3CC(=O)N=C3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C05 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1267560 Bionet1_004283 CCOC(=O)c1c(C)nn(c1C)c2ccc(NC(=O)Nc3ccc(C)cc3)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C06 compound treatment 0.077 0.00521 0.62 0.6177 1.0 1910734 Bionet1_004284 COc1cc2N=C(SCc3ccccc3)N4CC(=O)N=C4c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C07 compound treatment 0.08 0.00821 0.97 0.9732 1.0 1910735 Bionet1_004285 COc1ccc(cc1)C(=O)O/N=C/c2ccc(OCc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C08 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1910736 Bionet1_004286 FC(F)(F)c1cccc(c1)C(=O)N2CCN(CC2)c3ccc(C#N)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C09 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1910737 Bionet1_004287 Cc1ccc(N/C=C/C(=O)c2ccccc2OCc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C10 compound treatment 0.075 0.00321 0.38 0.3807 1.0 1430967 Bionet1_004288 Fc1cccc(Cl)c1Cn2cc(cc2C#N)C(=O)Cc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C11 compound treatment 0.0805 0.00871 1.03 1.0324 1.0 1212717 Bionet1_004289 CCOC(=O)c1ccc(cc1)n2cc(nn2)C(=O)c3ccc(cc3)n4ccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C12 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1741576 Bionet1_004290 Clc1cc(Cl)cc(Oc2nc3ccccc3nc2Cc4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C13 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910738 Bionet1_004291 Cc1ccc(/C=N/NC(=O)c2sc3nc(C)cc(C)c3c2n4cccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C14 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1910739 Bionet1_004292 [O-][N+](=O)c1ccc(C/2CCCC\C2=N\Nc3cccc(F)n3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C15 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1541859 Bionet1_004293 Clc1ccccc1Cn2nc(c3ccccc3)c(cc2=O)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C16 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910740 Bionet1_004294 [O-][N+](=O)c1ccc(C/2CCCC\C2=N\Nc3cccc(Cl)n3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C17 compound treatment 0.0815 0.00971 1.15 1.1509 1.0 1166194 Bionet1_004295 Cc1ccc(SCC2(O)CCN(CC2)S(=O)(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C18 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1910741 Bionet1_004296 [O-][N+](=O)c1ccc(C/2CCCC\C2=N\Nc3ccccc3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C19 compound treatment 0.079 0.00721 0.85 0.8547 1.0 1652199 Bionet1_004297 Fc1ccc(Cn2nc(c3ccccc3)c(cc2=O)N4CCCCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C20 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1234234 Bionet1_004298 Brc1ccccc1C(=O)c2c[nH]c(c2)C(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C21 compound treatment 0.0895 0.0177 2.1 2.0988 1.0 1492477 Bionet1_004299 Cc1cccc(Cn2nc(c3ccccc3)c(cc2=O)N4CCCCC4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C22 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1910742 Bionet1_004300 FC(F)(F)C(=O)/C=C/N1CCN(CC1)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C23 mock treatment 0.075 0.00321 0.38 0.3807 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 C24 mock treatment 0.077 0.00521 0.62 0.6177 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D01 mock treatment 0.0695 -0.00229 -0.27 -0.271 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D02 mock treatment 0.0755 0.00371 0.44 0.44 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D03 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1910743 Bionet1_004301 COc1ccccc1/C=C(/C(=O)NCCc2ccccc2)\c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D04 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910744 Bionet1_004302 Cc1ccc(N/C=C/C(=O)c2cnc(s2)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D05 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1910745 Bionet1_004303 COc1ccc(cc1)S(=O)(=O)NNC(=O)C2Cc3c(O2)ccc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D06 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1910746 Bionet1_004304 COc1ccc(Oc2nc3cc(Cl)c(Cl)cc3nc2C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D07 compound treatment 0.0855 0.0137 1.62 1.6249 1.0 1910747 Bionet1_004305 Fc1ccc(/C=N/Nc2nc3ccccc3nc2Cc4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D08 compound treatment 0.0875 0.0157 1.86 1.8618 1.0 1119539 Bionet1_004306 COc1ccc(cc1)c2ccnc(n2)c3ccc(OCc4cccc(F)c4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D09 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1910748 Bionet1_004307 COCCN1C(=O)NC(=O)/C(=C\c2ccc(Br)cc2)/C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D10 compound treatment 0.086 0.0142 1.68 1.6841 1.0 1910749 Bionet1_004308 CN(C)CCCNC(=O)c1cc(c[nH]1)C(=O)c2cccc(Cl)c2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D11 compound treatment 0.083 0.0112 1.33 1.3286 1.0 1910750 Bionet1_004309 CCc1cc(=O)[nH]c(SCc2cc(cc(c2)C(F)(F)F)C(F)(F)F)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D12 compound treatment 0.0875 0.0157 1.86 1.8618 1.0 1389266 Bionet1_004310 O=C(COc1ccc(cc1)c2nccc(n2)c3ccccn3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D13 compound treatment 0.0795 0.00771 0.91 0.9139 1.0 1259631 Bionet1_004311 COc1ccc(NC(=O)c2ccc(cc2)N3CCS(=O)(=O)CC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D14 compound treatment 0.0875 0.0157 1.86 1.8618 1.0 1910751 Bionet1_004312 COCCCNC(=O)COc1ccc(cc1)c2nccc(n2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D15 compound treatment 0.0805 0.00871 1.03 1.0324 1.0 1910752 Bionet1_004313 CCOC(=O)c1cnn2c(C)c(Cc3c(Cl)cccc3Cl)c(C)nc12 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D16 compound treatment 0.075 0.00321 0.38 0.3807 1.0 1910753 Bionet1_004314 CC(=O)Oc1c(C(=O)C)c2ccccn2c1c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D17 compound treatment 0.0805 0.00871 1.03 1.0324 1.0 1910754 Bionet1_004315 CC(=O)c1ccccc1N/C=C/C(=O)c2ccc(Oc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D18 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1671266 Bionet1_004316 O=C1C2(CC2c3ccccc3)CN(Cc4ccccc4)CC51CC5c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D19 compound treatment 0.0805 0.00871 1.03 1.0324 1.0 1426932 Bionet1_004317 CCOC(=O)c1cnc2ccc(C)cc2c1Sc3ccccc3C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D20 compound treatment 0.077 0.00521 0.62 0.6177 1.0 1439112 Bionet1_004318 CCOC(=O)c1c(C)nn(c1C)c2ccc(NC(=O)c3cccs3)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D21 compound treatment 0.085 0.0132 1.57 1.5656 1.0 1910755 Bionet1_004319 CCOC(=O)c1cnc2c(F)cccc2c1Oc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D22 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1397683 Bionet1_004320 CCOC(=O)c1c(C)nn(c1C)c2ccc(NC(=O)c3c(F)cccc3F)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D23 mock treatment 0.0735 0.00171 0.2 0.203 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 D24 mock treatment 0.075 0.00321 0.38 0.3807 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E01 mock treatment 0.074 0.00221 0.26 0.2622 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E02 mock treatment 0.078 0.00621 0.74 0.7362 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E03 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1910756 Bionet1_004321 COc1cnc(nc1Oc2ccc(Cl)c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E04 compound treatment 0.077 0.00521 0.62 0.6177 1.0 1910757 Bionet1_004322 Clc1ncc(COc2ccc3ccccc3c2C=C(C#N)C#N)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E05 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1210306 Bionet1_004323 OC1(CSc2ccccc2)CCN(CC1)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E06 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1148614 Bionet1_004324 CC(Oc1ccc(c(F)c1)c2ccccc2)c3ccn(n3)C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E07 compound treatment 0.0835 0.0117 1.39 1.3879 1.0 1590913 Bionet1_004325 OC1(CSc2ccc(F)cc2)CCN(CC1)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E08 compound treatment 0.0785 0.00671 0.8 0.7954 1.0 1910758 Bionet1_004326 Cc1ccc(cc1)c2ccnc(n2)c3ccc(OCc4ccc(cc4)[N+](=O)[O-])cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E09 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1349748 Bionet1_004327 OC1(CN2CCOCC2)CCN(CC1)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E10 compound treatment 0.0775 0.00571 0.68 0.6769 1.0 1910759 Bionet1_004328 Cc1nc(sc1C(=O)CC(C(C#N)C#N)c2ccccc2)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E11 compound treatment 0.082 0.0102 1.21 1.2102 1.0 1372261 Bionet1_004329 CN1CCN(CC2(O)CCN(CC2)S(=O)(=O)c3ccc(Cl)cc3)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E12 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1910760 Bionet1_004330 FC(F)(F)c1cc(cc(c1)C(F)(F)F)n2cc(nn2)C(=O)c3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E13 compound treatment 0.079 0.00721 0.85 0.8547 1.0 1274041 Bionet1_004331 Cc1cc(C)c(C#N)c(Sc2ccccc2NC(=O)c3cccs3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E14 compound treatment 0.078 0.00621 0.74 0.7362 1.0 1910761 Bionet1_004332 Cc1c(nnn1c2cc(cc(c2)C(F)(F)F)C(F)(F)F)C(=O)c3ccncc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E15 compound treatment 0.082 0.0102 1.21 1.2102 1.0 1251569 Bionet1_004333 Cc1cc(C)c(C#N)c(Sc2ccccc2NC(=O)c3ccc(F)cc3)n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E16 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1137482 Bionet1_004334 CC(Oc1ccc(c(F)c1)c2ccccc2)c3ccn(n3)C(=O)c4ccc(C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E17 compound treatment 0.078 0.00621 0.74 0.7362 1.0 1611768 Bionet1_004335 COc1cccc(c1)C(=O)Nc2ccccc2Sc3nc(C)cc(C)c3C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E18 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1910762 Bionet1_004336 FCCCOc1ccc(cc1)c2nccc(n2)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E19 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1372524 Bionet1_004337 Cc1cccc(c1)C(=O)Nc2ccccc2Sc3nc(C)cc(C)c3C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E20 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1262404 Bionet1_004338 CC(Oc1ccc(c(F)c1)c2ccccc2)c3ccn(n3)C(=O)c4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E21 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1200589 Bionet1_004339 Cn1nc(c(c1Cl)c2nc(no2)c3ccccc3Cl)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E22 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910763 Bionet1_004340 FCCCOc1ccc(cc1)c2nccc(n2)c3ccc(cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E23 mock treatment 0.074 0.00221 0.26 0.2622 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 E24 mock treatment 0.0725 7.13E-4 0.08 0.0845 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F01 mock treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F02 mock treatment 0.074 0.00221 0.26 0.2622 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F03 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1536260 Bionet1_004341 CCOC(=O)c1cnc2c(F)cccc2c1Oc3ccccc3C(=O)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F04 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1311426 Bionet1_004342 CCOC(=O)c1c(C)nn(c1C)c2ccc(NC(=O)c3ccco3)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F05 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1910764 Bionet1_004343 COC(=O)c1cc2cc(NS(=O)(=O)c3ccc(Cl)cc3)ccc2s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F06 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1492508 Bionet1_004344 COC(=O)C1=C(C)NC(=C(C1c2ccc3ccccc3n2)C(=O)OC)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F07 compound treatment 0.0785 0.00671 0.8 0.7954 1.0 1910765 Bionet1_004345 COC(=O)c1cc2cc(NS(=O)(=O)Cc3ccccc3)ccc2s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F08 compound treatment 0.0775 0.00571 0.68 0.6769 1.0 1910766 Bionet1_004346 Brc1cc2OCOc2cc1/C=C/C(=O)NCc3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F09 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1910767 Bionet1_004347 COC(=O)c1cc2cc(NC(=O)c3cccc(c3)C(F)(F)F)ccc2s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F10 compound treatment 0.08 0.00821 0.97 0.9732 1.0 1910768 Bionet1_004348 COCCCNC(=O)c1cc(c[nH]1)C(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F11 compound treatment 0.08 0.00821 0.97 0.9732 1.0 1601368 Bionet1_004349 COC(=O)C(C)Oc1ccc(cc1)c2nccc(n2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F12 compound treatment 0.0825 0.0107 1.27 1.2694 1.0 1910769 Bionet1_004350 Clc1ccc(NC(=O)NNC(=O)C2CC(=NO2)c3cccnc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F13 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1910770 Bionet1_004351 COC(=O)CCCOc1ccc(cc1)c2nccc(n2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F14 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1910771 Bionet1_004352 Cc1ccc(/C=C/2\S/C(=N\n3cnnc3)/N(C2=O)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F15 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1262536 Bionet1_004353 COc1ccc(cc1)c2nnc3SCC(=Nn23)c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F16 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910772 Bionet1_004354 CCCCCCCNC(=O)c1cc(c[nH]1)C(=O)c2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F17 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1593127 Bionet1_004355 Cc1nnc(COc2cccc3n(ccc23)S(=O)(=O)c4ccc(C)cc4)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F18 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1910773 Bionet1_004356 Clc1ccccc1NC(=O)NNC(=O)C2CC(=NO2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F19 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910774 Bionet1_004357 Cc1ccc(cc1)C(=O)CSc2nnc(o2)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F20 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910775 Bionet1_004358 FC(F)(F)c1cccc(c1)C(=O)c2c[nH]c(c2)C(=O)NCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F21 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1910776 Bionet1_004359 FC(F)(F)c1cccc(Oc2ccccc2C=C3C(=O)NC(=O)NC3=O)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F22 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1910777 Bionet1_004360 COc1ccc(NC(=O)NNC(=O)C2CC(=NO2)c3cccnc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F23 mock treatment 0.0725 7.13E-4 0.08 0.0845 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 F24 mock treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G01 mock treatment 0.067 -0.00479 -0.57 -0.5672 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G02 mock treatment 0.0705 -0.00129 -0.15 -0.1525 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G03 compound treatment 0.067 -0.00479 -0.57 -0.5672 -1.0 1412425 Bionet1_004361 Cn1nc(c(c1Cl)c2nc(no2)c3cccc(Cl)c3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G04 compound treatment 0.0705 -0.00129 -0.15 -0.1525 -1.0 1910778 Bionet1_004362 Cn1cccc1c2nnc(SCc3ccc(Br)cc3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G05 compound treatment 0.0665 -0.00529 -0.63 -0.6264 -1.0 1910779 Bionet1_004363 Cn1nc(c(c1Cl)c2nc(no2)c3ccc(Cl)cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G06 compound treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 1910780 Bionet1_004364 COc1ccc(cc1)C(=O)CSc2nnc(o2)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G07 compound treatment 0.077 0.00521 0.62 0.6177 1.0 1202055 Bionet1_004365 Cc1ccc(OC(=O)CN(c2ccccc2)S(=O)(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G08 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1910781 Bionet1_004366 COc1ccc(cc1)c2nnc(SCc3ccc(cc3)C(F)(F)F)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G09 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1443924 Bionet1_004367 Fc1ccc(OC(=O)CN(c2ccccc2)S(=O)(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G10 compound treatment 0.0685 -0.00329 -0.39 -0.3895 -1.0 1910782 Bionet1_004368 COc1ccc(cc1)c2nnc(SCC(=O)c3ccc(Cl)cc3Cl)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G11 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910783 Bionet1_004369 N/C(=N\OC(=O)c1ccccc1C(F)(F)F)/CS(=O)(=O)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G12 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1390277 Bionet1_004370 CCOC(=O)COc1ccc(cc1)c2nccc(n2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G13 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910784 Bionet1_004371 FC(F)(F)c1ccccc1C(=O)NNC(=O)c2sccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G14 compound treatment 0.0665 -0.00529 -0.63 -0.6264 -1.0 1910785 Bionet1_004372 OC(CN1CCN(CC1)c2ncc(cc2Cl)C(F)(F)F)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G15 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1910786 Bionet1_004373 FC(F)(F)c1cccc(c1)C(=O)NNC(=O)c2sccc2n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G16 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1910787 Bionet1_004374 COc1ccc(/C=C/C(OC(=O)Nc2cccc(F)c2)c3ccccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G17 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1471906 Bionet1_004375 COc1ccccc1NC(=O)c2nn(ccc2=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G18 compound treatment 0.0655 -0.00629 -0.74 -0.7449 -1.0 1910788 Bionet1_004376 COC(=O)CCCSC1=Nc2cc(OC)c(OC)cc2C3=NC(=O)CN31 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G19 compound treatment 0.0705 -0.00129 -0.15 -0.1525 -1.0 1910789 Bionet1_004377 COc1ccccc1NC(=O)c2nn(ccc2=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G20 compound treatment 0.0695 -0.00229 -0.27 -0.271 -1.0 1910790 Bionet1_004378 COc1cc2NC(=S)N3C(Cc4ccccc4)C(=O)N=C3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G21 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1502411 Bionet1_004379 COc1ccccc1NC(=O)c2nn(ccc2=O)c3ccc(F)c(F)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G22 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1910791 Bionet1_004380 Cc1ccc(cc1)C(=O)NNC(=O)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G23 mock treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 G24 mock treatment 0.067 -0.00479 -0.57 -0.5672 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H01 mock treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H02 mock treatment 0.073 0.00121 0.14 0.1437 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H03 compound treatment 0.0675 -0.00429 -0.51 -0.508 -1.0 1910792 Bionet1_004381 Cc1ccc(cc1)C2=Nn3c(nnc3SC2)c4ccc(cc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H04 compound treatment 0.0695 -0.00229 -0.27 -0.271 -1.0 1720607 Bionet1_004382 O=C(C1Cc2c(O1)ccc3ccccc23)N4CCN(CC4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H05 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910793 Bionet1_004383 O=C(Oc1ccc(cc1)c2nccc(n2)c3ccccn3)c4cccs4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H06 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1529856 Bionet1_004384 CC(C)(C)c1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H07 compound treatment 0.0845 0.0127 1.51 1.5064 1.0 1422956 Bionet1_004385 Cc1nc(sc1C(=O)COc2ccc(Cl)c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H08 compound treatment 0.08 0.00821 0.97 0.9732 1.0 1440387 Bionet1_004386 CC(C)(C)c1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCc3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H09 compound treatment 0.0785 0.00671 0.8 0.7954 1.0 1126110 Bionet1_004387 CCn1c(S)nnc1C2CCN(CC2)S(=O)(=O)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H10 compound treatment 0.085 0.0132 1.57 1.5656 1.0 1910794 Bionet1_004388 Clc1ccccc1CNC(=O)/C=C/c2cc3OCOc3cc2Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H11 compound treatment 0.078 0.00621 0.74 0.7362 1.0 1910795 Bionet1_004389 NC(=O)C1(CCN(CC1)c2ccc(cn2)C(F)(F)F)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H12 compound treatment 0.0845 0.0127 1.51 1.5064 1.0 1910796 Bionet1_004390 FC(F)(F)c1cccc(CNC(=O)C2Cc3c(O2)ccc4ccccc34)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H13 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910797 Bionet1_004391 NC(=O)C1(CCN(CC1)c2ncc(cc2Cl)C(F)(F)F)N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H14 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1910798 Bionet1_004392 Clc1ccc(CNC(=O)/C=C/c2cc3OCOc3cc2Br)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H15 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1742891 Bionet1_004393 CCn1c(SC)nnc1C2CCN(CC2)S(=O)(=O)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H16 compound treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 1910799 Bionet1_004394 Clc1ccc(CN2CCC(CC2)C(=O)NNC(=O)C3CC3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H17 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1910800 Bionet1_004395 COc1cccc(c1)C(=O)Nc2ccc3sc4ccccc4c(=O)c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H18 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1253700 Bionet1_004396 CC(C)(C)c1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCc3ccco3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H19 compound treatment 0.08 0.00821 0.97 0.9732 1.0 1910801 Bionet1_004397 CCOC(=O)c1cnc2ccc(cc2c1NCc3ccc(OC)cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H20 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1910802 Bionet1_004398 CCCCN(CCCC)C(=O)c1cc(c[nH]1)C(=O)c2ccc(cc2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H21 compound treatment 0.079 0.00721 0.85 0.8547 1.0 1193957 Bionet1_004399 Nc1c(C#N)c(Oc2ccc3ccccc3c2)sc1C(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H22 compound treatment 0.075 0.00321 0.38 0.3807 1.0 1910803 Bionet1_004400 Fc1ccc(cc1)S(=O)(=O)NNC(=O)C2CC(=NO2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H23 mock treatment 0.0735 0.00171 0.2 0.203 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 H24 mock treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I01 mock treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I02 mock treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I03 compound treatment 0.0665 -0.00529 -0.63 -0.6264 -1.0 1910804 Bionet1_004401 Cc1ccccc1NC(=O)c2nn(ccc2=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I04 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1910805 Bionet1_004402 Cc1ccc(cc1)S(=O)(=O)NNC(=O)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I05 compound treatment 0.066 -0.00579 -0.69 -0.6857 -1.0 1910806 Bionet1_004403 Cc1nnsc1SCCNS(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I06 compound treatment 0.0705 -0.00129 -0.15 -0.1525 -1.0 1910807 Bionet1_004404 Clc1cccc(c1)C(=O)NNC(=O)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I07 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910808 Bionet1_004405 Nn1c(SCc2ccc(Cl)cc2Cl)nnc1c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I08 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1338374 Bionet1_004406 Clc1ccc(C(=O)c2c[nH]c(c2)C(=O)NCC3CCCO3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I09 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1910809 Bionet1_004407 Cc1ccc(cc1)S(=O)(=O)NNC(=O)/C=C/c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I10 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1734049 Bionet1_004408 Cc1ccc(cc1)C(=O)n2ccc(n2)c3ccccc3OCc4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I11 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1910810 Bionet1_004409 Clc1ccc(/C=C/C(=O)NNC(=O)c2ccc(Cl)c(Cl)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I12 compound treatment 0.0665 -0.00529 -0.63 -0.6264 -1.0 1196488 Bionet1_004410 Fc1ccc(COc2ccccc2c3ccn(n3)C(=O)c4ccc(F)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I13 compound treatment 0.058 -0.0138 -1.63 -1.6336 -1.0 1439273 Bionet1_004411 COc1ccc(Cc2nc(cs2)C(=O)Nc3ccc(OC)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I14 compound treatment 0.0625 -0.00929 -1.1 -1.1004 -1.0 1267271 Bionet1_004412 Fc1ccc(COc2ccccc2c3ccn(Cc4ccc(Cl)cc4)n3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I15 compound treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 1481246 Bionet1_004413 COc1ccc(NC(=O)c2csc(Cc3ccc(Cl)cc3)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I16 compound treatment 0.066 -0.00579 -0.69 -0.6857 -1.0 1700978 Bionet1_004414 COCc1cc(nc(n1)S(=O)(=O)Cc2ccc(Cl)cc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I17 compound treatment 0.0695 -0.00229 -0.27 -0.271 -1.0 1614068 Bionet1_004415 COc1ccc(Cc2nc(cs2)C(=O)Nc3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I18 compound treatment 0.0665 -0.00529 -0.63 -0.6264 -1.0 1565931 Bionet1_004416 OC1(CN2CCCC2)CCN(CC1)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I19 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1667686 Bionet1_004417 COc1ccc(Cc2nc(cs2)C(=O)Nc3cc(Cl)cc(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I20 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1329348 Bionet1_004418 OC1(CN2CCCCC2)CCN(CC1)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I21 compound treatment 0.0785 0.00671 0.8 0.7954 1.0 1910811 Bionet1_004419 COc1ccc(Cc2nc(cs2)C(=O)Nc3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I22 compound treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 1224949 Bionet1_004420 CCN(CC)CC1(O)CCN(CC1)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I23 mock treatment 0.0675 -0.00429 -0.51 -0.508 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 I24 mock treatment 0.0665 -0.00529 -0.63 -0.6264 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J01 mock treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J02 mock treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J03 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1569213 Bionet1_004421 Fc1ccc(SCC(=O)N2CCC(CC2)c3nc4ccccc4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J04 compound treatment 0.0695 -0.00229 -0.27 -0.271 -1.0 1910812 Bionet1_004422 COc1ccccc1CNC(=O)/C=C/c2cc3OCOc3cc2Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J05 compound treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 1910813 Bionet1_004423 FC(F)(F)c1cccc(c1)C(=O)Nc2ccc3sc4ccccc4c(=O)c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J06 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1689211 Bionet1_004424 COc1ccc(CNC(=O)c2cc(c[nH]2)C(=O)c3ccc(cc3)C(C)(C)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J07 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1910814 Bionet1_004425 Clc1ccccc1C(=O)Nc2ccc3sc4ccccc4c(=O)c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J08 compound treatment 0.0815 0.00971 1.15 1.1509 1.0 1910815 Bionet1_004426 CS(=O)(=O)O/N=C/1\CCCCC1c2ccc(cc2[N+](=O)[O-])[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J09 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1521833 Bionet1_004427 CC(=O)N(N1C(=O)C2C(C3c4ccccc4C2c5ccccc35)C1=O)C(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J10 compound treatment 0.0775 0.00571 0.68 0.6769 1.0 1910816 Bionet1_004428 Fc1ccccc1CO/N=C/c2cc3OCOc3cc2Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J11 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1208446 Bionet1_004429 Clc1ccc(cc1)S(=O)(=O)N2CCC(CC2)NC(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J12 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1910817 Bionet1_004430 CN1C(=O)N(C)C(=O)C(=Cc2cc3OCOc3cc2Br)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J13 compound treatment 0.066 -0.00579 -0.69 -0.6857 -1.0 1521290 Bionet1_004431 CC(C)NC(=O)NC1CCN(CC1)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J14 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1910818 Bionet1_004432 COc1ccc(OC(=O)/C=C/c2cc3OCOc3cc2Br)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J15 compound treatment 0.0695 -0.00229 -0.27 -0.271 -1.0 1675076 Bionet1_004433 Clc1ccc(cc1)S(=O)(=O)N2CCC(CC2)NC(=O)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J16 compound treatment 0.067 -0.00479 -0.57 -0.5672 -1.0 1440868 Bionet1_004434 CN1CCN(CC1)c2ncc(CN3CCN(CC3)c4ccccc4)s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J17 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1243115 Bionet1_004435 CC(C)OC(=O)NC1CCN(CC1)S(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J18 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1737861 Bionet1_004436 Fc1cc(Br)ccc1NC(=S)Nc2ccc3nccnc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J19 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1416509 Bionet1_004437 Clc1ccc(cc1)S(=O)(=O)N2CCC(CC2)NC(=O)OCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J20 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1910819 Bionet1_004438 O=C/1N(/C(=N/n2cnnc2)/S\C1=C/c3cccs3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J21 compound treatment 0.075 0.00321 0.38 0.3807 1.0 1910820 Bionet1_004439 COc1cc(nc(Oc2cc(Cl)c(Cl)cc2Cl)n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J22 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1375910 Bionet1_004440 CCC(=O)CC(C)(O)Nc1cc(n[nH]1)c2sccc2n3c(C)ccc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J23 mock treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 J24 mock treatment 0.067 -0.00479 -0.57 -0.5672 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K01 mock treatment 0.0665 -0.00529 -0.63 -0.6264 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K02 mock treatment 0.077 0.00521 0.62 0.6177 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K03 compound treatment 0.0645 -0.00729 -0.86 -0.8634 -1.0 1459681 Bionet1_004441 COc1ccc(CNC(=O)c2csc(Cc3ccc(OC)cc3)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K04 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1292538 Bionet1_004442 OC1(CN2CCCCCC2)CCN(CC1)S(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K05 compound treatment 0.066 -0.00579 -0.69 -0.6857 -1.0 1204526 Bionet1_004443 Clc1ccc(Cc2nc(cs2)C(=O)Nc3cc(Cl)cc(Cl)c3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K06 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1910821 Bionet1_004444 Cc1ccc(cc1)S(=O)(=O)NNC(=O)/C=C/c2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K07 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1710874 Bionet1_004445 Clc1ccc(CNC(=O)c2csc(Cc3ccc(Cl)cc3)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K08 compound treatment 0.0705 -0.00129 -0.15 -0.1525 -1.0 1232613 Bionet1_004446 Clc1ccc(Cn2nc-3c(CCc4ccccc43)cc2=O)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K09 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1187522 Bionet1_004447 COc1ccc(CNC(=O)c2csc(Cc3ccc(Cl)cc3)n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K10 compound treatment 0.0675 -0.00429 -0.51 -0.508 -1.0 1222253 Bionet1_004448 Clc1ccc(Cn2nc-3c(CCc4ccccc43)cc2=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K11 compound treatment 0.0685 -0.00329 -0.39 -0.3895 -1.0 1333888 Bionet1_004449 COc1ccccc1CNC(=O)c2csc(Cc3ccc(Cl)cc3)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K12 compound treatment 0.0655 -0.00629 -0.74 -0.7449 -1.0 1910822 Bionet1_004450 CCSC/1=Nc2ccccc2\C1=N\Nc3c(Cl)cc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K13 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1633414 Bionet1_004451 COc1ccc(Cc2nc(cs2)C(=O)NCc3ccccc3OC)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K14 compound treatment 0.0655 -0.00629 -0.74 -0.7449 -1.0 1910823 Bionet1_004452 CCCSC/1=Nc2ccccc2\C1=N\Nc3c(Cl)cc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K15 compound treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 1910824 Bionet1_004453 COc1ccc(NC(=O)Cc2nc(no2)c3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K16 compound treatment 0.0655 -0.00629 -0.74 -0.7449 -1.0 1910825 Bionet1_004454 CC(C)SC/1=Nc2ccccc2\C1=N\Nc3c(Cl)cc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K17 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1243839 Bionet1_004455 O=C(C1CCN(CC1)S(=O)(=O)c2ccccc2)N3CCC4(CC3)OCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K18 compound treatment 0.066 -0.00579 -0.69 -0.6857 -1.0 1910826 Bionet1_004456 CCOc1ccc(NC(=O)Cn2c(nc3ccccc23)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K19 compound treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 1644095 Bionet1_004457 O=C(C1CCN(CC1)S(=O)(=O)c2ccccc2)N3CCCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K20 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1910827 Bionet1_004458 CCOc1ccccc1NC(=O)Cn2c(nc3ccccc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K21 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1660753 Bionet1_004459 CC1CN(CC(C)O1)C(=O)C2CCN(CC2)S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K22 compound treatment 0.0675 -0.00429 -0.51 -0.508 -1.0 1910828 Bionet1_004460 FC(F)(F)c1nc2ccccc2n1CC(=O)Nc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K23 mock treatment 0.0685 -0.00329 -0.39 -0.3895 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 K24 mock treatment 0.0655 -0.00629 -0.74 -0.7449 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L01 mock treatment 0.0675 -0.00429 -0.51 -0.508 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L02 mock treatment 0.0685 -0.00329 -0.39 -0.3895 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L03 compound treatment 0.0665 -0.00529 -0.63 -0.6264 -1.0 1210262 Bionet1_004461 Cc1ccc(cc1)S(=O)(=O)N2CCC(CC2)NC(=O)N3CCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L04 compound treatment 0.0675 -0.00429 -0.51 -0.508 -1.0 1910829 Bionet1_004462 Clc1ccc(/C=C/2\S/C(=N\n3cnnc3)/N(C2=O)c4ccccc4)cn1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L05 compound treatment 0.0685 -0.00329 -0.39 -0.3895 -1.0 1623157 Bionet1_004463 COc1ccc(cc1)S(=O)(=O)N2CCC(CC2)NC(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L06 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1910830 Bionet1_004464 Cc1ccc(C)n1c2ccsc2c3cc4ncc(C#N)c(n4n3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L07 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1220611 Bionet1_004465 COc1ccc(cc1)S(=O)(=O)N2CCC(CC2)NC(=O)NC(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L08 compound treatment 0.084 0.0122 1.45 1.4471 1.0 1910831 Bionet1_004466 CCN/1C(=O)/C(=C/c2ccc(NC(=O)C)cc2)/S\C1=N/n3cnnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L09 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1910832 Bionet1_004467 CCOC(=O)c1cnc(SC)nc1Oc2cc(Cl)ccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L10 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1910833 Bionet1_004468 COc1ccc(cc1)S(=O)(=O)NNC(=O)C2CC(=NO2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L11 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1910834 Bionet1_004469 COc1cc(nc(Oc2ccc(Cl)c3cccnc23)n1)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L12 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1910835 Bionet1_004470 O=C(NC1(CC2CC3CC(C2)C1)C3)/C(=C/c4cccs4)/c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L13 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1910836 Bionet1_004471 CCOC(=O)c1cnc(SC)nc1Oc2cc(Cl)c(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L14 compound treatment 0.0855 0.0137 1.62 1.6249 1.0 1910837 Bionet1_004472 Cc1onc(c1C(=O)N2CCN=C(C=C2)C(F)(F)F)c3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L15 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1910838 Bionet1_004473 CCOC(=O)c1cnc(SC)nc1Oc2ccc(Cl)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L16 compound treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 1910839 Bionet1_004474 O=C(NCCCN1CCOCC1)/C(=C/c2cccs2)/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L17 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910840 Bionet1_004475 CSc1nc2ccccc2cc1/C=N/OC(=O)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L18 compound treatment 0.0685 -0.00329 -0.39 -0.3895 -1.0 1910841 Bionet1_004476 Fc1cccc(CN2CCC(CC2)C(=O)NNC(=O)c3cccs3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L19 compound treatment 0.082 0.0102 1.21 1.2102 1.0 1910842 Bionet1_004477 Cc1cc(C)c2c(c(NC(=O)OCc3ccccc3)sc2n1)n4cccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L20 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1910843 Bionet1_004478 COc1cccc(c1)C(=O)c2c[nH]c(c2)C(=O)NCCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L21 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1328320 Bionet1_004479 COc1ccc(NC(=O)C(NC(=O)C)C(=O)NCc2ccccc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L22 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1910844 Bionet1_004480 Cc1ccc(C)n1c2sccc2c3cc4nccc(c5ccc(F)cc5)n4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L23 mock treatment 0.0735 0.00171 0.2 0.203 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 L24 mock treatment 0.067 -0.00479 -0.57 -0.5672 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M01 mock treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M02 mock treatment 0.0795 0.00771 0.91 0.9139 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M03 compound treatment 0.0655 -0.00629 -0.74 -0.7449 -1.0 1716501 Bionet1_004481 Clc1ccc(NC(=O)C2CCN(CC2)S(=O)(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M04 compound treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 1910845 Bionet1_004482 FC(F)(F)c1nc2ccccc2n1CC(=O)Nc3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M05 compound treatment 0.067 -0.00479 -0.57 -0.5672 -1.0 1594406 Bionet1_004483 COc1ccc(NC(=O)C2CCN(CC2)S(=O)(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M06 compound treatment 0.083 0.0112 1.33 1.3286 1.0 1910846 Bionet1_004484 FC(F)(F)c1nc2ccccc2n1CC(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M07 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1428687 Bionet1_004485 O=C(C1CCN(CC1)S(=O)(=O)c2ccccc2)C3C(=O)CCCC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M08 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1910847 Bionet1_004486 FC(F)(F)c1nc2ccccc2n1CC(=O)Nc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M09 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1316439 Bionet1_004487 CC1(C)CC(=O)C(C(=O)C2CCN(CC2)S(=O)(=O)c3ccccc3)C(=O)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M10 compound treatment 0.07 -0.00179 -0.21 -0.2117 -1.0 1910848 Bionet1_004488 FC(F)(F)c1nc2ccccc2n1CC(=O)Nc3ccccc3C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M11 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910849 Bionet1_004489 Clc1ccc(NC(=O)c2cnn(c2c3ccccc3)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M12 compound treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 1910850 Bionet1_004490 Cc1nc(sc1C(=O)CSc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M13 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1225671 Bionet1_004491 Cc1cccc(NC(=O)c2cnn(c2c3ccccc3)c4ccccc4)c1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M14 compound treatment 0.0695 -0.00229 -0.27 -0.271 -1.0 1910851 Bionet1_004492 Cc1nc(sc1C(=O)CSc2ccc(Cl)cc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M15 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1174308 Bionet1_004493 Cc1nc2cc(C)ccn2c1C(=O)CSc3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M16 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1910852 Bionet1_004494 Cc1nc(sc1C(=O)CSc2cccc(Cl)c2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M17 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1641329 Bionet1_004495 Cc1nc2cc(C)ccn2c1C(=O)CSc3cccc(Cl)c3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M18 compound treatment 0.0675 -0.00429 -0.51 -0.508 -1.0 1910853 Bionet1_004496 COC(=O)c1ccccc1SCC(=O)c2sc(nc2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M19 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1325357 Bionet1_004497 Cc1nc2cc(C)ccn2c1C(=O)CSc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M20 compound treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 1910854 Bionet1_004498 COc1cccc(SCC(=O)c2sc(nc2C)c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M21 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1910855 Bionet1_004499 Cc1nc2cc(C)ccn2c1C(=O)CSc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M22 compound treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 1910856 Bionet1_004500 Cc1nc(sc1C(=O)CS(=O)(=O)c2ccccc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M23 mock treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 M24 mock treatment 0.069 -0.00279 -0.33 -0.3302 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N01 mock treatment 0.0665 -0.00529 -0.63 -0.6264 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N02 mock treatment 0.0705 -0.00129 -0.15 -0.1525 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N03 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1910857 Bionet1_004501 FC(F)(F)c1nnc(nc1Oc2ccc(Cl)cc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N04 compound treatment 0.0715 -2.87E-4 -0.03 -0.034 -1.0 1910858 Bionet1_004502 COc1ccc(/C=C/2\S/C(=N\n3cnnc3)/N(C2=O)c4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N05 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910859 Bionet1_004503 CN(NC(=O)c1ccc(C)cc1)c2nc(nnc2C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N06 compound treatment 0.0805 0.00871 1.03 1.0324 1.0 1910860 Bionet1_004504 Fc1cccc(CN2CCC(CC2)C(=O)NNC(=O)c3cccc(Cl)c3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N07 compound treatment 0.078 0.00621 0.74 0.7362 1.0 1910861 Bionet1_004505 COC(=O)c1ccccc1OC(=O)Cn2c(nc3ccccc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N08 compound treatment 0.0815 0.00971 1.15 1.1509 1.0 1910862 Bionet1_004506 COc1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N09 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1263862 Bionet1_004507 COc1ccc(CNC(=O)C(NC(=O)C)C(=O)Nc2ccc(OC)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N10 compound treatment 0.081 0.00921 1.09 1.0917 1.0 1370698 Bionet1_004508 COc1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N11 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1173583 Bionet1_004509 COc1ccc(NC(=O)C(NC(=O)C)C(=O)NCc2ccccc2Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N12 compound treatment 0.076 0.00421 0.5 0.4992 1.0 1910863 Bionet1_004510 Cc1nc(sc1C(=O)/C=C/c2ccc(Oc3ccccc3)cc2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N13 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1151772 Bionet1_004511 COc1ccc(NC(=O)C(NC(=O)C)C(=O)NCc2ccccc2OC)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N14 compound treatment 0.079 0.00721 0.85 0.8547 1.0 1910864 Bionet1_004512 Cc1nc(sc1C(=O)/C=C/c2c(F)cccc2Cl)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N15 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1476122 Bionet1_004513 COc1ccc(NC(=O)C(NC(=O)C)C(=O)NCc2ccc(F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N16 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910865 Bionet1_004514 COc1ccc(/C=C/C(=O)c2sc(nc2C)c3ccccc3)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N17 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1910866 Bionet1_004515 CC(=O)Nc1ccc(OC(=O)Cn2c(nc3ccccc23)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N18 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910867 Bionet1_004516 CCCNC(=O)C(=O)c1cccn1c2c(cnn2c3ccccc3)C(=O)OCC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N19 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1910868 Bionet1_004517 CC(C)(C)c1ccc(OC(=O)Cn2c(nc3ccccc23)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N20 compound treatment 0.0755 0.00371 0.44 0.44 1.0 1910869 Bionet1_004518 COC(=O)c1sccc1n2cccc2C(=O)C(=O)Nc3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N21 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1910870 Bionet1_004519 CC(C)CC(=O)NN(C)c1nc(nnc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N22 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1910871 Bionet1_004520 COc1ccc(NC(=O)c2ccc(CNC(=O)OCC(F)(F)F)cc2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N23 mock treatment 0.0755 0.00371 0.44 0.44 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 N24 mock treatment 0.0745 0.00271 0.32 0.3215 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O01 mock treatment 0.0675 -0.00429 -0.51 -0.508 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O02 mock treatment 0.0695 -0.00229 -0.27 -0.271 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O03 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1910872 Bionet1_004521 Cc1ccc(NC(=O)Cc2nc(no2)c3cccc(c3)C(F)(F)F)c(C)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O04 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1591230 Bionet1_004522 Cc1nc(sc1C(=O)CSc2nc3ccccc3o2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O05 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1257867 Bionet1_004523 Clc1ccc(NC(=O)c2csc(Cc3ccccc3)n2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O06 compound treatment 0.075 0.00321 0.38 0.3807 1.0 1910873 Bionet1_004524 Clc1ccc(CSc2nnc(/C=C/c3ccccc3)o2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O07 compound treatment 0.078 0.00621 0.74 0.7362 1.0 1291488 Bionet1_004525 Clc1ccc(NC(=O)c2csc(Cc3ccccc3)n2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O08 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1910874 Bionet1_004526 Clc1ccc(CSc2nnc(/C=C/c3ccccc3)o2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O09 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1185400 Bionet1_004527 Clc1cc(Cl)cc(NC(=O)c2csc(Cc3ccccc3)n2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O10 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1910875 Bionet1_004528 Clc1ccc(CSc2cc3CCc4ccccc4-c3nn2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O11 compound treatment 0.0815 0.00971 1.15 1.1509 1.0 1733781 Bionet1_004529 COc1ccc(NC(=O)C2CCN(CC2)S(=O)(=O)c3ccc(C)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O12 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1910876 Bionet1_004530 Clc1ccc(CSc2cc3CCc4ccccc4-c3nn2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O13 compound treatment 0.075 0.00321 0.38 0.3807 1.0 1460748 Bionet1_004531 Cc1ccc(cc1)S(=O)(=O)N2CCC(CC2)C(=O)Nc3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O14 compound treatment 0.073 0.00121 0.14 0.1437 1.0 1910877 Bionet1_004532 Brc1ccc(cc1)S(=O)(=O)O/N=C\2/CCCc3occc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O15 compound treatment 0.075 0.00321 0.38 0.3807 1.0 1701733 Bionet1_004533 Cc1ccc(cc1)S(=O)(=O)N2CCC(CC2)C(=O)C3C(=O)CCCC3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O16 compound treatment 0.074 0.00221 0.26 0.2622 1.0 1910878 Bionet1_004534 FC(F)(F)c1nc2ccccc2n1CC(=O)NCc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O17 compound treatment 0.0815 0.00971 1.15 1.1509 1.0 1647370 Bionet1_004535 Cc1ccc(cc1)S(=O)(=O)N2CCC(CC2)C(=O)NC3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O18 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1910879 Bionet1_004536 COc1ccc(CNC(=O)Cn2c(nc3ccccc23)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O19 compound treatment 0.077 0.00521 0.62 0.6177 1.0 1235812 Bionet1_004537 Cc1ccc(cc1)S(=O)(=O)N2CCC(CC2)C(=O)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O20 compound treatment 0.08 0.00821 0.97 0.9732 1.0 1910880 Bionet1_004538 FC(F)(F)c1nc2ccccc2n1CC(=O)N3CCN(CC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O21 compound treatment 0.0815 0.00971 1.15 1.1509 1.0 1910881 Bionet1_004539 Fc1ccc(Sc2nc(nnc2C(F)(F)F)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O22 compound treatment 0.079 0.00721 0.85 0.8547 1.0 1910882 Bionet1_004540 Cc1ccc(C)n1c2ccsc2c3cc4nc(C)cc(n4n3)C(F)(F)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O23 mock treatment 0.082 0.0102 1.21 1.2102 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 O24 mock treatment 0.0755 0.00371 0.44 0.44 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P01 mock treatment 0.0655 -0.00629 -0.74 -0.7449 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P02 mock treatment 0.0575 -0.0143 -1.69 -1.6929 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P03 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1910883 Bionet1_004541 CN(NC(=O)C(C)(C)C)c1nc(nnc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P04 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1910884 Bionet1_004542 C/C(=N\OC(=O)Nc1cccc(Cl)c1)/c2sc(nc2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P05 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1910885 Bionet1_004543 FC(F)(F)c1nc2ccccc2n1CC(=O)Oc3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P06 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1910886 Bionet1_004544 C/C(=N\OC(=O)c1ccc(F)cc1)/c2sc(nc2C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P07 compound treatment 0.083 0.0112 1.33 1.3286 1.0 1910887 Bionet1_004545 FC(F)(F)c1nc2ccccc2n1CC(=O)Oc3cc(Cl)ccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P08 compound treatment 0.08 0.00821 0.97 0.9732 1.0 1516902 Bionet1_004546 Clc1ccc(Cn2cc(ccc2=O)c3nc(no3)c4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P09 compound treatment 0.0785 0.00671 0.8 0.7954 1.0 1910888 Bionet1_004547 CCCCC(=O)NN(C)c1nc(nnc1C(F)(F)F)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P10 compound treatment 0.0805 0.00871 1.03 1.0324 1.0 1656008 Bionet1_004548 Clc1ccc(Cn2cc(ccc2=O)c3nc(no3)c4ccncc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P11 compound treatment 0.0725 7.13E-4 0.08 0.0845 1.0 1910889 Bionet1_004549 FC(F)(F)c1nc2ccccc2n1CC(=O)Oc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P12 compound treatment 0.0765 0.00471 0.56 0.5585 1.0 1910890 Bionet1_004550 COC(=O)c1sc2ccccc2c1n3cccc3C(=O)C(=O)NCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P13 compound treatment 0.072 2.13E-4 0.03 0.0253 1.0 1529643 Bionet1_004551 COc1ccc(cc1)c2ccnc(n2)c3ccc(OC(=O)c4ccc(F)cc4)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P14 compound treatment 0.0705 -0.00129 -0.15 -0.1525 -1.0 1910891 Bionet1_004552 COC(=O)c1sc2ccccc2c1n3cccc3C(=O)C(=O)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P15 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1910892 Bionet1_004553 Fc1cccc(Cl)c1/C=C\2/C(OC(=O)Nc3ccccc3)C4CCN2CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P16 compound treatment 0.0735 0.00171 0.2 0.203 1.0 1245946 Bionet1_004554 Fc1ccc(cc1)N2CCN(CC2)c3cc(=O)[nH]nc3c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P17 compound treatment 0.086 0.0142 1.68 1.6841 1.0 1098329 Bionet1_004555 COc1ccc(cc1)C2C(=C(N)Oc3c2c(C)nn3c4ccccc4)C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P18 compound treatment 0.068 -0.00379 -0.45 -0.4487 -1.0 1538132 Bionet1_004556 Clc1ccc(cc1)C(=O)N2CCN(CC2)c3cc(=O)[nH]nc3c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P19 compound treatment 0.079 0.00721 0.85 0.8547 1.0 1910893 Bionet1_004557 Fc1cccc(Cl)c1COc2ccc(/C=C\3/SC(=O)NC3=O)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P20 compound treatment 0.0745 0.00271 0.32 0.3215 1.0 1910894 Bionet1_004558 Cc1ccc(CSc2nc(Cl)c3sc4nc(C)cc(C)c4c3n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P21 compound treatment 0.0815 0.00971 1.15 1.1509 1.0 1910895 Bionet1_004559 CN1C(=O)N(C)C(=O)C(=Cc2ccc(OCc3cccc(Cl)c3)cc2)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P22 compound treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 1486405 Bionet1_004560 COC(=O)C1CSC(N1C(=O)c2ccccc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P23 mock treatment 0.071 -7.87E-4 -0.09 -0.0932 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.581 P24 mock treatment 0.0655 -0.00629 -0.74 -0.7449 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A01 mock treatment 0.079 0.00572 0.68 0.6776 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A02 mock treatment 0.0775 0.00422 0.5 0.4999 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A03 compound treatment 0.08 0.00672 0.8 0.7961 1.0 1326034 Bionet1_004561 COC(=O)C1CSC(N1C(=O)c2ccc(OC)cc2)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A04 compound treatment 0.0785 0.00522 0.62 0.6184 1.0 1231839 Bionet1_004562 Cc1ccccc1Cn2nc(c3ccccc3)c(cc2=O)N4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A05 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1167778 Bionet1_004563 Cc1cc(C)c2c(n1)sc3c(nc(SCC=C)nc32)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A06 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1594179 Bionet1_004564 O=C(ON1C(=O)C2C(C3c4ccccc4C2c5ccccc35)C1=O)C6CC6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A07 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1910896 Bionet1_004565 Cc1ccc(cc1)S(=O)(=O)CC(=O)Nc2ccc(cc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A08 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1910897 Bionet1_004566 Cc1ccc(cc1)C(=O)NNC(=O)C(=O)c2c([nH]c3ccccc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A09 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1910898 Bionet1_004567 O=C(CS(=O)(=O)c1ccccc1)Nc2ccc(cc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A10 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1910899 Bionet1_004568 Fc1ccc(CON2C(=O)C3C(C4c5ccccc5C3c6ccccc46)C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A11 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1910900 Bionet1_004569 COC(=O)c1ccccc1SCC(=O)Nc2ccc(cc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A12 compound treatment 0.086 0.0127 1.51 1.507 1.0 1514147 Bionet1_004570 C(Sc1nc(N2CCCC2)c3sc4ccccc4c3n1)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A13 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1675788 Bionet1_004571 Clc1ccc(cc1)S(=O)(=O)Nc2ccc(cc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A14 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1197433 Bionet1_004572 Cc1ccc(CSc2nc(NCC=C)c3sc4ccccc4c3n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A15 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1910901 Bionet1_004573 CSc1nc2ccccc2cc1/C=C(\C#N)/c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A16 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1506850 Bionet1_004574 Cc1ccc(CSc2nc(NC3CC3)c4sc5ccccc5c4n2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A17 compound treatment 0.0795 0.00622 0.74 0.7369 1.0 1910902 Bionet1_004575 CSc1nc2ccccc2cc1/C=C(\C#N)/c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A18 compound treatment 0.069 -0.00428 -0.51 -0.5073 -1.0 1910903 Bionet1_004576 COC(=O)c1ccccc1Sc2nc(SC)nc3c4ccccc4sc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A19 compound treatment 0.08 0.00672 0.8 0.7961 1.0 1910904 Bionet1_004577 CSc1nc2ccccc2cc1/C=C(\C#N)/c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A20 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1910905 Bionet1_004578 CSc1nc(Sc2ccc(F)cc2)c3sc4ccccc4c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A21 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1910906 Bionet1_004579 COc1ccc(cc1OC)/C(=C/c2cc3ccccc3nc2SC)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A22 compound treatment 0.079 0.00572 0.68 0.6776 1.0 1910907 Bionet1_004580 CSc1nc(Oc2ccc3ccccc3c2)c4sc5ccccc5c4n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A23 mock treatment 0.0855 0.0122 1.45 1.4478 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 A24 mock treatment 0.0805 0.00722 0.86 0.8554 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B01 mock treatment 0.0765 0.00322 0.38 0.3814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B02 mock treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B03 compound treatment 0.083 0.00972 1.15 1.1516 1.0 1910908 Bionet1_004581 CCCc1c(C)nc2cc(nn2c1C)c3sccc3n4c(C)ccc4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B04 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1237533 Bionet1_004582 Cc1cccc(c1)c2nc(SCc3cccc(F)c3)c(C#N)c4CCCCc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B05 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1910909 Bionet1_004583 COCc1cc(O)n2nc(cc2n1)c3sccc3n4c(C)ccc4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B06 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1699363 Bionet1_004584 COC(=O)CSc1nc(c2cccc(C)c2)c3CCCCc3c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B07 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1910910 Bionet1_004585 COCCNC(=O)C1CCC(=O)N(C2CCCCC2)C1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B08 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1910911 Bionet1_004586 COC(=O)C1CCN(CC1)C(=O)CC(NC(=O)C(F)(F)F)c2cccs2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B09 compound treatment 0.069 -0.00428 -0.51 -0.5073 -1.0 1311118 Bionet1_004587 CCOC(=O)NC(C1COc2ccccc2C1=O)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B10 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1143750 Bionet1_004588 Cc1nc2c(cnn2c(N)c1c3ccc(F)cc3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B11 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1910912 Bionet1_004589 Cc1ccc(C)n1c2ccsc2c3cc4nccc(c5ccc(F)cc5)n4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B12 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1304964 Bionet1_004590 COc1ccc(cc1)c2cnn(c2N)c3nc(cs3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B13 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1910913 Bionet1_004591 COc1cc2NC(=S)N3C(CC4CCCCC4)C(=O)N=C3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B14 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1910914 Bionet1_004592 COC(=O)C(/C=N/Nc1ncc(cc1Cl)C(F)(F)F)n2cncn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B15 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1193808 Bionet1_004593 Fc1ccccc1N2CCN(CC2)C(=O)C3Cc4c(O3)ccc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B16 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1910915 Bionet1_004594 Cc1ccc(C)n1c2ccsc2c3cc4ncc(cn4n3)c5ccc(C)cc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B17 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1910916 Bionet1_004595 FC(F)(F)c1cnc(CC(=O)Nc2cccnc2Cl)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B18 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1910917 Bionet1_004596 FC(F)(F)c1cnc(CC(=O)Nc2cccc(Br)c2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B19 compound treatment 0.079 0.00572 0.68 0.6776 1.0 1910918 Bionet1_004597 [O-][N+](=O)c1ccc(C/2CCCC\C2=N/OC(=O)C3CCCC3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B20 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1910919 Bionet1_004598 FC(F)(F)C(=O)C/C(=N\Nc1nc(cs1)c2ccccc2)/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B21 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1910920 Bionet1_004599 [O-][N+](=O)c1ccc(C/2CCCC\C2=N/OC(=O)C3CCCCC3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B22 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1279709 Bionet1_004600 Cc1c(C)c(OCC(=O)c2ccc(Cl)cc2)ccc1Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B23 mock treatment 0.0785 0.00522 0.62 0.6184 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 B24 mock treatment 0.0755 0.00222 0.26 0.2629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C01 mock treatment 0.0745 0.00122 0.14 0.1444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C02 mock treatment 0.078 0.00472 0.56 0.5591 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C03 compound treatment 0.079 0.00572 0.68 0.6776 1.0 1577911 Bionet1_004601 Cc1cc(C)c2c(n1)sc3c(Oc4ccccc4)nc(SCC=C)nc32 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C04 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1910921 Bionet1_004602 Cc1ccc(cc1)C(=O)NNC(=O)c2cc3cc4ccccc4nc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C05 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1514812 Bionet1_004603 Cc1cccc(Oc2nc(SCC=C)nc3c2sc4nc(C)cc(C)c43)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C06 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1910922 Bionet1_004604 Clc1cccc(c1)C(=O)NNC(=O)c2cc3cc4ccccc4nc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C07 compound treatment 0.0825 0.00922 1.09 1.0923 1.0 1910923 Bionet1_004605 CCSc1nc(Sc2ccccc2)c3sc4nc(C)cc(C)c4c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C08 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1910924 Bionet1_004606 Cn1nc(c(/C=C(\C#N)/c2ccc(Cl)c(Cl)c2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C09 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1910925 Bionet1_004607 Clc1cccc(Cl)c1CSc2nnc(/C=C/c3ccccc3)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C10 compound treatment 0.08 0.00672 0.8 0.7961 1.0 1910926 Bionet1_004608 Fc1ccc(cc1)C(=O)NNC(=O)c2cc3cc4ccccc4nc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C11 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1910927 Bionet1_004609 COC(=O)c1ccc(CSc2nnc(/C=C/c3ccccc3)o2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C12 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1910928 Bionet1_004610 Cc1cccc(c1)C(=O)NNC(=O)c2cc3cc4ccccc4nc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C13 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1910929 Bionet1_004611 CCn1c(SCc2ccc(Cl)c(Cl)c2)nnc1/C=C/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C14 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1910930 Bionet1_004612 COc1ccc(cc1OC)/C(=C/c2c(Cl)n(C)nc2C(F)(F)F)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C15 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1605754 Bionet1_004613 Cc1ccc(cc1)C(=O)Nc2ccc(N3CCN(CC3)c4ccccc4)c(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C16 compound treatment 0.0795 0.00622 0.74 0.7369 1.0 1910931 Bionet1_004614 CC(C(=O)Nc1cc(C)cc(C)n1)n2c(nc3ccccc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C17 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1477371 Bionet1_004615 Fc1ccc(cc1)C(=O)Nc2ccc(N3CCN(CC3)c4ccccc4)c(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C18 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1910932 Bionet1_004616 CC(C(=O)Nc1ccc(F)cc1F)n2c(nc3ccccc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C19 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1637918 Bionet1_004617 Cc1cccc(c1)C(=O)Nc2ccc(N3CCN(CC3)c4ccccc4)c(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C20 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1550909 Bionet1_004618 CS(=O)(=O)N1CCN(CC1)c2ccc(NC(=O)c3cccs3)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C21 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1480987 Bionet1_004619 Fc1cc(NC(=O)Cc2ccccc2)ccc1N3CCN(CC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C22 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1476598 Bionet1_004620 Cc1ccc(cc1)C(=O)Nc2ccc(N3CCN(CC3)S(=O)(=O)C)c(F)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C23 mock treatment 0.075 0.00172 0.2 0.2037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 C24 mock treatment 0.0765 0.00322 0.38 0.3814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D01 mock treatment 0.0775 0.00422 0.5 0.4999 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D02 mock treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D03 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1910933 Bionet1_004621 [O-][N+](=O)c1ccc(C/2CCCC\C2=N/OC(=O)c3ccco3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D04 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1910934 Bionet1_004622 Fc1ccc(cc1)c2cnn3c(cc(nc23)c4cccc(Cl)c4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D05 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1910935 Bionet1_004623 COc1cccc(c1)c2onc3ccc(cc23)C(=O)/C=C/c4ccc(C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D06 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1910936 Bionet1_004624 Nc1c(cnn1c2nc(cs2)c3ccccc3F)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D07 compound treatment 0.0865 0.0132 1.57 1.5663 1.0 1910937 Bionet1_004625 CC(Oc1ccc(Cl)cc1Cl)c2ccnc3c(Cl)c(C)nn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D08 compound treatment 0.0805 0.00722 0.86 0.8554 1.0 1558024 Bionet1_004626 O=C(NCc1ccccc1)c2ccccc2C(=O)c3ccc4OCC(=O)Nc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D09 compound treatment 0.0785 0.00522 0.62 0.6184 1.0 1910938 Bionet1_004627 Cc1cc(C)n(n1)c2nc(c(Sc3ccc(Cl)cc3)s2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D10 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1910939 Bionet1_004628 Cc1ccccc1CSc2nc(c3CCCc3c2C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D11 compound treatment 0.0845 0.0112 1.33 1.3293 1.0 1910940 Bionet1_004629 Cc1ccccc1C(=O)O/N=C/2\CCCCC2c3ccc(cc3[N+](=O)[O-])[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D12 compound treatment 0.0815 0.00822 0.97 0.9738 1.0 1910941 Bionet1_004630 Fc1cccc(Cl)c1CSc2nc(c3CCCc3c2C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D13 compound treatment 0.081 0.00772 0.91 0.9146 1.0 1910942 Bionet1_004631 [O-][N+](=O)c1ccc(C/2CCCC\C2=N/OC(=O)c3ccccc3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D14 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1910943 Bionet1_004632 Clc1cccc(CSc2nc(c3CCCc3c2C#N)c4ccccc4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D15 compound treatment 0.0795 0.00622 0.74 0.7369 1.0 1120862 Bionet1_004633 O=C(COc1cccc2c(OCC(=O)c3ccccc3)cccc12)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D16 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1910944 Bionet1_004634 COC(=O)CC1COc2ccccc2N1C(=O)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D17 compound treatment 0.0825 0.00922 1.09 1.0923 1.0 1374274 Bionet1_004635 CC(N1C(C(C)N(C)C1=O)c2ccccc2)S(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D18 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1910945 Bionet1_004636 Cc1ccc(cc1)c2nc(SCc3cccc(C)c3)c(C#N)c4CCCCc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D19 compound treatment 0.0795 0.00622 0.74 0.7369 1.0 1910946 Bionet1_004637 COC(=O)CC(NC(=O)c1ccccc1F)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D20 compound treatment 0.0785 0.00522 0.62 0.6184 1.0 1910947 Bionet1_004638 CC(C)(C)c1ccc(cc1)c2nc(SCc3ccccc3)c(C#N)c4CCCc42 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D21 compound treatment 0.0805 0.00722 0.86 0.8554 1.0 1910948 Bionet1_004639 COC(=O)CC(NC(=O)c1ccco1)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D22 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1443206 Bionet1_004640 Cc1cc(C)cc(NC(=O)Cc2ccc(OC(=O)c3ccccc3C)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D23 mock treatment 0.077 0.00372 0.44 0.4406 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 D24 mock treatment 0.078 0.00472 0.56 0.5591 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E01 mock treatment 0.0755 0.00222 0.26 0.2629 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E02 mock treatment 0.077 0.00372 0.44 0.4406 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E03 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1910949 Bionet1_004641 Fc1ccc(CSc2nnc(/C=C/c3ccccc3)n2CC=C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E04 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1207756 Bionet1_004642 CS(=O)(=O)N1CCN(CC1)c2ccccc2NC(=O)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E05 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1910950 Bionet1_004643 CCn1c(SCc2cccc(c2)[N+](=O)[O-])nnc1/C=C/c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E06 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1281345 Bionet1_004644 CS(=O)(=O)N1CCN(CC1)c2ccccc2NC(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E07 compound treatment 0.0885 0.0152 1.8 1.8033 1.0 1667059 Bionet1_004645 OC(COc1ccccc1C#N)CS(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E08 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1418904 Bionet1_004646 Cc1cccc(c1)C(=O)Nc2ccccc2N3CCN(CC3)S(=O)(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E09 compound treatment 0.08 0.00672 0.8 0.7961 1.0 1306452 Bionet1_004647 OC(COc1ccc(F)cc1Cl)CS(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E10 compound treatment 0.084 0.0107 1.27 1.2701 1.0 1180995 Bionet1_004648 CS(=O)(=O)N1CCN(CC1)c2ccccc2NC(=O)c3cccs3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E11 compound treatment 0.0825 0.00922 1.09 1.0923 1.0 1729255 Bionet1_004649 OC(COc1ccc(C#N)cc1)CS(=O)(=O)c2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E12 compound treatment 0.0885 0.0152 1.8 1.8033 1.0 1910951 Bionet1_004650 Clc1ccc(C(=O)c2cc3cc4ccccc4nc3s2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E13 compound treatment 0.0815 0.00822 0.97 0.9738 1.0 1522784 Bionet1_004651 Cc1ccc(cc1)S(=O)(=O)CC(O)COc2ccc(F)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E14 compound treatment 0.08 0.00672 0.8 0.7961 1.0 1329072 Bionet1_004652 CN1CCN(CC1)c2ccc(NC(=O)CSc3ccc(Cl)cc3)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E15 compound treatment 0.08 0.00672 0.8 0.7961 1.0 1400891 Bionet1_004653 Cc1ccc(c(C)c1)S(=O)(=O)CC(O)COc2ccc(F)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E16 compound treatment 0.0805 0.00722 0.86 0.8554 1.0 1273257 Bionet1_004654 COc1ccc(SCC(=O)Nc2ccc(N3CCN(C)CC3)c(F)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E17 compound treatment 0.0785 0.00522 0.62 0.6184 1.0 1140815 Bionet1_004655 COc1ccccc1S(=O)(=O)CC(O)COc2ccc(F)cc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E18 compound treatment 0.081 0.00772 0.91 0.9146 1.0 1719581 Bionet1_004656 CN1CCN(CC1)c2ccc(NC(=O)CSc3ccc(C)cc3C)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E19 compound treatment 0.0785 0.00522 0.62 0.6184 1.0 1662007 Bionet1_004657 COc1ccccc1S(=O)(=O)CC(O)COc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E20 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1910952 Bionet1_004658 Cc1ccc(SCC(=O)Nc2ccc(N3CCOCC3)c(F)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E21 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1910953 Bionet1_004659 CC(=O)N1C(C)(C)CC(=NOC(=O)c2cccc(c2)C(F)(F)F)CC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E22 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1910954 Bionet1_004660 COc1ccccc1N2CCN(CC2)/C(=C/C(=O)Nc3ccccc3C)/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E23 mock treatment 0.076 0.00272 0.32 0.3221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 E24 mock treatment 0.074 7.19E-4 0.09 0.0852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F01 mock treatment 0.0765 0.00322 0.38 0.3814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F02 mock treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F03 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1623599 Bionet1_004661 COC(=O)c1ccc(NS(=O)(=O)c2ccc(OC)cc2)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F04 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1910955 Bionet1_004662 COC(=O)/C(=C\Nc1ccc(OCc2ccccc2)cc1)/n3cncn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F05 compound treatment 0.084 0.0107 1.27 1.2701 1.0 1910956 Bionet1_004663 Cc1ccc2SCC/C(=N\OC(=O)c3cccc(c3)C(F)(F)F)/c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F06 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1910957 Bionet1_004664 Cc1cc(n(n1)c2nc(c(CC(=O)NN)s2)c3ccccc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F07 compound treatment 0.0815 0.00822 0.97 0.9738 1.0 1649261 Bionet1_004665 Clc1ccc(cc1Cl)C(=O)Nc2cccc(Cl)c2N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F08 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1910958 Bionet1_004666 Cc1cc2nc(cc(n2n1)C(F)(F)Cl)c3ccc(cc3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F09 compound treatment 0.0805 0.00722 0.86 0.8554 1.0 1910959 Bionet1_004667 [O-][N+](=O)c1cccc(c1)C(=O)Nc2cccc(Cl)c2N3CCCCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F10 compound treatment 0.0795 0.00622 0.74 0.7369 1.0 1910960 Bionet1_004668 Cc1nn2c(cc(nc2c1Cl)c3ccc(cc3)C(F)(F)F)C(F)(F)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F11 compound treatment 0.0805 0.00722 0.86 0.8554 1.0 1910961 Bionet1_004669 FC(F)(F)c1cccc(OCc2nnc(S)n2c3ccccc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F12 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1345982 Bionet1_004670 COC(=O)c1sccc1n2cc(nn2)C(=O)c3ccc(cc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F13 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1910962 Bionet1_004671 CSc1nnc(COc2cccc(c2)C(F)(F)F)n1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F14 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1910963 Bionet1_004672 COC(=O)C/1=C(C)N(CCc2ccc(OC)c(OC)c2)C(=O)\C1=C/N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F15 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1910964 Bionet1_004673 NC(=O)CSc1nnc(COc2cccc3ccccc23)n1c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F16 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1319443 Bionet1_004674 Cc1ccc(C)n1c2ccsc2c3cc4nccc(c5cccnc5)n4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F17 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1280661 Bionet1_004675 OC(COc1ccc(C#N)cc1)CN2CCN(CC2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F18 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1910965 Bionet1_004676 Cc1nn(c(C)c1Cl)c2nc(c(Cl)s2)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F19 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1910966 Bionet1_004677 FC(F)(F)c1ccc(cc1)C(=O)Nc2ccc(nc2)N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F20 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1910967 Bionet1_004678 FC(F)(F)C1=NCCN(C=C1)S(=O)(=O)c2ccc3ccccc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F21 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1678897 Bionet1_004679 Cc1ccc2SCC(NC(=O)c3ccc(Cl)cc3Cl)C(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F22 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1910968 Bionet1_004680 CCC(CC)C(=O)c1c[nH]c(c1)C(=O)NCc2cccc(c2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F23 mock treatment 0.0735 2.19E-4 0.03 0.0259 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 F24 mock treatment 0.076 0.00272 0.32 0.3221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G01 mock treatment 0.0675 -0.00578 -0.69 -0.685 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G02 mock treatment 0.066 -0.00728 -0.86 -0.8628 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G03 compound treatment 0.0685 -0.00478 -0.57 -0.5665 -1.0 1910969 Bionet1_004681 CC(=O)N1C(C)(C)CC(=NOS(=O)(=O)c2ccccc2)CC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G04 compound treatment 0.069 -0.00428 -0.51 -0.5073 -1.0 1910970 Bionet1_004682 COC(=O)C(CSC1=NCCS1)NC(=O)OCc2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G05 compound treatment 0.068 -0.00528 -0.63 -0.6258 -1.0 1910971 Bionet1_004683 COc1ccc(cc1)S(=O)(=O)ON=C2CC(C)(C)N(C(=O)C)C(C)(C)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G06 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1307047 Bionet1_004684 Clc1ccc(COc2ccc(cc2)c3ccnc4ncnn34)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G07 compound treatment 0.079 0.00572 0.68 0.6776 1.0 1910972 Bionet1_004685 CC(=O)N1C(C)(C)CC(=NOS(=O)(=O)c2ccc(Cl)cc2)CC1(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G08 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1488121 Bionet1_004686 Cc1cc2nccc(c3ccc(OCc4ccc(Cl)cc4Cl)cc3)n2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G09 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1186461 Bionet1_004687 OC(COc1ccccc1Cl)CS(=O)(=O)Cc2ccc(Cl)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G10 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1497423 Bionet1_004688 O=C(COc1ccc(cc1)c2nccc(n2)c3cccs3)N4CCCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G11 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1480218 Bionet1_004689 OC(COc1ccccc1Cl)CS(=O)(=O)Cc2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G12 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1426075 Bionet1_004690 COc1ccc(NC(=O)C(CC(C)C)N2Cc3ccccc3C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G13 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1567341 Bionet1_004691 Cc1ccc(SCC2(O)CCN(CC2)C(=O)c3ccc(Cl)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G14 compound treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 1569471 Bionet1_004692 COc1cccc(c1)C(=O)Nc2ccc(I)cn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G15 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1556473 Bionet1_004693 COc1cccc(SCC2(O)CCN(CC2)C(=O)c3ccc(Cl)cc3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G16 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1315474 Bionet1_004694 COc1cccc(c1)C(=O)Nc2ncc(I)cc2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G17 compound treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 1910973 Bionet1_004695 COC(=O)C/1=C(C)N(CCc2c[nH]c3ccccc23)C(=O)\C1=C/N(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G18 compound treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 1910974 Bionet1_004696 Cc1ccc(NC(=O)C(Cc2ccccc2)N3CCS(=O)(=O)CC3)cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G19 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1910975 Bionet1_004697 FC(F)(F)c1cccc(c1)N2CCN(CC2)C3CCc4[nH]ccc4C3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G20 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1910976 Bionet1_004698 CCCCCC1CCC(CC1)c2ccc(NC(=O)c3ccc(cc3)[N+](=O)[O-])cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G21 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1910977 Bionet1_004699 FC(F)(F)c1ccc(COc2ccc(cc2)c3ncc4C(=O)CCCc4n3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G22 compound treatment 0.069 -0.00428 -0.51 -0.5073 -1.0 1268980 Bionet1_004700 O=C(COc1ccc(cc1)c2nccc(n2)c3ccccn3)NC4CCCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G23 mock treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 G24 mock treatment 0.069 -0.00428 -0.51 -0.5073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H01 mock treatment 0.074 7.19E-4 0.09 0.0852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H02 mock treatment 0.069 -0.00428 -0.51 -0.5073 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H03 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1910978 Bionet1_004701 COc1ccc(cc1)S(=O)(=O)O/N=C/2\CCSc3ccc(C)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H04 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1910979 Bionet1_004702 COC(=O)c1sccc1n2nnc(C(=O)c3ccc(Cl)cc3Cl)c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H05 compound treatment 0.082 0.00872 1.03 1.0331 1.0 1910980 Bionet1_004703 Cc1ccc2SCC/C(=N\OS(=O)(=O)c3ccc(Cl)cc3)/c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H06 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1910981 Bionet1_004704 CSc1nc2nc(C)c(Cc3cccc(c3)C(F)(F)F)c(C)n2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H07 compound treatment 0.084 0.0107 1.27 1.2701 1.0 1411497 Bionet1_004705 Cc1ccc2SCC(NC(=O)c3ccc(Cl)c(Cl)c3)C(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H08 compound treatment 0.0785 0.00522 0.62 0.6184 1.0 1910982 Bionet1_004706 COC(=O)c1sccc1n2cc(nn2)C(=O)C(C)Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H09 compound treatment 0.0815 0.00822 0.97 0.9738 1.0 1910983 Bionet1_004707 [O-][N+](=O)c1cccc(c1)C(=O)Nc2cc(Cl)ccc2N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H10 compound treatment 0.0815 0.00822 0.97 0.9738 1.0 1613707 Bionet1_004708 O=C1CC(C(C(=O)C1C2NCCc3ccccc23)n4cncn4)c5ccco5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H11 compound treatment 0.079 0.00572 0.68 0.6776 1.0 1508254 Bionet1_004709 CN1CCN(CC1)c2ccc(Cl)cc2NC(=O)c3ccc(Cl)c(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H12 compound treatment 0.082 0.00872 1.03 1.0331 1.0 1910984 Bionet1_004710 Cc1ccc(C)n1c2ccsc2c3cc4nccc(n4n3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H13 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1910985 Bionet1_004711 CN1CCN(CC1)c2ccc(Cl)cc2NC(=O)c3cccc(c3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H14 compound treatment 0.0785 0.00522 0.62 0.6184 1.0 1670767 Bionet1_004712 CCC(CC)C(=O)c1c[nH]c(c1)C(=O)N2CCN(CC2)c3ccc(OC)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H15 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1181310 Bionet1_004713 CN1CCN(CC1)c2ccc(Cl)cc2NC(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H16 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1910986 Bionet1_004714 Cc1ccccc1C(=O)c2c[nH]c(c2)C(=O)NCCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H17 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1638690 Bionet1_004715 Clc1ccc(C(=O)Nc2cc(Cl)ccc2N3CCCCCC3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H18 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1271631 Bionet1_004716 CCC(CC)C(=O)c1c[nH]c(c1)C(=O)N2CCN(CC2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H19 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1910987 Bionet1_004717 CCn1c(COc2cccc(c2)C(F)(F)F)nnc1SCC(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H20 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1910988 Bionet1_004718 Cc1ccccc1C(=O)c2c[nH]c(c2)C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H21 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1692808 Bionet1_004719 OC(COc1ccc(C#N)cc1)CN2CCN(CC2)c3ccc(F)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H22 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1910989 Bionet1_004720 O=C(Cc1ccccc1)c2c[nH]c(c2)C(=O)NCCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H23 mock treatment 0.075 0.00172 0.2 0.2037 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 H24 mock treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I01 mock treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I02 mock treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I03 compound treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 1407517 Bionet1_004721 Fc1cccc(Cl)c1COc2ccc(cc2)c3ccnc4ncnn34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I04 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1133771 Bionet1_004722 O=C(COc1ccc(cc1)c2nccc(n2)c3ccccn3)NCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I05 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1349838 Bionet1_004723 O=C(COc1ccc(cc1)c2nccc(n2)c3cccs3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I06 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1910990 Bionet1_004724 Fc1cc(Oc2ccccc2C=C3C(=O)NC(=O)NC3=O)ccc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I07 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1910991 Bionet1_004725 Cc1ccc(NC(=O)Cc2ncc(cc2Cl)C(F)(F)F)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I08 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1910992 Bionet1_004726 ClC1=C(NC(=O)OCCCc2ccccc2)C(=O)c3ccccc3C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I09 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1655921 Bionet1_004727 Cc1cccc(n1)n2cnc(c2)C(=O)Nc3ccc(cc3)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I10 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1910993 Bionet1_004728 [O-][N+](=O)c1ccc(C/2CCCC\C2=N\OCc3ccccc3F)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I11 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1288077 Bionet1_004729 Cc1cccc(n1)n2cnc(c2)C(=O)N3CCN(CC3)c4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I12 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1910994 Bionet1_004730 [O-][N+](=O)c1ccc(C/2CCCC\C2=N\OCc3ccc(F)cc3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I13 compound treatment 0.06 -0.0133 -1.57 -1.5737 -1.0 1910995 Bionet1_004731 FC(F)(F)c1nc2cc(Cl)c(Cl)cc2nc1Oc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I14 compound treatment 0.068 -0.00528 -0.63 -0.6258 -1.0 1910996 Bionet1_004732 [O-][N+](=O)c1cc(cc([N+](=O)[O-])c1NCCN2CCNCC2)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I15 compound treatment 0.069 -0.00428 -0.51 -0.5073 -1.0 1910997 Bionet1_004733 Cc1ccc(C)n1c2ccsc2c3cc4nccc(c5ccccc5)n4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I16 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1910998 Bionet1_004734 [O-][N+](=O)c1ccc(COC(=O)NC2=C(Cl)C(=O)c3ccccc3C2=O)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I17 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1910999 Bionet1_004735 COCc1cc(O)n2nc(cc2n1)c3ccsc3n4c(C)ccc4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I18 compound treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 1911000 Bionet1_004736 CC(=O)N1CCC(CC1)C(=O)NNc2ncc(cc2Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I19 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1911001 Bionet1_004737 CC(=O)C1=C(C)NC(=C(C1c2ccc(F)cc2)C(=O)OCc3ccccc3)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I20 compound treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 1911002 Bionet1_004738 Fc1ccc(C/N=C/c2ccn(c2)c3ccc(Br)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I21 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1911003 Bionet1_004739 Fc1ccc(OC(=O)/C=C/c2cc3OCOc3cc2Br)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I22 compound treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 1911004 Bionet1_004740 Clc1ccc(/N=C/c2ccn(c2)c3ccc(Br)cc3)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I23 mock treatment 0.07 -0.00328 -0.39 -0.3888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 I24 mock treatment 0.068 -0.00528 -0.63 -0.6258 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J01 mock treatment 0.074 7.19E-4 0.09 0.0852 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J02 mock treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J03 compound treatment 0.082 0.00872 1.03 1.0331 1.0 1911005 Bionet1_004741 CO/N=C/c1ccc(N2CCN(CC2)C(=O)c3ccc(F)cc3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J04 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1651261 Bionet1_004742 Cc1ccccc1C(=O)c2c[nH]c(c2)C(=O)N3CCN(CC3)c4ccccc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J05 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1911006 Bionet1_004743 CO/N=C/c1ccc(N2CCN(CC2)C(=O)c3ccc(C)cc3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J06 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1298358 Bionet1_004744 CCn1cc(n(Cc2ccccc2C)c1=O)S(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J07 compound treatment 0.08 0.00672 0.8 0.7961 1.0 1911007 Bionet1_004745 CO/N=C/c1ccc(N2CCN(CC2)C(=O)c3cccs3)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J08 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1476365 Bionet1_004746 Fc1ccc(cc1)N2CCN(Cc3cnc(s3)N4CCOCC4)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J09 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1911008 Bionet1_004747 Clc1ccc(c(Cl)c1)S(=O)(=O)Nc2ccc(cc2)n3cccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J10 compound treatment 0.081 0.00772 0.91 0.9146 1.0 1911009 Bionet1_004748 FC(F)(F)c1cccc(NC(=O)Nc2nccc(n2)c3cccs3)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J11 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1911010 Bionet1_004749 FC(F)(F)c1c(cnn1c2ccccc2)C(=O)N3CCN(CC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J12 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1911011 Bionet1_004750 Cc1cc(n(n1)c2nc(cs2)c3ccc(cc3)[N+](=O)[O-])C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J13 compound treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 1911012 Bionet1_004751 COc1ccc(NC(=O)c2cnn(c2C(F)(F)F)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J14 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1372053 Bionet1_004752 CCOC(=O)c1cnc(SC)nc1Oc2cccc(NS(=O)(=O)C)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J15 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1911013 Bionet1_004753 CO/N=C\c1ccc(Sc2c(Cl)cccc2Cl)c(c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J16 compound treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 1911014 Bionet1_004754 CC(OC(=O)Nc1ccccc1)c2sc(nc2C)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J17 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1911015 Bionet1_004755 CO/N=C/c1cc(ccc1Sc2c(Cl)cccc2Cl)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J18 compound treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 1190390 Bionet1_004756 CCSc1nc(Oc2ccc(C)cc2)c3sc4nc(C)cc(C)c4c3n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J19 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1911016 Bionet1_004757 CO/N=C/c1cc(ccc1Sc2cccc(Cl)c2Cl)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J20 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1911017 Bionet1_004758 Clc1ccc(CSc2nc3ccccc3cc2/C=N/OC(=O)C4CC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J21 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1637414 Bionet1_004759 Cc1ccc(C)n1c2ccccc2CNS(=O)(=O)Cc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J22 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1911018 Bionet1_004760 Fc1ccc(CNC(=O)c2cc(c[nH]2)C(=O)c3cccc(c3)C(F)(F)F)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J23 mock treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 J24 mock treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K01 mock treatment 0.07 -0.00328 -0.39 -0.3888 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K02 mock treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K03 compound treatment 0.07 -0.00328 -0.39 -0.3888 -1.0 1911019 Bionet1_004761 Fc1ccc(OC(=O)/C=C/c2cc3OCOc3cc2Br)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K04 compound treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 1911020 Bionet1_004762 CCc1ccc(CSC2=Nc3cc(OC)c(OC)cc3C4=NC(=O)CN42)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K05 compound treatment 0.07 -0.00328 -0.39 -0.3888 -1.0 1911021 Bionet1_004763 Fc1cccc(OC(=O)/C=C/c2cc3OCOc3cc2Br)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K06 compound treatment 0.068 -0.00528 -0.63 -0.6258 -1.0 1911022 Bionet1_004764 COc1cc2N=C(SCc3ccccc3F)N4CC(=O)N=C4c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K07 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1911023 Bionet1_004765 Clc1ccc(NC(=O)NNC(=O)C2CC(=NO2)c3cccs3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K08 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1911024 Bionet1_004766 COc1cc2N=C(SCCC(=C(F)F)F)N3CC(=O)N=C3c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K09 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1911025 Bionet1_004767 Clc1cccc(OC(=O)/C=C/c2cc3OCOc3cc2Br)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K10 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1341233 Bionet1_004768 O=C(C1CCC(=O)N(C2CCCCC2)C1c3ccccc3)n4ccnc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K11 compound treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 1676386 Bionet1_004769 COc1ccc(CNC(=O)c2c(C)onc2c3ccccc3Cl)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K12 compound treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 1458254 Bionet1_004770 Cc1cc2nccc(c3ccccc3OCc4ccc(Cl)cc4)n2n1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K13 compound treatment 0.068 -0.00528 -0.63 -0.6258 -1.0 1911026 Bionet1_004771 FC(F)(F)C1=NCCN(C=C1)S(=O)(=O)c2ccc(Br)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K14 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1125401 Bionet1_004772 Clc1ccc(COc2ccccc2c3ccn(n3)C(=O)c4cccs4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K15 compound treatment 0.07 -0.00328 -0.39 -0.3888 -1.0 1911027 Bionet1_004773 Clc1cccc(c1)C(=O)NNC(=O)c2cc3c(ccc4ccccc34)o2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K16 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1440171 Bionet1_004774 Clc1ccc(COc2ccccc2c3ccnc4c(C#N)cnn34)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K17 compound treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 1911028 Bionet1_004775 COc1ccc(CNc2ccc(cc2[N+](=O)[O-])C(F)(F)F)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K18 compound treatment 0.0685 -0.00478 -0.57 -0.5665 -1.0 1191209 Bionet1_004776 Cc1ccc(Cn2ccc(n2)c3ccccc3OCc4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K19 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1394166 Bionet1_004777 Clc1ccc(cc1Cl)S(=O)(=O)Nc2ccc3nccnc3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K20 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1265290 Bionet1_004778 Fc1ccc(Cn2ccc(n2)c3ccccc3OCc4ccc(Cl)cc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K21 compound treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 1911029 Bionet1_004779 COC(=O)CC(NC(=O)Nc1ccc(C)cc1)c2cccc(c2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K22 compound treatment 0.0685 -0.00478 -0.57 -0.5665 -1.0 1472238 Bionet1_004780 Clc1ccc(COc2ccccc2c3ccnc(n3)c4ccncc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K23 mock treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 K24 mock treatment 0.0685 -0.00478 -0.57 -0.5665 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L01 mock treatment 0.076 0.00272 0.32 0.3221 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L02 mock treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L03 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1204451 Bionet1_004781 Cc1ccc(C)n1c2ccccc2CNS(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L04 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1911030 Bionet1_004782 FC(F)(F)c1cccc(c1)C(=O)c2c[nH]c(c2)C(=O)NCC3CCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L05 compound treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 1911031 Bionet1_004783 Fc1ccc(NC(=O)c2cnn(c2C(F)(F)F)c3ccccc3)c(F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L06 compound treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 1911032 Bionet1_004784 FC(F)(F)c1cccc(c1)C(=O)c2c[nH]c(c2)C(=O)NCCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L07 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1183297 Bionet1_004785 Clc1ccc(CSc2nnc3c4ccccc4[nH]c3n2)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L08 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1118867 Bionet1_004786 CC(C)(C)c1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L09 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1911033 Bionet1_004787 Clc1ccc(cc1)c2nc3sc4CCCCc4n3c2/C=N/OC(=O)C5CC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L10 compound treatment 0.079 0.00572 0.68 0.6776 1.0 1123564 Bionet1_004788 CC(C)(C)c1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L11 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1670271 Bionet1_004789 Clc1cccc(Cl)c1Cn2nc-3c(CCc4ccccc43)cc2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L12 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1911034 Bionet1_004790 FC(F)(F)c1cccc(c1)C(=O)c2c[nH]c(c2)C(=O)NCc3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L13 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1911035 Bionet1_004791 Clc1ccc(/C=C/c2nnc(SCc3ccccc3)o2)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L14 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1911036 Bionet1_004792 CC(C)(C)c1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCCCn3ccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L15 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1911037 Bionet1_004793 CO/N=C(\CSc1ccc(Cl)cc1)/c2c(C)nc3cc(C)ccn23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L16 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1911038 Bionet1_004794 CC(C)(C)c1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L17 compound treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 1911039 Bionet1_004795 Clc1cccc(Cl)c1CSc2cc3CCc4ccccc4-c3nn2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L18 compound treatment 0.069 -0.00428 -0.51 -0.5073 -1.0 1911040 Bionet1_004796 Fc1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCCCN3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L19 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1911041 Bionet1_004797 FC(F)(F)c1nnc(nc1Sc2ccc(Cl)cc2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L20 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1256599 Bionet1_004798 COc1ccc(CNC(=O)c2cc(c[nH]2)C(=O)c3ccc(F)cc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L21 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1911042 Bionet1_004799 COC(=O)c1ccccc1NC(=O)Cn2c(nc3ccccc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L22 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1911043 Bionet1_004800 CN(C)CCCNC(=O)c1cc(c[nH]1)C(=O)c2ccc(cc2)C(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L23 mock treatment 0.0745 0.00122 0.14 0.1444 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 L24 mock treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M01 mock treatment 0.067 -0.00628 -0.74 -0.7443 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M02 mock treatment 0.0695 -0.00378 -0.45 -0.448 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M03 compound treatment 0.068 -0.00528 -0.63 -0.6258 -1.0 1911044 Bionet1_004801 Fc1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M04 compound treatment 0.07 -0.00328 -0.39 -0.3888 -1.0 1142783 Bionet1_004802 Clc1ccc(COc2ccccc2c3ccnc(n3)c4ccccn4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M05 compound treatment 0.07 -0.00328 -0.39 -0.3888 -1.0 1911045 Bionet1_004803 Cc1ccc(C)n1c2sccc2c3cc4nc(C)c(Cl)c(C)n4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M06 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1911046 Bionet1_004804 FC(F)(F)c1ccc(cc1)C(=O)c2c[nH]c(c2)C(=O)NCCCn3ccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M07 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1911047 Bionet1_004805 CCOC(=O)CC1COc2ccccc2N1C(=O)c3cccc(c3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M08 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1487961 Bionet1_004806 Clc1ccc(C(=O)c2c[nH]c(c2)C(=O)NCCc3ccccc3)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M09 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1911048 Bionet1_004807 COC(=O)C1=C(C)N(CCc2ccc(OC)c(OC)c2)C(=O)C1/C=[N+](\C)/[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M10 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1911049 Bionet1_004808 Fc1ccc(COc2ccccc2c3ccn(n3)C(=O)c4ccco4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M11 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1911050 Bionet1_004809 Cc1nn2c(cc(nc2c1Br)c3cccs3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M12 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1186956 Bionet1_004810 Cc1ccc(C)n1c2ccsc2c3cc4nc(C)c(Cl)c(C)n4n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M13 compound treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 1563971 Bionet1_004811 Cc1ccc(C)n1c2ccsc2c3cc4nc(cc(O)n4n3)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M14 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1468464 Bionet1_004812 Cc1nc2cc(nn2c(O)c1Cc3ccccc3)c4sccc4n5cccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M15 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1911051 Bionet1_004813 Cc1nn2c(ccnc2c1Br)c3ccc(Cl)cc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M16 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1291201 Bionet1_004814 Cc1cc(C)c(c(C)c1)S(=O)(=O)Nc2ccnc(n2)c3cccnc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M17 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1911052 Bionet1_004815 [O-][N+](=O)c1ccc(Cl)cc1C(=O)N2CCN(CC2)c3ccccc3F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M18 compound treatment 0.083 0.00972 1.15 1.1516 1.0 1437790 Bionet1_004816 CCOc1ccc(Oc2nc3ccccc3nc2Cc4ccccc4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M19 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1911053 Bionet1_004817 [O-][N+](=O)c1ccc(Cl)cc1C(=O)N2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M20 compound treatment 0.071 -0.00228 -0.27 -0.2703 -1.0 1911054 Bionet1_004818 FC(F)(F)c1cccc(c1)c2nc3c(C#N)c(ccn3n2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M21 compound treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 1609747 Bionet1_004819 CCC(CC)C(=O)c1c[nH]c(c1)C(=O)N2CCN(CC2)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M22 compound treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 1384241 Bionet1_004820 Cc1ccc(cc1)C(=O)n2cc(CCN3CCS(=O)(=O)CC3)c4ccccc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M23 mock treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 M24 mock treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N01 mock treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N02 mock treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N03 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1911055 Bionet1_004821 CN(NC(=O)c1cccc(C)c1)c2nc(nnc2C(F)(F)F)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N04 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1911056 Bionet1_004822 FC(F)(F)c1cccc(NC(=O)c2cc3cc4ccccc4nc3s2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N05 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1911057 Bionet1_004823 Nc1c(cnn1c2nc(cs2)c3cccc(F)c3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N06 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1911058 Bionet1_004824 CC(C(=O)Nc1ccc(Cl)cn1)n2c(nc3ccccc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N07 compound treatment 0.0785 0.00522 0.62 0.6184 1.0 1911059 Bionet1_004825 CCOC(=O)c1cnn(c2nc(cs2)C(F)(F)F)c1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N08 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1911060 Bionet1_004826 COC(=O)c1ccccc1NC(=O)C(C)n2c(nc3ccccc23)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N09 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1623232 Bionet1_004827 COC(=O)CC1COc2ccccc2N1C(=O)c3ccc(Br)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N10 compound treatment 0.089 0.0157 1.86 1.8625 1.0 1170896 Bionet1_004828 CCn1c(SCC=C)nnc1c2cc3cc4ccccc4nc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N11 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1620711 Bionet1_004829 Cc1cc(N2CCN(CC2)c3ccccc3)n4cc(nc4n1)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N12 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1911061 Bionet1_004830 CCn1c(SCCCF)nnc1c2cc3cc4ccccc4nc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N13 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1561349 Bionet1_004831 Fc1ccccc1C(=O)Nc2cccn3c(cnc23)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N14 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1911062 Bionet1_004832 Cn1nc(c(/C=N/c2ccc(Cl)c(Cl)c2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N15 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1648942 Bionet1_004833 Cc1cc(N2CCN(CC2)c3ccccn3)n4cc(nc4n1)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N16 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1911063 Bionet1_004834 Cn1nc(c(CNc2ccc(Cl)c(Cl)c2)c1Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N17 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1911064 Bionet1_004835 Cc1ccccc1c2nc(SCc3ccccc3)c(C#N)c4CCCc42 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N18 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1273314 Bionet1_004836 CN1CCN(CC1)c2ccc(NC(=O)CSc3ccccc3)cc2F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N19 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1615160 Bionet1_004837 Cc1cc(C)cc(NC(=O)Cc2ccc(OC(=O)C3CCCCC3)cc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N20 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1911065 Bionet1_004838 Fc1cc(NC(=O)CSc2ccc(Cl)cc2)ccc1N3CCOCC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N21 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1911066 Bionet1_004839 Clc1ccc(cc1)c2nc(SCc3ccccc3)c(C#N)c4CCCCc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N22 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1911067 Bionet1_004840 COc1ccc(SCC(=O)Nc2ccc(N3CCOCC3)c(F)c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N23 mock treatment 0.077 0.00372 0.44 0.4406 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 N24 mock treatment 0.0765 0.00322 0.38 0.3814 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O01 mock treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O02 mock treatment 0.0645 -0.00878 -1.04 -1.0405 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O03 compound treatment 0.0725 -7.81E-4 -0.09 -0.0926 -1.0 1244191 Bionet1_004841 Cc1ccccc1C(=O)c2c[nH]c(c2)C(=O)N3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O04 compound treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 1911068 Bionet1_004842 COc1cc2N=C(SCc3ccccc3C)N4CC(=O)N=C4c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O05 compound treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 1911069 Bionet1_004843 FC(F)(F)c1cnc(NCCN2C(=O)C3C4OC(C=C4)C3C2=O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O06 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1911070 Bionet1_004844 CN(CCOc1ccc(C=C2C(=O)N(C)C(=O)N(C)C2=O)cc1)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O07 compound treatment 0.0795 0.00622 0.74 0.7369 1.0 1911071 Bionet1_004845 COC(=O)CC(NS(=O)(=O)c1cccs1)c2ccccc2Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O08 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1911072 Bionet1_004846 CN(CCOc1ccc(C=C2C(=O)NC(=O)NC2=O)cc1)c3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O09 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1911073 Bionet1_004847 COc1cnc(nc1N2CCN(CC2)c3ccccc3F)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O10 compound treatment 0.0765 0.00322 0.38 0.3814 1.0 1285744 Bionet1_004848 Cc1onc(c1C(=O)c2c[nH]c(c2)C(=O)NCc3ccncc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O11 compound treatment 0.0735 2.19E-4 0.03 0.0259 1.0 1911074 Bionet1_004849 C/C(=N\OC(=O)c1ccc(F)cc1)/c2sc(nc2C)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O12 compound treatment 0.075 0.00172 0.2 0.2037 1.0 1336721 Bionet1_004850 Cc1onc(c1C(=O)c2c[nH]c(c2)C(=O)NCc3ccccn3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O13 compound treatment 0.07 -0.00328 -0.39 -0.3888 -1.0 1911075 Bionet1_004851 C/C(=N\OC(=O)c1ccc(C)cc1)/c2sc(nc2C)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O14 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1911076 Bionet1_004852 COCCCNC(=O)c1cc(c[nH]1)C(=O)c2ccccc2Br 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O15 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1911077 Bionet1_004853 C/C(=N\OC(=O)Nc1ccc(C)cc1)/c2sc(nc2C)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O16 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1169155 Bionet1_004854 O=C(NCc1cccs1)c2ccc(cc2)N3CCS(=O)(=O)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O17 compound treatment 0.073 -2.81E-4 -0.03 -0.0333 -1.0 1911078 Bionet1_004855 C/C(=N\OC(=O)NC1CCCCC1)/c2sc(nc2C)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O18 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1597254 Bionet1_004856 Cc1ccc(cc1)C(=O)Nc2ncccc2S(=O)(=O)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O19 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1911079 Bionet1_004857 COC(=O)c1sc2ccccc2c1n3cccc3C(=O)C(=O)NC4CC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O20 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1911080 Bionet1_004858 COc1ccc(cc1)C2CC(=O)CC(=O)C2c3ncc(cc3Cl)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O21 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1231787 Bionet1_004859 Clc1ccc(Cn2nc(c3ccccc3)c(cc2=O)N4CCCCC4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O22 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1126906 Bionet1_004860 Cc1nc2nc(C#N)c(C#N)n2c(C)c1Cc3c(Cl)cccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O23 mock treatment 0.0805 0.00722 0.86 0.8554 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 O24 mock treatment 0.083 0.00972 1.15 1.1516 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P01 mock treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P02 mock treatment 0.066 -0.00728 -0.86 -0.8628 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P03 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1518831 Bionet1_004861 Cc1ccccc1c2nc(SCc3cccc(F)c3)c(C#N)c4CCCc42 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P04 compound treatment 0.0715 -0.00178 -0.21 -0.2111 -1.0 1911081 Bionet1_004862 Fc1cc(NC(=O)CN2CCCCC2)ccc1N3CCN(CC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P05 compound treatment 0.0745 0.00122 0.14 0.1444 1.0 1911082 Bionet1_004863 COc1cc2C(NC(=O)C(F)(F)F)C(Br)C(=O)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P06 compound treatment 0.076 0.00272 0.32 0.3221 1.0 1911083 Bionet1_004864 CCN1CCN(CC(=O)Nc2ccc(N3CCOCC3)c(F)c2)CC1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P07 compound treatment 0.0845 0.0112 1.33 1.3293 1.0 1911084 Bionet1_004865 BrC(Br)(C(=O)c1ccccc1)c2ccccc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P08 compound treatment 0.0825 0.00922 1.09 1.0923 1.0 1546267 Bionet1_004866 Clc1ccc(CNC(=O)c2sccc2NC(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P09 compound treatment 0.08 0.00672 0.8 0.7961 1.0 1911085 Bionet1_004867 Cc1ccccc1c2nc(SCc3ccc(F)cc3)c(C#N)c4CCCc42 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P10 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1911086 Bionet1_004868 [O-][N+](=O)c1ccccc1/C=N/c2oc(c(c2C#N)c3ccccc3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P11 compound treatment 0.079 0.00572 0.68 0.6776 1.0 1911087 Bionet1_004869 Cc1ccc(CSc2nc(c3CCCc3c2C#N)c4ccccc4C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P12 compound treatment 0.081 0.00772 0.91 0.9146 1.0 1911088 Bionet1_004870 CN(C)c1ccc(/C=C/C=N/c2oc(c3ccco3)c(c2C#N)c4ccco4)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P13 compound treatment 0.0775 0.00422 0.5 0.4999 1.0 1911089 Bionet1_004871 Ic1cc(I)c2oc(=O)[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P14 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1247941 Bionet1_004872 O=C(NCc1ccco1)c2ccccc2C(=O)c3ccc4OCC(=O)Nc4c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P15 compound treatment 0.0755 0.00222 0.26 0.2629 1.0 1911090 Bionet1_004873 Cc1ccc(cc1)c2nc3sccn3c2C=C4C(=O)OC(C)(C)OC4=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P16 compound treatment 0.077 0.00372 0.44 0.4406 1.0 1911091 Bionet1_004874 Cc1ccc(cc1)c2nc(SCc3ccccc3)c(C#N)c4CCCCc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P17 compound treatment 0.0705 -0.00278 -0.33 -0.3296 -1.0 1911092 Bionet1_004875 Cc1ccc(cc1)c2nc3sccn3c2/C=C/C(=O)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P18 compound treatment 0.07 -0.00328 -0.39 -0.3888 -1.0 1520560 Bionet1_004876 COc1cc(cc(OC)c1OC)c2c3C(=O)c4ccccc4-c3nc(C)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P19 compound treatment 0.081 0.00772 0.91 0.9146 1.0 1911093 Bionet1_004877 Cc1ccc(cc1)c2nc3sccn3c2/C=N/OCc4c(F)cccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P20 compound treatment 0.078 0.00472 0.56 0.5591 1.0 1911094 Bionet1_004878 CCCCCCCc1ccc(cc1)C2C3=C(NC(=C2C#N)C)c4ccccc4C3=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P21 compound treatment 0.067 -0.00628 -0.74 -0.7443 -1.0 1911095 Bionet1_004879 Cc1cccc(CSc2nc(c3cccc(C)c3)c4CCCCc4c2C#N)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P22 compound treatment 0.074 7.19E-4 0.09 0.0852 1.0 1911096 Bionet1_004880 CCCCCCCc1ccc(cc1)c2c3C(=O)c4ccccc4-c3nc(C)c2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P23 mock treatment 0.072 -0.00128 -0.15 -0.1518 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.582 P24 mock treatment 0.062 -0.0113 -1.34 -1.3367 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A01 compound treatment 0.08 0.00714 0.85 0.846 1.0 1483669 MixCom3_000001 Cc1ccc(NC(=O)CSc2nc3ccccc3c(=O)n2CC4CCC(CC4)C(=O)NCC5CCCO5)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A02 compound treatment 0.075 0.00214 0.25 0.2535 1.0 1983416 MixCom3_000002 COc1ccc(cc1)[N+]2=C3SCCCN3C(O)(C2)c4ccc(Br)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A03 compound treatment 0.0785 0.00564 0.67 0.6682 1.0 1434267 MixCom3_000003 O=C(CSc1nc2ccccc2c(=O)n1NC(=O)c3cccs3)NC4CCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A04 compound treatment 0.0785 0.00564 0.67 0.6682 1.0 1983417 MixCom3_000004 CC1=NN(C(=O)C21C(c3ccccc3[N+](=O)[O-])C42C(=NN(C4=O)c5ccc(C)c(C)c5)C)c6ccc(C)c(C)c6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A05 compound treatment 0.074 0.00114 0.14 0.135 1.0 1159710 MixCom3_000005 Clc1ccc2[nH]c(=S)n(Cc3ccccn3)c(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A06 compound treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 1983418 MixCom3_000006 O[C@]1(NC(=C(C#N)[C@@H]([C@H]1[n+]2cccc3ccccc23)c4ccc(Cl)c(Cl)c4)S)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A07 compound treatment 0.0765 0.00364 0.43 0.4312 1.0 1296718 MixCom3_000007 COc1ccc(Cl)cc1C(=O)Nc2c3CS(=O)(=O)Cc3nn2c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A08 compound treatment 0.075 0.00214 0.25 0.2535 1.0 1983419 MixCom3_000008 CSc1nnc(c2ccco2)n1c3cccc(Cl)c3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A09 compound treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 1738349 MixCom3_000009 O=C(CSc1nc2ccccc2c(=O)n1CC3CCC(CC3)C(=O)NCc4ccco4)Nc5nccs5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A10 compound treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 1406547 MixCom3_000010 C(Nc1ncnc2oc(c(c3ccccc3)c12)c4ccccc4)c5ccco5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A11 compound treatment 0.074 0.00114 0.14 0.135 1.0 1562975 MixCom3_000011 C=CCn1c(SCC(=O)N2CCCC2)nc3cc(ccc3c1=O)C(=O)NCc4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A12 compound treatment 0.077 0.00414 0.49 0.4905 1.0 1983420 MixCom3_000012 CCOc1ccc(cc1)N2C(=O)C3C(C2=O)C4(/C=N/c5ccc(O)cc5)c6ccccc6C3c7ccccc74 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A13 compound treatment 0.0775 0.00464 0.55 0.5497 1.0 1983421 MixCom3_000013 Cc1ccc(cc1)C2CC(n3nc(cc3N2)C(=O)NCc4ccccc4)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A14 compound treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 1983422 MixCom3_000014 COc1ccc(cc1OC)[C@@H]2[C@H](N3[C@H](C=Cc4ccccc34)C2(C#N)C#N)C(=O)c5ccc(C)cc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A15 compound treatment 0.074 0.00114 0.14 0.135 1.0 1182556 MixCom3_000015 CN1CC=C2C(C1)C(c3ccc(OC(=O)C)cc3)C(C#N)(C#N)C(=C2C#N)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A16 compound treatment 0.074 0.00114 0.14 0.135 1.0 1523000 MixCom3_000016 CCn1cnc2sc(C(=O)N3CCCCC3C)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A17 mock treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A18 mock treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A19 mock treatment 0.076 0.00314 0.37 0.372 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A20 mock treatment 0.0735 6.4E-4 0.08 0.0758 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A21 mock treatment 0.076 0.00314 0.37 0.372 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A22 mock treatment 0.0765 0.00364 0.43 0.4312 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A23 mock treatment 0.0875 0.0146 1.73 1.7346 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 A24 mock treatment 0.0845 0.0116 1.38 1.3792 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B01 compound treatment 0.0645 -0.00836 -0.99 -0.9906 -1.0 1983423 MixCom3_000017 CC(=O)[C@@H]1[C@@H](c2ccccc2I)C(C#N)(C#N)[C@H]3C=Cc4ccccc4N13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B02 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 1911097 MixCom3_000018 Clc1ncc(Cn2cccc2/C=C(\C#N)/C(=O)c3ccccc3)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B03 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 1983424 MixCom3_000019 CCOCCn1cnc2sc(C(=O)NCCN(C)C)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B04 compound treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 1911098 MixCom3_000020 COc1ccc(CNc2nc(nc3ccsc23)c4ccccc4Cl)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B05 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 1983425 MixCom3_000021 COc1ccc2oc(=O)c(cc2c1)c3nc(c4ccccc4)c5cc(Br)ccc5n3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B06 compound treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 1911099 MixCom3_000022 CC(=O)Nc1ccc(cc1)S(=O)(=O)NCc2ccccc2n3c(C)ccc3C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B07 compound treatment 0.075 0.00214 0.25 0.2535 1.0 2074522 MixCom3_000023 CCO/C(=N/Oc1ccc(cc1[N+](=O)[O-])[N+](=O)[O-])/C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B08 compound treatment 0.068 -0.00486 -0.58 -0.5759 -1.0 1911100 MixCom3_000024 Cc1ccc2SCC(NC(=O)c3cccc(c3)C(F)(F)F)C(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B09 compound treatment 0.064 -0.00886 -1.05 -1.0499 -1.0 1067370 MixCom3_000025 CCOC(=O)C1=C(C)NC(=C(C1c2cccc(c2)[N+](=O)[O-])C(=O)OCC)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B10 compound treatment 0.066 -0.00686 -0.81 -0.8129 -1.0 2079820 MixCom3_000026 CN1CCN(CC1)C(=O)C2CCCN(C2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B11 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 1911101 MixCom3_000027 CCOC(=O)c1cnc2n(C)ncc2c1NCc3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B12 compound treatment 0.073 1.4E-4 0.02 0.0165 1.0 2079821 MixCom3_000028 CCCCNC(=O)C1CCCN(Cc2ccncc2)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B13 compound treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 1911102 MixCom3_000029 CCC(N1C(C(C)N(C)C1=O)c2ccccc2)S(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B14 compound treatment 0.0675 -0.00536 -0.64 -0.6352 -1.0 2079822 MixCom3_000030 CCCCCCCCCCCCNC(=O)C1CCCN(Cc2cccnc2)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B15 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1911103 MixCom3_000031 Fc1ccc(cc1)c2cnn3c(ccnc23)c4ccc(cc4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B16 compound treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 2079823 MixCom3_000032 COC(=O)C1CCN(CC1)C2CCN(CC2)C(=O)c3ccccc3N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B17 mock treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B18 compound treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 1538303 MixCom3_000033 O=C(OCc1ccccc1)N2CCNC(=O)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B19 mock treatment 0.075 0.00214 0.25 0.2535 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B20 mock treatment 0.0755 0.00264 0.31 0.3128 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B21 mock treatment 0.073 1.4E-4 0.02 0.0165 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B22 mock treatment 0.0765 0.00364 0.43 0.4312 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B23 mock treatment 0.076 0.00314 0.37 0.372 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 B24 mock treatment 0.0745 0.00164 0.19 0.1943 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C01 compound treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 1498486 MixCom3_000034 O=C(CSc1nc2ccccc2c(=O)n1NC(=O)c3cccs3)NCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C02 compound treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 1414620 MixCom3_000035 Cc1cc2NC(=O)CC(c3ccc(F)cc3)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C03 compound treatment 0.074 0.00114 0.14 0.135 1.0 1135125 MixCom3_000036 COC(Cn1c(=O)c2cc(Cl)ccc2[nH]c1=S)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C04 compound treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 1983426 MixCom3_000037 CCCCCCCOC(=O)c1ccc(cc1)N2C(=O)C3C(C4c5ccccc5C3c6ccccc46)C2=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C05 compound treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 1445658 MixCom3_000038 CCOc1ccc(NC(=O)CSc2nc3cc(ccc3c(=O)n2CCC4=CCCCC4)C(=O)OC)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C06 compound treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 1427597 MixCom3_000039 Brc1ccc(cc1)N2C(=O)C3C(C2=O)C4(C=O)c5ccccc5C3c6ccccc64 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C07 compound treatment 0.0785 0.00564 0.67 0.6682 1.0 1667678 MixCom3_000040 Cc1ccc(cc1)c2nc(Nc3c(F)cccc3F)c4ccccc4n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C08 compound treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 1983427 MixCom3_000041 CCOCCn1cnc2sc(C(=O)NC(C)CC)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C09 compound treatment 0.075 0.00214 0.25 0.2535 1.0 1143131 MixCom3_000042 CCOC(=O)c1ccc(cc1)n2c(=S)sc3c(=O)n(CC4CCCO4)c(SCC(=O)NC5CCCCC5)nc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C10 compound treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 1983428 MixCom3_000043 COc1ccc(cc1)[N+]2=C3CCCCN3C(O)(C2)c4ccc(OC)cc4F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C11 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 1241082 MixCom3_000044 COc1ccc(Nc2ncnc3n(cc(c4ccccc4)c23)c5cccc(Cl)c5)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C12 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 1983429 MixCom3_000045 O=C1C2C(C3c4ccccc4C2c5ccccc35)C(=O)N1CC6(CC7CC8CC(C7)C6)C8 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C13 compound treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 1514276 MixCom3_000046 Fc1ccc(cc1C(=O)Nc2ccc(Br)cc2F)S(=O)(=O)N3CCN(CC3)c4cccc(Cl)c4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C14 compound treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 1386236 MixCom3_000047 CC(C)(C)C1CC=C2C(C1)C(c3ccccc3)C(C#N)(C#N)C(=C2C#N)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C15 compound treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 1475162 MixCom3_000048 CC(=O)Oc1ccc(cc1)N2C(=O)C3C(C2=O)C4(C(=O)O)c5ccccc5C3c6ccccc64 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C16 compound treatment 0.073 1.4E-4 0.02 0.0165 1.0 1738262 MixCom3_000049 CCOC(=O)N1CCN(CC1)C(=O)c2sc3ncn(CC)c(=O)c3c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C17 mock treatment 0.075 0.00214 0.25 0.2535 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C18 mock treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C19 mock treatment 0.0755 0.00264 0.31 0.3128 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C20 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C21 mock treatment 0.075 0.00214 0.25 0.2535 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C22 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C23 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 C24 mock treatment 0.0765 0.00364 0.43 0.4312 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D01 compound treatment 0.068 -0.00486 -0.58 -0.5759 -1.0 1983430 MixCom3_000050 COc1ccc(C2C3C(N4C(C5C(N24)C(=O)N(C5=O)c6ccc(Cl)c(Cl)c6)c7ccc(OC)cc7OC)C(=O)N(C3=O)c8ccc(Cl)c(Cl)c8)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D02 compound treatment 0.068 -0.00486 -0.58 -0.5759 -1.0 1911104 MixCom3_000051 COc1cc(NC(=S)Nc2ccc3OCOc3c2)c(C#N)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D03 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1983431 MixCom3_000052 Cc1cccc[n+]1C2C(C(=C(NC2(O)C3CC3)[C-](C#N)C#N)C#N)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D04 compound treatment 0.076 0.00314 0.37 0.372 1.0 1911105 MixCom3_000053 COC(=O)c1cnc2cc(nn2c1N)c3sccc3n4c(C)ccc4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D05 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 1337417 MixCom3_000054 NC(=O)C1CCN(CC1)C(=O)c2ccc3c4nc5ccccc5n4c(=S)[nH]c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D06 compound treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 1911106 MixCom3_000055 Cc1ccc(cc1)S(=O)(=O)NNC(=O)c2cc3cc4ccccc4nc3s2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D07 compound treatment 0.085 0.0121 1.44 1.4384 1.0 2074523 MixCom3_000056 [O-][N+](=O)c1ccc(cc1)N2CCCCCCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D08 compound treatment 0.076 0.00314 0.37 0.372 1.0 1911107 MixCom3_000057 COC(=O)c1ccccc1Sc2nc(nc3ccsc23)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D09 compound treatment 0.076 0.00314 0.37 0.372 1.0 2074524 MixCom3_000058 OC(=O)c1cnc(O)c(Cl)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D10 compound treatment 0.0755 0.00264 0.31 0.3128 1.0 2079824 MixCom3_000059 O=C(NCCc1ccccc1)C2CCCN(C2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D11 compound treatment 0.0825 0.00964 1.14 1.1422 1.0 1911108 MixCom3_000060 Fc1cccc(CSc2nc(cc(=O)n2c3ccccc3)C(F)(F)F)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D12 compound treatment 0.08 0.00714 0.85 0.846 1.0 2079825 MixCom3_000061 O=C(NC1CCCCC1)C2CCCN(Cc3ccccn3)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D13 compound treatment 0.0875 0.0146 1.73 1.7346 1.0 1911109 MixCom3_000062 CC1C(N(CS(=O)(=O)c2ccc(C)cc2)C(=O)N1C)c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D14 compound treatment 0.077 0.00414 0.49 0.4905 1.0 2079826 MixCom3_000063 CN1CCC(CC1)NCCN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D15 compound treatment 0.078 0.00514 0.61 0.609 1.0 1911110 MixCom3_000064 CN(C)/C=C/C(=O)c1ccc(s1)N2CCN(CC2)c3cccc(Cl)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D16 compound treatment 0.076 0.00314 0.37 0.372 1.0 2079827 MixCom3_000065 CN1CCC(CC1)N(CCN2CCOCC2)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D17 mock treatment 0.08 0.00714 0.85 0.846 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D18 compound treatment 0.075 0.00214 0.25 0.2535 1.0 1344033 MixCom3_000066 OC(=O)c1ccc(C#Cc2ccccc2)o1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D19 mock treatment 0.0785 0.00564 0.67 0.6682 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D20 mock treatment 0.076 0.00314 0.37 0.372 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D21 mock treatment 0.078 0.00514 0.61 0.609 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D22 mock treatment 0.1045 0.0316 3.75 3.749 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D23 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 D24 mock treatment 0.077 0.00414 0.49 0.4905 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E01 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 1338666 MixCom3_000067 Clc1ccc2c(=O)n(Cc3ccccn3)c(=S)[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E02 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 1440708 MixCom3_000068 Cc1c(sc2ncn(Cc3cccc(F)c3)c(=O)c12)C(=O)N4CCCc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E03 compound treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 1473398 MixCom3_000069 COC(=O)c1ccc2c(=O)n(CCC3=CCCCC3)c(SCC(=O)NCCc4ccccc4)nc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E04 compound treatment 0.0745 0.00164 0.19 0.1943 1.0 1156085 MixCom3_000070 S=c1sc2SCC3(CSc2s1)OCCO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E05 compound treatment 0.0745 0.00164 0.19 0.1943 1.0 1574889 MixCom3_000071 CC(Oc1ccccc1)C(=O)Nc2c3CSCc3nn2c4ccc(C)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E06 compound treatment 0.075 0.00214 0.25 0.2535 1.0 1983432 MixCom3_000072 NC(=S)N/N=C/1\c2ccccc2C(=O)C1(Cl)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E07 compound treatment 0.0835 0.0106 1.26 1.2607 1.0 1437533 MixCom3_000073 Clc1ccc(cc1)C(=O)CSc2nc3ccccc3c(=O)n2CC4CCC(CC4)C(=O)NCc5ccco5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E08 compound treatment 0.0765 0.00364 0.43 0.4312 1.0 1983433 MixCom3_000074 CC1(C)OCC(O1)[C@H]2O[C@@H]3OC(C)(C)OC3C2OC(=O)Nc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E09 compound treatment 0.076 0.00314 0.37 0.372 1.0 1311946 MixCom3_000075 O=C(CSc1nc2ccccc2c(=O)n1CC3CCCO3)NCCc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E10 compound treatment 0.079 0.00614 0.73 0.7275 1.0 1311719 MixCom3_000076 CCn1cnc2sc(C(=O)NCCN3CCOCC3)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E11 compound treatment 0.0785 0.00564 0.67 0.6682 1.0 1725651 MixCom3_000077 COc1ccc(c2nc(no2)c3c(F)cccc3F)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E12 compound treatment 0.076 0.00314 0.37 0.372 1.0 1606515 MixCom3_000078 CCOc1ccc(cc1)C(Nc2ccc(Br)cc2)P3(=S)OCC(C)(C)CO3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E13 compound treatment 0.0775 0.00464 0.55 0.5497 1.0 1983434 MixCom3_000079 COc1ccc(cc1OC)C2(O)C[N+](=C3SCCCN32)c4cc(C)ccc4C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E14 compound treatment 0.078 0.00514 0.61 0.609 1.0 1983435 MixCom3_000080 Ic1ccccc1[C@@H]2[C@H](N3[C@H](C=Cc4c3ccc5ccccc45)C2(C#N)C#N)C(=O)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E15 compound treatment 0.079 0.00614 0.73 0.7275 1.0 1983436 MixCom3_000081 CCOc1ccc(cc1)N2C(=O)C3C(C2=O)C4(/C=N/c5ccccc5C)c6ccccc6C3c7ccccc74 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E16 compound treatment 0.0775 0.00464 0.55 0.5497 1.0 1983437 MixCom3_000082 CCOCCn1cnc2sc(C(=O)N3CCCCC3CC)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E17 mock treatment 0.0785 0.00564 0.67 0.6682 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E18 mock treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E19 mock treatment 0.076 0.00314 0.37 0.372 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E20 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E21 mock treatment 0.0755 0.00264 0.31 0.3128 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E22 mock treatment 0.0735 6.4E-4 0.08 0.0758 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E23 mock treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 E24 mock treatment 0.073 1.4E-4 0.02 0.0165 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F01 compound treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 1983438 MixCom3_000083 COc1ccc(cc1)c2nc(c([nH]2)c3ccc(cc3)[N+](=O)[O-])c4ccc(Oc5ccc(cc5)c6[nH]c(nc6c7ccc(cc7)[N+](=O)[O-])c8ccc(OC)cc8)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F02 compound treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 1911111 MixCom3_000084 CCCCCC1CCC(CC1)c2ccc(NC(=O)Oc3ccccc3)cc2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F03 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 1983439 MixCom3_000085 Cc1ccc(cc1)C(=O)[C@@H]2[C@@H](c3ccccc3I)C(C#N)(C#N)[C@H]4C=Cc5ccccc5N24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F04 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1911112 MixCom3_000086 CN1C(=O)N(C)C(=O)C(=Cc2cccn2c3ccc(Br)cc3)C1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F05 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 1983440 MixCom3_000087 Cc1ccc(cc1S(=O)(=O)n2ccnc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F06 compound treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 1911113 MixCom3_000088 CCn1c(COc2ccc(=O)n(n2)c3ccccc3)nnc1SCC=C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F07 compound treatment 0.079 0.00614 0.73 0.7275 1.0 2074525 MixCom3_000089 [O-][N+](=O)c1ccc(ON2C(=O)c3ccccc3C2=O)cc1[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F08 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 1911114 MixCom3_000090 Fc1ccc(cc1)C(=O)Nc2ccsc2C(=O)NCc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F09 compound treatment 0.075 0.00214 0.25 0.2535 1.0 2074526 MixCom3_000091 O=C1CC(Nc2ccccc2)C=C1Nc3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F10 compound treatment 0.096 0.0231 2.74 2.7418 1.0 2079828 MixCom3_000092 Cc1ccc(CNC(=O)C2CCCN(C2)C3CCN(Cc4ccccc4)CC3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F11 compound treatment 0.078 0.00514 0.61 0.609 1.0 1911115 MixCom3_000093 CCn1cc(n(Cc2ccc(Cl)cc2)c1=O)S(=O)(=O)c3ccc(C)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F12 compound treatment 0.0765 0.00364 0.43 0.4312 1.0 2079829 MixCom3_000094 O=C(NCc1ccccc1)C2CCCN(Cc3ccccn3)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F13 compound treatment 0.0755 0.00264 0.31 0.3128 1.0 1911116 MixCom3_000095 COc1cc(NC(=S)NCc2ccc(Cl)c(Cl)c2)c(C#N)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F14 compound treatment 0.073 1.4E-4 0.02 0.0165 1.0 2079830 MixCom3_000096 CC(=O)N1CCC(CC1)NCCN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F15 compound treatment 0.075 0.00214 0.25 0.2535 1.0 1911117 MixCom3_000097 COc1ccc(cc1OC)S(=O)(=O)N2CCc3cc(OC)c(OC)cc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F16 compound treatment 0.0965 0.0236 2.8 2.8011 1.0 2079831 MixCom3_000098 CN1CCC(CC1)N(CCN2CCOCC2)C(=O)CSCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F17 mock treatment 0.085 0.0121 1.44 1.4384 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F18 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 2074527 MixCom3_000099 FC(F)(F)c1cccc(NC(=O)C(=O)NCc2ccccc2)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F19 mock treatment 0.075 0.00214 0.25 0.2535 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F20 mock treatment 0.091 0.0181 2.15 2.1494 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F21 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F22 mock treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F23 mock treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 F24 mock treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G01 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1983441 MixCom3_000100 CCCCCn1c(SCC(=O)N2CCCC2)nc3cc(ccc3c1=O)C(=O)NCc4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G02 compound treatment 0.0625 -0.0104 -1.23 -1.2276 -1.0 1983442 MixCom3_000101 COc1ccc(cc1)[N+]2=C3SCCCN3C(O)(C2)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G03 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1383366 MixCom3_000102 CCCCN(C)c1ncnc2n(cc(c3ccccc3)c12)c4ccc(OC)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G04 compound treatment 0.065 -0.00786 -0.93 -0.9314 -1.0 1983443 MixCom3_000103 COc1ccc(cc1)C2(O)C[N+](=C3SCCCN32)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G05 compound treatment 0.0655 -0.00736 -0.87 -0.8721 -1.0 1634993 MixCom3_000104 Cc1ccc(cc1)c2nc(Nc3ccccc3F)c4ccccc4n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G06 compound treatment 0.0645 -0.00836 -0.99 -0.9906 -1.0 1983444 MixCom3_000105 CCCCCCCCCCCCN1C=C/C(=C\C=C(/C#N)\C(=O)ONc2ccccc2)/c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G07 compound treatment 0.077 0.00414 0.49 0.4905 1.0 1417902 MixCom3_000106 CCOC(=O)c1ccc(cc1)n2c(=S)sc3c(=O)n(CC4CCCO4)c(SCC(=O)NCc5ccccc5)nc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G08 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1983445 MixCom3_000107 Cc1c(/N=C/c2c(OC(=O)c3cccc4ccccc34)ccc5ccccc25)c(=O)n(c6ccccc6)n1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G09 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 1403336 MixCom3_000108 COc1ccc(cc1)n2cc(c3ccccc3)c4c(NCC(C)C)ncnc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G10 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1149116 MixCom3_000109 Cc1c(sc2ncn(C)c(=O)c12)C(=O)N3CCC(CC3)C(=O)N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G11 compound treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 1238519 MixCom3_000110 Fc1ccc(cc1C(=O)Nc2ccc(Br)cc2F)S(=O)(=O)N3CCN(CC3)c4ccccc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G12 compound treatment 0.073 1.4E-4 0.02 0.0165 1.0 1191183 MixCom3_000111 C1c2cc3ccccc3c(c2C[N+]14CCOCC4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G13 compound treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 1566471 MixCom3_000112 Cc1cc2NC(=O)CC(c3ccccc3F)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G14 compound treatment 0.0675 -0.00536 -0.64 -0.6352 -1.0 1983446 MixCom3_000113 CCCCCCCCN1C2=C(C(C3=C1CC(C)(C)CC3=O)c4ccccc4)C(=O)CC(C)(C)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G15 compound treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 1983447 MixCom3_000114 CCOC(=O)C1=NN(c2ccc(cc2)[N+](=O)[O-])C3(S1)N(N=C(c4ccccc4)c5ccccc53)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G16 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 1983448 MixCom3_000115 O[C@]1(NC(=C(C#N)[C@@H]([C@H]1[n+]2ccc3ccccc3c2)c4cccc(I)c4)S)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G17 mock treatment 0.068 -0.00486 -0.58 -0.5759 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G18 mock treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G19 mock treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G20 mock treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G21 mock treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G22 mock treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G23 mock treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 G24 mock treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H01 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1155483 MixCom3_000116 CN1C(=O)CCN=C(c2ccccc2)c3cc(Cl)ccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H02 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 1911118 MixCom3_000117 O=C(Nc1ccc2OCOc2c1)N(Cc3ccccc3)Cc4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H03 compound treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 1983449 MixCom3_000118 Ic1cccc(c1)[C@@H]2[C@H](N3[C@H](C=Cc4c3ccc5ccccc45)C2(C#N)C#N)C(=O)c6ccccc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H04 compound treatment 0.074 0.00114 0.14 0.135 1.0 1911119 MixCom3_000119 Brc1ccc(cc1)n2cccc2/C=C\3/C(=O)Nc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H05 compound treatment 0.092 0.0191 2.27 2.2678 1.0 2074528 MixCom3_000120 O=c1nc(c2ccccc2)c3ccccc3[nH]1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H06 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1911120 MixCom3_000121 O/N=C(/c1cc2cc3ccccc3nc2s1)\c4ccc(Cl)cc4Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H07 compound treatment 0.0835 0.0106 1.26 1.2607 1.0 1099382 MixCom3_000122 Cc1ccn2c(cnc2c1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H08 compound treatment 0.0745 0.00164 0.19 0.1943 1.0 1178265 MixCom3_000123 CCOC(=O)c1cc(NC(=O)c2ccccc2)c(=O)oc1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H09 compound treatment 0.0855 0.0126 1.5 1.4977 1.0 1323395 MixCom3_000124 Nc1ccc(cc1)S(=O)(=O)N2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H10 compound treatment 0.076 0.00314 0.37 0.372 1.0 2079832 MixCom3_000125 COC(=O)C1CCN(CC1)C(=O)C2CCCN(C2)C3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H11 compound treatment 0.078 0.00514 0.61 0.609 1.0 1911121 MixCom3_000126 COc1ccc(cc1OC)c2nc3ccc(cc3c(=O)[nH]2)N4CCCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H12 compound treatment 0.1045 0.0316 3.75 3.749 1.0 2079833 MixCom3_000127 O=C(NCCc1ccccc1)C2CCCN(Cc3cccnc3)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H13 compound treatment 0.0755 0.00264 0.31 0.3128 1.0 1911122 MixCom3_000128 CCn1c(SCC(=O)c2ccc(C)cc2)nc(cc1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H14 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 2079834 MixCom3_000129 CCCN1CCC(CC1)NCCN2CCOCC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H15 compound treatment 0.075 0.00214 0.25 0.2535 1.0 1911123 MixCom3_000130 CC(=O)c1ccc(s1)N2CCN(CC2)c3cccc(c3)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H16 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 2079835 MixCom3_000131 CCCN1CCC(CC1)N(CCN2CCOCC2)C(=O)COCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H17 mock treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H18 compound treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 2074529 MixCom3_000132 NNC(=O)c1cc2ccccc2s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H19 mock treatment 0.076 0.00314 0.37 0.372 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H20 mock treatment 0.0745 0.00164 0.19 0.1943 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H21 mock treatment 0.0795 0.00664 0.79 0.7867 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H22 mock treatment 0.0755 0.00264 0.31 0.3128 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H23 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 H24 mock treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I01 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1249110 MixCom3_000133 CCCN(CCC)c1ncnc2n(cc(c3ccccc3)c12)c4ccc(OC)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I02 compound treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 1983450 MixCom3_000134 CCOCCn1cnc2sc(C(=O)N(CC)CC)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I03 compound treatment 0.066 -0.00686 -0.81 -0.8129 -1.0 1983451 MixCom3_000135 CCc1c(C)sc(NC(=O)c2cc3NC(CC(n3n2)C(F)(F)F)c4ccc(Cl)cc4)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I04 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 1402833 MixCom3_000136 Cc1cc2NC(=O)CC(c3cc(F)ccc3F)c2cc1C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I05 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1549005 MixCom3_000137 O=C(CSc1nc2ccccc2c(=O)n1CC3CCC(CC3)C(=O)NCc4ccco4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I06 compound treatment 0.0675 -0.00536 -0.64 -0.6352 -1.0 1983452 MixCom3_000138 [O-][N+](=O)c1cc(cc2C(=C(C#N)C#N)c3cc(cc([N+](=O)[O-])c3-c21)S(=O)(=O)NC4CCCCC4)S(=O)(=O)NC5CCCCC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I07 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 1517182 MixCom3_000139 Clc1ccc2c(=O)n(c3cccc(c3)C(=O)NCc4ccccn4)c(=S)[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I08 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1983453 MixCom3_000140 CC(=O)OCC1OC(Oc2cccc(C)c2C)C(OC(=O)C)C(OC(=O)C)C1OC(=O)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I09 compound treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 1983454 MixCom3_000141 COc1ccc(c2nc(no2)c3cccc(c3)C(F)(F)F)c(OC)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I10 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1983455 MixCom3_000142 CCOCCn1cnc2sc(C(=O)N3C(C)CCc4cc(F)ccc34)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I11 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 1685265 MixCom3_000143 Oc1ccc(cc1O)C(=O)CSc2nc3ccccc3c(=O)n2CC4CCC(CC4)C(=O)NCCc5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I12 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1242528 MixCom3_000144 COc1ccc(OC)c(NC(=O)c2c(NCc3cccnc3)sc4CCCCCc24)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I13 compound treatment 0.0585 -0.0144 -1.7 -1.7016 -1.0 1363889 MixCom3_000145 Cc1c(sc2ncn(Cc3ccccc3Cl)c(=O)c12)C(=O)N4CCCc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I14 compound treatment 0.064 -0.00886 -1.05 -1.0499 -1.0 1983456 MixCom3_000146 CC(C)(C)NS(=O)(=O)c1cc2C(=C(C#N)C#N)c3cc(cc([N+](=O)[O-])c3-c2c(c1)[N+](=O)[O-])S(=O)(=O)NC(C)(C)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I15 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1913615 MixCom3_000147 Cc1ccc(cc1)c2cc3c4cccn4ccn3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I16 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 1983457 MixCom3_000148 CCN(CC)c1ccc(/C=N/NC(=O)C2C(C(C2c3ccccc3)C(=O)N4CCOCC4)c5ccccc5)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I17 mock treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I18 mock treatment 0.068 -0.00486 -0.58 -0.5759 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I19 mock treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I20 mock treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I21 mock treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I22 mock treatment 0.068 -0.00486 -0.58 -0.5759 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I23 mock treatment 0.068 -0.00486 -0.58 -0.5759 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 I24 mock treatment 0.064 -0.00886 -1.05 -1.0499 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J01 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1614812 MixCom3_000149 O=C(COc1ccccc1)Nc2ncnc3oc(c(c4ccccc4)c23)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J02 compound treatment 0.066 -0.00686 -0.81 -0.8129 -1.0 1911124 MixCom3_000150 CN(C)S(=O)(=O)c1ccc(NC(=O)N2CCN(CC2)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J03 compound treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 1983458 MixCom3_000151 CCCCCCCCCN1C=C/C(=C/C(=C2C(=O)c3ccccc3C2=O)C#N)/c4ccccc14 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J04 compound treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 1911125 MixCom3_000152 FC(F)(F)Oc1ccc(cc1)n2cccc2CC3C(=O)Nc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J05 compound treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 1043414 MixCom3_000153 NC(=N)SCc1ccc(o1)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J06 compound treatment 0.073 1.4E-4 0.02 0.0165 1.0 1911126 MixCom3_000154 Fc1ccc(CSc2nnc(o2)c3cc4cc5ccccc5nc4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J07 compound treatment 0.0765 0.00364 0.43 0.4312 1.0 1111259 MixCom3_000155 [O-][N+](=O)c1ccc2nc(c3ccccc3)c(nc2c1)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J08 compound treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 2079836 MixCom3_000156 COc1cc(OC)nc(n1)N2CCC(CC2)C(=O)N3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J09 compound treatment 0.0745 0.00164 0.19 0.1943 1.0 1911127 MixCom3_000157 Brc1ccc(cc1)n2ccc(/C=C/3\C(=O)Nc4ccccc34)c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J10 compound treatment 0.084 0.0111 1.32 1.3199 1.0 2079837 MixCom3_000158 CCCCCCCCCCCCNC(=O)C1CCCN(C1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J11 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 1911128 MixCom3_000159 Cc1cc(n2nc(nc2n1)N3CCN(CC3)c4ccccc4)C(F)(F)Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J12 compound treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 2079838 MixCom3_000160 O=C(C1CCCN(Cc2ccncc2)C1)N3CCc4ccccc4C3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J13 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1911129 MixCom3_000161 CCn1c(SCC(=O)c2ccc(Cl)cc2)nc(cc1=O)C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J14 compound treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 1139024 MixCom3_000162 C(CN1CCOCC1)NC2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J15 compound treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 1911130 MixCom3_000163 Cc1ccc(cc1)S(=O)(=O)/C(=C\Nc2[nH]ncc2c3ccc(Cl)cc3)/C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J16 compound treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 2079839 MixCom3_000164 OC(=O)CCC(=O)N(CCN1CCOCC1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J17 mock treatment 0.081 0.00814 0.96 0.9645 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J18 mock treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J19 mock treatment 0.0745 0.00164 0.19 0.1943 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J20 mock treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J21 mock treatment 0.073 1.4E-4 0.02 0.0165 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J22 mock treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J23 mock treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 J24 mock treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K01 compound treatment 0.0675 -0.00536 -0.64 -0.6352 -1.0 1983459 MixCom3_000165 CCc1c(C)sc(NC(=O)c2cc3NC(CC(n3n2)C(F)(F)F)c4ccc(C)cc4)c1C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K02 compound treatment 0.064 -0.00886 -1.05 -1.0499 -1.0 1983460 MixCom3_000166 CCCCCCOc1ccc(OC2OC(COC(=O)C)C(OC(=O)C)C(OC(=O)C)C2OC(=O)C)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K03 compound treatment 0.0635 -0.00936 -1.11 -1.1091 -1.0 1474950 MixCom3_000167 COc1ccc(cc1)C2C3=C(Nc4ncnn24)c5ccccc5OC3c6ccc(SC)cc6 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K04 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1983461 MixCom3_000168 CCSc1nnc(c2ccncc2)n1c3ccccc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K05 compound treatment 0.0655 -0.00736 -0.87 -0.8721 -1.0 1983462 MixCom3_000169 O=C(CSc1nc2ccccc2c(=O)n1C3CC3)N4CCN(CC4)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K06 compound treatment 0.065 -0.00786 -0.93 -0.9314 -1.0 1983463 MixCom3_000170 CC(OC1C(NC(=O)C)C(OCc2ccccc2)OC3COC(OC13)c4ccccc4)C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K07 compound treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 1456603 MixCom3_000171 COc1ccc(cc1)n2cc(c3ccccc3)c4c(NCC=C)ncnc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K08 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 1983464 MixCom3_000172 Cc1ccc(cc1)C(=O)[C@H]2[C@H](c3ccccc3I)C(C#N)(C#N)[C@H]4N2C=Cc5ccccc45 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K09 compound treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 1683624 MixCom3_000173 CCN(c1cccc(C)c1)S(=O)(=O)c2ccc3[nH]cc(C(=O)N(CCc4ccccc4)Cc5ccccc5)c(=O)c3c2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K10 compound treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 1983465 MixCom3_000174 CC(=O)[C@@H]1[C@@H](c2cccc(I)c2)C(C#N)(C#N)[C@H]3C=Cc4ccccc4N13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K11 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 1132204 MixCom3_000175 COC(Cn1c(=O)c2ccc(Cl)cc2[nH]c1=S)OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K12 compound treatment 0.0655 -0.00736 -0.87 -0.8721 -1.0 1278221 MixCom3_000176 CCn1cnc2sc(C(=O)N3CCN(C)CC3)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K13 compound treatment 0.0645 -0.00836 -0.99 -0.9906 -1.0 1983466 MixCom3_000177 OC1(C[N+](=C2SCCCN21)c3ccc(Br)cc3)c4ccc(cc4)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K14 compound treatment 0.0655 -0.00736 -0.87 -0.8721 -1.0 1408258 MixCom3_000178 Nc1nc2n(C3OC(CO)C(O)C3O)c(nc2c(=O)[nH]1)N4CCOCC4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K15 mock treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K16 mock treatment 0.0675 -0.00536 -0.64 -0.6352 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K17 mock treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K18 mock treatment 0.066 -0.00686 -0.81 -0.8129 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K19 mock treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K20 mock treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K21 mock treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K22 mock treatment 0.0675 -0.00536 -0.64 -0.6352 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K23 mock treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 K24 mock treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L01 compound treatment 0.0675 -0.00536 -0.64 -0.6352 -1.0 1530607 MixCom3_000179 CC1CCCN(C1)C(=O)c2sc3ncn(C)c(=O)c3c2C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L02 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1911131 MixCom3_000180 CN(C)S(=O)(=O)c1ccc(NC(=O)N2CCN(CC2)c3ccccn3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L03 compound treatment 0.09 0.0171 2.03 2.0309 1.0 1983467 MixCom3_000181 CC(=O)C1=C(C)NC(=C(C#N)C1c2ccccc2[N+](=O)[O-])SCc3ccc(cc3)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L04 compound treatment 0.066 -0.00686 -0.81 -0.8129 -1.0 1911132 MixCom3_000182 COc1cc2C(NC(=O)C(F)(F)F)/C(=C/N(C)C)/C(=O)c2cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L05 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 353 MixCom3_000183 Oc1cc(O)c2c(=O)c(O)c(oc2c1)c3ccc(O)c(O)c3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L06 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 1911133 MixCom3_000184 Cc1ccc(CSc2nnc(o2)c3cc4cc5ccccc5nc4s3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L07 compound treatment 0.074 0.00114 0.14 0.135 1.0 1287531 MixCom3_000185 CS(=O)(=O)c1ccc2nc(N)sc2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L08 compound treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 2079840 MixCom3_000186 CCCCCCCCCCCCNC(=O)C1CCN(CC1)c2nc(OC)cc(OC)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L09 compound treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 1911134 MixCom3_000187 Brc1ccc(cc1)n2cccc2C(=O)NCCc3ccccn3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L10 compound treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 2079841 MixCom3_000188 OC(=O)C1CCCN(Cc2ccccn2)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L11 compound treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 1911135 MixCom3_000189 Nc1c(cnc2cc(nn12)c3ccc(Cl)c(Cl)c3)c4ccc(Cl)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L12 compound treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 2079842 MixCom3_000190 Clc1ccc(CNC(=O)C2CCCN(Cc3cccnc3)C2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L13 compound treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 1911136 MixCom3_000191 COc1ccccc1CNC(=S)Nc2cc(OC)c(OC)cc2C#N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L14 compound treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 2079843 MixCom3_000192 COC(=O)C1CCN(CC1)C2CCN(CC2)C(=O)/C=C\C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L15 mock treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L16 compound treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 1028887 MixCom3_000193 OC(=O)c1cccc(I)c1C(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L17 mock treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L18 mock treatment 0.068 -0.00486 -0.58 -0.5759 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L19 mock treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L20 mock treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L21 mock treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L22 mock treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L23 mock treatment 0.073 1.4E-4 0.02 0.0165 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 L24 mock treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M01 compound treatment 0.066 -0.00686 -0.81 -0.8129 -1.0 1983468 MixCom3_000194 Fc1ccc(cc1C(=O)Nc2cc(ccc2Cl)C(F)(F)F)S(=O)(=O)NCc3ccccc3Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M02 compound treatment 0.0655 -0.00736 -0.87 -0.8721 -1.0 1983469 MixCom3_000195 Ic1cccc(c1)[C@@H]2[C@H](N3[C@H](C=Cc4ccccc34)C2(C#N)C#N)C(=O)C5(CC6CC7CC(C6)C5)C7 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M03 compound treatment 0.0645 -0.00836 -0.99 -0.9906 -1.0 1212579 MixCom3_000196 O=C(CSc1nc2ccccc2c(=O)n1CC3CCC(CC3)C(=O)NCC4CCCO4)NC5CCCC5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M04 compound treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 1983470 MixCom3_000197 OC1(C[N+](=C2SCCCN21)c3ccccc3)c4ccc(F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M05 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1192970 MixCom3_000198 Clc1ccc2c(=O)n(c3cccc(c3)C(=O)NCc4ccccc4)c(=S)[nH]c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M06 compound treatment 0.0655 -0.00736 -0.87 -0.8721 -1.0 1983471 MixCom3_000199 COc1ccc(cc1)[N+]2=C3CCCCN3C(O)(C2)c4ccc(OC(F)F)cc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M07 compound treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 1983472 MixCom3_000200 Cc1cccc(c1)N(CCOC(=O)c2ccc([N+](=O)[O-])c(C)c2)C3=NS(=O)(=O)c4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M08 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1983473 MixCom3_000201 [O-][N+](=O)c1ccc(cc1)S(=O)(=O)Oc2ccccc2/C=N/NC(=O)C3(CCC3)C(=O)N\N=C/c4ccccc4OS(=O)(=O)c5ccc(cc5)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M09 compound treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 1468233 MixCom3_000202 Cc1ccc(NC(=O)CSc2nc3ccccc3c(=O)n2CC4CCC(CC4)C(=O)NCc5ccco5)cc1Cl 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M10 compound treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 1216007 MixCom3_000203 NC(=O)C1C(c2cccc(I)c2)C(C#N)(C#N)C3N1C=Cc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M11 compound treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 1366300 MixCom3_000204 C=CCn1c(SCC(=O)c2ccccc2)nc3cc(ccc3c1=O)C(=O)NCc4ccco4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M12 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1983474 MixCom3_000205 CCn1cnc2sc(C(=O)N3CCC(CC3)(N4CCCCC4)C(=O)N)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M13 compound treatment 0.0675 -0.00536 -0.64 -0.6352 -1.0 1983475 MixCom3_000206 CCOCCn1cnc2sc(C(=O)N3CCN(Cc4ccccc4)CC3)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M14 compound treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 1944615 MixCom3_000207 CC(=O)c1c(C)oc2c1cc(O)c3n(nc(c4ccccc4)c23)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M15 mock treatment 0.068 -0.00486 -0.58 -0.5759 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M16 mock treatment 0.0675 -0.00536 -0.64 -0.6352 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M17 mock treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M18 mock treatment 0.0675 -0.00536 -0.64 -0.6352 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M19 mock treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M20 mock treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M21 mock treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M22 mock treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M23 mock treatment 0.0715 -0.00136 -0.16 -0.1612 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 M24 mock treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N01 compound treatment 0.0655 -0.00736 -0.87 -0.8721 -1.0 1677023 MixCom3_000208 CCCn1cnc2sc(C(=O)N3CCCc4ccccc34)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N02 compound treatment 0.0685 -0.00436 -0.52 -0.5167 -1.0 1911137 MixCom3_000209 Nc1c(cnc2c(cnn12)c3cccs3)S(=O)(=O)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N03 compound treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 1171251 MixCom3_000210 COC1Cc2ccccc2N(C(=O)N)c3ccccc13 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N04 compound treatment 0.0695 -0.00336 -0.4 -0.3982 -1.0 1911138 MixCom3_000211 CCOC(=O)c1cnn(c2nc(cs2)c3cccc(N)c3)c1C(F)(F)F 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N05 compound treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 2074530 MixCom3_000212 Cc1cc(C)c(O)c(N=Nc2ccc(Cl)cc2[N+](=O)[O-])c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N06 compound treatment 0.0705 -0.00236 -0.28 -0.2797 -1.0 1911139 MixCom3_000213 Fc1cc(NC(=O)CN2CCOCC2)ccc1N3CCN(CC3)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N07 compound treatment 0.0765 0.00364 0.43 0.4312 1.0 2074531 MixCom3_000214 CCOC(=O)C1=C(C)NC(=C(C1/C=C/c2ccccc2)C(=O)OCC)C 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N08 compound treatment 0.074 0.00114 0.14 0.135 1.0 2079844 MixCom3_000215 OC(=O)C1CCCN(C1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N09 compound treatment 0.0765 0.00364 0.43 0.4312 1.0 1911140 MixCom3_000216 Clc1cccc(Oc2ccccc2C3CC(=O)CC(=O)C3n4cncn4)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N10 compound treatment 0.076 0.00314 0.37 0.372 1.0 2079845 MixCom3_000217 OC(=O)C1CCCN(Cc2cccnc2)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N11 compound treatment 0.074 0.00114 0.14 0.135 1.0 1911141 MixCom3_000218 Cc1ccc(N/C=C/C(=O)c2ccc3noc(c4cccc(F)c4)c3c2)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N12 compound treatment 0.074 0.00114 0.14 0.135 1.0 2079846 MixCom3_000219 CCOC(=O)C1CCN(CC1)C(=O)C2CCCN(Cc3ccncc3)C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N13 compound treatment 0.073 1.4E-4 0.02 0.0165 1.0 1911142 MixCom3_000220 COc1cc(/N=C(\NCc2ccc(F)cc2)/SC)c(C#N)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N14 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 2079847 MixCom3_000221 COC(=O)C1CCN(CC1)C2CCN(CC2)C(=O)CCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N15 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N16 compound treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 1670164 MixCom3_000222 Cc1nc2ccccc2c(C(=O)O)c1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N17 mock treatment 0.076 0.00314 0.37 0.372 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N18 mock treatment 0.0805 0.00764 0.91 0.9052 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N19 mock treatment 0.08 0.00714 0.85 0.846 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N20 mock treatment 0.0765 0.00364 0.43 0.4312 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N21 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N22 mock treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N23 mock treatment 0.076 0.00314 0.37 0.372 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 N24 mock treatment 0.0755 0.00264 0.31 0.3128 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O01 compound treatment 0.07 -0.00286 -0.34 -0.3389 -1.0 1201763 MixCom3_000223 CCC(C)NC(=O)CSc1nc2ccccc2c(=O)n1CC3CCC(CC3)C(=O)NCC4CCCO4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O02 compound treatment 0.064 -0.00886 -1.05 -1.0499 -1.0 1983476 MixCom3_000224 CC(=O)Oc1ccc(cc1)[C@@H]2[C@H](N3[C@H](C=Cc4cc(Cl)ccc34)C2(C#N)C#N)C(=O)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O03 compound treatment 0.068 -0.00486 -0.58 -0.5759 -1.0 1983477 MixCom3_000225 COc1ccc(CCNC(=O)CSc2nc3ccccc3c(=O)n2C4CC4)cc1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O04 compound treatment 0.069 -0.00386 -0.46 -0.4574 -1.0 1072643 MixCom3_000226 Nc1ncnc2oc(c(c3ccccc3)c12)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O05 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 1325773 MixCom3_000227 COc1cccc(Nc2ncnc3n(cc(c4ccccc4)c23)c5ccc(Cl)cc5)c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O06 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 1288735 MixCom3_000228 Cc1ccccc1C2CC(=O)Nc3cc(C)c(C)cc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O07 compound treatment 0.076 0.00314 0.37 0.372 1.0 1983478 MixCom3_000229 CCOCCCNC(=O)c1c[nH]c2ccc(cc2c1=O)S(=O)(=O)N3CCc4ccccc34 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O08 compound treatment 0.074 0.00114 0.14 0.135 1.0 1983479 MixCom3_000230 [O-][N+](=O)c1ccc(cc1)c2nc([nH]c2c3ccc(Oc4ccc(cc4)c5nc([nH]c5c6ccc(cc6)[N+](=O)[O-])c7cccc(c7)[N+](=O)[O-])cc3)c8cccc(c8)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O09 compound treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 1665434 MixCom3_000231 Brc1ccc2[nH]c(=S)n(Cc3ccccn3)c(=O)c2c1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O10 compound treatment 0.074 0.00114 0.14 0.135 1.0 1983480 MixCom3_000232 Ic1ccccc1[C@@H]2[C@H](N3[C@H](C=Cc4ccccc34)C2(C#N)C#N)C(=O)C5(CC6CC7CC(C6)C5)C7 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O11 compound treatment 0.073 1.4E-4 0.02 0.0165 1.0 1627468 MixCom3_000233 COc1cc(Nc2ncnc3n(cc(c4ccccc4)c23)c5cccc(Cl)c5)cc(OC)c1OC 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O12 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 1983481 MixCom3_000234 CCOCCn1cnc2sc(C(=O)N3CCCCC3C)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O13 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 1983482 MixCom3_000235 [O-][N+](=O)c1ccc(cc1)c2nc(c([nH]2)c3ccc(Oc4ccc(cc4)c5nc([nH]c5c6ccccc6)c7ccc(cc7)[N+](=O)[O-])cc3)c8ccccc8 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O14 compound treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 1225447 MixCom3_000236 CCOc1ccccc1NC(=O)c2c(NCc3cccnc3)sc4CCCCCc24 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O15 mock treatment 0.0745 0.00164 0.19 0.1943 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O16 mock treatment 0.0965 0.0236 2.8 2.8011 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O17 mock treatment 0.073 1.4E-4 0.02 0.0165 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O18 mock treatment 0.08 0.00714 0.85 0.846 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O19 mock treatment 0.077 0.00414 0.49 0.4905 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O20 mock treatment 0.0775 0.00464 0.55 0.5497 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O21 mock treatment 0.0765 0.00364 0.43 0.4312 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O22 mock treatment 0.0795 0.00664 0.79 0.7867 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O23 mock treatment 0.0825 0.00964 1.14 1.1422 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 O24 mock treatment 0.076 0.00314 0.37 0.372 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P01 compound treatment 0.0625 -0.0104 -1.23 -1.2276 -1.0 1319070 MixCom3_000237 CCn1cnc2sc(C(=O)N3CC(C)CC(C)C3)c(C)c2c1=O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P02 compound treatment 0.0585 -0.0144 -1.7 -1.7016 -1.0 1911143 MixCom3_000238 COc1cc(cc(OC)c1OC)C(=O)N2CCc3cc(OC)c(OC)cc3C2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P03 compound treatment 0.0845 0.0116 1.38 1.3792 1.0 1423863 MixCom3_000239 COc1ccc(cc1)C2Nc3ccc(Br)cc3C(O2)c4ccccc4 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P04 compound treatment 0.0665 -0.00636 -0.75 -0.7537 -1.0 1911144 MixCom3_000240 Cc1ccc(C)n1c2ccccc2CNS(=O)(=O)c3ccc(Cl)cc3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P05 compound treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 2074532 MixCom3_000241 CC1CCCN(C1)c2ccc(cc2)[N+](=O)[O-] 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P06 compound treatment 0.0735 6.4E-4 0.08 0.0758 1.0 1911145 MixCom3_000242 COc1ccc(CNC(=O)c2sccc2NC(=O)c3ccccc3)cc1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P07 compound treatment 0.0725 -3.6E-4 -0.04 -0.0427 -1.0 2074533 MixCom3_000243 [O-][N+](=O)c1ccc(cc1)N2CCc3ccccc23 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P08 compound treatment 0.079 0.00614 0.73 0.7275 1.0 2079848 MixCom3_000244 COCCNC(=O)C1CCCN(C1)C2CCN(Cc3ccccc3)CC2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P09 compound treatment 0.0805 0.00764 0.91 0.9052 1.0 1911146 MixCom3_000245 Cc1ccc(cc1)c2cn3c(ccc4c(cc(nc43)C(F)(F)F)C(F)(F)F)n2 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P10 compound treatment 0.078 0.00514 0.61 0.609 1.0 2079849 MixCom3_000246 OC(=O)C1CCCN(Cc2ccncc2)C1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P11 compound treatment 0.0805 0.00764 0.91 0.9052 1.0 1911147 MixCom3_000247 CN1CCN(CC1)c2ccc3nc(c4ccccc4)c(nc3c2)c5ccccc5 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P12 compound treatment 0.075 0.00214 0.25 0.2535 1.0 2079850 MixCom3_000248 O=C(C1CCCN(Cc2ccccn2)C1)N3CCN(Cc4ccccc4)CC3 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P13 compound treatment 0.073 1.4E-4 0.02 0.0165 1.0 1911148 MixCom3_000249 CCNC(=O)Nc1nnc(SCc2cccc(c2)C(F)(F)F)s1 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P14 compound treatment 0.115 0.0421 4.99 4.9931 1.0 2079851 MixCom3_000250 COC(=O)C1CCN(CC1)C2CCN(CC2)C(=O)COCC(=O)O 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P15 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P16 compound treatment 0.077 0.00414 0.49 0.4905 1.0 2074534 MixCom3_000251 COC(=O)c1sc(SC)c(C#N)c1N 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P17 mock treatment 0.075 0.00214 0.25 0.2535 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P18 mock treatment 0.067 -0.00586 -0.69 -0.6944 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P19 mock treatment 0.0825 0.00964 1.14 1.1422 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P20 mock treatment 0.0835 0.0106 1.26 1.2607 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P21 mock treatment 0.074 0.00114 0.14 0.135 1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P22 mock treatment 0.071 -0.00186 -0.22 -0.2204 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P23 mock treatment 0.072 -8.6E-4 -0.1 -0.102 -1.0 370.0886 user{AvgAbs(0h)}(370.0886) YeastViabilityCBS 370.0886.669 P24 mock treatment 0.063 -0.00986 -1.17 -1.1684 -1.0